Classification, Labelling and Packaging Regulation

texts differ too much for an inline diff; shown separately

before (32008R1272)

ANNEX I
CLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES
This annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.
1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND LABELLING
1.0. Definitions
Gas means a substance which:
(i) at 50 oC has a vapour pressure greater than 300 kPa (absolute); or
(ii) is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;
Liquid means a substance or mixture which:
(i) at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);
(ii) is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and
(iii) which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;
Solid means a substance or mixture which does not meet the definitions of liquid or gas.
1.1. Classification of substances and mixtures
1.1.0. Cooperation to meet the requirements in this Regulation
Suppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.
Suppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.
Suppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.
The network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.
1.1.1. The role and application of expert judgement and weight of evidence determination
1.1.1.1. Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.
1.1.1.2. The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.
1.1.1.3. A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.
1.1.1.4. For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.
1.1.1.5. For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.
1.1.2. Specific concentration limits, M-factors and generic cut-off values
1.1.2.1. Specific concentration limits or M-factors shall be applied in accordance with Article 10.
1.1.2.2. Cut-off values
1.1.2.2.1. Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).
1.1.2.2.2. The cut-off values referred to in Article 11 shall be the following:
(a) For health and environmental hazards in Parts 3, 4 and 5 of this Annex:
(i) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or
(ii) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or
(iii) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or
(iv) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.
(b) For aquatic environmental hazards in section 4.1 of this Annex:
(i) for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or
(ii) for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.
Table 1.1
Generic cut-off values
Or < 1 % where relevant, see 3.2.3.3.1.Or < 1 % where relevant, see 3.3.3.3.1.Or < 0,1 % where relevant, see 4.1.3.1.
Hazard class Generic cut-off values to be taken into account
Acute Toxicity: Category 1-3 0,1 %
Category 4 1 %
Skin corrosion/Irritation 1 %
Serious damage to eyes/eye irritation 1 %
Hazardous to Aquatic Environment Acute Category 1 0,1 %
Chronic Category 1 0,1 %
Chronic Category 2-4 1 %
Note
Generic cut-off values are in weight percentages except for gaseous mixtures where they are in volume percentage.
1.1.3. Bridging principles for the classification of mixtures where test data are not available for the complete mixture
Where the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.
1.1.3.1. Dilution
If a mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:
the new mixture shall be classified as equivalent to the original mixture;
the method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;
in the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).
1.1.3.2. Batching
The hazard category of one production batch of a mixture can be assumed to be substantially equivalent to that of another production batch of the same commercial product, and produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the batch has changed. If the latter occurs, a new evaluation is necessary.
1.1.3.3. Concentration of highly hazardous mixtures
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a mixture is classified in the highest hazard category or sub-category, and the concentration of the ingredients of the mixture that are in that category or sub-category is increased, the new mixture shall be classified in that category or sub-category without additional testing.
1.1.3.4. Interpolation within one toxicity category
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures with identical hazardous ingredients, where mixtures A and B are in the same hazard category and mixture C has the same active hazardous ingredients with concentrations intermediate to the concentrations of those hazardous ingredients in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.
1.1.3.5. Substantially similar mixtures
Given the following:
(a) two mixtures each containing two ingredients:
(i) A + B
(ii) C + B;
(b) the concentration of ingredient B is essentially the same in both mixtures;
(c) the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);
(d) hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.
If mixture (i) is already classified in a particular hazard class based on test data, mixture (ii) shall be assigned the same hazard category.
1.1.3.6. Review of classification where the composition of a mixture has changed
The following variations in initial concentration are defined for the application of Article 15(2)(a):
Table 1.2
Bridging Principle for changes in the composition of a mixture
Initial concentration range of the constituent Permitted variation in initial concentration of the constituent
≤ 2,5 % ± 30 %
2,5 < C ≤  10 % ± 20 %
10 < C ≤  25 % ± 10 %
25 < C ≤  100 % ± 5 %
1.1.3.7. Aerosols
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.
1.2. Labelling
1.2.1. Dimensions and make-up of the label elements
1.2.1.1. Hazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.
1.2.1.2. Hazard pictograms shall be in the shape of a square set at a point. Each hazard pictogram shall cover at least one fifteenth of the surface area of the harmonised label but the minimum area shall not be less than 1 cm2.
1.2.1.3. The dimensions of the label shall be as follows:
Table 1.3
Dimension of labels
Capacity of the package Dimensions (in millimetres)
Not exceeding 3 litres: If possible, at least 52 × 74
Greater than 3 litres but, not exceeding 50 litres: At least 74 × 105
Greater than 50 litres but not exceeding 500 litres: At least 105 × 148
Greater than 500 litres: At least 148 × 210
1.3. Derogations from labelling requirements for special cases
In accordance with Article 23 the following derogations shall apply:
1.3.1. Transportable gas cylinders
For transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:
(a) A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to Gas cylinders — Precautionary labels. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.
(b) The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.
1.3.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)
1.3.2.1. If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.
1.3.2.2. No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).
1.3.2.3. For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.
1.3.3. Aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard
With regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.
1.3.4. Metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers
1.3.4.1. Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.
1.3.4.2. Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.
1.3.5. Explosives placed on the market with a view to obtaining an explosive or pyrotechnic effect
Explosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.
1.4. Request for use of an alternative chemical name
1.4.1. Requests for use of an alternative chemical name under Article 24 may be granted only where
(I) the substance has not been assigned a Community workplace exposure limit; and
(II) the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and
(III) the substance is classified exclusively as one or more of the following hazard categories:
(a) any of the hazard categories referred to in Part 2 of this Annex;
(b) Acute toxicity, Category 4;
(c) Skin corrosion/irritation, Category 2;
(d) Serious eye damage/eye irritation, Category 2;
(e) Specific target organ toxicity — Single exposure, Category 2 or 3;
(f) Specific target organ toxicity — Repeated exposure, Category 2;
(g) Hazardous to the aquatic environment — Chronic, Category 3 or 4.
1.4.2. The choice of the chemical name(s) for mixtures intended for the fragrance or perfume industry
In the case of substances occurring in nature, a chemical name or chemical names of the type essential oil of … or extract of … may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).
1.5. Exemptions from labelling and packaging requirements
1.5.1. Exemptions from Article 31 [(Article 29(1))]
1.5.1.1. Where Article 29(1) applies, the label elements mentioned in Article 17 may be provided in one of the following ways:
(a) in fold-out labels; or
(b) on tie-on tags; or
(c) on an outer packaging.
1.5.1.2. The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.
1.5.2. Exemptions from Article 17 [(Article 29(2)]
1.5.2.1. Labelling of packages where the contents do not exceed 125 ml
1.5.2.1.1. The hazard statements and the precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:
(a) the contents of the package do not exceed 125 ml; and
(b) the substance or mixture is classified in one or more of the following hazard categories:
1) Oxidising gases of category 1;
2) Gases under pressure;
3) Flammable liquids of category 2 or 3;
4) Flammable solids of category 1 or 2;
5) Self-reactive substances or mixtures Types C to F;
6) Self-heating substances or mixtures of category 2;
7) Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;
8) Oxidising liquids of category 2 or 3;
9) Oxidising solids of category 2 or 3;
10) Organic peroxides Types C to F;
11) Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;
12) Skin irritation of category 2;
13) Eye irritation of category 2;
14) Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;
15) Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;
16) Hazardous to the aquatic environment — Acute of category 1;
17) Hazardous to the aquatic environment — Chronic of category 1 or 2.
The exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.
1.5.2.1.2. The precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:
(a) the contents of the package do not exceed 125 ml; and
(b) the substance or mixture is classified in one or more of the following hazard categories:
1) Flammable gases of category 2;
2) Reproductive toxicity: effects on or via lactation;
3) Hazardous to the aquatic environment — Chronic of category 3 or 4.
1.5.2.1.3. The pictogram, the hazard statement and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:
(a) the contents of the package do not exceed 125 ml; and
(b) the substance or mixture is classified in one or more of the following hazard categories:
1) Corrosive to metals.
1.5.2.2. Labelling of soluble packaging for single use
The label elements required by Article 17 may be omitted from soluble packaging intended for single use where:
(a) The content of each soluble packaging does not exceed a volume of 25 ml;
(b) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b); and
(c) The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.
1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.
2. PART 2: PHYSICAL HAZARDS
2.1. Explosives
2.1.1. Definitions
2.1.1.1. The class of explosives comprises
(a) explosive substances and mixtures;
(b) explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and
(c) substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.
2.1.1.2. For the purposes of this Regulation the following definitions shall apply:
An explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.
A pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.
An unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.
An explosive article is an article containing one or more explosive substances or mixtures.
A pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.
An intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.
2.1.2. Classification criteria
2.1.2.1. Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.
2.1.2.2. Substances, mixtures and articles of this class, which are not classified as an unstable explosive, shall be assigned to one of the following six divisions depending on the type of hazard they present:
(a) Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);
(b) Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;
(c) Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:
(i) combustion of which gives rise to considerable radiant heat; or
(ii) which burn one after another, producing minor blast or projection effects or both;
(d) Division 1.4 Substances, mixtures and articles which present no significant hazard:
substances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;
(e) Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:
substances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;
(f) Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:
articles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.
2.1.2.3. Explosives, which are not classified as an unstable explosive, shall be classified in one of the six divisions referred to in paragraph 2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to the results of the tests laid down in Table 2.1.1:
Table 2.1.1
Criteria for explosives
This comprises substances, mixtures and articles which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.
Category Criteria
Unstable explosives or explosives of Divisions 1.1 to 1.6 For explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:
Explosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives shall not be subject to UN Test Series 2.
Sensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Thermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Further tests are necessary to allocate the correct Division.
2.1.2.4. If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.
2.1.3. Hazard Communication
Label elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.
NOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:
(a) the pictogram: exploding bomb;
(b) the signal word: Danger; and
(c) the hazard statement: explosive; mass explosion hazard
unless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.
Table 2.1.2
Label elements for explosives
Classification Unstable Explosive Division 1.1 Division 1.2 Division 1.3 Division 1.4 Division 1.5 Division 1.6
GHS Pictograms Signal Word Danger Danger Danger Danger Warning Danger No signal word
Hazard Statement H200: Unstable Explosive H201: Explosive; mass explosion hazard H202: Explosive; severe projection hazard H203: Explosive; fire, blast or projection hazard H204: Fire or projection hazard H205: May mass explode in fire No hazard statement
Precautionary Statement
Prevention P201
P202
P281 P210
P230
P240
P250
P280 P210
P230
P240
P250
P280 P210
P230
P240
P250
P280 P210
P240
P250
P280 P210
P230
P240
P250
P280 No precautionary statement
Precautionary Statement
Response P372
P373
P380 P370+P380
P372
P373 P370+P380
P372
P373 P370+P380
P372
P373 P370+P380
P372
P373 P370+P380
P372
P373 No precautionary statement
Precautionary Statement
Storage P401 P401 P401 P401 P401 P401 No precautionary statement
Precautionary Statement
Disposal P501 P501 P501 P501 P501 P501 No precautionary statement
2.1.4. Additional Classification Considerations
2.1.4.1. The classification of substances, mixtures and articles in the explosives hazard class and further allocation to a division is a very complex, three step procedure. Reference to Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria is necessary.
The first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE) is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.
Explosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).
Certain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.
The classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).
Figure 2.1.1
Overall scheme of the procedure for classifying a substance, mixture or article in the class of explosives (Class 1 for transport)
SUBSTANCE, MIXTURE OR ARTICLE FOR CLASSIFICATION
ACCEPTANCE PROCEDURE
CLASSIFY as an UNSTABLE EXPLOSIVE
REJECT Not an EXPLOSIVE
CLASSIFY AS AN EXPLOSIVE
HAZARDOUS DIVISION ASSIGNMENT
COMPATIBILITY GROUP ASSIGNMENT
DIVISION 1.1, 1.2, 1.3, 1.4, 1.5, OR 1.6 COMPATIBILITY GROUP A, B, C, D, E, F, G, H, J, K, L, N or S (*)
CLASSIFICATION CODE (*)
(*) see UN Recommendations on the Transport of Dangerous Goods, Model Regulations, 15th rev. ed, sub-section 2.1.2.
Figure 2.1.2
Procedure for provisional acceptance of a substance, mixture or article in the class of explosives (Class 1 for transport)
SUBSTANCE/MIXTURE FOR CLASSIFICATION
ARTICLE FOR CLASSIFICATION
Is the substance/ mixture manufactured with a view to producing a practical explosive or pyrotechnic effect
Yes
Substance/mixture to be considered for this Class
No
TEST SERIES 3
Is the substance/ mixture a candidate for ammonium nitrate emulsion suspension or gel, intermediate for blasting explosive ANE?
Is the substance/mixture thermally stable?
Yes
No
No
Yes
TEST SERIES 8 Go to figure 2.1.4
TEST SERIES 1 (*)
Is the substance/mixture too dangerous in the form in which it was tested?
No
Yes
No
Is it an explosive substance/mixture?
Encapsulate and/or package the substance/mixture
Yes
TEST SERIES 2
TEST SERIES 4
Yes
Is the substance/mixture too insensitive for acceptance into this Class?
No
Is the article, packed article or packaged substance/mixture too dangerous?
No
Yes
NOT AN EXPLOSIVE
CLASSIFY as an Unstable Explosive
PROVISIONALLY ACCEPT INTO THIS CLASS (go to figure 2.1.3)
(*) For classification purposes, start with Test Series 2.
Figure 2.1.3
Procedure for assignment to a division in the class of explosives (Class 1 for transport)
ARTICLE OR SUBSTANCE/MIXTURE PROVISIONALLY ACCEPTED IN THIS CLASS (from figure 2.1.2)
Is the article a candidate for Division 1.6?
No
Is the substance/mixture a candidate for Division 1.5?
No
Package the substance/ mixture
TEST SERIES 6
Yes
TEST SERIES 7
Yes
Is the result a mass explosion?
Yes
Is it an extremely insensitive article?
No
TEST SERIES 5
No
No
Yes
Yes
Is it a very insensitive explosive substance/mixture with a mass explosion hazard?
Is the major hazard that from dangerous projections?
Yes
No
No
Is the major hazard radiant heat and/or violent burning but with no dangerous blast or projection hazard?
No
Is there a small hazard in the event of ignition or initiation?
Yes
No
Is the substance/ mixture or article manufactured with the view to producing a practical explosive or pyrotechnic effect?
Yes
Yes
No
Would the hazard hinder fire-fighting in the immediate vicinity?
Yes
Is the product an article excluded by definition?
Yes
No
NOT AN EXPLOSIVE
DIVISION 1.6
DIVISION 1.5
DIVISION 1.4 Compatibility group S
DIVISION 1.4 Compatibility groups other than S
DIVISION 1.3
DIVISION 1.2
DIVISION 1.1
Figure 2.1.4
Procedure for classification of ammonium nitrate emulsions, suspensions or gels
TEST SERIES 8
TEST 8 (a) Thermal Stability Test Is the substance/mixture Thermally stable ?
No
Classify as unstable explosive
Yes
TEST 8 (b) ANE Large Scale Gap Test Is the substance/mixture too sensitive to shock to be accepted as an oxidising liquid or an oxidising solid ?
Yes
Substance/mixture to be considered for classification as an explosive other than as an unstable explosive; If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘no’, the substance/mixture shall be classified in Division 1.1
No
TEST 8 (c) Koenen Test Is the substance/mixture too sensitive to the effect of heating under confinement?
Yes
Substance/mixture to be considered for classification as an explosive of Division 1.5, proceed with Test Series 5. If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘yes’, the substance/mixture shall be classified in Division 1.5, if the answer is ‘no’ the substance shall be classified in Division 1.1
No
Substance/mixture accepted for classification as an oxidizing liquid or an oxidising solid as an ammonium nitrate emulsion, suspension orgel, intermediate for blasting explosives (ANE); (Sections 2.13 or 2.14)
2.1.4.2. Screening procedure
Explosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.
Note
Neither a Series 1 type (a) propagation of detonation test nor a Series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g.
2.1.4.3. A substance or mixture shall not be classified as explosive if:
(a) There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or
(b) The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;
The oxygen balance is calculated for the chemical reaction:
CxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O
Using the formula:
Oxygen balance = -1600 [2x + (y/2)-z]/molecular weight;
(c) When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or
(d) For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:
less than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;
less than 30 % by mass, if the oxidising substance is assigned to Category 3.
2.1.4.4. In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.
2.2. Flammable gases
2.2.1. Definition
Flammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.
2.2.2. Classification criteria
2.2.2.1. A flammable gas shall be classified in this class in accordance with Table 2.2.1:
Table 2.2.1
Criteria for flammable gases
Category Criteria
1 Gases, which at 20 oC and a standard pressure of 101,3 kPa:
(a) are ignitable when in a mixture of 13 % or less by volume in air; or
(b) have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.
2 Gases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.
Note
For the classification of aerosols, see 2.3.
2.2.3. Hazard Communication
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.
Table 2.2.2
Label elements for flammable gases
Classification Category 1 Category 2
GHS Pictogram No pictogram
Signal Word Danger Warning
Hazard Statement H220: Extremely flammable gas H221: Flammable gas
Precautionary Statement
Prevention P210 P210
Precautionary Statement
Response P377
P381 P377
P381
Precautionary Statement
Storage P403 P403
Precautionary Statement
Disposal 2.2.4. Additional Classification Considerations
2.2.4.1. Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.
2.3. Flammable aerosols
2.3.1. Definitions
Aerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.
2.3.2. Classification criteria
2.3.2.1. Aerosols shall be considered for classification as flammable in accordance with 2.3.2.2 if they contain any component which is classified as flammable according to the criteria contained in this Part, i.e.:
Liquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;
Flammable gases (see 2.2);
Flammable solids (see 2.7).
Note
Flammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.
2.3.2.2. A flammable aerosol shall be classified in one of the two categories for this Class on the basis of its components, of its chemical heat of combustion and, if applicable, of the results of the foam test (for foam aerosols) and of the ignition distance test and enclosed space test (for spray aerosols) in accordance with Figure 2.3.1 and the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-sections 31.4, 31.5 and 31.6.
Figure 2.3.1
Figure 2.3.1(a) for flammable aerosols
AEROSOL
Does it contain ≤ 1% flammable components and does it have a heat of combustion < 20 kJ/g?
YES
NOT CLASSIFIED
NO
Does it contain ≥ 85% flammable components and does it have a heat of combustion ≥ 30 kJ/g?
YES
Category 1
NO
Danger
For spray aerosols, go to decision logic 2.3.1 (b);
For foam aerosols, got to decision logic 2.3.1 (c).
Figure 2.3.1(b) for spray aerosols
SPRAY AEROSOL
In the ignition distance test, does ignition occur at a distance ≥ 75 cm?
YES
Category 1
NO
Does it have a heat of combustion < 20 kJ/g?
NO
Category 2
YES
In the ignition distance test, does ignition occur at a distance ≥ 15 cm?
YES
Category 2
NO
In the enclosed space ignition test; is:
a) the time equivalent ≤ 300 s/m3 or
b) the deflagration density ≤ 300 g/m3?
YES
Category 2
NO
NOT CLASSIFIED
Danger
Warning
Warning
Warning
Figure 2.3.1(c) for foam aerosols
FOAM AEROSOL
In the foam test, is: a) the flame height ≥ 20 cm and the flame duration ≥ 2 s; or b) the flame height ≥ 4 cm and the flame duration ≥ 7 s?
YES
Category 1
NO
In the foam test; is the flame height ≥ 4 cm and the flame duration ≥ 2 s?
YES
Category 2
NO
NOT CLASSIFIED
Danger
Warning
2.3.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.
Table 2.3.2
Label elements for flammable aerosols
Classification Category 1 Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H222: Extremely flammable aerosol H223: Flammable aerosol
Precautionary Statement
Prevention P210
P211
P251 P210
P211
P251
Precautionary Statement
Response Precautionary Statement
Storage P410 + P412 P410 + P412
Precautionary Statement
Disposal 2.3.4. Additional Classification Considerations
2.3.4.1. The chemical heat of combustion (ΔHc), in kilojoules per gram (kJ/g), is the product of the theoretical heat of combustion (ΔHcomb), and a combustion efficiency, usually less than 1,0 (a typical combustion efficiency is 0,95 or 95 %).
For a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:
ΔHc (product)=Σniwi % × ΔHc(i)
where:
ΔHc
chemical heat of combustion (kJ/g);
wi %
mass fraction of component i in the product;
ΔHc(i)
specific heat of combustion (kJ/g)of component i in the product.
The chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).
2.4. Oxidising gases
2.4.1. Definitions
Oxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.
2.4.2. Classification criteria
2.4.2.1. An oxidising gas shall be classified in a single category for this class in accordance with Table 2.4.1.:
Table 2.4.1
Criteria for oxidising gases
Category Criteria
1 Any gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.
Note
Gases which cause or contribute to the combustion of other material more than air means pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.
2.4.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.
Table 2.4.2
Label elements for oxidising gases
Classification Category 1
GHS Pictogram Signal Word Danger
Hazard Statement H270: May cause or intensify fire; oxidiser
Precautionary Statement
Prevention P220
P244
Precautionary Statement
Response P370 + P376
Precautionary Statement
Storage P403
Precautionary Statement
Disposal 2.4.4. Additional Classification Considerations
To classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.
2.5. Gases under pressure
2.5.1. Definition
2.5.1.1. Gases under pressure are gases which are contained in a receptacle at a pressure of 200 kPa (gauge) or more, or which are liquefied or liquefied and refrigerated.
They comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.
2.5.1.2. The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.
2.5.2. Classification criteria
Gases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:
Table 2.5.1
Criteria for gases under pressure
Group Criteria
Compressed gas A gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.
Liquefied gas A gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:
(i) high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and
(ii) low pressure liquefied gas: a gas with a critical temperature above + 65 oC.
Refrigerated liquefied gas A gas which when packaged is made partially liquid because of its low temperature.
Dissolved gas A gas which when packaged under pressure is dissolved in a liquid phase solvent.
2.5.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.
Table 2.5.2
Label elements for gases under pressure
Classification Compressed gas Liquefied gas Refrigerated liquefied gas Dissolved gas
GHS Pictograms Signal Word Warning Warning Warning Warning
Hazard Statement H280: Contains gas under pressure; may explode if heated H280: Contains gas under pressure; may explode if heated H281: Contains refrigerated gas; may cause cryogenic burns or injury H280: Contains gas under pressure; may explode if heated
Precautionary Statement
Prevention P282 Precautionary Statement
Response P336
P315 Precautionary Statement
Storage P410 + P403 P410 + P403 P403 P410 + P403
Precautionary Statement
Disposal 2.5.4. Additional Classification Considerations
For this group of gases, the following information is required to be known:
the vapour pressure at 50 oC;
the physical state at 20 oC at standard ambient pressure;
the critical temperature.
Data can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.
2.6. Flammable liquids
2.6.1. Definition
Flammable liquid means a liquid having a flash point of not more than 60 oC.
2.6.2. Classification criteria
2.6.2.1. A flammable liquid shall be classified in one of the three categories for this class in accordance with Table 2.6.1:
Table 2.6.1
Criteria for flammable liquids
For the purpose of this Regulation gas oils, diesel and light heating oils having a flash point between ≥ 55 oC and ≤ 75 oC may be regarded as Category 3.
Category Criteria
1 Flash point < 23 oC and initial boiling point ≤ 35 oC
2 Flash point < 23 oC and initial boiling point > 35 oC
3 Flash point ≥ 23 oC and ≤ 60 oC
2.6.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.
Table 2.6.2
Label elements for flammable liquids
Classification Category 1 Category 2 Category 3
GHS Pictograms Signal Word Danger Danger Warning
Hazard Statement H224: Extremely flammable liquid and vapour H225: Highly flammable liquid and vapour H226: Flammable liquid and vapour
Precautionary Statement
Prevention P210
P233
P240
P241
P242
P243
P280 P210
P233
P240
P241
P242
P243
P280 P210
P233
P240
P241
P242
P243
P280
Precautionary Statement
Response P303 + P361 + P353
P370 + P378 P303 + P361 + P353
P370 + P378 P303 + P361 + P353
P370 + P378
Precautionary Statement
Storage P403 + P235 P403 + P235 P403 + P235
Precautionary Statement
Disposal P501 P501 P501
2.6.4. Additional Classification Considerations
2.6.4.1. For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.
2.6.4.2. In the case of mixturesTo date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates. containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 oCIf the calculated flash point is less than 5 oC greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally. greater than the relevant classification criterion and provided that:
(a) the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);
(b) the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit;
(c) the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;
(d) the liquid phase is homogeneous.
2.6.4.3. One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.
2.6.4.4. Possible test methods for determining the flash point of flammable liquids are listed in Table 2.6.3.
Table 2.6.3
Methods for determining the flash point of flammable liquids
European standards: EN ISO 1516 as amended
Determination of flash/no flash — Closed cup equilibrium method
EN ISO 1523 as amended
Determination of flash point — Closed cup equilibrium method
EN ISO 2719 as amended
Determination of flash point — Pensky-Martens closed cup method
EN ISO 3679 as amended
Determination of flash point — Rapid equilibrium closed cup method
EN ISO 3680 as amended
Determination of flash/no flash — Rapid equilibrium closed cup method
EN ISO 13736 as amended
Petroleum products and other liquids — Determination of flash point — Abel closed cup method
National standards:
Association française de normalisation, AFNOR: NF M07-036 as amended
Détermination du point d'éclair — Vase clos Abel-Pensky
(identical to DIN 51755)
British Standards Institute, BS 2000 Part 170 as amended
(identical to EN ISO 13736)
Deutsches Institut für Normung DIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky
(identical to NF M07-036)
2.6.4.5. Liquids with a flash point of more than 35 oC need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.
2.7. Flammable solids
2.7.1. Definition
2.7.1.1. A flammable solid means a solid which is readily combustible, or may cause or contribute to fire through friction.
Readily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.
2.7.2. Classification criteria
2.7.2.1. Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.
2.7.2.2. Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.
2.7.2.3. A flammable solid shall be classified in one of the two categories for this class using Method N.1 as described in 33.2.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.7.1:
Table 2.7.1
Criteria for flammable solids
Category Criteria
1 Burning rate test
Substances and mixtures other than metal powders:
(a) wetted zone does not stop fire and
(b) burning time < 45 seconds or burning rate > 2,2 mm/s
Metal powders
burning time ≤ 5 minutes
2 Burning rate test
Substances and mixtures other than metal powders:
(a) wetted zone stops the fire for at least 4 minutes and
(b) burning time < 45 seconds or burning rate > 2,2 mm/s
Metal powders
burning time > 5 minutes and ≤ 10 minutes
Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.
2.7.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.
Table 2.7.2
Label elements for flammable solids
Classification Category 1 Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H228: Flammable Solid H228: Flammable Solid
Precautionary Statement
Prevention P210
P240
P241
P280 P210
P240
P241
P280
Precautionary Statement
Response P370 + P378 P370 + P378
Precautionary Statement
Storage Precautionary Statement
Disposal 2.8. Self-reactive substances and mixtures
2.8.1. Definition
2.8.1.1. Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.
2.8.1.2. A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.
2.8.2. Classification criteria
2.8.2.1. Any self-reactive substance or mixture shall be considered for classification in this class as a self-reactive substance or mixture unless:
(a) they are explosives, according to the criteria given in 2.1;
(b) they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;
(c) they are organic peroxides, according to the criteria given in 2.15;
(d) their heat of decomposition is less than 300 J/g; or
(e) their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3..
2.8.2.2. Mixtures of oxidising substances, meeting the criteria for classification as oxidising substances, which contain 5 % or more of combustible organic substances and which do not meet the criteria mentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjected to the self-reactive substances classification procedure;
Such a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
2.8.2.3. Self-reactive substances and mixtures shall be classified in one of the seven categories of types A to G for this class, according to the following principles:
(a) any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;
(b) any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;
(c) any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;
(d) any self-reactive substance or mixture which in laboratory testing:
(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or
(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or
(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as self-reactive substance TYPE D;
(e) any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;
(f) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;
(g) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
2.8.2.4. Criteria for temperature control
Self-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.
2.8.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.
Table 2.8.1
Label elements for self-reactive substances and mixtures
Classification Type A Type B Type C & D Type E & F Type G
GHS Pictograms There are no label elements allocated to this hazard category
Signal Word Danger Danger Danger Warning
Hazard Statement H240: Heating may cause an explosion H241: Heating may cause a fire or explosion H242: Heating may cause a fire H242: Heating may cause a fire
Precautionary Statement
Prevention P210
P220
P234
P280 P210
P220
P234
P280 P210
P220
P234
P280 P210
P220
P234
P280
Precautionary Statement
Response P370 + P378
P370 + P380 + P375 P370 + P378
P370 + P380 + P375 P370 + P378 P370 + P378 Precautionary Statement
Storage P403 + P235
P411
P420 P403 + P235
P411
P420 P403 + P235
P411
P420 P403 + P235 P411
P420 Precautionary Statement
Disposal P501 P501 P501 P501 Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.
2.8.4. Additional Classification Considerations
2.8.4.1. The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.
2.8.4.2. The classification procedures for self-reactive substances and mixtures need not be applied if:
(a) There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or
(b) For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Figure 2.8.1
Self-reactive substances and mixtures
SUBSTANCE/MIXTURE
Box 1
Test A
Box 2
Test B
1.1 Yes
Does it propogate a detonation?
1.3 No
2.1 Yes
Can it detonate as packaged?
2.2 No
1.2 Partial
Box 3
Test C
Can it propogate a deflagration?
3.1 Yes, rapidly
Box 4
Test C
Can it propogate a deflagration?
4.1 Yes, rapidly
3.2 Yes, slowly
3.3 No
Box 5
Test C
Can it propogate a deflagration?
5.1 Yes, rapidly
4.2 Yes, slowly
4.3 No
Box 6
Test D
5.3 No
5.2 Yes,
slowly
6.2 No
Does it deflagrate rapidly in package?
6.1 Yes
Box 7
Test E
What is the effect of heating under confinement?
7.1 Violent
Box 8
Test E
What is the effect of heating under confinement?
8.1 Violent
7.2 Medium
7.3 Low
7.4 No
Box 9
Test E
What is the effect of heating under confinement?
Box 10
Test G
8.2 Medium
8.3 Low
8.4 No
9.3 Low
9.4 No
Box 11
10.2 No
Can it explode as packaged?
10.1 Yes
Packaged in packages of more than 400 kg/450 l or to be considered for exemption?
11.1 Yes
Box F
Test F
What is its explosive power?
12.3 None
Box 13
Test E
12.1 No low
12.2 Low
What is effect of heating it under defined confinement?
11.2 No
13.1 Low
13.2 None
TYPE A
TYPE B
TYPE C
TYPE D
TYPE E
TYPE F
TYPE G
9.1 violent
9.2 Medium
2.9. Pyrophoric liquids
2.9.1. Definition
Pyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.
2.9.2. Classification criteria
2.9.2.1. A pyrophoric liquid shall be classified in a single category for this class using test N.3 in Part III, sub-section 33.3.1.5 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to Table 2.9.1:
Table 2.9.1
Criteria for pyrophoric liquids
Category Criteria
1 The liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min.
2.9.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.
Table 2.9.2
Label elements for pyrophoric liquids
Classification Category 1
GHS Pictogram Signal Word Danger
Hazard Statement H250: Catches fire spontaneously if exposed to air
Precautionary Statement
Prevention P210
P222
P280
Precautionary Statement
Response P302 + P334
P370 + P378
Precautionary Statement
Storage P422
Precautionary Statement
Disposal 2.9.4. Additional Classification Considerations
2.9.4.1. The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).
2.10. Pyrophoric solids
2.10.1. Definition
Pyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.
2.10.2. Classification criteria
2.10.2.1. A pyrophoric solid shall be classified in a single category for this class using test N.2 in Part III, sub-section 33.3.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.10.1:
Table 2.10.1
Criteria for pyrophoric solids
Category Criteria
1 The solid ignites within 5 minutes of coming into contact with air.
Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.
2.10.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.
Table 2.10.2
Label elements for pyrophoric solids
Classification Category 1
GHS Pictogram Signal Word Danger
Hazard Statement H250: Catches fire spontaneously if exposed to air
Precautionary Statement
Prevention P210
P222
P280
Precautionary Statement
Response P335 + P334
P370 +P378
Precautionary Statement
Storage P422
Precautionary Statement
Disposal 2.10.4. Additional Classification Considerations
2.10.4.1. The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).
2.11. Self-heating substances and mixtures
2.11.1. Definition
2.11.1.1. A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).
2.11.1.2. Self-heating of substances or mixtures, leading to spontaneous combustion, is caused by reaction of the substance or mixture with oxygen (in the air) and the heat developed not being conducted away rapidly enough to the surroundings. Spontaneous combustion occurs when the rate of heat production exceeds the rate of heat loss and the auto-ignition temperature is reached.
2.11.2. Classification criteria
2.11.2.1. A substance or mixture shall be classified as a self-heating substance or mixture of this class, if in the tests performed in accordance with the test method given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-section 33.3.1.6:
(a) a positive result is obtained using a 25 mm cube sample at 140 oC;
(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;
(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;
(d) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.
2.11.2.2. A self-heating substance or mixture shall be classified in one of the two categories for this class if, in a test performed in accordance with test method N.4 in Part III, sub-section 33.3.1.6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, the result meets the criteria according to Table 2.11.1:
Table 2.11.1
Criteria for self-heating substances and mixtures
Category Criteria
1 A positive result is obtained in a test using a 25 mm sample cube at 140 oC
2 (a) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or
(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or
(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.
Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.
2.11.2.3. Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.
2.11.2.4. Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.
2.11.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.
Table 2.11.2
Label elements for self-heating substances and mixtures
Classification Category 1 Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H251: Self-heating; may catch fire H252: Self-heating in large quantities; may catch fire
Precautionary Statement
Prevention P235 + P410
P280 P235 + P410
P280
Precautionary Statement
Response Precautionary Statement
Storage P407
P413
P420 P407
P413
P420
Precautionary Statement
Disposal 2.11.4. Additional Classification Considerations
2.11.4.1. For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.
2.11.4.2. The classification procedure for self-heating substances or mixtures need not be applied if the results of a screening test can be adequately correlated with the classification test and an appropriate safety margin is applied. Examples of screening tests are:
(a) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;
(b) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.
Figure 2.11.1.
Self-heating substances and mixtures
SUBSTANCE/MIXTURE
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 140°C?
NO
NOT CLASSIFIED
YES
Does it undergo dangerous self-heating when tested in a 25 mm sample cube at 140°C?
YES
Category 1
Danger
NO
Is it packaged in more than 3 m3?
YES
Category 2
Warning
NO
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 120°C?
NO
NOT CLASSIFIED
YES
Is it packaged in more than 450 litres volume?
YES
Category 2
Warning
NO
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 100°C?
YES
Category 2
Warning
NO
NOT CLASSIFIED
2.12. Substances and mixtures which in contact with water emit flammable gases
2.12.1. Definition
Substances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.
2.12.2. Classification criteria
2.12.2.1. A substance or mixture which, in contact with water, emits flammable gases shall be classified in one of the three categories for this class, using test N.5 in Part III, sub-section 33.4.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.12.1:
Table 2.12.1
Criteria for substances or mixtures which in contact with water emit flammable gases
Category Criteria
1 Any substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.
2 Any substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.
3 Any substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.
Note:
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form.
2.12.2.2. A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.
2.12.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.
Table 2.12.2
Label elements for substances or mixtures which in contact with water emit flammable gases
Classification Category 1 Category 2 Category 3
GHS Pictograms Signal Word Danger Danger Warning
Hazard Statement H260: In contact with water releases flammable gases which may ignite spontaneously H261: In contact with water releases flammable gases H261: In contact with water releases flammable gases
Precautionary Statement
Prevention P223
P231 + P232
P280 P223
P231 + P232
P280 P231 + P232
P280
Precautionary Statement
Response P335 + P334
P370 + P378 P335 + P334
P370 + P378 P370 + P378
Precautionary Statement
Storage P402 + P404 P402 + P404 P402 + P404
Precautionary Statement
Disposal P501 P501 P501
2.12.4. Additional Classification Considerations
2.12.4.1. The classification procedure for this class need not be applied if:
(a) the chemical structure of the substance or mixture does not contain metals or metalloids; or
(b) experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or
(c) the substance or mixture is known to be soluble in water to form a stable mixture.
2.13. Oxidising liquids
2.13.1. Definition
Oxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.
2.13.2. Classification criteria
2.13.2.1. An oxidising liquid shall be classified in one of the three categories for this class using test O.2 in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.13.1:
Table 2.13.1
Criteria for oxidising liquids
Category Criteria
1 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.
2 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.
3 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met.
2.13.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.
Table 2.13.2
Label elements for oxidising liquids
Classification Category 1 Category 2 Category 3
GHS Pictograms Signal Word Danger Danger Warning
Hazard Statement H271:May cause fire or explosion; strong oxidiser H272: May intensify fire; oxidiser H272: May intensify fire; oxidiser
Precautionary Statement
Prevention P210
P220
P221
P280
P283 P210
P220
P221
P280 P210
P220
P221
P280
Precautionary Statement
Response P306 + P360
P371 + P380 + P375
P370 + P378 P370 + P378 P370 + P378
Precautionary Statement
Storage Precautionary Statement
Disposal P501 P501 P501
2.13.4. Additional Classification Considerations
2.13.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:
(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or
(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
2.13.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
2.13.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.
2.13.4.4. In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.
2.14. Oxidising solids
2.14.1. Definition
Oxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.
2.14.2. Classification criteria
2.14.2.1. An oxidising solid shall be classified in one of the three categories for this class using test O.1 in Part III, sub-section 34.4.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.14.1:
Table 2.14.1
Criteria for oxidising solids
Category Criteria
1 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.
2 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.
3 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.
Note 1
Some oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the Resistance to detonation test (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.
Note 2
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.
2.14.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.
Table 2.14.2
Label elements for oxidising solids
Category 1 Category 2 Category 3
GHS Pictograms Signal Word Danger Danger Warning
Hazard Statement H271: May cause fire or explosion; strong oxidiser H272: May intensify fire; oxidiser H272: May intensify fire; oxidiser
Precautionary Statement
Prevention P210
P220
P221
P280
P283 P210
P220
P221
P280 P210
P220
P221
P280
Precautionary Statement
Response P306 + P360
P371 + P380 + P375
P370 + P378 P370 + P378 P370 + P378
Precautionary Statement
Storage Precautionary Statement
Disposal P501 P501 P501
2.14.4. Additional Classification Considerations
2.14.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:
(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or
(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
2.14.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
2.14.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.
2.15. Organic peroxides
2.15.1. Definition
2.15.1.1. Organic peroxides means liquid or solid organic substances which contain the bivalent -O-O- structure and may be considered derivatives of hydrogen peroxide, where one or both of the hydrogen atoms have been replaced by organic radicals. The term organic peroxide includes organic peroxide mixtures (formulations) containing at least one organic peroxide. Organic peroxides are thermally unstable substances or mixtures, which can undergo exothermic self-accelerating decomposition. In addition, they can have one or more of the following properties:
(i) be liable to explosive decomposition;
(ii) burn rapidly;
(iii) be sensitive to impact or friction;
(iv) react dangerously with other substances.
2.15.1.2. An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.
2.15.2. Classification criteria
2.15.2.1. Any organic peroxide shall be considered for classification in this class, unless it contains:
(a) not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or
(b) not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.
Note
The available oxygen content ( %) of an organic peroxide mixture is given by the formula:
16×Σnini×cimi
where:
ni
number of peroxygen groups per molecule of organic peroxide i;
ci
concentration (mass %) of organic peroxide i;
mi
molecular mass of organic peroxide i.
2.15.2.2. Organic peroxides shall be classified in one of the seven categories of Types A to G for this class, according to the following principles:
(a) any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;
(b) any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;
(c) any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;
(d) any organic peroxide which in laboratory testing:
(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or
(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or
(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as organic peroxide TYPE D;
(e) any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;
(f) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;
(g) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3., and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
2.15.2.3. Criteria for temperature control
The following organic peroxides need to be subjected to temperature control:
(a) Organic peroxide types B and C with an SADT ≤ 50 C;
(b) Organic peroxide type D showing a medium effect when heated under confinementAs determined by test series E as prescribed in UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II. with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and
(c) Organic peroxide types E and F with an SADT ≤ 45 oC.
Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.
2.15.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.
Table 2.15.1
Label elements for organic peroxides
Classification Type A Type B Type C & D Type E & F Type G
GHS Pictograms There are no label elements allocated to this hazard category
Signal Word Danger Danger Danger Warning
Hazard Statement H240: Heating may cause an explosion H241: Heating may cause a fire or explosion H242: Heating may cause a fire H242: Heating may cause a fire
Precautionary Statement
Prevention P210
P220
P234
P280 P210
P220
P234
P280 P210
P220
P234
P280 P210
P220
P234
P280
Precautionary Statement
Response Precautionary Statement
Storage P411 + P235
P410
P420 P411 + P235
P410
P420 P411 + P235
P410
P420 P411 + P235
P410
P420 Precautionary Statement
Disposal P501 P501 P501 P501 Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.
2.15.4. Additional Classification Considerations
2.15.4.1. Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.
2.15.4.2. Mixtures of already classified organic peroxides may be classified as the same type of organic peroxide as that of the most dangerous component. However, as two stable components can form a thermally less stable mixture, the SADT of the mixture shall be determined.
Note: The sum of the individual parts can be more hazardous than the individual components.
Figure 2.15.1
Organic Peroxides
SUBSTANCE/MIXTURE
Box 1
Test A
Box 2
Test B
1.1 Yes
Does it propogate a detonation?
1.3 No
2.1 Yes
Can it detonate as packaged?
2.2 No
1.2 Partial
Box 3 Test C
Can it propogate a detonation?
3.1 Yes, rapidly
Box 4 Test C
Can it propogate a detonation?
Box 5 Test C
Box 6 Test D
3.2 Yes, slowly
3.3 No
4.1 Yes rapidly
Can it propogate a detonation?
4.2 Yes, slowly
5.1 Yes, rapidly
4.3 No
5.3 No
Does it deflagrate rapidly in package?
6.2 No
Box 7 Test E
5.2 Yes, slowly
6.1 Yes
What is the effect of heating under confinement?
Box 8 Test E
7.1 Violent
What is the effect of heating under confinement?
Box 9 Test E
7.2 Medium
8.1 Violent
7.3 Low
7.4 No
What is the effect of heating under confinement?
Box 10 Test G
9.3 Low
8.2 Medium
9.1 Violent
8.3 Low
9.4 No
Can it explode as packaged?
10.2 No
8.4 No
9.2 Medium
Box 11
Packaged in packages of more than 400 kg/450 l or to be considered for exemption?
11.1 Yes
Box 12 Test F
11.2 No
What is its explosive power?
12.3 None
10.1 Yes
12.1 Not low
Box 13 Test E
12.2 Low
What is the effect of heating it under confinement?
13.1 Low
13.2 None
TYPE A
TYPE B
TYPE C
TYPE D
TYPE E
TYPE F
TYPE G
2.16. Corrosive to metals
2.16.1. Definition
A substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.
2.16.2. Classification criteria
2.16.2.1. A substance or a mixture which is corrosive to metals is classified in a single category for this class, using the test in Part III, sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.16.1:
Table 2.16.1
Criteria for substances and mixtures corrosive to metals
Category Criteria
1 Corrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.
Note
Where an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required.
2.16.3. Hazard Communication
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.
Table 2.16.2
Label elements for substances and mixtures corrosive to metals
Classification Category 1
GHS Pictogram Signal Word Warning
Hazard Statement H290: May be corrosive to metals
Precautionary Statement
Prevention P234
Precautionary Statement
Response P390
Precautionary Statement
Storage P406
Precautionary Statement
Disposal 2.16.4. Additional Classification Considerations
2.16.4.1. The corrosion rate can be measured according to the test method of Part III sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The specimen to be used for the test shall be made of the following materials:
(a) for the purposes of testing steel, steel types
S235JR+CR (1.0037 resp.St 37-2),
S275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;
(b) for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.
3. PART 3: HEALTH HAZARDS
3.1. Acute toxicity
3.1.1. Definitions
3.1.1.1. Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.
3.1.1.2. The hazard class Acute Toxicity is differentiated into:
Acute oral toxicity;
Acute dermal toxicity;
Acute inhalation toxicity.
3.1.2. Criteria for classification of substances as acutely toxic
3.1.2.1. Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.
Table 3.1.1
Acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories
Gas concentrations are expressed in parts per million per volume (ppmV).
Exposure Route Category 1 Category 2 Category 3 Category 4
Oral (mg/kg bodyweight)
See Note (a) ATE ≤ 5 5 < ATE ≤ 50 50 < ATE ≤ 300 300 < ATE ≤ 2000
Dermal (mg/kg
bodyweight)
See Note (a) ATE ≤ 50 50 < ATE ≤ 200 200 < ATE ≤ 1000 1000 < ATE ≤ 2000
Gases (ppmV see: Note (a)
Note (b) ATE ≤ 100 100 < ATE ≤ 500 500 < ATE ≤ 2500 2500 < ATE ≤ 20000
Vapours (mg/l) see: Note (a)
Note (b)
Note (c) ATE ≤ 0,5 0,5 < ATE ≤ 2,0 2,0 < ATE ≤ 10,0 10,0 < ATE ≤ 20,0
Dusts and Mists (mg/l) see: Note (a)
Note (b) ATE ≤ 0,05 0,05 < ATE ≤ 0,5 0,5 < ATE ≤ 1,0 1,0 < ATE ≤ 5,0
Notes to Table 3.1.1
(a) The acute toxicity estimate (ATE) for the classification of a substance or ingredient in a mixture is derived using:
the LD50/LC50 where available,
the appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or
the appropriate conversion value from Table 3.1.2 that relates to a classification category.
(b) Generic concentration limits for inhalation toxicity in the table are based on 4 hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1 hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.
(c) For some substances or mixtures the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances or mixtures the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2500 ppmV), Category 4 (20000 ppmV).
The terms dust, mist and vapour are defined as follows:
Dust: solid particles of a substance or mixture suspended in a gas (usually air);
Mist: liquid droplets of a substance or mixture suspended in a gas (usually air);
Vapour: the gaseous form of a substance or mixture released from its liquid or solid state.
Dust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.
3.1.2.2. Specific considerations for classification of substances as acutely toxic
3.1.2.2.1. The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.
3.1.2.3. Specific considerations for classification of substances as acutely toxic by the inhalation route
3.1.2.3.1. Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.
3.1.2.3.2. Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.
3.1.2.3.3. In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as corrosive to the respiratory tract (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.
3.1.3. Criteria for classification of mixtures as acutely toxic
3.1.3.1. The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.
3.1.3.2. For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all ingredients. If the acute toxicity is determined for more than one route of exposure, the more severe hazard category will be used for classification. All available information shall be considered and all relevant routes of exposure shall be identified for hazard communication.
3.1.3.3. In order to make use of all available data for purposes of classifying the hazards of the mixtures, certain assumptions have been made and are applied where appropriate in the tiered approach:
(a) the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).
(b) where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.
Figure 3.1.1
Tiered approach to classification of mixtures for acute toxicity
Test data on the mixture as a whole
No
Yes
Sufficient data available on similar mixtures to estimate classification hazards
Yes
Apply bridging principles outlined in section 1.1.3.
CLASSIFY
No
Available data for all ingredients
Yes
Apply formula in section 3.1.3.6.1
CLASSIFY
No
Other data available to estimate conversion values for classification
Yes
Apply formula in section 3.1.3.6.1
CLASSIFY
No
Convey hazards of the known ingredients
• Apply formula in section 3.1.3.6.1. (unknown ingredients equal or below 10 %)
• Apply formula in paragraph 3.1.3.6.2.3. (unknown ingredients > 10 %)
CLASSIFY
3.1.3.4. Classification of mixtures where acute toxicity data are available for the complete mixture
3.1.3.4.1. Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.
3.1.3.5. Classification of mixtures where acute toxicity data are available for the complete mixture: bridging principles
3.1.3.5.1. Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
3.1.3.5.2. If a mixture is diluted with water or other totally non-toxic material, the toxicity of the mixture can be calculated from test data on the undiluted mixture.
3.1.3.6. Classification of mixtures based on ingredients of the mixture (Additivity formula)
3.1.3.6.1. Data available for all ingredients
In order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:
(a) include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;
(b) ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);
(c) ignore ingredients if the oral limit test does not show acute toxicity at 2000 mg/kg bodyweight.
Ingredients that fall within the scope of this paragraph are considered to be ingredients with a known acute toxicity estimate (ATE).
The ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:100ATEmix=ΣnCiATEi
where:
Ci
concentration of ingredient i ( % w/w or % v/v)
i
the individual ingredient from 1 to n
n
the number of ingredients
ATEi
Acute Toxicity Estimate of ingredient i.
3.1.3.6.2. Classification of mixtures when data are not available for all components
3.1.3.6.2.1. Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.
This includes evaluation of:
(a) extrapolation between oral, dermal and inhalation acute toxicity estimatesFor ingredients with acute toxicity estimates available for other than the most appropriate exposure route, values may be extrapolated from the available exposure route(s) to the most appropriate route. Dermal and inhalation route data are not always required for ingredients. However, in case data requirements for specific ingredients include acute toxicity estimates for the dermal and inhalation route, the values to be used in the formula need to be from the required exposure route.. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;
(b) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;
(c) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or
(d) data from closely analogous substances using structure/activity relationships.
This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.
3.1.3.6.2.2. In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known ingredients only, with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity.
3.1.3.6.2.3. If the total concentration of the ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the total percentage of the unknown ingredient(s) as follows:
100-Σ C unknown if > 10 %ATEmix=ΣnCiATEi
Table 3.1.2
Conversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for classification for the respective routes of exposure
Exposure routes Classification Category or experimentally obtained acute toxicity range estimate Converted acute toxicity point estimate
(see Note 1)
Oral
(mg/kg bodyweight) 0 < Category 1 ≤ 5
5 < Category 2 ≤ 50
50 < Category 3 ≤ 300
300 < Category 4 ≤ 2000 0,5
5
100
500
Dermal
(mg/kg bodyweight) 0 < Category 1 ≤ 50
50 < Category 2 ≤ 200
200 < Category 3 ≤ 1000
1000 < Category 4 ≤ 2000 5
50
300
1100
Gases
(ppmV) 0 < Category 1 ≤ 100
100 < Category 2 ≤ 500
500 < Category 3 ≤ 2500
2500 < Category 4 ≤ 20000 10
100
700
4500
Vapours
(mg/l) 0 < Category 1 ≤ 0,5
0,5 < Category 2 ≤ 2,0
2,0 < Category 3 ≤ 10,0
10,0 < Category 4 ≤ 20,0 0,05
0,5
3
11
Dust/mist
(mg/l) 0< Category 1 ≤ 0,05
0,05 < Category 2 ≤ 0,5
0,5 < Category 3 ≤ 1,0
1,0 < Category 4 ≤ 5,0 0,005
0,05
0,5
1,5
Note 1
These values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results.
3.1.4. Hazard Communication
3.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.1.3.
Table 3.1.3
Acute toxicity label elements
Classification Category 1 Category 2 Category 3 Category 4
GHS Pictograms Signal Word Danger Danger Danger Warning
Hazard Statement:
Oral H300:
Fatal if swallowed H300:
Fatal if swallowed H301:
Toxic if swallowed H302:
Harmful if swallowed
Dermal H310:Fatal in contact with skin H310:Fatal in contact with skin H311: Toxic in contact with skin H312: Harmful in contact with skin
Inhalation
(see Note 1) H330:Fatal if inhaled H330: Fatal if inhaled H331: Toxic if inhaled H332: Harmful if inhaled
Precautionary Statement Prevention (oral) P264
P270 P264
P270 P264
P270 P264
P270
Precautionary Statement Response (oral) P301 + P310
P321
P330 P301 + P310
P321
P330 P301 + P310
P321
P330 P301 + P312
P330
Precautionary Statement Storage (oral) P405 P405 P405 Precautionary Statement Disposal (oral) P501 P501 P501 P501
Precautionary Statement Prevention (dermal) P262
P264
P270
P280 P262
P264
P270
P280 P280 P280
Precautionary Statement Response (dermal) P302 + P350
P310
P322
P361
P363 P302 + P350
P310
P322
P361
P363 P302 + P352
P312
P322
P361
P363 P302 + P352
P312
P322
P363
Precautionary Statement Storage (dermal) P405 P405 P405 Precautionary Statement Disposal (dermal) P501 P501 P501 P501
Precautionary Statement Prevention (inhalation) P260
P271
P284 P260
P271
P284 P261
P271 P261
P271
Precautionary Statement Response (inhalation) P304 + P340
P310
P320 P304 + P340
P310
P320 P304 + P340
P311
P321 P304 + P340
P312
Precautionary Statement Storage (inhalation) P403 + P233
P405 P403 + P233
P405 P403 + P233
P405 Precautionary Statement Disposal (inhalation) P501 P501 P501 Note 1
In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: corrosive to the respiratory tract — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement corrosive to the respiratory tract.
Note 2
In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity — see advice at 3.1.3.6.2.2.
3.2. Skin corrosion/irritation
3.2.1. Definitions
3.2.1.1. Skin Corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test substance for up to 4 hours. Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology shall be considered to evaluate questionable lesions.
Skin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.
3.2.2. Classification criteria for substances
3.2.2.1. Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.
3.2.2.2. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
3.2.2.3. If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.
3.2.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo skin irritation testing.
Although information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.
3.2.2.5. A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.
3.2.2.6. Corrosion
3.2.2.6.1. On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.
3.2.2.6.2. Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.
3.2.2.6.3. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.
Table 3.2.1
Skin Corrosive category and subcategories
Corrosive in > 1 of 3 animals
Corrosive subcategories Exposure Observation
Category 1: Corrosive 1A ≤ 3 minutes ≤ 1 hour
1B > 3 minutes - ≤ 1 hour ≤ 14 days
1C > 1 hour - ≤ 4 hours ≤ 14 days
3.2.2.7. Irritation
3.2.2.7.1. Using the results of animal testing a single irritant category (Category 2) is presented in Table 3.2.2. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5. The major criterion for the irritant category is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.
Table 3.2.2
Skin irritation category
Category Criteria
Category 2: Irritant (1) Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or
(2) Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or
(3) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.
3.2.2.8. Comments on responses obtained in skin irritation tests in animals
3.2.2.8.1. Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.
3.2.2.8.2. Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.
3.2.3. Classification criteria for mixtures
3.2.3.1. Classification of mixtures when data are available for the complete mixture
3.2.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.
3.2.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
3.2.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.2.3.2.1. Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
3.2.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture
3.2.3.3.1. In order to make use of all available data for purposes of classifying the skin irritation/corrosion hazards of mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:
Assumption: the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.
3.2.3.3.2. In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.
3.2.3.3.3. Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.
3.2.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.
3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.
3.2.3.3.4.3. A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.
3.2.3.3.5. On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.
3.2.3.3.6. If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.
Table 3.2.3
Generic concentration limits of ingredients classified for skin corrosive/irritant hazard (Category 1 or 2) that trigger classification of the mixture as corrosive/irritant to skin
Sum of ingredients classified as: Concentration triggering classification of a mixture as:
Skin Corrosive Skin Irritant
Category 1
(see note below) Category 2
Skin Corrosive Categories 1A, 1B, 1C ≥ 5 % ≥ 1 % but < 5 %
Skin irritant Category 2 ≥ 10 %
(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2 ≥ 10 %
Note
The sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.
Table 3.2.4
Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as corrosive/irritant to skin
Ingredient: Concentration: Mixture classified as: Skin
Acid with pH ≤ 2 ≥ 1 % Category 1
Base with pH ≥ 11,5 ≥ 1 % Category 1
Other corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply ≥ 1 % Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases ≥ 3 % Category 2
3.2.4. Hazard Communication
3.2.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.2.5.
Table 3.2.5
Label elements for skin corrosion/irritation
Classification Category 1 A/1 B/1 C Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H314: Causes severe skin burns and eye damage H315: Causes skin irritation
Precautionary Statement
Prevention P260
P264
P280 P264
P280
Precautionary Statement
Response P301 + P330 + P331
P303 + P361 + P353
P363
P304 + P340
P310
P321
P305 + P351 + P338 P302 + P352
P321
P332 + P313
P362
Precautionary Statement
Storage P405 Precautionary Statement
Disposal P501 3.3. Serious eye damage/eye irritation
3.3.1. Definitions
3.3.1.1. Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.
Eye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.
3.3.2. Classification criteria for substances
3.3.2.1. The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.
3.3.2.2. Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.
3.3.2.3. Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).
3.3.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.
3.3.2.5. A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.
3.3.2.6. Irreversible effects on the eye/serious damage to eyes (Category 1)
3.3.2.6.1. Substances that have the potential to seriously damage the eyes are classified in Category 1 (irreversible effects on the eye). Substances are classified in this hazard category on the basis of the results of animal testing, in accordance with the criteria listed in Table 3.3.1. These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.
Table 3.3.1
Category for irreversible eye effects
Category Criteria
Irreversible effects on the eye
(Category 1) If, when applied to the eye of an animal, a substance produces:
at least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or
at least in 2 of 3 tested animals, a positive response of:
corneal opacity ≥ 3 and/or
iritis > 1,5
calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.
3.3.2.6.2. The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
3.3.2.7. Reversible effects on the eye (Category 2)
3.3.2.7.1. Substances that have the potential to induce reversible eye irritation are classified in Category 2 (irritating to eyes).
Table 3.3.2
Category for reversible eye effects
Category Criteria
Irritating to eyes
(Category 2) if, when applied to the eye of an animal, a substance produces:
at least in 2 of 3 tested animals, a positive response of:
corneal opacity ≥ 1 and/or
iritis ≥ 1, and/or
conjunctival redness ≥ 2 and/or
conjunctival oedema (chemosis) ≥ 2
calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days
3.3.2.7.2. For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.
3.3.3. Classification criteria for mixtures
3.3.3.1. Classification of mixtures when data are available for the complete mixture
3.3.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.
3.3.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
3.3.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.3.3.2.1. Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
3.3.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture
3.3.3.3.1. In order to make use of all available data for purposes of classifying the eye irritation/serious eye damaging properties of the mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:
Assumption: The relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.
3.3.3.3.2. In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.
3.3.3.3.3. Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.
3.3.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.
3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.
3.3.3.3.4.3. A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.
3.3.3.3.5. On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.
3.3.3.3.6. If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.
Table 3.3.3
Generic concentration limits of ingredients of a mixture classified as Skin corrosive Category 1 and/or eye Category 1 or 2 for effects on the eye that trigger classification of the mixture for effects on the eye (Category 1 or 2)
Sum of ingredients classified as: Concentration triggering classification of a mixture as:
Irreversible Eye Effects Reversible Eye Effects
Category 1 Category 2
Eye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C ≥ 3 % ≥ 1 % but < 3 %
Eye Effects Category 2 ≥ 10 %
(10 × Eye Effects Category 1) + Eye effects Category 2 ≥ 10 %
Skin Corrosive Category 1A, 1B, 1C + Eye effects Category 1 ≥ 3 % ≥ 1 % but < 3 %
10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2 ≥ 10 %
Table 3.3.4
Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as hazardous to the eye
Ingredient Concentration Mixture classified as: Eye
Acid with pH ≤ 2 ≥ 1 % Category 1
Base with pH ≥ 11,5 ≥ 1 % Category 1
Other corrosive (Category 1) ingredients for which additivity does not apply ≥ 1 % Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases ≥ 3 % Category 2
3.3.4. Hazard Communication
3.3.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.3.5.
Table 3.3.5
Label elements for serious eye damage/eye irritation
Classification Category 1 Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H318: Causes serious eye damage H319: Causes serious eye irritation
Precautionary Statement
Prevention P280 P264
P280
Precautionary Statement
Response P305 + P351 + P338
P310 P305 + P351 + P338
P337 + P313
Precautionary Statement
Storage Precautionary Statement
Disposal 3.4. Respiratory or skin sensitisation
3.4.1. Definitions and general considerations
3.4.1.1. Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.
3.4.1.2. Skin sensitiser means a substance that will lead to an allergic response following skin contact.
3.4.1.3. For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.
3.4.1.4. For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.
3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found at section 3.4.4.
3.4.1.6. The hazard class Respiratory or Skin Sensitisation is differentiated into:
Respiratory Sensitisation;
Skin Sensitisation.
3.4.2. Classification criteria for substances
3.4.2.1. Respiratory sensitisers
Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the criteria in Table 3.4.1:
Table 3.4.1
Hazard category for respiratory sensitisers
Category Criteria
Category 1 Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the following criteria:
(a) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity and/or
(b) if there are positive results from an appropriate animal test.
3.4.2.1.1 Human evidence
3.4.2.1.1.1. Evidence that a substance can induce specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.
3.4.2.1.1.2. When considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:
(a) the size of the population exposed;
(b) the extent of exposure.
The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
3.4.2.1.1.3. The evidence referred to above could be
(a) clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:
(i) in vivo immunological test (e.g. skin prick test);
(ii) in vitro immunological test (e.g. serological analysis);
(iii) studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;
(iv) a chemical structure related to substances known to cause respiratory hypersensitivity;
(b) data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.
3.4.2.1.1.4. Clinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.
3.4.2.1.1.5. The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.
3.4.2.1.2. Animal studies
3.4.2.1.2.1. Data from appropriate animal studiesAt present recognised animal models for the testing of respiratory hypersensitivity are not available. which may be indicative of the potential of a substance to cause sensitisation by inhalation in humansThe mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers. may include:
(i) measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;
(ii) specific pulmonary responses in guinea pigs.
3.4.2.2. Skin sensitisers
3.4.2.2.1. Substances shall be classified as skin sensitisers (Category 1) in accordance with the criteria in Table 3.4.2:
Table 3.4.2
Hazard category for skin sensitisers
Category Criteria
Category 1 Substances shall be classified as skin sensitisers (Category 1) in accordance with the following criteria:
(i) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons, or
(ii) if there are positive results from an appropriate animal test (see specific criteria in paragraph 3.4.2.2.4.1).
3.4.2.2.2. Specific considerations
3.4.2.2.2.1. For classification of a substance as a skin sensitiser, evidence shall include any or all of the following:
(a) positive data from patch testing, normally obtained in more than one dermatology clinic;
(b) epidemiological studies showing allergic contact dermatitis caused by the substance; Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;
(c) positive data from appropriate animal studies;
(d) positive data from experimental studies on humans (see Article 7(3));
(e) well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic.
The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
3.4.2.2.2.2. Positive effects seen in either humans or animals will normally justify classification. Evidence from animal studies (see section 3.4.2.2.4) is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution, as the frequency of cases reflect, in addition to the intrinsic properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data can not normally be used to negate positive results from animal studies.
3.4.2.2.2.3. If none of the above mentioned conditions are met the substance need not be classified as a skin sensitiser. However, a combination of two or more indicators of skin sensitisation as listed below may alter the decision, which shall be considered on a case-by-case basis:
(a) isolated episodes of allergic contact dermatitis;
(b) epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;
(c) data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in paragraph 3.4.2.2.4.1, but which are sufficiently close to the limit to be considered significant;
(d) positive data from non-standard methods;
(e) positive results from close structural analogues.
3.4.2.2.3. Immunological contact urticaria
3.4.2.2.3.1. Some substances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration shall be given to classifying these substances also as skin sensitisers and including information concerning contact urticaria on the label or in the SDS using appropriate warning information.
3.4.2.2.3.2. For substances which produce signs of immunological contact urticaria but which do not fulfil the criteria as a respiratory sensitiser, consideration shall be given to classification as a skin sensitiser. There is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence, which will be similar to that for skin sensitisation.
3.4.2.2.4. Animal studies
3.4.2.2.4.1. When an adjuvant type guinea pig test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant guinea pig test method a response of at least 15 % of the animals is considered positive. Test methods for skin sensitisation described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) shall be used, or other methods provided that they are well-validated and scientific justification is given.
3.4.3. Classification criteria for mixtures
3.4.3.1. Classification of mixtures when data are available for the complete mixture
3.4.3.1.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.
3.4.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
3.4.3.3. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.3 for solid/liquid and gas respectively.
3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.1, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.3).
Table 3.4.3
Generic concentration limits of ingredients of a mixture classified as either skin sensitisers or respiratory sensitisers that trigger classification of the mixture
Ingredient classified as: Concentration triggering classification of a mixture as:
Skin Sensitiser Respiratory Sensitiser
All physical states Solid/Liquid Gas
Skin Sensitiser ≥ 0,1 %
(Note 1) — —
≥ 1,0 %
(Note 2) — —
Respiratory Sensitiser — ≥ 0,1 %
(Note 1) ≥ 0,1 %
(Note 1)
— ≥ 1,0 %
(Note 3) ≥ 0,2 %
(Note 3)
Note 1
This concentration limit is generally used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing an ingredient above this concentration.
Note 2
This concentration limit is used to trigger classification of a mixture as a skin sensitiser.
Note 3
This concentration limit is used to trigger classification of a mixture as a respiratory sensitiser.
3.4.4. Hazard communication
3.4.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.4.4.
Table 3.4.4
Respiratory or skin sensitisation label elements.
Classification Respiratory sensitisation Skin sensitisation
Category 1 Category 1
GHS Pictograms Signal Word Danger Warning
Hazard Statement H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled H317: May cause an allergic skin reaction
Precautionary Statement Prevention P261
P285 P261
P272
P280
Precautionary Statement Response P304 + P341
P342+ P311 P302 + P352
P333 + P313
P321
P363
Precautionary Statement Storage Precautionary Statement Disposal P501 P501
3.5. Germ cell mutagenicity
3.5.1. Definitions and general considerations
3.5.1.1. A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term mutation applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term mutagenic and mutagen will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.
3.5.1.2. The more general terms genotoxic and genotoxicity apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.
3.5.2. Classification criteria for substances
3.5.2.1. This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.
3.5.2.2. For the purpose of classification for germ cell mutagenicity, substances are allocated to one of two categories as shown in Table 3.5.1.
Table 3.5.1
Hazard categories for germ cell mutagens
Categories Criteria
CATEGORY 1: Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.
Substances known to induce heritable mutations in the germ cells of humans.
Category 1A: The classification in Category 1A is based on positive evidence from human epidemiological studies.
Substances to be regarded as if they induce heritable mutations in the germ cells of humans.
Category 1B: The classification in Category 1B is based on:
positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or
positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or
positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.
CATEGORY 2: Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans
The classification in Category 2 is based on:
positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:
somatic cell mutagenicity tests in vivo, in mammals; or
other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
Note: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.
3.5.2.3. Specific considerations for classification of substances as germ cell mutagens
3.5.2.3.1. To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.
3.5.2.3.2. The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.
3.5.2.3.3. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.
3.5.2.3.4. In vivo heritable germ cell mutagenicity tests, such as:
rodent dominant lethal mutation test;
mouse heritable translocation assay.
3.5.2.3.5. In vivo somatic cell mutagenicicty tests, such as:
mammalian bone marrow chromosome aberration test;
mouse spot test;
mammalian erythrocyte micronucleus test.
3.5.2.3.6. Mutagenicity/genotoxicity tests in germ cells, such as:
(a) mutagenicity tests:
mammalian spermatogonial chromosome aberration test;
spermatid micronucleus assay;
(b) Genotoxicity tests:
sister chromatid exchange analysis in spermatogonia;
unscheduled DNA synthesis test (UDS) in testicular cells.
3.5.2.3.7. Genotoxicity tests in somatic cells such as:
liver Unscheduled synthesis test (UDS) in vivo;
mammalian bone marrow Sister Chromatid Exchanges (SCE);
3.5.2.3.8. In vitro mutagenicity tests such as:
in vitro mammalian chromosome aberration test;
in vitro mammalian cell gene mutation test;
bacterial reverse mutation tests.
3.5.2.3.9. The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.
3.5.3. Classification criteria for mixtures
3.5.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.5.3.1.1. The mixture shall be classified as a mutagen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 mutagen and is present at or above the appropriate generic concentration limit as shown in Table 3.5.2 for Category 1A, Category 1B and Category 2 respectively.
Table 3.5.2
Generic concentration limits of ingredients of a mixture classified as germ cell mutagens that trigger classification of the mixture.
Concentration limits triggering classification of a mixture as:
Ingredient classified as: Category 1A mutagen Category 1B mutagen Category 2 mutagen
Category 1A mutagen ≥ 0,1 % — —
Category 1B mutagen — ≥ 0,1 % —
Category 2 mutagen — — ≥ 1,0 %
Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).
3.5.3.2. Classification of mixtures when data are available for the complete mixture
3.5.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
3.5.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.5.3.3.1. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
3.5.4. Hazard communication
3.5.4.1. Label elements shall be used in accordance with Table 3.5.3, for substances or mixtures meeting the criteria for classification in this hazard class.
Table 3.5.3
Label elements of germ cell mutagenicity
Classification Category 1A or Category 1B Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement
Prevention P201
P202
P281 P201
P202
P281
Precautionary Statement
Response P308 + P313 P308 + P313
Precautionary Statement
Storage P405 P405
Precautionary Statement
Disposal P501 P501
3.5.5. Additional classification considerations
It is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).
3.6. Carcinogenicity
3.6.1. Definition
3.6.1.1. Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.
3.6.2. Classification criteria for substances
3.6.2.1. For the purpose of classification for carcinogenicity, substances are allocated to one of two categories based on strength of evidence and additional considerations (weight of evidence). In certain instances, route-specific classification may be warranted, if it can be conclusively proved that no other route of exposure exhibits the hazard.
Table 3.6.1
Hazard categories for carcinogens
Note: See 3.6.2.2.4.
Categories Criteria
CATEGORY 1: Known or presumed human carcinogens
A substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:
Category 1A: Category 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or
Category 1B: Category 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.
The classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:
human studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or
animal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen).
In addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.
CATEGORY 2: Suspected human carcinogens
The placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.
3.6.2.2. Specific considerations for classification of substances as carcinogens
3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.
3.6.2.2.2. Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.
3.6.2.2.3. Strength of evidence involves the enumeration of tumours in human and animal studies and determination of their level of statistical significance. Sufficient human evidence demonstrates causality between human exposure and the development of cancer, whereas sufficient evidence in animals shows a causal relationship between the substance and an increased incidence of tumours. Limited evidence in humans is demonstrated by a positive association between exposure and cancer, but a causal relationship cannot be stated. Limited evidence in animals is provided when data suggest a carcinogenic effect, but are less than sufficient. The terms sufficient and limited have been used here as they have been defined by the International Agency for Research on Cancer (IARC) and read as follows:
(a) Carcinogenicity in humans
The evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:
sufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;
limited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.
(b) Carcinogenicity in experimental animals
Carcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:
sufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;
limited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.
3.6.2.2.4. Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.
3.6.2.2.5. The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.
3.6.2.2.6. Some important factors which may be taken into consideration, when assessing the overall level of concern are:
(a) tumour type and background incidence;
(b) multi-site responses;
(c) progression of lesions to malignancy;
(d) reduced tumour latency;
(e) whether responses are in single or both sexes;
(f) whether responses are in a single species or several species;
(g) structural similarity to a substance(s) for which there is good evidence of carcinogenicity;
(h) routes of exposure;
(i) comparison of absorption, distribution, metabolism and excretion between test animals and humans;
(j) the possibility of a confounding effect of excessive toxicity at test doses;
(k) mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.
Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.
3.6.2.2.7. A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.
3.6.2.2.8. The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.
3.6.2.2.9. It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.
3.6.3. Classification criteria for mixtures
3.6.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.6.3.1.1. The mixture will be classified as a carcinogen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 carcinogen and is present at or above the appropriate generic concentration limit as shown in Table 3.6.2 for Category 1A, Category 1B and Category 2 respectively.
Table 3.6.2
Generic concentration limits of ingredients of a mixture classified as carcinogen that trigger classification of the mixture
Ingredient classified as: Generic concentration limits triggering classification of a mixture as:
Category 1A carcinogen Category 1B carcinogen Category 2 carcinogen
Category 1A carcinogen ≥ 0,1 % — —
Category 1B carcinogen — ≥ 0,1 % —
Category 2 carcinogen — — ≥ 1,0 % [Note 1]
Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).
Note 1
If a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request.
3.6.3.2. Classification of mixtures when data are available for the complete mixture
3.6.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
3.6.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.6.3.3.1. Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
3.6.4. Hazard Communication
3.6.4.1. Label elements shall be used in accordance with Table 3.6.3, for substances or mixtures meeting the criteria for classification in this hazard class.
Table 3.6.3
Label elements for carcinogenicity
Classification Category 1A or Category 1B Category 2
GHS Pictograms Signal Word Danger Warning
Hazard Statement H350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement
Prevention P201
P202
P281 P201
P202
P281
Precautionary Statement
Response P308 + P313 P308 + P313
Precautionary Statement
Storage P405 P405
Precautionary Statement
Disposal P501 P501
3.7. Reproductive toxicity
3.7.1. Definitions and general considerations
3.7.1.1. Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based heritable effects in the offspring is addressed in Germ Cell Mutagenicity (section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.
In this classification system, reproductive toxicity is subdivided under two main headings:
(a) adverse effects on sexual function and fertility;
(b) adverse effects on development of the offspring.
Some reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.
3.7.1.2. For the purpose of classification the hazard class Reproductive Toxicity is differentiated into:
adverse effects
on sexual function and fertility, or
on development;
effects on or via lactation.
3.7.1.3. Adverse effects on sexual function and fertility
Any effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.
3.7.1.4. Adverse effects on development of the offspring
Developmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.
3.7.1.5. Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.
3.7.2. Classification criteria for substances
3.7.2.1. Hazard categories
3.7.2.1.1. For the purpose of classification for reproductive toxicity, substances are allocated to one of two categories. Within each category, effects on sexual function and fertility, and on development, are considered separately. In addition, effects on lactation are allocated to a separate hazard category.
Table 3.7.1(a)
Hazard categories for reproductive toxicants
Categories Criteria
CATEGORY 1 Known or presumed human reproductive toxicant
Substances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).
Category 1A Known human reproductive toxicant
The classification of a substance in Category 1A is largely based on evidence from humans.
Category 1B Presumed human reproductive toxicant
The classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.
CATEGORY 2 Suspected human reproductive toxicant
Substances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.
Such effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.
Table 3.7.1(b)
Hazard category for lactation effects
EFFECTS ON OR VIA LACTATION
Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:
(a) human evidence indicating a hazard to babies during the lactation period; and/or
(b) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or
(c) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.
3.7.2.2. Basis of classification
3.7.2.2.1. Classification is made on the basis of the appropriate criteria, outlined above, and an assessment of the total weight of evidence (see 1.1.1). Classification as a reproductive toxicant is intended to be used for substances which have an intrinsic, specific property to produce an adverse effect on reproduction and substances shall not be so classified if such an effect is produced solely as a non-specific secondary consequence of other toxic effects.
The classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.
3.7.2.2.2. In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).
3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.
3.7.2.3. Weight of evidence
3.7.2.3.1. Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).
3.7.2.3.2. Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.
3.7.2.3.3. If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.
3.7.2.3.4. Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.
3.7.2.3.5. If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.
3.7.2.4. Maternal toxicity
3.7.2.4.1. Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.
3.7.2.4.2. Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.
3.7.2.4.3. Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.
3.7.2.4.4. Some of the end points used to assess maternal effects are provided below. Data on these end points, if available, need to be evaluated in light of their statistical or biological significance and dose response relationship.
Maternal mortality:
an increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.
Mating index
(no. animals with seminal plugs or sperm/no. mated × 100)It is recognised that the Mating index and the Fertility index can also be affected by the male.
Fertility index
(no. animals with implants/no. of matings × 100)
Gestation length
(if allowed to deliver)
Body weight and body weight change:
Consideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.
Food and water consumption (if relevant):
The observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.
Clinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):
The observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.
Post-mortem data:
Increased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.
3.7.2.5. Animal and experimental data
3.7.2.5.1. A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).
3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.
3.7.2.5.3. Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.
3.7.2.5.4. Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.
3.7.2.5.5. It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.
3.7.2.5.6. Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.
3.7.2.5.7. There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.
3.7.2.5.8. In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.
3.7.2.5.9. However, specification of the actual limit dose will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.
3.7.3. Classification criteria for mixtures
3.7.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.7.3.1.1. The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.
3.7.3.1.2. The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.
Table 3.7.2
Generic concentration limits of ingredients of a mixture classified as reproduction toxicants or for effects on or via lactation that trigger classification of the mixture
Ingredient classified as: Generic concentration limits triggering classification of a mixture as:
Category 1A reproductive toxicant Category 1B reproductive toxicant Category 2 reproductive toxicant Additional category for effects on or via lactation
Category 1A reproductive toxicant ≥ 0,3 %
[Note 1] Category 1B reproductive toxicant ≥ 0,3 %
[Note 1] Category 2 reproductive toxicant ≥ 3,0 %
[Note 1] Additional category for effects on or via lactation ≥ 0,3 %
[Note 1]
Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).
Note 1
If a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request.
3.7.3.2. Classification of mixtures when data are available for the complete mixture
3.7.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
3.7.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
3.7.4. Hazard Communication
3.7.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.7.3
Table 3.7.3
Label elements for reproductive toxicity
Classification Category 1A or Category 1B Category 2 Additional category for effects on or via lactation
GHS Pictograms No pictogram
Signal Word Danger Warning No signal word
Hazard Statement H360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H362: May cause harm to breast-fed children.
Precautionary Statement Prevention P201
P202
P281 P201
P202
P281 P201
P260
P263
P264
P270
Precautionary Statement Response P308 + P313 P308 + P313 P308 + P313
Precautionary Statement Storage P405 P405 Precautionary Statement Disposal P501 P501 3.8. Specific target organ toxicity — single exposure
3.8.1. Definitions and general considerations
3.8.1.1. Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).
3.8.1.2. Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
3.8.1.3. These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.
3.8.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
3.8.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
3.8.1.6. Specific target organ toxicity following a repeated exposure is classified as described in Specific target organ toxicity — Repeated exposure (section 3.9) and is therefore excluded from section 3.8. Other specific toxic effects, listed below, are assessed separately and consequently are not included here:
(a) Acute toxicity (section 3.1);
(b) Skin corrosion/irritation (section 3.2);
(c) Serious eye damage/eye irritation (section 3.3);
(d) Respiratory or skin sensitisation (section 3.4);
(e) Germ cell mutagenicity (section 3.5);
(f) Carcinogenicity (section 3.6);
(g) Reproductive toxicity (section 3.7); and
(h) Aspiration toxicity (section 3.10).
3.8.1.7. The hazard class Specific Target Organ Toxicity — Single Exposure is differentiated into:
Specific target organ toxicity — single exposure, Category 1 and 2;
Specific target organ toxicity — single exposure, Category 3.
See Table 3.8.1.
Table 3.8.1
Categories for specific target organ toxicity-single exposure
Note: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).
Categories Criteria
Category 1 Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure
Substances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:
(a) reliable and good quality evidence from human cases or epidemiological studies; or
(b) observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.
Category 2 Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure
Substances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.
In exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).
Category 3 Transient target organ effects
This category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.
3.8.2. Classification criteria for substances
3.8.2.1. Substances of Category 1 and Category 2
3.8.2.1.1. Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).
3.8.2.1.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).
3.8.2.1.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.
3.8.2.1.5. The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.
3.8.2.1.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of target organ toxicity in Category 2:
(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or
(b) based on the nature and severity of effects.
Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.
3.8.2.1.7. Effects considered to support classification for Category 1 and 2
3.8.2.1.7.1. Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.
3.8.2.1.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
3.8.2.1.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:
(a) morbidity resulting from single exposure;
(b) significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);
(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;
(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;
(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;
(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;
(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.
3.8.2.1.8. Effects considered not to support classification for Category 1 and 2
It is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:
(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate significant toxicity;
(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;
(c) changes in organ weights with no evidence of organ dysfunction;
(d) adaptive responses that are not considered toxicologically relevant;
(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.
3.8.2.1.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals for Category 1 and 2
3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.
3.8.2.1.9.2. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).
3.8.2.1.9.3. The guidance value (C) ranges for single-dose exposure which has produced a significant non-lethal toxic effect are those applicable to acute toxicity testing, as indicated in Table 3.8.2.
Table 3.8.2
Guidance value ranges for single-dose exposures a
Guidance value ranges for:
Route of exposure Units Category 1 Category 2 Category 3
Oral (rat) mg/kg body weight C ≤ 300 2000 ≥ C > 300 Guidance values do not apply b
Dermal (rat or rabbit) mg/kg body weight C ≤ 1000 2000 ≥ C > 1000
Inhalation (rat) gas ppmV/4h C ≤ 2500 20000 ≥ C > 2500
Inhalation (rat) vapour mg/l/4h C ≤ 10 20 ≥ C > 10
Inhalation (rat) dust/mist/fume mg/l/4h C ≤ 1,0 5,0 ≥ C > 1,0
Note
(a) The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.
(b) Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation.
3.8.2.1.10. Other considerations
3.8.2.1.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
3.8.2.1.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.
3.8.2.1.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.
3.8.2.1.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection
3.8.2.2. Substances of Category 3: Transient target organ effects
3.8.2.2.1. Criteria for respiratory tract irritation
The criteria for classifying substances as Category 3 for respiratory tract irritation are:
(a) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;
(b) subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);
(c) the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of irritation shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;
(d) there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;
(e) this special classification would occur only when more severe organ effects including in the respiratory system are not observed.
3.8.2.2.2 Criteria for narcotic effects
The criteria for classifying substances as Category 3 for narcotic effects are:
(a) central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;
(b) narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.
3.8.3. Classification criteria for mixtures
3.8.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.
3.8.3.2. Classification of mixtures when data are available for the complete mixture
3.8.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.
3.8.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.8.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.
3.8.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture
3.8.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.
3.8.3.4.2. These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.
3.8.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.
Table 3.8.3
Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture as Category 1 or 2
Ingredient classified as: Generic concentration limits triggering classification of the mixture as:
Category 1 Category 2
Category 1
Specific Target Organ Toxicant Concentration ≥ 10 % 1,0 % ≤ concentration < 10 %
Category 2
Specific Target Organ Toxicant Concentration ≥ 10 % [(Note 1)]
Note 1
If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.
3.8.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.
3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised.
3.8.4. Hazard Communication
3.8.4.1 Label elements shall be used in accordance with Table 3.8.4., for substances or mixtures meeting the criteria for classification in this hazard class.
Table 3.8.4
Label elements for specific target organ toxicity after single exposure
Classification Category 1 Category 2 Category 3
GHS Pictograms Signal Word Danger Warning Warning
Hazard Statement H370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H335: May cause respiratory irritation; or
H336: May cause drowsiness or dizziness
Precautionary Statement Prevention P260
P264
P270 P260
P264
P270 P261
P271
Precautionary Statement Response P307 + P311
P321 P309 + P311 P304 + P340
P312
Precautionary Statement Storage P405 P405 P403 + P233
P405
Precautionary Statement Disposal P501 P501 P501
3.9. Specific target organ toxicity — repeated exposure
3.9.1. Definitions and general considerations
3.9.1.1. Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.
3.9.1.2. Classification for target organ toxicity (repeated exposure) identifies the substance as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
3.9.1.3. These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.
3.9.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
3.9.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
3.9.1.6. Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.
3.9.2. Classification criteria for substances
3.9.2.1. Substances are classified as specific target organ toxicants following repeated exposure by the use of expert judgement (see 1.1.1), on the basis of the weight of all evidence available, including the use of recommended guidance values which take into account the duration of exposure and the dose/concentration which produced the effect(s), (see 3.9.2.9), and are placed in one of two categories, depending upon the nature and severity of the effect(s) observed (Table 3.9.1).
Table 3.9.1
Categories for specific target organ toxicity-repeated exposure
Categories Criteria
Category 1 Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.
Substances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:
reliable and good quality evidence from human cases or epidemiological studies; or
observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.
Category 2 Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.
Substances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.
In exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).
Note
Attempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).
3.9.2.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified.
3.9.2.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
3.9.2.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.
3.9.2.5. The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.
3.9.2.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of specific target organ toxicity in Category 2:
(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or
(b) based on the nature and severity of effects.
Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.
3.9.2.7. Effects considered to support classification for specific target organ toxicity following repeated exposure
3.9.2.7.1. Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.
3.9.2.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
3.9.2.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, haematology, clinical chemistry, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, shall be taken into consideration in the classification process, including but not limited to the following toxic effects in humans and/or animals:
(a) morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;
(b) significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);
(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;
(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;
(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;
(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);
(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.
3.9.2.8. Effects considered not to support classification for specific target organ toxicity following repeated exposure
3.9.2.8.1. It is recognised that effects may be seen in humans and/or animals that do not justify classification. Such effects include, but are not limited to:
(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate significant toxicity;
(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;
(c) changes in organ weights with no evidence of organ dysfunction;
(d) adaptive responses that are not considered toxicologically relevant;
(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.
3.9.2.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals
3.9.2.9.1. In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.
3.9.2.9.2. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.
3.9.2.9.3. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).
3.9.2.9.4. The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.
3.9.2.9.5. The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.
3.9.2.9.6. Thus classification in Category 1 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur at or below the guidance values (C) as indicated in Table 3.9.2:
Table 3.9.2
Guidance values to assist in Category 1 classification
Route of exposure Units Guidance values (dose/concentration)
Oral (rat) mg/kg body weight/day C ≤ 10
Dermal (rat or rabbit) mg/kg body weight/day C ≤ 20
Inhalation (rat)gas ppmV/6h/day C ≤ 50
Inhalation (rat)vapour mg/litre/6h/day C ≤ 0,2
Inhalation (rat) dust/mist/fume mg/litre/6h/day C ≤ 0,02
3.9.2.9.7. Classification in Category 2 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur within the guidance value ranges as indicated in Table 3.9.3:
Table 3.9.3
Guidance values to assist in Category 2 classification
Route of Exposure Units Guidance Value Ranges:
(dose/concentration)
Oral (rat) mg/kg body weight/day 10 < C ≤ 100
Dermal (rat or rabbit) mg/kg body weight/day 20 < C ≤ 200
Inhalation (rat) gas ppmV/6h/day 50 < C ≤ 250
Inhalation (rat)vapour mg/litre/6h/day 0,2 < C ≤ 1,0
Inhalation (rat) dust/mist/fume mg/litre/6h/day 0,02 < C ≤ 0,2
3.9.2.9.8. The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.
3.9.2.9.9. Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.
3.9.2.10. Other considerations
3.9.2.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
3.9.2.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.
3.9.2.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.
3.9.2.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection
3.9.3. Classification criteria for mixtures
3.9.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.
3.9.3.2. Classification of mixtures when data are available for the complete mixture
3.9.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.
3.9.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.9.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.
3.9.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture
3.9.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, repeat exposure, or both when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as laid out in Table 3.9.4 for Category 1 and 2 respectively.
Table 3.9.4
Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture
Ingredient classified as: Generic concentration limits triggering classification of the mixture as:
Category 1 Category 2
Category 1
Specific Target Organ Toxicant Concentration ≥ 10 % 1,0 % ≤ concentration < 10 %
Category 2
Specific Target Organ Toxicant Concentration ≥ 10 % [(Note 1)]
Note 1
If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.
3.9.3.4.2. These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.
3.9.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.
3.9.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.
3.9.4. Hazard Communication
3.9.4.1. Label elements shall be used in accordance with Table 3.9.5 for substances or mixtures meeting the criteria for classification in this hazard class.
Table 3.9.5
Label elements for specific target organ toxicity after repeated exposure
Classification Category 1 Category 2
GHS Pictograms Signal word Danger Warning
Hazard Statement H372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement Prevention P260
P264
P270 P260
Precautionary Statement Response P314 P314
Precautionary Statement Storage Precautionary Statement Disposal P501 P501
3.10. Aspiration hazard
3.10.1. Definitions and general considerations
3.10.1.1. These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.
3.10.1.2 Aspiration means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.
3.10.1.3. Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.
3.10.1.4. Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.
3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.
3.10.1.6. Specific considerations
3.10.1.6.1. A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.
3.10.1.6.2. The classification criteria refer to kinematic viscosity. The following provides the conversion between dynamic and kinematic viscosity:
Dynamic viscosity mPa sDensity g/cm3=Kinematic viscosity mm2/s
3.10.1.6.3. Classification of aerosol/mist products
Aerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.
3.10.2. Classification criteria for substances
Table 3.10.1
Hazard category for aspiration toxicity
Category Criteria
Category 1 Substances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard
A substance is classified in Category 1:
(a) based on reliable and good quality human evidence
or
(b) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.
Note:
Substances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil.
3.10.3. Classification criteria for mixtures
3.10.3.1. Classification when data are available for the complete mixture
A mixture is classified in Category 1 based on reliable and good quality human evidence.
3.10.3.2. Classification when data are not available for the complete mixture: bridging principles
3.10.3.2.1. Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.
3.10.3.3. Classification when data are available for all components or only some components of the mixture
3.10.3.3.1. Category 1
3.10.3.3.1.1. A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.
3.10.3.3.1.2. In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.
3.10.4. Hazard Communication
3.10.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.10.2.
Table 3.10.2
Aspiration toxicity label elements
Classification Category 1
GHS Pictogram Signal Word Danger
Hazard Statement H304: May be fatal if swallowed and enters airways
Precautionary Statement
Prevention Precautionary Statement
Response P301 + P310
P331
Precautionary Statement
Storage P405
Precautionary Statement
Disposal P501
4. PART 4: ENVIRONMENTAL HAZARDS
4.1. Hazardous to the aquatic environment
4.1.1. Definitions and General Considerations
4.1.1.1. Definitions
Acute aquatic toxicity means the intrinsic property of a substance to be injurious to an organism in a short-term exposure to that substance.
Availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (Mo) compound can disaggregate from the rest of the compound (molecule).
Bioavailability (or biological availability) means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.
Bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).
Bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.
Chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during exposures which are determined in relation to the life-cycle of the organism.
Degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.
4.1.1.2. Basic elements
4.1.1.2.0. Hazardous to the Aquatic Environment is differentiated into:
Acute aquatic hazard;
Chronic (long term) aquatic hazard.
4.1.1.2.1. The basic elements used for classification for aquatic environmental hazards are:
Acute aquatic toxicity;
Potential for or actual bioaccumulation;
Degradation (biotic or abiotic) for organic chemicals; and
Chronic aquatic toxicity.
4.1.1.2.2. Preferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test method used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1.
4.1.1.3. Other considerations
4.1.1.3.1. Classification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of hazard is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.
4.1.1.3.2. While the classification system applies to all substances and mixtures, it is recognised that for special cases the Agency will issue guidance.
4.1.2. Classification criteria for substances
4.1.2.1. The core classification system for substances consists of one acute classification category and three chronic classification categories. The acute and the chronic classification categories are applied independently. The criteria for classification of a substance in acute Category 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the chronic categories combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data).
4.1.2.2. The system also introduces a safety net classification (referred to as Chronic Category 4) for use when the data available do not allow classification under the formal criteria but there are nevertheless some grounds for concern (see example in table 4.1.0).
4.1.2.3. The system for classification recognises that the core intrinsic hazard to aquatic organisms is represented by both the acute and chronic toxicity of a substance. Separate hazard categories are defined for both properties representing a gradation in the level of hazard identified. The lowest of the available toxicity values shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.
4.1.2.4. The principal hazard of a hazardous to the aquatic environment substance is defined by chronic toxicity, although acute toxicity at L(E)C50 levels ≤ 1 mg/l are also considered hazardous. The intrinsic properties of a lack of rapid degradability and/or a potential to bioconcentrate in combination with acute toxicity are used to assign a substance to a chronic (long term) hazard category.
4.1.2.5. Substances with acute toxicities well below 1 mg/l contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and 4.1.3.5.5).
4.1.2.6. The criteria for classifying and categorising substances as hazardous to the aquatic environment are summarised in Table 4.1.0.
Table 4.1.0
Classification categories for hazardous to the aquatic environment
Acute (short-term) aquatic hazard
Acute Category 1 (Note 1)
96 hr LC50 (for fish) ≤ 1 mg/l and/or
48 hr EC50 (for crustacea) ≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) ≤ 1 mg/l. (Note 2)
Chronic (long-term) aquatic hazard
Chronic Category 1 (Note 1)
96 hr LC50 (for fish) ≤ 1 mg/l and/or
48 hr EC50 (for crustacea) ≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) ≤ 1 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4).
Chronic Category 2
96 hr LC50 (for fish) > 1 to ≤ 10 mg/l and/or
48 hr EC50 (for crustacea) > 1 to ≤ 10 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) > 1 to ≤ 10 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4), unless the chronic toxicity NOECs are > 1 mg/l.
Chronic Category 3
96 hr LC50 (for fish) > 10 to ≤ 100 mg/l and/or
48 hr EC50 (for crustacea) > 10 to ≤ 100 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) > 10 to ≤ 100 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4) unless the chronic toxicity NOECs are > 1 mg/l.
Safety net classification
Chronic Category 4
Cases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 3), and which are not rapidly degradable and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or evidence of rapid degradation in the environment.
Note 1
When classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate an appropriate M-factor (see table 4.1.3).
Note 2
Classification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.
Note 3
No acute toxicity is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity.
4.1.2.7. Aquatic toxicity
4.1.2.7.1. Acute aquatic toxicity is normally determined using a fish 96 hour LC50, a crustacea species 48 hour EC50 and/or an algal species 72 or 96 hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).
4.1.2.7.2. For determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECS or other equivalent L(E)Cx (e.g. EC10) shall be used.
4.1.2.8. Bioaccumulation
4.1.2.8.1. Bioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes.
4.1.2.9. Rapid degradability of organic substances
4.1.2.9.1. Substances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.
4.1.2.9.2. One way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is readily biodegradable. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade rapidly in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of rapid degradability is met.
4.1.2.9.3. Many degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.
4.1.2.9.4. The criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.
4.1.2.9.5. Substances are considered rapidly degradable in the environment if one of the following criteria holds true:
(a) if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved;
(i) tests based on dissolved organic carbon: 70 %
(ii) tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.
These levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded; or
(b) if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or
(c) if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.
4.1.2.10. Inorganic compounds and metals
4.1.2.10.1. For inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with careSpecific guidance will be provided by the Agency on how these data for such substances may be used in meeting the requirements of the classification criteria..
4.1.2.10.2. Poorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution.
4.1.3. Classification criteria for mixtures
4.1.3.1. The classification system for mixtures covers all classification categories which are used for substances, i.e. Acute Category 1 and Chronic Categories 1 to 4. In order to make use of all available data for purposes of classifying the aquatic environmental hazards of the mixture, the following is applied where appropriate:
The relevant components of a mixture are those which are classified Acute Category 1 or Chronic Category 1 and present in a concentration of 0,1 % (w/w) or greater, and those which are classified Chronic Category 2, Chronic Category 3 or Chronic Category 4 and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as Acute Category 1 or Chronic Category 1 the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see 4.1.3.5.5.5).
4.1.3.2. The approach for classification of aquatic environmental hazards is tiered, and is dependent upon the type of information available for the mixture itself and for its components. Figure 4.1.2 outlines the process to be followed.
Elements of the tiered approach include:
classification based on tested mixtures;
classification based on bridging principles;
the use of summation of classified components and/or an additivity formula.
Figure 4.1.2
Tiered approach to classification of mixtures for acute and chronic (long term) aquatic environmental hazards
Aquatic toxicity test data available on the mixture as a whole
No
Yes
CLASSIFY
for acute/chronic aquatic hazard (see 4.1.3.3)
Sufficient data available on similar mixtures to estimate hazards
Yes
Apply bridging principles (see 4.1.3.4.)
CLASSIFY
for acute/chronic aquatic hazard
No
Either aquatic toxicity or classification data available for all relevant components
Yes
Apply summation Method (see 4.1.3.5.5) using:
• Percentage of all components classified as ‘Chronic’
• Percentage of components classified as ‘Acute’
• Percentage of components with acute toxicity data: apply Addititivity Formula (see 4.1.3.5.2) and convert the derived L(E)C50 to the appropriate ‘Acute’ Category
CLASSIFY
for acute/chronic aquatic hazard
No
Use available hazard data of known components.
Apply Summation Method and/or Additivity Formula (see 4.1.3.5) and apply 4.1.3.6
CLASSIFY
for acute/chronic aquatic hazard
4.1.3.3. Classification of mixtures when data are available for the complete mixture
4.1.3.3.1. When the mixture as a whole has been tested to determine its aquatic toxicity, it is classified according to the criteria that have been agreed for substances, but only for acute hazard. The classification is normally based on the data for fish, crustacea and algae/plants. Classification of mixtures by using LC50 or EC50 data for the mixture as a whole is not possible for chronic categories since both toxicity data and environmental fate data are needed, and there are no degradability and bioaccumulation data for mixtures as a whole. It is not possible to apply the criteria for chronic classification because the data from degradability and bioaccumulation tests of mixtures cannot be interpreted; they are meaningful only for single substances.
4.1.3.3.2. When there is acute toxicity test data (LC50 or EC50) available for the mixture as a whole, these data as well as information with respect to the classification of components for chronic (long-term) hazard shall be used to complete the classification for tested mixtures as follows. When chronic toxicity data (NOEC) is also available, this shall be used too.
(a) L(E)C50 (LC50 or EC50) of the tested mixture ≤ 100 mg/l and NOEC of the tested mixture ≤ 1 mg/l or unknown:
Classify mixture as Acute Category 1 (LC50 or EC50 of the tested mixture ≤ 1 mg/l) or no need for acute classification (LC50 and EC50 of the tested mixture > 1 mg/l).
Apply summation method (see 4.1.3.5.5) for chronic classification (Chronic Category 1, 2, 3, 4 or no need for chronic classification).
(b) L(E)C50 of the tested mixture ≤ 100 mg/l and NOEC(s) of the tested mixture > 1 mg/l:
No need to classify for acute hazard
Apply summation method (see 4.1.3.5.5) for classification as Chronic Category 1. If the mixture is not classified as Chronic Category 1, then there is no need for chronic classification.
(c) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC of the tested mixture ≤ 1 mg/l or unknown:
No need to classify for acute hazard
Apply summation method (see 4.1.3.5.5) for Chronic classification (Chronic Category 4 or no need for chronic classification).
(d) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC(s) of the tested mixture > 1 mg/l:
No need to classify for acute or chronic (long-term) hazard.
4.1.3.4. Classification of mixtures when data are not available for the complete mixture: Bridging principles
4.1.3.4.1. Where the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, paragraphs 4.1.3.4.2 and 4.1.3.4.3 shall be used.
4.1.3.4.2. Dilution: if a mixture is formed by diluting another mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the mixture may be classified as equivalent to the original mixture or substance.
4.1.3.4.3. If a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance
4.1.3.5. Classification of mixtures when data are available for all components or only for some components of the mixture
4.1.3.5.1. The classification of a mixture is based on summation of the classification of its components. The percentage of components classified as Acute or Chronic is fed straight in to the summation method. Details of the summation method are described in 4.1.3.5.5.
4.1.3.5.2. When a mixture consists of components that are not (yet) classified (as Acute Category 1 and/or Chronic Category 1, 2, 3 or 4) adequate data for these components shall be taken into account when available. When adequate toxicity data are available for more than one component in the mixture, the combined toxicity of those components is calculated using the following additivity formula, and the calculated toxicity is used to assign that portion of the mixture an acute category which is then subsequently used in applying the summation method.
ΣCiC(E)L50m = ΣηCiC(E)L50i
where:
Ci
concentration of component i (weight percentage)
L(E)C50 i
(mg/l) LC50 or EC50 for component i
η
number of components
L(E)C50 m
L(E) C50 of the part of the mixture with test data
4.1.3.5.3. When applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, daphnia, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute toxicity is then used to assess whether this part of the mixture shall be classified as Acute Category 1 using the same criteria described for substances.
4.1.3.5.4. If a mixture is classified in more than one way, the method yielding the more conservative result shall be used.
4.1.3.5.5. Summation method
4.1.3.5.5.1. Rationale
4.1.3.5.5.1.1. In case of the substance classification categories Acute Category 1 or Chronic Category 1 to Chronic Category 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of all substances classified as Acute Category 1/Chronic Category 1, Chronic Category 2 and Chronic Category 3 together.
4.1.3.5.5.1.2. When a mixture contains components classified as Acute Category 1 or Chronic Category 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an under-classification of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in paragraph 4.1.3.5.5.5.
4.1.3.5.5.2. Classification procedure
4.1.3.5.5.2.1. In general a more severe classification for mixtures overrides a less severe classification, e.g. a classification for chronic toxicity with Chronic Category 1 overrides a classification with Chronic Category 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic Category 1. A more severe classification than Chronic Category 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.
4.1.3.5.5.3. Classification for Acute Category 1
4.1.3.5.5.3.1. First all components classified as Acute Category 1 are considered. If the sum of these components is greater than 25 % the whole mixture is classified as Acute Category 1.
4.1.3.5.5.3.2. The classification of mixtures for acute hazards based on this summation of classified components, is summarised in Table 4.1.1.
Table 4.1.1
Classification of a mixture for acute hazards, based on summation of classified components
For explanation of the M-factor, see 4.1.3.5.5.5.
Sum of components classified as: Mixture is classified as:
Acute Category 1 × M ≥ 25 % Acute Category 1
4.1.3.5.5.4. Classification for the Chronic Categories 1, 2, 3 and 4
4.1.3.5.5.4.1. First all components classified as Chronic Category 1 are considered. If the sum of these components multiplied by their corresponding M-factors is equal to or greater than 25 % the mixture is classified as Chronic Category 1. If the result of the calculation is a classification of the mixture as Chronic Category 1 the classification procedure is completed.
4.1.3.5.5.4.2. In cases where the mixture is not classified as Chronic Category 1, classification of the mixture as Chronic Category 2 is considered. A mixture is classified as Chronic Category 2 if 10 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus the sum of all components classified as Chronic Category 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic Category 2, the classification process is completed.
4.1.3.5.5.4.3. In cases where the mixture is not classified either as Chronic Category 1 or Chronic Category 2, classification of the mixture as Chronic Category 3 is considered. A mixture is classified as Chronic Category 3 if 100 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus 10 times the sum of all components classified with Chronic Category 2 plus the sum of all components classified as Chronic Category 3 is ≥ 25 %.
4.1.3.5.5.4.4. If the mixture is still not classified in Chronic Category 1, 2 or 3, classification of the mixture as Chronic Category 4 shall be considered. A mixture is classified as Chronic Category 4 if the sum of the percentages of components classified as Chronic Category 1, 2, 3 and 4 is equal to or greater than 25 %.
4.1.3.5.5.4.5. The classification of mixtures for chronic (long term) hazards, based on this summation of classified components, is summarised in Table 4.1.2.
Table 4.1.2
Classification of a mixture for chronic (long term) hazards, based on summation of classified components
For explanation of the M-factor, see 4.1.3.5.5.5.
Sum of components classified as: Mixture is classified as:
Chronic Category 1 × M ≥ 25 % Chronic Category 1
(M × 10 × Chronic Category 1) + Chronic Category 2 ≥ 25 % Chronic Category 2
(M × 100 × Chronic Category 1) + (10 × Chronic Category 2) + Chronic Category 3 ≥ 25 % Chronic Category 3
Chronic Category 1 + Chronic Category 2 + Chronic Category 3 + Chronic Category 4 ≥ 25 % Chronic Category 4
4.1.3.5.5.5. Mixtures with highly toxic components
4.1.3.5.5.5.1. Acute Category 1 and Chronic Category 1 components with toxicities below 1 mg/l contribute to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach. When a mixture contains components classified as Acute or Chronic Category 1, one of the following shall be applied:
The tiered approach described in 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute Category 1 and Chronic Category 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of Acute Category 1 in the left column of Table 4.1.1 and the concentration of Chronic Category 1 in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic Category 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method;
The additivity formula (see 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.
Table 4.1.3
Multiplying factors for highly toxic components of mixtures
L(E)C50 value Multiplying factor (M)
0,1 < L(E) C50 ≤ 1 1
0,01 < L(E) C50 ≤ 0,1 10
0,001 < L(E) C50 ≤ 0,01 100
0,0001 < L(E) C50 ≤ 0,001 1000
0,00001 < L(E) C50 ≤ 0,0001 10000
(continue in factor 10 intervals) 4.1.3.6. Classification of mixtures with components without any useable information
4.1.3.6.1. In the event that no useable information on acute and/or chronic (long term) aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement in the SDS that: Contains x % of components with unknown hazards to the aquatic environment.
4.1.4. Hazard Communication
4.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 4.1.4.
Table 4.1.4
Label elements for hazardous to the aquatic environment
ACUTE
Category 1
GHS Pictogram Signal Word Warning
Hazard Statement H400: Very toxic to aquatic life
Precautionary Statement Prevention P273
Precautionary Statement Response P391
Precautionary Statement Storage Precautionary Statement Disposal P501
CHRONIC
Category 1 Category 2 Category 3 Category 4
GHS Pictograms No pictogram is used No pictogram is used
Signal Word Warning No signal word is used No signal word is used No signal word is used
Hazard Statement H410: Very toxic to aquatic life with long lasting effects H411: Toxic to aquatic life with long lasting effects H412: Harmful to aquatic life with long lasting effects H413: May cause long lasting harmful effects to aquatic life
Precautionary Statement Prevention P273 P273 P273 P273
Precautionary Statement Response P391 P391 Precautionary Statement Storage Precautionary Statement Disposal P501 P501 P501 P501
5. PART 5: ADDITIONAL EU HAZARD CLASS
5.1. Hazardous to the ozone layer
5.1.1. Definitions and general considerations
5.1.1.1. Substance Hazardous to the Ozone Layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 2037/2000 of the European Parliament and of the Council of 29 June 2000 on substances that deplete the ozone layerOJ L 244, 29.9.2000, p. 1. and its subsequent amendments.
5.1.2. Classification criteria for substances
5.1.2.1. A substance shall be classified as Hazardous to the Ozone Layer if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.
5.1.3. Classification criteria for mixtures
5.1.3.1. Mixtures shall be classified as Hazardous to the Ozone Layer on the basis of the individual concentration of the substance(s) contained therein that are also classified as Hazardous to the Ozone Layer, in accordance with Table 5.1.
Table 5.1
Generic concentration limits for substances (in a mixture), classified as Hazardous to the Ozone Layer, that trigger classification of the mixture as Hazardous to the Ozone Layer
Classification of the substance Classification of the mixture
Hazardous to the ozone layer C > 0,1 %
5.1.4. Hazard Communication
5.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 5.2
Table 5.2
Label elements for Hazardous to the Ozone Layer
Symbol/pictogram Signal Word Danger
Hazard Statement EUH059: Hazardous to the Ozone Layer
Precautionary Statements P273
P501

after (02008R1272-20101201)

ANNEX I
CLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES
This annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.


1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND LABELLING


1.0. Definitions
Gas means a substance which:

(i) at 50 oC has a vapour pressure greater than 300 kPa (absolute); or

(ii) is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;
Liquid means a substance or mixture which:

(i) at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);

(ii) is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and

(iii) which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;
Solid means a substance or mixture which does not meet the definitions of liquid or gas.


1.1. Classification of substances and mixtures


1.1.0. Cooperation to meet the requirements in this Regulation
Suppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.
Suppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.
Suppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.
The network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.


1.1.1. The role and application of expert judgement and weight of evidence determination
1.1.1.1. Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.

1.1.1.2. The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.
1.1.1.3. A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.
1.1.1.4. For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.
1.1.1.5. For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.


1.1.2. Specific concentration limits, M-factors and generic cut-off values
1.1.2.1. Specific concentration limits or M-factors shall be applied in accordance with Article 10.


1.1.2.2. Cut-off values
1.1.2.2.1. Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).

1.1.2.2.2. The cut-off values referred to in Article 11 shall be the following:

(a) For health and environmental hazards in Parts 3, 4 and 5 of this Annex:

(i) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or

(ii) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or

(iii) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or

(iv) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.

(b) For aquatic environmental hazards in section 4.1 of this Annex:

(i) for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or

(ii) for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.

Table 1.1
Generic cut-off values

Or < 1 % where relevant, see 3.2.3.3.1.
Or < 1 % where relevant, see 3.3.3.3.1.
Or < 0,1 % where relevant, see 4.1.3.1.

Hazard class
Generic cut-off values to be taken into account
Acute Toxicity:


Category 1-3
0,1 %

Category 4
1 %
Skin corrosion/Irritation
1 %
Serious damage to eyes/eye irritation
1 %
Hazardous to Aquatic Environment


Acute Category 1
0,1 %

Chronic Category 1
0,1 %

Chronic Category 2-4
1 %

Note
Generic cut-off values are in weight percentages except for gaseous mixtures where they are in volume percentage.


1.1.3. Bridging principles for the classification of mixtures where test data are not available for the complete mixture
Where the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.


1.1.3.1. Dilution
If a mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:

the new mixture shall be classified as equivalent to the original mixture;
the method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;
in the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).


1.1.3.2. Batching
The hazard category of one production batch of a mixture can be assumed to be substantially equivalent to that of another production batch of the same commercial product, and produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the batch has changed. If the latter occurs, a new evaluation is necessary.



1.1.3.3. Concentration of highly hazardous mixtures
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a mixture is classified in the highest hazard category or sub-category, and the concentration of the ingredients of the mixture that are in that category or sub-category is increased, the new mixture shall be classified in that category or sub-category without additional testing.


1.1.3.4. Interpolation within one toxicity category
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures with identical hazardous ingredients, where mixtures A and B are in the same hazard category and mixture C has the same active hazardous ingredients with concentrations intermediate to the concentrations of those hazardous ingredients in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.


1.1.3.5. Substantially similar mixtures
Given the following:

(a) two mixtures each containing two ingredients:

(i) A + B

(ii) C + B;

(b) the concentration of ingredient B is essentially the same in both mixtures;

(c) the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);

(d) hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.
If mixture (i) is already classified in a particular hazard class based on test data, mixture (ii) shall be assigned the same hazard category.


1.1.3.6. Review of classification where the composition of a mixture has changed
The following variations in initial concentration are defined for the application of Article 15(2)(a):

Table 1.2
Bridging Principle for changes in the composition of a mixture

Initial concentration range of the constituent
Permitted variation in initial concentration of the constituent
≤ 2,5 %
± 30 %
2,5 < C ≤ 10 %
± 20 %
10 < C ≤ 25 %
± 10 %
25 < C ≤ 100 %
± 5 %


1.1.3.7. Aerosols
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.



1.2. Labelling


1.2.1. Dimensions and make-up of the label elements
1.2.1.1. Hazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.
1.2.1.2. Hazard pictograms shall be in the shape of a square set at a point. Each hazard pictogram shall cover at least one fifteenth of the surface area of the harmonised label but the minimum area shall not be less than 1 cm2.
1.2.1.3. The dimensions of the label shall be as follows:

Table 1.3
Dimension of labels

Capacity of the package
Dimensions (in millimetres)
Not exceeding 3 litres:
If possible, at least 52 × 74
Greater than 3 litres but, not exceeding 50 litres:
At least 74 × 105
Greater than 50 litres but not exceeding 500 litres:
At least 105 × 148
Greater than 500 litres:
At least 148 × 210


1.3. Derogations from labelling requirements for special cases
In accordance with Article 23 the following derogations shall apply:


1.3.1. Transportable gas cylinders
For transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:

(a) A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to Gas cylinders — Precautionary labels. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.

(b) The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.


1.3.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)
1.3.2.1. If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.

1.3.2.2. No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).
1.3.2.3. For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.


1.3.3. Aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard
With regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.


1.3.4. Metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers
1.3.4.1. Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.
1.3.4.2. Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.


1.3.5. Explosives placed on the market with a view to obtaining an explosive or pyrotechnic effect
Explosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.


1.4. Request for use of an alternative chemical name


1.4.1. Requests for use of an alternative chemical name under Article 24 may be granted only where

(I) the substance has not been assigned a Community workplace exposure limit; and

(II) the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and

(III) the substance is classified exclusively as one or more of the following hazard categories:

(a) any of the hazard categories referred to in Part 2 of this Annex;

(b) Acute toxicity, Category 4;

(c) Skin corrosion/irritation, Category 2;

(d) Serious eye damage/eye irritation, Category 2;

(e) Specific target organ toxicity — Single exposure, Category 2 or 3;


(f) Specific target organ toxicity — Repeated exposure, Category 2;

(g) Hazardous to the aquatic environment — Chronic, Category 3 or 4.


1.4.2. The choice of the chemical name(s) for mixtures intended for the fragrance or perfume industry
In the case of substances occurring in nature, a chemical name or chemical names of the type essential oil of … or extract of … may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).


1.5. Exemptions from labelling and packaging requirements


1.5.1. Exemptions from Article 31 [(Article 29(1))]
1.5.1.1. Where Article 29(1) applies, the label elements mentioned in Article 17 may be provided in one of the following ways:

(a) in fold-out labels; or

(b) on tie-on tags; or

(c) on an outer packaging.
1.5.1.2. The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.


1.5.2. Exemptions from Article 17 [(Article 29(2)]


1.5.2.1. Labelling of packages where the contents do not exceed 125 ml
1.5.2.1.1. The hazard statements and the precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a) the contents of the package do not exceed 125 ml; and

(b) the substance or mixture is classified in one or more of the following hazard categories:

1) Oxidising gases of category 1;

2) Gases under pressure;

3) Flammable liquids of category 2 or 3;

4) Flammable solids of category 1 or 2;

5) Self-reactive substances or mixtures Types C to F;

6) Self-heating substances or mixtures of category 2;

7) Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;

8) Oxidising liquids of category 2 or 3;

9) Oxidising solids of category 2 or 3;

10) Organic peroxides Types C to F;

11) Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;

12) Skin irritation of category 2;

13) Eye irritation of category 2;

14) Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;


15) Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;

16) Hazardous to the aquatic environment — Acute of category 1;

17) Hazardous to the aquatic environment — Chronic of category 1 or 2.
The exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.
1.5.2.1.2. The precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a) the contents of the package do not exceed 125 ml; and

(b) the substance or mixture is classified in one or more of the following hazard categories:

1) Flammable gases of category 2;

2) Reproductive toxicity: effects on or via lactation;

3) Hazardous to the aquatic environment — Chronic of category 3 or 4.
1.5.2.1.3. The pictogram, the hazard statement and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a) the contents of the package do not exceed 125 ml; and

(b) the substance or mixture is classified in one or more of the following hazard categories:

1) Corrosive to metals.


1.5.2.2. Labelling of soluble packaging for single use
The label elements required by Article 17 may be omitted from soluble packaging intended for single use where:

(a) The content of each soluble packaging does not exceed a volume of 25 ml;

(b) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b); and

(c) The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.
1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.



2. PART 2: PHYSICAL HAZARDS


2.1. Explosives


2.1.1. Definitions
2.1.1.1. The class of explosives comprises

(a) explosive substances and mixtures;

(b) explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and

(c) substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.
2.1.1.2. For the purposes of this Regulation the following definitions shall apply:
An explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.
A pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.
An unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.
An explosive article is an article containing one or more explosive substances or mixtures.
A pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.
An intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.


2.1.2. Classification criteria
2.1.2.1. Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.
2.1.2.2. Substances, mixtures and articles of this class, which are not classified as an unstable explosive, shall be assigned to one of the following six divisions depending on the type of hazard they present:

(a) Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);

(b) Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;

(c) Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:

(i) combustion of which gives rise to considerable radiant heat; or


(ii) which burn one after another, producing minor blast or projection effects or both;

(d) Division 1.4 Substances, mixtures and articles which present no significant hazard:

substances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;

(e) Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:

substances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;

(f) Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:

articles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.
2.1.2.3. Explosives, which are not classified as an unstable explosive, shall be classified in one of the six divisions referred to in paragraph 2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to the results of the tests laid down in Table 2.1.1:

Table 2.1.1
Criteria for explosives

This comprises substances, mixtures and articles which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.

Category
Criteria
Unstable explosives or explosives of Divisions 1.1 to 1.6
For explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:
Explosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives shall not be subject to UN Test Series 2.
Sensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Thermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Further tests are necessary to allocate the correct Division.

2.1.2.4. If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.


2.1.3. Hazard Communication
Label elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.
NOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:

(a) the pictogram: exploding bomb;

(b) the signal word: Danger; and

(c) the hazard statement: explosive; mass explosion hazard
unless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.


Table 2.1.2
Label elements for explosives

Classification
Unstable Explosive
Division 1.1
Division 1.2
Division 1.3
Division 1.4
Division 1.5
Division 1.6
GHS Pictograms







Signal Word
Danger
Danger
Danger
Danger
Warning
Danger
No signal word
Hazard Statement
H200: Unstable Explosive
H201: Explosive; mass explosion hazard
H202: Explosive; severe projection hazard
H203: Explosive; fire, blast or projection hazard
H204: Fire or projection hazard
H205: May mass explode in fire
No hazard statement
Precautionary Statement
Prevention
P201
P202
P281
P210
P230
P240
P250
P280
P210
P230
P240
P250
P280
P210
P230
P240
P250
P280
P210
P240
P250
P280
P210
P230
P240
P250
P280
No precautionary statement
Precautionary Statement
Response
P372
P373
P380
P370+P380
P372
P373
P370+P380
P372
P373
P370+P380
P372
P373
P370+P380
P372
P373
P370+P380
P372
P373
No precautionary statement
Precautionary Statement
Storage
P401
P401
P401
P401
P401
P401
No precautionary statement
Precautionary Statement
Disposal
P501
P501
P501
P501
P501
P501
No precautionary statement



2.1.4. Additional Classification Considerations
2.1.4.1. The classification of substances, mixtures and articles in the explosives hazard class and further allocation to a division is a very complex, three step procedure. Reference to Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria is necessary.
The first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE) is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.
Explosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).
Certain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.
The classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).


Figure 2.1.1
Overall scheme of the procedure for classifying a substance, mixture or article in the class of explosives (Class 1 for transport)

SUBSTANCE, MIXTURE OR ARTICLE FOR CLASSIFICATION
ACCEPTANCE PROCEDURE
CLASSIFY as an UNSTABLE EXPLOSIVE
REJECT Not an EXPLOSIVE
CLASSIFY AS AN EXPLOSIVE
HAZARDOUS DIVISION ASSIGNMENT
COMPATIBILITY GROUP ASSIGNMENT
DIVISION 1.1, 1.2, 1.3, 1.4, 1.5, OR 1.6 COMPATIBILITY GROUP A, B, C, D, E, F, G, H, J, K, L, N or S (*)
CLASSIFICATION CODE (*)
(*) see UN Recommendations on the Transport of Dangerous Goods, Model Regulations, 15th rev. ed, sub-section 2.1.2.


Figure 2.1.2
Procedure for provisional acceptance of a substance, mixture or article in the class of explosives (Class 1 for transport)

SUBSTANCE/MIXTURE FOR CLASSIFICATION
ARTICLE FOR CLASSIFICATION
Is the substance/ mixture manufactured with a view to producing a practical explosive or pyrotechnic effect
Yes
Substance/mixture to be considered for this Class
No
TEST SERIES 3
Is the substance/ mixture a candidate for ammonium nitrate emulsion suspension or gel, intermediate for blasting explosive ANE?
Is the substance/mixture thermally stable?
Yes
No
No
Yes
TEST SERIES 8 Go to figure 2.1.4
TEST SERIES 1 (*)
Is the substance/mixture too dangerous in the form in which it was tested?
No
Yes
No
Is it an explosive substance/mixture?
Encapsulate and/or package the substance/mixture
Yes
TEST SERIES 2
TEST SERIES 4
Yes
Is the substance/mixture too insensitive for acceptance into this Class?
No
Is the article, packed article or packaged substance/mixture too dangerous?
No
Yes
NOT AN EXPLOSIVE
CLASSIFY as an Unstable Explosive
PROVISIONALLY ACCEPT INTO THIS CLASS (go to figure 2.1.3)
(*) For classification purposes, start with Test Series 2.


Figure 2.1.3
Procedure for assignment to a division in the class of explosives (Class 1 for transport)

ARTICLE OR SUBSTANCE/MIXTURE PROVISIONALLY ACCEPTED IN THIS CLASS (from figure 2.1.2)
Is the article a candidate for Division 1.6?
No
Is the substance/mixture a candidate for Division 1.5?
No
Package the substance/ mixture
TEST SERIES 6
Yes
TEST SERIES 7
Yes
Is the result a mass explosion?
Yes
Is it an extremely insensitive article?
No
TEST SERIES 5
No
No
Yes
Yes
Is it a very insensitive explosive substance/mixture with a mass explosion hazard?
Is the major hazard that from dangerous projections?
Yes
No
No
Is the major hazard radiant heat and/or violent burning but with no dangerous blast or projection hazard?
No
Is there a small hazard in the event of ignition or initiation?
Yes
No
Is the substance/ mixture or article manufactured with the view to producing a practical explosive or pyrotechnic effect?
Yes
Yes
No
Would the hazard hinder fire-fighting in the immediate vicinity?
Yes
Is the product an article excluded by definition?
Yes
No
NOT AN EXPLOSIVE
DIVISION 1.6
DIVISION 1.5
DIVISION 1.4 Compatibility group S
DIVISION 1.4 Compatibility groups other than S
DIVISION 1.3
DIVISION 1.2
DIVISION 1.1


Figure 2.1.4
Procedure for classification of ammonium nitrate emulsions, suspensions or gels

TEST SERIES 8
TEST 8 (a) Thermal Stability Test Is the substance/mixture Thermally stable ?
No
Classify as unstable explosive
Yes
TEST 8 (b) ANE Large Scale Gap Test Is the substance/mixture too sensitive to shock to be accepted as an oxidising liquid or an oxidising solid ?
Yes
Substance/mixture to be considered for classification as an explosive other than as an unstable explosive; If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘no’, the substance/mixture shall be classified in Division 1.1
No
TEST 8 (c) Koenen Test Is the substance/mixture too sensitive to the effect of heating under confinement?
Yes
Substance/mixture to be considered for classification as an explosive of Division 1.5, proceed with Test Series 5. If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘yes’, the substance/mixture shall be classified in Division 1.5, if the answer is ‘no’ the substance shall be classified in Division 1.1
No
Substance/mixture accepted for classification as an oxidizing liquid or an oxidising solid as an ammonium nitrate emulsion, suspension orgel, intermediate for blasting explosives (ANE); (Sections 2.13 or 2.14)



2.1.4.2. Screening procedure
Explosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.

Note
Neither a Series 1 type (a) propagation of detonation test nor a Series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g.
2.1.4.3. A substance or mixture shall not be classified as explosive if:

(a) There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or

(b) The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;
The oxygen balance is calculated for the chemical reaction:
CxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O
Using the formula:
Oxygen balance = -1600 [2x + (y/2)-z]/molecular weight;

(c) When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or

(d) For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:

less than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;
less than 30 % by mass, if the oxidising substance is assigned to Category 3.
2.1.4.4. In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.


2.2. Flammable gases


2.2.1. Definition
Flammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.


2.2.2. Classification criteria
2.2.2.1. A flammable gas shall be classified in this class in accordance with Table 2.2.1:


Table 2.2.1
Criteria for flammable gases

Category
Criteria
1
Gases, which at 20 oC and a standard pressure of 101,3 kPa:

(a) are ignitable when in a mixture of 13 % or less by volume in air; or

(b) have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.
2
Gases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.

Note
For the classification of aerosols, see 2.3.


2.2.3. Hazard Communication
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.

Table 2.2.2
Label elements for flammable gases

Classification
Category 1
Category 2
GHS Pictogram

No pictogram
Signal Word
Danger
Warning
Hazard Statement
H220: Extremely flammable gas
H221: Flammable gas
Precautionary Statement
Prevention
P210
P210
Precautionary Statement
Response
P377
P381
P377
P381
Precautionary Statement
Storage
P403
P403
Precautionary Statement
Disposal




2.2.4. Additional Classification Considerations
2.2.4.1. Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.



2.3. Flammable aerosols


2.3.1. Definitions
Aerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.


2.3.2. Classification criteria
2.3.2.1. Aerosols shall be considered for classification as flammable in accordance with 2.3.2.2 if they contain any component which is classified as flammable according to the criteria contained in this Part, i.e.:

Liquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;
Flammable gases (see 2.2);
Flammable solids (see 2.7).

Note
Flammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.
2.3.2.2. A flammable aerosol shall be classified in one of the two categories for this Class on the basis of its components, of its chemical heat of combustion and, if applicable, of the results of the foam test (for foam aerosols) and of the ignition distance test and enclosed space test (for spray aerosols) in accordance with Figure 2.3.1 and the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-sections 31.4, 31.5 and 31.6.

Figure 2.3.1

Figure 2.3.1(a) for flammable aerosols
AEROSOL
Does it contain ≤ 1% flammable components and does it have a heat of combustion < 20 kJ/g?
YES
NOT CLASSIFIED
NO
Does it contain ≥ 85% flammable components and does it have a heat of combustion ≥ 30 kJ/g?
YES
Category 1
NO
Danger
For spray aerosols, go to decision logic 2.3.1 (b);
For foam aerosols, got to decision logic 2.3.1 (c).


Figure 2.3.1(b) for spray aerosols
SPRAY AEROSOL
In the ignition distance test, does ignition occur at a distance ≥ 75 cm?
YES
Category 1
NO
Does it have a heat of combustion < 20 kJ/g?
NO
Category 2
YES
In the ignition distance test, does ignition occur at a distance ≥ 15 cm?
YES
Category 2
NO
In the enclosed space ignition test; is:
a) the time equivalent ≤ 300 s/m3 or
b) the deflagration density ≤ 300 g/m3?
YES
Category 2
NO
NOT CLASSIFIED
Danger
Warning
Warning
Warning


Figure 2.3.1(c) for foam aerosols
FOAM AEROSOL
In the foam test, is: a) the flame height ≥ 20 cm and the flame duration ≥ 2 s; or b) the flame height ≥ 4 cm and the flame duration ≥ 7 s?
YES
Category 1
NO
In the foam test; is the flame height ≥ 4 cm and the flame duration ≥ 2 s?
YES
Category 2
NO
NOT CLASSIFIED
Danger
Warning



2.3.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.

Table 2.3.2
Label elements for flammable aerosols

Classification
Category 1
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H222: Extremely flammable aerosol
H223: Flammable aerosol
Precautionary Statement
Prevention
P210
P211
P251
P210
P211
P251
Precautionary Statement
Response


Precautionary Statement
Storage
P410 + P412
P410 + P412
Precautionary Statement
Disposal




2.3.4. Additional Classification Considerations
2.3.4.1. The chemical heat of combustion (ΔHc), in kilojoules per gram (kJ/g), is the product of the theoretical heat of combustion (ΔHcomb), and a combustion efficiency, usually less than 1,0 (a typical combustion efficiency is 0,95 or 95 %).
For a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:
ΔHc (product)=Σniwi % × ΔHc(i)
where:

ΔHc
chemical heat of combustion (kJ/g);
wi %
mass fraction of component i in the product;
ΔHc(i)
specific heat of combustion (kJ/g)of component i in the product.
The chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).



2.4. Oxidising gases


2.4.1. Definitions
Oxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.


2.4.2. Classification criteria
2.4.2.1. An oxidising gas shall be classified in a single category for this class in accordance with Table 2.4.1.:

Table 2.4.1
Criteria for oxidising gases

Category
Criteria
1
Any gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.

Note
Gases which cause or contribute to the combustion of other material more than air means pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.


2.4.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.

Table 2.4.2
Label elements for oxidising gases

Classification
Category 1
GHS Pictogram

Signal Word
Danger
Hazard Statement
H270: May cause or intensify fire; oxidiser
Precautionary Statement
Prevention
P220
P244
Precautionary Statement
Response
P370 + P376
Precautionary Statement
Storage
P403
Precautionary Statement
Disposal



2.4.4. Additional Classification Considerations
To classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.



2.5. Gases under pressure


2.5.1. Definition
2.5.1.1. Gases under pressure are gases which are contained in a receptacle at a pressure of 200 kPa (gauge) or more, or which are liquefied or liquefied and refrigerated.
They comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.
2.5.1.2. The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.


2.5.2. Classification criteria
Gases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:

Table 2.5.1
Criteria for gases under pressure

Group
Criteria
Compressed gas
A gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.
Liquefied gas
A gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:

(i) high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and

(ii) low pressure liquefied gas: a gas with a critical temperature above + 65 oC.
Refrigerated liquefied gas
A gas which when packaged is made partially liquid because of its low temperature.
Dissolved gas
A gas which when packaged under pressure is dissolved in a liquid phase solvent.


2.5.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.

Table 2.5.2
Label elements for gases under pressure

Classification
Compressed gas
Liquefied gas
Refrigerated liquefied gas
Dissolved gas
GHS Pictograms




Signal Word
Warning
Warning
Warning
Warning
Hazard Statement
H280: Contains gas under pressure; may explode if heated
H280: Contains gas under pressure; may explode if heated
H281: Contains refrigerated gas; may cause cryogenic burns or injury
H280: Contains gas under pressure; may explode if heated
Precautionary Statement
Prevention


P282

Precautionary Statement
Response


P336
P315

Precautionary Statement
Storage
P410 + P403
P410 + P403
P403
P410 + P403
Precautionary Statement
Disposal






2.5.4. Additional Classification Considerations
For this group of gases, the following information is required to be known:

the vapour pressure at 50 oC;
the physical state at 20 oC at standard ambient pressure;
the critical temperature.
Data can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.


2.6. Flammable liquids


2.6.1. Definition
Flammable liquid means a liquid having a flash point of not more than 60 oC.


2.6.2. Classification criteria
2.6.2.1. A flammable liquid shall be classified in one of the three categories for this class in accordance with Table 2.6.1:

Table 2.6.1
Criteria for flammable liquids

For the purpose of this Regulation gas oils, diesel and light heating oils having a flash point between ≥ 55 oC and ≤ 75 oC may be regarded as Category 3.

Category
Criteria
1
Flash point < 23 oC and initial boiling point ≤ 35 oC
2
Flash point < 23 oC and initial boiling point > 35 oC
3
Flash point ≥ 23 oC and ≤ 60 oC



2.6.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.

Table 2.6.2
Label elements for flammable liquids

Classification
Category 1
Category 2
Category 3
GHS Pictograms



Signal Word
Danger
Danger
Warning
Hazard Statement
H224: Extremely flammable liquid and vapour
H225: Highly flammable liquid and vapour
H226: Flammable liquid and vapour
Precautionary Statement
Prevention
P210
P233
P240
P241
P242
P243
P280
P210
P233
P240
P241
P242
P243
P280
P210
P233
P240
P241
P242
P243
P280
Precautionary Statement
Response
P303 + P361 + P353
P370 + P378
P303 + P361 + P353
P370 + P378
P303 + P361 + P353
P370 + P378
Precautionary Statement
Storage
P403 + P235
P403 + P235
P403 + P235
Precautionary Statement
Disposal
P501
P501
P501


2.6.4. Additional Classification Considerations
2.6.4.1. For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.
2.6.4.2. In the case of mixturesTo date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates. containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 oCIf the calculated flash point is less than 5 oC greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally. greater than the relevant classification criterion and provided that:

(a) the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);


(b) the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit;

(c) the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;

(d) the liquid phase is homogeneous.
2.6.4.3. One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.
2.6.4.4. Possible test methods for determining the flash point of flammable liquids are listed in Table 2.6.3.

Table 2.6.3
Methods for determining the flash point of flammable liquids

European standards:
EN ISO 1516 as amended
Determination of flash/no flash — Closed cup equilibrium method
EN ISO 1523 as amended
Determination of flash point — Closed cup equilibrium method
EN ISO 2719 as amended
Determination of flash point — Pensky-Martens closed cup method
EN ISO 3679 as amended
Determination of flash point — Rapid equilibrium closed cup method
EN ISO 3680 as amended
Determination of flash/no flash — Rapid equilibrium closed cup method
EN ISO 13736 as amended
Petroleum products and other liquids — Determination of flash point — Abel closed cup method
National standards:
Association française de normalisation, AFNOR:
NF M07-036 as amended
Détermination du point d'éclair — Vase clos Abel-Pensky
(identical to DIN 51755)
British Standards Institute,
BS 2000 Part 170 as amended
(identical to EN ISO 13736)
Deutsches Institut für Normung
DIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky
(identical to NF M07-036)

2.6.4.5. Liquids with a flash point of more than 35 oC need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.


2.7. Flammable solids


2.7.1. Definition
2.7.1.1. A flammable solid means a solid which is readily combustible, or may cause or contribute to fire through friction.
Readily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.


2.7.2. Classification criteria
2.7.2.1. Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.
2.7.2.2. Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.
2.7.2.3. A flammable solid shall be classified in one of the two categories for this class using Method N.1 as described in 33.2.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.7.1:

Table 2.7.1
Criteria for flammable solids

Category
Criteria
1
Burning rate test
Substances and mixtures other than metal powders:

(a) wetted zone does not stop fire and

(b) burning time < 45 seconds or burning rate > 2,2 mm/s
Metal powders
burning time ≤ 5 minutes
2
Burning rate test
Substances and mixtures other than metal powders:

(a) wetted zone stops the fire for at least 4 minutes and

(b) burning time < 45 seconds or burning rate > 2,2 mm/s
Metal powders
burning time > 5 minutes and ≤ 10 minutes


Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.


2.7.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.

Table 2.7.2
Label elements for flammable solids

Classification
Category 1
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H228: Flammable Solid
H228: Flammable Solid
Precautionary Statement
Prevention
P210
P240
P241
P280
P210
P240
P241
P280
Precautionary Statement
Response
P370 + P378
P370 + P378
Precautionary Statement
Storage


Precautionary Statement
Disposal




2.8. Self-reactive substances and mixtures


2.8.1. Definition
2.8.1.1. Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.
2.8.1.2. A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.


2.8.2. Classification criteria
2.8.2.1. Any self-reactive substance or mixture shall be considered for classification in this class as a self-reactive substance or mixture unless:

(a) they are explosives, according to the criteria given in 2.1;


(b) they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;

(c) they are organic peroxides, according to the criteria given in 2.15;

(d) their heat of decomposition is less than 300 J/g; or

(e) their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3..
2.8.2.2. Mixtures of oxidising substances, meeting the criteria for classification as oxidising substances, which contain 5 % or more of combustible organic substances and which do not meet the criteria mentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjected to the self-reactive substances classification procedure;
Such a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
2.8.2.3. Self-reactive substances and mixtures shall be classified in one of the seven categories of types A to G for this class, according to the following principles:

(a) any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;

(b) any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;

(c) any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;

(d) any self-reactive substance or mixture which in laboratory testing:

(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or

(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or

(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as self-reactive substance TYPE D;

(e) any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;

(f) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;


(g) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.


2.8.2.4. Criteria for temperature control
Self-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.


2.8.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.

Table 2.8.1
Label elements for self-reactive substances and mixtures

Classification
Type A
Type B
Type C & D
Type E & F
Type G
GHS Pictograms




There are no label elements allocated to this hazard category
Signal Word
Danger
Danger
Danger
Warning
Hazard Statement
H240: Heating may cause an explosion
H241: Heating may cause a fire or explosion
H242: Heating may cause a fire
H242: Heating may cause a fire
Precautionary Statement
Prevention
P210
P220
P234
P280
P210
P220
P234
P280
P210
P220
P234
P280
P210
P220
P234
P280
Precautionary Statement
Response
P370 + P378
P370 + P380 + P375
P370 + P378
P370 + P380 + P375
P370 + P378
P370 + P378

Precautionary Statement
Storage
P403 + P235
P411
P420
P403 + P235
P411
P420
P403 + P235
P411
P420
P403 + P235 P411
P420

Precautionary Statement
Disposal
P501
P501
P501
P501

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.


2.8.4. Additional Classification Considerations
2.8.4.1. The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.
2.8.4.2. The classification procedures for self-reactive substances and mixtures need not be applied if:

(a) There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or

(b) For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).


Figure 2.8.1
Self-reactive substances and mixtures

SUBSTANCE/MIXTURE
Box 1
Test A
Box 2
Test B
1.1 Yes
Does it propogate a detonation?
1.3 No
2.1 Yes
Can it detonate as packaged?
2.2 No
1.2 Partial
Box 3
Test C
Can it propogate a deflagration?
3.1 Yes, rapidly
Box 4
Test C
Can it propogate a deflagration?
4.1 Yes, rapidly
3.2 Yes, slowly
3.3 No
Box 5
Test C
Can it propogate a deflagration?
5.1 Yes, rapidly
4.2 Yes, slowly
4.3 No
Box 6
Test D
5.3 No
5.2 Yes,
slowly
6.2 No
Does it deflagrate rapidly in package?
6.1 Yes
Box 7
Test E
What is the effect of heating under confinement?
7.1 Violent
Box 8
Test E
What is the effect of heating under confinement?
8.1 Violent
7.2 Medium
7.3 Low
7.4 No
Box 9
Test E
What is the effect of heating under confinement?
Box 10
Test G
8.2 Medium
8.3 Low
8.4 No
9.3 Low
9.4 No
Box 11
10.2 No
Can it explode as packaged?
10.1 Yes
Packaged in packages of more than 400 kg/450 l or to be considered for exemption?
11.1 Yes
Box F
Test F
What is its explosive power?
12.3 None
Box 13
Test E
12.1 No low
12.2 Low
What is effect of heating it under defined confinement?
11.2 No
13.1 Low
13.2 None
TYPE A
TYPE B
TYPE C
TYPE D
TYPE E
TYPE F
TYPE G
9.1 violent
9.2 Medium



2.9. Pyrophoric liquids


2.9.1. Definition
Pyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.


2.9.2. Classification criteria
2.9.2.1. A pyrophoric liquid shall be classified in a single category for this class using test N.3 in Part III, sub-section 33.3.1.5 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to Table 2.9.1:

Table 2.9.1
Criteria for pyrophoric liquids

Category
Criteria
1
The liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min.


2.9.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.

Table 2.9.2
Label elements for pyrophoric liquids

Classification
Category 1
GHS Pictogram

Signal Word
Danger
Hazard Statement
H250: Catches fire spontaneously if exposed to air
Precautionary Statement
Prevention
P210
P222
P280
Precautionary Statement
Response
P302 + P334
P370 + P378
Precautionary Statement
Storage
P422
Precautionary Statement
Disposal



2.9.4. Additional Classification Considerations
2.9.4.1. The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).



2.10. Pyrophoric solids


2.10.1. Definition
Pyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.


2.10.2. Classification criteria
2.10.2.1. A pyrophoric solid shall be classified in a single category for this class using test N.2 in Part III, sub-section 33.3.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.10.1:

Table 2.10.1
Criteria for pyrophoric solids

Category
Criteria
1
The solid ignites within 5 minutes of coming into contact with air.

Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.


2.10.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.

Table 2.10.2
Label elements for pyrophoric solids

Classification
Category 1
GHS Pictogram

Signal Word
Danger
Hazard Statement
H250: Catches fire spontaneously if exposed to air
Precautionary Statement
Prevention
P210
P222
P280
Precautionary Statement
Response
P335 + P334
P370 +P378
Precautionary Statement
Storage
P422
Precautionary Statement
Disposal




2.10.4. Additional Classification Considerations
2.10.4.1. The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).


2.11. Self-heating substances and mixtures


2.11.1. Definition
2.11.1.1. A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).
2.11.1.2. Self-heating of substances or mixtures, leading to spontaneous combustion, is caused by reaction of the substance or mixture with oxygen (in the air) and the heat developed not being conducted away rapidly enough to the surroundings. Spontaneous combustion occurs when the rate of heat production exceeds the rate of heat loss and the auto-ignition temperature is reached.


2.11.2. Classification criteria
2.11.2.1. A substance or mixture shall be classified as a self-heating substance or mixture of this class, if in the tests performed in accordance with the test method given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-section 33.3.1.6:

(a) a positive result is obtained using a 25 mm cube sample at 140 oC;

(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;

(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;

(d) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.
2.11.2.2. A self-heating substance or mixture shall be classified in one of the two categories for this class if, in a test performed in accordance with test method N.4 in Part III, sub-section 33.3.1.6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, the result meets the criteria according to Table 2.11.1:


Table 2.11.1
Criteria for self-heating substances and mixtures

Category
Criteria
1
A positive result is obtained in a test using a 25 mm sample cube at 140 oC
2

(a) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or

(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or

(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.

Note
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.
2.11.2.3. Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.
2.11.2.4. Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.


2.11.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.

Table 2.11.2
Label elements for self-heating substances and mixtures

Classification
Category 1
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H251: Self-heating; may catch fire
H252: Self-heating in large quantities; may catch fire
Precautionary Statement
Prevention
P235 + P410
P280
P235 + P410
P280
Precautionary Statement
Response


Precautionary Statement
Storage
P407
P413
P420
P407
P413
P420
Precautionary Statement
Disposal




2.11.4. Additional Classification Considerations
2.11.4.1. For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.
2.11.4.2. The classification procedure for self-heating substances or mixtures need not be applied if the results of a screening test can be adequately correlated with the classification test and an appropriate safety margin is applied. Examples of screening tests are:

(a) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;

(b) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.


Figure 2.11.1.
Self-heating substances and mixtures

SUBSTANCE/MIXTURE
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 140°C?
NO
NOT CLASSIFIED
YES
Does it undergo dangerous self-heating when tested in a 25 mm sample cube at 140°C?
YES
Category 1
Danger
NO
Is it packaged in more than 3 m3?
YES
Category 2
Warning
NO
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 120°C?
NO
NOT CLASSIFIED
YES
Is it packaged in more than 450 litres volume?
YES
Category 2
Warning
NO
Does it undergo dangerous self-heating when tested in a 100 mm sample cube at 100°C?
YES
Category 2
Warning
NO
NOT CLASSIFIED



2.12. Substances and mixtures which in contact with water emit flammable gases


2.12.1. Definition
Substances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.


2.12.2. Classification criteria
2.12.2.1. A substance or mixture which, in contact with water, emits flammable gases shall be classified in one of the three categories for this class, using test N.5 in Part III, sub-section 33.4.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.12.1:

Table 2.12.1
Criteria for substances or mixtures which in contact with water emit flammable gases

Category
Criteria
1
Any substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.
2
Any substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.
3
Any substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.

Note:
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form.
2.12.2.2. A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.


2.12.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.


Table 2.12.2
Label elements for substances or mixtures which in contact with water emit flammable gases

Classification
Category 1
Category 2
Category 3
GHS Pictograms



Signal Word
Danger
Danger
Warning
Hazard Statement
H260: In contact with water releases flammable gases which may ignite spontaneously
H261: In contact with water releases flammable gases
H261: In contact with water releases flammable gases
Precautionary Statement
Prevention
P223
P231 + P232
P280
P223
P231 + P232
P280
P231 + P232
P280
Precautionary Statement
Response
P335 + P334
P370 + P378
P335 + P334
P370 + P378
P370 + P378
Precautionary Statement
Storage
P402 + P404
P402 + P404
P402 + P404
Precautionary Statement
Disposal
P501
P501
P501


2.12.4. Additional Classification Considerations
2.12.4.1. The classification procedure for this class need not be applied if:

(a) the chemical structure of the substance or mixture does not contain metals or metalloids; or

(b) experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or

(c) the substance or mixture is known to be soluble in water to form a stable mixture.


2.13. Oxidising liquids


2.13.1. Definition
Oxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.


2.13.2. Classification criteria
2.13.2.1. An oxidising liquid shall be classified in one of the three categories for this class using test O.2 in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.13.1:


Table 2.13.1
Criteria for oxidising liquids

Category
Criteria
1
Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.
2
Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.
3
Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met.


2.13.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.

Table 2.13.2
Label elements for oxidising liquids

Classification
Category 1
Category 2
Category 3
GHS Pictograms



Signal Word
Danger
Danger
Warning
Hazard Statement
H271:May cause fire or explosion; strong oxidiser
H272: May intensify fire; oxidiser
H272: May intensify fire; oxidiser
Precautionary Statement
Prevention
P210
P220
P221
P280
P283
P210
P220
P221
P280
P210
P220
P221
P280
Precautionary Statement
Response
P306 + P360
P371 + P380 + P375
P370 + P378
P370 + P378
P370 + P378
Precautionary Statement
Storage



Precautionary Statement
Disposal
P501
P501
P501


2.13.4. Additional Classification Considerations
2.13.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:

(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or

(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
2.13.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
2.13.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.
2.13.4.4. In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.


2.14. Oxidising solids


2.14.1. Definition
Oxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.


2.14.2. Classification criteria
2.14.2.1. An oxidising solid shall be classified in one of the three categories for this class using test O.1 in Part III, sub-section 34.4.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.14.1:

Table 2.14.1
Criteria for oxidising solids

Category
Criteria
1
Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.
2
Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.

3
Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.

Note 1
Some oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the Resistance to detonation test (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.

Note 2
The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.


2.14.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.

Table 2.14.2
Label elements for oxidising solids


Category 1
Category 2
Category 3
GHS Pictograms



Signal Word
Danger
Danger
Warning
Hazard Statement
H271: May cause fire or explosion; strong oxidiser
H272: May intensify fire; oxidiser
H272: May intensify fire; oxidiser
Precautionary Statement
Prevention
P210
P220
P221
P280
P283
P210
P220
P221
P280
P210
P220
P221
P280
Precautionary Statement
Response
P306 + P360
P371 + P380 + P375
P370 + P378
P370 + P378
P370 + P378
Precautionary Statement
Storage



Precautionary Statement
Disposal
P501
P501
P501


2.14.4. Additional Classification Considerations
2.14.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:

(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or

(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
2.14.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
2.14.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.


2.15. Organic peroxides


2.15.1. Definition
2.15.1.1. Organic peroxides means liquid or solid organic substances which contain the bivalent -O-O- structure and may be considered derivatives of hydrogen peroxide, where one or both of the hydrogen atoms have been replaced by organic radicals. The term organic peroxide includes organic peroxide mixtures (formulations) containing at least one organic peroxide. Organic peroxides are thermally unstable substances or mixtures, which can undergo exothermic self-accelerating decomposition. In addition, they can have one or more of the following properties:

(i) be liable to explosive decomposition;

(ii) burn rapidly;

(iii) be sensitive to impact or friction;

(iv) react dangerously with other substances.
2.15.1.2. An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.


2.15.2. Classification criteria
2.15.2.1. Any organic peroxide shall be considered for classification in this class, unless it contains:

(a) not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or

(b) not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.

Note
The available oxygen content ( %) of an organic peroxide mixture is given by the formula:
16×Σnini×cimi
where:

ni
number of peroxygen groups per molecule of organic peroxide i;
ci
concentration (mass %) of organic peroxide i;
mi
molecular mass of organic peroxide i.
2.15.2.2. Organic peroxides shall be classified in one of the seven categories of Types A to G for this class, according to the following principles:

(a) any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;

(b) any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;

(c) any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;

(d) any organic peroxide which in laboratory testing:

(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or

(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or

(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as organic peroxide TYPE D;

(e) any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;

(f) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;

(g) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3., and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.


2.15.2.3. Criteria for temperature control
The following organic peroxides need to be subjected to temperature control:

(a) Organic peroxide types B and C with an SADT ≤ 50 C;

(b) Organic peroxide type D showing a medium effect when heated under confinementAs determined by test series E as prescribed in UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II. with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and

(c) Organic peroxide types E and F with an SADT ≤ 45 oC.
Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.


2.15.3. Hazard Communication
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.

Table 2.15.1
Label elements for organic peroxides

Classification
Type A
Type B
Type C & D
Type E & F
Type G
GHS Pictograms




There are no label elements allocated to this hazard category
Signal Word
Danger
Danger
Danger
Warning
Hazard Statement
H240: Heating may cause an explosion
H241: Heating may cause a fire or explosion
H242: Heating may cause a fire
H242: Heating may cause a fire
Precautionary Statement
Prevention
P210
P220
P234
P280
P210
P220
P234
P280
P210
P220
P234
P280
P210
P220
P234
P280
Precautionary Statement
Response





Precautionary Statement
Storage
P411 + P235
P410
P420
P411 + P235
P410
P420
P411 + P235
P410
P420
P411 + P235
P410
P420

Precautionary Statement
Disposal
P501
P501
P501
P501

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.


2.15.4. Additional Classification Considerations
2.15.4.1. Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.
2.15.4.2. Mixtures of already classified organic peroxides may be classified as the same type of organic peroxide as that of the most dangerous component. However, as two stable components can form a thermally less stable mixture, the SADT of the mixture shall be determined.
Note: The sum of the individual parts can be more hazardous than the individual components.


Figure 2.15.1
Organic Peroxides

SUBSTANCE/MIXTURE
Box 1
Test A
Box 2
Test B
1.1 Yes
Does it propogate a detonation?
1.3 No
2.1 Yes
Can it detonate as packaged?
2.2 No
1.2 Partial
Box 3 Test C
Can it propogate a detonation?
3.1 Yes, rapidly
Box 4 Test C
Can it propogate a detonation?
Box 5 Test C
Box 6 Test D
3.2 Yes, slowly
3.3 No
4.1 Yes rapidly
Can it propogate a detonation?
4.2 Yes, slowly
5.1 Yes, rapidly
4.3 No
5.3 No
Does it deflagrate rapidly in package?
6.2 No
Box 7 Test E
5.2 Yes, slowly
6.1 Yes
What is the effect of heating under confinement?
Box 8 Test E
7.1 Violent
What is the effect of heating under confinement?
Box 9 Test E
7.2 Medium
8.1 Violent
7.3 Low
7.4 No
What is the effect of heating under confinement?
Box 10 Test G
9.3 Low
8.2 Medium
9.1 Violent
8.3 Low
9.4 No
Can it explode as packaged?
10.2 No
8.4 No
9.2 Medium
Box 11
Packaged in packages of more than 400 kg/450 l or to be considered for exemption?
11.1 Yes
Box 12 Test F
11.2 No
What is its explosive power?
12.3 None
10.1 Yes
12.1 Not low
Box 13 Test E
12.2 Low
What is the effect of heating it under confinement?
13.1 Low
13.2 None
TYPE A
TYPE B
TYPE C
TYPE D
TYPE E
TYPE F
TYPE G



2.16. Corrosive to metals


2.16.1. Definition
A substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.


2.16.2. Classification criteria
2.16.2.1. A substance or a mixture which is corrosive to metals is classified in a single category for this class, using the test in Part III, sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.16.1:

Table 2.16.1
Criteria for substances and mixtures corrosive to metals

Category
Criteria
1
Corrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.

Note
Where an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required.


2.16.3. Hazard Communication
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.

Table 2.16.2
Label elements for substances and mixtures corrosive to metals

Classification
Category 1
GHS Pictogram

Signal Word
Warning
Hazard Statement
H290: May be corrosive to metals
Precautionary Statement
Prevention
P234
Precautionary Statement
Response
P390
Precautionary Statement
Storage
P406
Precautionary Statement
Disposal




2.16.4. Additional Classification Considerations
2.16.4.1. The corrosion rate can be measured according to the test method of Part III sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The specimen to be used for the test shall be made of the following materials:

(a) for the purposes of testing steel, steel types

S235JR+CR (1.0037 resp.St 37-2),
S275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;

(b) for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.



3. PART 3: HEALTH HAZARDS


3.1. Acute toxicity


3.1.1. Definitions
3.1.1.1. Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.
3.1.1.2. The hazard class Acute Toxicity is differentiated into:

Acute oral toxicity;
Acute dermal toxicity;
Acute inhalation toxicity.


3.1.2. Criteria for classification of substances as acutely toxic
3.1.2.1. Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.

Table 3.1.1
Acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories

Gas concentrations are expressed in parts per million per volume (ppmV).

Exposure Route
Category 1
Category 2
Category 3
Category 4
Oral (mg/kg bodyweight)
See Note (a)
ATE ≤ 5
5 < ATE ≤ 50
50 < ATE ≤ 300
300 < ATE ≤ 2000
Dermal (mg/kg
bodyweight)
See Note (a)
ATE ≤ 50
50 < ATE ≤ 200
200 < ATE ≤ 1000
1000 < ATE ≤ 2000
Gases (ppmV




see:
Note (a)
Note (b)
ATE ≤ 100
100 < ATE ≤ 500
500 < ATE ≤ 2500
2500 < ATE ≤ 20000
Vapours (mg/l)




see:
Note (a)
Note (b)
Note (c)
ATE ≤ 0,5
0,5 < ATE ≤ 2,0
2,0 < ATE ≤ 10,0
10,0 < ATE ≤ 20,0
Dusts and Mists (mg/l)




see:
Note (a)
Note (b)
ATE ≤ 0,05
0,05 < ATE ≤ 0,5
0,5 < ATE ≤ 1,0
1,0 < ATE ≤ 5,0


Notes to Table 3.1.1

(a) The acute toxicity estimate (ATE) for the classification of a substance or ingredient in a mixture is derived using:

the LD50/LC50 where available,
the appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or
the appropriate conversion value from Table 3.1.2 that relates to a classification category.

(b) Generic concentration limits for inhalation toxicity in the table are based on 4 hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1 hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.

(c) For some substances or mixtures the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances or mixtures the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2500 ppmV), Category 4 (20000 ppmV).
The terms dust, mist and vapour are defined as follows:

Dust: solid particles of a substance or mixture suspended in a gas (usually air);
Mist: liquid droplets of a substance or mixture suspended in a gas (usually air);
Vapour: the gaseous form of a substance or mixture released from its liquid or solid state.
Dust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.


3.1.2.2. Specific considerations for classification of substances as acutely toxic
3.1.2.2.1. The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.


3.1.2.3. Specific considerations for classification of substances as acutely toxic by the inhalation route
3.1.2.3.1. Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.

3.1.2.3.2. Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.
3.1.2.3.3. In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as corrosive to the respiratory tract (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.


3.1.3. Criteria for classification of mixtures as acutely toxic
3.1.3.1. The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.
3.1.3.2. For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all ingredients. If the acute toxicity is determined for more than one route of exposure, the more severe hazard category will be used for classification. All available information shall be considered and all relevant routes of exposure shall be identified for hazard communication.
3.1.3.3. In order to make use of all available data for purposes of classifying the hazards of the mixtures, certain assumptions have been made and are applied where appropriate in the tiered approach:

(a) the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).

(b) where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.


Figure 3.1.1
Tiered approach to classification of mixtures for acute toxicity

Test data on the mixture as a whole
No
Yes
Sufficient data available on similar mixtures to estimate classification hazards
Yes
Apply bridging principles outlined in section 1.1.3.
CLASSIFY
No
Available data for all ingredients
Yes
Apply formula in section 3.1.3.6.1
CLASSIFY
No
Other data available to estimate conversion values for classification
Yes
Apply formula in section 3.1.3.6.1
CLASSIFY
No
Convey hazards of the known ingredients
• Apply formula in section 3.1.3.6.1. (unknown ingredients equal or below 10 %)
• Apply formula in paragraph 3.1.3.6.2.3. (unknown ingredients > 10 %)
CLASSIFY


3.1.3.4. Classification of mixtures where acute toxicity data are available for the complete mixture
3.1.3.4.1. Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.


3.1.3.5. Classification of mixtures where acute toxicity data are available for the complete mixture: bridging principles
3.1.3.5.1. Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
3.1.3.5.2. If a mixture is diluted with water or other totally non-toxic material, the toxicity of the mixture can be calculated from test data on the undiluted mixture.


3.1.3.6. Classification of mixtures based on ingredients of the mixture (Additivity formula)


3.1.3.6.1. Data available for all ingredients
In order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:

(a) include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;

(b) ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);

(c) ignore ingredients if the oral limit test does not show acute toxicity at 2000 mg/kg bodyweight.

Ingredients that fall within the scope of this paragraph are considered to be ingredients with a known acute toxicity estimate (ATE).
The ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:
100ATEmix=ΣnCiATEi
where:

Ci
concentration of ingredient i ( % w/w or % v/v)
i
the individual ingredient from 1 to n
n
the number of ingredients
ATEi
Acute Toxicity Estimate of ingredient i.


3.1.3.6.2. Classification of mixtures when data are not available for all components
3.1.3.6.2.1. Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.
This includes evaluation of:

(a) extrapolation between oral, dermal and inhalation acute toxicity estimatesFor ingredients with acute toxicity estimates available for other than the most appropriate exposure route, values may be extrapolated from the available exposure route(s) to the most appropriate route. Dermal and inhalation route data are not always required for ingredients. However, in case data requirements for specific ingredients include acute toxicity estimates for the dermal and inhalation route, the values to be used in the formula need to be from the required exposure route.. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;

(b) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;

(c) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or

(d) data from closely analogous substances using structure/activity relationships.
This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.
3.1.3.6.2.2. In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known ingredients only, with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity.

3.1.3.6.2.3. If the total concentration of the ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the total percentage of the unknown ingredient(s) as follows:
100-Σ C unknown if > 10 %ATEmix=ΣnCiATEi

Table 3.1.2
Conversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for classification for the respective routes of exposure

Exposure routes
Classification Category or experimentally obtained acute toxicity range estimate
Converted acute toxicity point estimate
(see Note 1)
Oral
(mg/kg bodyweight)
0 < Category 1 ≤ 5
5 < Category 2 ≤ 50
50 < Category 3 ≤ 300
300 < Category 4 ≤ 2000
0,5
5
100
500
Dermal
(mg/kg bodyweight)
0 < Category 1 ≤ 50
50 < Category 2 ≤ 200
200 < Category 3 ≤ 1000
1000 < Category 4 ≤ 2000
5
50
300
1100
Gases
(ppmV)
0 < Category 1 ≤ 100
100 < Category 2 ≤ 500
500 < Category 3 ≤ 2500
2500 < Category 4 ≤ 20000
10
100
700
4500
Vapours
(mg/l)
0 < Category 1 ≤ 0,5
0,5 < Category 2 ≤ 2,0
2,0 < Category 3 ≤ 10,0
10,0 < Category 4 ≤ 20,0
0,05
0,5
3
11
Dust/mist
(mg/l)
0< Category 1 ≤ 0,05
0,05 < Category 2 ≤ 0,5
0,5 < Category 3 ≤ 1,0
1,0 < Category 4 ≤ 5,0
0,005
0,05
0,5
1,5

Note 1
These values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results.


3.1.4. Hazard Communication
3.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.1.3.


Table 3.1.3
Acute toxicity label elements

Classification
Category 1
Category 2
Category 3
Category 4
GHS Pictograms




Signal Word
Danger
Danger
Danger
Warning
Hazard Statement:

Oral
H300:
Fatal if swallowed
H300:
Fatal if swallowed
H301:
Toxic if swallowed
H302:
Harmful if swallowed

Dermal
H310:Fatal in contact with skin
H310:Fatal in contact with skin
H311: Toxic in contact with skin
H312: Harmful in contact with skin

Inhalation
(see Note 1)
H330:Fatal if inhaled
H330: Fatal if inhaled
H331: Toxic if inhaled
H332: Harmful if inhaled
Precautionary Statement Prevention (oral)
P264
P270
P264
P270
P264
P270
P264
P270
Precautionary Statement Response (oral)
P301 + P310
P321
P330
P301 + P310
P321
P330
P301 + P310
P321
P330
P301 + P312
P330
Precautionary Statement Storage (oral)
P405
P405
P405

Precautionary Statement Disposal (oral)
P501
P501
P501
P501
Precautionary Statement Prevention (dermal)
P262
P264
P270
P280
P262
P264
P270
P280
P280
P280
Precautionary Statement Response (dermal)
P302 + P350
P310
P322
P361
P363
P302 + P350
P310
P322
P361
P363
P302 + P352
P312
P322
P361
P363
P302 + P352
P312
P322
P363
Precautionary Statement Storage (dermal)
P405
P405
P405

Precautionary Statement Disposal (dermal)
P501
P501
P501
P501
Precautionary Statement Prevention (inhalation)
P260
P271
P284
P260
P271
P284
P261
P271
P261
P271
Precautionary Statement Response (inhalation)
P304 + P340
P310
P320
P304 + P340
P310
P320
P304 + P340
P311
P321
P304 + P340
P312
Precautionary Statement Storage (inhalation)
P403 + P233
P405
P403 + P233
P405
P403 + P233
P405

Precautionary Statement Disposal (inhalation)
P501
P501
P501

Note 1
In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: corrosive to the respiratory tract — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement corrosive to the respiratory tract.

Note 2
In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity — see advice at 3.1.3.6.2.2.


3.2. Skin corrosion/irritation


3.2.1. Definitions
3.2.1.1. Skin Corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test substance for up to 4 hours. Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology shall be considered to evaluate questionable lesions.
Skin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.


3.2.2. Classification criteria for substances
3.2.2.1. Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.
3.2.2.2. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.

3.2.2.3. If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.
3.2.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo skin irritation testing.
Although information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.
3.2.2.5. A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.


3.2.2.6. Corrosion
3.2.2.6.1. On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.
3.2.2.6.2. Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.
3.2.2.6.3. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.

Table 3.2.1
Skin Corrosive category and subcategories



Corrosive in > 1 of 3 animals

Corrosive subcategories
Exposure
Observation
Category 1: Corrosive
1A
≤ 3 minutes
≤ 1 hour
1B
> 3 minutes - ≤ 1 hour
≤ 14 days
1C
> 1 hour - ≤ 4 hours
≤ 14 days



3.2.2.7. Irritation
3.2.2.7.1. Using the results of animal testing a single irritant category (Category 2) is presented in Table 3.2.2. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5. The major criterion for the irritant category is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.

Table 3.2.2
Skin irritation category

Category
Criteria
Category 2: Irritant
(1) Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or
(2) Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or
(3) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.


3.2.2.8. Comments on responses obtained in skin irritation tests in animals
3.2.2.8.1. Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.
3.2.2.8.2. Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.


3.2.3. Classification criteria for mixtures


3.2.3.1. Classification of mixtures when data are available for the complete mixture
3.2.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.

3.2.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.


3.2.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.2.3.2.1. Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.


3.2.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture
3.2.3.3.1. In order to make use of all available data for purposes of classifying the skin irritation/corrosion hazards of mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:
Assumption: the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.
3.2.3.3.2. In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.
3.2.3.3.3. Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.
3.2.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.
3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.

3.2.3.3.4.3. A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.
3.2.3.3.5. On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.
3.2.3.3.6. If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.

Table 3.2.3
Generic concentration limits of ingredients classified for skin corrosive/irritant hazard (Category 1 or 2) that trigger classification of the mixture as corrosive/irritant to skin

Sum of ingredients classified as:
Concentration triggering classification of a mixture as:

Skin Corrosive
Skin Irritant

Category 1
(see note below)
Category 2
Skin Corrosive Categories 1A, 1B, 1C
≥ 5 %
≥ 1 % but < 5 %
Skin irritant Category 2

≥ 10 %
(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2

≥ 10 %

Note
The sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.


Table 3.2.4
Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as corrosive/irritant to skin

Ingredient:
Concentration:
Mixture classified as: Skin
Acid with pH ≤ 2
≥ 1 %
Category 1
Base with pH ≥ 11,5
≥ 1 %
Category 1
Other corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply
≥ 1 %
Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases
≥ 3 %
Category 2


3.2.4. Hazard Communication
3.2.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.2.5.

Table 3.2.5
Label elements for skin corrosion/irritation

Classification
Category 1 A/1 B/1 C
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H314: Causes severe skin burns and eye damage
H315: Causes skin irritation
Precautionary Statement
Prevention
P260
P264
P280
P264
P280
Precautionary Statement
Response
P301 + P330 + P331
P303 + P361 + P353
P363
P304 + P340
P310
P321
P305 + P351 + P338
P302 + P352
P321
P332 + P313
P362
Precautionary Statement
Storage
P405

Precautionary Statement
Disposal
P501



3.3. Serious eye damage/eye irritation


3.3.1. Definitions
3.3.1.1. Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.
Eye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.


3.3.2. Classification criteria for substances
3.3.2.1. The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.
3.3.2.2. Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.
3.3.2.3. Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).
3.3.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.
3.3.2.5. A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.


3.3.2.6. Irreversible effects on the eye/serious damage to eyes (Category 1)
3.3.2.6.1. Substances that have the potential to seriously damage the eyes are classified in Category 1 (irreversible effects on the eye). Substances are classified in this hazard category on the basis of the results of animal testing, in accordance with the criteria listed in Table 3.3.1. These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.

Table 3.3.1
Category for irreversible eye effects

Category
Criteria
Irreversible effects on the eye
(Category 1)
If, when applied to the eye of an animal, a substance produces:

at least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or
at least in 2 of 3 tested animals, a positive response of:

corneal opacity ≥ 3 and/or
iritis > 1,5
calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.
3.3.2.6.2. The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.


3.3.2.7. Reversible effects on the eye (Category 2)
3.3.2.7.1. Substances that have the potential to induce reversible eye irritation are classified in Category 2 (irritating to eyes).


Table 3.3.2
Category for reversible eye effects

Category
Criteria
Irritating to eyes
(Category 2)
if, when applied to the eye of an animal, a substance produces:

at least in 2 of 3 tested animals, a positive response of:

corneal opacity ≥ 1 and/or
iritis ≥ 1, and/or
conjunctival redness ≥ 2 and/or
conjunctival oedema (chemosis) ≥ 2
calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days
3.3.2.7.2. For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.


3.3.3. Classification criteria for mixtures


3.3.3.1. Classification of mixtures when data are available for the complete mixture
3.3.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.
3.3.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.


3.3.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.3.3.2.1. Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.



3.3.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture
3.3.3.3.1. In order to make use of all available data for purposes of classifying the eye irritation/serious eye damaging properties of the mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:
Assumption: The relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.
3.3.3.3.2. In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.
3.3.3.3.3. Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.
3.3.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.
3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.
3.3.3.3.4.3. A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.
3.3.3.3.5. On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.

3.3.3.3.6. If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.

Table 3.3.3
Generic concentration limits of ingredients of a mixture classified as Skin corrosive Category 1 and/or eye Category 1 or 2 for effects on the eye that trigger classification of the mixture for effects on the eye (Category 1 or 2)

Sum of ingredients classified as:
Concentration triggering classification of a mixture as:
Irreversible Eye Effects
Reversible Eye Effects
Category 1
Category 2
Eye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C
≥ 3 %
≥ 1 % but < 3 %
Eye Effects Category 2

≥ 10 %
(10 × Eye Effects Category 1) + Eye effects Category 2

≥ 10 %
Skin Corrosive Category 1A, 1B, 1C + Eye effects Category 1
≥ 3 %
≥ 1 % but < 3 %
10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2

≥ 10 %

Table 3.3.4
Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as hazardous to the eye

Ingredient
Concentration
Mixture classified as: Eye
Acid with pH ≤ 2
≥ 1 %
Category 1
Base with pH ≥ 11,5
≥ 1 %
Category 1
Other corrosive (Category 1) ingredients for which additivity does not apply
≥ 1 %
Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases
≥ 3 %
Category 2


3.3.4. Hazard Communication
3.3.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.3.5.


Table 3.3.5
Label elements for serious eye damage/eye irritation

Classification
Category 1
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H318: Causes serious eye damage
H319: Causes serious eye irritation
Precautionary Statement
Prevention
P280
P264
P280
Precautionary Statement
Response
P305 + P351 + P338
P310
P305 + P351 + P338
P337 + P313
Precautionary Statement
Storage


Precautionary Statement
Disposal




3.4. Respiratory or skin sensitisation


3.4.1. Definitions and general considerations
3.4.1.1. Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.
3.4.1.2. Skin sensitiser means a substance that will lead to an allergic response following skin contact.
3.4.1.3. For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.
3.4.1.4. For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.
3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found at section 3.4.4.

3.4.1.6. The hazard class Respiratory or Skin Sensitisation is differentiated into:

Respiratory Sensitisation;
Skin Sensitisation.


3.4.2. Classification criteria for substances


3.4.2.1. Respiratory sensitisers
Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the criteria in Table 3.4.1:

Table 3.4.1
Hazard category for respiratory sensitisers

Category
Criteria
Category 1
Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the following criteria:

(a) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity and/or

(b) if there are positive results from an appropriate animal test.


3.4.2.1.1 Human evidence
3.4.2.1.1.1. Evidence that a substance can induce specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.
3.4.2.1.1.2. When considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:

(a) the size of the population exposed;

(b) the extent of exposure.
The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
3.4.2.1.1.3. The evidence referred to above could be

(a) clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:

(i) in vivo immunological test (e.g. skin prick test);

(ii) in vitro immunological test (e.g. serological analysis);

(iii) studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;

(iv) a chemical structure related to substances known to cause respiratory hypersensitivity;


(b) data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.
3.4.2.1.1.4. Clinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.
3.4.2.1.1.5. The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.


3.4.2.1.2. Animal studies
3.4.2.1.2.1. Data from appropriate animal studiesAt present recognised animal models for the testing of respiratory hypersensitivity are not available. which may be indicative of the potential of a substance to cause sensitisation by inhalation in humansThe mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers. may include:

(i) measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;

(ii) specific pulmonary responses in guinea pigs.


3.4.2.2. Skin sensitisers
3.4.2.2.1. Substances shall be classified as skin sensitisers (Category 1) in accordance with the criteria in Table 3.4.2:

Table 3.4.2
Hazard category for skin sensitisers

Category
Criteria
Category 1
Substances shall be classified as skin sensitisers (Category 1) in accordance with the following criteria:

(i) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons, or

(ii) if there are positive results from an appropriate animal test (see specific criteria in paragraph 3.4.2.2.4.1).


3.4.2.2.2. Specific considerations
3.4.2.2.2.1. For classification of a substance as a skin sensitiser, evidence shall include any or all of the following:

(a) positive data from patch testing, normally obtained in more than one dermatology clinic;


(b) epidemiological studies showing allergic contact dermatitis caused by the substance; Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;

(c) positive data from appropriate animal studies;

(d) positive data from experimental studies on humans (see Article 7(3));

(e) well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic.
The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
3.4.2.2.2.2. Positive effects seen in either humans or animals will normally justify classification. Evidence from animal studies (see section 3.4.2.2.4) is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution, as the frequency of cases reflect, in addition to the intrinsic properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data can not normally be used to negate positive results from animal studies.
3.4.2.2.2.3. If none of the above mentioned conditions are met the substance need not be classified as a skin sensitiser. However, a combination of two or more indicators of skin sensitisation as listed below may alter the decision, which shall be considered on a case-by-case basis:

(a) isolated episodes of allergic contact dermatitis;

(b) epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;

(c) data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in paragraph 3.4.2.2.4.1, but which are sufficiently close to the limit to be considered significant;

(d) positive data from non-standard methods;

(e) positive results from close structural analogues.



3.4.2.2.3. Immunological contact urticaria
3.4.2.2.3.1. Some substances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration shall be given to classifying these substances also as skin sensitisers and including information concerning contact urticaria on the label or in the SDS using appropriate warning information.
3.4.2.2.3.2. For substances which produce signs of immunological contact urticaria but which do not fulfil the criteria as a respiratory sensitiser, consideration shall be given to classification as a skin sensitiser. There is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence, which will be similar to that for skin sensitisation.


3.4.2.2.4. Animal studies
3.4.2.2.4.1. When an adjuvant type guinea pig test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant guinea pig test method a response of at least 15 % of the animals is considered positive. Test methods for skin sensitisation described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) shall be used, or other methods provided that they are well-validated and scientific justification is given.


3.4.3. Classification criteria for mixtures


3.4.3.1. Classification of mixtures when data are available for the complete mixture
3.4.3.1.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.


3.4.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.


3.4.3.3. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.3 for solid/liquid and gas respectively.
3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.1, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.3).


Table 3.4.3
Generic concentration limits of ingredients of a mixture classified as either skin sensitisers or respiratory sensitisers that trigger classification of the mixture

Ingredient classified as:
Concentration triggering classification of a mixture as:
Skin Sensitiser
Respiratory Sensitiser
All physical states
Solid/Liquid
Gas
Skin Sensitiser
≥ 0,1 %
(Note 1)
—
—
≥ 1,0 %
(Note 2)
—
—
Respiratory Sensitiser
—
≥ 0,1 %
(Note 1)
≥ 0,1 %
(Note 1)
—
≥ 1,0 %
(Note 3)
≥ 0,2 %
(Note 3)


Note 1
This concentration limit is generally used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing an ingredient above this concentration.

Note 2
This concentration limit is used to trigger classification of a mixture as a skin sensitiser.

Note 3
This concentration limit is used to trigger classification of a mixture as a respiratory sensitiser.


3.4.4. Hazard communication
3.4.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.4.4.

Table 3.4.4
Respiratory or skin sensitisation label elements.

Classification
Respiratory sensitisation
Skin sensitisation
Category 1
Category 1
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled
H317: May cause an allergic skin reaction
Precautionary Statement Prevention
P261
P285
P261
P272
P280
Precautionary Statement Response
P304 + P341
P342+ P311
P302 + P352
P333 + P313
P321
P363
Precautionary Statement Storage


Precautionary Statement Disposal
P501
P501


3.5. Germ cell mutagenicity


3.5.1. Definitions and general considerations
3.5.1.1. A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term mutation applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term mutagenic and mutagen will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.
3.5.1.2. The more general terms genotoxic and genotoxicity apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.


3.5.2. Classification criteria for substances
3.5.2.1. This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.
3.5.2.2. For the purpose of classification for germ cell mutagenicity, substances are allocated to one of two categories as shown in Table 3.5.1.

Table 3.5.1
Hazard categories for germ cell mutagens

Categories
Criteria
CATEGORY 1:
Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.
Substances known to induce heritable mutations in the germ cells of humans.

Category 1A:
The classification in Category 1A is based on positive evidence from human epidemiological studies.
Substances to be regarded as if they induce heritable mutations in the germ cells of humans.
Category 1B:
The classification in Category 1B is based on:

positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or
positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or
positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.
CATEGORY 2:
Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans
The classification in Category 2 is based on:

positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:

somatic cell mutagenicity tests in vivo, in mammals; or
other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
Note: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.


3.5.2.3. Specific considerations for classification of substances as germ cell mutagens
3.5.2.3.1. To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.

3.5.2.3.2. The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.
3.5.2.3.3. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.
3.5.2.3.4. In vivo heritable germ cell mutagenicity tests, such as:

rodent dominant lethal mutation test;
mouse heritable translocation assay.
3.5.2.3.5. In vivo somatic cell mutagenicicty tests, such as:

mammalian bone marrow chromosome aberration test;
mouse spot test;
mammalian erythrocyte micronucleus test.
3.5.2.3.6. Mutagenicity/genotoxicity tests in germ cells, such as:

(a) mutagenicity tests:

mammalian spermatogonial chromosome aberration test;
spermatid micronucleus assay;

(b) Genotoxicity tests:

sister chromatid exchange analysis in spermatogonia;
unscheduled DNA synthesis test (UDS) in testicular cells.
3.5.2.3.7. Genotoxicity tests in somatic cells such as:

liver Unscheduled synthesis test (UDS) in vivo;
mammalian bone marrow Sister Chromatid Exchanges (SCE);
3.5.2.3.8. In vitro mutagenicity tests such as:

in vitro mammalian chromosome aberration test;
in vitro mammalian cell gene mutation test;
bacterial reverse mutation tests.
3.5.2.3.9. The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.



3.5.3. Classification criteria for mixtures


3.5.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.5.3.1.1. The mixture shall be classified as a mutagen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 mutagen and is present at or above the appropriate generic concentration limit as shown in Table 3.5.2 for Category 1A, Category 1B and Category 2 respectively.

Table 3.5.2
Generic concentration limits of ingredients of a mixture classified as germ cell mutagens that trigger classification of the mixture.


Concentration limits triggering classification of a mixture as:
Ingredient classified as:
Category 1A mutagen
Category 1B mutagen
Category 2 mutagen
Category 1A mutagen
≥ 0,1 %
—
—
Category 1B mutagen
—
≥ 0,1 %
—
Category 2 mutagen
—
—
≥ 1,0 %

Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).


3.5.3.2. Classification of mixtures when data are available for the complete mixture
3.5.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.


3.5.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.5.3.3.1. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.


3.5.4. Hazard communication
3.5.4.1. Label elements shall be used in accordance with Table 3.5.3, for substances or mixtures meeting the criteria for classification in this hazard class.


Table 3.5.3
Label elements of germ cell mutagenicity

Classification
Category 1A or Category 1B
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement
Prevention
P201
P202
P281
P201
P202
P281
Precautionary Statement
Response
P308 + P313
P308 + P313
Precautionary Statement
Storage
P405
P405
Precautionary Statement
Disposal
P501
P501


3.5.5. Additional classification considerations
It is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).


3.6. Carcinogenicity


3.6.1. Definition
3.6.1.1. Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.


3.6.2. Classification criteria for substances
3.6.2.1. For the purpose of classification for carcinogenicity, substances are allocated to one of two categories based on strength of evidence and additional considerations (weight of evidence). In certain instances, route-specific classification may be warranted, if it can be conclusively proved that no other route of exposure exhibits the hazard.


Table 3.6.1
Hazard categories for carcinogens

Note: See 3.6.2.2.4.

Categories
Criteria
CATEGORY 1:
Known or presumed human carcinogens
A substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:
Category 1A:
Category 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or
Category 1B:
Category 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.

The classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:

human studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or
animal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen).

In addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.
CATEGORY 2:
Suspected human carcinogens
The placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.


3.6.2.2. Specific considerations for classification of substances as carcinogens
3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.

3.6.2.2.2. Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.
3.6.2.2.3. Strength of evidence involves the enumeration of tumours in human and animal studies and determination of their level of statistical significance. Sufficient human evidence demonstrates causality between human exposure and the development of cancer, whereas sufficient evidence in animals shows a causal relationship between the substance and an increased incidence of tumours. Limited evidence in humans is demonstrated by a positive association between exposure and cancer, but a causal relationship cannot be stated. Limited evidence in animals is provided when data suggest a carcinogenic effect, but are less than sufficient. The terms sufficient and limited have been used here as they have been defined by the International Agency for Research on Cancer (IARC) and read as follows:

(a) Carcinogenicity in humans
The evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:

sufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;
limited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.

(b) Carcinogenicity in experimental animals
Carcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:

sufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;
limited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.
3.6.2.2.4. Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.
3.6.2.2.5. The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.
3.6.2.2.6. Some important factors which may be taken into consideration, when assessing the overall level of concern are:

(a) tumour type and background incidence;

(b) multi-site responses;

(c) progression of lesions to malignancy;

(d) reduced tumour latency;

(e) whether responses are in single or both sexes;

(f) whether responses are in a single species or several species;

(g) structural similarity to a substance(s) for which there is good evidence of carcinogenicity;

(h) routes of exposure;

(i) comparison of absorption, distribution, metabolism and excretion between test animals and humans;

(j) the possibility of a confounding effect of excessive toxicity at test doses;

(k) mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.
Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.

3.6.2.2.7. A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.
3.6.2.2.8. The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.
3.6.2.2.9. It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.


3.6.3. Classification criteria for mixtures


3.6.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.6.3.1.1. The mixture will be classified as a carcinogen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 carcinogen and is present at or above the appropriate generic concentration limit as shown in Table 3.6.2 for Category 1A, Category 1B and Category 2 respectively.

Table 3.6.2
Generic concentration limits of ingredients of a mixture classified as carcinogen that trigger classification of the mixture

Ingredient classified as:
Generic concentration limits triggering classification of a mixture as:
Category 1A carcinogen
Category 1B carcinogen
Category 2 carcinogen
Category 1A carcinogen
≥ 0,1 %
—
—
Category 1B carcinogen
—
≥ 0,1 %
—
Category 2 carcinogen
—
—
≥ 1,0 % [Note 1]

Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).

Note 1
If a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request.


3.6.3.2. Classification of mixtures when data are available for the complete mixture
3.6.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.



3.6.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.6.3.3.1. Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.


3.6.4. Hazard Communication
3.6.4.1. Label elements shall be used in accordance with Table 3.6.3, for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.6.3
Label elements for carcinogenicity

Classification
Category 1A or Category 1B
Category 2
GHS Pictograms


Signal Word
Danger
Warning
Hazard Statement
H350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement
Prevention
P201
P202
P281
P201
P202
P281
Precautionary Statement
Response
P308 + P313
P308 + P313
Precautionary Statement
Storage
P405
P405
Precautionary Statement
Disposal
P501
P501


3.7. Reproductive toxicity


3.7.1. Definitions and general considerations
3.7.1.1. Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based heritable effects in the offspring is addressed in Germ Cell Mutagenicity (section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.
In this classification system, reproductive toxicity is subdivided under two main headings:

(a) adverse effects on sexual function and fertility;

(b) adverse effects on development of the offspring.
Some reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.
3.7.1.2. For the purpose of classification the hazard class Reproductive Toxicity is differentiated into:

adverse effects

on sexual function and fertility, or
on development;
effects on or via lactation.


3.7.1.3. Adverse effects on sexual function and fertility
Any effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.


3.7.1.4. Adverse effects on development of the offspring
Developmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.
3.7.1.5. Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.



3.7.2. Classification criteria for substances


3.7.2.1. Hazard categories
3.7.2.1.1. For the purpose of classification for reproductive toxicity, substances are allocated to one of two categories. Within each category, effects on sexual function and fertility, and on development, are considered separately. In addition, effects on lactation are allocated to a separate hazard category.

Table 3.7.1(a)
Hazard categories for reproductive toxicants

Categories
Criteria
CATEGORY 1
Known or presumed human reproductive toxicant
Substances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).
Category 1A
Known human reproductive toxicant
The classification of a substance in Category 1A is largely based on evidence from humans.
Category 1B
Presumed human reproductive toxicant
The classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.
CATEGORY 2
Suspected human reproductive toxicant
Substances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.
Such effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.

Table 3.7.1(b)
Hazard category for lactation effects

EFFECTS ON OR VIA LACTATION
Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:

(a) human evidence indicating a hazard to babies during the lactation period; and/or

(b) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or

(c) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.


3.7.2.2. Basis of classification
3.7.2.2.1. Classification is made on the basis of the appropriate criteria, outlined above, and an assessment of the total weight of evidence (see 1.1.1). Classification as a reproductive toxicant is intended to be used for substances which have an intrinsic, specific property to produce an adverse effect on reproduction and substances shall not be so classified if such an effect is produced solely as a non-specific secondary consequence of other toxic effects.
The classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.
3.7.2.2.2. In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).
3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.


3.7.2.3. Weight of evidence
3.7.2.3.1. Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).
3.7.2.3.2. Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.
3.7.2.3.3. If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.
3.7.2.3.4. Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.

3.7.2.3.5. If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.


3.7.2.4. Maternal toxicity
3.7.2.4.1. Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.
3.7.2.4.2. Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.
3.7.2.4.3. Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.
3.7.2.4.4. Some of the end points used to assess maternal effects are provided below. Data on these end points, if available, need to be evaluated in light of their statistical or biological significance and dose response relationship.
Maternal mortality:
an increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.
Mating index
(no. animals with seminal plugs or sperm/no. mated × 100)It is recognised that the Mating index and the Fertility index can also be affected by the male.
Fertility index
(no. animals with implants/no. of matings × 100)
Gestation length
(if allowed to deliver)
Body weight and body weight change:
Consideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.
Food and water consumption (if relevant):
The observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.
Clinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):
The observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.
Post-mortem data:
Increased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.


3.7.2.5. Animal and experimental data
3.7.2.5.1. A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).
3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.
3.7.2.5.3. Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.
3.7.2.5.4. Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.
3.7.2.5.5. It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.

3.7.2.5.6. Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.
3.7.2.5.7. There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.
3.7.2.5.8. In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.
3.7.2.5.9. However, specification of the actual limit dose will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.


3.7.3. Classification criteria for mixtures


3.7.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture
3.7.3.1.1. The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.
3.7.3.1.2. The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.

Table 3.7.2
Generic concentration limits of ingredients of a mixture classified as reproduction toxicants or for effects on or via lactation that trigger classification of the mixture

Ingredient classified as:
Generic concentration limits triggering classification of a mixture as:
Category 1A reproductive toxicant
Category 1B reproductive toxicant
Category 2 reproductive toxicant
Additional category for effects on or via lactation
Category 1A reproductive toxicant
≥ 0,3 %
[Note 1]



Category 1B reproductive toxicant

≥ 0,3 %
[Note 1]


Category 2 reproductive toxicant


≥ 3,0 %
[Note 1]

Additional category for effects on or via lactation



≥ 0,3 %
[Note 1]


Note
The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).

Note 1
If a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request.


3.7.3.2. Classification of mixtures when data are available for the complete mixture
3.7.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.


3.7.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.


3.7.4. Hazard Communication
3.7.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.7.3


Table 3.7.3
Label elements for reproductive toxicity

Classification
Category 1A or Category 1B
Category 2
Additional category for effects on or via lactation
GHS Pictograms


No pictogram
Signal Word
Danger
Warning
No signal word
Hazard Statement
H360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H362: May cause harm to breast-fed children.
Precautionary Statement Prevention
P201
P202
P281
P201
P202
P281
P201
P260
P263
P264
P270
Precautionary Statement Response
P308 + P313
P308 + P313
P308 + P313
Precautionary Statement Storage
P405
P405

Precautionary Statement Disposal
P501
P501



3.8. Specific target organ toxicity — single exposure


3.8.1. Definitions and general considerations
3.8.1.1. Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).
3.8.1.2. Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
3.8.1.3. These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.

3.8.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
3.8.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
3.8.1.6. Specific target organ toxicity following a repeated exposure is classified as described in Specific target organ toxicity — Repeated exposure (section 3.9) and is therefore excluded from section 3.8. Other specific toxic effects, listed below, are assessed separately and consequently are not included here:

(a) Acute toxicity (section 3.1);

(b) Skin corrosion/irritation (section 3.2);

(c) Serious eye damage/eye irritation (section 3.3);

(d) Respiratory or skin sensitisation (section 3.4);

(e) Germ cell mutagenicity (section 3.5);

(f) Carcinogenicity (section 3.6);

(g) Reproductive toxicity (section 3.7); and

(h) Aspiration toxicity (section 3.10).
3.8.1.7. The hazard class Specific Target Organ Toxicity — Single Exposure is differentiated into:

Specific target organ toxicity — single exposure, Category 1 and 2;
Specific target organ toxicity — single exposure, Category 3.
See Table 3.8.1.

Table 3.8.1
Categories for specific target organ toxicity-single exposure

Note: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).

Categories
Criteria
Category 1
Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure
Substances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:

(a) reliable and good quality evidence from human cases or epidemiological studies; or

(b) observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.
Category 2
Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure
Substances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.
In exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).
Category 3
Transient target organ effects
This category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.


3.8.2. Classification criteria for substances


3.8.2.1. Substances of Category 1 and Category 2
3.8.2.1.1. Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).
3.8.2.1.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).
3.8.2.1.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.
3.8.2.1.5. The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.
3.8.2.1.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of target organ toxicity in Category 2:

(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or

(b) based on the nature and severity of effects.
Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.


3.8.2.1.7. Effects considered to support classification for Category 1 and 2
3.8.2.1.7.1. Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.
3.8.2.1.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
3.8.2.1.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:

(a) morbidity resulting from single exposure;

(b) significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);

(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;

(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;

(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;

(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;


(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.


3.8.2.1.8. Effects considered not to support classification for Category 1 and 2
It is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:

(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate significant toxicity;

(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;

(c) changes in organ weights with no evidence of organ dysfunction;

(d) adaptive responses that are not considered toxicologically relevant;

(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.


3.8.2.1.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals for Category 1 and 2
3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.
3.8.2.1.9.2. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).
3.8.2.1.9.3. The guidance value (C) ranges for single-dose exposure which has produced a significant non-lethal toxic effect are those applicable to acute toxicity testing, as indicated in Table 3.8.2.


Table 3.8.2
Guidance value ranges for single-dose exposures a


Guidance value ranges for:
Route of exposure
Units
Category 1
Category 2
Category 3
Oral (rat)
mg/kg body weight
C ≤ 300
2000 ≥ C > 300
Guidance values do not apply b
Dermal (rat or rabbit)
mg/kg body weight
C ≤ 1000
2000 ≥ C > 1000
Inhalation (rat) gas
ppmV/4h
C ≤ 2500
20000 ≥ C > 2500
Inhalation (rat) vapour
mg/l/4h
C ≤ 10
20 ≥ C > 10
Inhalation (rat) dust/mist/fume
mg/l/4h
C ≤ 1,0
5,0 ≥ C > 1,0

Note

(a) The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.

(b) Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation.


3.8.2.1.10. Other considerations
3.8.2.1.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
3.8.2.1.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.
3.8.2.1.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.

3.8.2.1.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection


3.8.2.2. Substances of Category 3: Transient target organ effects


3.8.2.2.1. Criteria for respiratory tract irritation
The criteria for classifying substances as Category 3 for respiratory tract irritation are:

(a) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;

(b) subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);

(c) the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of irritation shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;

(d) there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;

(e) this special classification would occur only when more severe organ effects including in the respiratory system are not observed.


3.8.2.2.2 Criteria for narcotic effects
The criteria for classifying substances as Category 3 for narcotic effects are:

(a) central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;

(b) narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.



3.8.3. Classification criteria for mixtures
3.8.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.


3.8.3.2. Classification of mixtures when data are available for the complete mixture
3.8.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.


3.8.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.8.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.


3.8.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture
3.8.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.
3.8.3.4.2. These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.
3.8.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.

Table 3.8.3
Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture as Category 1 or 2

Ingredient classified as:
Generic concentration limits triggering classification of the mixture as:
Category 1
Category 2
Category 1
Specific Target Organ Toxicant
Concentration ≥ 10 %
1,0 % ≤ concentration < 10 %
Category 2
Specific Target Organ Toxicant

Concentration ≥ 10 % [(Note 1)]

Note 1
If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.
3.8.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.
3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised.


3.8.4. Hazard Communication
3.8.4.1 Label elements shall be used in accordance with Table 3.8.4., for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.8.4
Label elements for specific target organ toxicity after single exposure

Classification
Category 1
Category 2
Category 3
GHS Pictograms



Signal Word
Danger
Warning
Warning
Hazard Statement
H370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H335: May cause respiratory irritation; or
H336: May cause drowsiness or dizziness
Precautionary Statement Prevention
P260
P264
P270
P260
P264
P270
P261
P271
Precautionary Statement Response
P307 + P311
P321
P309 + P311
P304 + P340
P312
Precautionary Statement Storage
P405
P405
P403 + P233
P405
Precautionary Statement Disposal
P501
P501
P501


3.9. Specific target organ toxicity — repeated exposure


3.9.1. Definitions and general considerations
3.9.1.1. Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.
3.9.1.2. Classification for target organ toxicity (repeated exposure) identifies the substance as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
3.9.1.3. These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.
3.9.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
3.9.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
3.9.1.6. Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.


3.9.2. Classification criteria for substances
3.9.2.1. Substances are classified as specific target organ toxicants following repeated exposure by the use of expert judgement (see 1.1.1), on the basis of the weight of all evidence available, including the use of recommended guidance values which take into account the duration of exposure and the dose/concentration which produced the effect(s), (see 3.9.2.9), and are placed in one of two categories, depending upon the nature and severity of the effect(s) observed (Table 3.9.1).


Table 3.9.1
Categories for specific target organ toxicity-repeated exposure

Categories
Criteria
Category 1
Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.
Substances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:

reliable and good quality evidence from human cases or epidemiological studies; or
observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.
Category 2
Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.
Substances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.
In exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).

Note
Attempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).
3.9.2.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified.
3.9.2.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
3.9.2.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.
3.9.2.5. The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.
3.9.2.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of specific target organ toxicity in Category 2:

(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or

(b) based on the nature and severity of effects.
Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.


3.9.2.7. Effects considered to support classification for specific target organ toxicity following repeated exposure
3.9.2.7.1. Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.
3.9.2.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
3.9.2.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, haematology, clinical chemistry, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, shall be taken into consideration in the classification process, including but not limited to the following toxic effects in humans and/or animals:

(a) morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;

(b) significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);


(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;

(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;

(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;

(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);

(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.


3.9.2.8. Effects considered not to support classification for specific target organ toxicity following repeated exposure
3.9.2.8.1. It is recognised that effects may be seen in humans and/or animals that do not justify classification. Such effects include, but are not limited to:

(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate significant toxicity;

(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;

(c) changes in organ weights with no evidence of organ dysfunction;

(d) adaptive responses that are not considered toxicologically relevant;

(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.


3.9.2.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals
3.9.2.9.1. In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.
3.9.2.9.2. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.
3.9.2.9.3. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).
3.9.2.9.4. The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.
3.9.2.9.5. The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.
3.9.2.9.6. Thus classification in Category 1 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur at or below the guidance values (C) as indicated in Table 3.9.2:

Table 3.9.2
Guidance values to assist in Category 1 classification

Route of exposure
Units
Guidance values (dose/concentration)
Oral (rat)
mg/kg body weight/day
C ≤ 10
Dermal (rat or rabbit)
mg/kg body weight/day
C ≤ 20
Inhalation (rat)gas
ppmV/6h/day
C ≤ 50
Inhalation (rat)vapour
mg/litre/6h/day
C ≤ 0,2
Inhalation (rat) dust/mist/fume
mg/litre/6h/day
C ≤ 0,02
3.9.2.9.7. Classification in Category 2 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur within the guidance value ranges as indicated in Table 3.9.3:


Table 3.9.3
Guidance values to assist in Category 2 classification

Route of Exposure
Units
Guidance Value Ranges:
(dose/concentration)
Oral (rat)
mg/kg body weight/day
10 < C ≤ 100
Dermal (rat or rabbit)
mg/kg body weight/day
20 < C ≤ 200
Inhalation (rat) gas
ppmV/6h/day
50 < C ≤ 250
Inhalation (rat)vapour
mg/litre/6h/day
0,2 < C ≤ 1,0
Inhalation (rat) dust/mist/fume
mg/litre/6h/day
0,02 < C ≤ 0,2
3.9.2.9.8. The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.
3.9.2.9.9. Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.


3.9.2.10. Other considerations
3.9.2.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
3.9.2.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.

3.9.2.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.
3.9.2.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection


3.9.3. Classification criteria for mixtures
3.9.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.


3.9.3.2. Classification of mixtures when data are available for the complete mixture
3.9.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.


3.9.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles
3.9.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.


3.9.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture
3.9.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, repeat exposure, or both when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as laid out in Table 3.9.4 for Category 1 and 2 respectively.

Table 3.9.4
Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture

Ingredient classified as:
Generic concentration limits triggering classification of the mixture as:
Category 1
Category 2
Category 1
Specific Target Organ Toxicant
Concentration ≥ 10 %
1,0 % ≤ concentration < 10 %
Category 2
Specific Target Organ Toxicant

Concentration ≥ 10 % [(Note 1)]

Note 1
If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.
3.9.3.4.2. These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.
3.9.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.
3.9.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.


3.9.4. Hazard Communication
3.9.4.1. Label elements shall be used in accordance with Table 3.9.5 for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.9.5
Label elements for specific target organ toxicity after repeated exposure

Classification
Category 1
Category 2
GHS Pictograms


Signal word
Danger
Warning
Hazard Statement
H372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
H373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement Prevention
P260
P264
P270
P260
Precautionary Statement Response
P314
P314
Precautionary Statement Storage


Precautionary Statement Disposal
P501
P501



3.10. Aspiration hazard


3.10.1. Definitions and general considerations
3.10.1.1. These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.
3.10.1.2 Aspiration means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.
3.10.1.3. Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.
3.10.1.4. Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.
3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.


3.10.1.6. Specific considerations
3.10.1.6.1. A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.
3.10.1.6.2. The classification criteria refer to kinematic viscosity. The following provides the conversion between dynamic and kinematic viscosity:
Dynamic viscosity mPa sDensity g/cm3=Kinematic viscosity mm2/s


3.10.1.6.3. Classification of aerosol/mist products
Aerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.



3.10.2. Classification criteria for substances

Table 3.10.1
Hazard category for aspiration toxicity

Category
Criteria
Category 1
Substances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard
A substance is classified in Category 1:

(a) based on reliable and good quality human evidence
or

(b) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.

Note:
Substances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil.


3.10.3. Classification criteria for mixtures


3.10.3.1. Classification when data are available for the complete mixture
A mixture is classified in Category 1 based on reliable and good quality human evidence.


3.10.3.2. Classification when data are not available for the complete mixture: bridging principles
3.10.3.2.1. Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.


3.10.3.3. Classification when data are available for all components or only some components of the mixture


3.10.3.3.1. Category 1
3.10.3.3.1.1. A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.
3.10.3.3.1.2. In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.


3.10.4. Hazard Communication
3.10.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.10.2.


Table 3.10.2
Aspiration toxicity label elements

Classification
Category 1
GHS Pictogram

Signal Word
Danger
Hazard Statement
H304: May be fatal if swallowed and enters airways
Precautionary Statement
Prevention

Precautionary Statement
Response
P301 + P310
P331
Precautionary Statement
Storage
P405
Precautionary Statement
Disposal
P501



4. PART 4: ENVIRONMENTAL HAZARDS


4.1. Hazardous to the aquatic environment


4.1.1. Definitions and General Considerations


4.1.1.1. Definitions
Acute aquatic toxicity means the intrinsic property of a substance to be injurious to an organism in a short-term exposure to that substance.
Availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (Mo) compound can disaggregate from the rest of the compound (molecule).
Bioavailability (or biological availability) means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.
Bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).
Bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.
Chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during exposures which are determined in relation to the life-cycle of the organism.
Degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.


4.1.1.2. Basic elements
4.1.1.2.0. Hazardous to the Aquatic Environment is differentiated into:

Acute aquatic hazard;
Chronic (long term) aquatic hazard.
4.1.1.2.1. The basic elements used for classification for aquatic environmental hazards are:

Acute aquatic toxicity;
Potential for or actual bioaccumulation;
Degradation (biotic or abiotic) for organic chemicals; and
Chronic aquatic toxicity.
4.1.1.2.2. Preferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test method used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1.



4.1.1.3. Other considerations
4.1.1.3.1. Classification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of hazard is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.
4.1.1.3.2. While the classification system applies to all substances and mixtures, it is recognised that for special cases the Agency will issue guidance.


4.1.2. Classification criteria for substances
4.1.2.1. The core classification system for substances consists of one acute classification category and three chronic classification categories. The acute and the chronic classification categories are applied independently. The criteria for classification of a substance in acute Category 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the chronic categories combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data).
4.1.2.2. The system also introduces a safety net classification (referred to as Chronic Category 4) for use when the data available do not allow classification under the formal criteria but there are nevertheless some grounds for concern (see example in table 4.1.0).
4.1.2.3. The system for classification recognises that the core intrinsic hazard to aquatic organisms is represented by both the acute and chronic toxicity of a substance. Separate hazard categories are defined for both properties representing a gradation in the level of hazard identified. The lowest of the available toxicity values shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.
4.1.2.4. The principal hazard of a hazardous to the aquatic environment substance is defined by chronic toxicity, although acute toxicity at L(E)C50 levels ≤ 1 mg/l are also considered hazardous. The intrinsic properties of a lack of rapid degradability and/or a potential to bioconcentrate in combination with acute toxicity are used to assign a substance to a chronic (long term) hazard category.
4.1.2.5. Substances with acute toxicities well below 1 mg/l contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and 4.1.3.5.5).
4.1.2.6. The criteria for classifying and categorising substances as hazardous to the aquatic environment are summarised in Table 4.1.0.

Table 4.1.0
Classification categories for hazardous to the aquatic environment

Acute (short-term) aquatic hazard
Acute Category 1
(Note 1)
96 hr LC50 (for fish)
≤ 1 mg/l and/or

48 hr EC50 (for crustacea)
≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)
≤ 1 mg/l.
(Note 2)
Chronic (long-term) aquatic hazard
Chronic Category 1
(Note 1)
96 hr LC50 (for fish)
≤ 1 mg/l and/or
48 hr EC50 (for crustacea)
≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)
≤ 1 mg/l
(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4).
Chronic Category 2
96 hr LC50 (for fish)
> 1 to ≤ 10 mg/l and/or
48 hr EC50 (for crustacea)
> 1 to ≤ 10 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)
> 1 to ≤ 10 mg/l
(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4), unless the chronic toxicity NOECs are > 1 mg/l.
Chronic Category 3
96 hr LC50 (for fish)
> 10 to ≤ 100 mg/l and/or
48 hr EC50 (for crustacea)
> 10 to ≤ 100 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)
> 10 to ≤ 100 mg/l
(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4) unless the chronic toxicity NOECs are > 1 mg/l.
Safety net classification
Chronic Category 4
Cases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 3), and which are not rapidly degradable and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or evidence of rapid degradation in the environment.


Note 1
When classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate an appropriate M-factor (see table 4.1.3).


Note 2
Classification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.

Note 3
No acute toxicity is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity.


4.1.2.7. Aquatic toxicity
4.1.2.7.1. Acute aquatic toxicity is normally determined using a fish 96 hour LC50, a crustacea species 48 hour EC50 and/or an algal species 72 or 96 hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).
4.1.2.7.2. For determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECS or other equivalent L(E)Cx (e.g. EC10) shall be used.


4.1.2.8. Bioaccumulation
4.1.2.8.1. Bioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes.


4.1.2.9. Rapid degradability of organic substances
4.1.2.9.1. Substances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.
4.1.2.9.2. One way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is readily biodegradable. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade rapidly in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of rapid degradability is met.
4.1.2.9.3. Many degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.
4.1.2.9.4. The criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.
4.1.2.9.5. Substances are considered rapidly degradable in the environment if one of the following criteria holds true:

(a) if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved;

(i) tests based on dissolved organic carbon: 70 %

(ii) tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.
These levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded; or

(b) if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or

(c) if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.


4.1.2.10. Inorganic compounds and metals
4.1.2.10.1. For inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with careSpecific guidance will be provided by the Agency on how these data for such substances may be used in meeting the requirements of the classification criteria..
4.1.2.10.2. Poorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution.



4.1.3. Classification criteria for mixtures
4.1.3.1. The classification system for mixtures covers all classification categories which are used for substances, i.e. Acute Category 1 and Chronic Categories 1 to 4. In order to make use of all available data for purposes of classifying the aquatic environmental hazards of the mixture, the following is applied where appropriate:
The relevant components of a mixture are those which are classified Acute Category 1 or Chronic Category 1 and present in a concentration of 0,1 % (w/w) or greater, and those which are classified Chronic Category 2, Chronic Category 3 or Chronic Category 4 and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as Acute Category 1 or Chronic Category 1 the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see 4.1.3.5.5.5).
4.1.3.2. The approach for classification of aquatic environmental hazards is tiered, and is dependent upon the type of information available for the mixture itself and for its components. Figure 4.1.2 outlines the process to be followed.
Elements of the tiered approach include:

classification based on tested mixtures;
classification based on bridging principles;
the use of summation of classified components and/or an additivity formula.

Figure 4.1.2
Tiered approach to classification of mixtures for acute and chronic (long term) aquatic environmental hazards

Aquatic toxicity test data available on the mixture as a whole
No
Yes
CLASSIFY
for acute/chronic aquatic hazard (see 4.1.3.3)
Sufficient data available on similar mixtures to estimate hazards
Yes
Apply bridging principles (see 4.1.3.4.)
CLASSIFY
for acute/chronic aquatic hazard
No
Either aquatic toxicity or classification data available for all relevant components
Yes
Apply summation Method (see 4.1.3.5.5) using:
• Percentage of all components classified as ‘Chronic’
• Percentage of components classified as ‘Acute’
• Percentage of components with acute toxicity data: apply Addititivity Formula (see 4.1.3.5.2) and convert the derived L(E)C50 to the appropriate ‘Acute’ Category
CLASSIFY
for acute/chronic aquatic hazard
No
Use available hazard data of known components.
Apply Summation Method and/or Additivity Formula (see 4.1.3.5) and apply 4.1.3.6
CLASSIFY
for acute/chronic aquatic hazard



4.1.3.3. Classification of mixtures when data are available for the complete mixture
4.1.3.3.1. When the mixture as a whole has been tested to determine its aquatic toxicity, it is classified according to the criteria that have been agreed for substances, but only for acute hazard. The classification is normally based on the data for fish, crustacea and algae/plants. Classification of mixtures by using LC50 or EC50 data for the mixture as a whole is not possible for chronic categories since both toxicity data and environmental fate data are needed, and there are no degradability and bioaccumulation data for mixtures as a whole. It is not possible to apply the criteria for chronic classification because the data from degradability and bioaccumulation tests of mixtures cannot be interpreted; they are meaningful only for single substances.
4.1.3.3.2. When there is acute toxicity test data (LC50 or EC50) available for the mixture as a whole, these data as well as information with respect to the classification of components for chronic (long-term) hazard shall be used to complete the classification for tested mixtures as follows. When chronic toxicity data (NOEC) is also available, this shall be used too.

(a) L(E)C50 (LC50 or EC50) of the tested mixture ≤ 100 mg/l and NOEC of the tested mixture ≤ 1 mg/l or unknown:

Classify mixture as Acute Category 1 (LC50 or EC50 of the tested mixture ≤ 1 mg/l) or no need for acute classification (LC50 and EC50 of the tested mixture > 1 mg/l).
Apply summation method (see 4.1.3.5.5) for chronic classification (Chronic Category 1, 2, 3, 4 or no need for chronic classification).

(b) L(E)C50 of the tested mixture ≤ 100 mg/l and NOEC(s) of the tested mixture > 1 mg/l:

No need to classify for acute hazard
Apply summation method (see 4.1.3.5.5) for classification as Chronic Category 1. If the mixture is not classified as Chronic Category 1, then there is no need for chronic classification.

(c) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC of the tested mixture ≤ 1 mg/l or unknown:

No need to classify for acute hazard
Apply summation method (see 4.1.3.5.5) for Chronic classification (Chronic Category 4 or no need for chronic classification).

(d) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC(s) of the tested mixture > 1 mg/l:

No need to classify for acute or chronic (long-term) hazard.


4.1.3.4. Classification of mixtures when data are not available for the complete mixture: Bridging principles
4.1.3.4.1. Where the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, paragraphs 4.1.3.4.2 and 4.1.3.4.3 shall be used.
4.1.3.4.2. Dilution: if a mixture is formed by diluting another mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the mixture may be classified as equivalent to the original mixture or substance.
4.1.3.4.3. If a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance


4.1.3.5. Classification of mixtures when data are available for all components or only for some components of the mixture
4.1.3.5.1. The classification of a mixture is based on summation of the classification of its components. The percentage of components classified as Acute or Chronic is fed straight in to the summation method. Details of the summation method are described in 4.1.3.5.5.
4.1.3.5.2. When a mixture consists of components that are not (yet) classified (as Acute Category 1 and/or Chronic Category 1, 2, 3 or 4) adequate data for these components shall be taken into account when available. When adequate toxicity data are available for more than one component in the mixture, the combined toxicity of those components is calculated using the following additivity formula, and the calculated toxicity is used to assign that portion of the mixture an acute category which is then subsequently used in applying the summation method.
ΣCiC(E)L50m = ΣηCiC(E)L50i
where:

Ci
concentration of component i (weight percentage)
L(E)C50 i
(mg/l) LC50 or EC50 for component i
η
number of components
L(E)C50 m
L(E) C50 of the part of the mixture with test data
4.1.3.5.3. When applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, daphnia, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute toxicity is then used to assess whether this part of the mixture shall be classified as Acute Category 1 using the same criteria described for substances.
4.1.3.5.4. If a mixture is classified in more than one way, the method yielding the more conservative result shall be used.



4.1.3.5.5. Summation method


4.1.3.5.5.1. Rationale
4.1.3.5.5.1.1. In case of the substance classification categories Acute Category 1 or Chronic Category 1 to Chronic Category 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of all substances classified as Acute Category 1/Chronic Category 1, Chronic Category 2 and Chronic Category 3 together.
4.1.3.5.5.1.2. When a mixture contains components classified as Acute Category 1 or Chronic Category 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an under-classification of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in paragraph 4.1.3.5.5.5.


4.1.3.5.5.2. Classification procedure
4.1.3.5.5.2.1. In general a more severe classification for mixtures overrides a less severe classification, e.g. a classification for chronic toxicity with Chronic Category 1 overrides a classification with Chronic Category 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic Category 1. A more severe classification than Chronic Category 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.


4.1.3.5.5.3. Classification for Acute Category 1
4.1.3.5.5.3.1. First all components classified as Acute Category 1 are considered. If the sum of these components is greater than 25 % the whole mixture is classified as Acute Category 1.
4.1.3.5.5.3.2. The classification of mixtures for acute hazards based on this summation of classified components, is summarised in Table 4.1.1.

Table 4.1.1
Classification of a mixture for acute hazards, based on summation of classified components

For explanation of the M-factor, see 4.1.3.5.5.5.

Sum of components classified as:
Mixture is classified as:
Acute Category 1 × M ≥ 25 %
Acute Category 1


4.1.3.5.5.4. Classification for the Chronic Categories 1, 2, 3 and 4
4.1.3.5.5.4.1. First all components classified as Chronic Category 1 are considered. If the sum of these components multiplied by their corresponding M-factors is equal to or greater than 25 % the mixture is classified as Chronic Category 1. If the result of the calculation is a classification of the mixture as Chronic Category 1 the classification procedure is completed.

4.1.3.5.5.4.2. In cases where the mixture is not classified as Chronic Category 1, classification of the mixture as Chronic Category 2 is considered. A mixture is classified as Chronic Category 2 if 10 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus the sum of all components classified as Chronic Category 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic Category 2, the classification process is completed.
4.1.3.5.5.4.3. In cases where the mixture is not classified either as Chronic Category 1 or Chronic Category 2, classification of the mixture as Chronic Category 3 is considered. A mixture is classified as Chronic Category 3 if 100 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus 10 times the sum of all components classified with Chronic Category 2 plus the sum of all components classified as Chronic Category 3 is ≥ 25 %.
4.1.3.5.5.4.4. If the mixture is still not classified in Chronic Category 1, 2 or 3, classification of the mixture as Chronic Category 4 shall be considered. A mixture is classified as Chronic Category 4 if the sum of the percentages of components classified as Chronic Category 1, 2, 3 and 4 is equal to or greater than 25 %.
4.1.3.5.5.4.5. The classification of mixtures for chronic (long term) hazards, based on this summation of classified components, is summarised in Table 4.1.2.

Table 4.1.2
Classification of a mixture for chronic (long term) hazards, based on summation of classified components

For explanation of the M-factor, see 4.1.3.5.5.5.

Sum of components classified as:
Mixture is classified as:
Chronic Category 1 × M ≥ 25 %
Chronic Category 1
(M × 10 × Chronic Category 1) + Chronic Category 2 ≥ 25 %
Chronic Category 2
(M × 100 × Chronic Category 1) + (10 × Chronic Category 2) + Chronic Category 3 ≥ 25 %
Chronic Category 3
Chronic Category 1 + Chronic Category 2 + Chronic Category 3 + Chronic Category 4 ≥ 25 %
Chronic Category 4


4.1.3.5.5.5. Mixtures with highly toxic components
4.1.3.5.5.5.1. Acute Category 1 and Chronic Category 1 components with toxicities below 1 mg/l contribute to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach. When a mixture contains components classified as Acute or Chronic Category 1, one of the following shall be applied:


The tiered approach described in 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute Category 1 and Chronic Category 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of Acute Category 1 in the left column of Table 4.1.1 and the concentration of Chronic Category 1 in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic Category 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method;
The additivity formula (see 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.

Table 4.1.3
Multiplying factors for highly toxic components of mixtures

L(E)C50 value
Multiplying factor (M)
0,1 < L(E) C50 ≤ 1
1
0,01 < L(E) C50 ≤ 0,1
10
0,001 < L(E) C50 ≤ 0,01
100
0,0001 < L(E) C50 ≤ 0,001
1000
0,00001 < L(E) C50 ≤ 0,0001
10000
(continue in factor 10 intervals)



4.1.3.6. Classification of mixtures with components without any useable information
4.1.3.6.1. In the event that no useable information on acute and/or chronic (long term) aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement in the SDS that: Contains x % of components with unknown hazards to the aquatic environment.


4.1.4. Hazard Communication
4.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 4.1.4.


Table 4.1.4
Label elements for hazardous to the aquatic environment

ACUTE

Category 1
GHS Pictogram

Signal Word
Warning
Hazard Statement
H400: Very toxic to aquatic life
Precautionary Statement Prevention
P273
Precautionary Statement Response
P391
Precautionary Statement Storage

Precautionary Statement Disposal
P501

CHRONIC

Category 1
Category 2
Category 3
Category 4
GHS Pictograms


No pictogram is used
No pictogram is used
Signal Word
Warning
No signal word is used
No signal word is used
No signal word is used
Hazard Statement
H410: Very toxic to aquatic life with long lasting effects
H411: Toxic to aquatic life with long lasting effects
H412: Harmful to aquatic life with long lasting effects
H413: May cause long lasting harmful effects to aquatic life
Precautionary Statement Prevention
P273
P273
P273
P273
Precautionary Statement Response
P391
P391


Precautionary Statement Storage




Precautionary Statement Disposal
P501
P501
P501
P501



5. PART 5: ADDITIONAL EU HAZARD CLASS


5.1. Hazardous to the ozone layer


5.1.1. Definitions and general considerations
5.1.1.1. Substance Hazardous to the Ozone Layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 2037/2000 of the European Parliament and of the Council of 29 June 2000 on substances that deplete the ozone layerOJ L 244, 29.9.2000, p. 1. and its subsequent amendments.


5.1.2. Classification criteria for substances
5.1.2.1. A substance shall be classified as Hazardous to the Ozone Layer if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.


5.1.3. Classification criteria for mixtures
5.1.3.1. Mixtures shall be classified as Hazardous to the Ozone Layer on the basis of the individual concentration of the substance(s) contained therein that are also classified as Hazardous to the Ozone Layer, in accordance with Table 5.1.

Table 5.1
Generic concentration limits for substances (in a mixture), classified as Hazardous to the Ozone Layer, that trigger classification of the mixture as Hazardous to the Ozone Layer

Classification of the substance
Classification of the mixture
Hazardous to the ozone layer
C > 0,1 %


5.1.4. Hazard Communication
5.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 5.2

Table 5.2
Label elements for Hazardous to the Ozone Layer

Symbol/pictogram

Signal Word
Danger
Hazard Statement
EUH059: Hazardous to the Ozone Layer
Precautionary Statements
P273
P501

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.

texts differ too much for an inline diff; shown separately

before (32008R1272)

ANNEX III
LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS
1. Part 1: hazard statements
The hazard statements shall be applied in accordance with Parts 2, 3 and 4 of Annex I.
Table 1.1
Hazard statements for physical hazards
The codification system for GHS hazard statements is still under discussion in the UN Committee of Experts and therefore amendments might be needed.
H200 Language 2.1 — Explosives, Unstable explosives
BG Нестабилен експлозив.
ES Explosivo inestable.
CS Nestabilní výbušnina.
DA Ustabilt eksplosiv.
DE Instabil, explosiv.
ET Ebapüsiv lõhkeaine.
EL Ασταθή εκρηκτικά.
EN Unstable explosives.
FR Explosif instable.
GA Pléascáin éagobhsaí.
IT Esplosivo instabile.
LV Nestabili sprādzienbīstami materiāli.
LT Nestabilios sprogios medžiagos.
HU Instabil robbanóanyagok.
MT Splussivi instabbli.
NL Instabiele ontplofbare stof.
PL Materiały wybuchowe niestabilne.
PT Explosivo instável.
RO Exploziv instabil.
SK Nestabilné výbušniny.
SL Nestabilni eksplozivi.
FI Epästabiili räjähde.
SV Instabilt explosivt.
H201 Language 2.1 — Explosives, Division 1.1
BG Експлозив; опасност от масова експлозия.
ES Explosivo; peligro de explosión en masa.
CS Výbušnina; nebezpečí masivního výbuchu.
DA Eksplosiv, masseeksplosionsfare.
DE Explosiv, Gefahr der Massenexplosion.
ET Plahvatusohtlik; massiplahvatusoht.
EL Εκρηκτικό· κίνδυνος μαζικής έκρηξης.
EN Explosive; mass explosion hazard.
FR Explosif; danger d'explosion en masse.
GA Pléascach; guais mhórphléasctha.
IT Esplosivo; pericolo di esplosione di massa.
LV Sprādzienbīstams; masveida sprādzienbīstamība.
LT Sprogios medžiagos, kelia masinio sprogimo pavojų.
HU Robbanóanyag; teljes tömeg felrobbanásának veszélye.
MT Splussiv; periklu li jisplodu kollha f'daqqa.
NL Ontplofbare stof; gevaar voor massa-explosie.
PL Materiał wybuchowy; zagrożenie wybuchem masowym.
PT Explosivo; perigo de explosão em massa.
RO Exploziv; pericol de explozie în masă.
SK Výbušnina, nebezpečenstvo rozsiahleho výbuchu.
SL Eksplozivno; nevarnost eksplozije v masi.
FI Räjähde; massaräjähdysvaara.
SV Explosivt. Fara för massexplosion.
H202 Language 2.1 — Explosives, Division 1.2
BG Експлозив; сериозна опасност от разпръскване.
ES Explosivo; grave peligro de proyección.
CS Výbušnina; vážné nebezpečí zasažení částicemi.
DA Eksplosiv, alvorlig fare for udslyngning af fragmenter.
DE Explosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.
ET Plahvatusohtlik; suur laialipaiskumisoht.
EL Εκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.
EN Explosive, severe projection hazard.
FR Explosif; danger sérieux de projection.
GA Pléascach, guais throm teilgin.
IT Esplosivo; grave pericolo di proiezione.
LV Sprādzienbīstams; augsta izmetes bīstamība.
LT Sprogios medžiagos, kelia didelį išsvaidymo pavojų.
HU Robbanóanyag; kivetés súlyos veszélye.
MT Splussiv, periklu serju ta' projezzjoni.
NL Ontplofbare stof, ernstig gevaar voor scherfwerking.
PL Materiał wybuchowy, poważne zagrożenie rozrzutem.
PT Explosivo, perigo grave de projecções.
RO Exploziv; pericol grav de proiectare.
SK Výbušnina, závažné nebezpečenstvo rozletenia úlomkov.
SL Eksplozivno, velika nevarnost za nastanek drobcev.
FI Räjähde; vakava sirpalevaara.
SV Explosivt. Allvarlig fara för splitter och kaststycken.
H203 Language 2.1 — Explosives, Division 1.3
BG Експлозив; опасност от пожар, взрив или разпръскване.
ES Explosivo; peligro de incendio, de onda expansiva o de proyección.
CS Výbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.
DA Eksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.
DE Explosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.
ET Plahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.
EL Εκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.
EN Explosive; fire, blast or projection hazard.
FR Explosif; danger d'incendie, d'effet de souffle ou de projection.
GA Pléascach; guais dóiteáin, phléasctha nó teilgin.
IT Esplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.
LV Sprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.
LT Sprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.
HU Robbanóanyag; tűz, robbanás vagy kivetés veszélye.
MT Splussiv; periklu ta' nar, blast jew projezzjoni.
NL Ontplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.
PL Materiał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.
PT Explosivo; perigo de incêndio, sopro ou projecções.
RO Exploziv; pericol de incendiu, detonare sau proiectare.
SK Výbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.
SL Eksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.
FI Räjähde; palo-, räjähdys- tai sirpalevaara.
SV Explosivt. Fara för brand, tryckvåg eller splitter och kaststycken.
H204 Language 2.1 — Explosives, Division 1.4
BG Опасност от пожар или разпръскване.
ES Peligro de incendio o de proyección.
CS Nebezpečí požáru nebo zasažení částicemi.
DA Fare for brand eller udslyngning af fragmenter.
DE Gefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.
ET Süttimis- või laialipaiskumisoht.
EL Κίνδυνος πυρκαγιάς ή εκτόξευσης.
EN Fire or projection hazard.
FR Danger d'incendie ou de projection.
GA Guais dóiteáin nó teilgin.
IT Pericolo di incendio o di proiezione.
LV Uguns vai izmetes bīstamība.
LT Gaisro arba išsvaidymo pavojus.
HU Tűz vagy kivetés veszélye.
MT Periklu ta' nar jew ta' projezzjoni.
NL Gevaar voor brand of scherfwerking.
PL Zagrożenie pożarem lub rozrzutem.
PT Perigo de incêndio ou projecções.
RO Pericol de incendiu sau de proiectare.
SK Nebezpečenstvo požiaru alebo rozletenia úlomkov.
SL Nevarnost za nastanek požara ali drobcev.
FI Palo- tai sirpalevaara.
SV Fara för brand eller splitter och kaststycken.
H205 Language 2.1 — Explosives, Division 1.5
BG Може да предизвика масова експлозия при пожар.
ES Peligro de explosión en masa en caso de incendio.
CS Při požáru může způsobit masivní výbuch.
DA Fare for masseeksplosion ved brand.
DE Gefahr der Massenexplosion bei Feuer.
ET Süttimise korral massiplahvatusoht.
EL Κίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.
EN May mass explode in fire.
FR Danger d'explosion en masse en cas d'incendie.
GA D'fhéadfadh sé go mbeadh mórphléascadh i dtine.
IT Pericolo di esplosione di massa in caso d'incendio.
LV Ugunī var masveidā eksplodēt.
LT Per gaisrą gali sukelti masinį sprogimą.
HU Tűz hatására a teljes tömeg felrobbanhat.
MT Jista' jisplodi f'daqqa fin-nar.
NL Gevaar voor massa-explosie bij brand.
PL Może wybuchać masowo w przypadku pożaru.
PT Perigo de explosão em massa em caso de incêndio.
RO Pericol de explozie în masă în caz de incendiu.
SK Nebezpečenstvo rozsiahleho výbuchu pri požiari.
SL Pri požaru lahko eksplodira v masi.
FI Koko massa voi räjähtää tulessa.
SV Fara för massexplosion vid brand.
H220 Language 2.2 — Flammable gases, Hazard Category 1
BG Изключително запалим газ.
ES Gas extremadamente inflamable.
CS Extrémně hořlavý plyn.
DA Yderst brandfarlig gas.
DE Extrem entzündbares Gas.
ET Eriti tuleohtlik gaas.
EL Εξαιρετικά εύφλεκτο αέριο.
EN Extremely flammable gas.
FR Gaz extrêmement inflammable.
GA Gás fíor-inadhainte.
IT Gas altamente infiammabile.
LV Īpaši viegli uzliesmojoša gāze.
LT Ypač degios dujos.
HU Rendkívül tűzveszélyes gáz.
MT Gass li jaqbad malajr ħafna.
NL Zeer licht ontvlambaar gas.
PL Skrajnie łatwopalny gaz.
PT Gás extremamente inflamável.
RO Gaz extrem de inflamabil.
SK Mimoriadne horľavý plyn.
SL Zelo lahko vnetljiv plin.
FI Erittäin helposti syttyvä kaasu.
SV Extremt brandfarlig gas.
H221 Language 2.2 — Flammable gases, Hazard Category 2
BG Запалим газ.
ES Gas inflamable.
CS Hořlavý plyn.
DA Brandfarlig gas.
DE Entzündbares Gas.
ET Tuleohtlik gaas.
EL Εύφλεκτο αέριο.
EN Flammable gas.
FR Gaz inflammable.
GA Gás inadhainte.
IT Gas infiammabile.
LV Uzliesmojoša gāze.
LT Degios dujos.
HU Tűzveszélyes gáz.
MT Gass li jaqbad.
NL Ontvlambaar gas.
PL Gaz łatwopalny.
PT Gás inflamável.
RO Gaz inflamabil.
SK Horľavý plyn.
SL Vnetljiv plin.
FI Syttyvä kaasu.
SV Brandfarlig gas.
H222 Language 2.3 — Flammable aerosols, Hazard Category 1
BG Изключително запалим аерозол.
ES Aerosol extremadamente inflamable.
CS Extrémně hořlavý aerosol.
DA Yderst brandfarlig aerosol.
DE Extrem entzündbares Aerosol.
ET Eriti tuleohtlik aerosool.
EL Εξαιρετικά εύφλεκτο αερόλυμα.
EN Extremely flammable aerosol.
FR Aérosol extrêmement inflammable.
GA Aerasól fíor-inadhainte.
IT Aerosol altamente infiammabile.
LV Īpaši viegli uzliesmojošs aerosols.
LT Ypač degus aerozolis.
HU Rendkívül tűzveszélyes aeroszol.
MT Aerosol li jaqbad malajr ħafna.
NL Zeer licht ontvlambare aerosol.
PL Skrajnie łatwopalny aerozol.
PT Aerossol extremamente inflamável.
RO Aerosol extrem de inflamabil.
SK Mimoriadne horľavý aerosól.
SL Zelo lahko vnetljiv aerosol.
FI Erittäin helposti syttyvä aerosoli.
SV Extremt brandfarlig aerosol.
H223 Language 2.3 — Flammable aerosols, Hazard Category 2
BG Запалим аерозол.
ES Aerosol inflamable.
CS Hořlavý aerosol.
DA Brandfarlig aerosol.
DE Entzündbares Aerosol.
ET Tuleohtlik aerosool.
EL Εύφλεκτο αερόλυμα.
EN Flammable aerosol.
FR Aérosol inflammable.
GA Aerasól inadhainte.
IT Aerosol infiammabile.
LV Uzliesmojošs aerosols.
LT Degus aerozolis.
HU Tűzveszélyes aeroszol.
MT Aerosol li jaqbad.
NL Ontvlambare aerosol.
PL Aerozol łatwopalny.
PT Aerossol inflamável.
RO Aerosol inflamabil.
SK Horľavý aerosól.
SL Vnetljiv aerosol.
FI Syttyvä aerosoli.
SV Brandfarlig aerosol.
H224 Language 2.6 — Flammable liquids, Hazard Category 1
BG Изключително запалими течност и пари.
ES Líquido y vapores extremadamente inflamables.
CS Extrémně hořlavá kapalina a páry.
DA Yderst brandfarlig væske og damp.
DE Flüssigkeit und Dampf extrem entzündbar.
ET Eriti tuleohtlik vedelik ja aur.
EL Υγρό και ατμοί εξαιρετικά εύφλεκτα.
EN Extremely flammable liquid and vapour.
FR Liquide et vapeurs extrêmement inflammables.
GA Leacht fíor-inadhainte agus gal fhíor-inadhainte.
IT Liquido e vapori altamente infiammabili.
LV Īpaši viegli uzliesmojošs šķidrums un tvaiki.
LT Ypač degūs skystis ir garai.
HU Rendkívül tűzveszélyes folyadék és gőz.
MT Likwidu u fwar li jaqbdu malajr ħafna.
NL Zeer licht ontvlambare vloeistof en damp.
PL Skrajnie łatwopalna ciecz i pary.
PT Líquido e vapor extremamente inflamáveis.
RO Lichid şi vapori extrem de inflamabili.
SK Mimoriadne horľavá kvapalina a pary.
SL Zelo lahko vnetljiva tekočina in hlapi.
FI Erittäin helposti syttyvä neste ja höyry.
SV Extremt brandfarlig vätska och ånga.
H225 Language 2.6 — Flammable liquids, Hazard Category 2
BG Силно запалими течност и пари.
ES Líquido y vapores muy inflamables.
CS Vysoce hořlavá kapalina a páry.
DA Meget brandfarlig væske og damp.
DE Flüssigkeit und Dampf leicht entzündbar.
ET Väga tuleohtlik vedelik ja aur.
EL Υγρό και ατμοί πολύ εύφλεκτα.
EN Highly flammable liquid and vapour.
FR Liquide et vapeurs très inflammables.
GA Leacht an-inadhainte agus gal an-inadhainte.
IT Liquido e vapori facilmente infiammabili.
LV Viegli uzliesmojošs šķidrums un tvaiki.
LT Labai degūs skystis ir garai.
HU Fokozottan tűzveszélyes folyadék és gőz.
MT Likwidu u fwar li jaqbdu malajr ħafna.
NL Licht ontvlambare vloeistof en damp.
PL Wysoce łatwopalna ciecz i pary.
PT Líquido e vapor facilmente inflamáveis.
RO Lichid şi vapori foarte inflamabili.
SK Veľmi horľavá kvapalina a pary.
SL Lahko vnetljiva tekočina in hlapi.
FI Helposti syttyvä neste ja höyry.
SV Mycket brandfarlig vätska och ånga.
H226 Language 2.6 — Flammable liquids, Hazard Category 3
BG Запалими течност и пари.
ES Líquidos y vapores inflamables.
CS Hořlavá kapalina a páry.
DA Brandfarlig væske og damp.
DE Flüssigkeit und Dampf entzündbar.
ET Tuleohtlik vedelik ja aur.
EL Υγρό και ατμοί εύφλεκτα.
EN Flammable liquid and vapour.
FR Liquide et vapeurs inflammables.
GA Leacht inadhainte agus gal inadhainte.
IT Liquido e vapori infiammabili.
LV Uzliesmojošs šķidrums un tvaiki.
LT Degūs skystis ir garai.
HU Tűzveszélyes folyadék és gőz.
MT Likwidu u fwar li jaqbdu.
NL Ontvlambare vloeistof en damp.
PL Łatwopalna ciecz i pary.
PT Líquido e vapor inflamáveis.
RO Lichid şi vapori inflamabili.
SK Horľavá kvapalina a pary.
SL Vnetljiva tekočina in hlapi.
FI Syttyvä neste ja höyry.
SV Brandfarlig vätska och ånga.
H228 Language 2.7 — Flammable solids, Hazard Category 1, 2
BG Запалимо твърдо вещество.
ES Sólido inflamable.
CS Hořlavá tuhá látka.
DA Brandfarligt fast stof.
DE Entzündbarer Feststoff.
ET Tuleohtlik tahke aine.
EL Εύφλεκτο στερεό.
EN Flammable solid.
FR Matière solide inflammable.
GA Solad inadhainte.
IT Solido infiammabile.
LV Uzliesmojoša cieta viela.
LT Degi kietoji medžiaga.
HU Tűzveszélyes szilárd anyag.
MT Solidu li jaqbad.
NL Ontvlambare vaste stof.
PL Substancja stała łatwopalna.
PT Sólido inflamável.
RO Solid inflamabil.
SK Horľavá tuhá látka.
SL Vnetljiva trdna snov.
FI Syttyvä kiinteä aine.
SV Brandfarligt fast ämne.
H240 Language 2.8 — Self-Reactive Substances and Mixtures, Type A
2.1.5 — Organic Peroxides, Type A
BG Може да предизвика експлозия при нагряване.
ES Peligro de explosión en caso de calentamiento.
CS Zahřívání může způsobit výbuch.
DA Eksplosionsfare ved opvarmning.
DE Erwärmung kann Explosion verursachen.
ET Kuumenemisel võib plahvatada.
EL Η θέρμανση μπορεί να προκαλέσει έκρηξη.
EN Heating may cause an explosion.
FR Peut exploser sous l'effet de la chaleur.
GA D'fhéadfadh téamh a bheith ina chúis le pléascadh.
IT Rischio di esplosione per riscaldamento.
LV Sakaršana var izraisīt eksploziju.
LT Kaitinant gali sprogti.
HU Hő hatására robbanhat.
MT It-tisħin jista' jikkawża splużjoni.
NL Ontploffingsgevaar bij verwarming.
PL Ogrzanie grozi wybuchem.
PT Risco de explosão sob a acção do calor.
RO Pericol de explozie în caz de încălzire.
SK Zahrievanie môže spôsobiť výbuch.
SL Segrevanje lahko povzroči eksplozijo.
FI Räjähdysvaarallinen kuumennettaessa.
SV Explosivt vid uppvärmning.
H241 Language 2.8 — Self-Reactive Substances and Mixtures, Type B
2.1.5 — Organic Peroxides, Type B
BG Може да предизвика пожар или експлозия при нагряване.
ES Peligro de incendio o explosión en caso de calentamiento.
CS Zahřívání může způsobit požár nebo výbuch.
DA Brand- eller eksplosionsfare ved opvarmning.
DE Erwärmung kann Brand oder Explosion verursachen.
ET Kuumenemisel võib süttida või plahvatada.
EL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.
EN Heating may cause a fire or explosion.
FR Peut s'enflammer ou exploser sous l'effet de la chaleur.
GA D'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.
IT Rischio d'incendio o di esplosione per riscaldamento.
LV Sakaršana var izraisīt degšanu vai eksploziju.
LT Kaitinant gali sukelti gaisrą arba sprogti.
HU Hő hatására meggyulladhat vagy robbanhat.
MT It-tisħin jista' jikkawża nar jew splużjoni.
NL Brand- of ontploffingsgevaar bij verwarming.
PL Ogrzanie może spowodować pożar lub wybuch.
PT Risco de explosão ou de incêndio sob a acção do calor.
RO Pericol de incendiu sau de explozie în caz de încălzire.
SK Zahrievanie môže spôsobiť požiar alebo výbuch.
SL Segrevanje lahko povzroči požar ali eksplozijo.
FI Räjähdys- tai palovaarallinen kuumennettaessa.
SV Brandfarligt eller explosivt vid uppvärmning.
H242 Language 2.8 — Self-Reactive Substances and Mixtures, Types C, D, E, F
2.1.5 — Organic Peroxides, Types C, D, E, F
BG Може да предизвика пожар при нагряване.
ES Peligro de incendio en caso de calentamiento.
CS Zahřívání může způsobit požár.
DA Brandfare ved opvarmning.
DE Erwärmung kann Brand verursachen.
ET Kuumenemisel võib süttida.
EL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά.
EN Heating may cause a fire.
FR Peut s'enflammer sous l'effet de la chaleur.
GA D'fhéadfadh téamh a bheith ina chúis le dóiteán.
IT Rischio d'incendio per riscaldamento.
LV Sakaršana var izraisīt degšanu.
LT Kaitinant gali sukelti gaisrą.
HU Hő hatására meggyulladhat.
MT It-tisħin jista' jikkawża nar.
NL Brandgevaar bij verwarming.
PL Ogrzanie może spowodować pożar.
PT Risco de incêndio sob a acção do calor.
RO Pericol de incendiu în caz de încălzire.
SK Zahrievanie môže spôsobiť požiar.
SL Segrevanje lahko povzroči požar.
FI Palovaarallinen kuumennettaessa.
SV Brandfarligt vid uppvärmning.
H250 Language 2.9 — Pyrophoric Liquids, Hazard Category 1
2.10 — Pyorphoric Solids, Hazard Category 1
BG Самозапалва се при контакт с въздух.
ES Se inflama espontáneamente en contacto con el aire.
CS Při styku se vzduchem se samovolně vznítí.
DA Selvantænder ved kontakt med luft.
DE Entzündet sich in Berührung mit Luft von selbst.
ET Kokkupuutel õhuga süttib iseenesest.
EL Αυταναφλέγεται εάν εκτεθεί στον αέρα.
EN Catches fire spontaneously if exposed to air.
FR S'enflamme spontanément au contact de l'air.
GA Téann trí thine go spontáineach má nochtar don aer.
IT Spontaneamente infiammabile all'aria.
LV Spontāni aizdegas saskarē ar gaisu.
LT Veikiami oro savaime užsidega.
HU Levegővel érintkezve önmagától meggyullad.
MT Jieħu n-nar spontanjament jekk ikun espost għall-arja.
NL Vat spontaan vlam bij blootstelling aan lucht.
PL Zapala się samorzutnie w przypadku wystawienia na działanie powietrza.
PT Risco de inflamação espontânea em contacto com o ar.
RO Se aprinde spontan, în contact cu aerul.
SK Pri kontakte so vzduchuom sa spontánne vznieti.
SL Samodejno se vžge na zraku.
FI Syttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.
SV Spontanantänder vid kontakt med luft.
H251 Language 2.11 — Self-Heating Substances and Mixtures, Hazard Category 1
BG Самонагряващо се: може да се запали.
ES Se calienta espontáneamente; puede inflamarse.
CS Samovolně se zahřívá: může se vznítit.
DA Selvopvarmende, kan selvantænde.
DE Selbsterhitzungsfähig; kann in Brand geraten.
ET Isekuumenev, võib süttida.
EL Αυτοθερμαίνεται: μπορεί να αναφλεγεί.
EN Self-heating: may catch fire.
FR Matière auto-échauffante; peut s'enflammer.
GA Féintéamh: d'fhéadfadh sé dul trí thine.
IT Autoriscaldante; può infiammarsi.
LV Pašsasilstošs; var aizdegties.
LT Savaime kaistančios, gali užsidegti.
HU Önmelegedő: meggyulladhat.
MT Jisħon waħdu: jista' jieħu n-nar.
NL Vatbaar voor zelfverhitting: kan vlam vatten.
PL Substancja samonagrzewająca się: może się zapalić.
PT Susceptível de auto-aquecimento: risco de inflamação.
RO Se autoîncălzeşte, pericol de aprindere.
SK Samovoľne sa zahrieva; môže sa vznietiť.
SL Samosegrevanje: lahko povzroči požar.
FI Itsestään kuumeneva; voi syttyä palamaan.
SV Självupphettande. Kan börja brinna.
H252 Language 2.11 — Self-Heating Substances and Mixtures, Hazard Category 2
BG Самонагряващо се в големи количества; може да се запали.
ES Se calienta espontáneamente en grandes cantidades; puede inflamarse.
CS Ve velkém množství se samovolně zahřívá; může se vznítit.
DA Selvopvarmende i store mængder, kan selvantænde.
DE In großen Mengen selbsterhitzungsfähig; kann in Brand geraten.
ET Suurtes kogustes isekuumenev, võib süttida.
EL Σε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.
EN Self-heating in large quantities; may catch fire.
FR Matière auto-échauffante en grandes quantités; peut s'enflammer.
GA Féintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.
IT Autoriscaldante in grandi quantità; può infiammarsi.
LV Lielos apjomos pašsasilstošs; var aizdegties.
LT Laikant dideliais kiekiais savaime kaista, gali užsidegti.
HU Nagy mennyiségben önmelegedő; meggyulladhat.
MT Jisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.
NL In grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.
PL Substancja samonagrzewająca się w dużych ilościach; może się zapalić.
PT Susceptível de auto-aquecimento em grandes quantidades: risco de inflamação.
RO Se autoîncălzeşte, în cantităţi mari pericol de aprindere.
SK Vo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.
SL Samosegrevanje v velikih količinah; lahko povzroči požar.
FI Suurina määrinä itsestään kuumeneva; voi syttyä palamaan.
SV Självupphettande i stora mängder. Kan börja brinna.
H260 Language 2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1
BG При контакт с вода отделя запалими газове, които могат да се самозапалят.
ES En contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.
CS Při styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.
DA Ved kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.
DE In Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.
ET Kokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.
EL Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.
EN In contact with water releases flammable gases which may ignite spontaneously.
FR Dégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.
GA I dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.
IT A contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.
LV Nonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.
LT Kontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.
HU Vízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.
MT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.
NL In contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.
PL W kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.
PT Em contacto com a água liberta gases que se podem inflamar espontaneamente.
RO În contact cu apa degajă gaze inflamabile care se pot aprinde spontan.
SK Pri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.
SL V stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.
FI Kehittää itsestään syttyviä kaasuja veden kanssa.
SV Vid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.
H261 Language 2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2
BG При контакт с вода отделя запалими газове.
ES En contacto con el agua desprende gases inflamables.
CS Při styku s vodou uvolňuje hořlavé plyny.
DA Ved kontakt med vand udvikles brandfarlige gasser.
DE In Berührung mit Wasser entstehen entzündbare Gase.
ET Kokkupuutel veega eraldab tuleohtlikke gaase.
EL Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.
EN In contact with water releases flammable gases.
FR Dégage au contact de l'eau des gaz inflammables.
GA I dteagmháil le huisce scaoiltear gáis inadhainte.
IT A contatto con l'acqua libera gas infiammabili.
LV Nonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.
LT Kontaktuodami su vandeniu išskiria degias dujas
HU Vízzel érintkezve tűzveszélyes gázokat bocsát ki.
MT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.
NL In contact met water komen ontvlambare gassen vrij.
PL W kontakcie z wodą uwalnia łatwopalne gazy.
PT Em contacto com a água liberta gases inflamáveis.
RO În contact cu apa degajă gaze inflamabile.
SK Pri kontakte s vodou uvoľňuje horľavé plyny.
SL V stiku z vodo se sproščajo vnetljivi plini.
FI Kehittää syttyviä kaasuja veden kanssa.
SV Vid kontakt med vatten utvecklas brandfarliga gaser.
H270 Language 2.4 — Oxidising Gases, Hazard Category 1
BG Може да предивзика или усили пожар; окислител.
ES Puede provocar o agravar un incendio; comburente.
CS Může způsobit nebo zesílit požár; oxidant.
DA Kan forårsage eller forstærke brand, brandnærende.
DE Kann Brand verursachen oder verstärken; Oxidationsmittel.
ET Võib põhjustada süttimise või soodustada põlemist; oksüdeerija.
EL Μπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.
EN May cause or intensify fire; oxidiser.
FR Peut provoquer ou aggraver un incendie; comburant.
GA D'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.
IT Può provocare o aggravare un incendio; comburente.
LV Var izraisīt vai pastiprināt degšanu, oksidētājs.
LT Gali sukelti arba padidinti gaisrą, oksidatorius.
HU Tüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.
MT Jista' jikkawża jew iżid in-nar; ossidant.
NL Kan brand veroorzaken of bevorderen; oxiderend.
PL Może spowodować lub intensyfikować pożar; utleniacz.
PT Pode provocar ou agravar incêndios; comburente.
RO Poate provoca sau agrava un incendiu; oxidant.
SK Môže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.
SL Lahko povzroči ali okrepi požar; oksidativna snov.
FI Aiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.
SV Kan orsaka eller intensifiera brand. Oxiderande.
H271 Language 2.13 — Oxidising Liquids, Hazard Category 1
2.14 — Oxidising Solids, Hazard Category 1
BG Може да предизвика пожар или експлозия; силен окислител.
ES Puede provocar un incendio o una explosión; muy comburente.
CS Může způsobit požár nebo výbuch; silný oxidant.
DA Kan forårsage brand eller eksplosion, stærkt brandnærende.
DE Kann Brand oder Explosion verursachen; starkes Oxidationsmittel.
ET Võib põhjustada süttimise või plahvatuse; tugev oksüdeerija.
EL Μπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.
EN May cause fire or explosion; strong oxidiser.
FR Peut provoquer un incendie ou une explosion; comburant puissant.
GA D'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.
IT Può provocare un incendio o un'esplosione; molto comburente.
LV Var izraisīt degšanu vai eksploziju, oksidētājs.
LT Gali sukelti gaisrą arba sprogimą, stiprus oksidatorius.
HU Tüzet vagy robbanást okozhat; erősen oxidáló hatású.
MT Jista' jikkawża nar jew splużjoni; ossidant qawwi.
NL Kan brand of ontploffingen veroorzaken; sterk oxiderend.
PL Może spowodować pożar lub wybuch; silny utleniacz.
PT Risco de incêndio ou de explosão; muito comburente.
RO Poate provoca un incendiu sau o explozie; oxidant puternic.
SK Môže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.
SL Lahko povzroči požar ali eksplozijo; močna oksidativna snov.
FI Aiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.
SV Kan orsaka brand eller explosion. Starkt oxiderande.
H272 Language 2.13 — Oxidising Liquids, Hazard Category 2, 3
2.14 — Oxidising Solids, Hazard Category 2, 3
BG Може да усили пожара; окислител.
ES Puede agravar un incendio; comburente.
CS Může zesílit požár; oxidant.
DA Kan forstærke brand, brandnærende.
DE Kann Brand verstärken; Oxidationsmittel.
ET Võib soodustada põlemist; oksüdeerija.
EL Μπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.
EN May intensify fire; oxidiser.
FR Peut aggraver un incendie; comburant.
GA D'fhéadfadh sé cur le tine; ocsaídeoir.
IT Può aggravare un incendio; comburente.
LV Var pastiprināt degšanu; oksidētājs.
LT Gali padidinti gaisrą, oksidatorius.
HU Fokozhatja a tűz intenzitását; oxidáló hatású.
MT Jista' jżid in-nar; ossidant.
NL Kan brand bevorderen; oxiderend.
PL Może intensyfikować pożar; utleniacz.
PT Pode agravar incêndios; comburente.
RO Poate agrava un incendiu; oxidant.
SK Môže prispieť k rozvoju požiaru; oxidačné činidlo.
SL Lahko okrepi požar; oksidativna snov.
FI Voi edistää tulipaloa; hapettava.
SV Kan intensifiera brand. Oxiderande.
H280 Language 2.5 — Gases under pressure:
Compressed gas
Liquefied gas
Dissolved gas
BG Съдържа газ под налягане; може да експлодира при нагряване.
ES Contiene gas a presión; peligro de explosión en caso de calentamiento.
CS Obsahuje plyn pod tlakem; při zahřívání může vybuchnout.
DA Indeholder gas under tryk, kan eksplodere ved opvarmning.
DE Enthält Gas unter Druck; kann bei Erwärmung explodieren.
ET Sisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.
EL Περιέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.
EN Contains gas under pressure; may explode if heated.
FR Contient un gaz sous pression; peut exploser sous l'effet de la chaleur.
GA Gás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.
IT Contiene gas sotto pressione; può esplodere se riscaldato.
LV Satur gāzi zem spiediena; karstumā var eksplodēt.
LT Turi slėgio veikiamų dujų, kaitinant gali sprogti.
HU Nyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.
MT Fih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.
NL Bevat gas onder druk; kan ontploffen bij verwarming.
PL Zawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.
PT Contém gás sob pressão; risco de explosão sob a acção do calor.
RO Conţine un gaz sub presiune; pericol de explozie în caz de încălzire.
SK Obsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.
SL Vsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.
FI Sisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.
SV Innehåller gas under tryck. Kan explodera vid uppvärmning.
H281 Language 2.5 — Gases under pressure: Refrigerated liquefied gas
BG Съдържа охладен газ; може да причини криогенни изгаряния или наранявания.
ES Contiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.
CS Obsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.
DA Indeholder nedkølet gas, kan forårsage kuldeskader.
DE Enthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.
ET Sisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.
EL Περιέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.
EN Contains refrigerated gas; may cause cryogenic burns or injury.
FR Contient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.
GA Gás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.
IT Contiene gas refrigerato; può provocare ustioni o lesioni criogeniche.
LV Satur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.
LT Turi atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.
HU Mélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.
MT Fih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.
NL Bevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.
PL Zawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.
PT Contém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.
RO Conţine un gaz răcit; poate cauza arsuri sau leziuni criogenice.
SK Obsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.
SL Vsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.
FI Sisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.
SV Innehåller kyld gas. Kan orsaka svåra köldskador.
H290 Language 2.16 — Corrosive to metals, Hazard Category 1
BG Може да бъде корозивно за металите.
ES Puede ser corrosivo para los metales.
CS Může být korozivní pro kovy.
DA Kan ætse metaller.
DE Kann gegenüber Metallen korrosiv sein.
ET Võib söövitada metalle.
EL Μπορεί να διαβρώσει μέταλλα.
EN May be corrosive to metals.
FR Peut être corrosif pour les métaux.
GA D'fhéadfadh sé a bheith creimneach do mhiotail.
IT Può essere corrosivo per i metalli.
LV Var kodīgi iedarboties uz metāliem.
LT Gali ėsdinti metalus.
HU Fémekre korrozív hatású lehet.
MT Jista' jkun korrużiv għall-metalli.
NL Kan bijtend zijn voor metalen.
PL Może powodować korozję metali.
PT Pode ser corrosivo para os metais.
RO Poate fi corosiv pentru metale.
SK Môže byť korozívna pre kovy.
SL Lahko je jedko za kovine.
FI Voi syövyttää metalleja.
SV Kan vara korrosivt för metaller.
Table 1.2
Hazard statements for health hazards
H300 Language 3.1 — Acute toxicity (oral), Hazard Category 1, 2
BG Смъртоносeн при поглъщане.
ES Mortal en caso de ingestión.
CS Při požití může způsobit smrt.
DA Livsfarlig ved indtagelse.
DE Lebensgefahr bei Verschlucken.
ET Allaneelamisel surmav.
EL Θανατηφόρο σε περίπτωση κατάποσης.
EN Fatal if swallowed.
FR Mortel en cas d'ingestion.
GA Marfach má shlogtar.
IT Letale se ingerito.
LV Norijot iestājas nāve.
LT Mirtina prarijus.
HU Lenyelve halálos.
MT Fatali jekk jinbela’.
NL Dodelijk bij inslikken.
PL Połknięcie grozi śmiercią.
PT Mortal por ingestão.
RO Mortal în caz de înghiţire.
SK Smrteľný po požití.
SL Smrtno pri zaužitju.
FI Tappavaa nieltynä.
SV Dödligt vid förtäring.
H301 Language 3.1 — Acute toxicity (oral), Hazard Category 3
BG Токсичен при поглъщане.
ES Tóxico en caso de ingestión.
CS Toxický při požití.
DA Giftig ved indtagelse.
DE Giftig bei Verschlucken.
ET Allaneelamisel mürgine.
EL Τοξικό σε περίπτωση κατάποσης.
EN Toxic if swallowed.
FR Toxique en cas d'ingestion.
GA Tocsaineach má shlogtar.
IT Tossico se ingerito.
LV Toksisks, ja norij.
LT Toksiška prarijus.
HU Lenyelve mérgező.
MT Tossiku jekk jinbela’.
NL Giftig bij inslikken.
PL Działa toksycznie po połknięciu.
PT Tóxico por ingestão.
RO Toxic în caz de înghiţire.
SK Toxický po požití.
SL Strupeno pri zaužitju.
FI Myrkyllistä nieltynä.
SV Giftigt vid förtäring.
H302 Language 3.1 — Acute toxicity (oral), Hazard Category 4
BG Вреден при поглъщане.
ES Nocivo en caso de ingestión.
CS Zdraví škodlivý při požití.
DA Farlig ved indtagelse.
DE Gesundheitsschädlich bei Verschlucken.
ET Allaneelamisel kahjulik.
EL Επιβλαβές σε περίπτωση κατάποσης.
EN Harmful if swallowed.
FR Nocif en cas d'ingestion.
GA Díobhálach má shlogtar.
IT Nocivo se ingerito.
LV Kaitīgs, ja norij.
LT Kenksminga prarijus.
HU Lenyelve ártalmas.
MT Jagħmel il-ħsara jekk jinbela’.
NL Schadelijk bij inslikken.
PL Działa szkodliwie po połknięciu.
PT Nocivo por ingestão.
RO Nociv în caz de înghiţire.
SK Škodlivý po požití.
SL Zdravju škodljivo pri zaužitju.
FI Haitallista nieltynä.
SV Skadligt vid förtäring.
H304 Language 3.10 — Aspiration hazard, Hazard Category 1
BG Може да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.
ES Puede ser mortal en caso de ingestión y penetración en las vías respiratorias.
CS Při požití a vniknutí do dýchacích cest může způsobit smrt.
DA Kan være livsfarligt, hvis det indtages og kommer i luftvejene.
DE Kann bei Verschlucken und Eindringen in die Atemwege tödlich sein.
ET Allaneelamisel või hingamisteedesse sattumisel võib olla surmav.
EL Μπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.
EN May be fatal if swallowed and enters airways.
FR Peut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.
GA D'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.
HU Lenyelve és a légutakba kerülve halálos lehet.
IT Può essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.
LV Var izraisīt nāvi, ja norij vai iekļūst elpceļos.
LT Prarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.
MT Jista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.
NL Kan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.
PL Połknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.
PT Pode ser mortal por ingestão e penetração nas vias respiratórias.
RO Poate fi mortal în caz de înghiţire şi de pătrundere în căile respiratorii.
SK Môže byť smrteľný po požití a vniknutí do dýchacích ciest.
SL Pri zaužitju in vstopu v dihalne poti je lahko smrtno.
FI Voi olla tappavaa nieltynä ja joutuessaan hengitysteihin.
SV Kan vara dödligt vid förtäring om det kommer ner i luftvägarna.
H310 Language 3.1 — Acute toxicity (dermal), Hazard Category 1, 2
BG Смъртоносeн при контакт с кожата.
ES Mortal en contacto con la piel.
CS Při styku s kůží může způsobit smrt.
DA Livsfarlig ved hudkontakt.
DE Lebensgefahr bei Hautkontakt.
ET Nahale sattumisel surmav.
EL Θανατηφόρο σε επαφή με το δέρμα.
EN Fatal in contact with skin.
FR Mortel par contact cutané.
GA Marfach i dteagmháil leis an gcraiceann.
HU Bőrrel érintkezve halálos.
IT Letale per contatto con la pelle.
LV Nonākot saskarē ar ādu, iestājas nāve.
LT Mirtina susilietus su oda.
MT Fatali jekk imiss mal-ġilda.
NL Dodelijk bij contact met de huid.
PL Grozi śmiercią w kontacie ze skórą.
PT Mortal em contacto com a pele.
RO Mortal în contact cu pielea.
SK Smrteľný pri kontakte s pokožkou.
SL Smrtno v stiku s kožo.
FI Tappavaa joutuessaan iholle.
SV Dödligt vid hudkontakt.
H311 Language 3.1 — Acute toxicity (dermal), Hazard Category 3
BG Токсичен при контакт с кожата.
ES Tóxico en contacto con la piel.
CS Toxický při styku s kůží.
DA Giftig ved hudkontakt.
DE Giftig bei Hautkontakt.
ET Nahale sattumisel mürgine.
EL Τοξικό σε επαφή με το δέρμα.
EN Toxic in contact with skin.
FR Toxique par contact cutané.
GA Tocsaineach i dteagmháil leis an gcraiceann.
IT Tossico per contatto con la pelle.
LV Toksisks, ja nonāk saskarē ar ādu.
LT Toksiška susilietus su oda.
HU Bőrrel érintkezve mérgező.
MT Tossiku meta jmiss mal-ġilda.
NL Giftig bij contact met de huid.
PL Działa toksycznie w kontakcie ze skórą.
PT Tóxico em contacto com a pele.
RO Toxic în contact cu pielea.
SK Toxický pri kontakte s pokožkou.
SL Strupeno v stiku s kožo.
FI Myrkyllistä joutuessaan iholle.
SV Giftigt vid hudkontakt.
H312 Language 3.1 — Acute toxicity (dermal), Hazard Category 4
BG Вреден при контакт с кожата.
ES Nocivo en contacto con la piel.
CS Zdraví škodlivý při styku s kůží.
DA Farlig ved hudkontakt.
DE Gesundheitsschädlich bei Hautkontakt.
ET Nahale sattumisel kahjulik.
EL Επιβλαβές σε επαφή με το δέρμα.
EN Harmful in contact with skin.
FR Nocif par contact cutané.
GA Díobhálach i dteagmháil leis an gcraiceann.
IT Nocivo per contatto con la pelle.
LV Kaitīgs, ja nonāk saskarē ar ādu.
LT Kenksminga susilietus su oda.
HU Bőrrel érintkezve ártalmas.
MT Jagħmel il-ħsara meta jmiss mal-ġilda.
NL Schadelijk bij contact met de huid.
PL Działa szkodliwie w kontakcie ze skórą.
PT Nocivo em contacto com a pele.
RO Nociv în contact cu pielea.
SK Škodlivý pri kontakte s pokožkou.
SL Zdravju škodljivo v stiku s kožo.
FI Haitallista joutuessaan iholle.
SV Skadligt vid hudkontakt.
H314 Language 3.2 — Skin corrosion/irritation, Hazard Category 1A, 1B, 1C
BG Причинява тежки изгаряния на кожата и сериозно увреждане на очите.
ES Provoca quemaduras graves en la piel y lesiones oculares graves.
CS Způsobuje těžké poleptání kůže a poškození očí.
DA Forårsager svære forbrændinger af huden og øjenskader.
DE Verursacht schwere Verätzungen der Haut und schwere Augenschäden.
ET Põhjustab rasket nahasöövitust ja silmakahjustusi.
EL Προκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.
EN Causes severe skin burns and eye damage.
FR Provoque des brûlures de la peau et des lésions oculaires graves.
GA Ina chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.
IT Provoca gravi ustioni cutanee e gravi lesioni oculari.
LV Izraisa smagus ādas apdegumus un acu bojājumus.
LT Smarkiai nudegina odą ir pažeidžia akis.
HU Súlyos égési sérülést és szemkárosodást okoz.
MT Jagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.
NL Veroorzaakt ernstige brandwonden en oogletsel.
PL Powoduje poważne oparzenia skóry oraz uszkodzenia oczu.
PT Provoca queimaduras na pele e lesões oculares graves.
RO Provoacă arsuri grave ale pielii şi lezarea ochilor.
SK Spôsobuje vážne poleptanie kože a poškodenie očí.
SL Povzroča hude opekline kože in poškodbe oči.
FI Voimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.
SV Orsakar allvarliga frätskador på hud och ögon.
H315 Language 3.2 — Skin corrosion/irritation, Hazard Category 2
BG Предизвиква дразнене на кожата.
ES Provoca irritación cutánea.
CS Dráždí kůži.
DA Forårsager hudirritation.
DE Verursacht Hautreizungen.
ET Põhjustab nahaärritust.
EL Προκαλεί ερεθισμό του δέρματος.
EN Causes skin irritation.
FR Provoque une irritation cutanée.
GA Ina chúis le greannú craicinn.
IT Provoca irritazione cutanea.
LV Kairina ādu.
LT Dirgina odą.
HU Bőrirritáló hatású.
MT Jagħmel irritazzjoni tal-ġilda.
NL Veroorzaakt huidirritatie.
PL Działa drażniąco na skórę.
PT Provoca irritação cutânea.
RO Provoacă iritarea pielii.
SK Dráždi kožu.
SL Povzroča draženje kože.
FI Ärsyttää ihoa.
SV Irriterar huden.
H317 Language 3.4 — Sensitisation — Skin, Hazard Category 1
BG Може да причини алергична кожна реакция.
ES Puede provocar una reacción alérgica en la piel.
CS Může vyvolat alergickou kožní reakci.
DA Kan forårsage allergisk hudreaktion.
DE Kann allergische Hautreaktionen verursachen.
ET Võib põhjustada allergilist nahareaktsiooni.
EL Μπορεί να προκαλέσει αλλεργική δερματική αντίδραση.
EN May cause an allergic skin reaction.
FR Peut provoquer une allergie cutanée.
GA D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.
IT Può provocare una reazione allergica cutanea.
LV Var izraisīt alerģisku ādas reakciju.
LT Gali sukelti alerginę odos reakciją.
HU Allergiás bőrreakciót válthat ki.
MT Jista’ jikkawża reazzjoni allerġika tal-ġilda.
NL Kan een allergische huidreactie veroorzaken.
PL Może powodować reakcję alergiczną skóry.
PT Pode provocar uma reacção alérgica cutânea.
RO Poate provoca o reacţie alergică a pielii.
SK Môže vyvolať alergickú kožnú reakciu.
SL Lahko povzroči alergijski odziv kože.
FI Voi aiheuttaa allergisen ihoreaktion.
SV Kan orsaka allergisk hudreaktion.
H318 Language 3.3 — Serious eye damage/eye irritation, Hazard Category 1
BG Предизвиква сериозно увреждане на очите.
ES Provoca lesiones oculares graves.
CS Způsobuje vážné poškození očí.
DA Forårsager alvorlig øjenskade.
DE Verursacht schwere Augenschäden.
ET Põhjustab raskeid silmakahjustusi.
EL Προκαλεί σοβαρή οφθαλμική βλάβη.
EN Causes serious eye damage.
FR Provoque des lésions oculaires graves.
GA Ina chúis le damáiste tromchúiseach don tsúil.
IT Provoca gravi lesioni oculari.
LV Izraisa nopietnus acu bojājumus.
LT Smarkiai pažeidžia akis.
HU Súlyos szemkárosodást okoz.
MT Jagħmel ħsara serja lill-għajnejn.
NL Veroorzaakt ernstig oogletsel.
PL Powoduje poważne uszkodzenie oczu.
PT Provoca lesões oculares graves.
RO Provoacă leziuni oculare grave.
SK Spôsobuje vážne poškodenie očí.
SL Povzroča hude poškodbe oči.
FI Vaurioittaa vakavasti silmiä.
SV Orsakar allvarliga ögonskador.
H319 Language 3.3 — Serious eye damage/eye irritation, Hazard Category 2
BG Предизвиква сериозно дразнене на очите.
ES Provoca irritación ocular grave.
CS Způsobuje vážné podráždění očí.
DA Forårsager alvorlig øjenirritation.
DE Verursacht schwere Augenreizung.
ET Põhjustab tugevat silmade ärritust.
EL Προκαλεί σοβαρό οφθαλμικό ερεθισμό.
EN Causes serious eye irritation.
FR Provoque une sévère irritation des yeux.
GA Ina chúis le greannú tromchúiseach don tsúil.
IT Provoca grave irritazione oculare.
LV Izraisa nopietnu acu kairinājumu.
LT Sukelia smarkų akių dirginimą.
HU Súlyos szemirritációt okoz.
MT Jagħmel irritazzjoni serja lill-għajnejn.
NL Veroorzaakt ernstige oogirritatie.
PL Działa drażniąco na oczy.
PT Provoca irritação ocular grave.
RO Provoacă o iritare gravă a ochilor.
SK Spôsobuje vážne podráždenie očí.
SL Povzroča hudo draženje oči.
FI Ärsyttää voimakkaasti silmiä.
SV Orsakar allvarlig ögonirritation.
H330 Language 3.1 — Acute toxicity (inhal.), Hazard Category 1, 2
BG Смъртоносен при вдишване.
ES Mortal en caso de inhalación.
CS Při vdechování může způsobit smrt.
DA Livsfarlig ved indånding.
DE Lebensgefahr bei Einatmen.
ET Sissehingamisel surmav.
EL Θανατηφόρο σε περίπτωση εισπνοής.
EN Fatal if inhaled.
FR Mortel par inhalation.
GA Marfach má ionanálaítear.
IT Letale se inalato.
LV Ieelpojot, iestājas nāve.
LT Mirtina įkvėpus.
HU Belélegezve halálos.
MT Fatali jekk jinxtamm.
NL Dodelijk bij inademing.
PL Wdychanie grozi śmiercią.
PT Mortal por inalação.
RO Mortal în caz de inhalare.
SK Smrteľný pri vdýchnutí.
SL Smrtno pri vdihavanju.
FI Tappavaa hengitettynä.
SV Dödligt vid inandning.
H331 Language 3.1 — Acute toxicity (inhal.), Hazard Category 3
BG Токсичен при вдишване.
ES Tóxico en caso de inhalación.
CS Toxický při vdechování.
DA Giftig ved indånding.
DE Giftig bei Einatmen.
ET Sissehingamisel mürgine.
EL Τοξικό σε περίπτωση εισπνοής.
EN Toxic if inhaled.
FR Toxique par inhalation.
GA Tocsaineach má ionanálaítear.
IT Tossico se inalato.
LV Toksisks ieelpojot.
LT Toksiška įkvėpus.
HU Belélegezve mérgező.
MT Tossiku jekk jinxtamm.
NL Giftig bij inademing.
PL Działa toksycznie w następstwie wdychania.
PT Tóxico por inalação.
RO Toxic în caz de inhalare.
SK Toxický pri vdýchnutí.
SL Strupeno pri vdihavanju.
FI Myrkyllistä hengitettynä.
SV Giftigt vid inandning.
H332 Language 3.1 — Acute toxicity (inhal.), Hazard Category 4
BG Вреден при вдишване.
ES Nocivo en caso de inhalación.
CS Zdraví škodlivý při vdechování.
DA Farlig ved indånding.
DE Gesundheitsschädlich bei Einatmen.
ET Sissehingamisel kahjulik.
EL Επιβλαβές σε περίπτωση εισπνοής.
EN Harmful if inhaled.
FR Nocif par inhalation.
GA Díobhálach má ionanálaítear.
IT Nocivo se inalato.
LV Kaitīgs ieelpojot.
LT Kenksminga įkvėpus.
HU Belélegezve ártalmas.
MT Jagħmel il-ħsara jekk jinxtamm.
NL Schadelijk bij inademing.
PL Działa szkodliwie w następstwie wdychania.
PT Nocivo por inalação.
RO Nociv în caz de inhalare.
SK Škodlivý pri vdýchnutí.
SL Zdravju škodljivo pri vdihavanju.
FI Haitallista hengitettynä.
SV Skadligt vid inandning.
H334 Language 3.4 — Sensitisation — Respirat., Hazard Category 1
BG Може да причини алергични или астматични симптоми или затруднения в дишането при вдишване.
ES Puede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.
CS Při vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.
DA Kan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.
DE Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.
ET Sissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.
EL Μπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.
EN May cause allergy or asthma symptoms or breathing difficulties if inhaled.
FR Peut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.
GA D'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.
IT Può provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.
LV Ja ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.
LT Įkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.
HU Belélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.
MT Jista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.
NL Kan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.
PL Może powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.
PT Quando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.
RO Poate provoca simptome de alergie sau astm sau dificultăţi de respiraţie în caz de inhalare.
SK Pri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.
SL Lahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.
FI Voi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.
SV Kan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.
H335 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation
BG Може да предизвика дразнене на дихателните пътища.
ES Puede irritar las vías respiratorias.
CS Může způsobit podráždění dýchacích cest.
DA Kan forårsage irritation af luftvejene.
DE Kann die Atemwege reizen.
ET Võib põhjustada hingamisteede ärritust.
EL Μπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.
EN May cause respiratory irritation.
FR Peut irriter les voies respiratoires.
GA D'fhéadfadh sé a bheith ina chúis le greannú riospráide.
IT Può irritare le vie respiratorie.
LV Var izraisīt elpceļu kairinājumu.
LT Gali dirginti kvėpavimo takus.
HU Légúti irritációt okozhat.
MT Jista’ jikkawża irritazzjoni respiratorja.
NL Kan irritatie van de luchtwegen veroorzaken.
PL Może powodować podrażnienie dróg oddechowych.
PT Pode provocar irritação das vias respiratórias.
RO Poate provoca iritarea căilor respiratorii.
SK Môže spôsobiť podráždenie dýchacích ciest.
SL Lahko povzroči draženje dihalnih poti.
FI Saattaa aiheuttaa hengitysteiden ärsytystä.
SV Kan orsaka irritation i luftvägarna.
H336 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis
BG Може да предизвика сънливост или световъртеж.
ES Puede provocar somnolencia o vértigo.
CS Může způsobit ospalost nebo závratě.
DA Kan forårsage sløvhed eller svimmelhed.
DE Kann Schläfrigkeit und Benommenheit verursachen.
ET Võib põhjustada unisust või peapööritust.
EL Μπορεί να προκαλέσει υπνηλία ή ζάλη.
EN May cause drowsiness or dizziness.
FR Peut provoquer somnolence ou vertiges.
GA D'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.
IT Può provocare sonnolenza o vertigini.
LV Var izraisīt miegainību vai reiboņus.
LT Gali sukelti mieguistumą arba galvos svaigimą.
HU Álmosságot vagy szédülést okozhat.
MT Jista’ jikkawża ħedla jew sturdament.
NL Kan slaperigheid of duizeligheid veroorzaken.
PL Może wywoływać uczucie senności lub zawroty głowy.
PT Pode provocar sonolência ou vertigens.
RO Poate provoca somnolenţă sau ameţeală.
SK Môže spôsobiť ospalosť alebo závraty.
SL Lahko povzroči zaspanost ali omotico.
FI Saattaa aiheuttaa uneliaisuutta ja huimausta.
SV Kan göra att man blir dåsig eller omtöcknad.
H340 Language 3.5 — Germ cell mutagenicity, Hazard Category 1A, 1B
BG Може да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Puede provocar defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía >.
CS Může vyvolat genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Kan forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Võib põhjustada geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Μπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
EN May cause genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Peut induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA D'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Può provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Genetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Jista’ jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Kan genetische schade veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Może powodować wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PT Pode provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Poate provoca anomalii genetice <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Môže spôsobovať genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Lahko povzroči genetske okvare <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Saattaa aiheuttaa perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Kan orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H341 Language 3.5 — Germ cell mutagenicity, Hazard Category 2
BG Предполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Se sospecha que provoca defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Podezření na genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Mistænkt for at forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann vermutlich genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Arvatavasti põhjustab geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Ύποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN Suspected of causing genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Susceptible d'induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA Ceaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Sospettato di provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Ir aizdomas, ka var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Įtariama, kad gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Feltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Suspettat li jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Verdacht van het veroorzaken van genetische schade <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Podejrzewa się, że powoduje wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PT Suspeito de provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Susceptibil de a provoca anomalii genetice < indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Podozrenie, že spôsobuje genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Sum povzročitve genetskih okvar <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Epäillään aiheuttavan perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Misstänks kunna orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H350 Language 3.6 — Carcinogenicity, Hazard Category 1A, 1B
BG Може да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Puede provocar cáncer <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Může vyvolat rakovinu <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Kan fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Võib põhjustada vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Μπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN May cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Peut provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA D'fhéadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Può provocare il cancro<indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Gali sukelti vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Rákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Jista’ jikkawża l-kanċer <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Kan kanker veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>
PL Może powodować raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PT Pode provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Poate provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Môže spôsobiť rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Lahko povzroči raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Saattaa aiheuttaa syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Kan orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H351 Language 3.6 — Carcinogenicity, Hazard Category 2
BG Предполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Se sospecha que provoca cáncer <indíquese la vía de exposición si se se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Podezření na vyvolání rakoviny <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Mistænkt for at fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann vermutlich Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Arvatavasti põhjustab vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Ύποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the hazard>.
FR Susceptible de provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA Ceaptar go bhféadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Sospettato di provocare il cancro <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Ir aizdomas, ka var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Įtariama, kad sukelia vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Feltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Suspettat li jikkawża l-kanċer <ara l-mod ta’ espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
NL Verdacht van het veroorzaken van kanker <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Podejrzewa się, że powoduje raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PT Suspeito de provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Susceptibil de a provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Podozrenie, že spôsobuje rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Sum povzročitve raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Epäillään aiheuttavan syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Misstänks kunna orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H360 Language 3.7 — Reproductive toxicity, Hazard Category 1A, 1B
BG Може да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Puede perjudicar la fertilidad o dañar al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Může poškodit reprodukční schopnost nebo plod v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Kan skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen <konkrete Wirkung angeben, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>.
ET Võib kahjustada viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Μπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN May damage fertility or the unborn child <state specific effect if known > <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Peut nuire à la fertilité ou au fœtus <indiquer l'effet spécifique s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA D'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Può nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto><indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Gali pakenkti vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Károsíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Jista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Kan de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Może działać szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Pode afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Poate dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Môže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Lahko škoduje plodnosti ali nerojenemu otroku <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Saattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Kan skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H361 Language 3.7 — Reproductive toxicity, Hazard Category 2
BG Предполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Se sospecha que perjudica la fertilidad o daña al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Podezření na poškození reprodukční schopnosti nebo plodu v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Mistænkt for at skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>
ET Arvatavasti kahjustab viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Ύποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN Suspected of damaging fertility or the unborn child <state specific effect if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Susceptible de nuire à la fertilité ou au fœtus <indiquer l'effet s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA Ceaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Sospettato di nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Ir aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Įtariama, kad kenkia vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Feltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Suspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
NL Kan mogelijks de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Podejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Suspeito de afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Susceptibil de a dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Podozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Sum škodljivosti za plodnost ali nerojenega otroka <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Epäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Misstänks kunna skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H362 Language 3.7 — Reproductive toxicity, Additional category, Effects on or via lactation
BG Може да бъде вреден за кърмачета.
ES Puede perjudicar a los niños alimentados con leche materna.
CS Může poškodit kojence prostřednictvím mateřského mléka.
DA Kan skade børn, der ammes.
DE Kann Säuglinge über die Muttermilch schädigen.
ET Võib kahjustada rinnaga toidetavat last.
EL Μπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.
EN May cause harm to breast-fed children.
FR Peut être nocif pour les bébés nourris au lait maternel.
GA D'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.
IT Può essere nocivo per i lattanti allattati al seno.
LV Var radīt kaitējumu ar krūti barotam bērnam.
LT Gali pakenkti žindomam vaikui.
HU A szoptatott gyermeket károsíthatja.
MT Jista’ jagħmel ħsara lit-tfal imreddgħa.
NL Kan schadelijk zijn via borstvoeding.
PL Może działać szkodliwie na dzieci karmione piersią.
PT Pode ser nocivo para as crianças alimentadas com leite materno.
RO Poate dăuna copiilor alăptaţi la sân.
SK Môže spôsobiť poškodenie u dojčených detí.
SL Lahko škoduje dojenim otrokom.
FI Saattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.
SV Kan skada spädbarn som ammas.
H370 Language 3.8 — Specific target organ toxicity — single exposure, Hazard Category 1
BG Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Provoca daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Schädigt die Organe <oder alle betroffenen Organe nennen, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
EN Causes damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Risque avéré d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA Déanann sé damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Rada orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Jagħmel ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Powoduje uszkodzenie narządów <podać szczególny skutek, jeśli jest znany> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Provoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H371 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 2
BG Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Puede provocar daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann die Organe schädigen <oder alle betroffenen Organe nennen, sofern bekann> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN May cause damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA D'fhéadfadh damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Károsíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MT Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta'’ espożizzjoni ieħor ma jikkawża l-periklu>.
NL Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Poate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H372 Language 3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 1
BG Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Provoca daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Schädigt die Organe <alle betroffenen Organe nennen> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
EN Causes damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Risque avéré d'effets graves pour les organes <indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA Déanann damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Izraisa orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinoma>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.
MT Jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Powoduje uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub powtarzane narażenie <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Provoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SV Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
H373 Language 3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 2
BG Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ES Puede provocar daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CS Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DA Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DE Kann die Organe schädigen <alle betroffenen Organe nennen, sofern bekannt> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ET Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
EL Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
EN May cause damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FR Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GA D'fhéadfadh sé damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
IT Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LV Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LT Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HU Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.
MT Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NL Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PL Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub narażenie powtarzane <podać drogę narażenia, jeśli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PT Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
RO Poate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SK Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SL Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FI Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>
SV Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.
Table 1.3
Hazard statements for environmental hazards
H400 Language 4.1 — Hazardous to the aquatic environment — AcuteHazard, Category 1
BG Силно токсичен за водните организми.
ES Muy tóxico para los organismos acuáticos.
CS Vysoce toxický pro vodní organismy.
DA Meget giftig for vandlevende organismer.
DE Sehr giftig für Wasserorganismen.
ET Väga mürgine veeorganismidele.
EL Πολύ τοξικό για τους υδρόβιους οργανισμούς.
EN Very toxic to aquatic life.
FR Très toxique pour les organismes aquatiques.
GA An-tocsaineach don saol uisceach.
IT Molto tossico per gli organismi acquatici.
LV Ļoti toksisks ūdens organismiem.
LT Labai toksiška vandens organizmams.
HU Nagyon mérgező a vízi élővilágra.
MT Tossiku ħafna għall-organiżmi akwatiċi.
NL Zeer giftig voor in het water levende organismen.
PL Działa bardzo toksycznie na organizmy wodne.
PT Muito tóxico para os organismos aquáticos.
RO Foarte toxic pentru mediul acvatic.
SK Veľmi toxický pre vodné organizmy.
SL Zelo strupeno za vodne organizme.
FI Erittäin myrkyllistä vesieliöille.
SV Mycket giftigt för vattenlevande organismer.
H410 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 1
BG Силно токсичен за водните организми, с дълготраен ефект.
ES Muy tóxico para los organismos acuáticos, con efectos nocivos duraderos.
CS Vysoce toxický pro vodní organismy, s dlouhodobými účinky.
DA Meget giftig med langvarige virkninger for vandlevende organismer.
DE Sehr giftig für Wasserorganismen mit langfristiger Wirkung.
ET Väga mürgine veeorganismidele, pikaajaline toime.
EL Πολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
EN Very toxic to aquatic life with long lasting effects.
FR Très toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GA An-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
IT Molto tossico per gli organismi acquatici con effetti di lunga durata.
LV Ļoti toksisks ūdens organismiem ar ilgstošām sekām.
LT Labai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.
HU Nagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.
MT Tossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NL Zeer giftig voor in het water levende organismen, met langdurige gevolgen.
PL Działa bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.
PT Muito tóxico para os organismos aquáticos com efeitos duradouros.
RO Foarte toxic pentru mediul acvatic cu efecte pe termen lung.
SK Veľmi toxický pre vodné organizmy, s dlhodobými účinkami.
SL Zelo strupeno za vodne organizme, z dolgotrajnimi učinki.
FI Erittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
SV Mycket giftigt för vattenlevande organismer med långtidseffekter.
H411 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 2
BG Токсичен за водните организми, с дълготраен ефект.
ES Tóxico para los organismos acuáticos, con efectos nocivos duraderos.
CS Toxický pro vodní organismy, s dlouhodobými účinky.
DA Giftig for vandlevende organismer, med langvarige virkninger.
DE Giftig für Wasserorganismen, mit langfristiger Wirkung.
ET Mürgine veeorganismidele, pikaajaline toime.
EL Τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
EN Toxic to aquatic life with long lasting effects.
FR Toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GA Tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
IT Tossico per gli organismi acquatici con effetti di lunga durata.
LV Toksisks ūdens organismiem ar ilgstošām sekām.
LT Toksiška vandens organizmams, sukelia ilgalaikius pakitimus.
HU Mérgező a vízi élővilágra, hosszan tartó károsodást okoz.
MT Tossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NL Giftig voor in het water levende organismen, met langdurige gevolgen.
PL Działa toksycznie na organizmy wodne, powodując długotrwałe skutki.
PT Tóxico para os organismos aquáticos com efeitos duradouros.
RO Toxic pentru mediul acvatic cu efecte pe termen lung.
SK Toxický pre vodné organizmy, s dlhodobými účinkami.
SL Strupeno za vodne organizme, z dolgotrajnimi učinki.
FI Myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
SV Giftigt för vattenlevande organismer med långtidseffekter.
H412 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 3
BG Вреден за водните организми, с дълготраен ефект.
ES Nocivo para los organismos acuáticos, con efectos nocivos duraderos.
CS Škodlivý pro vodní organismy, s dlouhodobými účinky.
DA Skadelig for vandlevende organismer, med langvarige virkninger.
DE Schädlich für Wasserorganismen, mit langfristiger Wirkung.
ET Ohtlik veeorganismidele, pikaajaline toime.
EL Επιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
EN Harmful to aquatic life with long lasting effects.
FR Nocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GA Díobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.
IT Nocivo per gli organismi acquatici con effetti di lunga durata.
LV Kaitīgs ūdens organismiem ar ilgstošām sekām.
LT Kenksminga vandens organizmams, sukelia ilgalaikius pakitimus.
HU Ártalmas a vízi élővilágra, hosszan tartó károsodást okoz.
MT Jagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NL Schadelijk voor in het water levende organismen, met langdurige gevolgen.
PL Działa szkodliwie na organizmy wodne, powodując długotrwałe skutki.
PT Nocivo para os organismos aquáticos com efeitos duradouros.
RO Nociv pentru mediul acvatic cu efecte pe termen lung.
SK Škodlivý pre vodné organizmy, s dlhodobými účinkami.
SL Škodljivo za vodne organizme, z dolgotrajnimi učinki.
FI Haitallista vesieliöille, pitkäaikaisia haittavaikutuksia.
SV Skadliga långtidseffekter för vattenlevande organismer.
H413 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 4
BG Може да причини дълготраен вреден ефект за водните организми.
ES Puede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.
CS Může vyvolat dlouhodobé škodlivé účinky pro vodní organismy.
DA Kan forårsage langvarige skadelige virkninger for vandlevende organismer.
DE Kann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.
ET Võib avaldada veeorganismidele pikaajalist kahjulikku toimet.
EL Μπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.
EN May cause long lasting harmful effects to aquatic life.
FR Peut être nocif à long terme pour les organismes aquatiques.
GA D'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.
IT Può essere nocivo per gli organismi acquatici con effetti di lunga durata.
LV Var radīt ilgstošas kaitīgas sekas ūdens organismiem.
LT Gali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.
HU Hosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.
MT Jista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.
NL Kan langdurige schadelijke gevolgen voor in het water levende organismen hebben.
PL Może powodować długotrwałe szkodliwe skutki dla organizmów wodnych.
PT Pode provocar efeitos nocivos duradouros nos organismos aquáticos.
RO Poate provoca efecte nocive pe termen lung asupra mediului acvatic.
SK Môže mať dlhodobé škodlivé účinky na vodné organizmy.
SL Lahko ima dolgotrajne škodljive učinke na vodne organizme.
FI Voi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.
SV Kan ge skadliga långtidseffekter på vattenlevande organismer.
2. Part 2: supplemental hazard information
Table 2.1
Physical properties
EUH 001 Language BG Експлозивен в сухо състояние.
ES Explosivo en estado seco.
CS Výbušný v suchém stavu.
DA Eksplosiv i tør tilstand.
DE In trockenem Zustand explosionsgefährlich.
ET Plahvatusohtlik kuivana.
EL Εκρηκτικό σε ξηρή κατάσταση.
EN Explosive when dry.
FR Explosif à l'état sec.
GA Pléascach agus é tirim.
IT Esplosivo allo stato secco.
LV Sprādzienbīstams sausā veidā.
LT Sausos būsenos gali sprogti.
HU Száraz állapotban robbanásveszélyes.
MT Jisplodi meta jinxef.
NL In droge toestand ontplofbaar.
PL Produkt wybuchowy w stanie suchym.
PT Explosivo no estado seco.
RO Exploziv în stare uscată.
SK V suchom stave výbušný.
SL Eksplozivno v suhem stanju.
FI Räjähtävää kuivana.
SV Explosivt i torrt tillstånd.
EUH 006 Language BG Експлозивен при или без контакт с въздуха.
ES Explosivo en contacto o sin contacto con el aire.
CS Výbušný za přístupu i bez přístupu vzduchu.
DA Eksplosiv ved og uden kontakt med luft.
DE Mit und ohne Luft explosionsfähig.
ET Plahvatusohtlik õhuga kokkupuutel või kokkupuuteta.
EL Εκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.
EN Explosive with or without contact with air.
FR Danger d'explosion en contact ou sans contact avec l'air.
GA Pléascach i dteagmháil le haer nó gan é.
IT Esplosivo a contatto o senza contatto con l'aria.
LV Sprādzienbīstams gaisa un bezgaisa vidē.
LT Gali sprogti ore arba beorėje erdvėje.
HU Levegővel érintkezve vagy anélkül is robbanásveszélyes.
MT Jista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.
NL Ontplofbaar met en zonder lucht.
PL Produkt wybuchowy z dostępem lub bez dostępu powietrza.
PT Perigo de explosão com ou sem contacto com o ar.
RO Exploziv în contact sau fără contactul cu aerul.
SK Výbušné pri kontakte alebo bez kontaktu so vzduchom.
SL Eksplozivno v stiku z zrakom ali brez stika z zrakom.
FI Räjähtävää sellaisenaan tai ilman kanssa.
SV Explosivt vid eller utan kontakt med luft.
EUH 014 Language BG Реагира бурно с вода.
ES Reacciona violentamente con el agua.
CS Prudce reaguje s vodou.
DA Reagerer voldsomt med vand.
DE Reagiert heftig mit Wasser.
ET Reageerib ägedalt veega.
EL Αντιδρά βίαια με νερό.
EN Reacts violently with water.
FR Réagit violemment au contact de l'eau.
GA Imoibríonn go foirtil le huisce.
IT Reagisce violentemente con l'acqua.
LV Aktīvi reaģē ar ūdeni.
LT Smarkiai reaguoja su vandeniu.
HU Vízzel hevesen reagál.
MT Jirreaġixxi bil-qawwa meta jmiss l-ilma.
NL Reageert heftig met water.
PL Reaguje gwałtownie z wodą.
PT Reage violentamente em contacto com a água.
RO Reacţionează violent în contact cu apa.
SK Prudko reaguje s vodou.
SL Burno reagira z vodo.
FI Reagoi voimakkaasti veden kanssa.
SV Reagerar häftigt med vatten.
EUH 018 Language BG При употреба може да се образува запалима/експлозивна паровъздушнa смес.
ES Al usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.
CS Při používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.
DA Ved brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.
DE Kann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.
ET Kasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.
EL Κατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.
EN In use may form flammable/explosive vapour-air mixture.
FR Lors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.
GA Agus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.
IT Durante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.
LV Izmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.
LT Naudojama gali sudaryti degius (sprogius) garų-oro mišinius.
HU A használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.
MT Meta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.
NL Kan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.
PL Podczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.
PT Pode formar mistura vapor-ar explosiva/inflamável durante a utilização.
RO În timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.
SK Pri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.
SL Pri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.
FI Käytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.
SV Vid användning kan brännbara/explosiva ång-luftblandningar bildas.
EUH 019 Language BG Може да образува експлозивни пероксиди.
ES Puede formar peróxidos explosivos.
CS Může vytvářet výbušné peroxidy.
DA Kan danne eksplosive peroxider.
DE Kann explosionsfähige Peroxide bilden.
ET Võib moodustada plahvatusohtlikke peroksiide.
EL Μπορεί να σχηματίσει εκρηκτικά υπεροξείδια.
EN May form explosive peroxides.
FR Peut former des peroxydes explosifs.
GA D'fhéadfadh sé sárocsaídí pléascacha a chruthú.
IT Può formare perossidi esplosivi.
LV Var veidot sprādzienbīstamus peroksīdus.
LT Gali sudaryti sprogius peroksidus.
HU Robbanásveszélyes peroxidokat képezhet.
MT Jista' jifforma perossidi esplussivi.
NL Kan ontplofbare peroxiden vormen.
PL Może tworzyć wybuchowe nadtlenki.
PT Pode formar peróxidos explosivos.
RO Poate forma peroxizi explozivi.
SK Môže vytvárat’ výbušné peroxidy.
SL Lahko tvori eksplozivne perokside.
FI Saattaa muodostaa räjähtäviä peroksideja.
SV Kan bilda explosiva peroxider.
EUH 044 Language BG Риск от експлозия при нагряване в затворено пространство.
ES Riesgo de explosión al calentarlo en ambiente confinado.
CS Nebezpečí výbuchu při zahřátí v uzavřeném obalu.
DA Eksplosionsfarlig ved opvarmning under indeslutning.
DE Explosionsgefahr bei Erhitzen unter Einschluss.
ET Plahvatusohtlik kuumutamisel kinnises mahutis.
EL Κίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.
EN Risk of explosion if heated under confinement.
FR Risque d'explosion si chauffé en ambiance confinée.
GA Baol pléasctha arna théamh i limistéar iata.
IT Rischio di esplosione per riscaldamento in ambiente confinato.
LV Sprādziena draudi, karsējot slēgtā vidē.
LT Gali sprogti, jei kaitinama sandariai uždaryta.
HU Zárt térben hő hatására robbanhat.
MT Riskju ta' splużjoni jekk jissaħħan fil-magħluq.
NL Ontploffingsgevaar bij verwarming in afgesloten toestand.
PL Zagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.
PT Risco de explosão se aquecido em ambiente fechado.
RO Risc de explozie, dacă este încălzit în spaţiu închis.
SK Riziko výbuchu pri zahrievaní v uzavretom priestore.
SL Nevarnost eksplozije ob segrevanju v zaprtem prostoru.
FI Räjähdysvaara kuumennettaessa suljetussa astiassa.
SV Explosionsrisk vid uppvärmning i sluten behållare.
Table 2.2
Health properties
EUH 029 Language BG При контакт с вода се отделя токсичен газ.
ES En contacto con agua libera gases tóxicos.
CS Uvolňuje toxický plyn při styku s vodou.
DA Udvikler giftig gas ved kontakt med vand.
DE Entwickelt bei Berührung mit Wasser giftige Gase.
ET Kokkupuutel veega eraldub mürgine gaas.
EL Σε επαφή με το νερό ελευθερώνονται τοξικά αέρια.
EN Contact with water liberates toxic gas.
FR Au contact de l'eau, dégage des gaz toxiques.
GA I dteagmháil le huisce scaoiltear gás tocsaineach.
IT A contatto con l'acqua libera un gas tossico.
LV Saskaroties ar ūdeni, izdala toksiskas gāzes.
LT Kontaktuodama su vandeniu išskiria toksiškas dujas.
HU Vízzel érintkezve mérgező gázok képződnek.
MT Jitfa' gass tossiku meta jmiss l-ilma.
NL Vormt giftig gas in contact met water.
PL W kontakcie z wodą uwalnia toksyczne gazy.
PT Em contacto com a água liberta gases tóxicos.
RO În contact cu apa, degajă un gaz toxic.
SK Pri kontakte s vodou uvoľňuje toxický plyn.
SL V stiku z vodo se sprošča strupen plin.
FI Kehittää myrkyllistä kaasua veden kanssa.
SV Utvecklar giftig gas vid kontakt med vatten.
EUH 031 Language BG При контакт с киселини се отделя токсичен газ.
ES En contacto con ácidos libera gases tóxicos.
CS Uvolňuje toxický plyn při styku s kyselinami.
DA Udvikler giftig gas ved kontakt med syre.
DE Entwickelt bei Berührung mit Säure giftige Gase.
ET Kokkupuutel hapetega eraldub mürgine gaas.
EL Σε επαφή με οξέα ελευθερώνονται τοξικά αέρια.
EN Contact with acids liberates toxic gas.
FR Au contact d'un acide, dégage un gaz toxique.
GA I dteagmháil le haigéid scaoiltear gás tocsaineach.
IT A contatto con acidi libera gas tossici.
LV Saskaroties ar skābēm, izdala toksiskas gāzes.
LT Kontaktuodama su rūgštimis išskiria toksiškas dujas.
HU Savval érintkezve mérgező gázok képződnek.
MT Jitfa' gass tossiku meta jmiss l-aċidi.
NL Vormt giftig gas in contact met zuren.
PL W kontakcie z kwasami uwalnia toksyczne gazy.
PT Em contacto com ácidos liberta gases tóxicos.
RO În contact cu acizi, degajă un gaz toxic.
SK Pri kontakte s kyselinami uvoľňuje toxický plyn.
SL V stiku s kislinami se sprošča strupen plin.
FI Kehittää myrkyllistä kaasua hapon kanssa.
SV Utvecklar giftig gas vid kontakt med syra.
EUH 032 Language BG При контакт с киселини се отделя силно токсичен газ.
ES En contacto con ácidos libera gases muy tóxicos.
CS Uvolňuje vysoce toxický plyn při styku s kyselinami.
DA Udvikler meget giftig gas ved kontakt med syre.
DE Entwickelt bei Berührung mit Säure sehr giftige Gase.
ET Kokkupuutel hapetega eraldub väga mürgine gaas.
EL Σε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.
EN Contact with acids liberates very toxic gas.
FR Au contact d'un acide, dégage un gaz très toxique.
GA I dteagmháil le haigéid scaoiltear gás an-tocsaineach.
IT A contatto con acidi libera gas molto tossici.
LV Saskaroties ar skābēm, izdala ļoti toksiskas gāzes.
LT Kontaktuodama su rūgštimis išskiria labai toksiškas dujas.
HU Savval érintkezve nagyon mérgező gázok képződnek.
MT Jitfa' gass tossiku ħafna meta jmiss l-aċidi.
NL Vormt zeer giftig gas in contact met zuren.
PL W kontakcie z kwasami uwalnia bardzo toksyczne gazy.
PT Em contacto com ácidos liberta gases muito tóxicos.
RO În contact cu acizi, degajă un gaz foarte toxic.
SK Pri kontakte s kyselinami uvoľňuje veľmi toxický plyn.
SL V stiku s kislinami se sprošča zelo strupen plin.
FI Kehittää erittäin myrkyllistä kaasua hapon kanssa.
SV Utvecklar mycket giftig gas vid kontakt med syra.
EUH 066 Language BG Повтарящата се експозиция може да предизвика изсушаване или напукване на кожата.
ES La exposición repetida puede provocar sequedad o formación de grietas en la piel.
CS Opakovaná expozice může způsobit vysušení nebo popraskání kůže.
DA Gentagen kontakt kan give tør eller revnet hud.
DE Wiederholter Kontakt kann zu spröder oder rissiger Haut führen.
ET Korduv kokkupuude võib põhjustada naha kuivust või lõhenemist.
EL Παρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.
EN Repeated exposure may cause skin dryness or cracking.
FR L'exposition répétée peut provoquer dessèchement ou gerçures de la peau.
GA D'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.
IT L'esposizione ripetuta può provocare secchezza o screpolature della pelle.
LV Atkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.
LT Pakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.
HU Ismétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.
MT Espożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.
NL Herhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.
PL Powtarzające się narażenie może powodować wysuszanie lub pękanie skóry.
PT Pode provocar pele seca ou gretada, por exposição repetida.
RO Expunerea repetată poate provoca uscarea sau crăparea pielii.
SK Opakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.
SL Ponavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.
FI Toistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.
SV Upprepad kontakt kan ge torr hud eller hudsprickor.
EUH 070 Language BG Токсично при контакт с очите.
ES Tóxico en contacto con los ojos.
CS Toxický při styku s očima.
DA Giftig ved kontakt med øjnene.
DE Giftig bei Berührung mit den Augen.
ET Silma sattumisel mürgine.
EL Τοξικό σε επαφή με τα μάτια.
EN Toxic by eye contact.
FR Toxique par contact oculaire.
GA Tocsaineach trí theagmháil leis an tsúil.
IT Tossico per contatto oculare.
LV Toksisks saskarē ar acīm.
LT Toksiška patekus į akis.
HU Szembe kerülve mérgező.
MT Tossiku meta jmiss ma’ l-għajnejn.
NL Giftig bij oogcontact.
PL Działa toksycznie w kontakcie z oczami.
PT Tóxico por contacto com os olhos.
RO Toxic în caz de contact cu ochii.
SK Toxické pri kontakte s očami.
SL Strupeno ob stiku z očmi.
FI Myrkyllistä joutuessaan silmään.
SV Giftigt vid kontakt med ögonen.
EUH 071 Language BG Корозивен за дихателните пътища.
ES Corrosivo para las vías respiratorias.
CS Způsobuje poleptání dýchacích cest.
DA Ætsende for luftvejene.
DE Wirkt ätzend auf die Atemwege.
ET Söövitav hingamisteedele.
EL Διαβρωτικό της αναπνευστικής οδού.
EN Corrosive to the respiratory tract.
FR Corrosif pour les voies respiratoires.
GA Creimneach don chonair riospráide.
IT Corrosivo per le vie respiratorie.
LV Kodīgs elpceļiem.
LT Ėsdina kvėpavimo takus.
HU Maró hatású a légutakra.
MT Korrużiv għas-sistema respiratorja.
NL Bijtend voor de luchtwegen.
PL Działa żrąco na drogi oddechowe.
PT Corrosivo para as vias respiratórias.
RO Corosiv pentru căile respiratorii.
SK Žieravé pre dýchacie cesty.
SL Jedko za dihalne poti.
FI Hengityselimiä syövyttävää.
SV Frätande på luftvägarna.
Table 2.3
Environmental properties
EUH 059 Language Additional EU Hazard Class
BG Опасно за озоновия слой.
ES Peligroso para la capa de ozono.
CS Nebezpečný pro ozonovou vrstvu.
DA Farlig for ozonlaget.
DE Die Ozonschicht schädigend.
ET Ohtlik osoonikihile.
EL Επικίνδυνο για τη στιβάδα του όζοντος.
EN Hazardous to the ozone layer.
FR Dangereux pour la couche d'ozone.
GA Guaiseach don chiseal ózóin.
IT Pericoloso per lo strato di ozono.
LV Bīstams ozona slānim.
LT Pavojinga ozono sluoksniui.
HU Veszélyes az ózonrétegre.
MT Perikoluż għas-saff ta' l-ożonu.
NL Gevaarlijk voor de ozonlaag.
PL Stwarza zagrożenie dla warstwy ozonowej.
PT Perigoso para a camada de ozono.
RO Periculos pentru stratul de ozon.
SK Nebezpečný pre ozónovú vrstvu.
SL Nevarno za ozonski plašč.
FI Vaarallista otsonikerrokselle.
SV Farligt för ozonskiktet.
3. Part 3: supplemental label elements/information on certain substances and mixtures
EUH 201/ 201A Language 201
201A BG Съдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.
Внимание! Съдържа олово.
201
201A ES Contiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.
¡Atención! Contiene plomo.
201
201A CS Obsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.
Pozor! Obsahuje olovo.
201
201A DA Indeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.
Advarsel! Indeholder bly.
201
201A DE Enthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.
Achtung! Enthält Blei.
201
201A ET Sisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.
Ettevaatust! Sisaldab pliid.
201
201A EL Περιέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.
Προσοχή! Περιέχει μόλυβδο.
201
201A EN Contains lead. Should not be used on surfaces liable to be chewed or sucked by children.
Warning! Contains lead.
201
201A FR Contient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.
Attention! Contient du plomb.
201
201A GA Luaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.
Rabhadh! Luaidhe ann.
201
201A IT Contiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.
Attenzione! Contiene piombo.
201
201A LV Satur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.
Brīdinājums! Satur svinu.
201
201A LT Sudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.
Atsargiai! Sudėtyje yra švino.
201
201A HU Ólmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.
Figyelem! Ólmot tartalmaz.
201
201A MT Fih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.
Twissija! Fih iċ-ċomb.
201
201A NL Bevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.
Let op! Bevat lood.
201
201A PL Zawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.
Uwaga! Zawiera ołów.
201
201A PT Contém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.
Atenção! Contém chumbo.
201
201A RO Conţine plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.
Atenţie! Conţine plumb.
201
201A SK Obsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.
Pozor! Obsahuje olovo.
201
201A SL Vsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.
Pozor! Vsebuje svinec.
201
201A FI Sisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.
Varoitus! Sisältää lyijyä.
201
201A SV Innehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.
Varning! Innehåller bly.
EUH 202 Language BG Цианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.
ES Cianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.
CS Kyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.
DA Cyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.
DE Cyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.
ET Tsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.
EL Κυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.
EN Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.
FR Cyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.
GA Cianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.
IT Cianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.
LV Ciānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.
LT Cianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.
HU Cianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.
MT Cyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.
NL Cyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.
PL Cyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.
PT Cianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.
RO Cianoacrilat. Pericol. Se lipeşte de piele şi ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.
SK Kyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.
SL Cianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.
FI Syanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.
SV Cyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.
EUH 203 Language BG Съдържа хром (VI). Може да причини алергична реакция.
ES Contiene cromo (VI). Puede provocar una reacción alérgica.
CS Obsahuje chrom (VI). Může vyvolat alergickou reakci.
DA Indeholder krom (VI). Kan udløse allergisk reaktion.
DE Enthält Chrom (VI). Kann allergische Reaktionen hervorrufen.
ET Sisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.
EL Περιέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.
EN Contains chromium (VI). May produce an allergic reaction.
FR Contient du chrome (VI). Peut produire une réaction allergique.
GA Cróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
IT Contiene cromo (VI). Può provocare una reazione allergica.
LV Satur hromu (VI). Var izraisīt alerģisku reakciju.
LT Sudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.
HU Krómot (VI) tartalmaz. Allergiás reakciót válthat ki.
MT Fih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.
NL Bevat zeswaardig chroom. Kan een allergische reactie veroorzaken.
PL Zawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.
PT Contém crómio (VI). Pode provocar uma reacção alérgica.
RO Conţine crom (VI). Poate provoca o reacţie alergică.
SK Obsahuje chróm (VI). Môže vyvolať alergickú reakciu.
SL Vsebuje krom (VI). Lahko povzroči alergijski odziv.
FI Sisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.
SV Innehåller krom (VI). Kan orsaka en allergisk reaktion.
EUH 204 Language BG Съдържа изоцианати. Може да причини алергична реакция.
ES Contiene isocianatos. Puede provocar una reacción alérgica.
CS Obsahuje isokyanáty. Může vyvolat alergickou reakci.
DA Indeholder isocyanater. Kan udløse allergisk reaktion.
DE Enthält Isocyanate. Kann allergische Reaktionen hervorrufen.
ET Sisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.
EL Περιέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
EN Contains isocyanates. May produce an allergic reaction.
FR Contient des isocyanates. Peut produire une réaction allergique.
GA Isicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
IT Contiene isocianati. Può provocare una reazione allergica.
LV Satur izocianātus. Var izraisīt alerģisku reakciju.
LT Sudėtyje yra izocianatų. Gali sukelti alerginę reakciją.
HU Izocianátokat tartalmaz. Allergiás reakciót válthat ki.
MT Fih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.
NL Bevat isocyanaten. Kan een allergische reactie veroorzaken.
PL Zawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.
PT Contém isocianatos. Pode provocar uma reacção alérgica.
RO Conţine izocianaţi. Poate provoca o reacţie alergică.
SK Obsahuje izokyanáty. Môže vyvolať alergickú reakciu.
SL Vsebuje izocianate. Lahko povzroči alergijski odziv.
FI Sisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.
SV Innehåller isocyanater. Kan orsaka en allergisk reaktion.
EUH 205 Language BG Съдържа епоксидни съставки. Може да причини алергична реакция.
ES Contiene componentes epoxídicos. Puede provocar una reacción alérgica.
CS Obsahuje epoxidové složky. Může vyvolat alergickou reakci.
DA Indeholder epoxyforbindelser. Kan udløse allergisk reaktion.
DE Enthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.
ET Sisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.
EL Περιέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
EN Contains epoxy constituents. May produce an allergic reaction.
FR Contient des composés époxydiques. Peut produire une réaction allergique.
GA Comhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
IT Contiene componenti epossidici. Può provocare una reazione allergica.
LV Satur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.
LT Sudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.
HU Epoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.
MT Fih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.
NL Bevat epoxyverbindingen. Kan een allergische reactie veroorzaken.
PL Zawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.
PT Contém componentes epoxídicos. Pode provocar uma reacção alérgica.
RO Conţine componenţi epoxidici. Poate provoca o reacţie alergică.
SK Obsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.
SL Vsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.
FI Sisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.
SV Innehåller epoxiförening. Kan orsaka en allergisk reaktion.
EUH 206 Language BG Внимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).
ES ¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).
CS Pozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).
DA Advarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.
DE Achtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.
ET Ettevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).
EL Προσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).
EN Warning! Do not use together with other products. May release dangerous gases (chlorine).
FR Attention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).
GA Rabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).
IT Attenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).
LV Brīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).
LT Atsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).
HU Figyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.
MT Twissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).
NL Let op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.
PL Uwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).
PT Atenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).
RO Atenţie! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).
SK Pozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).
SL Pozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).
FI Varoitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).
SV Varning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).
EUH 207 Language BG Внимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.
ES ¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.
CS Pozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.
DA Advarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.
DE Achtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.
ET Ettevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.
EL Προσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.
EN Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.
FR Attention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.
GA Rabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.
IT Attenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.
LV Brīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.
LT Atsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.
HU Figyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.
MT Twissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.
NL Let op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.
PL Uwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.
PT Atenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.
RO Atenţie! Conţine cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informaţiile furnizate de producător. A se respecta instrucţiunile privind siguranţa.
SK Pozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.
SL Pozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.
FI Varoitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.
SV Varning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.
EUH 208 Language BG Съдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.
ES Contiene <nombre de la sustancia sensibilizante>. Puede provocar una reacción alérgica.
CS Obsahuje <název senzibilizující látky>. Může vyvolat alergickou reakci.
DA Indeholder <navn på det sensibiliserende stof>. Kan udløse allergisk reaktion.
DE Enthält <Name des sensibilisierenden Stoffes>. Kann allergische Reaktionen hervorrufen.
ET Sisaldab <sensibiliseeriva aine nimetus>. Võib esile kutsuda allergilise reaktsiooni.
EL Περιέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.
EN Contains <name of sensitising substance>. May produce an allergic reaction.
FR Contient <nom de la substance sensibilisante>. Peut produire une réaction allergique.
GA <Ainm na substainte íograithe> ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
IT Contiene <denominazione della sostanza sensibilizzante>. Può provocare una reazione allergica.
LV Satur <sensibilizējošās vielas nosaukums>. Var izraisīt alerģisku reakciju.
LT Sudėtyje yra <jautrinančios medžiagos pavadinimas>. Gali sukelti alerginę reakciją.
HU <Allergén anyag neve>-t tartalmaz. Allergiás reakciót válthat ki.
MT Fih <l-isem tas-sustanza sensibbli>. Jista’ jagħmel reazzjoni allerġika.
NL Bevat <naam van de sensibiliserende stof>. Kan een allergische reactie veroorzaken.
PL Zawiera <nazwa substancji uczulającej>. Może powodować wystąpienie reakcji alergicznej.
PT Contém <nome da substância sensibilizante em questão>. Pode provocar uma reacção alérgica.
RO Conţine <denumirea substanţei sensibilizante>. Poate provoca o reacţie alergică.
SK Obsahuje <názov senzibilizujúcej látky>. Môže vyvolať alergickú reakciu.
SL Vsebuje <ime snovi, ki povzroča preobčutljivost>. Lahko povzroči alergijski odziv.
FI Sisältää <herkistävän aineen nimi>. Voi aiheuttaa allergisen reaktion.
SV Innehåller <namnet på det sensibiliserande ämnet>. Kan orsaka en allergisk reaktion.
EUH 209/ 209A Language 209
209A BG При употреба може да стане силно запалимо.
При употреба може да стане запалимо.
209
209A ES Puede inflamarse fácilmente al usarlo
Puede inflamarse al usarlo.
209
209A CS Při používání se může stát vysoce hořlavým.
Při používání se může stát hořlavým.
209
209A DA Kan blive meget brandfarlig ved brug.
Kan blive brandfarlig ved brug.
209
209A DE Kann bei Verwendung leicht entzündbar werden.
Kann bei Verwendung entzündbar werden.
209
209A ET Kasutamisel võib muutuda väga tuleohtlikuks.
Kasutamisel võib muutuda tuleohtlikuks.
209
209A EL Μπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.
Mπορεί να γίνει εύφλεκτο κατά τη χρήση.
209
209A EN Can become highly flammable in use.
Can become flammable in use.
209
209A FR Peut devenir facilement inflammable en cours d'utilisation.
Peut devenir inflammable en cours d'utilisation.
209
209A GA D'fhéadfadh sé éirí an-inadhainte agus é á úsáid.
D'fhéadfadh sé éirí inadhainte agus é á úsáid.
209
209A IT Può diventare facilmente infiammabile durante l'uso.
Può diventare infiammabile durante l'uso.
209
209A LV Lietojot var viegli uzliesmot.
Kļūt uzliesmojošs.
209
209A LT Naudojama gali tapti labai degi.
Naudojama gali tapti degi.
209
209A HU A használat során fokozottan tűzveszélyessé válhat.
A használat során tűzveszélyessé válhat.
209
209A MT Jista’ jieħu n-nar faċilment meta jintuża.
Jista’ jieħu n-nar meta jintuża.
209
209A NL Kan bij gebruik licht ontvlambaar worden.
Kan bij gebruik ontvlambaar worden.
209
209A PL Podczas stosowania może przekształcić się w substancję wysoce łatwopalną.
Podczas stosowania może przekształcić się w substancję łatwopalną.
209
209A PT Pode tornar-se facilmente inflamável durante o uso.
Pode tornar-se inflamável durante o uso.
209
209A RO Poate deveni foarte inflamabil în timpul utilizării.
Poate deveni inflamabil în timpul utilizării.
209
209A SK Pri používaní sa môže stať veľmi horľavou.
Pri používaní sa môže stať horľavou.
209
209A SL Med uporabo utegne postati lahko vnetljivo.
Med uporabo utegne postati vnetljivo.
209
209A FI Voi muuttua helposti syttyväksi käytössä.
Voi muuttua syttyväksi käytössä.
209
209A SV Kan bli mycket brandfarligt vid användning.
Kan bli brandfarligt vid användning.
EUH 210 Language BG Информационен лист за безопасност ще бъде представен при поискване.
ES Puede solicitarse la ficha de datos de seguridad.
CS Na vyžádání je kodispozici bezpečnostní list.
DA Sikkerhedsdatablad kan på anmodning rekvireres.
DE Sicherheitsdatenblatt auf Anfrage erhältlich.
ET Ohutuskaart nõudmisel kättesaadav.
EL Δελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.
EN Safety data sheet available on request.
FR Fiche de données de sécurité disponible sur demande.
GA Bileog sonraí sábháilteachta ar fáil arna iarraidh sin.
IT Scheda dati di sicurezza disponibile su richiesta.
LV Drošības datu lapa ir pieejama pēc pieprasījuma.
LT Saugos duomenų lapą galima gauti paprašius.
HU Kérésre biztonsági adatlap kapható.
MT Il-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.
NL Veiligheidsinformatieblad op verzoek verkrijgbaar.
PL Karta charakterystyki dostępna na żądanie.
PT Ficha de segurança fornecida a pedido.
RO Fişa cu date de securitate disponibilă la cerere.
SK Na požiadanie možno poskytnúť kartu bezpečnostných údajov.
SL Varnosti list na voljo na zahtevo.
FI Käyttöturvallisuustiedote toimitetaan pyynnöstä.
SV Säkerhetsdatablad finns att rekvirera.
EUH 401 Language BG За да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.
ES A fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.
CS Dodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.
DA Brugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.
DE Zur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.
ET Inimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.
EL Για να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.
EN To avoid risks to human health and the environment, comply with the instructions for use.
FR Respectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.
GA Chun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.
IT Per evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.
LT Siekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.
LV Lai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.
HU Az emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.
MT Biex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.
NL Volg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.
PL W celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.
PT Para evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.
RO Pentru a evita riscurile pentru sănătatea umană şi mediu, a se respecta instrucţiunile de utilizare.
SK Dodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.
SL Da bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.
FI Noudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.
SV För att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.

after (02008R1272-20101201)

ANNEX III
LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS


1. Part 1: hazard statements
The hazard statements shall be applied in accordance with Parts 2, 3 and 4 of Annex I.

Table 1.1
Hazard statements for physical hazards

The codification system for GHS hazard statements is still under discussion in the UN Committee of Experts and therefore amendments might be needed.

H200
Language
2.1 — Explosives, Unstable explosives

BG
Нестабилен експлозив.

ES
Explosivo inestable.

CS
Nestabilní výbušnina.

DA
Ustabilt eksplosiv.

DE
Instabil, explosiv.

ET
Ebapüsiv lõhkeaine.

EL
Ασταθή εκρηκτικά.

EN
Unstable explosives.

FR
Explosif instable.

GA
Pléascáin éagobhsaí.

IT
Esplosivo instabile.

LV
Nestabili sprādzienbīstami materiāli.

LT
Nestabilios sprogios medžiagos.

HU
Instabil robbanóanyagok.

MT
Splussivi instabbli.

NL
Instabiele ontplofbare stof.

PL
Materiały wybuchowe niestabilne.

PT
Explosivo instável.

RO
Exploziv instabil.

SK
Nestabilné výbušniny.

SL
Nestabilni eksplozivi.

FI
Epästabiili räjähde.

SV
Instabilt explosivt.

H201
Language
2.1 — Explosives, Division 1.1

BG
Експлозив; опасност от масова експлозия.

ES
Explosivo; peligro de explosión en masa.

CS
Výbušnina; nebezpečí masivního výbuchu.

DA
Eksplosiv, masseeksplosionsfare.

DE
Explosiv, Gefahr der Massenexplosion.

ET
Plahvatusohtlik; massiplahvatusoht.

EL
Εκρηκτικό· κίνδυνος μαζικής έκρηξης.


EN
Explosive; mass explosion hazard.

FR
Explosif; danger d'explosion en masse.

GA
Pléascach; guais mhórphléasctha.

IT
Esplosivo; pericolo di esplosione di massa.

LV
Sprādzienbīstams; masveida sprādzienbīstamība.

LT
Sprogios medžiagos, kelia masinio sprogimo pavojų.

HU
Robbanóanyag; teljes tömeg felrobbanásának veszélye.

MT
Splussiv; periklu li jisplodu kollha f'daqqa.

NL
Ontplofbare stof; gevaar voor massa-explosie.

PL
Materiał wybuchowy; zagrożenie wybuchem masowym.

PT
Explosivo; perigo de explosão em massa.

RO
Exploziv; pericol de explozie în masă.

SK
Výbušnina, nebezpečenstvo rozsiahleho výbuchu.

SL
Eksplozivno; nevarnost eksplozije v masi.

FI
Räjähde; massaräjähdysvaara.

SV
Explosivt. Fara för massexplosion.

H202
Language
2.1 — Explosives, Division 1.2

BG
Експлозив; сериозна опасност от разпръскване.

ES
Explosivo; grave peligro de proyección.

CS
Výbušnina; vážné nebezpečí zasažení částicemi.

DA
Eksplosiv, alvorlig fare for udslyngning af fragmenter.

DE
Explosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.

ET
Plahvatusohtlik; suur laialipaiskumisoht.

EL
Εκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.

EN
Explosive, severe projection hazard.

FR
Explosif; danger sérieux de projection.

GA
Pléascach, guais throm teilgin.

IT
Esplosivo; grave pericolo di proiezione.

LV
Sprādzienbīstams; augsta izmetes bīstamība.

LT
Sprogios medžiagos, kelia didelį išsvaidymo pavojų.

HU
Robbanóanyag; kivetés súlyos veszélye.

MT
Splussiv, periklu serju ta' projezzjoni.

NL
Ontplofbare stof, ernstig gevaar voor scherfwerking.

PL
Materiał wybuchowy, poważne zagrożenie rozrzutem.

PT
Explosivo, perigo grave de projecções.

RO
Exploziv; pericol grav de proiectare.

SK
Výbušnina, závažné nebezpečenstvo rozletenia úlomkov.

SL
Eksplozivno, velika nevarnost za nastanek drobcev.

FI
Räjähde; vakava sirpalevaara.

SV
Explosivt. Allvarlig fara för splitter och kaststycken.

H203
Language
2.1 — Explosives, Division 1.3

BG
Експлозив; опасност от пожар, взрив или разпръскване.

ES
Explosivo; peligro de incendio, de onda expansiva o de proyección.

CS
Výbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.

DA
Eksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.

DE
Explosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.

ET
Plahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.

EL
Εκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.

EN
Explosive; fire, blast or projection hazard.

FR
Explosif; danger d'incendie, d'effet de souffle ou de projection.

GA
Pléascach; guais dóiteáin, phléasctha nó teilgin.

IT
Esplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.

LV
Sprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.

LT
Sprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.

HU
Robbanóanyag; tűz, robbanás vagy kivetés veszélye.

MT
Splussiv; periklu ta' nar, blast jew projezzjoni.

NL
Ontplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.

PL
Materiał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.

PT
Explosivo; perigo de incêndio, sopro ou projecções.

RO
Exploziv; pericol de incendiu, detonare sau proiectare.

SK
Výbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.

SL
Eksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.

FI
Räjähde; palo-, räjähdys- tai sirpalevaara.

SV
Explosivt. Fara för brand, tryckvåg eller splitter och kaststycken.

H204
Language
2.1 — Explosives, Division 1.4

BG
Опасност от пожар или разпръскване.

ES
Peligro de incendio o de proyección.

CS
Nebezpečí požáru nebo zasažení částicemi.

DA
Fare for brand eller udslyngning af fragmenter.

DE
Gefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.

ET
Süttimis- või laialipaiskumisoht.

EL
Κίνδυνος πυρκαγιάς ή εκτόξευσης.

EN
Fire or projection hazard.

FR
Danger d'incendie ou de projection.

GA
Guais dóiteáin nó teilgin.

IT
Pericolo di incendio o di proiezione.

LV
Uguns vai izmetes bīstamība.

LT
Gaisro arba išsvaidymo pavojus.

HU
Tűz vagy kivetés veszélye.

MT
Periklu ta' nar jew ta' projezzjoni.

NL
Gevaar voor brand of scherfwerking.

PL
Zagrożenie pożarem lub rozrzutem.

PT
Perigo de incêndio ou projecções.

RO
Pericol de incendiu sau de proiectare.

SK
Nebezpečenstvo požiaru alebo rozletenia úlomkov.

SL
Nevarnost za nastanek požara ali drobcev.

FI
Palo- tai sirpalevaara.

SV
Fara för brand eller splitter och kaststycken.

H205
Language
2.1 — Explosives, Division 1.5

BG
Може да предизвика масова експлозия при пожар.

ES
Peligro de explosión en masa en caso de incendio.

CS
Při požáru může způsobit masivní výbuch.

DA
Fare for masseeksplosion ved brand.

DE
Gefahr der Massenexplosion bei Feuer.

ET
Süttimise korral massiplahvatusoht.

EL
Κίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.

EN
May mass explode in fire.

FR
Danger d'explosion en masse en cas d'incendie.

GA
D'fhéadfadh sé go mbeadh mórphléascadh i dtine.

IT
Pericolo di esplosione di massa in caso d'incendio.

LV
Ugunī var masveidā eksplodēt.

LT
Per gaisrą gali sukelti masinį sprogimą.

HU
Tűz hatására a teljes tömeg felrobbanhat.

MT
Jista' jisplodi f'daqqa fin-nar.

NL
Gevaar voor massa-explosie bij brand.

PL
Może wybuchać masowo w przypadku pożaru.

PT
Perigo de explosão em massa em caso de incêndio.

RO
Pericol de explozie în masă în caz de incendiu.

SK
Nebezpečenstvo rozsiahleho výbuchu pri požiari.

SL
Pri požaru lahko eksplodira v masi.

FI
Koko massa voi räjähtää tulessa.

SV
Fara för massexplosion vid brand.

H220
Language
2.2 — Flammable gases, Hazard Category 1

BG
Изключително запалим газ.

ES
Gas extremadamente inflamable.

CS
Extrémně hořlavý plyn.

DA
Yderst brandfarlig gas.

DE
Extrem entzündbares Gas.

ET
Eriti tuleohtlik gaas.

EL
Εξαιρετικά εύφλεκτο αέριο.

EN
Extremely flammable gas.

FR
Gaz extrêmement inflammable.

GA
Gás fíor-inadhainte.

IT
Gas altamente infiammabile.

LV
Īpaši viegli uzliesmojoša gāze.

LT
Ypač degios dujos.

HU
Rendkívül tűzveszélyes gáz.

MT
Gass li jaqbad malajr ħafna.

NL
Zeer licht ontvlambaar gas.

PL
Skrajnie łatwopalny gaz.

PT
Gás extremamente inflamável.

RO
Gaz extrem de inflamabil.

SK
Mimoriadne horľavý plyn.

SL
Zelo lahko vnetljiv plin.

FI
Erittäin helposti syttyvä kaasu.

SV
Extremt brandfarlig gas.

H221
Language
2.2 — Flammable gases, Hazard Category 2

BG
Запалим газ.

ES
Gas inflamable.

CS
Hořlavý plyn.

DA
Brandfarlig gas.

DE
Entzündbares Gas.

ET
Tuleohtlik gaas.

EL
Εύφλεκτο αέριο.

EN
Flammable gas.

FR
Gaz inflammable.

GA
Gás inadhainte.

IT
Gas infiammabile.

LV
Uzliesmojoša gāze.

LT
Degios dujos.

HU
Tűzveszélyes gáz.

MT
Gass li jaqbad.

NL
Ontvlambaar gas.

PL
Gaz łatwopalny.

PT
Gás inflamável.

RO
Gaz inflamabil.

SK
Horľavý plyn.

SL
Vnetljiv plin.

FI
Syttyvä kaasu.

SV
Brandfarlig gas.

H222
Language
2.3 — Flammable aerosols, Hazard Category 1

BG
Изключително запалим аерозол.

ES
Aerosol extremadamente inflamable.

CS
Extrémně hořlavý aerosol.

DA
Yderst brandfarlig aerosol.

DE
Extrem entzündbares Aerosol.

ET
Eriti tuleohtlik aerosool.

EL
Εξαιρετικά εύφλεκτο αερόλυμα.

EN
Extremely flammable aerosol.

FR
Aérosol extrêmement inflammable.

GA
Aerasól fíor-inadhainte.

IT
Aerosol altamente infiammabile.

LV
Īpaši viegli uzliesmojošs aerosols.

LT
Ypač degus aerozolis.

HU
Rendkívül tűzveszélyes aeroszol.

MT
Aerosol li jaqbad malajr ħafna.

NL
Zeer licht ontvlambare aerosol.

PL
Skrajnie łatwopalny aerozol.

PT
Aerossol extremamente inflamável.

RO
Aerosol extrem de inflamabil.

SK
Mimoriadne horľavý aerosól.

SL
Zelo lahko vnetljiv aerosol.

FI
Erittäin helposti syttyvä aerosoli.

SV
Extremt brandfarlig aerosol.

H223
Language
2.3 — Flammable aerosols, Hazard Category 2

BG
Запалим аерозол.

ES
Aerosol inflamable.

CS
Hořlavý aerosol.

DA
Brandfarlig aerosol.

DE
Entzündbares Aerosol.

ET
Tuleohtlik aerosool.

EL
Εύφλεκτο αερόλυμα.

EN
Flammable aerosol.

FR
Aérosol inflammable.

GA
Aerasól inadhainte.

IT
Aerosol infiammabile.

LV
Uzliesmojošs aerosols.

LT
Degus aerozolis.

HU
Tűzveszélyes aeroszol.

MT
Aerosol li jaqbad.

NL
Ontvlambare aerosol.

PL
Aerozol łatwopalny.

PT
Aerossol inflamável.

RO
Aerosol inflamabil.

SK
Horľavý aerosól.

SL
Vnetljiv aerosol.

FI
Syttyvä aerosoli.

SV
Brandfarlig aerosol.


H224
Language
2.6 — Flammable liquids, Hazard Category 1

BG
Изключително запалими течност и пари.

ES
Líquido y vapores extremadamente inflamables.

CS
Extrémně hořlavá kapalina a páry.

DA
Yderst brandfarlig væske og damp.

DE
Flüssigkeit und Dampf extrem entzündbar.

ET
Eriti tuleohtlik vedelik ja aur.

EL
Υγρό και ατμοί εξαιρετικά εύφλεκτα.

EN
Extremely flammable liquid and vapour.

FR
Liquide et vapeurs extrêmement inflammables.

GA
Leacht fíor-inadhainte agus gal fhíor-inadhainte.

IT
Liquido e vapori altamente infiammabili.

LV
Īpaši viegli uzliesmojošs šķidrums un tvaiki.

LT
Ypač degūs skystis ir garai.

HU
Rendkívül tűzveszélyes folyadék és gőz.

MT
Likwidu u fwar li jaqbdu malajr ħafna.

NL
Zeer licht ontvlambare vloeistof en damp.

PL
Skrajnie łatwopalna ciecz i pary.

PT
Líquido e vapor extremamente inflamáveis.

RO
Lichid și vapori extrem de inflamabili.

SK
Mimoriadne horľavá kvapalina a pary.

SL
Zelo lahko vnetljiva tekočina in hlapi.

FI
Erittäin helposti syttyvä neste ja höyry.

SV
Extremt brandfarlig vätska och ånga.

H225
Language
2.6 — Flammable liquids, Hazard Category 2

BG
Силно запалими течност и пари.

ES
Líquido y vapores muy inflamables.

CS
Vysoce hořlavá kapalina a páry.

DA
Meget brandfarlig væske og damp.

DE
Flüssigkeit und Dampf leicht entzündbar.

ET
Väga tuleohtlik vedelik ja aur.

EL
Υγρό και ατμοί πολύ εύφλεκτα.

EN
Highly flammable liquid and vapour.

FR
Liquide et vapeurs très inflammables.

GA
Leacht an-inadhainte agus gal an-inadhainte.

IT
Liquido e vapori facilmente infiammabili.

LV
Viegli uzliesmojošs šķidrums un tvaiki.

LT
Labai degūs skystis ir garai.

HU
Fokozottan tűzveszélyes folyadék és gőz.

MT
Likwidu u fwar li jaqbdu malajr ħafna.

NL
Licht ontvlambare vloeistof en damp.

PL
Wysoce łatwopalna ciecz i pary.

PT
Líquido e vapor facilmente inflamáveis.

RO
Lichid și vapori foarte inflamabili.

SK
Veľmi horľavá kvapalina a pary.

SL
Lahko vnetljiva tekočina in hlapi.

FI
Helposti syttyvä neste ja höyry.

SV
Mycket brandfarlig vätska och ånga.

H226
Language
2.6 — Flammable liquids, Hazard Category 3

BG
Запалими течност и пари.

ES
Líquidos y vapores inflamables.

CS
Hořlavá kapalina a páry.

DA
Brandfarlig væske og damp.

DE
Flüssigkeit und Dampf entzündbar.

ET
Tuleohtlik vedelik ja aur.

EL
Υγρό και ατμοί εύφλεκτα.

EN
Flammable liquid and vapour.

FR
Liquide et vapeurs inflammables.

GA
Leacht inadhainte agus gal inadhainte.

IT
Liquido e vapori infiammabili.

LV
Uzliesmojošs šķidrums un tvaiki.

LT
Degūs skystis ir garai.

HU
Tűzveszélyes folyadék és gőz.

MT
Likwidu u fwar li jaqbdu.

NL
Ontvlambare vloeistof en damp.

PL
Łatwopalna ciecz i pary.

PT
Líquido e vapor inflamáveis.

RO
Lichid și vapori inflamabili.

SK
Horľavá kvapalina a pary.

SL
Vnetljiva tekočina in hlapi.

FI
Syttyvä neste ja höyry.

SV
Brandfarlig vätska och ånga.

H228
Language
2.7 — Flammable solids, Hazard Category 1, 2

BG
Запалимо твърдо вещество.

ES
Sólido inflamable.

CS
Hořlavá tuhá látka.

DA
Brandfarligt fast stof.

DE
Entzündbarer Feststoff.

ET
Tuleohtlik tahke aine.

EL
Εύφλεκτο στερεό.

EN
Flammable solid.

FR
Matière solide inflammable.

GA
Solad inadhainte.

IT
Solido infiammabile.

LV
Uzliesmojoša cieta viela.

LT
Degi kietoji medžiaga.

HU
Tűzveszélyes szilárd anyag.

MT
Solidu li jaqbad.

NL
Ontvlambare vaste stof.

PL
Substancja stała łatwopalna.

PT
Sólido inflamável.

RO
Solid inflamabil.

SK
Horľavá tuhá látka.

SL
Vnetljiva trdna snov.

FI
Syttyvä kiinteä aine.

SV
Brandfarligt fast ämne.

H240
Language
2.8 — Self-Reactive Substances and Mixtures, Type A
2.1.5 — Organic Peroxides, Type A

BG
Може да предизвика експлозия при нагряване.

ES
Peligro de explosión en caso de calentamiento.

CS
Zahřívání může způsobit výbuch.

DA
Eksplosionsfare ved opvarmning.

DE
Erwärmung kann Explosion verursachen.

ET
Kuumenemisel võib plahvatada.

EL
Η θέρμανση μπορεί να προκαλέσει έκρηξη.

EN
Heating may cause an explosion.

FR
Peut exploser sous l'effet de la chaleur.

GA
D'fhéadfadh téamh a bheith ina chúis le pléascadh.

IT
Rischio di esplosione per riscaldamento.

LV
Sakaršana var izraisīt eksploziju.

LT
Kaitinant gali sprogti.

HU
Hő hatására robbanhat.

MT
It-tisħin jista' jikkawża splużjoni.

NL
Ontploffingsgevaar bij verwarming.

PL
Ogrzanie grozi wybuchem.

PT
Risco de explosão sob a acção do calor.

RO
Pericol de explozie în caz de încălzire.

SK
Zahrievanie môže spôsobiť výbuch.

SL
Segrevanje lahko povzroči eksplozijo.

FI
Räjähdysvaarallinen kuumennettaessa.

SV
Explosivt vid uppvärmning.

H241
Language
2.8 — Self-Reactive Substances and Mixtures, Type B
2.1.5 — Organic Peroxides, Type B

BG
Може да предизвика пожар или експлозия при нагряване.

ES
Peligro de incendio o explosión en caso de calentamiento.

CS
Zahřívání může způsobit požár nebo výbuch.

DA
Brand- eller eksplosionsfare ved opvarmning.

DE
Erwärmung kann Brand oder Explosion verursachen.

ET
Kuumenemisel võib süttida või plahvatada.

EL
Η θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.

EN
Heating may cause a fire or explosion.

FR
Peut s'enflammer ou exploser sous l'effet de la chaleur.

GA
D'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.

IT
Rischio d'incendio o di esplosione per riscaldamento.

LV
Sakaršana var izraisīt degšanu vai eksploziju.

LT
Kaitinant gali sukelti gaisrą arba sprogti.

HU
Hő hatására meggyulladhat vagy robbanhat.

MT
It-tisħin jista' jikkawża nar jew splużjoni.

NL
Brand- of ontploffingsgevaar bij verwarming.

PL
Ogrzanie może spowodować pożar lub wybuch.

PT
Risco de explosão ou de incêndio sob a acção do calor.

RO
Pericol de incendiu sau de explozie în caz de încălzire.

SK
Zahrievanie môže spôsobiť požiar alebo výbuch.

SL
Segrevanje lahko povzroči požar ali eksplozijo.

FI
Räjähdys- tai palovaarallinen kuumennettaessa.

SV
Brandfarligt eller explosivt vid uppvärmning.


H242
Language
2.8 — Self-Reactive Substances and Mixtures, Types C, D, E, F
2.1.5 — Organic Peroxides, Types C, D, E, F

BG
Може да предизвика пожар при нагряване.

ES
Peligro de incendio en caso de calentamiento.

CS
Zahřívání může způsobit požár.

DA
Brandfare ved opvarmning.

DE
Erwärmung kann Brand verursachen.

ET
Kuumenemisel võib süttida.

EL
Η θέρμανση μπορεί να προκαλέσει πυρκαγιά.

EN
Heating may cause a fire.

FR
Peut s'enflammer sous l'effet de la chaleur.

GA
D'fhéadfadh téamh a bheith ina chúis le dóiteán.

IT
Rischio d'incendio per riscaldamento.

LV
Sakaršana var izraisīt degšanu.

LT
Kaitinant gali sukelti gaisrą.

HU
Hő hatására meggyulladhat.

MT
It-tisħin jista' jikkawża nar.

NL
Brandgevaar bij verwarming.

PL
Ogrzanie może spowodować pożar.

PT
Risco de incêndio sob a acção do calor.

RO
Pericol de incendiu în caz de încălzire.

SK
Zahrievanie môže spôsobiť požiar.

SL
Segrevanje lahko povzroči požar.

FI
Palovaarallinen kuumennettaessa.

SV
Brandfarligt vid uppvärmning.

H250
Language
2.9 — Pyrophoric Liquids, Hazard Category 1
2.10 — Pyorphoric Solids, Hazard Category 1

BG
Самозапалва се при контакт с въздух.

ES
Se inflama espontáneamente en contacto con el aire.

CS
Při styku se vzduchem se samovolně vznítí.

DA
Selvantænder ved kontakt med luft.

DE
Entzündet sich in Berührung mit Luft von selbst.

ET
Kokkupuutel õhuga süttib iseenesest.

EL
Αυταναφλέγεται εάν εκτεθεί στον αέρα.

EN
Catches fire spontaneously if exposed to air.

FR
S'enflamme spontanément au contact de l'air.

GA
Téann trí thine go spontáineach má nochtar don aer.

IT
Spontaneamente infiammabile all'aria.

LV
Spontāni aizdegas saskarē ar gaisu.

LT
Veikiami oro savaime užsidega.

HU
Levegővel érintkezve önmagától meggyullad.

MT
Jieħu n-nar spontanjament jekk ikun espost għall-arja.

NL
Vat spontaan vlam bij blootstelling aan lucht.

PL
Zapala się samorzutnie w przypadku wystawienia na działanie powietrza.

PT
Risco de inflamação espontânea em contacto com o ar.

RO
Se aprinde spontan, în contact cu aerul.

SK
Pri kontakte so vzduchuom sa spontánne vznieti.

SL
Samodejno se vžge na zraku.

FI
Syttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.

SV
Spontanantänder vid kontakt med luft.

H251
Language
2.11 — Self-Heating Substances and Mixtures, Hazard Category 1

BG
Самонагряващо се: може да се запали.

ES
Se calienta espontáneamente; puede inflamarse.

CS
Samovolně se zahřívá: může se vznítit.

DA
Selvopvarmende, kan selvantænde.

DE
Selbsterhitzungsfähig; kann in Brand geraten.

ET
Isekuumenev, võib süttida.

EL
Αυτοθερμαίνεται: μπορεί να αναφλεγεί.

EN
Self-heating: may catch fire.

FR
Matière auto-échauffante; peut s'enflammer.

GA
Féintéamh: d'fhéadfadh sé dul trí thine.

IT
Autoriscaldante; può infiammarsi.

LV
Pašsasilstošs; var aizdegties.

LT
Savaime kaistančios, gali užsidegti.

HU
Önmelegedő: meggyulladhat.

MT
Jisħon waħdu: jista' jieħu n-nar.

NL
Vatbaar voor zelfverhitting: kan vlam vatten.

PL
Substancja samonagrzewająca się: może się zapalić.

PT
Susceptível de auto-aquecimento: risco de inflamação.

RO
Se autoîncălzește, pericol de aprindere.

SK
Samovoľne sa zahrieva; môže sa vznietiť.

SL
Samosegrevanje: lahko povzroči požar.

FI
Itsestään kuumeneva; voi syttyä palamaan.

SV
Självupphettande. Kan börja brinna.

H252
Language
2.11 — Self-Heating Substances and Mixtures, Hazard Category 2

BG
Самонагряващо се в големи количества; може да се запали.

ES
Se calienta espontáneamente en grandes cantidades; puede inflamarse.

CS
Ve velkém množství se samovolně zahřívá; může se vznítit.

DA
Selvopvarmende i store mængder, kan selvantænde.

DE
In großen Mengen selbsterhitzungsfähig; kann in Brand geraten.

ET
Suurtes kogustes isekuumenev, võib süttida.

EL
Σε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.

EN
Self-heating in large quantities; may catch fire.

FR
Matière auto-échauffante en grandes quantités; peut s'enflammer.

GA
Féintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.

IT
Autoriscaldante in grandi quantità; può infiammarsi.

LV
Lielos apjomos pašsasilstošs; var aizdegties.

LT
Laikant dideliais kiekiais savaime kaista, gali užsidegti.

HU
Nagy mennyiségben önmelegedő; meggyulladhat.

MT
Jisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.

NL
In grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.

PL
Substancja samonagrzewająca się w dużych ilościach; może się zapalić.

PT
Susceptível de auto-aquecimento em grandes quantidades: risco de inflamação.

RO
Se autoîncălzește, în cantități mari pericol de aprindere.

SK
Vo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.

SL
Samosegrevanje v velikih količinah; lahko povzroči požar.

FI
Suurina määrinä itsestään kuumeneva; voi syttyä palamaan.

SV
Självupphettande i stora mängder. Kan börja brinna.


H260
Language
2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1

BG
При контакт с вода отделя запалими газове, които могат да се самозапалят.

ES
En contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.

CS
Při styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.

DA
Ved kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.

DE
In Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.

ET
Kokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.

EL
Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.

EN
In contact with water releases flammable gases which may ignite spontaneously.

FR
Dégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.

GA
I dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.

IT
A contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.

LV
Nonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.

LT
Kontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.

HU
Vízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.

MT
Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.

NL
In contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.

PL
W kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.

PT
Em contacto com a água liberta gases que se podem inflamar espontaneamente.

RO
În contact cu apa degajă gaze inflamabile care se pot aprinde spontan.

SK
Pri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.

SL
V stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.

FI
Kehittää itsestään syttyviä kaasuja veden kanssa.

SV
Vid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.


H261
Language
2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2

BG
При контакт с вода отделя запалими газове.

ES
En contacto con el agua desprende gases inflamables.

CS
Při styku s vodou uvolňuje hořlavé plyny.

DA
Ved kontakt med vand udvikles brandfarlige gasser.

DE
In Berührung mit Wasser entstehen entzündbare Gase.

ET
Kokkupuutel veega eraldab tuleohtlikke gaase.

EL
Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.

EN
In contact with water releases flammable gases.

FR
Dégage au contact de l'eau des gaz inflammables.

GA
I dteagmháil le huisce scaoiltear gáis inadhainte.

IT
A contatto con l'acqua libera gas infiammabili.

LV
Nonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.

LT
Kontaktuodami su vandeniu išskiria degias dujas

HU
Vízzel érintkezve tűzveszélyes gázokat bocsát ki.

MT
Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.

NL
In contact met water komen ontvlambare gassen vrij.

PL
W kontakcie z wodą uwalnia łatwopalne gazy.

PT
Em contacto com a água liberta gases inflamáveis.

RO
În contact cu apa degajă gaze inflamabile.

SK
Pri kontakte s vodou uvoľňuje horľavé plyny.

SL
V stiku z vodo se sproščajo vnetljivi plini.

FI
Kehittää syttyviä kaasuja veden kanssa.

SV
Vid kontakt med vatten utvecklas brandfarliga gaser.


H270
Language
2.4 — Oxidising Gases, Hazard Category 1

BG
Може да предивзика или усили пожар; окислител.

ES
Puede provocar o agravar un incendio; comburente.

CS
Může způsobit nebo zesílit požár; oxidant.

DA
Kan forårsage eller forstærke brand, brandnærende.

DE
Kann Brand verursachen oder verstärken; Oxidationsmittel.

ET
Võib põhjustada süttimise või soodustada põlemist; oksüdeerija.

EL
Μπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.

EN
May cause or intensify fire; oxidiser.

FR
Peut provoquer ou aggraver un incendie; comburant.

GA
D'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.

IT
Può provocare o aggravare un incendio; comburente.

LV
Var izraisīt vai pastiprināt degšanu, oksidētājs.

LT
Gali sukelti arba padidinti gaisrą, oksidatorius.

HU
Tüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.

MT
Jista' jikkawża jew iżid in-nar; ossidant.

NL
Kan brand veroorzaken of bevorderen; oxiderend.

PL
Może spowodować lub intensyfikować pożar; utleniacz.

PT
Pode provocar ou agravar incêndios; comburente.

RO
Poate provoca sau agrava un incendiu; oxidant.

SK
Môže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.

SL
Lahko povzroči ali okrepi požar; oksidativna snov.

FI
Aiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.

SV
Kan orsaka eller intensifiera brand. Oxiderande.

H271
Language
2.13 — Oxidising Liquids, Hazard Category 1
2.14 — Oxidising Solids, Hazard Category 1

BG
Може да предизвика пожар или експлозия; силен окислител.

ES
Puede provocar un incendio o una explosión; muy comburente.

CS
Může způsobit požár nebo výbuch; silný oxidant.

DA
Kan forårsage brand eller eksplosion, stærkt brandnærende.

DE
Kann Brand oder Explosion verursachen; starkes Oxidationsmittel.

ET
Võib põhjustada süttimise või plahvatuse; tugev oksüdeerija.

EL
Μπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.

EN
May cause fire or explosion; strong oxidiser.

FR
Peut provoquer un incendie ou une explosion; comburant puissant.

GA
D'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.

IT
Può provocare un incendio o un'esplosione; molto comburente.

LV
Var izraisīt degšanu vai eksploziju, oksidētājs.

LT
Gali sukelti gaisrą arba sprogimą, stiprus oksidatorius.

HU
Tüzet vagy robbanást okozhat; erősen oxidáló hatású.

MT
Jista' jikkawża nar jew splużjoni; ossidant qawwi.

NL
Kan brand of ontploffingen veroorzaken; sterk oxiderend.

PL
Może spowodować pożar lub wybuch; silny utleniacz.

PT
Risco de incêndio ou de explosão; muito comburente.

RO
Poate provoca un incendiu sau o explozie; oxidant puternic.

SK
Môže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.

SL
Lahko povzroči požar ali eksplozijo; močna oksidativna snov.

FI
Aiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.

SV
Kan orsaka brand eller explosion. Starkt oxiderande.

H272
Language
2.13 — Oxidising Liquids, Hazard Category 2, 3
2.14 — Oxidising Solids, Hazard Category 2, 3

BG
Може да усили пожара; окислител.

ES
Puede agravar un incendio; comburente.

CS
Může zesílit požár; oxidant.

DA
Kan forstærke brand, brandnærende.

DE
Kann Brand verstärken; Oxidationsmittel.

ET
Võib soodustada põlemist; oksüdeerija.

EL
Μπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.

EN
May intensify fire; oxidiser.

FR
Peut aggraver un incendie; comburant.

GA
D'fhéadfadh sé cur le tine; ocsaídeoir.

IT
Può aggravare un incendio; comburente.

LV
Var pastiprināt degšanu; oksidētājs.

LT
Gali padidinti gaisrą, oksidatorius.

HU
Fokozhatja a tűz intenzitását; oxidáló hatású.

MT
Jista' jżid in-nar; ossidant.

NL
Kan brand bevorderen; oxiderend.

PL
Może intensyfikować pożar; utleniacz.

PT
Pode agravar incêndios; comburente.

RO
Poate agrava un incendiu; oxidant.

SK
Môže prispieť k rozvoju požiaru; oxidačné činidlo.

SL
Lahko okrepi požar; oksidativna snov.

FI
Voi edistää tulipaloa; hapettava.

SV
Kan intensifiera brand. Oxiderande.

H280
Language
2.5 —  Gases under pressure:
Compressed gas
Liquefied gas
Dissolved gas

BG
Съдържа газ под налягане; може да експлодира при нагряване.

ES
Contiene gas a presión; peligro de explosión en caso de calentamiento.

CS
Obsahuje plyn pod tlakem; při zahřívání může vybuchnout.

DA
Indeholder gas under tryk, kan eksplodere ved opvarmning.

DE
Enthält Gas unter Druck; kann bei Erwärmung explodieren.

ET
Sisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.

EL
Περιέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.

EN
Contains gas under pressure; may explode if heated.

FR
Contient un gaz sous pression; peut exploser sous l'effet de la chaleur.

GA
Gás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.

IT
Contiene gas sotto pressione; può esplodere se riscaldato.

LV
Satur gāzi zem spiediena; karstumā var eksplodēt.

LT
Turi slėgio veikiamų dujų, kaitinant gali sprogti.

HU
Nyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.

MT
Fih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.

NL
Bevat gas onder druk; kan ontploffen bij verwarming.

PL
Zawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.

PT
Contém gás sob pressão; risco de explosão sob a acção do calor.

RO
Conține un gaz sub presiune; pericol de explozie în caz de încălzire.

SK
Obsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.

SL
Vsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.

FI
Sisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.

SV
Innehåller gas under tryck. Kan explodera vid uppvärmning.

H281
Language
2.5 — Gases under pressure: Refrigerated liquefied gas

BG
Съдържа охладен газ; може да причини криогенни изгаряния или наранявания.

ES
Contiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.

CS
Obsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.

DA
Indeholder nedkølet gas, kan forårsage kuldeskader.

DE
Enthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.

ET
Sisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.

EL
Περιέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.

EN
Contains refrigerated gas; may cause cryogenic burns or injury.

FR
Contient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.

GA
Gás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.

IT
Contiene gas refrigerato; può provocare ustioni o lesioni criogeniche.

LV
Satur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.

LT
Turi atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.

HU
Mélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.

MT
Fih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.

NL
Bevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.

PL
Zawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.

PT
Contém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.

RO
Conține un gaz răcit; poate cauza arsuri sau leziuni criogenice.

SK
Obsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.

SL
Vsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.

FI
Sisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.

SV
Innehåller kyld gas. Kan orsaka svåra köldskador.

H290
Language
2.16 — Corrosive to metals, Hazard Category 1

BG
Може да бъде корозивно за металите.

ES
Puede ser corrosivo para los metales.

CS
Může být korozivní pro kovy.

DA
Kan ætse metaller.

DE
Kann gegenüber Metallen korrosiv sein.

ET
Võib söövitada metalle.

EL
Μπορεί να διαβρώσει μέταλλα.

EN
May be corrosive to metals.

FR
Peut être corrosif pour les métaux.

GA
D'fhéadfadh sé a bheith creimneach do mhiotail.

IT
Può essere corrosivo per i metalli.

LV
Var kodīgi iedarboties uz metāliem.

LT
Gali ėsdinti metalus.

HU
Fémekre korrozív hatású lehet.

MT
Jista' jkun korrużiv għall-metalli.

NL
Kan bijtend zijn voor metalen.

PL
Może powodować korozję metali.

PT
Pode ser corrosivo para os metais.

RO
Poate fi corosiv pentru metale.

SK
Môže byť korozívna pre kovy.

SL
Lahko je jedko za kovine.

FI
Voi syövyttää metalleja.

SV
Kan vara korrosivt för metaller.


Table 1.2
Hazard statements for health hazards

H300
Language
3.1 — Acute toxicity (oral), Hazard Category 1, 2

BG
Смъртоносeн при поглъщане.

ES
Mortal en caso de ingestión.

CS
Při požití může způsobit smrt.

DA
Livsfarlig ved indtagelse.

DE
Lebensgefahr bei Verschlucken.

ET
Allaneelamisel surmav.

EL
Θανατηφόρο σε περίπτωση κατάποσης.

EN
Fatal if swallowed.

FR
Mortel en cas d'ingestion.

GA
Marfach má shlogtar.

IT
Letale se ingerito.

LV
Norijot iestājas nāve.

LT
Mirtina prarijus.

HU
Lenyelve halálos.

MT
Fatali jekk jinbela’.

NL
Dodelijk bij inslikken.

PL
Połknięcie grozi śmiercią.

PT
Mortal por ingestão.

RO
Mortal în caz de înghițire.

SK
Smrteľný po požití.

SL
Smrtno pri zaužitju.

FI
Tappavaa nieltynä.

SV
Dödligt vid förtäring.

H301
Language
3.1 — Acute toxicity (oral), Hazard Category 3

BG
Токсичен при поглъщане.

ES
Tóxico en caso de ingestión.

CS
Toxický při požití.

DA
Giftig ved indtagelse.

DE
Giftig bei Verschlucken.

ET
Allaneelamisel mürgine.

EL
Τοξικό σε περίπτωση κατάποσης.

EN
Toxic if swallowed.

FR
Toxique en cas d'ingestion.

GA
Tocsaineach má shlogtar.

IT
Tossico se ingerito.

LV
Toksisks, ja norij.

LT
Toksiška prarijus.

HU
Lenyelve mérgező.

MT
Tossiku jekk jinbela’.

NL
Giftig bij inslikken.

PL
Działa toksycznie po połknięciu.

PT
Tóxico por ingestão.

RO
Toxic în caz de înghițire.

SK
Toxický po požití.

SL
Strupeno pri zaužitju.

FI
Myrkyllistä nieltynä.

SV
Giftigt vid förtäring.

H302
Language
3.1 — Acute toxicity (oral), Hazard Category 4

BG
Вреден при поглъщане.

ES
Nocivo en caso de ingestión.

CS
Zdraví škodlivý při požití.

DA
Farlig ved indtagelse.

DE
Gesundheitsschädlich bei Verschlucken.

ET
Allaneelamisel kahjulik.

EL
Επιβλαβές σε περίπτωση κατάποσης.

EN
Harmful if swallowed.

FR
Nocif en cas d'ingestion.

GA
Díobhálach má shlogtar.

IT
Nocivo se ingerito.

LV
Kaitīgs, ja norij.

LT
Kenksminga prarijus.

HU
Lenyelve ártalmas.

MT
Jagħmel il-ħsara jekk jinbela’.

NL
Schadelijk bij inslikken.

PL
Działa szkodliwie po połknięciu.

PT
Nocivo por ingestão.

RO
Nociv în caz de înghițire.

SK
Škodlivý po požití.

SL
Zdravju škodljivo pri zaužitju.

FI
Haitallista nieltynä.

SV
Skadligt vid förtäring.

H304
Language
3.10 — Aspiration hazard, Hazard Category 1

BG
Може да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.

ES
Puede ser mortal en caso de ingestión y penetración en las vías respiratorias.

CS
Při požití a vniknutí do dýchacích cest může způsobit smrt.

DA
Kan være livsfarligt, hvis det indtages og kommer i luftvejene.

DE
Kann bei Verschlucken und Eindringen in die Atemwege tödlich sein.

ET
Allaneelamisel või hingamisteedesse sattumisel võib olla surmav.

EL
Μπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.

EN
May be fatal if swallowed and enters airways.

FR
Peut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.

GA
D'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.

HU
Lenyelve és a légutakba kerülve halálos lehet.

IT
Può essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.

LV
Var izraisīt nāvi, ja norij vai iekļūst elpceļos.

LT
Prarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.

MT
Jista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.

NL
Kan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.

PL
Połknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.

PT
Pode ser mortal por ingestão e penetração nas vias respiratórias.

RO
Poate fi mortal în caz de înghițire și de pătrundere în căile respiratorii.

SK
Môže byť smrteľný po požití a vniknutí do dýchacích ciest.

SL
Pri zaužitju in vstopu v dihalne poti je lahko smrtno.

FI
Voi olla tappavaa nieltynä ja joutuessaan hengitysteihin.

SV
Kan vara dödligt vid förtäring om det kommer ner i luftvägarna.

H310
Language
3.1 — Acute toxicity (dermal), Hazard Category 1, 2

BG
Смъртоносeн при контакт с кожата.

ES
Mortal en contacto con la piel.

CS
Při styku s kůží může způsobit smrt.

DA
Livsfarlig ved hudkontakt.

DE
Lebensgefahr bei Hautkontakt.

ET
Nahale sattumisel surmav.

EL
Θανατηφόρο σε επαφή με το δέρμα.

EN
Fatal in contact with skin.

FR
Mortel par contact cutané.

GA
Marfach i dteagmháil leis an gcraiceann.

HU
Bőrrel érintkezve halálos.

IT
Letale per contatto con la pelle.

LV
Nonākot saskarē ar ādu, iestājas nāve.

LT
Mirtina susilietus su oda.

MT
Fatali jekk imiss mal-ġilda.

NL
Dodelijk bij contact met de huid.

PL
Grozi śmiercią w kontacie ze skórą.

PT
Mortal em contacto com a pele.

RO
Mortal în contact cu pielea.

SK
Smrteľný pri kontakte s pokožkou.

SL
Smrtno v stiku s kožo.

FI
Tappavaa joutuessaan iholle.

SV
Dödligt vid hudkontakt.

H311
Language
3.1 — Acute toxicity (dermal), Hazard Category 3

BG
Токсичен при контакт с кожата.

ES
Tóxico en contacto con la piel.

CS
Toxický při styku s kůží.

DA
Giftig ved hudkontakt.

DE
Giftig bei Hautkontakt.

ET
Nahale sattumisel mürgine.

EL
Τοξικό σε επαφή με το δέρμα.

EN
Toxic in contact with skin.

FR
Toxique par contact cutané.

GA
Tocsaineach i dteagmháil leis an gcraiceann.

IT
Tossico per contatto con la pelle.

LV
Toksisks, ja nonāk saskarē ar ādu.

LT
Toksiška susilietus su oda.

HU
Bőrrel érintkezve mérgező.

MT
Tossiku meta jmiss mal-ġilda.

NL
Giftig bij contact met de huid.

PL
Działa toksycznie w kontakcie ze skórą.

PT
Tóxico em contacto com a pele.

RO
Toxic în contact cu pielea.

SK
Toxický pri kontakte s pokožkou.

SL
Strupeno v stiku s kožo.

FI
Myrkyllistä joutuessaan iholle.

SV
Giftigt vid hudkontakt.


H312
Language
3.1 — Acute toxicity (dermal), Hazard Category 4

BG
Вреден при контакт с кожата.

ES
Nocivo en contacto con la piel.

CS
Zdraví škodlivý při styku s kůží.

DA
Farlig ved hudkontakt.

DE
Gesundheitsschädlich bei Hautkontakt.

ET
Nahale sattumisel kahjulik.

EL
Επιβλαβές σε επαφή με το δέρμα.

EN
Harmful in contact with skin.

FR
Nocif par contact cutané.

GA
Díobhálach i dteagmháil leis an gcraiceann.

IT
Nocivo per contatto con la pelle.

LV
Kaitīgs, ja nonāk saskarē ar ādu.

LT
Kenksminga susilietus su oda.

HU
Bőrrel érintkezve ártalmas.

MT
Jagħmel il-ħsara meta jmiss mal-ġilda.

NL
Schadelijk bij contact met de huid.

PL
Działa szkodliwie w kontakcie ze skórą.

PT
Nocivo em contacto com a pele.

RO
Nociv în contact cu pielea.

SK
Škodlivý pri kontakte s pokožkou.

SL
Zdravju škodljivo v stiku s kožo.

FI
Haitallista joutuessaan iholle.

SV
Skadligt vid hudkontakt.

H314
Language
3.2 — Skin corrosion/irritation, Hazard Category 1A, 1B, 1C

BG
Причинява тежки изгаряния на кожата и сериозно увреждане на очите.

ES
Provoca quemaduras graves en la piel y lesiones oculares graves.

CS
Způsobuje těžké poleptání kůže a poškození očí.

DA
Forårsager svære forbrændinger af huden og øjenskader.

DE
Verursacht schwere Verätzungen der Haut und schwere Augenschäden.

ET
Põhjustab rasket nahasöövitust ja silmakahjustusi.

EL
Προκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.

EN
Causes severe skin burns and eye damage.

FR
Provoque des brûlures de la peau et des lésions oculaires graves.

GA
Ina chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.

IT
Provoca gravi ustioni cutanee e gravi lesioni oculari.

LV
Izraisa smagus ādas apdegumus un acu bojājumus.

LT
Smarkiai nudegina odą ir pažeidžia akis.

HU
Súlyos égési sérülést és szemkárosodást okoz.

MT
Jagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.

NL
Veroorzaakt ernstige brandwonden en oogletsel.

PL
Powoduje poważne oparzenia skóry oraz uszkodzenia oczu.

PT
Provoca queimaduras na pele e lesões oculares graves.

RO
Provoacă arsuri grave ale pielii și lezarea ochilor.

SK
Spôsobuje vážne poleptanie kože a poškodenie očí.

SL
Povzroča hude opekline kože in poškodbe oči.

FI
Voimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.

SV
Orsakar allvarliga frätskador på hud och ögon.

H315
Language
3.2 — Skin corrosion/irritation, Hazard Category 2

BG
Предизвиква дразнене на кожата.

ES
Provoca irritación cutánea.

CS
Dráždí kůži.

DA
Forårsager hudirritation.

DE
Verursacht Hautreizungen.

ET
Põhjustab nahaärritust.

EL
Προκαλεί ερεθισμό του δέρματος.

EN
Causes skin irritation.

FR
Provoque une irritation cutanée.

GA
Ina chúis le greannú craicinn.

IT
Provoca irritazione cutanea.

LV
Kairina ādu.

LT
Dirgina odą.

HU
Bőrirritáló hatású.

MT
Jagħmel irritazzjoni tal-ġilda.

NL
Veroorzaakt huidirritatie.

PL
Działa drażniąco na skórę.

PT
Provoca irritação cutânea.

RO
Provoacă iritarea pielii.

SK
Dráždi kožu.

SL
Povzroča draženje kože.

FI
Ärsyttää ihoa.

SV
Irriterar huden.


H317
Language
3.4 — Sensitisation — Skin, Hazard Category 1

BG
Може да причини алергична кожна реакция.

ES
Puede provocar una reacción alérgica en la piel.

CS
Může vyvolat alergickou kožní reakci.

DA
Kan forårsage allergisk hudreaktion.

DE
Kann allergische Hautreaktionen verursachen.

ET
Võib põhjustada allergilist nahareaktsiooni.

EL
Μπορεί να προκαλέσει αλλεργική δερματική αντίδραση.

EN
May cause an allergic skin reaction.

FR
Peut provoquer une allergie cutanée.

GA
D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.

IT
Può provocare una reazione allergica cutanea.

LV
Var izraisīt alerģisku ādas reakciju.

LT
Gali sukelti alerginę odos reakciją.

HU
Allergiás bőrreakciót válthat ki.

MT
Jista’ jikkawża reazzjoni allerġika tal-ġilda.

NL
Kan een allergische huidreactie veroorzaken.

PL
Może powodować reakcję alergiczną skóry.

PT
Pode provocar uma reacção alérgica cutânea.

RO
Poate provoca o reacție alergică a pielii.

SK
Môže vyvolať alergickú kožnú reakciu.

SL
Lahko povzroči alergijski odziv kože.

FI
Voi aiheuttaa allergisen ihoreaktion.

SV
Kan orsaka allergisk hudreaktion.

H318
Language
3.3 — Serious eye damage/eye irritation, Hazard Category 1

BG
Предизвиква сериозно увреждане на очите.

ES
Provoca lesiones oculares graves.

CS
Způsobuje vážné poškození očí.

DA
Forårsager alvorlig øjenskade.

DE
Verursacht schwere Augenschäden.

ET
Põhjustab raskeid silmakahjustusi.

EL
Προκαλεί σοβαρή οφθαλμική βλάβη.

EN
Causes serious eye damage.

FR
Provoque des lésions oculaires graves.

GA
Ina chúis le damáiste tromchúiseach don tsúil.

IT
Provoca gravi lesioni oculari.

LV
Izraisa nopietnus acu bojājumus.

LT
Smarkiai pažeidžia akis.

HU
Súlyos szemkárosodást okoz.

MT
Jagħmel ħsara serja lill-għajnejn.

NL
Veroorzaakt ernstig oogletsel.

PL
Powoduje poważne uszkodzenie oczu.

PT
Provoca lesões oculares graves.

RO
Provoacă leziuni oculare grave.

SK
Spôsobuje vážne poškodenie očí.

SL
Povzroča hude poškodbe oči.

FI
Vaurioittaa vakavasti silmiä.

SV
Orsakar allvarliga ögonskador.

H319
Language
3.3 — Serious eye damage/eye irritation, Hazard Category 2

BG
Предизвиква сериозно дразнене на очите.

ES
Provoca irritación ocular grave.

CS
Způsobuje vážné podráždění očí.

DA
Forårsager alvorlig øjenirritation.

DE
Verursacht schwere Augenreizung.

ET
Põhjustab tugevat silmade ärritust.

EL
Προκαλεί σοβαρό οφθαλμικό ερεθισμό.

EN
Causes serious eye irritation.

FR
Provoque une sévère irritation des yeux.

GA
Ina chúis le greannú tromchúiseach don tsúil.

IT
Provoca grave irritazione oculare.

LV
Izraisa nopietnu acu kairinājumu.

LT
Sukelia smarkų akių dirginimą.

HU
Súlyos szemirritációt okoz.

MT
Jagħmel irritazzjoni serja lill-għajnejn.

NL
Veroorzaakt ernstige oogirritatie.

PL
Działa drażniąco na oczy.

PT
Provoca irritação ocular grave.

RO
Provoacă o iritare gravă a ochilor.

SK
Spôsobuje vážne podráždenie očí.

SL
Povzroča hudo draženje oči.

FI
Ärsyttää voimakkaasti silmiä.

SV
Orsakar allvarlig ögonirritation.

H330
Language
3.1 — Acute toxicity (inhal.), Hazard Category 1, 2

BG
Смъртоносен при вдишване.

ES
Mortal en caso de inhalación.

CS
Při vdechování může způsobit smrt.

DA
Livsfarlig ved indånding.

DE
Lebensgefahr bei Einatmen.

ET
Sissehingamisel surmav.

EL
Θανατηφόρο σε περίπτωση εισπνοής.

EN
Fatal if inhaled.

FR
Mortel par inhalation.

GA
Marfach má ionanálaítear.

IT
Letale se inalato.

LV
Ieelpojot, iestājas nāve.

LT
Mirtina įkvėpus.

HU
Belélegezve halálos.

MT
Fatali jekk jinxtamm.

NL
Dodelijk bij inademing.

PL
Wdychanie grozi śmiercią.

PT
Mortal por inalação.

RO
Mortal în caz de inhalare.

SK
Smrteľný pri vdýchnutí.

SL
Smrtno pri vdihavanju.

FI
Tappavaa hengitettynä.

SV
Dödligt vid inandning.

H331
Language
3.1 — Acute toxicity (inhal.), Hazard Category 3

BG
Токсичен при вдишване.

ES
Tóxico en caso de inhalación.

CS
Toxický při vdechování.

DA
Giftig ved indånding.

DE
Giftig bei Einatmen.

ET
Sissehingamisel mürgine.

EL
Τοξικό σε περίπτωση εισπνοής.

EN
Toxic if inhaled.

FR
Toxique par inhalation.

GA
Tocsaineach má ionanálaítear.

IT
Tossico se inalato.

LV
Toksisks ieelpojot.

LT
Toksiška įkvėpus.

HU
Belélegezve mérgező.

MT
Tossiku jekk jinxtamm.

NL
Giftig bij inademing.

PL
Działa toksycznie w następstwie wdychania.

PT
Tóxico por inalação.

RO
Toxic în caz de inhalare.

SK
Toxický pri vdýchnutí.

SL
Strupeno pri vdihavanju.

FI
Myrkyllistä hengitettynä.

SV
Giftigt vid inandning.


H332
Language
3.1 — Acute toxicity (inhal.), Hazard Category 4

BG
Вреден при вдишване.

ES
Nocivo en caso de inhalación.

CS
Zdraví škodlivý při vdechování.

DA
Farlig ved indånding.

DE
Gesundheitsschädlich bei Einatmen.

ET
Sissehingamisel kahjulik.

EL
Επιβλαβές σε περίπτωση εισπνοής.

EN
Harmful if inhaled.

FR
Nocif par inhalation.

GA
Díobhálach má ionanálaítear.

IT
Nocivo se inalato.

LV
Kaitīgs ieelpojot.

LT
Kenksminga įkvėpus.

HU
Belélegezve ártalmas.

MT
Jagħmel il-ħsara jekk jinxtamm.

NL
Schadelijk bij inademing.

PL
Działa szkodliwie w następstwie wdychania.

PT
Nocivo por inalação.

RO
Nociv în caz de inhalare.

SK
Škodlivý pri vdýchnutí.

SL
Zdravju škodljivo pri vdihavanju.

FI
Haitallista hengitettynä.

SV
Skadligt vid inandning.

H334
Language
3.4 — Sensitisation — Respirat., Hazard Category 1

BG
Може да причини алергични или астматични симптоми или затруднения в дишането при вдишване.

ES
Puede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.

CS
Při vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.

DA
Kan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.

DE
Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.

ET
Sissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.

EL
Μπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.

EN
May cause allergy or asthma symptoms or breathing difficulties if inhaled.

FR
Peut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.

GA
D'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.

IT
Può provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.

LV
Ja ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.

LT
Įkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.

HU
Belélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.

MT
Jista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.

NL
Kan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.

PL
Może powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.

PT
Quando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.

RO
Poate provoca simptome de alergie sau astm sau dificultăți de respirație în caz de inhalare.

SK
Pri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.

SL
Lahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.

FI
Voi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.

SV
Kan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.

H335
Language
3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation

BG
Може да предизвика дразнене на дихателните пътища.

ES
Puede irritar las vías respiratorias.

CS
Může způsobit podráždění dýchacích cest.

DA
Kan forårsage irritation af luftvejene.

DE
Kann die Atemwege reizen.

ET
Võib põhjustada hingamisteede ärritust.

EL
Μπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.

EN
May cause respiratory irritation.

FR
Peut irriter les voies respiratoires.

GA
D'fhéadfadh sé a bheith ina chúis le greannú riospráide.

IT
Può irritare le vie respiratorie.

LV
Var izraisīt elpceļu kairinājumu.

LT
Gali dirginti kvėpavimo takus.

HU
Légúti irritációt okozhat.

MT
Jista’ jikkawża irritazzjoni respiratorja.

NL
Kan irritatie van de luchtwegen veroorzaken.

PL
Może powodować podrażnienie dróg oddechowych.

PT
Pode provocar irritação das vias respiratórias.

RO
Poate provoca iritarea căilor respiratorii.

SK
Môže spôsobiť podráždenie dýchacích ciest.

SL
Lahko povzroči draženje dihalnih poti.

FI
Saattaa aiheuttaa hengitysteiden ärsytystä.

SV
Kan orsaka irritation i luftvägarna.

H336
Language
3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis

BG
Може да предизвика сънливост или световъртеж.

ES
Puede provocar somnolencia o vértigo.

CS
Může způsobit ospalost nebo závratě.

DA
Kan forårsage sløvhed eller svimmelhed.

DE
Kann Schläfrigkeit und Benommenheit verursachen.

ET
Võib põhjustada unisust või peapööritust.

EL
Μπορεί να προκαλέσει υπνηλία ή ζάλη.

EN
May cause drowsiness or dizziness.

FR
Peut provoquer somnolence ou vertiges.

GA
D'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.

IT
Può provocare sonnolenza o vertigini.

LV
Var izraisīt miegainību vai reiboņus.

LT
Gali sukelti mieguistumą arba galvos svaigimą.

HU
Álmosságot vagy szédülést okozhat.

MT
Jista’ jikkawża ħedla jew sturdament.

NL
Kan slaperigheid of duizeligheid veroorzaken.

PL
Może wywoływać uczucie senności lub zawroty głowy.

PT
Pode provocar sonolência ou vertigens.

RO
Poate provoca somnolență sau amețeală.

SK
Môže spôsobiť ospalosť alebo závraty.

SL
Lahko povzroči zaspanost ali omotico.

FI
Saattaa aiheuttaa uneliaisuutta ja huimausta.

SV
Kan göra att man blir dåsig eller omtöcknad.


H340
Language
3.5 — Germ cell mutagenicity, Hazard Category 1A, 1B

BG
Може да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Puede provocar defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía >.

CS
Může vyvolat genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Kan forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Võib põhjustada geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Μπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.

EN
May cause genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Peut induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
D'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Può provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Genetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Jista’ jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Kan genetische schade veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Może powodować wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.

PT
Pode provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Poate provoca anomalii genetice <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Môže spôsobovať genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Lahko povzroči genetske okvare <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Saattaa aiheuttaa perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Kan orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H341
Language
3.5 — Germ cell mutagenicity, Hazard Category 2

BG
Предполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Se sospecha que provoca defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Podezření na genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Mistænkt for at forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann vermutlich genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Arvatavasti põhjustab geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Ύποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
Suspected of causing genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Susceptible d'induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
Ceaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Sospettato di provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Ir aizdomas, ka var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Įtariama, kad gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Feltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Suspettat li jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Verdacht van het veroorzaken van genetische schade <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Podejrzewa się, że powoduje wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.

PT
Suspeito de provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Susceptibil de a provoca anomalii genetice < indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Podozrenie, že spôsobuje genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Sum povzročitve genetskih okvar <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Epäillään aiheuttavan perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Misstänks kunna orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H350
Language
3.6 — Carcinogenicity, Hazard Category 1A, 1B

BG
Може да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Puede provocar cáncer <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Může vyvolat rakovinu <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Kan fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Võib põhjustada vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Μπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
May cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Peut provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
D'fhéadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Può provocare il cancro<indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Gali sukelti vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Rákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Jista’ jikkawża l-kanċer <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Kan kanker veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>

PL
Może powodować raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.

PT
Pode provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Poate provoca cancer <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Môže spôsobiť rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Lahko povzroči raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Saattaa aiheuttaa syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Kan orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H351
Language
3.6 — Carcinogenicity, Hazard Category 2

BG
Предполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Se sospecha que provoca cáncer <indíquese la vía de exposición si se se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Podezření na vyvolání rakoviny <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Mistænkt for at fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann vermutlich Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Arvatavasti põhjustab vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Ύποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the hazard>.

FR
Susceptible de provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
Ceaptar go bhféadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Sospettato di provocare il cancro <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Ir aizdomas, ka var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Įtariama, kad sukelia vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Feltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Suspettat li jikkawża l-kanċer <ara l-mod ta’ espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.

NL
Verdacht van het veroorzaken van kanker <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Podejrzewa się, że powoduje raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.

PT
Suspeito de provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Susceptibil de a provoca cancer <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Podozrenie, že spôsobuje rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Sum povzročitve raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Epäillään aiheuttavan syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Misstänks kunna orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H360
Language
3.7 — Reproductive toxicity, Hazard Category 1A, 1B

BG
Може да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Puede perjudicar la fertilidad o dañar al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Může poškodit reprodukční schopnost nebo plod v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Kan skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen <konkrete Wirkung angeben, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Võib kahjustada viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Μπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
May damage fertility or the unborn child <state specific effect if known > <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Peut nuire à la fertilité ou au fœtus <indiquer l'effet spécifique s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
D'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Può nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto><indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Gali pakenkti vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Károsíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Jista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Kan de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Może działać szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Pode afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Poate dăuna fertilității sau fătului <indicați efectul specific, dacă este cunoscut><indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Môže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Lahko škoduje plodnosti ali nerojenemu otroku <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Saattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Kan skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H361
Language
3.7 — Reproductive toxicity, Hazard Category 2

BG
Предполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Se sospecha que perjudica la fertilidad o daña al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Podezření na poškození reprodukční schopnosti nebo plodu v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Mistænkt for at skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>

ET
Arvatavasti kahjustab viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Ύποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
Suspected of damaging fertility or the unborn child <state specific effect if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Susceptible de nuire à la fertilité ou au fœtus <indiquer l'effet s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
Ceaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Sospettato di nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Ir aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Įtariama, kad kenkia vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Feltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Suspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.

NL
Kan mogelijks de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Podejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Suspeito de afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Susceptibil de a dăuna fertilității sau fătului <indicați efectul specific, dacă este cunoscut><indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Podozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Sum škodljivosti za plodnost ali nerojenega otroka <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Epäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Misstänks kunna skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H362
Language
3.7 — Reproductive toxicity, Additional category, Effects on or via lactation

BG
Може да бъде вреден за кърмачета.

ES
Puede perjudicar a los niños alimentados con leche materna.

CS
Může poškodit kojence prostřednictvím mateřského mléka.

DA
Kan skade børn, der ammes.

DE
Kann Säuglinge über die Muttermilch schädigen.

ET
Võib kahjustada rinnaga toidetavat last.

EL
Μπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.

EN
May cause harm to breast-fed children.

FR
Peut être nocif pour les bébés nourris au lait maternel.

GA
D'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.

IT
Può essere nocivo per i lattanti allattati al seno.

LV
Var radīt kaitējumu ar krūti barotam bērnam.

LT
Gali pakenkti žindomam vaikui.

HU
A szoptatott gyermeket károsíthatja.

MT
Jista’ jagħmel ħsara lit-tfal imreddgħa.

NL
Kan schadelijk zijn via borstvoeding.

PL
Może działać szkodliwie na dzieci karmione piersią.

PT
Pode ser nocivo para as crianças alimentadas com leite materno.

RO
Poate dăuna copiilor alăptați la sân.

SK
Môže spôsobiť poškodenie u dojčených detí.

SL
Lahko škoduje dojenim otrokom.

FI
Saattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.

SV
Kan skada spädbarn som ammas.

H370
Language
3.8 — Specific target organ toxicity — single exposure, Hazard Category 1

BG
Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Provoca daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Schädigt die Organe <oder alle betroffenen Organe nennen, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.

EN
Causes damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Risque avéré d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
Déanann sé damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Rada orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Jagħmel ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Powoduje uszkodzenie narządów <podać szczególny skutek, jeśli jest znany> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Provoacă leziuni ale organelor <sau indicați toate organele afectate, dacă sunt cunoscute> <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H371
Language
3.8 — Specific target organ toxicity — Single exposure, Hazard Category 2

BG
Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Puede provocar daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann die Organe schädigen <oder alle betroffenen Organe nennen, sofern bekann> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
May cause damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
D'fhéadfadh damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Károsíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.

MT
Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta'’ espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Poate provoca leziuni ale organelor <sau indicați toate organele afectate, dacă sunt cunoscute> <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H372
Language
3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 1

BG
Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Provoca daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Schädigt die Organe <alle betroffenen Organe nennen> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.

EN
Causes damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Risque avéré d'effets graves pour les organes <indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
Déanann damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Izraisa orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinoma>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.

MT
Jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Powoduje uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub powtarzane narażenie <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Provoacă leziuni ale organelor <sau indicați toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.

SV
Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H373
Language
3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 2

BG
Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.

ES
Puede provocar daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.

CS
Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.

DA
Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.

DE
Kann die Organe schädigen <alle betroffenen Organe nennen, sofern bekannt> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.

ET
Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.

EL
Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.

EN
May cause damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.

FR
Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.

GA
D'fhéadfadh sé damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.

IT
Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.

LV
Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.

LT
Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.

HU
Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.

MT
Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.

NL
Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.

PL
Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub narażenie powtarzane <podać drogę narażenia, jeśli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.

PT
Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.

RO
Poate provoca leziuni ale organelor <sau indicați toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.

SK
Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.

SL
Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.

FI
Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>

SV
Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

Table 1.3
Hazard statements for environmental hazards

H400
Language
4.1 — Hazardous to the aquatic environment — AcuteHazard, Category 1

BG
Силно токсичен за водните организми.

ES
Muy tóxico para los organismos acuáticos.

CS
Vysoce toxický pro vodní organismy.

DA
Meget giftig for vandlevende organismer.

DE
Sehr giftig für Wasserorganismen.

ET
Väga mürgine veeorganismidele.

EL
Πολύ τοξικό για τους υδρόβιους οργανισμούς.

EN
Very toxic to aquatic life.

FR
Très toxique pour les organismes aquatiques.

GA
An-tocsaineach don saol uisceach.

IT
Molto tossico per gli organismi acquatici.

LV
Ļoti toksisks ūdens organismiem.

LT
Labai toksiška vandens organizmams.

HU
Nagyon mérgező a vízi élővilágra.

MT
Tossiku ħafna għall-organiżmi akwatiċi.

NL
Zeer giftig voor in het water levende organismen.

PL
Działa bardzo toksycznie na organizmy wodne.

PT
Muito tóxico para os organismos aquáticos.

RO
Foarte toxic pentru mediul acvatic.

SK
Veľmi toxický pre vodné organizmy.

SL
Zelo strupeno za vodne organizme.

FI
Erittäin myrkyllistä vesieliöille.

SV
Mycket giftigt för vattenlevande organismer.

H410
Language
4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 1

BG
Силно токсичен за водните организми, с дълготраен ефект.

ES
Muy tóxico para los organismos acuáticos, con efectos nocivos duraderos.

CS
Vysoce toxický pro vodní organismy, s dlouhodobými účinky.

DA
Meget giftig med langvarige virkninger for vandlevende organismer.

DE
Sehr giftig für Wasserorganismen mit langfristiger Wirkung.

ET
Väga mürgine veeorganismidele, pikaajaline toime.

EL
Πολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.

EN
Very toxic to aquatic life with long lasting effects.

FR
Très toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.

GA
An-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.

IT
Molto tossico per gli organismi acquatici con effetti di lunga durata.

LV
Ļoti toksisks ūdens organismiem ar ilgstošām sekām.

LT
Labai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.

HU
Nagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.

MT
Tossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.

NL
Zeer giftig voor in het water levende organismen, met langdurige gevolgen.

PL
Działa bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.

PT
Muito tóxico para os organismos aquáticos com efeitos duradouros.

RO
Foarte toxic pentru mediul acvatic cu efecte pe termen lung.

SK
Veľmi toxický pre vodné organizmy, s dlhodobými účinkami.

SL
Zelo strupeno za vodne organizme, z dolgotrajnimi učinki.

FI
Erittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.

SV
Mycket giftigt för vattenlevande organismer med långtidseffekter.

H411
Language
4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 2

BG
Токсичен за водните организми, с дълготраен ефект.

ES
Tóxico para los organismos acuáticos, con efectos nocivos duraderos.

CS
Toxický pro vodní organismy, s dlouhodobými účinky.

DA
Giftig for vandlevende organismer, med langvarige virkninger.

DE
Giftig für Wasserorganismen, mit langfristiger Wirkung.

ET
Mürgine veeorganismidele, pikaajaline toime.

EL
Τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.

EN
Toxic to aquatic life with long lasting effects.

FR
Toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.

GA
Tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.

IT
Tossico per gli organismi acquatici con effetti di lunga durata.

LV
Toksisks ūdens organismiem ar ilgstošām sekām.

LT
Toksiška vandens organizmams, sukelia ilgalaikius pakitimus.

HU
Mérgező a vízi élővilágra, hosszan tartó károsodást okoz.

MT
Tossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.

NL
Giftig voor in het water levende organismen, met langdurige gevolgen.

PL
Działa toksycznie na organizmy wodne, powodując długotrwałe skutki.

PT
Tóxico para os organismos aquáticos com efeitos duradouros.

RO
Toxic pentru mediul acvatic cu efecte pe termen lung.

SK
Toxický pre vodné organizmy, s dlhodobými účinkami.

SL
Strupeno za vodne organizme, z dolgotrajnimi učinki.

FI
Myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.

SV
Giftigt för vattenlevande organismer med långtidseffekter.

H412
Language
4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 3

BG
Вреден за водните организми, с дълготраен ефект.

ES
Nocivo para los organismos acuáticos, con efectos nocivos duraderos.

CS
Škodlivý pro vodní organismy, s dlouhodobými účinky.

DA
Skadelig for vandlevende organismer, med langvarige virkninger.

DE
Schädlich für Wasserorganismen, mit langfristiger Wirkung.

ET
Ohtlik veeorganismidele, pikaajaline toime.

EL
Επιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.

EN
Harmful to aquatic life with long lasting effects.

FR
Nocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.

GA
Díobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.

IT
Nocivo per gli organismi acquatici con effetti di lunga durata.

LV
Kaitīgs ūdens organismiem ar ilgstošām sekām.

LT
Kenksminga vandens organizmams, sukelia ilgalaikius pakitimus.

HU
Ártalmas a vízi élővilágra, hosszan tartó károsodást okoz.

MT
Jagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.

NL
Schadelijk voor in het water levende organismen, met langdurige gevolgen.

PL
Działa szkodliwie na organizmy wodne, powodując długotrwałe skutki.

PT
Nocivo para os organismos aquáticos com efeitos duradouros.

RO
Nociv pentru mediul acvatic cu efecte pe termen lung.

SK
Škodlivý pre vodné organizmy, s dlhodobými účinkami.

SL
Škodljivo za vodne organizme, z dolgotrajnimi učinki.

FI
Haitallista vesieliöille, pitkäaikaisia haittavaikutuksia.

SV
Skadliga långtidseffekter för vattenlevande organismer.

H413
Language
4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 4

BG
Може да причини дълготраен вреден ефект за водните организми.

ES
Puede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.

CS
Může vyvolat dlouhodobé škodlivé účinky pro vodní organismy.

DA
Kan forårsage langvarige skadelige virkninger for vandlevende organismer.

DE
Kann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.

ET
Võib avaldada veeorganismidele pikaajalist kahjulikku toimet.

EL
Μπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.

EN
May cause long lasting harmful effects to aquatic life.

FR
Peut être nocif à long terme pour les organismes aquatiques.

GA
D'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.

IT
Può essere nocivo per gli organismi acquatici con effetti di lunga durata.

LV
Var radīt ilgstošas kaitīgas sekas ūdens organismiem.

LT
Gali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.

HU
Hosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.

MT
Jista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.

NL
Kan langdurige schadelijke gevolgen voor in het water levende organismen hebben.

PL
Może powodować długotrwałe szkodliwe skutki dla organizmów wodnych.

PT
Pode provocar efeitos nocivos duradouros nos organismos aquáticos.

RO
Poate provoca efecte nocive pe termen lung asupra mediului acvatic.

SK
Môže mať dlhodobé škodlivé účinky na vodné organizmy.

SL
Lahko ima dolgotrajne škodljive učinke na vodne organizme.

FI
Voi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.

SV
Kan ge skadliga långtidseffekter på vattenlevande organismer.



2. Part 2: supplemental hazard information

Table 2.1
Physical properties

EUH 001
Language


BG
Експлозивен в сухо състояние.

ES
Explosivo en estado seco.

CS
Výbušný v suchém stavu.

DA
Eksplosiv i tør tilstand.

DE
In trockenem Zustand explosionsgefährlich.

ET
Plahvatusohtlik kuivana.

EL
Εκρηκτικό σε ξηρή κατάσταση.

EN
Explosive when dry.

FR
Explosif à l'état sec.

GA
Pléascach agus é tirim.

IT
Esplosivo allo stato secco.

LV
Sprādzienbīstams sausā veidā.

LT
Sausos būsenos gali sprogti.

HU
Száraz állapotban robbanásveszélyes.

MT
Jisplodi meta jinxef.

NL
In droge toestand ontplofbaar.

PL
Produkt wybuchowy w stanie suchym.

PT
Explosivo no estado seco.

RO
Exploziv în stare uscată.

SK
V suchom stave výbušný.

SL
Eksplozivno v suhem stanju.

FI
Räjähtävää kuivana.

SV
Explosivt i torrt tillstånd.

EUH 006
Language


BG
Експлозивен при или без контакт с въздуха.

ES
Explosivo en contacto o sin contacto con el aire.

CS
Výbušný za přístupu i bez přístupu vzduchu.

DA
Eksplosiv ved og uden kontakt med luft.

DE
Mit und ohne Luft explosionsfähig.

ET
Plahvatusohtlik õhuga kokkupuutel või kokkupuuteta.

EL
Εκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.

EN
Explosive with or without contact with air.

FR
Danger d'explosion en contact ou sans contact avec l'air.

GA
Pléascach i dteagmháil le haer nó gan é.

IT
Esplosivo a contatto o senza contatto con l'aria.

LV
Sprādzienbīstams gaisa un bezgaisa vidē.

LT
Gali sprogti ore arba beorėje erdvėje.

HU
Levegővel érintkezve vagy anélkül is robbanásveszélyes.

MT
Jista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.

NL
Ontplofbaar met en zonder lucht.

PL
Produkt wybuchowy z dostępem lub bez dostępu powietrza.

PT
Perigo de explosão com ou sem contacto com o ar.

RO
Exploziv în contact sau fără contactul cu aerul.

SK
Výbušné pri kontakte alebo bez kontaktu so vzduchom.

SL
Eksplozivno v stiku z zrakom ali brez stika z zrakom.

FI
Räjähtävää sellaisenaan tai ilman kanssa.

SV
Explosivt vid eller utan kontakt med luft.

EUH 014
Language


BG
Реагира бурно с вода.

ES
Reacciona violentamente con el agua.

CS
Prudce reaguje s vodou.

DA
Reagerer voldsomt med vand.

DE
Reagiert heftig mit Wasser.

ET
Reageerib ägedalt veega.

EL
Αντιδρά βίαια με νερό.

EN
Reacts violently with water.

FR
Réagit violemment au contact de l'eau.

GA
Imoibríonn go foirtil le huisce.

IT
Reagisce violentemente con l'acqua.

LV
Aktīvi reaģē ar ūdeni.

LT
Smarkiai reaguoja su vandeniu.

HU
Vízzel hevesen reagál.

MT
Jirreaġixxi bil-qawwa meta jmiss l-ilma.

NL
Reageert heftig met water.

PL
Reaguje gwałtownie z wodą.

PT
Reage violentamente em contacto com a água.

RO
Reacționează violent în contact cu apa.

SK
Prudko reaguje s vodou.

SL
Burno reagira z vodo.

FI
Reagoi voimakkaasti veden kanssa.

SV
Reagerar häftigt med vatten.


EUH 018
Language


BG
При употреба може да се образува запалима/експлозивна паровъздушнa смес.

ES
Al usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.

CS
Při používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.

DA
Ved brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.

DE
Kann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.

ET
Kasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.

EL
Κατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.

EN
In use may form flammable/explosive vapour-air mixture.

FR
Lors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.

GA
Agus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.

IT
Durante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.

LV
Izmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.

LT
Naudojama gali sudaryti degius (sprogius) garų-oro mišinius.

HU
A használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.

MT
Meta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.

NL
Kan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.

PL
Podczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.

PT
Pode formar mistura vapor-ar explosiva/inflamável durante a utilização.

RO
În timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.

SK
Pri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.

SL
Pri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.

FI
Käytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.

SV
Vid användning kan brännbara/explosiva ång-luftblandningar bildas.


EUH 019
Language


BG
Може да образува експлозивни пероксиди.

ES
Puede formar peróxidos explosivos.

CS
Může vytvářet výbušné peroxidy.

DA
Kan danne eksplosive peroxider.

DE
Kann explosionsfähige Peroxide bilden.

ET
Võib moodustada plahvatusohtlikke peroksiide.

EL
Μπορεί να σχηματίσει εκρηκτικά υπεροξείδια.

EN
May form explosive peroxides.

FR
Peut former des peroxydes explosifs.

GA
D'fhéadfadh sé sárocsaídí pléascacha a chruthú.

IT
Può formare perossidi esplosivi.

LV
Var veidot sprādzienbīstamus peroksīdus.

LT
Gali sudaryti sprogius peroksidus.

HU
Robbanásveszélyes peroxidokat képezhet.

MT
Jista' jifforma perossidi esplussivi.

NL
Kan ontplofbare peroxiden vormen.

PL
Może tworzyć wybuchowe nadtlenki.

PT
Pode formar peróxidos explosivos.

RO
Poate forma peroxizi explozivi.

SK
Môže vytvárat’ výbušné peroxidy.

SL
Lahko tvori eksplozivne perokside.

FI
Saattaa muodostaa räjähtäviä peroksideja.

SV
Kan bilda explosiva peroxider.

EUH 044
Language


BG
Риск от експлозия при нагряване в затворено пространство.

ES
Riesgo de explosión al calentarlo en ambiente confinado.

CS
Nebezpečí výbuchu při zahřátí v uzavřeném obalu.

DA
Eksplosionsfarlig ved opvarmning under indeslutning.

DE
Explosionsgefahr bei Erhitzen unter Einschluss.

ET
Plahvatusohtlik kuumutamisel kinnises mahutis.

EL
Κίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.

EN
Risk of explosion if heated under confinement.

FR
Risque d'explosion si chauffé en ambiance confinée.

GA
Baol pléasctha arna théamh i limistéar iata.

IT
Rischio di esplosione per riscaldamento in ambiente confinato.

LV
Sprādziena draudi, karsējot slēgtā vidē.

LT
Gali sprogti, jei kaitinama sandariai uždaryta.

HU
Zárt térben hő hatására robbanhat.

MT
Riskju ta' splużjoni jekk jissaħħan fil-magħluq.

NL
Ontploffingsgevaar bij verwarming in afgesloten toestand.

PL
Zagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.

PT
Risco de explosão se aquecido em ambiente fechado.

RO
Risc de explozie, dacă este încălzit în spațiu închis.

SK
Riziko výbuchu pri zahrievaní v uzavretom priestore.

SL
Nevarnost eksplozije ob segrevanju v zaprtem prostoru.

FI
Räjähdysvaara kuumennettaessa suljetussa astiassa.

SV
Explosionsrisk vid uppvärmning i sluten behållare.

Table 2.2
Health properties

EUH 029
Language


BG
При контакт с вода се отделя токсичен газ.

ES
En contacto con agua libera gases tóxicos.

CS
Uvolňuje toxický plyn při styku s vodou.

DA
Udvikler giftig gas ved kontakt med vand.

DE
Entwickelt bei Berührung mit Wasser giftige Gase.

ET
Kokkupuutel veega eraldub mürgine gaas.

EL
Σε επαφή με το νερό ελευθερώνονται τοξικά αέρια.

EN
Contact with water liberates toxic gas.

FR
Au contact de l'eau, dégage des gaz toxiques.

GA
I dteagmháil le huisce scaoiltear gás tocsaineach.

IT
A contatto con l'acqua libera un gas tossico.

LV
Saskaroties ar ūdeni, izdala toksiskas gāzes.

LT
Kontaktuodama su vandeniu išskiria toksiškas dujas.

HU
Vízzel érintkezve mérgező gázok képződnek.

MT
Jitfa' gass tossiku meta jmiss l-ilma.

NL
Vormt giftig gas in contact met water.

PL
W kontakcie z wodą uwalnia toksyczne gazy.

PT
Em contacto com a água liberta gases tóxicos.

RO
În contact cu apa, degajă un gaz toxic.

SK
Pri kontakte s vodou uvoľňuje toxický plyn.

SL
V stiku z vodo se sprošča strupen plin.

FI
Kehittää myrkyllistä kaasua veden kanssa.

SV
Utvecklar giftig gas vid kontakt med vatten.

EUH 031
Language


BG
При контакт с киселини се отделя токсичен газ.

ES
En contacto con ácidos libera gases tóxicos.

CS
Uvolňuje toxický plyn při styku s kyselinami.

DA
Udvikler giftig gas ved kontakt med syre.

DE
Entwickelt bei Berührung mit Säure giftige Gase.

ET
Kokkupuutel hapetega eraldub mürgine gaas.

EL
Σε επαφή με οξέα ελευθερώνονται τοξικά αέρια.

EN
Contact with acids liberates toxic gas.

FR
Au contact d'un acide, dégage un gaz toxique.

GA
I dteagmháil le haigéid scaoiltear gás tocsaineach.

IT
A contatto con acidi libera gas tossici.

LV
Saskaroties ar skābēm, izdala toksiskas gāzes.

LT
Kontaktuodama su rūgštimis išskiria toksiškas dujas.

HU
Savval érintkezve mérgező gázok képződnek.

MT
Jitfa' gass tossiku meta jmiss l-aċidi.

NL
Vormt giftig gas in contact met zuren.

PL
W kontakcie z kwasami uwalnia toksyczne gazy.

PT
Em contacto com ácidos liberta gases tóxicos.

RO
În contact cu acizi, degajă un gaz toxic.

SK
Pri kontakte s kyselinami uvoľňuje toxický plyn.

SL
V stiku s kislinami se sprošča strupen plin.

FI
Kehittää myrkyllistä kaasua hapon kanssa.

SV
Utvecklar giftig gas vid kontakt med syra.


EUH 032
Language


BG
При контакт с киселини се отделя силно токсичен газ.

ES
En contacto con ácidos libera gases muy tóxicos.

CS
Uvolňuje vysoce toxický plyn při styku s kyselinami.

DA
Udvikler meget giftig gas ved kontakt med syre.

DE
Entwickelt bei Berührung mit Säure sehr giftige Gase.

ET
Kokkupuutel hapetega eraldub väga mürgine gaas.

EL
Σε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.

EN
Contact with acids liberates very toxic gas.

FR
Au contact d'un acide, dégage un gaz très toxique.

GA
I dteagmháil le haigéid scaoiltear gás an-tocsaineach.

IT
A contatto con acidi libera gas molto tossici.

LV
Saskaroties ar skābēm, izdala ļoti toksiskas gāzes.

LT
Kontaktuodama su rūgštimis išskiria labai toksiškas dujas.

HU
Savval érintkezve nagyon mérgező gázok képződnek.

MT
Jitfa' gass tossiku ħafna meta jmiss l-aċidi.

NL
Vormt zeer giftig gas in contact met zuren.

PL
W kontakcie z kwasami uwalnia bardzo toksyczne gazy.

PT
Em contacto com ácidos liberta gases muito tóxicos.

RO
În contact cu acizi, degajă un gaz foarte toxic.

SK
Pri kontakte s kyselinami uvoľňuje veľmi toxický plyn.

SL
V stiku s kislinami se sprošča zelo strupen plin.

FI
Kehittää erittäin myrkyllistä kaasua hapon kanssa.

SV
Utvecklar mycket giftig gas vid kontakt med syra.

EUH 066
Language


BG
Повтарящата се експозиция може да предизвика изсушаване или напукване на кожата.

ES
La exposición repetida puede provocar sequedad o formación de grietas en la piel.

CS
Opakovaná expozice může způsobit vysušení nebo popraskání kůže.

DA
Gentagen kontakt kan give tør eller revnet hud.

DE
Wiederholter Kontakt kann zu spröder oder rissiger Haut führen.

ET
Korduv kokkupuude võib põhjustada naha kuivust või lõhenemist.

EL
Παρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.

EN
Repeated exposure may cause skin dryness or cracking.

FR
L'exposition répétée peut provoquer dessèchement ou gerçures de la peau.

GA
D'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.

IT
L'esposizione ripetuta può provocare secchezza o screpolature della pelle.

LV
Atkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.

LT
Pakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.

HU
Ismétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.

MT
Espożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.

NL
Herhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.

PL
Powtarzające się narażenie może powodować wysuszanie lub pękanie skóry.

PT
Pode provocar pele seca ou gretada, por exposição repetida.

RO
Expunerea repetată poate provoca uscarea sau crăparea pielii.

SK
Opakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.

SL
Ponavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.

FI
Toistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.

SV
Upprepad kontakt kan ge torr hud eller hudsprickor.

EUH 070
Language


BG
Токсично при контакт с очите.

ES
Tóxico en contacto con los ojos.

CS
Toxický při styku s očima.

DA
Giftig ved kontakt med øjnene.

DE
Giftig bei Berührung mit den Augen.

ET
Silma sattumisel mürgine.

EL
Τοξικό σε επαφή με τα μάτια.

EN
Toxic by eye contact.

FR
Toxique par contact oculaire.

GA
Tocsaineach trí theagmháil leis an tsúil.

IT
Tossico per contatto oculare.

LV
Toksisks saskarē ar acīm.

LT
Toksiška patekus į akis.

HU
Szembe kerülve mérgező.

MT
Tossiku meta jmiss ma’ l-għajnejn.

NL
Giftig bij oogcontact.

PL
Działa toksycznie w kontakcie z oczami.

PT
Tóxico por contacto com os olhos.

RO
Toxic în caz de contact cu ochii.

SK
Toxické pri kontakte s očami.

SL
Strupeno ob stiku z očmi.

FI
Myrkyllistä joutuessaan silmään.

SV
Giftigt vid kontakt med ögonen.

EUH 071
Language


BG
Корозивен за дихателните пътища.

ES
Corrosivo para las vías respiratorias.

CS
Způsobuje poleptání dýchacích cest.

DA
Ætsende for luftvejene.

DE
Wirkt ätzend auf die Atemwege.

ET
Söövitav hingamisteedele.

EL
Διαβρωτικό της αναπνευστικής οδού.

EN
Corrosive to the respiratory tract.

FR
Corrosif pour les voies respiratoires.

GA
Creimneach don chonair riospráide.

IT
Corrosivo per le vie respiratorie.

LV
Kodīgs elpceļiem.

LT
Ėsdina kvėpavimo takus.

HU
Maró hatású a légutakra.

MT
Korrużiv għas-sistema respiratorja.

NL
Bijtend voor de luchtwegen.

PL
Działa żrąco na drogi oddechowe.

PT
Corrosivo para as vias respiratórias.

RO
Corosiv pentru căile respiratorii.

SK
Žieravé pre dýchacie cesty.

SL
Jedko za dihalne poti.

FI
Hengityselimiä syövyttävää.

SV
Frätande på luftvägarna.

Table 2.3
Environmental properties

EUH 059
Language
Additional EU Hazard Class

BG
Опасно за озоновия слой.

ES
Peligroso para la capa de ozono.

CS
Nebezpečný pro ozonovou vrstvu.

DA
Farlig for ozonlaget.

DE
Die Ozonschicht schädigend.

ET
Ohtlik osoonikihile.

EL
Επικίνδυνο για τη στιβάδα του όζοντος.

EN
Hazardous to the ozone layer.

FR
Dangereux pour la couche d'ozone.

GA
Guaiseach don chiseal ózóin.

IT
Pericoloso per lo strato di ozono.

LV
Bīstams ozona slānim.

LT
Pavojinga ozono sluoksniui.

HU
Veszélyes az ózonrétegre.

MT
Perikoluż għas-saff ta' l-ożonu.

NL
Gevaarlijk voor de ozonlaag.

PL
Stwarza zagrożenie dla warstwy ozonowej.

PT
Perigoso para a camada de ozono.

RO
Periculos pentru stratul de ozon.

SK
Nebezpečný pre ozónovú vrstvu.

SL
Nevarno za ozonski plašč.

FI
Vaarallista otsonikerrokselle.

SV
Farligt för ozonskiktet.


3. Part 3: supplemental label elements/information on certain substances and mixtures

EUH 201/ 201A
Language

201
201A
BG
Съдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.
Внимание! Съдържа олово.
201
201A
ES
Contiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.
¡Atención! Contiene plomo.
201
201A
CS
Obsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.
Pozor! Obsahuje olovo.
201
201A
DA
Indeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.
Advarsel! Indeholder bly.
201
201A
DE
Enthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.
Achtung! Enthält Blei.
201
201A
ET
Sisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.
Ettevaatust! Sisaldab pliid.
201
201A
EL
Περιέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.
Προσοχή! Περιέχει μόλυβδο.
201
201A
EN
Contains lead. Should not be used on surfaces liable to be chewed or sucked by children.
Warning! Contains lead.
201
201A
FR
Contient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.
Attention! Contient du plomb.
201
201A
GA
Luaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.
Rabhadh! Luaidhe ann.
201
201A
IT
Contiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.
Attenzione! Contiene piombo.
201
201A
LV
Satur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.
Brīdinājums! Satur svinu.
201
201A
LT
Sudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.
Atsargiai! Sudėtyje yra švino.
201
201A
HU
Ólmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.
Figyelem! Ólmot tartalmaz.
201
201A
MT
Fih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.
Twissija! Fih iċ-ċomb.
201
201A
NL
Bevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.
Let op! Bevat lood.
201
201A
PL
Zawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.
Uwaga! Zawiera ołów.
201
201A
PT
Contém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.
Atenção! Contém chumbo.
201
201A
RO
Conține plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.
Atenție! Conține plumb.
201
201A
SK
Obsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.
Pozor! Obsahuje olovo.
201
201A
SL
Vsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.
Pozor! Vsebuje svinec.
201
201A
FI
Sisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.
Varoitus! Sisältää lyijyä.
201
201A
SV
Innehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.
Varning! Innehåller bly.


EUH 202
Language


BG
Цианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.

ES
Cianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.

CS
Kyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.

DA
Cyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.

DE
Cyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.

ET
Tsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.

EL
Κυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.

EN
Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.

FR
Cyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.

GA
Cianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.

IT
Cianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.

LV
Ciānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.

LT
Cianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.

HU
Cianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.

MT
Cyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.

NL
Cyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.

PL
Cyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.

PT
Cianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.

RO
Cianoacrilat. Pericol. Se lipește de piele și ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.

SK
Kyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.

SL
Cianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.

FI
Syanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.

SV
Cyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.

EUH 203
Language


BG
Съдържа хром (VI). Може да причини алергична реакция.

ES
Contiene cromo (VI). Puede provocar una reacción alérgica.

CS
Obsahuje chrom (VI). Může vyvolat alergickou reakci.

DA
Indeholder krom (VI). Kan udløse allergisk reaktion.

DE
Enthält Chrom (VI). Kann allergische Reaktionen hervorrufen.

ET
Sisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.

EL
Περιέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.

EN
Contains chromium (VI). May produce an allergic reaction.

FR
Contient du chrome (VI). Peut produire une réaction allergique.

GA
Cróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.

IT
Contiene cromo (VI). Può provocare una reazione allergica.

LV
Satur hromu (VI). Var izraisīt alerģisku reakciju.

LT
Sudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.

HU
Krómot (VI) tartalmaz. Allergiás reakciót válthat ki.

MT
Fih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.

NL
Bevat zeswaardig chroom. Kan een allergische reactie veroorzaken.

PL
Zawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.

PT
Contém crómio (VI). Pode provocar uma reacção alérgica.

RO
Conține crom (VI). Poate provoca o reacție alergică.

SK
Obsahuje chróm (VI). Môže vyvolať alergickú reakciu.

SL
Vsebuje krom (VI). Lahko povzroči alergijski odziv.

FI
Sisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.

SV
Innehåller krom (VI). Kan orsaka en allergisk reaktion.

EUH 204
Language


BG
Съдържа изоцианати. Може да причини алергична реакция.

ES
Contiene isocianatos. Puede provocar una reacción alérgica.

CS
Obsahuje isokyanáty. Může vyvolat alergickou reakci.

DA
Indeholder isocyanater. Kan udløse allergisk reaktion.

DE
Enthält Isocyanate. Kann allergische Reaktionen hervorrufen.

ET
Sisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.

EL
Περιέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.

EN
Contains isocyanates. May produce an allergic reaction.

FR
Contient des isocyanates. Peut produire une réaction allergique.

GA
Isicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.

IT
Contiene isocianati. Può provocare una reazione allergica.

LV
Satur izocianātus. Var izraisīt alerģisku reakciju.

LT
Sudėtyje yra izocianatų. Gali sukelti alerginę reakciją.

HU
Izocianátokat tartalmaz. Allergiás reakciót válthat ki.

MT
Fih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.

NL
Bevat isocyanaten. Kan een allergische reactie veroorzaken.

PL
Zawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.

PT
Contém isocianatos. Pode provocar uma reacção alérgica.

RO
Conține izocianați. Poate provoca o reacție alergică.

SK
Obsahuje izokyanáty. Môže vyvolať alergickú reakciu.

SL
Vsebuje izocianate. Lahko povzroči alergijski odziv.

FI
Sisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.

SV
Innehåller isocyanater. Kan orsaka en allergisk reaktion.


EUH 205
Language


BG
Съдържа епоксидни съставки. Може да причини алергична реакция.

ES
Contiene componentes epoxídicos. Puede provocar una reacción alérgica.

CS
Obsahuje epoxidové složky. Může vyvolat alergickou reakci.

DA
Indeholder epoxyforbindelser. Kan udløse allergisk reaktion.

DE
Enthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.

ET
Sisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.

EL
Περιέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.

EN
Contains epoxy constituents. May produce an allergic reaction.

FR
Contient des composés époxydiques. Peut produire une réaction allergique.

GA
Comhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.

IT
Contiene componenti epossidici. Può provocare una reazione allergica.

LV
Satur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.

LT
Sudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.

HU
Epoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.

MT
Fih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.

NL
Bevat epoxyverbindingen. Kan een allergische reactie veroorzaken.

PL
Zawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.

PT
Contém componentes epoxídicos. Pode provocar uma reacção alérgica.

RO
Conține componenți epoxidici. Poate provoca o reacție alergică.

SK
Obsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.

SL
Vsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.

FI
Sisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.

SV
Innehåller epoxiförening. Kan orsaka en allergisk reaktion.


EUH 206
Language


BG
Внимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).

ES
¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).

CS
Pozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).

DA
Advarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.

DE
Achtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.

ET
Ettevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).

EL
Προσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).

EN
Warning! Do not use together with other products. May release dangerous gases (chlorine).

FR
Attention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).

GA
Rabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).

IT
Attenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).

LV
Brīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).

LT
Atsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).

HU
Figyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.

MT
Twissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).

NL
Let op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.

PL
Uwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).

PT
Atenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).

RO
Atenție! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).

SK
Pozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).

SL
Pozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).

FI
Varoitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).

SV
Varning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).

EUH 207
Language


BG
Внимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.

ES
¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.

CS
Pozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.

DA
Advarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.

DE
Achtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.

ET
Ettevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.

EL
Προσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.

EN
Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.

FR
Attention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.

GA
Rabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.

IT
Attenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.

LV
Brīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.

LT
Atsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.

HU
Figyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.

MT
Twissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.

NL
Let op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.

PL
Uwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.

PT
Atenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.

RO
Atenție! Conține cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informațiile furnizate de producător. A se respecta instrucțiunile privind siguranța.

SK
Pozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.

SL
Pozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.

FI
Varoitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.

SV
Varning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.

EUH 208
Language


BG
Съдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.

ES
Contiene <nombre de la sustancia sensibilizante>. Puede provocar una reacción alérgica.

CS
Obsahuje <název senzibilizující látky>. Může vyvolat alergickou reakci.

DA
Indeholder <navn på det sensibiliserende stof>. Kan udløse allergisk reaktion.

DE
Enthält <Name des sensibilisierenden Stoffes>. Kann allergische Reaktionen hervorrufen.

ET
Sisaldab <sensibiliseeriva aine nimetus>. Võib esile kutsuda allergilise reaktsiooni.

EL
Περιέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.

EN
Contains <name of sensitising substance>. May produce an allergic reaction.

FR
Contient <nom de la substance sensibilisante>. Peut produire une réaction allergique.

GA
<Ainm na substainte íograithe> ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.

IT
Contiene <denominazione della sostanza sensibilizzante>. Può provocare una reazione allergica.

LV
Satur <sensibilizējošās vielas nosaukums>. Var izraisīt alerģisku reakciju.

LT
Sudėtyje yra <jautrinančios medžiagos pavadinimas>. Gali sukelti alerginę reakciją.

HU
<Allergén anyag neve>-t tartalmaz. Allergiás reakciót válthat ki.

MT
Fih <l-isem tas-sustanza sensibbli>. Jista’ jagħmel reazzjoni allerġika.

NL
Bevat <naam van de sensibiliserende stof>. Kan een allergische reactie veroorzaken.

PL
Zawiera <nazwa substancji uczulającej>. Może powodować wystąpienie reakcji alergicznej.

PT
Contém <nome da substância sensibilizante em questão>. Pode provocar uma reacção alérgica.

RO
Conține <denumirea substanței sensibilizante>. Poate provoca o reacție alergică.

SK
Obsahuje <názov senzibilizujúcej látky>. Môže vyvolať alergickú reakciu.

SL
Vsebuje <ime snovi, ki povzroča preobčutljivost>. Lahko povzroči alergijski odziv.

FI
Sisältää <herkistävän aineen nimi>. Voi aiheuttaa allergisen reaktion.

SV
Innehåller <namnet på det sensibiliserande ämnet>. Kan orsaka en allergisk reaktion.

EUH 209/ 209A
Language

209
209A
BG
При употреба може да стане силно запалимо.
При употреба може да стане запалимо.
209
209A
ES
Puede inflamarse fácilmente al usarlo
Puede inflamarse al usarlo.
209
209A
CS
Při používání se může stát vysoce hořlavým.
Při používání se může stát hořlavým.
209
209A
DA
Kan blive meget brandfarlig ved brug.
Kan blive brandfarlig ved brug.
209
209A
DE
Kann bei Verwendung leicht entzündbar werden.
Kann bei Verwendung entzündbar werden.
209
209A
ET
Kasutamisel võib muutuda väga tuleohtlikuks.
Kasutamisel võib muutuda tuleohtlikuks.
209
209A
EL
Μπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.
Mπορεί να γίνει εύφλεκτο κατά τη χρήση.
209
209A
EN
Can become highly flammable in use.
Can become flammable in use.
209
209A
FR
Peut devenir facilement inflammable en cours d'utilisation.
Peut devenir inflammable en cours d'utilisation.
209
209A
GA
D'fhéadfadh sé éirí an-inadhainte agus é á úsáid.
D'fhéadfadh sé éirí inadhainte agus é á úsáid.
209
209A
IT
Può diventare facilmente infiammabile durante l'uso.
Può diventare infiammabile durante l'uso.
209
209A
LV
Lietojot var viegli uzliesmot.
Kļūt uzliesmojošs.
209
209A
LT
Naudojama gali tapti labai degi.
Naudojama gali tapti degi.
209
209A
HU
A használat során fokozottan tűzveszélyessé válhat.
A használat során tűzveszélyessé válhat.
209
209A
MT
Jista’ jieħu n-nar faċilment meta jintuża.
Jista’ jieħu n-nar meta jintuża.
209
209A
NL
Kan bij gebruik licht ontvlambaar worden.
Kan bij gebruik ontvlambaar worden.
209
209A
PL
Podczas stosowania może przekształcić się w substancję wysoce łatwopalną.
Podczas stosowania może przekształcić się w substancję łatwopalną.
209
209A
PT
Pode tornar-se facilmente inflamável durante o uso.
Pode tornar-se inflamável durante o uso.
209
209A
RO
Poate deveni foarte inflamabil în timpul utilizării.
Poate deveni inflamabil în timpul utilizării.
209
209A
SK
Pri používaní sa môže stať veľmi horľavou.
Pri používaní sa môže stať horľavou.
209
209A
SL
Med uporabo utegne postati lahko vnetljivo.
Med uporabo utegne postati vnetljivo.
209
209A
FI
Voi muuttua helposti syttyväksi käytössä.
Voi muuttua syttyväksi käytössä.
209
209A
SV
Kan bli mycket brandfarligt vid användning.
Kan bli brandfarligt vid användning.


EUH 210
Language


BG
Информационен лист за безопасност ще бъде представен при поискване.

ES
Puede solicitarse la ficha de datos de seguridad.

CS
Na vyžádání je kodispozici bezpečnostní list.

DA
Sikkerhedsdatablad kan på anmodning rekvireres.

DE
Sicherheitsdatenblatt auf Anfrage erhältlich.

ET
Ohutuskaart nõudmisel kättesaadav.

EL
Δελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.

EN
Safety data sheet available on request.

FR
Fiche de données de sécurité disponible sur demande.

GA
Bileog sonraí sábháilteachta ar fáil arna iarraidh sin.

IT
Scheda dati di sicurezza disponibile su richiesta.

LV
Drošības datu lapa ir pieejama pēc pieprasījuma.

LT
Saugos duomenų lapą galima gauti paprašius.

HU
Kérésre biztonsági adatlap kapható.

MT
Il-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.

NL
Veiligheidsinformatieblad op verzoek verkrijgbaar.

PL
Karta charakterystyki dostępna na żądanie.

PT
Ficha de segurança fornecida a pedido.

RO
Fișa cu date de securitate disponibilă la cerere.

SK
Na požiadanie možno poskytnúť kartu bezpečnostných údajov.

SL
Varnosti list na voljo na zahtevo.

FI
Käyttöturvallisuustiedote toimitetaan pyynnöstä.

SV
Säkerhetsdatablad finns att rekvirera.

EUH 401
Language


BG
За да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.

ES
A fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.

CS
Dodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.

DA
Brugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.

DE
Zur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.

ET
Inimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.

EL
Για να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.

EN
To avoid risks to human health and the environment, comply with the instructions for use.

FR
Respectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.

GA
Chun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.

IT
Per evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.

LT
Siekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.

LV
Lai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.

HU
Az emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.

MT
Biex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.

NL
Volg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.

PL
W celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.

PT
Para evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.

RO
Pentru a evita riscurile pentru sănătatea umană și mediu, a se respecta instrucțiunile de utilizare.

SK
Dodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.

SL
Da bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.

FI
Noudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.

SV
För att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.

texts differ too much for an inline diff; shown separately

before (32008R1272)

ANNEX IV
LIST OF PRECAUTIONARY STATEMENTS
In selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.
1. Part 1: Criteria for the selection of precautionary statements
Table 6.1
Precautionary statements — General
Code General precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P101 If medical advice is needed, have product container or label at hand. as appropriate Consumer products
P102 Keep out of reach of children. as appropriate Consumer products
P103 Read label before use. as appropriate Consumer products
Table 6.2
Precautionary statements — Prevention
Code Prevention precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P201 Obtain special instructions before use. Explosives (section 2.1) Unstable explosive Germ cell mutagenicity (section 3.5) 1A, 1B, 2
Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 Reproductive toxicity — effects on or via lactation (section 3.7) Additional category P202 Do not handle until all safety precautions have been read and understood. Explosives (section 2.1) Unstable explosive Germ cell mutagenicity (section 3.5) 1A, 1B, 2
Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 P210 Keep away from heat/sparks/open flames/hot surfaces. — No smoking. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Manufacturer/supplier to specify applicable ignition source(s).
Flammable gases (section 2.2) 1, 2
Flammable aerosols (section 2.3) 1, 2
Flammable liquids (section 2.6) 1, 2, 3 Flammable solids (section 2.7) 1, 2 Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1 Organic peroxides (section 2.15) Types A, B, C, D, E, F Oxidising liquids (section 2.13) 1, 2, 3 Specify to keep away from heat.
Oxidising solids (section 2.14) 1, 2, 3
P211 Do not spray on an open flame or other ignition source. Flammable aerosols (section 2.3) 1, 2 P220 Keep/Store away from clothing/…/combustible materials. Oxidising gases (section 2.4) 1 … Manufacturer/supplier to specify incompatible materials.
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Oxidising liquids (section 2.13) 1 … Manufacturer/supplier to specify incompatible materials.
specify to keep away from clothing as well as other incompatible materials.
2, 3 … Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14) 1 … Manufacturer/supplier to specify incompatible materials.
specify to keep away from clothing as well as other incompatible materials.
2, 3 … Manufacturer/supplier to specify incompatible materials.
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P221 Take any precaution to avoid mixing with combustibles/… Oxidising liquids (section 2.13) 1, 2, 3 … Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14) 1, 2, 3
P222 Do not allow contact with air. Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1
P223 Keep away from any possible contact with water, because of violent reaction and possible flash fire. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2 P230 Keep wetted with … Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.5 … Manufacturer/supplier to specify appropriate material.
if drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).
P231 Handle under inert gas. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P232 Protect from moisture. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P233 Keep container tightly closed. Flammable liquids (section 2.6) 1, 2, 3 Acute toxicity — inhalation (section 3.1) 1, 2, 3 if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P234 Keep only in original container. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Organic peroxides (section 2.15) Types A, B, C, D, E, F
Corrosive to metals (section 2.16) 1
P235 Keep cool. Flammable liquids (section 2.6) 1, 2, 3 Self-reactive substances and mixtures (Section 2.8) Types A, B, C, D, E, F
Self-heating substances and mixtures (section 2.11) 1, 2
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P240 Ground/bond container and receiving equipment. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 if the explosive is electrostatically sensitive.
Flammable liquids (section 2.6) 1, 2, 3 if electrostatically sensitive material is for reloading.
if product is volatile so as to generate hazardous atmosphere.
Flammable solids (section 2.7) 1, 2 if electrostatically sensitive material is for reloading.
P241 Use explosion-proof electrical/ventilating/lighting/…/equipment. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify other equipment.
Flammable solids (section 2.7) 1, 2 … Manufacturer/supplier to specify other equipment.
if dust clouds can occur.
P242 Use only non-sparking tools. Flammable liquids (section 2.6) 1, 2, 3 P243 Take precautionary measures against static discharge. Flammable liquids (section 2.6) 1, 2, 3 P244 Keep reduction valves free from grease and oil. Oxidising gases (section 2.4) 1 P250 Do not subject to grinding/shock/…/friction. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … Manufacturer/supplier to specify applicable rough handling.
P251 Pressurized container: Do not pierce or burn, even after use. Flammable aerosols (section 2.3) 1, 2 P260 Do not breathe dust/fume/gas/mist/vapours/spray. Acute toxicity — inhalation (section 3.1) 1, 2 Manufacturer/supplier to specify applicable conditions.
Specific target organ toxicity — single exposure (section 3.8) 1, 2
Specific target organ toxicity — repeated exposure (section 3.9) 1, 2
Skin corrosion (section 3.2) 1A, 1B, 1C Specify do not breathe dusts or mists.
if inhalable particles of dusts or mists may occur during use.
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. Acute toxicity — inhalation (section 3.1) 3, 4 Manufacturer/supplier to specify applicable conditions.
Respiratory sensitisation (section 3.4) 1
Skin sensitisation (section 3.4) 1
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 P262 Do not get in eyes, on skin, or on clothing. Acute toxicity — dermal (section 3.1) 1, 2 P263 Avoid contact during pregnancy/while nursing. Reproductive toxicity — effects on or via lactation (section 3.7) Additional category P264 Wash … thoroughly after handling. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Manufacturer/supplier to specify parts of the body to be washed after handling.
Acute toxicity — dermal (section 3.1) 1, 2
Skin corrosion (section 3.2) 1A, 1B, 1C
Skin irritation (section 3.2) 2 Eye irritation (section 3.3) 2 Reproductive toxicity — effects on or via lactation (section 3.7) Additional category Specific target organ toxicity — single exposure (section 3.8) 1, 2 Specific target organ toxicity — repeated exposure (section 3.9) 1 P270 Do not eat, drink or smoke when using this product. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Acute toxicity — dermal (section 3.1) 1, 2
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category Specific target organ toxicity — single exposure (section 3.8) 1, 2 Specific target organ toxicity — repeated exposure (section 3.9) 1 P271 Use only outdoors or in a well-ventilated area. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P272 Contaminated work clothing should not be allowed out of the workplace. Skin sensitisation (section 3.4) 1 P273 Avoid release to the environment. Hazardous to the aquatic environment — acute aquatic hazard (section 4.1) 1 if this is not the intended use.
Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1) 1, 2, 3, 4
Hazardous to the ozone layer (section 5.1) 1 P280 Wear protective gloves/protective clothing/eye protection/face protection. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Manufacturer/supplier to specify type of equipment.
Specify face protection.
Flammable liquids (section 2.6) 1, 2, 3 Manufacturer/supplier to specify type of equipment.
Specify protective gloves and eye/face protection.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
Self-heating substances and mixtures (section 2.11) 1, 2 Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 Organic peroxides (section 2.15) Types A, B, C, D, E, F Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 Manufacturer/supplier to specify type of equipment.
Specify protective gloves/clothing.
Skin corrosion (section 3.2) 1A, 1B, 1C Manufacturer/supplier to specify type of equipment.
Specify protective gloves/clothing and eye/face protection.
Skin irritation (section 3.2) 2 Manufacturer/supplier to specify type of equipment.
Specify protective gloves.
Skin sensitisation (section 3.4) 1
Serious eye damage/eye irritation (section 3.3) 1 Manufacturer/supplier to specify type of equipment.
Specify eye/face protection.
Eye irritation (section 3.3) 2
P281 Use personal protective equipment as required. Explosives (section 2.1) Unstable explosive Germ cell mutagenicity (section 3.5) 1A, 1B, 2
Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 P282 Wear cold insulating gloves/face shield/eye protection. Gases under pressure (section 2.5) Refrigerated liquefied gas P283 Wear fire/flame resistant/retardant clothing. Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
P284 Wear respiratory protection. Acute toxicity — inhalation (section 3.1) 1, 2 Manufacturer/supplier to specify equipment.
P285 In case of inadequate ventilation wear respiratory protection. Respiratory sensitisation (section 3.4) 1 Manufacturer/supplier to specify equipment.
P231 + P232 Handle under inert gas. Protect from moisture. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P235 + P410 Keep cool. Protect from sunlight. Self-heating substances and mixtures (section 2.11) 1, 2 Table 6.3
Precautionary statements — Response
Code Response precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P301 IF SWALLOWED: Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
Aspiration Hazard (section 3.10) 1
P302 IF ON SKIN: Pyrophoric liquids (section 2.9) 1 Acute toxicity — dermal (section 3.1) 1, 2, 3, 4
Skin irritation (section 3.2) 2 Skin sensitisation (section 3.4) 1 P303 IF ON SKIN (or hair): Flammable liquids (section 2.6) 1, 2, 3 Skin corrosion (section 3.2) 1A, 1B, 1C
P304 IF INHALED: Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
Respiratory sensitisation (section 3.4) 1 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 P305 IF IN EYES: Skin corrosion (section 3.2) 1A, 1B, 1C Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P306 IF ON CLOTHING: Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
P307 IF exposed: Specific target organ toxicity — single exposure (section 3.8) 1 P308 IF exposed or concerned: Germ cell mutagenicity (section 3.5) 1A, 1B, 2 Carcinogenicity (section 3.6) 1A, 1B, 2
Reproductive toxicity (section 3.7) 1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P309 IF exposed or if you feel unwell: Specific target organ toxicity — single exposure (section 3.8) 2 P310 Immediately call a POISON CENTER or doctor/physician. Acute toxicity — oral (section 3.1) 1, 2, 3 Acute toxicity — dermal (section 3.1) 1, 2
Acute toxicity — inhalation (section 3.1) 1, 2 Skin corrosion (section 3.2) 1A, 1B, 1C Serious eye damage/eye irritation (section 3.3) 1 Aspiration hazard (section 3.10) 1 P311 Call a POISON CENTER or doctor/physician. Acute toxicity — inhalation (section 3.1) 3 Respiratory sensitisation (section 3.4) 1
Specific target organ toxicity — single exposure (section 3.8) 1, 2
P312 Call a POISON CENTER or doctor/physician if you feel unwell. Acute toxicity — oral (section 3.1) 4 Acute toxicity — dermal (section 3.1) 3, 4
Acute toxicity — inhalation (section 3.1) 4 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 P313 Get medical advice/attention. Skin irritation (section 3.2) 2, 3 Eye irritation (section 3.3) 2
Skin sensitisation (section 3.4) 1 Germ cell mutagenicity (section 3.5) 1A, 1B, 2 Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 Reproductive toxicity — effects on or via lactation (section 3.7) Additional category P314 Get medical advice/attention if you feel unwell. Specific target organ toxicity — repeated exposure (section 3.9) 1, 2 P315 Get immediate medical advice/attention. Gases under pressure (section 2.5) Refrigerated liquefied gas P320 Specific treatment is urgent (see … on this label). Acute toxicity — inhalation (section 3.1) 1, 2 … Reference to supplemental first aid instruction.
if immediate administration of antidote is required.
P321 Specific treatment (see … on this label). Acute toxicity — oral (section 3.1) 1, 2, 3 … Reference to supplemental first aid instruction.
if immediate administration of antidote is required.
Acute toxicity — inhalation (section 3.1) 3 … Reference to supplemental first aid instruction.
if immediate specific measures are required.
Specific target organ toxicity — single exposure (section 3.8) 1 … Reference to supplemental first aid instruction.
if immediate measures are required.
Skin sensitisation (section 3.4) 1 … Reference to supplemental first aid instruction.
manufacturer/supplier may specify a cleansing agent if appropriate.
Skin corrosion (section 3.2) 1A, 1B, 1C
Skin irritation (section 3.2) 2
P322 Specific measures (see … on this label). Acute toxicity — dermal (section 3.1) 1, 2 … Reference to supplemental first aid instruction.
if immediate measures such as specific cleansing agent is advised.
Acute toxicity — dermal (section 3.1) 3, 4 … Reference to supplemental first aid instruction.
if measures such as specific cleansing agent is advised.
P330 Rinse mouth. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
P331 Do NOT induce vomiting. Skin corrosion (section 3.2) 1A, 1B, 1C Aspiration hazard (section 3.10) 1
P332 If skin irritation occurs: Skin irritation (section 3.2) 2, 3 P333 If skin irritation or rash occurs: Skin sensitisation (section 3.4) 1 P334 Immerse in cool water/wrap in wet bandages. Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P335 Brush off loose particles from skin. Pyrophoric solids (section 2.10) 1 Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P336 Thaw frosted parts with lukewarm water. Do not rub affected area. Gases under pressure (section 2.5) Refrigerated liquefied gas P337 If eye irritation persists: Eye irritation (section 3.3) 2 P338 Remove contact lenses, if present and easy to do. Continue rinsing. Skin corrosion (section 3.2) 1A, 1B, 1C Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P340 Remove victim to fresh air and keep at rest in a position comfortable for breathing. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P341 If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. Respiratory sensitisation (section 3.4) 1 P342 If experiencing respiratory symptoms: Respiratory sensitisation (section 3.4) 1 P350 Gently wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 1, 2 P351 Rinse cautiously with water for several minutes. Skin corrosion (section 3.2) 1A, 1B, 1C Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P352 Wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 3, 4 Skin irritation (section 3.2) 2
Skin sensitisation (section 3.4) 1
P353 Rinse skin with water/shower. Flammable liquids (section 2.6) 1, 2, 3 Skin corrosion (section 3.2) 1A, 1B, 1C
P360 Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
P361 Remove/Take off immediately all contaminated clothing. Flammable liquids (section 2.6) 1, 2, 3 Acute toxicity — dermal (section 3.1) 1, 2, 3
Skin corrosion (section 3.2) 1A, 1B, 1C
P362 Take off contaminated clothing and wash before reuse. Skin irritation (section 3.2) 2 P363 Wash contaminated clothing before reuse. Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
Skin sensitisation (section 3.4) 1
P370 In case of fire: Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Oxidising gases (section 2.4) 1
Flammable liquids (section 2.6) 1, 2, 3 Flammable solids (section 2.7) 1, 2 Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Pyrophoric liquids (section 2.9) 1 Pyrophoric solids (section 2.10) 1 Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 P371 In case of major fire and large quantities: Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
P372 Explosion risk in case of fire. Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 except if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P373 DO NOT fight fire when fire reaches explosives. Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 P374 Fight fire with normal precautions from a reasonable distance. Explosives (section 2.1) Division 1.4 if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P375 Fight fire remotely due to the risk of explosion. Self-reactive substances and mixtures (section 2.8) Types A, B Oxidising liquids (section 2.13) 1
Oxidising solids (section 2.14) 1
P376 Stop leak if safe to do so. Oxidising gases (section 2.4) 1 P377 Leaking gas fire:
Do not extinguish, unless leak can be stopped safely. Flammable gases (section 2.2) 1, 2 P378 Use … for extinction. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify appropriate media
if water increases risk.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 P380 Evacuate area. Explosives (section 2.1) Unstable explosives Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Self-reactive substances and mixtures (section 2.8) Types A, B Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1 P381 Eliminate all ignition sources if safe to do so. Flammable gases (section 2.2) 1, 2 P390 Absorb spillage to prevent material damage. Corrosive to metals (section 2.16) 1 P391 Collect spillage. Hazardous to the aquatic environment – acute aquatic hazard (section 4.1) 1 Hazardous to the aquatic environment – chronic aquatic hazard (section 4.1) 1, 2
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. Acute toxicity — oral (section 3.1) 1, 2, 3 Aspiration hazard (section 3.10) 1
P301 + P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. Acute toxicity — oral (section 3.1) 4 P301 + P330 + P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. Skin corrosion (section 3.2) 1A, 1B, 1C P302 + P334 IF ON SKIN: Immerse in cool water/wrap in wet bandages. Pyrophoric liquids (section 2.9) 1 P302 + P350 IF ON SKIN: Gently wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 1, 2 P302 + P352 IF ON SKIN: Wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 3, 4 Skin irritation (section 3.2) 2
Skin sensitisation (section 3.4) 1
P303 + P361 + P353 IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. Flammable liquids (section 2.6) 1, 2, 3 Skin corrosion (section 3.2) 1A, 1B, 1C
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 Skin corrosion (section 3.2) 1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P304 + P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. Respiratory sensitisation (section 3.4) 1 P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Skin corrosion (section 3.2) 1A, 1B, 1C Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P306 + P360 IF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
P307 + P311 IF exposed: Call a POISON CENTER or doctor/physician. Specific target organ toxicity — single exposure (section 3.8) 1 P308 + P313 IF exposed or concerned: Get medical advice/attention. Germ cell mutagenicity (section 3.5) 1A, 1B, 2 Carcinogenicity (section 3.6) 1A, 1B, 2
Reproductive toxicity (section 3.7) 1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P309 + P311 IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician. Specific target organ toxicity — single exposure (section 3.8) 2 P332 + P313 If skin irritation occurs: Get medical advice/attention. Skin irritation (section 3.2) 2 P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. Skin sensitisation (section 3.4) 1 P335 + P334 Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. Pyrophoric solids (section 2.10) 1 Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P337 + P313 If eye irritation persists: Get medical advice/attention. Eye irritation (section 3.3) 2 P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Respiratory sensitisation (section 3.4) 1 P370 + P376 In case of fire: Stop leak if safe to do so. Oxidizing gases (section 2.4) 1 P370 + P378 In case of fire: Use … for extinction. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify appropriate media.
if water increases risk.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 P370 + P380 In case of fire: Evacuate area. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 P370 + P380 + P375 In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. Self-reactive substances and mixtures (section 2.8) Types A, B P371 + P380 + P375 In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. Oxidising liquids (section 2.13) 1 Oxidising solids (section 2.14) 1
Table 6.4
Precautionary statements — Storage
Code Storage precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P401 Store … Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … in accordance with local/regional/national/international regulations (to be specified).
P402 Store in a dry place. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P403 Store in a well-ventilated place. Flammable gases (section 2.2) 1, 2 if product is volatile so as to generate hazardous atmosphere.
Oxidising gases (section 2.4) 1
Gases under pressure (section 2.5) Compressed gas
Liquefied gas
Refrigerated Liquefied gas
Dissolved gas
Flammable liquids (section 2.6) 1, 2, 3 Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Acute toxicity — inhalation (section 3.1) 1, 2, 3 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 P404 Store in a closed container. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P405 Store locked up. Acute toxicity — oral (section 3.1) 1, 2, 3 Acute toxicity — dermal (section 3.1) 1, 2, 3
Acute toxicity — inhalation (section 3.1) 1, 2, 3 Skin corrosion (section 3.2) 1A, 1B, 1C Germ cell mutagenicity (section 3.5) 1A, 1B, 2 Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 Specific target organ toxicity — single exposure (section 3.8) 1, 2 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 Aspiration hazard (section 3.10) 1 P406 Store in corrosive resistant/… container with a resistant inner liner. Corrosive to metals (section 2.16) 1 … Manufacturer/supplier to specify other compatible materials.
P407 Maintain air gap between stacks/pallets. Self-heating substances and mixtures (section 2.11) 1, 2 P410 Protect from sunlight. Flammable aerosols (section 2.3) 1, 2 Gases under pressure (section 2.5) Compressed gas
Liquefied gas
Dissolved gas
Self-heating substances and mixtures (section 2.11) 1, 2 Organic peroxides (section 2.15) Types A, B, C, D, E, F P411 Store at temperatures not exceeding … oC/…oF. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F … Manufacturer/supplier to specify temperature
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P412 Do not expose to temperatures exceeding 50 oC/122 oF. Flammable aerosols (section 2.3) 1, 2 P413 Store bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF. Self-heating substances and mixtures (section 2.11) 1, 2 … Manufacturer/supplier to specify mass and temperature.
P420 Store away from other materials. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F Self-heating substances and mixtures (section 2.11) 1, 2
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P422 Store contents under … Pyrophoric liquids (section 2.9) 1 … Manufacturer/supplier to specify appropriate liquid or inert gas.
Pyrophoric solids (section 2.10) 1
P402 + P404 Store in a dry place. Store in a closed container. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 P403 + P233 Store in a well-ventilated place. Keep container tightly closed. Acute toxicity — inhalation (section 3.1) 1, 2, 3 if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P403 + P235 Store in a well-ventilated place. Keep cool. Flammable liquids (section 2.6) 1, 2, 3 Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
P410 + P403 Protect from sunlight. Store in a well-ventilated place. Gases under pressure (section 2.5) Compressed gas Liquefied gas
Dissolved gas
P410 + P412 Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. Flammable aerosols (section 2.3) 1, 2 P411 + P235 Store at temperatures not exceeding … oC/…oF. Keep cool. Organic peroxides (section 2.15) Types A, B, C, D, E, F … Manufacturer/supplier to specify temperature.
Table 6.5
Precautionary statements — Disposal
Code Disposal precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P501 Dispose of contents/container to … Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … in accordance with local/regional/national/international regulation (to be specified).
Flammable liquids (section 2.6) 1, 2, 3
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 Oxidising liquids (section 2.13) 1, 2, 3 Oxidising solids (section 2.14) 1, 2, 3 Organic peroxides (section 2.15) Types A, B, C, D, E, F Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 Acute toxicity — inhalation (section 3.1) 1, 2 Skin corrosion (section 3.2) 1A, 1B, 1C Respiratory sensitisation (section 3.4) 1 Skin sensitisation (section 3.4) 1
Germ cell mutagenicity (section 3.5) 1A, 1B, 2 Carcinogenicity (section 3.6) 1A, 1B, 2 Reproductive toxicity (section 3.7) 1A, 1B, 2 Specific target organ toxicity — single exposure (section 3.8) 1, 2 Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 Specific target organ toxicity — repeated exposure (section 3.9) 1, 2 Aspiration hazard (section 3.10) 1 Hazardous to the aquatic environment — acute aquatic hazard (section 4.1) 1 Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1) 1, 2, 3, 4 Hazardous to the ozone layer (section 5.1) 1 2. Part 2: precautionary statements
The precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.
Table 1.1
Precautionary statements — General
P101 Language BG При необходимост от медицинска помощ, носете опаковката или етикета на продукта.
ES Si se necesita consejo médico, tener a mano el envase o la etiqueta.
CS Je-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.
DA Hvis der er brug for lægehjælp, medbring da beholderen eller etiketten.
DE Ist ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.
ET Arsti poole pöördudes võtta kaasa toote pakend või etikett.
EL Εάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.
EN If medical advice is needed, have product container or label at hand.
FR En cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.
GA Más gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.
IT In caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.
LV Medicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.
LT Jei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.
HU Orvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.
MT Jekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.
NL Bij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.
PL W razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.
PT Se for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.
RO Dacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.
SK Ak je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.
SL Če je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.
FI Jos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.
SV Ha förpackningen eller etiketten till hands om du måste söka läkarvård.
P102 Language BG Да се съхранява извън обсега на деца.
ES Mantener fuera del alcance de los niños.
CS Uchovávejte mimo dosah dětí.
DA Opbevares utilgængeligt for børn.
DE Darf nicht in die Hände von Kindern gelangen.
ET Hoida lastele kättesaamatus kohas.
EL Μακριά από παιδιά.
EN Keep out of reach of children.
FR Tenir hors de portée des enfants.
GA Coimeád as aimsiú leanaí.
IT Tenere fuori dalla portata dei bambini.
LV Sargāt no bērniem.
LT Laikyti vaikams neprieinamoje vietoje.
HU Gyermekektől elzárva tartandó.
MT Żommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.
NL Buiten het bereik van kinderen houden.
PL Chronić przed dziećmi.
PT Manter fora do alcance das crianças.
RO A nu se lăsa la îndemâna copiilor.
SK Uchovávajte mimo dosahu detí.
SL Hraniti zunaj dosega otrok.
FI Säilytä lasten ulottumattomissa.
SV Förvaras oåtkomligt för barn.
P103 Language BG Преди употреба прочетете етикета.
ES Leer la etiqueta antes del uso.
CS Před použitím si přečtěte údaje na štítku.
DA Læs etiketten før brug.
DE Vor Gebrauch Kennzeichnungsetikett lesen.
ET Enne kasutamist tutvuda etiketil oleva infoga.
EL Διαβάστε την ετικέτα πριν από τη χρήση.
EN Read label before use.
FR Lire l’étiquette avant utilisation.
GA Léigh an lipéad roimh úsáid.
IT Leggere l’etichetta prima dell’uso.
LV Pirms izmantošanas izlasīt etiķeti.
LT Prieš naudojimą perskaityti etiketę.
HU Használat előtt olvassa el a címkén közölt információkat.
MT Aqra t-tikketta qabel l-użu.
NL Alvorens te gebruiken, het etiket lezen.
PL Przed użyciem przeczytać etykietę.
PT Ler o rótulo antes da utilização.
RO Citiţi eticheta înainte de utilizare.
SK Pred použitím si prečítajte etiketu.
SL Pred uporabo preberite etiketo.
FI Lue merkinnät ennen käyttöä.
SV Läs etiketten före användning.
Table 1.2
Precautionary statements — Prevention
P201 Language BG Преди употреба се снабдете със специални инструкции.
ES Pedir instrucciones especiales antes del uso.
CS Před použitím si obstarejte speciální instrukce.
DA Indhent særlige anvisninger før brug.
DE Vor Gebrauch besondere Anweisungen einholen.
ET Enne kasutamist tutvuda erijuhistega.
EL Εφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.
EN Obtain special instructions before use.
FR Se procurer les instructions avant utilisation.
GA Faigh treoracha speisialta roimh úsáid.
IT Procurarsi istruzioni specifiche prima dell’uso.
LV Pirms lietošanas saņemt speciālu instruktāžu.
LT Prieš naudojimą gauti specialias instrukcijas.
HU Használat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.
MT Ikseb struzzjonijiet speċjali qabel l-użu.
NL Alvorens te gebruiken de speciale aanwijzingen raadplegen.
PL Przed użyciem zapoznać się ze specjalnymi środkami ostrożności.
PT Pedir instruções específicas antes da utilização.
RO Procuraţi instrucţiuni speciale înainte de utilizare.
SK Pred použitím sa oboznámte s osobitnými pokynmi.
SL Pred uporabo pridobiti posebna navodila.
FI Lue erityisohjeet ennen käyttöä.
SV Inhämta särskilda instruktioner före användning.
P202 Language BG Не използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.
ES No manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.
CS Nepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.
DA Anvend ikke produktet, før alle advarsler er læst og forstået.
DE Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
ET Mitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.
EL Μην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.
EN Do not handle until all safety precautions have been read and understood.
FR Ne pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.
GA Ná láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.
IT Non manipolare prima di avere letto e compreso tutte le avvertenze.
LV Neizmantot pirms nav izlasīti un saprasti visi apzīmējumi.
LT Nenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.
HU Ne használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.
MT Tmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.
NL Pas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft
PL Nie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.
PT Não manuseie o produto antes de ter lido e percebido todas as precauções de segurança.
RO A nu se manipula decât după ce au fost citite şi înţelese toate măsurile de securitate.
SK Nepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.
SL Ne uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.
FI Lue varoitukset huolellisesti ennen käsittelyä.
SV Använd inte produkten innan du har läst och förstått säkerhetsanvisningarna
P210 Language BG Да се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.
ES Mantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.
CS Chraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.
DA Holdes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.
DE Von Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.
ET Hoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.
EL Μακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.
EN Keep away from heat/sparks/open flames/hot surfaces. — No smoking.
FR Tenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.
GA Coimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.
IT Tenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.
LV Nelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.
LT Laikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.
HU Hőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.
MT Żomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.
NL Verwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.
PL Przechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.
PT Manter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.
RO A se păstra departe de surse de căldură/scântei/flăcări deschise/suprafeţe încinse. — Fumatul interzis.
SK Uchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.
SL Hraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.
FI Suojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.
SV Får inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.
P211 Language BG Да не се пръска към открит пламък или друг източник на запалване.
ES No pulverizar sobre una llama abierta u otra fuente de ignición.
CS Nestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.
DA Spray ikke mod åben ild eller andre antændelseskilder.
DE Nicht gegen offene Flamme oder andere Zündquelle sprühen.
ET Mitte pihustada leekidesse või muusse süüteallikasse.
EL Μην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.
EN Do not spray on an open flame or other ignition source.
FR Ne pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.
GA Ná spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.
IT Non vaporizzare su una fiamma libera o altra fonte di accensione.
LV Neizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.
LT Nepurkšti į atvirą liepsną arba kitus degimo šaltinius.
HU Tilos nyílt lángra vagy más gyújtóforrásra permetezni.
MT Tisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.
NL Niet in een open vuur of op andere ontstekingsbronnen spuiten.
PL Nie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.
PT Não pulverizar sobre chama aberta ou outra fonte de ignição.
RO Nu pulverizaţi deasupra unei flăcări deschise sau unei alte surse de aprindere.
SK Nestriekajte na otvorený oheň ani iný zdroj zapálenia.
SL Ne pršiti proti odprtemu ognju ali drugemu viru vžiga.
FI Ei saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.
SV Spreja inte över öppen låga eller andra antändningskällor.
P220 Language BG Да се държи/съхранява далеч от облекло/…/горими материали
ES Mantener o almacenar alejado de la ropa/…/materiales combustibles.
CS Uchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.
DA Må ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.
DE Von Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.
ET Hoida eemal rõivastest/…/süttivast materjalist.
EL Διατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.
EN Keep/Store away from clothing/…/combustible materials.
FR Tenir/stocker à l’écart des vêtements/…/matières combustibles
GA Coimeád/Stóráil glan ar éadaí/…/ábhair indóite.
IT Tenere/conservare lontano da indumenti/…/materiali combustibili.
LV Turēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.
LT Laikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.
HU Ruhától/…/éghető anyagtól távol tartandó/tárolandó.
MT Żomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.
NL Van kleding/…/brandbare stoffen verwijderd houden/bewaren.
PL Trzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.
PT Manter/guardar afastado de roupa/…/matérias combustíveis.
RO A se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.
SK Uchovávajte/skladujte mimo odevov/…/horľavých materiálov.
SL Hraniti ločeno od oblačil/…/vnetljivih materialov.
FI Pidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.
SV Hålls/förvarad åtskilt från kläder/…/brännbara material.
P221 Language BG Вземете всички предпазни мерки за избягване на смесването с горими материали…
ES Tomar todas las precauciones necesarias para no mezclar con materias combustibles…
CS Proveďte preventivní opatření proti smíchání s hořlavými materiály…
DA Undgå at blande med brændbare materialer…
DE Mischen mit brennbaren Stoffen/… unbedingt verhindern.
ET Rakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…
EL Λάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…
EN Take any precaution to avoid mixing with combustibles…
FR Prendre toutes précautions pour éviter de mélanger avec des matières combustibles…
GA Déan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…
IT Prendere ogni precauzione per evitare di miscelare con sostanze combustibili…
LV Nekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…
LT Imtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…
HU Minden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.
MT Ħu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…
NL Vermenging met brandbare stoffen… absoluut vermijden.
PL Zastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …
PT Tomar todas as precauções para não misturar com combustíveis…
RO Luaţi toate măsurile de precauţie pentru a evita amestecul cu combustibili…
SK Prijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…
SL Preprečiti mešanje z vnetljivimi snovmi …
FI Varo sekoittamasta syttyvien materiaalien… kanssa.
SV Undvik att blanda med med brännbara ämnen…
P222 Language BG Не допускайте конктакт с въздух.
ES No dejar que entre en contacto con el aire.
CS Zabraňte styku se vzduchem.
DA Undgå kontakt med luft.
DE Kontakt mit Luft nicht zulassen.
ET Hoida õhuga kokkupuute eest.
EL Να μην έρθει σε επαφή με τον αέρα.
EN Do not allow contact with air.
FR Ne pas laisser au contact de l’air.
GA Ná ceadaigh teagmháil le haer.
IT Evitare il contatto con l’aria.
LV Nepieļaut kontaktu ar gaisu.
LT Saugoti nuo kontakto su oru.
HU Nem érintkezhet levegővel.
MT Tħallix li jkun hemm kuntatt ma' l-arja.
NL Contact met de lucht vermijden.
PL Nie dopuszczać do kontaktu z powietrzem.
PT Não deixar entrar em contacto com o ar.
RO A nu se lăsa în contact cu aerul.
SK Zabráňte kontaktu so vzduchom.
SL Preprečiti stik z zrakom.
FI Ei saa joutua kosketuksiin ilman kanssa.
SV Undvik kontakt med luft.
P223 Language BG Да се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.
ES Mantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.
CS Chraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.
DA Undgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.
DE Kontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.
ET Hoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.
EL Αποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.
EN Keep away from any possible contact with water, because of violent reaction and possible flash fire.
FR Éviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.
GA Ná ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.
IT Evitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.
LV Nepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.
LT Saugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.
HU Vízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.
MT Żomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.
NL Contact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.
PL Chronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.
PT Não deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.
RO A se evita orice contact cu apa, din cauza reacţiei violente şi a riscului de aprindere spontană.
SK Zabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.
SL Hraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.
FI Ei saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.
SV Undvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.
P230 Language BG Да се държи навлажнен с…
ES Mantener humedecido con…
CS Uchovávejte ve zvlhčeném stavu…
DA Holdes befugtet med…
DE Feucht halten mit …
ET Niisutada …-ga.
EL Να διατηρείται υγρό με …
EN Keep wetted with…
FR Maintenir humidifié avec…
GA Coimeád fliuchta le…
IT Mantenere umido con…
LV Vienmēr samitrināt ar …
LT Laikyti sudrėkintą (kuo)
HU …-val/-vel nedvesítve tartandó.
MT Żommu mxarrab bi …
NL Vochtig houden met…
PL Przechowywać produkt zwilżony…
PT Manter húmido com…
RO A se păstra umezit cu…
SK Uchovávajte zvlhčené …
SL Hraniti prepojeno z …
FI Säilytä kostutettuna …
SV Ska hållas fuktigt med…
P231 Language BG Да се използва под инертен газ.
ES Manipular en gas inerte.
CS Manipulace pod inertním plynem.
DA Håndteres under inaktiv gas.
DE Unter inertem Gas handhaben.
ET Käidelda inertgaasis.
EL Χειρισμός σε αδρανή ατμόσφαιρα.
EN Handle under inert gas.
FR Manipuler sous gaz inerte.
GA Láimhsigh faoi thriathghás.
IT Manipolare in atmosfera di gas inerte.
LV Rīkoties tikai inertas gāzes apstākļos.
LT Tvarkyti inertinėse dujose.
HU Inert gázban használandó.
MT Immaniġġja taħt gass inerti.
NL Onder inert gas werken.
PL Używać w atmosferze obojętnego gazu.
PT Manusear em atmosfera de gás inerte.
RO A se manipula sub un gaz inert.
SK Manipulujte v prostredí s inertným plynom.
SL Hraniti v ustreznem inertnem plinu.
FI Käsittele inertissä kaasussa.
SV Hanteras under inert gas.
P232 Language BG Да се пази от влага.
ES Proteger de la humedad.
CS Chraňte před vlhkem.
DA Beskyttes mod fugt.
DE Vor Feuchtigkeit schützen.
ET Hoida niiskuse eest.
EL Προστετέψτε από την υγρασία.
EN Protect from moisture.
FR Protéger de l’humidité.
GA Cosain ar thaise.
IT Proteggere dall’umidità.
LV Aizsargāt no mitruma.
LT Saugoti nuo drėgmės.
HU Nedvességtől védendő.
MT Ipproteġi mill-umdità.
NL Tegen vocht beschermen.
PL Chronić przed wilgocią.
PT Manter ao abrigo da humidade.
RO A se proteja de umiditate.
SK Chráňte pred vlhkosťou.
SL Zaščititi pred vlago.
FI Suojaa kosteudelta.
SV Skyddas från fukt.
P233 Language BG Съдът да се съхранява плътно затворен.
ES Mantener el recipiente herméticamente cerrado.
CS Uchovávejte obal těsně uzavřený.
DA Hold beholderen tæt lukket.
DE Behälter dicht verschlossen halten.
ET Hoida pakend tihedalt suletuna.
EL Να διατηρείται ο περιέκτης ερμητικά κλειστός.
EN Keep container tightly closed.
FR Maintenir le récipient fermé de manière étanche.
GA Coimeád an coimeádán dúnta go docht.
IT Tenere il recipiente ben chiuso.
LV Tvertni stingri noslēgt.
LT Talpyklą laikyti sandariai uždarytą.
HU Az edény szorosan lezárva tartandó.
MT Żomm il-kontenitur magħluq sew.
NL In goed gesloten verpakking bewaren.
PL Przechowywać pojemnik szczelnie zamknięty.
PT Manter o recipiente bem fechado.
RO Păstraţi recipientul închis etanş.
SK Nádobu uchovávajte tesne uzavretú.
SL Hraniti v tesno zaprti posodi.
FI Säilytä tiiviisti suljettuna.
SV Behållaren ska vara väl tillsluten.
P234 Language BG Да се съхранява само в оригиналната опаковка.
ES Conservar únicamente en el recipiente original.
CS Uchovávejte pouze v původním obalu.
DA Opbevares kun i den originale beholder.
DE Nur im Originalbehälter aufbewahren.
ET Hoida üksnes originaalpakendis.
EL Να διατηρείται μόνο στον αρχικό περιέκτη.
EN Keep only in original container.
FR Conserver uniquement dans le récipient d’origine.
GA Coimeád sa choimeádán bunaidh amháin.
IT Conservare soltanto nel contenitore originale.
LV Turēt tikai oriģinālā iepakojumā.
LT Laikyti tik originalioje talpykloje.
HU Az eredeti edényben tartandó.
MT Żomm biss fil-kontenitur oriġinali.
NL Uitsluitend in de oorspronkelijke verpakking bewaren.
PL Przechowywać wyłącznie w oryginalnym pojemniku.
PT Conservar unicamente no recipiente de origem.
RO Păstraţi numai în recipientul original.
SK Uchovávajte iba v pôvodnej nádobe.
SL Hraniti samo v originalni posodi.
FI Säilytä alkuperäispakkauksessa.
SV Förvaras endast i originalbehållaren.
P235 Language BG Да се държи на хладно.
ES Mantener en lugar fresco.
CS Uchovávejte v chladu.
DA Opbevares køligt.
DE Kühl halten.
ET Hoida jahedas.
EL Να διατηρείται δροσερό.
EN Keep cool.
FR Tenir au frais.
GA Coimeád fionnuar é
IT Conservare in luogo fresco.
LV Turēt vēsumā.
LT Laikyti vėsioje vietoje.
HU Hűvös helyen tartandó.
MT Żomm frisk.
NL Koel bewaren.
PL Przechowywać w chłodnym miejscu.
PT Conservar em ambiente fresco.
RO A se păstra la rece.
SK Uchovávajte v chlade.
SL Hraniti na hladnem.
FI Säilytä viileässä.
SV Förvaras svalt.
P240 Language BG Заземяване/еквипотенциална връзка на съда и приемателното устройство.
ES Conectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.
CS Uzemněte obal a odběrové zařízení.
DA Beholder og modtageudstyr jordforbindes/potentialudlignes.
DE Behälter und zu befüllende Anlage erden.
ET Mahuti ja vastuvõtuseade maandada/ühendada.
EL Γείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.
EN Ground/bond container and receiving equipment.
FR Mise à la terre/liaison équipotentielle du récipient et du matériel de réception.
GA Nasc an coimeádán agus an trealamh glactha leis an talamh.
IT Mettere a terra/massa il contenitore e il dispositivo ricevente.
LV Tvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt
LT Įžeminti/įtvirtinti talpyklą ir priėmimo įrangą.
HU A tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.
MT Poġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.
NL Opslag- en opvangreservoir aarden.
PL Uziemić/połączyć pojemnik i sprzęt odbiorczy.
PT Ligação à terra/equipotencial do recipiente e do equipamento receptor.
RO Legătură la pământ/conexiune echipotenţială cu recipientul şi cu echipamentul de recepţie.
SK Uzemnite/upevnite nádobu a plniace zariadenie.
SL Ozemljiti posodo in opremo za sprejem tekočine.
FI Säiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.
SV Jorda/potentialförbind behållare och mottagarutrustning.
P241 Language BG Използвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия
ES Utilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.
CS Používejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.
DA Anvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.
DE Explosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.
ET Kasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.
EL Να χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.
EN Use explosion-proof electrical/ventilating/lighting/…/equipment.
FR Utiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.
GA Bain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…
IT Utilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.
LV Izmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas
LT Naudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.
HU Robbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.
MT Uża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.
NL Explosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.
PL Używać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.
PT Utilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.
RO Utilizaţi echipamente electrice/de ventilare/de iluminat/…/antideflagrante.
SK Používajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.
SL Uporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.
FI Käytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.
SV Använd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.
P242 Language BG Използвайте само инструменти, които не предизвикват искри.
ES Utilizar únicamente herramientas que no produzcan chispas.
CS Používejte pouze nářadí z nejiskřícího kovu.
DA Anvend kun værktøj, som ikke frembringer gnister.
DE Nur funkenfreies Werkzeug verwenden.
ET Mitte kasutada seadmeid, mis võivad tekitada sädemeid.
EL Να χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.
EN Use only non-sparking tools.
FR Ne pas utiliser d'outils produisant des étincelles.
GA Bain úsáid as uirlisí neamhspréachta amháin.
IT Utilizzare solo utensili antiscintillamento.
LV Izmantot instrumentus, kas nerada dzirksteles.
LT Naudoti tik kibirkščių nekeliančius įrankius.
HU Szikramentes eszközök használandók.
MT Uża’ biss għodda li ma jtajrux żnied.
NL Uitsluitend vonkvrij gereedschap gebruiken.
PL Używać wyłącznie nieiskrzących narzędzi.
PT Utilizar apenas ferramentas antichispa.
RO Nu utilizaţi unelte care produc scântei.
SK Používajte iba neiskriace prístroje.
SL Uporabiti le orodje, ki ne povzroča isker.
FI Käytä ainoastaan kipinöimättömiä työkaluja.
SV Använd endast verktyg som inte ger upphov till gnistor.
P243 Language BG Вземете предпазни мерки срещу освобождаване на статично електричество.
ES Tomar medidas de precaución contra descargas electrostáticas.
CS Proveďte preventivní opatření proti výbojům statické elektřiny.
DA Træf foranstaltninger mod statisk elektricitet.
DE Maßnahmen gegen elektrostatische Aufladungen treffen.
ET Rakendada ettevaatusabinõusid staatilise elektri vastu.
EL Λάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.
EN Take precautionary measures against static discharge.
FR Prendre des mesures de précaution contre les décharges électrostatiques.
GA Déan bearta réamhchúraim in aghaidh díluchtú statach.
IT Prendere precauzioni contro le scariche elettrostatiche.
LV Nodrošināties pret statiskās enerģijas izlādi.
LT Imtis atsargumo priemonių statinei iškrovai išvengti.
HU Az elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.
MT Ħu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.
NL Voorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.
PL Przedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.
PT Evitar acumulação de cargas electrostáticas.
RO Luaţi măsuri de precauţie împotriva descărcărilor electrostatice.
SK Urobte preventívne opatrenia proti výbojom statickej elektriny.
SL Preprečiti statično naelektrenje.
FI Estä staattisen sähkön aiheuttama kipinöinti.
SV Vidta åtgärder mot statisk elektricitet.
P244 Language BG Почиствайте редуциращите вентили от смазка и масло
ES Mantener las válvulas de reducción limpias de grasa y aceite.
CS Udržujte redukční ventily bez maziva a oleje.
DA Reduktionsventilerne holdes fri for fedt og olie.
DE Druckminderer frei von Fett und Öl halten.
ET Hoida reduktsiooniklapid rasvast ja õlist puhtad.
EL Να διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.
EN Keep reduction valves free from grease and oil.
FR S’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.
GA Coimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.
IT Mantenere le valvole di riduzione libere da grasso e olio.
LV Turēt reducēšanās vārstus tīrus no taukiem un eļļas.
LT Saugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.
HU A nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.
MT Żomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.
NL Reduceerventielen vrij van olie en vet houden.
PL Chronić zawory redukcyjne przed tłuszczem i olejem.
PT Manter as válvulas de redução isentas de óleo e massa lubrificantes.
RO Protejaţi supapele reductoare de grăsimi și ulei.
SK Redukčné ventily udržiavajte bez mazadiel a oleja.
SL Preprečiti stik reducirnih ventilov z mastjo in oljem.
FI Pidä paineenalennusventtiilit vapaana rasvasta ja öljystä.
SV Reducerventilerna ska hållas fria från fett och olja.
P250 Language BG Да не се подлага на стържене/удар/…/триене
ES Evitar la abrasión/el choque/…/la fricción.
CS Nevystavujte obrušování/nárazům/…/tření.
DA Må ikke udsættes for slibning/stød/…/gnidning.
DE Nicht schleifen/stoßen/…/reiben.
ET Hoida kriimustamise/põrutuse/…/hõõrdumise eest.
EL Να αποφεύγεται άλεση/κρούση/…/τριβή.
EN Do not subject to grinding/shock/…/friction.
FR Éviter les abrasions/les chocs/…/les frottements.
GA Ná nocht do mheilt/do thurraing/…/do fhrithchuimilt.
IT Evitare le abrasioni/gli urti/…/gli attriti.
LV Nepakļaut drupināšanai/triecienam/…/berzei
LT Nešlifuoti/netrankyti/…/netrinti.
HU Tilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.
MT Tissottoponihomx għal brix/xokk/…/frizzjoni.
NL Malen/schokken/…/wrijving vermijden.
PL Nie poddawać szlifowaniu/wstrząsom/…/tarciu.
PT Não submeter a trituração/choque/…/fricção.
RO A nu supune la abraziuni/şocuri/…/frecare.
SK Nevystavujte brúseniu/nárazu/…/treniu.
SL Ne izpostavljati drgnjenju/udarcem/…/trenju.
FI Suojele rasitukselta/iskuilta/…/hankaukselta.
SV Får inte utsättas för gnidning/stötar/…/friktion.
P251 Language BG Съд под налягане: да не се пробива и изгаря дори след употреба.
ES Recipiente a presión: no perforar ni quemar, aun después del uso.
CS Tlakový obal: nepropichujte nebo nespalujte ani po použití.
DA Beholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.
DE Behälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.
ET Mahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.
EL Περιέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.
EN Pressurized container: Do not pierce or burn, even after use.
FR Récipient sous pression: ne pas perforer, ni brûler, même après usage.
GA Coimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.
IT Recipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.
LV Tvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.
LT Slėginis indas. Nepradurti ir nedeginti net panaudoto.
HU Nyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.
MT Kontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.
NL Houder onder druk: ook na gebruik niet doorboren of verbranden.
PL Pojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.
PT Recipiente sob pressão. Não furar nem queimar, mesmo após utilização.
RO Recipient sub presiune. Nu perforaţi sau ardeţi, chiar şi după utilizare.
SK Nádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.
SL Posoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.
FI Painesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.
SV Tryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.
P260 Language BG Не вдишвайте прах/пушек/газ/дим/изпарения/аерозоли
ES No respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
CS Nevdechujte prach/dým/plyn/mlhu/páry/aerosoly.
DA Indånd ikke pulver/røg/gas/tåge/damp/spray.
DE Staub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.
ET Tolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.
EL Μην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα
EN Do not breathe dust/fume/gas/mist/vapours/spray.
FR Ne pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
GA Ná hanálaigh deannach/múch/gás/ceo/gala/sprae.
IT Non respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
LV Neieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
LT Neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
HU A por/füst/gáz/köd/gőzök/permet belélegzése tilos.
MT Tiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
NL Stof/rook/gas/nevel/damp/spuitnevel niet inademen.
PL Nie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
PT Não respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
RO Nu inspiraţi praful/fumul/gazul/ceața/vaporii/spray-ul.
SK Nevdychujte prach/dym/plyn/hmlu/pary/aerosóly.
SL Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
FI Älä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.
SV Inandas inte damm/rök/gaser/dimma/ångor/sprej.
P261 Language BG Избягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли
ES Evitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
CS Zamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.
DA Undgå indånding af pulver/røg/gas/tåge/damp/spray.
DE Einatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.
ET Vältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.
EL Aποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.
EN Avoid breathing dust/fume/gas/mist/vapours/spray.
FR Éviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
GA Seachain deannach/múch/gás/ceo/gala/sprae a análú.
IT Evitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
LV Izvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
LT Stengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
HU Kerülje a por/füst/gáz/köd/gőzök/permet belélegzését.
MT Evita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
NL Inademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.
PL Unikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
PT Evitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
RO Evitaţi să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.
SK Zabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.
SL Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
FI Vältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.
SV Undvik att inandas damm/rök/gaser/dimma/ångor/sprej.
P262 Language BG Да се избягва контакт с очите, кожата или облеклото.
ES Evitar el contacto con los ojos, la piel o la ropa.
CS Zabraňte styku s očima, kůží nebo oděvem.
DA Må ikke komme i kontakt med øjne, hud eller tøj.
DE Nicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.
ET Vältida silma, nahale või rõivastele sattumist.
EL Να μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.
EN Do not get in eyes, on skin, or on clothing.
FR Éviter tout contact avec les yeux, la peau ou les vêtements.
GA Ná lig sna súile, ar an gcraiceann, ná ar éadaí.
IT Evitare il contatto con gli occhi, la pelle o gli indumenti.
LV Nepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.
LT Saugotis, kad nepatektų į akis, ant odos ar drabužių.
HU Szembe, bőrre vagy ruhára nem kerülhet.
MT Iddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.
NL Contact met de ogen, de huid of de kleding vermijden.
PL Nie wprowadzać do oczu, na skórę lub na odzież.
PT Não pode entrar em contacto com os olhos, a pele ou a roupa.
RO Evitaţi orice contact cu ochii, pielea sau îmbrăcămintea.
SK Zabráňte kontaktu s očami, pokožkou alebo odevom.
SL Preprečiti stik z očmi, kožo ali oblačili.
FI Varo kemikaalin joutumista silmiin, iholle tai vaatteisiin.
SV Får inte komma i kontakt med ögonen, huden eller kläderna.
P263 Language BG Да се избягва контакт по време на бременност/при кърмене.
ES Evitar el contacto durante el embarazo/la lactancia.
CS Zabraňte styku během těhotenství/kojení.
DA Undgå kontakt under graviditet/amning.
DE Kontakt während der Schwangerschaft/und der Stillzeit vermeiden.
ET Vältida kokkupuudet raseduse/imetamise ajal.
EL Aποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.
EN Avoid contact during pregnancy/while nursing.
FR Éviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.
GA Seachain teagmháil le linn toirchis/agus an chíoch á tabhairt.
IT Evitare il contatto durante la gravidanza/l’allattamento.
LV Izvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.
LT Vengti kontakto nėštumo metu/maitinant krūtimi.
HU A terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.
MT Evita l-kuntatt waqt it-tqala/waqt it-treddigħ.
NL Bij zwangerschap of borstvoeding aanraking vermijden.
PL Unikać kontaktu w czasie ciąży/karmienia piersią.
PT Evitar o contacto durante a gravidez/o aleitamento.
RO Evitaţi contactul în timpul sarcinii/alăptării.
SK Zabráňte kontaktu počas tehotenstva a dojčenia.
SL Preprečiti stik med nosečnostjo/dojenjem.
FI Vältä kosketusta raskauden tai imetyksen aikana.
SV Undvik kontakt under graviditet eller amning.
P264 Language BG Да се измие… старателно след употреба.
ES Lavarse … concienzudamente tras la manipulación.
CS Po manipulaci důkladně omyjte …
DA Vask … grundigt efter brug.
DE Nach Gebrauch … gründlich waschen.
ET Pärast käitlemist pesta hoolega …
EL Πλύνετε … σχολαστικά μετά το χειρισμό.
EN Wash … thoroughly after handling.
FR Se laver … soigneusement après manipulation.
GA Nigh … go lánchúramach tar éis láimhsithe.
IT Lavare accuratamente … dopo l’uso.
LV Pēc izmantošanas … kārtīgi nomazgāt.
LT Po naudojimo kruopščiai nuplauti …
HU A használatot követően a(z) … -t alaposan meg kell mosni.
MT Aħsel … sew wara li timmaniġġjah.
NL Na het werken met dit product … grondig wassen.
PL Dokładnie umyć … po użyciu.
PT Lavar … cuidadosamente após manuseamento.
RO Spălaţi-vă … bine după utilizare.
SK Po manipulácii starostlivo umyte…
SL Po uporabi temeljito umiti …
FI Pese … huolellisesti käsittelyn jälkeen.
SV Tvätta … grundligt efter användning.
P270 Language BG Да не се яде, пие или пуши при употреба на продукта.
ES No comer, beber ni fumar durante su utilización.
CS Při používání tohoto výrobku nejezte, nepijte ani nekuřte.
DA Der må ikke spises, drikkes eller ryges under brugen af dette produkt.
DE Bei Gebrauch nicht essen, trinken oder rauchen.
ET Toote käitlemise ajal mitte süüa, juua ega suitsetada.
EL Μην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.
EN Do no eat, drink or smoke when using this product.
FR Ne pas manger, boire ou fumer en manipulant ce produit.
GA Ná hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.
IT Non mangiare, né bere, né fumare durante l’uso.
LV Neēst, nedzert un nesmēķēt produkta izmantošanas laikā.
LT Naudojant šį produktą, nevalgyti, negerti ir nerūkyti.
HU A termék használata közben tilos enni, inni vagy dohányozni.
MT Tikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.
NL Niet eten, drinken of roken tijdens het gebruik van dit product.
PL Nie jeść, nie pić i nie palić podczas używania produktu.
PT Não comer, beber ou fumar durante a utilização deste produto.
RO A nu mânca, bea sau fuma în timpul utilizării produsului.
SK Pri používaní výrobku nejedzte, nepite ani nefajčite.
SL Ne jesti, piti ali kaditi med uporabo tega izdelka.
FI Syöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.
SV Ät inte, drick inte och rök inte när du använder produkten.
P271 Language BG Да се използва само на открито или на добре проветривомясто.
ES Utilizar únicamente en exteriores o en un lugar bien ventilado.
CS Používejte pouze venku nebo v dobře větraných prostorách.
DA Brug kun udendørs eller i et rum med god udluftning.
DE Nur im Freien oder in gut belüfteten Räumen verwenden.
ET Käidelda üksnes välitingimustes või hästi ventileeritavas kohas.
EL Να χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.
EN Use only outdoors or in a well-ventilated area.
FR Utiliser seulement en plein air ou dans un endroit bien ventilé.
GA Úsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.
IT Utilizzare soltanto all’aperto o in luogo ben ventilato.
LV Izmantot tikai ārā vai labi vēdināmās telpās.
LT Naudoti tik lauke arba gerai vėdinamoje patalpoje.
HU Kizárólag szabadban vagy jól szellőző helyiségben használható.
MT Uża biss barra jew f’post ventilat sew.
NL Alleen buiten of in een goed geventileerde ruimte gebruiken.
PL Stosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu
PT Utilizar apenas ao ar livre ou em locais bem ventilados.
RO A se utiliza numai în aer liber sau în spaţii bine ventilate.
SK Používajte iba na voľnom priestranstve alebo v dobre vetranom priestore.
SL Uporabljati le zunaj ali v dobro prezračevanem prostoru.
FI Käytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.
SV Används endast utomhus eller i väl ventilerade utrymmen.
P272 Language BG Да не се изнася замърсено работно облекло извън работното помещение.
ES Las prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.
CS Kontaminovaný pracovní oděv neodnášejte z pracoviště.
DA Tilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.
DE Kontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.
ET Saastunud töörõivaid töökohast mitte välja viia.
EL Τα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.
EN Contaminated work clothing should not be allowed out of the workplace.
FR Les vêtements de travail contaminés ne devraient pas sortir du lieu de travail.
GA Níor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.
IT Gli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.
LV Piesārņoto darba apģērbu neiznest ārpus darba telpām.
LT Užterštų darbo drabužių negalima išnešti iš darbo vietos.
HU Szennyezett munkaruhát tilos kivinni a munkahely területéről.
MT Ilbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.
NL Verontreinigde werkkleding mag de werkruimte niet verlaten.
PL Zanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.
PT A roupa de trabalho contaminada não pode sair do local de trabalho.
RO Nu scoateţi îmbrăcămintea de lucru contaminată în afara locului de muncă.
SK Je zakázané vyniesť kontaminovaný pracovný odev z pracoviska.
SL Kontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.
FI Saastuneita työvaatteita ei saa viedä työpaikalta.
SV Nedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.
P273 Language BG Да се избягва изпускане в околната среда.
ES Evitar su liberación al medio ambiente.
CS Zabraňte uvolnění do životního prostředí.
DA Undgå udledning til miljøet.
DE Freisetzung in die Umwelt vermeiden.
ET Vältida sattumist keskkonda.
EL Να αποφεύγεται η ελευθέρωση στο περιβάλλον.
EN Avoid release to the environment.
FR Éviter le rejet dans l’environnement.
GA Ná scaoiltear amach sa chomhshaol.
IT Non disperdere nell’ambiente.
LV Izvairīties no izplatīšanas apkārtējā vidē.
LT Saugoti, kad nepatektų į aplinką.
HU Kerülni kell az anyagnak a környezetbe való kijutását.
MT Evita r-rilaxx fl-ambjent.
NL Voorkom lozing in het milieu.
PL Unikać uwolnienia do środowiska.
PT Evitar a libertação para o ambiente.
RO Evitaţi dispersarea în mediu.
SK Zabráňte uvoľneniu do životného prostredia.
SL Preprečiti sproščanje v okolje.
FI Vältettävä päästämistä ympäristöön.
SV Undvik utsläpp till miljön.
P280 Language BG Използвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.
ES Llevar guantes/prendas/gafas/máscara de protección.
CS Používejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.
DA Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse
DE Schutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.
ET Kanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.
EL Να φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.
EN Wear protective gloves/protective clothing/eye protection/face protection.
FR Porter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.
GA Caith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.
IT Indossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.
LV Izmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.
LT Mūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.
HU Védőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.
MT Ilbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.
NL Beschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.
PL Stosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.
PT Usar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.
RO Purtaţi mănuşi de protecţie/îmbrăcăminte de protecţie/echipament de protecţie a ochilor/echipament de protecţie a feţei.
SK Noste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.
SL Nositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.
FI Käytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.
SV Använd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.
P281 Language BG Използвайте предписаните лични предпазни средства.
ES Utilizar el equipo de protección individual obligatorio.
CS Používejte požadované osobní ochranné prostředky.
DA Anvend de påkrævede personlige værnemidler.
DE Vorgeschriebene persönliche Schutzausrüstung verwenden.
ET Kasutada vajalikke isikukaitsevahendeid.
EL Χρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.
EN Use personal protective equipment as required.
FR Utiliser l’équipement de protection individuel requis.
GA Bain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.
IT Utilizzare il dispositivo di protezione individuale richiesto.
LV Izmantot personisko aizsargaprīkojumu atbilstoši prasībām.
LT Naudoti reikalaujamas asmenines apsaugos priemones.
HU Az előírt egyéni védőfelszerelés használata kötelező.
MT Uża’ t-tagħmir personali protettiv kif meħtieġ.
NL De nodige persoonlijke beschermingsuitrusting gebruiken.
PL Stosować wymagane środki ochrony indywidualnej.
PT Usar o equipamento de protecção individual exigido.
RO Utilizaţi echipamentul de protecţie individuală conform cerinţelor.
SK Používajte predpísané osobné ochranné prostriedky.
SL Uporabiti predpisano osebno zaščitno opremo.
FI Käytä vaadittuja henkilönsuojaimia.
SV Använd föreskriven personlig skyddsutrustning.
P282 Language BG Носете предпазващи от студ ръкавици/маска за лице/защитни очила.
ES Llevar guantes que aíslen del frío/gafas/máscara.
CS Používejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.
DA Bær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.
DE Schutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.
ET Kanda külmakaitsekindaid/kaitsemaski/kaitseprille.
EL Φοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.
EN Wear cold insulating gloves/face shield/eye protection.
FR Porter des gants isolants contre le froid/un équipement de protection du visage/des yeux.
GA Caith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.
IT Utilizzare guanti termici/schermo facciale/Proteggere gli occhi.
LV Izmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.
LT Mūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.
HU Hidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.
MT Ilbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.
NL Koude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.
PL Nosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.
PT Usar luvas de protecção contra o frio/escudo facial/protecção ocular.
RO Purtaţi mănuşi izolante împotriva frigului/echipament de protecţie a feţei/ochilor.
SK Používajte termostabilné rukavice/ochranný štít/ochranné okuliare.
SL Nositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.
FI Käytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.
SV Använd köldisolerande handskar/visir/ögonskydd.
P283 Language BG Носете огнеупорно/огнезащитно облекло.
ES Llevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.
CS Používejte ohnivzdorný/nehořlavý oděv.
DA Bær brandbestandig/brandhæmmende beklædning.
DE Schwer entflammbare/flammhemmende Kleidung tragen.
ET Kanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.
EL Φοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.
EN Wear fire/flame resistant/retardant clothing.
FR Porter des vêtements résistant au feu/aux flammes/ignifuges.
GA Caith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.
IT Indossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.
LV Izmantot aizsargapģērbu pret uguni/liesmām.
LT Dėvėti ugniai/liepsnai atsparius/antipireninius drabužius.
HU Tűz-/lángálló/-késleltető ruházat viselése kötelező.
MT Ilbies ħwejjeġ reżistenti għan-nar/fjammi.
NL Vuur/vlambestendige/brandwerende kleding dragen.
PL Nosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.
PT Usar vestuário ignífugo/retardador de fogo/chamas.
RO Purtaţi îmbrăcăminte rezistentă la foc/flacără/ignifugă.
SK Noste ohňovzdorný odev/odev so zníženou horľavosťou.
SL Nositi negorljiva oblačila in oblačila, odporna proti ognju.
FI Käytä palosuojattua/paloturvallista vaatetusta.
SV Använd brand-/flamsäkra eller brand-/flamhämmande kläder.
P284 Language BG Носете респираторни предпазни средства.
ES Llevar equipo de protección respiratoria.
CS Používejte vybavení pro ochranu dýchacích cest.
DA Anvend åndedrætsværn.
DE Atemschutz tragen.
ET Kanda hingamisteede kaitsevahendeid.
EL Φοράτε μέσα ατομικής προστασίας της αναπνοής.
EN Wear respiratory protection.
FR Porter un équipement de protection respiratoire.
GA Caith cosaint riospráide.
IT Utilizzare un apparecchio respiratorio.
LV Izmantot gāzmasku.
LT Naudoti kvėpavimo takų apsaugos priemones.
HU Légzésvédelem használata kötelező.
MT Ilbes protezzjoni respiratorja.
NL Adembescherming dragen.
PL Stosować indywidualne środki ochrony dróg oddechowych.
PT Usar protecção respiratória.
RO Purtaţi echipament de protecţie respiratorie.
SK Používajte ochranu dýchacích ciest.
SL Nositi opremo za zaščito dihal.
FI Käytä hengityksensuojainta.
SV Använd andningsskydd.
P285 Language BG В случай на лоша вентилация носете респираторни предпазни средства.
ES En caso de ventilación insuficiente, llevar equipo de protección respiratoria.
CS V případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.
DA Ved utilstrækkelig udluftning anvendes åndedrætsværn.
DE Bei unzureichender Belüfung Atemschutz tragen.
ET Ebapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.
EL Σε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.
EN In case of inadequate ventilation wear respiratory protection.
FR Lorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.
GA I gcás aerála uireasaigh caith cosaint riospráide.
IT In caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.
LV Neatbilstošas ventilācijas gadījumā izmantot gāzmasku.
LT Esant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.
HU Nem megfelelő szellőzés esetén légzésvédelem kötelező.
MT F’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.
NL Bij ontoereikende ventilatie een geschikte adembescherming dragen.
PL W przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.
PT Em caso de ventilação inadequada, usar protecção respiratória.
RO În cazul în care ventilarea este insuficientă, purtaţi echipament de protecţie respiratorie.
SK V prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.
SL Ob nezadostnem prezračevanju nositi opremo za zaščito dihal.
FI Käytä hengityksensuojainta, jos ilmanvaihto on riittämätön.
SV Använd andningsskydd vid otillräcklig ventilation.
P231 + P232 Language BG Да се използва под инертен газ. Да се пази от влага.
ES Manipular en gas inerte. Proteger de la humedad.
CS Manipulace pod inertním plynem. Chraňte před vlhkem.
DA Anvendes under inaktiv gas. Beskyttes mod fugt.
DE Unter inertem Gas handhaben. Vor Feuchtigkeit schützen.
ET Käidelda inertgaasis. Hoida niiskuse eest.
EL Χειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.
EN Handle under inert gas. Protect from moisture.
FR Manipuler sous gaz inerte. Protéger de l’humidité.
GA Láimhsigh faoi thriathghás. Cosain ó thaise.
IT Manipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.
LV Izmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.
LT Tvarkyti inertinėse dujose. Saugoti nuo drėgmės.
HU Inert gázban használandó. Nedvességtől védendő.
MT Uża’ taħt gass inerti. Ipproteġi mill-umdità.
NL Onder inert gas werken. Tegen vocht beschermen.
PL Używać w atmosferze obojętnego gazu Chronić przed wilgocią.
PT Manusear em atmosfera de gás inerte. Manter ao abrigo da humidade.
RO A se manipula sub un gaz inert. A se proteja de umiditate.
SK Manipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.
SL Hraniti v ustreznem inertnem plinu. Zaščititi pred vlago.
FI Käsittele inertissä kaasussa. Suojaa kosteudelta.
SV Hanteras under inert gas. Skyddas från fukt.
P235 + P410 Language BG Да се държи на хладно. Да се пази от пряка слънчева светлина.
ES Conservar en un lugar fresco. Proteger de la luz del sol.
CS Uchovávejte v chladu. Chraňte před slunečním zářením.
DA Opbevares køligt. Beskyttes mod sollys.
DE Kühl halten. Vor Sonnenbestrahlung schützen.
ET Hoida jahedas. Hoida päikesevalguse eest.
EL Να διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.
EN Keep cool. Protect from sunlight.
FR Tenir au frais. Protéger du rayonnement solaire.
GA Coimeád fionnuar. Cosain ó sholas na gréine.
IT Tenere in luogo fresco. Proteggere dai raggi solari.
LV Turēt vēsumā. Aizsargāt no saules gaismas.
LT Laikyti vėsioje vietoje. Saugoti nuo saulės šviesos.
HU Hűvös helyen tartandó. Napfénytől védendő.
MT Żomm frisk. Ipproteġi mir-raġġi tax-xemx.
NL Koel bewaren. Tegen zonlicht beschermen.
PL Przechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.
PT Conservar em ambiente fresco. Manter ao abrigo da luz solar.
RO A se păstra la rece. A se proteja de lumina solară.
SK Uchovávajte v chlade. Chráňte pred slnečným žiarením.
SL Hraniti na hladnem. Zaščititi pred sončno svetlobo.
FI Säilytä viileässä. Suojaa auringonvalolta.
SV Förvaras svalt. Skyddas från solljus.
Table 1.3
Precautionary statements — Response
P301 Language BG ПРИ ПОГЛЪЩАНЕ:
ES EN CASO DE INGESTIÓN:
CS PŘI POŽITÍ:
DA I TILFÆLDE AF INDTAGELSE:
DE BEI VERSCHLUCKEN:
ET ALLANEELAMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:
EN IF SWALLOWED:
FR EN CAS D’INGESTION:
GA MÁ SHLOGTAR:
IT IN CASO DI INGESTIONE:
LV NORĪŠANAS GADĪJUMĀ:
LT PRARIJUS:
HU LENYELÉS ESETÉN:
MT JEKK JINBELA’:
NL NA INSLIKKEN:
PL W PRZYPADKU POŁKNIĘCIA:
PT EM CASO DE INGESTÃO:
RO ÎN CAZ DE ÎNGHIŢIRE:
SK PO POŽITÍ:
SL PRI ZAUŽITJU:
FI JOS KEMIKAALIA ON NIELTY:
SV VID FÖRTÄRING:
P302 Language BG ПРИ КОНТАКТ С КОЖАТА:
ES EN CASO DE CONTACTO CON LA PIEL:
CS PŘI STYKU S KŮŽÍ:
DA VED KONTAKT MED HUDEN:
DE BEI BERÜHRUNG MIT DER HAUT:
ET NAHALE SATTUMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:
EN IF ON SKIN:
FR EN CAS DE CONTACT AVEC LA PEAU:
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:
IT IN CASO DI CONTATTO CON LA PELLE:
LV SASKARĒ AR ĀDU:
LT PATEKUS ANT ODOS:
HU HA BŐRRE KERÜL:
MT F'KAŻ TA' KUNTATT MAL-ĠILDA:
NL BIJ CONTACT MET DE HUID:
PL W PRZYPADKU KONTAKTU ZE SKÓRĄ:
PT SE ENTRAR EM CONTACTO COM A PELE:
RO ÎN CAZ DE CONTACT CU PIELEA:
SK PRI KONTAKTE S POKOŽKOU:
SL PRI STIKU S KOŽO:
FI JOS KEMIKAALIA JOUTUU IHOLLE:
SV VID HUDKONTAKT:
P303 Language BG ПРИ КОНТАКТ С КОЖАТА (или косата):
ES EN CASO DE CONTACTO CON LA PIEL (o el pelo):
CS PŘI STYKU S KŮŽÍ (nebo s vlasy):
DA VED KONTAKT MED HUDEN (eller håret):
DE BEI BERÜHRUNG MIT DER HAUT (oder dem Haar):
ET NAHALE (või juustele) SATTUMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):
EN IF ON SKIN (or hair):
FR EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):
IT IN CASO DI CONTATTO CON LA PELLE (o con i capelli):
LV SASKARĒ AR ĀDU (vai matiem):
LT PATEKUS ANT ODOS (arba plaukų):
HU HA BŐRRE (vagy hajra) KERÜL:
MT F'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):
NL BIJ CONTACT MET DE HUID (of het haar):
PL W PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):
PT SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):
RO ÎN CAZ DE CONTACT CU PIELEA (sau părul):
SK PRI KONTAKTE S POKOŽKOU (alebo vlasmi):
SL PRI STIKU S KOŽO (ali lasmi):
FI JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):
SV VID HUDKONTAKT (även håret):
P304 Language BG ПРИ ВДИШВАНЕ:
ES EN CASO DE INHALACIÓN:
CS PŘI VDECHNUTÍ:
DA VED INDÅNDING:
DE BEI EINATMEN:
ET SISSEHINGAMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:
EN IF INHALED:
FR EN CAS D’INHALATION:
GA MÁ IONANÁLAÍTEAR:
IT IN CASO DI INALAZIONE:
LV IEELPOJOT:
LT ĮKVĖPUS:
HU BELÉLEGZÉS ESETÉN:
MT JEKK JINĠIBED MAN-NIFS:
NL NA INADEMING:
PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:
PT EM CASO DE INALAÇÃO:
RO ÎN CAZ DE INHALARE:
SK PO VDÝCHNUTÍ:
SL PRI VDIHAVANJU:
FI JOS KEMIKAALIA ON HENGITETTY:
SV VID INANDNING:
P305 Language BG ПРИ КОНТАКТ С ОЧИТЕ:
ES EN CASO DE CONTACTO CON LOS OJOS:
CS PŘI ZASAŽENÍ OČÍ:
DA VED KONTAKT MED ØJNENE:
DE BEI KONTAKT MIT DEN AUGEN:
ET SILMA SATTUMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:
EN IF IN EYES:
FR EN CAS DE CONTACT AVEC LES YEUX:
GA I gCÁS TEAGMHÁLA LEIS NA SÚILE:
IT IN CASO DI CONTATTO CON GLI OCCHI:
LV IEKĻŪSTOT ACĪS:
LT PATEKUS Į AKIS:
HU SZEMBE KERÜLÉS ESETÉN:
MT JEKK JIDĦOL FL-GĦAJNEJN:
NL BIJ CONTACT MET DE OGEN:
PL W PRZYPADKU DOSTANIA SIĘ DO OCZU:
PT SE ENTRAR EM CONTACTO COM OS OLHOS:
RO ÎN CAZ DE CONTACT CU OCHII:
SK PO ZASIAHNUTÍ OČÍ:
SL PRI STIKU Z OČMI:
FI JOS KEMIKAALIA JOUTUU SILMIIN:
SV VID KONTAKT MED ÖGONEN:
P306 Language BG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:
ES EN CASO DE CONTACTO CON LA ROPA:
CS PŘI STYKU S ODĚVEM:
DA VED KONTAKT MED TØJET:
DE BEI KONTAMINIERTER KLEIDUNG:
ET RÕIVASTELE SATTUMISE KORRAL:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:
EN IF ON CLOTHING:
FR EN CAS DE CONTACT AVEC LES VÊTEMENTS:
GA I gCÁS TEAGMHÁLA LE hÉADAÍ:
IT IN CASO DI CONTATTO CON GLI INDUMENTI:
LV SASKARĒ AR APĢĒRBU:
LT PATEKUS ANT DRABUŽIŲ:
HU HA RUHÁRA KERÜL:
MT F'KAŻ TA' KUNTATT MA' L-ILBIES:
NL NA MORSEN OP KLEDING:
PL W PRZYPADKU KONTAKTU Z ODZIEŻĄ:
PT SE ENTRAR EM CONTACTO COM A ROUPA:
RO ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:
SK PRI KONTAKTE S ODEVOM:
SL PRI STIKU Z OBLAČILI:
FI JOS KEMIKAALIA JOUTUU VAATTEISIIN:
SV VID KONTAKT MED KLÄDERNA:
P307 Language BG ПРИ експозиция:
ES EN CASO DE exposición:
CS PŘI expozici:
DA VED eksponering:
DE BEI Exposition:
ET Kokkupuute korral:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:
EN IF exposed:
FR EN CAS d’exposition:
GA I gCÁS nochta:
IT IN CASO di esposizione:
LV JA saskaras:
LT Esant sąlyčiui:
HU Expozíció esetén:
MT JEKK espost:
NL NA blootstelling:
PL W PRZYPADKU narażenia:
PT EM CASO DE exposição:
RO ÎN CAZ DE expunere:
SK PO expozícii:
SL PRI izpostavljenosti:
FI Altistumisen tapahduttua:
SV Om du exponerats:
P308 Language BG ПРИ явна или предполагаема експозиция:
ES EN CASO DE exposición manifiesta o presunta:
CS PŘI expozici nebo podezření na ni:
DA VED eksponering eller mistanke om eksponering:
DE BEI Exposition oder falls betroffen
ET Kokkupuute või kokkupuutekahtluse korral:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:
EN IF exposed or concerned:
FR EN CAS d’exposition prouvée ou suspectée:
GA I gCÁS nochta nó má mheastar a bheith nochtaithe:
IT IN CASO di esposizione o di possibile esposizione:
LV Ja saskaras vai saistīts ar:
LT Esant sąlyčiui arba jeigu numanomas sąlytis:
HU Expozíció vagy annak gyanúja esetén:
MT JEKK espost jew konċernat:
NL NA (mogelijke) blootstelling:
PL W PRZYPADKU narażenia lub styczności:
PT EM CASO DE exposição ou suspeita de exposição:
RO ÎN CAZ DE expunere sau de posibilă expunere:
SK Po expozícii alebo podozrení z nej:
SL PRI izpostavljenosti ali sumu izpostavljenosti:
FI Altistumisen tapahduttua tai jos epäillään altistumista:
SV Vid exponering eller misstanke om exponering:
P309 Language BG ПРИ експозиция или при неразположение:
ES EN CASO DE exposición o malestar:
CS PŘI expozici nebo necítíte-li se dobře:
DA VED eksponering eller ubehag:
DE BEI Exposition oder Unwohlsein:
ET Kokkupuute või halva enesetunde korral:
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:
EN IF exposed or if you feel unwell:
FR EN CAS d’exposition ou d'un malaise:
GA I gCÁS nochta nó má bhraitear tinn:
IT IN CASO di esposizione o di malessere:
LV JA saskaras vai ja jums ir slikta pašsajūta:
LT Esant sąlyčiui arba blogai pasijutus:
HU Expozíció vagy rosszullét esetén:
MT JEKK espost jew tħossok ma tiflaħx:
NL NA blootstelling of bij onwel voelen:
PL W PRZYPADKU narażenia lub złego samopoczucia:
PT EM CASO DE exposição ou de indisposição:
RO ÎN CAZ DE expunere sau dacă nu vă simţiţi bine:
SK Po expozícii alebo pri zdravotných problémoch.
SL PRI izpostavljenosti ali slabem počutju:
FI Altistumisen tapahduttua tai jos ilmenee pahoinvointia:
SV Vid exponering eller obehag:
P310 Language BG Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES Llamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
CS Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA Ring omgående til en GIFTINFORMATION eller en læge.
DE Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN Immediately call a POISON CENTER or doctor/physician.
FR Appeler immédiatement un CENTRE ANTIPOISON ou un médecin.
GA Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
IT Contattare immediatamente un CENTRO ANTIVELENI o un medico.
LV Nekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL Onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
PL Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
PT Contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO Sunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK Okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL Takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SV Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.
P311 Language BG Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
CS Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA Ring til en GIFTINFORMATION eller en læge.
DE GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN Call a POISON CENTER or doctor/physician.
FR Appeler un CENTRE ANTIPOISON ou un médecin.
GA Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
IT Contattare un CENTRO ANTIVELENI o un medico.
LV Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL Een ANTIGIFCENTRUM of een arts raadplegen.
PL Skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
PT Contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO Sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK Volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL Pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SV Kontakta GIFTINFORMATIONSCENTRAL eller läkare.
P312 Language BG При неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.
CS Necítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
DE Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.
EN Call a POISON CENTER or doctor/physician if you feel unwell.
FR Appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
GA Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
IT In caso di malessere, contattare un CENTRO ANTIVELENI o un medico.
LV Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
LT Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Rosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
NL Bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
PL W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT Caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO Sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
SK Pri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL Ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
SV Vid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.
P313 Language BG Потърсете медицински съвет/помощ.
ES Consultar a un médico.
CS Vyhledejte lékařskou pomoc/ošetření.
DA Søg lægehjælp.
DE Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Pöörduda arsti poole.
EL Συμβουλευθείτε/Επισκεφθείτε γιατρό.
EN Get medical advice/attention.
FR Consulter un médecin.
GA Faigh comhairle/cúram liachta.
IT Consultare un medico.
LV Lūdziet palīdzību mediķiem.
LT Kreiptis į gydytoją.
HU Orvosi ellátást kell kérni.
MT Ikkonsulta tabib.
NL Een arts raadplegen.
PL Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Consulte um médico.
RO Consultaţi medicul.
SK Vyhľadajte lekársku pomoc/starostlivosť.
SL Poiščite zdravniško pomoč/oskrbo.
FI Hakeudu lääkäriin.
SV Sök läkarhjälp.
P314 Language BG При неразположение потърсете медицински съвет/помощ.
ES Consultar a un médico en caso de malestar.
CS Necítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.
DA Søg lægehjælp ved ubehag.
DE Bei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Halva enesetunde korral pöörduda arsti poole.
EL Συμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.
EN Get medical advice/attention if you feel unwell.
FR Consulter un médecin en cas de malaise.
GA Faigh comhairle/cúram liachta má bhraitheann tú tinn.
IT In caso di malessere, consultare un medico.
LV Lūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.
LT Pasijutus blogai, kreiptis į gydytoją.
HU Rosszullét esetén orvosi ellátást kell kérni.
MT Ikkonsulta tabib jekk tħossok ma tiflaħx.
NL Bij onwel voelen een arts raadplegen.
PL W przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Em caso de indisposição, consulte um médico.
RO Consultaţi medicul, dacă nu vă simţiţi bine.
SK Ak pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.
SL Ob slabem počutju poiščite zdravniško pomoč/oskrbo.
FI Hakeudu lääkäriin, jos ilmenee pahoinvointia.
SV Sök läkarhjälp vid obehag.
P315 Language BG Незабавно потърсете медицински съвет/помощ.
ES Consultar a un médico inmediatamente.
CS Okamžitě vyhledejte lékařskou pomoc/ošetření.
DA Søg omgående lægehjælp.
DE Sofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Pöörduda viivitamata arsti poole.
EL Συμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.
EN Get immediate medical advice/attention.
FR Consulter immédiatement un médecin.
GA Faigh comhairle/cúram liachta láithreach.
IT Consultare immediatamente un medico.
LV Nekavējoties lūdziet palīdzību mediķiem.
LT Nedelsiant kreiptis į gydytoją.
HU Azonnal orvosi ellátást kell kérni.
MT Ikkonsulta tabib minnufih.
NL Onmiddellijk een arts raadplegen.
PL Natychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Consulte imediatamente um médico.
RO Consultaţi imediat medicul.
SK Okamžite vyhľadajte lekársku pomoc/starostlivosť.
SL Takoj poiščite zdravniško pomoč/oskrbo.
FI Hakeudu välittömästi lääkäriin.
SV Sök omedelbart läkarhjälp.
P320 Language BG Спешна нужда от специализирано лечение (вж… на този етикет).
ES Se necesita urgentemente un tratamiento específico (ver … en esta etiqueta).
CS Je nutné odborné ošetření (viz … na tomto štítku).
DA Særlig behandling straks påkrævet (se … på denne etiket).
DE Besondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).
ET Nõuab viivitamatut eriravi (vt … käesoleval etiketil).
EL Χρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).
EN Specific treatment is urgent (see … on this label).
FR Un traitement spécifique est urgent (voir … sur cette étiquette).
GA Tá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).
IT Trattamento specifico urgente (vedere… su questa etichetta).
LV Steidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
LT Būtinas skubus specialus gydymas (žr. … šioje etiketėje).
HU Sürgős szakellátás szükséges (lásd … a címkén).
MT Trattament speċifiku hu urġenti (ara … fuq din it-tikketta).
NL Specifieke behandeling dringend vereist (zie … op dit etiket).
PL Pilnie zastosować określone leczenie (patrz … na etykiecie).
PT É urgente um tratamento específico (ver … no presente rótulo).
RO Un tratament specific este urgent (a se vedea … de pe această etichetă).
SK Odborné ošetrenie je naliehavé (pozri … na etikete).
SL Posebno zdravljenje je nujno (glejte … na tej etiketi).
FI Erityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).
SV Särskild behandling krävs omedelbart (se … på etiketten).
P321 Language BG Специализирано лечение (вж… на този етикет).
ES Se necesita un tratamiento específico (ver … en esta etiqueta).
CS Odborné ošetření (viz … na tomto štítku).
DA Særlig behandling (se … på denne etiket).
DE Besondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).
ET Nõuab eriravi (vt … käesoleval etiketil).
EL Χρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).
EN Specific treatment (see … on this label).
FR Traitement spécifique (voir … sur cette étiquette).
GA Cóir liachta ar leith (féach … ar an lipéad seo).
IT Trattamento specifico (vedere …su questa etichetta).
LV Īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
LT Specialus gydymas (žr. … šioje etiketėje).
HU Szakellátás (lásd … a címkén).
MT Trattament speċifiku (ara … fuq din it-tikketta).
NL Specifieke behandeling vereist (zie … op dit etiket).
PL Zastosować określone leczenie (patrz … na etykiecie).
PT Tratamento específico (ver … no presente rótulo).
RO Tratament specific (a se vedea … de pe această etichetă).
SK Odborné ošetrenie (pozri … na etikete).
SL Posebno zdravljenje (glejte … na tej etiketi).
FI Erityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).
SV Särskild behandling (se … på etiketten).
P322 Language BG Специални мерки (вж… на този етикет).
ES Se necesitan medidas específicas (ver … en esta etiqueta).
CS Specifické opatření (viz … na tomto štítku).
DA Særlige foranstaltninger (se … på denne etiket).
DE Gezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).
ET Nõuab erimeetmeid (vt … käesoleval etiketil).
EL Χρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).
EN Specific measures (see … on this label).
FR Mesures spécifiques (voir … sur cette étiquette).
GA Bearta ar leith (féach … ar an lipéad seo).
IT Misure specifiche (vedere …su questa etichetta).
LV Īpaši pasākumi (skat. … uz šīs etiķetes).
LT Specialios priemonės (žr. … šioje etiketėje).
HU Különleges intézkedések (lásd … a címkén).
MT Miżuri speċifiċi (ara … fuq din it-tikketta).
NL Specifieke maatregelen (zie … op dit etiket).
PL Środki szczególne (patrz … na etykiecie).
PT Medidas específicas (ver … no presente rótulo).
RO Măsuri specifice (a se vedea … de pe această etichetă).
SK Osobitné opatrenia (pozri … na etikete).
SL Posebni ukrepi (glejte … na tej etiketi).
FI Erityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).
SV Särskilda åtgärder (se … på etiketten).
P330 Language BG Изплакнете устата.
ES Enjuagarse la boca.
CS Vypláchněte ústa.
DA Skyl munden.
DE Mund ausspülen.
ET Loputada suud.
EL Ξεπλύνετε το στόμα.
EN Rinse mouth.
FR Rincer la bouche.
GA Sruthlaítear an béal.
IT Sciacquare la bocca.
LV Izskalot muti.
LT Išskalauti burną.
HU A szájat ki kell öblíteni.
MT Laħlaħ ħalqek.
NL De mond spoelen.
PL Wypłukać usta.
PT Enxaguar a boca.
RO Clătiţi gura.
SK Vypláchnite ústa.
SL Izprati usta.
FI Huuhdo suu.
SV Skölj munnen.
P331 Language BG НЕ предизвиквайте повръщане.
ES NO provocar el vómito.
CS NEVYVOLÁVEJTE zvracení.
DA Fremkald IKKE opkastning.
DE KEIN Erbrechen herbeiführen.
ET MITTE kutsuda esile oksendamist.
EL ΜΗΝ προκαλέσετε εμετό.
EN Do NOT induce vomiting.
FR NE PAS faire vomir.
GA NÁ spreagtar urlacan.
IT NON provocare il vomito.
LV NEIZRAISĪT vemšanu.
LT NESKATINTI vėmimo.
HU TILOS hánytatni.
MT TIPPROVOKAX ir-remettar.
NL GEEN braken opwekken.
PL NIE wywoływać wymiotów.
PT NÃO provocar o vómito.
RO NU provocaţi voma.
SK Nevyvolávajte zvracanie.
SL NE izzvati bruhanja.
FI EI saa oksennuttaa.
SV Framkalla INTE kräkning.
P332 Language BG При поява на кожно дразнене:
ES En caso de irritación cutánea:
CS Při podráždění kůže:
DA Ved hudirritation:
DE Bei Hautreizung:
ET Nahaärrituse korral:
EL Εάν παρατηρηθεί ερεθισμός του δέρματος:
EN If skin irritation occurs:
FR En cas d’irritation cutanée:
GA I gcás greannú craicinn:
IT In caso di irritazione della pelle:
LV Ja rodas ādas iekaisums:
LT Jeigu sudirginama oda:
HU Bőrirritáció esetén:
MT Jekk ikun hemm irritazzjoni tal-ġilda:
NL Bij huidirritatie:
PL W przypadku wystąpienia podrażnienia skóry:
PT Em caso de irritação cutânea:
RO În caz de iritare a pielii:
SK Ak sa prejaví podráždenie pokožky:
SL Če nastopi draženje kože:
FI Jos ilmenee ihoärsytystä:
SV Vid hudirritation:
P333 Language BG При поява на кожно дразнене или обрив на кожата:
ES En caso de irritación o erupción cutánea:
CS Při podráždění kůže nebo vyrážce:
DA Ved hudirritation eller udslet:
DE Bei Hautreizung oder -ausschlag:
ET Nahaärrituse või _obe korral:
EL Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:
EN If skin irritation or rash occurs:
FR En cas d’irritation ou d’éruption cutanée:
GA I gcás greannú nó grís craicinn:
IT In caso di irritazione o eruzione della pelle:
LV Ja rodas ādas iekaisums vai izsitumi:
LT Jeigu sudirginama oda arba ją išberia.
HU Bőrirritáció vagy kiütések megjelenése esetén:
MT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda:
NL Bij huidirritatie of uitslag:
PL W przypadku wystąpienia podrażnienia skóry lub wysypki:
PT Em caso de irritação ou erupção cutânea:
RO În caz de iritare a pielii sau de erupţie cutanată:
SK Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:
SL Če nastopi draženje kože ali se pojavi izpuščaj:
FI Jos ilmenee ihoärsytystä tai ihottumaa:
SV Vid hudirritation eller utslag:
P334 Language BG Потопете в хладка вода/сложете мокри компреси.
ES Sumergir en agua fresca/aplicar compresas húmedas.
CS Ponořte do studené vody/zabalte do vlhkého obvazu.
DA Skyl under koldt vand/anvend våde omslag.
DE In kaltes Wasser tauchen/nassen Verband anlegen.
ET Hoida jahedas vees/panna peale niiske kompress.
EL Βυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
EN Immerse in cool water/wrap in wet bandages.
FR Rincer à l’eau fraîche/poser une compresse humide.
GA Tum in uisce fionnuar/cuir bréid fliuch air.
IT Immergere in acqua fredda/avvolgere con un bendaggio umido.
LV Iegremdēt vēsā ūdenī/ietīt mitros apsējos.
LT Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HU Hideg vízzel/nedves kötéssel kell hűteni.
MT Daħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.
NL In koud water onderdompelen/nat verband aanbrengen.
PL Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PT Mergulhar em água fria/aplicar compressas húmidas.
RO Introduceţi în apă rece/acoperiţi cu o compresă umedă.
SK Ponorte do studenej vody/obviažte mokrými obväzmi.
SL Potopiti v hladno vodo/zaviti v mokre povoje.
FI Upota kylmään veteen/kääri märkiin siteisiin.
SV Skölj under kallt vatten/använd våta omslag.
P335 Language BG Отстранете от кожата посипаните частици.
ES Sacudir las partículas que se hayan depositado en la piel.
CS Volné částice odstraňte z kůže.
DA Børst løse partikler bort fra huden.
DE Lose Partikel von der Haut abbürsten.
ET Pühkida lahtised osakesed nahalt maha.
EL Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.
EN Brush off loose particles from skin.
FR Enlever avec précaution les particules déposées sur la peau.
GA Glan cáithníní scaoilte den chraiceann.
IT Rimuovere le particelle depositate sulla pelle.
LV Noberzt no ādas nepiestiprinātās daļiņas.
LT Neprilipusias daleles nuvalyti nuo odos.
HU A bőrre lazán tapadó szemcséket óvatosan le kell kefélni.
MT Farfar il-frak mhux imwaħħla minn fuq il-ġilda.
NL Losse deeltjes van de huid afvegen.
PL Nie związaną pozostałość strzepnąć ze skóry.
PT Sacudir da pele as partículas soltas.
RO Îndepărtaţi particulele depuse pe piele.
SK Z pokožky oprášte sypké čiastočky.
SL S krtačo odstraniti razsute delce s kože.
FI Poista irtohiukkaset iholta.
SV Borsta bort lösa partiklar från huden.
P336 Language BG Размразете замръзналите части в хладка вода. Не разтривайте засегнатото място.
ES Descongelar las partes heladas con agua tibia. No frotar la zona afectada.
CS Omrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.
DA Forsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.
DE Vereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.
ET Sulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.
EL Ξεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.
EN Thaw frosted parts with lukewarm water. Do no rub affected area.
FR Dégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.
GA Leáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.
IT Sgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.
LV Atkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.
LT Prišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.
HU A fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.
MT Ħoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.
NL Bevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.
PL Rozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.
PT Derreter as zonas congeladas com água morna. Não friccionar a zona afectada.
RO Dezgheţaţi părţile degerate cu apă călduţă. Nu frecaţi zona afectată.
SK Zmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.
SL Zamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.
FI Sulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.
SV Värm det köldskadade området med ljummet vatten. Gnid inte det skadade området.
P337 Language BG При продължително дразнене на очите:
ES Si persiste la irritación ocular:
CS Přetrvává-li podráždění očí:
DA Ved vedvarende øjenirritation:
DE Bei anhaltender Augenreizung:
ET Kui silmade ärritus ei möödu:
EL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:
EN If eye irritation persists:
FR Si l’irritation oculaire persiste:
GA Má mhaireann an greannú súile:
IT Se l’irritazione degli occhi persiste:
LV Ja acu iekaisums nepāriet:
LT Jei akių dirginimas nepraeina:
HU Ha a szemirritáció nem múlik el:
MT Jekk l-irritazzjoni ta' l-għajnejn tibqa’:
NL Bij aanhoudende oogirritatie:
PL W przypadku utrzymywania się działania drażniącego na oczy:
PT Caso a irritação ocular persista:
RO Dacă iritarea ochilor persistă:
SK Ak podráždenie očí pretrváva:
SL Če draženje oči ne preneha:
FI Jos silmä-ärsytys jatkuu:
SV Vid bestående ögonirritation:
P338 Language BG Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.
ES Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
CS Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
DA Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
DE Eventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.
ET Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
EL Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
EN Remove contact lenses, if present and easy to do. Continue rinsing.
FR Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
GA Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.
IT Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
LV Izņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.
LT Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
HU Adott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
MT Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
NL Contactlenzen verwijderen, indien mogelijk. Blijven spoelen.
PL Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
PT Se usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.
RO Scoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
SK Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
SL Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
FI Poista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.
SV Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.
P340 Language BG Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ES Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CS Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DA Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DE Die betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ET Toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
EL Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
EN Remove victim to fresh air and keep at rest in a position comfortable for breathing.
FR Transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GA Tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
IT Trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LV Izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LT Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HU Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MT Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NL Het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PL Wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PT Retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
RO Transportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
SK Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SL Prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FI Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SV Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen
P341 Language BG При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ES Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CS Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DA Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DE Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ET Hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
EL Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
EN If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
FR S'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GA Más deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
IT Se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LV Ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LT Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HU Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MT Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.
NL Bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PL W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PT Em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
RO Dacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
SK Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SL Pri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FI Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SV Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.
P342 Language BG При симптоми на затруднено дишане:
ES En caso de síntomas respiratorios:
CS Při dýchacích potížích:
DA Ved luftvejssymptomer:
DE Bei Symptomen der Atemwege:
ET Hingamisteede probleemide ilmnemise korral:
EL Εάν παρουσιάζονται αναπνευστικά συμπτώματα:
EN If experiencing respiratory symptoms:
FR En cas de symptômes respiratoires:
GA I gcás siomptóm riospráide:
IT In caso di sintomi respiratori:
LV Ja rodas elpošanas traucējumu simptomi:
LT Jeigu pasireiškia respiraciniai simptomai:
HU Légzési problémák esetén:
MT Jekk tkun qed tbati minn sintomi respiratorji:
NL Bij ademhalingssymptomen:
PL W przypadku wystąpienia objawów ze strony układu oddechowego:
PT Em caso de sintomas respiratórios:
RO În caz de simptome respiratorii:
SK Pri sťaženom dýchaní:
SL Pri respiratornih simptomih:
FI Jos ilmenee hengitysoireita:
SV Vid besvär i luftvägarna:
P350 Language BG Измийте внимателно и обилно със сапун и вода.
ES Lavar suavemente con agua y jabón abundantes.
CS Jemně omyjte velkým množstvím vody a mýdla.
DA Vask forsigtigt med rigeligt sæbe og vand.
DE Behutsam mit viel Wasser und Seife waschen.
ET Pesta õrnalt rohke vee ja seebiga.
EL Πλύνετε απαλά με άφθονο νερό και σαπούνι.
EN Gently wash with plenty of soap and water.
FR Laver avec précaution et abondamment à l’eau et au savon.
GA Nigh go bog le neart gallúnaí agus uisce.
IT Lavare delicatamente e abbondantemente con acqua e sapone.
LV Maigi izskalot ar lielu daudzumu ziepēm un ūdeni.
LT Atsargiai nuplauti dideliu kiekiu muilo ir vandens.
HU Óvatos lemosás bő szappanos vízzel.
MT Aħsel bil-mod b’ħafna sapun u ilma.
NL Voorzichtig wassen met veel water en zeep.
PL Delikatnie umyć dużą ilością wody z mydłem.
PT Lavar suavemente com sabonete e água abundantes.
RO Spălaţi uşor cu multă apă și săpun.
SK Opatrne umyte veľkým množstvom vody a mydla.
SL Nežno umiti z veliko mila in vode.
FI Pese varovasti runsaalla vedellä ja saippualla.
SV Tvätta försiktigt med mycket tvål och vatten.
P351 Language BG Промивайте внимателно с вода в продължение на няколко минути.
ES Aclarar cuidadosamente con agua durante varios minutos.
CS Několik minut opatrně oplachujte vodou.
DA Skyl forsigtigt med vand i flere minutter.
DE Einige Minuten lang behutsam mit Wasser ausspülen.
ET Loputada mitme minuti jooksul ettevaatlikult veega.
EL Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.
EN Rinse cautiously with water for several minutes.
FR Rincer avec précaution à l’eau pendant plusieurs minutes.
GA Sruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.
IT Sciacquare accuratamente per parecchi minuti.
LV Uzmanīgi skalot ar ūdeni vairākas minūtes.
LT Atsargiai plauti vandeniu kelias minutes.
HU Óvatos öblítés vízzel több percen keresztül.
MT Laħlaħ b'attenzjoni bl-ilma għal diversi minuti.
NL Voorzichtig afspoelen met water gedurende een aantal minuten.
PL Ostrożnie płukać wodą przez kilka minut.
PT Enxaguar cuidadosamente com água durante vários minutos.
RO Clătiţi cu atenţie cu apă, timp de mai multe minute.
SK Opatrne niekoľko minút oplachujte vodou.
SL Previdno izpirati z vodo nekaj minut.
FI Huuhdo huolellisesti vedellä usean minuutin ajan.
SV Skölj försiktigt med vatten i flera minuter.
P352 Language BG Измийте обилно със сапун и вода.
ES Lavar con agua y jabón abundantes.
CS Omyjte velkým množstvím vody a mýdla.
DA Vask med rigeligt sæbe og vand.
DE Mit viel Wasser und Seife waschen.
ET Pesta rohke vee ja seebiga.
EL Πλύνετε με άφθονο σαπούνι και νερό.
EN Wash with plenty of soap and water.
FR Laver abondamment à l’eau et au savon.
GA Nigh le neart gallúnaí agus uisce.
IT Lavare abbondantemente con acqua e sapone.
LV Mazgāt ar lielu daudzmu ziepēm un ūdeni.
LT Plauti dideliu kiekiu muilo ir vandens.
HU Lemosás bő szappanos vízzel.
MT Aħsel b’ħafna sapun u ilma.
NL Met veel water en zeep wassen.
PL Umyć dużą ilością wody z mydłem.
PT Lavar com sabonete e água abundantes.
RO Spălaţi cu multă apă și săpun.
SK Umyte veľkým množstvom vody a mydla.
SL Umiti z veliko mila in vode.
FI Pese runsaalla vedellä ja saippualla.
SV Tvätta med mycket tvål och vatten.
P353 Language BG Облейте кожата с вода/вземете душ.
ES Aclararse la piel con agua/ducharse.
CS Opláchněte kůži vodou/osprchujte.
DA Skyl/brus huden med vand.
DE Haut mit Wasser abwaschen/duschen.
ET Loputada nahka veega/loputada duši all.
EL Ξεπλύνετε την επιδερμίδα με νερό/στο ντους.
EN Rinse skin with water/shower.
FR Rincer la peau à l’eau/se doucher.
GA Sruthlaítear an craiceann le huisce/glac cithfholcadh.
IT Sciacquare la pelle/fare una doccia.
LV Noskalot ādu ar ūdeni/dušā.
LT Odą nuplauti vandeniu/čiurkšle.
HU A bőrt le kell öblíteni vízzel/zuhanyozás.
MT Laħlaħ il-ġilda bl-ilma/bix-xawer.
NL Huid met water afspoelen/afdouchen.
PL Spłukać skórę pod strumieniem wody/prysznicem.
PT Enxaguar a pele com água/tomar um duche.
RO Clătiţi pielea cu apă/faceţi duş.
SK Pokožku opláchnite vodou/sprchou.
SL Kožo izprati z vodo/prho.
FI Huuhdo/suihkuta iho vedellä.
SV Skölj huden med vatten/duscha.
P360 Language BG Незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
ES Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
CS Kontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.
DA Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
DE Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
ET Saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
EL Ξεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
EN Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
FR Rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
GA Sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.
IT Sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
LV Nekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.
LT Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
HU A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
MT Laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
NL Verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
PL Natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
PT Enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
RO Clătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
SK Kontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.
SL Takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
FI Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
SV Skölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.
P361 Language BG Незабавно свалете цялото замърсено облекло.
ES Quitarse inmediatamente las prendas contaminadas.
CS Veškeré kontaminované části oděvu okamžitě svlékněte.
DA Tilsmudset tøj tages straks af/fjernes.
DE Alle kontaminierten Kleidungsstücke sofort ausziehen.
ET Kõik saastunud rõivad viivitamata seljast võtta.
EL Αφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.
EN Remove/Take off immediately all contaminated clothing.
FR Enlever immédiatement les vêtements contaminés.
GA Bain díot láithreach na héadaí éillithe go léir.
IT Togliersi di dosso immediatamente tutti gli indumenti contaminati.
LV Noņemt/Novilkt nekavējoties visu piesārņoto apģērbu.
LT Nedelsiant nuvilkti/pašalinti visus užterštus drabužius.
HU Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.
MT Neħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.
NL Verontreinigde kleding onmiddellijk uittrekken.
PL Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież.
PT Despir/retirar imediatamente toda a roupa contaminada.
RO Scoateţi imediat toată îmbrăcămintea contaminată.
SK Ihneď odstráňte/vyzlečte všetky kontaminované časti odevu.
SL Takoj odstraniti/sleči vsa kontaminirana oblačila.
FI Riisu saastunut vaatetus välittömästi.
SV Ta omedelbart av alla nedstänkta kläder.
P362 Language BG Свалете замърсеното облекло и го изперете преди повторна употреба.
ES Quitarse las prendas contaminadas y lavarlas antes de volver a usarlas.
CS Kontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.
DA Forurenet tøj tages af og vaskes, før det bruges igen.
DE Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.
ET Võtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.
EL Βγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.
EN Take off contaminated clothing and wash before reuse.
FR Enlever les vêtements contaminés et les laver avant réutilisation
GA Bain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.
IT Togliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.
LV Novilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.
LT Nusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.
HU A szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.
MT Inża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.
NL Verontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.
PL Zanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.
PT Retirar a roupa contaminada e lavá-la antes de a voltar a usar.
RO Scoateţi îmbrăcămintea contaminată şi spălaţi-o înainte de reutilizare.
SK Kontaminovaný odev vyzlečte a pred ďalším použitím vyperte.
SL Sleči kontaminirana oblačila in jih oprati pred ponovno uporabo.
FI Riisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.
SV Nedstänkta kläder tas av och tvättas innan de används igen.
P363 Language BG Изперете замърсеното облекло преди повторна употреба.
ES Lavar las prendas contaminadas antes de volver a usarlas.
CS Kontaminovaný oděv před opětovným použitím vyperte.
DA Tilsmudset tøj skal vaskes, før det kan anvendes igen.
DE Kontaminierte Kleidung vor erneutem Tragen waschen.
ET Saastunud rõivad enne järgmist kasutamist pesta.
EL Πλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.
EN Wash contaminated clothing before reuse.
FR Laver les vêtements contaminés avant réutilisation.
GA Nigh éadaí éillithe sula ndéanfar iad a athúsáid.
IT Lavare gli indumenti contaminati prima di indossarli nuovamente.
LV Pirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.
LT Užterštus drabužius išskalbti prieš vėl juos apsivelkant.
HU A szennyezett ruhát újbóli használat előtt ki kell mosni.
MT Aħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.
NL Verontreinigde kleding wassen alvorens deze opnieuw te gebruiken.
PL Wyprać zanieczyszczoną odzież przed ponownym użyciem.
PT Lavar a roupa contaminada antes de a voltar a usar.
RO Spălaţi îmbracămintea contaminată, înainte de reutilizare.
SK Kontaminovaný odev pred ďalším použitím vyperte.
SL Kontaminirana oblačila oprati pred ponovno uporabo.
FI Pese saastunut vaatetus ennen uudelleenkäyttöä.
SV Nedstänkta kläder ska tvättas innan de används igen.
P370 Language BG При пожар:
ES En caso de incendio:
CS V případě požáru:
DA Ved brand:
DE Bei Brand:
ET Tulekahju korral:
EL Σε περίπτωση πυρκαγιάς:
EN In case of fire:
FR En cas d’incendie:
GA I gcás dóiteáin:
IT In caso di incendio:
LV Ugunsgrēka gadījumā:
LT Gaisro atveju:
HU Tűz esetén:
MT F’każ ta' nar:
NL In geval van brand:
PL W przypadku pożaru:
PT Em caso de incêndio:
RO În caz de incendiu:
SK V prípade požiaru:
SL Ob požaru:
FI Tulipalon sattuessa:
SV Vid brand:
P371 Language BG При голям пожар и значителни количества:
ES En caso de incendio importante y en grandes cantidades:
CS V případě velkého požáru a velkého množství:
DA Ved større brand og store mængder:
DE Bei Großbrand und großen Mengen:
ET Suure tulekahju korral ning kui on tegemist suurte kogustega:
EL Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:
EN In case of major fire and large quantities:
FR En cas d’incendie important et s’il s’agit de grandes quantités:
GA I gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:
IT In caso di incendio grave e di quantità rilevanti:
LV Ugunsgrēka un lielu apjomu gadījumā:
LT Didelio gaisro ir didelių kiekių atveju:
HU Nagyobb tűz és nagy mennyiség esetén:
MT F’każ ta' nar kbir u kwantitajiet kbar:
NL In geval van grote brand en grote hoeveelheden:
PL W przypadku poważnego pożaru i dużych ilości:
PT Em caso de incêndio importante e de grandes quantidades:
RO În caz de incendiu de proporţii şi de cantităţi mari de produs:
SK V prípade veľkého požiaru a veľkého množstva:
SL Ob velikem požaru in velikih količinah:
FI Jos tulipalo ja ainemäärät ovat suuret:
SV Vid större brand och stora mängder:
P372 Language BG Опасност от експлозия при пожар.
ES Riesgo de explosión en caso de incendio.
CS Nebezpečí výbuchu v případě požáru.
DA Eksplosionsfare ved brand.
DE Explosionsgefahr bei Brand.
ET Tulekahju korral plahvatusoht.
EL Κίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.
EN Explosion risk in case of fire.
FR Risque d’explosion en cas d’incendie.
GA Baol pléasctha i gcás dóiteáin.
IT Rischio di esplosione in caso di incendio.
LV Eksplozijas risks ugunsgrēka gadījumā:
LT Sprogimo pavojus gaisro atveju.
HU Tűz esetén robbanásveszély.
MT Riskju ta' splużjoni f’każ ta' nar.
NL Ontploffingsgevaar in geval van brand.
PL Ryzyko wybuchu w razie pożaru.
PT Risco de explosão em caso de incêndio.
RO Risc de explozie în caz de incendiu.
SK V prípade požiaru hrozí riziko výbuchu.
SL Nevarnost eksplozije ob požaru.
FI Tulipalon sattuessa räjähdysvaara.
SV Explosionsrisk vid brand.
P373 Language BG НЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.
ES NO luchar contra el incendio cuando el fuego llega a los explosivos.
CS Požár NEHASTE, dostane-li se k výbušninám.
DA BEKÆMP IKKE branden, hvis denne når eksplosiverne.
DE KEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.
ET Kui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.
EL ΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.
EN DO NOT fight fire when fire reaches explosives.
FR NE PAS combattre l’incendie lorsque le feu atteint les explosifs.
GA NÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.
IT NON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.
LV NECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.
LT NEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.
HU TILOS a tűz oltása, ha az robbanóanyagra átterjedt.
MT TIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.
NL NIET blussen wanneer het vuur de ontplofbare stoffen bereikt.
PL NIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe
PT Se o fogo atingir os explosivos, NÃO tentar combatê-lo.
RO NU încercaţi să stingeţi incendiul atunci când focul a ajuns la explozivi.
SK Požiar NEHASTE, ak sa oheň priblížil k výbušninám.
SL NE gasiti, ko ogenj doseže eksploziv.
FI Tulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.
SV Försök INTE bekämpa branden när den når explosiva varor.
P374 Language BG Гасете пожара с обичайните предпазни мерки от разумно разстояние.
ES Luchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.
CS Haste z přiměřené vzdálenosti a dodržujte běžná opatření.
DA Træf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.
DE Brandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.
ET Kustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.
EL Προσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.
EN Fight fire with normal precautions from a reasonable distance.
FR Combattre l’incendie à distance en prenant les précautions normales.
GA Déan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.
IT Utilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.
LV Dzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.
LT Gaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.
HU Tűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.
MT Itfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.
NL Met normale voorzorgen vanaf een redelijke afstand blussen.
PL Gasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.
PT Combater o incêndio tomando as precauções normais e a partir de uma distância razoável.
RO Stingeţi incendiul de la o distanţă rezonabilă, luând măsuri normale de precauţie.
SK Požiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.
SL Gasiti z običajno previdnostjo in s primerne razdalje.
FI Sammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.
SV Bekämpa branden på vanligt sätt på behörigt avstånd.
P375 Language BG Гасете пожара от разстояние поради опасност от експлозия.
ES Luchar contra el incendio a distancia, dado el riesgo de explosión.
CS Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DA Bekæmp branden på afstand på grund af eksplosionsfare.
DE Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ET Plahvatusohu tõttu teha kustutustöid eemalt.
EL Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
EN Fight fire remotely due to the risk of explosion.
FR Combattre l’incendie à distance à cause du risque d’explosion.
GA Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
IT Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LV Dzēst ugunsgrēku no attāluma eksplozijas riska dēļ.
LT Gaisrą gesinti iš toli dėl sprogimo pavojaus.
HU A tűz oltását robbanásveszély miatt távolból kell végezni.
MT Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NL Op afstand blussen omwille van ontploffingsgevaar.
PL Z powodu ryzyka wybuchu gasić pożar z odległości.
PT Combater o incêndio à distância, devido ao risco de explosão.
RO Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
SK Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SL Gasiti z večje razdalje zaradi nevarnosti eksplozije.
FI Sammuta palo etäältä räjähdysvaaran takia.
SV Bekämpa branden på avstånd på grund av explosionsrisken.
P376 Language BG Спрете теча, ако е безопасно.
ES Detener la fuga, si no hay peligro en hacerlo.
CS Zastavte únik, můžete-li tak učinit bez rizika.
DA Stands lækagen, hvis dette er sikkert.
DE Undichtigkeit beseitigen, wenn gefahrlos möglich.
ET Leke peatada, kui seda on võimalik teha ohutult.
EL Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
EN Stop leak if safe to do so.
FR Obturer la fuite si cela peut se faire sans danger.
GA Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
IT Bloccare la perdita se non c’è pericolo.
LV Apstādināt noplūdi, ja to var izdarīt drošā veidā.
LT Sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
HU Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
MT Waqqaf it-tnixxija jekk ma jkunx hemm periklu.
NL Het lek dichten als dat veilig gedaan kan worden.
PL Jeżeli jest to bezpieczne zahamować wyciek.
PT Deter a fuga se tal puder ser feito em segurança.
RO Opriţi scurgerea, dacă acest lucru se poate face în siguranţă.
SK Zastavte únik, ak je to bezpečné.
SL Zaustaviti puščanje, če je varno.
FI Sulje vuoto, jos sen voi tehdä turvallisesti.
SV Stoppa läckan om det kan göras på ett säkert sätt.
P377 Language BG Пожар от изтекъл газ:
Не гасете освен при възможност за безопасно отстраняване на теча.
ES Fuga de gas en llamas:
No apagar, salvo si la fuga puede detenerse sin peligro.
CS Požár unikajícího plynu:
Nehaste, nelze-li únik bezpečně zastavit.
DA Brand fra udsivende gas:
Sluk ikke, medmindre det er sikkert at stoppe lækagen.
DE Brand von ausströmendem Gas:
Nicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.
ET Lekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.
EL Διαρροή φλεγόμενου αερίου:
Μην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.
EN Leaking gas fire:
Do not extinguish, unless leak can be stopped safely.
FR Fuite de gaz enflammé:
Ne pas éteindre si la fuite ne peut pas être arrêtée sans danger.
GA Tine gháis ag sceitheadh:
Ná múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.
IT In caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.
LV Degšanas gāzes noplūde:
Nedzēst, ja vien noplūdi var apstādināt drošā veidā.
LT Dujų nuotėkio sukeltas gaisras:
Negesinti, nebent nuotėkį būtų galima saugiai sustabdyti.
HU Égő szivárgó gáz:
Csak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.
MT Tnixxija ta' gass tan-nar:
Tippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.
NL Brand door lekkend gas:
niet blussen, tenzij het lek veilig gedicht kan worden.
PL W przypadku płonięcia wyciekającego gazu:
Nie gasić, jeżeli nie można bezpiecznie zahamować wycieku.
PT Incêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.
RO Incendiu cauzat de o scurgere de gaz: nu încercaţi să stingeţi, decât dacă scurgerea poate fi oprită în siguranţă.
SK Požiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.
SL Požar zaradi uhajanja plina:
Ne gasiti, če puščanja ni mogoče varno zaustaviti.
FI Vuotavasta kaasusta johtuva palo:
Ei saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.
SV Läckande gas som brinner:
Försök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.
P378 Language BG Използвайте … за гасене.
ES Utilizar … para apagarlo.
CS K hašení použijte …
DA Anvend … til brandslukning.
DE … zum Löschen verwenden.
ET Kustutamiseks kasutada …
EL Χρησιμοποιήστε … για την κατάσβεση.
EN Use … for extinction.
FR Utiliser … pour l’extinction.
GA Úsáid … le haghaidh múchta.
IT Estinguere con…
LV Nodzēšanai izmantot…
LT Gesinimui naudoti …
HU Az oltáshoz … használandó.
MT Uża’ … biex titfi.
NL Blussen met …
PL Użyć … do gaszenia.
PT Para a extinção utilizar …
RO Utilizați… pentru stingere.
SK Na hasenie použite …
SL Za gašenje uporabiti …
FI Käytä palon sammuttamiseen …
SV Släck branden med …
P380 Language BG Евакуирайте зоната.
ES Evacuar la zona.
CS Vykliďte _roctor.
DA Evakuer området.
DE Umgebung räumen.
ET Ala evakueerida.
EL Εκκενώστε την περιοχή.
EN Evacuate area.
FR Évacuer la zone.
GA Aslonnaigh gach duine as an limistéar.
IT Evacuare la zona.
LV Evakuēt zonu.
LT Evakuoti zoną.
HU A területet ki kell üríteni.
MT Evakwa ż-żona.
NL Evacueren.
PL Ewakuować teren.
PT Evacuar a zona.
RO Evacuaţi zona.
SK Priestory evakuujte.
SL Izprazniti območje.
FI Evakuoi alue.
SV Utrym området.
P381 Language BG Премахнете всички източници на запалване, ако е безопасно.
ES Eliminar todas las fuentes de ignición si no hay peligro en hacerlo.
CS Odstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.
DA Fjern alle antændelseskilder, hvis dette kan gøres sikkert.
DE Alle Zündquellen entfernen, wenn gefahrlos möglich.
ET Eemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.
EL Απομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.
EN Eliminate all ignition sources if safe to do so.
FR Éliminer toutes les sources d’ignition si cela est faisable sans danger.
GA Díothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.
IT Eliminare ogni fonte di accensione se non c’è pericolo.
LV Novērst visus uzliesmošanas avotus, ja to var izdarīt droši.
LT Pašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.
HU Meg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.
MT Elimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.
NL Alle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.
PL Wyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.
PT Eliminar todas as fontes de ignição se tal puder ser feito em segurança.
RO Eliminaţi toate sursele de aprindere, dacă acest lucru se poate face în siguranţă.
SK Ak je to bezpečné, odstráňte všetky zdroje zapálenia.
SL Odstraniti vse vire vžiga, če je varno.
FI Poista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.
SV Avlägsna alla antändningskällor om det kan göras på ett säkert sätt.
P390 Language BG Попийте разлятото, за да се предотвратят материални вреди.
ES Absorber el vertido para que no dañe otros materiales.
CS Uniklý produkt absorbujte, aby se zabránilo materiálním škodám.
DA Absorber udslip for at undgå materielskade.
DE Verschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.
ET Mahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.
EL Σκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.
EN Absorb spillage to prevent material damage.
FR Absorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.
GA Ionsúigh doirteadh chun damáiste d’ábhar a chosc.
IT Assorbire la fuoriuscita per evitare danni materiali.
LV Uzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.
LT Absorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.
HU A kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.
MT Assorbi t-tixrid biex tipprevjeni ħsara fil-materjal.
NL Gelekte/gemorste stof opnemen om materiële schade te vermijden.
PL Usunąć wyciek, aby zapobiec szkodom materialnym.
PT Absorver o produto derramado a fim de evitar danos materiais.
RO Absorbiţi scurgerile de produs, pentru a nu afecta materialele din apropiere.
SK Absorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.
SL Odpraviti razlitje, da se prepreči materialna škoda.
FI Imeytä valumat vahinkojen estämiseksi.
SV Sug upp spill för att undvika materiella skador.
P391 Language BG Съберете разлятото.
ES Recoger el vertido.
CS Uniklý produkt seberte.
DA Udslip opsamles.
DE Verschüttete Mengen aufnehmen.
ET Mahavoolanud toode kokku koguda.
EL Μαζέψτε τη χυμένη ποσότητα.
EN Collect spillage.
FR Recueillir le produit répandu.
GA Bailigh doirteadh.
IT Raccogliere il materiale fuoriuscito.
LV Savākt izšļakstīto šķidrumu.
LT Surinkti ištekėjusią medžiagą.
HU A kiömlött anyagot össze kell gyűjteni.
MT Iġbor it-tixrid.
NL Gelekte/gemorste stof opruimen.
PL Zebrać wyciek.
PT Recolher o produto derramado.
RO Colectaţi scurgerile de produs.
SK Zozbierajte uniknutý produkt.
SL Prestreči razlito tekočino.
FI Valumat on kerättävä.
SV Samla upp spill.
P301 + P310 Language BG ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES EN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CS PŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA I TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.
DE BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET ALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
FR EN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.
GA MÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
IT IN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico
LV NORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT PRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU LENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL NA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
PL W PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT EM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO ÎN CAZ DE ÎNGHIŢIRE: sunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK PO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL PRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI JOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SV VID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.
P301 + P312 Language BG ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.
ES EN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.
CS PŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA I TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
DE BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET ALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.
EN IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
FR EN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
GA MÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
IT IN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.
LV NORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
LT PRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU LENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
NL NA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
PL W PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT EM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO ÎN CAZ DE ÎNGHIŢIRE: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
SK PO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL PRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI JOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
SV VID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.
P301 + P330 + P331 Language BG ПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.
ES EN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.
CS PŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.
DA I TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.
DE BEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.
ET ALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.
EN IF SWALLOWED: rinse mouth. Do NOT induce vomiting.
FR EN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.
GA MÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.
IT IN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.
LV NORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.
LT PRARIJUS: išskalauti burną. NESKATINTI vėmimo.
HU LENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.
MT JEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.
NL NA INSLIKKEN: de mond spoelen — GEEN braken opwekken.
PL W PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.
PT EM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.
RO ÎN CAZ DE ÎNGHIŢIRE: clătiţi gura. NU provocaţi voma.
SK PO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.
SL PRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.
FI JOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.
SV VID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.
P302 + P334 Language BG ПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.
ES EN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.
CS PŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.
DA VED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.
DE BEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.
ET NAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
EN IF ON SKIN: Immerse in cool water/wrap in wet bandages.
FR EN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.
IT IN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.
LV SASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.
LT PATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HU HA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.
MT JEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
NL BIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.
PL W PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PT SE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.
RO ÎN CAZ DE CONTACT CU PIELEA: introduceţi în apă rece/acoperiţi cu o compresă umedă.
SK PRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.
SL PRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.
FI JOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.
SV VID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.
P302 + P350 Language BG ПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.
ES EN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.
CS PŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.
DA VED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.
DE BEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.
ET NAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.
EN IF ON SKIN: Gently wash with plenty of soap and water.
FR EN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.
IT IN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.
LV SASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.
LT PATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.
HU HA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.
MT JEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.
NL BIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.
PL W PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.
PT SE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.
RO ÎN CAZ DE CONTACT CU PIELEA: spălaţi uşor cu multă apă şi săpun.
SK PRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.
SL PRI STIKU S KOŽO: nežno umiti z veliko mila in vode.
FI JOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.
SV VID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.
P302 + P352 Language BG ПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.
ES EN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.
CS PŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.
DA VED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.
DE BEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.
ET NAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.
EN IF ON SKIN: Wash with plenty of soap and water.
FR EN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.
IT IN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.
LV SASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.
LT PATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.
HU HA BŐRRE KERÜL: Lemosás bő szappanos vízzel.
MT JEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.
NL BIJ CONTACT MET DE HUID: met veel water en zeep wassen.
PL W PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.
PT SE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.
RO ÎN CAZ DE CONTACT CU PIELEA: spălaţi cu multă apă şi săpun.
SK PRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.
SL PRI STIKU S KOŽO: umiti z veliko mila in vode.
FI JOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.
SV VID HUDKONTAKT: Tvätta med mycket tvål och vatten.
P303 + P361 + P353 Language BG ПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ
ES EN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.
CS PŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.
DA VED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.
DE BEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.
ET NAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.
EN IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.
FR EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.
GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.
IT IN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.
LV SASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.
LT PATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.
HU HA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.
MT JEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.
NL BIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.
PL W PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.
PT SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.
RO ÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateţi imediat toată îmbrăcămintea contaminată. Clătiţi pielea cu apă/faceţi duş.
SK PRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.
SL PRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.
FI JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.
SV VID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.
P304 + P340 Language BG ПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ES EN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CS PŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DA VED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DE BEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ET SISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
EN IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
FR EN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GA MÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
IT IN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LV IEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LT ĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HU BELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MT JEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NL NA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PT EM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
RO ÎN CAZ DE INHALARE: transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
SK PO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SL PRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FI JOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SV VID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.
P304 + P341 Language BG ПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ES EN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CS PŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DA VED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DE BEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ET SISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
EN IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
FR EN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GA MÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
IT IN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LV IEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LT ĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HU BELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MT JEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NL NA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PT EM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
RO ÎN CAZ DE INHALARE: dacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
SK PO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SL PRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FI JOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SV VID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.
P305 + P351 + P338 Language BG ПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.
ES EN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
CS PŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
DA VED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
DE BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
ET SILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
EN IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
FR EN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
GA I gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.
IT IN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
LV SASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.
LT PATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
HU SZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
MT JEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
NL BIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.
PL W PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
PT SE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.
RO ÎN CAZ DE CONTACT CU OCHII: clătiţi cu atenţie cu apă timp de mai multe minute. Scoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
SK PO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
SL PRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
FI JOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.
SV VID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.
P306 + P360 Language BG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
ES EN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
CS PŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.
DA VED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
DE BEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
ET RÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
EN IF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
FR EN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
GA I gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.
IT IN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
LV SASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.
LT PATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
HU HA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
MT JEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
NL NA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
PL W PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
PT SE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
RO ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
SK PRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.
SL PRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
FI JOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
SV VID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.
P307 + P311 Language BG ПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES EN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CS PŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA VED eksponering: Ring til en GIFTINFORMATION eller en læge.
DE BEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Kokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN IF exposed: Call a POISON CENTER or doctor/physician.
FR EN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.
GA I gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
IT IN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.
LV Ja ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT Esant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Expozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT Jekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL NA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.
PL W przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT EM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO ÎN CAZ DE expunere: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK Po expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL PRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Altistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SV Om du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.
P308 + P313 Language BG ПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.
ES EN CASO DE exposición manifiesta o presunta: Consultar a un médico.
CS PŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.
DA VED eksponering eller mistanke om eksponering: Søg lægehjælp.
DE BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Kokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
EN IF exposed or concerned: Get medical advice/attention.
FR EN CAS d’exposition prouvée ou suspectée: consulter un médecin.
GA I gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.
IT IN CASO di esposizione o di possibile esposizione, consultare un medico.
LV Ja nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.
LT Esant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.
HU Expozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.
MT Jekk espost jew konċernat: Ikkonsulta tabib.
NL NA (mogelijke) blootstelling: een arts raadplegen.
PL W przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT EM CASO DE exposição ou suspeita de exposição: consulte um médico.
RO ÎN CAZ DE expunere sau de posibilă expunere: consultaţi medicul.
SK Po expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.
SL PRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.
FI Altistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.
SV Vid exponering eller misstanke om exponering Sök läkarhjälp.
P309 + P311 Language BG ПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES EN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CS PŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA VED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.
DE BEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Kokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
FR EN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.
GA I gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
IT IN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.
LV Ja nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT Esant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Expozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT JEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL NA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.
PL W przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT EM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO ÎN CAZ DE expunere sau dacă nu vă simţiţi bine: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK Po expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL PRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Altistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.
SV Vid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.
P332 + P313 Language BG При поява на кожно дразнене: Потърсете медицински съвет/помощ.
ES En caso de irritación cutánea: Consultar a un médico.
CS Při podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.
DA Ved hudirritation: Søg lægehjælp.
DE Bei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Nahaärrituse korral: pöörduda arsti poole.
EL Εάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
EN If skin irritation occurs: Get medical advice/attention.
FR En cas d’irritation cutanée: consulter un médecin.
GA I gcás greannú craicinn: Faigh comhairle/cúram liachta.
IT In caso di irritazione della pelle: consultare un medico.
LV Ja rodas ādas iekaisums: lūdziet mediķu palīdzību.
LT Jeigu sudirginama oda: kreiptis į gydytoją.
HU Bőrirritáció esetén: orvosi ellátást kell kérni.
MT Jekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.
NL Bij huidirritatie: een arts raadplegen.
PL W przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Em caso de irritação cutânea: consulte um médico.
RO În caz de iritare a pielii: consultaţi medicul.
SK Ak sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.
SL Če nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.
FI Jos ilmenee ihoärsytystä: Hakeudu lääkäriin.
SV Vid hudirritation: Sök läkarhjälp.
P333 + P313 Language BG При поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.
ES En caso de irritación o erupción cutánea: Consultar a un médico.
CS Při podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.
DA Ved hudirritation eller udslet: Søg lægehjælp.
DE Bei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Nahaärrituse või _obe korral: pöörduda arsti poole.
EL Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
EN If skin irritation or rash occurs: Get medical advice/attention.
FR En cas d’irritation ou d'éruption cutanée: consulter un médecin.
GA Má tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.
IT In caso di irritazione o eruzione della pelle: consultare un medico.
LV Ja rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.
LT Jeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.
HU Bőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.
MT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.
NL Bij huidirritatie of uitslag: een arts raadplegen.
PL W przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Em caso de irritação ou erupção cutânea: consulte um médico.
RO În caz de iritare a pielii sau de erupţie cutanată: consultaţi medicul.
SK Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.
SL Če nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.
FI Jos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.
SV Vid hudirritation eller utslag: Sök läkarhjälp.
P335 + P334 Language BG Отстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.
ES Sacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.
CS Volné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.
DA Børst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.
DE Lose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.
ET Pühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.
EL Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
EN Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
FR Enlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.
GA Scuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.
IT Rimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.
LV Noberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.
LT Neprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HU A bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.
MT Farfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
NL Losse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.
PL Nie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PT Sacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.
RO Îndepărtaţi particulele depuse pe piele. Introduceţi în apă rece/acoperiţi cu o compresă umedă.
SK Z pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.
SL S krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.
FI Poista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.
SV Borsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.
P337 + P313 Language BG При продължително дразнене на очите: Потърсете медицински съвет/помощ.
ES Si persiste la irritación ocular: Consultar a un médico.
CS Přetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.
DA Ved vedvarende øjenirritation: Søg lægehjælp.
DE Bei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ET Kui silmade ärritus ei möödu: pöörduda arsti poole.
EL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
EN If eye irritation persists: Get medical advice/attention.
FR Si l’irritation oculaire persiste: consulter un médecin.
GA Má mhaireann an greannú súile: Faigh comhairle/cúram liachta.
IT Se l’irritazione degli occhi persiste, consultare un medico.
LV Ja acu iekaisums nepāriet: lūdziet mediķu palīdzību.
LT Jei akių dirginimas nepraeina: kreiptis į gydytoją.
HU Ha a szemirritáció nem múlik el: orvosi ellátást kell kérni.
MT Jekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.
NL Bij aanhoudende oogirritatie: een arts raadplegen.
PL W przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PT Caso a irritação ocular persista: consulte um médico.
RO Dacă iritarea ochilor persistă: consultaţi medicul.
SK Ak podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.
SL Če draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.
FI Jos silmä-ärsytys jatkuu: Hakeudu lääkäriin.
SV Vid bestående ögonirritation: Sök läkarhjälp.
P342 + P311 Language BG При симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ES En caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CS Při dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DA Ved luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.
DE Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ET Hingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
EL Εάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
EN If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
FR En cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.
GA I gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
IT In caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.
LV Ja rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LT Jeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HU Légzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MT Jekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NL Bij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.
PL W przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PT Em caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
RO În caz de simptome respiratorii: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SK Pri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SL Pri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FI Jos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SV Vid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.
P370 + P376 Language BG При пожар: Спрете теча, ако е безопасно.
ES En caso de incendio: Detener la fuga, si no hay peligro en hacerlo.
CS V případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.
DA Ved brand: Stands lækagen, hvis dette er sikkert.
DE Bei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.
ET Tulekahju korral: leke peatada, kui seda on võimalik teha ohutult.
EL Σε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
EN In case of fire: Stop leak if safe to do so.
FR En cas d’incendie: obturer la fuite si cela peut se faire sans danger.
GA I gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
IT In caso di incendio: bloccare la perdita se non c’è pericolo.
LV Ugunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.
LT Gaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
HU Tűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
MT F’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.
NL In geval van brand: het lek dichten als dat veilig gedaan kan worden.
PL W przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.
PT Em caso de incêndio: deter a fuga se tal puder ser feito em segurança.
RO În caz de incendiu: opriţi scurgerea, dacă acest lucru se poate face în siguranţă.
SK V prípade požiaru: ak je to bezpečné, zastavte únik.
SL Ob požaru: zaustaviti puščanje, če je varno.
FI Tulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.
SV Vid brand: Stoppa läckan om det kan göras på ett säkert sätt.
P370 + P378 Language BG При пожар: Използвайте … за гасене.
ES En caso de incendio: Utilizar … para apagarlo.
CS V případě požáru: K hašení použijte …
DA Ved brand: Anvend … til brandslukning.
DE Bei Brand: … zum Löschen verwenden.
ET Tulekahju korral: kasutada kustutamiseks …
EL Σε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.
EN In case of fire: Use … for extinction.
FR En cas d’incendie: utiliser … pour l’extinction.
GA I gcás dóiteáin: Úsáid … le haghaidh múchta.
IT In caso di incendio: estinguere con…
LV Ugunsgrēka gadījumā: dzēšanai izmantojiet …
LT Gaisro atveju: gesinimui naudoti …
HU Tűz esetén: az oltáshoz …használandó.
MT F’każ ta' nar: Uża’ … għat-tifi.
NL In geval van brand: blussen met …
PL W przypadku pożaru: Użyć … do gaszenia.
PT Em caso de incêndio: para a extinção utilizar …
RO În caz de incendiu: utilizaţi… pentru stingere.
SK V prípade požiaru: na hasenie použite …
SL Ob požaru: za gašenje uporabiti …
FI Tulipalon sattuessa: Käytä palon sammuttamiseen …
SV Vid brand: Släck branden med …
P370 + P380 Language BG При пожар: Евакуирайте зоната.
ES En caso de incendio: Evacuar la zona.
CS V případě požáru: Vykliďte prostor.
DA Ved brand: Evakuer området.
DE Bei Brand: Umgebung räumen.
ET Tulekahju korral: ala evakueerida.
EL Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.
EN In case of fire: Evacuate area.
FR En cas d’incendie: évacuer la zone.
GA I gcás dóiteáin: Aslonnaigh gach duine as an limistéar.
IT Evacuare la zona in caso di incendio.
LV Ugunsgrēka gadījumā: evakuēt zonu.
LT Gaisro atveju: evakuoti zoną.
HU Tűz esetén: Ki kell üríteni a területet.
MT F’każ ta' nar: Evakwa ż-żona.
NL In geval van brand: evacueren.
PL W przypadku pożaru: Ewakuować teren.
PT Em caso de incêndio: evacuar a zona.
RO În caz de incendiu: evacuaţi zona.
SK V prípade požiaru: priestory evakuujte.
SL Ob požaru: izprazniti območje.
FI Tulipalon sattuessa: Evakuoi alue.
SV Vid brand: Utrym området.
P370 + P380 + P375 Language BG При пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
ES En caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
CS V případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DA Ved brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
DE Bei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ET Tulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
EL Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
EN In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
FR En cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
GA I gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
IT In caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LV Ugunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
LT Gaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
HU Tűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
MT F’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NL In geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
PL W przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
PT Em caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
RO În caz de incendiu: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
SK V prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SL Ob požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
FI Tulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
SV Vid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.
P371 + P380 + P375 Language BG При голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
ES En caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
CS V případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DA Ved større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
DE Bei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ET Suure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
EL Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
EN In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
FR En cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
GA I gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
IT In caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LV Ugunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
LT Didelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
HU Nagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
MT F’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NL In geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
PL W przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
PT Em caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
RO În caz de incendiu de proporţii şi de cantităţi mari de produs: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
SK V prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SL Ob velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
FI Jos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
SV Vid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.
Table 1.4
Precautionary statements — Storage
P401 Language BG Да се съхранява…
ES Almacenar …
CS Skladujte …
DA Opbevares …
DE … aufbewahren.
ET Hoida …
EL Αποθηκεύεται …
EN Store …
FR Stocker …
GA Stóráil …
IT Conservare…
LV Glabāt…
LT Laikyti…
HU Tárolás: … .
MT Aħżen …
NL … bewaren.
PL Przechowywać …
PT Armazenar …
RO A se depozita…
SK Uchovávajte …
SL Hraniti …
FI Varastoi …
SV Förvaras …
P402 Language BG Да се съхранява на сухо място.
ES Almacenar en un lugar seco.
CS Skladujte na suchém místě.
DA Opbevares et tørt sted.
DE An einem trockenen Ort aufbewahren.
ET Hoida kuivas.
EL Αποθηκεύεται σε στεγνό μέρος.
EN Store in a dry place.
FR Stocker dans un endroit sec.
GA Stóráil in áit thirim.
IT Conservare in luogo asciutto.
LV Glabāt sausā vietā.
LT Laikyti sausoje vietoje.
HU Száraz helyen tárolandó.
MT Aħżen f’post niexef.
NL Op een droge plaats bewaren.
PL Przechowywać w suchym miejscu.
PT Armazenar em local seco.
RO A se depozita într-un loc uscat.
SK Uchovávajte na suchom mieste.
SL Hraniti na suhem.
FI Varastoi kuivassa paikassa.
SV Förvaras torrt.
P403 Language BG Да се съхранява на добре проветриво място.
ES Almacenar en un lugar bien ventilado.
CS Skladujte na dobře větraném místě.
DA Opbevares på et godt ventileret sted.
DE An einem gut belüfteten Ort aufbewahren.
ET Hoida hästi ventileeritavas kohas.
EL Αποθηκεύεται σε καλά αεριζόμενο χώρο.
EN Store in a well-ventilated place.
FR Stocker dans un endroit bien ventilé.
GA Stóráil in áit dhea-aeráilte.
IT Conservare in luogo ben ventilato.
LV Glabāt labi vēdināmā vietā.
LT Laikyti gerai vėdinamoje vietoje.
HU Jól szellőző helyen tárolandó.
MT Aħżen f’post b'ventilazzjoni tajba.
NL Op een goed geventileerde plaats bewaren.
PL Przechowywać w dobrze wentylowanym miejscu.
PT Armazenar em local bem ventilado.
RO A se depozita într-un spaţiu bine ventilat.
SK Uchovávajte na dobre vetranom mieste.
SL Hraniti na dobro prezračevanem mestu.
FI Varastoi paikassa, jossa on hyvä ilmanvaihto.
SV Förvaras på väl ventilerad plats.
P404 Language BG Да се съхранява в затворен съд.
ES Almacenar en un recipiente cerrado.
CS Skladujte v uzavřeném obalu.
DA Opbevares i en lukket beholder.
DE In einem geschlossenen Behälter aufbewahren.
ET Hoida suletud mahutis.
EL Φυλάσσεται σε κλειστό περιέκτη.
EN Store in a closed container.
FR Stocker dans un récipient fermé.
GA Stóráil i gcoimeádán iata.
IT Conservare in un recipiente chiuso.
LV Glabāt slēgtā tvertnē.
LT Laikyti uždaroje talpykloje.
HU Zárt edényben tárolandó.
MT Aħżen f’kontenitur magħluq.
NL In gesloten verpakking bewaren.
PL Przechowywać w zamkniętym pojemniku.
PT Armazenar em recipiente fechado.
RO A se depozita într-un recipient închis.
SK Uchovávajte v uzavretej nádobe.
SL Hraniti v zaprti posodi.
FI Varastoi suljettuna.
SV Förvaras i sluten behållare.
P405 Language BG Да се съхранява под ключ.
ES Guardar bajo llave.
CS Skladujte uzamčené.
DA Opbevares under lås.
DE Unter Verschluss aufbewahren.
ET Hoida lukustatult.
EL Φυλάσσεται κλειδωμένο.
EN Store locked up.
FR Garder sous clef.
GA Stóráil faoi ghlas.
IT Conservare sotto chiave.
LV Glabāt slēgtā veidā.
LT Laikyti užrakintą.
HU Elzárva tárolandó.
MT Aħżen f'post imsakkar.
NL Achter slot bewaren.
PL Przechowywać pod zamknięciem.
PT Armazenar em local fechado à chave.
RO A se depozita sub cheie.
SK Uchovávajte uzamknuté.
SL Hraniti zaklenjeno.
FI Varastoi lukitussa tilassa.
SV Förvaras inlåst.
P406 Language BG Да се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.
ES Almacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.
CS Skladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.
DA Opbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.
DE In korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.
ET Hoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.
EL Αποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.
EN Store in corrosive resistant/… container with a resistant inner liner.
FR Stocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.
GA Stóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.
IT Conservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.
LV Glabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.
LT Laikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.
HU Saválló/saválló bélésű … edényben tárolandó.
MT Aħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.
NL In corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.
PL Przechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.
PT Armazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.
RO Depozitaţi într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.
SK Uchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.
SL Hraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.
FI Varastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.
SV Förvaras i korrosionsbeständig/… behållare med beständigt innerhölje.
P407 Language BG Да се остави въздушно пространство между купчините/палетите.
ES Dejar una separación entre los bloques/los palés de carga.
CS Mezi stohy/paletami ponechte vzduchovou mezeru.
DA Obevares med luftmellemrum mellem stakkene/pallerne.
DE Luftspalt zwischen Stapeln/Paletten lassen.
ET Jätta virnade/kaubaaluste vahele õhuvahe.
EL Να υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.
EN Maintain air gap between stacks/pallets.
FR Maintenir un intervalle d’air entre les piles/palettes.
GA Coimeád bearna aeir idir chruacha/phailléid.
IT Mantenere uno spazio libero tra gli scaffali/i pallet.
LV Saglabāt gaisa spraugu starp krāvumiem/paletēm.
LT Palikti oro tarpą tarp eilių/palečių.
HU A rakatok/raklapok között térközt kell hagyni.
MT Ħalli l-arja tgħaddi bejn l-imniezel/il-palits.
NL Ruimte laten tussen stapels/pallets.
PL Zachować szczelinę powietrzną pomiędzy stosami/paletami.
PT Respeitar as distâncias mínimas entre pilhas/paletes.
RO Păstraţi un spaţiu gol între stive/paleți.
SK Medzi regálmi/paletami ponechajte vzduchovú medzeru.
SL Ohraniti zračno režo med skladi/paletami.
FI Jätä pinojen/kuormalavojen väliin ilmarako.
SV Se till att det finns luft mellan staplar/pallar.
P410 Language BG Да се пази от пряка слънчева светлина.
ES Proteger de la luz del sol.
CS Chraňte před slunečním zářením.
DA Beskyttes mod sollys.
DE Vor Sonnenbestrahlung schützen.
ET Hoida päikesevalguse eest.
EL Να προστατεύεται από τις ηλιακές ακτίνες.
EN Protect from sunlight.
FR Protéger du rayonnement solaire.
GA Cosain ó sholas na gréine.
IT Proteggere dai raggi solari.
LV Aizsargāt no saules gaismas.
LT Saugoti nuo saulės šviesos.
HU Napfénytől védendő.
MT Ipproteġi mid-dawl tax-xemx.
NL Tegen zonlicht beschermen.
PL Chronić przed światłem słonecznym.
PT Manter ao abrigo da luz solar.
RO A se proteja de lumina solară.
SK Chráňte pred slnečným žiarením.
SL Zaščititi pred sončno svetlobo.
FI Suojaa auringonvalolta.
SV Skyddas från solljus.
P411 Language BG Да се съхранява при температури, не по-високи от … oC/…oF.
ES Almacenar a temperaturas no superiores a … oC/…oF.
CS Skladujte při teplotě nepřesahující … oC/…oF.
DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF.
DE Bei Temperaturen von nicht mehr als … oC/…aufbewahren.
ET Hoida temperatuuril mitte üle … oC/… oF.
EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
EN Store at temperatures not exceeding … oC/…oF.
FR Stocker à une température ne dépassant pas … oC/… oF.
GA Stóráil ag teocht nach airde ná … oC/…oF.
IT Conservare a temperature non superiori a … oC/…oF.
LV Uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
LT Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
HU A tárolási hőmérséklet legfeljebb … oC/…oF lehet.
MT Aħżen f’temperaturi li ma jeċċedux … oC/…oF.
NL Bij maximaal … oC/…oF bewaren.
PL Przechowywać w temperaturze nieprzekraczającej … oC/…oF.
PT Armazenar a uma temperatura não superior a … oC/…oF.
RO A se depozita la temperaturi care să nu depăşească … oC/…oF.
SK Uchovávajte pri teplotách do … oC/…oF
SL Hraniti pri temperaturi do … oC/… oF.
FI Varastoi alle … oC/…oF lämpötilassa.
SV Förvaras vid högst … oC/…oF.
P412 Language BG Да не се излага на температури, по-високи от 50 oC/122oF.
ES No exponer a temperaturas superiores a 50 oC/122oF.
CS Nevystavujte teplotě přesahující 50 oC/122 oF.
DA Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
DE Nicht Temperaturen von mehr als 50 oC aussetzen.
ET Mitte hoida temperatuuril üle 50 oC/122 oF.
EL Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
EN Do not expose to temperatures exceeding 50 oC/122oF.
FR Ne pas exposer à une température supérieure à 50 oC/122 oF.
GA Ná nocht do theocht níos airde ná 50 oC/122oF.
IT Non esporre a temperature superiori a 50 oC/122oF.
LV Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
LT Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
HU Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
MT Tesponix għal temperaturi li jeċċedu l-50 oC/122oF.
NL Niet blootstellen aan temperaturen boven 50 oC/122oF.
PL Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
PT Não expor a temperaturas superiores a 50 oC/122oF.
RO Nu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
SK Nevystavujte teplotám nad 50 oC/122 oF.
SL Ne izpostavljati temperaturam nad 50 oC/122 oF.
FI Ei saa altistaa yli 50 oC/122 oF lämpötiloille.
SV Får inte utsättas för temperaturer över 50 oC/122 oF.
P413 Language BG При насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.
ES Almacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.
CS Množství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.
DA Bulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.
DE Schüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren
ET Kogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.
EL Οι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
EN Store bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.
FR Stocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.
GA Stóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.
IT Conservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.
LV Lielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
LT Didesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
HU A … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.
MT Aħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.
NL Bulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.
PL Przechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.
PT Armazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.
RO Depozitaţi cantităţile în vrac mai mari de … kg/… lbs la temperaturi care să nu depăşească … oC/…oF.
SK Veľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.
SL Razsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.
FI Säilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.
SV Bulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.
P420 Language BG Да се съхранява на разстояние от други материали.
ES Almacenar alejado de otros materiales.
CS Skladujte odděleně od ostatních materiálů.
DA Må ikke opbevares i nærheden af andre materialer.
DE Von anderen Materialien entfernt aufbewahren.
ET Hoida eemal teistest materjalidest.
EL Αποθηκεύεται μακριά από άλλα υλικά.
EN Store away from other materials.
FR Stocker à l’écart des autres matières.
GA Stóráil glan ar ábhair eile.
IT Conservare lontano da altri materiali.
LV Glabāt atsevišķi no citiem materiāliem.
LT Laikyti atokiau nuo kitų medžiagų.
HU Más anyagoktól távol tárolandó.
MT Aħżen ‘l bogħod minn materjal ieħor.
NL Gescheiden van ander materiaal bewaren.
PL Przechowywać z dala od innych materiałów.
PT Armazenar afastado de outros materiais.
RO Depozitaţi departe de alte materiale.
SK Uchovávajte oddelene od iných materiálov.
SL Hraniti ločeno od drugih materialov.
FI Varastoi erillään muista materiaaleista.
SV Förvaras åtskilt från andra material.
P422 Language BG Съдържанието да се съхранява при…
ES Almacenar el contenido en …
CS Skladujte pod …
DA Indholdet skal opbevares under …
DE Inhalt in/unter … aufbewahren
ET Hoida sisu …
EL Το περιεχόμενο αποθηκεύεται σε …
EN Store contents under …
FR Stocker le contenu sous …
GA Stóráil an t-ábhar faoi …
IT Conservare sotto…
LV Saturu uzglabāt zem…
LT Turinį laikyti …
HU Tartalma … -ban/-ben tárolandó.
MT Aħżen il-kontenut taħt …
NL Onder … bewaren.
PL Zawartość przechowywać w …
PT Armazenar o conteúdo em …
RO Depozitaţi conţinutul sub …
SK Obsah uchovávajte v …
SL Vsebino hraniti v …
FI Varastoi sisältö …
SV Förvara innehållet i…
P402 + P404 Language BG Да се съхранява на сухо място. Да се съхранява в затворен съд.
ES Almacenar en un lugar seco. Almacenar en un recipiente cerrado.
CS Skladujte na suchém místě. Skladujte v uzavřeném obalu.
DA Opbevares et tørt sted. Opbevares i en lukket beholder.
DE In einem geschlossenen Behälter an einem trockenen Ort aufbewahren.
ET Hoida kuivas. Hoida suletud mahutis.
EL Αποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.
EN Store in a dry place. Store in a closed container.
FR Stocker dans un endroit sec. Stocker dans un récipient fermé.
GA Stóráil in áit thirim. Stóráil i gcoimeádán iata.
IT Conservare in luogo asciutto e in recipiente chiuso.
LV Glabāt sausā vietā. Glabāt aizvērtā tvertnē.
LT Laikyti sausoje vietoje. Laikyti uždaroje talpykloje.
HU Száraz helyen tárolandó. Zárt edényben tárolandó.
MT Aħżen f’post niexef. Aħżen f’kontenitur magħluq.
NL Op een droge plaats bewaren. In gesloten verpakking bewaren.
PL Przechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.
PT Armazenar em local seco. Armazenar em recipiente fechado.
RO A se depozita într-un loc uscat, într-un recipient închis.
SK Uchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.
SL Hraniti na suhem. Hraniti v zaprti posodi.
FI Varastoi kuivassa paikassa. Varastoi suljettuna.
SV Förvaras torrt. Förvaras i sluten behållare.
P403 + P233 Language BG Да се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.
ES Almacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.
CS Skladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.
DA Opbevares på et godt ventileret sted. Hold beholderen tæt lukket.
DE Behälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.
ET Hoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.
EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.
EN Store in a well-ventilated place. Keep container tightly closed.
FR Stocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.
GA Stóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.
IT Tenere il recipiente ben chiuso e in luogo ben ventilato.
LV Glabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.
LT Laikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.
HU Jól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.
MT Aħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.
NL Op een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.
PL Przechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.
PT Armazenar em local bem ventilado. Manter o recipiente bem fechado.
RO A se depozita într-un spaţiu bine ventilat. Păstraţi recipientul închis etanş.
SK Uchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.
SL Hraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.
FI Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.
SV Förvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.
P403 + P235 Language BG Да се съхранява на добре проветриво място. Да се съхранява на хладно.
ES Almacenar en un lugar bien ventilado. Mantener en lugar fresco.
CS Skladujte na dobře větraném místě. Uchovávejte v chladu.
DA Opbevares på et godt ventileret sted. Opbevares køligt.
DE Kühl an einem gut belüfteten Ort aufgewahren.
ET Hoida hästi ventileeritavas kohas. Hoida jahedas.
EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.
EN Store in a well-ventilated place. Keep cool.
FR Stocker dans un endroit bien ventilé. Tenir au frais.
GA Stóráil in áit dhea-aeráilte. Coimeád fionnuar.
IT Conservare in luogo fresco e ben ventilato.
LV Glabāt labi vēdināmās telpās. Turēt vēsumā.
LT Laikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.
HU Jól szellőző helyen tárolandó. Hűvös helyen tartandó.
MT Aħżen f'post b'ventilazzjoni tajba. Żomm frisk.
NL Op een goed geventileerde plaats bewaren. Koel bewaren.
PL Przechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.
PT Armazenar em local bem ventilado. Conservar em ambiente fresco.
RO A se depozita într-un spaţiu bine ventilat. A se păstra la rece.
SK Uchovávajte na dobre vetranom mieste. Uchovávajte v chlade.
SL Hraniti na dobro prezračevanem mestu. Hraniti na hladnem.
FI Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.
SV Förvaras på väl ventilerad plats. Förvaras svalt.
P410 + P403 Language BG Да се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.
ES Proteger de la luz del sol. Almacenar en un lugar bien ventilado.
CS Chraňte před slunečním zářením. Skladujte na dobře větraném místě.
DA Beskyttes mod sollys. Opbevares på et godt ventileret sted.
DE Vor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.
ET Hoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.
EL Να προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.
EN Protect from sunlight. Store in a well-ventilated place.
FR Protéger du rayonnement solaire. Stocker dans un endroit bien ventilé.
GA Cosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.
IT Proteggere dai raggi solari. Conservare in luogo ben ventilato.
LV Aizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.
LT Saugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.
HU Napfénytől védendő. Jól szellőző helyen tárolandó.
MT Ipproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.
NL Tegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.
PL Chronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.
PT Manter ao abrigo da luz solar. Armazenar em local bem ventilado.
RO A se proteja de lumina solară. A se depozita într-un spaţiu bine ventilat.
SK Chráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.
SL Zaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.
FI Suojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.
SV Skyddas från solljus. Förvaras på väl ventilerad plats.
P410 + P412 Language BG Да се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.
ES Proteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.
CS Chraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.
DA Beskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
DE Vor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.
ET Hoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.
EL Να προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
EN Protect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.
FR Protéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.
GA Cosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.
IT Proteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.
LV Aizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
LT Saugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
HU Napfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
MT Ipproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.
NL Tegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.
PL Chronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
PT Manter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.
RO A se proteja de lumina solară. Nu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
SK Chráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.
SL Zaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.
FI Suojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.
SV Skyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.
P411 + P235 Language BG Да се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.
ES Almacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.
CS Skladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.
DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.
DE Kühl und bei Temperaturen von nicht mehr als … oC aufbewahren.
ET Hoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.
EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.
EN Store at temperatures not exceeding … oC/…oF. Keep cool.
FR Stocker à une température ne dépassant pas … oC/… oF. Tenir au frais.
GA Stóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.
IT Conservare in luogo fresco a temperature non superiori a … oC/…oF.
LV Glabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.
LT Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.
HU A tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.
MT Aħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.
NL Bij maximaal … oC/…oF bewaren. Koel bewaren.
PL Przechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.
PT Armazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.
RO A se depozita la temperaturi care să nu depăşească … oC/…oF. A se păstra la rece.
SK Uchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.
SL Hraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.
FI Varastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.
SV Förvaras vid högst … oC/…oF. Förvaras svalt.
Table 1.5
Precautionary statements — Disposal
P501 Language BG Съдържанието/съдът да се изхвърли в …
ES Eliminar el contenido/el recipiente en …
CS Odstraňte obsah/obal …
DA Indholdet/beholderen bortskaffes i …
DE Inhalt/Behälter … zuführen.
ET Sisu/mahuti kõrvaldada …
EL Διάθεση του περιεχομένου/περιέκτη σε …
EN Dispose of contents/container to …
FR Éliminer le contenu/récipient dans …
GA Diúscair an t-ábhar/an coimeádán i …
IT Smaltire il prodotto/recipiente in …
LV Atbrīvoties no satura/tvertnes…
LT Turinį/talpyklą išpilti (išmesti) į …
HU A tartalom/edény elhelyezése hulladékként: …
MT Armi l-kontenut/il-kontenitur fi …
NL Inhoud/verpakking afvoeren naar …
PL Zawartość/pojemnik usuwać do …
PT Eliminar o conteúdo/recipiente em …
RO Aruncaţi conţinutul/recipientul la …
SK Zneškodnite obsah/nádobu …
SL Odstraniti vsebino/posodo …
FI Hävitä sisältö/pakkaus …
SV Innehållet/behållaren lämnas till…

after (02008R1272-20101201)

ANNEX IV
LIST OF PRECAUTIONARY STATEMENTS
In selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.


1. Part 1: Criteria for the selection of precautionary statements

Table 6.1
Precautionary statements — General

Code
General precautionary statements
Hazard class
Hazard category
Conditions for use
(1)
(2)
(3)
(4)
(5)
P101
If medical advice is needed, have product container or label at hand.
as appropriate

Consumer products
P102
Keep out of reach of children.
as appropriate

Consumer products
P103
Read label before use.
as appropriate

Consumer products

Table 6.2
Precautionary statements — Prevention

Code
Prevention precautionary statements
Hazard class
Hazard category
Conditions for use
(1)
(2)
(3)
(4)
(5)
P201
Obtain special instructions before use.
Explosives (section 2.1)
Unstable explosive

Germ cell mutagenicity (section 3.5)
1A, 1B, 2


Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2



Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category

P202
Do not handle until all safety precautions have been read and understood.
Explosives (section 2.1)
Unstable explosive

Germ cell mutagenicity (section 3.5)
1A, 1B, 2


Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2

P210
Keep away from heat/sparks/open flames/hot surfaces. — No smoking.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Manufacturer/supplier to specify applicable ignition source(s).
Flammable gases (section 2.2)
1, 2
Flammable aerosols (section 2.3)
1, 2


Flammable liquids (section 2.6)
1, 2, 3



Flammable solids (section 2.7)
1, 2



Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F



Pyrophoric liquids (section 2.9)
1



Pyrophoric solids (section 2.10)
1



Organic peroxides (section 2.15)
Types A, B, C, D, E, F



Oxidising liquids (section 2.13)
1, 2, 3

Specify to keep away from heat.


Oxidising solids (section 2.14)
1, 2, 3
P211
Do not spray on an open flame or other ignition source.
Flammable aerosols (section 2.3)
1, 2

P220
Keep/Store away from clothing/…/combustible materials.
Oxidising gases (section 2.4)
1
… Manufacturer/supplier to specify incompatible materials.
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F


Oxidising liquids (section 2.13)
1
… Manufacturer/supplier to specify incompatible materials.

specify to keep away from clothing as well as other incompatible materials.
2, 3
… Manufacturer/supplier to specify incompatible materials.


Oxidising solids (section 2.14)
1
… Manufacturer/supplier to specify incompatible materials.

specify to keep away from clothing as well as other incompatible materials.
2, 3
… Manufacturer/supplier to specify incompatible materials.


Organic peroxides (section 2.15)
Types A, B, C, D, E, F
P221
Take any precaution to avoid mixing with combustibles/…
Oxidising liquids (section 2.13)
1, 2, 3
… Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14)
1, 2, 3
P222
Do not allow contact with air.
Pyrophoric liquids (section 2.9)
1

Pyrophoric solids (section 2.10)
1
P223
Keep away from any possible contact with water, because of violent reaction and possible flash fire.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2

P230
Keep wetted with …
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.5
… Manufacturer/supplier to specify appropriate material.

if drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).
P231
Handle under inert gas.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P232
Protect from moisture.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P233
Keep container tightly closed.
Flammable liquids (section 2.6)
1, 2, 3

Acute toxicity — inhalation (section 3.1)
1, 2, 3

if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3
Specific target organ toxicity — single exposure; narcosis (section 3.8)
3
P234
Keep only in original container.
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F

Organic peroxides (section 2.15)
Types A, B, C, D, E, F
Corrosive to metals (section 2.16)
1
P235
Keep cool.
Flammable liquids (section 2.6)
1, 2, 3

Self-reactive substances and mixtures (Section 2.8)
Types A, B, C, D, E, F
Self-heating substances and mixtures (section 2.11)
1, 2
Organic peroxides (section 2.15)
Types A, B, C, D, E, F
P240
Ground/bond container and receiving equipment.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5

if the explosive is electrostatically sensitive.


Flammable liquids (section 2.6)
1, 2, 3

if electrostatically sensitive material is for reloading.
if product is volatile so as to generate hazardous atmosphere.


Flammable solids (section 2.7)
1, 2

if electrostatically sensitive material is for reloading.
P241
Use explosion-proof electrical/ventilating/lighting/…/equipment.
Flammable liquids (section 2.6)
1, 2, 3
… Manufacturer/supplier to specify other equipment.
Flammable solids (section 2.7)
1, 2
… Manufacturer/supplier to specify other equipment.

if dust clouds can occur.
P242
Use only non-sparking tools.
Flammable liquids (section 2.6)
1, 2, 3

P243
Take precautionary measures against static discharge.
Flammable liquids (section 2.6)
1, 2, 3

P244
Keep reduction valves free from grease and oil.
Oxidising gases (section 2.4)
1

P250
Do not subject to grinding/shock/…/friction.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5
… Manufacturer/supplier to specify applicable rough handling.
P251
Pressurized container: Do not pierce or burn, even after use.
Flammable aerosols (section 2.3)
1, 2

P260
Do not breathe dust/fume/gas/mist/vapours/spray.
Acute toxicity — inhalation (section 3.1)
1, 2
Manufacturer/supplier to specify applicable conditions.
Specific target organ toxicity — single exposure (section 3.8)
1, 2
Specific target organ toxicity — repeated exposure (section 3.9)
1, 2


Skin corrosion (section 3.2)
1A, 1B, 1C

Specify do not breathe dusts or mists.
if inhalable particles of dusts or mists may occur during use.
Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category
P261
Avoid breathing dust/fume/gas/mist/vapours/spray.
Acute toxicity — inhalation (section 3.1)
3, 4
Manufacturer/supplier to specify applicable conditions.
Respiratory sensitisation (section 3.4)
1
Skin sensitisation (section 3.4)
1


Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3

P262
Do not get in eyes, on skin, or on clothing.
Acute toxicity — dermal (section 3.1)
1, 2

P263
Avoid contact during pregnancy/while nursing.
Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category

P264
Wash … thoroughly after handling.
Acute toxicity — oral (section 3.1)
1, 2, 3, 4
Manufacturer/supplier to specify parts of the body to be washed after handling.
Acute toxicity — dermal (section 3.1)
1, 2
Skin corrosion (section 3.2)
1A, 1B, 1C


Skin irritation (section 3.2)
2



Eye irritation (section 3.3)
2



Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category



Specific target organ toxicity — single exposure (section 3.8)
1, 2



Specific target organ toxicity — repeated exposure (section 3.9)
1

P270
Do not eat, drink or smoke when using this product.
Acute toxicity — oral (section 3.1)
1, 2, 3, 4

Acute toxicity — dermal (section 3.1)
1, 2


Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category



Specific target organ toxicity — single exposure (section 3.8)
1, 2



Specific target organ toxicity — repeated exposure (section 3.9)
1

P271
Use only outdoors or in a well-ventilated area.
Acute toxicity — inhalation (section 3.1)
1, 2, 3, 4

Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3
Specific target organ toxicity — single exposure; narcosis (section 3.8)
3
P272
Contaminated work clothing should not be allowed out of the workplace.
Skin sensitisation (section 3.4)
1

P273
Avoid release to the environment.
Hazardous to the aquatic environment — acute aquatic hazard (section 4.1)
1

if this is not the intended use.
Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1)
1, 2, 3, 4


Hazardous to the ozone layer (section 5.1)
1

P280
Wear protective gloves/protective clothing/eye protection/face protection.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Manufacturer/supplier to specify type of equipment.

Specify face protection.


Flammable liquids (section 2.6)
1, 2, 3
Manufacturer/supplier to specify type of equipment.

Specify protective gloves and eye/face protection.
Flammable solids (section 2.7)
1, 2
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)
1
Pyrophoric solids (section 2.10)
1


Self-heating substances and mixtures (section 2.11)
1, 2



Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3



Oxidising liquids (section 2.13)
1, 2, 3



Oxidising solids (section 2.14)
1, 2, 3



Organic peroxides (section 2.15)
Types A, B, C, D, E, F



Acute toxicity — dermal (section 3.1)
1, 2, 3, 4
Manufacturer/supplier to specify type of equipment.

Specify protective gloves/clothing.


Skin corrosion (section 3.2)
1A, 1B, 1C
Manufacturer/supplier to specify type of equipment.

Specify protective gloves/clothing and eye/face protection.


Skin irritation (section 3.2)
2
Manufacturer/supplier to specify type of equipment.

Specify protective gloves.
Skin sensitisation (section 3.4)
1


Serious eye damage/eye irritation (section 3.3)
1
Manufacturer/supplier to specify type of equipment.

Specify eye/face protection.
Eye irritation (section 3.3)
2
P281
Use personal protective equipment as required.
Explosives (section 2.1)
Unstable explosive

Germ cell mutagenicity (section 3.5)
1A, 1B, 2


Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2

P282
Wear cold insulating gloves/face shield/eye protection.
Gases under pressure (section 2.5)
Refrigerated liquefied gas

P283
Wear fire/flame resistant/retardant clothing.
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1
P284
Wear respiratory protection.
Acute toxicity — inhalation (section 3.1)
1, 2
Manufacturer/supplier to specify equipment.
P285
In case of inadequate ventilation wear respiratory protection.
Respiratory sensitisation (section 3.4)
1
Manufacturer/supplier to specify equipment.
P231 + P232
Handle under inert gas. Protect from moisture.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P235 + P410
Keep cool. Protect from sunlight.
Self-heating substances and mixtures (section 2.11)
1, 2


Table 6.3
Precautionary statements — Response

Code
Response precautionary statements
Hazard class
Hazard category
Conditions for use
(1)
(2)
(3)
(4)
(5)
P301
IF SWALLOWED:
Acute toxicity — oral (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C
Aspiration Hazard (section 3.10)
1
P302
IF ON SKIN:
Pyrophoric liquids (section 2.9)
1

Acute toxicity — dermal (section 3.1)
1, 2, 3, 4


Skin irritation (section 3.2)
2



Skin sensitisation (section 3.4)
1

P303
IF ON SKIN (or hair):
Flammable liquids (section 2.6)
1, 2, 3

Skin corrosion (section 3.2)
1A, 1B, 1C
P304
IF INHALED:
Acute toxicity — inhalation (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C


Respiratory sensitisation (section 3.4)
1



Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3

P305
IF IN EYES:
Skin corrosion (section 3.2)
1A, 1B, 1C

Serious eye damage/eye irritation (section 3.3)
1
Eye irritation (section 3.3)
2
P306
IF ON CLOTHING:
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1
P307
IF exposed:
Specific target organ toxicity — single exposure (section 3.8)
1

P308
IF exposed or concerned:
Germ cell mutagenicity (section 3.5)
1A, 1B, 2

Carcinogenicity (section 3.6)
1A, 1B, 2
Reproductive toxicity (section 3.7)
1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category
P309
IF exposed or if you feel unwell:
Specific target organ toxicity — single exposure (section 3.8)
2

P310
Immediately call a POISON CENTER or doctor/physician.
Acute toxicity — oral (section 3.1)
1, 2, 3

Acute toxicity — dermal (section 3.1)
1, 2


Acute toxicity — inhalation (section 3.1)
1, 2



Skin corrosion (section 3.2)
1A, 1B, 1C



Serious eye damage/eye irritation (section 3.3)
1



Aspiration hazard (section 3.10)
1

P311
Call a POISON CENTER or doctor/physician.
Acute toxicity — inhalation (section 3.1)
3

Respiratory sensitisation (section 3.4)
1
Specific target organ toxicity — single exposure (section 3.8)
1, 2
P312
Call a POISON CENTER or doctor/physician if you feel unwell.
Acute toxicity — oral (section 3.1)
4

Acute toxicity — dermal (section 3.1)
3, 4


Acute toxicity — inhalation (section 3.1)
4



Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3

P313
Get medical advice/attention.
Skin irritation (section 3.2)
2, 3

Eye irritation (section 3.3)
2


Skin sensitisation (section 3.4)
1



Germ cell mutagenicity (section 3.5)
1A, 1B, 2



Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2



Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category

P314
Get medical advice/attention if you feel unwell.
Specific target organ toxicity — repeated exposure (section 3.9)
1, 2

P315
Get immediate medical advice/attention.
Gases under pressure (section 2.5)
Refrigerated liquefied gas

P320
Specific treatment is urgent (see … on this label).
Acute toxicity — inhalation (section 3.1)
1, 2
… Reference to supplemental first aid instruction.

if immediate administration of antidote is required.
P321
Specific treatment (see … on this label).
Acute toxicity — oral (section 3.1)
1, 2, 3
… Reference to supplemental first aid instruction.

if immediate administration of antidote is required.


Acute toxicity — inhalation (section 3.1)
3
… Reference to supplemental first aid instruction.

if immediate specific measures are required.


Specific target organ toxicity — single exposure (section 3.8)
1
… Reference to supplemental first aid instruction.

if immediate measures are required.


Skin sensitisation (section 3.4)
1
… Reference to supplemental first aid instruction.

manufacturer/supplier may specify a cleansing agent if appropriate.


Skin corrosion (section 3.2)
1A, 1B, 1C


Skin irritation (section 3.2)
2
P322
Specific measures (see … on this label).
Acute toxicity — dermal (section 3.1)
1, 2
… Reference to supplemental first aid instruction.

if immediate measures such as specific cleansing agent is advised.


Acute toxicity — dermal (section 3.1)
3, 4
… Reference to supplemental first aid instruction.

if measures such as specific cleansing agent is advised.
P330
Rinse mouth.
Acute toxicity — oral (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C
P331
Do NOT induce vomiting.
Skin corrosion (section 3.2)
1A, 1B, 1C

Aspiration hazard (section 3.10)
1
P332
If skin irritation occurs:
Skin irritation (section 3.2)
2, 3

P333
If skin irritation or rash occurs:
Skin sensitisation (section 3.4)
1

P334
Immerse in cool water/wrap in wet bandages.
Pyrophoric liquids (section 2.9)
1

Pyrophoric solids (section 2.10)
1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2
P335
Brush off loose particles from skin.
Pyrophoric solids (section 2.10)
1

Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2
P336
Thaw frosted parts with lukewarm water. Do not rub affected area.
Gases under pressure (section 2.5)
Refrigerated liquefied gas

P337
If eye irritation persists:
Eye irritation (section 3.3)
2

P338
Remove contact lenses, if present and easy to do. Continue rinsing.
Skin corrosion (section 3.2)
1A, 1B, 1C

Serious eye damage/eye irritation (section 3.3)
1
Eye irritation (section 3.3)
2
P340
Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Acute toxicity — inhalation (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3
Specific target organ toxicity — single exposure; narcosis (section 3.8)
3
P341
If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
Respiratory sensitisation (section 3.4)
1

P342
If experiencing respiratory symptoms:
Respiratory sensitisation (section 3.4)
1

P350
Gently wash with plenty of soap and water.
Acute toxicity — dermal (section 3.1)
1, 2

P351
Rinse cautiously with water for several minutes.
Skin corrosion (section 3.2)
1A, 1B, 1C

Serious eye damage/eye irritation (section 3.3)
1
Eye irritation (section 3.3)
2
P352
Wash with plenty of soap and water.
Acute toxicity — dermal (section 3.1)
3, 4

Skin irritation (section 3.2)
2
Skin sensitisation (section 3.4)
1
P353
Rinse skin with water/shower.
Flammable liquids (section 2.6)
1, 2, 3

Skin corrosion (section 3.2)
1A, 1B, 1C
P360
Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1
P361
Remove/Take off immediately all contaminated clothing.
Flammable liquids (section 2.6)
1, 2, 3

Acute toxicity — dermal (section 3.1)
1, 2, 3
Skin corrosion (section 3.2)
1A, 1B, 1C
P362
Take off contaminated clothing and wash before reuse.
Skin irritation (section 3.2)
2

P363
Wash contaminated clothing before reuse.
Acute toxicity — dermal (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C
Skin sensitisation (section 3.4)
1
P370
In case of fire:
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5

Oxidising gases (section 2.4)
1


Flammable liquids (section 2.6)
1, 2, 3



Flammable solids (section 2.7)
1, 2



Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F



Pyrophoric liquids (section 2.9)
1



Pyrophoric solids (section 2.10)
1



Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3



Oxidising liquids (section 2.13)
1, 2, 3



Oxidising solids (section 2.14)
1, 2, 3

P371
In case of major fire and large quantities:
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1
P372
Explosion risk in case of fire.
Explosives (section 2.1)
Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5

except if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P373
DO NOT fight fire when fire reaches explosives.
Explosives (section 2.1)
Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5

P374
Fight fire with normal precautions from a reasonable distance.
Explosives (section 2.1)
Division 1.4

if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P375
Fight fire remotely due to the risk of explosion.
Self-reactive substances and mixtures (section 2.8)
Types A, B

Oxidising liquids (section 2.13)
1
Oxidising solids (section 2.14)
1
P376
Stop leak if safe to do so.
Oxidising gases (section 2.4)
1

P377
Leaking gas fire:
Do not extinguish, unless leak can be stopped safely.
Flammable gases (section 2.2)
1, 2

P378
Use … for extinction.
Flammable liquids (section 2.6)
1, 2, 3
… Manufacturer/supplier to specify appropriate media

if water increases risk.
Flammable solids (section 2.7)
1, 2
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)
1
Pyrophoric solids (section 2.10)
1


Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3



Oxidising liquids (section 2.13)
1, 2, 3



Oxidising solids (section 2.14)
1, 2, 3

P380
Evacuate area.
Explosives (section 2.1)
Unstable explosives

Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5


Self-reactive substances and mixtures (section 2.8)
Types A, B



Oxidising liquids (section 2.13)
1



Oxidising solids (section 2.14)
1

P381
Eliminate all ignition sources if safe to do so.
Flammable gases (section 2.2)
1, 2

P390
Absorb spillage to prevent material damage.
Corrosive to metals (section 2.16)
1

P391
Collect spillage.
Hazardous to the aquatic environment – acute aquatic hazard (section 4.1)
1

Hazardous to the aquatic environment – chronic aquatic hazard (section 4.1)
1, 2
P301 + P310
IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
Acute toxicity — oral (section 3.1)
1, 2, 3

Aspiration hazard (section 3.10)
1
P301 + P312
IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
Acute toxicity — oral (section 3.1)
4

P301 + P330 + P331
IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
Skin corrosion (section 3.2)
1A, 1B, 1C

P302 + P334
IF ON SKIN: Immerse in cool water/wrap in wet bandages.
Pyrophoric liquids (section 2.9)
1

P302 + P350
IF ON SKIN: Gently wash with plenty of soap and water.
Acute toxicity — dermal (section 3.1)
1, 2

P302 + P352
IF ON SKIN: Wash with plenty of soap and water.
Acute toxicity — dermal (section 3.1)
3, 4

Skin irritation (section 3.2)
2
Skin sensitisation (section 3.4)
1
P303 + P361 + P353
IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.
Flammable liquids (section 2.6)
1, 2, 3

Skin corrosion (section 3.2)
1A, 1B, 1C
P304 + P340
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Acute toxicity — inhalation (section 3.1)
1, 2, 3, 4

Skin corrosion (section 3.2)
1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3
Specific target organ toxicity — single exposure; narcosis (section 3.8)
3
P304 + P341
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
Respiratory sensitisation (section 3.4)
1

P305 + P351 + P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Skin corrosion (section 3.2)
1A, 1B, 1C

Serious eye damage/eye irritation (section 3.3)
1
Eye irritation (section 3.3)
2
P306 + P360
IF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1
P307 + P311
IF exposed: Call a POISON CENTER or doctor/physician.
Specific target organ toxicity — single exposure (section 3.8)
1

P308 + P313
IF exposed or concerned: Get medical advice/attention.
Germ cell mutagenicity (section 3.5)
1A, 1B, 2

Carcinogenicity (section 3.6)
1A, 1B, 2
Reproductive toxicity (section 3.7)
1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)
Additional category
P309 + P311
IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
Specific target organ toxicity — single exposure (section 3.8)
2

P332 + P313
If skin irritation occurs: Get medical advice/attention.
Skin irritation (section 3.2)
2

P333 + P313
If skin irritation or rash occurs: Get medical advice/attention.
Skin sensitisation (section 3.4)
1

P335 + P334
Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
Pyrophoric solids (section 2.10)
1

Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2
P337 + P313
If eye irritation persists: Get medical advice/attention.
Eye irritation (section 3.3)
2

P342 + P311
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Respiratory sensitisation (section 3.4)
1

P370 + P376
In case of fire: Stop leak if safe to do so.
Oxidizing gases (section 2.4)
1

P370 + P378
In case of fire: Use … for extinction.
Flammable liquids (section 2.6)
1, 2, 3
… Manufacturer/supplier to specify appropriate media.

if water increases risk.
Flammable solids (section 2.7)
1, 2
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)
1
Pyrophoric solids (section 2.10)
1


Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3



Oxidising liquids (section 2.13)
1, 2, 3



Oxidising solids (section 2.14)
1, 2, 3

P370 + P380
In case of fire: Evacuate area.
Explosives (section 2.1)
Divisions 1.1, 1.2, 1.3, 1.4, 1.5

P370 + P380 + P375
In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
Self-reactive substances and mixtures (section 2.8)
Types A, B

P371 + P380 + P375
In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Oxidising liquids (section 2.13)
1

Oxidising solids (section 2.14)
1

Table 6.4
Precautionary statements — Storage

Code
Storage precautionary statements
Hazard class
Hazard category
Conditions for use
(1)
(2)
(3)
(4)
(5)
P401
Store …
Explosives (section 2.1)
Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5
… in accordance with local/regional/national/international regulations (to be specified).
P402
Store in a dry place.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P403
Store in a well-ventilated place.
Flammable gases (section 2.2)
1, 2

if product is volatile so as to generate hazardous atmosphere.
Oxidising gases (section 2.4)
1
Gases under pressure (section 2.5)
Compressed gas
Liquefied gas
Refrigerated Liquefied gas
Dissolved gas


Flammable liquids (section 2.6)
1, 2, 3



Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F



Acute toxicity — inhalation (section 3.1)
1, 2, 3



Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3

P404
Store in a closed container.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P405
Store locked up.
Acute toxicity — oral (section 3.1)
1, 2, 3

Acute toxicity — dermal (section 3.1)
1, 2, 3


Acute toxicity — inhalation (section 3.1)
1, 2, 3



Skin corrosion (section 3.2)
1A, 1B, 1C



Germ cell mutagenicity (section 3.5)
1A, 1B, 2



Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2



Specific target organ toxicity — single exposure (section 3.8)
1, 2




Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3



Aspiration hazard (section 3.10)
1

P406
Store in corrosive resistant/… container with a resistant inner liner.
Corrosive to metals (section 2.16)
1
… Manufacturer/supplier to specify other compatible materials.
P407
Maintain air gap between stacks/pallets.
Self-heating substances and mixtures (section 2.11)
1, 2

P410
Protect from sunlight.
Flammable aerosols (section 2.3)
1, 2

Gases under pressure (section 2.5)
Compressed gas
Liquefied gas
Dissolved gas


Self-heating substances and mixtures (section 2.11)
1, 2



Organic peroxides (section 2.15)
Types A, B, C, D, E, F

P411
Store at temperatures not exceeding … oC/…oF.
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
… Manufacturer/supplier to specify temperature
Organic peroxides (section 2.15)
Types A, B, C, D, E, F
P412
Do not expose to temperatures exceeding 50 oC/122 oF.
Flammable aerosols (section 2.3)
1, 2

P413
Store bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF.
Self-heating substances and mixtures (section 2.11)
1, 2
… Manufacturer/supplier to specify mass and temperature.
P420
Store away from other materials.
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F

Self-heating substances and mixtures (section 2.11)
1, 2
Organic peroxides (section 2.15)
Types A, B, C, D, E, F
P422
Store contents under …
Pyrophoric liquids (section 2.9)
1
… Manufacturer/supplier to specify appropriate liquid or inert gas.
Pyrophoric solids (section 2.10)
1
P402 + P404
Store in a dry place. Store in a closed container.
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3

P403 + P233
Store in a well-ventilated place. Keep container tightly closed.
Acute toxicity — inhalation (section 3.1)
1, 2, 3

if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3
Specific target organ toxicity — single exposure; narcosis (section 3.8)
3
P403 + P235
Store in a well-ventilated place. Keep cool.
Flammable liquids (section 2.6)
1, 2, 3

Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F
P410 + P403
Protect from sunlight. Store in a well-ventilated place.
Gases under pressure (section 2.5)
Compressed gas

Liquefied gas
Dissolved gas
P410 + P412
Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
Flammable aerosols (section 2.3)
1, 2

P411 + P235
Store at temperatures not exceeding … oC/…oF. Keep cool.
Organic peroxides (section 2.15)
Types A, B, C, D, E, F
… Manufacturer/supplier to specify temperature.


Table 6.5
Precautionary statements — Disposal

Code
Disposal precautionary statements
Hazard class
Hazard category
Conditions for use
(1)
(2)
(3)
(4)
(5)
P501
Dispose of contents/container to …
Explosives (section 2.1)
Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5
… in accordance with local/regional/national/international regulation (to be specified).
Flammable liquids (section 2.6)
1, 2, 3
Self-reactive substances and mixtures (section 2.8)
Types A, B, C, D, E, F


Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)
1, 2, 3



Oxidising liquids (section 2.13)
1, 2, 3



Oxidising solids (section 2.14)
1, 2, 3



Organic peroxides (section 2.15)
Types A, B, C, D, E, F



Acute toxicity — oral (section 3.1)
1, 2, 3, 4



Acute toxicity — dermal (section 3.1)
1, 2, 3, 4



Acute toxicity — inhalation (section 3.1)
1, 2



Skin corrosion (section 3.2)
1A, 1B, 1C



Respiratory sensitisation (section 3.4)
1

Skin sensitisation (section 3.4)
1


Germ cell mutagenicity (section 3.5)
1A, 1B, 2



Carcinogenicity (section 3.6)
1A, 1B, 2



Reproductive toxicity (section 3.7)
1A, 1B, 2



Specific target organ toxicity — single exposure (section 3.8)
1, 2



Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)
3



Specific target organ toxicity — single exposure; narcosis (section 3.8)
3



Specific target organ toxicity — repeated exposure (section 3.9)
1, 2



Aspiration hazard (section 3.10)
1



Hazardous to the aquatic environment — acute aquatic hazard (section 4.1)
1



Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1)
1, 2, 3, 4



Hazardous to the ozone layer (section 5.1)
1



2. Part 2: precautionary statements
The precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.

Table 1.1
Precautionary statements — General

P101
Language


BG
При необходимост от медицинска помощ, носете опаковката или етикета на продукта.

ES
Si se necesita consejo médico, tener a mano el envase o la etiqueta.

CS
Je-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.

DA
Hvis der er brug for lægehjælp, medbring da beholderen eller etiketten.

DE
Ist ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.

ET
Arsti poole pöördudes võtta kaasa toote pakend või etikett.

EL
Εάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.

EN
If medical advice is needed, have product container or label at hand.

FR
En cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.

GA
Más gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.

IT
In caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.

LV
Medicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.

LT
Jei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.

HU
Orvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.

MT
Jekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.

NL
Bij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.

PL
W razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.

PT
Se for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.

RO
Dacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.

SK
Ak je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.

SL
Če je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.

FI
Jos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.

SV
Ha förpackningen eller etiketten till hands om du måste söka läkarvård.

P102
Language


BG
Да се съхранява извън обсега на деца.

ES
Mantener fuera del alcance de los niños.

CS
Uchovávejte mimo dosah dětí.

DA
Opbevares utilgængeligt for børn.

DE
Darf nicht in die Hände von Kindern gelangen.

ET
Hoida lastele kättesaamatus kohas.

EL
Μακριά από παιδιά.

EN
Keep out of reach of children.

FR
Tenir hors de portée des enfants.

GA
Coimeád as aimsiú leanaí.

IT
Tenere fuori dalla portata dei bambini.

LV
Sargāt no bērniem.

LT
Laikyti vaikams neprieinamoje vietoje.

HU
Gyermekektől elzárva tartandó.

MT
Żommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.

NL
Buiten het bereik van kinderen houden.

PL
Chronić przed dziećmi.

PT
Manter fora do alcance das crianças.

RO
A nu se lăsa la îndemâna copiilor.

SK
Uchovávajte mimo dosahu detí.

SL
Hraniti zunaj dosega otrok.

FI
Säilytä lasten ulottumattomissa.

SV
Förvaras oåtkomligt för barn.


P103
Language


BG
Преди употреба прочетете етикета.

ES
Leer la etiqueta antes del uso.

CS
Před použitím si přečtěte údaje na štítku.

DA
Læs etiketten før brug.

DE
Vor Gebrauch Kennzeichnungsetikett lesen.

ET
Enne kasutamist tutvuda etiketil oleva infoga.

EL
Διαβάστε την ετικέτα πριν από τη χρήση.

EN
Read label before use.

FR
Lire l’étiquette avant utilisation.

GA
Léigh an lipéad roimh úsáid.

IT
Leggere l’etichetta prima dell’uso.

LV
Pirms izmantošanas izlasīt etiķeti.

LT
Prieš naudojimą perskaityti etiketę.

HU
Használat előtt olvassa el a címkén közölt információkat.

MT
Aqra t-tikketta qabel l-użu.

NL
Alvorens te gebruiken, het etiket lezen.

PL
Przed użyciem przeczytać etykietę.

PT
Ler o rótulo antes da utilização.

RO
Citiți eticheta înainte de utilizare.

SK
Pred použitím si prečítajte etiketu.

SL
Pred uporabo preberite etiketo.

FI
Lue merkinnät ennen käyttöä.

SV
Läs etiketten före användning.

Table 1.2
Precautionary statements — Prevention

P201
Language


BG
Преди употреба се снабдете със специални инструкции.

ES
Pedir instrucciones especiales antes del uso.

CS
Před použitím si obstarejte speciální instrukce.

DA
Indhent særlige anvisninger før brug.

DE
Vor Gebrauch besondere Anweisungen einholen.

ET
Enne kasutamist tutvuda erijuhistega.

EL
Εφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.

EN
Obtain special instructions before use.

FR
Se procurer les instructions avant utilisation.

GA
Faigh treoracha speisialta roimh úsáid.

IT
Procurarsi istruzioni specifiche prima dell’uso.

LV
Pirms lietošanas saņemt speciālu instruktāžu.

LT
Prieš naudojimą gauti specialias instrukcijas.

HU
Használat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.

MT
Ikseb struzzjonijiet speċjali qabel l-użu.

NL
Alvorens te gebruiken de speciale aanwijzingen raadplegen.

PL
Przed użyciem zapoznać się ze specjalnymi środkami ostrożności.

PT
Pedir instruções específicas antes da utilização.

RO
Procurați instrucțiuni speciale înainte de utilizare.

SK
Pred použitím sa oboznámte s osobitnými pokynmi.

SL
Pred uporabo pridobiti posebna navodila.

FI
Lue erityisohjeet ennen käyttöä.

SV
Inhämta särskilda instruktioner före användning.

P202
Language


BG
Не използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.

ES
No manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.

CS
Nepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.

DA
Anvend ikke produktet, før alle advarsler er læst og forstået.

DE
Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.

ET
Mitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.

EL
Μην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.

EN
Do not handle until all safety precautions have been read and understood.

FR
Ne pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.

GA
Ná láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.

IT
Non manipolare prima di avere letto e compreso tutte le avvertenze.

LV
Neizmantot pirms nav izlasīti un saprasti visi apzīmējumi.

LT
Nenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.

HU
Ne használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.

MT
Tmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.

NL
Pas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft

PL
Nie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.

PT
Não manuseie o produto antes de ter lido e percebido todas as precauções de segurança.

RO
A nu se manipula decât după ce au fost citite și înțelese toate măsurile de securitate.

SK
Nepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.

SL
Ne uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.

FI
Lue varoitukset huolellisesti ennen käsittelyä.

SV
Använd inte produkten innan du har läst och förstått säkerhetsanvisningarna

P210
Language


BG
Да се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.

ES
Mantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.

CS
Chraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.

DA
Holdes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.

DE
Von Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.

ET
Hoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.

EL
Μακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.

EN
Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

FR
Tenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.

GA
Coimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.

IT
Tenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.

LV
Nelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.

LT
Laikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.

HU
Hőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.

MT
Żomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.

NL
Verwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.

PL
Przechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.

PT
Manter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.

RO
A se păstra departe de surse de căldură/scântei/flăcări deschise/suprafețe încinse. — Fumatul interzis.

SK
Uchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.

SL
Hraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.

FI
Suojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.

SV
Får inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.

P211
Language


BG
Да не се пръска към открит пламък или друг източник на запалване.

ES
No pulverizar sobre una llama abierta u otra fuente de ignición.

CS
Nestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.

DA
Spray ikke mod åben ild eller andre antændelseskilder.

DE
Nicht gegen offene Flamme oder andere Zündquelle sprühen.

ET
Mitte pihustada leekidesse või muusse süüteallikasse.

EL
Μην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.

EN
Do not spray on an open flame or other ignition source.

FR
Ne pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.

GA
Ná spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.

IT
Non vaporizzare su una fiamma libera o altra fonte di accensione.

LV
Neizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.

LT
Nepurkšti į atvirą liepsną arba kitus degimo šaltinius.

HU
Tilos nyílt lángra vagy más gyújtóforrásra permetezni.

MT
Tisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.

NL
Niet in een open vuur of op andere ontstekingsbronnen spuiten.

PL
Nie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.

PT
Não pulverizar sobre chama aberta ou outra fonte de ignição.

RO
Nu pulverizați deasupra unei flăcări deschise sau unei alte surse de aprindere.

SK
Nestriekajte na otvorený oheň ani iný zdroj zapálenia.

SL
Ne pršiti proti odprtemu ognju ali drugemu viru vžiga.

FI
Ei saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.

SV
Spreja inte över öppen låga eller andra antändningskällor.

P220
Language


BG
Да се държи/съхранява далеч от облекло/…/горими материали

ES
Mantener o almacenar alejado de la ropa/…/materiales combustibles.

CS
Uchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.

DA
Må ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.

DE
Von Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.

ET
Hoida eemal rõivastest/…/süttivast materjalist.

EL
Διατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.

EN
Keep/Store away from clothing/…/combustible materials.

FR
Tenir/stocker à l’écart des vêtements/…/matières combustibles

GA
Coimeád/Stóráil glan ar éadaí/…/ábhair indóite.

IT
Tenere/conservare lontano da indumenti/…/materiali combustibili.

LV
Turēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.

LT
Laikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.

HU
Ruhától/…/éghető anyagtól távol tartandó/tárolandó.

MT
Żomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.

NL
Van kleding/…/brandbare stoffen verwijderd houden/bewaren.

PL
Trzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.

PT
Manter/guardar afastado de roupa/…/matérias combustíveis.

RO
A se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.

SK
Uchovávajte/skladujte mimo odevov/…/horľavých materiálov.

SL
Hraniti ločeno od oblačil/…/vnetljivih materialov.

FI
Pidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.

SV
Hålls/förvarad åtskilt från kläder/…/brännbara material.


P221
Language


BG
Вземете всички предпазни мерки за избягване на смесването с горими материали…

ES
Tomar todas las precauciones necesarias para no mezclar con materias combustibles…

CS
Proveďte preventivní opatření proti smíchání s hořlavými materiály…

DA
Undgå at blande med brændbare materialer…

DE
Mischen mit brennbaren Stoffen/… unbedingt verhindern.

ET
Rakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…

EL
Λάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…

EN
Take any precaution to avoid mixing with combustibles…

FR
Prendre toutes précautions pour éviter de mélanger avec des matières combustibles…

GA
Déan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…

IT
Prendere ogni precauzione per evitare di miscelare con sostanze combustibili…

LV
Nekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…

LT
Imtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…

HU
Minden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.

MT
Ħu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…

NL
Vermenging met brandbare stoffen… absoluut vermijden.

PL
Zastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …

PT
Tomar todas as precauções para não misturar com combustíveis…

RO
Luați toate măsurile de precauție pentru a evita amestecul cu combustibili…

SK
Prijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…

SL
Preprečiti mešanje z vnetljivimi snovmi …

FI
Varo sekoittamasta syttyvien materiaalien… kanssa.

SV
Undvik att blanda med med brännbara ämnen…


P222
Language


BG
Не допускайте конктакт с въздух.

ES
No dejar que entre en contacto con el aire.

CS
Zabraňte styku se vzduchem.

DA
Undgå kontakt med luft.

DE
Kontakt mit Luft nicht zulassen.

ET
Hoida õhuga kokkupuute eest.

EL
Να μην έρθει σε επαφή με τον αέρα.

EN
Do not allow contact with air.

FR
Ne pas laisser au contact de l’air.

GA
Ná ceadaigh teagmháil le haer.

IT
Evitare il contatto con l’aria.

LV
Nepieļaut kontaktu ar gaisu.

LT
Saugoti nuo kontakto su oru.

HU
Nem érintkezhet levegővel.

MT
Tħallix li jkun hemm kuntatt ma' l-arja.

NL
Contact met de lucht vermijden.

PL
Nie dopuszczać do kontaktu z powietrzem.

PT
Não deixar entrar em contacto com o ar.

RO
A nu se lăsa în contact cu aerul.

SK
Zabráňte kontaktu so vzduchom.

SL
Preprečiti stik z zrakom.

FI
Ei saa joutua kosketuksiin ilman kanssa.

SV
Undvik kontakt med luft.

P223
Language


BG
Да се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.

ES
Mantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.

CS
Chraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.

DA
Undgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.

DE
Kontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.

ET
Hoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.

EL
Αποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.

EN
Keep away from any possible contact with water, because of violent reaction and possible flash fire.

FR
Éviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.

GA
Ná ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.

IT
Evitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.

LV
Nepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.

LT
Saugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.

HU
Vízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.

MT
Żomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.

NL
Contact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.

PL
Chronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.

PT
Não deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.

RO
A se evita orice contact cu apa, din cauza reacției violente și a riscului de aprindere spontană.

SK
Zabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.

SL
Hraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.

FI
Ei saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.

SV
Undvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.

P230
Language


BG
Да се държи навлажнен с…

ES
Mantener humedecido con…

CS
Uchovávejte ve zvlhčeném stavu…

DA
Holdes befugtet med…

DE
Feucht halten mit …

ET
Niisutada …-ga.

EL
Να διατηρείται υγρό με …

EN
Keep wetted with…

FR
Maintenir humidifié avec…

GA
Coimeád fliuchta le…

IT
Mantenere umido con…

LV
Vienmēr samitrināt ar …

LT
Laikyti sudrėkintą (kuo)

HU
…-val/-vel nedvesítve tartandó.

MT
Żommu mxarrab bi …

NL
Vochtig houden met…

PL
Przechowywać produkt zwilżony…

PT
Manter húmido com…

RO
A se păstra umezit cu…

SK
Uchovávajte zvlhčené …

SL
Hraniti prepojeno z …

FI
Säilytä kostutettuna …

SV
Ska hållas fuktigt med…

P231
Language


BG
Да се използва под инертен газ.

ES
Manipular en gas inerte.

CS
Manipulace pod inertním plynem.

DA
Håndteres under inaktiv gas.

DE
Unter inertem Gas handhaben.

ET
Käidelda inertgaasis.

EL
Χειρισμός σε αδρανή ατμόσφαιρα.

EN
Handle under inert gas.

FR
Manipuler sous gaz inerte.

GA
Láimhsigh faoi thriathghás.

IT
Manipolare in atmosfera di gas inerte.

LV
Rīkoties tikai inertas gāzes apstākļos.

LT
Tvarkyti inertinėse dujose.

HU
Inert gázban használandó.

MT
Immaniġġja taħt gass inerti.

NL
Onder inert gas werken.

PL
Używać w atmosferze obojętnego gazu.

PT
Manusear em atmosfera de gás inerte.

RO
A se manipula sub un gaz inert.

SK
Manipulujte v prostredí s inertným plynom.

SL
Hraniti v ustreznem inertnem plinu.

FI
Käsittele inertissä kaasussa.

SV
Hanteras under inert gas.


P232
Language


BG
Да се пази от влага.

ES
Proteger de la humedad.

CS
Chraňte před vlhkem.

DA
Beskyttes mod fugt.

DE
Vor Feuchtigkeit schützen.

ET
Hoida niiskuse eest.

EL
Προστετέψτε από την υγρασία.

EN
Protect from moisture.

FR
Protéger de l’humidité.

GA
Cosain ar thaise.

IT
Proteggere dall’umidità.

LV
Aizsargāt no mitruma.

LT
Saugoti nuo drėgmės.

HU
Nedvességtől védendő.

MT
Ipproteġi mill-umdità.

NL
Tegen vocht beschermen.

PL
Chronić przed wilgocią.

PT
Manter ao abrigo da humidade.

RO
A se proteja de umiditate.

SK
Chráňte pred vlhkosťou.

SL
Zaščititi pred vlago.

FI
Suojaa kosteudelta.

SV
Skyddas från fukt.

P233
Language


BG
Съдът да се съхранява плътно затворен.

ES
Mantener el recipiente herméticamente cerrado.

CS
Uchovávejte obal těsně uzavřený.

DA
Hold beholderen tæt lukket.

DE
Behälter dicht verschlossen halten.

ET
Hoida pakend tihedalt suletuna.

EL
Να διατηρείται ο περιέκτης ερμητικά κλειστός.

EN
Keep container tightly closed.

FR
Maintenir le récipient fermé de manière étanche.

GA
Coimeád an coimeádán dúnta go docht.

IT
Tenere il recipiente ben chiuso.

LV
Tvertni stingri noslēgt.

LT
Talpyklą laikyti sandariai uždarytą.

HU
Az edény szorosan lezárva tartandó.

MT
Żomm il-kontenitur magħluq sew.

NL
In goed gesloten verpakking bewaren.

PL
Przechowywać pojemnik szczelnie zamknięty.

PT
Manter o recipiente bem fechado.

RO
Păstrați recipientul închis etanș.

SK
Nádobu uchovávajte tesne uzavretú.

SL
Hraniti v tesno zaprti posodi.

FI
Säilytä tiiviisti suljettuna.

SV
Behållaren ska vara väl tillsluten.

P234
Language


BG
Да се съхранява само в оригиналната опаковка.

ES
Conservar únicamente en el recipiente original.

CS
Uchovávejte pouze v původním obalu.

DA
Opbevares kun i den originale beholder.

DE
Nur im Originalbehälter aufbewahren.

ET
Hoida üksnes originaalpakendis.

EL
Να διατηρείται μόνο στον αρχικό περιέκτη.

EN
Keep only in original container.

FR
Conserver uniquement dans le récipient d’origine.

GA
Coimeád sa choimeádán bunaidh amháin.

IT
Conservare soltanto nel contenitore originale.

LV
Turēt tikai oriģinālā iepakojumā.

LT
Laikyti tik originalioje talpykloje.

HU
Az eredeti edényben tartandó.

MT
Żomm biss fil-kontenitur oriġinali.

NL
Uitsluitend in de oorspronkelijke verpakking bewaren.

PL
Przechowywać wyłącznie w oryginalnym pojemniku.

PT
Conservar unicamente no recipiente de origem.

RO
Păstrați numai în recipientul original.

SK
Uchovávajte iba v pôvodnej nádobe.

SL
Hraniti samo v originalni posodi.

FI
Säilytä alkuperäispakkauksessa.

SV
Förvaras endast i originalbehållaren.

P235
Language


BG
Да се държи на хладно.

ES
Mantener en lugar fresco.

CS
Uchovávejte v chladu.

DA
Opbevares køligt.

DE
Kühl halten.

ET
Hoida jahedas.

EL
Να διατηρείται δροσερό.

EN
Keep cool.

FR
Tenir au frais.

GA
Coimeád fionnuar é

IT
Conservare in luogo fresco.

LV
Turēt vēsumā.

LT
Laikyti vėsioje vietoje.

HU
Hűvös helyen tartandó.

MT
Żomm frisk.

NL
Koel bewaren.

PL
Przechowywać w chłodnym miejscu.

PT
Conservar em ambiente fresco.

RO
A se păstra la rece.

SK
Uchovávajte v chlade.

SL
Hraniti na hladnem.

FI
Säilytä viileässä.

SV
Förvaras svalt.

P240
Language


BG
Заземяване/еквипотенциална връзка на съда и приемателното устройство.

ES
Conectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.

CS
Uzemněte obal a odběrové zařízení.

DA
Beholder og modtageudstyr jordforbindes/potentialudlignes.

DE
Behälter und zu befüllende Anlage erden.

ET
Mahuti ja vastuvõtuseade maandada/ühendada.

EL
Γείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.

EN
Ground/bond container and receiving equipment.

FR
Mise à la terre/liaison équipotentielle du récipient et du matériel de réception.

GA
Nasc an coimeádán agus an trealamh glactha leis an talamh.

IT
Mettere a terra/massa il contenitore e il dispositivo ricevente.

LV
Tvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt

LT
Įžeminti/įtvirtinti talpyklą ir priėmimo įrangą.

HU
A tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.

MT
Poġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.

NL
Opslag- en opvangreservoir aarden.

PL
Uziemić/połączyć pojemnik i sprzęt odbiorczy.

PT
Ligação à terra/equipotencial do recipiente e do equipamento receptor.

RO
Legătură la pământ/conexiune echipotențială cu recipientul și cu echipamentul de recepție.

SK
Uzemnite/upevnite nádobu a plniace zariadenie.

SL
Ozemljiti posodo in opremo za sprejem tekočine.

FI
Säiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.

SV
Jorda/potentialförbind behållare och mottagarutrustning.

P241
Language


BG
Използвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия

ES
Utilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.

CS
Používejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.

DA
Anvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.

DE
Explosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.

ET
Kasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.

EL
Να χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.

EN
Use explosion-proof electrical/ventilating/lighting/…/equipment.

FR
Utiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.

GA
Bain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…

IT
Utilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.

LV
Izmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas

LT
Naudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.

HU
Robbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.

MT
Uża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.

NL
Explosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.

PL
Używać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.

PT
Utilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.

RO
Utilizați echipamente electrice/de ventilare/de iluminat/…/antideflagrante.

SK
Používajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.

SL
Uporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.

FI
Käytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.

SV
Använd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.

P242
Language


BG
Използвайте само инструменти, които не предизвикват искри.

ES
Utilizar únicamente herramientas que no produzcan chispas.

CS
Používejte pouze nářadí z nejiskřícího kovu.

DA
Anvend kun værktøj, som ikke frembringer gnister.

DE
Nur funkenfreies Werkzeug verwenden.

ET
Mitte kasutada seadmeid, mis võivad tekitada sädemeid.

EL
Να χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.

EN
Use only non-sparking tools.

FR
Ne pas utiliser d'outils produisant des étincelles.

GA
Bain úsáid as uirlisí neamhspréachta amháin.

IT
Utilizzare solo utensili antiscintillamento.

LV
Izmantot instrumentus, kas nerada dzirksteles.

LT
Naudoti tik kibirkščių nekeliančius įrankius.

HU
Szikramentes eszközök használandók.

MT
Uża’ biss għodda li ma jtajrux żnied.

NL
Uitsluitend vonkvrij gereedschap gebruiken.

PL
Używać wyłącznie nieiskrzących narzędzi.

PT
Utilizar apenas ferramentas antichispa.

RO
Nu utilizați unelte care produc scântei.

SK
Používajte iba neiskriace prístroje.

SL
Uporabiti le orodje, ki ne povzroča isker.

FI
Käytä ainoastaan kipinöimättömiä työkaluja.

SV
Använd endast verktyg som inte ger upphov till gnistor.


P243
Language


BG
Вземете предпазни мерки срещу освобождаване на статично електричество.

ES
Tomar medidas de precaución contra descargas electrostáticas.

CS
Proveďte preventivní opatření proti výbojům statické elektřiny.

DA
Træf foranstaltninger mod statisk elektricitet.

DE
Maßnahmen gegen elektrostatische Aufladungen treffen.

ET
Rakendada ettevaatusabinõusid staatilise elektri vastu.

EL
Λάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.

EN
Take precautionary measures against static discharge.

FR
Prendre des mesures de précaution contre les décharges électrostatiques.

GA
Déan bearta réamhchúraim in aghaidh díluchtú statach.

IT
Prendere precauzioni contro le scariche elettrostatiche.

LV
Nodrošināties pret statiskās enerģijas izlādi.

LT
Imtis atsargumo priemonių statinei iškrovai išvengti.

HU
Az elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.

MT
Ħu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.

NL
Voorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.

PL
Przedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.

PT
Evitar acumulação de cargas electrostáticas.

RO
Luați măsuri de precauție împotriva descărcărilor electrostatice.

SK
Urobte preventívne opatrenia proti výbojom statickej elektriny.

SL
Preprečiti statično naelektrenje.

FI
Estä staattisen sähkön aiheuttama kipinöinti.

SV
Vidta åtgärder mot statisk elektricitet.

P244
Language


BG
Почиствайте редуциращите вентили от смазка и масло

ES
Mantener las válvulas de reducción limpias de grasa y aceite.

CS
Udržujte redukční ventily bez maziva a oleje.

DA
Reduktionsventilerne holdes fri for fedt og olie.

DE
Druckminderer frei von Fett und Öl halten.

ET
Hoida reduktsiooniklapid rasvast ja õlist puhtad.

EL
Να διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.

EN
Keep reduction valves free from grease and oil.

FR
S’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.

GA
Coimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.

IT
Mantenere le valvole di riduzione libere da grasso e olio.

LV
Turēt reducēšanās vārstus tīrus no taukiem un eļļas.

LT
Saugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.

HU
A nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.

MT
Żomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.

NL
Reduceerventielen vrij van olie en vet houden.

PL
Chronić zawory redukcyjne przed tłuszczem i olejem.

PT
Manter as válvulas de redução isentas de óleo e massa lubrificantes.

RO
Protejați supapele reductoare de grăsimi și ulei.

SK
Redukčné ventily udržiavajte bez mazadiel a oleja.

SL
Preprečiti stik reducirnih ventilov z mastjo in oljem.

FI
Pidä paineenalennusventtiilit vapaana rasvasta ja öljystä.

SV
Reducerventilerna ska hållas fria från fett och olja.

P250
Language


BG
Да не се подлага на стържене/удар/…/триене

ES
Evitar la abrasión/el choque/…/la fricción.

CS
Nevystavujte obrušování/nárazům/…/tření.

DA
Må ikke udsættes for slibning/stød/…/gnidning.

DE
Nicht schleifen/stoßen/…/reiben.

ET
Hoida kriimustamise/põrutuse/…/hõõrdumise eest.

EL
Να αποφεύγεται άλεση/κρούση/…/τριβή.

EN
Do not subject to grinding/shock/…/friction.

FR
Éviter les abrasions/les chocs/…/les frottements.

GA
Ná nocht do mheilt/do thurraing/…/do fhrithchuimilt.

IT
Evitare le abrasioni/gli urti/…/gli attriti.

LV
Nepakļaut drupināšanai/triecienam/…/berzei

LT
Nešlifuoti/netrankyti/…/netrinti.

HU
Tilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.

MT
Tissottoponihomx għal brix/xokk/…/frizzjoni.

NL
Malen/schokken/…/wrijving vermijden.

PL
Nie poddawać szlifowaniu/wstrząsom/…/tarciu.

PT
Não submeter a trituração/choque/…/fricção.

RO
A nu supune la abraziuni/șocuri/…/frecare.

SK
Nevystavujte brúseniu/nárazu/…/treniu.

SL
Ne izpostavljati drgnjenju/udarcem/…/trenju.

FI
Suojele rasitukselta/iskuilta/…/hankaukselta.

SV
Får inte utsättas för gnidning/stötar/…/friktion.

P251
Language


BG
Съд под налягане: да не се пробива и изгаря дори след употреба.

ES
Recipiente a presión: no perforar ni quemar, aun después del uso.

CS
Tlakový obal: nepropichujte nebo nespalujte ani po použití.

DA
Beholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.

DE
Behälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.

ET
Mahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.

EL
Περιέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.

EN
Pressurized container: Do not pierce or burn, even after use.

FR
Récipient sous pression: ne pas perforer, ni brûler, même après usage.

GA
Coimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.

IT
Recipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.

LV
Tvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.

LT
Slėginis indas. Nepradurti ir nedeginti net panaudoto.

HU
Nyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.

MT
Kontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.

NL
Houder onder druk: ook na gebruik niet doorboren of verbranden.

PL
Pojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.

PT
Recipiente sob pressão. Não furar nem queimar, mesmo após utilização.

RO
Recipient sub presiune. Nu perforați sau ardeți, chiar și după utilizare.

SK
Nádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.

SL
Posoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.

FI
Painesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.

SV
Tryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.

P260
Language


BG
Не вдишвайте прах/пушек/газ/дим/изпарения/аерозоли

ES
No respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.

CS
Nevdechujte prach/dým/plyn/mlhu/páry/aerosoly.

DA
Indånd ikke pulver/røg/gas/tåge/damp/spray.

DE
Staub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.

ET
Tolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.

EL
Μην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα

EN
Do not breathe dust/fume/gas/mist/vapours/spray.

FR
Ne pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.

GA
Ná hanálaigh deannach/múch/gás/ceo/gala/sprae.

IT
Non respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.

LV
Neieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.

LT
Neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.

HU
A por/füst/gáz/köd/gőzök/permet belélegzése tilos.

MT
Tiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.

NL
Stof/rook/gas/nevel/damp/spuitnevel niet inademen.

PL
Nie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.

PT
Não respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.

RO
Nu inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.

SK
Nevdychujte prach/dym/plyn/hmlu/pary/aerosóly.

SL
Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.

FI
Älä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.

SV
Inandas inte damm/rök/gaser/dimma/ångor/sprej.

P261
Language


BG
Избягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли

ES
Evitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.

CS
Zamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.

DA
Undgå indånding af pulver/røg/gas/tåge/damp/spray.

DE
Einatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.

ET
Vältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.

EL
Aποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.

EN
Avoid breathing dust/fume/gas/mist/vapours/spray.

FR
Éviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.

GA
Seachain deannach/múch/gás/ceo/gala/sprae a análú.

IT
Evitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.

LV
Izvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.

LT
Stengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.

HU
Kerülje a por/füst/gáz/köd/gőzök/permet belélegzését.

MT
Evita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.

NL
Inademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.

PL
Unikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.

PT
Evitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.

RO
Evitați să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.

SK
Zabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.

SL
Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.

FI
Vältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.

SV
Undvik att inandas damm/rök/gaser/dimma/ångor/sprej.

P262
Language


BG
Да се избягва контакт с очите, кожата или облеклото.

ES
Evitar el contacto con los ojos, la piel o la ropa.

CS
Zabraňte styku s očima, kůží nebo oděvem.

DA
Må ikke komme i kontakt med øjne, hud eller tøj.

DE
Nicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.

ET
Vältida silma, nahale või rõivastele sattumist.

EL
Να μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.

EN
Do not get in eyes, on skin, or on clothing.

FR
Éviter tout contact avec les yeux, la peau ou les vêtements.

GA
Ná lig sna súile, ar an gcraiceann, ná ar éadaí.

IT
Evitare il contatto con gli occhi, la pelle o gli indumenti.

LV
Nepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.

LT
Saugotis, kad nepatektų į akis, ant odos ar drabužių.

HU
Szembe, bőrre vagy ruhára nem kerülhet.

MT
Iddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.

NL
Contact met de ogen, de huid of de kleding vermijden.

PL
Nie wprowadzać do oczu, na skórę lub na odzież.

PT
Não pode entrar em contacto com os olhos, a pele ou a roupa.

RO
Evitați orice contact cu ochii, pielea sau îmbrăcămintea.

SK
Zabráňte kontaktu s očami, pokožkou alebo odevom.

SL
Preprečiti stik z očmi, kožo ali oblačili.

FI
Varo kemikaalin joutumista silmiin, iholle tai vaatteisiin.

SV
Får inte komma i kontakt med ögonen, huden eller kläderna.


P263
Language


BG
Да се избягва контакт по време на бременност/при кърмене.

ES
Evitar el contacto durante el embarazo/la lactancia.

CS
Zabraňte styku během těhotenství/kojení.

DA
Undgå kontakt under graviditet/amning.

DE
Kontakt während der Schwangerschaft/und der Stillzeit vermeiden.

ET
Vältida kokkupuudet raseduse/imetamise ajal.

EL
Aποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.

EN
Avoid contact during pregnancy/while nursing.

FR
Éviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.

GA
Seachain teagmháil le linn toirchis/agus an chíoch á tabhairt.

IT
Evitare il contatto durante la gravidanza/l’allattamento.

LV
Izvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.

LT
Vengti kontakto nėštumo metu/maitinant krūtimi.

HU
A terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.

MT
Evita l-kuntatt waqt it-tqala/waqt it-treddigħ.

NL
Bij zwangerschap of borstvoeding aanraking vermijden.

PL
Unikać kontaktu w czasie ciąży/karmienia piersią.

PT
Evitar o contacto durante a gravidez/o aleitamento.

RO
Evitați contactul în timpul sarcinii/alăptării.

SK
Zabráňte kontaktu počas tehotenstva a dojčenia.

SL
Preprečiti stik med nosečnostjo/dojenjem.

FI
Vältä kosketusta raskauden tai imetyksen aikana.

SV
Undvik kontakt under graviditet eller amning.

P264
Language


BG
Да се измие… старателно след употреба.

ES
Lavarse … concienzudamente tras la manipulación.

CS
Po manipulaci důkladně omyjte …

DA
Vask … grundigt efter brug.

DE
Nach Gebrauch … gründlich waschen.

ET
Pärast käitlemist pesta hoolega …

EL
Πλύνετε … σχολαστικά μετά το χειρισμό.

EN
Wash … thoroughly after handling.

FR
Se laver … soigneusement après manipulation.

GA
Nigh … go lánchúramach tar éis láimhsithe.

IT
Lavare accuratamente … dopo l’uso.

LV
Pēc izmantošanas … kārtīgi nomazgāt.

LT
Po naudojimo kruopščiai nuplauti …

HU
A használatot követően a(z) … -t alaposan meg kell mosni.

MT
Aħsel … sew wara li timmaniġġjah.

NL
Na het werken met dit product … grondig wassen.

PL
Dokładnie umyć … po użyciu.

PT
Lavar … cuidadosamente após manuseamento.

RO
Spălați-vă … bine după utilizare.

SK
Po manipulácii starostlivo umyte…

SL
Po uporabi temeljito umiti …

FI
Pese … huolellisesti käsittelyn jälkeen.

SV
Tvätta … grundligt efter användning.

P270
Language


BG
Да не се яде, пие или пуши при употреба на продукта.

ES
No comer, beber ni fumar durante su utilización.

CS
Při používání tohoto výrobku nejezte, nepijte ani nekuřte.

DA
Der må ikke spises, drikkes eller ryges under brugen af dette produkt.

DE
Bei Gebrauch nicht essen, trinken oder rauchen.

ET
Toote käitlemise ajal mitte süüa, juua ega suitsetada.

EL
Μην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.

EN
Do no eat, drink or smoke when using this product.

FR
Ne pas manger, boire ou fumer en manipulant ce produit.

GA
Ná hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.

IT
Non mangiare, né bere, né fumare durante l’uso.

LV
Neēst, nedzert un nesmēķēt produkta izmantošanas laikā.

LT
Naudojant šį produktą, nevalgyti, negerti ir nerūkyti.

HU
A termék használata közben tilos enni, inni vagy dohányozni.

MT
Tikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.

NL
Niet eten, drinken of roken tijdens het gebruik van dit product.

PL
Nie jeść, nie pić i nie palić podczas używania produktu.

PT
Não comer, beber ou fumar durante a utilização deste produto.

RO
A nu mânca, bea sau fuma în timpul utilizării produsului.

SK
Pri používaní výrobku nejedzte, nepite ani nefajčite.

SL
Ne jesti, piti ali kaditi med uporabo tega izdelka.

FI
Syöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.

SV
Ät inte, drick inte och rök inte när du använder produkten.

P271
Language


BG
Да се използва само на открито или на добре проветривомясто.

ES
Utilizar únicamente en exteriores o en un lugar bien ventilado.

CS
Používejte pouze venku nebo v dobře větraných prostorách.

DA
Brug kun udendørs eller i et rum med god udluftning.

DE
Nur im Freien oder in gut belüfteten Räumen verwenden.

ET
Käidelda üksnes välitingimustes või hästi ventileeritavas kohas.

EL
Να χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.

EN
Use only outdoors or in a well-ventilated area.

FR
Utiliser seulement en plein air ou dans un endroit bien ventilé.

GA
Úsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.

IT
Utilizzare soltanto all’aperto o in luogo ben ventilato.

LV
Izmantot tikai ārā vai labi vēdināmās telpās.

LT
Naudoti tik lauke arba gerai vėdinamoje patalpoje.

HU
Kizárólag szabadban vagy jól szellőző helyiségben használható.

MT
Uża biss barra jew f’post ventilat sew.

NL
Alleen buiten of in een goed geventileerde ruimte gebruiken.

PL
Stosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu

PT
Utilizar apenas ao ar livre ou em locais bem ventilados.

RO
A se utiliza numai în aer liber sau în spații bine ventilate.

SK
Používajte iba na voľnom priestranstve alebo v dobre vetranom priestore.

SL
Uporabljati le zunaj ali v dobro prezračevanem prostoru.

FI
Käytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.

SV
Används endast utomhus eller i väl ventilerade utrymmen.

P272
Language


BG
Да не се изнася замърсено работно облекло извън работното помещение.

ES
Las prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.

CS
Kontaminovaný pracovní oděv neodnášejte z pracoviště.

DA
Tilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.

DE
Kontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.

ET
Saastunud töörõivaid töökohast mitte välja viia.

EL
Τα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.

EN
Contaminated work clothing should not be allowed out of the workplace.

FR
Les vêtements de travail contaminés ne devraient pas sortir du lieu de travail.

GA
Níor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.

IT
Gli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.

LV
Piesārņoto darba apģērbu neiznest ārpus darba telpām.

LT
Užterštų darbo drabužių negalima išnešti iš darbo vietos.

HU
Szennyezett munkaruhát tilos kivinni a munkahely területéről.

MT
Ilbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.

NL
Verontreinigde werkkleding mag de werkruimte niet verlaten.

PL
Zanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.

PT
A roupa de trabalho contaminada não pode sair do local de trabalho.

RO
Nu scoateți îmbrăcămintea de lucru contaminată în afara locului de muncă.

SK
Je zakázané vyniesť kontaminovaný pracovný odev z pracoviska.

SL
Kontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.

FI
Saastuneita työvaatteita ei saa viedä työpaikalta.

SV
Nedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.

P273
Language


BG
Да се избягва изпускане в околната среда.

ES
Evitar su liberación al medio ambiente.

CS
Zabraňte uvolnění do životního prostředí.

DA
Undgå udledning til miljøet.

DE
Freisetzung in die Umwelt vermeiden.

ET
Vältida sattumist keskkonda.

EL
Να αποφεύγεται η ελευθέρωση στο περιβάλλον.

EN
Avoid release to the environment.

FR
Éviter le rejet dans l’environnement.

GA
Ná scaoiltear amach sa chomhshaol.

IT
Non disperdere nell’ambiente.

LV
Izvairīties no izplatīšanas apkārtējā vidē.

LT
Saugoti, kad nepatektų į aplinką.

HU
Kerülni kell az anyagnak a környezetbe való kijutását.

MT
Evita r-rilaxx fl-ambjent.

NL
Voorkom lozing in het milieu.

PL
Unikać uwolnienia do środowiska.

PT
Evitar a libertação para o ambiente.

RO
Evitați dispersarea în mediu.

SK
Zabráňte uvoľneniu do životného prostredia.

SL
Preprečiti sproščanje v okolje.

FI
Vältettävä päästämistä ympäristöön.

SV
Undvik utsläpp till miljön.

P280
Language


BG
Използвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.

ES
Llevar guantes/prendas/gafas/máscara de protección.

CS
Používejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.

DA
Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse

DE
Schutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.

ET
Kanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.

EL
Να φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.

EN
Wear protective gloves/protective clothing/eye protection/face protection.

FR
Porter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.

GA
Caith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.

IT
Indossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.

LV
Izmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.

LT
Mūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.

HU
Védőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.

MT
Ilbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.

NL
Beschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.

PL
Stosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.

PT
Usar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.

RO
Purtați mănuși de protecție/îmbrăcăminte de protecție/echipament de protecție a ochilor/echipament de protecție a feței.

SK
Noste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.

SL
Nositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.

FI
Käytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.

SV
Använd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.

P281
Language


BG
Използвайте предписаните лични предпазни средства.

ES
Utilizar el equipo de protección individual obligatorio.

CS
Používejte požadované osobní ochranné prostředky.

DA
Anvend de påkrævede personlige værnemidler.

DE
Vorgeschriebene persönliche Schutzausrüstung verwenden.

ET
Kasutada vajalikke isikukaitsevahendeid.

EL
Χρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.

EN
Use personal protective equipment as required.

FR
Utiliser l’équipement de protection individuel requis.

GA
Bain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.

IT
Utilizzare il dispositivo di protezione individuale richiesto.

LV
Izmantot personisko aizsargaprīkojumu atbilstoši prasībām.

LT
Naudoti reikalaujamas asmenines apsaugos priemones.

HU
Az előírt egyéni védőfelszerelés használata kötelező.

MT
Uża’ t-tagħmir personali protettiv kif meħtieġ.

NL
De nodige persoonlijke beschermingsuitrusting gebruiken.

PL
Stosować wymagane środki ochrony indywidualnej.

PT
Usar o equipamento de protecção individual exigido.

RO
Utilizați echipamentul de protecție individuală conform cerințelor.

SK
Používajte predpísané osobné ochranné prostriedky.

SL
Uporabiti predpisano osebno zaščitno opremo.

FI
Käytä vaadittuja henkilönsuojaimia.

SV
Använd föreskriven personlig skyddsutrustning.

P282
Language


BG
Носете предпазващи от студ ръкавици/маска за лице/защитни очила.

ES
Llevar guantes que aíslen del frío/gafas/máscara.

CS
Používejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.

DA
Bær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.

DE
Schutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.

ET
Kanda külmakaitsekindaid/kaitsemaski/kaitseprille.

EL
Φοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.

EN
Wear cold insulating gloves/face shield/eye protection.

FR
Porter des gants isolants contre le froid/un équipement de protection du visage/des yeux.

GA
Caith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.

IT
Utilizzare guanti termici/schermo facciale/Proteggere gli occhi.

LV
Izmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.

LT
Mūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.

HU
Hidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.

MT
Ilbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.

NL
Koude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.

PL
Nosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.

PT
Usar luvas de protecção contra o frio/escudo facial/protecção ocular.

RO
Purtați mănuși izolante împotriva frigului/echipament de protecție a feței/ochilor.

SK
Používajte termostabilné rukavice/ochranný štít/ochranné okuliare.

SL
Nositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.

FI
Käytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.

SV
Använd köldisolerande handskar/visir/ögonskydd.

P283
Language


BG
Носете огнеупорно/огнезащитно облекло.

ES
Llevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.

CS
Používejte ohnivzdorný/nehořlavý oděv.

DA
Bær brandbestandig/brandhæmmende beklædning.

DE
Schwer entflammbare/flammhemmende Kleidung tragen.

ET
Kanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.

EL
Φοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.

EN
Wear fire/flame resistant/retardant clothing.

FR
Porter des vêtements résistant au feu/aux flammes/ignifuges.

GA
Caith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.

IT
Indossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.

LV
Izmantot aizsargapģērbu pret uguni/liesmām.

LT
Dėvėti ugniai/liepsnai atsparius/antipireninius drabužius.

HU
Tűz-/lángálló/-késleltető ruházat viselése kötelező.

MT
Ilbies ħwejjeġ reżistenti għan-nar/fjammi.

NL
Vuur/vlambestendige/brandwerende kleding dragen.

PL
Nosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.

PT
Usar vestuário ignífugo/retardador de fogo/chamas.

RO
Purtați îmbrăcăminte rezistentă la foc/flacără/ignifugă.

SK
Noste ohňovzdorný odev/odev so zníženou horľavosťou.

SL
Nositi negorljiva oblačila in oblačila, odporna proti ognju.

FI
Käytä palosuojattua/paloturvallista vaatetusta.

SV
Använd brand-/flamsäkra eller brand-/flamhämmande kläder.

P284
Language


BG
Носете респираторни предпазни средства.

ES
Llevar equipo de protección respiratoria.

CS
Používejte vybavení pro ochranu dýchacích cest.

DA
Anvend åndedrætsværn.

DE
Atemschutz tragen.

ET
Kanda hingamisteede kaitsevahendeid.

EL
Φοράτε μέσα ατομικής προστασίας της αναπνοής.

EN
Wear respiratory protection.

FR
Porter un équipement de protection respiratoire.

GA
Caith cosaint riospráide.

IT
Utilizzare un apparecchio respiratorio.

LV
Izmantot gāzmasku.

LT
Naudoti kvėpavimo takų apsaugos priemones.

HU
Légzésvédelem használata kötelező.

MT
Ilbes protezzjoni respiratorja.

NL
Adembescherming dragen.

PL
Stosować indywidualne środki ochrony dróg oddechowych.

PT
Usar protecção respiratória.

RO
Purtați echipament de protecție respiratorie.

SK
Používajte ochranu dýchacích ciest.

SL
Nositi opremo za zaščito dihal.

FI
Käytä hengityksensuojainta.

SV
Använd andningsskydd.


P285
Language


BG
В случай на лоша вентилация носете респираторни предпазни средства.

ES
En caso de ventilación insuficiente, llevar equipo de protección respiratoria.

CS
V případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.

DA
Ved utilstrækkelig udluftning anvendes åndedrætsværn.

DE
Bei unzureichender Belüfung Atemschutz tragen.

ET
Ebapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.

EL
Σε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.

EN
In case of inadequate ventilation wear respiratory protection.

FR
Lorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.

GA
I gcás aerála uireasaigh caith cosaint riospráide.

IT
In caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.

LV
Neatbilstošas ventilācijas gadījumā izmantot gāzmasku.

LT
Esant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.

HU
Nem megfelelő szellőzés esetén légzésvédelem kötelező.

MT
F’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.

NL
Bij ontoereikende ventilatie een geschikte adembescherming dragen.

PL
W przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.

PT
Em caso de ventilação inadequada, usar protecção respiratória.

RO
În cazul în care ventilarea este insuficientă, purtați echipament de protecție respiratorie.

SK
V prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.

SL
Ob nezadostnem prezračevanju nositi opremo za zaščito dihal.

FI
Käytä hengityksensuojainta, jos ilmanvaihto on riittämätön.

SV
Använd andningsskydd vid otillräcklig ventilation.


P231 + P232
Language


BG
Да се използва под инертен газ. Да се пази от влага.

ES
Manipular en gas inerte. Proteger de la humedad.

CS
Manipulace pod inertním plynem. Chraňte před vlhkem.

DA
Anvendes under inaktiv gas. Beskyttes mod fugt.

DE
Unter inertem Gas handhaben. Vor Feuchtigkeit schützen.

ET
Käidelda inertgaasis. Hoida niiskuse eest.

EL
Χειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.

EN
Handle under inert gas. Protect from moisture.

FR
Manipuler sous gaz inerte. Protéger de l’humidité.

GA
Láimhsigh faoi thriathghás. Cosain ó thaise.

IT
Manipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.

LV
Izmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.

LT
Tvarkyti inertinėse dujose. Saugoti nuo drėgmės.

HU
Inert gázban használandó. Nedvességtől védendő.

MT
Uża’ taħt gass inerti. Ipproteġi mill-umdità.

NL
Onder inert gas werken. Tegen vocht beschermen.

PL
Używać w atmosferze obojętnego gazu Chronić przed wilgocią.

PT
Manusear em atmosfera de gás inerte. Manter ao abrigo da humidade.

RO
A se manipula sub un gaz inert. A se proteja de umiditate.

SK
Manipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.

SL
Hraniti v ustreznem inertnem plinu. Zaščititi pred vlago.

FI
Käsittele inertissä kaasussa. Suojaa kosteudelta.

SV
Hanteras under inert gas. Skyddas från fukt.

P235 + P410
Language


BG
Да се държи на хладно. Да се пази от пряка слънчева светлина.

ES
Conservar en un lugar fresco. Proteger de la luz del sol.

CS
Uchovávejte v chladu. Chraňte před slunečním zářením.

DA
Opbevares køligt. Beskyttes mod sollys.

DE
Kühl halten. Vor Sonnenbestrahlung schützen.

ET
Hoida jahedas. Hoida päikesevalguse eest.

EL
Να διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.

EN
Keep cool. Protect from sunlight.

FR
Tenir au frais. Protéger du rayonnement solaire.

GA
Coimeád fionnuar. Cosain ó sholas na gréine.

IT
Tenere in luogo fresco. Proteggere dai raggi solari.

LV
Turēt vēsumā. Aizsargāt no saules gaismas.

LT
Laikyti vėsioje vietoje. Saugoti nuo saulės šviesos.

HU
Hűvös helyen tartandó. Napfénytől védendő.

MT
Żomm frisk. Ipproteġi mir-raġġi tax-xemx.

NL
Koel bewaren. Tegen zonlicht beschermen.

PL
Przechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.

PT
Conservar em ambiente fresco. Manter ao abrigo da luz solar.

RO
A se păstra la rece. A se proteja de lumina solară.

SK
Uchovávajte v chlade. Chráňte pred slnečným žiarením.

SL
Hraniti na hladnem. Zaščititi pred sončno svetlobo.

FI
Säilytä viileässä. Suojaa auringonvalolta.

SV
Förvaras svalt. Skyddas från solljus.

Table 1.3
Precautionary statements — Response

P301
Language


BG
ПРИ ПОГЛЪЩАНЕ:

ES
EN CASO DE INGESTIÓN:

CS
PŘI POŽITÍ:

DA
I TILFÆLDE AF INDTAGELSE:

DE
BEI VERSCHLUCKEN:

ET
ALLANEELAMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:

EN
IF SWALLOWED:

FR
EN CAS D’INGESTION:

GA
MÁ SHLOGTAR:

IT
IN CASO DI INGESTIONE:

LV
NORĪŠANAS GADĪJUMĀ:

LT
PRARIJUS:

HU
LENYELÉS ESETÉN:

MT
JEKK JINBELA’:

NL
NA INSLIKKEN:

PL
W PRZYPADKU POŁKNIĘCIA:

PT
EM CASO DE INGESTÃO:

RO
ÎN CAZ DE ÎNGHIȚIRE:

SK
PO POŽITÍ:

SL
PRI ZAUŽITJU:

FI
JOS KEMIKAALIA ON NIELTY:

SV
VID FÖRTÄRING:

P302
Language


BG
ПРИ КОНТАКТ С КОЖАТА:

ES
EN CASO DE CONTACTO CON LA PIEL:

CS
PŘI STYKU S KŮŽÍ:

DA
VED KONTAKT MED HUDEN:

DE
BEI BERÜHRUNG MIT DER HAUT:

ET
NAHALE SATTUMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:

EN
IF ON SKIN:

FR
EN CAS DE CONTACT AVEC LA PEAU:

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:

IT
IN CASO DI CONTATTO CON LA PELLE:

LV
SASKARĒ AR ĀDU:

LT
PATEKUS ANT ODOS:

HU
HA BŐRRE KERÜL:

MT
F'KAŻ TA' KUNTATT MAL-ĠILDA:

NL
BIJ CONTACT MET DE HUID:

PL
W PRZYPADKU KONTAKTU ZE SKÓRĄ:

PT
SE ENTRAR EM CONTACTO COM A PELE:

RO
ÎN CAZ DE CONTACT CU PIELEA:

SK
PRI KONTAKTE S POKOŽKOU:

SL
PRI STIKU S KOŽO:

FI
JOS KEMIKAALIA JOUTUU IHOLLE:

SV
VID HUDKONTAKT:

P303
Language


BG
ПРИ КОНТАКТ С КОЖАТА (или косата):

ES
EN CASO DE CONTACTO CON LA PIEL (o el pelo):

CS
PŘI STYKU S KŮŽÍ (nebo s vlasy):

DA
VED KONTAKT MED HUDEN (eller håret):

DE
BEI BERÜHRUNG MIT DER HAUT (oder dem Haar):

ET
NAHALE (või juustele) SATTUMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):

EN
IF ON SKIN (or hair):

FR
EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):

IT
IN CASO DI CONTATTO CON LA PELLE (o con i capelli):

LV
SASKARĒ AR ĀDU (vai matiem):

LT
PATEKUS ANT ODOS (arba plaukų):

HU
HA BŐRRE (vagy hajra) KERÜL:

MT
F'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):

NL
BIJ CONTACT MET DE HUID (of het haar):

PL
W PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):

PT
SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):

RO
ÎN CAZ DE CONTACT CU PIELEA (sau părul):

SK
PRI KONTAKTE S POKOŽKOU (alebo vlasmi):

SL
PRI STIKU S KOŽO (ali lasmi):

FI
JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):

SV
VID HUDKONTAKT (även håret):

P304
Language


BG
ПРИ ВДИШВАНЕ:

ES
EN CASO DE INHALACIÓN:

CS
PŘI VDECHNUTÍ:

DA
VED INDÅNDING:

DE
BEI EINATMEN:

ET
SISSEHINGAMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:

EN
IF INHALED:

FR
EN CAS D’INHALATION:

GA
MÁ IONANÁLAÍTEAR:

IT
IN CASO DI INALAZIONE:

LV
IEELPOJOT:

LT
ĮKVĖPUS:

HU
BELÉLEGZÉS ESETÉN:

MT
JEKK JINĠIBED MAN-NIFS:

NL
NA INADEMING:

PL
W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:

PT
EM CASO DE INALAÇÃO:

RO
ÎN CAZ DE INHALARE:

SK
PO VDÝCHNUTÍ:

SL
PRI VDIHAVANJU:

FI
JOS KEMIKAALIA ON HENGITETTY:

SV
VID INANDNING:

P305
Language


BG
ПРИ КОНТАКТ С ОЧИТЕ:

ES
EN CASO DE CONTACTO CON LOS OJOS:

CS
PŘI ZASAŽENÍ OČÍ:

DA
VED KONTAKT MED ØJNENE:

DE
BEI KONTAKT MIT DEN AUGEN:

ET
SILMA SATTUMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:

EN
IF IN EYES:

FR
EN CAS DE CONTACT AVEC LES YEUX:

GA
I gCÁS TEAGMHÁLA LEIS NA SÚILE:

IT
IN CASO DI CONTATTO CON GLI OCCHI:

LV
IEKĻŪSTOT ACĪS:

LT
PATEKUS Į AKIS:

HU
SZEMBE KERÜLÉS ESETÉN:

MT
JEKK JIDĦOL FL-GĦAJNEJN:

NL
BIJ CONTACT MET DE OGEN:

PL
W PRZYPADKU DOSTANIA SIĘ DO OCZU:

PT
SE ENTRAR EM CONTACTO COM OS OLHOS:

RO
ÎN CAZ DE CONTACT CU OCHII:

SK
PO ZASIAHNUTÍ OČÍ:

SL
PRI STIKU Z OČMI:

FI
JOS KEMIKAALIA JOUTUU SILMIIN:

SV
VID KONTAKT MED ÖGONEN:

P306
Language


BG
ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:

ES
EN CASO DE CONTACTO CON LA ROPA:

CS
PŘI STYKU S ODĚVEM:

DA
VED KONTAKT MED TØJET:

DE
BEI KONTAMINIERTER KLEIDUNG:

ET
RÕIVASTELE SATTUMISE KORRAL:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:

EN
IF ON CLOTHING:

FR
EN CAS DE CONTACT AVEC LES VÊTEMENTS:

GA
I gCÁS TEAGMHÁLA LE hÉADAÍ:

IT
IN CASO DI CONTATTO CON GLI INDUMENTI:

LV
SASKARĒ AR APĢĒRBU:

LT
PATEKUS ANT DRABUŽIŲ:

HU
HA RUHÁRA KERÜL:

MT
F'KAŻ TA' KUNTATT MA' L-ILBIES:

NL
NA MORSEN OP KLEDING:

PL
W PRZYPADKU KONTAKTU Z ODZIEŻĄ:

PT
SE ENTRAR EM CONTACTO COM A ROUPA:

RO
ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:

SK
PRI KONTAKTE S ODEVOM:

SL
PRI STIKU Z OBLAČILI:

FI
JOS KEMIKAALIA JOUTUU VAATTEISIIN:

SV
VID KONTAKT MED KLÄDERNA:

P307
Language


BG
ПРИ експозиция:

ES
EN CASO DE exposición:

CS
PŘI expozici:

DA
VED eksponering:

DE
BEI Exposition:

ET
Kokkupuute korral:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:

EN
IF exposed:

FR
EN CAS d’exposition:

GA
I gCÁS nochta:

IT
IN CASO di esposizione:

LV
JA saskaras:

LT
Esant sąlyčiui:

HU
Expozíció esetén:

MT
JEKK espost:

NL
NA blootstelling:

PL
W PRZYPADKU narażenia:

PT
EM CASO DE exposição:

RO
ÎN CAZ DE expunere:

SK
PO expozícii:

SL
PRI izpostavljenosti:

FI
Altistumisen tapahduttua:

SV
Om du exponerats:

P308
Language


BG
ПРИ явна или предполагаема експозиция:

ES
EN CASO DE exposición manifiesta o presunta:

CS
PŘI expozici nebo podezření na ni:

DA
VED eksponering eller mistanke om eksponering:

DE
BEI Exposition oder falls betroffen

ET
Kokkupuute või kokkupuutekahtluse korral:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:

EN
IF exposed or concerned:

FR
EN CAS d’exposition prouvée ou suspectée:

GA
I gCÁS nochta nó má mheastar a bheith nochtaithe:

IT
IN CASO di esposizione o di possibile esposizione:

LV
Ja saskaras vai saistīts ar:

LT
Esant sąlyčiui arba jeigu numanomas sąlytis:

HU
Expozíció vagy annak gyanúja esetén:

MT
JEKK espost jew konċernat:

NL
NA (mogelijke) blootstelling:

PL
W PRZYPADKU narażenia lub styczności:

PT
EM CASO DE exposição ou suspeita de exposição:

RO
ÎN CAZ DE expunere sau de posibilă expunere:

SK
Po expozícii alebo podozrení z nej:

SL
PRI izpostavljenosti ali sumu izpostavljenosti:

FI
Altistumisen tapahduttua tai jos epäillään altistumista:

SV
Vid exponering eller misstanke om exponering:

P309
Language


BG
ПРИ експозиция или при неразположение:

ES
EN CASO DE exposición o malestar:

CS
PŘI expozici nebo necítíte-li se dobře:

DA
VED eksponering eller ubehag:

DE
BEI Exposition oder Unwohlsein:

ET
Kokkupuute või halva enesetunde korral:

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:

EN
IF exposed or if you feel unwell:

FR
EN CAS d’exposition ou d'un malaise:

GA
I gCÁS nochta nó má bhraitear tinn:

IT
IN CASO di esposizione o di malessere:

LV
JA saskaras vai ja jums ir slikta pašsajūta:

LT
Esant sąlyčiui arba blogai pasijutus:

HU
Expozíció vagy rosszullét esetén:

MT
JEKK espost jew tħossok ma tiflaħx:

NL
NA blootstelling of bij onwel voelen:

PL
W PRZYPADKU narażenia lub złego samopoczucia:

PT
EM CASO DE exposição ou de indisposição:

RO
ÎN CAZ DE expunere sau dacă nu vă simțiți bine:

SK
Po expozícii alebo pri zdravotných problémoch.

SL
PRI izpostavljenosti ali slabem počutju:

FI
Altistumisen tapahduttua tai jos ilmenee pahoinvointia:

SV
Vid exponering eller obehag:

P310
Language


BG
Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
Llamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.

CS
Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
Ring omgående til en GIFTINFORMATION eller en læge.

DE
Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
Immediately call a POISON CENTER or doctor/physician.

FR
Appeler immédiatement un CENTRE ANTIPOISON ou un médecin.

GA
Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.

IT
Contattare immediatamente un CENTRO ANTIVELENI o un medico.

LV
Nekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
Onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.

PL
Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.

PT
Contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
Sunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
Okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
Takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.

SV
Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.

P311
Language


BG
Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.

CS
Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
Ring til en GIFTINFORMATION eller en læge.

DE
GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
Call a POISON CENTER or doctor/physician.

FR
Appeler un CENTRE ANTIPOISON ou un médecin.

GA
Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.

IT
Contattare un CENTRO ANTIVELENI o un medico.

LV
Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
Een ANTIGIFCENTRUM of een arts raadplegen.

PL
Skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.

PT
Contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
Sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
Volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
Pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.

SV
Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P312
Language


BG
При неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.

CS
Necítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.

DE
Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.

EN
Call a POISON CENTER or doctor/physician if you feel unwell.

FR
Appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.

GA
Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.

IT
In caso di malessere, contattare un CENTRO ANTIVELENI o un medico.

LV
Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.

LT
Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Rosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.

NL
Bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.

PL
W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
Caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
Sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.

SK
Pri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
Ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.

SV
Vid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P313
Language


BG
Потърсете медицински съвет/помощ.

ES
Consultar a un médico.

CS
Vyhledejte lékařskou pomoc/ošetření.

DA
Søg lægehjælp.

DE
Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Pöörduda arsti poole.

EL
Συμβουλευθείτε/Επισκεφθείτε γιατρό.

EN
Get medical advice/attention.

FR
Consulter un médecin.

GA
Faigh comhairle/cúram liachta.

IT
Consultare un medico.

LV
Lūdziet palīdzību mediķiem.

LT
Kreiptis į gydytoją.

HU
Orvosi ellátást kell kérni.

MT
Ikkonsulta tabib.

NL
Een arts raadplegen.

PL
Zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Consulte um médico.

RO
Consultați medicul.

SK
Vyhľadajte lekársku pomoc/starostlivosť.

SL
Poiščite zdravniško pomoč/oskrbo.

FI
Hakeudu lääkäriin.

SV
Sök läkarhjälp.


P314
Language


BG
При неразположение потърсете медицински съвет/помощ.

ES
Consultar a un médico en caso de malestar.

CS
Necítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.

DA
Søg lægehjælp ved ubehag.

DE
Bei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Halva enesetunde korral pöörduda arsti poole.

EL
Συμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.

EN
Get medical advice/attention if you feel unwell.

FR
Consulter un médecin en cas de malaise.

GA
Faigh comhairle/cúram liachta má bhraitheann tú tinn.

IT
In caso di malessere, consultare un medico.

LV
Lūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.

LT
Pasijutus blogai, kreiptis į gydytoją.

HU
Rosszullét esetén orvosi ellátást kell kérni.

MT
Ikkonsulta tabib jekk tħossok ma tiflaħx.

NL
Bij onwel voelen een arts raadplegen.

PL
W przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Em caso de indisposição, consulte um médico.

RO
Consultați medicul, dacă nu vă simțiți bine.

SK
Ak pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.

SL
Ob slabem počutju poiščite zdravniško pomoč/oskrbo.

FI
Hakeudu lääkäriin, jos ilmenee pahoinvointia.

SV
Sök läkarhjälp vid obehag.

P315
Language


BG
Незабавно потърсете медицински съвет/помощ.

ES
Consultar a un médico inmediatamente.

CS
Okamžitě vyhledejte lékařskou pomoc/ošetření.

DA
Søg omgående lægehjælp.

DE
Sofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Pöörduda viivitamata arsti poole.

EL
Συμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.

EN
Get immediate medical advice/attention.

FR
Consulter immédiatement un médecin.

GA
Faigh comhairle/cúram liachta láithreach.

IT
Consultare immediatamente un medico.

LV
Nekavējoties lūdziet palīdzību mediķiem.

LT
Nedelsiant kreiptis į gydytoją.

HU
Azonnal orvosi ellátást kell kérni.

MT
Ikkonsulta tabib minnufih.

NL
Onmiddellijk een arts raadplegen.

PL
Natychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Consulte imediatamente um médico.

RO
Consultați imediat medicul.

SK
Okamžite vyhľadajte lekársku pomoc/starostlivosť.

SL
Takoj poiščite zdravniško pomoč/oskrbo.

FI
Hakeudu välittömästi lääkäriin.

SV
Sök omedelbart läkarhjälp.

P320
Language


BG
Спешна нужда от специализирано лечение (вж… на този етикет).

ES
Se necesita urgentemente un tratamiento específico (ver … en esta etiqueta).

CS
Je nutné odborné ošetření (viz … na tomto štítku).

DA
Særlig behandling straks påkrævet (se … på denne etiket).

DE
Besondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).

ET
Nõuab viivitamatut eriravi (vt … käesoleval etiketil).

EL
Χρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).

EN
Specific treatment is urgent (see … on this label).

FR
Un traitement spécifique est urgent (voir … sur cette étiquette).

GA
Tá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).

IT
Trattamento specifico urgente (vedere… su questa etichetta).

LV
Steidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).

LT
Būtinas skubus specialus gydymas (žr. … šioje etiketėje).

HU
Sürgős szakellátás szükséges (lásd … a címkén).

MT
Trattament speċifiku hu urġenti (ara … fuq din it-tikketta).

NL
Specifieke behandeling dringend vereist (zie … op dit etiket).

PL
Pilnie zastosować określone leczenie (patrz … na etykiecie).

PT
É urgente um tratamento específico (ver … no presente rótulo).

RO
Un tratament specific este urgent (a se vedea … de pe această etichetă).

SK
Odborné ošetrenie je naliehavé (pozri … na etikete).

SL
Posebno zdravljenje je nujno (glejte … na tej etiketi).

FI
Erityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).

SV
Särskild behandling krävs omedelbart (se … på etiketten).

P321
Language


BG
Специализирано лечение (вж… на този етикет).

ES
Se necesita un tratamiento específico (ver … en esta etiqueta).

CS
Odborné ošetření (viz … na tomto štítku).

DA
Særlig behandling (se … på denne etiket).

DE
Besondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).

ET
Nõuab eriravi (vt … käesoleval etiketil).

EL
Χρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).

EN
Specific treatment (see … on this label).

FR
Traitement spécifique (voir … sur cette étiquette).

GA
Cóir liachta ar leith (féach … ar an lipéad seo).

IT
Trattamento specifico (vedere …su questa etichetta).

LV
Īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).

LT
Specialus gydymas (žr. … šioje etiketėje).

HU
Szakellátás (lásd … a címkén).

MT
Trattament speċifiku (ara … fuq din it-tikketta).

NL
Specifieke behandeling vereist (zie … op dit etiket).

PL
Zastosować określone leczenie (patrz … na etykiecie).

PT
Tratamento específico (ver … no presente rótulo).

RO
Tratament specific (a se vedea … de pe această etichetă).

SK
Odborné ošetrenie (pozri … na etikete).

SL
Posebno zdravljenje (glejte … na tej etiketi).

FI
Erityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).

SV
Särskild behandling (se … på etiketten).

P322
Language


BG
Специални мерки (вж… на този етикет).

ES
Se necesitan medidas específicas (ver … en esta etiqueta).

CS
Specifické opatření (viz … na tomto štítku).

DA
Særlige foranstaltninger (se … på denne etiket).

DE
Gezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).

ET
Nõuab erimeetmeid (vt … käesoleval etiketil).

EL
Χρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).

EN
Specific measures (see … on this label).

FR
Mesures spécifiques (voir … sur cette étiquette).

GA
Bearta ar leith (féach … ar an lipéad seo).

IT
Misure specifiche (vedere …su questa etichetta).

LV
Īpaši pasākumi (skat. … uz šīs etiķetes).

LT
Specialios priemonės (žr. … šioje etiketėje).

HU
Különleges intézkedések (lásd … a címkén).

MT
Miżuri speċifiċi (ara … fuq din it-tikketta).

NL
Specifieke maatregelen (zie … op dit etiket).

PL
Środki szczególne (patrz … na etykiecie).

PT
Medidas específicas (ver … no presente rótulo).

RO
Măsuri specifice (a se vedea … de pe această etichetă).

SK
Osobitné opatrenia (pozri … na etikete).

SL
Posebni ukrepi (glejte … na tej etiketi).

FI
Erityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).

SV
Särskilda åtgärder (se … på etiketten).

P330
Language


BG
Изплакнете устата.

ES
Enjuagarse la boca.

CS
Vypláchněte ústa.

DA
Skyl munden.

DE
Mund ausspülen.

ET
Loputada suud.

EL
Ξεπλύνετε το στόμα.

EN
Rinse mouth.

FR
Rincer la bouche.

GA
Sruthlaítear an béal.

IT
Sciacquare la bocca.

LV
Izskalot muti.

LT
Išskalauti burną.

HU
A szájat ki kell öblíteni.

MT
Laħlaħ ħalqek.

NL
De mond spoelen.

PL
Wypłukać usta.

PT
Enxaguar a boca.

RO
Clătiți gura.

SK
Vypláchnite ústa.

SL
Izprati usta.

FI
Huuhdo suu.

SV
Skölj munnen.

P331
Language


BG
НЕ предизвиквайте повръщане.

ES
NO provocar el vómito.

CS
NEVYVOLÁVEJTE zvracení.

DA
Fremkald IKKE opkastning.

DE
KEIN Erbrechen herbeiführen.

ET
MITTE kutsuda esile oksendamist.

EL
ΜΗΝ προκαλέσετε εμετό.

EN
Do NOT induce vomiting.

FR
NE PAS faire vomir.

GA
NÁ spreagtar urlacan.

IT
NON provocare il vomito.

LV
NEIZRAISĪT vemšanu.

LT
NESKATINTI vėmimo.

HU
TILOS hánytatni.

MT
TIPPROVOKAX ir-remettar.

NL
GEEN braken opwekken.

PL
NIE wywoływać wymiotów.

PT
NÃO provocar o vómito.

RO
NU provocați voma.

SK
Nevyvolávajte zvracanie.

SL
NE izzvati bruhanja.

FI
EI saa oksennuttaa.

SV
Framkalla INTE kräkning.


P332
Language


BG
При поява на кожно дразнене:

ES
En caso de irritación cutánea:

CS
Při podráždění kůže:

DA
Ved hudirritation:

DE
Bei Hautreizung:

ET
Nahaärrituse korral:

EL
Εάν παρατηρηθεί ερεθισμός του δέρματος:

EN
If skin irritation occurs:

FR
En cas d’irritation cutanée:

GA
I gcás greannú craicinn:

IT
In caso di irritazione della pelle:

LV
Ja rodas ādas iekaisums:

LT
Jeigu sudirginama oda:

HU
Bőrirritáció esetén:

MT
Jekk ikun hemm irritazzjoni tal-ġilda:

NL
Bij huidirritatie:

PL
W przypadku wystąpienia podrażnienia skóry:

PT
Em caso de irritação cutânea:

RO
În caz de iritare a pielii:

SK
Ak sa prejaví podráždenie pokožky:

SL
Če nastopi draženje kože:

FI
Jos ilmenee ihoärsytystä:

SV
Vid hudirritation:

P333
Language


BG
При поява на кожно дразнене или обрив на кожата:

ES
En caso de irritación o erupción cutánea:

CS
Při podráždění kůže nebo vyrážce:

DA
Ved hudirritation eller udslet:

DE
Bei Hautreizung oder -ausschlag:

ET
Nahaärrituse või _obe korral:

EL
Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:

EN
If skin irritation or rash occurs:

FR
En cas d’irritation ou d’éruption cutanée:

GA
I gcás greannú nó grís craicinn:

IT
In caso di irritazione o eruzione della pelle:

LV
Ja rodas ādas iekaisums vai izsitumi:

LT
Jeigu sudirginama oda arba ją išberia.

HU
Bőrirritáció vagy kiütések megjelenése esetén:

MT
Jekk ikun hemm irritazzjoni jew raxx tal-ġilda:

NL
Bij huidirritatie of uitslag:

PL
W przypadku wystąpienia podrażnienia skóry lub wysypki:

PT
Em caso de irritação ou erupção cutânea:

RO
În caz de iritare a pielii sau de erupție cutanată:

SK
Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:

SL
Če nastopi draženje kože ali se pojavi izpuščaj:

FI
Jos ilmenee ihoärsytystä tai ihottumaa:

SV
Vid hudirritation eller utslag:

P334
Language


BG
Потопете в хладка вода/сложете мокри компреси.

ES
Sumergir en agua fresca/aplicar compresas húmedas.

CS
Ponořte do studené vody/zabalte do vlhkého obvazu.

DA
Skyl under koldt vand/anvend våde omslag.

DE
In kaltes Wasser tauchen/nassen Verband anlegen.

ET
Hoida jahedas vees/panna peale niiske kompress.

EL
Βυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.

EN
Immerse in cool water/wrap in wet bandages.

FR
Rincer à l’eau fraîche/poser une compresse humide.

GA
Tum in uisce fionnuar/cuir bréid fliuch air.

IT
Immergere in acqua fredda/avvolgere con un bendaggio umido.

LV
Iegremdēt vēsā ūdenī/ietīt mitros apsējos.

LT
Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.

HU
Hideg vízzel/nedves kötéssel kell hűteni.

MT
Daħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.

NL
In koud water onderdompelen/nat verband aanbrengen.

PL
Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.

PT
Mergulhar em água fria/aplicar compressas húmidas.

RO
Introduceți în apă rece/acoperiți cu o compresă umedă.

SK
Ponorte do studenej vody/obviažte mokrými obväzmi.

SL
Potopiti v hladno vodo/zaviti v mokre povoje.

FI
Upota kylmään veteen/kääri märkiin siteisiin.

SV
Skölj under kallt vatten/använd våta omslag.


P335
Language


BG
Отстранете от кожата посипаните частици.

ES
Sacudir las partículas que se hayan depositado en la piel.

CS
Volné částice odstraňte z kůže.

DA
Børst løse partikler bort fra huden.

DE
Lose Partikel von der Haut abbürsten.

ET
Pühkida lahtised osakesed nahalt maha.

EL
Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.

EN
Brush off loose particles from skin.

FR
Enlever avec précaution les particules déposées sur la peau.

GA
Glan cáithníní scaoilte den chraiceann.

IT
Rimuovere le particelle depositate sulla pelle.

LV
Noberzt no ādas nepiestiprinātās daļiņas.

LT
Neprilipusias daleles nuvalyti nuo odos.

HU
A bőrre lazán tapadó szemcséket óvatosan le kell kefélni.

MT
Farfar il-frak mhux imwaħħla minn fuq il-ġilda.

NL
Losse deeltjes van de huid afvegen.

PL
Nie związaną pozostałość strzepnąć ze skóry.

PT
Sacudir da pele as partículas soltas.

RO
Îndepărtați particulele depuse pe piele.

SK
Z pokožky oprášte sypké čiastočky.

SL
S krtačo odstraniti razsute delce s kože.

FI
Poista irtohiukkaset iholta.

SV
Borsta bort lösa partiklar från huden.

P336
Language


BG
Размразете замръзналите части в хладка вода. Не разтривайте засегнатото място.

ES
Descongelar las partes heladas con agua tibia. No frotar la zona afectada.

CS
Omrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.

DA
Forsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.

DE
Vereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.

ET
Sulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.

EL
Ξεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.

EN
Thaw frosted parts with lukewarm water. Do no rub affected area.

FR
Dégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.

GA
Leáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.

IT
Sgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.

LV
Atkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.

LT
Prišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.

HU
A fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.

MT
Ħoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.

NL
Bevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.

PL
Rozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.

PT
Derreter as zonas congeladas com água morna. Não friccionar a zona afectada.

RO
Dezghețați părțile degerate cu apă călduță. Nu frecați zona afectată.

SK
Zmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.

SL
Zamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.

FI
Sulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.

SV
Värm det köldskadade området med ljummet vatten. Gnid inte det skadade området.

P337
Language


BG
При продължително дразнене на очите:

ES
Si persiste la irritación ocular:

CS
Přetrvává-li podráždění očí:

DA
Ved vedvarende øjenirritation:

DE
Bei anhaltender Augenreizung:

ET
Kui silmade ärritus ei möödu:

EL
Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:

EN
If eye irritation persists:

FR
Si l’irritation oculaire persiste:

GA
Má mhaireann an greannú súile:

IT
Se l’irritazione degli occhi persiste:

LV
Ja acu iekaisums nepāriet:

LT
Jei akių dirginimas nepraeina:

HU
Ha a szemirritáció nem múlik el:

MT
Jekk l-irritazzjoni ta' l-għajnejn tibqa’:

NL
Bij aanhoudende oogirritatie:

PL
W przypadku utrzymywania się działania drażniącego na oczy:

PT
Caso a irritação ocular persista:

RO
Dacă iritarea ochilor persistă:

SK
Ak podráždenie očí pretrváva:

SL
Če draženje oči ne preneha:

FI
Jos silmä-ärsytys jatkuu:

SV
Vid bestående ögonirritation:

P338
Language


BG
Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.

ES
Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.

CS
Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.

DA
Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.

DE
Eventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.

ET
Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.

EL
Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.

EN
Remove contact lenses, if present and easy to do. Continue rinsing.

FR
Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.

GA
Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.

IT
Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.

LV
Izņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.

LT
Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.

HU
Adott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.

MT
Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.

NL
Contactlenzen verwijderen, indien mogelijk. Blijven spoelen.

PL
Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.

PT
Se usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.

RO
Scoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.

SK
Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.

SL
Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.

FI
Poista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.

SV
Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.

P340
Language


BG
Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.

ES
Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.

CS
Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.

DA
Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.

DE
Die betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.

ET
Toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.

EL
Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.

EN
Remove victim to fresh air and keep at rest in a position comfortable for breathing.

FR
Transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.

GA
Tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.

IT
Trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.

LV
Izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.

LT
Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.

HU
Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.

MT
Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.

NL
Het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.

PL
Wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.

PT
Retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.

RO
Transportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.

SK
Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.

SL
Prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.

FI
Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.

SV
Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen

P341
Language


BG
При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.

ES
Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.

CS
Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.

DA
Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.

DE
Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.

ET
Hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.

EL
Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.

EN
If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.

FR
S'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.

GA
Más deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.

IT
Se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.

LV
Ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.

LT
Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.

HU
Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.

MT
Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.

NL
Bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.

PL
W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.

PT
Em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.

RO
Dacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.

SK
Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.

SL
Pri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.

FI
Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.

SV
Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P342
Language


BG
При симптоми на затруднено дишане:

ES
En caso de síntomas respiratorios:

CS
Při dýchacích potížích:

DA
Ved luftvejssymptomer:

DE
Bei Symptomen der Atemwege:

ET
Hingamisteede probleemide ilmnemise korral:

EL
Εάν παρουσιάζονται αναπνευστικά συμπτώματα:

EN
If experiencing respiratory symptoms:

FR
En cas de symptômes respiratoires:

GA
I gcás siomptóm riospráide:

IT
In caso di sintomi respiratori:

LV
Ja rodas elpošanas traucējumu simptomi:

LT
Jeigu pasireiškia respiraciniai simptomai:

HU
Légzési problémák esetén:

MT
Jekk tkun qed tbati minn sintomi respiratorji:

NL
Bij ademhalingssymptomen:

PL
W przypadku wystąpienia objawów ze strony układu oddechowego:

PT
Em caso de sintomas respiratórios:

RO
În caz de simptome respiratorii:

SK
Pri sťaženom dýchaní:

SL
Pri respiratornih simptomih:

FI
Jos ilmenee hengitysoireita:

SV
Vid besvär i luftvägarna:

P350
Language


BG
Измийте внимателно и обилно със сапун и вода.

ES
Lavar suavemente con agua y jabón abundantes.

CS
Jemně omyjte velkým množstvím vody a mýdla.

DA
Vask forsigtigt med rigeligt sæbe og vand.

DE
Behutsam mit viel Wasser und Seife waschen.

ET
Pesta õrnalt rohke vee ja seebiga.

EL
Πλύνετε απαλά με άφθονο νερό και σαπούνι.

EN
Gently wash with plenty of soap and water.

FR
Laver avec précaution et abondamment à l’eau et au savon.

GA
Nigh go bog le neart gallúnaí agus uisce.

IT
Lavare delicatamente e abbondantemente con acqua e sapone.

LV
Maigi izskalot ar lielu daudzumu ziepēm un ūdeni.

LT
Atsargiai nuplauti dideliu kiekiu muilo ir vandens.

HU
Óvatos lemosás bő szappanos vízzel.

MT
Aħsel bil-mod b’ħafna sapun u ilma.

NL
Voorzichtig wassen met veel water en zeep.

PL
Delikatnie umyć dużą ilością wody z mydłem.

PT
Lavar suavemente com sabonete e água abundantes.

RO
Spălați ușor cu multă apă și săpun.

SK
Opatrne umyte veľkým množstvom vody a mydla.

SL
Nežno umiti z veliko mila in vode.

FI
Pese varovasti runsaalla vedellä ja saippualla.

SV
Tvätta försiktigt med mycket tvål och vatten.

P351
Language


BG
Промивайте внимателно с вода в продължение на няколко минути.

ES
Aclarar cuidadosamente con agua durante varios minutos.

CS
Několik minut opatrně oplachujte vodou.

DA
Skyl forsigtigt med vand i flere minutter.

DE
Einige Minuten lang behutsam mit Wasser ausspülen.

ET
Loputada mitme minuti jooksul ettevaatlikult veega.

EL
Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.

EN
Rinse cautiously with water for several minutes.

FR
Rincer avec précaution à l’eau pendant plusieurs minutes.

GA
Sruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.

IT
Sciacquare accuratamente per parecchi minuti.

LV
Uzmanīgi skalot ar ūdeni vairākas minūtes.

LT
Atsargiai plauti vandeniu kelias minutes.

HU
Óvatos öblítés vízzel több percen keresztül.

MT
Laħlaħ b'attenzjoni bl-ilma għal diversi minuti.

NL
Voorzichtig afspoelen met water gedurende een aantal minuten.

PL
Ostrożnie płukać wodą przez kilka minut.

PT
Enxaguar cuidadosamente com água durante vários minutos.

RO
Clătiți cu atenție cu apă, timp de mai multe minute.

SK
Opatrne niekoľko minút oplachujte vodou.

SL
Previdno izpirati z vodo nekaj minut.

FI
Huuhdo huolellisesti vedellä usean minuutin ajan.

SV
Skölj försiktigt med vatten i flera minuter.

P352
Language


BG
Измийте обилно със сапун и вода.

ES
Lavar con agua y jabón abundantes.

CS
Omyjte velkým množstvím vody a mýdla.

DA
Vask med rigeligt sæbe og vand.

DE
Mit viel Wasser und Seife waschen.

ET
Pesta rohke vee ja seebiga.

EL
Πλύνετε με άφθονο σαπούνι και νερό.

EN
Wash with plenty of soap and water.

FR
Laver abondamment à l’eau et au savon.

GA
Nigh le neart gallúnaí agus uisce.

IT
Lavare abbondantemente con acqua e sapone.

LV
Mazgāt ar lielu daudzmu ziepēm un ūdeni.

LT
Plauti dideliu kiekiu muilo ir vandens.

HU
Lemosás bő szappanos vízzel.

MT
Aħsel b’ħafna sapun u ilma.

NL
Met veel water en zeep wassen.

PL
Umyć dużą ilością wody z mydłem.

PT
Lavar com sabonete e água abundantes.

RO
Spălați cu multă apă și săpun.

SK
Umyte veľkým množstvom vody a mydla.

SL
Umiti z veliko mila in vode.

FI
Pese runsaalla vedellä ja saippualla.

SV
Tvätta med mycket tvål och vatten.

P353
Language


BG
Облейте кожата с вода/вземете душ.

ES
Aclararse la piel con agua/ducharse.

CS
Opláchněte kůži vodou/osprchujte.

DA
Skyl/brus huden med vand.

DE
Haut mit Wasser abwaschen/duschen.

ET
Loputada nahka veega/loputada duši all.

EL
Ξεπλύνετε την επιδερμίδα με νερό/στο ντους.

EN
Rinse skin with water/shower.

FR
Rincer la peau à l’eau/se doucher.

GA
Sruthlaítear an craiceann le huisce/glac cithfholcadh.

IT
Sciacquare la pelle/fare una doccia.

LV
Noskalot ādu ar ūdeni/dušā.

LT
Odą nuplauti vandeniu/čiurkšle.

HU
A bőrt le kell öblíteni vízzel/zuhanyozás.

MT
Laħlaħ il-ġilda bl-ilma/bix-xawer.

NL
Huid met water afspoelen/afdouchen.

PL
Spłukać skórę pod strumieniem wody/prysznicem.

PT
Enxaguar a pele com água/tomar um duche.

RO
Clătiți pielea cu apă/faceți duș.

SK
Pokožku opláchnite vodou/sprchou.

SL
Kožo izprati z vodo/prho.

FI
Huuhdo/suihkuta iho vedellä.

SV
Skölj huden med vatten/duscha.

P360
Language


BG
Незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.

ES
Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.

CS
Kontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.

DA
Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.

DE
Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.

ET
Saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.

EL
Ξεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.

EN
Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.

FR
Rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.

GA
Sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.

IT
Sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.

LV
Nekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.

LT
Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.

HU
A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.

MT
Laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.

NL
Verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.

PL
Natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.

PT
Enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.

RO
Clătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.

SK
Kontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.

SL
Takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.

FI
Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.

SV
Skölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.

P361
Language


BG
Незабавно свалете цялото замърсено облекло.

ES
Quitarse inmediatamente las prendas contaminadas.

CS
Veškeré kontaminované části oděvu okamžitě svlékněte.

DA
Tilsmudset tøj tages straks af/fjernes.

DE
Alle kontaminierten Kleidungsstücke sofort ausziehen.

ET
Kõik saastunud rõivad viivitamata seljast võtta.

EL
Αφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.

EN
Remove/Take off immediately all contaminated clothing.

FR
Enlever immédiatement les vêtements contaminés.

GA
Bain díot láithreach na héadaí éillithe go léir.

IT
Togliersi di dosso immediatamente tutti gli indumenti contaminati.

LV
Noņemt/Novilkt nekavējoties visu piesārņoto apģērbu.

LT
Nedelsiant nuvilkti/pašalinti visus užterštus drabužius.

HU
Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.

MT
Neħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.

NL
Verontreinigde kleding onmiddellijk uittrekken.

PL
Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież.

PT
Despir/retirar imediatamente toda a roupa contaminada.

RO
Scoateți imediat toată îmbrăcămintea contaminată.

SK
Ihneď odstráňte/vyzlečte všetky kontaminované časti odevu.

SL
Takoj odstraniti/sleči vsa kontaminirana oblačila.

FI
Riisu saastunut vaatetus välittömästi.

SV
Ta omedelbart av alla nedstänkta kläder.


P362
Language


BG
Свалете замърсеното облекло и го изперете преди повторна употреба.

ES
Quitarse las prendas contaminadas y lavarlas antes de volver a usarlas.

CS
Kontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.

DA
Forurenet tøj tages af og vaskes, før det bruges igen.

DE
Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.

ET
Võtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.

EL
Βγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.

EN
Take off contaminated clothing and wash before reuse.

FR
Enlever les vêtements contaminés et les laver avant réutilisation

GA
Bain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.

IT
Togliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.

LV
Novilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.

LT
Nusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.

HU
A szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.

MT
Inża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.

NL
Verontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.

PL
Zanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.

PT
Retirar a roupa contaminada e lavá-la antes de a voltar a usar.

RO
Scoateți îmbrăcămintea contaminată și spălați-o înainte de reutilizare.

SK
Kontaminovaný odev vyzlečte a pred ďalším použitím vyperte.

SL
Sleči kontaminirana oblačila in jih oprati pred ponovno uporabo.

FI
Riisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.

SV
Nedstänkta kläder tas av och tvättas innan de används igen.


P363
Language


BG
Изперете замърсеното облекло преди повторна употреба.

ES
Lavar las prendas contaminadas antes de volver a usarlas.

CS
Kontaminovaný oděv před opětovným použitím vyperte.

DA
Tilsmudset tøj skal vaskes, før det kan anvendes igen.

DE
Kontaminierte Kleidung vor erneutem Tragen waschen.

ET
Saastunud rõivad enne järgmist kasutamist pesta.

EL
Πλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.

EN
Wash contaminated clothing before reuse.

FR
Laver les vêtements contaminés avant réutilisation.

GA
Nigh éadaí éillithe sula ndéanfar iad a athúsáid.

IT
Lavare gli indumenti contaminati prima di indossarli nuovamente.

LV
Pirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.

LT
Užterštus drabužius išskalbti prieš vėl juos apsivelkant.

HU
A szennyezett ruhát újbóli használat előtt ki kell mosni.

MT
Aħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.

NL
Verontreinigde kleding wassen alvorens deze opnieuw te gebruiken.

PL
Wyprać zanieczyszczoną odzież przed ponownym użyciem.

PT
Lavar a roupa contaminada antes de a voltar a usar.

RO
Spălați îmbracămintea contaminată, înainte de reutilizare.

SK
Kontaminovaný odev pred ďalším použitím vyperte.

SL
Kontaminirana oblačila oprati pred ponovno uporabo.

FI
Pese saastunut vaatetus ennen uudelleenkäyttöä.

SV
Nedstänkta kläder ska tvättas innan de används igen.

P370
Language


BG
При пожар:

ES
En caso de incendio:

CS
V případě požáru:

DA
Ved brand:

DE
Bei Brand:

ET
Tulekahju korral:

EL
Σε περίπτωση πυρκαγιάς:

EN
In case of fire:

FR
En cas d’incendie:

GA
I gcás dóiteáin:

IT
In caso di incendio:

LV
Ugunsgrēka gadījumā:

LT
Gaisro atveju:

HU
Tűz esetén:

MT
F’każ ta' nar:

NL
In geval van brand:

PL
W przypadku pożaru:

PT
Em caso de incêndio:

RO
În caz de incendiu:

SK
V prípade požiaru:

SL
Ob požaru:

FI
Tulipalon sattuessa:

SV
Vid brand:

P371
Language


BG
При голям пожар и значителни количества:

ES
En caso de incendio importante y en grandes cantidades:

CS
V případě velkého požáru a velkého množství:

DA
Ved større brand og store mængder:

DE
Bei Großbrand und großen Mengen:

ET
Suure tulekahju korral ning kui on tegemist suurte kogustega:

EL
Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:

EN
In case of major fire and large quantities:

FR
En cas d’incendie important et s’il s’agit de grandes quantités:

GA
I gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:

IT
In caso di incendio grave e di quantità rilevanti:

LV
Ugunsgrēka un lielu apjomu gadījumā:

LT
Didelio gaisro ir didelių kiekių atveju:

HU
Nagyobb tűz és nagy mennyiség esetén:

MT
F’każ ta' nar kbir u kwantitajiet kbar:

NL
In geval van grote brand en grote hoeveelheden:

PL
W przypadku poważnego pożaru i dużych ilości:

PT
Em caso de incêndio importante e de grandes quantidades:

RO
În caz de incendiu de proporții și de cantități mari de produs:

SK
V prípade veľkého požiaru a veľkého množstva:

SL
Ob velikem požaru in velikih količinah:

FI
Jos tulipalo ja ainemäärät ovat suuret:

SV
Vid större brand och stora mängder:

P372
Language


BG
Опасност от експлозия при пожар.

ES
Riesgo de explosión en caso de incendio.

CS
Nebezpečí výbuchu v případě požáru.

DA
Eksplosionsfare ved brand.

DE
Explosionsgefahr bei Brand.

ET
Tulekahju korral plahvatusoht.

EL
Κίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.

EN
Explosion risk in case of fire.

FR
Risque d’explosion en cas d’incendie.

GA
Baol pléasctha i gcás dóiteáin.

IT
Rischio di esplosione in caso di incendio.

LV
Eksplozijas risks ugunsgrēka gadījumā:

LT
Sprogimo pavojus gaisro atveju.

HU
Tűz esetén robbanásveszély.

MT
Riskju ta' splużjoni f’każ ta' nar.

NL
Ontploffingsgevaar in geval van brand.

PL
Ryzyko wybuchu w razie pożaru.

PT
Risco de explosão em caso de incêndio.

RO
Risc de explozie în caz de incendiu.

SK
V prípade požiaru hrozí riziko výbuchu.

SL
Nevarnost eksplozije ob požaru.

FI
Tulipalon sattuessa räjähdysvaara.

SV
Explosionsrisk vid brand.

P373
Language


BG
НЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.

ES
NO luchar contra el incendio cuando el fuego llega a los explosivos.

CS
Požár NEHASTE, dostane-li se k výbušninám.

DA
BEKÆMP IKKE branden, hvis denne når eksplosiverne.

DE
KEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.

ET
Kui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.

EL
ΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.

EN
DO NOT fight fire when fire reaches explosives.

FR
NE PAS combattre l’incendie lorsque le feu atteint les explosifs.

GA
NÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.

IT
NON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.

LV
NECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.

LT
NEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.

HU
TILOS a tűz oltása, ha az robbanóanyagra átterjedt.

MT
TIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.

NL
NIET blussen wanneer het vuur de ontplofbare stoffen bereikt.

PL
NIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe

PT
Se o fogo atingir os explosivos, NÃO tentar combatê-lo.

RO
NU încercați să stingeți incendiul atunci când focul a ajuns la explozivi.

SK
Požiar NEHASTE, ak sa oheň priblížil k výbušninám.

SL
NE gasiti, ko ogenj doseže eksploziv.

FI
Tulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.

SV
Försök INTE bekämpa branden när den når explosiva varor.

P374
Language


BG
Гасете пожара с обичайните предпазни мерки от разумно разстояние.

ES
Luchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.

CS
Haste z přiměřené vzdálenosti a dodržujte běžná opatření.

DA
Træf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.

DE
Brandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.

ET
Kustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.

EL
Προσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.

EN
Fight fire with normal precautions from a reasonable distance.

FR
Combattre l’incendie à distance en prenant les précautions normales.

GA
Déan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.

IT
Utilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.

LV
Dzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.

LT
Gaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.

HU
Tűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.

MT
Itfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.

NL
Met normale voorzorgen vanaf een redelijke afstand blussen.

PL
Gasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.

PT
Combater o incêndio tomando as precauções normais e a partir de uma distância razoável.

RO
Stingeți incendiul de la o distanță rezonabilă, luând măsuri normale de precauție.

SK
Požiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.

SL
Gasiti z običajno previdnostjo in s primerne razdalje.

FI
Sammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.

SV
Bekämpa branden på vanligt sätt på behörigt avstånd.

P375
Language


BG
Гасете пожара от разстояние поради опасност от експлозия.

ES
Luchar contra el incendio a distancia, dado el riesgo de explosión.

CS
Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.

DA
Bekæmp branden på afstand på grund af eksplosionsfare.

DE
Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.

ET
Plahvatusohu tõttu teha kustutustöid eemalt.

EL
Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.

EN
Fight fire remotely due to the risk of explosion.

FR
Combattre l’incendie à distance à cause du risque d’explosion.

GA
Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.

IT
Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.

LV
Dzēst ugunsgrēku no attāluma eksplozijas riska dēļ.

LT
Gaisrą gesinti iš toli dėl sprogimo pavojaus.

HU
A tűz oltását robbanásveszély miatt távolból kell végezni.

MT
Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.

NL
Op afstand blussen omwille van ontploffingsgevaar.

PL
Z powodu ryzyka wybuchu gasić pożar z odległości.

PT
Combater o incêndio à distância, devido ao risco de explosão.

RO
Stingeți incendiul de la distanță din cauza pericolului de explozie.

SK
Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.

SL
Gasiti z večje razdalje zaradi nevarnosti eksplozije.

FI
Sammuta palo etäältä räjähdysvaaran takia.

SV
Bekämpa branden på avstånd på grund av explosionsrisken.

P376
Language


BG
Спрете теча, ако е безопасно.

ES
Detener la fuga, si no hay peligro en hacerlo.

CS
Zastavte únik, můžete-li tak učinit bez rizika.

DA
Stands lækagen, hvis dette er sikkert.

DE
Undichtigkeit beseitigen, wenn gefahrlos möglich.

ET
Leke peatada, kui seda on võimalik teha ohutult.

EL
Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.

EN
Stop leak if safe to do so.

FR
Obturer la fuite si cela peut se faire sans danger.

GA
Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.

IT
Bloccare la perdita se non c’è pericolo.

LV
Apstādināt noplūdi, ja to var izdarīt drošā veidā.

LT
Sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.

HU
Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.

MT
Waqqaf it-tnixxija jekk ma jkunx hemm periklu.

NL
Het lek dichten als dat veilig gedaan kan worden.

PL
Jeżeli jest to bezpieczne zahamować wyciek.

PT
Deter a fuga se tal puder ser feito em segurança.

RO
Opriți scurgerea, dacă acest lucru se poate face în siguranță.

SK
Zastavte únik, ak je to bezpečné.

SL
Zaustaviti puščanje, če je varno.

FI
Sulje vuoto, jos sen voi tehdä turvallisesti.

SV
Stoppa läckan om det kan göras på ett säkert sätt.

P377
Language


BG
Пожар от изтекъл газ:
Не гасете освен при възможност за безопасно отстраняване на теча.

ES
Fuga de gas en llamas:
No apagar, salvo si la fuga puede detenerse sin peligro.

CS
Požár unikajícího plynu:
Nehaste, nelze-li únik bezpečně zastavit.

DA
Brand fra udsivende gas:
Sluk ikke, medmindre det er sikkert at stoppe lækagen.

DE
Brand von ausströmendem Gas:
Nicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.

ET
Lekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.

EL
Διαρροή φλεγόμενου αερίου:
Μην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.

EN
Leaking gas fire:
Do not extinguish, unless leak can be stopped safely.

FR
Fuite de gaz enflammé:
Ne pas éteindre si la fuite ne peut pas être arrêtée sans danger.

GA
Tine gháis ag sceitheadh:
Ná múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.

IT
In caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.

LV
Degšanas gāzes noplūde:
Nedzēst, ja vien noplūdi var apstādināt drošā veidā.

LT
Dujų nuotėkio sukeltas gaisras:
Negesinti, nebent nuotėkį būtų galima saugiai sustabdyti.

HU
Égő szivárgó gáz:
Csak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.

MT
Tnixxija ta' gass tan-nar:
Tippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.

NL
Brand door lekkend gas:
niet blussen, tenzij het lek veilig gedicht kan worden.

PL
W przypadku płonięcia wyciekającego gazu:
Nie gasić, jeżeli nie można bezpiecznie zahamować wycieku.

PT
Incêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.

RO
Incendiu cauzat de o scurgere de gaz: nu încercați să stingeți, decât dacă scurgerea poate fi oprită în siguranță.

SK
Požiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.

SL
Požar zaradi uhajanja plina:
Ne gasiti, če puščanja ni mogoče varno zaustaviti.

FI
Vuotavasta kaasusta johtuva palo:
Ei saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.

SV
Läckande gas som brinner:
Försök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.

P378
Language


BG
Използвайте … за гасене.

ES
Utilizar … para apagarlo.

CS
K hašení použijte …

DA
Anvend … til brandslukning.

DE
… zum Löschen verwenden.

ET
Kustutamiseks kasutada …

EL
Χρησιμοποιήστε … για την κατάσβεση.

EN
Use … for extinction.

FR
Utiliser … pour l’extinction.

GA
Úsáid … le haghaidh múchta.

IT
Estinguere con…

LV
Nodzēšanai izmantot…

LT
Gesinimui naudoti …

HU
Az oltáshoz … használandó.

MT
Uża’ … biex titfi.

NL
Blussen met …

PL
Użyć … do gaszenia.

PT
Para a extinção utilizar …

RO
Utilizați… pentru stingere.

SK
Na hasenie použite …

SL
Za gašenje uporabiti …

FI
Käytä palon sammuttamiseen …

SV
Släck branden med …

P380
Language


BG
Евакуирайте зоната.

ES
Evacuar la zona.

CS
Vykliďte _roctor.

DA
Evakuer området.

DE
Umgebung räumen.

ET
Ala evakueerida.

EL
Εκκενώστε την περιοχή.

EN
Evacuate area.

FR
Évacuer la zone.

GA
Aslonnaigh gach duine as an limistéar.

IT
Evacuare la zona.

LV
Evakuēt zonu.

LT
Evakuoti zoną.

HU
A területet ki kell üríteni.

MT
Evakwa ż-żona.

NL
Evacueren.

PL
Ewakuować teren.

PT
Evacuar a zona.

RO
Evacuați zona.

SK
Priestory evakuujte.

SL
Izprazniti območje.

FI
Evakuoi alue.

SV
Utrym området.

P381
Language


BG
Премахнете всички източници на запалване, ако е безопасно.

ES
Eliminar todas las fuentes de ignición si no hay peligro en hacerlo.

CS
Odstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.

DA
Fjern alle antændelseskilder, hvis dette kan gøres sikkert.

DE
Alle Zündquellen entfernen, wenn gefahrlos möglich.

ET
Eemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.

EL
Απομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.

EN
Eliminate all ignition sources if safe to do so.

FR
Éliminer toutes les sources d’ignition si cela est faisable sans danger.

GA
Díothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.

IT
Eliminare ogni fonte di accensione se non c’è pericolo.

LV
Novērst visus uzliesmošanas avotus, ja to var izdarīt droši.

LT
Pašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.

HU
Meg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.

MT
Elimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.

NL
Alle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.

PL
Wyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.

PT
Eliminar todas as fontes de ignição se tal puder ser feito em segurança.

RO
Eliminați toate sursele de aprindere, dacă acest lucru se poate face în siguranță.

SK
Ak je to bezpečné, odstráňte všetky zdroje zapálenia.

SL
Odstraniti vse vire vžiga, če je varno.

FI
Poista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.

SV
Avlägsna alla antändningskällor om det kan göras på ett säkert sätt.

P390
Language


BG
Попийте разлятото, за да се предотвратят материални вреди.

ES
Absorber el vertido para que no dañe otros materiales.

CS
Uniklý produkt absorbujte, aby se zabránilo materiálním škodám.

DA
Absorber udslip for at undgå materielskade.

DE
Verschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.

ET
Mahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.

EL
Σκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.

EN
Absorb spillage to prevent material damage.

FR
Absorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.

GA
Ionsúigh doirteadh chun damáiste d’ábhar a chosc.

IT
Assorbire la fuoriuscita per evitare danni materiali.

LV
Uzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.

LT
Absorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.

HU
A kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.

MT
Assorbi t-tixrid biex tipprevjeni ħsara fil-materjal.

NL
Gelekte/gemorste stof opnemen om materiële schade te vermijden.

PL
Usunąć wyciek, aby zapobiec szkodom materialnym.

PT
Absorver o produto derramado a fim de evitar danos materiais.

RO
Absorbiți scurgerile de produs, pentru a nu afecta materialele din apropiere.

SK
Absorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.

SL
Odpraviti razlitje, da se prepreči materialna škoda.

FI
Imeytä valumat vahinkojen estämiseksi.

SV
Sug upp spill för att undvika materiella skador.

P391
Language


BG
Съберете разлятото.

ES
Recoger el vertido.

CS
Uniklý produkt seberte.

DA
Udslip opsamles.

DE
Verschüttete Mengen aufnehmen.

ET
Mahavoolanud toode kokku koguda.

EL
Μαζέψτε τη χυμένη ποσότητα.

EN
Collect spillage.

FR
Recueillir le produit répandu.

GA
Bailigh doirteadh.

IT
Raccogliere il materiale fuoriuscito.

LV
Savākt izšļakstīto šķidrumu.

LT
Surinkti ištekėjusią medžiagą.

HU
A kiömlött anyagot össze kell gyűjteni.

MT
Iġbor it-tixrid.

NL
Gelekte/gemorste stof opruimen.

PL
Zebrać wyciek.

PT
Recolher o produto derramado.

RO
Colectați scurgerile de produs.

SK
Zozbierajte uniknutý produkt.

SL
Prestreči razlito tekočino.

FI
Valumat on kerättävä.

SV
Samla upp spill.

P301 + P310
Language


BG
ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
EN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.

CS
PŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
I TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.

DE
BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
ALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

FR
EN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.

GA
MÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.

IT
IN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico

LV
NORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
PRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
LENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
NA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.

PL
W PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
EM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
ÎN CAZ DE ÎNGHIȚIRE: sunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
PO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
PRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
JOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.

SV
VID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.

P301 + P312
Language


BG
ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.

ES
EN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.

CS
PŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
I TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.

DE
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
ALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.

EN
IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.

FR
EN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.

GA
MÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.

IT
IN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.

LV
NORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.

LT
PRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
LENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.

NL
NA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.

PL
W PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
EM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
ÎN CAZ DE ÎNGHIȚIRE: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.

SK
PO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
PRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
JOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.

SV
VID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.

P301 + P330 + P331
Language


BG
ПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.

ES
EN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.

CS
PŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.

DA
I TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.

DE
BEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.

ET
ALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.

EN
IF SWALLOWED: rinse mouth. Do NOT induce vomiting.

FR
EN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.

GA
MÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.

IT
IN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.

LV
NORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.

LT
PRARIJUS: išskalauti burną. NESKATINTI vėmimo.

HU
LENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.

MT
JEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.

NL
NA INSLIKKEN: de mond spoelen — GEEN braken opwekken.

PL
W PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.

PT
EM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.

RO
ÎN CAZ DE ÎNGHIȚIRE: clătiți gura. NU provocați voma.

SK
PO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.

SL
PRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.

FI
JOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.

SV
VID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.

P302 + P334
Language


BG
ПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.

ES
EN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.

CS
PŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.

DA
VED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.

DE
BEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.

ET
NAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.

EN
IF ON SKIN: Immerse in cool water/wrap in wet bandages.

FR
EN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.

IT
IN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.

LV
SASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.

LT
PATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.

HU
HA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.

MT
JEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.

NL
BIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.

PL
W PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.

PT
SE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.

RO
ÎN CAZ DE CONTACT CU PIELEA: introduceți în apă rece/acoperiți cu o compresă umedă.

SK
PRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.

SL
PRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.

FI
JOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.

SV
VID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.

P302 + P350
Language


BG
ПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.

ES
EN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.

CS
PŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.

DA
VED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.

DE
BEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.

ET
NAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.

EN
IF ON SKIN: Gently wash with plenty of soap and water.

FR
EN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.

IT
IN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.

LV
SASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.

LT
PATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.

HU
HA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.

MT
JEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.

NL
BIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.

PL
W PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.

PT
SE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.

RO
ÎN CAZ DE CONTACT CU PIELEA: spălați ușor cu multă apă și săpun.

SK
PRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.

SL
PRI STIKU S KOŽO: nežno umiti z veliko mila in vode.

FI
JOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.

SV
VID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.

P302 + P352
Language


BG
ПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.

ES
EN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.

CS
PŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.

DA
VED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.

DE
BEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.

ET
NAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.

EN
IF ON SKIN: Wash with plenty of soap and water.

FR
EN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.

IT
IN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.

LV
SASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.

LT
PATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.

HU
HA BŐRRE KERÜL: Lemosás bő szappanos vízzel.

MT
JEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.

NL
BIJ CONTACT MET DE HUID: met veel water en zeep wassen.

PL
W PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.

PT
SE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.

RO
ÎN CAZ DE CONTACT CU PIELEA: spălați cu multă apă și săpun.

SK
PRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.

SL
PRI STIKU S KOŽO: umiti z veliko mila in vode.

FI
JOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.

SV
VID HUDKONTAKT: Tvätta med mycket tvål och vatten.

P303 + P361 + P353
Language


BG
ПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ

ES
EN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.

CS
PŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.

DA
VED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.

DE
BEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.

ET
NAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.

EN
IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.

FR
EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.

GA
I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.

IT
IN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.

LV
SASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.

LT
PATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.

HU
HA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.

MT
JEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.

NL
BIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.

PL
W PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.

PT
SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.

RO
ÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateți imediat toată îmbrăcămintea contaminată. Clătiți pielea cu apă/faceți duș.

SK
PRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.

SL
PRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.

FI
JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.

SV
VID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.

P304 + P340
Language


BG
ПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.

ES
EN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.

CS
PŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.

DA
VED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.

DE
BEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.

ET
SISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.

EN
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.

FR
EN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.

GA
MÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.

IT
IN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.

LV
IEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.

LT
ĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.

HU
BELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.

MT
JEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.

NL
NA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.

PL
W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.

PT
EM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.

RO
ÎN CAZ DE INHALARE: transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.

SK
PO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.

SL
PRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.

FI
JOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.

SV
VID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P304 + P341
Language


BG
ПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.

ES
EN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.

CS
PŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.

DA
VED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.

DE
BEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.

ET
SISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.

EN
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.

FR
EN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.

GA
MÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.

IT
IN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.

LV
IEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.

LT
ĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.

HU
BELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.

MT
JEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.

NL
NA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.

PL
W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.

PT
EM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.

RO
ÎN CAZ DE INHALARE: dacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.

SK
PO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.

SL
PRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.

FI
JOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.

SV
VID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P305 + P351 + P338
Language


BG
ПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.

ES
EN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.

CS
PŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.

DA
VED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.

DE
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

ET
SILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.

EN
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

FR
EN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.

GA
I gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.

IT
IN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.

LV
SASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.

LT
PATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.

HU
SZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.

MT
JEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.

NL
BIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.

PL
W PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.

PT
SE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.

RO
ÎN CAZ DE CONTACT CU OCHII: clătiți cu atenție cu apă timp de mai multe minute. Scoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.

SK
PO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.

SL
PRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.

FI
JOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.

SV
VID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.

P306 + P360
Language


BG
ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.

ES
EN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.

CS
PŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.

DA
VED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.

DE
BEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.

ET
RÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.

EN
IF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.

FR
EN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.

GA
I gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.

IT
IN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.

LV
SASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.

LT
PATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.

HU
HA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.

MT
JEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.

NL
NA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.

PL
W PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.

PT
SE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.

RO
ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.

SK
PRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.

SL
PRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.

FI
JOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.

SV
VID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.

P307 + P311
Language


BG
ПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
EN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.

CS
PŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
VED eksponering: Ring til en GIFTINFORMATION eller en læge.

DE
BEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Kokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
IF exposed: Call a POISON CENTER or doctor/physician.

FR
EN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.

GA
I gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.

IT
IN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.

LV
Ja ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
Esant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Expozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
Jekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
NA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.

PL
W przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
EM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
ÎN CAZ DE expunere: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
Po expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
PRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Altistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.

SV
Om du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P308 + P313
Language


BG
ПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.

ES
EN CASO DE exposición manifiesta o presunta: Consultar a un médico.

CS
PŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.

DA
VED eksponering eller mistanke om eksponering: Søg lægehjælp.

DE
BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Kokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.

EN
IF exposed or concerned: Get medical advice/attention.

FR
EN CAS d’exposition prouvée ou suspectée: consulter un médecin.

GA
I gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.

IT
IN CASO di esposizione o di possibile esposizione, consultare un medico.

LV
Ja nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.

LT
Esant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.

HU
Expozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.

MT
Jekk espost jew konċernat: Ikkonsulta tabib.

NL
NA (mogelijke) blootstelling: een arts raadplegen.

PL
W przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
EM CASO DE exposição ou suspeita de exposição: consulte um médico.

RO
ÎN CAZ DE expunere sau de posibilă expunere: consultați medicul.

SK
Po expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.

SL
PRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.

FI
Altistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.

SV
Vid exponering eller misstanke om exponering Sök läkarhjälp.

P309 + P311
Language


BG
ПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
EN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.

CS
PŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
VED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.

DE
BEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Kokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.

FR
EN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.

GA
I gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.

IT
IN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.

LV
Ja nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
Esant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Expozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
JEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
NA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.

PL
W przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
EM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
ÎN CAZ DE expunere sau dacă nu vă simțiți bine: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
Po expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
PRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Altistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.

SV
Vid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P332 + P313
Language


BG
При поява на кожно дразнене: Потърсете медицински съвет/помощ.

ES
En caso de irritación cutánea: Consultar a un médico.

CS
Při podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.

DA
Ved hudirritation: Søg lægehjælp.

DE
Bei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Nahaärrituse korral: pöörduda arsti poole.

EL
Εάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.

EN
If skin irritation occurs: Get medical advice/attention.

FR
En cas d’irritation cutanée: consulter un médecin.

GA
I gcás greannú craicinn: Faigh comhairle/cúram liachta.

IT
In caso di irritazione della pelle: consultare un medico.

LV
Ja rodas ādas iekaisums: lūdziet mediķu palīdzību.

LT
Jeigu sudirginama oda: kreiptis į gydytoją.

HU
Bőrirritáció esetén: orvosi ellátást kell kérni.

MT
Jekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.

NL
Bij huidirritatie: een arts raadplegen.

PL
W przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Em caso de irritação cutânea: consulte um médico.

RO
În caz de iritare a pielii: consultați medicul.

SK
Ak sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.

SL
Če nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.

FI
Jos ilmenee ihoärsytystä: Hakeudu lääkäriin.

SV
Vid hudirritation: Sök läkarhjälp.

P333 + P313
Language


BG
При поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.

ES
En caso de irritación o erupción cutánea: Consultar a un médico.

CS
Při podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.

DA
Ved hudirritation eller udslet: Søg lægehjælp.

DE
Bei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Nahaärrituse või _obe korral: pöörduda arsti poole.

EL
Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.

EN
If skin irritation or rash occurs: Get medical advice/attention.

FR
En cas d’irritation ou d'éruption cutanée: consulter un médecin.

GA
Má tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.

IT
In caso di irritazione o eruzione della pelle: consultare un medico.

LV
Ja rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.

LT
Jeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.

HU
Bőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.

MT
Jekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.

NL
Bij huidirritatie of uitslag: een arts raadplegen.

PL
W przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Em caso de irritação ou erupção cutânea: consulte um médico.

RO
În caz de iritare a pielii sau de erupție cutanată: consultați medicul.

SK
Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.

SL
Če nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.

FI
Jos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.

SV
Vid hudirritation eller utslag: Sök läkarhjälp.

P335 + P334
Language


BG
Отстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.

ES
Sacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.

CS
Volné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.

DA
Børst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.

DE
Lose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.

ET
Pühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.

EL
Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.

EN
Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.

FR
Enlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.

GA
Scuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.

IT
Rimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.

LV
Noberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.

LT
Neprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.

HU
A bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.

MT
Farfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.

NL
Losse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.

PL
Nie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.

PT
Sacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.

RO
Îndepărtați particulele depuse pe piele. Introduceți în apă rece/acoperiți cu o compresă umedă.

SK
Z pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.

SL
S krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.

FI
Poista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.

SV
Borsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.

P337 + P313
Language


BG
При продължително дразнене на очите: Потърсете медицински съвет/помощ.

ES
Si persiste la irritación ocular: Consultar a un médico.

CS
Přetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.

DA
Ved vedvarende øjenirritation: Søg lægehjælp.

DE
Bei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

ET
Kui silmade ärritus ei möödu: pöörduda arsti poole.

EL
Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.

EN
If eye irritation persists: Get medical advice/attention.

FR
Si l’irritation oculaire persiste: consulter un médecin.

GA
Má mhaireann an greannú súile: Faigh comhairle/cúram liachta.

IT
Se l’irritazione degli occhi persiste, consultare un medico.

LV
Ja acu iekaisums nepāriet: lūdziet mediķu palīdzību.

LT
Jei akių dirginimas nepraeina: kreiptis į gydytoją.

HU
Ha a szemirritáció nem múlik el: orvosi ellátást kell kérni.

MT
Jekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.

NL
Bij aanhoudende oogirritatie: een arts raadplegen.

PL
W przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.

PT
Caso a irritação ocular persista: consulte um médico.

RO
Dacă iritarea ochilor persistă: consultați medicul.

SK
Ak podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.

SL
Če draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.

FI
Jos silmä-ärsytys jatkuu: Hakeudu lääkäriin.

SV
Vid bestående ögonirritation: Sök läkarhjälp.

P342 + P311
Language


BG
При симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.

ES
En caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.

CS
Při dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.

DA
Ved luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.

DE
Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.

ET
Hingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.

EL
Εάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.

EN
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.

FR
En cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.

GA
I gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.

IT
In caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.

LV
Ja rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.

LT
Jeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.

HU
Légzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.

MT
Jekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.

NL
Bij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.

PL
W przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.

PT
Em caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.

RO
În caz de simptome respiratorii: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.

SK
Pri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.

SL
Pri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.

FI
Jos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.

SV
Vid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P370 + P376
Language


BG
При пожар: Спрете теча, ако е безопасно.

ES
En caso de incendio: Detener la fuga, si no hay peligro en hacerlo.

CS
V případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.

DA
Ved brand: Stands lækagen, hvis dette er sikkert.

DE
Bei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.

ET
Tulekahju korral: leke peatada, kui seda on võimalik teha ohutult.

EL
Σε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.

EN
In case of fire: Stop leak if safe to do so.

FR
En cas d’incendie: obturer la fuite si cela peut se faire sans danger.

GA
I gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.

IT
In caso di incendio: bloccare la perdita se non c’è pericolo.

LV
Ugunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.

LT
Gaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.

HU
Tűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.

MT
F’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.

NL
In geval van brand: het lek dichten als dat veilig gedaan kan worden.

PL
W przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.

PT
Em caso de incêndio: deter a fuga se tal puder ser feito em segurança.

RO
În caz de incendiu: opriți scurgerea, dacă acest lucru se poate face în siguranță.

SK
V prípade požiaru: ak je to bezpečné, zastavte únik.

SL
Ob požaru: zaustaviti puščanje, če je varno.

FI
Tulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.

SV
Vid brand: Stoppa läckan om det kan göras på ett säkert sätt.

P370 + P378
Language


BG
При пожар: Използвайте … за гасене.

ES
En caso de incendio: Utilizar … para apagarlo.

CS
V případě požáru: K hašení použijte …

DA
Ved brand: Anvend … til brandslukning.

DE
Bei Brand: … zum Löschen verwenden.

ET
Tulekahju korral: kasutada kustutamiseks …

EL
Σε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.

EN
In case of fire: Use … for extinction.

FR
En cas d’incendie: utiliser … pour l’extinction.

GA
I gcás dóiteáin: Úsáid … le haghaidh múchta.

IT
In caso di incendio: estinguere con…

LV
Ugunsgrēka gadījumā: dzēšanai izmantojiet …

LT
Gaisro atveju: gesinimui naudoti …

HU
Tűz esetén: az oltáshoz …használandó.

MT
F’każ ta' nar: Uża’ … għat-tifi.

NL
In geval van brand: blussen met …

PL
W przypadku pożaru: Użyć … do gaszenia.

PT
Em caso de incêndio: para a extinção utilizar …

RO
În caz de incendiu: utilizați… pentru stingere.

SK
V prípade požiaru: na hasenie použite …

SL
Ob požaru: za gašenje uporabiti …

FI
Tulipalon sattuessa: Käytä palon sammuttamiseen …

SV
Vid brand: Släck branden med …

P370 + P380
Language


BG
При пожар: Евакуирайте зоната.

ES
En caso de incendio: Evacuar la zona.

CS
V případě požáru: Vykliďte prostor.

DA
Ved brand: Evakuer området.

DE
Bei Brand: Umgebung räumen.

ET
Tulekahju korral: ala evakueerida.

EL
Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.

EN
In case of fire: Evacuate area.

FR
En cas d’incendie: évacuer la zone.

GA
I gcás dóiteáin: Aslonnaigh gach duine as an limistéar.

IT
Evacuare la zona in caso di incendio.

LV
Ugunsgrēka gadījumā: evakuēt zonu.

LT
Gaisro atveju: evakuoti zoną.

HU
Tűz esetén: Ki kell üríteni a területet.

MT
F’każ ta' nar: Evakwa ż-żona.

NL
In geval van brand: evacueren.

PL
W przypadku pożaru: Ewakuować teren.

PT
Em caso de incêndio: evacuar a zona.

RO
În caz de incendiu: evacuați zona.

SK
V prípade požiaru: priestory evakuujte.

SL
Ob požaru: izprazniti območje.

FI
Tulipalon sattuessa: Evakuoi alue.

SV
Vid brand: Utrym området.


P370 + P380 + P375
Language


BG
При пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.

ES
En caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.

CS
V případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.

DA
Ved brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.

DE
Bei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.

ET
Tulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.

EL
Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.

EN
In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.

FR
En cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.

GA
I gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.

IT
In caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.

LV
Ugunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.

LT
Gaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.

HU
Tűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.

MT
F’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.

NL
In geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.

PL
W przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.

PT
Em caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.

RO
În caz de incendiu: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.

SK
V prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.

SL
Ob požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.

FI
Tulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.

SV
Vid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.

P371 + P380 + P375
Language


BG
При голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.

ES
En caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.

CS
V případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.

DA
Ved større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.

DE
Bei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.

ET
Suure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.

EL
Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.

EN
In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.

FR
En cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.

GA
I gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.

IT
In caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.

LV
Ugunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.

LT
Didelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.

HU
Nagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.

MT
F’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.

NL
In geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.

PL
W przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.

PT
Em caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.

RO
În caz de incendiu de proporții și de cantități mari de produs: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.

SK
V prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.

SL
Ob velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.

FI
Jos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.

SV
Vid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.

Table 1.4
Precautionary statements — Storage

P401
Language


BG
Да се съхранява…

ES
Almacenar …

CS
Skladujte …

DA
Opbevares …

DE
… aufbewahren.

ET
Hoida …

EL
Αποθηκεύεται …

EN
Store …

FR
Stocker …

GA
Stóráil …

IT
Conservare…

LV
Glabāt…

LT
Laikyti…

HU
Tárolás: … .

MT
Aħżen …

NL
… bewaren.

PL
Przechowywać …

PT
Armazenar …

RO
A se depozita…

SK
Uchovávajte …

SL
Hraniti …

FI
Varastoi …

SV
Förvaras …

P402
Language


BG
Да се съхранява на сухо място.

ES
Almacenar en un lugar seco.

CS
Skladujte na suchém místě.

DA
Opbevares et tørt sted.

DE
An einem trockenen Ort aufbewahren.

ET
Hoida kuivas.

EL
Αποθηκεύεται σε στεγνό μέρος.

EN
Store in a dry place.

FR
Stocker dans un endroit sec.

GA
Stóráil in áit thirim.

IT
Conservare in luogo asciutto.

LV
Glabāt sausā vietā.

LT
Laikyti sausoje vietoje.

HU
Száraz helyen tárolandó.

MT
Aħżen f’post niexef.

NL
Op een droge plaats bewaren.

PL
Przechowywać w suchym miejscu.

PT
Armazenar em local seco.

RO
A se depozita într-un loc uscat.

SK
Uchovávajte na suchom mieste.

SL
Hraniti na suhem.

FI
Varastoi kuivassa paikassa.

SV
Förvaras torrt.

P403
Language


BG
Да се съхранява на добре проветриво място.

ES
Almacenar en un lugar bien ventilado.

CS
Skladujte na dobře větraném místě.

DA
Opbevares på et godt ventileret sted.

DE
An einem gut belüfteten Ort aufbewahren.

ET
Hoida hästi ventileeritavas kohas.

EL
Αποθηκεύεται σε καλά αεριζόμενο χώρο.

EN
Store in a well-ventilated place.

FR
Stocker dans un endroit bien ventilé.

GA
Stóráil in áit dhea-aeráilte.

IT
Conservare in luogo ben ventilato.

LV
Glabāt labi vēdināmā vietā.

LT
Laikyti gerai vėdinamoje vietoje.

HU
Jól szellőző helyen tárolandó.

MT
Aħżen f’post b'ventilazzjoni tajba.

NL
Op een goed geventileerde plaats bewaren.

PL
Przechowywać w dobrze wentylowanym miejscu.

PT
Armazenar em local bem ventilado.

RO
A se depozita într-un spațiu bine ventilat.

SK
Uchovávajte na dobre vetranom mieste.

SL
Hraniti na dobro prezračevanem mestu.

FI
Varastoi paikassa, jossa on hyvä ilmanvaihto.

SV
Förvaras på väl ventilerad plats.

P404
Language


BG
Да се съхранява в затворен съд.

ES
Almacenar en un recipiente cerrado.

CS
Skladujte v uzavřeném obalu.

DA
Opbevares i en lukket beholder.

DE
In einem geschlossenen Behälter aufbewahren.

ET
Hoida suletud mahutis.

EL
Φυλάσσεται σε κλειστό περιέκτη.

EN
Store in a closed container.

FR
Stocker dans un récipient fermé.

GA
Stóráil i gcoimeádán iata.

IT
Conservare in un recipiente chiuso.

LV
Glabāt slēgtā tvertnē.

LT
Laikyti uždaroje talpykloje.

HU
Zárt edényben tárolandó.

MT
Aħżen f’kontenitur magħluq.

NL
In gesloten verpakking bewaren.

PL
Przechowywać w zamkniętym pojemniku.

PT
Armazenar em recipiente fechado.

RO
A se depozita într-un recipient închis.

SK
Uchovávajte v uzavretej nádobe.

SL
Hraniti v zaprti posodi.

FI
Varastoi suljettuna.

SV
Förvaras i sluten behållare.


P405
Language


BG
Да се съхранява под ключ.

ES
Guardar bajo llave.

CS
Skladujte uzamčené.

DA
Opbevares under lås.

DE
Unter Verschluss aufbewahren.

ET
Hoida lukustatult.

EL
Φυλάσσεται κλειδωμένο.

EN
Store locked up.

FR
Garder sous clef.

GA
Stóráil faoi ghlas.

IT
Conservare sotto chiave.

LV
Glabāt slēgtā veidā.

LT
Laikyti užrakintą.

HU
Elzárva tárolandó.

MT
Aħżen f'post imsakkar.

NL
Achter slot bewaren.

PL
Przechowywać pod zamknięciem.

PT
Armazenar em local fechado à chave.

RO
A se depozita sub cheie.

SK
Uchovávajte uzamknuté.

SL
Hraniti zaklenjeno.

FI
Varastoi lukitussa tilassa.

SV
Förvaras inlåst.

P406
Language


BG
Да се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.

ES
Almacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.

CS
Skladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.

DA
Opbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.

DE
In korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.

ET
Hoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.

EL
Αποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.

EN
Store in corrosive resistant/… container with a resistant inner liner.

FR
Stocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.

GA
Stóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.

IT
Conservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.

LV
Glabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.

LT
Laikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.

HU
Saválló/saválló bélésű … edényben tárolandó.

MT
Aħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.

NL
In corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.

PL
Przechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.

PT
Armazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.

RO
Depozitați într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.

SK
Uchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.

SL
Hraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.

FI
Varastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.

SV
Förvaras i korrosionsbeständig/… behållare med beständigt innerhölje.

P407
Language


BG
Да се остави въздушно пространство между купчините/палетите.

ES
Dejar una separación entre los bloques/los palés de carga.

CS
Mezi stohy/paletami ponechte vzduchovou mezeru.

DA
Obevares med luftmellemrum mellem stakkene/pallerne.

DE
Luftspalt zwischen Stapeln/Paletten lassen.

ET
Jätta virnade/kaubaaluste vahele õhuvahe.

EL
Να υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.

EN
Maintain air gap between stacks/pallets.

FR
Maintenir un intervalle d’air entre les piles/palettes.

GA
Coimeád bearna aeir idir chruacha/phailléid.

IT
Mantenere uno spazio libero tra gli scaffali/i pallet.

LV
Saglabāt gaisa spraugu starp krāvumiem/paletēm.

LT
Palikti oro tarpą tarp eilių/palečių.

HU
A rakatok/raklapok között térközt kell hagyni.

MT
Ħalli l-arja tgħaddi bejn l-imniezel/il-palits.

NL
Ruimte laten tussen stapels/pallets.

PL
Zachować szczelinę powietrzną pomiędzy stosami/paletami.

PT
Respeitar as distâncias mínimas entre pilhas/paletes.

RO
Păstrați un spațiu gol între stive/paleți.

SK
Medzi regálmi/paletami ponechajte vzduchovú medzeru.

SL
Ohraniti zračno režo med skladi/paletami.

FI
Jätä pinojen/kuormalavojen väliin ilmarako.

SV
Se till att det finns luft mellan staplar/pallar.

P410
Language


BG
Да се пази от пряка слънчева светлина.

ES
Proteger de la luz del sol.

CS
Chraňte před slunečním zářením.

DA
Beskyttes mod sollys.

DE
Vor Sonnenbestrahlung schützen.

ET
Hoida päikesevalguse eest.

EL
Να προστατεύεται από τις ηλιακές ακτίνες.

EN
Protect from sunlight.

FR
Protéger du rayonnement solaire.

GA
Cosain ó sholas na gréine.

IT
Proteggere dai raggi solari.

LV
Aizsargāt no saules gaismas.

LT
Saugoti nuo saulės šviesos.

HU
Napfénytől védendő.

MT
Ipproteġi mid-dawl tax-xemx.

NL
Tegen zonlicht beschermen.

PL
Chronić przed światłem słonecznym.

PT
Manter ao abrigo da luz solar.

RO
A se proteja de lumina solară.

SK
Chráňte pred slnečným žiarením.

SL
Zaščititi pred sončno svetlobo.

FI
Suojaa auringonvalolta.

SV
Skyddas från solljus.


P411
Language


BG
Да се съхранява при температури, не по-високи от … oC/…oF.

ES
Almacenar a temperaturas no superiores a … oC/…oF.

CS
Skladujte při teplotě nepřesahující … oC/…oF.

DA
Opbevares ved en temperatur, som ikke overstiger … oC/…oF.

DE
Bei Temperaturen von nicht mehr als … oC/…aufbewahren.

ET
Hoida temperatuuril mitte üle … oC/… oF.

EL
Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.

EN
Store at temperatures not exceeding … oC/…oF.

FR
Stocker à une température ne dépassant pas … oC/… oF.

GA
Stóráil ag teocht nach airde ná … oC/…oF.

IT
Conservare a temperature non superiori a … oC/…oF.

LV
Uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.

LT
Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.

HU
A tárolási hőmérséklet legfeljebb … oC/…oF lehet.

MT
Aħżen f’temperaturi li ma jeċċedux … oC/…oF.

NL
Bij maximaal … oC/…oF bewaren.

PL
Przechowywać w temperaturze nieprzekraczającej … oC/…oF.

PT
Armazenar a uma temperatura não superior a … oC/…oF.

RO
A se depozita la temperaturi care să nu depășească … oC/…oF.

SK
Uchovávajte pri teplotách do … oC/…oF

SL
Hraniti pri temperaturi do … oC/… oF.

FI
Varastoi alle … oC/…oF lämpötilassa.

SV
Förvaras vid högst … oC/…oF.

P412
Language


BG
Да не се излага на температури, по-високи от 50 oC/122oF.

ES
No exponer a temperaturas superiores a 50 oC/122oF.

CS
Nevystavujte teplotě přesahující 50 oC/122 oF.

DA
Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.

DE
Nicht Temperaturen von mehr als 50 oC aussetzen.

ET
Mitte hoida temperatuuril üle 50 oC/122 oF.

EL
Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.

EN
Do not expose to temperatures exceeding 50 oC/122oF.

FR
Ne pas exposer à une température supérieure à 50 oC/122 oF.

GA
Ná nocht do theocht níos airde ná 50 oC/122oF.

IT
Non esporre a temperature superiori a 50 oC/122oF.

LV
Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.

LT
Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.

HU
Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.

MT
Tesponix għal temperaturi li jeċċedu l-50 oC/122oF.

NL
Niet blootstellen aan temperaturen boven 50 oC/122oF.

PL
Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.

PT
Não expor a temperaturas superiores a 50 oC/122oF.

RO
Nu expuneți la temperaturi care depășesc 50 oC/122 oF.

SK
Nevystavujte teplotám nad 50 oC/122 oF.

SL
Ne izpostavljati temperaturam nad 50 oC/122 oF.

FI
Ei saa altistaa yli 50 oC/122 oF lämpötiloille.

SV
Får inte utsättas för temperaturer över 50 oC/122 oF.

P413
Language


BG
При насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.

ES
Almacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.

CS
Množství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.

DA
Bulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.

DE
Schüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren

ET
Kogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.

EL
Οι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.

EN
Store bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.

FR
Stocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.

GA
Stóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.

IT
Conservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.

LV
Lielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.

LT
Didesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.

HU
A … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.

MT
Aħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.

NL
Bulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.

PL
Przechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.

PT
Armazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.

RO
Depozitați cantitățile în vrac mai mari de … kg/… lbs la temperaturi care să nu depășească … oC/…oF.

SK
Veľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.

SL
Razsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.

FI
Säilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.

SV
Bulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.

P420
Language


BG
Да се съхранява на разстояние от други материали.

ES
Almacenar alejado de otros materiales.

CS
Skladujte odděleně od ostatních materiálů.

DA
Må ikke opbevares i nærheden af andre materialer.

DE
Von anderen Materialien entfernt aufbewahren.

ET
Hoida eemal teistest materjalidest.

EL
Αποθηκεύεται μακριά από άλλα υλικά.

EN
Store away from other materials.

FR
Stocker à l’écart des autres matières.

GA
Stóráil glan ar ábhair eile.

IT
Conservare lontano da altri materiali.

LV
Glabāt atsevišķi no citiem materiāliem.

LT
Laikyti atokiau nuo kitų medžiagų.

HU
Más anyagoktól távol tárolandó.

MT
Aħżen ‘l bogħod minn materjal ieħor.

NL
Gescheiden van ander materiaal bewaren.

PL
Przechowywać z dala od innych materiałów.

PT
Armazenar afastado de outros materiais.

RO
Depozitați departe de alte materiale.

SK
Uchovávajte oddelene od iných materiálov.

SL
Hraniti ločeno od drugih materialov.

FI
Varastoi erillään muista materiaaleista.

SV
Förvaras åtskilt från andra material.

P422
Language


BG
Съдържанието да се съхранява при…

ES
Almacenar el contenido en …

CS
Skladujte pod …

DA
Indholdet skal opbevares under …

DE
Inhalt in/unter … aufbewahren

ET
Hoida sisu …

EL
Το περιεχόμενο αποθηκεύεται σε …

EN
Store contents under …

FR
Stocker le contenu sous …

GA
Stóráil an t-ábhar faoi …

IT
Conservare sotto…

LV
Saturu uzglabāt zem…

LT
Turinį laikyti …

HU
Tartalma … -ban/-ben tárolandó.

MT
Aħżen il-kontenut taħt …

NL
Onder … bewaren.

PL
Zawartość przechowywać w …

PT
Armazenar o conteúdo em …

RO
Depozitați conținutul sub …

SK
Obsah uchovávajte v …

SL
Vsebino hraniti v …

FI
Varastoi sisältö …

SV
Förvara innehållet i…


P402 + P404
Language


BG
Да се съхранява на сухо място. Да се съхранява в затворен съд.

ES
Almacenar en un lugar seco. Almacenar en un recipiente cerrado.

CS
Skladujte na suchém místě. Skladujte v uzavřeném obalu.

DA
Opbevares et tørt sted. Opbevares i en lukket beholder.

DE
In einem geschlossenen Behälter an einem trockenen Ort aufbewahren.

ET
Hoida kuivas. Hoida suletud mahutis.

EL
Αποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.

EN
Store in a dry place. Store in a closed container.

FR
Stocker dans un endroit sec. Stocker dans un récipient fermé.

GA
Stóráil in áit thirim. Stóráil i gcoimeádán iata.

IT
Conservare in luogo asciutto e in recipiente chiuso.

LV
Glabāt sausā vietā. Glabāt aizvērtā tvertnē.

LT
Laikyti sausoje vietoje. Laikyti uždaroje talpykloje.

HU
Száraz helyen tárolandó. Zárt edényben tárolandó.

MT
Aħżen f’post niexef. Aħżen f’kontenitur magħluq.

NL
Op een droge plaats bewaren. In gesloten verpakking bewaren.

PL
Przechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.

PT
Armazenar em local seco. Armazenar em recipiente fechado.

RO
A se depozita într-un loc uscat, într-un recipient închis.

SK
Uchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.

SL
Hraniti na suhem. Hraniti v zaprti posodi.

FI
Varastoi kuivassa paikassa. Varastoi suljettuna.

SV
Förvaras torrt. Förvaras i sluten behållare.

P403 + P233
Language


BG
Да се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.

ES
Almacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.

CS
Skladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.

DA
Opbevares på et godt ventileret sted. Hold beholderen tæt lukket.

DE
Behälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.

ET
Hoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.

EL
Αποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.

EN
Store in a well-ventilated place. Keep container tightly closed.

FR
Stocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.

GA
Stóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.

IT
Tenere il recipiente ben chiuso e in luogo ben ventilato.

LV
Glabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.

LT
Laikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.

HU
Jól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.

MT
Aħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.

NL
Op een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.

PL
Przechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.

PT
Armazenar em local bem ventilado. Manter o recipiente bem fechado.

RO
A se depozita într-un spațiu bine ventilat. Păstrați recipientul închis etanș.

SK
Uchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.

SL
Hraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.

FI
Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.

SV
Förvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.

P403 + P235
Language


BG
Да се съхранява на добре проветриво място. Да се съхранява на хладно.

ES
Almacenar en un lugar bien ventilado. Mantener en lugar fresco.

CS
Skladujte na dobře větraném místě. Uchovávejte v chladu.

DA
Opbevares på et godt ventileret sted. Opbevares køligt.

DE
Kühl an einem gut belüfteten Ort aufgewahren.

ET
Hoida hästi ventileeritavas kohas. Hoida jahedas.

EL
Αποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.

EN
Store in a well-ventilated place. Keep cool.

FR
Stocker dans un endroit bien ventilé. Tenir au frais.

GA
Stóráil in áit dhea-aeráilte. Coimeád fionnuar.

IT
Conservare in luogo fresco e ben ventilato.

LV
Glabāt labi vēdināmās telpās. Turēt vēsumā.

LT
Laikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.

HU
Jól szellőző helyen tárolandó. Hűvös helyen tartandó.

MT
Aħżen f'post b'ventilazzjoni tajba. Żomm frisk.

NL
Op een goed geventileerde plaats bewaren. Koel bewaren.

PL
Przechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.

PT
Armazenar em local bem ventilado. Conservar em ambiente fresco.

RO
A se depozita într-un spațiu bine ventilat. A se păstra la rece.

SK
Uchovávajte na dobre vetranom mieste. Uchovávajte v chlade.

SL
Hraniti na dobro prezračevanem mestu. Hraniti na hladnem.

FI
Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.

SV
Förvaras på väl ventilerad plats. Förvaras svalt.

P410 + P403
Language


BG
Да се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.

ES
Proteger de la luz del sol. Almacenar en un lugar bien ventilado.

CS
Chraňte před slunečním zářením. Skladujte na dobře větraném místě.

DA
Beskyttes mod sollys. Opbevares på et godt ventileret sted.

DE
Vor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.

ET
Hoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.

EL
Να προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.

EN
Protect from sunlight. Store in a well-ventilated place.

FR
Protéger du rayonnement solaire. Stocker dans un endroit bien ventilé.

GA
Cosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.

IT
Proteggere dai raggi solari. Conservare in luogo ben ventilato.

LV
Aizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.

LT
Saugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.

HU
Napfénytől védendő. Jól szellőző helyen tárolandó.

MT
Ipproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.

NL
Tegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.

PL
Chronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.

PT
Manter ao abrigo da luz solar. Armazenar em local bem ventilado.

RO
A se proteja de lumina solară. A se depozita într-un spațiu bine ventilat.

SK
Chráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.

SL
Zaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.

FI
Suojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.

SV
Skyddas från solljus. Förvaras på väl ventilerad plats.

P410 + P412
Language


BG
Да се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.

ES
Proteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.

CS
Chraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.

DA
Beskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.

DE
Vor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.

ET
Hoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.

EL
Να προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.

EN
Protect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.

FR
Protéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.

GA
Cosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.

IT
Proteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.

LV
Aizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.

LT
Saugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.

HU
Napfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.

MT
Ipproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.

NL
Tegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.

PL
Chronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.

PT
Manter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.

RO
A se proteja de lumina solară. Nu expuneți la temperaturi care depășesc 50 oC/122 oF.

SK
Chráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.

SL
Zaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.

FI
Suojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.

SV
Skyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.

P411 + P235
Language


BG
Да се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.

ES
Almacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.

CS
Skladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.

DA
Opbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.

DE
Kühl und bei Temperaturen von nicht mehr als … oC aufbewahren.

ET
Hoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.

EL
Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.

EN
Store at temperatures not exceeding … oC/…oF. Keep cool.

FR
Stocker à une température ne dépassant pas … oC/… oF. Tenir au frais.

GA
Stóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.

IT
Conservare in luogo fresco a temperature non superiori a … oC/…oF.

LV
Glabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.

LT
Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.

HU
A tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.

MT
Aħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.

NL
Bij maximaal … oC/…oF bewaren. Koel bewaren.

PL
Przechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.

PT
Armazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.

RO
A se depozita la temperaturi care să nu depășească … oC/…oF. A se păstra la rece.

SK
Uchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.

SL
Hraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.

FI
Varastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.

SV
Förvaras vid högst … oC/…oF. Förvaras svalt.

Table 1.5
Precautionary statements — Disposal

P501
Language


BG
Съдържанието/съдът да се изхвърли в …

ES
Eliminar el contenido/el recipiente en …

CS
Odstraňte obsah/obal …

DA
Indholdet/beholderen bortskaffes i …

DE
Inhalt/Behälter … zuführen.

ET
Sisu/mahuti kõrvaldada …

EL
Διάθεση του περιεχομένου/περιέκτη σε …

EN
Dispose of contents/container to …

FR
Éliminer le contenu/récipient dans …

GA
Diúscair an t-ábhar/an coimeádán i …

IT
Smaltire il prodotto/recipiente in …

LV
Atbrīvoties no satura/tvertnes…

LT
Turinį/talpyklą išpilti (išmesti) į …

HU
A tartalom/edény elhelyezése hulladékként: …

MT
Armi l-kontenut/il-kontenitur fi …

NL
Inhoud/verpakking afvoeren naar …

PL
Zawartość/pojemnik usuwać do …

PT
Eliminar o conteúdo/recipiente em …

RO
Aruncați conținutul/recipientul la …

SK
Zneškodnite obsah/nádobu …

SL
Odstraniti vsebino/posodo …

FI
Hävitä sisältö/pakkaus …

SV
Innehållet/behållaren lämnas till…

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.

texts differ too much for an inline diff; shown separately

before (32008R1272)

ANNEX VI
Harmonised classification and labelling for certain hazardous substances
Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.
Part 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.
Part 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.
1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED CLASSIFICATIONS AND LABELLING
1.1. Information listed for each entry
1.1.1. Numbering of entries and identification of a substance
1.1.1.1. Index numbers
Entries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled Index No.
1.1.1.2. EC numbers
The EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS)OJ C 146A, 15.6.1990.. The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of No-longer-polymers (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled EC No.
1.1.1.3. CAS number
The Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled CAS No.
1.1.1.4. International Chemical Identification
Wherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of No-longer-polymers are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.
Impurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.
Some substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.
Where specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.
Without prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.
Certain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: (containing ≥ xx % impurity). The reference in brackets is then to be considered as a part of the name, and must be included on the label.
1.1.1.5. Entries for groups of substances
A number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.
In some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase except those specified elsewhere in this Annex.
In some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.
Entries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.
EC or CAS numbers are not usually included for entries which comprise more than four individual substances.
1.1.2. Information related to the classification and labelling of each entry in Table 3.1
1.1.2.1. Classification codes
1.1.2.1.1. Hazard class and category codes
The classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.
The Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.
Table 1.1
see Note U in 1.1.3.
Hazard Class Hazard Class and Category Code
Explosive Unst. Expl.
Expl. 1.1
Expl. 1.2
Expl. 1.3
Expl. 1.4
Expl. 1.5
Expl. 1.6
Flammable gas Flam. Gas 1
Flam. Gas 2
Flammable aerosol Flam. Aerosol 1
Flam. Aerosol 2
Oxidising gas Ox. Gas 1
Gases under pressure Press. Gas
Flammable liquid Flam. Liq. 1
Flam. Liq. 2
Flam. Liq. 3
Flammable solid Flam. Sol. 1
Flam. Sol. 2
Self-reactive substance or mixture Self-react. A
Self-react. B
Self-react. CD
Self-react. EF
Self-react. G
Pyrophoric liquid Pyr. Liq. 1
Pyrophoric solid Pyr. Sol. 1
Self-heating substance or mixture Self-heat. 1
Self-heat. 2
Substance or mixture which in contact with water emits flammable gas Water-react. 1
Water-react. 2
Water-react. 3
Oxidising liquid Ox. Liq. 1
Ox. Liq. 2
Ox. Liq. 3
Oxidising solid Ox. Sol. 1
Ox. Sol. 2
Ox. Sol. 3
Organic peroxide Org. Perox. A
Org. Perox. B
Org. Perox. CD
Org. Perox. EF
Org. Perox. G
Substance or mixture corrosive to metals Met. Corr. 1
Acute toxicity Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 4
Skin corrosion/irritation Skin Corr. 1A
Skin Corr. 1B
Skin Corr. 1C
Skin Irrit. 2
Serious eye damage/eye irritation Eye Dam. 1
Eye Irrit. 2
Respiratory/skin sensitization Resp. Sens. 1
Skin Sens. 1
Germ cell mutagenicity Muta. 1A
Muta. 1B
Muta. 2
Carcinogenicity Carc. 1A
Carc. 1B
Carc. 2
Reproductive toxicity Repr. 1A
Repr. 1B
Repr. 2
Lact.
Specific target organ toxicity — single exposure STOT SE 1
STOT SE 2
STOT SE 3
Specific target organ toxicity — repeated exposure STOT RE 1
STOT RE 2
Aspiration hazard Asp. Tox. 1
Hazardous to the aquatic environment Aquatic Acute 1
Aquatic Chronic 1
Aquatic Chronic 2
Aquatic Chronic 3
Aquatic Chronic 4
Hazardous for the ozone layer Ozone
1.1.2.1.2. Hazard statement codes
The hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:
H350i May cause cancer by inhalation.
H360F May damage fertility.
H360D May damage the unborn child.
H361f Suspected of damaging fertility.
H361d Suspected of damaging the unborn child.
H360FD May damage fertility. May damage the unborn child.
H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
H360Fd May damage fertility. Suspected of damaging the unborn child.
H360Df May damage the unborn child. Suspected of damaging fertility.
1.1.2.2. Labelling codes
In the labelling column, the following elements are listed:
(i) the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;
(ii) the signal word code Dgr for Dangeror Wng for Warning, in accordance with the precedence rule in Article 20(3);
(iii) the hazard statement codes as specified in Annex III, in accordance with the classification;
(iv) the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.
1.1.2.3. Specific concentration limits and M-factors
Specific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.
Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.
In case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in the same column as the specific concentration limits. Where an M-factor is not given in Table 3.1, an M-factor based on available data for the substance shall be set by the manufacturer, importer or downstream user. When a mixture including the substance is classified by the manufacturer, importer or downstream user using the summation method, this M-factor shall be used. For the setting of M-factors, see paragraph 4.1.3.5.5.5 of Annex I.
1.1.3. Notes assigned to an entry
The note(s) assigned to an entry are listed in the column entitled Notes. The meaning of the notes is as follows:
1.1.3.1. Notes relating to the identification, classification and labelling of substances
Note A:
Without prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.
In Part 3, use is sometimes made of a general description such as ... compounds or ... salts. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.
Note B:
Some substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.
In Part 3 entries with Note B have a general designation of the following type: nitric acid … %.
In this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.
Note C:
Some organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.
In this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.
Note D:
Certain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.
However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words non-stabilised.
Note E (Table 3.2):
Substances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word Also.
Note F:
This substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.
Note G:
This substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.
Note H (Table 3.1):
The classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.
The final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.
Note H (Table 3.2):
The classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.
Note J:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.
Note K:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.
Note L:
The classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.
Note M:
The classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.
Note N:
The classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.
Note P:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).
When the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.
This note applies only to certain complex oil-derived substances in Part 3.
Note Q:
The classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:
a short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or
a short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or
an appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or
absence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.
Note R:
The classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.
Note S:
This substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).
This substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).
Note T:
This substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.
Note U (Table 3.1):
When put on the market gases have to be classified as Gases under pressure, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.
1.1.3.2. Notes relating to the classification and labelling of mixtures
Note 1:
The concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.
Note 2:
The concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.
Note 3:
The concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.
Note 5:
The concentration limits for gaseous mixtures are expressed as volume per volume percentage.
Note 7:
Alloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.
1.1.4. Information related to the classification and labelling of each entry in Table 3.2
1.1.4.1. Classification codes
The classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;
The abbreviation for each of the categories of danger is shown below:
explosive: E
oxidising: O
extremely flammable: F+
highly flammable: F
flammable: R10
very toxic: T+
Toxic: T
harmful: Xn
corrosive: C
irritant: Xi
sensitising: R42 and/or R43
carcinogenic: Carc. Cat. (1, 2 or 3)
mutagenic: Muta. Cat. (1, 2 or 3)
toxic for reproduction: Repr. Cat. (1, 2 or 3)
dangerous for the environment: N or R52 and/or R53;
1.1.4.2. Labelling codes
(i) the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);
(ii) the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;
(iii) the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.
Note that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.
S1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.
S2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.
Safety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.
1.1.4.3. Specific Concentration Limits
The concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.
Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.
Where no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.
1.1.4.4. Non-conformity with Table 3.1 for physical hazards
It is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.
Until these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference ⊗ in Table 3.2.
1.2. Classifications and hazard statements in table 3.1 arising from translation of classifications listed in Annex i to directive 67/548/EEC
1.2.1. Minimum classification
For certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:
the manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;
the minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.
Minimum classification for a category is indicated by the reference * in the column Classification in Table 3.1.
The reference * can also be found in the column Specific concentration Limits and M-factors where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be translated into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.
1.2.2. Route of exposure cannot be excluded
For certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.
These hazard statements are indicated by the reference ** in Table 3.1.
1.2.3. Hazard statements for reproductive toxicity
Hazard statements H360 and H361 indicate a general concern for effects on both fertility and development: May damage/Suspected of damaging fertility or the unborn child. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.
In order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.
These hazard statements are indicated by the reference *** in Table 3.1.
1.2.4. Correct classification for physical hazards could not be established
For some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.
The entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.
2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION AND LABELLING
This Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.
The relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.
For all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.
A dossier for harmonised classification and labelling shall contain the following:
Proposal
The proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.
Justification for the proposed harmonised classification and labelling
A comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.
Justification for other effects at Community level
For other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.
3. PART 3: HARMONISED CLASSIFICATION AND LABELLING TABLES
Table 3.1: List of harmonised classification and labelling of hazardous substances is listed in the separate Volume IIIa.
Table 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC is listed in the separate Volume IIIb.
Table 3.1
List of harmonised classification and labelling of hazardous substances
Index No International Chemical Identification EC No CAS No Classification Labelling Specific Conc. Limits, M-factors Notes
Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s) 001-001-00-9 hydrogen 215-605-7 1333-74-0 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 Water-react. 1 H260 GHS02
Dgr H260 001-003-00-X sodium hydride 231-587-3 7646-69-7 Water-react. 1 H260 GHS02
Dgr H260 001-004-00-5 calcium hydride 232-189-2 7789-78-8 Water-react. 1 H260 GHS02
Dgr H260 003-001-00-4 lithium 231-102-5 7439-93-2 Water-react. 1
Skin Corr. 1B H260
H314 GHS02
GHS05
Dgr H260
H314 EUH014 003-002-00-X n-hexyllithium 404-950-0 21369-64-2 Water-react. 1
Pyr. Sol. 1
Skin Corr. 1A H260
H250
H314 GHS02
GHS05
Dgr H260
H250
H314 EUH014 004-001-00-7 beryllium 231-150-7 7440-41-7 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H350i
H330
H301
H372 **
H319
H335
H315
H317 GHS06
GHS08
Dgr H350i
H330
H301
H372 **
H319
H335
H315
H317 004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex — — Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H350i
H330
H301
H372 **
H319
H335
H315
H317
H411 GHS06
GHS08
GHS09
Dgr H350i
H330
H301
H372 **
H319
H335
H315
H317
H411 A
004-003-00-8 beryllium oxide 215-133-1 1304-56-9 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H350i
H330
H301
H372 **
H319
H335
H315
H317 GHS06
GHS08
Dgr H350i
H330
H301
H372 **
H319
H335
H315
H317 005-001-00-X boron trifluoride 231-569-5 7637-07-2 Press. Gas
Acute Tox. 2 *
Skin Corr. 1A H330
H314 GHS04
GHS06
GHS05
Dgr H330
H314 EUH014 U
005-002-00-5 boron trichloride 233-658-4 10294-34-5 Press. Gas
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1B H330
H300
H314 GHS04
GHS06
GHS05
Dgr H330
H300
H314 EUH014 U
005-003-00-0 boron tribromide 233-657-9 10294-33-4 Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A H330
H300
H314 GHS06
GHS05
Dgr H330
H300
H314 EUH014 005-004-00-6 trialkylboranes, solid — — Pyr. Sol. 1
Skin Corr. 1B H250
H314 GHS02
GHS05
Dgr H250
H314 A
005-004-01-3 trialkylboranes, liquid — — Pyr. Liq. 1
Skin Corr. 1B H250
H314 GHS02
GHS05
Dgr H250
H314 A
005-005-00-1 trimethyl borate 204-468-9 121-43-7 Flam. Liq. 3
Acute Tox. 4 * H226
H312 GHS02
GHS07
Wng H226
H312 005-006-00-7 dibutyltin hydrogen borate 401-040-5 75113-37-0 STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H372 **
H312
H302
H318
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H372 **
H312
H302
H318
H317
H410 005-009-00-3 tetrabutylammonium butyltriphenylborate 418-080-4 120307-06-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 422-050-6 118612-00-3 Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1 H351
H302
H315
H318 GHS08
GHS05
GHS07
Dgr H351
H302
H315
H318 005-012-00-X diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate 418-070-1 141714-54-7 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 006-001-00-2 carbon monoxide 211-128-3 630-08-0 Flam. Gas 1
Press. Gas
Repr. 1A
Acute Tox. 3 *
STOT RE 1 H220
H360D ***
H331
H372 ** GHS02
GHS04
GHS06
GHS08
Dgr H220
H360D ***
H331
H372 ** U
006-002-00-8 phosgene;
carbonyl chloride 200-870-3 75-44-5 Press. Gas
Acute Tox. 2 *
Skin Corr. 1B H330
H314 GHS04
GHS06
GHS05
Dgr H330
H314 U
006-003-00-3 carbon disulphide 200-843-6 75-15-0 Flam. Liq. 2
Repr. 2
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2 H225
H361fd
H372 **
H319
H315 GHS02
GHS08
GHS07
Dgr H225
H361fd
H372 **
H319
H315 Repr. 2; H361fd: C ≥ 1 %
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤C < 1 % 006-004-00-9 calcium carbide 200-848-3 75-20-7 Water-react. 1 H260 GHS02
Dgr H260 T
006-005-00-4 thiram (ISO);
tetramethylthiuram disulphide 205-286-2 137-26-8 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H373 **
H319
H315
H317
H400
H410 GHS08
GHS07
GHS09
Wng H332
H302
H373 **
H319
H315
H317
H410 M = 10 006-006-00-X hydrogen cyanide;
hydrocyanic acid 200-821-6 74-90-8 Flam. Liq. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H224
H330
H400
H410 GHS02
GHS06
GHS09
Dgr H224
H330
H410 006-006-01-7 hydrogen cyanide … %;
hydrocyanic acid … % 200-821-6 74-90-8 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 B
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 EUH032 A
006-008-00-0 antu (ISO);
1-(1-naphthyl)-2-thiourea 201-706-3 86-88-4 Acute Tox. 2 *
Carc. 2 H300
H351 GHS06
GHS08
Dgr H300
H351 006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan 204-318-2 119-38-0 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan 204-525-8 122-15-6 Acute Tox. 3 * H301 GHS06
Dgr H301 006-011-00-7 carbaryl (ISO);
1-naphthyl methylcarbamate 200-555-0 63-25-2 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1 H351
H302
H400 GHS08
GHS07
GHS09
Wng H351
H302
H400 006-012-00-2 ziram (ISO);
zinc bis dimethyldithiocarbamate 205-288-3 137-30-4 Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H302
H373 **
H335
H318
H317
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H330
H302
H373 **
H335
H318
H317
H410 M = 100 006-013-00-8 metam-sodium (ISO);
sodium methyldithiocarbamate 205-293-0 137-42-8 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H317
H410 EUH031 006-014-00-3 nabam (ISO);
disodium ethylenebis(N,N'-dithiocarbamate) 205-547-0 142-59-6 Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H335
H317
H410 GHS07
GHS09
Wng H302
H335
H317
H410 006-015-00-9 diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4 330-54-1 Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H373 **
H410 006-016-00-4 propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate 204-043-8 114-26-1 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 006-017-00-X aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 204-123-2 116-06-3 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H311
H400
H410 GHS06
GHS09
Dgr H330
H300
H311
H410 006-018-00-5 aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate 217-990-7 2032-59-9 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 006-019-00-0 di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 218-961-1 2303-16-4 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H410 006-020-00-6 barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 202-930-4 101-27-9 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 006-021-00-1 linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 206-356-5 330-55-2 Repr. 1B
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H351
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Dgr H360Df
H351
H302
H373 **
H410 006-022-00-7 decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate — 1563-67-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 006-023-00-2 mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 217-991-2 2032-65-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 006-024-00-8 proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate 205-443-5 140-93-2 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2 H302
H315
H411 GHS07
GHS09
Wng H302
H315
H411 006-025-00-3 allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] 209-542-4 [1]
249-013-5 [2]-[3] 584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3] Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H400
H410 GHS07
GHS09
Wng H332
H302
H410 C
006-026-00-9 carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 216-353-0 1563-66-2 Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H400
H410 GHS06
GHS09
Dgr H330
H300
H410 006-028-00-X dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 213-546-1 973-21-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 006-029-00-5 dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 230-253-4 6988-21-2 Acute Tox. 3 *
Aquatic Chronic 2 H301
H411 GHS06
GHS09
Dgr H301
H411 006-030-00-0 EPTC (ISO);
S-ethyl dipropylthiocarbamate 212-073-8 759-94-4 Acute Tox. 4 * H302 GHS07
Wng H302 006-031-00-6 formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 244-879-0 22259-30-9 Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H317
H400
H410 GHS06
GHS09
Dgr H330
H300
H317
H410 006-032-00-1 monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea 217-129-5 1746-81-2 Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H410 006-033-00-7 metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 243-433-2 19937-59-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 006-034-00-2 pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate 214-215-4 1114-71-2 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 006-035-00-8 pirimicarb (ISO);
5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate 245-430-1 23103-98-2 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 006-036-00-3 benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea 217-685-9 1929-88-0 Acute Tox. 4 * H302 GHS07
Wng H302 006-037-00-9 promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate 220-113-0 2631-37-0 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 006-038-00-4 sulfallate (ISO);
2-chloroallyl N,N-dimethyldithiocarbamate 202-388-9 95-06-7 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 006-039-00-X tri-allate (ISO);
S-2,3,3-trichloroallyl diisopropylthiocarbamate 218-962-7 2303-17-5 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H317
H410 006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan — 2532-43-6 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 006-041-00-0 dimethylcarbamoyl chloride 201-208-6 79-44-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H350
H331
H302
H319
H335
H315 GHS06
GHS08
Dgr H350
H331
H302
H319
H335
H315 Carc. 1B; H350: C ≥ 0,001 % 006-042-00-6 monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea 205-766-1 150-68-5 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H410 006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA — 140-41-0 Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H319
H315
H400
H410 GHS08
GHS07
GHS09
Wng H351
H319
H315
H410 006-044-00-7 isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-4 34123-59-6 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 M = 10 006-045-00-2 methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate 240-815-0 16752-77-5 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H400
H410 GHS06
GHS09
Dgr H300
H410 006-046-00-8 bendiocarb (ISO);
2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate 245-216-8 22781-23-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H312
H410 GHS06
GHS09
Dgr H331
H301
H312
H410 006-047-00-3 bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate — 8065-36-9 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 006-048-00-9 ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate 249-981-9 29973-13-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 006-049-00-4 dixanthogen;
O,O-diethyl dithiobis(thioformate) 207-944-4 502-55-6 Acute Tox. 4 * H302 GHS07
Wng H302 006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA — 4482-55-7 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 006-051-00-5 ferbam (ISO);
iron tris(dimethyldithiocarbamate) 238-484-2 14484-64-1 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H410 006-052-00-0 formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 245-656-0 23422-53-9 Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H317
H400
H410 GHS06
GHS09
Dgr H330
H300
H317
H410 006-053-00-6 isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate 220-114-6 2631-40-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 006-054-00-1 mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 206-249-3 315-18-4 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H312
H400
H410 GHS06
GHS09
Dgr H300
H312
H410 006-055-00-7 xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC 219-364-9 2425-10-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 006-056-00-2 metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC 214-446-0 1129-41-5 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 006-057-00-8 nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine 217-682-2 1929-82-4 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 006-058-00-3 noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea — 2163-79-3 Acute Tox. 4 * H302 GHS07
Wng H302 006-059-00-9 oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; 245-445-3 23135-22-0 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Chronic 2 H330
H300
H312
H411 GHS06
GHS09
Dgr H330
H300
H312
H411 006-060-00-4 oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 226-066-2 5259-88-1 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride 243-193-9 19622-19-6 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 006-062-00-5 methyl 3,4-dichlorophenylcarbanilate;
SWEP. — 1918-18-9 Acute Tox. 4 * H302 GHS07
Wng H302 006-063-00-0 thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate 248-924-5 28249-77-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 006-064-00-6 thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime 254-346-4 39196-18-4 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid — 15271-41-7 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Chronic 2 H300
H311
H411 GHS06
GHS09
Dgr H300
H311
H411 006-066-00-7 vernolate (ISO);
S-propyl dipropylthiocarbamate 217-681-7 1929-77-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 006-067-00-2 XMC;
3,5-xylyl methylcarbamate — 2655-14-3 Acute Tox. 4 * H302 GHS07
Wng H302 006-068-00-8 diazomethane 206-382-7 334-88-3 Carc. 1B H350 GHS08
Dgr H350 006-069-00-3 thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 245-740-7 23564-05-8 Muta. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H332
H317
H400
H410 GHS08
GHS07
GHS09
Wng H341
H332
H317
H410 006-070-00-9 furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide 262-302-0 60568-05-0 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 401-620-8 87731-18-8 Skin Sens. 1 H317 GHS07
Wng H317 006-072-00-X prosulfocarb (ISO);
S-benzyl N,N-dipropylthiocarbamate 401-730-6 52888-80-9 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 006-073-00-5 3-(dimethylamino)propylurea 401-950-2 31506-43-1 Eye Dam. 1 H318 GHS05
Dgr H318 006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 402-440-2 2094-99-7 Acute Tox. 2 *
Skin Corr. 1B
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H314
H373 **
H334
H317
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H330
H314
H373 **
H334
H317
H410 006-076-00-1 mancozeb (ISO) — 8018-01-7 STOT SE 3
Skin Sens. 1 H335
H317 GHS07
Wng H335
H317 006-077-00-7 maneb (ISO) 235-654-8 12427-38-2 STOT SE 3
Skin Sens. 1 H335
H317 GHS07
Wng H335
H317 006-078-00-2 zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric) 235-180-1 12122-67-7 STOT SE 3
Skin Sens. 1 H335
H317 GHS07
Wng H335
H317 006-079-00-8 disulfiram;
tetraethylthiuramdisulfide 202-607-8 97-77-8 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H317
H410 006-080-00-3 tetramethylthiuram monosulphide 202-605-7 97-74-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 006-081-00-9 zinc bis(dibutyldithiocarbamate) 205-232-8 136-23-2 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H317
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H317
H410 006-082-00-4 zinc bis(diethyldithiocarbamate) 238-270-9 14324-55-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H315
H317
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H315
H317
H410 006-083-00-X butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 252-139-3 34681-10-2 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H226
H331
H311
H301
H319
H400
H410 GHS02
GHS06
GHS09
Dgr H226
H331
H311
H301
H319
H410 006-084-00-5 carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 259-565-9 55285-14-8 Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H317
H400
H410 GHS06
GHS09
Dgr H331
H301
H317
H410 006-085-00-0 fenobucarb (ISO);
2-butylphenyl methylcarbamate 223-188-8 3766-81-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 006-086-00-6 ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;
fenoxycarb 276-696-7 72490-01-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 006-087-00-1 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;
furathiocarb 265-974-3 65907-30-4 Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H301
H373 **
H319
H315
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H301
H373 **
H319
H315
H317
H410 006-088-00-7 benfuracarb;
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate — 82560-54-1 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 006-089-00-2 chlorine dioxide 233-162-8 10049-04-4 Ox. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1 H270
H330
H314
H400 GHS03
GHS04
GHS06
GHS05
GHS09
Dgr H270
H330
H314
H400 EUH006 M = 1000 U
006-089-01-X chlorine dioxide . . . % 233-162-8 10049-04-4 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H301
H314
H400 GHS06
GHS05
GHS09
Dgr H301
H314
H400 Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 10 %
STOT SE 3; H335: C ≥ 3 %
M = 10 B
006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 408-010-0 88558-41-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H332
H318
H412 GHS05
GHS07
Dgr H332
H318
H412 007-001-00-5 ammonia, anhydrous 231-635-3 7664-41-7 Flam. Gas 2
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H221
H331
H314
H400 GHS04
GHS06
GHS05
GHS09
Dgr H221
H331
H314
H400 U
007-001-01-2 ammonia ….% 215-647-6 1336-21-6 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 STOT SE 3; H335: C ≥ 5 % B
007-002-00-0 nitrogen dioxide; [1]
dinitrogen tetraoxide [2] 233-272-6 [1]
234-126-4 [2] 10102-44-0 [1]
10544-72-6 [2] Press. Gas
Acute Tox. 2 *
Skin Corr. 1B H330
H314 GHS04
GHS06
GHS05
Dgr H330
H314 * U
5
007-003-00-6 chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride 213-666-4 999-81-5 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 007-004-00-1 nitric acid … % 231-714-2 7697-37-2 Ox. Liq. 3
Skin Corr. 1A H272
H314 GHS03
GHS05
Dgr H272
H314 Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Ox. Liq. 3; H272: C ≥ 65 % B
007-006-00-2 ethyl nitrite 203-722-6 109-95-5 Flam. Gas 1
Press. Gas
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H220
H332
H312
H302 GHS02
GHS04
GHS07
Dgr H220
H332
H312
H302 U
007-007-00-8 ethyl nitrate 210-903-3 625-58-1 Unst. Expl. H200 GHS01
Dgr H200 007-008-00-3 hydrazine 206-114-9 302-01-2 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H226
H350
H331
H311
H301
H314
H317
H400
H410 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H226
H350
H331
H311
H301
H314
H317
H410 Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 3 % ≤ C < 10 % 007-009-00-9 dicyclohexylammonium nitrite 221-515-9 3129-91-7 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 * 007-010-00-4 sodium nitrite 231-555-9 7632-00-0 Ox. Sol. 3
Acute Tox. 3 *
Aquatic Acute 1 H272
H301
H400 GHS03
GHS06
GHS09
Dgr H272
H301
H400 * 007-011-00-X potassium nitrite 231-832-4 7758-09-0 Ox. Sol. 2
Acute Tox. 3 *
Aquatic Acute 1 H272
H301
H400 GHS03
GHS06
GHS09
Dgr H272
H301
H400 * 007-012-00-5 N,N-dimethylhydrazine 200-316-0 57-14-7 Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2 H225
H350
H331
H301
H314
H411 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H225
H350
H331
H301
H314
H411 007-013-00-0 1,2-dimethylhydrazine — 540-73-8 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H350
H331
H311
H301
H411 GHS06
GHS08
GHS09
Dgr H350
H331
H311
H301
H411 Carc. 1B; H350: C ≥ 0,01 % 007-014-00-6 salts of hydrazine — — Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H331
H311
H301
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H331
H311
H301
H317
H410 A
007-015-00-1 O-ethylhydroxylamine 402-030-3 624-86-2 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H225
H331
H311
H301
H372 **
H319
H317
H400 GHS02
GHS06
GHS08
GHS09
Dgr H225
H331
H311
H301
H372 **
H319
H317
H400 007-016-00-7 butyl nitrite 208-862-1 544-16-1 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 * H225
H331
H301 GHS02
GHS06
Dgr H225
H331
H301 007-017-00-2 isobutyl nitrite 208-819-7 542-56-3 Flam. Liq. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H350
H341
H332
H302 GHS02
GHS08
GHS07
Dgr H225
H350
H341
H332
H302 007-018-00-8 sec-butyl nitrite 213-104-8 924-43-6 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H302 GHS02
GHS07
Dgr H225
H332
H302 007-019-00-3 tert-butyl nitrite 208-757-0 540-80-7 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H302 GHS02
GHS07
Dgr H225
H332
H302 007-020-00-9 pentyl nitrite; [1]
amyl nitrite, mixed isomers [2] 207-332-7 [1]
203-770-8 [2] 463-04-7 [1]
110-46-3 [2] Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H302 GHS02
GHS07
Dgr H225
H332
H302 007-021-00-4 hydrazobenzene;
1,2-diphenylhydrazine 204-563-5 122-66-7 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) 405-030-1 — Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H350
H302
H314
H317
H412 GHS08
GHS05
GHS07
Dgr H350
H302
H314
H317
H412 007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate 405-510-0 — Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 007-024-00-0 2-(decylthio)ethylammonium chloride 405-640-8 36362-09-1 STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H315
H318
H400
H410 GHS08
GHS05
GHS09
Dgr H373 **
H315
H318
H410 007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 406-090-1 81880-96-8 Muta. 2
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H301
H372 **
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H301
H372 **
H317
H410 007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 413-230-5 122035-71-6 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 420-190-2 771478-66-1 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H373 **
H314
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H312
H302
H373 **
H314
H317
H410 008-001-00-8 oxygen 231-956-9 7782-44-7 Ox. Gas 1
Press. Gas H270 GHS03
GHS04
Dgr H270 U
008-003-00-9 hydrogen peroxide solution … % 231-765-0 7722-84-1 Ox. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H271
H332
H302
H314 GHS03
GHS05
GHS07
Dgr H271
H332
H302
H314 Ox. Liq. 1; H271: C ≥ 70 %****
Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****
*
Skin Corr. 1A; H314: C ≥ 70 %
Skin Corr. 1B; H314: 50 % ≤ C < 70 %
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 8 %
STOT SE 3; H335; C ≥ 35 % B
009-001-00-0 fluorine 231-954-8 7782-41-4 Ox. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1A H270
H330
H314 GHS03
GHS04
GHS06
GHS05
Dgr H270
H330
H314 U
009-002-00-6 hydrogen fluoride 231-634-8 7664-39-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A H330
H310
H300
H314 GHS06
GHS05
Dgr H330
H310
H300
H314 009-003-00-1 hydrofluoric acid … % 231-634-8 7664-39-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A H330
H310
H300
H314 GHS06
GHS05
Dgr H330
H310
H300
H314 Skin Corr. 1A; H314: C ≥ 7 %
Skin Corr. 1B; H314: 1 % ≤ C < 7 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % B
009-004-00-7 sodium fluoride 231-667-8 7681-49-4 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2 H301
H319
H315 GHS06
Dgr H301
H319
H315 EUH032 009-005-00-2 potassium fluoride 232-151-5 7789-23-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 009-006-00-8 ammonium fluoride 235-185-9 12125-01-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 009-007-00-3 sodium bifluoride;
sodium hydrogen difluoride 215-608-3 1333-83-1 Acute Tox. 3 *
Skin Corr. 1B H301
H314 GHS06
GHS05
Dgr H301
H314 *
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-008-00-9 potassium bifluoride;
potassium hydrogen difluoride 232-156-2 7789-29-9 Acute Tox. 3 *
Skin Corr. 1B H301
H314 GHS06
GHS05
Dgr H301
H314 *
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-009-00-4 ammonium bifluoride;
ammonium hydrogen difluoride 215-676-4 1341-49-7 Acute Tox. 3 *
Skin Corr. 1B H301
H314 GHS06
GHS05
Dgr H301
H314 *
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 009-010-00-X fluoroboric acid ... % 240-898-3 16872-11-0 Skin Corr. 1B H314 GHS05
Dgr H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
009-011-00-5 fluorosilicic acid ... % 241-034-8 16961-83-4 Skin Corr. 1B H314 GHS05
Dgr H314 B
009-012-00-0 alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3] 240-934-8 [1]
240-896-2 [2]
240-968-3 [3] 16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 * A
009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 * H302 GHS07
Wng H302 * A
009-014-00-1 lead hexafluorosilicate 247-278-1 25808-74-6 Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H332
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Dgr H360Df
H332
H302
H373 **
H410 1
009-015-00-7 sulphuryl difluoride 220-281-5 2699-79-8 Press. Gas
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1 H331
H373 **
H400 GHS04
GHS06
GHS08
GHS09
Dgr H331
H373 **
H400 U
009-016-00-2 trisodium hexafluoroaluminate;
cryolite 237-410-6
239-148-8 13775-53-6
15096-52-3 STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H372 **
H332
H302
H411 GHS08
GHS07
GHS09
Dgr H372 **
H332
H302
H411 C
009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 400-040-2 12091-08-6 Flam. Sol. 1
Water-react. 1
Skin Corr. 1A
Acute Tox. 4 * H228
H270
H314
H332 GHS02
GHS05
GHS07
Dgr H228
H270
H314
H332 EUH014 T
009-018-00-3 magnesium hexafluorosilicate 241-022-2 16949-65-8 Acute Tox. 3 * H301 GHS06
Dgr H301 * 011-001-00-0 sodium 231-132-9 7440-23-5 Water-react. 1
Skin Corr. 1B H260
H314 GHS02
GHS05
Dgr H260
H314 EUH014 011-002-00-6 sodium hydroxide;
caustic soda 215-185-5 1310-73-2 Skin Corr. 1A H314 GHS05
Dgr H314 Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 011-003-00-1 sodium peroxide 215-209-4 1313-60-6 Ox. Sol. 1
Skin Corr. 1A H271
H314 GHS03
GHS05
Dgr H271
H314 011-004-00-7 sodium azide 247-852-1 26628-22-8 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H400
H410 GHS06
GHS09
Dgr H300
H400
H410 EUH032 011-005-00-2 sodium carbonate 207-838-8 497-19-8 Eye Irrit. 2 H319 GHS07
Wng H319 011-006-00-8 sodium cyanate 213-030-6 917-61-3 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 011-007-00-3 propoxycarbazone-sodium — 181274-15-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 M = 10 012-001-00-3 magnesium powder (pyrophoric) 231-104-6 7439-95-4 Water-react. 1
Pyr. Sol. 1 H260
H250 GHS02
Dgr H260
H250 T
012-002-00-9 magnesium, powder or turnings 231-104-6 — Flam. Sol. 1
Water-react. 2
Self-heat. 1 H228
H261
H252 GHS02
Dgr H228
H261
H252 T
012-003-00-4 magnesium alkyls — — Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B H250
H260
H314 GHS02
GHS05
Dgr H250
H260
H314 EUH014 A
013-001-00-6 aluminium powder (pyrophoric) 231-072-3 7429-90-5 Water-react. 2
Pyr. Sol. 1 H261
H250 GHS02
Dgr H261
H250 T
013-002-00-1 aluminium powder (stabilised) 231-072-3 — Water-react. 2
Flam.Sol. 3 H261
H228 GHS02
Dgr H261
H228 T
013-003-00-7 aluminium chloride, anhydrous 231-208-1 7446-70-0 Skin Corr. 1B H314 GHS05
Dgr H314 013-004-00-2 aluminium alkyls — — Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B H250
H260
H314 GHS02
GHS05
Dgr H250
H260
H314 EUH014 A
013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 401-160-8 55426-95-4 Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A H260
H250
H314 GHS02
GHS05
Dgr H260
H250
H314 EUH014 013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised 402-370-2 — Flam. Liq. 3
Eye Dam. 1 H226
H318 GHS02
GHS05
Dgr H226
H318 013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) 403-430-0 — Eye Dam. 1 H318 GHS05
Dgr H318 013-008-00-4 di-n-octylaluminium iodide 408-190-0 7585-14-0 Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H250
H314
H400
H410 GHS02
GHS05
GHS09
Dgr H250
H314
H410 EUH014 013-009-00-X sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5 418-720-2 — Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A H228
H260
H250
H332
H314 GHS02
GHS05
GHS07
Dgr H228
H260
H250
H332
H314 EUH014 T
014-001-00-9 trichlorosilane 233-042-5 10025-78-2 Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H224
H250
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H224
H250
H332
H302
H314 EUH014
EUH029 *
STOT SE 3; H335: C ≥ 1 % T
014-002-00-4 silicon tetrachloride 233-054-0 10026-04-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 EUH014 014-003-00-X dimethyldichlorosilane 200-901-0 75-78-5 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H225
H319
H335
H315 GHS02
GHS07
Dgr H225
H319
H335
H315 014-004-00-5 trichloro(methyl)silane;
methyltrichlorosilane 200-902-6 75-79-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H225
H319
H335
H315 GHS02
GHS07
Dgr H225
H319
H335
H315 EUH014 Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % 014-005-00-0 tetraethyl silicate;
ethyl silicate 201-083-8 78-10-4 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H226
H332
H319
H335 GHS02
GHS07
Wng H226
H332
H319
H335 014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride 401-380-4 — Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 014-007-00-1 triethoxyisobutylsilane 402-810-3 17980-47-1 Skin Irrit. 2 H315 GHS07
Wng H315 014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 401-200-4 85491-26-5 Aquatic Chronic 2 H411 GHS09 H411 014-009-00-2 isobutylisopropyldimethoxysilane 402-580-4 111439-76-0 Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2 H226
H332
H315 GHS02
GHS07
Wng H226
H332
H315 014-010-00-8 disodium metasilicate 229-912-9 6834-92-0 Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 014-011-00-3 cyclohexyldimethoxymethylsilane 402-140-1 17865-32-6 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine 403-480-3 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 014-013-00-4 α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) 404-920-7 — Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2 H312
H302
H314
H411 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H411 014-014-00-X etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane 253-704-7 37894-46-5 Repr. 1B
Acute Tox. 4 *
STOT RE 2 * H360D ***
H302
H373 ** GHS08
GHS07
Dgr H360D ***
H302
H373 ** 014-015-00-5 α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane)) 406-420-4 69430-40-6 Aquatic Chronic 4 H413 — H413 014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane 406-490-6 — Aquatic Chronic 2 H411 GHS09 H411 014-017-00-6 flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane — 85509-19-9 Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H351
H360D ***
H302
H411 GHS08
GHS07
GHS09
Dgr H351
H360D ***
H302
H411 014-018-00-1 octamethylcyclotetrasiloxane 209-136-7 556-67-2 Repr. 2
Aquatic Chronic 4 H361f ***
H413 GHS08
Wng H361f ***
H413 014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole 403-250-2 — Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H351
H360D ***
H302
H411 GHS08
GHS07
GHS09
Dgr H351
H360D ***
H302
H411 014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 414-960-7 53863-99-3 Acute Tox. 4 * H332 GHS07
Wng H332 014-021-00-8 tris(isopropenyloxy)phenyl silane 411-340-8 52301-18-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H400
H410 014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) 401-530-9 — Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H228
H370 **
H332
H312
H302 GHS02
GHS08
GHS07
Dgr H228
H370 **
H332
H312
H302 T
014-023-00-9 α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 408-160-7 125613-45-8 Aquatic Chronic 2 H411 GHS09 H411 014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 412-620-2 121626-74-2 Aquatic Chronic 2 H411 GHS09 H411 014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 411-400-3 102089-33-8 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H302
H373 **
H315
H318
H412 GHS08
GHS05
GHS07
Dgr H302
H373 **
H315
H318
H412 014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 407-180-3 770722-36-6 Skin Corr. 1A H314 GHS05
Dgr H314 014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 410-270-5 770722-46-8 Skin Corr. 1A H314 GHS05
Dgr H314 014-028-00-6 α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 415-290-8 193159-06-7 Skin Sens. 1 H317 GHS07
Wng H317 014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 421-870-1 156145-66-3 Repr. 2
Acute Tox. 4 *
STOT RE 2 * H361f ***
H302
H373 ** GHS08
GHS07
Wng H361f ***
H302
H373 ** 014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium 422-060-0 137390-08-0 Acute Tox. 2 * H300 GHS06
Dgr H300 014-031-00-2 bis(1-methylethyl)-dimethoxysilane 421-540-7 18230-61-0 Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H226
H315
H317
H412 GHS02
GHS07
Wng H226
H315
H317
H412 014-032-00-8 dicyclopentyldimethoxysilane 404-370-8 126990-35-0 Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 015-001-00-1 white phosphorus 231-768-7 12185-10-3 Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1 H250
H330
H300
H314
H400 GHS02
GHS06
GHS05
GHS09
Dgr H250
H330
H300
H314
H400 015-002-00-7 red phosphorus 231-768-7 7723-14-0 Flam. Sol. 1
Aquatic Chronic 3 H228
H412 GHS02
Dgr H228
H412 015-003-00-2 calcium phosphide;
tricalcium diphosphide 215-142-0 1305-99-3 Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1 H260
H300
H400 GHS02
GHS06
GHS09
Dgr H260
H300
H400 EUH029 T
015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1 H260
H300
H400 GHS02
GHS06
GHS09
Dgr H260
H300
H400 EUH029
EUH032 T
015-005-00-3 magnesium phosphide;
trimagnesium diphosphide 235-023-7 12057-74-8 Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1 H260
H300
H400 GHS02
GHS06
GHS09
Dgr H260
H300
H400 EUH029 T
015-006-00-9 trizinc diphosphide;
zinc phosphide 215-244-5 1314-84-7 Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H260
H300
H400
H410 GHS02
GHS06
GHS09
Dgr H260
H300
H410 EUH029
EUH032 T
015-007-00-4 phosphorus trichloride 231-749-3 7719-12-2 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A H330
H300
H373 **
H314 GHS06
GHS08
GHS05
Dgr H330
H300
H373 **
H314 EUH014
EUH029 015-008-00-X phosphorus pentachloride 233-060-3 10026-13-8 Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B H330
H302
H373 **
H314 GHS06
GHS08
GHS05
Dgr H330
H302
H373 **
H314 EUH014
EUH029 015-009-00-5 phosphoryl trichloride 233-046-7 10025-87-3 Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A H330
H372 **
H302
H314 GHS06
GHS08
GHS05
Dgr H330
H372 **
H302
H314 EUH014
EUH029 015-010-00-0 phosphorus pentoxide 215-236-1 1314-56-3 Skin Corr. 1A H314 GHS05
Dgr H314 015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 231-633-2 7664-38-2 Skin Corr. 1B H314 GHS05
Dgr H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
015-012-00-1 tetraphosphorus trisulphide;
phosphorus sesquisulphid 215-245-0 1314-85-8 Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1 H228
H260
H302
H400 GHS02
GHS07
GHS09
Dgr H228
H260
H302
H400 T
015-013-00-7 triethyl phosphate 201-114-5 78-40-0 Acute Tox. 4 * H302 GHS07
Wng H302 015-014-00-2 tributyl phosphate 204-800-2 126-73-8 Carc. 2
Acute Tox. 4 *
Skin Irrit. 2 H351
H302
H315 GHS08
GHS07
Wng H351
H302
H315 015-015-00-8 tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); 201-103-5 78-30-8 STOT SE 1
Aquatic Chronic 2 H370 **
H411 GHS08
GHS09
Dgr H370 **
H411 STOT SE 1; H370: C ≥ 1 %
STOT SE 2; H371: 0,2 % ≤ C < 1 % C
015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); 201-105-6 78-32-0 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H312
H302
H411 GHS07
GHS09
Wng H312
H302
H411 * C
015-019-00-X dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate 200-547-7 62-73-7 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1 H330
H311
H301
H317
H400 GHS06
GHS09
Dgr H330
H311
H301
H317
H400 015-020-00-5 mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 232-095-1 7786-34-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 M = 10000 015-021-00-0 trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 200-149-3 52-68-6 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H400
H410 M = 1000 015-022-00-6 phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate 236-116-5 13171-21-6 Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H341
H300
H311
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H300
H311
H410 015-023-00-1 pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate — 108-34-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H330
H310
H300 GHS06
Dgr H330
H310
H300 015-024-00-7 triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide — 1031-47-6 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-025-00-2 TEPP (ISO);
tetraethyl pyrophosphate 203-495-3 107-49-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1 H310
H300
H400 GHS06
GHS09
Dgr H310
H300
H400 015-026-00-8 schradan (ISO);
octamethylpyrophosphoramide 205-801-0 152-16-9 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-027-00-3 sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate 222-995-2 3689-24-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 M = 1000 015-028-00-9 demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate 206-053-8 298-03-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1 H310
H300
H400 GHS06
GHS09
Dgr H310
H300
H400 015-029-00-4 demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate 204-801-8 126-75-0 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-030-00-X demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate 212-758-1 867-27-6 Acute Tox. 3 * H301 GHS06
Dgr H301 015-031-00-5 demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate 213-052-6 919-86-8 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H311
H301
H411 GHS06
GHS09
Dgr H311
H301
H411 015-032-00-0 prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 218-893-2 2275-18-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 3 H310
H300
H412 GHS06
Dgr H310
H300
H412 015-033-00-6 phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate 206-052-2 298-02-2 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 M = 1000 015-034-00-1 parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate 200-271-7 56-38-2 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H311
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H300
H311
H372 **
H410 M = 100 015-035-00-7 parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate 206-050-1 298-00-0 Flam. Liq. 3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H226
H330
H300
H311
H373 **
H400
H410 GHS02
GHS06
GHS08
GHS09
Dgr H226
H330
H300
H311
H373 **
H410 M = 100 015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN 218-276-8 2104-64-5 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-037-00-8 phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate 218-892-7 2275-14-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 015-038-00-3 coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 200-285-3 56-72-4 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H312
H400
H410 GHS06
GHS09
Dgr H300
H312
H410 015-039-00-9 azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 201-676-1 86-50-0 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H311
H317
H400
H410 GHS06
GHS09
Dgr H330
H300
H311
H317
H410 015-040-00-4 diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 206-373-8 333-41-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H400
H410 015-041-00-X malathion (ISO);
1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate 204-497-7 121-75-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H400
H410 M = 100 015-042-00-5 chlorthion
O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate 207-902-5 500-28-7 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 M = 100 015-043-00-0 phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate — 5826-76-6 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 015-044-00-6 carbophenothion (ISO);
4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate 212-324-1 786-19-6 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 015-045-00-1 mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate 219-993-9 2595-54-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H400
H410 015-046-00-7 oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 206-110-7 301-12-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1 H311
H301
H400 GHS06
GHS09
Dgr H311
H301
H400 015-047-00-2 ethion (ISO);
O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);
diethion 209-242-3 563-12-2 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 M = 10000 015-048-00-8 fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 200-231-9 55-38-9 Muta. 2
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H341
H331
H372 **
H312
H302
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H331
H372 **
H312
H302
H410 015-049-00-3 endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 220-472-3 2778-04-3 Acute Tox. 3 *
Acute Tox. 3 * H311
H301 GHS06
Dgr H311
H301 015-050-00-9 thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 211-362-6 640-15-3 Acute Tox. 3 *
Acute Tox. 4 * H301
H312 GHS06
Dgr H301
H312 015-051-00-4 dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate 200-480-3 60-51-5 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 015-052-00-X fenchlorphos (ISO);
O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 206-082-6 299-84-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 015-053-00-5 menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate 201-123-4 78-57-9 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 015-054-00-0 fenitrothion (ISO);
O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate 204-524-2 122-14-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 015-055-00-6 naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 206-098-3 300-76-5 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1 H312
H302
H319
H315
H400 GHS07
GHS09
Wng H312
H302
H319
H315
H400 M = 1000 015-056-00-1 azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 220-147-6 2642-71-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 015-057-00-7 formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate 219-818-6 2540-82-1 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 015-058-00-2 morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 205-628-0 144-41-2 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 015-059-00-8 vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 218-894-8 2275-23-2 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1 H301
H312
H400 GHS06
GHS09
Dgr H301
H312
H400 015-060-00-3 disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate 206-054-3 298-04-4 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-061-00-9 dimefox (ISO);
tetramethylphosphorodiamidic fluoride 204-076-8 115-26-4 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-062-00-4 mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride 206-742-3 371-86-8 STOT SE 1 H370 ** GHS08
Dgr H370 ** 015-063-00-X dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 201-107-7 78-34-2 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H311
H400
H410 GHS06
GHS09
Dgr H330
H300
H311
H410 M = 1000 015-064-00-5 bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 225-399-0 4824-78-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate — 2703-37-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2 H330
H310
H300
H411 GHS06
GHS09
Dgr H330
H310
H300
H411 015-066-00-6 omethoate (ISO);
O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate 214-197-8 1113-02-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1 H301
H312
H400 GHS06
GHS09
Dgr H301
H312
H400 015-067-00-1 phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate 218-996-2 2310-17-0 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 015-068-00-7 dichlofenthion (ISO);
O—2,4-dichlorophenyl O,O-diethyl phosphorothioate 202-564-5 97-17-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H400
H410 015-069-00-2 methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 213-449-4 950-37-8 Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H312
H400
H410 GHS06
GHS09
Dgr H300
H312
H410 015-070-00-8 cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 223-099-4 3734-95-0 Acute Tox. 2 *
Acute Tox. 3 * H300
H311 GHS06
Dgr H300
H311 015-071-00-3 chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate 207-432-0 470-90-6 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 015-072-00-9 monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 230-042-7 6923-22-4 Muta. 2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H341
H330
H300
H311
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H330
H300
H311
H410 015-073-00-4 dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 205-494-3 141-66-2 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 015-074-00-X crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 206-083-1 299-86-5 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate — 2635-50-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 015-076-00-0 potasan;
O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate — 299-45-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 M = 1000 015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate — 7076-53-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 015-078-00-1 demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate 241-109-5 17040-19-6 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2 H301
H312
H411 GHS06
GHS09
Dgr H301
H312
H411 015-079-00-7 acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate 250-241-2 30560-19-1 Acute Tox. 4 * H302 GHS07
Wng H302 015-080-00-2 amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate — 919-76-6 Acute Tox. 4 * H302 GHS07
Wng H302 015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 221-817-0 3244-90-4 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 015-082-00-3 azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 227-419-3 5834-96-8 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 015-083-00-9 bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 212-010-4 741-58-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 015-084-00-4 chlorpyrifos (ISO);
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 220-864-4 2921-88-2 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H400
H410 M = 10000 015-085-00-X chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride 204-105-4 115-78-6 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H301
H312
H319
H315 GHS06
Dgr H301
H312
H319
H315 015-086-00-5 coumithoate (ISO);
O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate — 572-48-5 Acute Tox. 3 * H301 GHS06
Dgr H301 015-087-00-0 cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate 220-130-3 2636-26-2 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 015-088-00-6 dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 233-689-3 10311-84-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H400
H410 015-089-00-1 ethoate-methyl (ISO);
ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 204-121-1 116-01-8 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 015-090-00-7 fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 204-114-3 115-90-2 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-091-00-2 fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate 213-408-0 944-22-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-092-00-8 phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 223-874-7 4104-14-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-093-00-3 leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 244-472-8 21609-90-5 Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H370 **
H312
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H370 **
H312
H410 015-094-00-9 mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 213-447-3 950-10-7 Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2 H310
H300
H411 GHS06
GHS09
Dgr H310
H300
H411 015-095-00-4 methamidophos (ISO);
O,S-dimethyl phosphoramidothioate 233-606-0 10265-92-6 Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1 H330
H300
H311
H400 GHS06
GHS09
Dgr H330
H300
H311
H400 015-096-00-X oxydisulfoton (ISO);
O,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate 219-679-1 2497-07-6 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 M = 10 015-097-00-5 phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 219-997-0 2597-03-7 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 M = 100 015-098-00-0 trichloronate (ISO);
O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 206-326-1 327-98-0 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 015-099-00-6 pirimiphos-ethyl (ISO);
O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 245-704-0 23505-41-1 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 015-100-00-X phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-3 14816-18-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 M = 1000 015-101-00-5 phosmet (ISO);
O,O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4 732-11-6 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 M = 100 015-102-00-0 tris(2-chloroethyl) phosphate 204-118-5 115-96-8 Carc. 2
Acute Tox. 4 *
Aquatic Chronic 2 H351
H302
H411 GHS08
GHS07
GHS09
Wng H351
H302
H411 015-103-00-6 phosphorus tribromide 232-178-2 7789-60-8 Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 EUH014 015-104-00-1 diphosphorus pentasulphide;
phosphorus pentasulphide 215-242-4 1314-80-3 Flam. Sol. 1
Water-react. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H228
H260
H332
H302
H400 GHS02
GHS07
GHS09
Dgr H228
H260
H332
H302
H400 EUH029 T
015-105-00-7 triphenyl phosphite 202-908-4 101-02-0 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H400
H410 GHS07
GHS09
Wng H319
H315
H410 Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 % 015-106-00-2 hexamethylphosphoric triamide;
hexamethylphosphoramide 211-653-8 680-31-9 Carc. 1B
Muta. 1B H350
H340 GHS08
Dgr H350
H340 Carc. 1B; H350: C ≥ 0,01 % 015-107-00-8 ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate 236-152-1 13194-48-4 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H301
H317
H400
H410 GHS06
GHS09
Dgr H330
H310
H301
H317
H410 015-108-00-3 bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 218-277-3 2104-96-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 M = 100 015-109-00-9 crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 231-720-5 7700-17-6 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 M = 10 015-110-00-4 cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate — 13067-93-1 Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H301
H370 **
H312
H319
H411 GHS06
GHS08
GHS09
Dgr H301
H370 **
H312
H319
H411 015-111-00-X phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate 213-423-2 947-02-4 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-112-00-5 thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate; 206-049-6 297-97-2 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-114-00-6 chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate 246-538-1 24934-91-6 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 015-115-00-1 chlorthiophos (ISO) 244-663-6 21923-23-9 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 015-116-00-7 demephion-O (ISO);
O,O-dimethyl O-2-methylthioethyl phosphorothioate 211-666-9 682-80-4 Acute Tox. 2 *
Acute Tox. 3 * H300
H311 GHS06
Dgr H300
H311 015-117-00-2 demephion-S (ISO);
O,O-dimethyl S-2-methylthioethyl phosphorothioate 219-971-9 2587-90-8 Acute Tox. 2 *
Acute Tox. 3 * H300
H311 GHS06
Dgr H300
H311 015-118-00-8 demeton — 8065-48-3 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1 H310
H300
H400 GHS06
GHS09
Dgr H310
H300
H400 015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate — 3254-63-5 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-120-00-9 ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate 225-875-8 5131-24-8 Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 015-121-00-4 edifenphos (ISO);
O-ethyl S,S-diphenyl phosphorodithioate 241-178-1 17109-49-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H312
H317
H400
H410 GHS06
GHS09
Dgr H331
H301
H312
H317
H410 015-122-00-X etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate 253-855-9 38260-54-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 M = 10 015-123-00-5 fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 M = 100 015-124-00-0 fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate 244-437-7 21548-32-3 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 015-125-00-6 glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine 219-468-4 2439-99-8 Eye Dam. 1 H318 GHS05
Dgr H318 015-126-00-1 heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 245-737-0 23560-59-0 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 M = 100 015-127-00-7 iprobenfos(ISO);
S-benzyl diisopropyl phosphorothioate 247-449-0 26087-47-8 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 015-128-00-2 IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate — 5827-05-4 Acute Tox. 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H301
H400
H410 GHS06
GHS09
Dgr H310
H301
H410 M = 100 015-129-00-8 isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 246-814-1 25311-71-1 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 M = 100 015-130-00-3 isothioate (ISO);
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; — 36614-38-7 Acute Tox. 3 *
Acute Tox. 3 * H311
H301 GHS06
Dgr H311
H301 015-131-00-9 isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 242-624-8 18854-01-8 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;
methylcarbophenothione — 953-17-3 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 M = 1000 015-133-00-X piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate — 24151-93-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 M = 10 015-134-00-5 pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate 249-528-5 29232-93-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 015-135-00-0 profenofos (ISO)
O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; 255-255-2 41198-08-7 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 M = 1000 015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO) 250-517-2 31218-83-4 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 M = 100 015-137-00-1 pyrazophos (ISO);
O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 236-656-1 13457-18-6 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H400
H410 GHS07
GHS09
Wng H332
H302
H410 015-138-00-7 quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate 237-031-6 13593-03-8 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 M = 1000 015-139-00-2 terbufos (ISO);
S-tert-butylthiomethyl O,O-diethylphosphorodithioate; 235-963-8 13071-79-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 M = 1000 015-140-00-8 triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate 245-986-5 24017-47-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H312
H400
H410 GHS06
GHS09
Dgr H331
H301
H312
H410 015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers 400-520-1 — Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H314
H302
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H302
H410 015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate 401-100-0 — Flam. Liq. 2
Eye Irrit. 2
Aquatic Chronic 2 H225
H319
H411 GHS02
GHS07
GHS09
Dgr H225
H319
H411 T
015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,
reaction mass of isomers 401-740-0 — Acute Tox. 4 * H302 GHS07
Wng H302 015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 402-090-0 87025-52-3 Skin Corr. 1B H314 GHS05
Dgr H314 015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate 401-520-4 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate 401-850-9 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) 400-930-0 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H315
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H411 015-148-00-1 2-(diphosphonomethyl)succinic acid 403-070-4 51395-42-7 Skin Corr. 1B
Skin Sens. 1 H314
H317 GHS05
GHS07
Dgr H314
H317 015-149-00-7 reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide 403-470-9 — Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 404-940-6 86608-70-0 Acute Tox. 4 *
Eye Dam. 1
STOT RE 2 *
Aquatic Chronic 3 H302
H318
H373 **
H412 GHS08
GHS05
GHS07
Dgr H302
H318
H373 **
H412 015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate 405-010-2 — Aquatic Chronic 2 H411 GHS09 H411 015-152-00-3 dioxabenzofos (ISO);
2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide 223-292-3 3811-49-2 Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
Aquatic Chronic 2 H311
H301
H370 **
H411 GHS06
GHS08
GHS09
Dgr H311
H301
H370 **
H411 015-153-00-9 isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate 255-863-8 42509-80-8 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H311
H301
H373 **
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H311
H301
H373 **
H317
H410 015-154-00-4 2-chloroethylphosphonic acid;
ethephon 240-718-3 16672-87-0 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3 H332
H312
H314
H412 GHS05
GHS07
Dgr H332
H312
H314
H412 STOT SE 3; H335: C ≥ 5 % 015-155-00-X ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;
glufosinate ammonium 278-636-5 77182-82-2 Acute Tox. 4 * H302 GHS07
Wng H302 015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 250-366-9 [1]-[2] 30864-28-9 [1]
62610-77-9 [2] Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 015-157-00-0 phosphonic acid; [1]
phosphorous acid [2] 237-066-7 [1]
233-663-1
[2] 13598-36-2 [1]
10294-56-1 [2] Acute Tox. 4 *
Skin Corr. 1A H302
H314 GHS05
GHS07
Dgr H302
H314 015-158-00-6 (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) 402-340-9 32760-80-8 Aquatic Chronic 3 H412 — H412 015-159-00-1 hydroxyphosphonoacetic acid 405-710-8 23783-26-8 Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1 H302
H373 **
H314
H317 GHS08
GHS05
GHS07
Dgr H302
H373 **
H314
H317 015-160-00-7 vanadyl pyrophosphate 406-260-5 58834-75-6 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H319
H317
H412 GHS07
Wng H319
H317
H412 015-161-00-2 divanadyl pyrophosphate 407-130-0 65232-89-5 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped 407-350-7 — Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2 H332
H373 **
H318
H411 GHS08
GHS05
GHS07
GHS09
Dgr H332
H373 **
H318
H411 015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 412-010-6 145052-34-2 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 400-480-5 36669-85-9 Aquatic Chronic 3 H412 — H412 015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate 404-986-7 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 410-290-4 80693-00-1 Aquatic Chronic 4 H413 — H413 015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 411-200-6 14657-64-8 Eye Dam. 1 H318 GHS05
Dgr H318 015-168-00-0 fosthiazate (ISO);
(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate — 98886-44-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H312
H317
H400
H410 GHS06
GHS09
Dgr H331
H301
H312
H317
H410 EUH070 015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate 413-520-1 — Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H314
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H302
H373 **
H314
H317
H410 015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate 407-490-9 — Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate 406-940-1 — Aquatic Chronic 2 H411 GHS09 H411 015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate 406-240-6 — Flam. Liq. 3
Skin Corr. 1B
Aquatic Chronic 2 H226
H314
H411 GHS02
GHS05
GHS09
Dgr H226
H314
H411 015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 414-080-3 117291-73-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 411-370-1 82857-68-9 Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 2 H301
H318
H411 GHS06
GHS05
GHS09
Dgr H301
H318
H411 015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 412-880-7 35000-38-5 Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H301
H373 **
H319
H317
H411 GHS06
GHS08
GHS09
Dgr H301
H373 **
H319
H317
H411 015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 413-430-2 116163-96-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 412-170-7 83623-61-4 STOT RE 2 *
Eye Dam. 1
Skin Sens. 1 H373 **
H318
H317 GHS08
GHS05
Dgr H373 **
H318
H317 015-178-00-5 (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 418-570-8 25383-07-7 Repr. 2
Aquatic Chronic 2 H361f ***
H411 GHS08
GHS09
Wng H361f ***
H411 015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 422-720-8 166242-53-1 Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H373 **
H314
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H351
H302
H373 **
H314
H317
H410 015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 415-820-8 137590-32-0 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 015-181-00-1 phosphine 232-260-8 7803-51-2 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1 H220
H330
H314
H400 GHS02
GHS04
GHS06
GHS05
GHS09
Dgr H220
H330
H314
H400 U
015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex — — Aquatic Chronic 2 H411 GHS09 H411 A
015-186-00-9 chlorpyrifos-methyl (ISO)
O,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 227-011-5 5598-13-0 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 M = 10000 015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide 417-540-1 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 016-001-00-4 hydrogen sulphide 231-977-3 7783-06-4 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Aquatic Acute 1 H220
H330
H400 GHS02
GHS04
GHS06
GHS09
Dgr H220
H330
H400 U
016-002-00-X barium sulphide 244-214-4 21109-95-5 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H332
H302
H400 GHS07
GHS09
Wng H332
H302
H400 EUH031 016-003-00-5 barium polysulphides 256-814-3 50864-67-0 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H319
H335
H315
H400 GHS07
GHS09
Wng H319
H335
H315
H400 EUH031 016-004-00-0 calcium sulphide 243-873-5 20548-54-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H319
H335
H315
H400 GHS07
GHS09
Wng H319
H335
H315
H400 EUH031 016-005-00-6 calcium polysulphides 215-709-2 1344-81-6 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H319
H335
H315
H400 GHS07
GHS09
Wng H319
H335
H315
H400 EUH031 016-006-00-1 dipotassium sulphide;
potassium sulphide 215-197-0 1312-73-8 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH031 016-007-00-7 potassium polysulphides 253-390-1 37199-66-9 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH031 016-008-00-2 ammonium polysulphides 232-989-1 9080-17-5 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH031 EUH031: C ≥ 1 % 016-009-00-8 disodium sulphide;
sodium sulphide 215-211-5 1313-82-2 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH031 016-010-00-3 sodium polysulphides 215-686-9 1344-08-7 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H301
H314
H400 GHS06
GHS05
GHS09
Dgr H301
H314
H400 EUH031 016-011-00-9 sulphur dioxide 231-195-2 7446-09-5 Press. Gas
Acute Tox. 3 *
Skin Corr. 1B H331
H314 GHS04
GHS06
GHS05
Dgr H331
H314 * U
5
016-012-00-4 disulphur dichloride;
sulfur monochloride 233-036-2 10025-67-9 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1 H301
H332
H314
H400 GHS06
GHS05
GHS09
Dgr H301
H332
H314
H400 EUH014
EUH029 STOT SE 3; H335: C ≥ 1 % 016-013-00-X sulphur dichloride 234-129-0 10545-99-0 Skin Corr. 1B
STOT SE 3
Aquatic Acute 1 H314
H335
H400 GHS05
GHS07
GHS09
Dgr H314
H335
H400 EUH014 STOT SE 3; H335: C ≥ 5 % 016-014-00-5 sulphur tetrachloride — 13451-08-6 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH014 STOT SE 3; H335: C ≥ 5 % 016-015-00-0 thionyl dichloride;
thionyl chloride 231-748-8 7719-09-7 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H332
H302
H314 GHS05
GHS07
Dgr H332
H302
H314 EUH014
EUH029 STOT SE 3; H335: C ≥ 1 % 016-016-00-6 sulphuryl chloride 232-245-6 7791-25-5 Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 EUH014 016-017-00-1 chlorosulphonic acid 232-234-6 7790-94-5 Skin Corr. 1A
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 EUH014 016-018-00-7 fluorosulphonic acid 232-149-4 7789-21-1 Acute Tox. 4 *
Skin Corr. 1A H332
H314 GHS05
GHS07
Dgr H332
H314 016-019-00-2 oleum ... % SO3 — — Skin Corr. 1A
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 EUH014 B
016-020-00-8 sulphuric acid ... % 231-639-5 7664-93-9 Skin Corr. 1A H314 GHS05
Dgr H314 Skin Corr. 1A; H314: C ≥ 15 %
Skin Irrit. 2; H315: 5 % ≤ C < 15 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 % B
016-021-00-3 methanethiol;
methyl mercaptan 200-822-1 74-93-1 Flam. Gas. 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H220
H331
H400
H410 GHS02
GHS04
GHS06
GHS09
Dgr H220
H331
H410 U
016-022-00-9 ethanethiol;
ethyl mercaptan 200-837-3 75-08-1 Flam. Liq. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H225
H332
H400
H410 GHS02
GHS07
GHS09
Dgr H225
H332
H410 016-023-00-4 dimethyl sulphate 201-058-1 77-78-1 Carc. 1B
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H350
H341
H330
H301
H314
H317 GHS06
GHS08
GHS05
Dgr H350
H341
H330
H301
H314
H317 Carc. 1B; H350: C ≥ 0,01 %
Muta. 2; H341: C ≥ 0,01 %
STOT SE 3; H335: C ≥ 5 % 016-024-00-X dimexano(ISO);
bis(methoxythiocarbonyl) disulphide 215-993-8 1468-37-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 016-025-00-5 disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES 205-259-5 149-26-8 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1 H302
H315
H318 GHS05
GHS07
Dgr H302
H315
H318 016-026-00-0 sulphamidic acid;
sulphamic acid;
sulfamic acid 226-218-8 5329-14-6 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H319
H315
H412 GHS07
Wng H319
H315
H412 016-027-00-6 diethyl sulphate 200-589-6 64-67-5 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H350
H340
H332
H312
H302
H314 GHS05
GHS08
GHS07
Dgr H350
H340
H332
H312
H302
H314 016-028-00-1 sodium dithionite;
sodium hydrosulphite 231-890-0 7775-14-6 Self-heat. 1
Acute Tox. 4 * H251
H302 GHS02
GHS07
Dgr H251
H302 EUH031 016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 — — Skin Corr. 1B H314 GHS05
Dgr H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % 016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 203-180-0 104-15-4 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 STOT SE 3; H335: C ≥ 20 % 016-031-00-8 tetrahydrothiophene-1,1-dioxide;
sulpholane 204-783-1 126-33-0 Acute Tox. 4 * H302 GHS07
Wng H302 016-032-00-3 1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide 214-317-9 1120-71-4 Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 * H350
H312
H302 GHS08
GHS07
Dgr H350
H312
H302 Carc. 1B; H350: C ≥ 0,01 % 016-033-00-9 dimethylsulfamoylchloride 236-412-4 13360-57-1 Carc. 1B
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H350
H330
H312
H302
H314 GHS06
GHS05
GHS08
Dgr H350
H330
H312
H302
H314 016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 400-010-9 81898-60-4 Skin Sens. 1 H317 GHS07
Wng H317 016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate 400-120-7 — Eye Irrit. 2 H319 GHS07
Wng H319 016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate 400-130-1 — Resp. Sens. 1
Aquatic Chronic 2 H334
H411 GHS08
GHS09
Dgr H334
H411 016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 400-350-8 85153-93-1 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 400-380-1 86393-35-3 Skin Sens. 1 H317 GHS07
Wng H317 016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate 400-430-2 — Skin Sens. 1 H317 GHS07
Wng H317 016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate 400-570-4 — Eye Irrit. 2 H319 GHS07
Wng H319 016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate 400-710-4 — Acute Tox. 4 * H332 GHS07
Wng H332 016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 400-790-0 85665-97-0 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate 401-010-1 — Skin Sens. 1 H317 GHS07
Wng H317 016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate 401-320-7 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 401-560-2 108624-00-6 Skin Sens. 1 H317 GHS07
Wng H317 016-046-00-X sodium hydrogensulphate 231-665-7 7681-38-1 Eye Dam. 1 H318 GHS05
Dgr H318 016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 401-650-1 85665-96-9 Skin Sens. 1 H317 GHS07
Wng H317 016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate 401-870-8 — Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 016-049-00-6 calcium octadecylxylenesulphonate 402-040-8 — Skin Corr. 1B
Aquatic Chronic 2 H314
H411 GHS05
GHS09
Dgr H314
H411 016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat 402-150-6 — Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 402-170-5 106359-91-5 Skin Sens. 1 H317 GHS07
Wng H317 016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 402-240-5 102561-46-6 Acute Tox. 4 *
Aquatic Chronic 2 H332
H411 GHS07
GHS09
Wng H332
H411 016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate 402-460-1 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4 H315
H317
H413 GHS07
Wng H315
H317
H413 016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate 400-030-8 — Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Sens. 1 H331
H372 **
H302
H319
H335
H317 GHS06
GHS08
Dgr H331
H372 **
H302
H319
H335
H317 016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) 400-510-7 — Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 016-056-00-4 potassium hydrogensulphate 231-594-1 7646-93-7 Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 016-057-00-X styrene-4-sulfonyl chloride 404-770-2 2633-67-2 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H315
H318
H317 GHS05
GHS07
Dgr H315
H318
H317 016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine 404-820-3 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H315
H317
H412 GHS07
Wng H315
H317
H412 016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 405-300-9 17339-60-5 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H317
H400
H410 GHS07
GHS09
Wng H302
H319
H317
H410 016-060-00-6 diammonium peroxodisulphate;
ammonium persulphate 231-786-5 7727-54-0 Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1 H272
H302
H319
H335
H315
H334
H317 GHS03
GHS08
GHS07
Dgr H272
H302
H319
H335
H315
H334
H317 016-061-00-1 dipotassium peroxodisulphate;
potassium persulphate 231-781-8 7727-21-1 Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1 H272
H302
H319
H335
H315
H334
H317 GHS03
GHS08
GHS07
Dgr H272
H302
H319
H335
H315
H334
H317 016-062-00-7 bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane — 17606-31-4 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 016-063-00-2 sodium metabisulphite 231-673-0 7681-57-4 Acute Tox. 4 *
Eye Dam. 1 H302
H318 GHS05
GHS07
Dgr H302
H318 EUH031 016-064-00-8 sodium hydrogensulphite . . . %;
sodium bisulphite . . . % 231-548-0 7631-90-5 Acute Tox. 4 * H302 GHS07
Wng H302 EUH031 B
016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 400-100-8 84057-97-6 Aquatic Chronic 2 H411 GHS09 H411 016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 404-070-7 116912-62-0 Aquatic Chronic 3 H412 — H412 016-067-00-4 (4-methylphenyl)mesitylene sulfonate 407-530-5 67811-06-7 Aquatic Chronic 4 H413 — H413 016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 407-720-8 155160-86-4 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 407-990-7 141915-64-2 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone 408-220-2 — Aquatic Chronic 4 H413 — H413 016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 410-130-3 136248-03-8 Skin Sens. 1 H317 GHS07
Wng H317 016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 411-520-6 112195-27-4 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 404-310-0 10591-85-2 Aquatic Chronic 4 H413 — H413 016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene 405-410-7 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H315
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H411 016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 411-570-9 41481-66-7 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 411-290-7 131538-00-6 Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H410 016-077-00-9 2-chloro-p-toluenesulfochloride 412-890-1 42413-03-6 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H314
H317
H412 GHS05
GHS07
Dgr H314
H317
H412 016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 413-300-5 56187-04-3 Aquatic Chronic 4 H413 — 016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 412-920-3 16695-22-0 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 412-320-1 31361-99-6 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide 418-350-1 — Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H341
H302
H319
H317
H411 GHS08
GHS07
GHS09
Wng H341
H302
H319
H317
H411 016-082-00-6 ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea — 126801-58-9 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 016-083-00-1 acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester 420-050-0 135158-54-2 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H317
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H317
H410 016-084-00-7 prosulfuron;
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea — 94125-34-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 016-085-00-2 flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea — 104040-78-0 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 402-590-9 109125-56-6 Eye Dam. 1 H318 GHS05
Dgr H318 016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate 403-490-8 104558-95-4 Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H319
H317
H400
H410 GHS07
GHS09
Wng H319
H317
H410 016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 407-280-7 71297-11-5 Aquatic Chronic 3 H412 — H412 016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene 413-840-1 — Self-react. C ****
Aquatic Chronic 4 H242
H413 GHS02
Dgr H242
H413 016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 415-040-8 14653-91-9 Acute Tox. 4 *
STOT SE 3
Eye Dam. 1 H302
H335
H318 GHS05
GHS07
Dgr H302
H335
H318 016-091-00-5 C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate 414-110-5 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 414-770-4 140698-96-0 Self-react. C ****
Carc. 2 H242
H351 GHS02
GHS08
Dgr H242
H351 016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) 417-980-4 — Self-react. C ****
Carc. 2 H242
H351 GHS02
GHS08
Dgr H242
H351 016-096-00-2 thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate — 79277-27-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 017-001-00-7 chlorine 231-959-5 7782-50-5 Ox. Gas 1
Press. Gas
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H270
H331
H319
H335
H315
H400 GHS03
GHS04
GHS06
GHS09
Dgr H270
H331
H319
H335
H315
H400 U
017-002-00-2 hydrogen chloride 231-595-7 7647-01-0 Press. Gas
Acute Tox. 3 *
Skin Corr. 1A H331
H314 GHS04
GHS06
GHS05
Dgr H331
H314 U
5
017-002-01-X hydrochloric acid ... % 231-595-7 — Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 % B
017-003-00-8 barium chlorate 236-760-7 13477-00-4 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H271
H332
H302
H411 GHS03
GHS07
GHS09
Dgr H271
H332
H302
H411 017-004-00-3 potassium chlorate 223-289-7 3811-04-9 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H271
H332
H302
H411 GHS03
GHS07
GHS09
Dgr H271
H332
H302
H411 017-005-00-9 sodium chlorate 231-887-4 7775-09-9 Ox. Sol. 1
Acute Tox. 4 *
Aquatic Chronic 2 H271
H302
H411 GHS03
GHS07
GHS09
Dgr H271
H302
H411 017-006-00-4 perchloric acid ... % 231-512-4 7601-90-3 Ox. Liq. 1
Skin Corr. 1A H271
H314 GHS03
GHS05
Dgr H271
H314 Skin Corr. 1A; H314: C ≥ 50 %
Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 10 %
Ox. Liq. 1; H271: C > 50 %:
Ox. Liq. 2; H272: C ≤ 50 %: B
017-007-00-X barium perchlorate 236-710-4 13465-95-7 Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 * H271
H332
H302 GHS03
GHS07
Dgr H271
H332
H302 017-008-00-5 potassium perchlorate 231-912-9 7778-74-7 Ox. Sol. 1
Acute Tox. 4 * H271
H302 GHS03
GHS07
Dgr H271
H302 017-009-00-0 ammonium perchlorate 232-235-1 7790-98-9 Expl. 1.1
Ox. Sol. 1 H201
H271 GHS01
Dgr H201
H271 EUH044 T
017-010-00-6 sodium perchlorate 231-511-9 7601-89-0 Ox. Sol. 1
Acute Tox. 4 * H271
H302 GHS03
GHS07
Dgr H271
H302 017-011-00-1 sodium hypochlorite, solution ... % Cl active 231-668-3 7681-52-9 Skin Corr. 1B
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 EUH031 EUH031: C ≥ 5 % B
017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1 H272
H302
H314
H400 GHS03
GHS05
GHS07
GHS09
Dgr H272
H302
H314
H400 EUH031 Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Dam. 1; H31: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
STOT SE 3; H335: C ≥ 3 % T
017-013-00-2 calcium chloride 233-140-8 10043-52-4 Eye Irrit. 2 H319 GHS07
Wng H319 017-014-00-8 ammonium chloride 235-186-4 12125-02-9 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 417-410-4 61807-67-8 Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1 H302
H314
H317 GHS05
GHS07
Dgr H302
H314
H317 017-016-00-9 methyltriphenylphosphonium chloride 418-400-2 1031-15-8 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H312
H302
H315
H318
H411 GHS05
GHS07
GHS09
Dgr H312
H302
H315
H318
H411 017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 426-210-6 120086-58-0 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride 405-660-7 — Aquatic Chronic 2 H411 GHS09 H411 017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 415-110-8 54417-53-7 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 017-020-00-0 ethyl propoxy aluminium chloride 421-790-7 13014-29-4 Water-react. 1
Skin Corr. 1A H260
H314 GHS02
GHS05
Dgr H260
H314 EUH014 017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 423-420-1 136920-10-0 Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H318
H317
H410 019-001-00-2 potassium 231-119-8 7440-09-7 Water-react. 1
Skin Corr. 1B H260
H314 GHS02
GHS05
Dgr H260
H314 EUH014 019-002-00-8 potassium hydroxide;
caustic potash 215-181-3 1310-58-3 Acute Tox. 4 *
Skin Corr. 1A H302
H314 GHS05
GHS07
Dgr H302
H314 Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 020-001-00-X calcium 231-179-5 7440-70-2 Water-react. 2 H261 GHS02
Dgr H261 020-002-00-5 calcium cyanide 209-740-0 592-01-8 Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H400
H410 GHS06
GHS09
Dgr H300
H410 EUH032 020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] 420-470-4 — Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 022-001-00-5 titanium tetrachloride 231-441-9 7550-45-0 Skin Corr. 1B H314 GHS05
Dgr H314 EUH014 022-002-00-0 titanium(4+) oxalate 403-260-7 — Eye Dam. 1 H318 GHS05
Dgr H318 022-003-00-6 bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 412-000-1 125051-32-3 Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2 H228
H361f ***
H373 **
H411 GHS02
GHS08
GHS09
Dgr H228
H361f ***
H373 **
H411 T
023-001-00-8 divanadium pentaoxide;
vanadium pentoxide 215-239-8 1314-62-1 Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2 H341
H361d ***
H372 **
H332
H302
H335
H411 GHS08
GHS07
GHS09
Dgr H341
H361d ***
H372 **
H332
H302
H335
H411 024-001-00-0 chromium (VI) trioxide 215-607-8 1333-82-0 Ox. Sol. 1
Carc. 1A
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H400
H410 GHS03
GHS06
GHS08
GHS05
GHS09
Dgr H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H410 STOT SE 3; H335: C ≥ 1 % 024-002-00-6 potassium dichromate 231-906-6 7778-50-9 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410 GHS03
GHS06
GHS08
GHS05
GHS09
Dgr H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410 STOT SE 3; H335: C ≥ 5 % 3
024-003-00-1 ammonium dichromate 232-143-1 7789-09-5 Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410 GHS03
GHS06
GHS08
GHS05
GHS09
Dgr H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410 STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 % G
3
024-004-00-7 sodium dichromate anhydrate 234-190-3 10588-01-9 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410 GHS03
GHS06
GHS08
GHS05
GHS09
Dgr H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410 STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 % 3
024-004-01-4 sodium dichromate, dihydrate 234-190-3 7789-12-0 Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410 GHS03
GHS06
GHS08
GHS05
GHS09
Dgr H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410 STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 % 3
024-005-00-2 chromyl dichloride;
chromic oxychloride 239-056-8 14977-61-8 Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H271
H350i
H340
H314
H317
H400
H410 GHS03
GHS08
GHS05
GHS07
GHS09
Dgr H271
H350i
H340
H314
H317
H410 Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 5 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: 0,5 % ≤ C < 5 %
Skin Sens. 1; H317: C ≥ 0,5 % T
3
024-006-00-8 potassium chromate 232-140-5 7789-00-6 Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350i
H340
H319
H335
H315
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350i
H340
H319
H335
H315
H317
H410 Skin Sens. 1; H317: C ≥ 0,5 % 3
024-007-00-3 zinc chromates including zinc potassium chromate — — Carc. 1A
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H317
H410 A
024-008-00-9 calcium chromate 237-366-8 13765-19-0 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 024-009-00-4 strontium chromate 232-142-6 7789-06-2 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H400
H410 024-010-00-X dichromium tris(chromate);
chromium III chromate;
chromic chromate 246-356-2 24613-89-6 Ox. Sol. 1
Carc. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H271
H350
H314
H317
H400
H410 GHS03
GHS08
GHS05
GHS07
GHS09
Dgr H271
H350
H314
H317
H410 T
024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 400-110-2 109125-51-1 Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1 H242
H400
H410 GHS02
GHS09
Dgr H242
H410 024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) 400-810-8 — Muta. 2 H341 GHS08
Wng H341 024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) 402-500-8 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 402-870-0 93952-24-0 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) 404-930-1 — Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H332
H318
H411 GHS05
GHS07
GHS09
Dgr H332
H318
H411 024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 405-110-6 88377-66-6 STOT RE 2 *
Aquatic Chronic 4 H373 **
H413 GHS08
Wng H373 **
H413 024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex — — Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350i
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350i
H317
H410 A
024-018-00-3 sodium chromate 231-889-5 7775-11-3 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410 Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 % 3
024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-230-1 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) 418-220-4 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 025-001-00-3 manganese dioxide 215-202-6 1313-13-9 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 025-002-00-9 potassium permanganate 231-760-3 7722-64-7 Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H272
H302
H400
H410 GHS03
GHS07
GHS09
Dgr H272
H302
H410 025-003-00-4 manganese sulphate 232-089-9 7785-87-7 STOT RE 2 *
Aquatic Chronic 2 H373 **
H411 GHS08
GHS09
Wng H373 **
H411 025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 411-760-1 116633-53-5 Aquatic Chronic 2 H411 GHS09 H411 025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) 417-660-4 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 026-001-00-6 (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate 407-840-0 100011-37-8 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 026-002-00-1 (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate 407-880-9 117549-13-0 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 027-001-00-9 cobalt 231-158-0 7440-48-4 Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4 H334
H317
H413 GHS08
Dgr H334
H317
H413 027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 027-003-00-X cobalt sulphide 215-273-3 1317-42-6 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 027-004-00-5 cobalt dichloride 231-589-4 7646-79-9 Carc. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350i
H302
H334
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350i
H302
H334
H317
H410 Carc. 1B; H350i: C ≥ 0,01 %
* 1
027-005-00-0 cobalt sulphate 233-334-2 10124-43-3 Carc. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350i
H302
H334
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350i
H302
H334
H317
H410 Carc. 1B; H350i: C ≥ 0,01 % 1
028-001-00-1 tetracarbonylnickel;
nickel tetracarbonyl 236-669-2 13463-39-3 Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H225
H351
H360D ***
H330
H400
H410 GHS02
GHS06
GHS08
GHS09
Dgr H225
H351
H360D ***
H330
H410 028-002-00-7 nickel 231-111-4 7440-02-0 Carc. 2
Skin Sens. 1 H351
H317 GHS08
GHS07
Wng H351
H317 028-003-00-2 nickel monoxide 215-215-7 1313-99-1 Carc. 1Ai
Skin Sens. 1
Aquatic Chronic 4 H350i
H317
H413 GHS08
GHS07
Dgr H350i
H317
H413 028-004-00-8 nickel dioxide 234-823-3 12035-36-8 Carc. 1Ai
Skin Sens. 1
Aquatic Chronic 4 H350i
H317
H413 GHS08
GHS07
Dgr H350i
H317
H413 028-005-00-3 dinickel trioxide 215-217-8 1314-06-3 Carc. 1Ai
Skin Sens. 1
Aquatic Chronic 4 H350i
H317
H413 GHS08
GHS07
Dgr H350i
H317
H413 028-006-00-9 nickel sulphide 240-841-2 16812-54-7 Carc. 1Ai
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350i
H317
H400
H410 GHS08
GHS07
GHS07
GHS09
Dgr H350i
H317
H410 028-007-00-4 nickel subsulphide;
trinickel disulphide 234-829-6 12035-72-2 Carc. 1Ai
Skin Sens. 1
Aquatic Chronic 2 H350i
H317
H411 GHS08
GHS07
GHS09
Dgr H350i
H317
H411 028-008-00-X nickel dihydroxide 235-008-5 12054-48-7 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H332
H302
H317
H400
H410 GHS08
GHS07
GHS09
Wng H351
H332
H302
H317
H410 028-009-00-5 nickel sulphate 232-104-9 7786-81-4 Carc. 2
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H334
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H351
H302
H334
H317
H410 028-010-00-0 nickel carbonate 222-068-2 3333-67-3 Carc. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H317
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H317
H410 029-001-00-4 copper chloride;
copper (I) chloride;
cuprous chloride 231-842-9 7758-89-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H400
H410 029-002-00-X dicopper oxide;
copper (I) oxide 215-270-7 1317-39-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 029-003-00-5 Naphthenic acids, copper salts;
copper naphthenate 215-657-0 1338-02-9 Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H226
H302
H400
H410 GHS02
GHS07
GHS09
Wng H226
H302
H410 029-004-00-0 copper sulphate 231-847-6 7758-98-7 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H315
H410 029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid 401-260-1 — Eye Irrit. 2 H319 GHS07
Wng H319 029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) 403-210-4 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 404-670-9 89797-01-3 Skin Sens. 1 H317 GHS07
Wng H317 G
029-008-00-2 copper(II) methanesulfonate 405-400-2 54253-62-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H318
H410 029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 413-650-9 93971-95-0 Aquatic Chronic 3 H412 — H412 029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 407-700-9 101408-30-4 Skin Sens. 1 H317 GHS07
Wng H317 029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 412-730-0 150522-10-4 Skin Corr. 1B H314 GHS05
Dgr H314 029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 407-340-2 124719-24-0 Eye Dam. 1 H318 GHS05
Dgr H318 029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 030-001-00-1 zinc powder — zinc dust (pyrophoric) 231-175-3 7440-66-6 Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1 H260
H250
H400
H410 GHS02
GHS09
Dgr H260
H250
H410 T
030-001-01-9 zinc powder — zinc dust (stabilised) 231-175-3 7440-66-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 030-003-00-2 zinc chloride 231-592-0 7646-85-7 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H410 STOT SE 3; H335: C ≥ 5 % 030-004-00-8 dimethylzinc; [1]
diethylzinc [2] 208-884-1 [1]
209-161-3 [2] 544-97-8 [1]
557-20-0 [2] Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H250
H260
H314
H400
H410 GHS02
GHS05
GHS09
Dgr H250
H260
H314
H410 EUH014 030-005-00-3 diamminediisocyanatozinc 401-610-3 — Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1 H302
H318
H334
H317
H400 GHS05
GHS08
GHS07
GHS09
Dgr H302
H318
H334
H317
H400 030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2] 231-793-3 [1]
231-793-3 [2] 7446-19-7 [1]
7733-02-0 [2] Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H318
H410 030-007-00-4 bis(3,5-di-tert-butylsalicylato-O1,O2)zinc 403-360-0 42405-40-3 Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H228
H302
H400
H410 GHS02
GHS07
GHS09
Dgr H228
H302
H410 T
030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 403-750-0 113036-91-2 Acute Tox. 4 *
Aquatic Chronic 2 H332
H411 GHS07
GHS09
Wng H332
H411 030-011-00-6 trizinc bis(orthophosphate) 231-944-3 7779-90-0 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 030-013-00-7 zinc oxide 215-222-5 1314-13-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 033-001-00-X arsenic 231-148-6 7440-38-2 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 * A
1
033-003-00-0 diarsenic trioxide;
arsenic trioxide 215-481-4 1327-53-3 Carc. 1A
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H300
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H350
H300
H314
H410 033-004-00-6 diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide 215-116-9 1303-28-2 Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H331
H301
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H331
H301
H410 033-005-00-1 arsenic acid and its salts — — Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H331
H301
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H331
H301
H410 A
033-006-00-7 arsine 232-066-3 7784-42-1 Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H220
H330
H373 **
H400
H410 GHS02
GHS04
GHS06
GHS08
GHS09
Dgr H220
H330
H373 **
H410 U
033-007-00-2 tert-butylarsine 423-320-6 4262-43-5 Pyr. Liq. 1
Acute Tox. 2 * H250
H330 GHS02
GHS06
Dgr H250
H330 034-001-00-2 selenium 231-957-4 7782-49-2 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4 H331
H301
H373 **
H413 GHS06
GHS08
Dgr H331
H301
H373 **
H413 034-002-00-8 selenium compounds except cadmium sulphoselenide — — Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H301
H373 **
H410 A
034-003-00-3 sodium selenite 233-267-9 10102-18-8 Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2 H300
H331
H317
H411 GHS06
GHS09
Dgr H300
H331
H317
H411 EUH031 035-001-00-5 bromine 231-778-1 7726-95-6 Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1 H330
H314
H400 GHS06
GHS05
GHS09
Dgr H330
H314
H400 035-002-00-0 hydrogen bromide 233-113-0 10035-10-6 Press. Gas
Skin Corr. 1A
STOT SE 3 H314
H335 GHS04
GHS05
GHS07
Dgr H314
H335 U
035-002-01-8 hydrobromic acid ... % — — Skin Corr. 1B
STOT SE 3 H314
H335 GHS05
GHS07
Dgr H314
H335 Skin Corr. 1B; H314: C ≥ 40 %
Skin Irrit. 2; H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319: 10 % ≤ C < 40 %
STOT SE 3; H335: C ≥ 10 % B
035-003-00-6 potassium bromate 231-829-8 7758-01-2 Ox. Sol. 1
Carc. 1B
Acute Tox. 3 * H271
H350
H301 GHS03
GHS06
GHS08
Dgr H271
H350
H301 035-004-00-1 2-hydroxyethylammonium perbromide 407-440-6 — Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1 H272
H302
H314
H317
H400 GHS03
GHS05
GHS07
GHS09
Dgr H272
H302
H314
H317
H400 040-001-00-3 zirconium powder (pyrophoric) 231-176-9 7440-67-7 Water-react. 1
Pyr. Sol. 1 H260
H250 GHS02
Dgr H260
H250 T
040-002-00-9 zirconium powder, dry (non pyrophoric) — — Self-heat. 1 H251 GHS02
Dgr H251 T
042-001-00-9 molybdenum trioxide 215-204-7 1313-27-5 STOT RE 2 *
Eye Irrit. 2
STOT SE 3 H373 **
H319
H335 GHS08
GHS07
Wng H373 **
H319
H335 042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) 404-760-8 117342-25-3 Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 4 H331
H318
H413 GHS06
GHS05
Dgr H331
H318
H413 042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 404-860-1 116810-46-9 Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H228
H318
H400
H410 GHS02
GHS05
GHS09
Dgr H228
H318
H410 T
042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) 412-780-3 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H315
H317
H411 GHS07
GHS09
Wng H315
H317
H411 047-001-00-2 silver nitrate 231-853-9 7761-88-8 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),
reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 * A
1
048-002-00-0 cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2] 231-152-8 [1]
215-146-2 [2] 7440-43-9 [1]
1306-19-0 [2] Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H341
H361fd
H330
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H341
H361fd
H330
H372 **
H410 048-003-00-6 cadmium diformate;
cadmiumformate 224-729-0 4464-23-7 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H351
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H301
H351
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,25 % 048-004-00-1 cadmium cyanide 208-829-1 542-83-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H351
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H351
H373 **
H410 EUH032 STOT RE 2; H373: C ≥ 0,1 %
EUH032: C ≥ 1 % 048-005-00-7 cadmiumhexafluorosilicate(2-);
cadmium fluorosilica 241-084-0 17010-21-8 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H351
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H301
H351
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,1 % 048-006-00-2 cadmium fluoride 232-222-0 7790-79-6 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H340
H360FD
H330
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H340
H360FD
H330
H301
H372 **
H410 Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2: 0,1 % ≤ C < 7 % 048-007-00-8 cadmium iodide 232-223-6 7790-80-9 Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H351
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H301
H351
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,1 % 048-008-00-3 cadmium chloride 233-296-7 10108-64-2 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H340
H360FD
H330
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H340
H360FD
H330
H301
H372 **
H410 Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 % 048-009-00-9 cadmium sulphate 233-331-6 10124-36-4 Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H340
H360FD
H330
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H340
H360FD
H330
H301
H372 **
H410 Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 % 048-010-00-4 cadmium sulphide 215-147-8 1306-23-6 Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4 H350
H341
H361fd
H372 **
H302
H413 GHS08
GHS07
Dgr H350
H341
H361fd
H372 **
H302
H413 *
STOT RE 1; H372: C ≥ 10 %
STOT RE 2; H373: 0,1 % ≤ C < 10 % 1
048-011-00-X cadmium (pyrophoric) 231-152-8 7440-43-9 Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H250
H350
H341
H361fd
H330
H372 **
H400
H410 GHS02
GHS06
GHS08
GHS09
Dgr H250
H350
H341
H361fd
H330
H372 **
H410 050-001-00-5 tin tetrachloride;
stannic chloride 231-588-9 7646-78-8 Skin Corr. 1B
Aquatic Chronic 3 H314
H412 GHS05
Dgr H314
H412 STOT SE 3; H335: C ≥ 5 % 050-002-00-0 cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide 236-049-1 13121-70-5 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 050-003-00-6 fentin acetate (ISO);
triphenyltin acetate 212-984-0 900-95-8 Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H410 050-004-00-1 fentin hydroxide (ISO);
triphenyltin hydroxide 200-990-6 76-87-9 Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H351
H361d ***
H330
H311
H301
H372 **
H335
H315
H318
H410 050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 * A
1
050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 * A
1
050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 * A
1
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H301
H372 **
H312
H319
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H372 **
H312
H319
H315
H410 * oral
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
* dermal
Eye Irrit. 2; H319: C ≥ 1 %
Skin Irrit. 2; H315: C ≥ 1 % A
1
050-009-00-9 fluorotripentylstannane; [1]
hexapentyldistannoxane [2] 243-546-7 [1]
247-143-7 [2] 20153-49-5 [1]
25637-27-8 [2] Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 * 1
050-010-00-4 fluorotrihexylstannane 243-547-2 20153-50-8 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 * 1
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 * A
1
050-012-00-5 tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3] 215-910-5 [1]
221-437-5 [2]
230-358-5 [3] 1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3] Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 * A
1
050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4 H319
H335
H315
H413 GHS07
Wng H319
H335
H315
H413 Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % A
1
050-017-00-2 fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide 236-407-7 13356-08-6 Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H330
H319
H315
H400
H410 GHS06
GHS09
Dgr H330
H319
H315
H410 050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1 H314
H302
H317 GHS05
GHS07
Dgr H314
H302
H317 050-019-00-3 azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H-1,2,4-triazole 255-209-1 41083-11-8 Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H301
H335
H315
H318
H400
H410 GHS06
GHS05
GHS09
Dgr H330
H301
H335
H315
H318
H410 050-020-00-9 trioctylstannane 413-320-4 869-59-0 STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4 H372 **
H315
H413 GHS08
GHS07
Dgr H372 **
H315
H413 051-001-00-8 antimony trichloride 233-047-2 10025-91-9 Skin Corr. 1B
Aquatic Chronic 2 H314
H411 GHS05
GHS09
Dgr H314
H411 STOT SE 3; H335: C ≥ 5 % 051-002-00-3 antimony pentachloride 231-601-8 7647-18-9 Skin Corr. 1B
Aquatic Chronic 2 H314
H411 GHS05
GHS09
Dgr H314
H411 STOT SE 3; H335: C ≥ 5 % 051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H332
H302
H411 GHS07
GHS09
Wng H332
H302
H411 * A
1
051-004-00-4 antimony trifluoride 232-009-2 7783-56-4 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H331
H311
H301
H411 GHS06
GHS09
Dgr H331
H311
H301
H411 051-005-00-X antimony trioxide 215-175-0 1309-64-4 Carc. 2 H351 GHS08
Wng H351 051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate 403-500-0 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 404-420-9 71786-70-4 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 053-001-00-3 iodine 231-442-4 7553-56-2 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H332
H312
H400 GHS07
GHS09
Wng H332
H312
H400 053-002-00-9 hydrogen iodide 233-109-9 10034-85-2 Press. Gas
Skin Corr. 1A H314 GHS04
GHS05
Dgr H314 Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %
Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %
STOT SE 3; H335: C ≥ 0,02 % U
5
053-002-01-6 hydriodic acid ... % — — Skin Corr. 1B H314 GHS05
Dgr Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 422-960-3 178233-72-2 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Wng H312
H302
H373 **
H410 056-001-00-1 barium peroxide 215-128-4 1304-29-6 Ox. Sol. 2
Acute Tox. 4 *
Acute Tox. 4 * H272
H332
H302 GHS03
GHS07
Dgr H272
H332
H302 056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 * A
1
056-003-00-2 barium carbonate 208-167-3 513-77-9 Acute Tox. 4 * H302 GHS07
Wng H302 056-004-00-8 barium chloride 233-788-1 10361-37-2 Acute Tox. 3 *
Acute Tox. 4 * H301
H332 GHS06
Dgr H301
H332 072-001-00-4 hafnium tetra-n-butoxide 411-740-2 22411-22-9 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 074-001-00-X hexasodium tungstate hydrate 412-770-9 12141-67-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione 408-250-6 — Flam. Liq. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H225
H332
H314
H317
H400
H410 GHS02
GHS05
GHS07
GHS09
Dgr H225
H332
H314
H317
H410 076-001-00-5 osmium tetraoxide;
osmic acid 244-058-7 20816-12-0 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B H330
H310
H300
H314 GHS06
GHS05
Dgr H330
H310
H300
H314 078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H318
H334
H317 A
078-002-00-6 diammonium tetrachloroplatinate 237-499-1 13820-41-2 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H315
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H315
H318
H334
H317 078-003-00-1 disodium tetrachloroplatinate 233-051-4 10026-00-3 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H315
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H315
H318
H334
H317 078-004-00-7 dipotassium tetrachloroplatinate 233-050-9 10025-99-7 Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H315
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H315
H318
H334
H317 078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H318
H334
H317 A
078-006-00-8 disodium hexachloroplatinate 240-983-5 16923-58-3 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H318
H334
H317 078-007-00-3 dipotassium hexachloroplatinate 240-979-3 16921-30-5 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H318
H334
H317 078-008-00-9 diammonium hexachloroplatinate 240-973-0 16919-58-7 Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H301
H318
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H318
H334
H317 078-009-00-4 hexachloroplatinic acid 241-010-7 16941-12-1 Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1 H301
H314
H334
H317 GHS06
GHS05
GHS08
Dgr H301
H314
H334
H317 080-001-00-0 mercury 231-106-7 7439-97-6 Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H373 **
H410 080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,1 % A
1
080-003-00-1 dimercury dichloride;
mercurous chloride;
calomel 233-307-5 10112-91-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H315
H410 080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,1 % A
1
080-005-00-2 mercury difulminate;
mercuric fulminate;
fulminate of mercury 211-057-8 628-86-4 Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H200
H331
H311
H301
H373 **
H400
H410 GHS01
GHS06
GHS08
GHS09
Dgr H200
H331
H311
H301
H373 **
H400
H410 080-005-01-X mercury difulminate;
mercuric fulminate;
fulminate of mercury [≥ 20 % phlegmatiser] 211-057-8 628-86-4 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H331
H311
H301
H373 **
H400
H410 GHS01
GHS06
GHS08
GHS09
Dgr H201
H331
H311
H301
H373 **
H400
H410 080-006-00-8 dimercury dicyanide oxide;
mercuric oxycyanide 215-629-8 1335-31-5 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H331
H311
H301
H373 **
H400
H410 GHS01
GHS06
GHS08
GHS09
Dgr H201
H331
H311
H301
H373 **
H410 T
080-007-00-3 dimethylmercury; [1]
diethylmercury [2] 209-805-3 [1]
211-000-7 [2] 593-74-8 [1]
627-44-1 [2] Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H410 *
STOT RE 2; H373: C ≥ 0,05 % 1
080-008-00-9 phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3] 200-242-9 [1]
202-866-7 [2]
-[3] 55-68-5 [1]
100-57-2 [2]
8003-05-2 [3] Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H301
H372 **
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H301
H372 **
H314
H410 080-009-00-4 2-methoxyethylmercury chloride 204-659-7 123-88-6 Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H301
H372 **
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H301
H372 **
H314
H410 080-010-00-X mercury dichloride;
mercuric chloride 231-299-8 7487-94-7 Acute Tox. 2 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H300
H372 **
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H300
H372 **
H314
H410 080-011-00-5 phenylmercury acetate 200-532-5 62-38-4 Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H301
H372 **
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H301
H372 **
H314
H410 081-001-00-3 thallium 231-138-1 7440-28-0 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4 H330
H300
H373 **
H413 GHS06
GHS08
Dgr H330
H300
H373 **
H413 081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H330
H300
H373 **
H411 GHS06
GHS08
GHS09
Dgr H330
H300
H373 **
H411 A
081-003-00-4 dithallium sulphate;
thallic sulphate 231-201-3 7446-18-6 Acute Tox. 2 *
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 2 H300
H372 **
H315
H411 GHS06
GHS08
GHS09
Dgr H300
H372 **
H315
H411 082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex — — Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H332
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Dgr H360Df
H332
H302
H373 **
H410 Repr. 2; H361f: C ≥ 2,5 %
*
STOT RE 2; H373: C ≥ 0,5 % A
1
082-002-00-1 lead alkyls — — Repr. 1A
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H360Df
H330
H310
H300
H373 **
H410 Repr. 1A; H360D: C ≥ 0,1 %
*
STOT RE 2; H373: C ≥ 0,05 % A
1
082-003-00-7 lead diazide;
lead azide 236-542-1 13424-46-9 Unst. Expl.
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H200
H360Df
H332
H302
H373 **
H400
H410 GHS01
GHS08
GHS07
GHS09
Dgr H200
H360Df
H332
H302
H373 **
H410 1
082-003-01-4 lead diazide;
lead azide [≥ 20 % phlegmatiser] 236-542-1 13424-46-9 Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H360Df
H332
H302
H373 **
H400
H410 GHS01
GHS08
GHS07
GHS09
Dgr H201
H360Df
H332
H302
H373 **
H410 1
082-004-00-2 lead chromate 231-846-0 7758-97-6 Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H351
H360Df
H373 **
H410 1
082-005-00-8 lead di(acetate) 206-104-4 301-04-2 Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H360Df
H373 **
H410 1
082-006-00-3 trilead bis(orthophosphate) 231-205-5 7446-27-7 Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H360Df
H373 **
H410 1
082-007-00-9 lead acetate, basic 215-630-3 1335-32-6 Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H351
H360Df
H373 **
H410 1
082-008-00-4 lead(II) methanesulphonate 401-750-5 17570-76-2 Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1 H360Df
H332
H302
H373 **
H315
H318 GHS08
GHS05
GHS07
Dgr H360Df
H332
H302
H373 **
H315
H318 1
082-009-00-X Lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 215-693-7 1344-37-2 Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H351
H360Df
H373 **
H410 1
082-010-00-5 Lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 235-759-9 12656-85-8 Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H351
H360Df
H373 **
H410 1
082-011-00-0 lead hydrogen arsenate 232-064-2 7784-40-9 Carc. 1A
Repr. 1A
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H360Df
H331
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H360Df
H331
H301
H373 **
H410 1
092-001-00-8 uranium 231-170-6 7440-61-1 Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4 H330
H300
H373 **
H413 GHS06
GHS08
Dgr H330
H300
H373 **
H413 092-002-00-3 uranium compounds — — Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H330
H300
H373 **
H411 GHS06
GHS08
GHS09
Dgr H330
H300
H373 **
H411 A
601-001-00-4 methane 200-812-7 74-82-8 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
601-002-00-X ethane 200-814-8 74-84-0 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
601-003-00-5 propane 200-827-9 74-98-6 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
601-004-00-0 butane; [1]
and isobutane [2] 203-448-7 [1]
200-857-2 [2] 106-97-8 [1]
75-28-5 [2] Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 C U
601-004-01-8 butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] 203-448-7 [1]
200-857-2 [2] 106-97-8 [1]
75-28-5 [2] Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 C S U
601-005-00-6 2,2-dimethylpropane;
neopentane 207-343-7 463-82-1 Flam. Gas 1
Press. Gas
Aquatic Chronic 2 H220
H411 GHS02
GHS04
GHS09
Dgr H220
H411 U
601-006-00-1 pentane 203-692-4 109-66-0 Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2 H225
H304
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H336
H411 EUH066 C
601-007-00-7 hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6)) — — Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2 H225
H304
H315
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H411 C
601-008-00-2 heptane [and isomers] [1] 205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10] 142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10] Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H225
H304
H315
H336
H400
H410 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H410 C
601-009-00-8 octane [and isomers] [1] 203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19] 111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19] Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H225
H304
H315
H336
H400
H410 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H410 C
601-010-00-3 ethylene 200-815-3 74-85-1 Flam. Gas 1
Press. Gas
STOT SE 3 H220
H336 GHS02
GHS04
GHS07
Dgr H220
H336 U
601-011-00-9 propene;
propylene 204-062-1 115-07-1 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
601-012-00-4 but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5] 203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5] 106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5] Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 C U
601-013-00-X 1,3-butadiene;
buta-1,3-diene 203-450-8 106-99-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 D U
601-014-00-5 isoprene (stabilised)
2-methyl-1,3-butadiene 201-143-3 78-79-5 Flam. Liq. 1
Carc. 1B
Muta. 2
Aquatic Chronic 3 H224
H350
H341
H412 GHS02
GHS08
Dgr H224
H350
H341
H412 D
601-015-00-0 acetylene;
ethyne 200-816-9 74-86-2 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 EUH006 U
601-016-00-6 cyclopropane 200-847-8 75-19-4 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
601-017-00-1 cyclohexane 203-806-2 110-82-7 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H225
H304
H315
H336
H400
H410 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H410 601-018-00-7 methylcyclohexane 203-624-3 108-87-2 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2 H225
H304
H315
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H411 601-019-00-2 1,4-dimethylcyclohexane 209-663-2 589-90-2 Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2 H225
H304
H315
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H225
H304
H315
H336
H411 601-020-00-8 benzene 200-753-7 71-43-2 Flam. Liq. 2
Carc. 1A
Muta. 1B
STOT RE 1
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2 H225
H350
H340
H372 **
H304
H319
H315 GHS02
GHS08
GHS07
Dgr H225
H350
H340
H372 **
H304
H319
H315 E
601-021-00-3 toluene 203-625-9 108-88-3 Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3 H225
H361d ***
H304
H373 **
H315
H336 GHS02
GHS08
GHS07
Dgr H225
H361d ***
H304
H373 **
H315
H336 601-022-00-9 o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4] 202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4] 95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4] Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2 H226
H332
H312
H315 GHS02
GHS07
Wng H226
H332
H312
H315 * C
601-023-00-4 ethylbenzene 202-849-4 100-41-4 Flam. Liq. 2
Acute Tox. 4 * H225
H332 GHS02
GHS07
Dgr H225
H332 601-024-00-X cumene; [1]
propylbenzene [2] 202-704-5 [1]
203-132-9 [2] 98-82-8 [1]
103-65-1 [2] Flam. Liq. 3
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2 H226
H304
H335
H411 GHS02
GHS08
GHS07
GHS09
Dgr H226
H304
H335
H411 C
601-025-00-5 mesitylene;
1,3,5-trimethylbenzene 203-604-4 108-67-8 Flam. Liq. 3
STOT SE 3
Aquatic Chronic 2 H226
H335
H411 GHS02
GHS07
GHS09
Wng H226
H335
H411 STOT SE 3; H335: C ≥ 25 % 601-026-00-0 styrene 202-851-5 100-42-5 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H226
H332
H319
H315 GHS02
GHS07
Wng H226
H332
H319
H315 * D
601-027-00-6 2-phenylpropene;
α-methylstyrene 202-705-0 98-83-9 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2 H226
H319
H335
H411 GHS02
GHS07
GHS09
Wng H226
H319
H335
H411 STOT SE 3; H335: C ≥ 25 % 601-028-00-1 2-methylstyrene;
2-vinyltoluene 210-256-7 611-15-4 Acute Tox. 4 *
Aquatic Chronic 2 H332
H411 GHS07
GHS09
Wng H332
H411 601-029-00-7 dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5] 138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5] Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H226
H315
H317
H400
H410 GHS02
GHS07
GHS09
Wng H226
H315
H317
H410 C
601-030-00-2 cyclopentane 206-016-6 287-92-3 Flam. Liq. 2
Aquatic Chronic 3 H225
H412 GHS02
Dgr H225
H412 601-031-00-8 2,4,4-trimethylpent-1-ene 203-486-4 107-39-1 Flam. Liq. 2
Aquatic Chronic 2 H225
H411 GHS02
GHS09
Dgr H225
H411 601-032-00-3 benzo[a]pyrene;
benzo[def]chrysene 200-028-5 50-32-8 Carc. 1B
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H340
H360FD
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H340
H360FD
H317
H410 Carc. 1B; H350: C ≥ 0,01 % 601-033-00-9 benz[a]anthracene 200-280-6 56-55-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 601-034-00-4 benz[e]acephenanthrylene 205-911-9 205-99-2 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 601-035-00-X benzo[j]fluoranthene 205-910-3 205-82-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 601-036-00-5 benzo[k]fluoranthene 205-916-6 207-08-9 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 601-037-00-0 n-hexane 203-777-6 110-54-3 Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2 H225
H361f ***
H304
H373 **
H315
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H225
H361f ***
H304
H373 **
H315
H336
H411 STOT RE 2; H373: C ≥ 5 % 601-041-00-2 dibenz[a,h]anthracene 200-181-8 53-70-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 Carc. 1B; H350: C ≥ 0,01 % 601-042-00-8 biphenyl;
diphenyl 202-163-5 92-52-4 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H410 601-043-00-3 1,2,4-trimethylbenzene 202-436-9 95-63-6 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H226
H332
H319
H335
H315
H411 GHS02
GHS07
GHS09
Wng H226
H332
H319
H335
H315
H411 601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 201-052-9 77-73-6 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H225
H332
H302
H319
H335
H315
H411 GHS02
GHS07
GHS09
Dgr H225
H332
H302
H319
H335
H315
H411 601-045-00-4 1,2,3,4-tetrahydronaphthalene 204-340-2 119-64-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H319
H315
H411 GHS07
GHS09
Wng H319
H315
H411 EUH019 601-046-00-X 7-methylocta-1,6-diene 404-210-7 42152-47-6 Flam. Liq. 3
Aquatic Acute 1
Aquatic Chronic 1 H226
H400
H410 GHS02
GHS09
Wng H226
H410 601-047-00-5 m-mentha-1,3(8)-diene 404-150-1 17092-80-7 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 601-048-00-0 chrysene 205-923-4 218-01-9 Carc. 1B
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1 H350
H341
H400
H410 GHS08
GHS09
Dgr H350
H341
H410 601-049-00-6 benzo[e]pyrene 205-892-7 192-97-2 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 601-051-00-7 4-phenylbut-1-ene 405-980-7 768-56-9 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 601-052-00-2 naphthalene 202-049-5 91-20-3 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H400
H410 GHS07
GHS08
GHS09
Wng H351
H302
H410 601-053-00-8 nonylphenol; [1]
4-nonylphenol, branched [2] 246-672-0 [1]
284-325-5 [2] 25154-52-3 [1]
84852-15-3 [2] Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H361fd
H302
H314
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H361fd
H302
H314
H410 601-054-00-3 reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene 405-570-8 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes 410-190-0 132983-41-6 Eye Irrit. 2
Aquatic Chronic 4 H319
H413 GHS07
Wng H319
H413 601-056-00-4 reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane 405-470-4 73807-39-3 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 421-130-8 156679-41-3 Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H318
H317
H410 601-058-00-5 di-L-para-menthene 417-870-6 83648-84-4 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 420-940-9 15768-07-7 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H319
H315
H411 GHS07
GHS09
Wng H319
H315
H411 601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 417-610-1 155522-09-1 Skin Sens. 1 H317 GHS07
Wng H317 601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) 418-960-8 — Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H314
H317
H411 GHS05
GHS07
GHS09
Dgr H314
H317
H411 601-062-00-7 reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane 417-030-9 151006-59-6 Aquatic Chronic 4 H413 — H413 601-063-00-2 reaction mass of isomers of branched tetracosane 417-060-2 151006-61-0 Acute Tox. 4 *
Aquatic Chronic 4 H332
H413 GHS07
Wng H332
H413 601-064-00-8 branched hexatriacontane 417-070-7 151006-62-1 Aquatic Chronic 4 H413 — H413 601-065-00-3 reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) 416-930-9 — STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2 H373 **
H318
H411 GHS08
GHS05
GHS09
Dgr H373 **
H318
H411 601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone 426-820-2 78531-60-9 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 601-067-00-4 triethyl arsenate 427-700-2 15606-95-8 Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H331
H301
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H331
H301
H410 601-068-00-X 1,2-diacetoxybut-3-ene 421-720-5 18085-02-4 Acute Tox. 4 * H302 GHS07
Wng H302 601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 422-680-1 287933-44-2 Aquatic Chronic 3 H412 — H412 601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 423-830-9 20627-73-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 601-073-00-7 1-bromo-3,5-difluorobenzene 416-710-2 461-96-1 Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H226
H302
H373 **
H315
H317
H400
H410 GHS02
GHS08
GHS07
GHS09
Wng H226
H302
H373 **
H315
H317
H410 601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] 422-040-1 — Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H319
H315
H411 GHS07
GHS09
Wng H319
H315
H411 601-085-00-2 isopentane;
2-methylbutane 201-142-8 78-78-4 Flam. Liq. 1
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2 H224
H304
H336
H411 GHS02
GHS08
GHS07
GHS09
Dgr H224
H304
H336
H411 EUH066 602-001-00-7 chloromethane;
methyl chloride 200-817-4 74-87-3 Flam. Gas 1
Press. Gas
Carc. 2
STOT RE 2 * H220
H351
H373 ** GHS02
GHS04
GHS08
Dgr H220
H351
H373 ** U
602-002-00-2 bromomethane;
methylbromide 200-813-2 74-83-9 Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone H341
H331
H301
H373 **
H319
H335
H315
H400
EUH059 GHS04
GHS06
GHS08
GHS09
Dgr H341
H331
H301
H373 **
H319
H335
H315
H400 EUH059 U
602-003-00-8 dibromomethane 200-824-2 74-95-3 Acute Tox. 4 *
Aquatic Chronic 3 H332
H412 GHS07
Wng H332
H412 * 602-004-00-3 dichloromethane;
methylene chloride 200-838-9 75-09-2 Carc. 2 H351 GHS08
Wng H351 602-005-00-9 methyl iodide;
iodomethane 200-819-5 74-88-4 Carc. 2
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2 H351
H312
H331
H301
H335
H315 GHS06
GHS08
Dgr H351
H312
H331
H301
H335
H315 602-006-00-4 trichloromethane;
chloroform 200-663-8 67-66-3 Carc. 2
Acute Tox. 4 *
STOT RE 2 *
STOT RE 2 *
Skin Irrit. 2 H351
H302
H373 **
H373 **
H315 GHS07
GHS08
Wng H351
H302
H373 **
H373 **
H315 *
STOT RE 2; H373: C ≥ 5 % 602-007-00-X bromoform;
tribromomethane 200-854-6 75-25-2 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H331
H319
H315
H411 GHS06
GHS09
Dgr H331
H319
H315
H411 602-008-00-5 carbon tetrachloride;
tetrachloromethane 200-262-8 56-23-5 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
Ozone H351
H331
H311
H301
H372 **
H412
EUH059 GHS06
GHS08
Dgr H351
H331
H311
H301
H372 **
H412 EUH059 *
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 % 602-009-00-0 chloroethane 200-830-5 75-00-3 Flam. Gas 1
Press. Gas
Carc. 2
Aquatic Chronic 3 H220
H351
H412 GHS02
GHS04
GHS08
Dgr H220
H351
H412 U
602-010-00-6 1,2-dibromoethane 203-444-5 106-93-4 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H350
H331
H311
H301
H319
H335
H315
H411 GHS06
GHS08
GHS09
Dgr H350
H331
H311
H301
H319
H335
H315
H411 * 602-011-00-1 1,1-dichloroethane 200-863-5 75-34-3 Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3 H225
H302
H319
H335
H412 GHS02
GHS07
Dgr H225
H302
H319
H335
H412 * 602-012-00-7 1,2-dichloroethane;
ethylene dichloride 203-458-1 107-06-2 Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H225
H350
H302
H319
H335
H315 GHS02
GHS08
GHS07
Dgr H225
H350
H302
H319
H335
H315 602-013-00-2 1,1,1-trichloroethane;
methyl chloroform 200-756-3 71-55-6 Acute Tox. 4 *
Ozone H332
EUH059 GHS07
Wng H332 EUH059 F
602-014-00-8 1,1,2-trichloroethane 201-166-9 79-00-5 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H351
H332
H312
H302 GHS08
GHS07
Wng H351
H332
H312
H302 EUH066 * 602-015-00-3 1,1,2,2-tetrachloroethane 201-197-8 79-34-5 Acute Tox. 2 *
Acute Tox. 1
Aquatic Chronic 2 H330
H310
H411 GHS06
GHS09
Dgr H330
H310
H411 602-016-00-9 1,1,2,2-tetrabromoethane 201-191-5 79-27-6 Acute Tox. 2 *
Eye Irrit. 2
Aquatic Chronic 3 H330
H319
H412 GHS06
Dgr H330
H319
H412 602-017-00-4 pentachloroethane 200-925-1 76-01-7 Carc. 2
STOT RE 1
Aquatic Chronic 2 H351
H372 **
H411 GHS08
GHS09
Dgr H351
H372 **
H411 STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 % 602-018-00-X 1-chloropropane; [1]
2-chloropropane [2] 208-749-7 [1]
200-858-8 [2] 540-54-5 [1]
75-29-6 [2] Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H312
H302 GHS02
GHS07
Dgr H225
H332
H312
H302 C
602-019-00-5 1-bromopropane;
n-propyl bromide 203-445-0 106-94-5 Flam. Liq. 2
Repr. 1B
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
STOT SE 3 H225
H360FD
H373 **
H319
H335
H315
H336 GHS02
GHS08
GHS07
Dgr H225
H360FD
H373 **
H319
H335
H315
H336 602-020-00-0 1,2-dichloropropane;
propylene dichloride 201-152-2 78-87-5 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H302 GHS02
GHS07
Dgr H225
H332
H302 602-021-00-6 1,2-dibromo-3-chloropropane 202-479-3 96-12-8 Carc. 1B
Muta. 1B
Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H350
H340
H360F ***
H301
H373 **
H412 GHS06
GHS08
Dgr H350
H340
H360F ***
H301
H373 **
H412 602-022-00-1 1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3] 208-846-4 [1]
210-885-7 [2]
210-467-4 [3] 543-59-9 [1]
625-29-6 [2]
616-20-6 [3] Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H312
H302 GHS02
GHS07
Dgr H225
H332
H312
H302 C
602-023-00-7 vinyl chloride;
chloroethylene 200-831-0 75-01-4 Press. Gas
Flam. Gas 1
Carc. 1A H220
H350 GHS02
GHS08
Dgr H220
H350 D U
602-024-00-2 bromoethylene 209-800-6 593-60-2 Press. Gas
Flam. Gas 1
Carc. 1B H220
H350 GHS02
GHS08
Dgr H220
H350 U
602-025-00-8 1,1-dichloroethylene;
vinylidene chloride 200-864-0 75-35-4 Flam. Liq. 1
Carc. 2
Acute Tox. 4 * H224
H351
H332 GHS02
GHS08
GHS07
Dgr H224
H351
H332 * D
602-026-00-3 1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3] 208-750-2 [1]
205-859-7 [2]
205-860-2 [3] 540-59-0 [1]
156-59-2 [2]
156-60-5 [3] Flam. Liq. 2
Acute Tox. 4 *
Aquatic Chronic 3 H225
H332
H412 GHS02
GHS07
Dgr H225
H332
H412 * C
602-027-00-9 trichloroethylene;
trichloroethene 201-167-4 79-01-6 Carc. 1B
Muta. 2
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 3 H350
H341
H319
H315
H336
H412 GHS08
GHS07
Dgr H350
H341
H319
H315
H336
H412 602-028-00-4 tetrachloroethylene 204-825-9 127-18-4 Carc. 2
Aquatic Chronic 2 H351
H411 GHS08
GHS09
Wng H351
H411 602-029-00-X 3-chloropropene;
allyl chloride 203-457-6 107-05-1 Flam. Liq. 2
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400 GHS02
GHS08
GHS07
GHS09
Dgr H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400 D
602-030-00-5 1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2] 208-826-5 [1]
233-195-8 [2] 542-75-6 [1]
10061-01-5 [2] Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H226
H301
H332
H312
H319
H335
H315
H317
H400
H410 GHS02
GHS06
GHS09
Dgr H226
H301
H332
H312
H319
H335
H315
H317
H410 C D
602-031-00-0 1,1-dichloropropene 209-253-3 563-58-6 Flam. Liq. 2
Acute Tox. 3 *
Aquatic Chronic 3 H225
H301
H412 GHS02
GHS06
Dgr H225
H301
H412 602-032-00-6 3-chloro-2-methylpropene 209-251-2 563-47-3 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H225
H332
H302
H314
H317
H411 GHS02
GHS05
GHS07
GHS09
Dgr H225
H332
H302
H314
H317
H411 602-033-00-1 chlorobenzene 203-628-5 108-90-7 Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2 H226
H332
H411 GHS02
GHS07
GHS09
Wng H226
H332
H411 * 602-034-00-7 1,2-dichlorobenzene;
o-dichlorobenzene 202-425-9 95-50-1 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H315
H410 * 602-035-00-2 1,4-dichlorobenzene;
p-dichlorobenzene 203-400-5 106-46-7 Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H319
H400
H410 GHS08
GHS09
Wng H351
H319
H410 602-036-00-8 chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised) 204-818-0 126-99-8 Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H225
H350
H332
H302
H373 **
H319
H335
H315 GHS02
GHS08
GHS07
Dgr H225
H350
H332
H302
H373 **
H319
H335
H315 D
602-037-00-3 α-chlorotoluene;
benzyl chloride 202-853-6 100-44-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H350
H331
H302
H373 **
H335
H315
H318 GHS06
GHS08
GHS05
Dgr H350
H331
H302
H373 **
H335
H315
H318 602-038-00-9 α, α,α-trichlorotoluene;
benzotrichloride 202-634-5 98-07-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H350
H331
H302
H335
H315
H318 GHS06
GHS08
GHS05
Dgr H350
H331
H302
H335
H315
H318 602-039-00-4 polychlorobiphenyls;
PCB 215-648-1 1336-36-3 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H400
H410 GHS08
GHS09
Wng H373 **
H410 STOT RE 2; H373: C ≥ 0,005 % C
602-040-00-X 2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4] 202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4] 95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4] Acute Tox. 4 *
Aquatic Chronic 2 H332
H411 GHS07
GHS09
Wng H332
H411 C
602-041-00-5 penthachloronaphthalene 215-320-8 1321-64-8 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H319
H315
H400
H410 GHS07
GHS09
Wng H312
H302
H319
H315
H410 C
602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex — — Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H301
H312
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H301
H312
H410 A C
602-043-00-6 lindane (ISO);
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane 200-401-2 58-89-9 Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1 H301
H332
H312
H373 **
H362
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H332
H312
H373 **
H362
H410 M=10 602-044-00-1 camphechlor (ISO);
toxaphene; 232-283-3 8001-35-2 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H301
H312
H335
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H301
H312
H335
H315
H410 602-045-00-7 DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane 200-024-3 50-29-3 Carc. 2
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H301
H372 **
H410 602-046-00-2 heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 200-962-3 76-44-8 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H311
H301
H373 **
H410 602-047-00-8 chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 200-349-0 57-74-9 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H312
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H312
H302
H410 602-048-00-3 aldrin (ISO) 206-215-8 309-00-2 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H311
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H311
H301
H372 **
H410 602-049-00-9 dieldrin (ISO) 200-484-5 60-57-1 Carc. 2
Acute Tox. 1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H310
H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H310
H301
H372 **
H410 602-050-00-4 (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;
isodrin 207-366-2 465-73-6 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 602-051-00-X endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 200-775-7 72-20-8 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H311
H400
H410 GHS06
GHS09
Dgr H300
H311
H410 602-052-00-5 endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite 204-079-4 115-29-7 Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H319
H400
H410 GHS06
GHS09
Dgr H311
H301
H319
H410 602-053-00-0 isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 206-045-4 297-78-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1 H310
H300
H400 GHS06
GHS09
Dgr H310
H300
H400 602-054-00-6 3-iodpropene;
allyl iodide 209-130-4 556-56-9 Flam. Liq. 2
Skin Corr. 1B H226
H314 GHS02
GHS05
Dgr H226
H314 602-055-00-1 bromoethane;
ethyl bromide 200-825-8 74-96-4 Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 * H225
H351
H332
H302 GHS02
GHS08
GHS07
Dgr H225
H351
H332
H302 602-056-00-7 α, α,α-trifluorotoluene;
benzotrifluoride 202-635-0 98-08-8 Flam. Liq. 2
Aquatic Chronic 2 H225
H411 GHS02
GHS09
Dgr H225
H411 602-057-00-2 α-bromotoluene;
benzyl bromide 202-847-3 100-39-0 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 602-058-00-8 α, α-dichlorotoluene;
benzylidene chloride;
benzal chloride 202-709-2 98-87-3 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H351
H331
H302
H335
H315
H318 GHS06
GHS08
GHS05
Dgr H351
H331
H302
H335
H315
H318 602-059-00-3 1-chlorobutane;
butyl chloride 203-696-6 109-69-3 Flam. Liq. 2 H225 GHS02
Dgr H225 602-060-00-9 bromobenzene 203-623-8 108-86-1 Flam. Liq. 3
Skin Irrit. 2
Aquatic Chronic 2 H226
H315
H411 GHS02
GHS07
GHS09
Wng H226
H315
H411 602-061-00-4 hexafluoropropene;
hexafluoropropylene 204-127-4 116-15-4 Press. Gas
Acute Tox. 4 *
STOT SE 3 H332
H335 GHS07
Wng H332
H335 U
602-062-00-X 1,2,3-trichloropropane 202-486-1 96-18-4 Carc. 1B
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H350
H360F ***
H332
H312
H302 GHS08
GHS07
Dgr H350
H360F ***
H332
H312
H302 D
602-063-00-5 heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 213-831-0 1024-57-3 Carc. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H301
H373 **
H410 602-064-00-0 1,3-dichloro-2-propanol 202-491-9 96-23-1 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 * H350
H301
H312 GHS06
GHS08
Dgr H350
H301
H312 602-065-00-6 hexachlorobenzene 204-273-9 118-74-1 Carc. 1B
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H372 **
H400
H410 GHS08
GHS09
Dgr H350
H372 **
H410 602-066-00-1 tetrachloro-p-benzoquinone 204-274-4 118-75-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H400
H410 GHS07
GHS09
Wng H319
H315
H410 602-067-00-7 1,3-dichlorbenzene 208-792-1 541-73-1 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 602-068-00-2 ethylene bis(trichloroacetate) 219-732-9 2514-53-6 Skin Irrit. 2 H315 GHS07
Wng H315 602-069-00-8 dichloroacetylene — 7572-29-4 Unst. Expl.
Carc. 2
STOT RE 2 * H200
H351
H373 ** GHS01
GHS08
Wng H200
H351
H373 ** 602-070-00-3 3-chloro-4,5,α, α,α-pentafluorotoluene 401-930-3 77227-99-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H226
H332
H302
H400 GHS02
GHS07
GHS09
Wng H226
H332
H302
H400 602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 402-210-1 99688-47-8 STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H373 **
H317
H410 602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) 278-404-3 76253-60-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 602-073-00-X 1,4-dichlorobut-2-ene 212-121-8 764-41-0 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H330
H311
H301
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H350
H330
H311
H301
H314
H410 Carc. 1B; H350: C ≥ 0,01 %
STOT SE 3; H335: C ≥ 5 % 602-074-00-5 pentachlorobenzene 210-172-0 608-93-5 Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H228
H302
H400
H410 GHS02
GHS07
GHS09
Dgr H228
H302
H410 T
602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 404-060-2 22432-68-4 Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B H330
H302
H314 GHS06
GHS05
Dgr H330
H302
H314 602-076-00-6 2,3,4-trichlorobut-1-ene 219-397-9 2431-50-7 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H331
H302
H319
H335
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H331
H302
H319
H335
H315
H410 Carc. 2; H351: C ≥ 0,1 % 602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex 219-196-6 2385-85-5 Carc. 2
Repr. 2
Lact.
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H361fd
H362
H312
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H361fd
H362
H312
H302
H410 602-078-00-7 hexachlorocyclopentadiene 201-029-3 77-47-4 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H330
H311
H302
H314
H400
H410 GHS06
GHS05
GHS09
Dgr H330
H311
H302
H314
H410 602-079-00-2 2,3-dichloropropene;
2,3-dichloropropylene 201-153-8 78-88-6 Flam. Liq. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H225
H341
H332
H312
H302
H335
H315
H318
H412 GHS02
GHS08
GHS05
GHS07
Dgr H225
H341
H332
H312
H302
H335
H315
H318
H412 602-080-00-8 alkanes, C10-13, chloro 287-476-5 85535-84-8 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 602-081-00-3 2-chloro-4,5-difluorobenzoic acid 405-380-5 — Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H312
H302
H318
H317 GHS05
GHS07
Dgr H312
H302
H318
H317 602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 408-020-5 109678-33-3 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 251-084-2 32534-81-9 STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H362
H400
H410 GHS08
GHS09
Wng H373 **
H362
H410 602-084-00-X 1,1-dichloro-1-fluoroethane 404-080-1 1717-00-6 Aquatic Chronic 3
Ozone H412
EUH059 — H412 EUH059 602-085-00-5 2-bromopropane 200-855-1 75-26-3 Flam. Liq. 2
Repr. 1A
STOT RE 2 * H225
H360F ***
H373 ** GHS02
GHS08
Dgr H225
H360F ***
H373 ** EUH066 602-086-00-0 trifluoroiodomethane;
trifluoromethyl iodide 219-014-5 2314-97-8 Muta. 2 H341 GHS08
Wng H341 602-087-00-6 1,2,4-trichlorobenzene 204-428-0 120-82-1 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H400
H410 GHS07
GHS09
Wng H302
H315
H410 602-088-00-1 2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol 202-480-9 96-13-9 Carc. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H350
H361f ***
H311
H332
H302
H412 GHS08
GHS07
Dgr H350
H361f ***
H311
H332
H302
H412 602-089-00-7 4-bromo-2-chlorofluorobenzene 405-580-2 60811-21-4 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H400
H410 GHS07
GHS09
Wng H302
H315
H410 602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 406-630-6 121626-73-1 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 602-091-00-8 1,3-dichloro-4-fluorobenzene 406-160-1 1435-48-9 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2 H302
H373 **
H315
H411 GHS08
GHS07
Wng H302
H373 **
H315
H411 602-092-00-3 1-bromo-3,4,5-trifluorobenzene 418-480-9 138526-69-9 Flam. Liq. 3
Carc. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H226
H351
H315
H318
H411 GHS02
GHS08
GHS05
GHS09
Dgr H226
H351
H315
H318
H411 602-093-00-9 α, α,α,4-tetrachlorotoluene;
p-chlorobenzotrichloride 226-009-1 5216-25-1 Carc. 1B
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2 H350
H361f ***
H372 **
H312
H302
H335
H315 GHS08
GHS07
Dgr H350
H361f ***
H372 **
H312
H302
H335
H315 602-094-00-4 diphenylether; octabromo derivate 251-087-9 32536-52-0 Repr. 1B H360Df GHS08
Dgr H360Df 602-096-00-5 malachite green hydrochloride; [1]
malachite green oxalate [2] 209-322-8 [1]
219-441-7 [2] 569-64-2 [1]
2437-29-8 [2] Repr. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H302
H318
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H361d ***
H302
H318
H410 602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 422-850-5 148757-89-5 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 603-001-00-X methanol 200-659-6 67-56-1 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1 H225
H331
H311
H301
H370 ** GHS02
GHS06
GHS08
Dgr H225
H331
H311
H301
H370 ** *
STOT SE 1; H370: C ≥ 10 %
STOT SE 2; H371: 3 % ≤ C < 10 % 603-002-00-5 ethanol;
ethyl alcohol 200-578-6 64-17-5 Flam. Liq. 2 H225 GHS02
Dgr H225 603-003-00-0 propan-1-ol;
n-propanol 200-746-9 71-23-8 Flam. Liq. 2
Eye Dam. 1
STOT SE 3 H225
H318
H336 GHS02
GHS05
GHS07
Dgr H225
H318
H336 603-004-00-6 butan-1-ol;
n-butanol 200-751-6 71-36-3 Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3 H226
H302
H335
H315
H318
H336 GHS02
GHS05
GHS07
Dgr H226
H302
H335
H315
H318
H336 603-005-00-1 2-methylpropan-2-ol;
tert-butyl alcohol 200-889-7 75-65-0 Flam. Liq. 2
Acute Tox. 4 * H225
H332 GHS02
GHS07
Dgr H225
H332 603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex 250-378-8 Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3 H226
H332
H335 GHS02
GHS07
Wng H226
H332
H335 EUH066 C
603-007-00-2 2-methylbutan-2-ol;
tert-pentanol 200-908-9 75-85-4 Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2 H225
H332
H335
H315 GHS02
GHS07
Dgr H225
H332
H335
H315 603-008-00-8 4-methylpentan-2-ol;
methyl isobutyl carbinol 203-551-7 108-11-2 Flam. Liq. 3
STOT SE 3 H226
H335 GHS02
GHS07
Wng H226
H335 STOT SE 3; H335: C ≥ 25 % 603-009-00-3 cyclohexanol 203-630-6 108-93-0 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2 H332
H302
H335
H315 GHS07
Wng H332
H302
H335
H315 603-010-00-9 2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3] 209-512-0 [1]
231-187-9 [2]
231-186-3 [3] 583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3] Acute Tox. 4 * H332 GHS07
Wng H332 C
603-011-00-4 2-methoxyethanol;
ethylene glycol monomethyl ether 203-713-7 109-86-4 Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H226
H360FD
H332
H312
H302 GHS02
GHS08
GHS07
Dgr H226
H360FD
H332
H312
H302 603-012-00-X 2-ethoxyethanol;
ethylene glycol monoethyl ether 203-804-1 110-80-5 Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H226
H360FD
H332
H312
H302 GHS02
GHS08
GHS07
Dgr H226
H360FD
H332
H312
H302 603-013-00-5 2-isopropoxyethanol;
ethylene glycol monoisopropyl ether 203-685-6 109-59-1 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2 H332
H312
H319 GHS07
Wng H332
H312
H319 603-014-00-0 2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve 203-905-0 111-76-2 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H332
H312
H302
H319
H315 GHS07
Wng H332
H312
H302
H319
H315 603-015-00-6 allyl alcohol 203-470-7 107-18-6 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H225
H331
H311
H301
H319
H335
H315
H400 GHS02
GHS06
GHS09
Dgr H225
H331
H311
H301
H319
H335
H315
H400 603-016-00-1 4-hydroxy-4-methylpentan-2-one;
diacetone alcohol 204-626-7 123-42-2 Eye Irrit. 2 H319 GHS07
Wng H319 Eye Irrit. 2; H319: C ≥ 10 % 603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 * 603-019-00-8 dimethyl ether 204-065-8 115-10-6 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
603-020-00-3 ethyl methyl ether — 540-67-0 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 U
603-021-00-9 methyl vinyl ether 203-475-4 107-25-5 Flam. Gas 1
Press. Gas H220 GHS02
GHS04
Dgr H220 D U
603-022-00-4 diethyl ether;
ether 200-467-2 60-29-7 Flam. Liq. 1
Acute Tox. 4 *
STOT SE 3 H224
H302
H336 GHS02
GHS07
Dgr H224
H302
H336 EUH019
EUH066 603-023-00-X ethylene oxide;
oxirane 200-849-9 75-21-8 Flam. Gas 1
Press. Gas
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H220
H350
H340
H331
H319
H335
H315 GHS02
GHS04
GHS06
GHS08
Dgr H220
H350
H340
H331
H319
H335
H315 U
603-024-00-5 1,4-dioxane 204-661-8 123-91-1 Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3 H225
H351
H319
H335 GHS02
GHS08
GHS07
Dgr H225
H351
H319
H335 EUH019
EUH066 D
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H335 GHS02
GHS07
Dgr H225
H319
H335 EUH019 Eye Irrit. 2; H319: C ≥ 25 %
STOT SE 3; H335: C ≥ 25 % 603-026-00-6 1-chloro-2,3-epoxypropane;
epichlorhydrin 203-439-8 106-89-8 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H226
H350
H331
H311
H301
H314
H317 GHS02
GHS06
GHS08
GHS05
Dgr H226
H350
H331
H311
H301
H314
H317 * 603-027-00-1 ethanediol;
ethylene glycol 203-473-3 107-21-1 Acute Tox. 4 * H302 GHS07
Wng H302 603-028-00-7 2-chloroethanol;
ethylene chlorohydrin 203-459-7 107-07-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H330
H310
H300 GHS06
Dgr H330
H310
H300 603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 Carc. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H351
H330
H310
H300 GHS06
GHS08
Dgr H351
H330
H310
H300 603-030-00-8 2-aminoethanol;
ethanolamine 205-483-3 141-43-5 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H332
H312
H302
H314 GHS05
GHS07
Dgr H332
H312
H302
H314 STOT SE 3; H335: C ≥ 5 % 603-031-00-3 1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME 203-794-9 110-71-4 Flam. Liq. 2
Repr. 1B
Acute Tox. 4 * H225
H360FD
H332 GHS02
GHS08
GHS07
Dgr H225
H360FD
H332 EUH019 603-032-00-9 ethylene dinitrate;
ethylene glycol dinitrate 211-063-0 628-96-6 Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 * H200
H330
H310
H300
H373 ** GHS01
GHS06
GHS08
Dgr H200
H330
H310
H300
H373 ** 603-033-00-4 oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate 211-745-8 693-21-0 Unst. Expl
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3 H200
H330
H310
H300
H373 **
H412 GHS01
GHS06
GHS08
Dgr H200
H330
H310
H300
H373 **
H412 603-033-01-1 oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate;
[>25 % phlegmatiser] 211-745-8 693-21-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3 H201
H330
H310
H300
H373 **
H412 GHS01
GHS06
GHS08
Dgr H201
H330
H310
H300
H373 **
H412 603-034-00-X glycerol trinitrate;
nitroglycerine 200-240-8 55-63-0 Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H200
H330
H310
H300
H373 **
H411 GHS01
GHS06
GHS08
GHS09
Dgr H200
H330
H310
H300
H373 **
H411 603-034-01-7 glycerol trinitrate;
nitroglycerine;
[>40 % phlegmatiser] 200-240-8 55-63-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H201
H330
H310
H300
H373 **
H411 GHS01
GHS06
GHS08
GHS09
Dgr H201
H330
H310
H300
H373 **
H411 603-035-00-5 pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N. 201-084-3 78-11-5 Unst. Expl. H200 GHS01
Dgr H200 603-035-01-2 pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.;
[>20 % phlegmatiser] 201-084-3 78-11-5 Expl. 1.1 H201 GHS01
Dgr H201 T
603-036-00-0 mannitol hexanitrate;
nitromannite 239-924-6 15825-70-4 Unst. Expl. H200 GHS01
Dgr H200 603-036-01-8 mannitol hexanitrate;
nitromannite;
[>40 % phlegmatiser] 239-924-6 15825-70-4 Expl. 1.1 H201 GHS01
Dgr H201 603-037-00-6 cellulose nitrate; — — Expl. 1.1 H201 GHS01
Dgr H201 EUH001 T
603-038-00-1 allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether 203-442-4 106-92-3 Flam. Liq. 3
Carc. 2
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412 GHS02
GHS08
GHS05
GHS07
Dgr H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412 603-039-00-7 butyl glycidyl ether;
butyl 2,3-epoxypropyl ether 219-376-4 2426-08-6 Flam. Liq. 3
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Chronic 3 H226
H351
H341
H332
H302
H335
H317
H412 GHS02
GHS08
GHS07
Wng H226
H351
H341
H332
H302
H335
H317
H412 603-040-00-2 sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3] 204-699-5 [1]
212-736-1 [2]
212-737-7 [3] 124-41-4 [1]
865-33-8 [2]
865-34-9 [3] Self-heat 1
Skin Corr. 1B H251
H314 GHS02
GHS05
Dgr H251
H314 EUH014 T
603-041-00-8 potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2] 213-029-0 [1]
205-487-5 [2] 917-58-8 [1]
141-52-6 [2] Self-heat 1
Skin Corr. 1B H251
H314 GHS02
GHS05
Dgr H251
H314 EUH014 T
603-042-00-3 aluminium-tri-isopropoxide 209-090-8 555-31-7 Flam. Sol. 1 H228 GHS02
Dgr H228 T
603-043-00-9 triarimol (ISO);
2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol — 26766-27-8 Acute Tox. 4 * H302 GHS07
Wng H302 603-044-00-4 dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol 204-082-0 115-32-2 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H315
H317
H400
H410 GHS07
GHS09
Wng H312
H302
H315
H317
H410 603-045-00-X diisopropyl ether; [1]
dipropyl ether [2] 203-560-6 [1]
203-869-6 [2] 108-20-3 [1]
111-43-3 [2] Flam. Liq. 2
STOT SE 3 H225
H336 GHS02
GHS07
Dgr H225
H336 EUH019
EUH066 C
603-046-00-5 bis (chloromethyl) ether;
oxybis(chloromethane) 208-832-8 542-88-1 Flam. Liq. 2
Carc. 1A
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 * H225
H350
H330
H311
H302 GHS02
GHS06
GHS08
Dgr H225
H350
H330
H311
H302 Carc. 1A; H350: C ≥ 0,001 % 603-047-00-0 2-dimethylaminoethanol;
N,N-dimethylethanolamine 203-542-8 108-01-0 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H226
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H226
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 5 % 603-048-00-6 2-diethylaminoethanol;
N,N-diethylethanolamine 202-845-2 100-37-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H226
H332
H312
H302
H314 GHS02
GHS05
GHS07 GHS09
Dgr H226
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 5 % 603-049-00-1 chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol 201-246-3 80-06-8 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 603-050-00-7 1-(2-butoxypropoxy)propan-2-ol 246-011-6 24083-03-2 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 603-051-00-2 2-ethylbutan-1-ol 202-621-4 97-95-0 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 603-052-00-8 3-butoxypropan-2-ol;
propylene glycol monobutyl ether 225-878-4 5131-66-8 Eye Irrit. 2
Skin Irrit. 2 H319
H315 GHS07
Wng H319
H315 603-053-00-3 2-methylpentane-2,4-diol 203-489-0 107-41-5 Eye Irrit. 2
Skin Irrit. 2 H319
H315 GHS07
Wng H319
H315 603-054-00-9 di-n-butyl ether;
dibutyl ether 205-575-3 142-96-1 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3 H226
H319
H335
H315
H412 GHS02
GHS07
Wng H226
H319
H335
H315
H412 STOT SE 3; H335: C ≥ 10 % 603-055-00-4 propylene oxide;
1,2-epoxypropane;
methyloxirane 200-879-2 75-56-9 Flam. Liq. 1
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H224
H350
H340
H332
H312
H302
H319
H335
H315 GHS02
GHS08
GHS07
Dgr H224
H350
H340
H332
H312
H302
H319
H335
H315 603-056-00-X [(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropyl o-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4] 218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4] 2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4] Muta. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H341
H315
H317
H411 GHS08
GHS07
GHS09
Wng H341
H315
H317
H411 C
603-057-00-5 benzyl alcohol 202-859-9 100-51-6 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 603-058-00-0 1,3-propylene oxide 207-964-3 503-30-0 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H312
H302 GHS02
GHS07
Dgr H225
H332
H312
H302 603-059-00-6 hexan-1-ol 203-852-3 111-27-3 Acute Tox. 4 * H302 GHS07
Wng H302 603-060-00-1 2,2'-bioxirane;
1,2:3,4-diepoxybutane 215-979-1 1464-53-5 Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B H350
H340
H330
H311
H301
H314 GHS06
GHS08
GHS05
Dgr H350
H340
H330
H311
H301
H314 603-061-00-7 tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Eye Irrit. 2 H319 GHS07
Wng H319 603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 203-239-0 104-80-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 STOT SE 3; H335: C ≥ 10 % 603-063-00-8 2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol 209-128-3 556-52-5 Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H350
H341
H360F ***
H331
H312
H302
H319
H335
H315 GHS06
GHS08
Dgr H350
H341
H360F ***
H331
H312
H302
H319
H335
H315 603-064-00-3 1-methoxy-2-propanol;
monopropylene glycol methyl ether 203-539-1 107-98-2 Flam. Liq. 3 H226 GHS02
Wng H226 603-065-00-9 resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene 202-987-5 101-90-6 Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H351
H341
H312
H302
H319
H315
H317
H412 GHS08
GHS07
Wng H351
H341
H312
H302
H319
H315
H317
H412 603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;
vinylcyclohexane diepoxide 203-437-7 106-87-6 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2 H331
H311
H301
H351 GHS06
GHS08
Dgr H331
H311
H301
H351 * 603-067-00-X phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane 204-557-2 122-60-1 Carc. 1B
Muta. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H350
H341
H332
H335
H315
H317
H412 GHS08
GHS07
Dgr H350
H341
H332
H335
H315
H317
H412 603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether — 130014-35-6 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 202-013-9 90-72-2 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H302
H319
H315 GHS07
Wng H302
H319
H315 603-070-00-6 2-amino-2-methylpropanol 204-709-8 124-68-5 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H319
H315
H412 GHS07
Wng H319
H315
H412 603-071-00-1 2,2'-iminodiethanol;
diethanolamine 203-868-0 111-42-2 Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1 H302
H373 **
H315
H318 GHS08
GHS05
GHS07
Dgr H302
H373 **
H315
H318 603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether 219-371-7 2425-79-8 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H332
H312
H319
H315
H317 GHS07
Wng H332
H312
H319
H315
H317 603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 216-823-5 1675-54-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 % 603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700) 500-033-5 25068-38-6 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H315
H317
H411 GHS07
GHS09
Wng H319
H315
H317
H411 Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 % 603-075-00-3 chlormethyl methyl ether;
chlorodimethyl ether 203-480-1 107-30-2 Flam. Liq. 2
Carc. 1A
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H225
H350
H332
H312
H302 GHS02
GHS08
GHS07
Dgr H225
H350
H332
H312
H302 603-076-00-9 but-2-yne-1,4-diol;
2-butyne-1,4-diol 203-788-6 110-65-6 Skin Corr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1 H314
H331
H301
H312
H373 **
H317 GHS06
GHS05
GHS08
Dgr H314
H331
H301
H312
H373 **
H317 Skin Corr. 1B; H314: C ≥ 50 %
Skin Irrit. 2; H315: 25 % ≤ C < 50 %
Eye Irrit. 2; H319: 25 % ≤ C < 50 % D
603-077-00-4 1-dimethylaminopropan-2-ol;
dimepranol (INN) 203-556-4 108-16-7 Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B H226
H302
H314 GHS02
GHS05
GHS07
Dgr H226
H302
H314 603-078-00-X prop-2-yn-1-ol;
propargyl alcohol 203-471-2 107-19-7 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2 H226
H331
H311
H301
H314
H411 GHS02
GHS06
GHS05
GHS09
Dgr H226
H331
H311
H301
H314
H411 603-079-00-5 2,2'-(methylimino)diethanol;
N-methyldiethanolamine 203-312-7 105-59-9 Eye Irrit. 2 H319 GHS07
Wng H319 603-080-00-0 2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol 203-710-0 109-83-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05 GHS07
Dgr H312
H302
H314 STOT SE 3; H335: C ≥ 5 % 603-081-00-6 2,2'-thiodiethanol;
thiodiglycol 203-874-3 111-48-8 Eye Irrit. 2 H319 GHS07
Wng H319 603-082-00-1 1-aminopropan-2-ol;
isopropanolamine 201-162-7 78-96-6 Skin Corr. 1B H314 GHS05
Dgr H314 603-083-00-7 1,1'-iminodipropan-2-ol;
di-isopropanolamine 203-820-9 110-97-4 Eye Irrit. 2 H319 GHS07
Wng H319 603-084-00-2 styrene oxide;
(epoxyethyl)benzene;
phenyloxirane 202-476-7 96-09-3 Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2 H350
H312
H319 GHS08
GHS07
Dgr H350
H312
H319 603-085-00-8 bronopol (INN);
2-bromo-2-nitropropane-1,3-diol 200-143-0 52-51-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1 H312
H302
H335
H315
H318
H400 GHS05
GHS07
GHS09
Dgr H312
H302
H335
H315
H318
H400 603-086-00-3 ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol 245-949-3 23947-60-6 Acute Tox. 4 * H312 GHS07
Wng H312 603-087-00-9 2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol 202-377-9 94-96-2 Eye Dam. 1 H318 GHS05
Dgr H318 603-088-00-4 2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide 222-598-4 3547-33-9 Eye Dam. 1 H318 GHS05
Dgr H318 603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol 400-390-6 — Skin Corr. 1A
Acute Tox. 4 * H314
H302 GHS05
GHS07
Dgr H314
H302 603-090-00-5 2-(2-bromoethoxy)anisole 402-010-4 4463-59-6 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 402-470-6 87172-89-2 Acute Tox. 4 *
Eye Dam. 1 H302
H318 GHS05
GHS07
Dgr H302
H318 603-092-00-6 2-methyl-4-phenylpentanol 402-770-7 92585-24-5 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 603-093-00-1 cinmethylin (ISO);
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane 402-410-9 87818-31-3 Acute Tox. 4 *
Aquatic Chronic 2 H332
H411 GHS07
GHS09
Dgr H332
H411 603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 241-536-7 17557-23-2 Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 603-095-00-2 2-(propyloxy)ethanol;
EGPE 220-548-6 2807-30-9 Acute Tox. 4 *
Eye Irrit. 2 H312
H319 GHS07
Wng H312
H319 603-096-00-8 2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether 203-961-6 112-34-5 Eye Irrit. 2 H319 GHS07
Wng H319 603-097-00-3 1,1',1''-nitrilotripropan-2-ol;
triisopropanolamine 204-528-4 122-20-3 Eye Irrit. 2
Aquatic Chronic 3 H319
H412 GHS07
Wng H319
H412 603-098-00-9 2-phenoxyethanol 204-589-7 122-99-6 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 403-440-5 93633-79-5 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 603-100-00-8 1,2-dimethoxypropane 404-630-0 7778-85-0 Flam. Liq. 2 H225 GHS02
Dgr H225 EUH019 603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Eye Irrit. 2 H319 GHS07
Wng H319 603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3 H225
H351
H332
H312
H302
H319
H335
H315
H412 GHS02
GHS08
GHS07
Dgr H225
H351
H332
H312
H302
H319
H335
H315
H412 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 603-104-00-X fenarimol (ISO);
2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol 262-095-7 60168-88-9 Repr. 2
Lact.
Aquatic Chronic 2 H361fd
H362
H411 GHS08 GHS09
Wng H361fd
H362
H411 603-105-00-5 furan 203-727-3 110-00-9 Flam. Liq. 1
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3 H224
H350
H341
H332
H302
H373 **
H315
H412 GHS02
GHS08
GHS07
Dgr H224
H350
H341
H332
H302
H373 **
H315
H412 EUH019 603-106-00-0 2-methoxypropanol 216-455-5 1589-47-5 Flam. Liq. 3
Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H226
H360D ***
H335
H315
H318 GHS02
GHS08
GHS05
GHS07
Dgr H226
H360D ***
H335
H315
H318 603-107-00-6 2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether 203-906-6 111-77-3 Repr. 2 H361d *** GHS08
Wng H361d *** 603-108-00-1 2-methylpropan-1-ol;
iso-butanol 201-148-0 78-83-1 Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3 H226
H335
H315
H318
H336 GHS02
GHS05
GHS07
Dgr H226
H335
H315
H318
H336 603-117-00-0 propan-2-ol;
isopropyl alcohol;
isopropanol 200-661-7 67-63-0 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 603-118-00-6 6-dimethylaminohexan-1-ol 404-680-3 1862-07-3 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3 H302
H314
H412 GHS05
GHS07
Dgr H302
H314
H412 603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) 405-840-5 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 603-120-00-7 2-methyl-5-phenylpentanol 405-890-8 25634-93-9 Eye Irrit. 2
Skin Irrit. 2 H319
H315 GHS07
Wng H319
H315 603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 406-057-1 114565-66-1 Carc. 2
Skin Sens. 1
Aquatic Chronic 4 H351
H317
H413 GHS08
GHS07
Wng H351
H317
H413 603-122-00-8 sodium 2-ethylhexanolate 406-150-7 38411-13-1 Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3 H228
H314
H412 GHS02
GHS05
Dgr H228
H314
H412 T
603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 406-330-5 122760-84-3 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H315
H317
H411 GHS07
GHS09
Wng H315
H317
H411 603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 406-900-3 84563-49-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol 407-850-5 89544-40-1 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 408-090-7 100418-33-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H302
H317
H412 GHS07
Wng H302
H317
H412 603-127-00-5 butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4] 201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4] 78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4] Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3 H226
H319
H335
H336 GHS02
GHS07
Wng H226
H319
H335
H336 C
603-128-00-0 2-(phenylmethoxy)naphthalene 405-490-3 613-62-7 Aquatic Chronic 4 H413 — H413 603-129-00-6 1-tert-butoxypropan-2-ol 406-180-0 57018-52-7 Flam. Liq. 3
Eye Dam. 1 H226
H318 GHS02
GHS05
Dgr H226
H318 603-130-00-1 reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) 406-325-8 — Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) 407-290-1 — Eye Dam. 1 H318 GHS05
Dgr H318 603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 408-200-3 63187-91-7 Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H315
H318
H412 GHS05
Dgr H315
H318
H412 603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) 408-240-1 — Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. 410-450-3 — Aquatic Chronic 4 H413 — H413 603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium 410-500-4 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 410-910-3 104226-19-9 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol 411-130-6 — Eye Dam. 1 H318 GHS05
Dgr H318 603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol 403-140-4 103694-68-4 Aquatic Chronic 3 H412 — H412 603-139-00-0 bis(2-methoxyethyl) ether 203-924-4 111-96-6 Flam. Liq. 3
Repr. 1B H226
H360FD GHS02
GHS08
Dgr H226
H360FD EUH019 603-140-00-6 2,2' -oxybisethanol;
diethylene glycol 203-872-2 111-46-6 Acute Tox. 4 * H302 GHS07
Wng H302 603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane 413-780-6 — Aquatic Chronic 3 H412 — H412 603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 407-360-1 116230-20-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1 H312
H302
H373 **
H315
H318 GHS06
GHS08
GHS05
Dgr H312
H302
H373 **
H315
H318 603-143-00-2 R—2,3-epoxy-1-propanol 404-660-4 57044-25-4 Self-react. C ****
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H242
H350
H341
H360F ***
H331
H312
H302
H314 GHS02
GHS06
GHS08
GHS05
Dgr H242
H350
H341
H360F ***
H331
H312
H302
H314 603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol 413-530-6 111850-00-1 Aquatic Chronic 2 H411 GHS09 H411 603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 406-970-5 129228-11-1 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 406-080-7 83016-70-0 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3 H302
H314
H412 GHS05
GHS07
Dgr H302
H314
H412 603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 406-030-4 105812-81-5 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 413-370-7 17351-75-6 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07 GHS09
Wng H317
H411 603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 407-640-3 63767-86-2 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H319
H315
H411 GHS07 GHS09
Wng H319
H315
H411 603-150-00-0 (±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 411-580-3 107898-54-4 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol 413-570-4 — Aquatic Chronic 3 H412 — H412 603-152-00-1 2-(4-tert-butylphenyl)ethanol 410-020-5 5406-86-0 Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2 H361f ***
H373 **
H318
H411 GHS08
GHS05
GHS09
Dgr H361f ***
H373 **
H318
H411 603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 410-010-0 104333-00-8 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 412-300-2 139504-68-0 Aquatic Chronic 2 H411 GHS09 H411 603-155-00-8 Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane 410-560-1 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 411-210-0 89544-48-9 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 411-450-6 143747-72-2 Aquatic Chronic 4 H413 — H413 603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene 412-460-3 — Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07 GHS09
Wng H315
H411 603-159-00-X 2-cyclododecylpropan-1-ol 411-410-8 118562-73-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 603-160-00-5 1,2-diethoxypropane 412-180-1 10221-57-5 Flam. Liq. 2 H225 GHS02
Dgr H225 EUH019 603-161-00-0 1,3-diethoxypropane 413-140-6 3459-83-4 Flam. Liq. 3 H226 GHS02
Wng H226 603-162-00-6 α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 413-420-8 144736-29-8 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H314
H317
H411 GHS05
GHS07
GHS09
Dgr H314
H317
H411 603-163-00-1 2-phenyl-1,3-propanediol 411-810-2 1570-95-2 Eye Dam. 1 H318 GHS05
Dgr H318 603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 412-420-5 133909-99-6 Aquatic Chronic 4 H413 — H413 603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol 417-470-1 — Muta. 2
Skin Sens. 1 H341
H317 GHS08
GHS07
Wng H341
H317 603-166-00-8 R-1-chloro-2,3-epoxypropane 424-280-2 51594-55-9 Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H226
H350
H331
H311
H301
H314
H317 GHS02
GHS06
GHS08
GHS05
Dgr H226
H350
H331
H311
H301
H314
H317 603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 407-920-5 6390-69-8 Aquatic Chronic 4 H413 GHS05
Dgr H413 603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 408-080-2 70445-33-9 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 415-550-0 109887-53-8 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol 415-990-3 67739-11-1 Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 603-171-00-5 5-thiazolylmethanol 414-780-9 38585-74-9 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 415-180-1 773058-82-5 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 421-750-9 57280-22-5 Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 420-630-3 83926-73-2 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 603-175-00-7 2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol 203-988-3 112-59-4 Acute Tox. 4 *
Eye Dam. 1 H312
H318 GHS05
GHS07
Dgr H312
H318 603-176-00-2 1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme 203-977-3 112-49-2 Repr. 1B H360Df GHS08
Dgr H360Df EUH019 603-177-00-8 1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2] 216-374-5 [1]
259-370-9 [2] 1569-02-4 [1]
54839-24-6 [2] Flam. Liq. 3
STOT SE 3 H226
H336 GHS02
GHS07
Wng H226
H336 603-178-00-3 2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol 203-951-1 112-25-4 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 603-179-00-9 ergocalciferol (ISO);
Vitamin D2 200-014-9 50-14-6 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1 H330
H311
H301
H372 ** GHS06
GHS08
Dgr H330
H311
H301
H372 ** 603-180-00-4 colecalciferol;
Vitamin D3 200-673-2 67-97-0 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1 H330
H311
H301
H372 ** GHS06
GHS08
Dgr H330
H311
H301
H372 ** 603-181-00-X tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane 216-653-1 1634-04-4 Flam. Liq. 2
Skin Irrit. 2 H225
H315 GHS02
GHS07
Dgr H225
H315 603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol 205-592-6 143-22-6 Eye Dam. 1 H318 GHS05
Dgr H318 Eye Dam. 1; H318: C ≥ 30 %
Eye Irrit. 2; H319: 20 % ≤ C < 30 % 603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 416-380-1 146925-83-9 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 420-740-1 99817-36-4 Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H318
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H301
H318
H317
H410 603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 419-050-3 79944-37-9 Skin Sens. 1 H317 GHS07
Wng H317 603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 419-360-9 163661-77-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol 405-250-8 — Aquatic Chronic 2 H411 GHS09 H411 603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 419-740-4 137658-79-8 Aquatic Chronic 4 H413 — H413 603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 430-810-3 154825-62-4 Aquatic Chronic 3 H412 — H412 603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2 H302
H373 **
H411 GHS08
GHS07
GHS09
Wng H302
H373 **
H411 603-197-00-7 tebuconazole (ISO);
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2 H361d ***
H302
H411 GHS08
GHS07
GHS09
Wng H361d ***
H302
H411 603-199-00-8 etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 M = 100 604-001-00-2 phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol 203-632-7 108-95-2 Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B H341
H331
H311
H301
H373 **
H314 GHS06
GHS08 GHS05
Dgr H341
H331
H311
H301
H373 **
H314 *
Skin Corr. 1B; H314: C ≥ 3 %
Skin Irrit. 2; H315: 1 % ≤ C < 3 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 % 604-002-00-8 pentachlorophenol 201-778-6 87-86-5 Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H330
H311
H301
H319
H335
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H330
H311
H301
H319
H335
H315
H410 604-003-00-3 sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2] 205-025-2 [1]
231-911-3 [2] 131-52-2 [1]
7778-73-6 [2] Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H330
H311
H301
H319
H335
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H330
H311
H301
H319
H335
H315
H410 604-004-00-9 m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4] 203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4] 108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4] Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B H311
H301
H314 GHS06
GHS05
Dgr H311
H301
H314 * C
604-005-00-4 1,4-dihydroxybenzene;
hydroquinone;
quinol 204-617-8 123-31-9 Carc. 2
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H351
H341
H302
H318
H317
H400 GHS08
GHS05
GHS07
GHS09
Dgr H351
H341
H302
H318
H317
H400 604-006-00-X 3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7] 202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7] 95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7] Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2 H311
H301
H314
H411 GHS06
GHS05
GHS09
Dgr H311
H301
H314
H411 C
604-007-00-5 2-naphthol 205-182-7 135-19-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H332
H302
H400 GHS07
GHS09
Wng H332
H302
H400 604-008-00-0 2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4] 202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4] 95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4] Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H332
H312
H302
H411 GHS07 GHS09
Wng H332
H312
H302
H411 C
604-009-00-6 pyrogallol;
1,2,3-trihydroxybenzene 201-762-9 87-66-1 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H341
H332
H312
H302
H412 GHS08
GHS07
Wng H341
H332
H312
H302
H412 * 604-010-00-1 resorcinol;
1,3-benzenediol 203-585-2 108-46-3 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1 H302
H319
H315
H400 GHS07
GHS09
Wng H302
H319
H315
H400 * 604-011-00-7 2,4-dichlorophenol 204-429-6 120-83-2 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2 H311
H302
H314
H411 GHS06
GHS05
GHS09
Dgr H311
H302
H314
H411 604-012-00-2 4-chloro-o-cresol;
4-chloro-2-methyl phenol 216-381-3 1570-64-5 Acute Tox. 3 *
Skin Corr. 1A
Aquatic Acute 1 H331
H314
H400 GHS06
GHS05
GHS09
Dgr H331
H314
H400 STOT SE 3; H335: C ≥ 1 % 604-013-00-8 2,3,4,6-tetrachlorophenol 200-402-8 58-90-2 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H301
H319
H315
H400
H410 GHS06
GHS09
Dgr H301
H319
H315
H410 *
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 % 604-014-00-3 chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol 200-431-6 59-50-7 Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H312
H302
H318
H317
H400 GHS05
GHS07
GHS09
Dgr H312
H302
H318
H317
H400 * 604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene 200-733-8 70-30-4 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H301
H400
H410 GHS06
GHS09
Dgr H311
H301
H410 * 604-016-00-4 1,2-dihydroxybenzene;
pyrocatechol 204-427-5 120-80-9 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H312
H302
H319
H315 GHS07
Wng H312
H302
H319
H315 604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H315
H410 *
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 % 604-018-00-5 2,4,6-trichlorophenol 201-795-9 88-06-2 Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H319
H315
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H319
H315
H410 604-019-00-0 dichlorophen (ISO) 202-567-1 97-23-4 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H400
H410 GHS07
GHS09
Wng H302
H319
H410 604-020-00-6 2-phenylphenol (ISO)
biphenyl-2-ol;
2-hydroxybiphenyl; 201-993-5 90-43-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H319
H335
H315
H400 GHS07
GHS09
Wng H319
H335
H315
H400 604-021-00-1 sodium 2-biphenylate;
2-phenylphenol, sodium salt 205-055-6 132-27-4 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1 H302
H335
H315
H318
H400 GHS05
GHS07
GHS09
Wng H302
H335
H315
H318
H400 604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 400-900-7 22961-82-6 Eye Dam. 1 H318 GHS05
Dgr H318 604-023-00-2 2,4-dichloro-3-ethylphenol 401-060-4 — Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 604-024-00-8 4,4-isobutylethylidenediphenol 401-720-1 6807-17-6 Repr. 1B
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H360F ***
H319
H400
H410 GHS08
GHS09
Dgr H360F ***
H319
H410 604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone 400-220-0 — Aquatic Chronic 2 H411 GHS09 H411 604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) 400-270-3 — Aquatic Chronic 2 H411 GHS09 H411 604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone 400-530-6 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 604-028-00-X 4-amino-3-fluorophenol 402-230-0 399-95-1 Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H350
H302
H317
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H317
H411 604-029-00-5 1-naphtol 201-969-4 90-15-3 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H312
H302
H335
H315
H318 GHS05
GHS07
Dgr H312
H302
H335
H315
H318 604-030-00-0 bisphenol A;
4,4'-isopropylidenediphenol 201-245-8 80-05-7 Repr. 2
STOT SE 3
Eye Dam. 1
Skin Sens. 1 H361f ***
H335
H318
H317 GHS08
GHS05 GHS07
Dgr H361f ***
H335
H318
H317 604-031-00-6 guaiacol 201-964-7 90-05-1 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H302
H319
H315 GHS07
Wng H302
H319
H315 604-032-00-1 thymol 201-944-8 89-83-8 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2 H302
H314
H411 GHS05
GHS07
GHS09
Dgr H302
H314
H411 604-033-00-7 isobutyl but-3-enoate 401-170-2 24342-03-8 Flam. Liq. 3 H226 GHS02
Wng H226 604-034-00-2 4,4'-thiodi-o-cresol 403-330-7 24197-34-0 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol 404-160-6 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 404-590-4 90884-29-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 604-037-00-9 3,5-xylenol;
3,5-dimethylphenol 203-606-5 108-68-9 Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B H311
H301
H314 GHS06
GHS05
Dgr H311
H301
H314 604-038-00-4 4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2] 201-793-8 [1]
215-316-6 [2] 88-04-0 [1]
1321-23-9 [2] Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H302
H319
H315
H317 GHS07
Wng H302
H319
H315
H317 604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl 266-362-9 66441-23-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 604-040-00-5 fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide 276-439-9 72178-02-0 Acute Tox. 4 * H302 GHS07
Wng H302 604-041-00-0 acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2] 256-634-5 [1]
263-560-7 [2] 50594-66-6 [1]
62476-59-9 [2] Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H315
H318
H410 604-042-00-6 4-nitrosophenol 203-251-6 104-91-6 Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H341
H302
H318
H411 GHS08
GHS05
GHS07
GHS09
Dgr H341
H302
H318
H411 604-043-00-1 monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether 203-083-3 103-16-2 Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 604-044-00-7 mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether 205-769-8 150-76-5 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1 H302
H319
H317 GHS07
Wng H302
H319
H317 604-045-00-2 2,3,5-trimethylhydroquinone 211-838-3 700-13-0 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H335
H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H332
H335
H315
H318
H317
H410 604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 405-520-5 95235-30-6 Aquatic Chronic 2 H411 GHS09 H411 604-047-00-3 4-(4-tolyloxy)biphenyl 405-730-7 51601-57-1 STOT RE 2 *
Aquatic Chronic 4 H373 **
H413 GHS08
Wng H373 **
H413 604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 405-800-7 27955-94-8 Aquatic Chronic 2 H411 GHS09 H411 604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 407-480-4 93589-69-6 Aquatic Chronic 2 H411 GHS09 H411 604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 401-110-5 87113-78-8 Aquatic Chronic 3 H412 — H412 604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 403-800-1 103597-45-1 Aquatic Chronic 4 H413 — H413 604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 410-760-9 157661-93-3 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol 412-020-0 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 413-900-7 85954-11-6 Muta. 2 H341 GHS08
Wng H341 604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 412-520-9 99610-72-7 Flam. Sol. 2
Repr. 2
Acute Tox. 4 * H228
H361f ***
H302 GHS02
GHS07
GHS08
Dgr H228
H361f ***
H302 604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 401-680-5 — Aquatic Chronic 2 H411 GHS09 H411 604-058-00-3 1,2-bis(3-methylphenoxy)ethane 402-730-9 54914-85-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 604-059-00-9 2-n-hexadecylhydroquinone 406-400-5 — STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4 H373 **
H315
H317
H413 GHS08
GHS07
Wng H373 **
H315
H317
H413 604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 406-950-6 3236-71-3 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H400
H410 GHS07
GHS09
Wng H319
H315
H410 604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl 407-740-7 — Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H315
H317
H412 GHS07
Wng H315
H317
H412 604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol 411-220-5 — Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 604-063-00-0 5,6-dihydroxyindole 412-130-9 3131-52-0 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05 GHS07
GHS09
Dgr H302
H318
H411 604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 411-380-6 147315-50-2 Aquatic Chronic 4 H413 — H413 604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 407-460-5 111850-25-0 Aquatic Chronic 2 H411 GHS09 H411 604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol 414-550-8 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) 414-520-4 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 415-170-5 90274-24-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1 H332
H302
H317 GHS07
Wng H332
H302
H317 604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 421-740-4 51390-14-8 Skin Corr. 1B
Aquatic Chronic 2 H314
H411 GHS05
GHS09
Dgr H314
H411 604-070-00-9 triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol 222-182-2 3380-34-5 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H400
H410 GHS07
GHS09
Wng H319
H315
H410 M = 100 605-001-00-5 formaldehyde ...% 200-001-8 50-00-0 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H351
H331
H311
H301
H314
H317 GHS06
GHS08
GHS05
Dgr H351
H331
H311
H301
H314
H317 *
Skin Corr. 1B; H314: C ≥25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 5 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 5 %
Skin Sens. 1; H317: C ≥ 0,2 % B D
605-002-00-0 1,3,5-trioxan;
trioxymethylene 203-812-5 110-88-3 Flam. Sol. 1
Repr. 2
STOT SE 3 H228
H361d ***
H335 GHS02
GHS08
GHS07
Dgr H228
H361d ***
H335 T
605-003-00-6 acetaldehyde;
ethanal 200-836-8 75-07-0 Flam. Liq. 1
Carc. 2
Eye Irrit. 2
STOT SE 3 H224
H351
H319
H335 GHS02
GHS08
GHS07
Dgr H224
H351
H319
H335 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxan;
paraldehyde 204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02
Dgr H226 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde 203-600-2 108-62-3 Flam. Sol. 2
Acute Tox. 4 * H228
H302 GHS02
GHS07
Wng H228
H302 605-006-00-2 butyraldehyde 204-646-6 123-72-8 Flam. Liq. 2 H225 GHS02
Dgr H225 605-007-00-8 1,1-dimethoxyethane;
dimethyl acetal 208-589-8 534-15-6 Flam. Liq. 2 H225 GHS02
Dgr H225 605-008-00-3 acrylaldehyde;
acrolein;
prop-2-enal 203-453-4 107-02-8 Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H225
H330
H311
H301
H314
H400 GHS02
GHS06
GHS05
GHS09
Dgr H225
H330
H311
H301
H314
H400 D
605-009-00-9 crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2] 224-030-0 [1]
204-647-1 [2] 4170-30-3 [1]
123-73-9 [2] Flam. Liq. 2
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1 H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400 605-010-00-4 2-furaldehyde 202-627-7 98-01-1 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H351
H331
H301
H312
H319
H335 GHS06
GHS08
Dgr H351
H331
H301
H312
H319
H335 * 605-011-00-X 2-chlorobenzaldehyde;
o-chlorobenzaldehyde 201-956-3 89-98-5 Skin Corr. 1B H314 GHS05
Dgr H314 605-012-00-5 benzaldehyde 202-860-4 100-52-7 Acute Tox. 4 * H302 GHS07
Wng H302 605-013-00-0 chloralose (INN);
(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;
glucochloralose;
anhydroglucochloral 240-016-7 15879-93-3 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 605-014-00-6 chloral hydrate;
2,2,2-trichloroethane-1,1-diol 206-117-5 302-17-0 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2 H301
H319
H315 GHS06
Dgr H301
H319
H315 605-015-00-1 1,1-diethoxyethane;
acetal 203-310-6 105-57-7 Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2 H225
H319
H315 GHS02
GHS07
Dgr H225
H319
H315 605-016-00-7 glyoxal...%;
ethandial...% 203-474-9 107-22-2 Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H341
H332
H319
H315
H317 GHS07
GHS08
Wng H341
H332
H319
H315
H317 * B
605-017-00-2 1,3-dioxolane 211-463-5 646-06-0 Flam. Liq. 2 H225 GHS02
Dgr H225 605-018-00-8 propanal;
propionaldehyde 204-623-0 123-38-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H225
H319
H335
H315 GHS02
GHS07
Dgr H225
H319
H335
H315 605-019-00-3 citral 226-394-6 5392-40-5 Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 605-020-00-9 safrole;
5-allyl-1,3-benzodioxole 202-345-4 94-59-7 Carc. 1B
Muta. 2
Acute Tox. 4 * H350
H341
H302 GHS08
GHS07
Dgr H350
H341
H302 605-021-00-4 formaldehyde, reaction products with butylphenol 294-145-9 91673-30-2 Skin Sens. 1 H317 GHS07
Wng H317 605-022-00-X glutaral;
glutaraldehyde;
1,5-pentanedial 203-856-5 111-30-8 Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1 H331
H301
H314
H334
H317
H400 GHS06
GHS08
GHS05
GHS09
Dgr H331
H301
H314
H334
H317
H400 *
Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 10 %
Eye Dam. ; H318: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
STOT SE; H335: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 % 605-025-00-6 chloroacetaldehyde 203-472-8 107-20-0 Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H351
H330
H311
H301
H314
H400 GHS06
GHS08
GHS05
GHS09
Dgr H351
H330
H311
H301
H314
H400 STOT SE 3; H335: C ≥ 5 % 605-026-00-1 2,5,7,7-tetramethyloctanal 405-690-0 114119-97-0 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H315
H317
H411 GHS07 GHS09
Wng H315
H317
H411 605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde 410-480-7 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 605-028-00-2 β-methyl-3-(1-methylethyl)-benzenepropanal 412-050-4 125109-85-5 Aquatic Chronic 2 H411 GHS09 H411 605-029-00-8 2-cyclohexylpropanal 412-270-0 2109-22-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 411-510-1 3353-51-3 Skin Sens. 1 H317 GHS07
Wng H317 605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)] 421-890-0 — Skin Sens. 1 H317 GHS07
Wng H317 606-001-00-8 acetone;
propan-2-one;
propanone 200-662-2 67-64-1 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 EUH066 606-002-00-3 butanone;
ethyl methyl ketone 201-159-0 78-93-3 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 EUH066 606-003-00-9 heptan-3-one;
butyl ethyl ketone 203-388-1 106-35-4 Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2 H226
H332
H319 GHS02
GHS07
Wng H226
H332
H319 606-004-00-4 4-methylpentan-2-one;
isobutyl methyl ketone 203-550-1 108-10-1 Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H225
H332
H319
H335 GHS02
GHS07
Dgr H225
H332
H319
H335 EUH066 606-005-00-X 2,6-dimethylheptan-4-one;
di-isobutyl ketone 203-620-1 108-83-8 Flam. Liq. 3
STOT SE 3 H226
H335 GHS02
GHS07
Wng H226
H335 STOT SE 3; H335: C ≥ 10 % 606-006-00-5 pentan-3-one;
diethyl ketone 202-490-3 96-22-0 Flam. Liq. 2
STOT SE 3
STOT SE 3 H225
H335
H336 GHS02
GHS07
Dgr H225
H335
H336 EUH066 606-007-00-0 3-methylbutan-2-one;
methyl isopropyl ketone 209-264-3 563-80-4 Flam. Liq. 2 H225 GHS02
Dgr H225 606-009-00-1 4-methylpent-3-en-2-one;
mesityl oxide 205-502-5 141-79-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H226
H332
H312
H302 GHS02
GHS07
Wng H226
H332
H312
H302 * 606-010-00-7 cyclohexanone 203-631-1 108-94-1 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 606-011-00-2 2-methylcyclohexanone 209-513-6 583-60-8 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 606-012-00-8 3,5,5-trimethylcyclohex-2-enone;
isophorone 201-126-0 78-59-1 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H351
H312
H302
H319
H335 GHS08
GHS07
Wng H351
H312
H302
H319
H335 STOT SE 3; H335: C ≥ 10 % 606-013-00-3 p-benzoquinone;
quinone 203-405-2 106-51-4 Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1 H331
H301
H319
H335
H315
H400 GHS06
GHS09
Dgr H331
H301
H319
H335
H315
H400 606-014-00-9 chlorophacinone (ISO);
2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione 223-003-0 3691-35-8 Acute Tox. 1
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H331
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H310
H300
H331
H372 **
H410 606-016-00-X pindone (ISO);
2-pivaloylindan-1,3-dione 201-462-8 83-26-1 Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H372 **
H410 606-017-00-5 diketene;
diketen 211-617-1 674-82-8 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 D
606-018-00-0 dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone 204-210-5 117-80-6 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H315
H410 606-019-00-6 chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one 205-601-3 143-50-0 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H311
H301
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H311
H301
H410 606-020-00-1 5-methylheptan-3-one 208-793-7 541-85-5 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3 H226
H319
H335 GHS02
GHS07
Wng H226
H319
H335 STOT SE 3; H335: C ≥ 10 % 606-021-00-7 N-methyl-2-pyrrolidone 212-828-1 872-50-4 Eye Irrit. 2
Skin Irrit. 2 H319
H315 GHS07
Wng H319
H315 606-022-00-2 1-phenyl-3-pyrazolidone 202-155-1 92-43-3 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 606-023-00-8 4-methoxy-4-methylpentan-2-one 203-512-4 107-70-0 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 606-024-00-3 heptan-2-one;
methyl amyl ketone 203-767-1 110-43-0 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 * H226
H332
H302 GHS02
GHS07
Wng H226
H332
H302 606-025-00-9 cyclopentanone 204-435-9 120-92-3 Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2 H226
H319
H315 GHS02
GHS07
Wng H226
H319
H315 606-026-00-4 5-methylhexan-2-one;
isoamyl methyl ketone 203-737-8 110-12-3 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 606-027-00-X heptan-4-one;
di-n-propyl ketone 204-608-9 123-19-3 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 606-028-00-5 2,4-dimethylpentan-3-one;
di-isopropyl ketone 209-294-7 565-80-0 Flam. Liq. 2
Acute Tox. 4 * H225
H332 GHS02
GHS07
Dgr H225
H332 606-029-00-0 pentane-2,4-dione;
acetylacetone 204-634-0 123-54-6 Flam. Liq. 3
Acute Tox. 4 * H226
H302 GHS02
GHS07
Wng H226
H302 606-030-00-6 hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone 209-731-1 591-78-6 Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3 H226
H361f ***
H372 **
H336 GHS02
GHS08
GHS07
Dgr H226
H361f ***
H372 **
H336 606-031-00-1 3-propanolide;
1,3-propiolactone 200-340-1 57-57-8 Carc. 1B
Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2 H350
H330
H319
H315 GHS06
GHS08
Dgr H350
H330
H319
H315 606-032-00-7 hexachloroacetone 204-129-5 116-16-5 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole 243-761-6 20354-26-1 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H312
H302
H319
H315
H411 GHS07
GHS09
Wng H312
H302
H319
H315
H411 606-034-00-8 metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one 244-209-7 21087-64-9 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 606-035-00-3 chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon 216-920-2 1698-60-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 606-036-00-9 quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one 219-455-3 2439-01-2 Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361f ***
H332
H312
H302
H373 **
H319
H317
H400
H410 GHS08
GHS07
GHS09
Wng H361f ***
H332
H312
H302
H373 **
H319
H317
H410 606-037-00-4 triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone 256-103-8 43121-43-3 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 606-038-00-X diphacinone (ISO);
2-diphenylacetylindan-1,3-dione 201-434-5 82-66-6 Acute Tox. 2 *
STOT RE 1 H300
H372 ** GHS06
GHS08
Dgr H300
H372 ** 606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one 400-680-2 — Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H400
H410 GHS07
GHS09
Wng H332
H410 606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 401-840-4 55845-90-4 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 400-600-6 71868-10-5 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 606-042-00-1 acetophenone 202-708-7 98-86-2 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 606-043-00-7 2,4-di-tert-butylcyclohexanone 405-340-7 13019-04-0 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 606-044-00-2 2,4,6-trimethylbenzophenone 403-150-9 954-16-5 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H400
H410 GHS07
GHS09
Wng H302
H319
H410 606-045-00-8 oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 243-215-7 19666-30-9 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — Aquatic Chronic 4 H413 — H413 606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 412-480-2 72453-58-8 Aquatic Chronic 2 H411 GHS09 H411 606-051-00-0 4-pentylcyclohexanone 406-670-4 61203-83-6 Aquatic Chronic 2 H411 GHS09 H411 606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 410-410-5 54574-82-2 Aquatic Chronic 3 H412 — H412 606-053-00-1 flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-054-00-7 isoxaflutole (ISO);
5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. 2
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H400
H410 GHS08
GHS09
Wng H361d ***
H410 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2 H302
H373 **
H411 GHS08
GHS07
GHS09
Wng H302
H373 **
H411 606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-057-00-3 4-propylcyclohexanone 406-810-4 40649-36-3 Skin Irrit. 2
Aquatic Chronic 3 H315
H412 GHS07
Wng H315
H412 606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 407-500-1 21983-80-2 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 606-059-00-4 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 412-390-3 86386-75-6 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H302
H318
H317 GHS05
GHS07
Dgr H302
H318
H317 606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane 412-950-7 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 423-290-4 66938-41-8 Muta. 2
Aquatic Acute 1
Aquatic Chronic 1 H341
H400
H410 GHS08
GHS09
Wng H341
H410 606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 407-330-8 61571-06-0 Repr. 1B
Eye Dam. 1
Aquatic Chronic 3 H360D ***
H318
H412 GHS08
GHS05
Dgr H360D ***
H318
H412 606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 410-980-5 112704-51-5 Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 407-450-0 7093-55-2 Aquatic Chronic 4 H413 — H413 606-065-00-7 1-(4-morpholinophenyl)butan-1-one 413-790-0 — Aquatic Chronic 2 H411 GHS09 H411 606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 410-440-9 164058-20-2 Aquatic Chronic 2 H411 GHS09 H411 606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone 414-870-8 96792-67-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 415-770-7 1638-05-7 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3 H373 **
H317
H412 GHS08
GHS07
Wng H373 **
H317
H412 606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 415-460-1 154171-76-3 Aquatic Chronic 2 H411 GHS09 H411 606-070-00-4 butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one 414-790-3 138164-12-2 Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H361fd
H302
H315
H400
H410 GHS08
GHS07
GHS09
Wng H361fd
H302
H315
H410 606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 421-050-3 13258-43-0 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 421-600-2 719-86-8 STOT RE 2 *
Aquatic Chronic 2 H373 **
H411 GHS08
GHS09
Wng H373 **
H411 606-073-00-0 4,4'-bis(dimethylamino)benzophenone;
Michler's ketone 202-027-5 90-94-8 Carc. 1B
Muta. 2
Eye Dam. 1 H350
H341
H318 GHS08
GHS05
Dgr H350
H341
H318 606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 417-340-4 65855-02-9 Acute Tox. 4 * H302 GHS07
Wng H302 606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 418-630-3 136465-99-1 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 418-650-2 104872-06-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-078-00-8 1-octylazepin-2-one 420-040-6 59227-88-2 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H314
H317
H411 GHS05
GHS07
GHS09
Dgr H314
H317
H411 606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H317
H410 606-080-00-9 Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene 417-100-9 — Aquatic Chronic 4 H413 H413 606-081-00-4 (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 419-790-7 4229-69-0 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 606-082-00-X reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane 406-930-7 STOT RE 1
Skin Sens. 1
Aquatic Chronic 3 H372 **
H317
H412 GHS08
GHS07
Dgr H372 **
H317
H412 606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 407-750-1 137193-60-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H319
H315
H317
H412 GHS07
Wng H319
H315
H317
H412 606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 414-540-3 484-33-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 418-530-1 79200-56-9 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H302
H318
H317 GHS05
GHS07
Dgr H302
H318
H317 606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 422-330-8 56973-87-6 Aquatic Chronic 2 H411 GHS09 H411 606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 422-460-5 137234-87-8 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 422-520-0 74338-72-0 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone 423-220-2 12223-77-7 Aquatic Chronic 4 H413 — H413 606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 421-320-0 118289-55-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one 422-320-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-001-00-0 formic acid ... % 200-579-1 64-18-6 Skin Corr. 1A H314 GHS05
Dgr H314 Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 10 % ≤ C < 90 %
Skin Irrit. 2; H315: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 2 % ≤ C < 10 % B
607-002-00-6 acetic acid ... % 200-580-7 64-19-7 Flam. Liq. 3
Skin Corr. 1A H226
H314 GHS02
GHS05
Dgr H226
H314 Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 25 % ≤ C < 90 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
607-003-00-1 chloroacetic acid 201-178-4 79-11-8 Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1 H301
H314
H400 GHS06
GHS05
GHS09
Dgr H301
H314
H400 607-004-00-7 TCA (ISO);
trichloroacetic acid 200-927-2 76-03-9 Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 STOT SE 3; H335: C ≥ 1 % 607-005-00-2 TCA-sodium (ISO);
sodium trichloroacetate 211-479-2 650-51-1 STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H335
H400
H410 GHS07
GHS09
Wng H335
H410 607-006-00-8 oxalic acid 205-634-3 144-62-7 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 * 607-007-00-3 salts of oxalic acid — — Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 * A
607-008-00-9 acetic anhydride 203-564-8 108-24-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H226
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H226
H332
H302
H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Dam. 1; H318: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 1 % ≤ C < 5 %
STOT SE 3; H335: C ≥ 5 % 607-009-00-4 phthalic anhydride 201-607-5 85-44-9 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H302
H335
H315
H318
H334
H317 GHS08
GHS05
GHS07
Dgr H302
H335
H315
H318
H334
H317 607-010-00-X propionic anhydride 204-638-2 123-62-6 Skin Corr. 1B H314 GHS05
Dgr H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 % 607-011-00-5 acetyl chloride 200-865-6 75-36-5 Flam. Liq. 2
Skin Corr. 1B H225
H314 GHS02
GHS05
Dgr H225
H314 EUH014 607-012-00-0 benzoyl chloride 202-710-8 98-88-4 Skin Corr. 1B H314 GHS05
Dgr H314 607-013-00-6 dimethyl carbonate 210-478-4 616-38-6 Flam. Liq. 2 H225 GHS02
Dgr H225 607-014-00-1 methyl formate 203-481-7 107-31-3 Flam. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H224
H332
H302
H319
H335 GHS02
GHS07
Dgr H224
H332
H302
H319
H335 607-015-00-7 ethyl formate 203-721-0 109-94-4 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H225
H332
H302
H319
H335 GHS02
GHS07
Dgr H225
H332
H302
H319
H335 607-016-00-2 propyl formate; [1]
isopropyl formate [2] 203-798-0 [1]
210-901-2 [2] 110-74-7 [1]
625-55-8 [2] Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3 H225
H319
H335
H336 GHS02
GHS07
Dgr H225
H319
H335
H336 C
607-017-00-8 butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3] 209-772-5 [1]
212-105-0 [2]
208-818-1 [3] 592-84-7 [1]
762-75-4 [2]
542-55-2 [3] Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H335 GHS02
GHS07
Dgr H225
H319
H335 C
607-018-00-3 isopentyl formate; [1]
2-methylbutyl formate [2] 203-769-2 [1]
252-343-2 [2] 110-45-2 [1]
35073-27-9 [2] Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H335 GHS02
GHS07
Dgr H225
H319
H335 C
607-019-00-9 methyl chloroformate 201-187-3 79-22-1 Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H225
H330
H312
H302
H314 GHS02
GHS06
GHS05
Dgr H225
H330
H312
H302
H314 607-020-00-4 ethyl chloroformate 208-778-5 541-41-3 Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B H225
H330
H302
H314 GHS02
GHS06
GHS05
Dgr H225
H330
H302
H314 607-021-00-X methyl acetate 201-185-2 79-20-9 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 EUH066 607-022-00-5 ethyl acetate 205-500-4 141-78-6 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 EUH066 607-023-00-0 vinyl acetate 203-545-4 108-05-4 Flam. Liq. 2 H225 GHS02
Dgr H225 D
607-024-00-6 propyl acetate; [1]
isopropyl acetate [2] 203-686-1 [1]
203-561-1 [2] 109-60-4 [1]
108-21-4 [2] Flam. Liq. 2
Eye Irrit. 2
STOT SE 3 H225
H319
H336 GHS02
GHS07
Dgr H225
H319
H336 EUH066 C
607-025-00-1 n-butyl acetate 204-658-1 123-86-4 Flam. Liq. 3
STOT SE 3 H226
H336 GHS02
GHS07
Wng H226
H336 EUH066 607-026-00-7 sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3] 203-300-1 [1]
203-745-1 [2]
208-760-7 [3] 105-46-4 [1]
110-19-0 [2]
540-88-5 [3] Flam. Liq. 2 H225 GHS02
Dgr H225 EUH066 C
607-027-00-2 methyl propionate 209-060-4 554-12-1 Flam. Liq. 2
Acute Tox. 4 * H225
H332 GHS02
GHS07
Dgr H225
H332 607-028-00-8 ethyl propionate 203-291-4 105-37-3 Flam. Liq. 2 H225 GHS02
Dgr H225 607-029-00-3 n-butyl propionate; [1]
sec-butyl propionate; [2]
iso-butyl propionate [3] 209-669-5 [1]
- [2]
208-746-0 [3] 590-01-2 [1]
591-34-4 [2]
540-42-1 [3] Flam. Liq. 3 H226 GHS02
Wng H226 C
607-030-00-9 propyl propionate 203-389-7 106-36-5 Flam. Liq. 3
Acute Tox. 4 * H226
H332 GHS02
GHS07
Wng H226
H332 607-031-00-4 butyl butyrate 203-656-8 109-21-7 Flam. Liq. 3 H226 GHS02
Wng H226 C
607-032-00-X ethyl acrylate 205-438-8 140-88-5 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H225
H332
H312
H302
H319
H335
H315
H317 GHS02
GHS07
Dgr H225
H332
H312
H302
H319
H335
H315
H317 Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 % D
607-033-00-5 n-butyl methacrylate 202-615-1 97-88-1 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H226
H319
H335
H315
H317 GHS02
GHS07
Wng H226
H319
H335
H315
H317 D
607-034-00-0 methyl acrylate;
methyl propenoate 202-500-6 96-33-3 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H225
H332
H312
H302
H319
H335
H315
H317 GHS02
GHS07
Dgr H225
H332
H312
H302
H319
H335
H315
H317 D
607-035-00-6 methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate 201-297-1 80-62-6 Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H225
H335
H315
H317 GHS02
GHS07
Dgr H225
H335
H315
H317 D
607-036-00-1 2-methoxyethyl acetate;
methylglycol acetate 203-772-9 110-49-6 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H360FD
H332
H312
H302 GHS08
GHS07
Dgr H360FD
H332
H312
H302 607-037-00-7 2-ethoxyethyl acetate;
ethylglycol acetate 203-839-2 111-15-9 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H360FD
H332
H312
H302 GHS08
GHS07
Dgr H360FD
H332
H312
H302 607-038-00-2 2-butoxyethyl acetate;
butylglycol acetate 203-933-3 112-07-2 Acute Tox. 4 *
Acute Tox. 4 * H332
H312 GHS07
Wng H332
H312 607-039-00-8 2,4-D (ISO);
2,4-dichlorophenoxyacetic acid 202-361-1 94-75-7 Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H302
H335
H318
H317
H412 GHS05
GHS07
Dgr H302
H335
H318
H317
H412 607-040-00-3 salts of 2,4-D — — Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 A
607-041-00-9 2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid 202-273-3 93-76-5 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H315
H410 607-042-00-4 salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid — — Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H315
H410 A
607-043-00-X dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid 217-635-6 1918-00-9 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2] 218-951-7 [1]
233-002-7 [2] 2300-66-5 [1]
10007-85-9 [2] Eye Irrit. 2
Aquatic Chronic 3 H319
H412 GHS07
Wng H319
H412 607-045-00-0 dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid 204-390-5 120-36-5 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1 H312
H302
H315
H318 GHS05
GHS07
Dgr H312
H302
H315
H318 607-046-00-6 salts of dichlorprop — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 A
607-047-00-1 fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid 202-271-2 93-72-1 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H400
H410 GHS07
GHS09
Wng H302
H315
H410 607-048-00-7 salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 A
607-049-00-2 mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2] 230-386-8 [1]
202-264-4 [2] 7085-19-0 [1]
708519-0 [2] Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H315
H318
H410 M=100 607-050-00-8 salts of mecoprop — — Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H315
H318
H410 A
607-051-00-3 MCPA (ISO);
4-chloro-o-tolyloxyacetic acid 202-360-6 94-74-6 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1 H302
H315
H318 GHS05
GHS07
Dgr H302
H315
H318 607-052-00-9 salts and esters of MCPA — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 A
607-053-00-4 MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid 202-365-3 94-81-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-054-00-X salts and esters of MCPB — — Acute Tox. 4 * H302 GHS07
Wng H302 A
607-055-00-5 endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate 204-959-8 129-67-9 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H301
H312
H319
H335
H315 GHS06
Dgr H301
H312
H319
H335
H315 607-056-00-0 warfarin (ISO); [1]
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3] 201-377-6 [1]
226-907-3 [2]
226-908-9 [3] 81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3] Repr. 1A
STOT RE 1
Aquatic Chronic 3 H360D ***
H372 **
H412 GHS08
Dgr H360D ***
H372 **
H412 607-057-00-6 coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin 201-378-1 81-82-3 STOT RE 2 *
Aquatic Chronic 3 H373 **
H412 GHS08
Wng H373 **
H412 607-058-00-1 coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin 204-195-5 117-52-2 Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3 H301
H372 **
H412 GHS06
GHS08
Dgr H301
H372 **
H412 607-059-00-7 coumatetralyl;
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 227-424-0 5836-29-3 Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Chronic 3 H310
H300
H372 **
H412 GHS06
GHS08
Dgr H310
H300
H372 **
H412 607-060-00-2 dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) 200-632-9 66-76-2 STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 2 H372 **
H302
H411 GHS08
GHS07
GHS09
Dgr H372 **
H302
H411 607-061-00-8 acrylic acid;
prop-2-enoic acid 201-177-9 79-10-7 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1 H226
H332
H312
H302
H314
H400 GHS02
GHS05
GHS07
GHS09
Dgr H226
H332
H312
H302
H314
H400 STOT SE 3; H335: C ≥ 1 % D
607-062-00-3 n-butyl acrylate 205-480-7 141-32-2 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H226
H319
H335
H315
H317 GHS02
GHS07
Wng H226
H319
H335
H315
H317 D
607-063-00-9 isobutyric acid 201-195-7 79-31-2 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 607-064-00-4 benzyl chloroformate 207-925-0 501-53-1 Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H314
H400
H410 GHS05
GHS09
Dgr H314
H410 STOT SE 3; H335: C ≥ 5 % 607-065-00-X bromoacetic acid 201-175-8 79-08-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1A
Aquatic Acute 1 H331
H311
H301
H314
H400 GHS06
GHS05
GHS09
Dgr H331
H311
H301
H314
H400 607-066-00-5 dichloroacetic acid 201-207-0 79-43-6 Skin Corr. 1A
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 607-067-00-0 dichloroacetyl chloride 201-199-9 79-36-7 Skin Corr. 1A
Aquatic Acute 1 H314
H400 GHS05
GHS09
Dgr H314
H400 607-068-00-6 iodoacetic acid 200-590-1 64-69-7 Acute Tox. 3 *
Skin Corr. 1A H301
H314 GHS06
GHS05
Dgr H301
H314 607-069-00-1 ethyl bromoacetate 203-290-9 105-36-2 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H330
H310
H300 GHS06
Dgr H330
H310
H300 607-070-00-7 ethyl chloroacetate 203-294-0 105-39-5 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1 H331
H311
H301
H400 GHS06
GHS09
Dgr H331
H311
H301
H400 607-071-00-2 ethyl methacrylate 202-597-5 97-63-2 Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H225
H319
H335
H315
H317 GHS02
GHS07
Dgr H225
H319
H335
H315
H317 D
607-072-00-8 2-hydroxyethyl acrylate 212-454-9 818-61-1 Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1 H311
H314
H317
H400 GHS06
GHS05
GHS09
Dgr H311
H314
H317
H400 *
Skin Sens. 1; H317: C ≥ 0,2 % D
607-073-00-3 4-CPA (ISO);
4-chlorophenoxyacetic acid 204-581-3 122-88-3 Acute Tox. 4 * H302 GHS07
Wng H302 607-074-00-9 chlorfenac(ISO);
2,3,6-trichlorophenylacetic acid 201-599-3 85-34-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-075-00-4 chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate 238-413-5 14437-17-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 607-076-00-X dodine(ISO);
dodecylguanidinium acetate 219-459-5 2439-10-3 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H315
H400
H410 GHS07
GHS09
Wng H302
H319
H315
H410 607-077-00-5 erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate — 136-25-4 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-078-00-0 fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate — 4301-50-2 Acute Tox. 1
Acute Tox. 2 * H310
H300 GHS06
Dgr H310
H300 607-079-00-6 kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate — 4234-79-1 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2 H311
H302
H411 GHS06
GHS09
Dgr H311
H302
H411 607-080-00-1 chloroacetyl chloride 201-171-6 79-04-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Aquatic Acute 1 H331
H311
H301
H372 **
H314
H400 GHS06
GHS08
GHS05
GHS09
Dgr H331
H311
H301
H372 **
H314
H400 EUH014
EUH029 607-081-00-7 fluoroacetic acid 205-631-7 144-49-0 Acute Tox. 2 *
Aquatic Acute 1 H300
H400 GHS06
GHS09
Dgr H300
H400 607-082-00-2 fluoroacetates, soluble — — Acute Tox. 2 *
Aquatic Acute 1 H300
H400 GHS06
GHS09
Dgr H300
H400 A
607-083-00-8 2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid 202-366-9 94-82-6 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-084-00-3 salts of 2,4-DB — — Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 A
607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Acute Tox. 4 * H302 GHS07
Wng H302 607-086-00-4 diallyl phthalate 205-016-3 131-17-9 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-088-00-5 methacrylic acid;
2-methylpropenoic acid 201-204-4 79-41-4 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 STOT SE 3; H335: C ≥ 1 % D
607-089-00-0 propionic acid ... % 201-176-3 79-09-4 Skin Corr. 1B H314 GHS05
Dgr H314 Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H319: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 % B
607-090-00-6 thioglycolic acid 200-677-4 68-11-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B H331
H311
H301
H314 GHS06
GHS05
Dgr H331
H311
H301
H314 * 607-091-00-1 trifluoroacetic acid . . . % 200-929-3 76-05-1 Acute Tox. 4 * H332 GHS05 H332 * B
Skin Corr. 1A
Aquatic Chronic 3 H314
H412 GHS07
Dgr H314
H412 607-092-00-7 methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4] 208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4] 547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4] Flam. Liq. 3
Eye Irrit. 2
STOT SE 3 H226
H319
H335 GHS02
GHS07
Wng H226
H319
H335 C
607-093-00-2 propionyl chloride 201-170-0 79-03-8 Flam. Liq. 2
Skin Corr. 1B H225
H314 GHS02
GHS05
Dgr H225
H314 EUH014 B D
607-094-00-8 peracetic acid . . . % 201-186-8 79-21-0 Flam. Liq. 3
Org. Perox. D ****
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1 H226
H242
H332
H312
H302
H314
H400 GHS02
GHS05
GHS07
GHS09
Dgr H226
H242
H332
H312
H302
H314
H400 *
STOT SE 3; H335: C ≥ 1 % B D
607-095-00-3 maleic acid 203-742-5 110-16-7 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H302
H319
H335
H315 GHS07
Wng H302
H319
H335
H315 607-096-00-9 maleic anhydride 203-571-6 108-31-6 Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1 H302
H314
H334
H317 GHS08
GHS05
GHS07
Dgr H302
H314
H334
H317 607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride 209-008-0 552-30-7 STOT SE 3
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H335
H318
H334
H317 GHS08
GHS05
GHS07
Dgr H335
H318
H334
H317 607-098-00-X benzene-1,2:4,5-tetracarboxylic dianhydride;
benzene-1,2:4,5-tetracarboxylic dianhydride;
pyromellitic dianhydride 201-898-9 89-32-7 Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H318
H334
H317 GHS08
GHS05
Dgr H318
H334
H317 607-099-00-5 1,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4] 201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4] 85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4] Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H334
H317
H412 GHS08
GHS05
Dgr H318
H334
H317
H412 C
607-100-00-9 benzophenone-3,3',4,4'-tetracarboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride) 219-348-1 2421-28-5 Eye Irrit. 2
STOT SE 3 H319
H335 GHS07
Wng H319
H335 Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % 607-101-00-4 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride 204-077-3 115-27-5 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % 607-102-00-X cyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicarboxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3] 201-604-9 [1]
236-086-3 [2]
238-009-9 [3] 85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3] Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H318
H334
H317 GHS08
GHS05
Dgr H318
H334
H317 C
607-103-00-5 succinic anhydride 203-570-0 108-30-5 Eye Irrit. 2
STOT SE 3 H319
H335 GHS07
Wng H319
H335 Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % 607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Eye Irrit. 2
STOT SE 3 H319
H335 GHS07
Wng H319
H335 Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 % 607-105-00-6 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 204-957-7 [1]
212-557-9 [2]
220-384-5 [3] 129-64-6 [1]
826-62-0 [2]
2746-19-2 [3] Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H318
H334
H317 GHS08
GHS05
Dgr H318
H334
H317 C
607-106-00-1 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride — 123748-85-6 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H302
H319
H335
H315
H334 GHS08
GHS07
Dgr H302
H319
H335
H315
H334 STOT SE 3; H335: C ≥ 10 % C
607-107-00-7 2-ethylhexyl acrylate 203-080-7 103-11-7 STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H335
H315
H317 GHS07
Wng H335
H315
H317 D
607-108-00-2 2-hydroxy-1-methylethylacrylate; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3] 220-852-9 [1]
213-663-8 [2]
247-118-0 [3] 2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H331
H311
H301
H314
H317 GHS06
GHS05
Dgr H331
H311
H301
H314
H317 *
Skin Sens. 1; H317: C ≥ 0,2 % C D
607-109-00-8 hexamethylene diacrylate;
hexane-1,6-diol diacrylate 235-921-9 13048-33-4 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-110-00-3 pentaerythritol triacrylate 222-540-8 3524-68-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-111-00-9 2,2-bis(acryloyloxymethyl)butyl acrylate;
trimethylolpropane triacrylate 239-701-3 15625-89-5 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-112-00-4 2,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate 218-741-5 2223-82-7 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H311
H319
H315
H317 GHS06
Dgr H311
H319
H315
H317 * D
607-113-00-X isobutyl methacrylate 202-613-0 97-86-9 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H226
H319
H335
H315
H317
H400 GHS02
GHS07
GHS09
Wng H226
H319
H335
H315
H317
H400 D
607-114-00-5 ethylene dimethacrylate 202-617-2 97-90-5 STOT SE 3
Skin Sens. 1 H335
H317 GHS07
Wng H335
H317 STOT SE 3; H335: C ≥ 10 % D
607-115-00-0 isobutyl acrylate 203-417-8 106-63-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1 H226
H332
H312
H315
H317 GHS02
GHS07
Wng H226
H332
H312
H315
H317 D
607-116-00-6 cyclohexyl acrylate 221-319-3 3066-71-5 STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H335
H315
H411 GHS07
GHS09
Wng H335
H315
H411 STOT SE 3; H335: C ≥ 10 % D
607-117-00-1 2,3-epoxypropyl acrylate;
glycidyl acrylate 203-440-3 106-90-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1 H331
H311
H301
H314
H317 GHS06
GHS05
Dgr H331
H311
H301
H314
H317 *
Skin Sens. 1; H317: C ≥ 0,2 % D
607-118-00-7 1-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate 243-105-9 19485-03-1 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H312
H314
H317 GHS05
GHS07
Dgr H312
H314
H317 D
607-119-00-2 tetramethylene diacrylate;
1,4-butyleneglycol diacrylate 213-979-6 1070-70-8 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H312
H314
H317 GHS05
GHS07
Dgr H312
H314
H317 D
607-120-00-8 2,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate 223-791-6 4074-88-8 Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H311
H319
H315
H317 GHS06
Dgr H311
H319
H315
H317 *
Skin Sens. 1; H317: C ≥ 0,2 % D
607-121-00-3 8,9,10-trinorborn-2-yl acrylate — 10027-06-2 Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1 H312
H315
H317 GHS07
Wng H312
H315
H317 D
607-122-00-9 pentaerythritol tetraacrylate 225-644-1 4986-89-4 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-123-00-4 2,3-epoxypropyl methacrylate;
glycidyl methacrylate 203-441-9 106-91-2 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H332
H312
H302
H319
H315
H317 GHS07
Wng H332
H312
H302
H319
H315
H317 D
607-124-00-X 2-hydroxyethyl methacrylate 212-782-2 868-77-9 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-125-00-5 2-hydroxypropyl methacrylate; [1]
3-hydroxypropyl methacrylate [2] 213-090-3 [1]
220-426-2 [2] 923-26-2 [1]
2761-09-3 [2] Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 C D
607-126-00-0 2,2'-(ethylenedioxy)diethyl diacrylate;
triethylene glycol diacrylate 216-853-9 1680-21-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-127-00-6 2-diethylaminoethyl methacrylate 203-275-7 105-16-8 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H332
H319
H315
H317 GHS07
Wng H332
H319
H315
H317 D
607-128-00-1 2-tert-butylaminoethyl methacrylate 223-228-4 3775-90-4 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 D
607-129-00-7 ethyl lactate;
ethyl DL-lactate; [1]
ethyl (S)-2-hydroxypropionate;
ethyl L-lactate;
ethyl-(S)-lactate [2] 202-598-0 [1]
211-694-1 [2] 97-64-3 [1]
687-47-8 [2] Flam. Liq. 3
STOT SE 3
Eye Dam. 1 H226
H335
H318 GHS02
GHS05
GHS07
Dgr H226
H335
H318 C
607-130-00-2 pentyl acetate; [1]
isopentyl acetate; [2]
1-methylbutyl acetate; [3]
2-methylbutyl acetat; [4]
2(or 3)-methylbutyl acetate [5] 211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5] 628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5] Flam. Liq. 3 H226 GHS02
Wng H226 EUH066 C
607-131-00-8 isopentyl propionate; [1]
pentyl propionate; [2]
2-methylbutyl propionate [3] 203-322-1 [1]
210-852-7 [2]
219-449-0 [3] 105-68-0 [1]
624-54-4 [2]
2438-20-2 [3] Flam. Liq. 3 H226 GHS02
Wng H226 C
607-132-00-3 2-dimethylaminoethyl methacrylate 220-688-8 2867-47-2 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H312
H302
H319
H315
H317 GHS07
Wng H312
H302
H319
H315
H317 D
607-133-00-9 monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H319
H335
H315
H411 GHS07
GHS09
Wng H319
H335
H315
H411 STOT SE 3; H335: C ≥ 10 % A
607-134-00-4 monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 STOT SE 3; H335: C ≥ 10 % A
607-135-00-X butyric acid 203-532-3 107-92-6 Skin Corr. 1B H314 GHS05
Dgr H314 607-136-00-5 butyryl chloride 205-498-5 141-75-3 Flam. Liq. 2
Skin Corr. 1B H225
H314 GHS02
GHS05
Dgr H225
H314 607-137-00-0 methyl acetoacetate 203-299-8 105-45-3 Eye Irrit. 2 H319 GHS07
Wng H319 607-138-00-6 butyl chloroformate;
chloroformic acid butyl ester 209-750-5 592-34-7 Flam. Liq. 3
Acute Tox. 3 *
Skin Corr. 1B H226
H331
H314 GHS02
GHS06
GHS05
Dgr H226
H331
H314 607-139-00-1 2-chloropropionic acid 209-952-3 598-78-7 Acute Tox. 4 *
Skin Corr. 1A H302
H314 GHS05
GHS07
Dgr H302
H314 607-140-00-7 isobutyryl chloride 201-194-1 79-30-1 Flam. Liq. 2
Skin Corr. 1A H225
H314 GHS02
GHS05
Dgr H225
H314 607-141-00-2 oxydiethylene bis(chloroformate) 203-430-9 106-75-2 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H302
H315
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H315
H318
H411 607-142-00-8 propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate 203-687-7 109-61-5 Flam. Liq. 2
Acute Tox. 3 *
Skin Corr. 1B H225
H331
H314 GHS02
GHS06
GHS05
Dgr H225
H331
H314 607-143-00-3 valeric acid 203-677-2 109-52-4 Skin Corr. 1B
Aquatic Chronic 3 H314
H412 GHS05
Dgr H314
H412 607-144-00-9 adipic acid 204-673-3 124-04-9 Eye Irrit. 2 H319 GHS07
Wng H319 607-145-00-4 methanesulphonic acid 200-898-6 75-75-2 Skin Corr. 1B H314 GHS05
Dgr H314 607-146-00-X fumaric acid 203-743-0 110-17-8 Eye Irrit. 2 H319 GHS07
Wng H319 607-147-00-5 oxalic acid diethylester;
diethyl oxalate 202-464-1 95-92-1 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 607-148-00-0 guanidinium chloride;
guanadine hydrochloride 200-002-3 50-01-1 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2 H302
H319
H315 GHS07
Wng H302
H319
H315 607-149-00-6 urethane (INN);
ethyl carbamate 200-123-1 51-79-6 Carc. 1B H350 GHS08
Dgr H350 607-150-00-1 endothal (ISO);
7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid 205-660-5 145-73-3 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H301
H312
H319
H335
H315 GHS06
Dgr H301
H312
H319
H335
H315 607-151-00-7 propargite (ISO);
2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite 219-006-1 2312-35-8 Carc. 2
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H331
H315
H318
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H351
H331
H315
H318
H410 M = 10 607-152-00-2 2,3,6-TBA (ISO);
2,3,6-trichlorobenzoic acid 200-026-4 50-31-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-153-00-8 benazolin (ISO);
4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid 223-297-0 3813-05-6 Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H319
H315
H412 GHS07
Wng H319
H315
H412 607-154-00-3 ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;
benzoylprop-ethyl (ISO) 244-845-5 22212-55-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-155-00-9 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;
blasticidin-s — 2079-00-7 Acute Tox. 2 * H300 GHS06
Dgr H300 607-156-00-4 chlorfenson (ISO);
4-chlorophenyl 4-chlorobenzenesulfonate 201-270-4 80-33-1 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H400
H410 GHS07
GHS09
Wng H302
H315
H410 607-157-00-X 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;
difenacoum 259-978-4 56073-07-5 Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H300
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H300
H372 **
H410 607-158-00-5 sodium salt of chloroacetic acid;
sodium chloroacetate 223-498-3 3926-62-3 Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1 H301
H315
H400 GHS06
GHS09
Dgr H301
H315
H400 607-159-00-0 chlorobenzilate (ISO);
ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;
ethyl 4,4'-dichlorobenzilate 208-110-2 510-15-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-160-00-6 isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;
clofop-isobutyl (ISO) — 51337-71-4 Acute Tox. 4 * H302 GHS07
Wng H302 607-161-00-1 diethanolamine salt of 4-CPA — — Acute Tox. 4 * H302 GHS07
Wng H302 607-162-00-7 2,2-dichloropropionic acid;
dalapon 200-923-0 75-99-0 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H302
H315
H318
H412 GHS05
GHS07
Dgr H302
H315
H318
H412 607-163-00-2 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;
dehydracetic acid 208-293-9 520-45-6 Acute Tox. 4 * H302 GHS07
Wng H302 607-164-00-8 sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;
sodium dehydracetate 224-580-1 4418-26-2 Acute Tox. 4 * H302 GHS07
Wng H302 607-165-00-3 diclofop-methyl (ISO)
methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;
methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; 257-141-8 51338-27-3 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 607-166-00-9 medinoterb acetate (ISO);
6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate 219-634-6 2487-01-6 Acute Tox. 3 *
Acute Tox. 4 * H301
H312 GHS06
Dgr H301
H312 607-167-00-4 sodium 3-chloroacrylate — 4312-97-4 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 607-168-00-X dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;
propylisome — 83-59-0 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H311
H302
H400
H410 GHS06
GHS09
Dgr H311
H302
H410 607-169-00-5 sodium fluoroacetate 200-548-2 62-74-8 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1 H330
H310
H300
H400 GHS06
GHS09
Dgr H330
H310
H300
H400 607-170-00-0 bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;
thiocyclam-oxalate 250-859-2 31895-22-4 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 607-172-00-1 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;
brodifacoum 259-980-5 56073-10-0 Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H310
H300
H372 **
H410 607-173-00-7 dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate 400-460-6 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-174-00-2 reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate 400-580-9 — Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 607-175-00-8 methyl 2-(2-nitrobenzylidene)acetoacetate 400-650-9 39562-27-1 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-176-00-3 reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) 400-830-7 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-177-00-9 methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate 401-190-1 101200-48-0 Skin Sens. 1 H317 GHS07
Wng H317 607-178-00-4 methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate 401-340-6 83055-99-6 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-179-00-X (benzothiazol-2-ylthio)succinic acid 401-450-4 95154-01-1 Skin Sens. 1 H317 GHS07
Wng H317 607-180-00-5 potassium 2-hydroxycarbazole-1-carboxylate 401-630-2 96566-70-0 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3 H302
H319
H335
H412 GHS07
Wng H302
H319
H335
H412 607-181-00-0 3,5-dichloro-2,4-difluorobenzoyl fluoride 401-800-6 101513-70-6 Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H331
H314
H302
H317
H412 GHS06
GHS05
Dgr H331
H314
H302
H317
H412 EUH029 607-182-00-6 methyl 3-sulphamoyl-2-thenoate 402-050-2 — Skin Sens. 1 H317 GHS07
Wng H317 607-183-00-1 zinc 2-hydroxy-5-C13-18alkylbenzoate 402-280-3 — Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H319
H315
H411 GHS07
GHS09
Wng H319
H315
H411 607-184-00-7 S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate 402-290-8 85702-90-5 Flam. Liq. 3
Resp. Sens. 1
Skin Sens. 1 H226
H334
H317 GHS02
GHS08
Dgr H226
H334
H317 607-185-00-2 ethyl trans-3-dimethylaminoacrylate 402-650-4 1117-37-9 Skin Sens. 1 H317 GHS07
Wng H317 607-186-00-8 quinclorac (ISO);
3,7-dichloroquinoline-8-carboxylic acid 402-780-1 84087-01-4 Skin Sens. 1 H317 GHS07
Wng H317 607-187-00-3 bis(2,2,6,6-tetramethyl-4-piperidyl) succinate 402-940-0 62782-03-0 Eye Irrit. 2
Aquatic Chronic 3 H319
H412 GHS07
Wng H319
H412 607-188-00-9 hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate 402-970-4 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-189-00-4 trimethylenediaminetetraacetic acid 400-400-9 1939-36-2 Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H318
H410 607-190-00-X methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) 401-890-7 77402-03-0 Carc. 1B
Muta. 1B
Acute Tox. 4 *
Eye Irrit. 2 H350
H340
H302
H319 GHS08
GHS07
Dgr H350
H340
H302
H319 607-191-00-5 isobutyl 3,4-epoxybutyrate 401-920-9 100181-71-3 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 607-192-00-0 disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate 402-360-8 92511-22-3 Eye Dam. 1 H318 GHS05
Dgr H318 607-194-00-1 propylene carbonate 203-572-1 108-32-7 Eye Irrit. 2 H319 GHS07
Wng H319 607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 Flam. Liq. 3
Eye Irrit. 2 H226
H319 GHS02
GHS07
Wng H226
H319 607-196-00-2 heptanoic acid 203-838-7 111-14-8 Skin Corr. 1B H314 GHS05
Dgr H314 607-197-00-8 nonanoic acid 203-931-2 112-05-0 Skin Corr. 1B H314 GHS05
Dgr H314 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 607-199-00-9 octyl 3,4,5-trihydroxybenzoate 213-853-0 1034-01-1 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 607-200-00-2 dodecyl 3,4,5-trihydroxybenzoate 214-620-6 1166-52-5 Skin Sens. 1 H317 GHS07
Wng H317 607-201-00-8 thiocarbonyl chloride 207-341-6 463-71-8 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H331
H302
H319
H335
H315 GHS06
Dgr H331
H302
H319
H335
H315 607-203-00-9 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate 279-452-8 80387-97-9 Repr. 1B
Skin Sens. 1
Aquatic Chronic 3 H360D ***
H317
H412 GHS08
GHS07
Dgr H360D ***
H317
H412 607-204-00-4 (chlorophenyl)(chlorotolyl)methane, mixed isomers 400-140-6 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-205-00-X methyl chloroacetate 202-501-1 96-34-4 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H226
H331
H301
H335
H315
H318 GHS02
GHS06
GHS05
Dgr H226
H331
H301
H335
H315
H318 607-206-00-5 isopropyl chloroacetate 203-301-7 105-48-6 Flam. Liq. 3
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H226
H301
H319
H335
H315 GHS02
GHS06
Dgr H226
H301
H319
H335
H315 607-207-00-0 haloxyfop-etotyl (ISO);
2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;
haloxyfop-(2-ethoxyethyl) 402-560-5 87237-48-7 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-208-00-6 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers 403-000-2 91853-67-7 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 607-209-00-1 reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate 403-030-6 — Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 607-210-00-7 methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) 403-230-3 77402-05-2 Carc. 1B
Muta. 1B
Skin Corr. 1B
Skin Sens. 1 H350
H340
H314
H317 GHS08
GHS05
GHS07
Dgr H350
H340
H314
H317 607-211-00-2 methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate 403-270-1 6386-39-6 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-212-00-8 poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate 403-300-3 — Skin Sens. 1 H317 GHS07
Wng H317 607-213-00-3 ethyl 3,3-bis(tert-pentylperoxy)butyrate 403-320-2 67567-23-1 Org. Perox. D ****
Flam. Liq. 3
Aquatic Chronic 2 H242
H226
H411 GHS02
GHS09
Dgr H242
H226
H411 607-214-00-9 N,N-hydrazinodiacetic acid 403-510-5 19247-05-3 Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3 H301
H373 **
H317
H412 GHS06
GHS08
Dgr H301
H373 **
H317
H412 607-215-00-4 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid 403-920-4 107551-67-7 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 607-216-00-X glutamic acid, reaction products with N-(C12-14alkyl)propylenediamine 403-950-8 — Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H330
H302
H314
H400
H410 GHS06
GHS05
GHS09
Dgr H330
H302
H314
H410 607-217-00-5 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate 403-960-2 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 607-218-00-0 dichlorprop-P (ISO);
(+)-R-2-(2,4-dichlorophenoxy)propionic acid 403-980-1 15165-67-0 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H302
H315
H318
H317 GHS05
GHS07
Dgr H302
H315
H318
H317 607-219-00-6 bis(2-ethylhexyl) dithiodiacetate 404-510-8 62268-47-7 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 607-221-00-7 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid 404-550-6 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 607-222-00-2 6-(2,3-dimethylmaleimido)hexyl methacrylate 404-870-6 63740-41-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-223-00-8 transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 405-060-5 118712-89-3 Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 607-224-00-3 methyl 2-(3-nitrobenzylidene)acetoacetate 405-270-7 39562-17-9 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 607-225-00-9 3-azidosulfonylbenzoic acid 405-310-3 15980-11-7 Self-React. C ****
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1 H241
H373 **
H318
H317 GHS02
GHS08
GHS05
GHS07
Dgr H241
H373 **
H318
H317 607-226-00-4 reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate 405-360-6 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H315
H318
H317
H412 GHS05
GHS07
Dgr H315
H318
H317
H412 607-227-00-X potassium 2-amino-2-methylpropionate octahydrate 405-560-3 120447-91-8 Acute Tox. 4 *
Skin Corr. 1A H302
H314 GHS05
GHS07
Dgr H302
H314 607-228-00-5 bis(2-methoxyethyl) phthalate 204-212-6 117-82-8 Repr. 1B H360Df GHS08
Dgr H360Df 607-229-00-0 diethylcarbamoyl chloride 201-798-5 88-10-8 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H351
H332
H302
H319
H335
H315 GHS08
GHS07
Wng H351
H332
H302
H319
H335
H315 607-230-00-6 2-ethylhexanoic acid 205-743-6 149-57-5 Repr. 2 H361d *** GHS08
Wng H361d *** 607-231-00-1 3,6-dichloropyridine-2-carboxylic acid;
clopyralid 216-935-4 1702-17-6 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 607-232-00-7 pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H335
H315
H317
H411 GHS07
GHS09
Wng H319
H335
H315
H317
H411 607-234-00-8 flurenol (ISO);
9-hydroxy-9H-fluorene-9-carboxylic acid 207-397-1 467-69-6 Aquatic Chronic 2 H411 GHS09 H411 607-235-00-3 mecrilate;
methyl 2-cyanoacrylate 205-275-2 137-05-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 STOT SE 3; H335: C ≥ 10 % 607-236-00-9 ethyl 2-cyanoacrylate 230-391-5 7085-85-0 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 STOT SE 3; H335: C ≥ 10 % 607-237-00-4 benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;
flurazole 276-942-3 72850-64-7 Aquatic Chronic 2 H411 GHS09 H411 607-238-00-X tau-fluvalinate (ISO);
cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate — 102851-06-9 Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H315
H400
H410 GHS07
GHS09
Wng H302
H315
H410 607-239-00-5 fenpropathrin (ISO);
α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate 254-485-0 39515-41-8 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H301
H312
H400
H410 GHS06
GHS09
Dgr H330
H301
H312
H410 607-240-00-0 cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethylphthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] 216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7] 1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7] Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H318
H334
H317 GHS08
GHS05
Dgr H318
H334
H317 C
607-241-00-6 hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4] 243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4] 19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4] Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H318
H334
H317 GHS08
GHS05
Dgr H318
H334
H317 C
607-242-00-1 tetrachlorophthalic anhydride 204-171-4 117-08-8 Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H334
H317
H400
H410 GHS08
GHS05
GHS09
Dgr H318
H334
H317
H410 607-243-00-7 sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 217-846-3 [1]
246-590-5 [2]
258-527-9 [3] 1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3] Aquatic Chronic 3 H412 — H412 607-244-00-2 isooctyl acrylate 249-707-8 29590-42-9 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H410 STOT SE 3; H335: C ≥ 10 % 607-245-00-8 tert-butyl acrylate 216-768-7 1663-39-4 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H225
H332
H312
H302
H335
H315
H317
H412 GHS02
GHS07
Dgr H225
H332
H312
H302
H335
H315
H317
H412 D
607-246-00-3 allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester 202-473-0 96-05-9 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1 H226
H331
H312
H302
H400 GHS02
GHS06
GHS09
Dgr H226
H331
H312
H302
H400 607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H335
H315
H400
H410 GHS07
GHS09
Wng H319
H335
H315
H410 STOT SE 3; H335: C ≥ 10 % 607-248-00-4 naptalam-sodium (ISO);
sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Acute Tox. 4 * H302 GHS07
Wng H302 607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 256-032-2 42978-66-5 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H335
H315
H317
H411 GHS07
GHS09
Wng H319
H335
H315
H317
H411 STOT SE 3; H335: C ≥ 10 % 607-250-00-5 4H-3,1-benzoxazine-2,4(1H)-dione 204-255-0 118-48-9 Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 607-251-00-0 2-methoxypropyl acetate 274-724-2 70657-70-4 Flam. Liq. 3
Repr. 1B
STOT SE 3 H226
H360D ***
H335 GHS02
GHS08
GHS07
Dgr H226
H360D ***
H335 607-252-00-6 lambda-cyhalothrin (ISO);
reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) 415-130-7 91465-08-6 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H301
H312
H400
H410 GHS06
GHS09
Dgr H330
H301
H312
H410 607-253-00-1 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
cyfluthrin 269-855-7 68359-37-5 Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H300
H331
H400
H410 GHS06
GHS09
Dgr H300
H331
H410 607-254-00-7 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
beta-cyfluthrin 269-855-7 68359-37-5 Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H400
H410 GHS06
GHS09
Dgr H330
H300
H410 607-255-00-2 fluroxypyr (ISO);
4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid — 69377-81-7 Aquatic Chronic 3 H412 — H412 607-256-00-8 azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate — 131860-33-8 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H400
H410 GHS06
GHS09
Dgr H331
H410 607-257-00-3 isopropyl propionate 211-300-8 637-78-5 Flam. Liq. 2 H225 GHS02
Dgr H225 607-258-00-9 dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate 403-990-6 70950-45-7 Aquatic Chronic 4 H413 — H413 607-259-00-4 methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate 404-130-2 105560-93-8 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 607-260-00-X ethyl 2-(3-nitrobenzylidene)acetoacetate 404-490-0 39562-16-8 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 607-261-00-5 iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate 404-800-4 118832-72-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-262-00-0 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 405-050-0 86393-33-1 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 607-263-00-6 potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate 405-680-6 — Self-heat. 2 ****
Aquatic Chronic 2 H252
H411 GHS02
GHS09
Wng H252
H411 607-264-00-1 2-chloro-4-(methylsulfonyl)benzoic acid 406-520-8 53250-83-2 Eye Dam. 1 H318 GHS05
Dgr H318 607-265-00-7 ethyl-2-chloro-2,2-diphenylacetate 406-580-5 52460-86-3 Skin Irrit. 2
Aquatic Chronic 3 H315
H412 GHS07
Wng H315
H412 607-266-00-2 reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];
3,5-di-tert-butyl-salicylic acid 406-890-0 130296-87-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-267-00-8 tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 407-620-4 33610-13-8 Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H334
H317
H412 GHS08
Dgr H334
H317
H412 607-268-00-3 2-methylpropyl (R)-2-hydroxypropanoate 407-770-0 61597-96-4 Eye Irrit. 2 H319 GHS07
Wng H319 607-269-00-9 (R)-2-(4-hydroxyphenoxy)propanoic acid 407-960-3 94050-90-5 Eye Dam. 1 H318 GHS05
Dgr H318 607-270-00-4 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane 410-730-5 90498-90-1 Acute Tox. 4 * H312 GHS07
Wng H312 607-271-00-X 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane 417-420-9 156324-82-2 Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 607-272-00-5 fluroxypyr-meptyl (ISO);
methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 279-752-9 [1]
- [2] 81406-37-3 [1]
154486-27-8 [2] Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-273-00-0 ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate 404-520-2 — Aquatic Chronic 3 H412 — H412 607-274-00-6 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate 405-350-1 54527-73-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-275-00-1 sodium benzoyloxybenzene-4-sulfonate 405-450-5 66531-87-1 Skin Sens. 1 H317 GHS07
Wng H317 607-276-00-7 bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex 405-635-0 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 607-277-00-2 reaction mass of: 2-(hexylthio)ethylamine hydrochloride;
sodium propionate 405-720-2 — Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 607-278-00-8 reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;
sodium naphthylethylbenzenesulfonate 405-760-0 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 607-279-00-3 reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate 405-960-8 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-280-00-9 sodium 4-chloro-1-hydroxybutane-1-sulfonate 406-190-5 54322-20-2 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1 H302
H319
H317 GHS07
Wng H302
H319
H317 607-281-00-4 reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates 407-000-3 127519-17-9 Aquatic Chronic 2 H411 GHS09 H411 607-282-00-X 2-acetoxymethyl-4-benzyloxybut-1-yl acetate 407-140-5 131266-10-9 Aquatic Chronic 3 H412 — H412 607-283-00-5 E-ethyl-4-oxo-4-phenylcrotonate 408-040-4 15121-89-8 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H312
H302
H315
H318
H317
H410 607-284-00-0 reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);
lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) 410-040-4 136213-76-8 Aquatic Chronic 2 H411 GHS09 H411 607-285-00-6 reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;
sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;
potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate 410-065-0 — Skin Sens. 1 H317 GHS07
Wng 607-286-00-1 reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate 410-070-8 141880-36-6 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-287-00-7 O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate 410-140-8 — Aquatic Chronic 3 H412 — H412 607-288-00-2 tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively 410-160-7 148732-74-5 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H319
H317
H412 GHS07
Wng H319
H317
H412 607-289-00-8 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid 410-370-9 105488-33-3 Aquatic Chronic 4 H413 — H413 607-290-00-3 reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;
ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate 410-540-2 — Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 607-291-00-9 dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate 410-630-1 104051-92-5 Aquatic Chronic 4 H413 — H413 607-292-00-4 reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid 410-640-6 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 607-293-00-X reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate 410-650-0 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 607-294-00-5 sodium 2-benzoyloxy-1-hydroxyethane-sulfonate 410-680-4 — Skin Sens. 1 H317 GHS07
Wng H317 607-295-00-0 reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tetracarboxylate 410-800-5 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-296-00-6 reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid 410-830-9 — Aquatic Chronic 4 H413 — H413 607-297-00-1 (E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) 410-960-6 92761-26-7 Eye Dam. 1 H318 GHS05
Dgr H318 607-298-00-7 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate 411-010-3 — Skin Sens. 1 H317 GHS07
Wng H317 607-299-00-2 methyl 3-(acetylthio)-2-methyl-propanoate 411-040-7 97101-46-7 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 607-300-00-6 trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 411-430-7 — Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 607-301-00-1 reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid 411-860-5 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-302-00-7 reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid 411-910-6 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H315
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H411 607-303-00-2 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 413-760-7 93107-30-3 Repr. 2
Aquatic Chronic 3 H361f ***
H412 GHS08
Wng H361f ***
H412 607-304-00-8 fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 274-125-6 69806-50-4 Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H400
H410 GHS08
GHS09
Dgr H360D ***
H410 607-305-00-3 fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate — 79241-46-6 Repr. 2
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H400
H410 GHS08
GHS09
Wng H361d ***
H410 607-306-00-9 chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate 282-714-4 84332-86-5 Carc. 2
Aquatic Chronic 2 H351
H411 GHS08
GHS09
Wng H351
H411 607-307-00-4 vinclozolin (ISO);
N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione 256-599-6 50471-44-8 Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Chronic 2 H351
H360FD
H317
H411 GHS08
GHS07
GHS09
Dgr H351
H360FD
H317
H411 607-308-00-X esters of 2,4-D — — Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 A
607-309-00-5 carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate — 128639-02-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-310-00-0 kresoxim-methyl (ISO);
methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate — 143390-89-0 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 607-311-00-6 benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate 246-591-0 25059-80-7 Aquatic Chronic 2 H411 GHS09 H411 607-312-00-1 methoxyacetic acid 210-894-6 625-45-6 Repr. 1B
Acute Tox. 4 *
Skin Corr. 1B H360FD
H302
H314 GHS08
GHS05
GHS07
Dgr H360FD
H302
H314 STOT SE 3; H335: C ≥ 5 % 607-313-00-7 neodecanoyl chloride 254-875-0 40292-82-8 Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B H330
H302
H314 GHS06
GHS06
Dgr H330
H302
H314 STOT SE 3; H335: C ≥ 5 % 607-314-00-2 ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate 247-525-3 26225-79-6 Aquatic Chronic 2 H411 GHS09 H411 607-315-00-8 glyphosate (ISO);
N-(phosphonomethyl)glycine 213-997-4 1071-83-6 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 607-316-00-3 glyphosate-trimesium;
glyphosate-trimethylsulfonium — 81591-81-3 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07 GHS09
Wng H302
H411 607-317-00-9 bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP 204-211-0 117-81-7 Repr. 1B H360FD GHS08
Dgr H360FD 607-318-00-4 dibutyl phthalate;
DBP 201-557-4 84-74-2 Repr. 1B
Aquatic Acute 1 H360Df
H400 GHS08
GHS09
Dgr H360Df
H400 607-319-00-X deltamethrin (ISO);
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate 258-256-6 52918-63-5 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 607-320-00-5 bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate 413-930-0 130066-57-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 607-321-00-0 (S)-methyl-2-chloropropionate 412-470-8 73246-45-4 Flam. Liq. 3
STOT RE 2 *
Eye Irrit. 2 H226
H373 **
H319 GHS02
GHS08
Wng H226
H373 **
H319 607-322-00-6 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid 413-120-7 107144-30-9 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-323-00-1 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate 413-850-6 123968-25-2 Aquatic Chronic 4 H413 — H413 607-324-00-7 reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;
dihydrogenated alkyl (C14-C18)amine 413-800-3 — Aquatic Chronic 4 H413 — H413 607-325-00-2 (S)-2-chloropropionic acid 411-150-5 29617-66-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 607-326-00-8 reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate 410-720-0 141847-13-4 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 607-327-00-3 2-(2-iodoethyl)-1,3-propanediol diacetate 411-780-0 127047-77-2 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-328-00-9 methyl 4-bromomethyl-3-methoxybenzoate 410-310-1 70264-94-7 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H410 607-329-00-4 reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;
sodium 2-octadecenyl-amino-1,4-butandioate 411-250-9 — Skin Sens. 1 H317 GHS07
Wng H317 607-330-00-X (S)-2,3-dihydro-1H-indole-2-carboxylic acid 410-860-2 79815-20-6 Repr. 2
STOT RE 2 *
Skin Sens. 1 H361f ***
H373 **
H317 GHS08
GHS07
Wng H361f ***
H373 **
H317 607-331-00-5 reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;
1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane 406-750-9 — Aquatic Chronic 4 H413 — H413 607-332-00-0 cyclopentyl chloroformate 411-460-0 50715-28-1 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1 H226
H331
H302
H373 **
H318
H317 GHS02
GHS06
GHS08
GHS05
Dgr H226
H331
H302
H373 **
H318
H317 607-333-00-6 reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;
tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate 405-670-1 — Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H314
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H302
H373 **
H314
H410 607-334-00-1 ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 405-880-3 100501-62-0 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-335-00-7 methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate 406-250-0 72619-32-0 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 607-336-00-2 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate 406-560-6 122760-85-4 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H315
H317
H411 GHS07
GHS09
Wng H315
H317
H411 607-337-00-8 di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate 406-052-4 125078-60-6 Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H226
H302
H315
H318
H411 GHS02
GHS05
GHS07
GHS09
Dgr H226
H302
H315
H318
H411 607-338-00-3 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate 406-235-9 72531-53-4 Eye Irrit. 2
Skin Irrit. 2 H319
H315 GHS07
Wng H319
H315 607-339-00-9 2,3,4,5-tetrachlorobenzoylchloride 406-760-3 42221-52-3 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H302
H314
H317 GHS05
GHS07
Dgr H302
H314
H317 607-340-00-4 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate 406-990-4 — Aquatic Chronic 2 H411 GHS09 H411 607-341-00-X (9S)-9-amino-9-deoxyerythromycin 406-790-7 26116-56-3 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 607-342-00-5 4-chlorobutyl veratrate 410-950-1 69788-75-6 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-343-00-0 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) 407-410-2 — Aquatic Chronic 4 H413 — H413 607-344-00-6 reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;
3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate 407-810-7 — STOT RE 2 * H373 ** GHS08
Wng H373 ** 607-345-00-1 potassium 2-(2,4-dichlorophenoxy)-(R)-propionate 413-580-9 113963-87-4 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H302
H315
H318
H317 GHS05
GHS07
Dgr H302
H315
H318
H317 607-346-00-7 3-icosyl-4-henicosylidene-2-oxetanone 401-210-9 83708-14-9 Aquatic Chronic 4 H413 — H413 607-347-00-2 sodium (R)-2-(2,4-dichlorophenoxy)propionate 413-340-3 119299-10-4 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H302
H315
H318
H317 GHS05
GHS07
Dgr H302
H315
H318
H317 607-348-00-8 magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) 413-360-2 — Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H302
H315
H318
H317 GHS05
GHS07
Dgr H302
H315
H318
H317 607-349-00-3 mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate 411-270-8 — Aquatic Chronic 3 H412 H412 607-350-00-9 bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane 412-060-9 136210-32-7 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-351-00-4 methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate 407-550-4 69184-17-4 Aquatic Chronic 2 H411 GHS09 H411 607-352-00-X 4,4'-oxydiphthalic anhydride 412-830-4 1823-59-2 Aquatic Chronic 3 H412 — H412 607-353-00-5 reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;
ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate 407-520-0 80657-64-3 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 607-354-00-0 ethyl 2-cyclohexylpropionate 412-280-5 2511-00-4 Aquatic Chronic 2 H411 GHS09 H411 607-355-00-6 p-tolyl 4-chlorobenzoate 411-530-0 15024-10-9 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 607-356-00-1 ethyl trans-2,2,6-trimethylcyclohexanecarboxylate 412-540-8 — Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 607-357-00-7 reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran 412-450-9 131766-73-9 Skin Sens. 1 H317 GHS07
Wng H317 607-358-00-2 (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate 412-670-5 54275-93-3 Resp. Sens. 1 H334 GHS08
Dgr H334 607-359-00-8 (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate 412-800-0 76109-32-5 Resp. Sens. 1 H334 GHS08
Dgr H334 607-360-00-3 sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate 411-680-7 133167-77-8 Skin Sens. 1 H317 GHS07
Wng H317 607-361-00-9 methyl (R)-2-(4-hydroxyphenoxy)propionate 411-950-4 96562-58-2 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 607-362-00-4 reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate 413-500-2 — Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H315
H318
H411 GHS05
GHS09
Dgr H315
H318
H411 607-363-00-X methyl-3-methoxyacrylate 412-900-4 5788-17-0 Skin Sens. 1 H317 GHS07
Wng H317 607-364-00-5 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione 413-330-9 134724-55-3 Aquatic Chronic 4 H413 H413 607-365-00-0 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 410-620-7 119154-86-8 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H302
H314
H317 GHS05
GHS07
Dgr H302
H314
H317 607-366-00-6 3,5-dimethylbenzoyl chloride 413-010-9 6613-44-1 Skin Corr. 1B
Skin Sens. 1 H314
H317 GHS05
GHS07
Dgr H314
H317 607-367-00-1 potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate 411-640-9 153352-59-1 Acute Tox. 4 * H302 GHS07
Wng H302 607-368-00-7 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole 411-650-3 110895-43-7 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 607-369-00-2 reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid 411-660-8 147027-04-1 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H302
H315
H318
H317 GHS05
GHS07
Dgr H302
H315
H318
H317 607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 412-210-3 41620-33-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 Aquatic Chronic 4 H413 — H413 607-372-00-9 ethoxylated bis phenol A di-(norbornene carboxylate) 412-410-0 — Aquatic Chronic 3 H412 — H412 607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 119738-06-6 Muta. 2
Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H341
H360Df
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Dgr H341
H360Df
H302
H373 **
H410 607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-375-00-5 reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;
trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 421-960-0 90035-08-8 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H372 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H372 **
H410 607-376-00-0 benzyl 2,4-dibromobutanoate 420-710-8 23085-60-1 Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361f ***
H315
H317
H400
H410 GHS08
GHS07
GHS09
Wng H361f ***
H315
H317
H410 607-377-00-6 trans-4-cyclohexyl-L-proline monohydrochloride 419-160-1 90657-55-9 Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H361f ***
H302
H315
H318
H317 GHS08
GHS05
GHS07
Dgr H361f ***
H302
H315
H318
H317 607-378-00-1 ammonium (Z)-α-methoxyimino-2-furylacetate 405-990-1 97148-39-5 Flam. Sol. 2 H228 GHS02
Dgr H228 T
607-379-00-7 reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;
sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;
sodium [bis(2-hydroxyethyl)amino]methylsulfonate;
N,N-bis(2-hydroxyethyl)stearamide 401-230-8 Aquatic Chronic 3 H412 — H412 607-380-00-2 reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate 407-320-3 — Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H315
H318
H412 GHS05
Dgr H315
H318
H412 607-381-00-8 reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid 413-710-4 — Aquatic Chronic 4 H413 — H413 607-382-00-3 2-((4-amino-2-nitrophenyl)amino)benzoic acid 411-260-3 117907-43-4 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 607-383-00-9 reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate 415-430-8 86403-32-9 Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H318
H317
H410 607-384-00-4 reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate 413-750-2 171090-93-0 Aquatic Chronic 4 H413 — H413 607-385-00-X Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate 414-590-6 125229-74-5 Aquatic Chronic 2 H411 GHS09 H411 607-386-00-5 reaction mass of: tetradecanoic acid (42,5-47,5 %);
poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %) 412-580-6 174591-51-6 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H410 607-387-00-0 reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid (60-65 %) 412-590-0 58856-63-6 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H410 607-388-00-6 4-ethylamino-3-nitrobenzoic acid 412-090-2 2788-74-1 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H302
H317
H412 GHS07
Wng H302
H317
H412 607-389-00-1 trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate 414-130-4 119710-96-2 Acute Tox. 4 * H302 GHS07
Wng H302 607-390-00-7 1,2,3,4-tetrahydro-6-nitro-quinoxaline 414-270-6 41959-35-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 607-391-00-2 dimethylcyclopropane-1,1-dicarboxylate 414-240-2 6914-71-2 Aquatic Chronic 3 H412 — H412 607-392-00-8 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate 414-260-1 88938-37-8 Aquatic Chronic 4 H413 — H413 607-393-00-3 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 415-750-8 106447-44-3 Skin Sens. 1 H317 GHS07
Wng H317 607-394-00-9 5-methylpyrazine-2-carboxylic acid 413-260-9 5521-55-1 Eye Dam. 1 H318 GHS05
Dgr H318 607-395-00-4 reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate 410-230-7 — Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H314
H317
H411 GHS05
GHS07
GHS09
Dgr H314
H317
H411 607-396-00-X bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate 414-840-4 147783-69-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-397-00-5 reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurized phenates (branched C10-14 and C18-30 alkylated) 415-930-6 — Skin Sens. 1 H317 GHS07
Wng H317 607-398-00-0 ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate 414-820-5 125630-94-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-399-00-6 2,2-dimethyl 3-methyl-3-butenyl propanoate 415-610-6 104468-21-5 Skin Irrit. 2
Aquatic Chronic 3 H315
H412 GHS07
Wng H315
H412 607-400-00-X methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate 414-400-1 32750-89-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-401-00-5 ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate 414-450-4 88805-65-6 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H315
H318
H317 GHS05
GHS07
Dgr H315
H318
H317 607-402-00-0 methyl N-(phenoxycarbonyl)-L-valinate 414-500-5 153441-77-1 Aquatic Chronic 3 H412 — H412 607-403-00-6 reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol 414-810-0 — STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H318
H400
H410 GHS08
GHS05
GHS09
Dgr H373 **
H318
H410 607-404-00-1 reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid 415-190-4 — Skin Sens. 1 H317 GHS07
Wng H317 607-405-00-7 2-hexyldecyl-p-hydroxybenzoate 415-380-7 148348-12-3 Aquatic Chronic 2 H411 GHS09 H411 607-406-00-2 potassium 2,5-dichlorobenzoate 415-700-5 184637-62-5 Acute Tox. 4 *
Eye Dam. 1 H302
H318 GHS05
GHS07
Dgr H302
H318 607-407-00-8 ethyl 2-carboxy-3-(2-thienyl)propionate 415-680-8 143468-96-6 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H315
H318
H317 GHS05
GHS07
Dgr H315
H318
H317 607-408-00-3 potassium N-(4-fluorophenyl)glycinate 415-710-1 184637-63-6 STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H373 **
H318
H317
H412 GHS08
GHS05
GHS07
Dgr H373 **
H318
H317
H412 607-409-00-9 reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass from Aspergillus terreus 415-840-7 — Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-410-00-4 mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate 415-880-5 779343-34-9 Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H315
H318
H317
H410 607-411-00-X oxiranemethanol, 4-methylbenzene-sulfonate, (S)- 417-210-7 70987-78-9 Carc. 1B
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H350
H341
H318
H317
H411 GHS08
GHS05
GHS07
GHS09
Dgr H350
H341
H318
H317
H411 607-412-00-5 ethyl 2-(1-cyanocyclohexyl)acetate 415-970-4 133481-10-4 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3 H302
H373 **
H412 GHS08
GHS07
Wng H302
H373 **
H412 607-413-00-0 trans-4-phenyl-L-proline 416-020-1 96314-26-0 Repr. 2
Skin Sens. 1 H361f ***
H317 GHS08
GHS07
Wng H361f ***
H317 607-414-00-6 tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 402-070-1 88122-99-0 Aquatic Chronic 4 H413 — H413 607-415-00-1 poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride) 419-590-1 — Flam. Sol. 1
Skin Sens. 1 H228
H317 GHS02
GHS07
Dgr H228
H317 T
607-416-00-7 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide 420-730-7 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-418-00-8 2-ethylhexyl 4-aminobenzoate 420-170-3 26218-04-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-419-00-3 (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid 422-240-9 166596-68-5 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 607-420-00-9 2,2-bis(hydroxymethyl)butanoic acid 424-090-1 10097-02-6 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 607-421-00-4 cypermethrin cis/trans +/- 40/60;
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H335
H400
H410 GHS07
GHS09
Wng H332
H302
H335
H410 607-422-00-X α-cypermethrin 257-842-9 67375-30-8 Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H301
H373 **
H335
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H373 **
H335
H410 607-423-00-5 esters of mecoprop and of mecoprop-P — — Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 A
607-424-00-0 trifloxystrobin (ISO);
(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester — 141517-21-7 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 607-425-00-6 metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate 260-979-7 57837-19-1 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H302
H317
H412 GHS07
Wng H302
H317
H412 607-426-00-1 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4] 284-032-2 [1]
- [2]
205-017-9 [3]
210-088-4 [4] 84777-06-0 [1]
- [2]
131-18-0 [3]
605-50-5 [4] Repr. 1B
Aquatic Acute 1 H360FD
H400 GHS08
GHS09
Dgr H360FD
H400 607-427-00-7 bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate 260-300-4 56634-95-8 Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H332
H302
H317
H400
H410 GHS08
GHS07
GHS09
Wng H361d ***
H332
H302
H317
H410 607-430-00-3 BBP;
benzyl butyl phthalate e 201-622-7 85-68-7 Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H400
H410 GHS08
GHS09
Dgr H360Df
H410 607-431-00-9 prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 245-387-9 23031-36-9 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H302
H400
H410 GHS06
GHS09
Dgr H331
H302
H410 607-432-00-4 S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] - [1]
- [2] 87392-12-9 [1]
178961-20-1 [2] Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 607-433-00-X cypermethrin cis/trans +/- 80/20;
(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H335
H315
H317
H400
H410 GHS07
GHS09
Wng H302
H335
H315
H317
H410 607-434-00-5 mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methylphenoxy)propionic acid 240-539-0 16484-77-8 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 607-435-00-0 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate 416-810-6 111969-64-3 STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2 H373 **
H318
H411 GHS08
GHS05
GHS09
Dgr H373 **
H318
H411 607-436-00-6 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate 417-350-9 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 607-437-00-1 3-(4-aminophenyl)-2-cyano-2-propenoic acid 417-480-6 252977-62-1 Skin Sens. 1 H317 GHS07
Wng H317 607-438-00-7 methyl-2-[(aminosulfonyl)methyl]benzoate 419-010-5 112941-26-1 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 607-439-00-2 methyl tetrahydro-2-furancarboxylate 420-670-1 37443-42-8 Eye Dam. 1 H318 GHS05
Dgr H318 607-440-00-8 methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate 421-220-7 144740-59-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 607-441-00-3 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid 421-490-6 167684-63-1 Aquatic Chronic 4 H413 — H413 607-442-00-9 benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate 416-050-5 87460-09-1 Eye Dam. 1 H318 GHS05
Dgr H318 607-443-00-4 bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate 416-140-4 145650-60-8 Aquatic Chronic 4 H413 — H413 607-444-00-X reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate 416-230-3 35541-81-2 Aquatic Chronic 4 H413 — H413 607-445-00-5 Iron (III) tris(4-methylbenzenesulfonate) 420-960-8 77214-82-5 Eye Dam. 1 H318 GHS05
Dgr H318 607-446-00-0 methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate 416-240-8 155522-12-6 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 607-447-00-6 sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate 416-370-5 156738-27-1 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 607-448-00-1 2,3,5,6-tetrafluorobenzoic acid 416-800-1 652-18-6 Skin Irrit. 2
Eye Dam. 1 H315
H318 GHS05
Dgr H315
H318 607-449-00-7 reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 417-080-1 — Self-react. D ****
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H242
H317
H400
H410 GHS02
GHS07
GHS09
Dgr H242
H317
H410 607-450-00-2 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate 419-040-9 89604-92-2 Aquatic Chronic 4 H413 — H413 607-451-00-8 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt 417-640-5 161935-19-9 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 607-453-00-9 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) 418-100-1 172964-15-7 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 607-454-00-4 reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid 418-170-3 116193-72-7 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 607-455-00-X 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt 419-520-8 172890-93-6 Skin Sens. 1 H317 GHS07
Wng H317 607-456-00-5 3-amino-4-chlorobenzoic acid, hexadecyl ester 419-700-6 143269-74-3 Aquatic Chronic 2 H411 GHS09 H411 607-457-00-0 tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) 420-350-1 172277-97-3 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 607-458-00-6 reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] 420-850-1 — Aquatic Chronic 2 H411 GHS09 H411 607-459-00-1 isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate 418-930-4 — Aquatic Chronic 4 H413 — H413 607-460-00-7 3-tridecyloxy-propyl-ammonium 9-octadecenoate 418-990-1 778577-53-0 STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H319
H315
H400
H410 GHS08
GHS07
GHS09
Wng H373 **
H319
H315
H410 607-461-00-2 reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;
pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate 421-160-1 — Aquatic Chronic 3 H412 — H412 607-462-00-8 reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates 421-230-1 88230-35-7 Aquatic Chronic 2 H411 GHS09 H411 607-463-00-3 3-(phenothiazin-10-yl)propionic acid 421-260-5 362-03-8 Aquatic Chronic 2 H411 GHS09 H411 607-464-00-9 reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 421-280-4 Aquatic Chronic 3 H412 — H412 607-465-00-4 tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate 421-440-3 778583-04-3 Aquatic Chronic 3 H412 — H412 607-466-00-X reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate 421-480-1 — Aquatic Chronic 2 H411 GHS09 H411 607-467-00-5 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate 419-430-9 56533-00-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H373 **
H314
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H312
H302
H373 **
H314
H410 607-468-00-0 reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate 419-450-8 — Skin Sens. 1 H317 GHS07
Wng H317 607-469-00-6 disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate 419-460-2 120029-06-3 Aquatic Chronic 3 H412 — H412 607-470-00-1 potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 414-100-0 154336-20-6 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 607-472-00-2 ammonium iron(III) trimethylenediaminetetraacetate hemihydrate 400-660-3 111687-36-6 Aquatic Chronic 2 H411 GHS09 H411 607-474-00-3 (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid 410-430-4 117573-89-4 Aquatic Chronic 4 H413 — H413 607-475-00-9 reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) 412-940-2 148878-18-6 Skin Sens. 1 H317 GHS07
Wng H317 607-476-00-4 trisodium N,N-bis(carboxymethyl)-β-alanine 414-070-9 129050-62-0 Skin Corr. 1B
Aquatic Chronic 3 H314
H412 GHS05
Dgr H314
H412 607-478-00-5 tetramethylammonium hydrogen phthalate 416-900-5 79723-02-7 Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1 H301
H373 **
H400 GHS06
GHS08
GHS09
Dgr H301
H373 **
H400 607-479-00-0 hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate 418-550-9 168689-49-4 Aquatic Chronic 4 H413 — H413 607-480-00-6 1,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters 271-084-6 68515-42-4 Repr. 1B H360Df GHS08
Dgr H360Df 607-487-00-4 reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate 402-660-9 — Repr. 1B
Aquatic Chronic 3 H360D ***
H412 GHS08
Dgr H360D ***
H412 607-488-00-X ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate 414-210-9 147379-38-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-489-00-5 reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate 414-890-7 71302-79-9 Skin Sens. 1 H317 GHS07
Wng H317 607-490-00-0 N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate 415-060-7 — Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 607-492-00-1 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate 415-490-5 141773-73-1 Aquatic Chronic 2 H411 GHS09 H411 607-493-00-7 methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate 415-670-3 78850-37-0 Eye Dam. 1 H318 GHS05
Dgr H318 607-494-00-2 bis(2-ethylhexyl)octylphosphonate 417-170-0 52894-02-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-495-00-8 sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate 417-550-6 168151-92-6 Skin Sens. 1 H317 GHS07
Wng H317 607-496-00-3 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite 418-310-3 126050-54-2 Aquatic Chronic 4 H413 — H413 607-497-00-9 cerium oxide isostearate 419-760-3 — Aquatic Chronic 4 H413 — H413 607-498-00-4 (E)-3,7-dimethyl-2,6-octadienylhexadecanoate 421-370-3 3681-73-0 Skin Irrit. 2
Aquatic Chronic 4 H315
H413 GHS07
Wng H315
H413 607-499-00-X bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) 421-660-1 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 607-500-00-3 calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate 421-670-4 — Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H315
H400
H410 GHS07
GHS09
Wng H315
H410 607-501-00-9 reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives 421-820-9 192268-65-8 Aquatic Chronic 4 H413 — H413 607-502-00-4 (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate 422-200-0 178277-55-9 Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H314
H302
H411 GHS05
GHS07
GHS09
Dgr H314
H302
H411 607-503-00-X 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane 422-210-5 68957-94-8 Skin Corr. 1B H314 GHS05
Dgr H314 607-505-00-0 pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate 422-930-1 Aquatic Chronic 3 H412 — H412 607-506-00-6 reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate 422-970-8 Aquatic Chronic 2 H411 GHS09 H411 607-507-00-1 potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate 422-980-2 187026-95-5 Eye Dam. 1 H318 GHS05
Dgr H318 607-508-00-7 disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] 423-110-4 — Eye Dam. 1 H318 GHS05
Dgr H318 607-512-00-9 trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate 423-970-0 182926-43-8 Aquatic Chronic 3 H412 — H412 607-513-00-4 reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid 423-200-3 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 607-515-00-5 reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate 429-650-7 147732-60-3 Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 607-516-00-0 N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine 429-670-6 105996-54-1 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 607-517-00-6 (S)-α-(acetylthio)benzenepropanoic acid 430-300-0 76932-17-7 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H302
H318
H317 GHS05
GHS07
Dgr H302
H318
H317 607-526-00-5 cartap (ISO);
1,3-bis(carbamoylthio)-2-(dimethylamino)propane — 15263-53-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 607-527-00-0 reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate 423-180-6 — STOT RE 2 * H373 ** GHS08
Wng H373 ** 607-696-00-0 pentyl formate 211-340-6 638-49-3 Flam. Liq. 3
Eye Irrit. 2
STOT SE 3 H226
H319
H335 GHS02
GHS07
Dgr H226
H319
H335 C
607-697-00-6 tert-butyl propionate — 20487-40-5 Flam. Liq. 2 H225 GHS02
Dgr H225 C
608-001-00-3 acetonitrile;
cyanomethane 200-835-2 75-05-8 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2 H225
H332
H312
H302
H319 GHS02
GHS07
Dgr H225
H332
H312
H302
H319 608-002-00-9 trichloroacetonitrile 208-885-7 545-06-2 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H331
H311
H301
H411 GHS06
GHS09
Dgr H331
H311
H301
H411 608-003-00-4 acrylonitrile 203-466-5 107-13-1 Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H225
H350
H331
H311
H301
H335
H315
H318
H317
H411 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H225
H350
H331
H311
H301
H335
H315
H318
H317
H411 * D
608-004-00-X 2-hydroxy-2-methylpropionitrile;
2-cyanopropan-2-ol;
acetone cyanohydrin 200-909-4 75-86-5 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H400
H410 GHS06
GHS09
Dgr H330
H310
H300
H410 608-005-00-5 n-butyronitrile 203-700-6 109-74-0 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H225
H331
H311
H301 GHS02
GHS06
Dgr H225
H331
H311
H301 608-006-00-0 bromoxynil (ISO)
3,5-dibromo-4-hydroxybenzonitrile;
bromoxynil phenol 216-882-7 1689-84-5 Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H330
H301
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H330
H301
H317
H410 M = 10 608-007-00-6 ioxynil (ISO)
4-hydroxy-3,5-diiodobenzonitrile 216-881-1 1689-83-4 Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H331
H301
H312
H373 **
H319
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H331
H301
H312
H373 **
H319
H410 M = 10 608-008-00-1 chloroacetonitrile 203-467-0 107-14-2 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H331
H311
H301
H411 GHS06
GHS09
Dgr H331
H311
H301
H411 608-009-00-7 malononitrile 203-703-2 109-77-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 608-010-00-2 methacrylonitrile;
2-methyl-2-propene nitrile 204-817-5 126-98-7 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1 H225
H331
H311
H301
H317 GHS02
GHS06
Dgr H225
H331
H311
H301
H317 *
Skin Sens. 1; H317: C ≥ 0,2 % D
608-011-00-8 oxalonitrile;
cyanogen 207-306-5 460-19-5 Flam. Gas 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H220
H331
H400
H410 GHS02
GHS04
GHS06
GHS09
Dgr H220
H331
H410 U
608-012-00-3 benzonitrile 202-855-7 100-47-0 Acute Tox. 4 *
Acute Tox. 4 * H312
H302 GHS07
Wng H312
H302 608-013-00-9 2-chlorobenzonitrile 212-836-5 873-32-5 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2 H312
H302
H319 GHS07
Wng H312
H302
H319 608-014-00-4 chlorothalonil (ISO);
tetrachloroisophthalonitrile 217-588-1 1897-45-6 Carc. 2
Acute Tox. 2 *
Eye Dam. 1
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H330
H318
H335
H317
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H351
H330
H318
H335
H317
H410 M = 10 608-015-00-X dichlobenil (ISO);
2,6-dichlorobenzonitrile 214-787-5 1194-65-6 Acute Tox. 4 *
Aquatic Chronic 2 H312
H411 GHS07
GHS09
Wng H312
H411 608-016-00-5 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene 401-550-8 1897-41-2 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 608-017-00-0 bromoxynil octanoate (ISO);
2,6-dibromo-4-cyanophenyl octanoate 216-885-3 1689-99-2 Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H331
H302
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H331
H302
H317
H410 M = 10 608-018-00-6 ioxynil octanoate (ISO);
4-cyano-2,6-diiodophenyl octanoate 223-375-4 3861-47-0 Repr. 2
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H301
H319
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H301
H319
H317
H410 M = 10 608-019-00-1 2,2'-dimethyl-2,2'-azodipropiononitrile;
ADZN 201-132-3 78-67-1 Self-react. C
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H242
H332
H302
H412 GHS02
GHS07
Dgr H242
H332
H302
H412 T
608-021-00-2 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile 403-710-2 76823-93-3 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 608-022-00-8 3,7-dimethyloctanenitrile 403-620-3 40188-41-8 Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H315
H317
H411 GHS07
GHS09
Wng H315
H317
H411 608-023-00-3 fenbuconazole (ISO);
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile 406-140-2 114369-43-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 608-024-00-9 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile 407-650-8 97460-76-9 Aquatic Chronic 4 H413 — H413 608-025-00-4 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile 410-970-0 117568-27-1 Aquatic Chronic 4 H413 — H413 608-026-00-X 3-cyano-3,5,5-trimethylcyclohexanone 411-490-4 7027-11-4 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3 H302
H373 **
H317
H412 GHS08
GHS07
Wng H302
H373 **
H317
H412 608-027-00-5 reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(3-ethylphenyl)-2,2-dimethylpropanenitrile 412-660-0 — Aquatic Chronic 2 H411 GHS09 H411 608-028-00-0 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate 413-510-7 147374-67-2 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H373 **
H317
H411 GHS08
GHS09
Wng H373 **
H317
H411 608-029-00-6 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile 411-990-2 68612-94-2 Skin Sens. 1 H317 GHS07
Wng H317 608-030-00-1 N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide 412-340-0 147741-93-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 608-031-00-7 2-benzyl-2-methyl-3-butenitrile 407-870-4 97384-48-0 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 608-033-00-8 N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide 407-970-8 75511-91-0 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 608-034-00-3 chlorfenapyr;
4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile — 122453-73-0 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H302
H400
H410 GHS06
GHS09
Dgr H331
H302
H410 608-035-00-9 (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile 419-290-9 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 608-036-00-4 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile 419-060-8 79026-02-1 Aquatic Chronic 4 H413 — H413 608-037-00-X reaction mass of: (E)-2,12-tridecadiennitrile;
(E)-3,12-tridecadiennitrile;
(Z)-3,12-tridecadiennitrile 422-190-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 608-038-00-5 2,2,4-trimethyl-4-phenyl-butane-nitrile 422-580-8 75490-39-0 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 423-500-4 138401-24-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 608-043-00-2 3-(cis-3-hexenyloxy)propanenitril 415-220-6 142653-61-0 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H302
H400
H410 GHS06
GHS09
Dgr H331
H302
H410 608-065-00-2 salts of bromoxynil with the exception of those specified elsewhere in this Annex — — Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H330
H301
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H330
H301
H317
H410 M = 10 A
608-066-00-8 salts of ioxynil with the exception of those specified elsewhere in this Annex — — Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H331
H301
H312
H373 **
H319
H400
H410 GHS06
GHS08
GHS09
Dgr H361d ***
H331
H301
H312
H373 **
H319
H410 M = 10 A
609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H226
H332
H312
H302 GHS02
GHS07
Wng H226
H332
H312
H302 * 609-002-00-1 2-nitropropane 201-209-1 79-46-9 Flam. Liq. 3
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 * H226
H350
H332
H302 GHS02
GHS08
GHS07
Dgr H226
H350
H332
H302 609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 2 H351
H361f ***
H331
H311
H301
H372 **
H411 GHS06
GHS08
GHS09
Dgr H351
H361f ***
H331
H311
H301
H372 **
H411 609-004-00-2 dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4] 246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4] 25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4] Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H410 609-005-00-8 1,3,5-trinitrobenzene 202-752-7 99-35-4 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H330
H310
H300
H373 **
H400
H410 GHS01
GHS06
GHS08
GHS09
Dgr H201
H330
H310
H300
H373 **
H410 609-006-00-3 4-nitrotoluene 202-808-0 99-99-0 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 609-007-00-9 2,4-dinitrotoluene;
dinitrotoluene, technical grade; [1]
dinitrotoluene [2] 204-450-0 [1]
246-836-1 [2] 121-14-2 [1]
25321-14-6 [2] Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H350
H341
H361f ***
H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H411 609-008-00-4 2,4,6-trinitrotoluene;
TNT 204-289-6 118-96-7 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H201
H331
H311
H301
H373 **
H411 GHS01
GHS06
GHS08
GHS09
Dgr H201
H331
H311
H301
H373 **
H411 609-009-00-X 2,4,6-trinitrophenol;
picric acid 201-865-9 88-89-1 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H201
H331
H311
H301 GHS01
GHS06
Dgr H201
H331
H311
H301 609-010-00-5 salts of picric acid — — Unst. Expl
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H201
H331
H311
H301 GHS01
GHS06
Dgr H201
H331
H311
H301 T
609-011-00-0 2,4,6-trinitroanisole — 606-35-9 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H201
H332
H312
H302
H411 GHS01
GHS07
GHS09
Wng H201
H332
H312
H302
H411 609-012-00-6 2,4,6-trinitro-m-cresol 210-027-1 602-99-3 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H201
H332
H312
H302 GHS01
GHS07
Wng H201
H332
H312
H302 609-013-00-1 2,4,6-trinitro-m-xylene 211-187-5 632-92-8 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 * H201
H332
H312
H302
H373 ** GHS01
GHS08
GHS07
Wng H201
H332
H312
H302
H373 ** 609-015-00-2 4-nitrophenol;
p-nitrophenol 202-811-7 100-02-7 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 * H332
H312
H302
H373 ** GHS08
GHS07
Wng H332
H312
H302
H373 ** 609-016-00-8 dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2] 247-096-2 [1]
275-732-9 [2] 25550-58-7 [1]
71629-74-8 [2] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 609-018-00-9 2,4,6-trinitroresorcinol;
styphnic acid 201-436-6 82-71-3 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H201
H332
H312
H302 GHS01
GHS07
Wng H201
H332
H312
H302 T
609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate 239-290-0 15245-44-0 Unst. Expl
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H200
H360Df
H332
H302
H373 **
H400
H410 GHS01
GHS08
GHS07
GHS09
Dgr H200
H360Df
H332
H302
H373 **
H410 1
609-019-01-1 lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate (≥ 20 % phlegmatiser) 239-290-0 15245-44-0 Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H360Df
H332
H302
H373 **
H400
H410 GHS01
GHS08
GHS07
GHS09
Dgr H201
H360Df
H332
H302
H373 **
H410 1
609-020-00-X DNOC (ISO);
4,6-dinitro-o-cresol 208-601-1 534-52-1 Muta. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H330
H310
H300
H315
H318
H317
H400
H410 GHS06
GHS08
GHS05
GHS07
GHS09
Dgr H341
H330
H310
H300
H315
H318
H317
H410 EUH044 609-021-00-5 sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC;
potassium 4,6-dinitro-o-cresolate [2] 219-007-7 [1]
- [2] 2312-76-7 [1]
5787-96-2 [2] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 609-022-00-0 ammonium salt of DNOC;
ammonium 4,6-dinitro-o-tolyl oxide 221-037-0 2980-64-5 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H310
H300
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H410 609-023-00-6 dinocap (ISO) 254-408-0 39300-45-3 Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H332
H373 **
H315
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H360D ***
H332
H373 **
H315
H317
H410 609-024-00-1 binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 207-612-9 485-31-4 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H312
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H360D ***
H312
H302
H410 609-025-00-7 dinoseb(ISO);
6-sec-butyl-2,4-dinitrophenol 201-861-7 88-85-7 Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H311
H301
H319
H400
H410 GHS06
GHS08
GHS09
Dgr H360Df
H311
H301
H319
H410 EUH044 609-026-00-2 salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex — — Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H311
H301
H319
H400
H410 GHS06
GHS08
GHS09
Dgr H360Df
H311
H301
H319
H410 EUH044 A
609-027-00-8 dinocton;
reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate — 63919-26-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 609-028-00-3 dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol 205-042-5 131-89-5 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 609-029-00-9 salts and esters of dinex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 A
609-030-00-4 dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol 215-813-8 1420-07-1 Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H300
H311
H400
H410 GHS06
GHS08
GHS09
Dgr H360D ***
H300
H311
H410 EUH044 609-031-00-X salts and esters of dinoterb — — Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H300
H311
H400
H410 GHS06
GHS08
GHS09
Dgr H360D ***
H300
H311
H410 A
609-032-00-5 bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 236-129-6 13181-17-4 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 609-033-00-0 dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol — 4097-36-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 609-034-00-6 salts and esters of dinosam — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H410 A
609-035-00-1 nitroethane 201-188-9 79-24-3 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 * H226
H332
H302 GHS02
GHS07
Wng H226
H332
H302 * 609-036-00-7 nitromethane 200-876-6 75-52-5 Flam. Liq. 3
Acute Tox. 4 * H226
H302 GHS02
GHS07
Wng H226
H302 * 609-037-00-2 5-nitroacenaphthene 210-025-0 602-87-9 Carc. 1B H350 GHS08
Dgr H350 609-038-00-8 2-nitronaphthalene 209-474-5 581-89-5 Carc. 1B
Aquatic Chronic 2 H350
H411 GHS08
GHS09
Dgr H350
H411 609-039-00-3 4-nitrobiphenyl 202-204-7 92-93-3 Carc. 1B
Aquatic Chronic 2 H350
H411 GHS08
GHS09
Dgr H350
H411 609-040-00-9 nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether 217-406-0 1836-75-5 Carc. 1B
Repr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H360D ***
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H360D ***
H302
H410 609-041-00-4 2,4-dinitrophenol 200-087-7 51-28-5 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1 H331
H311
H301
H373 **
H400 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H400 609-042-00-X pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 254-938-2 40487-42-1 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 609-043-00-5 quintozene (ISO);
pentachloronitrobenzene 201-435-0 82-68-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 609-044-00-0 tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene 204-178-2 117-18-0 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 609-045-00-6 reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;
dinocton-6 — 8069-76-9 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 609-046-00-1 trifluralin (ISO) (containing < 0.5 ppm NPDA);
α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) 216-428-8 1582-09-8 Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H319
H317
H400
H410 GHS07
GHS09
Wng H319
H317
H410 609-047-00-7 2-nitroanisole 202-052-1 91-23-6 Carc. 1B
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 609-048-00-2 sodium 3-nitrobenzenesulphonate 204-857-3 127-68-4 Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 609-049-00-8 2,6-dinitrotoluene 210-106-0 606-20-2 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H350
H341
H361f ***
H331
H311
H301
H373 **
H412 GHS06
GHS08
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H412 609-050-00-3 2,3-dinitrotoluene 210-013-5 602-01-7 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H341
H361f ***
H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H410 609-051-00-9 3,4-dinitrotoluene 210-222-1 610-39-9 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H350
H341
H361f ***
H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H411 609-052-00-4 3,5-dinitrotoluene 210-566-2 618-85-9 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H350
H341
H361f ***
H331
H311
H301
H373 **
H412 GHS06
GHS08
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H412 609-053-00-X hydrazine-trinitromethane 414-850-9 — Expl. 1.1 ****
Self-react. A
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1 H201
H240
H350
H331
H301
H317 GHS01
GHS06
GHS08
Dgr H201
H240
H350
H331
H301
H317 609-054-00-5 2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5] 200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
- [5] 66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
- [5] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 609-055-00-0 2,5-dinitrotoluene 210-581-4 619-15-8 Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H350
H341
H361f ***
H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H350
H341
H361f ***
H331
H311
H301
H373 **
H411 609-056-00-6 2,2-dibromo-2-nitroethanol 412-380-9 69094-18-4 Expl. 1.1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H201
H351
H302
H373 **
H314
H317
H400
H410 GHS01
GHS08
GHS05
GHS07
GHS09
Dgr H201
H351
H302
H373 **
H314
H317
H410 *
STOT SE 3; H335: C ≥ 1 % T
609-057-00-1 3-chloro-2,4-difluoronitrobenzene 411-980-8 3847-58-3 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H317
H410 609-058-00-7 2-nitro-2-phenyl-1,3-propanediol 410-360-4 5428-02-4 STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H372 **
H312
H302
H317
H411 GHS08
GHS07
GHS09
Dgr H372 **
H312
H302
H317
H411 EUH070 609-059-00-2 2-chloro-6-(ethylamino)-4-nitrophenol 411-440-1 131657-78-8 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 609-060-00-8 4-[(3-hydroxypropyl)amino]-3-nitrophenol 406-305-9 92952-81-3 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 609-061-00-3 (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime 406-100-4 94097-88-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 609-062-00-9 2-bromo-2-nitropropanol 407-030-7 24403-04-1 Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H311
H302
H373 **
H314
H317
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H311
H302
H373 **
H314
H317
H410 609-063-00-4 2-[(4-chloro-2-nitrophenyl)amino]ethanol 413-280-8 59320-13-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 609-064-00-X mesotrione(ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione — 104206-82-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 609-065-00-5 2-nitrotoluene 201-853-3 88-72-2 Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2 H350
H340
H361f ***
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H340
H361f ***
H302
H411 609-066-00-0 lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 418-870-9 154212-58-5 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2 ** H332
H312
H302
H371 ** GHS08
GHS07
Dgr H332
H312
H302
H371 ** 609-067-00-6 sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine 416-280-6 156769-97-0 Skin Sens. 1 H317 GHS07
Wng H317 609-068-00-1 musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-4 81-15-2 Expl. 1.1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H201
H351
H400
H410 GHS01
GHS08
GHS09
Wng H201
H351
H410 T
609-070-00-2 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene 415-580-4 130841-23-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 423-520-3 156137-33-6 Skin Sens. 1 H317 GHS07
Wng H317 610-001-00-3 trichloronitromethane;
chloropicrin 200-930-9 76-06-2 Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H330
H302
H319
H335
H315 GHS06
Dgr H330
H302
H319
H335
H315 610-002-00-9 1,1-dichloro-1-nitroethane 209-854-0 594-72-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 610-003-00-4 chlorodinitrobenzene — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 C
610-004-00-X 2-chloro-1,3,5-trinitrobenzene 201-864-3 88-88-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H201
H330
H310
H300
H400
H410 GHS01
GHS06
GHS09
Dgr H201
H330
H310
H300
H410 610-005-00-5 1-chloro-4-nitrobenzene 202-809-6 100-00-5 Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H351
H341
H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H351
H341
H331
H311
H301
H373 **
H411 610-006-00-0 chloronitroanilines with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H330
H310
H300
H373 **
H411 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H411 A C
610-007-00-6 1-chloro-1-nitropropane 209-990-0 600-25-9 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 * 610-008-00-1 2,6-dichloro-4-nitroanisole 403-350-6 17742-69-7 Acute Tox. 3 *
Aquatic Chronic 2 H301
H411 GHS06
GHS09
Dgr H301
H411 610-009-00-7 2-chloro-4-nitroaniline 204-502-2 121-87-9 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 610-010-00-2 2-bromo-1-(2-furyl)-2-nitroethylene 406-110-9 35950-52-8 Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H314
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H302
H373 **
H314
H317
H410 611-001-00-6 azobenzene 203-102-5 103-33-3 Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H341
H332
H302
H373 **
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H341
H332
H302
H373 **
H410 611-002-00-1 azoxybenzene 207-802-1 495-48-7 Acute Tox. 4 *
Acute Tox. 4 * H332
H302 GHS07
Wng H332
H302 611-003-00-7 fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate 205-419-4 140-56-7 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 3 H301
H312
H412 GHS06
Dgr H301
H312
H412 611-004-00-2 methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate 209-765-7 592-62-1 Carc. 1B
Repr. 1B H350
H360D *** GHS08
Dgr H350
H360D *** 611-005-00-8 disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);
CI Direct Brown 95 240-221-1 16071-86-6 Carc. 1B H350 GHS08
Dgr H350 611-006-00-3 4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene 202-591-2 97-56-3 Carc. 1B
Skin Sens. 1 H350
H317 GHS08
Dgr H350
H317 611-007-00-9 tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole; 255-559-5 41814-78-2 Acute Tox. 4 * H302 GHS07
Wng H302 611-008-00-4 4-aminoazobenzene;
4-phenylazoaniline 200-453-6 60-09-3 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 611-009-00-X sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) 401-220-3 — Acute Tox. 4 *
Aquatic Chronic 3 H332
H412 GHS07
Wng H332
H412 611-010-00-5 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide 403-010-7 106359-94-8 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 611-011-00-0 N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate 403-340-1 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dg H318
H411 611-012-00-6 reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate 403-410-1 114565-65-0 Skin Sens. 1 H317 GHS07
Wng H317 611-013-00-1 trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate 403-650-7 117409-78-6 Expl. 1.3 ****
Aquatic Chronic 2 H203
H411 GHS01
GHS09
Dgr H203
H411 611-014-00-7 (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide 404-250-5 115099-55-3 Skin Sens. 1 H317 GHS07
Wng H317 611-015-00-2 tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 404-320-5 116889-78-2 Skin Sens. 1 H317 GHS07
Wng H317 611-016-00-8 reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride 404-540-1 — Skin Sens. 1 H317 GHS07
Wng H317 611-017-00-3 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide 404-910-2 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-018-00-9 tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate 405-130-5 — Skin Sens. 1 H317 GHS07
Wng H317 611-019-00-4 tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-150-4 106028-58-4 Skin Sens. 1 H317 GHS07
Wng H317 611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-170-3 116340-05-7 Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 3 H301
H317
H412 GHS06
Dgr H301
H317
H412 611-021-00-5 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate 405-480-9 — Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 4 H302
H373 **
H315
H413 GHS08
GHS07
Wng H302
H373 **
H315
H413 611-022-00-0 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate 404-980-4 — Self-react. C
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H242
H331
H301
H312
H373 **
H318
H317
H400
H410 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H242
H331
H301
H312
H373 **
H318
H317
H410 T
611-023-00-6 disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate 404-600-7 — Skin Sens. 1 H317 GHS07
Wng H317 611-024-00-1 Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex — — Carc. 1B H350 GHS08
Dgr H350 A
611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38 217-710-3 1937-37-7 Carc. 1B
Repr. 2 H350
H361d *** GHS08
Dgr H350
H361d *** 611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6 220-012-1 2602-46-2 Carc. 1B
Repr. 2 H350
H361d *** GHS08
Dgr H350
H361d *** 611-027-00-8 disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);
C.I. Direct Red 28 209-358-4 573-58-0 Carc. 1B
Repr. 2 H350
H361d *** GHS08
Dgr H350
H361d *** 611-028-00-3 C,C'-azodi(formamide) 204-650-8 123-77-3 Resp. Sens. 1 H334 GHS08
Dgr H334 G
611-029-00-9 o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex — — Carc. 1B H350 GHS08
Dgr H350 A H
611-030-00-4 o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex — — Carc. 1B H350 GHS08
Dgr H350 A H
611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9 209-321-2 569-61-9 Carc. 1B H350 GHS08
Dgr H350 611-032-00-5 1,4,5,8-tetraaminoanthraquinone;
C.I. Disperse Blue 1 219-603-7 2475-45-8 Carc. 1B
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1 H350
H315
H318
H317 GHS08
GHS05
GHS07
Dgr H350
H315
H318
H317 611-033-00-0 hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) 400-020-3 82027-60-9 Aquatic Chronic 2 H411 GHS09 H411 611-034-00-6 N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide 402-430-8 105076-77-5 Aquatic Chronic 4 H413 — H413 611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 403-660-1 107246-80-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-036-00-7 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate 405-440-0 — Skin Sens. 1 H317 GHS07
Wng H317 611-037-00-2 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate 406-055-0 124584-00-5 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 611-038-00-8 trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate 406-820-9 — Eye Irrit. 2 H319 GHS07
Wng H319 611-039-00-3 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid 407-050-6 117715-57-8 Skin Sens. 1 H317 GHS07
Wng H317 611-040-00-9 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid 407-670-7 115099-58-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 611-041-00-4 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide 407-680-1 98809-11-1 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 611-042-00-X trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate 411-770-6 136213-71-3 Aquatic Chronic 3 H412 — H412 611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) 402-850-1 — Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) 403-720-7 117527-94-3 Aquatic Chronic 2 H411 GHS09 H411 611-045-00-6 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene 404-830-8 — Aquatic Chronic 4 H413 — H413 611-046-00-1 4,4'-diamino-2-methylazobenzene 407-590-2 43151-99-1 Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H373 **
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H373 **
H317
H410 611-047-00-7 reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-890-3 111381-11-4 Aquatic Chronic 4 H413 — H413 611-048-00-2 reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-900-6 111381-12-5 Aquatic Chronic 4 H413 — H413 611-049-00-8 reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) 408-000-6 118658-98-3 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3 H373 **
H317
H412 GHS08
Wng H373 **
H317
H412 611-051-00-9 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride 411-110-7 136213-74-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 611-052-00-4 monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex 400-720-9 — Aquatic Chronic 3 H412 — H412 611-053-00-X 2,2'-azobis[2-methylpropionamidine] dihydrochloride 221-070-0 2997-92-4 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 611-055-00-0 C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 220-600-8 2832-40-8 Carc. 2
Skin Sens. 1 H351
H317 GHS08
GHS07
Wng H351
H317 611-056-00-6 C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol 212-668-2 842-07-9 Carc. 2
Muta. 2
Skin Sens. 1
Aquatic Chronic 4 H351
H341
H317
H413 GHS08
GHS07
Wng H351
H341
H317
H413 611-057-00-1 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile 400-340-3 85136-74-9 Carc. 1B
Aquatic Chronic 4 H350
H413 GHS08
Wng H350
H413 611-058-00-7 (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 402-060-7 108225-03-2 Carc. 1B
Eye Dam. 1
Aquatic Chronic 2 H350
H318
H411 GHS08
GHS05
GHS09
Dgr H350
H318
H411 611-059-00-2 octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate 412-960-1 148878-21-1 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid 413-180-4 187285-15-0 Eye Dam. 1 H318 GHS05
Dgr H318 611-061-00-3 disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate 412-530-3 — Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 611-062-00-9 octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate 413-550-5 — Skin Irrit. 2
Eye Dam. 1 H315
H318 GHS05
Dgr H315
H318 611-063-00-4 trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) 413-590-3 164058-22-4 Carc. 1B H350 GHS08
Dgr H350 611-064-00-X 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol 410-600-8 124719-26-2 STOT RE 2 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H315
H400
H410 GHS08
GHS07
GHS09
Wng H373 **
H315
H410 611-065-00-5 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol 410-610-2 111850-24-9 STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H319
H315
H317
H400
H410 GHS08
GHS07
GHS09
Wng H373 **
H319
H315
H317
H410 611-066-00-0 tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 411-540-5 130201-57-9 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 611-067-00-6 reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;
bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate 406-910-8 — Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 611-068-00-1 tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 400-690-7 85665-98-1 Aquatic Chronic 2 H411 GHS09 H411 611-069-00-7 N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline 413-380-1 — Aquatic Chronic 2 H411 GHS09 H411 611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) 405-665-4 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 611-071-00-8 tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate 406-073-9 131013-81-5 Acute Tox. 3 *
Aquatic Chronic 3 H301
H412 GHS06
Dgr H301
H412 611-072-00-3 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride 407-010-8 118208-02-9 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2 H302
H318
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H411 611-073-00-9 dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate 407-310-9 122630-55-1 Aquatic Chronic 4 H413 — H413 611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) 407-100-7 — Skin Sens. 1 H317 GHS07
Wng H317 611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) 406-000-0 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 611-076-00-5 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole 406-280-4 117584-16-4 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 611-077-00-0 dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) 407-230-4 126637-70-5 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 611-078-00-6 (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate 407-240-9 159604-94-1 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-079-00-1 disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate 410-390-8 147703-64-8 Eye Dam. 1 H318 GHS05
Dgr H318 611-080-00-7 sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate 410-150-2 147703-65-9 Skin Sens. 1 H317 GHS07
Wng H317 611-081-00-2 tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) 411-470-5 141048-13-7 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 611-082-00-8 reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);
pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) 407-570-3 — Aquatic Chronic 2 H411 GHS09 H411 611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) 411-560-4 — STOT RE 1
Skin Sens. 1
Aquatic Chronic 2 H372 **
H317
H411 GHS08
GHS07
GHS09
Dgr H372 **
H317
H411 611-084-00-9 reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;
N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide 412-550-2 — Aquatic Chronic 4 H413 — H413 611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine 411-880-4 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate 411-360-7 — Aquatic Chronic 3 H412 — H412 611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) 411-710-9 — Aquatic Chronic 4 H413 — H413 611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate 411-890-9 — Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 611-089-00-6 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate 411-100-2 136213-73-5 STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H373 **
H317
H410 611-090-00-1 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate 413-290-2 93672-52-7 Self-react. C
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H242
H302
H318
H317
H412 GHS02
GHS05
GHS07
Dgr H242
H302
H318
H317
H412 T
611-091-00-7 sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate 413-470-0 134595-59-8 Skin Sens. 1 H317 GHS07
Wng H317 611-092-00-2 tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate 413-210-6 — Aquatic Chronic 2 H411 GHS09 H411 611-093-00-8 sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate 410-770-3 146177-84-6 Skin Sens. 1 H317 GHS07
Wng H317 611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 411-600-0 143145-93-1 Aquatic Chronic 4 H413 — H413 611-095-00-9 hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide 412-240-7 89797-03-5 Aquatic Chronic 2 H411 GHS09 H411 611-096-00-4 methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate 413-040-2 149850-30-6 Skin Sens. 1 H317 GHS07
Wng H317 611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) 414-150-3 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-098-00-5 tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate 405-950-3 131013-83-7 Acute Tox. 3 *
Aquatic Chronic 3 H301
H412 GHS06
Dgr H301
H412 611-099-00-0 (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride 401-500-5 118658-99-4 Carc. 1B
Aquatic Chronic 2 H350
H411 GHS08
GHS09
Dgr H350
H411 611-100-00-4 potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate 403-810-6 140876-13-7 Eye Dam. 1 H318 GHS05
Dgr H318 611-101-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide 405-200-5 104366-25-8 Skin Sens. 1 H317 GHS07
Wng H317 611-103-00-0 trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) 407-110-1 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);
trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate 406-870-1 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-105-00-1 sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate 407-800-2 136213-75-7 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-106-00-7 hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate 410-180-6 157627-99-1 Eye Dam. 1 H318 GHS05
Dgr H318 611-107-00-2 potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate 412-490-7 — Skin Sens. 1 H317 GHS07
Wng H317 611-108-00-8 disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate 413-600-6 6527-62-4 Aquatic Chronic 3 H412 — H412 611-109-00-3 reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) 407-710-3 — Aquatic Chronic 2 H411 GHS09 H411 611-110-00-9 tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene 408-210-8 124605-82-9 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-111-00-4 disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) 414-230-8 — Skin Sens. 1 H317 GHS07
Wng H317 611-112-00-X tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate 413-070-6 — Skin Sens. 1 H317 GHS07
Wng H317 611-113-00-5 lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) 414-280-0 149626-00-6 Aquatic Chronic 2 H411 GHS09 H411 611-114-00-0 lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) 414-250-7 149564-66-9 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 611-115-00-6 trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) 414-290-5 149564-65-8 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 611-116-00-1 reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 414-620-8 — Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 611-117-00-7 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt 415-100-3 149850-29-3 Skin Sens. 1 H317 GHS07
Wng H317 611-118-00-2 sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt 413-990-8 Skin Sens. 1 H317 GHS07
Wng H317 611-119-00-8 tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 415-400-4 148878-22-2 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 611-120-00-3 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt 418-340-7 157707-94-3 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 611-121-00-9 main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol 417-280-9 30785-74-1 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 611-122-00-4 hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel 417-250-5 151436-99-6 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 611-123-00-X 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate 424-310-4 178452-66-9 Eye Dam. 1 H318 GHS05
Dgr H318 611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate 424-320-9 Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 611-125-00-0 reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex 423-940-7 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 611-126-00-6 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride 424-120-1 174514-06-8 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 611-127-00-1 pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate 423-790-2 — Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 G
611-128-00-7 N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt 419-500-9 171599-85-2 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 418-230-9 163879-69-4 Expl. 1.3 ****
Repr. 2
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H203
H361f ***
H373 **
H317
H411 GHS01
GHS08
GHS07
GHS09
Dgr H203
H361f ***
H373 **
H317
H411 611-130-00-8 tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate 418-520-5 183130-96-3 Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H400
H410 GHS07
GHS09
Wng H319
H410 611-131-00-3 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one 420-580-2 151798-26-4 Repr. 1B
Aquatic Chronic 4 H360D ***
H413 GHS08
Dgr H360D ***
H413 611-132-00-9 pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-210-2 178452-71-6 Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 611-133-00-4 Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt 419-260-5 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 611-134-00-X trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex 423-770-3 — Eye Dam. 1
Aquatic Chronic 2 H318
H411 GHS05
GHS09
Dgr H318
H411 611-135-00-5 reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt 424-250-9 — Eye Dam. 1
Aquatic Chronic 3 H318
H412 GHS05
Dgr H318
H412 611-136-00-0 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate 424-260-3 — Repr. 2
Eye Dam. 1
Aquatic Chronic 2 H361f ***
H318
H411 GHS05
GHS08
GHS09
Dgr H361f ***
H318
H411 611-137-00-6 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole 419-870-1 159038-16-1 Aquatic Chronic 4 H413 — H413 611-138-00-1 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole 415-910-7 152828-25-6 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 611-140-00-2 azafenidin (ISO);
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one — 68049-83-2 Repr. 1B
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H360Df
H373 **
H400
H410 GHS08
GHS09
Dgr H360Df
H373 **
H410 M = 1000 612-001-00-9 mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3] 200-820-0 [1]
204-697-4 [2]
200-875-0 [3] 74-89-5 [1]
124-40-3 [2]
75-50-3 [3] Flam. Gas 1
Press. Gas
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1 H220
H332
H335
H315
H318 GHS02
GHS04
GHS05
GHS07
Dgr H220
H332
H335
H315
H318 *
Skin Irrit. 2; H315: C ≥ 5 %
Eye Dam. 1; H318: C ≥ 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: C ≥ 5 % U
5
612-001-01-6 mono-methylamine ... %; [1]
di-methylamine ... %; [2]
tri-methylamine ... % [3] 200-820-0 [1]
204-697-4 [2]
200-875-0 [3] 74-89-5 [1]
124-40-3 [2]
75-50-3 [3] Flam. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H224
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H224
H332
H302
H314 *
STOT SE 3; H335: C ≥ 5 % B
612-002-00-4 ethylamine 200-834-7 75-04-7 Flam. Gas 1
Press. Gas
Eye Irrit. 2
STOT SE 3 H220
H319
H335 GHS02
GHS04
GHS07
Dgr H220
H319
H335 U
612-003-00-X diethylamine 203-716-3 109-89-7 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H225
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 1 % 612-004-00-5 triethylamine 204-469-4 121-44-8 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H225
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 1 % 612-005-00-0 butylamine 203-699-2 109-73-9 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H225
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 1 % 612-006-00-6 ethylenediamine;
1,2-diaminoethane 203-468-6 107-15-3 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1 H226
H312
H302
H314
H334
H317 GHS02
GHS08
GHS05
GHS07
Dgr H226
H312
H302
H314
H334
H317 612-007-00-1 2-aminopropane;
isopropylamine 200-860-9 75-31-0 Flam. Liq. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H224
H319
H335
H315 GHS02
GHS07
Dgr H224
H319
H335
H315 612-008-00-7 aniline 200-539-3 62-53-3 Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H351
H341
H331
H311
H301
H372 **
H318
H317
H400 GHS06
GHS08
GHS05
GHS09
Dgr H351
H341
H331
H311
H301
H372 **
H318
H317
H400 *
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 % 612-009-00-2 salts of aniline — — Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H351
H341
H331
H311
H301
H372 **
H318
H317
H400 GHS06
GHS08
GHS05
GHS09
Dgr H351
H341
H331
H311
H301
H372 **
H318
H317
H400 *
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 % A
612-010-00-8 chloroanilines (with exception of those specified elsewhere in this Annex) — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 C
612-011-00-3 4-nitrosoaniline 211-535-6 659-49-4 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 612-012-00-9 o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3] 201-855-4 [1]
202-729-1 [2]
202-810-1 [3] 88-74-4 [1]
99-09-2 [2]
100-01-6 [3] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H331
H311
H301
H373 **
H412 GHS06
GHS08
Dgr H331
H311
H301
H373 **
H412 C
612-013-00-4 3-aminobenzene sulphonic acid;
metanilic acid 204-473-6 121-47-1 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 612-014-00-X sulphanilic acid;
4-aminobenzenesulphonic acid 204-482-5 121-57-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H319
H315
H317 GHS07
Wng H319
H315
H317 612-015-00-5 N-methylaniline 202-870-9 100-61-8 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 612-016-00-0 N,N-dimethylaniline 204-493-5 121-69-7 Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H351
H331
H311
H301
H411 GHS06
GHS08
GHS09
Dgr H351
H331
H311
H301
H411 612-017-00-6 N-methyl-N,2,4,6-tetranitroaniline;
tetryl 207-531-9 479-45-8 Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H201
H331
H311
H301
H373 ** GHS01
GHS06
GHS08
Dgr H201
H331
H311
H301
H373 ** 612-018-00-1 bis(2,4,6-trinitrophenyl)amine;
hexyl 205-037-8 131-73-7 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H201
H330
H310
H300
H373 **
H411 GHS01
GHS06
GHS08
GHS09
Dgr H201
H330
H310
H300
H373 **
H411 612-019-00-7 dipicrylamine, ammonium salt 220-639-0 2844-92-0 Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H201
H330
H310
H300
H373 **
H411 GHS01
GHS06
GHS08
GHS09
Dgr H201
H330
H310
H300
H373 **
H411 EUH001 612-020-00-2 1-naphthylamine 205-138-7 134-32-7 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 612-022-00-3 2-naphthylamine 202-080-4 91-59-8 Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 Carc. 1A; H350: C ≥ 0,01 % 612-023-00-9 phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4] 202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4] 100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4] Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400 GHS06
GHS08
GHS09
Dgr H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400 612-024-00-4 m-toluidine;
3-aminotoluene 203-583-1 108-44-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1 H331
H311
H301
H373 **
H400 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H400 612-025-00-X nitrotoluidines, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 C
612-026-00-5 diphenylamine 204-539-4 122-39-4 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H373 **
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H410 612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 C
612-028-00-6 p-phenylenediamine 203-404-7 106-50-3 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H319
H317
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H319
H317
H410 612-029-00-1 benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride 210-834-9 624-18-0 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H319
H317
H400
H410 GHS06
GHS09
Dgr H331
H311
H301
H319
H317
H410 612-030-00-7 2-methyl-p-phenylenediamine sulphate [1] 210-431-8 [1]
228-871-4 [2] 615-50-9 [1]
6369-59-1 [2] Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H301
H332
H312
H317
H411 GHS06
GHS09
Dgr H301
H332
H312
H317
H411 612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2] 220-623-3 [1]
202-807-5 [2] 2836-04-6 [1]
99-98-9 [2] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H331
H311
H301 GHS06
Dgr H331
H311
H301 C
612-032-00-8 N,N,N',N'-tetramethyl-p-phenylenediamine 202-831-6 100-22-1 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 612-033-00-3 2-aminophenol 202-431-1 95-55-6 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 * H341
H332
H302 GHS08
GHS07
Wng H341
H332
H302 612-034-00-9 2-amino-4,6-dinitrophenol;
picramic acid (< 20 % water) 202-544-6 96-91-3 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H201
H332
H312
H302
H412 GHS01
GHS07
Wng H201
H332
H312
H302
H412 T
612-034-01-6 2-amino-4,6-dinitrophenol;
picramic acid;
[≥ 20 % water] 202-544-6 96-91-3 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H332
H312
H302
H412 GHS07
Wng H332
H312
H302
H412 G
612-035-00-4 2-methoxyaniline;
o-anisidine 201-963-1 90-04-0 Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 * H350
H341
H331
H311
H301 GHS06
GHS08
Dgr H350
H341
H331
H311
H301 612-036-00-X 3,3'-dimethoxybenzidine;
o-dianisidine 204-355-4 119-90-4 Carc. 1B
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 612-037-00-5 salts of 3,3'-dimethoxybenzidine;
salts of o-dianisidine — — Carc. 1B
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 A
612-038-00-0 2-nitro-p-anisidine;
4-methoxy-2-nitroaniline 202-547-2 96-96-8 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3 H330
H310
H300
H373 **
H412 GHS06
GHS08
Dgr H330
H310
H300
H373 **
H412 612-039-00-6 2-ethoxyaniline;
o-phenetidine 202-356-4 94-70-2 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H331
H311
H301
H373 ** GHS06
GHS08
Dgr H331
H311
H301
H373 ** 612-040-00-1 2,4-dinitroaniline 202-553-5 97-02-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2 H330
H310
H300
H373 **
H411 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H411 612-041-00-7 4,4'-bi-o-toluidine 204-358-0 119-93-7 Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 612-042-00-2 benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine 202-199-1 92-87-5 Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 Carc. 1A; H350: C ≥ 0,01 % 612-043-00-8 N,N'-dimethylbenzidine — 2810-74-4 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 612-044-00-3 N,N'-diacetylbenzidine 210-338-2 613-35-4 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H332
H312
H302 GHS07
Wng H332
H312
H302 612-046-00-4 allylamine 203-463-9 107-11-9 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H225
H331
H311
H301
H411 GHS02
GHS06
GHS09
Dgr H225
H331
H311
H301
H411 612-047-00-X benzylamine 202-854-1 100-46-9 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 612-048-00-5 dipropylamine 205-565-9 142-84-7 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H225
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H312
H302
H314 STOT SE 3; H335: C ≥ 1 % 612-049-00-0 di-n-butylamine; [1]
di-sec-butylamine [2] 203-921-8 [1]
210-937-9 [2] 111-92-2 [1]
626-23-3 [2] Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H226
H332
H312
H302 GHS02
GHS07
Wng H226
H332
H312
H302 612-050-00-6 cyclohexylamine 203-629-0 108-91-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H226
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H226
H312
H302
H314 612-051-00-1 4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline 202-974-4 101-77-9 Carc. 1B
Muta. 2
STOT SE 1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H350
H341
H370 **
H373 **
H317
H411 GHS08
GHS07
GHS09
Dgr H350
H341
H370 **
H373 **
H317
H411 612-052-00-7 (S)-sec-butylamine;
(S)-2-aminobutane; [1]
(R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3] 208-164-7 [1]
236-232-6 [2]
237-732-7 [3] 513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3] Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1 H225
H332
H302
H314
H400 GHS02
GHS05
GHS07
GHS09
Dgr H225
H332
H302
H314
H400 C
612-053-00-2 N-ethylaniline 203-135-5 103-69-5 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H331
H311
H301
H373 ** GHS06
GHS08
Dgr H331
H311
H301
H373 ** 612-054-00-8 N,N-diethylaniline 202-088-8 91-66-7 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 * 612-055-00-3 N-methyl-o-toluidine; [1]
N-methyl-m-toluidine; [2]
N-methyl-p-toluidine [3] 210-260-9 [1]
211-795-0 [2]
210-769-6 [3] 611-21-2 [1]
696-44-6 [2]
623-08-5 [3] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H331
H311
H301
H373 **
H412 GHS06
GHS08
Dgr H331
H311
H301
H373 **
H412 C
612-056-00-9 N,N-dimethyl-p-toluidine; [1]
N,N-dimethyl-m-toluidine; [2]
N,N-dimethyl-o-toluidine [3] 202-805-4 [1]
204-495-6 [2]
210-199-8 [3] 99-97-8 [1]
121-72-2 [2]
609-72-3 [3] Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3 H331
H311
H301
H373 **
H412 GHS06
GHS08
Dgr H331
H311
H301
H373 **
H412 * C
612-057-00-4 piperazine 203-808-3 110-85-0 Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H314
H334
H317
H412 GHS08
GHS05
Dgr H314
H334
H317
H412 612-058-00-X 2,2'-iminodiethylamine;
diethylenetriamine 203-865-4 111-40-0 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H312
H302
H314
H317 GHS05
GHS07
Dgr H312
H302
H314
H317 612-059-00-5 3,6-diazaoctanethylenediamin;
triethylenetetramine 203-950-6 112-24-3 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H312
H314
H317
H412 GHS05
GHS07
Dgr H312
H314
H317
H412 612-060-00-0 3,6,9-triazaundecamethylenediamine;
tetraethylenepentamine 203-986-2 112-57-2 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H312
H302
H314
H317
H411 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H317
H411 612-061-00-6 3-aminopropyldimethylamine;
N,N-dimethyl-1,3-diaminopropane 203-680-9 109-55-7 Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H226
H302
H314
H317 GHS02
GHS05
GHS07
Dgr H226
H302
H314
H317 612-062-00-1 3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane 203-236-4 104-78-9 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H226
H312
H302
H314
H317 GHS02
GHS05
GHS07
Dgr H226
H312
H302
H314
H317 612-063-00-7 3,3'-iminodi(propylamine);
dipropylenetriamine 200-261-2 56-18-8 Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1 H330
H311
H302
H314
H317 GHS06
GHS05
Dgr H330
H311
H302
H314
H317 612-064-00-2 3,6,9,12-tetra-azatetradecamethylenediamine;
pentacthylenehexamine 223-775-9 4067-16-7 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H317
H410 612-065-00-8 polyethlyenepolyamines with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H317
H410 612-066-00-3 dicyclohexylamine 202-980-7 101-83-7 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H410 612-067-00-9 3-aminomethyl-3,5,5-trimethylcyclohexylamine 220-666-8 2855-13-2 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H312
H302
H314
H317
H412 GHS05
GHS07
Dgr H312
H302
H314
H317
H412 612-068-00-4 3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine 202-109-0 91-94-1 Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H312
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H312
H317
H410 612-069-00-X salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine — — Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H312
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H312
H317
H410 A
612-070-00-5 salts of benzidine 208-519-6
208-520-1
244-236-4
252-984-8 531-85-1
531-86-2
21136-70-9
36341-27-2 Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 A
612-071-00-0 salts of 2-naphthylamine 209-030-0
210-313-6 553-00-4
612-52-2 Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 A
612-072-00-6 biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl 202-177-1 92-67-1 Carc. 1A
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 612-073-00-1 salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl — — Carc. 1A
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 A
612-074-00-7 benzyldimethylamine 203-149-1 103-83-3 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3 H226
H332
H312
H302
H314
H412 GHS02
GHS05
GHS07
Dgr H226
H332
H312
H302
H314
H412 612-075-00-2 2-aminoethyldimethylamine;
2-dimethylaminoethylamine 203-541-2 108-00-9 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H225
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H312
H302
H314 612-076-00-8 ethyldimethylamine 209-940-8 598-56-1 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H225
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H302
H314 612-077-00-3 dimethylnitrosoamine;
N-nitrosodimethylamine 200-549-8 62-75-9 Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 2 H350
H330
H301
H372 **
H411 GHS06
GHS08
GHS09
Dgr H350
H330
H301
H372 **
H411 Carc. 1B; H350: C ≥ 0,001 % 612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline) 202-918-9 101-14-4 Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline) — — Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H410 A
612-080-00-X 4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine 202-214-1 93-05-0 Acute Tox. 3 *
Skin Corr. 1B H301
H314 GHS06
GHS05
Dgr H301
H314 612-081-00-5 salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts of o-tolidine 210-322-5
265-294-7
277-985-0 612-82-8
64969-36-4
74753-18-7 Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 A
612-082-00-0 thiourea;
thiocarbamide 200-543-5 62-56-6 Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2 H351
H361d ***
H302
H411 GHS08
GHS07
GHS09
Wng H351
H361d ***
H302
H411 612-083-00-6 1-methyl-3-nitro-1-nitrosoguanidine 200-730-1 70-25-7 Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H350
H332
H319
H315
H411 GHS08
GHS07
GHS09
Dgr H350
H332
H319
H315
H411 Carc. 1B; H350: C ≥ 0,01 % 612-084-00-1 dapsone;
4,4'-diamino diphenyl sulfone 201-248-4 80-08-0 Acute Tox. 4 * H302 GHS07
Wng H302 612-085-00-7 4,4'-methylenedi-o-toluidine 212-658-8 838-88-0 Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H350
H302
H317
H410 612-086-00-2 amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl) methylamine 251-375-4 33089-61-1 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H317
H410 M = 10 612-087-00-8 guazatine (ISO) 108173-90-6 Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H312
H302
H335
H315
H318
H400
H410 GHS06
GHS05
GHS09
Dgr H330
H312
H302
H335
H315
H318
H410 612-088-00-3 simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 204-535-2 122-34-9 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 612-089-00-9 1,5-naphthylenediamine 218-817-8 2243-62-1 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 612-090-00-4 2,2'-(nitrosoimino)bisethanol 214-237-4 1116-54-7 Carc. 1B H350 GHS08
Dgr H350 612-091-00-X o-toluidine;
2-aminotoluene 202-429-0 95-53-4 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1 H350
H331
H301
H319
H400 GHS06
GHS08
GHS09
Dgr H350
H331
H301
H319
H400 612-092-00-5 N,N'-(2,2-dimethylpropylidene)hexamethylenediamine 401-660-6 1000-78-8 Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 612-093-00-0 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline 401-790-3 104147-32-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 612-094-00-6 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride 402-190-4 — STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H372 **
H302
H318
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H372 **
H302
H318
H317
H410 612-095-00-1 benzyl-2-hydroxydodecyldimethylammonium benzoate 402-610-6 113694-52-3 Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H314
H302
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H302
H410 612-096-00-7 4,4'-carbonimidoylbis[N,N-dimethylaniline] 207-762-5 492-80-8 Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H351
H302
H319
H411 GHS08
GHS07
GHS09
Wng H351
H302
H319
H411 612-097-00-2 salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] — — Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H351
H302
H319
H411 GHS08
GHS07
GHS09
Wng H351
H302
H319
H411 A
612-098-00-8 nitrosodipropylamine 210-698-0 621-64-7 Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 Carc. 1B; H350: C ≥ 0,001 % 612-099-00-3 4-methyl-m-phenylenediamine;
2,4-toluenediamine 202-453-1 95-80-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H350
H301
H312
H319
H317
H411 GHS06
GHS08
GHS09
Dgr H350
H301
H312
H319
H317
H411 612-100-00-7 propylenediamine 201-155-9 78-90-0 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A H226
H312
H302
H314 GHS02
GHS05
GHS07
Dgr H226
H312
H302
H314 612-101-00-2 methenamine;
hexamethylenetetramine 202-905-8 100-97-0 Flam. Sol. 2
Resp. Sens. 1
Skin Sens. 1 H228
H334
H317 GHS02
GHS08
Dgr H228
H334
H317 612-102-00-8 N,N-bis(3-aminopropyl)methylamine 203-336-8 105-83-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B H331
H311
H302
H314 GHS06
GHS05
Dgr H331
H311
H302
H314 612-103-00-3 N,N,N',N'-tetramethylethylenediamine 203-744-6 110-18-9 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H225
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H302
H314 612-104-00-9 hexamethylenediamine 204-679-6 124-09-4 Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Corr. 1B H312
H302
H335
H314 GHS05
GHS07
Dgr H312
H302
H335
H314 612-105-00-4 2-piperazin-1-ylethylamine 205-411-0 140-31-8 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H312
H302
H314
H317
H412 GHS05
GHS07
Dgr H312
H302
H314
H317
H412 612-106-00-X 2,6-diethylaniline 209-445-7 579-66-8 Acute Tox. 4 * H302 — H302 612-107-00-5 1-phenylethylamine; [1]
DL-α-methylbenzylamine [2] 202-706-6 [1]
210-545-8 [2] 98-84-0 [1]
618-36-0 [2] Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 612-108-00-0 3-aminopropyltriethoxysilane 213-048-4 919-30-2 Acute Tox. 4 *
Skin Corr. 1B H302
H314 GHS05
GHS07
Dgr H302
H314 612-109-00-6 bis(2-dimethylaminoethyl)(methyl)amine 221-201-1 3030-47-5 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B H311
H302
H314 GHS06
GHS05
Dgr H311
H302
H314 612-110-00-1 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) 229-962-1 6864-37-5 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Chronic 2 H331
H311
H302
H314
H411 GHS06
GHS05
GHS09
Dgr H331
H311
H302
H314
H411 612-111-00-7 2-methyl-m-phenylenediamine;
2,6-toluenediamine 212-513-9 823-40-5 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H341
H312
H302
H317
H411 GHS08
GHS07
GHS09
Wng H341
H312
H302
H317
H411 612-112-00-2 p-anisidine;
4-methoxyaniline 203-254-2 104-94-9 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1 H330
H310
H300
H373 **
H400 GHS06
GHS08
GHS09
Dgr H330
H310
H300
H373 **
H400 612-113-00-8 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine 403-240-8 106264-79-3 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 612-114-00-3 R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate 404-390-7 — Flam. Sol. 1
Skin Sens. 1
Aquatic Chronic 3 H228
H317
H412 GHS02
GHS07
Wng H228
H317
H412 612-115-00-9 dimethyldioctadecylammonium hydrogen sulfate 404-050-8 123312-54-9 Eye Irrit. 2
Aquatic Chronic 4 H319
H413 GHS07
Wng H319
H413 612-116-00-4 C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate 404-690-8 68132-19-4 Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H314
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H331
H314
H317
H410 612-117-00-X C12-14-tert-alkylamine, methylphosphonic acid salt 404-750-3 119415-07-5 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2 H302
H314
H411 GHS05
GHS07
GHS09
Dgr H302
H314
H411 612-118-00-5 A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;
(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide 405-080-4 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 612-119-00-0 benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate 405-330-2 — Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H400
H410 GHS05
GHS09
Dgr H315
H318
H410 612-120-00-6 aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 612-121-00-1 amines, polyethylenepoly-;
HEPA 268-626-9 68131-73-7 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H317
H410 612-122-00-7 hydroxylamine 232-259-2 7803-49-8 Unst. Expl.
Met. Corr. 1
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H200
H290
H302
H373 **
H335
H315
H318
H317
H400 GHS01
GHS08
GHS05
GHS07
GHS09
Dgr H200
H290
H302
H373 **
H335
H315
H318
H317
H400 T
612-123-00-2 hydroxylammonium chloride;
hydroxylamine hydrochloride; [1]
bis(hydroxylammonium) sulphate;
hydroxylamine sulphate (2:1); [2]
hydroxylammonium hydrogensulphate;
hydroxylamine sulphate (1:1) [3] 226-798-2 [1]
233-118-8 [2]
233-154-4 [3] 5470-11-1 [1]
10039-54-0 [2]
10046-00-1 [3] Met. Corr. 1
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H290
H302
H373 **
H319
H315
H317
H400 GHS08
GHS05
GHS07
GHS09
Wng H290
H302
H373 **
H319
H315
H317
H400 G T
612-124-00-8 N,N,N-trimethylanilinium chloride 205-319-0 138-24-9 Acute Tox. 3 *
Acute Tox. 3 * H311
H301 GHS06
Dgr H311
H301 612-125-00-3 2-methyl-p-phenylenediamine;
2,5-toluenediamine 202-442-1 95-70-5 Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H301
H332
H312
H317
H411 GHS06
GHS09
Dgr H301
H332
H312
H317
H411 612-126-00-9 toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate 265-697-8 65321-67-7 Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H350
H301
H312
H319
H317
H411 GHS06
GHS08
GHS09
Dgr H350
H301
H312
H319
H317
H411 612-127-00-4 3-aminophenol 209-711-2 591-27-5 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H332
H302
H411 GHS07
GHS09
Wng H332
H302
H411 612-128-00-X 4-aminophenol 204-616-2 123-30-8 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H341
H332
H302
H400
H410 GHS08
GHS07
GHS09
Wng H341
H332
H302
H410 612-129-00-5 diisopropylamine 203-558-5 108-18-9 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H225
H332
H302
H314 GHS02
GHS05
GHS07
Dgr H225
H332
H302
H314 STOT SE 3; H335: C ≥ 5 % 612-130-00-0 2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2]
diethylmethylbenzenediamine [3] 218-255-3 [1]
218-256-9 [2]
270-877-4 [3] 2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3] Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H373 **
H319
H400
H410 GHS08
GHS07
GHS09
Wng H312
H302
H373 **
H319
H410 C
612-131-00-6 didecyldimethylammonium chloride 230-525-2 7173-51-5 Acute Tox. 4 *
Skin Corr. 1B H302
H314 GHS05
GHS07
Dgr H302
H314 612-132-00-1 N,N'-diphenyl-p-phenylenediamine;
N,N'-diphenyl-1,4-benzenediamine 200-806-4 74-31-7 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 247-162-0 25646-77-9 Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H373 **
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H301
H373 **
H317
H410 612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 247-161-5 25646-71-3 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 612-135-00-8 N-2-naphthylaniline;
N-phenyl-2-naphthylamine 205-223-9 135-88-6 Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H351
H319
H315
H317
H411 GHS08
GHS07
GHS09
Wng H351
H319
H315
H317
H411 612-136-00-3 N-isopropyl-N'-phenyl-p-phenylenediamine 202-969-7 101-72-4 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 Skin Sens. 1; H317: C ≥ 0,1 % 612-137-00-9 4-chloroaniline 203-401-0 106-47-8 Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H331
H311
H301
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H331
H311
H301
H317
H410 612-138-00-4 furalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate 260-875-1 57646-30-7 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 612-139-00-X mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 277-328-8 73250-68-7 Aquatic Chronic 2 H411 GHS09 H411 612-140-00-5 quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides 264-151-6 63449-41-2 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1 H312
H302
H314
H400 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H400 612-141-00-0 4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine) 243-420-1 19900-65-3 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H410 612-142-00-6 biphenyl-2-ylamine 201-990-9 90-41-5 Carc. 2
Acute Tox. 4 *
Aquatic Chronic 3 H351
H302
H412 GHS08
GHS07
Wng H351
H302
H412 612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride 218-130-3 2051-79-8 Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H319
H317
H400
H410 GHS06
GHS09
Dgr H301
H319
H317
H410 612-144-00-7 flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine — 62924-70-3 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H317
H400
H410 GHS07
GHS09
Wng H319
H315
H317
H410 612-145-00-2 o-phenylenediamine 202-430-6 95-54-5 Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H341
H301
H332
H312
H319
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H341
H301
H332
H312
H319
H317
H410 612-146-00-8 o-phenylenediamine dihydrochloride 210-418-7 615-28-1 Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H341
H301
H332
H312
H319
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H341
H301
H332
H312
H319
H317
H410 612-147-00-3 m-phenylenediamine 203-584-7 108-45-2 Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H331
H311
H301
H319
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H331
H311
H301
H319
H317
H410 612-148-00-9 m-phenylenediamine dihydrochloride 208-790-0 541-69-5 Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H331
H311
H301
H319
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H341
H331
H311
H301
H319
H317
H410 612-149-00-4 1,3-diphenylguanidine 203-002-1 102-06-7 Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H361f ***
H302
H319
H335
H315
H411 GHS08
GHS07
GHS09
Wng H361f ***
H302
H319
H335
H315
H411 612-150-00-X spiroxamine (ISO);
8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H315
H317
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H315
H317
H410 612-151-00-5 diaminotoluene, technical product - reaction mass of [2] and [3];
methyl-phenylenediamine; [1]
4-methyl-m-phenylene diamine; [2]
2-methyl-m-phenylene diamine [3] 246-910-3 [1]
202-453-1 [2]
212-513-9 [3] 25376-45-8 [1]
95-80-7 [2]
823-40-5 [3] Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H350
H301
H332
H312
H319
H317
H411 GHS06
GHS08
GHS09
Dgr H350
H301
H332
H312
H319
H317
H411 612-152-00-0 N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine 406-610-7 62478-82-4 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3 H226
H332
H302
H373 **
H314
H412 GHS02
GHS08
GHS05
GHS07
Dgr H226
H332
H302
H373 **
H314
H412 612-153-00-6 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride 407-020-2 132885-85-9 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H302
H317
H412 GHS07
Wng H302
H317
H412 612-154-00-1 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] 410-890-6 95235-29-3 Aquatic Chronic 4 H413 — H413 612-155-00-7 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene 411-730-8 93071-94-4 Aquatic Chronic 4 H413 — H413 612-156-00-2 reaction mass of: trihexadecylmethylammonium chloride;
dihexadecyldimethylammonium chloride 405-620-9 — Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 612-157-00-8 (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride 410-780-8 — Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H373 **
H318
H317
H411 GHS08
GHS05
GHS07
GHS09
Dgr H302
H373 **
H318
H317
H411 612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime 410-820-4 — Aquatic Chronic 4 H413 — H413 612-159-00-9 Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid 410-880-1 — Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H410 612-160-00-4 p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3] 203-403-1 [1]
208-740-8 [2]
208-741-3 [3] 106-49-0 [1]
540-23-8 [2]
540-25-0 [3] Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H351
H331
H311
H301
H319
H317
H400 GHS06
GHS08
GHS09
Dgr H351
H331
H311
H301
H319
H317
H400 612-161-00-X 2,6-xylidine;
2,6-dimethylaniline 201-758-7 87-62-7 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H351
H332
H312
H302
H335
H315
H411 GHS08
GHS07
GHS09
Wng H351
H332
H312
H302
H335
H315
H411 612-162-00-5 dimethyldioctadecylammonium chloride;
DODMAC 203-508-2 107-64-2 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 612-163-00-0 metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester — 70630-17-0 Acute Tox. 4 *
Eye Dam. 1 H302
H318 GHS05
GHS07
Dgr H302
H318 612-164-00-6 2-butyl-2-ethyl-1,5-diaminopentane 412-700-7 137605-95-9 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H312
H302
H373 **
H314
H317
H412 GHS08
GHS05
GHS07
Dgr H312
H302
H373 **
H314
H317
H412 612-165-00-1 N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine 413-810-8 65181-78-4 Aquatic Chronic 2 H411 GHS09 H411 612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 411-830-1 114765-88-7 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H318
H317
H412 GHS05
GHS07
Dgr H318
H317
H412 612-167-00-2 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride 410-490-1 — Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H373 **
H318
H317
H411 GHS08
GHS05
GHS07
GHS09
Dgr H302
H373 **
H318
H317
H411 612-168-00-8 3,5-dichloro-2,6-difluoropyrdine-4-amine 220-630-1 2840-00-8 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H312
H302
H411 GHS07
GHS09
Wng H312
H302
H411 612-170-00-9 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime 405-260-2 — Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 612-171-00-4 N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane 410-060-3 130728-76-6 Muta. 2
Skin Sens. 1
Aquatic Chronic 2 H341
H317
H411 GHS08
GHS09
Wng H341
H317
H411 612-172-00-X 4,4'-methylenebis(N,N'-dimethylcyclohexanamine 412-840-9 13474-64-1 Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3 H302
H373 **
H314
H412 GHS08
GHS05
GHS07
Dgr H302
H373 **
H314
H412 612-173-00-5 lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate 411-140-0 125328-86-1 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 612-174-00-0 4,4-dimethoxybutylamine 407-690-6 19060-15-2 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3 H302
H314
H317
H412 GHS05
GHS07
Dgr H302
H314
H317
H412 612-175-00-6 2-(O-aminooxy)ethylamine dihydrochloride 412-310-7 37866-45-8 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 612-176-00-1 polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine 410-570-6 143747-73-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 612-177-00-7 2-naphthylamino-6-sulfomethylamide 412-120-4 104295-55-8 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H373 **
H317
H411 GHS08
GHS09
Wng H373 **
H317
H411 612-178-00-2 1,4,7,10-tetraazacyclododecane disulfate 412-080-8 112193-77-8 Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
Aquatic Chronic 3 H302
H335
H318
H412 GHS05
GHS07
Dgr H302
H335
H318
H412 612-179-00-8 1-(2-propenyl)pyridinium chloride 412-740-5 25965-81-5 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 612-180-00-3 3-aminobenzylamine 412-230-2 4403-70-7 Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2 H302
H314
H411 GHS05
GHS07
GHS09
Dgr H302
H314
H411 612-181-00-9 2-phenylthioaniline 413-030-8 1134-94-7 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 612-182-00-4 1-ethyl-1-methylmorpholinium bromide 418-210-1 65756-41-4 Muta. 2 H341 GHS08
Wng H341 612-183-00-X 1-ethyl-1-methylpyrrolidinium bromide 418-200-5 69227-51-6 Muta. 2 H341 GHS08
Wng H341 612-184-00-5 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one 403-830-5 89331-94-2 Aquatic Chronic 3 H412 — H412 612-185-00-0 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide 407-400-8 59493-72-0 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 612-186-00-6 bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate 406-770-8 149057-64-7 STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H318
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H373 **
H318
H317
H410 612-187-00-1 2,3,4-trifluoroaniline 407-170-9 3862-73-5 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H312
H302
H373 **
H315
H318
H411 GHS08
GHS05
GHS07
GHS09
Dgr H312
H302
H373 **
H315
H318
H411 612-188-00-7 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) 407-560-9 107934-68-9 Aquatic Chronic 2 H411 GHS09 H411 612-189-00-2 4-amino-2-(aminomethyl)phenol dihydrochloride 412-510-4 135043-64-0 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 612-190-00-8 4,4'-methylenebis(2-isopropyl-6-methylaniline) 415-150-6 16298-38-7 STOT RE 2 *
Aquatic Chronic 2 H373 **
H411 GHS08
GHS09
Wng H373 **
H411 612-191-00-3 polymer of allylamine hydrochloride 415-050-2 71550-12-4 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 612-192-00-9 2-isopropyl-4-(N-methyl)aminomethylthiazole 414-800-6 154212-60-9 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H312
H302
H315
H318
H411 GHS05
GHS07
GHS09
Dgr H312
H302
H315
H318
H411 612-193-00-4 3-methylaminomethylphenylamine 414-570-7 18759-96-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H312
H302
H314
H317
H410 612-194-00-X 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride 414-670-0 141890-30-4 Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H318
H410 612-195-00-5 bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate 415-210-1 160236-81-7 Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H332
H302
H318
H410 612-196-00-0 4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2] 202-441-6 [1]
221-627-8 [2] 95-69-2 [1]
3165-93-3 [2] Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H350
H341
H331
H311
H301
H400
H410 GHS06
GHS08
GHS09
Dgr H350
H341
H331
H311
H301
H410 612-197-00-6 2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2] 205-282-0 [1] - [2] 137-17-7 [1]
21436-97-5 [2] Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H350
H331
H311
H301
H411 GHS06
GHS08
GHS09
Dgr H350
H331
H311
H301
H411 612-198-00-1 4,4'-thiodianiline and its salts 205-370-9 139-65-1 Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2 H350
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H302
H411 612-199-00-7 4,4'-oxydianiline and its salts;
p-aminophenyl ether 202-977-0 101-80-4 Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2 H350
H340
H361f ***
H331
H311
H301
H411 GHS06
GHS08
GHS09
Dgr H350
H340
H361f ***
H331
H311
H301
H411 612-200-00-0 2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2] 210-406-1 [1]
254-323-9 [2] 615-05-4 [1]
39156-41-7 [2] Carc. 1B
Muta. 2
Acute Tox. 4 *
Aquatic Chronic 2 H350
H341
H302
H411 GHS08
GHS07
GHS09
Dgr H350
H341
H302
H411 612-201-00-6 N,N,N',N'-tetramethyl-4,4'-methylendianiline 202-959-2 101-61-1 Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1 H350
H400
H410 GHS08
GHS09
Dgr H350
H410 612-202-00-1 3,4-dichloroaniline 202-448-4 95-76-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H318
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H331
H311
H301
H318
H317
H410 612-204-00-2 C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 208-953-6 548-62-9 Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H318
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H351
H302
H318
H410 612-205-00-8 C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5) 208-953-6 548-62-9 Carc. 1B
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H302
H318
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H350
H302
H318
H410 612-206-00-3 famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione — 131807-57-3 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H400
H410 GHS08
GHS09
Wng H373 **
H410 612-207-00-9 4-ethoxyaniline;
p-phenetidine 205-855-5 156-43-4 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1 H341
H332
H312
H302
H319
H317 GHS08
GHS07
Wng H341
H332
H312
H302
H319
H317 612-209-00-X 6-methoxy-m-toluidine;
p-cresidine 204-419-1 120-71-8 Carc. 1B
Acute Tox. 4 * H350
H302 GHS08
GHS07
Dgr H350
H302 612-210-00-5 5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2] 202-765-8 [1]
256-960-8 [2] 99-55-8 [1]
51085-52-0 [2] Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 3 H351
H331
H311
H301
H412 GHS06
GHS08
Dgr H351
H331
H311
H301
H412 612-211-00-0 N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide 416-470-9 170292-97-4 Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 612-212-00-6 2,6-dichloro-4-trifluoromethylaniline 416-430-0 24279-39-8 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H315
H317
H400
H410 GHS07
GHS09
Wng H332
H302
H315
H317
H410 612-213-00-1 isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine 419-850-2 148348-13-4 Skin Corr. 1B
Aquatic Chronic 3 H314
H412 GHS05
Dgr H314
H412 612-214-00-7 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine 421-390-2 89114-90-9 Aquatic Chronic 4 H413 — H413 612-215-00-2 3-chloro-2-(isopropylthio)aniline 421-700-6 179104-32-6 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 612-217-00-3 1-methoxy-2-propylamine 422-550-4 37143-54-7 Flam. Liq. 2
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3 H225
H314
H302
H412 GHS02
GHS05
GHS07
Dgr H225
H314
H302
H412 613-001-00-1 ethyleneimine;
aziridine 205-793-9 151-56-4 Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Chronic 2 H225
H350
H340
H330
H310
H300
H314
H411 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H225
H350
H340
H330
H310
H300
H314
H411 D
613-002-00-7 pyridine 203-809-9 110-86-1 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H225
H332
H312
H302 GHS02
GHS07
Dgr H225
H332
H312
H302 * 613-003-00-2 1,2,3,4-tetranitrocarbazole — 6202-15-9 Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 * H201
H332
H312
H302 GHS01
GHS07
Wng H201
H332
H312
H302 613-004-00-8 crimidine (ISO);
2-chloro-6-methylpyrimidin-4-yldimethylamine 208-622-6 535-89-7 Acute Tox. 2 * H300 GHS06
Dgr H300 613-007-00-4 desmetryne (ISO);
6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine 213-800-1 1014-69-3 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 613-008-00-X dazomet (ISO);
tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione 208-576-7 533-74-4 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H400
H410 GHS07
GHS09
Wng H302
H319
H410 613-009-00-5 2,4,6-trichloro-1,3,5-triazine;
cyanuric chloride 203-614-9 108-77-0 Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1 H330
H302
H314
H317 GHS06
GHS05
Dgr H330
H302
H314
H317 EUH014 STOT SE 3; H335: C ≥ 5 % 613-010-00-0 ametryn (ISO);
2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine 212-634-7 834-12-8 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-011-00-6 amitrole (ISO);
1,2,4-triazol-3-ylamine 200-521-5 61-82-5 Repr. 2
STOT RE 2 *
Aquatic Chronic 2 H361d ***
H373 **
H411 GHS08
GHS09
Wng H361d ***
H373 **
H411 613-012-00-1 bentazone (ISO);
3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 246-585-8 25057-89-0 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H302
H319
H317
H412 GHS07
Wng H302
H319
H317
H412 613-013-00-7 cyanazine (ISO);
2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile 244-544-9 21725-46-2 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-014-00-2 ethoxyquin(ISO);
6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline 202-075-7 91-53-2 Acute Tox. 4 * H302 GHS07
Wng H302 613-015-00-8 fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate 238-134-9 14255-88-0 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 613-016-00-3 fuberidazole(ISO);
2-(2-furyl)benzimidazole 223-404-0 3878-19-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-017-00-9 bis (8-hydroxyquinolinium) sulphate 205-137-1 134-31-6 Acute Tox. 4 * H302 GHS07
Wng H302 613-018-00-4 morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion — 7411-47-4 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3 H302
H319
H335
H315
H412 GHS07
Wng H302
H319
H335
H315
H412 613-019-00-X thioquinox(ISO);
2-thio-1,3-dithiolo(4,5,b)quinoxaline 202-272-8 93-75-4 Acute Tox. 4 * H302 GHS07
Wng H302 613-020-00-5 tridemorph (ISO);
2,6-dimethyl-4-tridecylmorpholine 246-347-3 24602-86-6 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H332
H302
H315
H400
H410 GHS08
GHS07
GHS09
Dgr H360D ***
H332
H302
H315
H410 613-021-00-0 dithianon (ISO);
5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile 222-098-6 3347-22-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-022-00-6 pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 A
613-023-00-1 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;
pyrethrin I 204-455-8 121-21-1 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 613-024-00-7 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
pyrethrin II 204-462-6 121-29-9 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 613-025-00-2 cinerin I;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 246-948-0 25402-06-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-026-00-8 cinerin II;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate 204-454-2 121-20-0 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-027-00-3 piperidine 203-813-0 110-89-4 Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B H225
H331
H311
H314 GHS02
GHS06
GHS05
Dgr H225
H331
H311
H314 * 613-028-00-9 morpholine 203-815-1 110-91-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H226
H332
H312
H302
H314 GHS02
GHS05
GHS07
Dg H226
H332
H312
H302
H314 613-029-00-4 dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid 220-487-5 2782-57-2 Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H272
H302
H319
H335
H400
H410 GHS03
GHS07
GHS09
Dgr H272
H302
H319
H335
H410 EUH031 T
613-030-00-X troclosene potassium; [1]
troclosene sodium [2] 218-828-8 [1]
220-767-7 [2] 2244-21-5 [1]
2893-78-9 [2] Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H272
H302
H319
H335
H400
H410 GHS03
GHS07
GHS09
Dgr H272
H302
H319
H335
H410 EUH031 *
STOT SE 3; H335: C ≥ 10 %
EUH031: C ≥ 10 % 613-030-01-7 troclosene sodium, dihydrate 220-767-7 51580-86-0 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H335
H400
H410 GHS07
GHS09
Wng H302
H319
H335
H410 EUH031 613-031-00-5 symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion 201-782-8 87-90-1 Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1 H272
H302
H319
H335
H400
H410 GHS03
GHS07
GHS09
Dgr H272
H302
H319
H335
H410 EUH031 613-032-00-0 methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine 236-035-5 13108-52-6 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1 H312
H302
H319
H317 GHS07
Wng H312
H302
H319
H317 613-033-00-6 2-methylaziridine;
propyleneimine 200-878-7 75-55-8 Flam. Liq. 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Eye Dam. 1
Aquatic Chronic 2 H225
H350
H330
H310
H300
H318
H411 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H225
H350
H330
H310
H300
H318
H411 Carc. 1B; H350: C ≥ 0,01 % 613-034-00-1 1,2-dimethylimidazole 217-101-2 1739-84-0 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1 H302
H315
H318 GHS05
GHS07
Dgr H302
H315
H318 613-035-00-7 1-methylimidazole 210-484-7 616-47-7 Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B H312
H302
H314 GHS05
GHS07
Dgr H312
H302
H314 613-036-00-2 2-methylpyridine;
2-picoline 203-643-7 109-06-8 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3 H226
H332
H312
H302
H319
H335 GHS02
GHS07
Wng H226
H332
H312
H302
H319
H335 613-037-00-8 4-methylpyridine;
4-picoline 203-626-4 108-89-4 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H226
H311
H332
H302
H319
H335
H315 GHS02
GHS06
Dgr H226
H311
H332
H302
H319
H335
H315 613-038-00-3 6-phenyl-1,3,5-triazine-2,4-diyldiamine;
6-phenyl-1,3,5-triazine-2,4-diamine;
benzoguanamine 202-095-6 91-76-9 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 613-039-00-9 ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol 202-506-9 96-45-7 Repr. 1B
Acute Tox. 4 * H360D ***
H302 GHS08
GHS07
Dgr H360D ***
H302 613-040-00-4 azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole 262-102-3 60207-31-0 Acute Tox. 4 * H302 GHS07
Wng H302 613-041-00-X morpholine-4-carbonyl chloride 239-213-0 15159-40-7 Carc. 2
Eye Irrit. 2
Skin Irrit. 2 H351
H319
H315 GHS08
Wng H351
H319
H315 EUH014 613-042-00-5 imazalil (ISO);
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H332
H302
H318
H410 613-043-00-0 imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]
281-291-3 [2] 58594-72-2 [1]
83918-57-4 [2] Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 613-043-01-8 imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]
281-291-3 [2] 58594-72-2 [1]
83918-57-4 [2] Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Wng H302
H314
H317
H410 Skin Corr. 1B; H314: C ≥ 50 %
Skin Irrit. 2; H315: 30 % ≤ C < 50 %
Eye Dam. 1; H318: 15 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 % 613-044-00-6 captan (ISO);
1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide 205-087-0 133-06-2 Carc. 2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H351
H331
H318
H317
H400 GHS06
GHS08
GHS05
GHS09
Dgr H351
H331
H318
H317
H400 613-045-00-1 folpet (ISO);
N-(trichloromethylthio)phthalimide 205-088-6 133-07-3 Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1 H351
H332
H319
H317
H400 GHS08
GHS07
GHS09
Wng H351
H332
H319
H317
H400 613-046-00-7 captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide 219-363-3 2425-06-1 Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H350
H317
H400
H410 GHS08
GHS09
Dgr H350
H317
H410 613-047-00-2 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;
dimetilan (ISO) 211-420-0 644-64-4 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 613-048-00-8 carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate 234-232-0 10605-21-7 Muta. 1B
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H340
H360FD
H400
H410 GHS08
GHS09
Dgr H340
H360FD
H410 613-049-00-3 benomyl (ISO);
methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate 241-775-7 17804-35-2 Muta. 1B
Repr. 1B
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H340
H360FD
H335
H315
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H340
H360FD
H335
H315
H317
H410 M = 10 613-050-00-9 carbadox (INN);
methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;
2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide 229-879-0 6804-07-5 Flam. Sol. 1
Carc. 1B
Acute Tox. 4 * H228
H350
H302 GHS02
GHS08
GHS07
Dgr H228
H350
H302 T
613-051-00-4 molinate (ISO);
S-ethyl 1-perhydroazepinecarbothioate;
S-ethyl perhydroazepine-1-carbothioate 218-661-0 2212-67-1 Carc. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H361f ***
H332
H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H351
H361f ***
H332
H302
H373 **
H317
H410 M = 100 613-052-00-X trifenmorph (ISO);
4-tritylmorpholine 215-812-2 1420-06-0 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-053-00-5 anilazine (ISO);
2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline 202-910-5 101-05-3 Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H315
H400
H410 GHS07
GHS09
Wng H319
H315
H410 613-054-00-0 thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole 205-725-8 148-79-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-056-00-1 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;
difenzoquat methyl sulfate 256-152-5 43222-48-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS09
Wng H302
H410 613-057-00-7 dodemorph (ISO);
4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2 H319
H335
H315
H411 GHS07
GHS09
Wng H319
H335
H315
H411 613-058-00-2 permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H317
H400
H410 GHS07
GHS09
Wng H332
H302
H317
H410 M = 1000 613-059-00-8 profluralin (ISO);
N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine 247-656-6 26399-36-0 Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H400
H410 GHS07
GHS09
Wng H319
H410 613-060-00-3 resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate 233-940-7 10453-86-8 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-061-00-9 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;
ryania 239-732-2 15662-33-6 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 613-062-00-4 sabadilla (ISO);
veratrine — 8051-02-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H319
H335
H315 GHS07
Wng H319
H335
H315 613-063-00-X secbumeton (ISO);
2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 247-554-1 26259-45-0 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H400
H410 GHS07
GHS09
Wng H302
H319
H410 613-064-00-5 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;
sesamex — 51-14-9 Acute Tox. 4 * H302 GHS07
Wng H302 613-065-00-0 simetryn (ISO);
2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine 213-801-7 1014-70-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-066-00-6 terbumeton (ISO);
2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 251-637-8 33693-04-8 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-067-00-1 propazine(ISO);
2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine 205-359-9 139-40-2 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 613-068-00-7 atrazine (ISO);
2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine 217-617-8 1912-24-9 STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H317
H400
H410 GHS08
GHS09
Wng H373 **
H317
H410 613-069-00-2 ε-caprolactam 203-313-2 105-60-2 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2 H332
H302
H319
H335
H315 GHS07
Wng H332
H302
H319
H335
H315 613-070-00-8 propylenethiourea — 2122-19-2 Repr. 2
Acute Tox. 4 *
Aquatic Chronic 3 H361d ***
H302
H412 GHS08
GHS07
Wng H361d ***
H302
H412 613-071-00-3 2-fluoro-5-trifluoromethylpyridine 400-290-2 69045-82-5 Flam. Liq. 3
Skin Sens. 1
Aquatic Chronic 3 H226
H317
H412 GHS02
GHS07
Wng H226
H317
H412 613-072-00-9 N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine 401-280-0 91273-04-0 Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H314
H317
H411 GHS05
GHS07
GHS09
Dgr H314
H317
H411 613-073-00-4 N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine 401-410-6 10357-99-0 STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H373 **
H317
H411 GHS08
GHS09
Wng H373 **
H317
H411 613-074-00-X 3-(3-methylpent-3-yl)isoxazol-5-ylamine 401-460-9 82560-06-3 Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 3 H331
H301
H318
H412 GHS06
GHS05
Dgr H331
H301
H318
H412 613-075-00-5 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 401-570-7 89415-87-2 Ox. Sol. 1 ****
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1 H271
H331
H314
H302
H317
H400 GHS03
GHS06
GHS05
GHS09
Dgr H271
H331
H314
H302
H317
H400 613-076-00-0 3-chloro-5-trifluoromethyl-2-pyridylamine 401-670-0 79456-26-1 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 613-077-00-6 reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine 401-940-8 — Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H302
H319
H411 GHS07
GHS09
Wng H302
H319
H411 613-078-00-1 N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine 401-990-0 106990-43-6 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-079-00-7 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers 402-520-7 — Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H315
H317
H400
H410 GHS07
GHS09
Wng H312
H302
H315
H317
H410 613-080-00-2 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione 402-540-6 105254-85-1 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H317
H410 613-081-00-8 1-butyl-2-methylpyridinium bromide 402-680-8 26576-84-1 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 613-082-00-3 2-methyl-1-pentylpyridinium bromide 402-690-2 — Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H312
H302
H412 GHS07
Wng H312
H302
H412 613-083-00-9 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate 402-120-2 — Skin Corr. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H314
H373 **
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H314
H373 **
H317
H410 613-084-00-4 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate 402-490-5 106359-93-7 Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H400
H410 GHS07
GHS09
Wng H319
H410 613-085-00-X reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione 401-970-1 — Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 613-086-00-5 caffeine 200-362-1 58-08-2 Acute Tox. 4 * H302 GHS07
Wng H302 613-087-00-0 tetrahydrothiophene 203-728-9 110-01-0 Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H225
H332
H312
H302
H319
H315
H412 GHS02
GHS07
Dgr H225
H332
H312
H302
H319
H315
H412 613-088-00-6 1,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one 220-120-9 2634-33-5 Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H302
H315
H318
H317
H400 GHS05
GHS07
GHS09
Dgr H302
H315
H318
H317
H400 Skin Sens. 1; H317: C ≥ 0,05 % 613-089-00-1 diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] 201-579-4 [1]
223-714-6 [2]
301-467-6 [3] 85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3] Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H372 **
H302
H319
H335
H315
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H372 **
H302
H319
H335
H315
H317
H410 613-090-00-7 paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 217-615-7 [1]
218-196-3 [2] 1910-42-5 [1]
2074-50-2 [2] Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H330
H311
H301
H372 **
H319
H335
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H330
H311
H301
H372 **
H319
H335
H315
H410 613-091-00-2 morfamquat dichloride; [1]
morfamquat sulfate [2] 225-062-8 [1]
[2] 4636-83-3 [1]
29873-36-7 [2] Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3 H302
H319
H335
H315
H412 GHS07
Wng H302
H319
H335
H315
H412 613-092-00-8 1,10-phenanthroline 200-629-2 66-71-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 613-093-00-3 hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 400-050-7 85153-92-0 Resp. Sens. 1
Skin Sens. 1 H334
H317 GHS08
Dgr H334
H317 613-094-00-9 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine 401-360-5 5248-39-5 Acute Tox. 4 *
STOT RE 2 * H302
H373 ** GHS08
GHS07
Wng H302
H373 ** 613-095-00-4 sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate 403-080-9 92484-48-5 Eye Dam. 1 H318 GHS05
Dgr H318 613-096-00-X 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine 403-580-7 62096-63-3 Acute Tox. 4 * H302 GHS07
Wng H302 613-097-00-5 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 403-690-5 111298-82-9 Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H334
H317
H412 GHS08
Dgr H334
H317
H412 613-098-00-0 N-(n-octyl)-2-pyrrolidone 403-700-8 2687-94-7 Skin Corr. 1B
Aquatic Chronic 2 H314
H411 GHS05
GHS09
Dgr H314
H411 613-099-00-6 1-dodecyl-2-pyrrolidone 403-730-1 2687-96-9 Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H314
H317
H410 613-100-00-X 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione 404-230-6 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 613-101-00-5 N—tert-pentyl-2-benzothiazolesulfenamide 404-380-2 110799-28-5 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 613-102-00-0 dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine 404-200-2 110488-70-5 Aquatic Chronic 2 H411 GHS09 H411 613-103-00-6 sodium 5-n-butylbenzotriazole 404-450-2 118685-34-0 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H302
H314
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H314
H317
H411 613-104-00-1 5-tert-butyl-3-isoxazolylamine hydrochloride 404-840-2 — Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 3 H302
H373 **
H318
H412 GHS08
GHS05
GHS07
Dgr H302
H373 **
H318
H412 613-105-00-7 hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) 405-160-9 124537-30-0 Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 3 H301
H317
H412 GHS06
Dgr H301
H317
H412 613-106-00-2 tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate 405-240-3 — Skin Sens. 1 H317 GHS07
Wng H317 613-107-00-8 hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate 405-280-1 76508-02-6 Eye Irrit. 2 H319 GHS07
Wng H319 613-108-00-3 benzothiazole-2-thiol 205-736-8 149-30-4 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 613-109-00-9 bis(piperidinothiocarbonyl) disulphide 202-328-1 94-37-1 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1 H319
H335
H315
H317 GHS07
Wng H319
H335
H315
H317 613-110-00-4 dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate 262-784-2 61432-55-1 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 613-111-00-X 1,2,4-triazole 206-022-9 288-88-0 Repr. 2
Acute Tox. 4 *
Eye Irrit. 2 H361d ***
H302
H319 GHS08
GHS07
Wng H361d ***
H302
H319 613-112-00-5 octhilinone (ISO);
2-octyl-2H-isothiazol-3-one 247-761-7 26530-20-1 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H302
H314
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H331
H311
H302
H314
H317
H410 Skin Sens. 1; H317: C ≥ 0,05 % 613-113-00-0 2-(morpholinothio)benzothiazole 203-052-4 102-77-2 Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H315
H317
H411 GHS07
GHS09
Wng H319
H315
H317
H411 613-114-00-6 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;
1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine 225-208-0 4719-04-4 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 Skin Sens. 1; H317: C ≥ 0,1 % 613-115-00-1 hymexazol (ISO);
3-hydroxy-5-methylisoxazole 233-000-6 10004-44-1 Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3 H302
H318
H412 GHS05
GHS07
Dgr H302
H318
H412 613-116-00-7 tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide 211-986-9 731-27-1 Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H373 **
H319
H335
H315
H317
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H373 **
H319
H335
H315
H317
H410 613-117-00-2 diniconazole (ISO);
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol — 76714-88-0 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-118-00-8 flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline 253-703-1 37893-02-0 Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H319
H400
H410 GHS07
GHS09
Wng H319
H410 613-119-00-3 (benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB 244-445-0 21564-17-0 Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H330
H302
H319
H315
H317
H400
H410 GHS06
GHS09
Dgr H330
H302
H319
H315
H317
H410 613-120-00-9 bioresmethrin;
(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate 249-014-0 28434-01-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-121-00-4 chlorsulfuron (ISO);
2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide 265-268-5 64902-72-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-122-00-X diclobutrazole (ISO);
(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol — 75736-33-3 Eye Irrit. 2
Aquatic Chronic 2 H319
H411 GHS07
GHS09
Wng H319
H411 613-123-00-5 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;
etem 251-684-4 33813-20-6 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-124-00-0 fenpropimorph (ISO);
cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 266-719-9 67564-91-4 Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2 H361d ***
H302
H315
H411 GHS08
GHS07
GHS09
Wng H361d ***
H302
H315
H411 613-125-00-6 hexythiazox(ISO);
trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide — 78587-05-0 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-126-00-1 imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate — 81334-34-1 Eye Irrit. 2
Aquatic Chronic 3 H319
H412 GHS07
Wng H319
H412 613-127-00-7 1,1-dimethylpiperidinium chloride;
mepiquat chloride 246-147-6 24307-26-4 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 613-128-00-2 prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide 266-994-5 67747-09-5 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-129-00-8 metamitron (ISO);
4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one 255-349-3 41394-05-2 Acute Tox. 4 *
Aquatic Acute 1 H302
H400 GHS07
GHS09
Wng H302
H400 613-131-00-9 pyroquilon (ISO);
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one — 57369-32-1 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 613-132-00-4 hexazinone (ISO);
3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione 257-074-4 51235-04-2 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H400
H410 GHS07
GHS09
Wng H302
H319
H410 613-133-00-X etridiazole (ISO);
5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H331
H312
H302
H400
H410 GHS06
GHS08
GHS09
Dgr H351
H331
H312
H302
H410 613-134-00-5 myclobutanil(ISO);
2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H361d ***
H302
H319
H411 GHS08
GHS07
GHS09
Wng H361d ***
H302
H319
H411 613-135-00-0 di(benzothiazol-2-yl) disulphide 204-424-9 120-78-5 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 EUH031 613-136-00-6 N-cyclohexylbenzothiazole-2-sulphenamide 202-411-2 95-33-0 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 613-137-00-1 methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-dimethylurea 242-505-0 18691-97-9 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-138-00-7 quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline — 124495-18-7 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 613-139-00-2 metsulfuron-methyl;
2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid — 74223-64-6 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-140-00-8 cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione 200-636-0 66-81-9 Muta. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Chronic 2 H341
H360D ***
H300
H411 GHS06
GHS08
GHS09
Dgr H341
H360D ***
H300
H411 613-141-00-3 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone 401-470-3 93686-63-6 Aquatic Chronic 4 H413 — H413 613-142-00-9 trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate 405-860-4 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-143-00-4 1-(3-phenylpropyl)-2-methylpyridinium bromide 405-930-4 10551-42-5 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3 H302
H319
H412 GHS07
Wng H302
H319
H412 613-144-00-X reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate 406-460-2 125139-08-4 Aquatic Chronic 3 H412 — H412 613-145-00-5 (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate 406-960-0 77497-97-3 Aquatic Chronic 2 H411 GHS09 H411 613-146-00-0 N-ethyl-N-methylpiperidinium iodide 407-780-5 4186-71-4 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 613-147-00-6 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine 407-940-4 111681-72-2 Eye Dam. 1 H318 GHS05
Dgr H318 613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 411-240-4 143683-23-2 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 613-149-00-7 pyridaben (ISO);
2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H400
H410 GHS06
GHS09
Dgr H331
H301
H410 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — Aquatic Chronic 4 H413 — H413 613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 Aquatic Chronic 4 H413 — H413 613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-153-00-9 2,3,5-trichloropyridine 407-270-2 16063-70-0 Aquatic Chronic 3 H412 — H412 613-154-00-4 2-amino-4-chloro-6-methoxypyrimidine 410-050-9 5734-64-5 Acute Tox. 4 * H302 GHS07
Wng H302 613-155-00-X 5-chloro-2,3-difluoropyridine 410-090-7 89402-43-7 Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 3 H226
H302
H412 GHS02
GHS07
Wng H226
H302
H412 613-156-00-5 2-butyl-4-chloro-5-formylimidazole 410-260-0 83857-96-9 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-157-00-0 2,4-diamino-5-methoxymethylpyrimidine 410-330-0 54236-98-5 Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2 H302
H373 **
H319 GHS08
GHS07
Wng H302
H373 **
H319 613-158-00-6 2,3-dichloro-5-trifluoromethyl-pyridine 410-340-5 69045-84-7 Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H332
H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H332
H302
H318
H317
H411 613-159-00-1 fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline 410-580-0 120928-09-8 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H332
H400
H410 GHS06
GHS09
Dgr H301
H332
H410 613-160-00-7 (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide 411-000-9 125224-62-6 Skin Sens. 1 H317 GHS07
Wng H317 613-163-00-3 azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea — 120162-55-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-164-00-9 flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide — 142459-58-3 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H317
H410 613-165-00-4 flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt — 144740-54-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-166-00-X flumioxazin (ISO);
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H—1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide — 103361-09-7 Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H360D ***
H400
H410 GHS08
GHS09
Dgr H360D ***
H410 613-167-00-5 reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) — 55965-84-9 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H311
H301
H314
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H331
H311
H301
H314
H317
H410 Skin Corr. 1B; H314: C ≥ 0,6 %
Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %
Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %
Skin Sens. 1; H317: C ≥ 0,0015 % 613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1 H351
H332
H312
H302
H373 **
H335
H318 GHS06
GHS05
GHS09
Dgr H351
H332
H312
H302
H373 **
H335
H318 D
613-169-00-6 9-vinylcarbazole 216-055-0 1484-13-5 Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H341
H312
H302
H315
H317
H400
H410 GHS08
GHS07
GHS09
Wng H341
H312
H302
H315
H317
H410 613-170-00-1 2,2-ethylmethylthiazolidine 404-500-3 694-64-4 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 613-171-00-7 hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol 413-050-7 79983-71-4 Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H302
H317
H411 GHS07
GHS09
Wng H302
H317
H411 613-172-00-2 5-chloro-1,3-dihydro-2H-indol-2-one 412-200-9 17630-75-0 Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3 H361f ***
H302
H317
H412 GHS08
GHS07
Wng H361f ***
H302
H317
H412 613-173-00-8 fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one 411-960-9 136426-54-5 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H372 **
H312
H315
H400
H410 GHS06
GHS08
GHS09
Dgr H331
H301
H372 **
H312
H315
H410 613-174-00-3 (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 407-760-6 112281-77-3 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H351
H332
H302
H411 GHS08
GHS07
GHS09
Wng H351
H332
H302
H411 613-175-00-9 epoxiconazole(ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. 2
Repr. 2
Aquatic Chronic 2 H351
H361fd
H411 GHS08
GHS09
Wng H351
H361fd
H411 613-176-00-4 2-methyl-2-azabicyclo[2.2.1]heptane 404-810-9 4524-95-2 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B H226
H312
H302
H373 **
H314 GHS02
GHS08
GHS05
GHS07
Dgr H226
H312
H302
H373 **
H314 613-177-00-X 8-amino-7-methylquinoline 412-760-4 5470-82-6 Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2 H312
H302
H317
H411 GHS07
GHS09
Wng H312
H302
H317
H411 613-178-00-5 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine 410-470-2 137796-06-6 Skin Corr. 1B
Skin Sens. 1 H314
H317 GHS05
GHS07
Dgr H314
H317 STOT SE 3; H335: C ≥ 5 % 613-179-00-0 lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide 411-690-1 111337-53-2 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2 H302
H314
H317
H411 GHS05
GHS07
Dgr H302
H314
H317
H411 613-180-00-6 N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide 407-430-1 3741-80-8 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-181-00-1 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone 405-090-9 67485-29-4 STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H372 **
H302
H319
H400
H410 GHS08
GHS07
GHS09
Dgr H372 **
H302
H319
H410 613-182-00-7 1-(1-naphthylmethyl)quinolinium chloride 406-220-7 65322-65-8 Carc. 2
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3 H351
H341
H302
H315
H318
H412 GHS08
GHS05
GHS07
Dgr H351
H341
H302
H315
H318
H412 613-183-00-2 reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;
5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one 413-640-4 — STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H400
H410 GHS08
GHS09
Wng H373 **
H410 613-184-00-8 nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate 413-670-8 — Eye Irrit. 2
Skin Sens. 1 H319
H317 GHS07
Wng H319
H317 613-185-00-3 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one 407-630-9 82633-79-2 Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H301
H318
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H301
H318
H317
H410 613-186-00-9 (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate 408-050-9 76855-69-1 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H317
H411 GHS07
GHS09
Wng H319
H317
H411 613-188-00-X 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone 411-500-7 116256-11-2 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 613-189-00-5 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane 414-030-0 52667-88-6 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 613-190-00-0 disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate 414-040-5 149530-93-8 Acute Tox. 4 *
Skin Sens. 1 H302
H317 GHS07
Wng H302
H317 613-191-00-6 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 421-150-7 143860-04-2 Repr. 1B
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H360F ***
H314
H400
H410 GHS08
GHS05
GHS09
Dgr H360F ***
H314
H410 613-193-00-7 pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate 414-930-3 — Aquatic Chronic 2 H411 GHS09 H411 613-194-00-2 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt 418-000-8 163062-28-0 Eye Dam. 1 H318 GHS05
Dgr H318 613-195-00-8 2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one) 418-280-1 18600-59-4 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 613-196-00-3 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt 418-380-5 168113-78-8 Eye Dam. 1 H318 GHS05
Dgr H318 613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 420-390-1 187547-46-2 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;
reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione 421-550-1 — Carc. 1B
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3 H350
H360D ***
H317
H412 GHS08
Dgr H350
H360D ***
H317
H412 613-200-00-3 Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts 420-980-7 — Eye Dam. 1 H318 GHS05
Dgr H318 613-201-00-9 (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole 422-390-5 143322-57-0 Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361f ***
H372 **
H332
H302
H317
H400
H410 GHS08
GHS07
GHS09
Dgr H361f ***
H372 **
H332
H302
H317
H410 EUH070 613-202-00-4 pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one — 123312-89-0 Carc. 2
Aquatic Chronic 3 H351
H412 GHS08
Wng H351
H412 613-203-00-X pyraflufen-ethyl; [1]
pyraflufen [2] -[1]
-[2] 129630-19-9 [1]
129630-17-7 [2] Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-204-00-5 oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;
5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one 254-637-6 39807-15-3 Repr. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H373 **
H400
H410 GHS08
GHS09
Wng H361d ***
H373 **
H410 613-205-00-0 propiconazole(ISO);
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole 262-104-4 60207-90-1 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 613-206-00-6 fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one — 161326-34-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-208-00-7 imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid — 114311-32-9 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-209-00-2 cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride 417-430-3 63645-17-0 Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2 H301
H373 **
H317
H411 GHS06
GHS08
GHS09
Dgr H301
H373 **
H317
H411 613-210-00-8 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 417-650-1 88128-57-8 STOT RE 2 *
Aquatic Chronic 3 H373 **
H412 GHS08
Wng H373 **
H412 613-211-00-3 N-methyl-4-(p-formylstyryl)pyridinium methylsulfate 418-240-3 74401-04-0 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 613-212-00-9 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) 418-320-8 133467-41-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 613-213-00-4 cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline 416-040-0 120807-02-5 Aquatic Chronic 3 H412 — H412 613-214-00-X N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide 416-260-7 147613-95-4 Aquatic Chronic 4 H413 — H413 613-215-00-5 2-chloromethyl-3,4-dimethoxypyridinium chloride 416-440-5 72830-09-2 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H312
H302
H373 **
H315
H318
H317
H411 GHS08
GHS05
GHS07
GHS09
Dgr H312
H302
H373 **
H315
H318
H317
H411 613-216-00-0 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole 416-490-8 162208-01-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-217-00-6 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine 416-770-1 73754-27-5 Aquatic Chronic 4 H413 — H413 613-218-00-1 6-hydroxyindole 417-020-4 2380-86-1 Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H302
H318
H317
H411 GHS05
GHS07
GHS09
Dgr H302
H318
H317
H411 613-219-00-7 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole 417-140-7 79185-77-6 Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 613-220-00-2 trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide 417-290-3 147086-81-5 Acute Tox. 4 * H302 GHS07
Wng H302 613-221-00-8 2-chloro-5-methyl-pyridine 418-050-0 18368-64-4 Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 3 H312
H302
H315
H412 GHS07
Wng H312
H302
H315
H412 613-222-00-3 4-(1-oxo-2-propenyl)-morpholine 418-140-1 5117-12-4 Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1 H302
H373 **
H318
H317 GHS08
GHS05
GHS07
Dgr H302
H373 **
H318
H317 613-223-00-9 N-isopropyl-3-(4-fluorophenyl)-1H-indole 418-790-4 93957-49-4 Aquatic Chronic 4 H413 — H413 613-224-00-4 2,5-dimercaptomethyl-1,4-dithiane 419-770-8 136122-15-1 Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H317
H410 613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. 421-290-9 — STOT RE 2 *
Aquatic Chronic 4 H373 **
H413 GHS08
Wng H373 **
H413 613-226-00-5 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride 420-950-3 163831-67-2 Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H318
H400
H410 GHS05
GHS09
Dgr H318
H410 613-227-00-0 (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-600-2 99199-90-3 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 613-228-00-6 (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-630-6 793669-26-8 Aquatic Chronic 2 H411 GHS09 H411 613-230-00-7 florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide — 145701-23-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 613-233-00-3 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane 423-230-7 56552-15-9 Eye Dam. 1 H318 GHS05
Dgr H318 614-001-00-4 nicotine (ISO);
3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 Acute Tox. 1
Acute Tox. 3 *
Aquatic Chronic 2 H310
H301
H411 GHS06
GHS09
Dgr H310
H301
H411 614-002-00-X salts of nicotine — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2 H330
H310
H300
H411 GHS06
GHS09
Dgr H330
H310
H300
H411 A
614-003-00-5 strychnine 200-319-7 57-24-9 Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H310
H300
H400
H410 GHS06
GHS09
Dgr H310
H300
H410 614-004-00-0 salts of strychnine — — Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1 H330
H300
H400
H410 GHS06
GHS09
Dgr H330
H300
H410 A
614-005-00-6 colchicine 200-598-5 64-86-8 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-006-00-1 brucine;
2,3-dimethoxystrychnine 206-614-7 357-57-3 Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3 H330
H300
H412 GHS06
Dgr H330
H300
H412 614-007-00-7 brucine sulphate; [1]
brucine nitrate; [2]
strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4] 4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4] Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3 H330
H300
H412 GHS06
Dgr H330
H300
H412 A
614-008-00-2 aconitine 206-121-7 302-27-2 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-009-00-8 salts of aconitine — — Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 A
614-010-00-3 atropine 200-104-8 51-55-8 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-011-00-9 salts of atropine — — Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 A
614-012-00-4 hyoscyamine 202-933-0 101-31-5 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-013-00-X salts of hyoscyamine — — Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 A
614-014-00-5 hyoscine 200-090-3 51-34-3 Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H330
H310
H300 GHS06
Dgr H330
H310
H300 614-015-00-0 salts of hyoscine — — Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 * H330
H310
H300 GHS06
Dgr H330
H310
H300 A
614-016-00-6 pilocarpine 202-128-4 92-13-7 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-017-00-1 salts of pilocarpine — — Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 A
614-018-00-7 papaverine 200-397-2 58-74-2 Acute Tox. 4 * H302 GHS07
Wng H302 614-019-00-2 salts of papaverine — — Acute Tox. 4 * H302 GHS07
Wng H302 A
614-020-00-8 physostigmine 200-332-8 57-47-6 Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 614-021-00-3 salts of physostigmine — — Acute Tox. 2 *
Acute Tox. 2 * H330
H300 GHS06
Dgr H330
H300 A
614-022-00-9 digitoxin 200-760-5 71-63-6 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H331
H301
H373 ** GHS06
GHS08
Dgr H331
H301
H373 ** 614-023-00-4 ephedrine 206-080-5 299-42-3 Acute Tox. 4 * H302 GHS07
Wng H302 614-024-00-X salts of ephedrine — — Acute Tox. 4 * H302 GHS07
Wng H302 A
614-025-00-5 ouabain 211-139-3 630-60-4 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H331
H301
H373 ** GHS06
GHS08
Dgr H331
H301
H373 ** 614-026-00-0 strophantin-K 234-239-9 11005-63-3 Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 * H331
H301
H373 ** GHS06
GHS08
Dgr H331
H301
H373 ** 614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;
red squill;
scilliroside 208-077-4 507-60-8 Acute Tox. 2 * H300 GHS06
Dgr H300 614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside 414-420-0 — Eye Dam. 1 H318 GHS05
Dgr H318 614-029-00-7 constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside 419-640-0 68784-14-5 Acute Tox. 4 * H302 GHS07
Wng H302 615-001-00-7 methyl isocyanate 210-866-3 624-83-9 Flam. Liq. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H225
H361d ***
H330
H311
H301
H335
H315
H318
H334
H317 GHS02
GHS06
GHS06
GHS08
GHS05
Dgr H225
H361d ***
H330
H311
H301
H335
H315
H318
H334
H317 615-002-00-2 methyl isothiocyanate 209-132-5 556-61-6 Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H314
H317
H400
H410 GHS06
GHS05
GHS09
Dgr H331
H301
H314
H317
H410 615-003-00-8 thiocyanic acid 207-337-4 463-56-9 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H332
H312
H302
H412 GHS07
Wng H332
H312
H302
H412 EUH032 615-004-00-3 salts of thiocyanic acid — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H332
H312
H302
H412 GHS07
Wng H332
H312
H302
H412 EUH032 A
615-005-00-9 4,4'-methylenediphenyl diisocyanate;
diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate;
diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4] 202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4] 101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4] Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1 H332
H319
H335
H315
H334
H317 GHS08
GHS07
Dgr H332
H319
H335
H315
H334
H317 Eye Irrit.; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
Resp. Sens. 1; H334: C ≥ 0,1 % C
2
615-006-00-4 2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3] 202-039-0 [1]
209-544-5 [2]
247-722-4 [3] 91-08-7 [1]
584-84-9 [2]
26471-62-5 [3] Carc. 2
Acute Tox. 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H351
H330
H319
H335
H315
H334
H317
H412 GHS06
GHS08
Dgr H351
H330
H319
H335
H315
H334
H317
H412 Resp. Sens. 1; H334: C ≥ 0,1 % C
615-007-00-X 1,5-naphthylene diisocyanate 221-641-4 3173-72-6 Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Aquatic Chronic 3 H332
H319
H335
H315
H334
H412 GHS08
GHS07
Dgr H332
H319
H335
H315
H334
H412 615-008-00-5 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;
isophorone di-isocyanate 223-861-6 4098-71-9 Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2 H331
H319
H335
H315
H334
H317
H411 GHS06
GHS08
GHS09
Dgr H331
H319
H335
H315
H334
H317
H411 *
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens.1; H317: C ≥ 0,5 % 2
615-009-00-0 4,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate 225-863-2 5124-30-1 Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1 H331
H319
H335
H315
H334
H317 GHS06
GHS08
Dgr H331
H319
H335
H315
H334
H317 *
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 % 2
615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 241-001-8 [1]
239-714-4 [2] 16938-22-0 [1]
15646-96-5 [2] Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H331
H319
H335
H315
H334 GHS06
GHS08
Dgr H331
H319
H335
H315
H334 *
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 % C
2
615-011-00-1 hexamethylene-di-isocyanate 212-485-8 822-06-0 Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1 H331
H319
H335
H315
H334
H317 GHS06
GHS08
Dgr H331
H319
H335
H315
H334
H317 *
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 % 2
615-012-00-7 4-isocyanatosulphonyltoluene;
tosyl isocyanate 223-810-8 4083-64-1 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 EUH014 Eye Irrit.; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 % 615-013-00-2 cyanamide;
carbanonitril 206-992-3 420-04-2 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H301
H312
H319
H315
H317 GHS06
Dgr H301
H312
H319
H315
H317 615-014-00-8 tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate — 7276-58-6 Acute Tox. 4 * H302 GHS07
Wng H302 615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate 204-081-5 115-31-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 615-016-00-9 potassium cyanate 209-676-3 590-28-3 Acute Tox. 4 * H302 GHS07
Wng H302 615-017-00-4 calcium cyanamide 205-861-8 156-62-7 Acute Tox. 4 *
STOT SE 3
Eye Dam. 1 H302
H335
H318 GHS05
GHS07
Dgr H302
H335
H318 615-018-00-X 2-(2-butoxyethoxy)ethyl thiocyanate 203-985-7 112-56-1 Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 * H226
H311
H301 GHS02
GHS06
Dgr H226
H311
H301 615-019-00-5 dicyclohexylcarbodiimide 208-704-1 538-75-0 Acute Tox. 3 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H311
H302
H318
H317 GHS06
GHS05
Dgr H311
H302
H318
H317 615-020-00-0 methylene dithiocyanate 228-652-3 6317-18-6 Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1 H330
H301
H314
H317
H400 GHS06
GHS05
GHS09
Dgr H330
H301
H314
H317
H400 615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC 219-514-3 2451-62-9 Muta. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H340
H331
H301
H373 **
H318
H317
H412 GHS06
GHS08
GHS05
Dgr H340
H331
H301
H373 **
H318
H317
H412 615-022-00-1 methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate 410-550-7 79277-18-2 STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1 H373 **
H334
H317 GHS08
Dgr E; R2
H373 **
H334
H317 EUH014 615-023-00-7 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate 410-900-9 83056-32-0 Flam. Liq. 3
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1 H226
H341
H332
H373 **
H318
H334 GHS02
GHS08
GHS05
GHS07
Dgr H226
H341
H332
H373 **
H318
H334 EUH014 615-024-00-2 2-phenylethylisocyanate 413-080-0 1943-82-4 Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2 H331
H302
H314
H334
H317
H411 GHS06
GHS08
GHS05
GHS09
Dgr H331
H302
H314
H334
H317
H411 615-025-00-8 4,4'-ethylidenediphenyl dicyanate 405-740-1 47073-92-7 Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H302
H373 **
H318
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H332
H302
H373 **
H318
H410 615-026-00-3 4,4'-methylenebis(2,6-dimethylphenyl cyanate) 405-790-4 101657-77-6 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 410-220-2 77375-79-2 ****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1 H302
H373 **
H318
H334
H317 GHS08
GHS05
GHS07
Dgr E; R2
H302
H373 **
H318
H334
H317 EUH014 615-029-00-X 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane 411-280-2 — Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3 H330
H302
H314
H334
H317
H412 GHS06
GHS08
GHS05
Dgr H330
H302
H314
H334
H317
H412 615-030-00-5 alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3 H332
H312
H302
H412 GHS07
Wng H332
H312
H302
H412 EUH032 A
615-031-00-0 thallium salt of thiocyanic acid 222-571-7 3535-84-0 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2 H332
H312
H302
H411 GHS07
GHS09
Wng H332
H312
H302
H411 EUH032 A
615-032-00-6 metal salts of thiocyanic acid not mentioned elsewhere in this Annex — — Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H332
H312
H302
H400
H410 GHS07
GHS09
Wng H332
H312
H302
H410 EUH032 A
616-001-00-X N,N-dimethylformamide;
dimethyl formamide 200-679-5 68-12-2 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2 H360D ***
H332
H312
H319 GHS08
GHS07
Dgr H360D ***
H332
H312
H319 616-002-00-5 2-fluoroacetamide 211-363-1 640-19-7 Acute Tox. 2 *
Acute Tox. 3 * H300
H311 GHS06
Dgr H300
H311 616-003-00-0 acrylamide;
prop-2-enamide 201-173-7 79-06-1 Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1 H350
H340
H361f ***
H301
H372 **
H332
H312
H319
H315
H317 GHS06
GHS08
Dgr H350
H340
H361f ***
H301
H372 **
H332
H312
H319
H315
H317 D
616-004-00-6 allidochlor (ISO);
N,N-diallylchloroacetamide 202-270-7 93-71-0 Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H312
H302
H319
H315
H411 GHS07
GHS09
Wng H312
H302
H319
H315
H411 616-005-00-1 chlorthiamid (ISO);
2,6-dichloro (thiobenzamide) 217-637-7 1918-13-4 Acute Tox. 4 * H302 GHS07
Wng H302 616-006-00-7 dichlofluanid (ISO);
N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide 214-118-7 1085-98-9 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H319
H317
H400
H410 GHS07
GHS09
Wng H332
H319
H317
H410 616-007-00-2 diphenamid (ISO);
N,N-dimethyl-2,2-diphenylacetamide 213-482-4 957-51-7 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 616-008-00-8 propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropylacetanilide 217-638-2 1918-16-7 Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H319
H317
H400
H410 GHS07
GHS09
Wng H302
H319
H317
H410 616-009-00-3 propanil (ISO);
3',4'-dichloropropionanilide 211-914-6 709-98-8 Acute Tox. 4 *
Aquatic Acute 1 H302
H400 GHS07
GHS09
Wng H302
H400 616-010-00-9 tosylchloramide sodium 204-854-7 127-65-1 Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1 H302
H314
H334 GHS08
GHS05
GHS07
Dg H302
H314
H334 EUH031 616-011-00-4 N,N-dimethylacetamide 204-826-4 127-19-5 Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 * H360D ***
H332
H312 GHS08
GHS07
Dgr H360D ***
H332
H312 Repr. 1B; H360D: C ≥ 5 % 616-012-00-X N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide 211-952-3 719-96-0 Skin Irrit. 2 H315 GHS07
Wng H315 616-013-00-5 butyraldehyde oxime 203-792-8 110-69-0 Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2 H311
H302
H319 GHS06
Dgr H311
H302
H319 616-014-00-0 2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime 202-496-6 96-29-7 Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1 H351
H312
H318
H317 GHS08
GHS05
GHS07
Dgr H351
H312
H318
H317 616-015-00-6 alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 240-110-8 15972-60-8 Carc. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H317
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H317
H410 M=10 616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide — 5836-73-7 Acute Tox. 2 * H300 GHS06
Dgr H300 616-017-00-7 cartap hydrochloride 239-309-2 15263-52-2 Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H312
H302
H400
H410 GHS07
GHS09
Wng H312
H302
H410 616-018-00-2 N,N-diethyl-m-toluamide;
deet 205-149-7 134-62-3 Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H302
H319
H315
H412 GHS07
Wng H302
H319
H315
H412 616-019-00-8 perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; 253-718-3 37924-13-3 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 616-020-00-3 tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 251-793-7 34014-18-1 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 616-021-00-9 thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 246-901-4 25366-23-8 Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 616-022-00-4 acetamide 200-473-5 60-35-5 Carc. 2 H351 GHS08
Wng H351 616-023-00-X N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide 401-980-6 — Skin Irrit. 2
Skin Sens. 1 H315
H317 GHS07
Wng H315
H317 616-024-00-5 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide 402-260-4 54942-74-4 Aquatic Chronic 4 H413 — H413 616-025-00-0 valinamide 402-840-7 20108-78-5 Repr. 2
Eye Irrit. 2
Skin Sens. 1 H361f ***
H319
H317 GHS08
Wng H361f ***
H319
H317 616-026-00-6 thioacetamide 200-541-4 62-55-5 Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3 H350
H302
H319
H315
H412 GHS08
GHS07
Dgr H350
H302
H319
H315
H412 616-027-00-1 tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate 403-760-5 — Skin Sens. 1 H317 GHS07
Wng H317 616-028-00-7 N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 403-790-9 108673-51-4 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-029-00-2 N,N'-ethylenebis(vinylsulfonylacetamide) 404-790-1 66710-66-5 Eye Dam. 1
Skin Sens. 1 H318
H317 GHS05
GHS07
Dgr H318
H317 616-030-00-8 ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 250-010-6 30043-49-3 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 616-031-00-3 dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; 256-625-6 50563-36-5 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 616-032-00-9 diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide — 83164-33-4 Aquatic Chronic 3 H412 — H412 616-033-00-4 cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 274-050-9 69581-33-5 Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H312
H400
H410 GHS06
GHS09
Dgr H301
H312
H410 616-034-00-X pyracarbolid; (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 246-419-4 24691-76-7 Aquatic Chronic 3 H412 — H412 616-035-00-5 cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 616-036-00-0 2-chloracetamide 201-174-2 79-07-2 Repr. 2
Acute Tox. 3 *
Skin Sens. 1 H361f ***
H301
H317 GHS06
GHS08
Dgr H361f ***
H301
H317 Skin Sens. 1; H317: C ≥ 0,1 % 616-037-00-6 acetochlor (ISO);
2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide 251-899-3 34256-82-1 Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H332
H335
H315
H317
H400
H410 GHS07
GHS09
Wng H332
H335
H315
H317
H410 616-038-00-1 (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride 406-010-5 88918-84-7 Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H318
H317
H411 GHS05
GHS07
GHS09
Dgr H318
H317
H411 616-039-00-7 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide 406-200-8 117827-06-2 Skin Sens. 1 H317 GHS07
Wng H317 616-040-00-2 potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide 406-650-5 97888-41-0 Eye Dam. 1 H318 GHS05
Dgr H318 616-041-00-8 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide 406-840-8 101664-25-9 Aquatic Chronic 4 H413 — H413 616-042-00-3 N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide 407-070-5 142859-67-4 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-043-00-9 isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 407-190-8 82558-50-7 Aquatic Chronic 4 H413 — H413 616-044-00-4 N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide 402-510-2 — Aquatic Chronic 2 H411 GHS09 H411 616-045-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide 405-190-2 122371-93-1 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-046-00-5 N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 406-390-2 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide 406-640-0 — Skin Sens. 1 H317 GHS07
Wng H317 616-048-00-6 3'-trifluoromethylisobutyranilide 406-740-4 1939-27-1 STOT RE 2 *
Aquatic Chronic 2 H373 **
H411 GHS08
GHS09
Wng H373 **
H411 616-049-00-1 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide 408-150-2 99141-89-6 Aquatic Chronic 4 H413 — H413 616-050-00-7 lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 410-690-9 103055-07-8 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene 411-070-0 — Aquatic Chronic 4 H413 — H413 616-052-00-8 formamide 200-842-0 75-12-7 Repr. 1B H360D *** GHS08
Dgr H360D *** 616-053-00-3 N-methylacetamide 201-182-6 79-16-3 Repr. 1B H360D *** GHS08
Dgr H360D *** 616-054-00-9 iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 253-178-9 36734-19-7 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 616-055-00-4 propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 245-951-4 23950-58-5 Carc. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H400
H410 GHS08
GHS09
Wng H351
H410 616-056-00-X N-methylformamide 204-624-6 123-39-7 Repr. 1B
Acute Tox. 4 * H360D ***
H312 GHS08
GHS07
Dg H360D ***
H312 616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide 412-790-8 — Carc. 1B
Muta. 2
STOT RE 2 * H350
H341
H373 ** GHS08
Dgr H350
H341
H373 ** 616-058-00-0 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene 412-570-1 119462-56-5 STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H318
H317
H400
H410 GHS08
GHS05
GHS07
GHS09
Dgr H373 **
H318
H317
H410 616-059-00-6 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide 412-650-6 121487-83-0 Aquatic Chronic 4 H413 — H413 616-060-00-1 Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) 413-770-1 — Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H314
H317
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H314
H317
H410 616-061-00-7 N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide 413-610-0 124172-53-8 Eye Irrit. 2
Aquatic Chronic 3 H319
H412 GHS07
Wng H319
H412 616-062-00-2 N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide 411-590-8 70693-57-1 Skin Corr. 1B
Aquatic Chronic 3 H314
H412 GHS05
Dgr H314
H412 616-063-00-8 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione 411-920-0 106917-30-0 Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1 H331
H302
H373 **
H314
H400
H410 GHS06
GHS08
GHS05
GHS09
Dgr H331
H302
H373 **
H314
H410 616-064-00-3 N—tert-butyl-3-methylpicolinamide 406-720-5 32998-95-1 Aquatic Chronic 3 H412 — H412 616-065-00-9 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea 411-970-3 79881-89-3 Acute Tox. 4 *
STOT RE 2 * H302
H373 ** GHS08
GHS07
Wng H302
H373 ** 616-066-00-4 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone 405-100-1 115662-06-1 Repr. 2 H361f *** GHS08
Wng H361f *** 616-067-00-X dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate 407-300-4 92683-20-0 Aquatic Chronic 4 H413 — H413 616-068-00-5 potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate 406-500-9 174393-75-0 Skin Sens. 1 H317 GHS07
Wng H317 616-069-00-0 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide 406-210-2 110560-22-0 Aquatic Chronic 4 H413 — H413 616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-530-2 — Aquatic Chronic 4 H413 — H413 616-071-00-1 reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) 406-550-1 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-072-00-7 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine 407-120-6 55612-11-8 Aquatic Chronic 4 H413 — H413 616-073-00-2 4'-ethoxy-2-benzimidazoleanilide 407-600-5 120187-29-3 Muta. 2
Aquatic Chronic 4 H341
H413 GHS08
Wng H341
H413 616-074-00-8 N-butyl-2-(4-morpholinylcarbonyl)benzamide 407-730-2 104958-67-0 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H319
H317
H412 GHS07
Wng H319
H317
H412 616-075-00-3 D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) 408-120-9 65197-96-8 Acute Tox. 4 *
Eye Dam. 1 H302
H318 GHS05
GHS07
Dgr H302
H318 616-076-00-9 tebufenozide (ISO);
N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide 412-850-3 112410-23-8 Aquatic Chronic 2 H411 GHS09 H411 616-077-00-4 reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate 411-310-4 — Eye Dam. 1 H318 GHS05
Dgr H318 616-078-00-X 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide 411-330-3 104541-33-5 Aquatic Chronic 4 H413 — H413 616-079-00-5 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate 411-700-4 140921-24-0 Skin Sens. 1 H317 GHS07
Wng H317 616-080-00-0 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) 411-850-0 119018-29-0 Aquatic Chronic 3 H412 — H412 616-081-00-6 5-bromo-8-naphtholactam 413-480-5 24856-00-6 Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H317
H400
H410 GHS07
GHS09
Wng H302
H317
H410 616-082-00-1 N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide 413-200-1 129604-78-0 Skin Sens. 1 H317 GHS07
Wng H317 616-083-00-7 [2-[(4-nitrophenyl)amino]ethyl]urea 410-700-1 27080-42-8 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 616-084-00-2 2,4-bis[N'-(4-methylphenyl)ureido]toluene 411-790-5 — Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-085-00-8 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione 412-190-6 168900-02-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-086-00-3 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene 412-250-1 102387-48-4 Aquatic Chronic 4 H413 — H413 616-087-00-9 reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate 412-260-6 52658-19-2 Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H319
H317
H411 GHS07
GHS09
Wng H319
H317
H411 616-088-00-4 2-aminosulfonyl-N,N-dimethylnicotinamide 413-440-7 112006-75-4 Skin Sens. 1
Aquatic Chronic 3 H317
H412 GHS07
Wng H317
H412 616-089-00-X 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran 415-360-8 41107-56-6 Muta. 2 H341 GHS08
Wng H341 616-090-00-5 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride 415-660-9 70918-74-0 Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2 H331
H311
H301
H373 **
H411 GHS06
GHS08
GHS09
Dgr H331
H311
H301
H373 **
H411 616-091-00-0 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione 423-400-0 59653-74-6 Muta. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1 H340
H331
H302
H373 **
H318
H317 GHS06
GHS08
GHS05
Dgr H340
H331
H302
H373 **
H318
H317 616-092-00-6 Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide 404-035-6 — Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-093-00-1 Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride 406-620-1 129217-90-9 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 616-094-00-7 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea 406-370-3 58890-25-8 Skin Sens. 1
Aquatic Chronic 4 H317
H413 GHS07
Wng H317
H413 616-095-00-2 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-690-3 43136-14-7 Aquatic Chronic 4 H413 — H413 616-096-00-8 N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide 408-110-4 110483-07-3 Aquatic Chronic 4 H413 — H413 616-097-00-3 N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide 411-840-6 83372-55-8 Aquatic Chronic 4 H413 — H413 616-098-00-9 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide 411-750-7 119126-15-7 Aquatic Chronic 2 H411 GHS09 H411 616-099-00-4 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide 414-170-2 135937-20-1 Aquatic Chronic 4 H413 — H413 616-100-00-8 1,3-dimethyl-1,3-bis(trimethylsilyl)urea 414-180-7 10218-17-4 Acute Tox. 4 *
Skin Irrit. 2 H302
H315 GHS07
Wng H302
H315 616-101-00-3 (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide 414-600-9 149182-72-9 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 616-102-00-9 reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] 415-870-0 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 616-103-00-4 (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide 415-030-3 120298-38-6 Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H317
H400
H410 GHS07
GHS09
Wng H317
H410 616-104-00-X benalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate 275-728-7 71626-11-4 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-105-00-5 chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea 239-592-2 15545-48-9 Carc. 2
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1 H351
H361d ***
H400
H410 GHS08
GHS09
Wng H351
H361d ***
H410 616-106-00-0 phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate 237-199-0 13684-63-4 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-108-00-1 iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide — 144550-36-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-109-00-7 sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea — 141776-32-1 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-110-00-2 cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid 419-150-7 113136-77-9 Acute Tox. 4 *
Aquatic Chronic 2 H302
H411 GHS07
GHS09
Wng H302
H411 616-111-00-8 fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid 422-530-5 126833-17-8 Aquatic Chronic 2 H411 GHS09 H411 616-112-00-3 oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate — 144651-06-9 STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1 H373 **
H400
H410 GHS08
GHS09
Wng H373 **
H410 616-113-00-9 desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate 237-198-5 13684-56-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 M=10 616-114-00-4 dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- 418-010-2 136897-58-0 Aquatic Chronic 4 H413 — H413 616-115-00-X N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide 416-150-9 136450-06-1 Aquatic Chronic 4 H413 — H413 616-116-00-5 N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate 416-790-9 143052-96-4 Aquatic Chronic 4 H413 — H413 616-117-00-0 N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide 416-860-9 777891-21-1 Repr. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H361f ***
H317
H400
H410 GHS08
GHS09
Wng H361f ***
H317
H410 616-118-00-6 N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride 417-950-0 65797-42-4 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 616-119-00-1 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide 418-060-5 118020-93-2 Aquatic Chronic 4 H413 — H413 616-120-00-7 reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide 420-600-1 — STOT RE 2 *
Aquatic Chronic 2 H373 **
H411 GHS08
GHS09
Wng H373 **
H411 616-121-00-2 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide 419-090-1 129205-19-2 Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 616-123-00-3 N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide 414-740-0 96141-86-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide 415-300-0 90076-65-6 Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 3 H311
H301
H314
H412 GHS06
GHS05
Dgr H311
H301
H314
H412 616-125-00-4 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide 415-730-9 151338-11-3 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng 410 616-127-00-5 reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide) 430-050-2 — Skin Sens. 1
Aquatic Chronic 2 H317
H411 GHS07
GHS09
Wng H317
H411 616-128-00-0 N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide 417-530-7 123590-00-1 Aquatic Chronic 4 H413 — H413 616-129-00-6 N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide 419-710-0 42774-15-2 Acute Tox. 4 *
Eye Irrit. 2 H302
H319 GHS07
Wng H302
H319 616-130-00-1 N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide 421-780-2 150919-56-5 Aquatic Chronic 4 H413 — H413 616-132-00-2 N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide 423-250-6 130016-98-7 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 616-133-00-8 N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide 423-990-1 149118-66-1 Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H318
H400
H410 GHS05
GHS07
GHS09
Dgr H302
H318
H410 616-134-00-3 3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide 401-820-5 793710-14-2 Aquatic Chronic 3 H412 — H412 616-135-00-9 (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide 430-230-0 136522-17-3 Acute Tox. 4 *
Aquatic Chronic 3 H302
H412 GHS07
Wng H302
H412 616-142-00-7 1,3-Bis(vinylsulfonylacetamido)propane 428-350-3 93629-90-4 Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3 H341
H318
H317
H412 GHS08
GHS05
GHS07
Dgr H341
H318
H317
H412 616-143-00-2 N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide 422-560-9 149591-38-8 Repr. 2
Eye Irrit. 2
Aquatic Chronic 4 H361f ***
H319
H413 GHS08
Wng H361f ***
H319
H413 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E
Flam. Liq. 2 H242
H225 GHS02
Dgr H242
H225 617-002-00-8 α, α-dimethylbenzyl hydroperoxide;
cumene hydroperoxide 201-254-7 80-15-9 Org. Perox. E
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 2 H242
H331
H312
H302
H373 **
H314
H411 GHS02
GHS06
GHS08
GHS05
GHS09
Dgr H242
H331
H312
H302
H373 **
H314
H411 Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Dam. 1; H318: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %
STOT SE 3; H335: C < 10 % 617-003-00-3 dilauroyl peroxide 203-326-3 105-74-8 Org. Perox. D H242 GHS02
Dgr H242 617-004-00-9 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide 212-230-0 771-29-9 Org. Perox. D
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1 H242
H302
H314
H400
H410 GHS02
GHS05
GHS07
GHS09
Dgr H242
H302
H314
H410 STOT SE 3; H335: C ≥ 5 % 617-006-00-X bis(α, α-dimethylbenzyl) peroxide 201-279-3 80-43-3 Org. Perox. F
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2 H242
H319
H315
H411 GHS02
GHS07
GHS09
Wng H242
H319
H315
H411 617-007-00-5 tert-butyl α, α-dimethylbenzyl peroxide 222-389-8 3457-61-2 Org. Perox. E Skin Irrit. 2
Aquatic Chronic 2 H242
H315
H411 GHS02
GHS07
GHS09
Wng H242
H315
H411 617-008-00-0 dibenzoyl peroxide;
benzoyl peroxide 202-327-6 94-36-0 Org. Perox. B
Eye Irrit. 2
Skin Sens. 1 H241
H319
H317 GHS01
GHS02
GHS07
Wng H241
H319
H317 T
617-010-00-1 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
[> 91 % solution] 201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4] 78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4] Org. Perox. A
Acute Tox. 4 *
Skin Corr. 1B H240
H302
H314 GHS01
GHS05
GHS07
Dgr H240
H302
H314 STOT SE 3; H335: C ≥ 5 % C T
617-010-01-9 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
[≤ 91 % solution] 201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4] 78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4] Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B H242
H302
H314 GHS02
GHS05
GHS07
Dgr H242
H302
H314 STOT SE 3; H335: C ≥ 5 % C T
617-012-00-2 8-p-menthyl hydroperoxide;
p-menthane hydroperoxide 201-281-4 80-47-7 Org. Perox. D
Skin Corr. 1B
Acute Tox. 4 * H242
H314
H332 GHS02
GHS05
GHS07
Dgr H242
H314
H332 STOT SE 3; H335: C ≥ 5 % 617-013-00-8 O,O-tert-butyl O-docosyl monoperoxyoxalate 404-300-6 116753-76-5 Org. Perox. C ****
Aquatic Acute 1
Aquatic Chronic 1 H242
H400
H410 GHS02
GHS09
Dgr H242
H410 617-014-00-3 6-(nonylamino)-6-oxo-peroxyhexanoic acid 406-680-9 104788-63-8 Org. Perox. C ****
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1 H242
H318
H317
H400 GHS02
GHS05
GHS07
GHS09
Dgr H242
H318
H317
H400 617-015-00-9 bis(4-methylbenzoyl)peroxide 407-950-9 895-85-2 Org. Perox. B ****
Aquatic Acute 1
Aquatic Chronic 1 H241
H400
H410 GHS01
GHS02
GHS09
Dgr H241
H410 617-016-00-4 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate 413-910-1 — Org. Perox. C ****
Flam. Liq. 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H242
H226
H315
H400
H410 GHS02
GHS07
GHS09
Dgr H242
H226
H315
H410 617-017-00-X reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene 412-140-3 32144-25-5 Org. Perox. D ****
Aquatic Chronic 4 H242
H413 GHS02
Dgr H242
H413 T
617-018-00-5 reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight 410-840-3 71566-50-2 Org. Perox. C ****
Aquatic Chronic 2 H242
H411 GHS02
GHS09
Dgr H242
H411 T
617-019-00-0 6-(phthalimido)peroxyhexanoic acid 410-850-8 128275-31-0 Org. Perox. D
Eye Dam. 1
Aquatic Acute 1 H242
H318
H400 GHS02
GHS05
GHS09
DgDgr H242
H318
H400 T
617-020-00-6 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) 420-060-5 117663-11-3 Flam. Liq. 3
Org. Perox. D ****
Aquatic Chronic 2 H226
H242
H411 GHS02
GHS09
Dgr H226
H242
H411 647-001-00-8 glucosidase, β- 232-589-7 9001-22-3 Resp. Sens. 1 H334 GHS08
Dgr H334 647-002-00-3 cellulase 232-734-4 9012-54-8 Resp. Sens. 1 H334 GHS08
Dgr H334 647-003-00-9 cellobiohydrolase, exo- 253-465-9 37329-65-0 Resp. Sens. 1 H334 GHS08
Dgr H334 647-004-00-4 cellulases with the exception of those specified elsewhere in this Annex — — Resp. Sens. 1 H334 GHS08
Dgr H334 A
647-005-00-X bromelain, juice 232-572-4 9001-00-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-006-00-5 ficin 232-599-1 9001-33-6 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-007-00-0 papain 232-627-2 9001-73-4 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-008-00-6 pepsin A 232-629-3 9001-75-6 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-009-00-1 rennin 232-645-0 9001-98-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-010-00-7 trypsin 232-650-8 9002-07-7 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-011-00-2 chymotrypsin 232-671-2 9004-07-3 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-012-00-8 subtilisin 232-752-2 9014-01-1 STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1 H335
H315
H318
H334 GHS08
GHS05 GHS07
Dgr H335
H315
H318
H334 647-013-00-3 proteinase, microbial neutral 232-966-6 9068-59-1 Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-014-00-9 proteases with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1 H319
H335
H315
H334 GHS08
GHS07
Dgr H319
H335
H315
H334 647-015-00-4 amylase, α- 232-565-6 9000-90-2 Resp. Sens. 1 H334 GHS08
Dgr H334 647-016-00-X amylases with the exception of those specified elsewhere in this Annex — — Resp. Sens. 1 H334 GHS08
Dgr H334 648-001-00-0 Distillates (coal tar), benzole fraction;
Light Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).] 283-482-7 84650-02-2 Carc. 1B H350 GHS08
Dgr H350 H
648-002-00-6 Tar oils, brown-coal;
Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] 302-674-4 94114-40-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-003-00-1 Benzol forerunnings (coal);
Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] 266-023-5 65996-88-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-004-00-7 Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] 309-984-9 101896-26-8 Carc. 1B H350 GHS08
Dgr H350 H J
648-005-00-2 Aromatic hydrocarbons, C6-10, C8-rich;
Light Oil Redistillate, low boiling 292-697-5 90989-41-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-006-00-8 Solvent naphtha (coal), light;
Light Oil Redistillate, low boiling 287-498-5 85536-17-0 Carc. 1B H350 GHS08
Dgr H350 H J
648-007-00-3 Solvent naphtha (coal), xylene-styrene cut;
Light Oil Redistillate, intermediate boiling 287-502-5 85536-20-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-008-00-9 Solvent naphtha (coal), coumarone-styrene contg.;
Light Oil Redistillate, intermediate boiling 287-500-4 85536-19-2 Carc. 1B H350 GHS08
Dgr H350 H J
648-009-00-4 Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] 292-636-2 90641-12-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-010-00-X Aromatic hydrocarbons, C8;
Light Oil Redistillate, high boiling 292-694-9 90989-38-1 Carc. 1B H350 GHS08
Dgr H350 H J
648-012-00-0 Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).] 295-281-1 91995-20-9 Carc. 1B H350 GHS08
Dgr H350 H J
648-013-00-6 Aromatic hydrocarbons, C9-12, benzene distn.;
Light Oil Redistillate, high boiling 295-551-9 92062-36-7 Carc. 1B H350 GHS08
Dgr H350 H J
648-014-00-1 Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.] 295-323-9 91995-61-8 Carc. 1B H350 GHS08
Dgr H350 H J
648-015-00-7 Extract residues (coal tar), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).] 309-868-8 101316-63-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-016-00-2 Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] 298-725-2 93821-38-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-017-00-8 Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] 292-625-2 90641-02-4 Carc. 1B H350 GHS08
Dgr H350 H J
648-018-00-3 Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling 309-867-2 101316-62-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-019-00-9 Extract residues (coal), light oil alk., indene naphtha fraction;
Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] 292-626-8 90641-03-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-020-00-4 Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] 266-013-0 65996-79-4 Carc. 1B H350 GHS08
Dgr H350 H J
648-021-00-X Distillates (coal tar), light oils, neutral fraction;
Light Oil Extract Residues, high boiling;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.] 309-971-8 101794-90-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-022-00-5 Distillates (coal tar), light oils, acid exts.;
Light Oil Extract Residues, high boiling;
[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).] 292-609-5 90640-87-2 Carc. 1B H350 GHS08
Dgr H350 H J
648-023-00-0 Distillates (coal tar), light oils;
Carbolic Oil;
[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).] 283-483-2 84650-03-3 Carc. 1B H350 GHS08
Dgr H350 H J
648-024-00-6 Tar oils, coal;
Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] 266-016-7 65996-82-9 Carc. 1B H350 GHS08
Dgr H350 H J
648-026-00-7 Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue;
[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] 292-624-7 90641-01-3 Carc. 1B H350 GHS08
Dgr H350 H J
648-027-00-2 Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue;
[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] 266-021-4 65996-87-4 Carc. 1B H350 GHS08
Dgr H350 H J
648-028-00-8 Extract oils (coal), light oil;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-622-6 90640-99-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-029-00-3 Pyridine, alkyl derivs.;
Crude Tar Bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] 269-929-9 68391-11-7 Carc. 1B H350 GHS08
Dgr H350 H J
648-030-00-9 Tar bases, coal, picoline fraction;
Distillate Bases;
[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] 295-548-2 92062-33-4 Carc. 1B H350 GHS08
Dgr H350 H J
648-031-00-4 Tar bases, coal, lutidine fraction;
Distillate Bases 293-766-2 91082-52-9 Carc. 1B H350 GHS08
Dgr H350 H J
648-032-00-X Extract oils (coal), tar base, collidine fraction;
Distillate Bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] 273-077-3 68937-63-3 Carc. 1B H350 GHS08
Dgr H350 H J
648-033-00-5 Tar bases, coal, collidine fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] 295-543-5 92062-28-7 Carc. 1B H350 GHS08
Dgr H350 H J
648-034-00-0 Tar bases, coal, aniline fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] 295-541-4 92062-27-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-035-00-6 Tar bases, coal, toluidine fraction;
Distillate Bases 293-767-8 91082-53-0 Carc. 1B H350 GHS08
Dgr H350 H J
648-036-00-1 Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).] 295-292-1 91995-31-2 Carc. 1B H350 GHS08
Dgr H350 H J
648-037-00-7 Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.] 295-295-8 91995-35-6 Carc. 1B H350 GHS08
Dgr H350 H J
648-038-00-2 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;
Redistillates;
[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] 295-329-1 91995-66-3 Carc. 1B H350 GHS08
Dgr H350 H J
648-039-00-8 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] 310-170-0 122070-79-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-040-00-3 Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;
Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] 310-171-6 122070-80-8 Carc. 1B H350 GHS08
Dgr H350 H J
648-041-00-9 Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).] 309-851-5 101316-45-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-042-00-4 Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] 284-900-0 84989-11-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-043-00-X Creosote oil, acenaphthene fraction, acenaphthene-free;
Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] 292-606-9 90640-85-0 Carc. 1B H350 GHS08
Dgr H350 H
648-044-00-5 Distillates (coal tar), heavy oils;
Heavy Anthracene Oil;
[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.] 292-607-4 90640-86-1 Carc. 1B H350 GHS08
Dgr H350 H
648-045-00-0 Distillates (coal tar), upper;
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] 266-026-1 65996-91-0 Carc. 1B H350 GHS08
Dgr H350 H M
648-046-00-6 Anthracene oil, acid ext.;
Anthracene Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] 295-274-3 91995-14-1 Carc. 1B H350 GHS08
Dgr H350 H M
648-047-00-1 Distillates (coal tar);
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] 266-027-7 65996-92-1 Carc. 1B H350 GHS08
Dgr H350 H M
648-048-00-7 Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] 295-312-9 91995-51-6 Carc. 1B H350 GHS08
Dgr H350 H M
648-049-00-2 Distillates (coal tar), pitch;
Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] 309-855-7 101316-49-8 Carc. 1B H350 GHS08
Dgr H350 H M
648-050-00-8 Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.] 295-304-5 91995-42-5 Carc. 1B H350 GHS08
Dgr H350 H M
648-051-00-3 Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.] 295-313-4 91995-52-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-052-00-9 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract;
[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-296-6 97926-76-6 Carc. 1B H350 GHS08
Dgr H350 H M
648-053-00-4 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-297-1 97926-77-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-054-00-X Pitch;
Pitch 263-072-4 61789-60-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-055-00-5 Pitch, coal tar, high-temp.;
Pitch;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. 1B H350 GHS08
Dgr H350 H
648-056-00-0 Pitch, coal tar, high-temp., heat-treated;
Pitch;
[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 310-162-7 121575-60-8 Carc. 1B H350 GHS08
Dgr H350 H M
648-057-00-6 Pitch, coal tar, high-temp., secondary;
Pitch Redistillate;
[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.] 302-650-3 94114-13-3 Carc. 1B H350 GHS08
Dgr H350 H M
648-058-00-1 Residues (coal tar), pitch distn.;
Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] 295-507-9 92061-94-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-059-00-7 Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] 295-535-1 92062-20-9 Carc. 1B H350 GHS08
Dgr H350 H M
648-060-00-2 Tar, coal, storage residues;
Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] 293-764-1 91082-50-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-061-00-8 Tar, coal, high-temp., residues;
Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] 309-726-5 100684-51-3 Carc. 1B H350 GHS08
Dgr H350 H M
648-062-00-3 Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] 273-615-7 68990-61-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-063-00-9 Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] 295-549-8 92062-34-5 Carc. 1B H350 GHS08
Dgr H350 H M
648-064-00-4 Extract residues (coal), brown;
Coal Tar Extract;
[The residue from extraction of dried coal.] 294-285-0 91697-23-3 Carc. 1B H350 GHS08
Dgr H350 H M
648-065-00-X Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-454-1 92045-71-1 Carc. 1B H350 GHS08
Dgr H350 H M
648-066-00-5 Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-455-7 92045-72-2 Carc. 1B H350 GHS08
Dgr H350 H M
648-067-00-0 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-298-7 97926-78-8 Carc. 1B H350 GHS08
Dgr H350 H M
648-068-00-6 Tar, coal, low-temp., distn. residues;
Tar Oil, intermediate boiling;
[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] 309-887-1 101316-85-2 Carc. 1B H350 GHS08
Dgr H350 H M
648-069-00-1 Pitch, coal tar, low-temp;
Pitch Residue;
[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-651-4 90669-57-1 Carc. 1B H350 GHS08
Dgr H350 H M
648-070-00-7 Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-654-0 90669-59-3 Carc. 1B H350 GHS08
Dgr H350 H M
648-071-00-2 Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised;
Pitch Residue, heat-treated;
[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.] 292-653-5 90669-58-2 Carc. 1B H350 GHS08
Dgr H350 H M
648-072-00-8 Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.] 269-159-3 68188-48-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-073-00-3 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-956-6 101794-74-5 Carc. 1B H350 GHS08
Dgr H350 H M
648-074-00-9 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-957-1 101794-75-6 Carc. 1B H350 GHS08
Dgr H350 H M
648-075-00-4 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-958-7 101794-76-7 Carc. 1B H350 GHS08
Dgr H350 H M
648-076-00-X Pitch, coal tar-petroleum;
Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] 269-109-0 68187-57-5 Carc. 1B H350 GHS08
Dgr H350 H M
648-077-00-5 Phenanthrene, distn. residues;
Heavy Anthracene Oil Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.] 310-169-5 122070-78-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-078-00-0 Distillates (coal tar), upper, fluorene-free;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] 284-899-7 84989-10-6 Carc. 1B H350 GHS08
Dgr H350 H M
648-079-00-6 Anthracene oil;
Anthracene oil;
[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.] 292-602-7 90640-80-5 Carc. 1B H350 GHS08
Dgr H350 H M
648-080-00-1 Residues (coal tar), creosote oil distn.;
Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.] 295-506-3 92061-93-3 Carc. 1B H350 GHS08
Dgr H350 H
648-081-00-7 Tar, coal;
Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.] 232-361-7 8007-45-2 Carc. 1A H350 GHS08
Dgr H350 H
648-082-00-2 Tar, coal, high-temp.;
Coal tar;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] 266-024-0 65996-89-6 Carc. 1A H350 GHS08
Dgr H350 H
648-083-00-8 Tar, coal, low-temp.;
Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] 266-025-6 65996-90-9 Carc. 1A H350 GHS08
Dgr H350 H
648-084-00-3 Distillates (coal), coke-oven light oil, naphthalene cut;
Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).] 285-076-5 85029-51-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-085-00-9 Distillates (coal tar), naphthalene oils;
Naphthalene Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).] 283-484-8 84650-04-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-086-00-4 Distillates (coal tar), naphthalene oils, naphthalene-low;
Naphthalene Oil Redistillate;
[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] 284-898-1 84989-09-3 Carc. 1B H350 GHS08
Dgr H350 HJM
648-087-00-X Distillates (coal tar), naphthalene oil crystn. mother liquor;
Naphthalene Oil Redistillate;
[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] 295-310-8 91995-49-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-088-00-5 Extract residues (coal), naphthalene oil, alk.;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] 310-166-9 121620-47-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-089-00-0 Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] 310-167-4 121620-48-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-090-00-6 Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] 292-612-1 90640-90-7 Carc. 1B H350 GHS08
Dgr H350 HJM
648-091-00-1 Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] 292-627-3 90641-04-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-092-00-7 Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).] 309-985-4 101896-27-9 Carc. 1B H350 GHS08
Dgr H350 HJM
648-093-00-2 Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] 309-972-3 101794-91-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-094-00-8 Distillates (coal tar), naphthalene oils, acid exts.;
Methylnaphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] 295-309-2 91995-48-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-095-00-3 Extract residues (coal), naphthalene oil alk., distn. residues;
Methylnaphthalene Oil Extract Residue;
[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] 292-628-9 90641-05-7 Carc. 1B H350 GHS08
Dgr H350 HJM
648-096-00-9 Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue;
[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] 284-901-6 84989-12-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-097-00-4 Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.] 310-165-3 121620-46-0 Carc. 1B H350 GHS08
Dgr H350 HJM
648-098-00-X Creosote oil, acenaphthene fraction;
Wash Oil;
[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] 292-605-3 90640-84-9 Carc. 1B H350 GHS08
Dgr H350 H
648-099-00-5 Creosote oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).] 263-047-8 61789-28-4 Carc. 1B H350 GHS08
Dgr H350 H
648-100-00-9 Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).] 274-565-9 70321-79-8 Carc. 1B H350 GHS08
Dgr H350 H
648-101-00-4 Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] 232-287-5 8001-58-9 Carc. 1B H350 GHS08
Dgr H350 H
648-102-00-X Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] 310-189-4 122384-77-4 Carc. 1B H350 GHS08
Dgr H350 H
648-103-00-5 Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] 292-603-2 90640-81-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-104-00-0 Anthracene oil, anthracene-low;
Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] 292-604-8 90640-82-7 Carc. 1B H350 GHS08
Dgr H350 HJM
648-105-00-6 Residues (coal tar), anthracene oil distn.;
Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.] 295-505-8 92061-92-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-106-00-1 Anthracene oil, anthracene paste, anthracene fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-275-9 91995-15-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-107-00-7 Anthracene oil, anthracene paste, carbazole fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.] 295-276-4 91995-16-3 Carc. 1B H350 GHS08
Dgr H350 HJM
648-108-00-2 Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] 295-278-5 91995-17-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-109-00-8 Tar oils, coal, low-temp.;
Tar Oil, high boiling;
[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).] 309-889-2 101316-87-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-110-00-3 Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] 310-191-5 122384-78-5 Carc. 1B H350 GHS08
Dgr H350 HJM
648-111-00-9 Phenols, ammonia liquor ext.;
Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.] 284-881-9 84988-93-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-112-00-4 Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-610-0 90640-88-3 Carc. 1B H350 GHS08
Dgr H350 HJM
648-113-00-X Extracts, coal tar oil alk.;
Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 266-017-2 65996-83-0 Carc. 1B H350 GHS08
Dgr H350 HJM
648-114-00-5 Distillates (coal tar), naphthalene oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.] 292-611-6 90640-89-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-115-00-0 Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols;
[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] 292-629-4 90641-06-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-116-00-6 Tar acids, coal, crude;
Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] 266-019-3 65996-85-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-117-00-1 Tar acids, brown-coal, crude;
Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] 309-888-7 101316-86-3 Carc. 1B H350 GHS08
Dgr H350 HJM
648-118-00-7 Tar acids, brown-coal gasification;
Crude Phenols;
[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] 295-536-7 92062-22-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-119-00-2 Tar acids, distn. residues;
Distillate Phenols;
[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).] 306-251-5 96690-55-0 Carc. 1B H350 GHS08
Dgr H350 HJM
648-120-00-8 Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-892-9 84989-04-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-121-00-3 Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.] 284-893-4 84989-05-9 Carc. 1B H350 GHS08
Dgr H350 HJM
648-122-00-9 Tar acids, xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-895-5 84989-06-0 Carc. 1B H350 GHS08
Dgr H350 HJM
648-123-00-4 Tar acids, ethylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-891-3 84989-03-7 Carc. 1B H350 GHS08
Dgr H350 HJM
648-124-00-X Tar acids, 3,5-xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] 284-896-0 84989-07-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-125-00-5 Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.] 270-713-1 68477-23-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-126-00-0 Tar acids, cresylic, residues;
Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.] 271-418-0 68555-24-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-127-00-6 Phenols, C9-11;
Distillate Phenols 293-435-2 91079-47-9 Carc. 1B H350 GHS08
Dgr H350 HJM
648-128-00-1 Tar acids, cresylic;
Distillate Phenols;
[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.] 295-540-9 92062-26-5 Carc. 1B H350 GHS08
Dgr H350 HJM
648-129-00-7 Tar acids, brown-coal, C2-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.] 302-662-9 94114-29-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-130-00-2 Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-623-1 90641-00-2 Carc. 1B H350 GHS08
Dgr H350 HJM
648-131-00-8 Tar bases, quinoline derivs.;
Distillate Bases 271-020-7 68513-87-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-132-00-3 Tar bases, coal, quinoline derivs. fraction;
Distillate Bases 274-560-1 70321-67-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-133-00-9 Tar bases, coal, distn. residues;
Distillate Bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] 295-544-0 92062-29-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-134-00-4 Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] 309-745-9 100801-63-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-135-00-X Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).] 309-748-5 100801-65-8 Carc. 1B H350 GHS08
Dgr H350 HJM
648-136-00-5 Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).] 309-749-0 100801-66-9 Carc. 1B H350 GHS08
Dgr H350 HJM
648-137-00-0 Extract residues (coal), tar oil alk., naphthalene distn. residues;
Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] 277-567-8 73665-18-6 Carc. 1B H350 GHS08
Dgr H350 HJM
648-138-00-6 Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).] 274-566-4 70321-80-1 Carc. 1B H350 GHS08
Dgr H350 H
648-139-00-1 Tar acids, cresylic, sodium salts, caustic solns.;
Alkaline Extract 272-361-4 68815-21-4 Carc. 1B H350 GHS08
Dgr H350 HJM
648-140-00-7 Extract oils (coal), tar base;
Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] 266-020-9 65996-86-3 Carc. 1B H350 GHS08
Dgr H350 HJM
648-141-00-2 Tar bases, coal, crude;
Crude Tar Bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] 266-018-8 65996-84-1 Carc. 1B H350 GHS08
Dgr H350 HJM
648-142-00-8 Residues (coal), liq. solvent extn.;
[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] 302-681-2 94114-46-2 Carc. 1B H350 GHS08
Dgr H350 H M
648-143-00-3 Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] 302-682-8 94114-47-3 Carc. 1B H350 GHS08
Dgr H350 H M
648-144-00-9 Coal liquids, liq. solvent extn.;
[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] 302-683-3 94114-48-4 Carc. 1B H350 GHS08
Dgr H350 H M
648-145-00-4 Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).] 309-885-0 101316-83-0 Carc. 1A H350 GHS08
Dgr H350 H
648-146-00-X Tar, brown-coal, low-temp.;
[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] 309-886-6 101316-84-1 Carc. 1A H350 GHS08
Dgr H350 H
648-147-00-5 Light oil (coal), coke-oven;
Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] 266-012-5 65996-78-3 Carc. 1B H350 GHS08
Dgr H350 H J
648-148-00-0 Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] 302-688-0 94114-52-0 Carc. 1B H350 GHS08
Dgr H350 H J
648-149-00-6 Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-689-6 94114-53-1 Carc. 1B H350 GHS08
Dgr H350 H J
648-150-00-1 Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-690-1 94114-54-2 Carc. 1B H350 GHS08
Dgr H350 H J
648-151-00-7 Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] 302-691-7 94114-55-3 Carc. 1B H350 GHS08
Dgr H350 H
648-152-00-2 Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] 302-692-2 94114-56-4 Carc. 1B H350 GHS08
Dgr H350 H J
648-153-00-8 Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] 302-693-8 94114-57-5 Carc. 1B H350 GHS08
Dgr H350 H J
648-154-00-3 Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. 2 H351 GHS08
Wng H350 H
648-155-00-9 Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;
[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] 302-695-9 94114-59-7 Carc. 2 H351 GHS08
Wng H350 H
648-156-00-4 Light oil (coal), semi-coking process;
Fresh oil;
[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] 292-635-7 90641-11-5 Carc. 1B H350 GHS08
Dgr H350 H J
649-001-00-3 Extracts (petroleum), light naphthenic distillate solvent 265-102-1 64742-03-6 Carc. 1B H350 GHS08
Dgr H350 H
649-002-00-9 Extracts (petroleum), heavy paraffinic distillate solvent 265-103-7 64742-04-7 Carc. 1B H350 GHS08
Dgr H350 H
649-003-00-4 Extracts (petroleum), light paraffinic distillate solvent 265-104-2 64742-05-8 Carc. 1B H350 GHS08
Dgr H350 H
649-004-00-X Extracts (petroleum), heavy naphthenic distillate solvent 265-111-0 64742-11-6 Carc. 1B H350 GHS08
Dgr H350 H
649-005-00-5 Extracts (petroleum), light vacuum gas oil solvent 295-341-7 91995-78-7 Carc. 1B H350 GHS08
Dgr H350 H
649-006-00-0 hydrocarbons C26-55, arom-rich 307-753-7 97722-04-8 Carc. 1B H350 GHS08
Dgr H350 H
649-007-00-6 fatty acids, tall-oil, reaction products with iminodiethanol and boric acid 400-160-5 — Skin Irrit. 2
Aquatic Chronic 2 H315
H411 GHS07
GHS09
Wng H315
H411 649-008-00-1 Residues (petroleum), atm. tower;
Heavy Fuel oil;
[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-045-2 64741-45-3 Carc. 1B H350 GHS08
Dgr H350 H
649-009-00-7 Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-058-3 64741-57-7 Carc. 1B H350 GHS08
Dgr H350 H
649-010-00-2 Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-063-0 64741-61-3 Carc. 1B H350 GHS08
Dgr H350 H
649-011-00-8 Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-064-6 64741-62-4 Carc. 1B H350 GHS08
Dgr H350 H
649-012-00-3 Residues (petroleum), hydrocracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).] 265-076-1 64741-75-9 Carc. 1B H350 GHS08
Dgr H350 H
649-013-00-9 Residues (petroleum), thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-081-9 64741-80-6 Carc. 1B H350 GHS08
Dgr H350 H
649-014-00-4 Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-082-4 64741-81-7 Carc. 1B H350 GHS08
Dgr H350 H
649-015-00-X Gas oils (petroleum), hydrotreated vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-162-9 64742-59-2 Carc. 1B H350 GHS08
Dgr H350 H
649-016-00-5 Residues (petroleum), hydrodesulfurized atmospheric tower;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-181-2 64742-78-5 Carc. 1B H350 GHS08
Dgr H350 H
649-017-00-0 Gas oils (petroleum), hydrodesulfurized heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-189-6 64742-86-5 Carc. 1B H350 GHS08
Dgr H350 H
649-018-00-6 Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-193-8 64742-90-1 Carc. 1B H350 GHS08
Dgr H350 H
649-019-00-1 Residues (petroleum), atmospheric;
Heavy Fuel oil;
[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-777-3 68333-22-2 Carc. 1B H350 GHS08
Dgr H350 H
649-020-00-7 Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-782-0 68333-26-6 Carc. 1B H350 GHS08
Dgr H350 H
649-021-00-2 Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 269-783-6 68333-27-7 Carc. 1B H350 GHS08
Dgr H350 H
649-022-00-8 Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 269-784-1 68333-28-8 Carc. 1B H350 GHS08
Dgr H350 H
649-023-00-3 Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil 270-674-0 68476-32-4 Carc. 1B H350 GHS08
Dgr H350 H
649-024-00-9 Fuel oil, residual;
Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] 270-675-6 68476-33-5 Carc. 1B H350 GHS08
Dgr H350 H
649-025-00-4 Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).] 270-792-2 68478-13-7 Carc. 1B H350 GHS08
Dgr H350 H
649-026-00-X Residues (petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-796-4 68478-17-1 Carc. 1B H350 GHS08
Dgr H350 H
649-027-00-5 Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-983-0 68512-61-8 Carc. 1B H350 GHS08
Dgr H350 H
649-028-00-0 Residues (petroleum), light vacuum;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-984-6 68512-62-9 Carc. 1B H350 GHS08
Dgr H350 H
649-029-00-6 Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).] 271-013-9 68513-69-9 Carc. 1B H350 GHS08
Dgr H350 H
649-030-00-1 Fuel oil, No 6;
Heavy Fuel oil;
[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] 271-384-7 68553-00-4 Carc. 1B H350 GHS08
Dgr H350 H
649-031-00-7 Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] 271-763-7 68607-30-7 Carc. 1B H350 GHS08
Dgr H350 H
649-032-00-2 Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).] 272-184-2 68783-08-4 Carc. 1B H350 GHS08
Dgr H350 H
649-033-00-8 Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;
Heavy Fuel oil;
[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.] 272-187-9 68783-13-1 Carc. 1B H350 GHS08
Dgr H350 H
649-034-00-3 Distillates (petroleum), petroleum residues vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] 273-263-4 68955-27-1 Carc. 1B H350 GHS08
Dgr H350 H
649-035-00-9 Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[A complex residuum from the distillation of steam-cracked petroleum residues.] 273-272-3 68955-36-2 Carc. 1B H350 GHS08
Dgr H350 H
649-036-00-4 Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-683-0 70592-76-6 Carc. 1B H350 GHS08
Dgr H350 H
649-037-00-X Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).] 274-684-6 70592-77-7 Carc. 1B H350 GHS08
Dgr H350 H
649-038-00-5 Distillates (petroleum), vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-685-1 70592-78-8 Carc. 1B H350 GHS08
Dgr H350 H
649-039-00-0 Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 285-555-9 85117-03-9 Carc. 1B H350 GHS08
Dgr H350 H
649-040-00-6 Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] 292-657-7 90669-75-3 Carc. 1B H350 GHS08
Dgr H350 H
649-041-00-1 Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] 292-658-2 90669-76-4 Carc. 1B H350 GHS08
Dgr H350 H
649-042-00-7 Fuel oil, heavy, high-sulfur;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 295-396-7 92045-14-2 Carc. 1B H350 GHS08
Dgr H350 H
649-043-00-2 Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).] 295-511-0 92061-97-7 Carc. 1B H350 GHS08
Dgr H350 H
649-044-00-8 Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] 295-990-6 92201-59-7 Carc. 1B H350 GHS08
Dgr H350 H
649-045-00-3 Residual oils (petroleum);
Heavy Fuel oil;
[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] 298-754-0 93821-66-0 Carc. 1B H350 GHS08
Dgr H350 H
649-046-00-9 Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).] 308-733-0 98219-64-8 Carc. 1B H350 GHS08
Dgr H350 H
649-047-00-4 Distillates (petroleum), hydrodesulfurized full-range middle;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).] 309-863-0 101316-57-8 Carc. 1B H350 GHS08
Dgr H350 H
649-048-00-X Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.] 265-069-3 64741-67-9 Carc. 1B H350 GHS08
Dgr H350 H
649-049-00-5 Petroleum;
Crude oil;
[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. 1B H350 GHS08
Dgr H350 H
649-050-00-0 Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] 265-051-5 64741-50-0 Carc. 1A H350 GHS08
Dgr H350 H
649-051-00-6 Distillates (petroleum), heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] 265-052-0 64741-51-1 Carc. 1A H350 GHS08
Dgr H350 H
649-052-00-1 Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-053-6 64741-52-2 Carc. 1A H350 GHS08
Dgr H350 H
649-053-00-7 Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-054-1 64741-53-3 Carc. 1A H350 GHS08
Dgr H350 H
649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-117-3 64742-18-3 Carc. 1A H350 GHS08
Dgr H350 H
649-055-00-8 Distillates (petroleum), acid-treated light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-118-9 64742-19-4 Carc. 1A H350 GHS08
Dgr H350 H
649-056-00-3 Distillates (petroleum), acid-treated heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).] 265-119-4 64742-20-7 Carc. 1A H350 GHS08
Dgr H350 H
649-057-00-9 Distillates (petroleum), acid-treated light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-121-5 64742-21-8 Carc. 1A H350 GHS08
Dgr H350 H
649-058-00-4 Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] 265-127-8 64742-27-4 Carc. 1A H350 GHS08
Dgr H350 H
649-059-00-X Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-128-3 64742-28-5 Carc. 1A H350 GHS08
Dgr H350 H
649-060-00-5 Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-135-1 64742-34-3 Carc. 1A H350 GHS08
Dgr H350 H
649-061-00-0 Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-136-7 64742-35-4 Carc. 1A H350 GHS08
Dgr H350 H
649-062-00-6 Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] 270-755-0 68477-73-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-063-00-1 Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-756-6 68477-74-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-064-00-7 Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] 270-757-1 68477-75-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-065-00-2 Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] 270-758-7 68477-76-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-066-00-8 Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] 270-760-8 68477-79-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-067-00-3 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] 270-765-5 68477-83-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-068-00-9 Gases (petroleum), C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-767-6 68477-85-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-069-00-4 Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] 270-768-1 68477-86-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-070-00-X Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-769-7 68477-87-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-071-00-5 Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.] 270-772-3 68477-90-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-072-00-0 Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-773-9 68477-91-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-073-00-6 Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] 270-777-0 68477-94-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-074-00-1 Gases (petroleum), Girbatol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-778-6 68477-95-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-075-00-7 Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas 270-782-8 68477-99-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-076-00-2 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-802-5 68478-21-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-077-00-8 Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-803-0 68478-22-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-078-00-3 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] 270-804-6 68478-24-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-079-00-9 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-806-7 68478-26-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-080-00-4 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] 270-813-5 68478-32-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-081-00-X Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.] 270-814-0 68478-33-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-082-00-5 Tail gas (petroleum), vacuum residues thermal cracker;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-815-6 68478-34-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-083-00-0 Hydrocarbons, C3-4-rich, petroleum distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] 270-990-9 68512-91-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-084-00-6 Gases (petroleum), full-range straight-run naphtha dehexanizer off;
petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-000-8 68513-15-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-085-00-1 Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] 271-001-3 68513-16-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-086-00-7 Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-002-9 68513-17-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-087-00-2 Residues (petroleum), alkylation splitter, C4-rich;
Petroleum gas;
[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).] 271-010-2 68513-66-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-088-00-8 Hydrocarbons, C1-4;
Petroleum gas;
[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (- 263 oF to 31 oF).] 271-032-2 68514-31-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-089-00-3 Hydrocarbons, C1-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).] 271-038-5 68514-36-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-090-00-9 Hydrocarbons, C1-3;
Petroleum gas;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (- 263 oF to - 44 oF).] 271-259-7 68527-16-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-091-00-4 Hydrocarbons, C1-4, debutanizer fraction;
Petroleum gas 271-261-8 68527-19-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-092-00-X Gases (petroleum), C1-5, wet;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 271-624-0 68602-83-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-093-00-5 Hydrocarbons, C2-4;
Petroleum gas 271-734-9 68606-25-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-094-00-0 Hydrocarbons, C3;
Petroleum gas 271-735-4 68606-26-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-095-00-6 Gases (petroleum), alkylation feed;
Petroleum gas;
[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 271-737-5 68606-27-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-096-00-1 Gases (petroleum), depropanizer bottoms fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] 271-742-2 68606-34-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-097-00-7 Gases (petroleum), refinery blend;
Petroleum gas;
[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-183-7 68783-07-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-098-00-2 Gases (petroleum), catalytic cracking;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 272-203-4 68783-64-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-099-00-8 Gases (petroleum), C2-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).] 272-205-5 68783-65-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-100-00-1 Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-871-7 68918-99-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-101-00-7 Gases (petroleum), dehexanizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-872-2 68919-00-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-102-00-2 Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-878-5 68919-05-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-103-00-8 Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-879-0 68919-06-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-104-00-3 Gases (petroleum), straight-run naphtha catalytic reforming off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] 272-882-7 68919-09-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-105-00-9 Gases (petroleum), fluidized catalytic cracker splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.] 272-893-7 68919-20-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-106-00-4 Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-883-2 68919-10-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-107-00-X Gases (petroleum), catalytic cracked naphtha debutanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-169-3 68952-76-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-108-00-5 Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-170-9 68952-77-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-110-00-6 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-176-1 68952-82-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-111-00-1 Gases (petroleum, light steam-cracked, butadiene conc.;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.] 273-265-5 68955-28-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-112-00-7 Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 273-270-2 68955-34-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-113-00-2 Hydrocarbons, C4;
Petroleum gas 289-339-5 87741-01-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-114-00-8 Alkanes, C1-4, C3-rich;
Petroleum gas 292-456-4 90622-55-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-115-00-3 Gases (petroleum), steam-cracker C3-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (- 94 oF to 32 oF).] 295-404-9 92045-22-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-116-00-9 Hydrocarbons, C4, steam-cracker distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).] 295-405-4 92045-23-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-117-00-4 Petroleum gases, liquefied, sweetened, C4 fraction;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] 295-463-0 92045-80-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 HKSU
649-118-00-X Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;
Petroleum gas 306-004-1 95465-89-7 Flam. Gas 1
Press. Gas
Carc. 1B H220
H350 GHS02
GHS04
GHS08
Dgr H220
H350 H K U
649-119-00-5 Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;
Petroleum gas 307-769-4 97722-19-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-120-00-0 Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] 270-746-1 68477-65-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-121-00-6 Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] 270-747-7 68477-66-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-122-00-1 Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.] 270-748-2 68477-67-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-123-00-7 Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-749-8 68477-68-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-124-00-2 Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-759-2 68477-77-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-125-00-8 Gases (petroleum), C6-8 catalytic reformer recycle;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-761-3 68477-80-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-126-00-3 Gases (petroleum), C6-8 catalytic reformer;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] 270-762-9 68477-81-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-127-00-9 Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;
Refinery gas 270-763-4 68477-82-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-128-00-4 Gases (petroleum), C2-return stream;
Refinery gas;
[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] 270-766-0 68477-84-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-129-00-X Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-774-4 68477-92-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-130-00-5 Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.] 270-776-5 68477-93-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-131-00-0 Gases (petroleum), hydrogen absorber off;
Refinery gas;
[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] 270-779-1 68477-96-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-132-00-6 Gases (petroleum), hydrogen-rich;
Refinery gas;
[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] 270-780-7 68477-97-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-133-00-1 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-781-2 68477-98-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-134-00-7 Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 270-783-3 68478-00-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-135-00-2 Gases (petroleum), reformer make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-784-9 68478-01-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-136-00-8 Gases (petroleum), reforming hydrotreater;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.] 270-785-4 68478-02-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-137-00-3 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] 270-787-5 68478-03-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-138-00-9 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-788-0 68478-04-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-139-00-4 Gases (petroleum), thermal cracking distn.;
Refinery gas;
[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-789-6 68478-05-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber;
Refinery gas;
[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-141-00-5 Tail gas (petroleum), catalytic reformed naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-807-2 68478-27-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-142-00-0 Tail gas (petroleum), catalytic reformed naphtha stabilizer;
Refinery gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-808-8 68478-28-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-143-00-6 Tail gas (petroleum), cracked distillate hydrotreater separator;
Refinery gas;
[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-809-3 68478-29-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-144-00-1 Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-810-9 68478-30-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-145-00-7 Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] 270-999-8 68513-14-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-146-00-2 Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-003-4 68513-18-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-147-00-8 Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-005-5 68513-19-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-148-00-3 Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] 271-258-1 68527-15-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-149-00-9 Gases (petroleum), benzene unit hydrotreater depentanizer overheads;
Refinery gas;
[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] 271-623-5 68602-82-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-150-00-4 Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;
Refinery gas;
[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 271-625-6 68602-84-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-151-00-X Petroleum products, refinery gases;
Refinery gas;
[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-750-6 68607-11-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-152-00-5 Gases (petroleum), hydrocracking low-pressure separator;
Refinery gas;
[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-182-1 68783-06-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-153-00-0 Gases (petroleum), refinery;
Refinery gas;
[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-338-9 68814-67-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-154-00-6 Gases (petroleum), platformer products separator off;
Refinery gas;
[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 272-343-6 68814-90-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-155-00-1 Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] 272-775-5 68911-58-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-156-00-7 Gases (petroleum), hydrotreated sour kerosine flash drum;
Refinery gas;
[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.] 272-776-0 68911-59-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-157-00-2 Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] 272-873-8 68919-01-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-158-00-8 Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-874-3 68919-02-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-159-00-3 Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] 272-875-9 68919-03-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-160-00-9 Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5]. 272-876-4 68919-04-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-161-00-4 Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.] 272-880-6 68919-07-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-162-00-X Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-881-1 68919-08-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-163-00-5 Gases (petroleum), tar stripper off;
Refinery gas;
[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-884-8 68919-11-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-164-00-0 Gases (petroleum), unifiner stripper off;
Refinery gas;
[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] 272-885-3 68919-12-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-165-00-6 Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] 273-173-5 68952-79-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-166-00-1 Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;
Refinery gas;
[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 273-174-0 68952-80-7 Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-167-00-7 Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-269-7 68955-33-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-169-00-8 Gases (petroleum), gas oil diethanolamine scrubber off;
Refinery gas;
[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 295-397-2 92045-15-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-170-00-3 Gases (petroleum), gas oil hydrodesulfurization effluent;
Refinery gas;
[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 295-398-8 92045-16-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-171-00-9 Gases (petroleum), gas oil hydrodesulfurization purge;
Refinery gas;
[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 295-399-3 92045-17-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-172-00-4 Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 295-400-7 92045-18-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-173-00-X Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] 295-401-2 92045-19-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-174-00-5 Gases (petroleum), residue visbaking off;
Refinery gas;
[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 295-402-8 92045-20-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-175-00-0 Foots oil (petroleum), acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-225-7 93924-31-3 Flam. Gas 1
Press. Gas
Carc. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-176-00-6 Foots oil (petroleum), clay-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-226-2 93924-32-4 Flam. Gas 1
Press. Gas
Carc. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-177-00-1 Gases (petroleum), C3-4;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60oF to 30 oF.)] 268-629-5 68131-75-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-178-00-7 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;
Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-617-2 68307-98-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-179-00-2 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-618-8 68307-99-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-180-00-8 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-619-3 68308-00-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-181-00-3 Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-620-9 68308-01-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-182-00-9 Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-630-3 68308-10-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-183-00-4 Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-623-5 68308-03-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-184-00-X Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-624-0 68308-04-3 Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-185-00-5 Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.] 269-625-6 68308-05-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-186-00-0 Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-626-1 68308-06-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-187-00-6 Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-627-7 68308-07-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-188-00-1 Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-629-8 68308-09-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-189-00-7 Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-631-9 68308-11-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-190-00-2 Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-632-4 68308-12-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-191-00-8 Gases (petroleum), catalytic cracked overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (- 54 oF to 90 oF).] 270-071-2 68409-99-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-193-00-9 Alkanes, C1-2;
Petroleum gas 270-651-5 68475-57-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-194-00-4 Alkanes, C2-3;
Petroleum gas 270-652-0 68475-58-1 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-195-00-X Alkanes, C3-4;
Petroleum gas 270-653-6 68475-59-2 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-196-00-5 Alkanes, C4-5;
Petroleum gas 270-654-1 68475-60-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-197-00-0 Fuel gases;
Petroleum gas;
[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] 270-667-2 68476-26-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-198-00-6 Fuel gases, crude oil of distillates;
Petroleum gas;
[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).] 270-670-9 68476-29-9 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-199-00-1 Hydrocarbons, C3-4;
Petroleum gas 270-681-9 68476-40-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-200-00-5 Hydrocarbons, C4-5;
Petroleum gas 270-682-4 68476-42-6 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-201-00-0 Hydrocarbons, C2-4, C3-rich;
Petroleum gas 270-689-2 68476-49-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-202-00-6 Petroleum gases, liquefied;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-704-2 68476-85-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 HKSU
649-203-00-1 Petroleum gases, liquefied, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-705-8 68476-86-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 HKSU
649-204-00-7 Gases (petroleum), C3-4, isobutane-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] 270-724-1 68477-33-8 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-205-00-2 Distillates (petroleum), C3-6, piperylene-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] 270-726-2 68477-35-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-206-00-8 Gases (petroleum), butane splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-750-3 68477-69-0 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-207-00-3 Gases (petroleum), C2-;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] 270-751-9 68477-70-3 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-208-00-9 Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-752-4 68477-71-4 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-209-00-4 Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-754-5 68477-72-5 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-210-00-X Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-628-2 68308-08-7 Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B H220
H350
H340 GHS02
GHS04
GHS08
Dgr H220
H350
H340 H K U
649-211-00-5 Foots oil (petroleum), carbon-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-126-0 97862-76-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-212-00-0 Distillates (petroleum), sweetened middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-088-7 64741-86-2 Carc. 1B H350 GHS08
Dgr H350 H N
649-213-00-6 Gas oils (petroleum), solvent-refined;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-092-9 64741-90-8 Carc. 1B H350 GHS08
Dgr H350 H N
649-214-00-1 Distillates (petroleum), solvent-refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-093-4 64741-91-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-215-00-7 Gas oils (petroleum), acid-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-112-6 64742-12-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-216-00-2 Distillates (petroleum), acid-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-113-1 64742-13-8 Carc. 1B H350 GHS08
Dgr H350 H N
649-217-00-8 Distillates (petroleum), acid-treated light;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-114-7 64742-14-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-218-00-3 Gas oils (petroleum), chemically neutralized;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-129-9 64742-29-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-219-00-9 Distillates (petroleum), chemically neutralized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-130-4 64742-30-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-220-00-4 Distillates (petroleum), clay-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-139-3 64742-38-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-221-00-X Distillates (petroleum), hydrotreated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-148-2 64742-46-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-222-00-5 Gas oils (petroleum), hydrodesulfurized;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-182-8 64742-79-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-223-00-0 Distillates (petroleum), hydrodesulfurized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-183-3 64742-80-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-224-00-6 Fuels, diesel;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).] 269-822-7 68334-30-5 Carc. 2 H351 GHS08
Wng H351 H N
649-225-00-1 Fuel oil, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).] 270-671-4 68476-30-2 Carc. 2 H351 GHS08
Wng H351 H
649-226-00-7 Fuel oil, No 4;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] 270-673-5 68476-31-3 Carc. 2 H351 GHS08
Wng H351 H
649-227-00-2 Fuels, diesel, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] 270-676-1 68476-34-6 Carc. 2 H351 GHS08
Wng H351 H
649-228-00-8 Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).] 270-719-4 68477-29-2 Carc. 1B H350 GHS08
Dgr H350 H N
649-229-00-3 Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).] 270-721-5 68477-30-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-230-00-9 Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil — unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).] 270-722-0 68477-31-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-231-00-4 Distillates (petroleum), highly refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] 292-615-8 90640-93-0 Carc. 1B H350 GHS08
Dgr H350 H N
649-232-00-X Distillates (petroleum) catalytic reformer, heavy arom. conc.;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 295-294-2 91995-34-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-233-00-5 Gas oils, paraffinic;
Gasoil — unspecified;
[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).] 300-227-8 93924-33-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-234-00-0 Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil — unspecified 307-035-3 97488-96-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-235-00-6 Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-659-6 97675-85-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-236-00-1 Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-660-1 97675-86-0 Carc. 1B H350 GHS08
Dgr H350 H N
649-237-00-7 Hydrocarbons, C11-17, solvent-extd. light naphthenic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 307-757-9 97722-08-2 Carc. 1B H350 GHS08
Dgr H350 H N
649-238-00-2 Gas oils, hydrotreated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).] 308-128-1 97862-78-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-239-00-8 Distillates (petroleum), carbon-treated light paraffinic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] 309-667-5 100683-97-4 Carc. 1B H350 GHS08
Dgr H350 H N
649-240-00-3 Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-668-0 100683-98-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-241-00-9 Distillates (petroleum), intermediate paraffinic, clay-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-669-6 100683-99-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-242-00-4 Alkanes, C12-26-branched and linear 292-454-3 90622-53-0 Carc. 1B H350 GHS08
Dgr H350 H N
649-243-00-X Lubricating greases;
Grease;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] 278-011-7 74869-21-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-244-00-5 Slack wax (petroleum);
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 265-165-5 64742-61-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-245-00-0 Slack wax (petroleum), acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 292-659-8 90669-77-5 Carc. 1B H350 GHS08
Dgr H350 H N
649-246-00-6 Slack wax (petroleum), clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] 292-660-3 90669-78-6 Carc. 1B H350 GHS08
Dgr H350 H N
649-247-00-1 Slack wax (petroleum), hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 295-523-6 92062-09-4 Carc. 1B H350 GHS08
Dgr H350 H N
649-248-00-7 Slack wax (petroleum), low-melting;
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-524-1 92062-10-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-249-00-2 Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-525-7 92062-11-8 Carc. 1B H350 GHS08
Dgr H350 H N
649-250-00-8 Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-155-9 97863-04-2 Carc. 1B H350 GHS08
Dgr H350 H N
649-251-00-3 Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-156-4 97863-05-3 Carc. 1B H350 GHS08
Dgr H350 H N
649-252-00-9 Slack wax (petroleum), low-melting, silicic acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-158-5 97863-06-4 Carc. 1B H350 GHS08
Dgr H350 H N
649-253-00-4 Slack wax (petroleum), carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] 309-723-9 100684-49-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-254-00-X Petrolatum;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 232-373-2 8009-03-8 Carc. 1B H350 GHS08
Dgr H350 H N
649-255-00-5 Petrolatum (petroleum), oxidized;
Petrolatum;
[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] 265-206-7 64743-01-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-256-00-0 Petrolatum (petroleum), alumina-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 285-098-5 85029-74-9 Carc. 1B H350 GHS08
Dgr H350 H N
649-257-00-6 Petrolatum (petroleum), hydrotreated;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] 295-459-9 92045-77-7 Carc. 1B H350 GHS08
Dgr H350 H N
649-258-00-1 Petrolatum (petroleum), carbon-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-149-6 97862-97-0 Carc. 1B H350 GHS08
Dgr H350 H N
649-259-00-7 Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-150-1 97862-98-1 Carc. 1B H350 GHS08
Dgr H350 H N
649-260-00-2 Petrolatum (petroleum), clay-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] 309-706-6 100684-33-1 Carc. 1B H350 GHS08
Dgr H350 H N
649-261-00-8 Gasoline, natural;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (- 4 oF to 248 oF).] 232-349-1 8006-61-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-262-00-3 Naphtha;
Low boiling point naphtha;
[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]] 232-443-2 8030-30-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-263-00-9 Ligroine;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).] 232-453-7 8032-32-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-264-00-4 Naphtha (petroleum), heavy straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-041-0 64741-41-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-265-00-X Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (- 4 oF to 428 oF).] 265-042-6 64741-42-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-266-00-5 Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-046-8 64741-46-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-267-00-0 Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).] 265-192-2 64742-89-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-268-00-6 Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (- 127 oF to 210 oF).] 270-077-5 68410-05-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-269-00-1 Gasoline, vapor-recovery;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).] 271-025-4 68514-15-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-270-00-7 Gasoline, straight-run, topping-plant;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).] 271-727-0 68606-11-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-271-00-2 Naphtha (petroleum), unsweetened;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).] 272-186-3 68783-12-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-272-00-8 Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;
Low boiling point naphtha;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..] 272-931-2 68921-08-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-273-00-3 Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 309-945-6 101631-20-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-274-00-9 Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-066-7 64741-64-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-275-00-4 Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).] 265-067-2 64741-65-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-276-00-X Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).] 265-068-8 64741-66-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-277-00-5 Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] 265-073-5 64741-70-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-278-00-0 Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 265-086-6 64741-84-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-279-00-6 Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-095-5 64741-92-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-280-00-1 Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] 270-088-5 68410-71-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-281-00-7 Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] 270-349-3 68425-35-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-282-00-2 Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] 271-267-0 68527-27-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-283-00-8 Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] 295-315-5 91995-53-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-284-00-3 Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-430-0 92045-49-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-285-00-9 Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).] 295-436-3 92045-55-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-286-00-4 Naphtha (petroleum), isomerization, C6-fraction;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).] 295-440-5 92045-58-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-287-00-X Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).] 295-446-8 92045-64-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-288-00-5 Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).] 309-871-4 101316-67-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-289-00-0 Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-055-7 64741-54-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-290-00-6 Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-056-2 64741-55-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-291-00-1 Hydrocarbons, C3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).] 270-686-6 68476-46-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-292-00-7 Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-185-8 68783-09-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-293-00-2 Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;
Low boiling point cat-cracked naphtha.;
[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.] 295-311-3 91995-50-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-294-00-8 Naphtha (petroleum), heavy catalytic cracked, sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).] 295-431-6 92045-50-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-295-00-3 Naphtha (petroleum), light catalytic cracked sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-441-0 92045-59-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-296-00-9 Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 295-794-0 92128-94-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-297-00-4 Hydrocarbons, C8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).] 309-974-4 101794-97-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-298-00-X Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;
Low boiling point cat-cracked naphtha 309-987-5 101896-28-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-299-00-5 Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]] 265-065-1 64741-63-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-300-00-9 Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-070-9 64741-68-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-301-00-4 Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).] 270-660-4 68475-79-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-302-00-X Hydrocarbons, C2-6, C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha 270-687-1 68476-47-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-303-00-5 Residues (petroleum), C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha';
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 270-794-3 68478-15-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-304-00-0 Naphtha (petroleum), light catalytic reformed, arom.-free;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] 270-993-5 68513-03-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-305-00-6 Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-008-1 68513-63-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-306-00-1 Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).] 271-058-4 68514-79-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-307-00-7 Naphtha (petroleum, full-range reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 272-895-8 68919-37-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-308-00-2 Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.] 273-271-8 68955-35-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-309-00-8 Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).] 285-509-8 85116-58-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-310-00-3 Aromatic hydrocarbons, C8, catalytic reforming-derived;
Low boiling point cat-reformed naphtha 295-279-0 91995-18-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-311-00-9 Aromatic hydrocarbons, C7-12, C8-rich;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).] 297-401-8 93571-75-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-312-00-4 Gasoline, C5-11, high-octane stabilized reformed;
Low boiling point cat-reformed naphtha;
[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).] 297-458-9 93572-29-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-313-00-X Hydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.] 297-465-7 93572-35-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-314-00-5 Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.] 297-466-2 93572-36-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-315-00-0 Foots oil (petroleum), silicic acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-127-6 97862-77-6 Carc. 1B H350
H304 GHS08
Dgr H350
H304 H L
649-316-00-6 Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).] 265-075-6 64741-74-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-317-00-1 Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).] 265-085-0 64741-83-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-318-00-7 Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] 267-563-4 67891-79-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-319-00-2 Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] 267-565-5 67891-80-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-320-00-8 Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).] 270-344-6 68425-29-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-321-00-3 Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;
Low boiling point thermally cracked naphtha;
A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] 270-658-3 68475-70-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-322-00-9 Distillates (petroleum), thermal cracked naphtha and gas oil;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).] 271-631-9 68603-00-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-323-00-4 Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).] 271-632-4 68603-01-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-324-00-X Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).] 271-634-5 68603-03-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-325-00-5 Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] 273-266-0 68955-29-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-326-00-0 Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).] 295-447-3 92045-65-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-327-00-6 Naphtha (petroleum), hydrotreated heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-150-3 64742-48-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-328-00-1 Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-151-9 64742-49-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-329-00-7 Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-178-6 64742-73-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-330-00-2 Naphtha (petroleum), hydrodesulfurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-185-4 64742-82-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-331-00-8 Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).] 270-092-7 68410-96-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-332-00-3 Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).] 270-093-2 68410-97-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-333-00-9 Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).] 270-094-8 68410-98-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-334-00-4 Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 270-988-8 68512-78-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-335-00-X Naphtha (petroleum), hydrodesulfurized thermal cracked light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).] 285-511-9 85116-60-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-336-00-5 Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 285-512-4 85116-61-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-337-00-0 Naphtha (petroleum), heavy steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha 295-432-1 92045-51-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-338-00-6 Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).] 295-433-7 92045-52-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-339-00-1 Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 295-438-4 92045-57-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-340-00-7 Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).] 295-443-1 92045-61-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-341-00-2 Solvent naphtha (petroleum), hydrotreated light naphthenic;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).] 295-529-9 92062-15-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-342-00-8 Naphtha (petroleum), light steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha;
[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.] 296-942-7 93165-55-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-343-00-3 Hydrocarbons, C6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-852-0 93763-33-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-344-00-9 Hydrocarbons, C9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-853-6 93763-34-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-345-00-4 Stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.] 232-489-3 8052-41-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-346-00-X Natural gas condensates (petroleum);
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] 265-047-3 64741-47-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-347-00-5 Natural gas (petroleum), raw liq. mix;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] 265-048-9 64741-48-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-348-00-0 Naphtha (petroleum), light hydrocracked;
Low boiling naphtha — unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-071-4 64741-69-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-349-00-6 Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).] 265-079-8 64741-78-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-350-00-1 Naphtha (petroleum), sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).] 265-089-2 64741-87-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-351-00-7 Naphtha (petroleum), acid-treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-115-2 64742-15-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-352-00-2 Naphtha (petroleum), chemically neutralized heavy;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-122-0 64742-22-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-353-00-8 Naphtha (petroleum), chemically neutralized light;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-123-6 64742-23-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-354-00-3 Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 265-170-2 64742-66-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-355-00-9 Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.] 265-187-5 64742-83-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-356-00-4 Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 265-199-0 64742-95-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-357-00-X Aromatic hydrocarbons, C6-10, acid-treated, neutralized;
Low boiling point naphtha — unspecified 268-618-5 68131-49-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-358-00-5 Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] 270-725-7 68477-34-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-359-00-0 Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]] 270-735-1 68477-50-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-360-00-6 Distillates (petroleum), steam-cracked, C5-12 fraction;
Low boiling point naphtha — unspecified;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-736-7 68477-53-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-361-00-1 Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;
Low boiling point naphtha — unspecified 270-738-8 68477-55-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-362-00-7 Extracts (petroleum), cold-acid, C4-6;
Low boiling point naphtha — unspecified;
[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 270-741-4 68477-61-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-363-00-2 Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-771-8 68477-89-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-364-00-8 Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha — unspecified;
[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-791-7 68478-12-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-365-00-3 Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha — unspecified;
[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-795-9 68478-16-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-366-00-9 Naphtha (petroleum), full-range coker;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).] 270-991-4 68513-02-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-367-00-4 Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).]] 271-138-9 68516-20-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-368-00-X Naphtha (petroleum), clay-treated full-range straight-run;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).] 271-262-3 68527-21-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-369-00-5 Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.] 271-263-9 68527-22-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-370-00-0 Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).] 271-264-4 68527-23-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-371-00-6 Naphtha (petroleum), light steam-cracked, debenzenized;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).] 271-266-5 68527-26-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-372-00-1 Naphtha (petroleum), arom.-contg.;
Low boiling point naphtha — unspecified 271-635-0 68603-08-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-373-00-7 Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] 271-726-5 68606-10-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-374-00-2 Naphtha (petroleum), light, sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).] 272-206-0 68783-66-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-375-00-8 Natural gas condensates;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] 272-896-3 68919-39-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H J
649-376-00-3 Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 272-932-8 68921-09-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-377-00-9 Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).] 285-510-3 85116-59-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-378-00-4 Gasoline;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).] 289-220-8 86290-81-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-379-00-X Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;
Low boiling point naphtha — unspecified 292-698-0 90989-42-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-380-00-5 Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).] 295-298-4 91995-38-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-381-00-0 Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 295-302-4 91995-41-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-382-00-6 Extracts (petroleum), catalytic reformed light naphtha solvent;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 295-331-2 91995-68-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-383-00-1 Naphtha (petroleum), hydrodesulfurized light, dearomatized;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).] 295-434-2 92045-53-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-384-00-7 Naphtha (petroleum), light, C5-rich, sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).] 295-442-6 92045-60-8 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-385-00-2 Hydrocarbons, C8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).] 295-444-7 92045-62-0 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-386-00-8 Hydrocarbons, C4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).] 295-445-2 92045-63-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-387-00-3 Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.] 296-028-8 92201-97-3 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-388-00-9 Distillates (petroleum), C6-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).] 296-903-4 93165-19-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-389-00-4 Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha — unspecified;
[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).] 302-639-3 94114-03-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-390-00-X Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 305-750-5 95009-23-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-391-00-5 Extracts (petroleum) heavy naphtha solvent, clay-treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).] 308-261-5 97926-43-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-392-00-0 Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).] 308-713-1 98219-46-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-393-00-6 Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).] 308-714-7 98219-47-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-394-00-1 Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).] 309-862-5 101316-56-7 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-395-00-7 Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).] 309-870-9 101316-66-9 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-396-00-2 Naphtha (petroleum), hydrodesulfurized full-range coker;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).] 309-879-8 101316-76-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-397-00-8 Naphtha (petroleum), sweetened light;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).] 309-976-5 101795-01-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-398-00-3 Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] 310-012-0 102110-14-5 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-399-00-9 Hydrocarbons, C5-rich, dicyclopentadiene-contg.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).] 310-013-6 102110-15-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-400-00-2 Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).] 310-057-6 102110-55-4 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-401-00-8 Hydrocarbons, C≥ 5, C5-6-rich;
Low boiling point naphtha — unspecified 270-690-8 68476-50-6 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-402-00-3 Hydrocarbons, C5-rich;
Low boiling point naphtha — unspecified 270-695-5 68476-55-1 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-403-00-9 Aromatic hydrocarbons, C8-10;
Low boiling point naphtha — unspecified 292-695-4 90989-39-2 Carc. 1B
Asp. Tox. 1 H350
H304 GHS08
Dgr H350
H304 H P
649-404-00-4 Kerosine (petroleum);
Straight run kerosine;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).] 232-366-4 8008-20-6 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-405-00-X Solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).] 265-191-7 64742-88-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-406-00-5 Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] 265-200-4 64742-96-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-407-00-0 Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] 295-418-5 92045-37-9 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-408-00-6 Distillates (petroleum), steam-cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] 265-194-3 64742-91-2 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-409-00-1 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).] 270-728-3 68477-39-4 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-410-00-7 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] 270-729-9 68477-40-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-411-00-2 Distillates (petroleum), steam-cracked, C8-12 fraction;
Cracked kerosine;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 270-737-2 68477-54-3 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-412-00-8 Kerosine (petroleum), hydrodesulfurized thermal cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).] 285-507-7 85116-55-8 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-413-00-3 Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] 292-621-0 90640-98-5 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-414-00-9 Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).] 292-637-8 90641-13-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-415-00-4 Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.] 309-866-7 101316-61-4 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-416-00-X Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-938-8 101631-13-4 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-417-00-5 Solvent naphtha (petroleum), hydrocracked heavy arom.;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] 309-881-9 101316-80-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-418-00-0 Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-940-9 101631-15-6 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-419-00-6 Distillates (petroleum), alkylate;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).] 265-074-0 64741-73-7 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-420-00-1 Extracts (petroleum), heavy naphtha solvent;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-099-7 64741-98-6 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-421-00-7 Distillates (petroleum), chemically neutralized light;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-132-5 64742-31-0 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-422-00-2 Distillates (petroleum), hydrotreated light;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-149-8 64742-47-8 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-423-00-8 Kerosine (petroleum), hydrodesulfurized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-184-9 64742-81-0 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-424-00-3 Solvent naphtha (petroleum), heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] 265-198-5 64742-94-5 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-425-00-9 Naphtha (petroleum), heavy coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] 269-778-9 68333-23-3 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-426-00-4 Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).] 285-508-2 85116-57-0 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-427-00-X Kerosine (petroleum), sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] 294-799-5 91770-15-9 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-428-00-5 Kerosine (petroleum), solvent-refined sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] 295-416-4 92045-36-8 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-429-00-0 Hydrocarbons, C9-16, hydrotreated, dearomatized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-854-1 93763-35-0 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-430-00-6 Kerosine (petroleum), solvent-refined hydrodesulfurized;
Kerosine — unspecified 307-033-2 97488-94-3 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-431-00-1 Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] 309-864-6 101316-58-9 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-432-00-7 Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] 309-882-4 101316-81-8 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-433-00-2 Solvent naphtha (petroleum), hydrodesulfurized medium;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] 309-884-5 101316-82-9 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-434-00-8 Kerosine (petroleum), hydrotreated;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] 309-944-0 101631-19-0 Asp. Tox. 1 H304 GHS08
Dgr H304 H
649-435-00-3 Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 265-060-4 64741-59-9 Carc. 1B H350 GHS08
Dgr H350 H
649-436-00-9 Distillates (petroleum), intermediate catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 265-062-5 64741-60-2 Carc. 1B H350 GHS08
Dgr H350 H
649-437-00-4 Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).] 265-078-2 64741-77-1 Carc. 2 H351 GHS08
Wng H351 H
649-438-00-X Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).] 265-084-5 64741-82-8 Carc. 1B H350 GHS08
Dgr H350 H
649-439-00-5 Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 269-781-5 68333-25-5 Carc. 1B H350 GHS08
Dgr H350 H
649-440-00-0 Distillates (petroleum), light steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] 270-662-5 68475-80-9 Carc. 1B H350 GHS08
Dgr H350 H
649-441-00-6 Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] 270-727-8 68477-38-3 Carc. 1B H350 GHS08
Dgr H350 H
649-442-00-1 Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] 271-260-2 68527-18-4 Carc. 1B H350 GHS08
Dgr H350 H
649-443-00-7 Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 285-505-6 85116-53-6 Carc. 1B H350 GHS08
Dgr H350 H
649-444-00-2 Gas oils (petroleum), thermal-cracked, hydrodesulfurized;
Cracked gasoil 295-411-7 92045-29-9 Carc. 1B H350 GHS08
Dgr H350 H
649-445-00-8 Residues (petroleum), hydrogenated steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).] 295-514-7 92062-00-5 Carc. 1B H350 GHS08
Dgr H350 H
649-446-00-3 Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] 295-517-3 92062-04-9 Carc. 1B H350 GHS08
Dgr H350 H
649-447-00-9 Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.] 295-991-1 92201-60-0 Carc. 1B H350 GHS08
Dgr H350 H
649-448-00-4 Residues (petroleum), steam-cracked heat-soaked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] 297-905-8 93763-85-0 Carc. 1B H350 GHS08
Dgr H350 H
649-449-00-X Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] 307-662-2 97675-88-2 Carc. 2 H351 GHS08
Wng H351 H
649-450-00-5 Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] 308-278-8 97926-59-5 Carc. 1B H350 GHS08
Dgr H350 H
649-451-00-0 Distillates (petroleum), hydrodesulfurized middle coker;
Cracked gasoil;
[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] 309-865-1 101316-59-0 Carc. 1B H350 GHS08
Dgr H350 H
649-452-00-6 Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] 309-939-3 101631-14-5 Carc. 1B H350 GHS08
Dgr H350 H
649-453-00-1 Distillates (petroleum), heavy hydrocracked;
Baseoil — unspecified;
[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] 265-077-7 64741-76-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-454-00-7 Distillates (petroleum), solvent-refined heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-090-8 64741-88-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-455-00-2 Distillates (petroleum), solvent-refined light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-091-3 64741-89-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-456-00-8 Residual oils (petroleum), solvent deasphalted;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-096-0 64741-95-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-457-00-3 Distillates (petroleum), solvent-refined heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] 265-097-6 64741-96-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-458-00-9 Distillates (petroleum), solvent-refined light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-098-1 64741-97-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-459-00-4 Residual oils (petroleum,) solvent-refined;
Baseoil — unspecified;
[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-101-6 64742-01-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-460-00-X Distillates (petroleum), clay-treated paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-137-2 64742-36-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-461-00-5 Distillates (petroleum), clay-treated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-138-8 64742-37-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-462-00-0 Residual oils (petroleum), clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-143-5 64742-41-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-463-00-6 Distillates (petroleum), clay-treated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-146-1 64742-44-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-464-00-1 Distillates (petroleum), clay-treated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-147-7 64742-45-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-465-00-7 Distillates (petroleum), hydrotreated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-155-0 64742-52-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-466-00-2 Distillates (petroleum), hydrotreated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-156-6 64742-53-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-467-00-8 Distillates (petroleum), hydrotreated heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-157-1 64742-54-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-468-00-3 Distillates (petroleum), hydrotreated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-158-7 64742-55-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-469-00-9 Distillates (petroleum), solvent-dewaxed light paraffinic;
Baseoil — unspecified;
[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-159-2 64742-56-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-470-00-4 Residual oils (petroleum), hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-160-8 64742-57-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-471-00-X Residual oils (petroleum), solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-166-0 64742-62-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-472-00-5 Distillates (petroleum), solvent-dewaxed heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-167-6 64742-63-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-473-00-0 Distillates (petroleum), solvent-dewaxed light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-168-1 64742-64-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-474-00-6 Distillates (petroleum), solvent-dewaxed heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-169-7 64742-65-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-475-00-1 Naphthenic oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-172-3 64742-68-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-476-00-7 Naphthenic oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-173-9 64742-69-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-477-00-2 Paraffin oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-174-4 64742-70-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-478-00-8 Paraffin oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-176-5 64742-71-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-479-00-3 Naphthenic oils (petroleum), complex dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-179-1 64742-75-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-480-00-9 Naphthenic oils (petroleum), complex dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-180-7 64742-76-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-481-00-4 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-736-3 72623-85-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-482-00-X Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] 276-737-9 72623-86-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-483-00-5 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-738-4 72623-87-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-484-00-0 Lubricating oils;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] 278-012-2 74869-22-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-485-00-6 Distillates (petroleum), complex dewaxed heavy paraffinci;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-613-7 90640-91-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-486-00-1 Distillates (petroleum), complex dewaxed light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-614-2 90640-92-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-487-00-7 Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-616-3 90640-94-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-488-00-2 Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-617-9 90640-95-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-489-00-8 Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-618-4 90640-96-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-490-00-3 Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-620-5 90640-97-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-491-00-9 Residual oils (petroleum), hydrotreated solvent dewaxed;
Baseoil — unspecified 292-656-1 90669-74-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-492-00-4 Residual oils (petroleum), catalytic dewaxed;
Baseoil — unspecified 294-843-3 91770-57-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-493-00-X Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] 295-300-3 91995-39-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-494-00-5 Distillates (petroleum), dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] 295-301-9 91995-40-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-495-00-0 Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
Baseoil — unspecified;
[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] 295-306-6 91995-45-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-496-00-6 Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] 295-316-0 91995-54-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-497-00-1 Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;
Baseoil — unspecified 295-423-2 92045-42-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-498-00-7 Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
Baseoil — unspecified 295-424-8 92045-43-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-499-00-2 Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] 295-499-7 92061-86-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-500-00-6 Paraffin oils (petroleum), solvent-refined dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] 295-810-6 92129-09-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-501-00-1 Lubricating oils (petroleum), base oils, paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] 297-474-6 93572-43-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-502-00-7 Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
Baseoil — unspecified 297-857-8 93763-38-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-503-00-2 Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;
Baseoil — unspecified 300-257-1 93924-61-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-504-00-8 Distillates (petroleum), solvent-refined hydrotreated heavy;
hydrogenated;
Baseoil — unspecified 305-588-5 94733-08-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-505-00-3 Distillates (petroleum), solvent-refined hydrocracked light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).] 305-589-0 94733-09-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-506-00-9 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-594-8 94733-15-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-507-00-4 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-595-3 94733-16-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-508-00-X Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified 305-971-7 95371-04-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-509-00-5 Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified 305-972-2 95371-05-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-510-00-0 Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
Baseoil — unspecified 305-974-3 95371-07-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-511-00-6 Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;
Baseoil — unspecified 305-975-9 95371-08-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-512-00-1 Distillates (petroleum), hydrocracked solvent-refined light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.] 307-010-7 97488-73-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-513-00-7 Distillates (petroleum), solvent-refined hydrogenated heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).] 307-011-2 97488-74-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-514-00-2 Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;
Baseoil — unspecified 307-034-8 97488-95-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-515-00-8 Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).] 307-661-7 97675-87-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-516-00-3 Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] 307-755-8 97722-06-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-517-00-9 Hydrocarbons, C13-27, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).] 307-758-4 97722-09-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-518-00-4 Hydrocarbons, C14-29, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] 307-760-5 97722-10-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-519-00-X Hydrocarbons, C27-42, dearomatized;
Baseoil — unspecified 308-131-8 97862-81-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-520-00-5 Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;
Baseoil — unspecified 308-132-3 97862-82-3 Carc. 1B H350 GHS08
Dgr H350 H L
649-521-00-0 Hydrocarbons, C27-45, naphthenic vacuum distn.;
Baseoil — unspecified 308-133-9 97862-83-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-522-00-6 Hydrocarbons, C27-45, dearomatized;
Baseoil — unspecified 308-287-7 97926-68-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-523-00-1 Hydrocarbons, C20-58, hydrotreated;
Baseoil — unspecified 308-289-8 97926-70-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-524-00-7 Hydrocarbons, C27-42, naphthenic;
Baseoil — unspecified 308-290-3 97926-71-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-525-00-2 Residual oils (petroleum), carbon-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] 309-710-8 100684-37-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-526-00-8 Residual oils (petroleum), clay-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] 309-711-3 100684-38-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-527-00-3 Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] 309-874-0 101316-69-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-528-00-9 Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] 309-875-6 101316-70-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-529-00-4 Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] 309-876-1 101316-71-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-530-00-X Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] 309-877-7 101316-72-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-531-00-5 Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] 272-175-3 68783-00-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-532-00-0 Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 272-180-0 68783-04-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-533-00-6 Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] 272-342-0 68814-89-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-534-00-1 Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] 292-631-5 90641-07-9 Carc. 1B H350 GHS08
Dgr H350 H L
649-535-00-7 Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF). 292-632-0 90641-08-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-536-00-2 Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).] 292-633-6 90641-09-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-537-00-8 Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 295-335-4 91995-73-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-538-00-3 Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 295-338-0 91995-75-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-539-00-9 Extracts (petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 295-339-6 91995-76-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-540-00-4 Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] 295-340-1 91995-77-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-541-00-X Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 295-342-2 91995-79-8 Carc. 1B H350 GHS08
Dgr H350 H L
649-542-00-5 Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] 296-437-1 92704-08-0 Carc. 1B H350 GHS08
Dgr H350 H L
649-543-00-0 Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-827-4 93763-10-1 Carc. 1B H350 GHS08
Dgr H350 H L
649-544-00-6 Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-829-5 93763-11-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-545-00-1 Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-672-2 100684-02-4 Carc. 1B H350 GHS08
Dgr H350 H L
649-546-00-7 Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-673-8 100684-03-5 Carc. 1B H350 GHS08
Dgr H350 H L
649-547-00-2 Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-674-3 100684-04-6 Carc. 1B H350 GHS08
Dgr H350 H L
649-548-00-8 Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-675-9 100684-05-7 Carc. 1B H350 GHS08
Dgr H350 H L
649-549-00-3 Foots oil (petroleum);
Foots oil;
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 265-171-8 64742-67-2 Carc. 1B H350 GHS08
Dgr H350 H L
649-550-00-9 Foots oil (petroleum), hydrotreated;
Foots oil 295-394-6 92045-12-0 Carc. 1B H350 GHS08
Dgr H350 H L
650-002-00-6 turpentine, oil 232-350-7 8006-64-2 Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2 H226
H332
H312
H302
H304
H319
H315
H317
H411 GHS02
GHS08
GHS07
GHS09
Dgr H226
H332
H312
H302
H304
H319
H315
H317
H411 650-003-00-1 fenson (ISO);
4-chlorophenyl benzenesulphonate; 201-274-6 80-38-6 Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2 H302
H319
H411 GHS07
GHS09
Wng H302
H319
H411 650-004-00-7 norbormide (ISO);
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide 213-589-6 991-42-4 Acute Tox. 4 * H302 GHS07
Wng H302 650-005-00-2 (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone 201-501-9 83-79-4 Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1 H301
H319
H335
H315
H400
H410 GHS06
GHS09
Dgr H301
H319
H335
H315
H410 650-006-00-8 benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime 207-807-9 495-73-8 Acute Tox. 3 *
Acute Tox. 4 * H301
H312 GHS06
Dgr H301
H312 650-007-00-3 chlordimeform (ISO);
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine 228-200-5 6164-98-3 Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H312
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H312
H302
H410 650-008-00-9 drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone 227-197-8 5707-69-7 Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1 H301
H400
H410 GHS06
GHS09
Dgr H301
H410 650-009-00-4 chlordimeform hydrochloride;
N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride 243-269-1 19750-95-9 Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H351
H302
H400
H410 GHS08
GHS07
GHS09
Wng H351
H302
H410 650-010-00-X benzyl violet 4B;
α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate 216-901-9 1694-09-3 Carc. 2 H351 GHS08
Wng H351 650-012-00-0 erionite — 12510-42-8 Carc. 1A H350 GHS08
Dgr H350 650-013-00-6 asbestos —
—
—
—
—
—
— 12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5 Carc. 1A
STOT RE 1 H350
H372 ** GHS08
Dgr H350
H372 ** 650-014-00-1 diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate 401-770-4 — Skin Corr. 1B
Acute Tox. 4 * H314
H302 GHS05
GHS07
Dgr H314
H302 650-015-00-7 rosin;
colophony 232-475-7
232-484-6
277-299-1 8050-09-7
8052-10-6
73138-82-6 Skin Sens. 1 H317 GHS07
Wng H317 650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] — — Carc. 2
Skin Irrit. 2 H351
H315 GHS08
GHS07
Wng H351
H315 AQR
650-017-00-8 Refractory Ceramic Fibres;
Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] — — Carc. 1B
Skin Irrit. 2 H350i
H315 GHS08
GHS07
Dgr H350i
H315 A R
650-018-00-3 Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid 406-230-1 — Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H226
H351
H314
H332
H317
H400
H410 GHS02
GHS08
GHS05 GHS07
GHS09
Dgr H226
H351
H314
H332
H317
H410 650-031-00-4 bis(4-hydroxy-N-methylanilinium) sulphate 200-237-1 55-55-0 Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H302
H373 **
H317
H400
H410 GHS08
GHS07
GHS09
Wng H302
H373 **
H317
H410 650-032-00-X cyproconazole (ISO);
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol — 94361-06-5 Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H361d ***
H302
H400
H410 GHS08
GHS07 GHS09
Wng H361d ***
H302
H410 650-033-00-5 (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;
esfenvalerate — 66230-04-4 Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H331
H301
H317
H400
H410 GHS06
GHS09
Dgr H331
H301
H317
H410 650-041-00-9 triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea — 82097-50-5 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 650-042-00-4 reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates 417-450-2 — Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3 H319
H315
H317
H412 GHS07
Wng H319
H315
H317
H412 650-043-00-X reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate 420-310-3 — Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1 H302
H400
H410 GHS07
GHS09
Wng H302
H410 650-044-00-5 mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin 420-480-9 158570-99-1 Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H317
H400
H410 GHS07
GHS09
Wng H315
H317
H410 650-045-00-0 reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate 417-110-3 — Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2 H225
H315
H318
H411 GHS02
GHS05
GHS09
Dgr H225
H315
H318
H411 650-046-00-6 di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates 416-180-2 12222-04-7 Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2 H302
H373 **
H411 GHS08
GHS07
GHS09
Wng H302
H373 **
H411 650-047-00-1 dibenzylphenylsulfonium hexafluoroantimonate 417-760-8 134164-24-2 STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2 H372 **
H302
H318
H317
H411 GHS08
GHS05 GHS07
GHS09
Dgr H372 **
H302
H318
H317
H411 650-048-00-7 reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid 420-070-1 — Org. Perox. D ****
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1 H242
H332
H312
H302
H314
H400 GHS02
GHS05 GHS07
GHS09
Dgr H242
H332
H312
H302
H314
H400 650-049-00-2 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl 417-960-5 — Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1 H315
H318
H317
H400
H410 GHS05 GHS07
GHS09
Dgr H315
H318
H317
H410 650-050-00-8 reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8 — Aquatic Chronic 2 H411 GHS09 H411 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 Aquatic Acute 1
Aquatic Chronic 1 H400
H410 GHS09
Wng H410 Table 3.2
The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC
Index No International Chemical Identification EC No CAS No Classification Labelling Concentration Limits Notes
001-001-00-9 hydrogen 215-605-7 1333-74-0 F+; R12 F+
R: 12
S: (2-)9-16-33 001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 F; R15 F
R: 15
S: (2-)7/8-24/25-43 001-003-00-X sodium hydride 231-587-3 7646-69-7 F; R15 F
R: 15
S: (2-)7/8-24/25-43 001-004-00-5 calcium hydride 232-189-2 7789-78-8 F; R15 F
R: 15
S: (2-)7/8-24/25-43 003-001-00-4 lithium 231-102-5 7439-93-2 F; R15
R14
C; R34 F; C
R: 14/15-34
S: (1/2-)8-43-45 003-002-00-X n-hexyllithium 404-950-0 21369-64-2 F; R15-17
R14
C; R35 F; C
R: 14/15-17-35
S: (1/2-)6-16-26-30-36/37/39-43-45 004-001-00-7 beryllium 231-150-7 7440-41-7 Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43 T+
R: 49-25-26-36/37/38-43-48/23
S: 53-45 E
004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex — — Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43
N; R51-53 T+; N
R: 49-25-26-36/37/38-43-48/23-51/53
S: 53-45-61 AE
004-003-00-8 beryllium oxide 215-133-1 1304-56-9 Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43 T+
R: 49-25-26-36/37/38-43-48/23
S: 53-45 E
005-001-00-X boron trifluoride 231-569-5 7637-07-2 R14
T+; R26
C; R35 T+; C
R: 14-26-35
S: (1/2-)9-26-28-36/37/39-45 005-002-00-5 boron trichloride 233-658-4 10294-34-5 R14
T+; R26/28
C; R34 T+
R: 14-26/28-34
S: (1/2-)9-26-28-36/37/39-45 005-003-00-0 boron tribromide 233-657-9 10294-33-4 R14
T+; R26/28
C; R35 T+; C
R: 14-26/28-35
S: (1/2-)9-26-28-36/37/39-45 005-004-00-6 trialkylboranes — — F; R17
C; R34 F; C
R: 17-34
S: (1/2-)7-23-26-36/37/39-43-45 A
005-005-00-1 trimethyl borate 204-468-9 121-43-7 R10
Xn; R21 Xn
R: 10-21
S: (2-)23-25 005-006-00-7 dibutyltin hydrogen borate 401-040-5 75113-37-0 T; R48/25
Xn; R21/22
Xi; R41
R43
N; R50-53 T; N
R: 21/22-41-43-48/25-50/53
S: (1/2-)22-26-36/37-45-60-61 005-009-00-3 tetrabutylammonium butyltriphenylborate 418-080-4 120307-06-4 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-56-61 005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 422-050-6 118612-00-3 Carc. Cat. 3; R40
Xn; R22
Xi; R38-41 Xn
R: 22-38-40-41
S: (2-)22-26-36/37/39 005-012-00-X diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate 418-070-1 141714-54-7 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 006-001-00-2 carbon monoxide 211-128-3 630-08-0 F+; R12
Repr. Cat. 1; R61
T; R23-48/23 F+; T
R: 61-12-23-48/23
S: 53-45 E
006-002-00-8 phosgene;
carbonyl chloride 200-870-3 75-44-5 T+; R26
C; R34 T+
R: 26-34
S: (1/2-)9-26-36/37/39-45 006-003-00-3 carbon disulphide 200-843-6 75-15-0 F; R11
Repr. Cat. 3; R62-63
T; R48/23
Xi; R36/38 F; T
R: 11-36/38-48/23-62-63
S: (1/2-)16-33-36/37-45 Repr. Cat. 3; R62-63: C ≥ 1 %
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 % 006-004-00-9 calcium carbide 200-848-3 75-20-7 F; R15 F
R: 15
S: (2-)8-43 006-005-00-4 thiram (ISO);
tetramethylthiuram disulphide 205-286-2 137-26-8 Xn; R20/22-48/22
Xi; R36/38
R43
N; R50-53 Xn; N
R: 20/22-36/38-43-48/22-50/53
S: (2-)26-36/37-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 006-006-00-X hydrogen cyanide;
hydrocyanic acid 200-821-6 74-90-8 F+; R12
T+; R26
N; R50-53 F+; T+; N
R: 12-26-50/53
S: (1/2-)7/9-16-36/37-38-45-60-61 006-006-01-7 hydrogen cyanide ...%;
hydrocyanic acid ...% 200-821-6 74-90-8 T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)7/9-36/37-38-45-60-61 B
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide — — T+; R26/27/28
R32
N; R50-53 T+; N
R: 26/27/28-32-50/53
S: (1/2-)7-28-29-45-60-61 A
006-008-00-0 antu (ISO);
1-(1-naphthyl)-2-thiourea 201-706-3 86-88-4 T+; R28
Carc. Cat. 3; R40 T+
R: 28-40
S: (1/2-)25-36/37-45 006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan 204-318-2 119-38-0 T+; R27/28 T+
R: 27/28
S: (1/2-)28-36/37/39-45 006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan 204-525-8 122-15-6 T; R25 T
R: 25
S: (1/2-)36/37-45 006-011-00-7 carbaryl (ISO);
1-naphthyl methylcarbamate 200-555-0 63-25-2 Carc. Cat. 3; R40
Xn; R22
N; R50 Xn; N
R: 22-40-50
S: (2-)22-24-36/37-46-61 006-012-00-2 ziram (ISO);
zinc bis dimethyldithiocarbamate 205-288-3 137-30-4 T+; R26
Xn; R22-48/22
Xi; R37-41
R43
N; R50-53 T+; N
R: 22-26-37-41-43-48/22-50/53
S: (1/2-)22-26-28-36/37/39-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 006-013-00-8 metam-sodium (ISO);
sodium methyldithiocarbamate 205-293-0 137-42-8 Xn; R22
R31
C; R34
R43
N; R50-53 C; N
R: 22-31-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 006-014-00-3 nabam (ISO);
disodium ethylenebis(N,N'-dithiocarbamate) 205-547-0 142-59-6 Xn; R22
Xi; R37
R43
N; R50-53 Xn; N
R: 22-37-43-50/53
S: (2-)8-24/25-46-60-61 006-015-00-9 diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4 330-54-1 Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53 Xn; N
R: 22-40-48/22-50/53
S: (2-)13-22-23-37-46-60-61 006-016-00-4 propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate 204-043-8 114-26-1 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)37-45-60-61 006-017-00-X aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 204-123-2 116-06-3 T+; R26/28
T; R24
N; R50-53 T+; N
R: 24-26/28-50/53
S: (1/2-)22-36/37-45-60-61 006-018-00-5 aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate 217-990-7 2032-59-9 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 006-019-00-0 di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 218-961-1 2303-16-4 Carc. Cat. 3; R40
Xn; R22
N; R50-53 Xn; N
R: 22-40-50/53
S: (2-)25-36/37-60-61 006-020-00-6 barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 202-930-4 101-27-9 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-36/37-60-61 006-021-00-1 linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 206-356-5 330-55-2 Repr. Cat. 2; R61
Repr. Cat. 3; R62
Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53 T; N
R: 61-22-40-48/22-62-50/53
S: 53-45-60-61 E
006-022-00-7 decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate — 1563-67-3 T; R23/24/25 T
R: 23/24/25
S: (1/2-)13-36/37-45 006-023-00-2 mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 217-991-2 2032-65-7 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)22-37-45-60-61 006-024-00-8 proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate 205-443-5 140-93-2 Xn; R22
Xi; R38
N; R51-53 Xn; N
R: 22-38-51/53
S: (2-)13-61 006-025-00-3 allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] 209-542-4 [1]
249-013-5 [2]
- [3] 584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3] Xn; R20/22
N; R50-53 Xn; N
R: 20/22-50/53
S: (2-)36-60-61 C
006-026-00-9 carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 216-353-0 1563-66-2 T+; R26/28
N; R50-53 T+; N
R: 26/28-50/53
S: (1/2-)36/37-45-60-61 006-028-00-X dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 213-546-1 973-21-7 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)37-45-60-61 006-029-00-5 dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 230-253-4 6988-21-2 T; R25
N; R51-53 T; N
R: 25-51/53
S: (1/2-)37-45-61 006-030-00-0 EPTC (ISO);
S-ethyl dipropylthiocarbamate 212-073-8 759-94-4 Xn; R22 Xn
R: 22
S: (2-)23 006-031-00-6 formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 244-879-0 22259-30-9 T+; R26/28
R43
N; R50-53 T+; N
R: 26/28-43-50/53
S: (1/2-)24-28-37/39-45-60-61 006-032-00-1 monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea 217-129-5 1746-81-2 Xn; R22-48/22
N; R50-53 Xn; N
R: 22-48/22-50/53
S: (2-)22-60-61 006-033-00-7 metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 243-433-2 19937-59-8 N; R50-53 N
R: 50/53
S: 60-61 006-034-00-2 pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate 214-215-4 1114-71-2 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)23-61 006-035-00-8 pirimicarb (ISO);
5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate 245-430-1 23103-98-2 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)22-37-45-60-61 006-036-00-3 benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea 217-685-9 1929-88-0 Xn; R22 Xn
R: 22
S: (2-)24/25 006-037-00-9 promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate 220-113-0 2631-37-0 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)24-37-45-60-61 006-038-00-4 sulfallate (ISO);
2-chloroallyl N,N-dimethyldithiocarbamate 202-388-9 95-06-7 Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 E
006-039-00-X tri-allate (ISO);
S-2,3,3-trichloroallyl diisopropylthiocarbamate 218-962-7 2303-17-5 Xn; R22-48/22
R43
N; R50-53 Xn; N
R: 22-43-48/22-50/53
S: (2-)24-37-60-61 006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan — 2532-43-6 T; R23/24/25 T
R: 23/24/25
S: (1/2-)13-45 006-041-00-0 dimethylcarbamoyl chloride 201-208-6 79-44-7 Carc. Cat. 2; R45
T; R23
Xn; R22
Xi; R36/37/38 T
R: 45-22-23-36/37/38
S: 53-45 Carc. Cat. 2; R45: C ≥ 0,001 % E
006-042-00-6 monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea 205-766-1 150-68-5 Carc. Cat. 3; R40
Xn; R22
N; R50-53 Xn; N
R: 22-40-50/53
S: (2-)36/37-60-61 006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA — 140-41-0 Xi; R36/38
Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 36/38-40-50/53
S: (2-)36/37-60-61 006-044-00-7 isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-4 34123-59-6 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 006-045-00-2 methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate 240-815-0 16752-77-5 T+;R28
N; R50-53 T+; N
R: 28-50/53
S: (1/2-)22-36/37-45-60-61 006-046-00-8 bendiocarb (ISO);
2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate 245-216-8 22781-23-3 T; R23/25
Xn; R21
N; R50-53 T; N
R: 21-23/25-50/53
S: (1/2-)22-36/37-45-60-61 006-047-00-3 bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate — 8065-36-9 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 006-048-00-9 ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate 249-981-9 29973-13-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 006-049-00-4 dixanthogen;
O,O-diethyl dithiobis(thioformate) 207-944-4 502-55-6 Xn; R22 Xn
R: 22
S: (2-)24 006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA — 4482-55-7 Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)60-61 006-051-00-5 ferbam (ISO);
iron tris(dimethyldithiocarbamate) 238-484-2 14484-64-1 Xi; R36/37/38
N; R50-53 Xi; N
R: 36/37/38-50/53
S: (2-)60-61 006-052-00-0 formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 245-656-0 23422-53-9 T+; R26/28
R43
N; R50-53 T+; N
R: 26/28-43-50/53
S: (1/2-)24-28-37/39-45-60-61 006-053-00-6 isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate 220-114-6 2631-40-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 006-054-00-1 mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 206-249-3 315-18-4 T+; R28
Xn; R21
N; R50-53 T+; N
R: 21-28-50/53
S: (1/2-)36/37-45-60-61 006-055-00-7 xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC 219-364-9 2425-10-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 006-056-00-2 metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC 214-446-0 1129-41-5 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 006-057-00-8 nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine 217-682-2 1929-82-4 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)24-61 006-058-00-3 noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea — 2163-79-3 Xn; R22 Xn
R: 22
S: (2-) 006-059-00-9 oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; 245-445-3 23135-22-0 T+; R26/28
Xn; R21
N; R51-53 T+; N
R: 21-26/28-51/53
S: (1/2-)36/37-45-61 006-060-00-4 oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 226-066-2 5259-88-1 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride 243-193-9 19622-19-6 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 006-062-00-5 methyl 3,4-dichlorophenylcarbanilate;
SWEP. — 1918-18-9 Xn; R22 Xn
R: 22
S: (2-) 006-063-00-0 thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate; 248-924-5 28249-77-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 006-064-00-6 thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime; 254-346-4 39196-18-4 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)27-36/37-45-60-61 006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid — 15271-41-7 T+; R28
T; R24
N; R51-53 T+; N
R: 24-28-51/53
S: (1/2-)28-36/37-45-61 006-066-00-7 vernolate (ISO);
S-propyl dipropylthiocarbamate; 217-681-7 1929-77-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 006-067-00-2 XMC;
3,5-xylyl methylcarbamate — 2655-14-3 Xn; R22 Xn
R: 22
S: (2-) 006-068-00-8 diazomethane 206-382-7 334-88-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 006-069-00-3 thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 245-740-7 23564-05-8 Muta. Cat. 3; R68
Xn; R20
R43
N; R50-53 Xn; N
R: 20-43-50/53-68
S: (2-)36/37-46-60-61 006-070-00-9 furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide; 262-302-0 60568-05-0 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 401-620-8 87731-18-8 R43 Xi
R: 43
S: (2-)24-37 006-072-00-X prosulfocarb(ISO);
S-benzyl N,N-dipropylthiocarbamate; 401-730-6 52888-80-9 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)24-37-61 006-073-00-5 3-(dimethylamino)propylurea 401-950-2 31506-43-1 Xi; R41 Xi
R: 41
S: (2-)26-39 006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 402-440-2 2094-99-7 T+; R26
C; R34
Xn; R48/20
R42/43
N; R50-53 T+; N
R: 26-34-42/43-48/20-50/53
S: (1/2-)7-15-28-36/37/39-38-45-60-61 006-076-00-1 mancozeb (ISO) — 8018-01-7 Xi; R37
R43 Xi
R: 37-43
S: (2-)8-24/25-46 006-077-00-7 maneb (ISO) 235-654-8 12427-38-2 Xi; R37
R43 Xi
R: 37-43
S: (2-)8-24/25-46 006-078-00-2 zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric) 235-180-1 12122-67-7 Xi; R37
R43 Xi
R: 37-43
S: (2-)8-24/25-46 006-079-00-8 disulfiram;
tetraethylthiuramdisulfide 202-607-8 97-77-8 Xn; R22-48/22
R43
N; R50-53 Xn; N
R: 22-43-48/22-50/53
S: (2-)24-37-60-61 006-080-00-3 tetramethylthiuram monosulphide 202-605-7 97-74-5 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)24-26-37-61 006-081-00-9 zinc bis(dibutyldithiocarbamate) 205-232-8 136-23-2 Xi; R36/37/38
R43
N; R50-53 Xi; N
R: 36/37/38-43-50/53
S: (2-)24-37-60-61 006-082-00-4 zinc bis(diethyldithiocarbamate) 238-270-9 14324-55-1 Xn; R22
Xi; R36/37/38
R43
N; R50-53 Xn; N
R: 22-36/37/38-43-50/53
S: (2-)24-37-60-61 006-083-00-X butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 252-139-3 34681-10-2 R10
T; R23/24/25
Xi; R36
N; R50-53 T; N
R: 10-23/24/25-36-50/53
S: (1/2-)36/37-45-60-61 006-084-00-5 carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate; 259-565-9 55285-14-8 T; R23/25
R43
N; R50-53 T; N
R: 23/25-43-50/53
S: (1/2-)24-37-38-45-60-61 006-085-00-0 fenobucarb (ISO);
2-butylphenyl methylcarbamate; 223-188-8 3766-81-2 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 006-086-00-6 ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;
fenoxycarb 276-696-7 72490-01-8 N; R50-53 N
R: 50/53
S: 60-61 006-087-00-1 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;
furathiocarb 265-974-3 65907-30-4 T+; R26
T; R25
Xn; R48/22
Xi; R36/38
R43
N; R50-53 T+; N
R: 25-26-36/38-43-48/22-50/53
S: (1/2-)28-36/37-38-45-60-61 006-088-00-7 benfuracarb;
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate — 82560-54-1 T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)36/37-45-60-61 006-089-00-2 chlorine dioxide 233-162-8 10049-04-4 O; R8
R6
T+; R26
C; R34
N; R50 O; T+; N
R: 6-8-26-34-50
S: (1/2-)23-26-28-36/37/39-38-45-61 N; R50: C ≥ 0,02 % 5
006-089-01-X chlorine dioxide … % 233-162-8 10049-04-4 T; R25
C; R34
N; R50 T; N
R: 25-34-50
S: (1/2-)23-26-28-36/37/39-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 3 % ≤ C < 10 %
Xi; R36: 0,3 % ≤ C < 3 %
N; R50: C ≥ 3 % B
006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 408-010-0 88558-41-2 Xn; R20
Xi; R41
R52-53 Xn
R: 20-41-52/53
S: (2-)22-26-39-61 007-001-00-5 ammonia, anhydrous 231-635-3 7664-41-7 R10 ⊗
T; R23
C; R34
N; R50 T; N
R: 10-23-34-50
S: (1/2-)9-16-26-36/37/39-45-61 007-001-01-2 ammonia ....% 215-647-6 1336-21-6 C; R34
N; R50 C; N
R: 34-50
S: (1/2-)26-36/37/39-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % B
007-002-00-0 nitrogen dioxide; [1]
dinitrogen tetraoxide [2] 233-272-6 [1]
234-126-4 [2] 10102-44-0 [1]
10544-72-6 [2] T+; R26
C; R34 T+
R: 26-34
S: (1/2-)9-26-28-36/37/39-45 T+; R26: C ≥ 10 %
T; R23: 1 % ≤ C < 10 %
Xn; R20: 0,1 % ≤ C < 1 % 5
007-003-00-6 chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride 213-666-4 999-81-5 Xn; R21/22 Xn
R: 21/22
S: (2-)36/37 007-004-00-1 nitric acid ... % 231-714-2 7697-37-2 O; R8
C; R35 O; C
R: 8-35
S: (1/2-)23-26-36-45 C; R35: C ≥ 20 %
C; R34: 5 % ≤ C < 20 %
Footnote:
O; R8: C ≥ 70 % B
007-006-00-2 ethyl nitrite 203-722-6 109-95-5 E; R2
Xn; R20/21/22 E; Xn
R: 2-20/21/22
S: (2-) 007-007-00-8 ethyl nitrate 210-903-3 625-58-1 E; R2 ⊗ E
R: 2
S: (2-)23-24/25 007-008-00-3 hydrazine 206-114-9 302-01-2 R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43
N; R50-53 T; N
R: 45-10-23/24/25-34-43-50/53
S: 53-45-60-61 C; R34: C ≥ 10 %
Xi; R36/38: 3 % ≤ C < 10 % E
007-009-00-9 dicyclohexylammonium nitrite 221-515-9 3129-91-7 Xn; R20/22 Xn
R: 20/22
S: (2-)15-41 Xn; R20/22: C ≥ 10 % 007-010-00-4 sodium nitrite 231-555-9 7632-00-0 O; R8
T; R25
N; R50 O; T; N
R: 8-25-50
S: (1/2-)45-61 T; R25: C ≥ 5 %
Xn; R22: 1 % ≤ C < 5 % 007-011-00-X potassium nitrite 231-832-4 7758-09-0 O; R8
T; R25
N; R50 O; T; N
R: 8-25-50
S: (1/2-)45-61 T; R25: C ≥ 5 %
Xn; R22: 1 % ≤ C < 5 % 007-012-00-5 N,N-dimethylhydrazine 200-316-0 57-14-7 F; R11
Carc. Cat. 2; R45
T; R23/25
C; R34
N; R51-53 F; T; N
R: 45-11-23/25-34-51/53
S: 53-45-61 E
007-013-00-0 1,2-dimethylhydrazine — 540-73-8 Carc. Cat. 2; R45
T; R23/24/25
N; R51-53 T; N
R: 45-23/24/25-51/53
S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
007-014-00-6 salts of hydrazine — — Carc. Cat. 2; R45
T; R23/24/25
R43
N; R50-53 T; N
R: 45-23/24/25-43-50/53
S: 53-45-60-61 AE
007-015-00-1 O-ethylhydroxylamine 402-030-3 624-86-2 F; R11
T; R23/24/25-48/23
Xi; R36
R43
N; R50 F; T; N
R: 11-23/24/25-36-43-48/23-50
S: (1/2-)16-26-36/37/39-45-60-61 007-016-00-7 butyl nitrite 208-862-1 544-16-1 F; R11
T; R23/25 F; T
R: 11-23/25
S: (1/2-)16-24-45 007-017-00-2 isobutyl nitrite 208-819-7 542-56-3 F; R11
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22 F; T
R: 11-20/22-45-68
S: 53-45 E
007-018-00-8 sec-butyl nitrite 213-104-8 924-43-6 F; R11
Xn; R20/22 F; Xn
R: 11-20/22
S: (2-)16-24-46 007-019-00-3 tert-butyl nitrite 208-757-0 540-80-7 F; R11
Xn; R20/22 F; Xn
R: 11-20/22
S: (2-)16-24-46 007-020-00-9 pentyl nitrite; [1]
amyl nitrite, mixed isomers [2] 207-332-7 [1]
203-770-8 [2] 463-04-7 [1]
110-46-3 [2] F; R11
Xn; R20/22 F; Xn
R: 11-20/22
S: (2-)16-24-46 007-021-00-4 hydrazobenzene;
1,2-diphenylhydrazine 204-563-5 122-66-7 Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 E
007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) 405-030-1 — Carc. Cat. 2; R45
Xn; R22
C; R34
R43
R52-53 T
R: 45-22-34-43-52/53
S: 53-45-61 E
007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate 405-510-0 — Xi; R38
R43 Xi
R: 38-43
S: (2-)24-37 007-024-00-0 2-(decylthio)ethylammonium chloride 405-640-8 36362-09-1 Xn; R48/22
Xi; R38-41
N; R50-53 Xn; N
R: 38-41-48/22-50/53
S: (2-)26-36/37/39-60-61 007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 406-090-1 81880-96-8 Muta. Cat. 3; R68
T; R25-48/25
R43
N; R50-53 T; N
R: 25-43-48/25-68-50/53
S: (1/2-)22-36/37/39-45-60-61 007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 413-230-5 122035-71-6 Xi; R41
R43 Xi
R: 41-43
S: (2-)8-22-24-26-30-37/39 007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 420-190-2 771478-66-1 C; R34
Xn; R21/22-48/21
R43
N; R50-53 C; N
R: 21/22-34-43-48/21-50/53
S: (1/2-)7-26-36/37/39-45-60-61 008-001-00-8 oxygen 231-956-9 7782-44-7 O; R8 O
R: 8
S: (2-)17 008-003-00-9 hydrogen peroxide solution ... % 231-765-0 7722-84-1 R5
O; R8
C; R35
Xn; R20/22 O; C
R: 5-8-20/22-35
S: (1/2-)17-26-28-36/37/39-45 Xn; R20: C ≥ 50 %
Xn; R22: C ≥ 8 %
C; R35: C ≥ 70 %
C; R34: 50 % ≤ C < 70 %
Xi; R37/38: 35 % ≤ C < 50 %
Xi; R41: 8 % ≤ C < 50 %
Xi; R36: 5 % ≤ C < 8 %
Footnote:
O; R8: C ≥ 50 %
R5: C ≥ 70 % B
009-001-00-0 fluorine 231-954-8 7782-41-4 R7 ⊗
T+; R26
C; R35 T+; C
R: 7-26-35
S: (1/2-)9-26-36/37/39-45 009-002-00-6 hydrogen fluoride 231-634-8 7664-39-3 T+; R26/27/28
C; R35 T+; C
R: 26/27/28-35
S: (1/2-)7/9-26-36/37/39-45 009-003-00-1 hydrofluoric acid ... % 231-634-8 7664-39-3 T+; R26/27/28
C; R35 T+; C
R: 26/27/28-35
S: (1/2-)7/9-26-36/37-45 C; R35: C ≥ 7 %
C; R34: 1 % ≤ C < 7 %
Xi; R36: 0,1 % ≤ C < 1 % B
009-004-00-7 sodium fluoride 231-667-8 7681-49-4 T; R25
Xi; R36/38
R32 T
R: 25-32-36/38
S: (1/2-)22-36-45 009-005-00-2 potassium fluoride 232-151-5 7789-23-3 T; R23/24/25 T
R: 23/24/25
S: (1/2-)26-45 009-006-00-8 ammonium fluoride 235-185-9 12125-01-8 T; R23/24/25 T
R: 23/24/25
S: (1/2-)26-45 009-007-00-3 sodium bifluoride;
sodium hydrogen difluoride 215-608-3 1333-83-1 T; R25
C; R34 T; C
R: 25-34
S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 % 009-008-00-9 potassium bifluoride;
potassium hydrogen difluoride 232-156-2 7789-29-9 T; R25
C; R34 T; C
R: 25-34
S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 % 009-009-00-4 ammonium bifluoride;
ammonium hydrogen difluoride 215-676-4 1341-49-7 T; R25
C; R34 T; C
R: 25-34
S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 % 009-010-00-X fluoroboric acid ... % 240-898-3 16872-11-0 C; R34 C
R: 34
S: (1/2-)26-27-45 C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 % B
009-011-00-5 fluorosilicic acid ... % 241-034-8 16961-83-4 C; R34 C
R: 34
S: (1/2-)26-27-45 B
009-012-00-0 alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3] 240-934-8 [1]
240-896-2 [2]
240-968-3 [3] 16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3] T; R23/24/25 T
R: 23/24/25
S: (1/2-)26-45 T; R23/24/25: C ≥ 10 %
Xn; R20/21/22: 1 % ≤ C < 10 % A
009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this annex — — Xn; R22 Xn
R: 22
S: (2-)13-24/25 Xn; R22: C ≥ 10 % A
009-014-00-1 lead hexafluorosilicate 247-278-1 25808-74-6 Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53 T; N
R: 61-62-20/22-33-50/53
S: 53-45-60-61 E
1
009-015-00-7 sulphuryl difluoride 220-281-5 2699-79-8 T; R23
Xn; R48/20
N; R50 T; N
R: 23-48/20-50
S: (1/2-)45-63-60-61 009-016-00-2 trisodium hexafluoroaluminate;
cryolite 237-410-6
239-148-8 13775-53-6
15096-52-3 T; R48/23/25
Xn; R20/22
N; R51-53 T; N
R: 20/22-48/23/25-51/53
S: (1/2-)22-37-45-61 C
009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 400-040-2 12091-08-6 F; R11-14/15
C; R35
Xn; R20 F; C
R: 11-14/15-20-35
S: (1/2-)16-30-36/39-43-45 009-018-00-3 magnesium hexafluorosilicate 241-022-2 16949-65-8 T; R25 T
R: 25
S: (1/2-)24/25-45 T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 % 011-001-00-0 sodium 231-132-9 7440-23-5 F; 15
R14
C; R34 F; C
R: 14/15-34
S: (1/2-)5-8-43-45 011-002-00-6 sodium hydroxide;
caustic soda 215-185-5 1310-73-2 C; R35 C
R: 35
S: (1/2-)26-37/39-45 C; R35: C ≥ 5 %
C; R34: 2 % ≤ C < 5 %
Xi; R36/38: 0,5 % ≤ C < 2 % 011-003-00-1 sodium peroxide 215-209-4 1313-60-6 O; R8
C; R35 O; C
R: 8-35
S: (1/2-)8-27-39-45 011-004-00-7 sodium azide 247-852-1 26628-22-8 T+; R28
R32
N; R50-53 T+; N
R: 28-32-50/53
S: (1/2-)28-45-60-61 011-005-00-2 sodium carbonate 207-838-8 497-19-8 Xi; R36 Xi
R: 36
S: (2-)22-26 011-006-00-8 sodium cyanate 213-030-6 917-61-3 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)24/25-61 011-007-00-3 propoxycarbazone-sodium — 181274-15-7 N; R50-53 N
R: 50/53
S: 60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 012-001-00-3 magnesium powder (pyrophoric) 231-104-6 7439-95-4 F; R15-17 F
R: 15-17
S: (2-)7/8-43 012-002-00-9 magnesium, powder or turnings 231-104-6 — F; R11-15 F
R: 11-15
S: (2-)7/8-43 012-003-00-4 magnesium alkyls — — R14
F; R17
C; R34 F; C
R: 14-17-34
S: (1/2-)16-43-45 A
013-001-00-6 aluminium powder (pyrophoric) 231-072-3 7429-90-5 F; R15-17 F
R: 15-17
S: (2-)7/8-43 013-002-00-1 aluminium powder (stabilised) 231-072-3 — F; R15
R10 ⊗ F
R: 10-15
S: (2-)7/8-43 013-003-00-7 aluminium chloride, anhydrous 231-208-1 7446-70-0 C; R34 C
R: 34
S: (1/2-)7/8-28-45 013-004-00-2 aluminium alkyls — — R14
F; R17
C; R34 F; C
R: 14-17-34
S: (1/2-)16-43-45 A
013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 401-160-8 55426-95-4 F; R 15-17
R14
C; R35 F; C
R: 14/15-17-35
S: (1/2-)6-16-30-36/39-43-45 013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised 402-370-2 — R10
Xi; R41 Xi
R: 10-41
S: (2-)26-39 013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) 403-430-0 — Xi; R41 Xi
R: 41
S: (2-)26-39 013-008-00-4 di-n-octylaluminium iodide 408-190-0 7585-14-0 R14
F; R17
C; R34
N; R50-53 F; C; N
R: 14-17-34-50/53
S: (1/2-)6-16-26-36/37/39-43-45-60-61 013-009-00-X sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5 418-720-2 — F; R11-15-17
R14
Xn; R20
C; R35 F; C
R: 11-14/15-17-20-35
S: (1/2-)6-16-26-30-36/37/39-43-45 014-001-00-9 trichlorosilane 233-042-5 10025-78-2 F+; R12
R14
F; R17
Xn; R20/22
R29
C; R35 F+; C
R: 12-14-17-20/22-29-35
S: (2-)7/9-16-26-36/37/39-43-45 Xn; R20/22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 014-002-00-4 silicon tetrachloride 233-054-0 10026-04-7 R14
Xi; R36/37/38 Xi
R: 14-36/37/38
S: (2-)7/8-26 014-003-00-X dimethyldichlorosilane 200-901-0 75-78-5 F; R11
Xi; R36/37/38 F; Xi
R: 11-36/37/38
S: (2-) 014-004-00-5 trichloro(methyl)silane;
methyltrichlorosilane 200-902-6 75-79-6 R14
F; R11
Xi; R36/37/38 F; Xi
R: 11-14-36/37/38
S: (2-)26-39 Xi; R36/37/38: C ≥ 1 % 014-005-00-0 tetraethyl silicate;
ethyl silicate 201-083-8 78-10-4 R10
Xn; R20
Xi; R36/37 Xn
R: 10-20-36/37
S: (2-) 014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride 401-380-4 — Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 014-007-00-1 triethoxyisobutylsilane 402-810-3 17980-47-1 Xi; R38 Xi
R: 38
S: (2-)24 014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 401-200-4 85491-26-5 N; R51-53 N
R: 51/53
S: 61 014-009-00-2 isobutylisopropyldimethoxysilane 402-580-4 111439-76-0 R10
Xn; R20
Xi; R38 Xn
R: 10-20-38
S: (2-)25-26-36/37 014-010-00-8 disodium metasilicate 229-912-9 6834-92-0 C; R34
Xi; R37 C
R: 34-37
S: (1/2-)13-24/25-36/37/39-45 014-011-00-3 cyclohexyldimethoxymethylsilane 402-140-1 17865-32-6 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)24-61 014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine 403-480-3 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)24-26-39-61 014-013-00-4 α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) 404-920-7 — Xn; R21/22
C; R34
N; R51-53 C; N
R: 21/22-34-51/53
S: (1/2-)26-36/37/39-45-61 014-014-00-X etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane; 253-704-7 37894-46-5 Repr. Cat. 2; R61
Xn; R22-48/22 T
R: 61-22-48/22
S: 53-45 E
014-015-00-5 α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane)) 406-420-4 69430-40-6 R53 R: 53
S: 61 014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane 406-490-6 — N; R51-53 N
R: 51/53
S: 61 014-017-00-6 flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane — 85509-19-9 Carc. Cat. 3; R40
Repr. Cat. 2; R61
Xn; R22
N; R51-53 T; N
R: 61-22-40-51/53
S: 53-45-61 E
014-018-00-1 octamethylcyclotetrasiloxane 209-136-7 556-67-2 Repr. Cat. 3; R62
R53 Xn
R: 53-62
S: (2-)36/37-46-51-61 014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole 403-250-2 — Carc. Cat. 3; R40
Repr. Cat. 2; R61
Xn; R22
N; R51-53 T; N
R: 61-22-40-51/53
S: 53-45-61 E
014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 414-960-7 53863-99-3 Xn; R20 Xn
R: 20
S: (2) 014-021-00-8 tris(isopropenyloxy)phenyl silane 411-340-8 52301-18-5 N; R50-53 N
R: 50/53
S: 60-61 014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) 401-530-9 — F; R11
T; R39/23/24/25
Xn; R20/21/22 F; T
R: 11-20/21/22-39/23/24/25
S: (1/2-)16-29-36/37-45 014-023-00-9 α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 408-160-7 125613-45-8 N; R51-53 N
R: 51/53
S: 61 014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 412-620-2 121626-74-2 N; R51-53 N
R: 51/53
S: 61 014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 411-400-3 102089-33-8 Xn; R22-48/21
Xi; R38-41
R52-53 Xn
R: 22-38-41-48/21-52/53
S: (2-)26-36/37/39-61 014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 407-180-3 770722-36-6 C; R35 C
R: 35
S: (1/2-)26-36/37/39-45 014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 410-270-5 770722-46-8 C; R35 C
R: 35
S: (1/2-)8-26-28-36/37/39-45 014-028-00-6 α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 415-290-8 193159-06-7 R43 Xi
R: 43
S: (2-)24-37 014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 421-870-1 156145-66-3 Repr. Cat. 3; R62
Xn; R22-48/22 Xn
R: 22-48/22-62
S: (2-)36/37 014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium 422-060-0 137390-08-0 T+; R28 T+
R: 28
S: (1/2-)6-22-28-36/37-45 014-031-00-2 bis(1-methylethyl)-dimethoxysilane 421-540-7 18230-61-0 R10
Xi; R38
R43
R52-53 Xi
R: 10-38-43-52/53
S: (2-)24-37-61 014-032-00-8 dicyclopentyldimethoxysilane 404-370-8 126990-35-0 Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 015-001-00-1 white phosphorus 231-768-7 12185-10-3 F; R17
T+; R26/28
C; R35
N; R50 F; T+; C; N
R: 17-26/28-35-50
S: (1/2-)5-26-38-45-61 015-002-00-7 red phosphorus 231-768-7 7723-14-0 F; R11
R16
R52-53 F
R: 11-16-52/53
S: (2-)7-43-61 015-003-00-2 calcium phosphide;
tricalcium diphosphide 215-142-0 1305-99-3 F; R15/29
T+; R28
N; R50 F; T+; N
R: 15/29-28-50
S: (1/2-)22-43-45-61 015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 F; R15/29
T+; R28
R32
N; R50 F; T+; N
R: 15/29-28-32-50
S: (1/2-)3/9/14-30-36/37-45-61 015-005-00-3 magnesium phosphide;
trimagnesium diphosphide 235-023-7 12057-74-8 F; R15/29
T+; R28
N; R50 F; T+; N
R: 15/29-28-50
S: (1/2-)22-43-45-61 015-006-00-9 trizinc diphosphide;
zinc phosphide 215-244-5 1314-84-7 F; R15/29
T+; R28
R32
N; R50-53 F; T+; N
R: 15/29-28-32-50/53
S: (1/2-)3/9/14-30-36/37-45-60-61 015-007-00-4 phosphorus trichloride 231-749-3 7719-12-2 R14
T+; R26/28
Xn; R48/20
C; R35
R29 T+; C
R: 14-26/28-35-48/20
S: (1/2-)7/8-26-36/37/39-45 015-008-00-X phosphorus pentachloride 233-060-3 10026-13-8 R14
T+; R26
Xn; R22-48/20
C; R34
R29 T+
R: 14-22-26-34-48/20
S: (1/2-)7/8-26-36/37/39-45 015-009-00-5 phosphoryl trichloride 233-046-7 10025-87-3 R14
T+; R26
T; R48/23
Xn; R22
C; R35
R29 T+; C
R: 14-22-26-35-48/23
S: (1/2-)7/8-26-36/37/39-45 015-010-00-0 phosphorus pentoxide 215-236-1 1314-56-3 C; R35 C
R: 35
S: (1/2-)22-26-45 015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 231-633-2 7664-38-2 C; R34 C
R: 34
S: (1/2-)26-45 C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 % B
015-012-00-1 tetraphosphorus trisulphide;
phosphorus sesquisulphid 215-245-0 1314-85-8 F; R11
Xn; R22
N; R50 F; Xn; N
R: 11-22-50
S: (2-)7-16-24/25-61 015-013-00-7 triethyl phosphate 201-114-5 78-40-0 Xn; R22 Xn
R: 22
S: (2-)25 015-014-00-2 tributyl phosphate 204-800-2 126-73-8 Carc. Cat. 3; R40
Xn; R22
Xi; R38 Xn
R: 22-38-40
S: (2-)36/37-46 015-015-00-8 tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); 201-103-5 78-30-8 T; R39/23/24/25
N; R51-53 T; N
R: 39/23/24/25-51/53
S: (1/2-)20/21-28-45-61 T; R39/23/24/25: C ≥ 1 %
Xn; R68/20/21/22: 0,2 % ≤ C < 1 % C
015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); 201-105-6 78-32-0 Xn; R21/22
N; R51-53 Xn; N
R: 21/22-51/53
S: (2-)28-61 Xn; R21/22: C ≥ 5 % C
015-019-00-X dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate 200-547-7 62-73-7 T+; R26
T; R24/25
R43
N; R50 T+; N
R: 24/25-26-43-50
S: (1/2-)28-36/37-45-61 015-020-00-5 mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 232-095-1 7786-34-7 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 % 015-021-00-0 trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 200-149-3 52-68-6 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-022-00-6 phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate 236-116-5 13171-21-6 T+; R28
T; R24
Muta. Cat. 3; R68
N; R50-53 T+; N
R: 24-28-50/53-68
S: (1/2-)23-36/37-45-60-61 015-023-00-1 pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate — 108-34-9 T+; R26/27/28 T+
R: 26/27/28
S: (1/2-)13-28-45 015-024-00-7 triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide — 1031-47-6 T+; R27/28 T+
R: 27/28
S: (1/2-)22-28-36/37-45 015-025-00-2 TEPP (ISO);
tetraethyl pyrophosphate 203-495-3 107-49-3 T+; R27/28
N; R50 T+; N
R: 27/28-50
S: (1/2-)36/37/39-38-45-61 015-026-00-8 schradan (ISO);
octamethylpyrophosphoramide 205-801-0 152-16-9 T+; R27/28 T+
R: 27/28
S: (1/2-)36/37-38-45 015-027-00-3 sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate 222-995-2 3689-24-5 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-028-00-9 demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate 206-053-8 298-03-3 T+; R27/28
N; R50 T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61 015-029-00-4 demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate 204-801-8 126-75-0 T+; R27/28 T+
R: 27/28
S: (1/2-)28-36/37-45 015-030-00-X demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate 212-758-1 867-27-6 T; R25 T
R: 25
S: (1/2-)24-36/37-45 015-031-00-5 demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate 213-052-6 919-86-8 T; R24/25
N; R51-53 T; N
R: 24/25-51/53
S: (1/2-)28-36/37-45-61 015-032-00-0 prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 218-893-2 2275-18-5 T+; R27/28
R52-53 T+
R: 27/28-52/53
S: (1/2-)28-36/37-45-61 015-033-00-6 phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate 206-052-2 298-02-2 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-034-00-1 parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate 200-271-7 56-38-2 T+; R26/28
T; R24-48/25
N; R50-53 T+; N
R: 24-26/28-48/25-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-035-00-7 parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate 206-050-1 298-00-0 R5
R10
T+; R26/28
T; R24
Xn; R48/22
N; R50-53 T+; N
R: 5-10-24-26/28-48/22-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN 218-276-8 2104-64-5 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)22-36/37-45-60-61 015-037-00-8 phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate 218-892-7 2275-14-1 T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 015-038-00-3 coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 200-285-3 56-72-4 T+; R28
Xn; R21
N; R50-53 T+; N
R: 21-28-50/53
S: (1/2-)28-36/37-45-60-61 015-039-00-9 azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 201-676-1 86-50-0 T+; R26/28
T; R24
R43
N; R50-53 T+; N
R: 24-26/28-43-50/53
S: (1/2-)28-36/37-45-60-61 015-040-00-4 diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 206-373-8 333-41-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24/25-60-61 015-041-00-X malathion (ISO);
1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate 204-497-7 121-75-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-042-00-5 chlorthion
O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate 207-902-5 500-28-7 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-043-00-0 phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate — 5826-76-6 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)13 015-044-00-6 carbophenothion (ISO);
4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate 212-324-1 786-19-6 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 015-045-00-1 mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate 219-993-9 2595-54-2 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)36/37-45-60-61 015-046-00-7 oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 206-110-7 301-12-2 T; R24/25
N; R50 T; N
R: 24/25-50
S: (1/2-)23-36/37-45-61 015-047-00-2 ethion (ISO);
O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);
diethion 209-242-3 563-12-2 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)25-36/37-45-60-61 N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 % 015-048-00-8 fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 200-231-9 55-38-9 Muta. Cat. 3; R68
T; R23-48/25
Xn; R21/22
N; R50-53 T; N
R: 21/22-23-48/25-50/53-68
S: (1/2-)36/37-45-60-61 015-049-00-3 endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 220-472-3 2778-04-3 T; R24/25 T
R: 24/25
S: (1/2-)36/37-45 015-050-00-9 thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 211-362-6 640-15-3 T; R25
Xn; R21 T
R: 21-25
S: (1/2-)36/37-45 015-051-00-4 dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate 200-480-3 60-51-5 Xn; R21/22 Xn
R: 21/22
S: (2-)36/37 015-052-00-X fenchlorphos (ISO);
O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 206-082-6 299-84-3 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)25-36/37-60-61 015-053-00-5 menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate 201-123-4 78-57-9 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 015-054-00-0 fenitrothion (ISO);
O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate 204-524-2 122-14-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 015-055-00-6 naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 206-098-3 300-76-5 Xn; R21/22
Xi; R36/38
N; R50 Xn; N
R: 21/22-36/38-50
S: (2-)36/37-61 N; R50: C ≥ 0,025 % 015-056-00-1 azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 220-147-6 2642-71-9 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 015-057-00-7 formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate 219-818-6 2540-82-1 Xn; R21/22 Xn
R: 21/22
S: (2-)36/37 015-058-00-2 morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 205-628-0 144-41-2 T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 015-059-00-8 vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 218-894-8 2275-23-2 T; R25
Xn; R21
N; R50 T; N
R: 21-25-50
S: (1/2-)36/37-45-61 015-060-00-3 disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate 206-054-3 298-04-4 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61 015-061-00-9 dimefox (ISO);
tetramethylphosphorodiamidic fluoride 204-076-8 115-26-4 T+; R27/28 T+
R: 27/28
S: (1/2-)23-28-36/37-38-45 015-062-00-4 mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride 206-742-3 371-86-8 T+; R39/26/27/28 T+
R: 39/26/27/28
S: (1/2-)13-45 015-063-00-X dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 201-107-7 78-34-2 T+; R26/28
T; R24
N; R50-53 T+; N
R: 24-26/28-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-064-00-5 bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 225-399-0 4824-78-6 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)28-36/37-45-60-61 015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate — 2703-37-9 T+; R26/27/28
N; R51-53 T+; N
R: 26/27/28-51/53
S: (1/2-)13-28-45-61 015-066-00-6 omethoate (ISO);
O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate 214-197-8 1113-02-6 T; R25
Xn; R21
N; R50 T; N
R: 21-25-50
S: (1/2-)23-36/37-45-61 015-067-00-1 phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate 218-996-2 2310-17-0 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)36/37-45-60-61 015-068-00-7 dichlofenthion (ISO);
O-,4-dichlorophenyl O,O-diethyl phosphorothioate 202-564-5 97-17-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 015-069-00-2 methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 213-449-4 950-37-8 T+; R28
Xn; R21
N; R50-53 T+; N
R: 21-28-50/53
S: (1/2-)22-28-36/37-45-60-61 015-070-00-8 cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 223-099-4 3734-95-0 T+; R28
T; R24 T+
R: 24-28
S: (1/2-)36/37-45 015-071-00-3 chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate 207-432-0 470-90-6 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 015-072-00-9 monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 230-042-7 6923-22-4 Muta. Cat. 3; R68
T+; R26/28
T; R24
N; R50-53 T+; N
R: 24-26/28-50/53-68
S: (1/2-)36/37-45-60-61 015-073-00-4 dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 205-494-3 141-66-2 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 015-074-00-X crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 206-083-1 299-86-5 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate — 2635-50-9 T; R23/24/25 T
R: 23/24/25
S: (1/2-)13-45 015-076-00-0 potasan;
O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate — 299-45-6 T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)13-28-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate — 7076-53-1 T; R23/24/25 T
R: 23/24/25
S: (1/2-)13-45 015-078-00-1 demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate 241-109-5 17040-19-6 T; R25
Xn; R21
N; R51-53 T; N
R: 21-25-51/53
S: (1/2-)22-28-36/37-45-61 015-079-00-7 acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate 250-241-2 30560-19-1 Xn; R22 Xn
R: 22
S: (2-)36 015-080-00-2 amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate — 919-76-6 Xn; R22 Xn
R: 22
S: (2-)24-36 015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 221-817-0 3244-90-4 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 015-082-00-3 azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 227-419-3 5834-96-8 Xn; R20/22 Xn
R: 20/22
S: (2-)13 015-083-00-9 bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 212-010-4 741-58-2 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24-36-60-61 015-084-00-4 chlorpyrifos (ISO);
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 220-864-4 2921-88-2 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)45-60-61 N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 % 015-085-00-X chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride 204-105-4 115-78-6 T; R25
Xn; R21
Xi; R36/38 T
R: 21-25-36/38
S: (1/2-)36/37/39-45 015-086-00-5 coumithoate (ISO);
O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate — 572-48-5 T; R25 T
R: 25
S: (1/2-)28-36/37-45 015-087-00-0 cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate 220-130-3 2636-26-2 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 015-088-00-6 dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 233-689-3 10311-84-9 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 015-089-00-1 ethoate-methyl (ISO);
ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 204-121-1 116-01-8 Xn; R21/22 Xn
R: 21/22
S: (2-)36/37 015-090-00-7 fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 204-114-3 115-90-2 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61 015-091-00-2 fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate 213-408-0 944-22-9 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61 015-092-00-8 phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 223-874-7 4104-14-7 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61 015-093-00-3 leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 244-472-8 21609-90-5 T; R25-39/25
Xn; R21
N; R50-53 T; N
R: 21-25-39/25-50/53
S: (1/2-)25-36/37/39-45-60-61 015-094-00-9 mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 213-447-3 950-10-7 T+; R27/28
N; R51-53 T+; N
R: 27/28-51/53
S: (1/2-)36/37/39-45-61 015-095-00-4 methamidophos (ISO);
O,S-dimethyl phosphoramidothioate 233-606-0 10265-92-6 T+; R26/28
T; R24
N; R50 T+; N
R: 24-26/28-50
S: (1/2-)28-36/37-45-61 015-096-00-X oxydisulfoton (ISO);
O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate 219-679-1 2497-07-6 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 015-097-00-5 phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 219-997-0 2597-03-7 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)22-36/37-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-098-00-0 trichloronate (ISO);
O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 206-326-1 327-98-0 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)23-28-36/37-45-60-61 015-099-00-6 pirimiphos-ethyl (ISO);
O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 245-704-0 23505-41-1 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)23-36/37-45-60-61 015-100-00-X phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-3 14816-18-3 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)36-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-101-00-5 phosmet (ISO);
O,O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4 732-11-6 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)22-36/37-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-102-00-0 tris(2-chloroethyl) phosphate 204-118-5 115-96-8 Carc. Cat. 3; R40
Xn; R22
N; R51-53 Xn; N
R: 22-40-51/53
S: (2-)36/37-61 015-103-00-6 phosphorus tribromide 232-178-2 7789-60-8 R14
C; R34
Xi; R37 C
R: 14-34-37
S: (1/2-)26-45 015-104-00-1 diphosphorus pentasulphide;
phosphorus pentasulphide 215-242-4 1314-80-3 F; R11
R29
Xn; R20/22
N; R50 F; Xn; N
R: 11-20/22-29-50
S: (2-)61 015-105-00-7 triphenyl phosphite 202-908-4 101-02-0 Xi; R36/38
N; R50-53 Xi; N
R: 36/38-50/53
S: (2-)28-60-61 Xi; R36/38: C ≥ 5 % 015-106-00-2 hexamethylphosphoric triamide;
hexamethylphosphoramide 211-653-8 680-31-9 Carc. Cat. 2; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 Carc. Cat. 2; R45: C ≥ 0,01 % 015-107-00-8 ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate 236-152-1 13194-48-4 T+; R26/27
T; R25
R43
N; R50-53 T+; N
R: 25-26/27-43-50/53
S: (1/2-)27/28-36/37/39-45-60-61 015-108-00-3 bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 218-277-3 2104-96-3 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-) 46-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-109-00-9 crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 231-720-5 7700-17-6 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 015-110-00-4 cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate — 13067-93-1 T; R25-39/25
Xn; R21
Xi; R36
N; R51-53 T; N
R: 21-25-36-39/25-51/53
S: (1/2-)36/37-45-61 015-111-00-X phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate 213-423-2 947-02-4 T+; R27/28 T+
R: 27/28
S: (1/2-)28-36/37-45 015-112-00-5 thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate; 206-049-6 297-97-2 T+; R27/28 T+
R: 27/28
S: (1/2-)36/37/39-38-45 015-114-00-6 chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate 246-538-1 24934-91-6 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61 015-115-00-1 chlorthiophos (ISO) 244-663-6 21923-23-9 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61 015-116-00-7 demephion-O (ISO);
O,O-dimethyl O-2-methylthioethyl phosphorothioate 211-666-9 682-80-4 T+; R28
T; R24 T+
R: 24-28
S: (1/2-)28-36/37-45 015-117-00-2 demephion-S (ISO);
O,O-dimethyl S-2-methylthioethyl phosphorothioate 219-971-9 2587-90-8 T+; R28
T; R24 T+
R: 24-28
S: (1/2-)28-36/37-45 015-118-00-8 demeton — 8065-48-3 T+; R27/28
N; R50 T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61 015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate — 3254-63-5 T+; R27/28 T+
R: 27/28
S: (1/2-)28-36/37-45 015-120-00-9 ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate; 225-875-8 5131-24-8 Xi; R38
R43 Xi
R: 38-43
S: (2-)36/37 015-121-00-4 edifenphos (ISO);
O-ethyl S,S-diphenyl phosphorodithioate 241-178-1 17109-49-8 T; R23/25
Xn; R21
R43
N; R50-53 T; N
R: 21-23/25-43-50/53
S: (1/2-)36/37-45-60-61 015-122-00-X etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate; 253-855-9 38260-54-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 015-123-00-5 fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-124-00-0 fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate; 244-437-7 21548-32-3 T+; R27/28 T+
R: 27/28
S: (1/2-)36/37-45 015-125-00-6 glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine 219-468-4 2439-99-8 Xi; R41 Xi
R: 41
S: (2-)26 015-126-00-1 heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 245-737-0 23560-59-0 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)23-28-37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-127-00-7 iprobenfos (ISO);
S-benzyl diisopropyl phosphorothioate 247-449-0 26087-47-8 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 015-128-00-2 IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate — 5827-05-4 T+; R27
T; R25
N; R50-53 T+; N
R: 25-27-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-129-00-8 isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 246-814-1 25311-71-1 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-130-00-3 isothioate (ISO)
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; — 36614-38-7 T; R24/25 T
R: 24/25
S: (1/2-)28-36/37-45 015-131-00-9 isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 242-624-8 18854-01-8 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;
methylcarbophenothione — 953-17-3 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-133-00-X piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate — 24151-93-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 015-134-00-5 pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate 249-528-5 29232-93-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 015-135-00-0 profenofos (ISO);
O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate 255-255-2 41198-08-7 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)36/37-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO) 250-517-2 31218-83-4 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)37-45-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 015-137-00-1 pyrazophos (ISO);
O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 236-656-1 13457-18-6 Xn; R20/22
N; R50-53 Xn; N
R: 20/22-50/53
S: (2-)36/37-46-60-61 015-138-00-7 quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate 237-031-6 13593-03-8 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)22-36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-139-00-2 terbufos (ISO)
S-tert-butylthiomethyl O,O-diethylphosphorodithioate; 235-963-8 13071-79-9 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 015-140-00-8 triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate 245-986-5 24017-47-8 T; R23/25
Xn; R21
N; R50-53 T; N
R: 21-23/25-50/53
S: (1/2-)36/37-45-60-61 015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers 400-520-1 — C; R34
Xn; R22
N; R50-53 C; N
R: 22-34-50/53
S: (1/2-)24/25-26-28-39-45-60-61 015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate 401-100-0 — F; R11
Xi; R36
N; R51-53 F; Xi; N
R: 11-36-51/53
S: (2-)7/9-16-26-43-61 015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers 401-740-0 — Xn; R22 Xn
R: 22
S: (2-) 015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 402-090-0 87025-52-3 C; R34 C
R: 34
S: (1/2-)26-36/37/39-45 015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate 401-520-4 — N; R50-53 N
R: 50/53
S: 60-61 015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate 401-850-9 — N; R50-53 N
R: 50/53
S: 60-61 015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) 400-930-0 — Xi; R38-41
N; R51-53
R43 Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61 015-148-00-1 2-(diphosphonomethyl)succinic acid 403-070-4 51395-42-7 C; R34
R43 C
R: 34-43
S: (1/2-)26-36/37/39-45 015-149-00-7 reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide 403-470-9 — C; R34
N; R50-53 C; N
R: 34-50/53
S: (1/2-)26-36/37/39-45-60-61 015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 404-940-6 86608-70-0 Xn; R22
Xi; R41
R33
R52-53 Xn
R: 22-33-41-52/53
S: (2-)22-26-39-61 015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate 405-010-2 — N; R51-53 N
R: 51/53
S: 61 015-152-00-3 dioxabenzofos (ISO);
2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide; 223-292-3 3811-49-2 T; R24/25-39/25
N; R51-53 T; N
R: 24/25-39/25-51/53
S: (1/2-)36/37-38-45-61 015-153-00-9 isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate; 255-863-8 42509-80-8 T+; R26
T; R24/25
Xn; R48/20
R43
N; R50-53 T+; N
R: 24/25-26-43-48/20-50/53
S: (1/2-)28-36/37-38-45-59-61 015-154-00-4 2-chloroethylphosphonic acid;
ethephon 240-718-3 16672-87-0 Xn; R20/21
C; R34
R52-53 C
R: 20/21-34-52/53
S: (1/2-)26-28-36/37/39-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 015-155-00-X ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;
glufosinate ammonium 278-636-5 77182-82-2 Xn; R22 Xn
R: 22
S: (2-) 015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 250-366-9 [1]
- [2] 30864-28-9 [1]
62610-77-9 [2] Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61 015-157-00-0 phosphonic acid; [1]
phosphorous acid [2] 237-066-7 [1]
233-663-1 [2] 13598-36-2 [1]
10294-56-1 [2] Xn; R22
C; R35 C
R: 22-35
S: (1/2-)26-36/37/39-45 015-158-00-6 (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) 402-340-9 32760-80-8 R52-53 R: 52/53
S: 61 015-159-00-1 hydroxyphosphonoacetic acid 405-710-8 23783-26-8 Xn; R22-48/22
C; R34
R43 C
R: 22-34-43-48/22
S: (1/2-)22-26-36/37/39-45 015-160-00-7 vanadyl pyrophosphate 406-260-5 58834-75-6 Xi; R36
R43
R52-53 Xi
R: 36-43-52/53
S: (2-)24-26-37-61 015-161-00-2 divanadyl pyrophosphate 407-130-0 65232-89-5 Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61 015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped 407-350-7 — Xn; R20-48/22
Xi; R41
N; R51-53 Xn; N
R: 20-41-48/22-51/53
S: (2-)22-26-36/39-61 015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 412-010-6 145052-34-2 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 400-480-5 36669-85-9 R52-53 R: 52/53
S: 61 015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate 404-986-7 — Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)15-26-39-60-61 015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 410-290-4 80693-00-1 R53 R: 53
S: 61 015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 411-200-6 14657-64-8 Xi; R41 Xi
R: 41
S: (2-)26-39 015-168-00-0 fosthiazate (ISO);
(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate — 98886-44-3 T; R23/25-39
Xn; R21
Xi; R41
R43
N; R50-53 T; N
R: 21-23/25-39-41-43-50/53
S: (1/2-)53-45-25-26-39-60-61 015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate 413-520-1 — Xn; R22-48/22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-48/22-50/53
S: (1/2-)26-28-36/37/39-45-60-61 015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate 407-490-9 — Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-36/37/39-45 015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate 406-940-1 — N; R51-53 N
R: 51/53
S: 61 015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate 406-240-6 — R10
C; R34
N; R51-53 C; N
R: 10-34-51/53
S: (1/2-)23-26-28-36/37/39-45-61 015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 414-080-3 117291-73-3 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)23-36-60-61 015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 411-370-1 82857-68-9 T; R25
Xi; R41
N; R51-53 T; N
R: 25-41-51/53
S: (1/2-)26-37/39-41-45-61 015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 412-880-7 35000-38-5 T; R25
Xn; R48/22
Xi; R36
R43
N; R51-53 T; N
R: 25-36-43-48/22-51/53
S: (1/2-)26-36/37/39-45-61 015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 413-430-2 116163-96-3 N; R50-53 N
R: 50/53
S: 60-61 015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 412-170-7 83623-61-4 Xn; R48/22
Xi; R41
R43 Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39 015-178-00-5 (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 418-570-8 25383-07-7 Repr. Cat. 3; R62
N; R51-53 Xn; N
R: 62-51/53
S: (2-)22-36/37-61 015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 422-720-8 166242-53-1 Carc. Cat. 3; R40
Xn; R22-48/22
C; R34
R43
N; R50-53 C; N
R: 22-34-40-43-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61 015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 415-820-8 137590-32-0 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 015-181-00-1 phosphine 232-260-8 7803-51-2 F+; R12
R17
T+; R26
C; R34
N; R50 F+; T+; N
R: 12-17-26-34-50
S: (1/2-)28-36/37-45-61-63 015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex — — N; R51-53 N
R: 51/53
S: 61 A
015-186-00-9 chlorpyrifos-methyl (ISO),
O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 227-011-5 5598-13-0 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)36/37-60-61 N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 % 015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide 417-540-1 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 R43
R53 Xi
R: 43-53
S: (2-)22-24-37-61 016-001-00-4 hydrogen sulphide 231-977-3 7783-06-4 F+; R12
T+; R26
N; R50 F+; T+; N
R: 12-26-50
S: (1/2-)9-16-36-38-45-61 016-002-00-X barium sulphide 244-214-4 21109-95-5 R31
Xn; R20/22
N; R50 Xn; N
R: 20/22-31-50
S: (2-)28-61 016-003-00-5 barium polysulphides 256-814-3 50864-67-0 R31
Xi; R36/37/38
N; R50 Xi; N
R: 31-36/37/38-50
S: (2-)28-61 016-004-00-0 calcium sulphide 243-873-5 20548-54-3 R31
Xi; R36/37/38
N; R50 Xi; N
R: 31-36/37/38-50
S: (2-)28-61 016-005-00-6 calcium polysulphides 215-709-2 1344-81-6 R31
Xi; R36/37/38
N; R50 Xi; N
R: 31-36/37/38-50
S: (2-)28-61 016-006-00-1 dipotassium sulphide;
potassium sulphide 215-197-0 1312-73-8 R31
C; R34
N; R50 C; N
R: 31-34-50
S: (1/2-)26-45-61 016-007-00-7 potassium polysulphides 253-390-1 37199-66-9 R31
C; R34
N; R50 C; N
R: 31-34-50
S: (1/2-)26-45-61 016-008-00-2 ammonium polysulphides 232-989-1 9080-17-5 R31
C; R34
N; R50 C; N
R: 31-34-50
S: (1/2-)26-45-61 C; R34: C ≥ 5 %
Xi; R36/38: 1 % ≤ C < 5 %
R31: C ≥ 1 % 016-009-00-8 disodium sulphide;
sodium sulphide 215-211-5 1313-82-2 R31
C; R34
N; R50 C; N
R: 31-34-50
S: (1/2-)26-45-61 016-010-00-3 sodium polysulphides 215-686-9 1344-08-7 T; R25
R31
C; R34
N; R50 T; N
R: 25-31-34-50
S: (1/2-)26-36/37/39-45-61 016-011-00-9 sulphur dioxide 231-195-2 7446-09-5 T; R23
C; R34 T
R: 23-34
S: (1/2-)9-26-36/37/39-45 T; R23: C ≥ 20 %
Xn; R20: 5 % ≤ C < 20 % 5
016-012-00-4 disulphur dichloride;
sulfur monochloride 233-036-2 10025-67-9 R14
T; R25
Xn; R20
R29
C; R35
N; R50 T; C; N
R: 14-20-25-29-35-50
S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 016-013-00-X sulphur dichloride 234-129-0 10545-99-0 R14
C; R34
Xi; R37
N; R50 C; N
R: 14-34-37-50
S: (1/2-)26-45-61 016-014-00-5 sulphur tetrachloride — 13451-08-6 R14
C; R34
N; R50 C; N
R: 14-34-50
S: (1/2-)26-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 016-015-00-0 thionyl dichloride;
thionyl chloride 231-748-8 7719-09-7 R14
Xn; R20/22
R29
C; R35 C
R: 14-20/22-29-35
S: (1/2-)26-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 016-016-00-6 sulphuryl chloride 232-245-6 7791-25-5 R14
C; R34
Xi; R37 C
R: 14-34-37
S: (1/2-)26-45 016-017-00-1 chlorosulphonic acid 232-234-6 7790-94-5 R14
C; R35
Xi; R37 C
R: 14-35-37
S: (1/2-)26-45 016-018-00-7 fluorosulphonic acid 232-149-4 7789-21-1 Xn; R20
C; R35 C
R: 20-35
S: (1/2-)26-45 016-019-00-2 oleum ... % SO3 — — R14
C; R35
Xi; R37 C
R: 14-35-37
S: (1/2-)26-30-45 B
016-020-00-8 sulphuric acid ... % 231-639-5 7664-93-9 C; R35 C
R: 35
S: (1/2-)26-30-45 C; R35: C ≥ 15 %
Xi; R36/38: 5 % ≤ C < 15 % B
016-021-00-3 methanethiol;
methyl mercaptan 200-822-1 74-93-1 F+; R12
T; R23
N; R50-53 F+; T; N
R: 12-23-50/53
S: (2-)16-25-60-61 016-022-00-9 ethanethiol;
ethyl mercaptan 200-837-3 75-08-1 F; R11
Xn; R20
N; R50-53 F; Xn; N
R: 11-20-50/53
S: (2-)16-25-60-61 016-023-00-4 dimethyl sulphate 201-058-1 77-78-1 Carc. Cat. 2; R45
Muta. Cat. 3; R68
T+; R26
T; R25
C; R34
R43 T+
R: 45-25-26-34-43-68
S: 53-45 Car. Cat. 2; R45: C ≥ 0,01 %
Muta. Cat. 3, R68: C ≥ 0,01 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % E
016-024-00-X dimexano (ISO);
bis(methoxythiocarbonyl) disulphide 215-993-8 1468-37-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 016-025-00-5 disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES 205-259-5 149-26-8 Xn; R22
Xi; R38-41 Xn
R: 22-38-41
S: (2-)26 016-026-00-0 sulphamidic acid;
sulphamic acid;
sulfamic acid 226-218-8 5329-14-6 Xi; R36/38
R52-53 Xi
R: 36/38-52/53
S: (2-)26-28-61 016-027-00-6 diethyl sulphate 200-589-6 64-67-5 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R20/21/22
C; R34 T
R: 45-46-20/21/22-34
S: 53-45 E
016-028-00-1 sodium dithionite;
sodium hydrosulphite 231-890-0 7775-14-6 R7
R31
Xn; R22 Xn
R: 7-22-31
S: (2-)7/8-26-28-43 016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 — — C; R34 C
R: 34
S: (1/2-)26-37/39-45 C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 % 016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 203-180-0 104-15-4 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)26-37 016-031-00-8 tetrahydrothiophene-1,1-dioxide;
sulpholane 204-783-1 126-33-0 Xn; R22 Xn
R: 22
S: (2-)25 016-032-00-3 1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide 214-317-9 1120-71-4 Carc. Cat. 2; R45
Xn; R21/22 T
R: 45-21/22
S: 53-45 Carc. Cat. 2; R45: C ≥ 0,01 % E
016-033-00-9 dimethylsulfamoylchloride 236-412-4 13360-57-1 Carc. Cat. 2; R45
T+; R26
Xn; R21/22
C; R34 T+
R: 45-21/22-26-34
S: 53-45 E
016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 400-010-9 81898-60-4 R43 Xi
R: 43
S: (2-)22-24-37 016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate 400-120-7 — Xi; R36 Xi
R: 36
S: (2-)22-26 016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate 400-130-1 — R42
N; R51-53 Xn; N
R: 42-51/53
S: (2-)22-61 016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 400-350-8 85153-93-1 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 400-380-1 86393-35-3 R43 Xi
R: 43
S: (2-)22-24-37 016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate 400-430-2 — R43 Xi
R: 43
S: (2-)22-24-37 016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate 400-570-4 — Xi; R36 Xi
R: 36
S: (2-)26 016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate 400-710-4 — Xn; R20 Xn
R: 20
S: (2-) 016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 400-790-0 85665-97-0 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)22-24/25-37 016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate 401-010-1 — R43 Xi
R: 43
S: (2-)24-37 016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate 401-320-7 — R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 401-560-2 108624-00-6 R43 Xi
R: 43
S: (2-)22-24-37 016-046-00-X sodium hydrogensulphate 231-665-7 7681-38-1 Xi; R41 Xi
R: 41
S: (2-)24-26 016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 401-650-1 85665-96-9 R43 Xi
R: 43
S: (2-)22-24-37 016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate 401-870-8 — Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-61 016-049-00-6 calcium octadecylxylenesulphonate 402-040-8 — C; R34
N; R51-53 C; N
R: 34-51/53
S: (1/2-)26-28-36/37/39-45-61 016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat 402-150-6 — Xi; R36
R43 Xi
R: 36-43
S: (2-)22-24-26-37 016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 402-170-5 106359-91-5 R43 Xi
R: 43
S: (2-)22-24-37 016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 402-240-5 102561-46-6 Xn; R20
N; R51-53 Xn; N
R: 20-51/53
S: (2-)22-61 016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate 402-460-1 — Xi; R38
R43
R53 Xi
R: 38-43-53
S: (2-)24-37-61 016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate 400-030-8 — T; R23-48/23
Xn; R22
Xi; R36/37
R43 T
R: 22-23-36/37-43-48/23
S: (1/2-)22-24-36-45 016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) 400-510-7 — Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 016-056-00-4 potassium hydrogensulphate 231-594-1 7646-93-7 C; R34
Xi; R37 C
R: 34-37
S: (1/2-)26-36/37/39-45 016-057-00-X styrene-4-sulfonyl chloride 404-770-2 2633-67-2 Xi; R38-41
R43 Xi
R: 38-41-43
S: (2-)24-26-37/39 016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine 404-820-3 — Xi; R38
R43
R52-53 Xi
R: 38-43-52/53
S: (2-)36/37-61 016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 405-300-9 17339-60-5 Xn; R22
Xi; R36
R43
N; R50-53 Xn; N
R: 22-36-43-50/53
S: (2-)26-36/37-60-61 016-060-00-6 diammonium peroxodisulphate;
ammonium persulphate 231-786-5 7727-54-0 O; R8
Xn; R22
Xi; R36/37/38
R42/43 O; Xn
R: 8-22-36/37/38-42/43
S: (2-)22-24-26-37 016-061-00-1 dipotassium peroxodisulphate;
potassium persulphate 231-781-8 7727-21-1 O; R8
Xn; R22
Xi; R36/37/38
R42/43 O; Xn
R: 8-22-36/37/38-42/43
S: (2-)22-24-26-37 016-062-00-7 bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane — 17606-31-4 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 016-063-00-2 sodium metabisulphite 231-673-0 7681-57-4 Xn; R22
Xi; R41
R31 Xn
R: 22-31-41
S: (2-)26-39-46 016-064-00-8 sodium hydrogensulphite … %;
sodium bisulphite … % 231-548-0 7631-90-5 Xn; R22
R31 Xn
R: 22-31
S: (2-)25-46 B
016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 400-100-8 84057-97-6 N; R51-53 N
R: 51/53
S: 61 016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 404-070-7 116912-62-0 R52-53 R: 52/53
S: 61 016-067-00-4 (4-methylphenyl)mesitylene sulfonate 407-530-5 67811-06-7 R53 R: 53
S: 61 016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 407-720-8 155160-86-4 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 407-990-7 141915-64-2 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone 408-220-2 — R53 R: 53
S: 61 016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 410-130-3 136248-03-8 R43 Xi
R: - 43
S: (2-)22-24-37 016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 411-520-6 112195-27-4 Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61 016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 404-310-0 10591-85-2 R53 R: 53
S: 61 016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene 405-410-7 — Xi; R38-41
R43
N; R51-53 Xi; N
R: 38-41-43-51/53
S: (2-)26-36/37/39-61 016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 411-570-9 41481-66-7 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 411-290-7 131538-00-6 Xn; R22-48/22
N; R50-53 Xn; N
R: 22-48/22-50/53
S: (2-)23-24/25-36-60-61 016-077-00-9 2-chloro-p-toluenesulfochloride 412-890-1 42413-03-6 C; R34
R43
R52-53 C
R: 34-43-52/53
S: (1/2-)23-26-36/37/39-45-61 016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 413-300-5 56187-04-3 R53 R: 53
S: 61 016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 412-920-3 16695-22-0 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 412-320-1 31361-99-6 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide 418-350-1 — Muta. Cat. 3; R68
Xn; R22
Xi; R36
R43
N; R51-53 Xn; N
R: 22-36-43-68-51/53
S: (2-)26-36/37-61 016-082-00-6 ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea — 126801-58-9 N; R50-53 N
R: 50/53
S: 60-61 016-083-00-1 acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester 420-050-0 135158-54-2 Xi; R36/37/38
R43
N; R50-53 Xi; N
R: 36/37/38-43-50/53
S: (2-)24/25-37-46-59-60-61 016-084-00-7 prosulfuron;
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea — 94125-34-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 016-085-00-2 flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea — 104040-78-0 N; R50-53 N
R: 50/53
S: 60-61 016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 402-590-9 109125-56-6 Xi; R41 Xi
R: 41
S: (2-)22-26-39 016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate 403-490-8 104558-95-4 Xi; R36
R43
N; R50-53 Xi; N
R: 36-43-50/53
S: (2-)24-26-37-60-61 016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 407-280-7 71297-11-5 R52-53 R: 52/53
S: 61 016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene 413-840-1 — E; R2
F; R11
R53 E
R: 2-11-53
S: (2-)33-35-40-61 016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 415-040-8 14653-91-9 Xn; R22
Xi; R37-41 Xn
R: 22-37-41
S: (2-)26-39 016-091-00-5 C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate 414-110-5 — Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 414-770-4 140698-96-0 F; R11
Carc. Cat. 3; R40 F; Xn
R: 11-40
S: (2-)7-36/37 016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) 417-980-4 — F; R11
Carc. Cat. 3; R40 F; Xn
R: 11-40
S: (2-)7-36/37 016-096-00-2 thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate — 79277-27-3 N; R50-53 N
R: 50/53
S: 60-61 017-001-00-7 chlorine 231-959-5 7782-50-5 T; R23
Xi; R36/37/38
N; R50 T; N
R: 23-36/37/38-50
S: (1/2-)9-45-61 017-002-00-2 hydrogen chloride 231-595-7 7647-01-0 T; R23
C; R35 T; C
R: 23-35
S: (1/2-)9-26-36/37/39-45 5
017-002-01-X hydrochloric acid ... % 231-595-7 — C; R34
Xi; R37 C
R: 34-37
S: (1/2-)26-45 C; R34-37: C ≥ 25 %
Xi; R36/37/38: 10 % ≤ C < 25 % B
017-003-00-8 barium chlorate 236-760-7 13477-00-4 O; R9
Xn; R20/22
N; R51-53 O; Xn; N
R: 9-20/22-51/53
S: (2-)13-27-61 017-004-00-3 potassium chlorate 223-289-7 3811-04-9 O; R9
Xn; R20/22
N; R51-53 O; Xn; N
R: 9-20/22-51/53
S: (2-)13-16-27-61 017-005-00-9 sodium chlorate 231-887-4 7775-09-9 O; R9
Xn; R22
N; R51-53 O; Xn; N
R: 9-22-51/53
S: (2-)13-17-46-61 017-006-00-4 perchloric acid ... % 231-512-4 7601-90-3 R5
O; R8
C; R35 O; C
R: 5-8-35
S: (1/2-)23-26-36-45 C; R35: C ≥ 50 %
C; R34: 10 % ≤ C < 50 %
Xi; R36/38: 1 % ≤ C < 10 %
Footnote
O; R5-8: C > 50 % B
017-007-00-X barium perchlorate 236-710-4 13465-95-7 O; R9
Xn; R20/22 O; Xn
R: 9-20/22
S: (2-)27 017-008-00-5 potassium perchlorate 231-912-9 7778-74-7 O; R9
Xn; R22 O; Xn
R: 9-22
S: (2-)13-22-27 017-009-00-0 ammonium perchlorate 232-235-1 7790-98-9 O; R9
R44 ⊗ O
R: 9-44
S: (2-)14-16-27-36/37 G
017-010-00-6 sodium perchlorate 231-511-9 7601-89-0 O; R9
Xn; R22 O; Xn
R: 9-22
S: (2-)13-22-27 017-011-00-1 sodium hypochlorite, solution ... % Cl active 231-668-3 7681-52-9 C; R34
R31
N; R50 C; N
R: 31-34-50
S: (1/2-)28-45-50-61 R31: C ≥ 5 % B
017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 O; R8 ⊗
Xn; R22
R31
C; R34
N; R50 O; C; N
R: 8-22-31-34-50
S: (1/2-)26-36/37/39-45-61 C; R34: C ≥ 10 %
Xi; R37/38-41: 3 % ≤ C < 10 %
Xi; R36: 0,5 % ≤ C < 3 % 017-013-00-2 calcium chloride 233-140-8 10043-52-4 Xi; R36 Xi
R: 36
S: (2-)22-24 017-014-00-8 ammonium chloride 235-186-4 12125-02-9 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)22 017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 417-410-4 61807-67-8 Xn; R22
C; R35
R43 C
R: 22-35-43
S: (1/2-)26-36/37/39-45 017-016-00-9 methyltriphenylphosphonium chloride 418-400-2 1031-15-8 Xn; R21/22
Xi; R38-41
N; R51-53 Xn; N
R: 21/22-38-41-51/53
S: (2-)22-26-36/37/39-61 017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 426-210-6 120086-58-0 C; R34
N; R50-53 C; N
R: 34-50/53
S: (2-)26-36/37/39-45-60-61 017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride 405-660-7 — N; R51-53 N
R: 51/53
S: 61 017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 415-110-8 54417-53-7 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 017-020-00-0 ethyl propoxy aluminium chloride 421-790-7 13014-29-4 F; R15
R 14
C; R35 F; C
R: 14/15-35
S: (1/2-)16-23-26-30-36/37/39-43-45 017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 423-420-1 136920-10-0 Xi; R41
R43
N; R50-53 Xi; N
R: 41-43-50/53
S: (2-)26-36/37/39-60-61 019-001-00-2 potassium 231-119-8 7440-09-7 F; R15
R14
C; R34 F; C
R: 14/15-34
S: (1/2-)5-8-45 019-002-00-8 potassium hydroxide;
caustic potash 215-181-3 1310-58-3 Xn; R22
C; R35 C
R: 22-35
S: (1/2-)26-36/37/39-45 C; R35: C ≥ 5 %
C; R34: 2 % ≤ C < 5 %
Xi; R36/38: 0.5 % ≤ C < 2 % 020-001-00-X calcium 231-179-5 7440-70-2 F; R15 F
R: 15
S: (2-)8-24/25-43 020-002-00-5 calcium cyanide 209-740-0 592-01-8 T+; R28
R32
N; R50-53 T+; N
R: 28-32-50/53
S: (1/2-)7/8-23-36/37-45-60-61 020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] 420-470-4 — Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)24-26-37 022-001-00-5 titanium tetrachloride 231-441-9 7550-45-0 R14
C; R34 C
R: 14-34
S: (1/2-)7/8-26-36/37/39-45 022-002-00-0 titanium(4+) oxalate 403-260-7 — Xi; R41 Xi
R: 41
S: (2-)26-39 022-003-00-6 bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 412-000-1 125051-32-3 F; R11
Repr. Cat. 3; R62
Xn; R48/22
N; R51-53 F; Xn; N
R: 11-48/22-62-51/53
S: (2-)7-22-33-36/37-61 023-001-00-8 divanadium pentaoxide;
vanadium pentoxide 215-239-8 1314-62-1 Muta. Cat. 3; R68
Repr. Cat. 3; R63
T; R48/23
Xn; R20/22
Xi; R37
N; R51-53 T; N
R: 20/22-37-48/23-51/53-63-68
S: (1/2-)36/37-38-45-61 024-001-00-0 chromium (VI) trioxide 215-607-8 1333-82-0 O; R9
Carc. Cat. 1; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T+; R26
T; R24/25-48/23
C; R35
R42/43
N; R50-53 O; T+; N
R: 45-46-9-24/25-26-35-42/43-48/23-62-50/53
S: 53-45-60-61 C: R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % E
024-002-00-6 potassium dichromate 231-906-6 7778-50-9 O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53 T+; N; O
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 C; R34: C ≥ 10 %:
Xi; R36/37/38: 5 % ≤ C < 10 % E
3
024-003-00-1 ammonium dichromate 232-143-1 7789-09-5 E; R2
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53 E; T+; N
R: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 % E
3
024-004-00-7 sodium dichromate anhydrate 234-190-3 10588-01-9 O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; 50-53 T+; N; O
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 % E
3
024-004-01-4 sodium dichromate, dihydrate 234-190-3 7789-12-0 O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53 T+; N; O
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 % E
3
024-005-00-2 chromyl dichloride;
chromic oxychloride 239-056-8 14977-61-8 O; R8
Carc. Cat. 2; R49
Muta. Cat. 2; R46
C; R35
R43
N; R50-53 O; T; C; N
R: 49-46-8-35-43-50/53
S: 53-45-60-61 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 0,5 % ≤ C < 5 %
R43: C ≥ 0,5 % 3
024-006-00-8 potassium chromate 232-140-5 7789-00-6 Carc. Cat. 2; R49
Muta. Cat. 2; R46
Xi; R36/37/38
R43
N; R50-53 T; N
R: 49-46-36/37/38-43-50/53
S: 53-45-60-61 R43: C ≥ 0,5 % 3
024-007-00-3 zinc chromates including zinc potassium chromate — — Carc. Cat. 1; R45
Xn; R22
R43
N; R50-53 T; N
R: 45-22-43-50/53
S: 53-45-60-61 AE
024-008-00-9 calcium chromate 237-366-8 13765-19-0 Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 E
024-009-00-4 strontium chromate 232-142-6 7789-06-2 Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 E
024-010-00-X dichromium tris(chromate);
chromium III chromate;
chromic chromate 246-356-2 24613-89-6 O; R8
Carc. Cat. 2; R45
C; R35
R43
N; R50-53 O; T; C; N
R: 45-8-35-43-50/53
S: 53-45-60-61 024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 400-110-2 109125-51-1 F; R11
N; R50-53 F; N
R: 11-50/53
S: (2-)33-60-61 024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) 400-810-8 — Muta. Cat. 3; R68 Xn
R: 68
S: (2-)22-36/37 024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) 402-500-8 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 402-870-0 93952-24-0 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) 404-930-1 — Xn; R20
Xi; R41
N; R51-53 Xn; N
R: 20-41-51/53
S: (2-)26-39-61 024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 405-110-6 88377-66-6 Xn; R48/22
R53 Xn
R: 48/22-53
S: (2-)22-36-61 024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex — — Carc. Cat. 2; R49
R43
N; R50-53 T; N
R: 49-43-50/53
S: 53-45-60-61 A
024-018-00-3 sodium chromate 231-889-5 7775-11-3 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53 T+; N
R: 45-46-60-61-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 R42/43: C ≥ 0,2 % E
3
024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-230-1 — R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III) 418-220-4 — R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 025-001-00-3 manganese dioxide 215-202-6 1313-13-9 Xn; R20/22 Xn
R: 20/22
S: (2-)25 025-002-00-9 potassium permanganate 231-760-3 7722-64-7 O; R8
Xn; R22
N; R50-53 O; Xn; N
R: 8-22-50/53
S: (2-)60-61 025-003-00-4 manganese sulphate 232-089-9 7785-87-7 Xn; R48/20/22
N; R51-53 Xn; N
R: 48/20/22-51/53
S: (2-)22-61 025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 411-760-1 116633-53-5 N; R51-53 N
R: 51/53
S: 61 025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) 417-660-4 — N; R50-53 N
R: 50/53
S: 60-61 026-001-00-6 (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate 407-840-0 100011-37-8 Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)22-26-39-61 026-002-00-1 (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate 407-880-9 117549-13-0 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)26-61 027-001-00-9 cobalt 231-158-0 7440-48-4 R42/43
R53 Xn
R: 42/43-53
S: (2-)22-24-37-61 027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 027-003-00-X cobalt sulphide 215-273-3 1317-42-6 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 027-004-00-5 cobalt dichloride 231-589-4 7646-79-9 Carc. Cat. 2; R49
Xn; R22
R42/43
N; R50-53 T; N
R: 49-22-42/43-50/53
S: (2-)22-53-45-60-61 Carc. Cat. 2; R49: C ≥ 0,01 %
Xn; R22: C ≥ 2,5 % E
1
027-005-00-0 cobalt sulphate 233-334-2 10124-43-3 Carc. Cat. 2; R49
Xn; R22
R42/43
N; R50-53 T; N
R: 49-22-42/43-50/53
S: (2-)22-53-45-60-61 Carc. Cat. 2; R49: C ≥ 0,01 % E
1
028-001-00-1 tetracarbonylnickel;
nickel tetracarbonyl 236-669-2 13463-39-3 F; R11
Carc. Cat. 3; R40
Repr. Cat. 2; R61
T+; R26
N; R50-53 F; T+; N
R: 61-11-26-40-50/53
S: 53-45-60-61 E
028-002-00-7 nickel 231-111-4 7440-02-0 Carc. Cat. 3; R40
R43 Xn
R: 40-43
S: (2-)22-36 028-003-00-2 nickel monoxide 215-215-7 1313-99-1 Carc. Cat. 1; R49
R43
R53 T
R: 49-43-53
S: 53-45-61 028-004-00-8 nickel dioxide 234-823-3 12035-36-8 Carc. Cat. 1; R49
R43
R53 T
R: 49-43-53
S: 53-45-61 028-005-00-3 dinickel trioxide 215-217-8 1314-06-3 Carc. Cat. 1; R49
R43
R53 T
R: 49-43-53
S: 53-45-61 028-006-00-9 nickel sulphide 240-841-2 16812-54-7 Carc. Cat. 1; R49
R43
N; R50-53 T; N
R: 49-43-50/53
S: 53-45-60-61 028-007-00-4 nickel subsulphide;
trinickel disulphide 234-829-6 12035-72-2 Carc. Cat. 1; R49
R43
N; R51-53 T; N
R: 49-43-51/53
S: 53-45-61 028-008-00-X nickel dihydroxide 235-008-5 12054-48-7 Carc. Cat. 3; R40
Xn; R20/22
R43
N; R50-53 Xn; N
R: 20/22-40-43-50/53
S: (2-)22-36-60-61 028-009-00-5 nickel sulphate 232-104-9 7786-81-4 Carc. Cat. 3; R40
Xn; R22
R42/43
N; R50-53 Xn; N
R: 22-40-42/43-50/53
S: (2-)22-36/37-60-61 028-010-00-0 nickel carbonate 222-068-2 3333-67-3 Carc. Cat. 3; R40
Xn; R22
R43
N; R50-53 Xn; N
R: 22-40-43-50/53
S: (2-)22-36/37-60-61 029-001-00-4 copper chloride;
copper (I) chloride;
cuprous chloride 231-842-9 7758-89-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-60-61 029-002-00-X dicopper oxide;
copper (I) oxide 215-270-7 1317-39-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-60-61 029-003-00-5 Naphthenic acids, copper salts;
copper naphthenate 215-657-0 1338-02-9 R10
Xn; R22
N; R50-53 Xn; N
R: 10-22-50/53
S: (2-)60-61 029-004-00-0 copper sulphate 231-847-6 7758-98-7 Xn; R22
Xi; R36/38
N; R50-53 Xn; N
R: 22-36/38-50/53
S: (2-)22-60-61 029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid 401-260-1 — Xi; R36 Xi
R: 36
S: (2-)26 029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) 403-210-4 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)22-26-39-61 029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 404-670-9 89797-01-3 E; R2
R43 E; Xi
R: 2-43
S: (2-)22-24-35-37 029-008-00-2 copper(II) methanesulfonate 405-400-2 54253-62-2 Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-50/53
S: (2-)26-36/37/39-60-61 029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 413-650-9 93971-95-0 R52-53 R: 52/53
S: 61 029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 407-700-9 101408-30-4 R43 Xi
R: 43
S: (2-)24-37 029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 412-730-0 150522-10-4 C; R34 C
R: 34
S: (1/2-)22-26-36/37/39-45 029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 407-340-2 124719-24-0 Xi; R41 Xi
R: 41
S: (2-)26-39 029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)24-37-61 030-001-00-1 zinc powder — zinc dust (pyrophoric) 231-175-3 7440-66-6 F; R15-17
N; R50-53 F; N
R: 15-17-50/53
S: (2-)43-46-60-61 030-001-01-9 zinc powder — zinc dust (stabilised) 231-175-3 7440-66-6 N; R50-53 N
R: 50/53
S: 60-61 030-003-00-2 zinc chloride 231-592-0 7646-85-7 C; R34
Xn; R22
N; R50-53 C; N
R: 22-34-50/53
S: (1/2-)26-36/37/39-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 030-004-00-8 dimethylzinc; [1]
diethylzinc [2] 208-884-1 [1]
209-161-3 [2] 544-97-8 [1]
557-20-0 [2] F; R17
R14
C; R34
N; R50-53 F; C; N
R: 14-17-34-50/53
S: (1/2-)16-43-45-60-61 030-005-00-3 diamminediisocyanatozinc 401-610-3 — Xn; R22
Xi; R41
R42/43
N; R50 Xn; N
R: 22-41-42/43-50
S: (2-)22-26-36/37/39-41-61 030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2] 231-793-3 [1]
231-793-3 [2] 7446-19-7 [1]
7733-02-0 [2] Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-50/53
S: (2-)22-26-39-46-60-61 030-007-00-4 bis(3,5-di-tert-butylsalicylato-O1,O2)zinc 403-360-0 42405-40-3 F; R11
Xn; R22
N; R50-53 F; Xn; N
R: 11-22-50/53
S: (2-)7-22-60-61 030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 403-750-0 113036-91-2 Xn; R20
N; R51-53 Xn; N
R: 20-51/53
S: (2-)22-57-61 030-011-00-6 trizinc bis(orthophosphate) 231-944-3 7779-90-0 N; R50-53 N
R: 50/53
S: 60-61 030-013-00-7 zinc oxide 215-222-5 1314-13-2 N; R50-53 N
R: 50/53
S: 60-61 033-001-00-X arsenic 231-148-6 7440-38-2 T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)20/21-28-45-60-61 033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex — — T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)20/21-28-45-60-61 T; R23/25: C ≥ 0,2 %
Xn; R20/22: 0,1 % ≤ C < 0,2 % A
1
033-003-00-0 diarsenic trioxide;
arsenic trioxide 215-481-4 1327-53-3 Carc. Cat. 1; R45
T+; R28
C; R34
N; R50-53 T+; N
R: 45-28-34-50/53
S: 53-45-60-61 E
033-004-00-6 diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide 215-116-9 1303-28-2 Carc. Cat. 1; R45
T; R23/25
N; R50-53 T; N
R: 45-23/25-50/53
S: 53-45-60-61 E
033-005-00-1 arsenic acid and its salts — — Carc. Cat. 1; R45
T; R23/25
N; R50-53 T; N
R: 45-23/25-50/53
S: 53-45-60-61 AE
033-006-00-7 arsine 232-066-3 7784-42-1 F+; R12
T+; R26
Xn; R48/20
N; R50-53 F+; T+; N
R: 12-26-48/20-50/53
S: (1/2-)9-16-28-33-36/37-45-60-61 033-007-00-2 tert-butylarsine 423-320-6 4262-43-5 F; R17
T+; R26 F; T+
R: 17-26
S: (1/2-)9-28-36/37-43-45 034-001-00-2 selenium 231-957-4 7782-49-2 T; R23/25
R33
R53 T
R: 23/25-33-53
S: (1/2-)20/21-28-45-61 034-002-00-8 selenium compounds except cadmium sulphoselenide — — T; R23/25
R33
N; R50-53 T; N
R: 23/25-33-50/53
S: (1/2-)20/21-28-45-60-61 A
034-003-00-3 sodium selenite 233-267-9 10102-18-8 T+; R28
T; R23
R31
R43
N; R51-53 T+; N
R: 23-28-31-43-51/53
S: (1/2-)28-36/37-45-61 035-001-00-5 bromine 231-778-1 7726-95-6 T+; R26
C; R35
N; R50 T+; C; N
R: 26-35-50
S: (1/2-)7/9-26-45-61 035-002-00-0 hydrogen bromide 233-113-0 10035-10-6 C; R35
Xi; R37 C
R: 35-37
S: (1/2-)7/9-26-45 035-002-01-8 hydrobromic acid ... % — — C; R34
Xi; R37 C
R: 34-37
S: (1/2-)7/9-26-45 C; R34: C ≥ 40 %
Xi; R36/38: 10 % ≤ C < 40 %
Xi; R37: C ≥ 10 % B
035-003-00-6 potassium bromate 231-829-8 7758-01-2 O; R9
Carc. Cat. 2; R45
T; R25 T; O
R: 45-9-25
S: 53-45 E
035-004-00-1 2-hydroxyethylammonium perbromide 407-440-6 — O; R8
Xn; R22
C; R35
R43
N; R50 O; C; N
R: 8-22-35-43-50
S: (1/2-)3/7-14-26-36/37/39-45-60-61 040-001-00-3 zirconium powder (pyrophoric) 231-176-9 7440-67-7 F; R15-17 F
R: 15-17
S: (2-)7/8-43 040-002-00-9 zirconium powder (non pyrophoric) — — F; R15 F
R: 15
S: (2-)7/8-43 042-001-00-9 molybdenum trioxide 215-204-7 1313-27-5 Xn; R48/20/22
Xi; R36/37 Xn
R: 36/37-48/20/22
S: (2-)22-25 042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) 404-760-8 117342-25-3 T; R23
Xi; R41
R53 T
R: 23-41-53
S: (1/2-)26-37/39-45-61 042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 404-860-1 116810-46-9 F; R11
Xi; R41
N; R50-53 F; Xi; N
R: 11-41-50/53
S: (2-)26-39-60-61 042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) 412-780-3 — Xi; R38
R43
N; R51-53 Xi; N
R: 38-43-51/53
S: 24/25-37-61 047-001-00-2 silver nitrate 231-853-9 7761-88-8 ⊗ C; R34
N; R50-53 C; N
R: 34-50/53
S: (1/2-)26-45-60-61 048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex — — Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)60-61 Xn; R20/21/22: C ≥ 0,1 % A
1
048-002-00-0 cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2] 231-152-8 [1]
215-146-2 [2] 7440-43-9 [1]
1306-19-0 [2] Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T+; R26
T; R48/23/25
N; R50-53 T+; N
R: 45-26-48/23/25-62-63-68-50/53
S: 53-45-60-61 E
048-003-00-6 cadmium diformate;
cadmiumformate 224-729-0 4464-23-7 T; R23/25
R33
Xn; R68
N; R50-53 T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %
Xn; R20/22: 0,25 % ≤ C < 10 %
R33: C ≥ 0,25 % 048-004-00-1 cadmium cyanide 208-829-1 542-83-6 T+; R26/27/28
R32
R33
Xn; R68
N; R50-53 T+; N
R: 26/27/28-32-33-68-50/53
S: (1/2-)7-28-29-45-60-61 R32: C ≥ 1 %
R33: C ≥ 0,1 % 048-005-00-7 cadmiumhexafluorosilicate(2-);
cadmium fluorosilica 241-084-0 17010-21-8 T; R23/25
R33
Xn; R68
N; R50-53 T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %
Xn; R20/22: 0,1 % ≤ C < 10 %
R33: C ≥ 0,1 % 048-006-00-2 cadmium fluoride 232-222-0 7790-79-6 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53 T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-007-00-8 cadmium iodide 232-223-6 7790-80-9 T; R23/25
R33
Xn; R68
N; R50-53 T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %
Xn; R20/22: 0,1 % ≤ C < 10 %
R33: C ≥ 0,1 % 048-008-00-3 cadmium chloride 233-296-7 10108-64-2 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53 T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-009-00-9 cadmium sulphate 233-331-6 10124-36-4 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53 T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-010-00-4 cadmium sulphide 215-147-8 1306-23-6 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T; R48/23/25
Xn; R22
R53 T;
R: 45-22-48/23/25-62-63-68-53
S: 53-45-61 Xn; R22: C ≥ 10 %
T; R48/23/25: C ≥ 10 %
Xn; R48/20/22: 0,1 % ≤ C < 10 % E
1
048-011-00-X cadmium (pyrophoric) 231-152-8 7440-43-9 F; R17
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T+; R26
T; R48/23/25
N; R50-53 F; T+; N
R: 45-17-26-48/23/25-62-63-68-50/53
S: 53-45-7/8-43-60-61 E
050-001-00-5 tin tetrachloride;
stannic chloride 231-588-9 7646-78-8 C; R34
R52-53 C
R: 34-52/53
S: (1/2-)7/8-26-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 050-002-00-0 cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide 236-049-1 13121-70-5 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 050-003-00-6 fentin acetate (ISO);
triphenyltin acetate 212-984-0 900-95-8 Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53 T+; N
R: 24/25-26-37/38-40-41-48/23-50/53-63
S: (1/2-)26-28-36/37/39-45-60-61 050-004-00-1 fentin hydroxide (ISO);
triphenyltin hydroxide 200-990-6 76-87-9 Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53 T+; N
R: 24/25-26-37/38-40-41-48/23-50/53-63
S: (1/2-)26-28-36/37/39-45-60-61 050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)26-27-28-45-60-61 T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 % A
1
050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)26-27-28-45-60-61 T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 % A
1
050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61 T; R23/24/25: C ≥ 0,5 %
Xn; R20/21/22: 0,1 % ≤ C < 0,5 % A
1
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53 T; N
R: 21-25-36/38-48/23/25-50/53
S: (1/2-)35-36/37/39-45-60-61 T; R25: C ≥ 1 %
Xn; R22: 0,25 % ≤ C < 1 %
T; R48/23/25: C ≥ 1 %
Xn; R48/20/22: 0,25 % ≤ C < 1 %
Xn; R21: C ≥ 1 %
Xi; R36/38: C ≥ 1 % A
1
050-009-00-9 fluorotripentylstannane; [1]
hexapentyldistannoxane [2] 243-546-7 [1]
247-143-7 [2] 20153-49-5 [1]
25637-27-8 [2] Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % 1
050-010-00-4 fluorotrihexylstannane 243-547-2 20153-50-8 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % 1
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,25 % ≤ C < 1 % A
1
050-012-00-5 tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3] 215-910-5 [1]
221-437-5 [2]
230-358-5 [3] 1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3] Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % A
1
050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38
R53 Xi
R: 36/37/38-53
S: (2-)61 Xi; R36/37/38: C ≥ 1 % A
1
050-017-00-2 fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide 236-407-7 13356-08-6 T+; R26
Xi; R36/38
N; R50-53 T+; N
R: 26-36/38-50/53
S: (1/2-)28-36/37-45-60-61 050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 C; R34
Xn; R22
R43 C
R: 22-34-43
S: (1/2-)22-26-36/37/39-45 050-019-00-3 azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H-1,2,4-triazole; 255-209-1 41083-11-8 T+; R26
T; R25
Xi; R37/38-41
N; R50-53 T+; N
R: 25-26-37/38-41-50/53
S: (1/2-)26-28-36/37/39-38-45-60-61 050-020-00-9 trioctylstannane 413-320-4 869-59-0 T; R48/25
Xi; R38
R53 T
R: 38-48/25-53
S: (1/2-)23-36/37-45-61 051-001-00-8 antimony trichloride 233-047-2 10025-91-9 C; R34
N; R51-53 C; N
R: 34-51/53
S: (1/2-)26-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 051-002-00-3 antimony pentachloride 231-601-8 7647-18-9 C; R34
N; R51-53 C; N
R: 34-51/53
S: (1/2-)26-45-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex — — Xn; R20/22
N; R51-53 Xn; N
R: 20/22-51/53
S: (2-)61 Xn; R20/22: C ≥ 0,25 % A
1
051-004-00-4 antimony trifluoride 232-009-2 7783-56-4 T; R23/24/25
N; R51-53 T; N
R: 23/24/25-51/53
S: (1/2-)7-26-45-61 051-005-00-X antimony trioxide 215-175-0 1309-64-4 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)22-36/37 051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate 403-500-0 — R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 404-420-9 71786-70-4 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 053-001-00-3 iodine 231-442-4 7553-56-2 Xn; R20/21
N; R50 Xn; N
R: 20/21-50
S: (2-)23-25-61 053-002-00-9 hydrogen iodide 233-109-9 10034-85-2 C; R35 C
R: 35
S: (1/2-)9-26-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 0,2 % ≤ C < 10 %
Xi; R36/37/38: 0,02 % ≤ C < 0,2 % 5
053-002-01-6 hydriodic acid ... % — — C; R34 C
R: 34
S: (1/2-)26-45 C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 % B
053-003-00-4 iodoxybenzene — 696-33-3 E; R1 ⊗ E
R: 1
S: (2-)35 053-004-00-X calcium iodoxybenzoate — — E; R1 ⊗ E
R: 1
S: (2-)35 C
053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 422-960-3 178233-72-2 Xn; R21/22-48/22
N; R50-53 Xn; N
R: 21/22-48/22-50/53
S: (2-)22-36/37-60-61 056-001-00-1 barium peroxide 215-128-4 1304-29-6 O; R8
Xn; R20/22 O; Xn
R: 8-20/22
S: (2-)13-27 056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex — — Xn; R20/22 Xn
R: 20/22
S: (2-)28 Xn; R20/22: C ≥ 1 % A
1
056-003-00-2 barium carbonate 208-167-3 513-77-9 Xn; R22 Xn
R: 22
S: (2-)24/25 056-004-00-8 barium chloride 233-788-1 10361-37-2 T; R25
Xn; R20 T
R: 20-25
S: (1/2-)45 072-001-00-4 hafnium tetra-n-butoxide 411-740-2 22411-22-9 Xi; R41
R43 Xi
R: 41-43
S: (2-)24/25-26-37/39 074-001-00-X hexasodium tungstate hydrate 412-770-9 12141-67-2 Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)22-26-39-61 074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione 408-250-6 — F; R11
Xn; R20
C; R34
R43
N; R50-53 F; C; N
R: 11-20-34-43-50/53
S: (1/2-)16-26-29-33-36/37/39-45-60-61 076-001-00-5 osmium tetraoxide;
osmic acid 244-058-7 20816-12-0 T+; R26/27/28
C; R34 T+
R: 26/27/28-34
S: (1/2-)7/9-26-45 078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex — — T; R25
Xi; R41
R42/43 T
R: 25-41-42/43
S: (2-)22-26-36/37/39-45 A
078-002-00-6 diammonium tetrachloroplatinate 237-499-1 13820-41-2 T; R25
Xi; R38-41
R42/43 T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45 078-003-00-1 disodium tetrachloroplatinate 233-051-4 10026-00-3 T; R25
Xi; R38-41
R42/43 T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45 078-004-00-7 dipotassium tetrachloroplatinate 233-050-9 10025-99-7 T; R25
Xi; R38-41
R42/43 T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45 078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex — — T; R25
Xi; R41
R42/43 T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45 A
078-006-00-8 disodium hexachloroplatinate 240-983-5 16923-58-3 T; R25
Xi; R41
R42/43 T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45 078-007-00-3 dipotassium hexachloroplatinate 240-979-3 16921-30-5 T; R25
Xi; R41
R42/43 T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45 078-008-00-9 diammonium hexachloroplatinate 240-973-0 16919-58-7 T; R25
Xi; R41
R42/43 T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45 078-009-00-4 hexachloroplatinic acid 241-010-7 16941-12-1 T; R25
C; R34
R42/43 T
R: 25-34-42/43
S: (1/2-)22-26-36/37/39-45 080-001-00-0 mercury 231-106-7 7439-97-6 T; R23
R33
N; R50-53 T; N
R: 23-33-50/53
S: (1/2-)7-45-60-61 080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex — — T+; R26/27/28
R33
N; R50-53 T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-45-60-61 T+; R26/27/28: C ≥ 2 %
T; R23/24/25: 0,5 % ≤ C < 2 %
Xn; R20/21/22: 0,1 % ≤ C < 0,5 %
R33: C ≥ 0,1 % A
1
080-003-00-1 dimercury dichloride;
mercurous chloride;
calomel 233-307-5 10112-91-1 Xn; R22
Xi; R36/37/38
N; R50-53 Xn; N
R: 22-36/37/38-50/53
S: (2-)13-24/25-46-60-61 080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex — — T+; R26/27/28
R33
N; R50-53 T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-36-45-60-61 T+; R26/27/28: C ≥ 2 %
T; R23/24/25: 0,5 % ≤ C < 2 %
Xn; R20/21/22: 0,05 % ≤ C < 0,5 %
R33: C ≥ 0,05 % A
1
080-005-00-2 mercury difulminate;
mercuric fulminate;
fulminate of mercury 211-057-8 628-86-4 E; R3
T; R23/24/25
R33
N; R50-53 E; T; N
R: 3-23/24/25-33-50/53
S: (1/2-)3-45-60-61 080-006-00-8 dimercury dicyanide oxide;
mercuric oxycyanide 215-629-8 1335-31-5 E; R3 ⊗
T; R23/24/25
R33
N; R50-53 E; T; N
R: 3-23/24/25-33-50/53
S: (1/2-)28-35-45-60-61 080-007-00-3 dimethylmercury; [1]
diethylmercury [2] 209-805-3 [1]
211-000-7 [2] 593-74-8 [1]
627-44-1 [2] T+; R26/27/28
R33
N; R50-53 T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-36-45-60-61 T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
R33: C ≥ 0,05 % 1
080-008-00-9 phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3] 200-242-9 [1]
202-866-7 [2]
- [3] 55-68-5 [1]
100-57-2 [2]
8003-05-2 [3] T; R25-48/24/25
C; R34
N; R50-53 T; N
R: 25-34-48/24/25-50/53
S: (1/2-)23-24/25-37-45-60-61 080-009-00-4 2-methoxyethylmercury chloride 204-659-7 123-88-6 T; R25-48/25
C; R34
N; R50-53 T; N
R: 25-34-48/25-50/53
S: (1/2-)36/37/39-45-60-61 080-010-00-X mercury dichloride;
mercuric chloride 231-299-8 7487-94-7 T+; R28
T; R48/24/25
C; R34
N; R50-53 T+; N
R: 28-34-48/24/25-50/53
S: (1/2-)36/37/39-45-60-61 080-011-00-5 phenylmercury acetate 200-532-5 62-38-4 T; R25-48/24/25
C; R34
N; R50-53 T; N
R: 25-34-48/24/25-50/53
S: (1/2-)23-24/25-37-45-60-61 081-001-00-3 thallium 231-138-1 7440-28-0 T+; R26/28
R33
R53 T+
R: 26/28-33-53
S: (1/2-)13-28-45-61 081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/28
R33
N; R51-53 T+; N
R: 26/28-33-51/53
S: (1/2-)13-28-45-61 A
081-003-00-4 dithallium sulphate;
thallic sulphate 231-201-3 7446-18-6 T+; R28
T; R48/25
Xi; R38
N; R51-53 T+; N
R: 28-38-48/25-51/53
S: (1/2-)13-36/37-45-61 082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex — — Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53 T; N
R: 61-20/22-33-62-50/53
S: 53-45-60-61 Repr. Cat. 3; R62: C ≥ 2,5 %
Xn; R20/22: C ≥ 1 %
R33: C ≥ 0,5 % AE
1
082-002-00-1 lead alkyls — — Repr. Cat. 1; R61
Repr. Cat. 3; R62
T+; R26/27/28
R33
N; R50-53 T+; N
R: 61-26/27/28-33-62-50/53
S: 53-45-60-61 Repr. Cat. 1; R61: C ≥ 0,1 %
T+; R26/27/28: C ≥ 0,25 %
T; R23/24/25: 0,1 % ≤ C < 0,25 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
R33: C ≥ 0,05 % AE
1
082-003-00-7 lead diazide;
lead azide 236-542-1 13424-46-9 E; R3
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53 E; T; N
R: 61-3-20/22-33-50/53-62
S: 53-45-60-61 E
1
082-004-00-2 lead chromate 231-846-0 7758-97-6 Carc. Cat. 3; R40
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53 T; N
R: 61-33-40-50/53-62
S: 53-45-60-61 1
082-005-00-8 lead di(acetate) 206-104-4 301-04-2 Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53 T; N
R: 61-33-48/22-50/53-62
S: 53-45-60-61 E
1
082-006-00-3 trilead bis(orthophosphate) 231-205-5 7446-27-7 Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53 T; N
R: 61-33-48/22-50/53-62
S: 53-45-60-61 E
1
082-007-00-9 lead acetate, basic; 215-630-3 1335-32-6 Carc. Cat. 3; R40
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53 T; N
R: 61-33-40-48/22-50/53-62
S: 53-45-60-61 E
1
082-008-00-4 lead(II) methanesulphonate 401-750-5 17570-76-2 Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22-48/20/22
Xi; R38-41
N; R58
R33 T; N
R: 61-62-20/22-33-38-41-48/20/22-58
S: 53-45-57-61 E
1
082-009-00-X Lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 215-693-7 1344-37-2 Carc. Cat. 3; R40
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53 T; N
R: 61-33-40-50/53-62
S: 53-45-60-61 1
082-010-00-5 Lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 235-759-9 12656-85-8 Carc. Cat. 3; R40
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53 T; N
R: 61-33-40-50/53-62
S: 53-45-60-61 1
082-011-00-0 lead hydrogen arsenate 232-064-2 7784-40-9 Carc. Cat. 1; R45
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R23/25
R33
N; R50-53 T; N
R: 45-61-23/25-33-50/53-62
S: 53-45-60-61 E
1
092-001-00-8 uranium 231-170-6 7440-61-1 T+; R26/28
R33
R53 T+
R: 26/28-33-53
S: (1/2-)20/21-45-61 092-002-00-3 uranium compounds — — T+; R26/28
R33
N; R51-53 T+; N
R: 26/28-33-51/53
S: (1/2-)20/21-45-61 A
601-001-00-4 methane 200-812-7 74-82-8 F+; R12 F+
R: 12
S: (2-)9-16-33 601-002-00-X ethane 200-814-8 74-84-0 F+; R12 F+
R: 12
S: (2-)9-16-33 601-003-00-5 propane 200-827-9 74-98-6 F+; R12 F+
R: 12
S: (2-)9-16 601-004-00-0 butane; [1]
and isobutane [2] 203-448-7 [1]
200-857-2 [2] 106-97-8 [1]
75-28-5 [2] F+; R12 F+
R: 12
S: (2-)9-16 C
601-004-01-8 butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] 203-448-7 [1]
200-857-2 [2] 106-97-8 [1]
75-28-5 [2] F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46 F+; T
R: 45-46-12
S: 53-45 CS
601-005-00-6 2,2-dimethylpropane;
neopentane 207-343-7 463-82-1 F+; R12
N; R51-53 F+; N
R: 12-51/53
S: (2-)9-16-33-61 601-006-00-1 pentane; [1]
isopentane;
2-methylbutane [2] 203-692-4 [1]
201-142-8 [2] 109-66-0 [1]
78-78-4 [2] F+; R12
Xn; R65
R66
R67
N; R51-53 F+; Xn; N
R: 12-51/53-65-66-67
S: (2-)9-16-29-33-61-62 C
601-007-00-7 hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6)) — — F; R11
Xn; R65
Xi; R38
R67
N; R51-53 F; Xn; N
R: 11-38-51/53-65-67
S: (2-)9-16-29-33-61-62 C
601-008-00-2 heptane [and isomers] [1] 205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10] 142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10] F; R11
Xn; R65
Xi; R38
R67
N; R50-53 F; Xn; N
R: 11-38-50/53-65-67
S: (2-)9-16-29-33-60-61-62 C
601-009-00-8 octane [and isomers] [1] 203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12] 111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19] F; R11
Xn; R65
Xi; R38
R67
N; R50-53 F; Xn; N
R: 11-38-50/53-65-67
S: (2-)9-16-29-33-60-61-62 C
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19] 601-010-00-3 ethylene 200-815-3 74-85-1 F+; R12
R67 F+
R: 12-67
S: (2-)9-16-33-45 601-011-00-9 propene;
propylene 204-062-1 115-07-1 F+; R12 F+
R: 12
S: (2-)9-16-33 601-012-00-4 but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5] 203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5] 106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5] F+; R12 F+
R: 12
S: (2-)9-16-33 C
601-013-00-X 1,3-butadiene;
buta-1,3-diene 203-450-8 106-99-0 F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46 F+; T
R: 45-46-12
S: 53-45 D
601-014-00-5 isoprene (stabilised)
2-methyl-1,3-butadiene 201-143-3 78-79-5 F+; R12
Carc. Cat. 2; R45
Muta. Cat. 3; R68
R52-53 F+; T
R: 45-12-68-52/53
S: 53-45-61 D
601-015-00-0 acetylene;
ethyne 200-816-9 74-86-2 R5
R6
F+; R12 F+
R: 5-6-12
S: (2-)9-16-33 601-016-00-6 cyclopropane 200-847-8 75-19-4 F+; R12 F+
R: 12
S: (2-)9-16-33 601-017-00-1 cyclohexane 203-806-2 110-82-7 F; R11
Xn; R65
Xi; R38
R67
N; R50-53 F; Xn; N
R: 11-38-65-67-50/53
S: (2-)9-16-25-33-60-61-62 601-018-00-7 methylcyclohexane 203-624-3 108-87-2 F; R11
Xn; R65
Xi; R38
R67
N; R51-53 F; Xn; N
R: 11-38-51/53-65-67
S: (2-)9-16-33-61-62 601-019-00-2 1,4-dimethylcyclohexane 209-663-2 589-90-2 F; R11
Xn; R65
Xi; R38
R67
N; R51-53 F; Xn; N
R: 11-38-51/53-65-67
S: (2-)9-16-33-61-62 601-020-00-8 benzene 200-753-7 71-43-2 F; R11
Carc. Cat. 1; R45
Muta. Cat. 2; R46
T; R48/23/24/25
Xn; R65
Xi; R36/38 F; T
R: 45-46-11-36/38-48/23/24/25-65
S: 53-45 E
601-021-00-3 toluene 203-625-9 108-88-3 F; R11
Repr. Cat. 3; R63
Xn; R48/20-65
Xi; R38
R67 F; Xn
R: 11-38-48/20-63-65-67
S: (2-)36/37-46-62 601-022-00-9 o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4] 202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4] 95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4] R10
Xn; R20/21
Xi; R38 Xn
R: 10-20/21-38
S: (2-)25 Xn; R20/21: C ≥ 12,5 % C
601-023-00-4 ethylbenzene 202-849-4 100-41-4 F; R11
Xn; R20 F; Xn
R: 11-20
S: (2-)16-24/25-29 601-024-00-X cumene; [1]
propylbenzene [2] 202-704-5 [1]
203-132-9 [2] 98-82-8 [1]
103-65-1 [2] R10
Xn; R65
Xi; R37
N; R51-53 Xn; N
R: 10-37-51/53-65
S: (2-)24-37-61-62 C
601-025-00-5 mesitylene;
1,3,5-trimethylbenzene 203-604-4 108-67-8 R10
Xi; R37
N; R51-53 Xi; N
R: 10-37-51/53
S: (2-)61 Xi; R37: C ≥ 25 % 601-026-00-0 styrene 202-851-5 100-42-5 R10
Xn; R20
Xi; R36/38 Xn
R: 10-20-36/38
S: (2-)23 Xn; R20: C ≥ 12,5 %
Xi; R36/38: C ≥ 12,5 % D
601-027-00-6 2-phenylpropene;
α-methylstyrene 202-705-0 98-83-9 R10
Xi; R36/37
N; R51-53 Xi; N
R: 10-36/37-51/53
S: (2-)61 Xi; R36/37: C ≥ 25 % 601-028-00-1 2-methylstyrene;
2-vinyltoluene 210-256-7 611-15-4 Xn; R20
N; R51-53 Xn; N
R: 20-51/53
S: (2-)24-61 601-029-00-7 dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5] 138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5] R10
Xi; R38
R43
N; R50-53 Xi; N
R: 10-38-43-50/53
S: (2-)24-37-60-61 C
601-030-00-2 cyclopentane 206-016-6 287-92-3 F; R11
R52-53 F
R: 11-52/53
S: (2-)9-16-29-33-61 601-031-00-8 2,4,4-trimethylpent-1-ene 203-486-4 107-39-1 F; R11
N; R51-53 F; N
R: 11-51/53
S: (2-)9-16-29-33-61 601-032-00-3 benzo[a]pyrene;
benzo[def]chrysene 200-028-5 50-32-8 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
R43
N; R50-53 T; N
R: 45-46-60-61-43-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 % 601-033-00-9 benz[a]anthracene 200-280-6 56-55-3 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 601-034-00-4 benz[e]acephenanthrylene 205-911-9 205-99-2 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 601-035-00-X benzo[j]fluoranthene 205-910-3 205-82-3 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 601-036-00-5 benzo[k]fluoranthene 205-916-6 207-08-9 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 601-037-00-0 n-hexane 203-777-6 110-54-3 F; R11
Repr. Cat. 3; R62
Xn; R65-48/20
Xi; R38
R67
N; R51-53 F; Xn; N
R: 11-38-48/20-62-65-67-51/53
S: (2-)9-16-29-33-36/37-61-62 Xn; R48/20: C ≥ 5 % 601-041-00-2 dibenz[a,h]anthracene 200-181-8 53-70-3 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 % 601-042-00-8 biphenyl;
diphenyl 202-163-5 92-52-4 Xi; R36/37/38
N; R50-53 Xi; N
R: 36/37/38-50/53
S: (2-)23-60-61 601-043-00-3 1,2,4-trimethylbenzene 202-436-9 95-63-6 R10
Xn; R20
Xi; R36/37/38
N; R51-53 Xn; N
R: 10-20-36/37/38-51/53
S: (2-)26-61 601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 201-052-9 77-73-6 F; R11
Xn; R20/22
Xi; R36/37/38
N; R51-53 F; Xn; N
R: 11-20/22-36/37/38-51/53
S: (2-)36/37-61 601-045-00-4 1,2,3,4-tetrahydronaphthalene 204-340-2 119-64-2 R19
Xi; R36/38
N; R51-53 Xi; N
R: 19-36/38-51/53
S: (2-)26-28-61 601-046-00-X 7-methylocta-1,6-diene 404-210-7 42152-47-6 R10
N; R50-53 N
R: 10-50/53
S: (2-)60-61 601-047-00-5 m-mentha-1,3(8)-diene 404-150-1 17092-80-7 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 601-048-00-0 chrysene 205-923-4 218-01-9 Carc. Cat. 2; R45
Muta. Cat. 3; R68
N; R50-53 T; N
R: 45-68-50/53
S: 53-45-60-61 601-049-00-6 benzo[e]pyrene 205-892-7 192-97-2 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 601-051-00-7 4-phenylbut-1-ene 405-980-7 768-56-9 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 601-052-00-2 naphthalene 202-049-5 91-20-3 Carc. Cat. 3; R40
Xn; R22
N; R50-53 Xn; N
R: 22-40-50/53
S: (2-)36/37-46-60-61 601-053-00-8 nonylphenol; [1]
4-nonylphenol, branched [2] 246-672-0 [1]
284-325-5 [2] 25154-52-3 [1]
84852-15-3 [2] Repr. Cat. 3; R62-63
Xn; R22
C; R34
N; R50-53 C; N
R: 22-34-62-63-50/53
S: (1/2-)26-36/37/39-45-46-60-61 601-054-00-3 reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene 405-570-8 — N; R50-53 N
R: 50/53
S: 60-61 601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes 410-190-0 132983-41-6 Xi; R36
R53 Xi
R: 36-53
S: (2-)26-61 601-056-00-4 reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane 405-470-4 73807-39-3 Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)37-60-61 601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 421-130-8 156679-41-3 Xi; R41
R43
N; R50-53 Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61 601-058-00-5 di-L-para-menthene 417-870-6 83648-84-4 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)23-24-37-60-61 601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 420-940-9 15768-07-7 Xi; R36/38
N; R51-53 Xi; N
R: 36/38-51/53
S: (2-)26-37/39-61 601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 417-610-1 155522-09-1 R43 Xi
R: 43
S: (2-)22-24-37 601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) 418-960-8 — C; R34
R43
N; R51-53 C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61 601-062-00-7 reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane 417-030-9 151006-59-6 R53 R: 53
S: 61 601-063-00-2 reaction mass of isomers of branched tetracosane 417-060-2 151006-61-0 Xn; R20
R53 Xn
R: 20-53
S: (2-)61 601-064-00-8 branched hexatriacontane 417-070-7 151006-62-1 R53 R: 53
S: 61 601-065-00-3 reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) 416-930-9 — Xn; R48/22
Xi; R41
N; R51-53 Xn; N
R: 41-48/22-51/53
S: (2-)22-26-37/39-61 601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone 426-820-2 78531-60-9 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 601-067-00-4 triethyl arsenate 427-700-2 15606-95-8 Carc. Cat. 1; R45
T; R23/25
N; R50-53 T; N
R: 45-23/25-50/53
S: 53-45-60-61 E
601-068-00-X 1,2-diacetoxybut-3-ene 421-720-5 18085-02-4 Xn; R22 Xn
R: 22
S: (2-) 601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 422-680-1 287933-44-2 R52-53 R: 52/53
S: 61 601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 423-830-9 20627-73-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 601-073-00-7 1-bromo-3,5-difluorobenzene 416-710-2 461-96-1 R10
Xn; R22-48/22
Xi; R38
R43
N; R50-53 Xn; N
R: 10-22-38-43-48/22-50/53
S: (2-)24-36/37-60-61 601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] 422-040-1 — Xi; R36/38
N; R51-53 Xi; N
R: 36/38-51/53
S: (2-)26-37-61 602-001-00-7 chloromethane;
methyl chloride 200-817-4 74-87-3 F+; R12
Carc. Cat. 3; R40
Xn; R48/20 F+; Xn
R: 12-40-48/20
S: (2-)9-16-33 602-002-00-2 bromomethane;
methylbromide 200-813-2 74-83-9 Muta. Cat. 3; R68
T; R23/25
Xn; R48/20
Xi; R36/37/38
N; R50
N; R59 T; N
R: 23/25-36/37/38-48/20-50-59-68
S: (1/2-)15-27-36/39-38-45-59-61 602-003-00-8 dibromomethane 200-824-2 74-95-3 Xn; R20
R52-53 Xn
R: 20-52/53
S: (2-)24-61 Xn; R20: C ≥ 12,5 % 602-004-00-3 dichloromethane;
methylene chloride 200-838-9 75-09-2 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)23-24/25-36/37 602-005-00-9 methyl iodide;
iodomethane 200-819-5 74-88-4 Carc. Cat. 3; R40
Xn; R21
T; R23/25
Xi; R37/38 T
R: 21-23/25-37/38-40
S: (1/2-)36/37-38-45 602-006-00-4 trichloromethane;
chloroform 200-663-8 67-66-3 Xn; R22-48/20/22
Xi; R38
Carc. Cat. 3; R40 Xn
R: 22-38-40-48/20/22
S: (2-)36/37 Xn; R22: C ≥ 5 %
Xn; R48/20/22: C ≥ 5 % 602-007-00-X bromoform;
tribromomethane 200-854-6 75-25-2 T; R23
Xi; R36/38
N; R51-53 T; N
R: 23-36/38-51/53
S: (1/2-)28-45-61 602-008-00-5 carbon tetrachloride;
tetrachloromethane 200-262-8 56-23-5 Carc. Cat. 3; R40
T; R23/24/25-48/23
N; R59
R52-53 T; N
R: 23/24/25-40-48/23-59-52/53
S: (1/2-)23-36/37-45-59-61 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 %
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 % 602-009-00-0 chloroethane 200-830-5 75-00-3 F+; R12
Carc. Cat. 3; R40
R52-53 F+; Xn
R: 12-40-52/53
S: (2-)9-16-33-36/37-61 602-010-00-6 1,2-dibromoethane 203-444-5 106-93-4 Carc. Cat. 2; R45
T; R23/24/25
Xi; R36/37/38
N; R51-53 T; N
R: 45-23/24/25-36/37/38-51/53
S: 53-45-61 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,1 % ≤ C < 1 % E
602-011-00-1 1,1-dichloroethane 200-863-5 75-34-3 F; R11
Xn; R22
Xi; R36/37
R52-53 F; Xn
R: 11-22-36/37-52/53
S: (2-)16-23-61 Xn; R22: C ≥ 12,5 % 602-012-00-7 1,2-dichloroethane;
ethylene dichloride 203-458-1 107-06-2 F; R11
Carc. Cat. 2; R45
Xn; R22
Xi; R36/37/38 F; T
R: 45-11-22-36/37/38
S: 53-45 E
602-013-00-2 1,1,1-trichloroethane;
methyl chloroform 200-756-3 71-55-6 Xn; R20
N; R59 Xn; N
R: 20-59
S: (2-)24/25-59-61 F
602-014-00-8 1,1,2-trichloroethane 201-166-9 79-00-5 Carc. Cat. 3; R40
Xn; R20/21/22
R66 Xn
R: 20/21/22-40-66
S: (2-)9-36/37-46 Xn; R20/21/22: C ≥ 5 % 602-015-00-3 1,1,2,2-tetrachloroethane 201-197-8 79-34-5 T+; R26/27
N; R51-53 T+; N
R: 26/27-51/53
S: (1/2-)38-45-61 602-016-00-9 1,1,2,2-tetrabromoethane 201-191-5 79-27-6 T+; R26
Xi; R36
R52-53 T+
R: 26-36-52/53
S: (1/2-)24-27-45-61 602-017-00-4 pentachloroethane 200-925-1 76-01-7 Carc. Cat. 3; R40
T; R48/23
N; R51-53 T; N
R: 40-48/23-51/53
S: (1/2-)23-36/37-45-61 T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 % 602-018-00-X 1-chloropropane; [1]
2-chloropropane [2] 208-749-7 [1]
200-858-8 [2] 540-54-5 [1]
75-29-6 [2] F; R11
Xn; R20/21/22 F; Xn
R: 11-20/21/22
S: (2-)9-29 C
602-019-00-5 1-bromopropane;
n-propyl bromide 203-445-0 106-94-5 F; R11
Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R48/20
Xi; R36/37/38
R67 F; T
R: 60-11-36/37/38-48/20-63-67
S: 53-45 E
602-020-00-0 1,2-dichloropropane;
propylene dichloride 201-152-2 78-87-5 F; R11
Xn; R20/22 F; Xn
R: 11-20/22
S: (2-)16-24 602-021-00-6 1,2-dibromo-3-chloropropane 202-479-3 96-12-8 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 1; R60
T; R25
Xn; R48/20/22
R52-53 T
R: 45-46-60-25-48/20/22-52/53
S: 53-45-61 E
602-022-00-1 1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3] 208-846-4 [1]
210-885-7 [2]
210-467-4 [3] 543-59-9 [1]
625-29-6 [2]
616-20-6 [3] F; R11
Xn; R20/21/22 F; Xn
R: 11-20/21/22
S: (2-)9-29 C
602-023-00-7 vinyl chloride;
chloroethylene 200-831-0 75-01-4 F+; R12
Carc. Cat. 1; R45 F+; T
R: 45-12
S: 53-45 D
602-024-00-2 bromoethylene 209-800-6 593-60-2 F+; R12
Carc. Cat. 2; R45 F+; T
R: 45-12
S: 53-45 602-025-00-8 1,1-dichloroethylene;
vinylidene chloride 200-864-0 75-35-4 F+; R12
Carc. Cat. 3; R40
Xn; R20 F+; Xn
R: 12-20-40
S: (2-)7-16-29-36/37-46 Xn; R20: C ≥ 12,5 % D
602-026-00-3 1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3] 208-750-2 [1]
205-859-7 [2]
205-860-2 [3] 540-59-0 [1]
156-59-2 [2]
156-60-5 [3] F; R11
Xn; R20
R52-53 F; Xn
R: 11-20-52/53
S: (2-)7-16-29-61 Xn; R20: C ≥ 12,5 % C
602-027-00-9 trichloroethylene;
trichloroethene 201-167-4 79-01-6 Carc. Cat. 2; R45
Muta. Cat. 3; R68
R67
Xi; R36/38
R52-53 T
R: 45-36/38-52/53-67
S: 53-45-61 602-028-00-4 tetrachloroethylene 204-825-9 127-18-4 Carc. Cat. 3; R40
N; R51-53 Xn; N
R: 40-51/53
S: (2-)23-36/37-61 602-029-00-X 3-chloropropene;
allyl chloride 203-457-6 107-05-1 F; R11
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R20/21/22-48/20
Xi; R36/37/38
N; R50 F; Xn; N
R: 11-20/21/22-36/37/38-40-48/20-68-50
S: (2-)16-25-26-36/37-46-61 D
602-030-00-5 1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2] 208-826-5 [1]
233-195-8 [2] 542-75-6 [1]
10061-01-5 [2] R10
T; R25
Xn; R20/21
Xi; R36/37/38
R43
N; R50-53 T; N
R: 10-20/21-25-36/37/38-43-50/53
S: (1/2-)36/37-45-60-61 DC
602-031-00-0 1,1-dichloropropene 209-253-3 563-58-6 F; R11
T; R25
R52-53 F; T
R: 11-25-52/53
S: (1/2-)16-29-33-45-61 602-032-00-6 3-chloro-2-methylpropene 209-251-2 563-47-3 F; R11
Xn; R20/22
C; R34
R43
N; R51-53 F; C; N
R: 11-20/22-34-43-51/53
S: (2-)9-16-26-29-36/37/39-45-61 602-033-00-1 chlorobenzene 203-628-5 108-90-7 R10
Xn; R20
N; R51-53 Xn; N
R: 10-20-51/53
S: (2-)24/25-61 Xn; R20: C ≥ 5 % 602-034-00-7 1,2-dichlorobenzene;
o-dichlorobenzene 202-425-9 95-50-1 Xn; R22
Xi; R36/37/38
N; R50-53 Xn; N
R: 22-36/37/38-50/53
S: (2-)23-60-61 Xn; R22: C ≥ 5 % 602-035-00-2 1,4-dichlorobenzene;
p-dichlorobenzene 203-400-5 106-46-7 Carc. Cat. 3; R40
Xi; R36
N; R50-53 Xn; N
R: 36-40-50/53
S: (2-)36/37-46-60-61 602-036-00-8 chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised) 204-818-0 126-99-8 F; R11
Carc. Cat. 2; R45
Xn; R20/22-48/20
Xi; R36/37/38 F; T
R: 45-11-20/22-36/37/38-48/20
S: 53-45 D E
602-037-00-3 α-chlorotoluene;
benzyl chloride 202-853-6 100-44-7 Carc. Cat. 2; R45
T; R23
Xn; R22-48/22
Xi; R37/38-41 T
R: 45-22-23-37/38-41-48/22
S: 53-45 E
602-038-00-9 α,α,α-trichlorotoluene;
benzotrichloride 202-634-5 98-07-7 Carc. Cat. 2; R45
T; R23
Xn; R22
Xi; R37/38-41 T
R: 45-22-23-37/38-41
S: 53-45 E
602-039-00-4 polychlorobiphenyls;
PCB 215-648-1 1336-36-3 R33
N; R50-53 N
R: 33-50/53
S: (2-)-60-61 R33: C ≥ 0,005 % C
602-040-00-X 2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4] 202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4] 95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4] Xn; R20
N; R51-53 Xn; N
R: 20-51/53
S: (2-)24/25-61 C
602-041-00-5 penthachloronaphthalene 215-320-8 1321-64-8 Xn; R21/22
Xi; R36/38
N; R50-53 Xn; N
R: 21/22-36/38-50/53
S: (2-)-60-61 C
602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex — — Carc. Cat. 3; R40
T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-40-50/53
S: (1/2-)22-36/37-45-60-61 A C
602-043-00-6 lindane (ISO)
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane; 200-401-2 58-89-9 T; R25
Xn; R20/21-48/22
R64
N; R50-53 T; N
R: 20/21-25-48/22-64-50/53
S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 602-044-00-1 camphechlor (ISO)
toxaphene; 232-283-3 8001-35-2 Carc. Cat. 3; R40
T; R25
Xn; R21
Xi; R37/38
N; R50-53 T; N
R: 21-25-37/38-40-50/53
S: (1/2-)36/37-45-60-61 602-045-00-7 DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane 200-024-3 50-29-3 T; R25-48/25
Carc. Cat. 3; R40
N; R50-53 T; N
R: 25-40-48/25-50/53
S: (1/2-)22-36/37-45-60-61 602-046-00-2 heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 200-962-3 76-44-8 T; R24/25
Carc. Cat. 3; R40
R33
N; R50-53 T; N
R: 24/25-33-40-50/53
S: (1/2-)36/37-45-60-61 602-047-00-8 chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 200-349-0 57-74-9 Carc. Cat. 3; R40
Xn; R21/22
N; R50-53 Xn; N
R: 21/22-40-50/53
S: (2-)36/37-60-61 602-048-00-3 aldrin (ISO) 206-215-8 309-00-2 T; R24/25-48/24/25
Carc. Cat. 3; R40
N; R50-53 T; N
R: 24/25-40-48/24/25-50/53
S: (1/2-)22-36/37-45-60-61 602-049-00-9 dieldrin (ISO) 200-484-5 60-57-1 T+; R27
T; R25-48/25
Carc. Cat. 3; R40
N; R50-53 T+; N
R: 25-27-40-48/25-50/53
S: (1/2-)22-36/37-45-60-61 602-050-00-4 (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;
isodrin 207-366-2 465-73-6 T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)13-28-45-60-61 602-051-00-X endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 200-775-7 72-20-8 T+; R28
T; R24
N; R50-53 T+; N
R: 24-28-50/53
S: (1/2-)22-36/37-45-60-61 602-052-00-5 endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite 204-079-4 115-29-7 T; R24/25
Xi; R36
N; R50-53 T; N
R: 24/25-36-50/53
S: (1/2-)28-36/37-45-60-61 602-053-00-0 isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 206-045-4 297-78-9 T+; R27/28
N; R50 T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61 602-054-00-6 3-iodpropene;
allyl iodide 209-130-4 556-56-9 R10
C; R34 C
R: 10-34
S: (1/2-)7-26-45 602-055-00-1 bromoethane;
ethyl bromide 200-825-8 74-96-4 F; R11
Carc. Cat. 3; R40
Xn; R20/22 F; Xn
R: 11-20/22-40
S: (2-)36/37 602-056-00-7 α,α,α-trifluorotoluene;
benzotrifluoride 202-635-0 98-08-8 F; R11
N; R51-53 F; N
R: 11-51/53
S: (2-)16-23-61 602-057-00-2 α-bromotoluene;
benzyl bromide 202-847-3 100-39-0 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)39 602-058-00-8 α,α-dichlorotoluene;
benzylidene chloride;
benzal chloride 202-709-2 98-87-3 Carc. Cat. 3; R40
T; R23
Xn; R22
Xi; R37/38-41 T
R: 22-23-37/38-40-41
S: (1/2-)36/37-38-45 602-059-00-3 1-chlorobutane;
butyl chloride 203-696-6 109-69-3 F; R11 F
R: 11
S: (2-)9-16-29 602-060-00-9 bromobenzene 203-623-8 108-86-1 R10
Xi; R38
N; R51-53 Xi; N
R: 10-38-51/53
S: (2-)61 602-061-00-4 hexafluoropropene;
hexafluoropropylene 204-127-4 116-15-4 Xn; R20
Xi; R37 Xn
R: 20-37
S: (2-)41 602-062-00-X 1,2,3-trichloropropane 202-486-1 96-18-4 Carc. Cat. 2; R45
Repr. Cat. 2; R60
Xn; R20/21/22 T
R: 45-60-20/21/22
S: 53-45 E D
602-063-00-5 heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 213-831-0 1024-57-3 T; R25
Carc. Cat. 3; R40
R33
N; R50-53 T; N
R: 25-33-40-50/53
S: (1/2-)36/37-45-60-61 602-064-00-0 1,3-dichloro-2-propanol 202-491-9 96-23-1 Carc. Cat. 2; R45
T; R25
Xn; R21 T
R: 45-21-25
S: 53-45 E
602-065-00-6 hexachlorobenzene 204-273-9 118-74-1 Carc. Cat. 2; R45
T; R48/25
N; R50-53 T; N
R: 45-48/25-50/53
S: 53-45-60-61 E
602-066-00-1 tetrachloro-p-benzoquinone 204-274-4 118-75-2 Xi; R36/38
N; R50-53 Xi; N
R: 36/38-50/53
S: (2-)37-60-61 602-067-00-7 1,3-dichlorbenzene 208-792-1 541-73-1 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 602-068-00-2 ethylene bis(trichloroacetate) 219-732-9 2514-53-6 Xi; R38 Xi
R: 38
S: (2-) 602-069-00-8 dichloroacetylene — 7572-29-4 E; R2
Carc. Cat. 3; R40
Xn; R48/20 E; Xn
R: 2-40-48/20
S: (2-)36/37 602-070-00-3 3-chloro-4,5,α, α,α-pentafluorotoluene 401-930-3 77227-99-7 R10
Xn; R20/22
N; R50-58 Xn; N
R: 10-20/22-50-58
S: (2-)51-60-61 602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 402-210-1 99688-47-8 Xn; R48/22
R43
N; R50-53 Xn; N
R: 43-48/22-50/53
S: (2-)24-37-41-60-61 602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) 278-404-3 76253-60-6 N; R50-53 N
R: 50/53
S: 60-61 602-073-00-X 1,4-dichlorobut-2-ene 212-121-8 764-41-0 Carc. Cat. 2; R45
T+; R26
T; R24/25
C; R34
N; R50-53 T+; N
R: 45-24/25-26-34-50/53
S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % E
602-074-00-5 pentachlorobenzene 210-172-0 608-93-5 F; R11
Xn; R22
N; R50-53 F; Xn; N
R: 11-22-50/53
S: (2-)41-46-50-60-61 602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 404-060-2 22432-68-4 T+; R26
Xn; R22
C; R34 T+
R: 22-26-34
S: (1/2-)9-26-28-36/37/39-45 602-076-00-6 2,3,4-trichlorobut-1-ene 219-397-9 2431-50-7 Carc. Cat. 3; R40
T; R23
Xn; R22
Xi; R36/37/38
N; R50-53 T; N
R: 22-23-36/37/38-40-50/53
S: (1/2-)36/37-45-60-61 Carc. Cat. 3; R40: C ≥ 0,1 % 602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex 219-196-6 2385-85-5 Carc. Cat. 3; R40
Repr. Cat. 3; R62-63
R64
Xn; R21/22
N; R50/53 Xn; N
R: 21/22-40-50/53-62-63-64
S: (2-)13-36/37-46-60-61 602-078-00-7 hexachlorocyclopentadiene 201-029-3 77-47-4 T+; R26
T; R24
Xn; R22
C; R34
N; R50-53 T+; N
R: 22-24-26-34-50/53
S: (1/2-)25-39-45-53-60-61 602-079-00-2 2,3-dichloropropene;
2,3-dichloropropylene 201-153-8 78-88-6 F; R11
Muta. Cat. 3; R68
Xn; R20/21/22
Xi; R37/38-41
R52-53 F; Xn
R: 11-20/21/22-37/38-41-52/53-68
S: (2-)9-16-23-26-36/37/39-61 602-080-00-8 alkanes, C10-13, chloro 287-476-5 85535-84-8 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)24-36/37-60-61 602-081-00-3 2-chloro-4,5-difluorobenzoic acid 405-380-5 — Xn; R21/22
Xi; R41
R43 Xn
R: 21/22-41-43
S: (2-)26-36/37/39 602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 408-020-5 109678-33-3 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-41-61 602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 251-084-2 32534-81-9 Xn; R48/21/22
R64
N; R50-53 Xn; N
R: 48/21/22-50/53-64
S: (1/2-)36/37-45-60-61 602-084-00-X 1,1-dichloro-1-fluoroethane 404-080-1 1717-00-6 R52-53
N; R59 N
R: 52/53-59
S: 59-61 602-085-00-5 2-bromopropane 200-855-1 75-26-3 F; R11
Repr. Cat. 1; R60
Xn; R48/20
R66 F; T
R: 60-11-48/20-66
S: 53-45 E
602-086-00-0 trifluoroiodomethane;
trifluoromethyl iodide 219-014-5 2314-97-8 Muta. Cat. 3; R68 Xn
R: 68
S: (2-)36/37 602-087-00-6 1,2,4-trichlorobenzene 204-428-0 120-82-1 Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-50/53
S: (2-)23-37/39-60-61 602-088-00-1 2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol 202-480-9 96-13-9 Carc. Cat. 2; R45
Repr. Cat. 3; R62
T; R24
Xn; R20/22
R52-53 T
R: 45-20/22-24-52/53-62
S: 53-45-61 E
602-089-00-7 4-bromo-2-chlorofluorobenzene 405-580-2 60811-21-4 Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-50/53
S: (2-)26-36/37-60-61 602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 406-630-6 121626-73-1 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)23-37-61 602-091-00-8 1,3-dichloro-4-fluorobenzene 406-160-1 1435-48-9 Xn; R22-48/20/22
Xi; R38
N; R51-53 Xn; N
R: 22-38-48/20/22-51/53
S: (2-)36/37-61 602-092-00-3 1-bromo-3,4,5-trifluorobenzene 418-480-9 138526-69-9 R10
Carc. Cat. 3; R40
Xi; R38-41
N; R51-53 Xn; N
R: 10-38-40-41-51/53
S: (2-)23-26-36/37/39-61 602-093-00-9 α, α,α,4-tetrachlorotoluene;
p-chlorobenzotrichloride 226-009-1 5216-25-1 Carc. Cat. 2; R45
Repr. Cat. 3; R62
T; R48/23
Xn; R21/22
Xi; R37/38 T
R: 45-21/22-37/38-48/23-62
S: 53-45 E
602-094-00-4 diphenylether; octabromo derivate 251-087-9 32536-52-0 Repr. Cat. 2; R61
Repr. Cat. 3; R62 T
R: 61-62
S: 53-45 602-096-00-5 malachite green hydrochloride; [1]
malachite green oxalate [2] 209-322-8 [1]
219-441-7 [2] 569-64-2 [1]
2437-29-8 [2] Repr. Cat. 3; R63
Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-63-50/53
S: (2-)26-36/37-39-46-60-61 602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 422-850-5 148757-89-5 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 603-001-00-X methanol 200-659-6 67-56-1 F; R11
T; R23/24/25-39/23/24/25 F; T
R: 11-23/24/25-39/23/24/25
S: (1/2-)7-16-36/37-45 T; R23/24/25: C ≥ 20 %
Xn; R20/21/22: 3 % ≤ C < 20 %
T; R39/23/24/25: C ≥ 10 %
Xn; R68/20/21/22: 3 % ≤ C < 10 % 603-002-00-5 ethanol;
ethyl alcohol 200-578-6 64-17-5 F; R11 F
R: 11
S: (2-)7-16 603-003-00-0 propan-1-ol;
n-propanol 200-746-9 71-23-8 F; R11
Xi; R41
R67 F; Xi
R: 11-41-67
S: (2-)7-16-24-26-39 603-004-00-6 butan-1-ol;
n-butanol 200-751-6 71-36-3 R10
Xn; R22
Xi; R37/38-41
R67 Xn
R: 10-22-37/38-41-67
S: (2-)7/9-13-26-37/39-46 603-005-00-1 2-methylpropan-2-ol;
tert-butyl alcohol 200-889-7 75-65-0 F; R11
Xn; R20 F; Xn
R: 11-20
S: (2-)9-16 603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex 250-378-8 R10
Xn; R20
Xi; R37
R66 Xn
R: 10-20-37-66
S: (2-)46 C
603-007-00-2 2-methylbutan-2-ol;
tert-pentanol 200-908-9 75-85-4 F; R11
Xn; R20
Xi; R37/38 F; Xn
R: 11-20-37/38
S: (2-)46 603-008-00-8 4-methylpentan-2-ol;
methyl isobutyl carbinol 203-551-7 108-11-2 R10
Xi; R37 Xi
R: 10-37
S: (2-)24/25 Xi; R37: C ≥ 25 % 603-009-00-3 cyclohexanol 203-630-6 108-93-0 Xn; R20/22
Xi; R37/38 Xn
R: 20/22-37/38
S: (2-)24/25 603-010-00-9 2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3] 209-512-0 [1]
231-187-9 [2]
231-186-3 [3] 583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3] Xn; R20 Xn
R: 20
S: (2-)24/25 C
603-011-00-4 2-methoxyethanol;
ethylene glycol monomethyl ether 203-713-7 109-86-4 R10
Repr. Cat. 2; R60-61
Xn; R20/21/22 T
R: 60-61-10-20/21/22
S: 53-45 E
603-012-00-X 2-ethoxyethanol;
ethylene glycol monoethyl ether 203-804-1 110-80-5 R10
Repr. Cat. 2; R60-61
Xn; R20/21/22 T
R: 60-61-10-20/21/22
S: 53-45 E
603-013-00-5 2-isopropoxyethanol;
ethylene glycol monoisopropyl ether 203-685-6 109-59-1 Xn; R20/21
Xi; R36 Xn
R: 20/21-36
S: (2-)24/25 603-014-00-0 2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve 203-905-0 111-76-2 Xn; R20/21/22
Xi; R36/38 Xn
R: 20/21/22-36/38
S: (2-)36/37-46 603-015-00-6 allyl alcohol 203-470-7 107-18-6 R10
T; R23/24/25
Xi; R36/37/38
N; R50 T; N
R: 10-23/24/25-36/37/38-50
S: (1/2-)36/37/39-38-45-61 603-016-00-1 4-hydroxy-4-methylpentan-2-one;
diacetone alcohol 204-626-7 123-42-2 Xi; R36 Xi
R: 36
S: (2-)24/25 Xi; R36: C ≥ 10 % 603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-) Xn; R20/21/22: C ≥ 5 % 603-019-00-8 dimethyl ether 204-065-8 115-10-6 F+; R12 F+
R: 12
S: (2-)9-16-33 603-020-00-3 ethyl methyl ether — 540-67-0 F+; R12 F+
R: 12
S: (2-)9-16-33 603-021-00-9 methyl vinyl ether 203-475-4 107-25-5 F+; R12 F+
R: 12
S: (2-)9-16-33 D
603-022-00-4 diethyl ether;
ether 200-467-2 60-29-7 F+; R12
R19
Xn; R22
R66
R67 F+; Xn
R: 12-19-22-66-67
S: (2-)9-16-29-33 603-023-00-X ethylene oxide;
oxirane 200-849-9 75-21-8 F+; R12 ⊗
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T; R23
Xi; R36/37/38 F+; T
R: 45-46-12-23-36/37/38
S: 53-45 E
603-024-00-5 1,4-dioxane 204-661-8 123-91-1 F; R11-19
Carc. Cat. 3; R40
Xi; R36/37
R66 F; Xn
R: 11-19-36/37-40-66
S: (2-)9-16-36/37-46 D
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 F; R11-19
Xi; R36/37 F; Xi
R: 11-19-36/37
S: (2-)16-29-33 Xi; R36/37: C ≥ 25 % 603-026-00-6 1-chloro-2,3-epoxypropane;
epichlorhydrin 203-439-8 106-89-8 R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43 T
R: 45-10-23/24/25-34-43
S: 53-45 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,1 % ≤ C < 1 % E
603-027-00-1 ethanediol;
ethylene glycol 203-473-3 107-21-1 Xn; R22 Xn
R: 22
S: (2-) 603-028-00-7 2-chloroethanol;
ethylene chlorohydrin 203-459-7 107-07-3 T+; R26/27/28 T+
R: 26/27/28
S: (1/2-)7/9-28-45 603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 R10 ⊗
Carc. Cat. 3; R40
T+; R26/27/28 T+
R: 10-26/27/28-40
S: (1/2-)7/9-27-28-36/37-45 603-030-00-8 2-aminoethanol;
ethanolamine 205-483-3 141-43-5 Xn; R20/21/22
C; R34 C
R: 20/21/22-34
S: (1/2-)26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 603-031-00-3 1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME 203-794-9 110-71-4 F; R11
R19
Repr. Cat. 2; R60
Repr. Cat. 2; R61
Xn; R20 F; T
R: 60-61-11-19-20
S: 53-45 E
603-032-00-9 ethylene dinitrate;
ethylene glycol dinitrate 211-063-0 628-96-6 E; R2 $
T+; R26/27/28
R33 E; T+
R: 2-26/27/28-33
S: (1/2-)33-35-36/37-45 603-033-00-4 oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate 211-745-8 693-21-0 E; R3
T+; R26/27/28
R33
R52-53 E; T+
R: 3-26/27/28-33-52/53
S: (1/2-)33-35-36/37-45-61 603-034-00-X glycerol trinitrate;
nitroglycerine 200-240-8 55-63-0 E; R3
T+; R26/27/28
R33
N; R51-53 E; T+; N
R: 3-26/27/28-33-51/53
S: (1/2-)33-35-36/37-45-61 603-035-00-5 pentaerythritol tetranitrate;
P.E.T.N. 201-084-3 78-11-5 E; R3 E
R: 3
S: (2-)35 603-036-00-0 mannitol hexanitrate;
nitromannite 239-924-6 15825-70-4 E; R3 E
R: 3
S: (2-)35 603-037-00-6 cellulose nitrate;
nitrocellulose, containing more than 12,6 % nitrogen — — E; R3 $
R1 E
R: 1-3
S: (2-)35 603-037-01-3 cellulose nitrate;
nitrocellulose, containing a maximum of 12,6 % nitrogen — — F; R11 $ F
R: 11
S: (2-)16-33-37/39 603-038-00-1 allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether 203-442-4 106-92-3 R10
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R20/22
Xi; R37/38-41
R43
R52-53 Xn
R: 10-20/22-37/38-40-41-43-52/53-62-68
S: (2-)24/25-26-36/37/39-61 603-039-00-7 butyl glycidyl ether;
butyl 2,3-epoxypropyl ether 219-376-4 2426-08-6 R10
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R20/22
Xi; R37
R43
R52-53 Xn
R: 10-20/22-37-40-43-52/53-68
S: (2-)24/25-36/37-61 603-040-00-2 sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3] 204-699-5 [1]
212-736-1 [2]
212-737-7 [3] 124-41-4 [1]
865-33-8 [2]
865-34-9 [3] F; R11
C; R34
R14 F; C
R: 11-14-34
S: (1/2-)8-16-26-43-45 603-041-00-8 potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2] 213-029-0 [1]
205-487-5 [2] 917-58-8 [1]
141-52-6 [2] F; R11
C; R34
R14 F; C
R: 11-14-34
S: (1/2-)8-16-26-43-45 603-042-00-3 aluminium-tri-isopropoxide 209-090-8 555-31-7 F; R11 F
R: 11
S: (2-)8-16 603-043-00-9 triarimol (ISO);
2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol — 26766-27-8 Xn; R22 Xn
R: 22
S: (2-) 603-044-00-4 dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol 204-082-0 115-32-2 Xn; R21/22
Xi; R38
R43
N; R50-53 Xn; N
R: 21/22-38-43-50/53
S: (2-)36/37-60-61 603-045-00-X diisopropyl ether; [1]
dipropyl ether [2] 203-560-6 [1]
203-869-6 [2] 108-20-3 [1]
111-43-3 [2] F; R11
R19
R66
R67 F
R: 11-19-66-67
S: (2-)9-16-29-33 C
603-046-00-5 bis (chloromethyl) ether;
oxybis(chloromethane) 208-832-8 542-88-1 R10 $
Carc. Cat. 1; R45
T+; R26
T; R24
Xn; R22 T+
R: 45-10-22-24-26
S: 53-45 Carc. Cat. 1; R45: C ≥ 0,001 % E
603-047-00-0 2-dimethylaminoethanol;
N,N-dimethylethanolamine 203-542-8 108-01-0 R10
Xn; R20/21/22
C; R34 C
R: 10-20/21/22-34
S: (1/2-)25-26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 603-048-00-6 2-diethylaminoethanol;
N,N-diethylethanolamine 202-845-2 100-37-8 R10
Xn; R20/21/22
C; R34 C
R: 10-20/21/22-34
S: (1/2-)25-26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 603-049-00-1 chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol 201-246-3 80-06-8 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)36-61 603-050-00-7 1-(2-Butoxypropoxy)propan-2-ol 246-011-6 24083-03-2 Xn; R21/22 Xn
R: 21/22
S: (2-) 603-051-00-2 2-ethylbutan-1-ol 202-621-4 97-95-0 Xn; R21/22 Xn
R: 21/22
S: (2-) 603-052-00-8 3-butoxypropan-2-ol;
propylene glycol monobutyl ether 225-878-4 5131-66-8 Xi; R36/38 Xi
R: 36/38
S: (2-) 603-053-00-3 2-methylpentane-2,4-diol 203-489-0 107-41-5 Xi; R36/38 Xi
R: 36/38
S: (2-) Xi; R36/38: C ≥ 10 % 603-054-00-9 di-n-butyl ether;
dibutyl ether 205-575-3 142-96-1 R10
Xi; R36/37/38
R52-53 Xi
R: 10-36/37/38-52/53
S: (2-)61 Xi; R36/37/38: C ≥ 10 % 603-055-00-4 propylene oxide;
1,2-epoxypropane;
methyloxirane 200-879-2 75-56-9 F+; R12
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R20/21/22
Xi; R36/37/38 F+; T
R: 45-46-12-20/21/22-36/37/38
S: 53-45 E
603-056-00-X [(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropyl o-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4] 218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4] 2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4] Muta. Cat. 3; R68
Xi; R38
R43
N; R51-53 Xn; N
R: 38-43-51/53-68
S: (2-)36/37-61 C
603-057-00-5 benzyl alcohol 202-859-9 100-51-6 Xn; R20/22 Xn
R: 20/22
S: (2-)26 603-058-00-0 1,3-propylene oxide 207-964-3 503-30-0 F; R11
Xn; R20/21/22 F; Xn
R: 11-20/21/22
S: (2-)9-16-26-29 603-059-00-6 hexan-1-ol 203-852-3 111-27-3 Xn; R22 Xn
R: 22
S: (2-)24/25 603-060-00-1 2,2'-bioxirane;
1,2:3,4-diepoxybutane 215-979-1 1464-53-5 Carc. Cat. 2; R45
Muta. Cat. 2; R46
T+; R26
T; R24/25
C; R34 T+
R: 45-46-24/25-26-34
S: 53-45 E
603-061-00-7 tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Xi; R36 Xi
R: 36
S: (2-)39 Xi; R36: C ≥ 10 % 603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 203-239-0 104-80-3 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)39 Xi; R36/37/38: C ≥ 10 % 603-063-00-8 2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol 209-128-3 556-52-5 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 2; R60
T; R23
Xn; R21/22
Xi; R36/37/38 T
R: 45-60-21/22-23-36/37/38-68
S: 53-45 E
603-064-00-3 1-methoxy-2-propanol;
monopropylene glycol methyl ether 203-539-1 107-98-2 R10 R: 10
S: (2-)24 603-065-00-9 resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene 202-987-5 101-90-6 Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
R43
R52-53 Xn
R: 21/22-36/38-40-43-52/53-68
S: (2-)23-36/37-61 603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;
vinylcyclohexane diepoxide 203-437-7 106-87-6 T; R23/24/25
Xn; R68 T
R: 23/24/25-68
S: (1/2-)23-24-45 T; R23/24/25: C ≥ 1 %:
Xn; R20/21/22: 0,1 % ≤ C < 1 % 603-067-00-X phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane 204-557-2 122-60-1 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20
Xi; R37/38
R43
R52-53 T
R: 45-20-37/38-43-68-52/53
S: 53-45-61 E
603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether — 130014-35-6 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)26-28-37/39 603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 202-013-9 90-72-2 Xn; R22
Xi; R36/38 Xn
R: 22-36/38
S: (2-)26-28 603-070-00-6 2-amino-2-methylpropanol 204-709-8 124-68-5 Xi; R36/38
R52-53 Xi
R: 36/38-52/53
S: (2-)61 Xi; R36/38: C ≥ 10 % 603-071-00-1 2,2'-iminodiethanol;
diethanolamine 203-868-0 111-42-2 Xn; R22-48/22
Xi; R38-41 Xn
R: 22-38-41-48/22
S: (2-)26-36/37/39-46 603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether 219-371-7 2425-79-8 Xn; R20/21
Xi; R36/38
R43 Xn
R: 20/21-36/38-43
S: (2-)26-28-37/39 603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 216-823-5 1675-54-3 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)28-37/39 Xi; R36/38: C ≥ 5 % 603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700) 500-033-5 25068-38-6 Xi; R36/38
R43
N; R51-53 Xi; N
R: 36/38-43-51/53
S: (2-)28-37/39-61 Xi; R36/38: C ≥ 5 % 603-075-00-3 chlormethyl methyl ether;
chlorodimethyl ether 203-480-1 107-30-2 F; R11
Carc. Cat. 1; R45
Xn; R20/21/22 F; T
R: 45-11-20/21/22
S: 53-45 E
603-076-00-9 but-2-yne-1,4-diol;
2-butyne-1,4-diol 203-788-6 110-65-6 C; R34
T; R23/25
Xn; R21-48/22
R43 C; T
R: 21-23/25-34-43-48/22
S: (1/2-)25-26-36/37/39-45-46 C; R34: C ≥ 50 %
Xi; R36/38: 25 % ≤ C < 50 % D
603-077-00-4 1-dimethylaminopropan-2-ol;
dimepranol (INN) 203-556-4 108-16-7 R10
Xn; R22
C; R34 C
R: 10-22-34
S: (1/2-)23-26-36-45 603-078-00-X prop-2-yn-1-ol;
propargyl alcohol 203-471-2 107-19-7 R10
T; R23/24/25
C; R34
N; R51-53 T; N
R: 10-23/24/25-34-51/53
S: (1/2-)26-28-36-45-61 603-079-00-5 2,2'-(methylimino)diethanol;
N-methyldiethanolamine 203-312-7 105-59-9 Xi; R36 Xi
R: 36
S: (2-)24 603-080-00-0 2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol 203-710-0 109-83-1 Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 603-081-00-6 2,2'-thiodiethanol;
thiodiglycol 203-874-3 111-48-8 Xi; R36 Xi
R: 36
S: (2-) 603-082-00-1 1-aminopropan-2-ol;
isopropanolamine 201-162-7 78-96-6 C; R34 C
R: 34
S: (1/2-)23-26-36-45 603-083-00-7 1,1'-iminodipropan-2-ol;
di-isopropanolamine 203-820-9 110-97-4 Xi; R36 Xi
R: 36
S: (2-)26 603-084-00-2 styrene oxide;
(epoxyethyl)benzene;
phenyloxirane 202-476-7 96-09-3 Carc. Cat. 2; R45
Xn; R21
Xi; R36 T
R: 45-21-36
S: 53-45 E
603-085-00-8 bronopol (INN);
2-bromo-2-nitropropane-1,3-diol 200-143-0 52-51-7 Xn; R21/22
Xi; R37/38-41
N; R50 Xn; N
R: 21/22-37/38-41-50
S: (2-)26-37/39-61 603-086-00-3 ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol 245-949-3 23947-60-6 Xn; R21 Xn
R: 21
S: (2-)36/37 603-087-00-9 2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol 202-377-9 94-96-2 Xi; R41 Xi
R: 41
S: (2-)25-26-39-46 603-088-00-4 2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide 222-598-4 3547-33-9 Xi; R41 Xi
R: 41
S: (2-)26 603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol 400-390-6 — C; R35
Xn; R22 C
R: 22-35
S: (1/2-)26-28-36/37/39-45 603-090-00-5 2-(2-bromoethoxy)anisole 402-010-4 4463-59-6 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 402-470-6 87172-89-2 Xn; R22
Xi; R41 Xn
R: 22-41
S: (2-)26-39 603-092-00-6 2-methyl-4-phenylpentanol 402-770-7 92585-24-5 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 603-093-00-1 cinmethylin (ISO)
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane 402-410-9 87818-31-3 Xn; R20
N; R51-53 Xn; N
R: 20-51/53
S: (2-)23-61 603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 241-536-7 17557-23-2 Xi; R38
R43 Xi
R: 38-43
S: (2-)24-37 603-095-00-2 2-(propyloxy)ethanol;
EGPE 220-548-6 2807-30-9 Xn; R21
Xi; R36 Xn
R: 21-36
S: (2-)26-36/37-46 603-096-00-8 2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether 203-961-6 112-34-5 Xi; R36 Xi
R: 36
S: (2-)24-26 603-097-00-3 1,1',1''-nitrilotripropan-2-ol;
triisopropanolamine 204-528-4 122-20-3 Xi; R36
R52-53 Xi
R: 36-52/53
S: (2-)26-61 603-098-00-9 2-phenoxyethanol 204-589-7 122-99-6 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)26 603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 403-440-5 93633-79-5 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 603-100-00-8 1,2-dimethoxypropane 404-630-0 7778-85-0 F; R11-19 F
R: 11-19
S: (2-)9-16-24/25-33 603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Xi; R36 Xi
R: 36
S: (2-)25-26 603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 F; R11
Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R36/37/38
R52-53 F; Xn
R: 11-20/21/22-36/37/38-40-52/53
S: (2-)9-16-29-36/37-61 603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Xi; R38
R43 Xi
R: 38-43
S: (2-)24-37 603-104-00-X fenarimol (ISO);
2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol 262-095-7 60168-88-9 Repr. Cat. 3; R62-63
R64
N; R51-53 Xn; N
R: 51/53-62-63-64
S: (2-)36/37-61 603-105-00-5 furan 203-727-3 110-00-9 F+; R12
R19
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22-48/22
Xi; R38
R52-53 F+; T
R: 45-12-19-20/22-38-48/22-68-52/53
S: 53-45-61 E
603-106-00-0 2-methoxypropanol 216-455-5 1589-47-5 R10
Repr. Cat. 2; R61
Xi; R37/38-41 T
R: 61-10-37/38-41
S: 53-45 603-107-00-6 2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether 203-906-6 111-77-3 Repr. Cat. 3; R63 Xn
R: 63
S: (2-)36/37 603-108-00-1 2-methylpropan-1-ol;
iso-butanol 201-148-0 78-83-1 R10
Xi; R37/38-41
R67 Xi
R: 10-37/38-41-67
S: (2-)7/9-13-26-37/39-46 603-117-00-0 propan-2-ol;
isopropyl alcohol;
isopropanol 200-661-7 67-63-0 F; R11
Xi; R36
R67 F; Xi
R: 11-36-67
S: (2-)7-16-24/25-26 603-118-00-6 6-dimethylaminohexan-1-ol 404-680-3 1862-07-3 Xn; R22
C; R34
R52-53 C
R: 22-34-52/53
S: (1/2-)26-36/37/39-45-61 603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) 405-840-5 — R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 603-120-00-7 2-methyl-5-phenylpentanol 405-890-8 25634-93-9 Xi; R36/38 Xi
R: 36/38
S: (2-)26-37 603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 406-057-1 114565-66-1 Carc. Cat. 3; R40
R43
R53 Xn
R: 40-43-53
S: (2-)36/37-61 603-122-00-8 sodium 2-ethylhexanolate 406-150-7 38411-13-1 F; R11
C; R34
R52-53 F; C
R: 11-34-52/53
S: (1/2-)7-26-36/37/39-45-61 603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 406-330-5 122760-84-3 Xi; R38
R43
N; R51-53 Xi; N
R: 38-43-51/53
S: (2-)24-37-61 603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 406-900-3 84563-49-5 N; R50-53 N
R: 50/53
S: 60-61 603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol 407-850-5 89544-40-1 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)26-39-61 603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 408-090-7 100418-33-5 Xn; R22
R43
R52-53 Xn
R: 22-43-52/53
S: (2-)36/37-61 603-127-00-5 butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4] 201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4] 78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4] R10
Xi; R36/37
R67 Xi
R: 10-36/37-67
S: (2-)7/9-13-24/25-26-46 C
603-128-00-0 2-(phenylmethoxy)naphthalene 405-490-3 613-62-7 R53 R: 53
S: 61 603-129-00-6 1-tert-butoxypropan-2-ol 406-180-0 57018-52-7 R10
Xi; R41 Xi
R: 10-41
S: (2-)26-39 603-130-00-1 reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) 406-325-8 — Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)39-61 603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) 407-290-1 — Xi; R41 Xi
R: 41
S: (2-)26-39 603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 408-200-3 63187-91-7 Xi; R38-41
R52-53 Xi
R: 38-41-52/53
S: (2-)26-37/39-61 603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) 408-240-1 — Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-36-61 603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. 410-450-3 — R53 R: 53
S: 61 603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium 410-500-4 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 410-910-3 104226-19-9 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol 411-130-6 — Xi; R41 Xi
R: 41
S: (2-)26-39 603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol 403-140-4 103694-68-4 R52-53 R: 52/53
S: 61 603-139-00-0 bis(2-methoxyethyl) ether 203-924-4 111-96-6 R10
R19
Repr. Cat. 2; R60-61 T
R: 60-61-10-19
S: 53-45 603-140-00-6 2,2' -oxybisethanol;
diethylene glycol 203-872-2 111-46-6 Xn; R22 Xn
R: 22
S: (2-)46 603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane 413-780-6 — R52-53 R: 52/53
S: 61 603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 407-360-1 116230-20-7 Xn; R21/22-48/20
Xi; R38-41 Xn
R: 21/22-38-41-48/20
S: (2-)26-36/37/39 603-143-00-2 R-2,3-epoxy-1-propanol 404-660-4 57044-25-4 E; R2
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 2; R60
T; R23
Xn; R21/22
C; R34 E; T
R: 45-60-2-21/22-23-34-68
S: 53-45 E
603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol 413-530-6 111850-00-1 N; R51-53 N
R: 51/53
S: 61 603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 406-970-5 129228-11-1 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)36/37-61 603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 406-080-7 83016-70-0 Xn; R22
C; R34
R52-53 C
R: 22-34-52/53
S: (1/2-)23-26-36/37/39-45-61 603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 406-030-4 105812-81-5 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)22-24-26-37/39-61 603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 413-370-7 17351-75-6 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 407-640-3 63767-86-2 Xi; R36/38
N; R51-53 Xi; N
R: 36/38-51/53
S: (2-)26-37-61 603-150-00-0 (±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 411-580-3 107898-54-4 Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)24/25-37-60-61 603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol 413-570-4 — R52-53 R: 52/53
S: 61 603-152-00-1 2-(4-tert-butylphenyl)ethanol 410-020-5 5406-86-0 Repr. Cat. 3; R62
Xn; R48/22
Xi; R41
N; R51-53 Xn; N
R: 41-48/22-62-51/53
S: (2-)26-36/37/39-61 603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 410-010-0 104333-00-8 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 412-300-2 139504-68-0 N; R51-53 N
R: 51/53
S: 61 603-155-00-8 Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane 410-560-1 — N; R50-53 N
R: 50/53
S: 60-61 603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 411-210-0 89544-48-9 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 411-450-6 143747-72-2 R53 R: 53
S: 61 603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene 412-460-3 — Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 603-159-00-X 2-cyclododecylpropan-1-ol 411-410-8 118562-73-5 N; R50-53 N
R: 50/53
S: 60-61 603-160-00-5 1,2-diethoxypropane 412-180-1 10221-57-5 F; R11
R19 F
R: 11-19
S: (2-)9-16-24-33 603-161-00-0 1,3-diethoxypropane 413-140-6 3459-83-4 R10 R: 10
S: (2-)9-24 603-162-00-6 α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 413-420-8 144736-29-8 C; R34
R43
N; R51-53 C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61 603-163-00-1 2-phenyl-1,3-propanediol 411-810-2 1570-95-2 Xi; R41 Xi
R: 41
S: (2-)26-39 603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 412-420-5 133909-99-6 R53 R: 53
S: 61 603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol 417-470-1 — Muta. Cat. 3; R68
R43 Xn
R: 43-68
S: (2-)36/37 603-166-00-8 R-1-chloro-2,3-epoxypropane 424-280-2 51594-55-9 R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43 T
R: 45-10-23/24/25-34-43
S: 53-45 E
603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 407-920-5 6390-69-8 R53 R: 53
S: 61 603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 408-080-2 70445-33-9 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 415-550-0 109887-53-8 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61 603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol 415-990-3 67739-11-1 Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 603-171-00-5 5-thiazolylmethanol 414-780-9 38585-74-9 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 415-180-1 773058-82-5 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61 603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 421-750-9 57280-22-5 Xi; R36
R43 Xi
R: 36-43
S: (2-)26-36/37 603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 420-630-3 83926-73-2 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 603-175-00-7 2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol 203-988-3 112-59-4 Xn; R21
Xi; R41 Xn
R: 21-41
S: (2-)26-36/37/39-46 603-176-00-2 1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme 203-977-3 112-49-2 R19
Repr. Cat. 2; R61
Repr. Cat. 3; R62 T
R: 61-19-62
S: 53-45 603-177-00-8 1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2] 216-374-5 [1]
259-370-9 [2] 1569-02-4 [1]
54839-24-6 [2] R10
R67 R: 10-67
S: (2-)24 603-178-00-3 2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol 203-951-1 112-25-4 Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-36/37/39-45 603-179-00-9 ergocalciferol (ISO);
Vitamin D2 200-014-9 50-14-6 T+; R26
T; R24/25-48/25 T+
R: 24/25-26-48/25
S: (1/2-)28-36/37-45 603-180-00-4 colecalciferol;
Vitamin D3 200-673-2 67-97-0 T+; R26
T; R24/25-48/25 T+
R: 24/25-26-48/25
S: (1/2-)28-36/37-45 603-181-00-X tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane 216-653-1 1634-04-4 F; R11
Xi; R38 F; Xi
R: 11-38
S: (2-)9-16-24 603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol 205-592-6 143-22-6 Xi; R41 Xi
R: 41
S: (2-)26-39-46 Xi; R41: C ≥ 30 %
Xi; R36: 20 % ≤ C < 30 % 603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 416-380-1 146925-83-9 N; R50-53 N
R: 50/53
S: 60-61 603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 420-740-1 99817-36-4 T; R25
Xi; R41
R43
N; R50-53 T; N
R: 25-41-43-50/53
S: (1/2-)26-36/37/39-45-60-61 603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 419-050-3 79944-37-9 R43 Xi
R: 43
S: (2-)22-24/25-26-37 603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 419-360-9 163661-77-6 N; R50-53 N
R: 50/53
S: 60-61 603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol 405-250-8 — N; R51-53 N
R: 51/53
S: 61 603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 419-740-4 137658-79-8 R53 R: 53
S: 61 603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 430-810-3 154825-62-4 R52-53 R: 52/53
S: 61 603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Xn; 22-48/22
N; R51-53 Xn; N
R: 22-48/22-51/53
S: (2-)36/37/39-61 603-197-00-7 tebuconazole (ISO);
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. Cat. 3; R63
Xn; R22
N; R51-53 Xn; N
R: 22-51/53-63
S: (2-)22-36/37-61 603-199-00-8 etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 N; R50-53 N
R: 50/53
S: 60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 604-001-00-2 phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol 203-632-7 108-95-2 Muta. Cat. 3; R68
T; R23/24/25
Xn; R48/20/21/22
C; R34 T;
R: 23/24/25-34-48/20/21/22-68
S: (1/2-)24/25-26-28-36/37/39-45 T; R23/24/25: C ≥ 10 %
Xn; R20/21/22: 3 % ≤ C < 10 %
C; R34: C ≥ 3 %
Xi; R36/38: 1 % ≤ C < 3 % 604-002-00-8 pentachlorophenol 201-778-6 87-86-5 Carc. Cat. 3; R40
T+; R26
T; R24/25
Xi; R36/37/38
N; R50-53 T+; N
R: 24/25-26-36/37/38-40-50/53
S: (1/2-)22-36/37-45-52-60-61 604-003-00-3 sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2] 205-025-2 [1]
231-911-3 [2] 131-52-2 [1]
7778-73-6 [2] Carc. Cat. 3; R40
T+; R26
T; R24/25
Xi; R36/37/38
N; R50-53 T+; N
R: 24/25-26-36/37/38-40-50/53
S: (1/2-)22-28-36/37-45-52-60-61 604-004-00-9 m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4] 203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4] 108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4] T; R24/25
C; R34 T
R: 24/25-34
S: (1/2-)36/37/39-45 T; R24/25: C ≥ 5 %
Xn; R21/22: 1 % ≤ C < 5 %
C; R34: C ≥ 5 %
Xi; R36/38: 1 % ≤ C < 5 % C
604-005-00-4 1,4-dihydroxybenzene;
hydroquinone;
quinol 204-617-8 123-31-9 Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R22
Xi; R41
R43
N; R50 Xn; N
R: 22-40-41-43-50-68
S: (2-)26-36/37/39-61 604-006-00-X 3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7] 202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7] 95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7] T; R24/25
C; R34
N; R51-53 T; N
R: 24/25-34-51/53
S: (1/2-)26-36/37/39-45-61 C
604-007-00-5 2-naphthol 205-182-7 135-19-3 Xn; R20/22
N; R50 Xn; N
R: 20/22-50
S: (2-)24/25-61 604-008-00-0 2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4] 202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4] 95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4] Xn; R20/21/22
N; R51-53 Xn; N
R: 20/21/22-51/53
S: (2-)28-61 C
604-009-00-6 pyrogallol;
1,2,3-trihydroxybenzene 201-762-9 87-66-1 Muta. Cat. 3; R68
Xn; R20/21/22
R52-53 Xn
R: 20/21/22-68-52/53
S: (2-)36/37-61 Xn; R20/21/22: C ≥ 10 % 604-010-00-1 resorcinol;
1,3-benzenediol 203-585-2 108-46-3 Xn; R22
Xi; R36/38
N; R50 Xn; N
R: 22-36/38-50
S: (2-)26-61 Xn; R22: C ≥ 10 % 604-011-00-7 2,4-dichlorophenol 204-429-6 120-83-2 T; R24
Xn; R22
C; R34
N; R51-53 T; N
R: 22-24-34-51/53
S: (1/2-)26-36/37/39-45-61 604-012-00-2 4-chloro-o-cresol;
4-chloro-2-methyl phenol 216-381-3 1570-64-5 T; R23
C; R35
N; R50 T; C; N
R: 23-35-50
S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 604-013-00-8 2,3,4,6-tetrachlorophenol 200-402-8 58-90-2 T; R25
Xi; R36/38
N; R50-53 T; N
R: 25-36/38-50/53
S: (1/2-)26-28-37-45-60-61 T; R25: C ≥ 5 %
Xn; R22: 0,5 % ≤ C < 5 %
Xi; R36/38: C ≥ 5 % 604-014-00-3 chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol 200-431-6 59-50-7 Xn; R21/22
Xi; R41
R43
N; R50 Xn; N
R: 21/22-41-43-50
S: (2-)26-36/37/39-61 Xn; R21/22: C ≥ 10 % 604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene 200-733-8 70-30-4 T; R24/25
N; R50-53 T; N
R: 24/25-50/53
S: (1/2-)20-37-45-60-61 T; R24/25: C ≥ 2 %
Xn; R21/22: 0,2 % ≤ C < 2 % 604-016-00-4 1,2-dihydroxybenzene;
pyrocatechol 204-427-5 120-80-9 Xn; R21/22
Xi; R36/38 Xn
R: 21/22-36/38
S: (2-)22-26-37 604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Xn; R22
Xi; R36/38
N; R50-53 Xn; N
R: 22-36/38-50/53
S: (2-)26-28-60-61 Xn; R22: C ≥ 20 %
Xi; R36/38: C ≥ 5 % 604-018-00-5 2,4,6-trichlorophenol 201-795-9 88-06-2 Carc. Cat. 3; R40
Xn; R22
Xi; R36/38
N; R50-53 Xn; N
R: 22-36/38-40-50/53
S: (2-)36/37-60-61 604-019-00-0 dichlorophen (ISO) 202-567-1 97-23-4 Xn; R22
Xi; R36
N; R50-53 Xn; N
R: 22-36-50/53
S: (2-)26-60-61 604-020-00-6 2-phenylphenol (ISO);
biphenyl-2-ol;
2-hydroxybiphenyl; 201-993-5 90-43-7 Xi; R36/37/38
N; R50 Xi; N
R: 36/37/38-50
S: (2-)22-61 604-021-00-1 sodium 2-biphenylate;
2-phenylphenol, sodium salt 205-055-6 132-27-4 Xn; R22
Xi; R37/38-41
N; R50 Xn; N
R: 22-37/38-41-50
S: (2-)22-26-61 604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 400-900-7 22961-82-6 Xi; R41 Xi
R: 41
S: (2-)24-26-39 604-023-00-2 2,4-dichloro-3-ethylphenol 401-060-4 — C; R34
N; R50-53 C; N
R: 34-50/53
S: (1/2-)26-36/39-45-60-61 604-024-00-8 4,4-isobutylethylidenediphenol 401-720-1 6807-17-6 Repr. Cat. 2; R60
Xi; R36
N; R50-53 T; N
R: 60-36-50/53
S: 53-45-60-61 604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone 400-220-0 — N; R51-53 N
R: 51/53
S: 61 604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) 400-270-3 — N; R51-53 N
R: 51/53
S: 61 604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone 400-530-6 — Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24/25-26-37-61 604-028-00-X 4-amino-3-fluorophenol 402-230-0 399-95-1 Carc. Cat. 2; R45
Xn; R22
R43
N; R51-53 T; N
R: 45-22-43-51/53
S: 53-45-61 E
604-029-00-5 1-naphtol 201-969-4 90-15-3 Xn; R21/22
Xi; R37/38-41 Xn
R: 21/22-37/38-41
S: (2-)22-26-37/39 604-030-00-0 bisphenol A;
4,4'-isopropylidenediphenol 201-245-8 80-05-7 Repr. Cat. 3; R62
Xi; R37-41
R43 Xn
R: 37-41-43-62
S: (2-)26-36/37-39-46 604-031-00-6 guaiacol 201-964-7 90-05-1 Xn; R22
Xi; R36/38 Xn
R: 22-36/38
S: (2-)26 604-032-00-1 thymol 201-944-8 89-83-8 Xn; R22
C; R34
N; R51-53 C; N
R: 22-34-51/53
S: (1/2-)26-28-36/37/39-45-61 604-033-00-7 isobutyl but-3-enoate 401-170-2 24342-03-8 R10 R: 10
S: (2-) 604-034-00-2 4,4'-thiodi-o-cresol 403-330-7 24197-34-0 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol 404-160-6 — R43
R53 X
R: 43-53
S: (2-)24-37-61 604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 404-590-4 90884-29-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 604-037-00-9 3,5-xylenol;
3,5-dimethylphenol 203-606-5 108-68-9 T; R24/25
C; R34 T
R: 24/25-34
S: (1/2-)26-28-36/37/39-45 604-038-00-4 4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2] 201-793-8 [1]
215-316-6 [2] 88-04-0 [1]
1321-23-9 [2] Xn; R22
Xi; R36/38
R43 Xn
R: 22-36/38-43
S: (2-)24-37 604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl 266-362-9 66441-23-4 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 604-040-00-5 fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide 276-439-9 72178-02-0 Xn; R22 Xn
R: 22
S: (2-) 604-041-00-0 acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2] 256-634-5 [1]
263-560-7 [2] 50594-66-6 [1]
62476-59-9 [2] Xn; R22
Xi; R38-41
N; R50-53 Xn; N
R: 22-38-41-50/53
S: (2-)24-39-60-61 604-042-00-6 4-nitrosophenol 203-251-6 104-91-6 Muta. Cat. 3; R68
Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53-68
S: (2-)26-36/37/39-47-49-61 604-043-00-1 monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether 203-083-3 103-16-2 Xi; R36
R43 Xi
R: 36-43
S: (2-)24/25-26-37 604-044-00-7 mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether 205-769-8 150-76-5 Xn; R22
Xi; R36
R43 Xn
R: 22-36-43
S: (2-)24/25-26-37/39-46 604-045-00-2 2,3,5-trimethylhydroquinone 211-838-3 700-13-0 Xn; R20
Xi; R37/38-41
R43
N; R50-53 Xn; N
R: 20-37/38-41-43-50/53
S: (2-)24-26-37/39-60-61 604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 405-520-5 95235-30-6 N; R51-53 N
R: 51/53
S: 61 604-047-00-3 4-(4-tolyloxy)biphenyl 405-730-7 51601-57-1 Xn; R48/22
R53 Xn
R: 48/22-53
S: (2-)22-36-61 604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 405-800-7 27955-94-8 N; R51-53 N
R: 51/53
S: 61 604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 407-480-4 93589-69-6 N; R51-53 N
R: 51/53
S: 61 604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 401-110-5 87113-78-8 R52-53 R: 52/53
S: 61 604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 403-800-1 103597-45-1 R53 R: 53
S: 61 604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 410-760-9 157661-93-3 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol 412-020-0 — R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 413-900-7 85954-11-6 Muta. Cat. 3; R68 Xn
R: 68
S: (2-)22-36-37 604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 412-520-9 99610-72-7 F; R11
Repr. Cat. 3; R62
Xn; R22 F; Xn
R: 11-22-62
S: (2-)22-33-36/37 604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 401-680-5 — N; R51-53 N
R: 51/53
S: 61 604-058-00-3 1,2-bis(3-methylphenoxy)ethane 402-730-9 54914-85-1 N; R50-53 N
R: 50/53
S: 60-61 604-059-00-9 2-n-hexadecylhydroquinone 406-400-5 — Xn; R48/22
Xi; R38
R43
R53 Xn
R: 38-43-48/22-53
S: (2-)22-36/37-61 604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 406-950-6 3236-71-3 Xi; R36-38
N; R50-53 Xi; N
R: 36/38-50/53
S: (2-)26-37-60-61 604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl 407-740-7 — Xi; R38
R43
R52-53 Xi
R: 38-43-52/53
S: (2-)24-37-61 604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol 411-220-5 — Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 604-063-00-0 5,6-dihydroxyindole 412-130-9 3131-52-0 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)22-26-36/37/39-61 604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 411-380-6 147315-50-2 R53 R: 53
S: 61 604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 407-460-5 111850-25-0 N; R51-53 N
R: 51/53
S: 61 604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol 414-550-8 — N; R50-53 N
R: 50/53
S: 60-61 604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) 414-520-4 — Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 415-170-5 90274-24-1 Xn; R20/22
R43 Xn
R: 20/22-43
S: (2-)24-26-37 604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 421-740-4 51390-14-8 C; R34
N; R51-53 C; N
R: 34-51/53
S: (1/2-)26-36/37/39-45-61 604-070-00-9 triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol 222-182-2 3380-34-5 Xi; R36/38
N; R50-53 Xi; N
R: 36/38-50/53
S: 26-39-46-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 605-001-00-5 formaldehyde … % 200-001-8 50-00-0 Carc. Cat. 3; R40
T; R23/24/25
C; R34
R43 T
R: 23/24/25-34-40-43
S: (1/2-)26-36/37/39-45-51 T; R23/24/25: C ≥25 %
Xn; R20/21/22: 5 % ≤ C < 25 %
C; R34: C ≥25 %
Xi; R36/37/38: 5 % ≤ C < 25 %
R43: C ≥ 0,2 % B D
605-002-00-0 1,3,5-trioxan;
trioxymethylene 203-812-5 110-88-3 F; R11
Repr. Cat. 3; R63
Xi; R37 F; Xn
R: 11-37-63
S: (2-)36/37-46 605-003-00-6 acetaldehyde;
ethanal 200-836-8 75-07-0 F+; R12
Carc. Cat. 3; R40
Xi; R36/37 F+; Xn
R: 12-36/37-40
S: (2-)16-33-36/37 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxan;
paraldehyde 204-639-8 123-63-7 F; R11 $ F
R: 11
S: (2-)9-16-29-33 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde 203-600-2 108-62-3 R10 $
Xn; R22 Xn
R: 10-22
S: (2-)13-25-46 605-006-00-2 butyraldehyde 204-646-6 123-72-8 F; R11 F
R: 11
S: (2-)9-29-33 605-007-00-8 1,1-dimethoxyethane;
dimethyl acetal 208-589-8 534-15-6 F; R11 F
R: 11
S: (2-)9-16-33 605-008-00-3 acrylaldehyde;
acrolein;
prop-2-enal 203-453-4 107-02-8 F; R11
T+; R26
T; R24/25
C; R34
N; R50 F; T+; N
R: 11-24/25-26-34-50
S: 23-26-28-36/37/39-45-61 D
605-009-00-9 crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2] 224-030-0 [1]
204-647-1 [2] 4170-30-3 [1]
123-73-9 [2] F; R11
Muta. Cat. 3; R68
T+; R26
T; R24/25
Xn; R48/22
Xi; R37/38-41
N; R50 F; T+; N
R: 11-24/25-26-37/38-41-48/22-50-68
S: (1/2-)26-28-36/37/39-45-61 605-010-00-4 2-furaldehyde 202-627-7 98-01-1 Carc. Cat. 3; R40
T; R23/25
Xn; R21
Xi; R36/37 T
R: 21-23/25-36/37-40
S: (1/2-)26-36/37/39-45 T; R23/25: C ≥ 5 %
Xn; R20/22: 1 % ≤ C < 5 % 605-011-00-X 2-chlorobenzaldehyde;
o-chlorobenzaldehyde 201-956-3 89-98-5 C; R34 C
R: 34
S: (1/2-)26-45 605-012-00-5 benzaldehyde 202-860-4 100-52-7 Xn; R22 Xn
R: 22
S: (2-)24 605-013-00-0 chloralose (INN);
(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;
glucochloralose;
anhydroglucochloral 240-016-7 15879-93-3 Xn; R20/22 Xn
R: 20/22
S: (2-)16-24/25-28 605-014-00-6 chloral hydrate;
2,2,2-trichloroethane-1,1-diol 206-117-5 302-17-0 T; R25
Xi; R36/38 T
R: 25-36/38
S: (1/2-)25-45 605-015-00-1 1,1-diethoxyethane;
acetal 203-310-6 105-57-7 F; R11
Xi; R36/38 F; Xi
R: 11-36/38
S: (2-)9-16-33 Xi; R36/38: C ≥ 10 % 605-016-00-7 glyoxal … %;
ethandial … % 203-474-9 107-22-2 Muta. Cat. 3; R68
Xn; R20
Xi; R36/38
R43 Xn
R: 20-36/38-43-68
S: (2-)36/37 Xn; R20: C ≥ 10 %
Xi; R36/38: C ≥ 10 % B
605-017-00-2 1,3-dioxolane 211-463-5 646-06-0 F; R11 F
R: 11
S: (2-)16 605-018-00-8 propanal;
propionaldehyde 204-623-0 123-38-6 F; R11
Xi; R36/37/38 F; Xi
R: 11-36/37/38
S: (2-)9-16-29 605-019-00-3 citral 226-394-6 5392-40-5 Xi; R38
R43 Xi
R: 38-43
S: (2-)24/25-37 605-020-00-9 safrole;
5-allyl-1,3-benzodioxole 202-345-4 94-59-7 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R22 T
R: 45-22-68
S: 53-45 E
605-021-00-4 formaldehyde, reaction products with butylphenol 294-145-9 91673-30-2 R43 Xi
R: 43
S: (2-)24-37 605-022-00-X glutaral;
glutaraldehyde;
1,5-pentanedial 203-856-5 111-30-8 T; R23/25
C; R34
R42/43
N; R50 T; N
R: 23/25-34-42/43-50
S: (1/2-)26-36/37/39-45-61 T; R25: C ≥ 50 %
Xn; R22: 2 % ≤ C < 50 %
T; R23: C ≥ 25 %
Xn; R20: 2 % ≤ C < 25 %
C; R34: C ≥ 10 %
Xi; R37/38-41: 2 % ≤ C < 10 %
Xi; R36/37/38: 0,5 % ≤ C < 2 %
R43: C ≥ 0,5 % 605-025-00-6 chloroacetaldehyde 203-472-8 107-20-0 Carc. Cat. 3; R40
T+; R26
T; R24/25
C; R34
N; R50 T+; N
R: 24/25-26-34-40-50
S: (1/2-)26-28-36/37/39-45-61 605-026-00-1 2,5,7,7-tetramethyloctanal 405-690-0 114119-97-0 Xi; R38
R43
N; R51-53 Xi; N
R: 38-43-51/53
S: (2-)24-37-61 605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde 410-480-7 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 605-028-00-2 β-methyl-3-(1-methylethyl)-benzenepropanal 412-050-4 125109-85-5 N; R51-53 N
R: 51/53
S: 61 605-029-00-8 2-cyclohexylpropanal 412-270-0 2109-22-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 411-510-1 3353-51-3 R43 Xi
R: 43
S: (2-)24-37 605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)] 421-890-0 — R43 Xi
R: 43
S: (2-)24-37 606-001-00-8 acetone;
propan-2-one;
propanone 200-662-2 67-64-1 F; R11
Xi; R36
R66
R67 F; Xi
R: 11-36-66-67
S: (2-)9-16-26 606-002-00-3 butanone;
ethyl methyl ketone 201-159-0 78-93-3 F; R11
Xi; R36
R66
R67 F; Xi
R: 11-36-66-67
S: (2-)9-16 606-003-00-9 heptan-3-one;
butyl ethyl ketone 203-388-1 106-35-4 R10
Xn; R20
Xi; R36 Xn
R: 10-20-36
S: (2-)24 606-004-00-4 4-methylpentan-2-one;
isobutyl methyl ketone 203-550-1 108-10-1 F; R11
Xn; R20
Xi; R36/37
R66 F; Xn
R: 11-20-36/37-66
S: (2-)9-16-29 606-005-00-X 2,6-dimethylheptan-4-one;
di-isobutyl ketone 203-620-1 108-83-8 R10
Xi; R37 Xi
R: 10-37
S: (2-)24 Xi; R37: C ≥ 10 % 606-006-00-5 pentan-3-one;
diethyl ketone 202-490-3 96-22-0 F; R11
Xi; R37
R66
R67 F; Xi
R: 11-37-66-67
S: (2-)9-16-25-33 606-007-00-0 3-methylbutan-2-one;
methyl isopropyl ketone 209-264-3 563-80-4 F; R11 F
R: 11
S: (2-)9-16-33 606-009-00-1 4-methylpent-3-en-2-one;
mesityl oxide 205-502-5 141-79-7 R10
Xn; R20/21/22 Xn
R: 10-20/21/22
S: (2-)25 Xn; R20/21/22: C ≥ 5 % 606-010-00-7 cyclohexanone 203-631-1 108-94-1 R10
Xn; R20 Xn
R: 10-20
S: (2-)25 606-011-00-2 2-methylcyclohexanone 209-513-6 583-60-8 R10
Xn; R20 Xn
R: 10-20
S: (2-)25 606-012-00-8 3,5,5-trimethylcyclohex-2-enone;
isophorone 201-126-0 78-59-1 Carc. Cat. 3; R40
Xn; R21/22
Xi; R36/37 Xn
R: 21/22-36/37-40
S: (2-)13-23-36/37/39-46 Xi; R36/37: C ≥ 10 % 606-013-00-3 p-benzoquinone;
quinone 203-405-2 106-51-4 T; R23/25
Xi; R36/37/38
N; R50 T; N
R: 23/25-36/37/38-50
S: (1/2-)26-28-45-61 606-014-00-9 chlorophacinone (ISO);
2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione 223-003-0 3691-35-8 T+; R27/28
T; R23-48/24/25
N; R50-53 T+; N
R: 23-27/28-48/24/25-50/53
S: (1/2-)36/37-45-60-61 606-016-00-X pindone (ISO);
2-pivaloylindan-1,3-dione 201-462-8 83-26-1 T; R25-48/25
N; R50-53 T; N
R: 25-48/25-50/53
S: (1/2-)37-45-60-61 606-017-00-5 diketene;
diketen 211-617-1 674-82-8 R10
Xn; R20 Xn
R: 10-20
S: (2-)3 D
606-018-00-0 dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone 204-210-5 117-80-6 Xn; R22
Xi; R36/38
N; R50-53 Xn; N
R: 22-36/38-50/53
S: (2-)26-60-61 606-019-00-6 chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one 205-601-3 143-50-0 Carc. Cat. 3; R40
T; R24/25
N; R50-53 T; N
R: 24/25-40-50/53
S: (1/2-)22-36/37-45-60-61 606-020-00-1 5-methylheptan-3-one 208-793-7 541-85-5 R10
Xi; R36/37 Xi
R: 10-36/37
S: (2-)23 Xi; R36/37: C ≥ 10 % 606-021-00-7 N-methyl-2-pyrrolidone 212-828-1 872-50-4 Xi; R36/38 Xi
R: 36/38
S: (2-)41 Xi; R36/38: C ≥ 10 % 606-022-00-2 1-phenyl-3-pyrazolidone 202-155-1 92-43-3 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 606-023-00-8 4-methoxy-4-methylpentan-2-one 203-512-4 107-70-0 R10
Xn; R20 Xn
R: 10-20
S: (2-)23-24/25 606-024-00-3 heptan-2-one;
methyl amyl ketone 203-767-1 110-43-0 R10
Xn; R20/22 Xn
R: 10-20/22
S: (2-)24/25 606-025-00-9 cyclopentanone 204-435-9 120-92-3 R10
Xi; R36/38 Xi
R: 10-36/38
S: (2-)23 606-026-00-4 5-methylhexan-2-one;
isoamyl methyl ketone 203-737-8 110-12-3 R10
Xn; R20 Xn
R: 10-20
S: (2-)23-24/25 606-027-00-X heptan-4-one;
di-n-propyl ketone 204-608-9 123-19-3 R10
Xn; R20 Xn
R: 10-20
S: (2-)24/25 606-028-00-5 2,4-dimethylpentan-3-one;
di-isopropyl ketone 209-294-7 565-80-0 F; R11
Xn; R20 F; Xn
R: 11-20
S: (2-)9-16-24/25 606-029-00-0 pentane-2,4-dione;
acetylacetone 204-634-0 123-54-6 R10
Xn; R22 Xn
R: 10-22
S: (2-)21-23-24/25 606-030-00-6 hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone 209-731-1 591-78-6 R10
Repr. Cat. 3; R62
T; R48/23
R67 T
R: 10-48/23-62-67
S: (1/2-)36/37-45 606-031-00-1 3-propanolide;
1,3-propiolactone 200-340-1 57-57-8 Carc. Cat. 2; R45
T+; R26
Xi; R36/38 T+
R: 45-26-36/38
S: 53-45 E
606-032-00-7 hexachloroacetone 204-129-5 116-16-5 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)24/25-61 606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole 243-761-6 20354-26-1 Xn; R21/22
Xi; R36/38
N; R51-53 Xn; N
R: 21/22-36/38-51/53
S: (2-)36/37-61 606-034-00-8 metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one 244-209-7 21087-64-9 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 606-035-00-3 chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon 216-920-2 1698-60-8 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 606-036-00-9 quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one 219-455-3 2439-01-2 Repr. Cat. 3; R62
Xn; R20/21/22-48/22
Xi; R36
R43
N; R50-53 Xn; N
R: 20/21/22-36-43-48/22-50/53-62
S: (2-)24-37-60-61 606-037-00-4 triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone 256-103-8 43121-43-3 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)24-37-61 606-038-00-X diphacinone (ISO);
2-diphenylacetylindan-1,3-dione 201-434-5 82-66-6 T+; R28
T; R48/23/24/25 T+
R: 28-48/23/24/25
S: (1/2-)36/37-45 606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one 400-680-2 — Xn; R20
N; R50-53 Xn; N
R: 20-50/53
S: (2-)60-61 606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 401-840-4 55845-90-4 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 400-600-6 71868-10-5 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-61 606-042-00-1 acetophenone 202-708-7 98-86-2 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)26 606-043-00-7 2,4-di-tert-butylcyclohexanone 405-340-7 13019-04-0 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 606-044-00-2 2,4,6-trimethylbenzophenone 403-150-9 954-16-5 Xn; R22
Xi; R36
N; R50-53 Xn; N
R: 22-36-50/53
S: (2-)26-60-61 606-045-00-8 oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 243-215-7 19666-30-9 N; R50-53 N
R: 50/53
S: 60-61 606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 N; R50-53 N
R: 50/53
S: 60-61 606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 N; R50-53 N
R: 50/53
S: 60-61 606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — R53 R: 53
S: 61 606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 412-480-2 72453-58-8 N; R51-53 N
R: 51/53
S: 61 606-051-00-0 4-pentylcyclohexanone 406-670-4 61203-83-6 N; R51-53 N
R: 51/53
S: 61 606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 410-410-5 54574-82-2 R52-53 R: 52/53
S: 61 606-053-00-1 flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 N; R50-53 N
R: 50/53
S: 60-61 606-054-00-7 isoxaflutole (ISO);
5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. Cat. 3; R63
N; R50-53 Xn; N
R: 50/53-63
S: (2-)36/37-60-61 606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Xn; R22-48/22
N; R51-53 Xn; N
R: 22-48/22-51/53
S: (2-)24-36-61 606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 N; R50-53 N
R: 50/53
S: 60-61 606-057-00-3 4-propylcyclohexanone 406-810-4 40649-36-3 Xi; R38
R52-53 Xi
R: 38-52/53
S: (2-)25-37-61 606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 407-500-1 21983-80-2 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 606-059-00-4 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 412-390-3 86386-75-6 Xn; R22
Xi; R41
R43 Xn
R: 22-41-43
S: (2-)22-26-36/37/39 606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane 412-950-7 — N; R50-53 N
R: 50/53
S: 60-61 606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 423-290-4 66938-41-8 Muta. Cat. 3; R68
N; R50-53 Xn; N
R: 68-50/53
S: (2-)22-36/37-60-61 606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 407-330-8 61571-06-0 Repr. Cat. 2; R61
Xi; R41
R52-53 T
R: 61-41-52/53
S: 53-45-61 606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 410-980-5 112704-51-5 Xi; R36
R43 Xi
R: 36-43
S: (2-)24-26-37 606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 407-450-0 7093-55-2 R53 R: 53
S: 61 606-065-00-7 1-(4-morpholinophenyl)butan-1-one 413-790-0 — N; R51-53 N
R: 51/53
S: 61 606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 410-440-9 164058-20-2 N; R51-53 N
R: 51/53
S: 61 606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone 414-870-8 96792-67-5 N; R50-53 N
R: 50/53
S: 60-61 606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 415-770-7 1638-05-7 Xn; R48/22
R43
R52-53 Xn
R: 43-48/22-52/53
S: (2-)22-36/37-61 606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 415-460-1 154171-76-3 N; R51-53 N
R: 51/53
S: 24-61 606-070-00-4 butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one 414-790-3 138164-12-2 Repr. Cat. 3; R62-63
Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-62-63-50/53
S: (2-)22-36/37-60-61 606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 421-050-3 13258-43-0 N; R50-53 N
R: 50/53
S: 22-60-61 606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 421-600-2 719-86-8 Xn; R48/22
N; R51-53 Xn; N
R: 48/22-51/53
S: (2-)22-36/37-61 606-073-00-0 4,4'-bis(dimethylamino)benzophenone;
Michler's ketone 202-027-5 90-94-8 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xi; R41 T
R: 45-41-68
S: 53-45 606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 417-340-4 65855-02-9 Xn; R22 Xn
R: 22
S: (2-)22 606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 418-630-3 136465-99-1 Xi; R41
R43 Xi
R: 41-43
S: (2-)24-26-37/39 606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 418-650-2 104872-06-2 N; R50-53 N
R: 50/53
S: 60-61 606-078-00-8 1-octylazepin-2-one 420-040-6 59227-88-2 C; R34
R43
N; R51-53 C; N
R: 34-43-51/53
S: (1/2-)26-36/37/39-45-61 606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 C; R34
R43
N; R50-53 C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 606-080-00-9 Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene 417-100-9 — R53 R: 53
S: 61 606-081-00-4 (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 419-790-7 4229-69-0 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-36/37-61 606-082-00-X reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane 406-930-7 T; R48/25
R43
R52-53 T
R: 43-48/25-52/53
S: (1/2-)25-36/37-45-61 606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 407-750-1 137193-60-3 Xi; R36/38
R43
R52-53 Xi
R: 36/38-43-52/53
S: (2-)24-26-37-61 606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 414-540-3 484-33-3 N; R50-53 N
R: 50/53
S: 60-61 606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 418-530-1 79200-56-9 Xn; R22
Xi; R41
R43 Xn
R: 22-41-43
S: (2-)24-26-37/39 606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 422-330-8 56973-87-6 N; R51-53 N
R: 51/53
S: 61 606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 422-460-5 137234-87-8 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 422-520-0 74338-72-0 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone 423-220-2 12223-77-7 R53 R: 53
S: 61 606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 421-320-0 118289-55-7 N; R50-53 N
R: 50/53
S: 60-61 606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one 422-320-3 N; R50-53 N
R: 50/53
S: 60-61 607-001-00-0 formic acid … % 200-579-1 64-18-6 C; R35 C
R: 35
S: (1/2-)23-26-45 C; R35: C ≥ 90 %
C; R34: 10 % ≤ C < 90 %
Xi; R36/38: 2 % ≤ C < 10 % B
607-002-00-6 acetic acid … % 200-580-7 64-19-7 R10
C; R35 C
R: 10-35
S: (1/2-)23-26-45 C; R35: C ≥ 90 %
C; R34: 25 % ≤ C < 90 %
Xi; R36/38: 10 % ≤ C < 25 % B
607-003-00-1 chloroacetic acid 201-178-4 79-11-8 T; R25
C; R34
N; R50 T; N
R: 25-34-50
S: (1/2-)23-37-45-61 607-004-00-7 TCA (ISO);
trichloroacetic acid 200-927-2 76-03-9 C; R35
N; R50-53 C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 607-005-00-2 TCA-sodium (ISO);
sodium trichloroacetate 211-479-2 650-51-1 Xi; R37
N; R50-53 Xi; N
R: 37-50/53
S: (2-)46-60-61 607-006-00-8 oxalic acid 205-634-3 144-62-7 Xn; R21/22 Xn
R: 21/22
S: (2-)24/25 Xn; R21/22: C ≥ 5 % 607-007-00-3 salts of oxalic acid — — Xn; R21/22 Xn
R: 21/22
S: (2-)24/25 Xn; R21/22: C ≥ 5 % A
607-008-00-9 acetic anhydride 203-564-8 108-24-7 R10
Xn; R20/22
C; R34 C
R: 10-20/22-34
S: (1/2-)26-36/37/39-45 C; R34: C ≥ 25 %
Xi; R37/38-41: 5 % ≤ C < 25 %
Xi; R36: 1 % ≤ C < 5 % 607-009-00-4 phthalic anhydride 201-607-5 85-44-9 Xn; R22
Xi; R37/38-41
R42/43 Xn
R: 22-37/38-41-42/43
S: (2-)23-24/25-26-37/39-46 607-010-00-X propionic anhydride 204-638-2 123-62-6 C; R34 C
R: 34
S: (1/2-)26-45 C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 % 607-011-00-5 acetyl chloride 200-865-6 75-36-5 F; R11
R14
C; R34 F; C
R: 11-14-34
S: (1/2-)9-16-26-45 607-012-00-0 benzoyl chloride 202-710-8 98-88-4 C; R34 C
R: 34
S: (1/2-)26-45 607-013-00-6 dimethyl carbonate 210-478-4 616-38-6 F; R11 F
R: 11
S: (2-)9-16 607-014-00-1 methyl formate 203-481-7 107-31-3 F+; R12
Xn; R20/22
Xi; R36/37 F+; Xn
R: 12-20/22-36/37
S: (2-)9-16-24-26-33 607-015-00-7 ethyl formate 203-721-0 109-94-4 F; R11
Xn; R20/22
Xi; R36/37 F; Xn
R: 11-20/22-36/37
S: (2-)9-16-24-26-33 607-016-00-2 propyl formate; [1]
isopropyl formate [2] 203-798-0 [1]
210-901-2 [2] 110-74-7 [1]
625-55-8 [2] F; R11
Xi; R36/37
R67 F; Xi
R: 11-36/37-67
S: (2-)9-16-24-33 C
607-017-00-8 butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3] 209-772-5 [1]
212-105-0 [2]
208-818-1 [3] 592-84-7 [1]
762-75-4 [2]
542-55-2 [3] F; R11
Xi; R36/37 F; Xi
R: 11-36/37
S: (2-)9-16-24-33 C
607-018-00-3 isopentyl formate; [1]
pentyl formate; [2]
2-methylbutyl formate [3] 203-769-2 [1]
211-340-6 [2]
252-343-2 [3] 110-45-2 [1]
638-49-3 [2]
35073-27-9 [3] R10
Xi; R36/37 Xi
R: 10-36/37
S: (2-)24 C
607-019-00-9 methyl chloroformate 201-187-3 79-22-1 F; R11
T+; R26
Xn; R21/22
C; R34 F; T+
R: 11-21/22-26-34
S: (1/2-)14-26-28-36/37/39-45-46-63 607-020-00-4 ethyl chloroformate 208-778-5 541-41-3 F; R11
T+; R26
Xn; R22
C; R34 F; T+
R: 11-22-26-34
S: (1/2-)9-16-26-28-33-36/37/39-45 607-021-00-X methyl acetate 201-185-2 79-20-9 F; R11
Xi; R36
R66
R67 F; Xi
R: 11-36-66-67
S: (2-)16-26-29-33 607-022-00-5 ethyl acetate 205-500-4 141-78-6 F; R11
Xi; R36
R66
R67 F; Xi
R: 11-36-66-67
S: (2-)16-26-33 607-023-00-0 vinyl acetate 203-545-4 108-05-4 F; R11 F
R: 11
S: (2-)16-23-29-33 D
607-024-00-6 propyl acetate; [1]
isopropyl acetate [2] 203-686-1 [1]
203-561-1 [2] 109-60-4 [1]
108-21-4 [2] F; R11
Xi; R36
R66
R67 F; Xi
R: 11-36-66-67
S: (2-)16-26-29-33 C
607-025-00-1 n-butyl acetate 204-658-1 123-86-4 R10
R66
R67 R: 10-66-67
S: (2-)25 607-026-00-7 sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3] 203-300-1 [1]
203-745-1 [2]
208-760-7 [3] 105-46-4 [1]
110-19-0 [2]
540-88-5 [3] F; R11
R66 F
R: 11-66
S: (2-)16-23-25-29-33 C
607-027-00-2 methyl propionate 209-060-4 554-12-1 F; R11
Xn; R20 F; Xn
R: 11-20
S: (2-)16-24-29-33 607-028-00-8 ethyl propionate 203-291-4 105-37-3 F; R11 F
R: 11
S: (2-)16-23-24-29-33 607-029-00-3 n-butyl propionate; [1]
sec-butyl propionate; [2]
tert-butyl propionate; [3]
iso-butyl propionate [4] 209-669-5 [1]
- [2]
- [3]
208-746-0 [4] 590-01-2 [1]
591-34-4 [2]
20487-40-5 [3]
540-42-1 [4] R10 R: 10
S: (2-) C
607-030-00-9 propyl propionate 203-389-7 106-36-5 R10
Xn; R20 Xn
R: 10-20
S: (2-)24 607-031-00-4 butyl butyrate 203-656-8 109-21-7 R10 R: 10
S: (2-) C
607-032-00-X ethyl acrylate 205-438-8 140-88-5 F; R11
Xn; R20/21/22
Xi; R36/37/38
R43 F; Xn
R: 11-20/21/22-36/37/38-43
S: (2-)9-16-33-36/37 Xi; 36/37/38: C ≥ 5 % D
607-033-00-5 n-butyl methacrylate 202-615-1 97-88-1 R10
Xi; R36/37/38
R43 Xi
R: 10-36/37/38-43
S: (2-) D
607-034-00-0 methyl acrylate;
methyl propenoate 202-500-6 96-33-3 F; R11
Xn; R20/21/22
Xi; R36/37/38
R43 F; Xn
R: 11-20/21/22-36/37/38-43
S: (2-)9-25-26-33-36/37-43 D
607-035-00-6 methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate 201-297-1 80-62-6 F; R11
Xi; R37/38
R43 F; Xi
R: 11-37/38-43
S: (2-)24-37-46 D
607-036-00-1 2-methoxyethyl acetate;
methylglycol acetate 203-772-9 110-49-6 Repr. Cat. 2; R60-61
Xn; R20/21/22 T
R: 60-61-20/21/22
S: 53-45 E
607-037-00-7 2-ethoxyethyl acetate;
ethylglycol acetate 203-839-2 111-15-9 $ Repr. Cat. 2; R60-61
Xn; R20/21/22 T
R: 60-61-20/21/22
S: 53-45 E
607-038-00-2 2-butoxyethyl acetate;
butylglycol acetate 203-933-3 112-07-2 Xn; R20/21 Xn
R: 20/21
S: (2-)24 607-039-00-8 2,4-D (ISO);
2,4-dichlorophenoxyacetic acid 202-361-1 94-75-7 Xn; R22
Xi; R37-41
R43
R52-53 Xn
R: 22-37-41-43-52/53
S: (2-)24/25-26-36/37/39-46-61 607-040-00-3 salts of 2,4-D — — Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)24/25-26-36/37/39-46-61 A
607-041-00-9 2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid 202-273-3 93-76-5 Xn; R22
Xi; R36/37/38
N; R50-53 Xn; N
R: 22-36/37/38-50/53
S: (2-)24-60-61 607-042-00-4 salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid — — Xn; R22
Xi; R36/37/38
N; R50-53 Xn; N
R: 22-36/37/38-50/53
S: (2-)24-60-61 A
607-043-00-X dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid 217-635-6 1918-00-9 Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)26-61 607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2] 218-951-7 [1]
233-002-7 [2] 2300-66-5 [1]
10007-85-9 [2] Xi; R36
R52-53 Xi
R: 36-52/53
S: (2-)26-61 607-045-00-0 dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid 204-390-5 120-36-5 Xn; R21/22
Xi; R38-41 Xn
R: 21/22-38-41
S: (2-)26-36/37 607-046-00-6 salts of dichlorprop — — Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)13 A
607-047-00-1 fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid 202-271-2 93-72-1 Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-50/53
S: (2-)37-60-61 607-048-00-7 salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid — — Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 A
607-049-00-2 mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2] 230-386-8 [1]
202-264-4 [2] 7085-19-0 [1]
7085-19-0 [2] Xn; R22
Xi; R38-41
N; R50-53 Xn; N
R: 22-38-41-50/53
S: (2-)13-26-37/39-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 607-050-00-8 salts of mecoprop — — Xn; R22
Xi; R38-41
N; R50-53 Xn; N
R: 22-38-41-50/53
S: (2-)13-26-37/39-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % A
607-051-00-3 MCPA (ISO);
4-chloro-o-tolyloxyacetic acid 202-360-6 94-74-6 Xn; R22
Xi; R38-41 Xn
R: 22-38-41
S: (2-)26-37-39 607-052-00-9 salts and esters of MCPA — — Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)13 A
607-053-00-4 MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid 202-365-3 94-81-5 N; R50-53 N
R: 50/53
S: 60-61 607-054-00-X salts and esters of MCPB — — Xn; R22 Xn
R: 22
S: (2-)24/25 A
607-055-00-5 endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate 204-959-8 129-67-9 T; R25
Xn; R21
Xi; R36/37/38 T
R: 21-25-36/37/38
S: (1/2-)36/37/39-45 607-056-00-0 warfarin (ISO); [1]
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3] 201-377-6 [1]
226-907-3 [2]
226-908-9 [3] 81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3] Repr. Cat. 1; R61
T; R48/25
R52-53 T
R: 61-48/25-52/53
S: 53-45-61 E
607-057-00-6 coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin 201-378-1 81-82-3 Xn; R48/22
R52-53 Xn
R: 48/22-52/53
S: (2-)37-61 607-058-00-1 coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin 204-195-5 117-52-2 T; R25-48/25
R52-53 T
R: 25-48/25-52/53
S: (1/2-)37-45-61 607-059-00-7 coumatetralyl;
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 227-424-0 5836-29-3 T+; R27/28
T; R48/24/25
R52-53 T+
R: 27/28-48/24/25-52/53
S: (1/2-)28-36/37-45-61 607-060-00-2 dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) 200-632-9 66-76-2 T; R48/25
Xn; R22
N; R51-53 T; N
R: 22-48/25-51/53
S: (1/2-)37-45-61 607-061-00-8 acrylic acid;
prop-2-enoic acid 201-177-9 79-10-7 R10
Xn; R20/21/22
C; R35
N; R50 C; N
R: 10-20/21/22-35-50
S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % D
607-062-00-3 n-butyl acrylate 205-480-7 141-32-2 R10
Xi; R36/37/38
R43 Xi
R: 10-36/37/38-43
S: (2-)9 D
607-063-00-9 isobutyric acid 201-195-7 79-31-2 Xn; R21/22 Xn
R: 21/22
S: (2-) 607-064-00-4 benzyl chloroformate 207-925-0 501-53-1 C; R34
N; R50-53 C; N
R: 34-50/53
S: (1/2-)26-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 607-065-00-X bromoacetic acid 201-175-8 79-08-3 T; R23/24/25
C; R35
N; R50 T; C; N
R: 23/24/25-35-50
S: (1/2-)26-36/37/39-45-61 607-066-00-5 dichloroacetic acid 201-207-0 79-43-6 C; R35
N; R50 C; N
R: 35-50
S: (1/2-)26-45-61 607-067-00-0 dichloroacetyl chloride 201-199-9 79-36-7 C; R35
N; R50 C; N
R: 35-50
S: (1/2-)9-26-45-61 607-068-00-6 iodoacetic acid 200-590-1 64-69-7 T; R25
C; R35 T; C
R: 25-35
S: (1/2-)22-36/37/39-45 607-069-00-1 ethyl bromoacetate 203-290-9 105-36-2 T+; R26/27/28 T+
R: 26/27/28
S: (1/2-)7/9-26-45 607-070-00-7 ethyl chloroacetate 203-294-0 105-39-5 T; R23/24/25
N; R50 T; N
R: 23/24/25-50
S: (1/2-)7/9-45-61 607-071-00-2 ethyl methacrylate 202-597-5 97-63-2 F; R11
Xi; R36/37/38
R43 F; Xi
R: 11-36/37/38-43
S: (2-)9-16-29-33 D
607-072-00-8 2-hydroxyethyl acrylate 212-454-9 818-61-1 T; R24
C; R34
R43
N; R50 T; N
R: 24-34-43-50
S: (1/2-)26-36/39-45-61 T; R24: C ≥ 2 %
Xn; R21: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 % D
607-073-00-3 4-CPA (ISO);
4-chlorophenoxyacetic acid 204-581-3 122-88-3 Xn; R22 Xn
R: 22
S: (2-) 607-074-00-9 chlorfenac (ISO);
2,3,6-trichlorophenylacetic acid 201-599-3 85-34-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)36-61 607-075-00-4 chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate 238-413-5 14437-17-3 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 607-076-00-X dodine (ISO);
dodecylguanidinium acetate 219-459-5 2439-10-3 Xn; R22
Xi; R36/38
N; R50-53 Xn; N
R: 22-36/38-50/53
S: (2-)26-60-61 607-077-00-5 erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate — 136-25-4 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 607-078-00-0 fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate — 4301-50-2 T+; R27/28 T+
R: 27/28
S: (1/2-)28-36/
37-45 607-079-00-6 kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate — 4234-79-1 T; R24
Xn; R22
N; R51-53 T; N
R: 22-24-51/53
S: (1/2-)36/37-45-61 607-080-00-1 chloroacetyl chloride 201-171-6 79-04-9 R14
R29
T; R23/24/25-48/23
C; R35
N; R50 T; C; N
R: 14-23/24/25-29-35-48/23-50
S: (1/2-)7/8-9-26-36/37/39-45-61 607-081-00-7 fluoroacetic acid 205-631-7 144-49-0 T+; R28
N; R50 T+; N
R: 28-50
S: (1/2-)20-22-26-45-61 607-082-00-2 fluoroacetates, soluble — — T+; R28
N; R50 T+; N
R: 28-50
S: (1/2-)20-22-26-45-61 A
607-083-00-8 2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid 202-366-9 94-82-6 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)25-29-46-61 607-084-00-3 salts of 2,4-DB — — Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)26-29-39-46-61 A
607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Xn; R22 Xn
R: 22
S: (2-)25 607-086-00-4 diallyl phthalate 205-016-3 131-17-9 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24/25-60-61 607-088-00-5 methacrylic acid;
2-methylpropenoic acid 201-204-4 79-41-4 Xn; R21/22
C; R35 C
R: 21/22-35
S: (1/2-)26-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % D
607-089-00-0 propionic acid … % 201-176-3 79-09-4 C; R34 C
R: 34
S: (1/2-)23-36-45 C; R34: C ≥ 25 %
Xi; R36/37/38: 10 % ≤ C < 25 % B
607-090-00-6 thioglycolic acid 200-677-4 68-11-1 T; R23/24/25
C; R34 T
R: 23/24/25-34
S: (1/2-)25-27-28-45 T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 % 607-091-00-1 trifluoroacetic acid . . . % 200-929-3 76-05-1 Xn; R20
C; R35
R52-53 C
R: 20-35-52/53
S: (1/2-)9-26-27-28-45-61 Xn; R20: C ≥ 10 % B
607-092-00-7 methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4] 208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4] 547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4] R10
Xi; R36/37 Xi
R: 10-36/37
S: (2-)24 C
607-093-00-2 propionyl chloride 201-170-0 79-03-8 F; R11
R14
C; R34 F; C
R: 11-14-34
S: (1/2-)9-16-26-45 B D
607-094-00-8 peracetic acid . . . % 201-186-8 79-21-0 R10
O; R7
Xn; R20/21/22
C; R35
N; R50 O; C; N
R: 7-10-20/21/22-35-50
S: (1/2-)3/7-14-36/37/39-45-61 Xn; R20/21/22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % B D
607-095-00-3 maleic acid 203-742-5 110-16-7 Xn; R22
Xi; R36/37/38 Xn
R: 22-36/37/38
S: (2-)26-28-37 607-096-00-9 maleic anhydride 203-571-6 108-31-6 Xn; R22
C; R34
R42/43 C
R: 22-34-42/43
S: (2-)22-26-36/37/39-45 607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride 209-008-0 552-30-7 Xi; R37-41
R42/43 Xn
R: 37-41-42/43
S: (2-)22-26-36/37/39 607-098-00-X benzene-1,2:4,5-tetracarboxylic dianhydride;
benzene-1,2:4,5-tetracarboxylic dianhydride;
pyromellitic dianhydride 201-898-9 89-32-7 Xi; R41
R42/43 Xn
R: 41-42/43
S: (2-)22-24-26-37/39 607-099-00-5 1,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4] 201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4] 85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4] Xi; R41
R42/43
R52-53 Xn
R: 41-42/43-52/53
S: (2-)22-24-26-37/39-61 C
607-100-00-9 benzophenone-3,3',4,4'-tetracarboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride) 219-348-1 2421-28-5 Xi; R36/37 Xi
R: 36/37
S: (2-)25 Xi; R36/37: C ≥ 1 % 607-101-00-4 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride 204-077-3 115-27-5 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)25 Xi; R36/37/38: C ≥ 1 % 607-102-00-X cyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicarboxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3] 201-604-9 [1]
236-086-3 [2]
238-009-9 [3] 85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3] Xi; R41
R42/43 Xn
R: 41-42/43
S: (2-)23-24-26-37/39 C
607-103-00-5 succinic anhydride 203-570-0 108-30-5 Xi; R36/37 Xi
R: 36/37
S: (2-)25 Xi; R36/37: C ≥ 1 % 607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Xi; R36/37 Xi
R: 36/37
S: (2-)25 Xi; R36/37: C ≥ 1 % 607-105-00-6 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 204-957-7 [1]
212-557-9 [2]
220-384-5 [3] 129-64-6 [1]
826-62-0 [2]
2746-19-2 [3] Xi; R41
R42/43 Xn
R: 41-42/43
S: (2-)22-24-26-37/39 C
607-106-00-1 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride — 123748-85-6 Xn; R22
Xi; R36/37/38
R42 Xn
R: 22-36/37/38-42
S: (2-)39 Xi; R36/37/38: C ≥ 10 % C
607-107-00-7 2-ethylhexyl acrylate 203-080-7 103-11-7 Xi; R37/38
R43 Xi
R: 37/38-43
S: (2-)36/37-46 D
607-108-00-2 2-hydroxy-1-methylethylacrylate; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3] 220-852-9 [1]
213-663-8 [2]
247-118-0 [3] 2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3] T; R23/24/25
C; R34
R43 T
R: 23/24/25-34-43
S: (1/2-)26-36/37/39-45 T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 % C D
607-109-00-8 hexamethylene diacrylate;
hexane-1,6-diol diacrylate 235-921-9 13048-33-4 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)39 D
607-110-00-3 pentaerythritol triacrylate 222-540-8 3524-68-3 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)39 D
607-111-00-9 2,2-bis(acryloyloxymethyl)butyl acrylate;
trimethylolpropane triacrylate 239-701-3 15625-89-5 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)39 D
607-112-00-4 2,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate 218-741-5 2223-82-7 T; R24
Xi; R36/38
R43 T
R: 24-36/38-43
S: (1/2-)28-39-45 T; R24: C ≥ 5 %
Xn; R21: 0,2 % ≤ C < 5 % D
607-113-00-X isobutyl methacrylate 202-613-0 97-86-9 R10
Xi; R36/37/38
R43
N; R50 Xi; N
R: 10-36/37/38-43-50
S: (2-)24-37-61 D
607-114-00-5 ethylene dimethacrylate 202-617-2 97-90-5 Xi; R37
R43 Xi
R: 37-43
S: (2-)24-37 Xi; R37: C ≥ 10 % D
607-115-00-0 isobutyl acrylate 203-417-8 106-63-8 R10
Xn; R20/21
Xi; R38
R43 Xn
R: 10-20/21-38-43
S: (2-)9-24-37 Xi; R38: C ≥ 10 % D
607-116-00-6 cyclohexyl acrylate 221-319-3 3066-71-5 Xi; R37/38
N; R51-53 Xi; N
R: 37/38-51/53
S: (2-)61 Xi; R37/38: C ≥ 10 % D
607-117-00-1 2,3-epoxypropyl acrylate;
glycidyl acrylate 203-440-3 106-90-1 T; R23/24/25
C; R34
R43 T
R: 23/24/25-34-43
S: (1/2-)26-36/37/39-45 T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 % D
607-118-00-7 1-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate 243-105-9 19485-03-1 Xn; R21
C; R34
R43 C
R: 21-34-43
S: (1/2-)26-36/37/39-45 D
607-119-00-2 tetramethylene diacrylate;
1,4-butyleneglycol diacrylate 213-979-6 1070-70-8 Xn; R21
C; R34
R43 C
R: 21-34-43
S: (1/2-)26-36/37/39-45 D
607-120-00-8 2,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate 223-791-6 4074-88-8 T; R24
Xi; R36/38
R43 T
R: 24-36/38-43
S: (1/2-)28-39-45 T; R24: C ≥ 2 %
Xn; R21: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 % D
607-121-00-3 8,9,10-trinorborn-2-yl acrylate — 10027-06-2 Xn; R21
Xi; R38
R43 Xn
R: 21-38-43
S: (2-)28 Xi; R38: C ≥ 10 % D
607-122-00-9 pentaerythritol tetraacrylate 225-644-1 4986-89-4 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)26-39 D
607-123-00-4 2,3-epoxypropyl methacrylate;
glycidyl methacrylate 203-441-9 106-91-2 Xn; R20/21/22
Xi; R36/38
R43 Xn
R: 20/21/22-36/38-43
S: (2-)26-28 Xi; R36/38: C ≥ 10 % D
607-124-00-X 2-hydroxyethyl methacrylate 212-782-2 868-77-9 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)26-28 D
607-125-00-5 2-hydroxypropyl methacrylate; [1]
3-hydroxypropyl methacrylate [2] 213-090-3 [1]
220-426-2 [2] 923-26-2 [1]
2761-09-3 [2] Xi; R36
R43 Xi
R: 36-43
S: (2-)24/25-26-37/39 C D
607-126-00-0 2,2'-(ethylenedioxy)diethyl diacrylate;
triethylene glycol diacrylate 216-853-9 1680-21-3 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)26-28 D
607-127-00-6 2-diethylaminoethyl methacrylate 203-275-7 105-16-8 Xn; R20
Xi; R36/38
R43 Xn
R: 20-36/38-43
S: (2-)26 Xi; R36/38: C ≥ 10 % D
607-128-00-1 2-tert-butylaminoethyl methacrylate 223-228-4 3775-90-4 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)26 D
607-129-00-7 ethyl lactate;
ethyl DL-lactate; [1]
ethyl (S)-2-hydroxypropionate;
ethyl L-lactate;
ethyl-(S)-lactate [2] 202-598-0 [1]
211-694-1 [2] 97-64-3 [1]
687-47-8 [2] R10
Xi; R37-41 Xi
R: 10-37-41
S: (2-)24-26-39 C
607-130-00-2 pentyl acetate; [1]
isopentyl acetate; [2]
1-methylbutyl acetate; [3]
2-methylbutyl acetat; [4]
2(or 3)-methylbutyl acetate [5] 211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5] 628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5] R10
R66 R: 10-66
S: (2-)23-25 C
607-131-00-8 isopentyl propionate; [1]
pentyl propionate; [2]
2-methylbutyl propionate [3] 203-322-1 [1]
210-852-7 [2]
219-449-0 [3] 105-68-0 [1]
624-54-4 [2]
2438-20-2 [3] R10 R: 10
S: (2-)23-24 C
607-132-00-3 2-dimethylaminoethyl methacrylate 220-688-8 2867-47-2 Xn; R21/22
Xi; R36/38
R43 Xn
R: 21/22-36/38-43
S: (2-)26-28 Xi; R36/38: C ≥ 10 % D
607-133-00-9 monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38
N; R51-53 Xi; N
R: 36/37/38-51/53
S: (2-)26-28-61 Xi; R36/37/38: C ≥ 10 % A
607-134-00-4 monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)26-28 Xi; R36/37/38: C ≥ 10 % A
607-135-00-X butyric acid 203-532-3 107-92-6 C; R34 C
R: 34
S: (1/2-)26-36-45 607-136-00-5 butyryl chloride 205-498-5 141-75-3 F; R11
C; R34 F; C
R: 11-34
S: (1/2-)16-23-26-36-45 607-137-00-0 methyl acetoacetate 203-299-8 105-45-3 Xi; R36 Xi
R: 36
S: (2-)26 607-138-00-6 butyl chloroformate;
chloroformic acid butyl ester 209-750-5 592-34-7 R10
T; R23
C; R34 T
R: 10-23-34
S: (1/2-)26-36-45 607-139-00-1 2-chloropropionic acid 209-952-3 598-78-7 Xn; R22
C; R35 C
R: 22-35
S: (1/2-)23-26-28-36-45 607-140-00-7 isobutyryl chloride 201-194-1 79-30-1 F; R11
C; R35 F; C
R: 11-35
S: (1/2-)16-23-26-36-45 607-141-00-2 oxydiethylene bis(chloroformate) 203-430-9 106-75-2 Xn; R22
Xi; R38-41
N; R51-53 Xn; N
R: 22-38-41-51/53
S: (2-)23-26-61 607-142-00-8 propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate 203-687-7 109-61-5 R10 $
T; R23
C; R34 T
R: 10-23-34
S: (1/2-)26-36-45 607-143-00-3 valeric acid 203-677-2 109-52-4 C; R34
R52-53 C
R: 34-52/53
S: (1/2-)26-36-45-61 607-144-00-9 adipic acid 204-673-3 124-04-9 Xi; R36 Xi
R: 36
S: (2-) 607-145-00-4 methanesulphonic acid 200-898-6 75-75-2 C; R34 C
R: 34
S: (1/2-)26-36-45 607-146-00-X fumaric acid 203-743-0 110-17-8 Xi; R36 Xi
R: 36
S: (2-)26 607-147-00-5 oxalic acid diethylester;
diethyl oxalate 202-464-1 95-92-1 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)23 607-148-00-0 guanidinium chloride;
guanadine hydrochloride 200-002-3 50-01-1 Xn; R22
Xi; R36/38 Xn
R: 22-36/38
S: (2-)22 607-149-00-6 urethane (INN);
ethyl carbamate 200-123-1 51-79-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 607-150-00-1 endothal (ISO);
7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid 205-660-5 145-73-3 T; R25
Xn; R21
Xi; R36/37/38 T
R: 21-25-36/37/38
S: (1/2-)36/37/39-45 607-151-00-7 propargite (ISO);
2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite 219-006-1 2312-35-8 Carc. Cat. 3; R40
T; R23
Xi; R38-41
N; R50-53 T; N
R: 23-38-40-41-50/53
S: (1/2-)26-36/37/39-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 607-152-00-2 2,3,6-TBA (ISO);
2,3,6-trichlorobenzoic acid 200-026-4 50-31-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 607-153-00-8 benazolin (ISO);
4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid 223-297-0 3813-05-6 Xi; R36/38
R52-53 Xi
R: 36/38-52/53
S: (2-)22-61 607-154-00-3 ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;
benzoylprop-ethyl (ISO) 244-845-5 22212-55-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24-60-61 607-155-00-9 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;
blasticidin-s — 2079-00-7 T+; R28 T+
R: 28
S: (1/2-)24/25-36/37-45 607-156-00-4 chlorfenson (ISO);
4-chlorophenyl 4-chlorobenzenesulfonate 201-270-4 80-33-1 Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-50/53
S: (2-)37-60-61 607-157-00-X 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;
difenacoum 259-978-4 56073-07-5 T+; R28
T; R48/25
N; R50-53 T+; N
R: 28-48/25-50/53
S: (1/2-)36/37-45-60-61 607-158-00-5 sodium salt of chloroacetic acid;
sodium chloroacetate 223-498-3 3926-62-3 T; R25
Xi; R38
N; R50 T; N
R: 25-38-50
S: (1/2-)22-37-45-61 607-159-00-0 chlorobenzilate (ISO);
ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;
ethyl 4,4'-dichlorobenzilate 208-110-2 510-15-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 607-160-00-6 isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;
clofop-isobutyl (ISO) — 51337-71-4 Xn; R22 Xn
R: 22
S: (2-) 607-161-00-1 diethanolamine salt of 4-CPA — — Xn; R22 Xn
R: 22
S: (2-) 607-162-00-7 2,2-dichloropropionic acid;
dalapon 200-923-0 75-99-0 Xn; R22
Xi; R38-41
R52-53 Xn
R: 22-38-41-52/53
S: (2-)26-39-61 607-163-00-2 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;
dehydracetic acid 208-293-9 520-45-6 Xn; R22 Xn
R: 22
S: (2-) 607-164-00-8 sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;
sodium dehydracetate 224-580-1 4418-26-2 Xn; R22 Xn
R: 22
S: (2-) 607-165-00-3 diclofop-methyl (ISO);
methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;
methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; 257-141-8 51338-27-3 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 607-166-00-9 medinoterb acetate (ISO);
6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate 219-634-6 2487-01-6 T; R25
Xn; R21 T
R: 21-25
S: (1/2-)36/37-45 607-167-00-4 sodium 3-chloroacrylate — 4312-97-4 Xn; R21/22 Xn
R: 21/22
S: (2-)36/37 607-168-00-X dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;
propylisome — 83-59-0 T; R24
Xn; R22
N; R50-53 T; N
R: 22-24-50/53
S: (1/2-)36/37-45-60-61 607-169-00-5 sodium fluoroacetate 200-548-2 62-74-8 T+; R26/27/28
N; R50 T+; N
R: 26/27/28-50
S: (1/2-)13-22-36/37-45-61 607-170-00-0 bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;
thiocyclam-oxalate 250-859-2 31895-22-4 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-46-60-61 607-172-00-1 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;
brodifacoum 259-980-5 56073-10-0 T+; R27/28
T; R48/24/25
N; R50-53 T+; N
R: 27/28-48/24/25-50/53
S: (1/2-)36/37-45-60-61 607-173-00-7 dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate 400-460-6 — R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 607-174-00-2 reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate 400-580-9 — Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)28-61 607-175-00-8 methyl 2-(2-nitrobenzylidene)acetoacetate 400-650-9 39562-27-1 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-176-00-3 reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) 400-830-7 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)36/37-61 607-177-00-9 methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate 401-190-1 101200-48-0 R43 Xi
R: 43
S: (2-)22-24-37 607-178-00-4 methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate 401-340-6 83055-99-6 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-179-00-X (benzothiazol-2-ylthio)succinic acid 401-450-4 95154-01-1 R43 Xi
R: 43
S: (2-)24-37 607-180-00-5 potassium 2-hydroxycarbazole-1-carboxylate 401-630-2 96566-70-0 Xn; R22
Xi; R36/37
R52-53 Xn
R: 22-36/37-52/53
S: (2-)22-26-61 607-181-00-0 3,5-dichloro-2,4-difluorobenzoyl fluoride 401-800-6 101513-70-6 T; R23
C; R34
Xn; R22
R29
R43
R52-53 T; C
R: 22-23-29-34-43-52/53
S: (1/2-)26-36/37/39-45-61 607-182-00-6 methyl 3-sulphamoyl-2-thenoate 402-050-2 — R43 Xi
R: 43
S: (2-)24-37 607-183-00-1 zinc 2-hydroxy-5-C13-18alkylbenzoate 402-280-3 — Xi; R36/38
N; R51-53 Xi; N
R: 36/38-51/53
S: (2-)26-61 607-184-00-7 S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate 402-290-8 85702-90-5 R10
R42/43 Xn
R: 10-42/43
S: (2-)23-24-37 607-185-00-2 ethyl trans-3-dimethylaminoacrylate 402-650-4 1117-37-9 R43 Xi
R: 43
S: (2-)24-37 607-186-00-8 quinclorac (ISO);
3,7-dichloroquinoline-8-carboxylic acid 402-780-1 84087-01-4 R43 Xi
R: 43
S: (2-)24-37 607-187-00-3 bis(2,2,6,6-tetramethyl-4-piperidyl) succinate 402-940-0 62782-03-0 Xi; R36
R52-53 Xi
R: 36-52/53
S: (2-)26-61 607-188-00-9 hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate 402-970-4 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-189-00-4 trimethylenediaminetetraacetic acid 400-400-9 1939-36-2 Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-50/53
S: (2-)22-26-39-60-61 607-190-00-X methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) 401-890-7 77402-03-0 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22
Xi; R36 T
R: 45-46-22-36
S: 53-45 E
607-191-00-5 isobutyl 3,4-epoxybutyrate 401-920-9 100181-71-3 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-28-36/37-60-61 607-192-00-0 disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate 402-360-8 92511-22-3 Xi; R41 Xi
R: 41
S: (2-)26-39 607-194-00-1 propylene carbonate 203-572-1 108-32-7 Xi; R36 Xi
R: 36
S: (2-) 607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 R10
Xi; R36 Xi
R: 10-36
S: (2-)25 607-196-00-2 heptanoic acid 203-838-7 111-14-8 C; R34 C
R: 34
S: (1/2-)26-28-36/37/39-45 607-197-00-8 nonanoic acid 203-931-2 112-05-0 C; R34 C
R: 34
S: (1/2-)26-28-36/37/39-45 607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Xn; R22
R43 Xn
R: 22-43
S: (2-)24-37 607-199-00-9 octyl 3,4,5-trihydroxybenzoate 213-853-0 1034-01-1 Xn; R22
R43 Xn
R: 22-43
S: (2-)24-37 607-200-00-2 dodecyl 3,4,5-trihydroxybenzoate 214-620-6 1166-52-5 R43 Xi
R: 43
S: (2-)24-37 607-201-00-8 thiocarbonyl chloride 207-341-6 463-71-8 T; R23
Xn; R22
Xi; R36/37/38 T
R: 22-23-36/37/38
S: (1/2-)7-9-36/37-45 607-203-00-9 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate 279-452-8 80387-97-9 Repr. Cat. 2; R61
R43
R52-53 T
R: 61-43-52/53
S: 53-45-61 607-204-00-4 (chlorophenyl)(chlorotolyl)methane, mixed isomers 400-140-6 — N; R50-53 N
R: 50/53
S: 60-61 607-205-00-X methyl chloroacetate 202-501-1 96-34-4 R10
T; R23/25
Xi; R37/38-41 T
R: 10-23/25-37/38-41
S: (1/2-)26-37/39-45 607-206-00-5 isopropyl chloroacetate 203-301-7 105-48-6 R10
T; R25
Xi; R36/37/38 T
R: 10-25-36/37/38
S: (1/2-)26-37/39-45 607-207-00-0 haloxyfop-etotyl (ISO)
2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;
haloxyfop-(2-ethoxyethyl) 402-560-5 87237-48-7 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-36-60-61 607-208-00-6 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers 403-000-2 91853-67-7 Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)37/39-60-61 607-209-00-1 reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate 403-030-6 — Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61 607-210-00-7 methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) 403-230-3 77402-05-2 Carc. Cat. 2; R45
Muta. Cat. 2; R46
C; R34
R43 T
R: 45-46-34-43
S: 53-45 607-211-00-2 methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate 403-270-1 6386-39-6 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)36-61 607-212-00-8 poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate 403-300-3 — R43 Xi
R: 43
S: (2-)24-37 607-213-00-3 ethyl 3,3-bis(tert-pentylperoxy)butyrate 403-320-2 67567-23-1 E; R2 $
O; R7
R10
N; R51-53 E; N
R: 2-7-10-51/53
S: (2-)3/7-14-33-36/37/39-61 607-214-00-9 N,N-hydrazinodiacetic acid 403-510-5 19247-05-3 T; R25
Xn; R48/22
R43
R52-53 T
R: 25-43-48/22-52/53
S: (1/2-)26-36/37/39-45-61 607-215-00-4 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid 403-920-4 107551-67-7 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)25-26-36 607-216-00-X glutamic acid, reaction products with N-(C12-14alkyl)propylenediamine 403-950-8 — T+; R26
Xn; R22
C; R34
N; R50-53 T+; N
R: 22-26-34-50/53
S: (1/2-)26-36/37/39-38-45-60-61 607-217-00-5 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate 403-960-2 — R43
R53 Xi
R: 43-53
S: (2-)24-37-61 607-218-00-0 dichlorprop-P (ISO);
(+)-R-2-(2,4-dichlorophenoxy)propionic acid 403-980-1 15165-67-0 Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43
S: (2-)24-26-37/39 607-219-00-6 bis(2-ethylhexyl) dithiodiacetate 404-510-8 62268-47-7 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)24/25-37-61 607-221-00-7 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid 404-550-6 — R43
R53 Xi
R: 43-53
S: (2-)24-37-61 607-222-00-2 6-(2,3-dimethylmaleimido)hexyl methacrylate 404-870-6 63740-41-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-223-00-8 transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 405-060-5 118712-89-3 Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)36/37-60-61 607-224-00-3 methyl 2-(3-nitrobenzylidene)acetoacetate 405-270-7 39562-17-9 Xi; R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 607-225-00-9 3-azidosulfonylbenzoic acid 405-310-3 15980-11-7 E; R2
Xn; R48/22
Xi; R41
R43 E; Xn
R: 2-41-43-48/22
S: (2-)22-26-35-36/37/39 607-226-00-4 reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate 405-360-6 — Xi; R38-41
R43
R52-53 Xi
R: 38-41-43-52/53
S: (2-)24-26-37/39-61 607-227-00-X potassium 2-amino-2-methylpropionate octahydrate 405-560-3 120447-91-8 Xn; R22
C; R35 C
R: 22-35
S: (1/2-)26-28-36/37/39-45 607-228-00-5 bis(2-methoxyethyl) phthalate 204-212-6 117-82-8 Repr. Cat. 2; R61
Repr. Cat. 3; R62 T
R: 61-62
S: 53-45 607-229-00-0 diethylcarbamoyl chloride 201-798-5 88-10-8 Carc. Cat. 3; R40
Xn; R20/22
Xi; R36/37/38 Xn
R: 20/22-36/37/38-40
S: (2-)26-36/37 607-230-00-6 2-ethylhexanoic acid 205-743-6 149-57-5 Repr. Cat. 3; R63 Xn
R: 63
S: (2-)36/37 607-231-00-1 3,6-dichloropyridine-2-carboxylic acid;
clopyralid 216-935-4 1702-17-6 Xi; R41
N; R51-53 X; N
R: 41-51/53
S: (2-)26-39-61 607-232-00-7 pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Xi; R36/37/38
R43
N; R51-53 Xi; N
R: 36/37/38-43-51/53
S: (2-)24-26-37-61 607-234-00-8 flurenol (ISO);
9-hydroxy-9H-fluorene-9-carboxylic acid 207-397-1 467-69-6 N; R51-53 N
R: 51/53
S: 61 607-235-00-3 mecrilate;
methyl 2-cyanoacrylate 205-275-2 137-05-3 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)23-24/25-26 Xi; R36/37/38: C ≥ 10 % 607-236-00-9 ethyl 2-cyanoacrylate 230-391-5 7085-85-0 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)23-24/25-26 Xi; R36/37/38: C ≥ 10 % 607-237-00-4 benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;
flurazole 276-942-3 72850-64-7 N; R51-53 N
R: 51/53
S: 61 607-238-00-X tau-fluvalinate (ISO);
cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate — 102851-06-9 Xn; R22
Xi; R38
N; R50-53 Xn; N
R: 22-38-50/53
S: (2-)24-59-61 607-239-00-5 fenpropathrin (ISO);
α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate; 254-485-0 39515-41-8 T+; R26
T; R25
Xn; R21
N; R50-53 T+; N
R: 21-25-26-50/53
S: (1/2-)28-36/37-38-45-60-61 607-240-00-0 cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethylphthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] 216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7] 1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7] Xi; R41
R42/43 Xn
R: 41-42/43
S: (2-)22-24-26-37/39 C
607-241-00-6 hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4] 243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4] 19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4] Xi; R41
R42/43 Xn
R: 41-42/43
S: (2-)22-24-26-37/39 C
607-242-00-1 tetrachlorophthalic anhydride 204-171-4 117-08-8 Xi; R41
R42/43
N; R50-53 Xn; N
R: 41-42/43-50/53
S: (2-)22-24-26-37/39-60-61 607-243-00-7 sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 217-846-3 [1]
246-590-5 [2]
258-527-9 [3] 1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3] R52-53 R: 52/53
S: 61 607-244-00-2 isooctyl acrylate 249-707-8 29590-42-9 Xi; R36/37/38
N; R50-53 Xi; N
R: 36/37/38-50/53
S: (2-)26-28-60-61 Xi; R36/37/38: C ≥ 10 % 607-245-00-8 tert-butyl acrylate 216-768-7 1663-39-4 F; R11
Xn; R20/21/22
Xi; R37/38
R43
N; R52-53 F; Xn
R: 11-20/21/22-37/38-43-52/53
S: (2-)16-25-37-61 D
607-246-00-3 allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester 202-473-0 96-05-9 R10
T; R23
Xn; R21/22
N; R50 T; N
R: 10-21/22-23-50
S: (1/2-)36/37-45-61 607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 Xi; 36/37/38
N; R50-53 Xi; N
R: 36/37/38-50/53
S: (2-)26-28-60-61 Xi; R36/37/38: C ≥ 10 % 607-248-00-4 naptalam-sodium (ISO);
sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Xn; R22 Xn
R: 22
S: (2-) 607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 256-032-2 42978-66-5 Xi; R36/37/38
R43
N; R51-53 Xi; N
R: 36/37/38-43-51/53
S: (2-)24-37-61 Xi; R36/37/38: C ≥ 10 % 607-250-00-5 4H-3,1-benzoxazine-2,4(1H)-dione 204-255-0 118-48-9 Xi; R36
R43 Xi
R: 36-43
S: (2-)24-26-37 607-251-00-0 2-methoxypropyl acetate 274-724-2 70657-70-4 R10
Repr. Cat. 2; R61
Xi; R37 T
R: 61-10-37
S: 53-45 607-252-00-6 lambda-cyhalothrin (ISO);
reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) 415-130-7 91465-08-6 T+; R26
T; R25
Xn; R21
N; R50-53 T+; N
R: 21-25-26-50/53
S: (1/2-)28-36/37/39-38-45-60-61 607-253-00-1 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
cyfluthrin 269-855-7 68359-37-5 T+; R28
T; R23
N; R50-53 T+; N
R: 23-28-50/53
S: (1/2-)36/37/39-45-60-61 607-254-00-7 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
beta-cyfluthrin 269-855-7 68359-37-5 T+; R26/28
N; R50-53 T+; N
R: 26/28-50/53
S: (1/2-)36/37/39-45-60-61 607-255-00-2 fluroxypyr (ISO);
4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid — 69377-81-7 R52-53 R: 52/53
S: 61 607-256-00-8 azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate — 131860-33-8 T; R23
N; 50-53 T; N
R: 23-50/53
S: (1/2-)22-45-60-61 607-257-00-3 isopropyl propionate 211-300-8 637-78-5 F; R11 F
R: 11
S: (2-)16-23-24-29-33 607-258-00-9 dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate 403-990-6 70950-45-7 R53 R: 53
S: 61 607-259-00-4 methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate 404-130-2 105560-93-8 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 607-260-00-X ethyl 2-(3-nitrobenzylidene)acetoacetate 404-490-0 39562-16-8 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 607-261-00-5 iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate 404-800-4 118832-72-7 N; R50-53 N
R: 50/53
S: 60-61 607-262-00-0 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 405-050-0 86393-33-1 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 607-263-00-6 potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate 405-680-6 — E; R2
N; R51-53 E; N
R: 2-51/53
S: (2-)35-61 607-264-00-1 2-chloro-4-(methylsulfonyl)benzoic acid 406-520-8 53250-83-2 Xi; R41 Xi
R: 41
S: (2-)26-39 607-265-00-7 ethyl-2-chloro-2,2-diphenylacetate 406-580-5 52460-86-3 Xi; R38
R52-53 Xi
R: 38-52/53
S: (2-)37-61 607-266-00-2 reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];
3,5-di-tert-butyl-salicylic acid 406-890-0 130296-87-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-60-61 607-267-00-8 tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 407-620-4 33610-13-8 R42/43
R52-53 Xn
R: 42/43-52/53
S: (2-)22-24-37-61 607-268-00-3 2-methylpropyl (R)-2-hydroxypropanoate 407-770-0 61597-96-4 Xi; R36 Xi
R: 36
S: (2-)26 607-269-00-9 (R)-2-(4-hydroxyphenoxy)propanoic acid 407-960-3 94050-90-5 Xi; R41 Xi
R: 41
S: (2-)26-39 607-270-00-4 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane 410-730-5 90498-90-1 Xn; R21 Xn
R: 21
S: (2-)36/37 607-271-00-X 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane 417-420-9 156324-82-2 Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 607-272-00-5 fluroxypyr-meptyl (ISO);
methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 279-752-9 [1]
- [2] 81406-37-3 [1]
154486-27-8 [2] N; R50-53 N
R: 50/53
S: 60-61 607-273-00-0 ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate 404-520-2 — R52-53 R: 52/53
S: 61 607-274-00-6 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate 405-350-1 54527-73-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-275-00-1 sodium benzoyloxybenzene-4-sulfonate 405-450-5 66531-87-1 R43 Xi
R: 43
S: (2-)24-37 607-276-00-7 bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex 405-635-0 — Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 607-277-00-2 reaction mass of: 2-(hexylthio)ethylamine hydrochloride;
sodium propionate 405-720-2 — Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61 607-278-00-8 reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;
sodium naphthylethylbenzenesulfonate 405-760-0 — Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 607-279-00-3 reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate 405-960-8 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-280-00-9 sodium 4-chloro-1-hydroxybutane-1-sulfonate 406-190-5 54322-20-2 Xn; R22
Xi; R36
R43 Xn
R: 22-36-43
S: (2-)22-26-36/37 607-281-00-4 reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates 407-000-3 127519-17-9 N; R51-53 N
R: 51/53
S: 61 607-282-00-X 2-acetoxymethyl-4-benzyloxybut-1-yl acetate 407-140-5 131266-10-9 R52-53 R: 52/53
S: 61 607-283-00-5 E-ethyl-4-oxo-4-phenylcrotonate 408-040-4 15121-89-8 Xn; R21/22
Xi; R38-41
R43
N; R50-53 Xn; N
R: 21/22-38-41-43-50/53
S: (2-)26-36/37/39-60-61 607-284-00-0 reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);
lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) 410-040-4 136213-76-8 N; R51-53 N
R: 51/53
S: 61 607-285-00-6 reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;
sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;
potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate 410-065-0 — R43 Xi
R: 43
S: (2-)22-24-37 607-286-00-1 reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate 410-070-8 141880-36-6 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 607-287-00-7 O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate 410-140-8 — R52-53 R: 52/53
S: 61 607-288-00-2 Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively 410-160-7 148732-74-5 Xi; R36
R43
R52-53 Xi
R: 36-43-52/53
S: (2-)22-26-36/37-61 607-289-00-8 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid 410-370-9 105488-33-3 R53 R: 53
S: 61 607-290-00-3 reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;
ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate 410-540-2 — Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 607-291-00-9 dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate 410-630-1 104051-92-5 R53 R: 53
S: 61 607-292-00-4 reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid 410-640-6 — Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 607-293-00-X reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate 410-650-0 — Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)26-36/37/39-61 607-294-00-5 sodium 2-benzoyloxy-1-hydroxyethane-sulfonate 410-680-4 — R43 Xi
R: 43
S: (2-)24-37 607-295-00-0 reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tetracarboxylate 410-800-5 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-296-00-6 reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid 410-830-9 — R53 R: 53
S: 61 607-297-00-1 (E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) 410-960-6 92761-26-7 Xi; R41 Xi
R: 41
S: (2-)26-39 607-298-00-7 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate 411-010-3 — R43 Xi
R: 43
S: (2-)22-36/37 607-299-00-2 methyl 3-(acetylthio)-2-methyl-propanoate 411-040-7 97101-46-7 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 607-300-00-6 trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 411-430-7 — Xi; R41
R43 Xi
R: 41-43
S: (2-)26-36/37/39 607-301-00-1 reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid 411-860-5 — R43
N; R51-53 Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61 607-302-00-7 reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid 411-910-6 — Xi; R38-41
R43
N; R51-53 Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61 607-303-00-2 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 413-760-7 93107-30-3 Repr. Cat. 3; R62
R52-53 Xn
R: 62-52/53
S: (2-)22-36/37-61 607-304-00-8 fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 274-125-6 69806-50-4 Repr. Cat. 2; R61
N; R50-53 T; N
R: 61-50/53
S: 53-45-60-61 607-305-00-3 fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate — 79241-46-6 Repr. Cat. 3; R63
N; R50-53 Xn; N
R: 50/53-63
S: (2-)29-36/37-46-60-61 607-306-00-9 chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate 282-714-4 84332-86-5 Carc. Cat. 3; R40
N; R51-53 Xn; N
R: 40-51/53
S: (2-)36/37-61 607-307-00-4 vinclozolin (ISO);
N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione 256-599-6 50471-44-8 Carc. Cat. 3; R40
Repr. Cat. 2; R60-61
R43
N; R51-53 T; N
R: 60-61-40-43-51/53
S: 53-45-61 607-308-00-X esters of 2,4-D — — Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)26-29-36/37-46-60-61 A
607-309-00-5 carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate — 128639-02-1 N; R50-53 N
R: 50/53
S: 60-61 607-310-00-0 kresoxim-methyl (ISO);
methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate — 143390-89-0 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 607-311-00-6 benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate 246-591-0 25059-80-7 N; R51-53 N
R: 51/53
S: 61 607-312-00-1 methoxyacetic acid 210-894-6 625-45-6 Repr. Cat. 2; R60-61
Xn; R22
C; R34 T
R: 60-61-22-34
S: 53-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % E
607-313-00-7 neodecanoyl chloride 254-875-0 40292-82-8 T+; R26
Xn; R22
C; R34 T+
R: 22-26-34
S: (1/2-)26-28-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 607-314-00-2 ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate 247-525-3 26225-79-6 N; R51-53 N
R: 51/53
S: 61 607-315-00-8 glyphosate (ISO);
N-(phosphonomethyl)glycine 213-997-4 1071-83-6 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 607-316-00-3 glyphosate-trimesium;
glyphosate-trimethylsulfonium — 81591-81-3 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)36/37-46-61 607-317-00-9 bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP 204-211-0 117-81-7 Repr. Cat. 2; R60-61 T
R: 60-61
S: 53-45 607-318-00-4 dibutyl phthalate;
DBP 201-557-4 84-74-2 Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R50 T; N
R: 61-50-62
S: 53-45-61 607-319-00-X deltamethrin (ISO);
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate 258-256-6 52918-63-5 T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)24-28-36/37/39-38-45-60-61 607-320-00-5 bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate 413-930-0 130066-57-8 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 607-321-00-0 (S)-methyl-2-chloropropionate 412-470-8 73246-45-4 R10
Xn; R48/22
Xi; R36 Xn
R: 10-36-48/22
S: (2-)23-26-36 607-322-00-6 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid 413-120-7 107144-30-9 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-61 607-323-00-1 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate 413-850-6 123968-25-2 R53 R: 53
S: 61 607-324-00-7 reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;
dihydrogenated alkyl (C14-C18)amine 413-800-3 — R53 R: 53
S: 61 607-325-00-2 (S)-2-chloropropionic acid 411-150-5 29617-66-1 Xn; R21/22
C; R35 C
R: 21/22-35
S: (1/2-)23-26-28-36/37/39-45 607-326-00-8 reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate 410-720-0 141847-13-4 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 607-327-00-3 2-(2-iodoethyl)-1,3-propanediol diacetate 411-780-0 127047-77-2 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)36-61 607-328-00-9 methyl 4-bromomethyl-3-methoxybenzoate 410-310-1 70264-94-7 Xi; R38-41
R43
N; R50-53 Xi; N
R: 38-41-43-50/53
S: (2-)26-36/37/39-60-61 607-329-00-4 reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;
sodium 2-octadecenyl-amino-1,4-butandioate 411-250-9 — R43 Xi
R: 43
S: (2-)24-26-37/39 607-330-00-X (S)-2,3-dihydro-1H-indole-2-carboxylic acid 410-860-2 79815-20-6 Repr. Cat. 3; R62
Xn; R48/22
R43 Xn
R: 43-48/22-62
S: (2-)22-25-26-36/37 607-331-00-5 reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;
1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane 406-750-9 — R53 R: 53
S: 23-61 607-332-00-0 cyclopentyl chloroformate 411-460-0 50715-28-1 R10
T; R23
Xn; R22-48/22
Xi; R41
R43 T
R: 10-22-23-41-43-48/22
S: (1/2-)26-36/37/39-45 607-333-00-6 reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;
tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate 405-670-1 — Xn; R22-48/22
C; R34
N; R50-53 C; N
R: 22-34-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61 607-334-00-1 ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 405-880-3 100501-62-0 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 607-335-00-7 methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate 406-250-0 72619-32-0 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 607-336-00-2 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate 406-560-6 122760-85-4 Xi; R38
R43
N; R51-53 Xi; N
R: 38-43-51/53
S: (2-)36/37-61 607-337-00-8 di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate 406-052-4 125078-60-6 R10
Xn; R22
Xi; R38-41
N; R51-53 Xn; N
R: 10-22-38-41-51/53
S: (2-)26-37/39-61 607-338-00-3 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate 406-235-9 72531-53-4 Xi; R36/38 Xi
R: 36/38
S: (2-)26-37 607-339-00-9 2,3,4,5-tetrachlorobenzoylchloride 406-760-3 42221-52-3 Xn; R22
C; R34
R43 C
R: 22-34-43
S: (1/2-)26-36/37/39-45 607-340-00-4 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate 406-990-4 — N; R51-53 N
R: 51/53
S: 61 607-341-00-X (9S)-9-amino-9-deoxyerythromycin 406-790-7 26116-56-3 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 607-342-00-5 4-chlorobutyl veratrate 410-950-1 69788-75-6 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 607-343-00-0 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) 407-410-2 — R53 R: 53
S: 61 607-344-00-6 reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;
3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate 407-810-7 — Xn; R48/22 Xn
R: 48/22
S: (2-)21-22-36/37 607-345-00-1 potassium 2-(2,4-dichlorophenoxy)-(R)-propionate 413-580-9 113963-87-4 Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43
S: (2-)24-26-37/39 607-346-00-7 3-icosyl-4-henicosylidene-2-oxetanone 401-210-9 83708-14-9 R53 R: 53
S: 61 607-347-00-2 sodium (R)-2-(2,4-dichlorophenoxy)propionate 413-340-3 119299-10-4 Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43
S: (2-)22-26-36/37/39 607-348-00-8 magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) 413-360-2 — Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43
S: (2-)22-26-36/37/39 607-349-00-3 mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate 411-270-8 — R52-53 R: 52/53
S: 61 607-350-00-9 bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane 412-060-9 136210-32-7 R43
R52-53 Xi
R: 43-52/53
S: (2-)36/37-61 607-351-00-4 methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate 407-550-4 69184-17-4 N; R51-53 N
R: 51/53
S: 20/21-61 607-352-00-X 4,4'-oxydiphthalic anhydride 412-830-4 1823-59-2 R52-53 R: 52/53
S: 61 607-353-00-5 reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;
ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate 407-520-0 80657-64-3 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 607-354-00-0 ethyl 2-cyclohexylpropionate 412-280-5 2511-00-4 N; R51-53 N
R: 51/53
S: 61 607-355-00-6 p-tolyl 4-chlorobenzoate 411-530-0 15024-10-9 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 607-356-00-1 ethyl trans-2,2,6-trimethylcyclohexanecarboxylate 412-540-8 — Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 607-357-00-7 reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran 412-450-9 131766-73-9 R43 Xi
R: 43
S: (2-)24-37 607-358-00-2 (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate 412-670-5 54275-93-3 R42 Xn
R: 42
S: (2-)22 607-359-00-8 (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate 412-800-0 76109-32-5 R42 Xn
R: 42
S: (2-)22 607-360-00-3 sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate 411-680-7 133167-77-8 R43 Xi
R: 43
S: (2-)24-37 607-361-00-9 methyl (R)-2-(4-hydroxyphenoxy)propionate 411-950-4 96562-58-2 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 607-362-00-4 reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate 413-500-2 — Xi; R38-41
N; R51-53 Xi; N
R: 38-41-51/53
S: (2-)26-37/39-61 607-363-00-X methyl-3-methoxyacrylate 412-900-4 5788-17-0 R43 Xi
R: 43
S: (2-)24-37 607-364-00-5 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione 413-330-9 134724-55-3 R53 R: 53
S: 61 607-365-00-0 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 410-620-7 119154-86-8 Xn; R22
C; R34
R43 C
R: 22-34-43
S: (1/2-)22-26-36/37/39-45 607-366-00-6 3,5-dimethylbenzoyl chloride 413-010-9 6613-44-1 C; R34
R43 C
R: 34-43
S: (1/2-)26-36/37/39-45 607-367-00-1 potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate 411-640-9 153352-59-1 Xn; R22 Xn
R: 22
S: (2-)37 607-368-00-7 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole 411-650-3 110895-43-7 T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)37-38-45-60-61 607-369-00-2 reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid 411-660-8 147027-04-1 Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43
S: (2-)22-24-26-37/39 607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 412-210-3 41620-33-1 N; R50-53 N
R: 50/53
S: 60-61 607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 R53 R: 53
S: 61 607-372-00-9 ethoxylated bis phenol A di-(norbornene carboxylate) 412-410-0 — R52-53 R: 52/53
S: 61 607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 119738-06-6 Muta. Cat. 3; R68
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22-48/22
N; R50-53 T; N
R: 61-22-48/22-62-68-50/53
S: 53-45-60-61 E
607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-36/37-61 607-375-00-5 reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;
trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 421-960-0 90035-08-8 T+; R26/27/28
T; R48/23/24/25
N; R50-53 T+; N
R: 26/27/28-48/23/24/25-50/53
S: (1/2-)28-36/37/39-45-60-61 607-376-00-0 benzyl 2,4-dibromobutanoate 420-710-8 23085-60-1 Repr. Cat. 3; R62
Xi; R38
R43
N; R50-53 Xn; N
R: 38-43-62-50/53
S: (2-)23-36/37-41-60-61 607-377-00-6 trans-4-cyclohexyl-L-proline monohydrochloride 419-160-1 90657-55-9 Repr. Cat. 3; R62
Xn; R22
Xi; R38-41
R43 Xn
R: 22-38-41-43-62
S: (2-)22-26-36/37/39 607-378-00-1 ammonium (Z)-α-methoxyimino-2-furylacetate 405-990-1 97148-39-5 F; R11 F
R: 11
S: (2-)22-43 607-379-00-7 reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;
sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;
sodium [bis(2-hydroxyethyl)amino]methylsulfonate;
N,N-bis(2-hydroxyethyl)stearamide 401-230-8 R52-53 R: 52/53
S: 61 607-380-00-2 reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate 407-320-3 — Xi; R38-41
R52-53 Xi
R: 38-41-52/53
S: (2-)26-37/39-61 607-381-00-8 reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid 413-710-4 — R53 R: 53
S: 61 607-382-00-3 2-((4-amino-2-nitrophenyl)amino)benzoic acid 411-260-3 117907-43-4 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 607-383-00-9 reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate 415-430-8 86403-32-9 Xi; R41
R43
N; R50-53 Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61 607-384-00-4 reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate 413-750-2 171090-93-0 R53 R: 53
S: 61 607-385-00-X Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate 414-590-6 125229-74-5 N; R51-53 N
R: 51/53
S: 61 607-386-00-5 reaction mass of: tetradecanoic acid (42.5-47.5 %);
poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %) 412-580-6 174591-51-6 Xi; R38-41
R43
N; R50-53 Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61 607-387-00-0 reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid (60-65 %) 412-590-0 58856-63-6 Xi; R38-41
R43
N; R50-53 Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61 607-388-00-6 4-ethylamino-3-nitrobenzoic acid 412-090-2 2788-74-1 Xn; R22
R43
R52-53 Xn
R: 22-43-52/53
S: (2-)22-24-37-61 607-389-00-1 trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate 414-130-4 119710-96-2 Xn; R22 Xn
R: 22
S: (2-)22 607-390-00-7 1,2,3,4-tetrahydro-6-nitro-quinoxaline 414-270-6 41959-35-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-61 607-391-00-2 dimethylcyclopropane-1,1-dicarboxylate 414-240-2 6914-71-2 R52-53 R: 52/53
S: 61 607-392-00-8 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate 414-260-1 88938-37-8 R53 R: 53
S: 61 607-393-00-3 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 415-750-8 106447-44-3 R43 Xi
R: 43
S: (2-)22-24-37 607-394-00-9 5-methylpyrazine-2-carboxylic acid 413-260-9 5521-55-1 Xi; R41 Xi
R: 41
S: (2-)26-39 607-395-00-4 reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate 410-230-7 — C; R34
R43
N; R51-53 C; N
R: 34-43-51/53
S: (1/2-)26-36/37/39-45-61 607-396-00-X bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate 414-840-4 147783-69-5 N; R50-53 N
R: 50/53
S: 22-60-61 607-397-00-5 reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurized phenates (branched C10-14 and C18-30 alkylated) 415-930-6 — R43 Xi
R: 43
S: (2-)36/37 607-398-00-0 ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate 414-820-5 125630-94-6 N; R50-53 N
R: 50/53
S: 60-61 607-399-00-6 2,2-dimethyl 3-methyl-3-butenyl propanoate 415-610-6 104468-21-5 Xi; R38
R52-53 Xi
R: 38-52/53
S: (2-)37-61 607-400-00-X methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate 414-400-1 32750-89-3 N; R50-53 N
R: 50/53
S: 60-61 607-401-00-5 ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate 414-450-4 88805-65-6 Xi; R38-41
R43 Xi
R: 38-41-43
S: (2-)24-26-37/39 607-402-00-0 methyl N-(phenoxycarbonyl)-L-valinate 414-500-5 153441-77-1 R52-53 R: 52/53
S: 61 607-403-00-6 reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol 414-810-0 — Xn; R48/22
Xi; R41
N; R50-53 Xn; N
R: 41-48/22-50/53
S: (2-)22-26-36/39-60-61 607-404-00-1 reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid 415-190-4 — R43 Xi
R: 43
S: (2-)24-37 607-405-00-7 2-hexyldecyl-p-hydroxybenzoate 415-380-7 148348-12-3 N; R51-53 N
R: 51/53
S: 61 607-406-00-2 potassium 2,5-dichlorobenzoate 415-700-5 184637-62-5 Xn; R22
Xi; R41 Xn
R: 22-41
S: (2-)26-39 607-407-00-8 ethyl 2-carboxy-3-(2-thienyl)propionate 415-680-8 143468-96-6 Xi; R38-41
R43 Xi
R: 38-41-43
S: (2-)24-26-37/39 607-408-00-3 potassium N-(4-fluorophenyl)glycinate 415-710-1 184637-63-6 Xn; R48/22
Xi; R41
R43
R52-53 Xn
R: 41-43-48/22-52/53
S: (2-)22-26-36/37/39-61 607-409-00-9 reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass from Aspergillus terreus 415-840-7 — R43
R52-53 Xi
R: 43-52/53
S: (2-)36/37-61 607-410-00-4 mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate 415-880-5 779343-34-9 Xi; R38-41
R43
N; R50-53 Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61 607-411-00-X oxiranemethanol, 4-methylbenzene-sulfonate, (S)- 417-210-7 70987-78-9 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xi; R41
R43
N; R51-53 T; N
R: 45-41-43-68-51/53
S: 53-45-61 607-412-00-5 ethyl 2-(1-cyanocyclohexyl)acetate 415-970-4 133481-10-4 Xn; R22-48/22
R52-53 Xn
R: 22-48/22-52/53
S: (2-)36/37-61 607-413-00-0 trans-4-phenyl-L-proline 416-020-1 96314-26-0 Repr. Cat. 3; R62
R43 Xn
R: 43-62
S: (2-)22-36/37 607-414-00-6 tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 402-070-1 88122-99-0 R53 R: 53
S: 61 607-415-00-1 poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) 419-590-1 — F; R11
R43 F; Xi
R: 11-43
S: (2-)24-37-43 607-416-00-7 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide 420-730-7 — N; R50-53 N
R: 50/53
S: 60-61 607-418-00-8 2-ethylhexyl 4-aminobenzoate 420-170-3 26218-04-2 N; R50-53 N
R: 50/53
S: 60-61 607-419-00-3 (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid 422-240-9 166596-68-5 Xi; R41
R43 Xi
R: 41-43
S: (2-)26-36/37/39 607-420-00-9 2,2-bis(hydroxymethyl)butanoic acid 424-090-1 10097-02-6 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 607-421-00-4 cypermethrin cis/trans +/- 40/60;
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Xn; R20/22
Xi; R37
N; R50-53 Xn; N
R: 20/22-37-50/53
S: (2-)24-36/37/39-60-61 607-422-00-X α-cypermethrin 257-842-9 67375-30-8 T; R25
Xn; R48/22
Xi; R37
N; R50-53 T; N
R: 25-37-48/22-50/53
S: (2-)36/37/39-45-60-61 607-423-00-5 esters of mecoprop and of mecoprop-P — — Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)13-36/37-60-61 A
607-424-00-0 trifloxystrobin (ISO);
(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester — 141517-21-7 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61 607-425-00-6 metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate 260-979-7 57837-19-1 Xn; R22
R43
R52-53 Xn
R: 22-43-52/53
S: (2-)13-24-37-46-61 607-426-00-1 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4] 284-032-2 [1]
- [2]
205-017-9 [3]
210-088-4 [4] 84777-06-0 [1]
- [2]
131-18-0 [3]
605-50-5 [4] Repr. Cat. 2; R60-61
N; R50 T; N
R: 60-61-50
S: 53-45-61 607-427-00-7 bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate 260-300-4 56634-95-8 Repr. Cat. 3; R63
Xn; R20/22
R43
N; R50-53 Xn; N
R: 20/22-43-63-50/53
S: (2-)36/37-46-60-61 607-430-00-3 BBP;
benzyl butyl phthalate 201-622-7 85-68-7 Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R50-53 T; N
R: 61-62-50/53
S: 53-45-60-61 607-431-00-9 prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 245-387-9 23031-36-9 T; R23
Xn; R22
N; R50-53 T; N
R: 22-23-50/53
S: (1/2-)45-60-61 607-432-00-4 S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1]
(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] - [1]
- [2] 87392-12-9 [1]
178961-20-1 [2] R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 607-433-00-X cypermethrin cis/trans +/- 80/20;
(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Xn; R22
Xi; R37/38
R43
N; R50-53 Xn; N
R: 22-37/38-43-50/53
S: (2-)36/37/39-60-61 607-434-00-5 mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methylphenoxy)propionic acid 240-539-0 16484-77-8 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)13-26-37/39-46-61 607-435-00-0 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate 416-810-6 111969-64-3 Xn; R48/22
Xi; R41
N; R51-53 Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61 607-436-00-6 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate 417-350-9 — Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-28-37/39-60-61 607-437-00-1 3-(4-aminophenyl)-2-cyano-2-propenoic acid 417-480-6 252977-62-1 R43 Xi
R: 43
S: (2-)22-24-37 607-438-00-7 methyl-2-[(aminosulfonyl)methyl]benzoate 419-010-5 112941-26-1 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)22-26 607-439-00-2 methyl tetrahydro-2-furancarboxylate 420-670-1 37443-42-8 Xi; R41 Xi
R: 41
S: (2-)26-39 607-440-00-8 methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate 421-220-7 144740-59-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 607-441-00-3 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid 421-490-6 167684-63-1 R53 R: 53
S: 57-61 607-442-00-9 benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate 416-050-5 87460-09-1 Xi; R41 Xi
R: 41
S: (2-)26-36/39 607-443-00-4 bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate 416-140-4 145650-60-8 R53 R: 53
S: 61 607-444-00-X reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate 416-230-3 35541-81-2 R53 R: 53
S: 61 607-445-00-5 Iron (III) tris(4-methylbenzenesulfonate) 420-960-8 77214-82-5 Xi; R41 Xi
R: 41
S: (2-)24-26-39 607-446-00-0 methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate 416-240-8 155522-12-6 R43
R53 Xi
R: 43-53
S: (2-)22-24-37-61 607-447-00-6 sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate 416-370-5 156738-27-1 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 607-448-00-1 2,3,5,6-tetrafluorobenzoic acid 416-800-1 652-18-6 Xi; R38-41 Xi
R: 38-41
S: (2-)22-26-37/39 607-449-00-7 reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 417-080-1 — E; R2
R43
N; R50-53 E; Xi; N
R: 2-43-50/53
S: (2-)24-37-60-61 607-450-00-2 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate 419-040-9 89604-92-2 R53 R: 53
S: 61 607-451-00-8 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt 417-640-5 161935-19-9 Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 607-453-00-9 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) 418-100-1 172964-15-7 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 607-454-00-4 reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid 418-170-3 116193-72-7 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)25-26-39-61 607-455-00-X 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt 419-520-8 172890-93-6 R43 Xi
R: 43
S: (2-)22-24-37 607-456-00-5 3-amino-4-chlorobenzoic acid, hexadecyl ester 419-700-6 143269-74-3 N; R51-53 N
R: 51/53
S: 61 607-457-00-0 tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) 420-350-1 172277-97-3 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 607-458-00-6 reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] 420-850-1 — N; R51-53 N
R: 51/53
S: 61 607-459-00-1 isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate 418-930-4 — R53 R: 53
S: 61 607-460-00-7 3-tridecyloxy-propyl-ammonium 9-octadecenoate 418-990-1 778577-53-0 Xn; R48/22
Xi; R36/38
N; R50-53 Xn; N
R: 36/38-48/22-50/53
S: (2-)23-26-37/39-60-61 607-461-00-2 reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;
pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate 421-160-1 — R52-53 R: 52/53
S: 61 607-462-00-8 reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates 421-230-1 88230-35-7 N; R51-53 N
R: 51/53
S: 61 607-463-00-3 3-(phenothiazin-10-yl)propionic acid 421-260-5 362-03-8 N; R51-53 N
R: 51/53
S: 24/25-61 607-464-00-9 reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 421-280-4 R52-53 R: 52/53
S: 61 607-465-00-4 tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate 421-440-3 778583-04-3 R52-53 R: 52/53
S: 61 607-466-00-X reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate 421-480-1 — N; R51-53 N
R: 51/53
S: 37/39-61 607-467-00-5 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate 419-430-9 56533-00-7 Xn; R21/22-48/22
C; R34
N; R50-53 C; N
R: 21/22-34-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61 607-468-00-0 reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate 419-450-8 — R43 Xi
R: 43
S: (2-)22-24-37 607-469-00-6 disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate 419-460-2 120029-06-3 R52-53 R: 52/53
S: 61 607-470-00-1 potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 414-100-0 154336-20-6 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)39-22-26-61 607-472-00-2 ammonium iron(III) trimethylenediaminetetraacetate hemihydrate 400-660-3 111687-36-6 N; R51-53 N
R: 51/53
S: 61 607-474-00-3 (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid 410-430-4 117573-89-4 R53 R: 53
S: 61 607-475-00-9 reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) 412-940-2 148878-18-6 R43 Xi
R: 43
S: (2-)22-24-37 607-476-00-4 trisodium N,N-bis(carboxymethyl)-β-alanine 414-070-9 129050-62-0 C; R34
R52-53 C
R: 34-52/53
S: (1/2-)26-36/37/39-45-61 607-478-00-5 tetramethylammonium hydrogen phthalate 416-900-5 79723-02-7 T; R25
Xn; R48/22
N; R50 T; N
R: 25-48/22-50
S: (1/2-)25-36-45-61 607-479-00-0 hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate 418-550-9 168689-49-4 R53 R: 53
S: 61 607-480-00-6 1,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters 271-084-6 68515-42-4 Repr. Cat. 2; R61
Repr. Cat. 3; R62 T
R: 61-62
S: 53-45 607-487-00-4 reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate 402-660-9 — Repr. Cat. 2; R61
R52-53 T
R: 61-52/53
S: 53-45-61 607-488-00-X ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate 414-210-9 147379-38-2 N; R50-53 N
R: 50/53
S: 60-61 607-489-00-5 reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate 414-890-7 71302-79-9 R43 Xi
R: 43
S: (2-)24-37 607-490-00-0 N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate 415-060-7 — Xi; R41
R43 Xi
R: 41-43
S: (2-)24-26-37/39 607-492-00-1 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate 415-490-5 141773-73-1 N; R51-53 N
R: 51/53
S: 61 607-493-00-7 methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate 415-670-3 78850-37-0 Xi; R41 Xi
R: 41
S: (2-)26-39 607-494-00-2 bis(2-ethylhexyl)octylphosphonate 417-170-0 52894-02-7 N; R50-53 N
R: 50/53
S: 60-61 607-495-00-8 sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate 417-550-6 168151-92-6 R43 Xi
R: 43
S: (2-)24-37 607-496-00-3 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite 418-310-3 126050-54-2 R53 R: 53
S: 61 607-497-00-9 cerium oxide isostearate 419-760-3 — R53 R: 53
S: 61 607-498-00-4 (E)-3,7-dimethyl-2,6-octadienylhexadecanoate 421-370-3 3681-73-0 Xi; R38
R53 Xi
R: 38-53
S: (2-)37-61 607-499-00-X bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) 421-660-1 — Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61 607-500-00-3 calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate 421-670-4 — Xi; R38
N; R50-53 Xi; N
R: 38-50/53
S: (2-)37-60-61 607-501-00-9 reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives 421-820-9 192268-65-8 R53 R: 53
S: 61 607-502-00-4 (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate 422-200-0 178277-55-9 C; R34
Xn; R22
N; R51-53 C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61 607-503-00-X 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane 422-210-5 68957-94-8 C; R34 C
R: 34
S: (1/2-)26-36/37/39-45 607-505-00-0 pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate 422-930-1 R52-53 R: 52/53
S: 22-61 607-506-00-6 reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate 422-970-8 N; R51-53 N
R: 51/53
S: 22-61 607-507-00-1 potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate 422-980-2 187026-95-5 Xi; R41 Xi
R: 41
S: (2-)22-26-39 607-508-00-7 disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] 423-110-4 — Xi; R41 Xi
R: 41
S: (2-)22-26-39 607-512-00-9 trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate 423-970-0 182926-43-8 R52-53 R: 52/53
S: 22-61 607-513-00-4 reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid 423-200-3 — Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)22-26-36/37/39-61 607-515-00-5 reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate 429-650-7 147732-60-3 Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 607-516-00-0 N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine 429-670-6 105996-54-1 Xi; R41
R43 Xi
R: 41-43
S: (2-)24-26-37/39 607-517-00-6 (S)-α-(acetylthio)benzenepropanoic acid 430-300-0 76932-17-7 Xn; R22
Xi; R41
R43 Xn
R: 22-41-43
S: (2-)22-26-36/37/39 607-526-00-5 cartap (ISO);
1,3-bis(carbamoylthio)-2-(dimethylamino)propane — 15263-53-3 N; R50-53 N
R: 50/53
S: 60-61 607-527-00-0 reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate 423-180-6 — Xn; R48/22 Xn
R: 48/22
S: (2-)36 608-001-00-3 acetonitrile;
cyanomethane 200-835-2 75-05-8 F; R11
Xn; R20/21/22
Xi; R36 F; Xn
R: 11-20/21/22-36
S: (2-)16-36/37 608-002-00-9 trichloroacetonitrile 208-885-7 545-06-2 T; R23/24/25
N; R51-53 T; N
R: 23/24/25-51/53
S: (1/2-)45-61 608-003-00-4 acrylonitrile 203-466-5 107-13-1 F; R11
Carc. Cat. 2; R45
T; R23/24/25
Xi; R37/38-41
R43
N; R51-53 F; T; N
R: 45-11-23/24/25-37/38-41-43-51/53
S: - 53-45-61 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 % D E
608-004-00-X 2-hydroxy-2-methylpropionitrile;
2-cyanopropan-2-ol;
acetone cyanohydrin 200-909-4 75-86-5 T+; R26/27/28
N; R50-53 T+; N
R: 26/27/28-50/53
S: (1/2-)7/9-27-45-60-61 608-005-00-5 n-butyronitrile 203-700-6 109-74-0 R10 ⊗
T; R23/24/25 T
R: 10-23/24/25
S: (1/2-)45 608-006-00-0 bromoxynil (ISO)
3,5-dibromo-4-hydroxybenzonitrile;
bromoxynil phenol 216-882-7 1689-84-5 Repr. Cat. 3; R63
T+; R26
T; R25
R43
N; R50-53 T+; N
R: 25-26-43-63-50/53
S: (1/2-)27/28-36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 608-007-00-6 ioxynil (ISO)
4-hydroxy-3,5-diiodobenzonitrile 216-881-1 1689-83-4 Repr. Cat. 3; R63
T; R23/25
Xn; R21-48/22
Xi; R36
N; R50-53 T; N
R: 21-23/25-36-48/22-63-50/53
S: (1/2-)36/37-45-60-61-63 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 608-008-00-1 chloroacetonitrile 203-467-0 107-14-2 T; R23/24/25
N; R51-53 T; N
R: 23/24/25-51/53
S: (1/2-)45-61 608-009-00-7 malononitrile 203-703-2 109-77-3 T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)23-27-45-60-61 608-010-00-2 methacrylonitrile;
2-methyl-2-propene nitrile 204-817-5 126-98-7 F; R11
T; R23/24/25
R43 F; T
R: 11-23/24/25-43
S: (1/2-)9-16-18-29-45 T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 %
R43: C ≥ 0,2 % D
608-011-00-8 oxalonitrile;
cyanogen 207-306-5 460-19-5 F; R11 ⊗
T; R23
N; R50-53 F; T; N
R: 11-23-50/53
S: (1/2-)23-45-60-61 608-012-00-3 benzonitrile 202-855-7 100-47-0 Xn; R21/22 Xn
R: 21/22
S: (2-)23 608-013-00-9 2-chlorobenzonitrile 212-836-5 873-32-5 Xn; R21/22
Xi; R36 Xn
R: 21/22-36
S: (2-)23 608-014-00-4 chlorothalonil (ISO);
tetrachloroisophthalonitrile 217-588-1 1897-45-6 Carc. Cat. 3; R40
T+; R26
Xi; R41
Xi; R37
R43
N; R50-53 T+; N
R: 26-37-40-41-43-50/53
S: (2-)28-36/37/39-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 608-015-00-X dichlobenil (ISO);
2,6-dichlorobenzonitrile 214-787-5 1194-65-6 Xn; R21
N; R51-53 Xn; N
R: 21-51/53
S: (2-)36/37-61 608-016-00-5 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene 401-550-8 1897-41-2 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 608-017-00-0 bromoxynil octanoate (ISO);
2,6-dibromo-4-cyanophenyl octanoate 216-885-3 1689-99-2 Repr. Cat. 3; R63
T; R23
Xn; R22
R43
N; R50-53 T; N
R: 22-23-43-63-50/53
S: (1/2-)36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 608-018-00-6 ioxynil octanoate (ISO);
4-cyano-2,6-diiodophenyl octanoate 223-375-4 3861-47-0 Repr. Cat. 3; R63
T; R25
Xi; R36
R43
N; R50-53 T; N
R: 25-36-43-63-50/53
S: (1/2-)26-36/37-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 608-019-00-1 2,2'-dimethyl-2,2'-azodipropiononitrile;
ADZN 201-132-3 78-67-1 E; R2
F; R11
Xn; R20/22
R52-53 E; Xn
R: 2-11-20/22-52/53
S: (2-)39-41-47-61 608-021-00-2 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile 403-710-2 76823-93-3 Xn; R22
R43 Xn
R: 22-43
S: (2-)22-24-37 608-022-00-8 3,7-dimethyloctanenitrile 403-620-3 40188-41-8 Xi; R38
R43
N; R51-53 Xi; N
R: 38-43-51/53
S: (2-)36/37-61 608-023-00-3 fenbuconazole (ISO)
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile 406-140-2 114369-43-6 N; R50-53 N
R: 50/53
S: 60-61 608-024-00-9 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile 407-650-8 97460-76-9 R53 R: 53
S: 61 608-025-00-4 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile 410-970-0 117568-27-1 R53 R: 53
S: 61 608-026-00-X 3-cyano-3,5,5-trimethylcyclohexanone 411-490-4 7027-11-4 Xn; R22-48/22
R43
R52-53 Xn
R: 22-43-48/22-52/53
S: (2-)36/37-61 608-027-00-5 reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(3-ethylphenyl)-2,2-dimethylpropanenitrile 412-660-0 — N; R51-53 N
R: 51/53
S: 61 608-028-00-0 4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate 413-510-7 147374-67-2 Xn; R48/20/21
R43
N; R51-53 Xn; N
R: 43-48/20/21-51/53
S: (2-)36/37-61 608-029-00-6 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile 411-990-2 68612-94-2 R43 Xi
R: 43
S: (2-)24-37 608-030-00-1 N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide 412-340-0 147741-93-3 N; R50-53 N
R: 50/53
S: 60-61 608-031-00-7 2-benzyl-2-methyl-3-butenitrile 407-870-4 97384-48-0 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 608-033-00-8 N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide 407-970-8 75511-91-0 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 608-034-00-3 chlorfenapyr;
4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile — 122453-73-0 T; R23
Xn; R22
N; R50-53 T; N
R: 22-23-50/53
S: (1/2-)13-36/37-45-60-61 608-035-00-9 (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile 419-290-9 — R43
R53 Xi
R: 43-53
S: (2-)24-37-61 608-036-00-4 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile 419-060-8 79026-02-1 R53 R: 53
S: 61 608-037-00-X reaction mass of: (E)-2,12-tridecadiennitrile;
(E)-3,12-tridecadiennitrile;
(Z)-3,12-tridecadiennitrile 422-190-8 N; R50-53 N
R: 50/53
S: 60-61 608-038-00-5 2,2,4-trimethyl-4-phenyl-butane-nitrile 422-580-8 75490-39-0 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)23-60-61 608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 N; R50-53 N
R: 50/53
S: 60-61 608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 423-500-4 138401-24-8 N; R50-53 N
R: 50/53
S: 60-61 608-043-00-2 3-(cis-3-hexenyloxy)propanenitril 415-220-6 142653-61-0 T; R23
Xn; R22
N; R50-53 T; N
R: 22-23-50/53
S: (1/2-)13-36/37-45-60-61 608-065-00-2 salts of bromoxynil with the exception of those specified elsewhere in this Annex — — Repr. Cat. 3; R63
T+; R26
T; R25
R43
N; R50-53 T+; N
R: 25-26-43-50/53
S: (1/2-)27/28-36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % A
608-066-00-8 salts of ioxynil with the exception of those specified elsewhere in this Annex — — Repr. Cat. 3; R63
T; R23/25
Xn; R21-48/22
Xi; R36
N; R50-53 T; N
R: 21-23/25-36-48/22-63-50/53
S: (1/2-)36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % A
609-001-00-6 1-nitropropane 203-544-9 108-03-2 R10
Xn; R20/21/22 Xn
R: 10-20/21/22
S: (2-)9 Xn; R20/21/22: C ≥ 5 % 609-002-00-1 2-nitropropane 201-209-1 79-46-9 R10
Carc. Cat. 2; R45
Xn; R20/22 T
R: 45-10-20/22
S: 53-45 E
609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. Cat. 3; R40
Repr. Cat. 3; R62
T; R23/24/25-48/23/24
N; R51-53 T; N
R: 23/24/25-40-48/23/24-51/53-62
S: (1/2-)28-36/37-45-61 609-004-00-2 dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4] 246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4] 25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4] T+; R26/27/28
R33
N; R50-53 T+; N
R: 26/27/28-33-50/53
S: (1/2-)28-36/37-45-60-61 609-005-00-8 1,3,5-trinitrobenzene 202-752-7 99-35-4 E; R2 ⊗
T+; R26/27/28
R33
N; R50-53 E; T+; N
R: 2-26/27/28-33-50/53
S: (1/2-)35-45-60-61 609-006-00-3 4-nitrotoluene 202-808-0 99-99-0 T; R23/24/25
R33
N; R51-53 T; N
R: 23/24/25-33-51/53
S: (1/2-)28-37-45-61 609-007-00-9 2,4-dinitrotoluene;
dinitrotoluene, technical grade; [1]
dinitrotoluene [2] 204-450-0 [1]
246-836-1 [2] 121-14-2 [1]
25321-14-6 [2] Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R51-53 T; N
R: 45-23/24/25-48/22-62-68-51/53
S: 53-45-61 E
609-008-00-4 2,4,6-trinitrotoluene;
TNT 204-289-6 118-96-7 E; R2
T; R23/24/25
R33
N; R51-53 E; T; N
R: 2-23/24/25-33-51/53
S: (1/2-)35-45-61 609-009-00-X 2,4,6-trinitrophenol;
picric acid 201-865-9 88-89-1 E; R2 ⊗
R4
T; R23/24/25 E; T
R: 2-4-23/24/25
S: (1/2-)28-35-37-45 609-010-00-5 salts of picric acid — — E; R3
T; R23/24/25 E; T
R: 3-23/24/25
S: (1/2-)28-35-37-45 A
609-011-00-0 2,4,6-trinitroanisole — 606-35-9 E; R2
Xn; R20/21/22
N; R51-53 E; Xn; N
R: 2-20/21/22-51/53
S: (2-)35-61 609-012-00-6 2,4,6-trinitro-m-cresol 210-027-1 602-99-3 E; R2
R4
Xn; R20/21/22 E; Xn
R: 2-4-20/21/22
S: (2-)35 609-013-00-1 2,4,6-trinitro-m-xylene 211-187-5 632-92-8 E; R2
Xn; R20/21/22
R33 E; Xn
R: 2-20/21/22-33
S: (2-)35 609-015-00-2 4-nitrophenol;
p-nitrophenol 202-811-7 100-02-7 Xn; R20/21/22
R33 Xn
R: 20/21/22-33
S: (2-)28 609-016-00-8 dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2] 247-096-2 [1]
275-732-9 [2] 25550-58-7 [1]
71629-74-8 [2] T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)28-37-45-60-61 609-018-00-9 2,4,6-trinitroresorcinol;
styphnic acid 201-436-6 82-71-3 E; R2 ⊗
R4
Xn; R20/21/22 E; Xn
R: 2-4-20/21/22
S: (2-)35 609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate 239-290-0 15245-44-0 E; R3
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53 E; T; N
R: 61-3-20/22-33-50/53-62
S: 53-45-60-61 E
1
609-020-00-X DNOC (ISO);
4,6-dinitro-o-cresol 208-601-1 534-52-1 Muta. Cat. 3; R68
T+; R26/27/28
Xi; R38-41
R43
R44
N; R50-53 T+; N
R: 26/27/28-38-41-43-44-50/53-68
S: (1/2-)36/37-45-60-61 609-021-00-5 sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC;
potassium 4,6-dinitro-o-cresolate [2] 219-007-7 [1]
[2] 2312-76-7 [1]
5787-96-2 [2] T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)13-45-60-61 609-022-00-0 ammonium salt of DNOC;
ammonium 4,6-dinitro-o-tolyl oxide 221-037-0 2980-64-5 T+; R26/27/28
R33
N; R50-53 T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-45-60-61 609-023-00-6 dinocap (ISO) 254-408-0 39300-45-3 Repr. Cat. 2; R61
Xn; R20-48/22
Xi; R38
R43
N; R50-53 T; N
R: 61-20-22-38-43-48/22-50/53
S: 53-45-60-61 E
609-024-00-1 binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 207-612-9 485-31-4 Repr. Cat. 2; R61
Xn; R21/22
N; R50-53 T; N
R: 61-21/22-50/53
S: 53-45-60-61 E
609-025-00-7 dinoseb (ISO);
6-sec-butyl-2,4-dinitrophenol 201-861-7 88-85-7 R44
T; R24/25
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R36
N; R50-53 T; N
R: 61-62-24/25-36-44-50/53
S: 53-45-60-61 E
609-026-00-2 salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex — — R44
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R24/25
Xi; R36
N; R50-53 T; N
R: 61-62-24/25-36-44-50/53
S: 53-45-60-61 AE
609-027-00-8 dinocton;
reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate — 63919-26-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 609-028-00-3 dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol 205-042-5 131-89-5 T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 609-029-00-9 salts and esters of dinex — — T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 A
609-030-00-4 dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol 215-813-8 1420-07-1 Repr. Cat. 2; R61
T+; R28
T; R24
R44
N; R50-53 T+; N
R: 61-24-28-44-50/53
S: 53-45-60-61 E
609-031-00-X salts and esters of dinoterb — — Repr. Cat. 2; R61
T+; R28
T; R24
N; R50-53 T+; N
R: 61-24-28-50/53
S: 45-53-60-61 AE
609-032-00-5 bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 236-129-6 13181-17-4 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)25-60-61 609-033-00-0 dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol — 4097-36-3 T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 609-034-00-6 salts and esters of dinosam — — T; R23/24/25
N; R50-53 T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61 A
609-035-00-1 nitroethane 201-188-9 79-24-3 R10
Xn; R20/22 Xn
R: 10-20/22
S: (2-)9-25-41 Xn; R20/22: C ≥ 12,5 % 609-036-00-7 nitromethane 200-876-6 75-52-5 R5-10
Xn; R22 Xn
R: 5-10-22
S: (2-)41 Xn; R22: C ≥ 12,5 % 609-037-00-2 5-nitroacenaphthene 210-025-0 602-87-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 609-038-00-8 2-nitronaphthalene 209-474-5 581-89-5 Carc. Cat. 2; R45
N; R51-53 T; N
R: 45-51/53
S: 53-45-61 609-039-00-3 4-nitrobiphenyl 202-204-7 92-93-3 Carc. Cat. 2; R45
N; R51-53 T; N
R: 45-51/53
S: 53-45-61 609-040-00-9 nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether 217-406-0 1836-75-5 Carc. Cat. 2; R45
Repr. Cat. 2; R61
Xn; R22
N; R50-53 T; N
R: 45-61-22-50/53
S: 53-45-60-61 E
609-041-00-4 2,4-dinitrophenol 200-087-7 51-28-5 T; R23/24/25
R33
N; R50 T; N
R: 23/24/25-33-50
S: (1/2-)28-37-45-61 609-042-00-X pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 254-938-2 40487-42-1 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-29-37-60-61 609-043-00-5 quintozene (ISO);
pentachloronitrobenzene 201-435-0 82-68-8 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)13-24-37-60-61 609-044-00-0 tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene 204-178-2 117-18-0 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 609-045-00-6 reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;
dinocton-6 — 8069-76-9 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 609-046-00-1 trifluralin (ISO) (containing < 0.5 ppm NPDA);
α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) 216-428-8 1582-09-8 Xi; R36
R43
N; R50-53 Xi; N
R: 36-43-50/53
S: (2-)24-37-60-61 609-047-00-7 2-nitroanisole 202-052-1 91-23-6 Carc. Cat. 2; R45
Xn; R22 T
R: 45-22
S: 53-45 E
609-048-00-2 sodium 3-nitrobenzenesulphonate 204-857-3 127-68-4 Xi; R36
R43 Xi
R: 36-43
S: (2-)24-26-37 609-049-00-8 2,6-dinitrotoluene 210-106-0 606-20-2 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
R52-53 T
R: 45-23/24/25-48/22-62-68-52/53
S: 53-45-61 E
609-050-00-3 2,3-dinitrotoluene 210-013-5 602-01-7 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53 T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61 E
609-051-00-9 3,4-dinitrotoluene 210-222-1 610-39-9 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R51-53 T; N
R: 45-23/24/25-48/22-62-68-51/53
S: 53-45-61 E
609-052-00-4 3,5-dinitrotoluene 210-566-2 618-85-9 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
R52-53 T
R: 45-23/24/25-48/22-62-68-52/53
S: 53-45-61 E
609-053-00-X hydrazine-trinitromethane 414-850-9 — E; R3
O; R8
Carc. Cat. 2; R45
T; R23/25
R43 E; T
R: 45-3-8-23/25-43
S: 53-45 E
609-054-00-5 2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5] 200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
[5] 66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
[5] T; R23/24/25
R33
N; R51-53 T; N
R: 23/24/25-33-51
S: (1/2-)28-37-45-61 609-055-00-0 2,5-dinitrotoluene 210-581-4 619-15-8 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R51-53 T; N
R: 45-23/24/25-48/22-62-68-51/53
S: 53-45-61 E
609-056-00-6 2,2-dibromo-2-nitroethanol 412-380-9 69094-18-4 E; R2
Carc. Cat. 3; R40
Xn; R22-48/22
C; R35
R43
N; R50-53 E; C; N
R: 2-22-35-40-43-48/22-50/53
S: (1/2-)23-26-36/37/39-45-60-61 Xn; R22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 609-057-00-1 3-chloro-2,4-difluoronitrobenzene 411-980-8 3847-58-3 Xn; R22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-50/53
S: (1/2-)22-26-28-36/37/39-45-60-61 609-058-00-7 2-nitro-2-phenyl-1,3-propanediol 410-360-4 5428-02-4 T; R39-48/25
Xn; R21/22
Xi; R41
R43
N; R51-53 T; N
R: 21/22-39-41-43-48/25-51/53
S: 53-45-61 609-059-00-2 2-chloro-6-(ethylamino)-4-nitrophenol 411-440-1 131657-78-8 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)22-24-37/39-61 609-060-00-8 4-[(3-hydroxypropyl)amino]-3-nitrophenol 406-305-9 92952-81-3 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 609-061-00-3 (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime 406-100-4 94097-88-8 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 609-062-00-9 2-bromo-2-nitropropanol 407-030-7 24403-04-1 T; R24
Xn; R22-48/22
C; R34
R43
N; R50-53 T; N
R: 22-24-34-43-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61 609-063-00-4 2-[(4-chloro-2-nitrophenyl)amino]ethanol 413-280-8 59320-13-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-61 609-064-00-X mesotrione (ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione — 104206-82-8 N; R50-53 N
R: 50/53
S: 60-61 609-065-00-5 2-nitrotoluene 201-853-3 88-72-2 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
Xn; R22
N; R51-53 T; N
R: 45-46-22-62-51/53
S: 53-45-61 E
609-066-00-0 lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 418-870-9 154212-58-5 Xn; R20/21/22-68/20/21/22 Xn
R: 20/21/22-68/20/21/22
S: (2-)36/37 609-067-00-6 sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine 416-280-6 156769-97-0 R43 Xi
R: 43
S: (2-)22-24-37 609-068-00-1 musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-4 81-15-2 E; R2
Carc. Cat. 3; R40
N; R50-53 E; Xn; N
R: 2-40-50/53
S: (2-)36/37-46-60-61 609-070-00-2 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene 415-580-4 130841-23-5 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)36/37/39-60-61 609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 423-520-3 156137-33-6 R43 Xi
R: 43
S: (2-)22-24-37 610-001-00-3 trichloronitromethane;
chloropicrin 200-930-9 76-06-2 Xn; R22
T+; R26
Xi; R36/37/38 T+
R: 22-26-36/37/38
S: (1/2-)36/37-38-45 610-002-00-9 1,1-dichloro-1-nitroethane 209-854-0 594-72-9 T; R23/24/25 T
R: 23/24/25
S: (1/2-)26-45 610-003-00-4 chlorodinitrobenzene — — T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61 C
610-004-00-X 2-chloro-1,3,5-trinitrobenzene 201-864-3 88-88-0 E; R2
T+; R26/27/28
N; R50-53 E; T+; N
R: 2-26/27/28-50/53
S: (1/2-)28-36/37-45-60-61 610-005-00-5 1-chloro-4-nitrobenzene 202-809-6 100-00-5 Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25
Xn; R48/20/21/22
N; R51-53 T; N
R: 23/24/25-40-48/20/21/22-68-51/53
S: (1/2-)28-36/37-45-61 610-006-00-0 chloronitroanilines with the exception of those specified elsewhere in this Annex — — T+; R26/27/28
R33
N; R51-53 T+; N
R: 26/27/28-33-51/53
S: (1/2-)28-36/37-45-61 A C
610-007-00-6 1-chloro-1-nitropropane 209-990-0 600-25-9 Xn; R20/22 Xn
R: 20/22
S: (2-) Xn; R20/22: C ≥ 5 % 610-008-00-1 2,6-dichloro-4-nitroanisole 403-350-6 17742-69-7 T; R25
N; R51-53 T; N
R: 25-51/53
S: (1/2-)36/37-45-61 610-009-00-7 2-chloro-4-nitroaniline 204-502-2 121-87-9 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-24-61 610-010-00-2 2-bromo-1-(2-furyl)-2-nitroethylene 406-110-9 35950-52-8 Xn; R22-48/22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-48/22-50/53
S: (1/2-)22-26-36/37/39-45-60-61 611-001-00-6 azobenzene 203-102-5 103-33-3 Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22-48/22
N; R50-53 T; N
R: 45-20/22-48/22-68-50/53
S: 53-45-60-61 E
611-002-00-1 azoxybenzene 207-802-1 495-48-7 Xn; R20/22 Xn
R: 20/22
S: (2-)28 611-003-00-7 fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate 205-419-4 140-56-7 T; R25
Xn; R21
R52-53 T
R: 21-25-52/53
S: (1/2-)36/37-45-61 611-004-00-2 methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate 209-765-7 592-62-1 Carc. Cat. 2; R45
Repr. Cat. 2; R61 T
R: 45-61
S: 53-45 611-005-00-8 disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);
CI Direct Brown 95 240-221-1 16071-86-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 611-006-00-3 4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene 202-591-2 97-56-3 Carc. Cat. 2; R45
R43 T
R: 45-43
S: 53-45 611-007-00-9 tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole 255-559-5 41814-78-2 Xn; R22 Xn
R: 22
S: (2-) 611-008-00-4 4-aminoazobenzene;
4-phenylazoaniline 200-453-6 60-09-3 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 611-009-00-X sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) 401-220-3 — Xn; R20
R52-53 Xn
R: 20-52/53
S: (2-)61 611-010-00-5 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide 403-010-7 106359-94-8 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 611-011-00-0 N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate 403-340-1 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 611-012-00-6 reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate 403-410-1 114565-65-0 R43 Xi
R: 43
S: (2-)22-24-26-37 611-013-00-1 trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate 403-650-7 117409-78-6 E; R2
N; R51-53 E; N
R: 2-51/53
S: (2-)35-61 611-014-00-7 (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide 404-250-5 115099-55-3 R43 Xi
R: 43
S: (2-)22-24-37 611-015-00-2 tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 404-320-5 116889-78-2 R43 Xi
R: 43
S: (2-)22-24-37 611-016-00-8 reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride 404-540-1 — R43 Xi
R: 43
S: (2-)22-24-37 611-017-00-3 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide 404-910-2 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 611-018-00-9 tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate 405-130-5 — R43 Xi
R: 43
S: (2-)24-37 611-019-00-4 tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-150-4 106028-58-4 R43 Xi
R: 43
S: (2-)24-37 611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-170-3 116340-05-7 T; R25
R43
R52-53 T
R: 25-43-52/53
S: (1/2-)22-24-37-45-61 611-021-00-5 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate 405-480-9 — Xn; R22-48/22
Xi; R38
R53 Xn
R: 22-38-48/22-53
S: (2-)22-36/37-61 611-022-00-0 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate 404-980-4 — E; R2
T; R23/25
Xn; R21-48/22
Xi; R41
R43
N; R50/53 E; T; N
R: 2-21-23/25-41-43-48/22-50/53
S: (1/2-)3-12-26-35-36/37/39-45-61 611-023-00-6 disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate 404-600-7 — R43 X
R: 43
S: (2-)22-24-37 611-024-00-1 Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex — — Carc. Cat. 2; R45 T
R: 45
S: 53-45 A
611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38 217-710-3 1937-37-7 Carc. Cat. 2; R45
Repr. Cat. 3; R63 T
R: 45-63
S: 53-45 611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6 220-012-1 2602-46-2 Carc. Cat. 2; R45
Repr. Cat. 3; R63 T
R: 45-63
S: 53-45 611-027-00-8 disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);
C.I. Direct Red 28 209-358-4 573-58-0 Carc. Cat. 2; R45
Repr. Cat. 3; R63 T
R: 45-63
S: 53-45 611-028-00-3 C,C'-azodi(formamide) 204-650-8 123-77-3 R42
R44 ⊗ Xn
R: 42-44
S: (2-)22-24-37 611-029-00-9 o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex — — Carc. Cat. 2; R45 T
R: 45
S: 53-45 A H
611-030-00-4 o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex — — Carc. Cat. 2; R45 T
R: 45
S: 53-45 A H
611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9 209-321-2 569-61-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 611-032-00-5 1,4,5,8-tetraaminoanthraquinone;
C.I. Disperse Blue 1 219-603-7 2475-45-8 Carc. Cat. 2; R45
Xi; R38-41
R43 T
R: 45-38-41-43
S: 53-45 611-033-00-0 hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) 400-020-3 82027-60-9 N; R51-53 N
R: 51/53
S: 61 611-034-00-6 N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide 402-430-8 105076-77-5 R53 R: 53
S: 61 611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 403-660-1 107246-80-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 611-036-00-7 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate 405-440-0 — R43 Xi
R: 43
S: (2-)22-24-37 611-037-00-2 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate 406-055-0 124584-00-5 Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)22-24-26-37/39-61 611-038-00-8 trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate 406-820-9 — Xi; R36 Xi
R: 36
S: (2-)25-26 611-039-00-3 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid 407-050-6 117715-57-8 R43 Xi
R: 43
S: (2-)22-24-37 611-040-00-9 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid 407-670-7 115099-58-6 N; R50-53 N
R: 50/53
S: 60-61 611-041-00-4 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide 407-680-1 98809-11-1 Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61 611-042-00-X trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate 411-770-6 136213-71-3 R52-53 R: 52/53
S: 61 611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) 402-850-1 — Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) 403-720-7 117527-94-3 N; R51-53 N
R: 51/53
S: 61 611-045-00-6 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene 404-830-8 — R53 R: 53
S: 61 611-046-00-1 4,4'-diamino-2-methylazobenzene 407-590-2 43151-99-1 T; R25
Xn; R48/22
R43
N; R50-53 T; N
R: 25-43-48/22-50/53
S: (1/2-)22-28-36/37-45-60-61 611-047-00-7 reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-890-3 111381-11-4 R53 R: 53
S: 61 611-048-00-2 reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-900-6 111381-12-5 R53 R: 53
S: 61 611-049-00-8 reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) 408-000-6 118658-98-3 Xn; R48/22
R43
R52-53 Xn
R: 43-48/22-52/53
S: (2-)22-36/37-61 611-051-00-9 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride 411-110-7 136213-74-6 N; R50-53 N
R: 50/53
S: 60-61 611-052-00-4 monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex 400-720-9 — R52-53 R: 52/53
S: 61 611-053-00-X 2,2'-azobis[2-methylpropionamidine] dihydrochloride 221-070-0 2997-92-4 Xn; R22
R43 Xn
R: 22-43
S: (2-)24-37 611-055-00-0 C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 220-600-8 2832-40-8 Carc. Cat. 3; R40
R43 Xn
R: 40-43
S: (2-)22-36/37-46 611-056-00-6 C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol 212-668-2 842-07-9 Carc. Cat. 3; R40
Muta. Cat. 3; R68
R43
R53 Xn
R: 40-43-53-68
S: (2-)22-36/37-46-61 611-057-00-1 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile 400-340-3 85136-74-9 Carc. Cat. 2; R45
R53 T
R: 45-53
S: 53-45-61 611-058-00-7 (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 402-060-7 108225-03-2 Carc. Cat. 2; R45
Xi; R41
N; R51-53 T; N
R: 45-41-51/53
S: 53-45-61 611-059-00-2 octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate 412-960-1 148878-21-1 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61 611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid 413-180-4 187285-15-0 Xi; R41 Xi
R: 41
S: (2-)22-26-39 611-061-00-3 disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate 412-530-3 — Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 611-062-00-9 octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate 413-550-5 — Xi; R38-41 Xi
R: 38-41
S: (2-)22-26-37/39 611-063-00-4 trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) 413-590-3 164058-22-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 611-064-00-X 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol 410-600-8 124719-26-2 Xn; R48/22
Xi; R38
N; R50-53 Xn; N
R: 38-48/22-50/53
S: (2-)23-25-36/37-60-61 611-065-00-5 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol 410-610-2 111850-24-9 Xn; R48/22
Xi; R36/38
R43
N; R50-53 Xn; N
R: 36/38-43-48/22-50/53
S: (2-)23-26-36/37-60-61 611-066-00-0 tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 411-540-5 130201-57-9 Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)22-24-26-37/39-61 611-067-00-6 reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;
bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate 406-910-8 — Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)26-36/39-61 611-068-00-1 tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 400-690-7 85665-98-1 N; R51-53 N
R: 51/53
S: 61 611-069-00-7 N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline 413-380-1 — N; R51-53 N
R: 51/53
S: 61 611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) 405-665-4 — R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 611-071-00-8 tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate 406-073-9 131013-81-5 T; R25
R52-53 T
R: 25-52/53
S: (1/2-)37-45-61 611-072-00-3 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride 407-010-8 118208-02-9 Xn; R22
Xi; R41
N; R51-53 Xn; N
R: 22-41-51/53
S: (2-)26-39-61 611-073-00-9 dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate 407-310-9 122630-55-1 R53 R: 53
S: 61 611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) 407-100-7 — R43 Xi
R: 43
S: (2-)22-24-37 611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) 406-000-0 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 611-076-00-5 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole 406-280-4 117584-16-4 N; R50-53 N
R: 50/53
S: 60-61 611-077-00-0 dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) 407-230-4 126637-70-5 Xn; R22
R43 Xn
R: 22-43
S: (2-)22-24-37 611-078-00-6 (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate 407-240-9 159604-94-1 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 611-079-00-1 disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate 410-390-8 147703-64-8 Xi; R41 Xi
R: 41
S: (2-)22-26-39 611-080-00-7 sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate 410-150-2 147703-65-9 R43 Xi
R: 43
S: (2-)22-24-37 611-081-00-2 tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) 411-470-5 141048-13-7 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 611-082-00-8 reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);
pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) 407-570-3 — N; R51-53 N
R: 51/53
S: 61 611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) 411-560-4 — T; R48/25
R43
N; R51-53 T; N
R: 43-48/25-51/53
S: (1/2-)22-36/37-45-61 611-084-00-9 reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;
N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide 412-550-2 — R53 R: 53
S: 61 611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine 411-880-4 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate 411-360-7 — R52-53 R: 52/53
S: 61 611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) 411-710-9 — R53 R: 53
S: 61 611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate 411-890-9 — Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)22-26-39-61 611-089-00-6 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate 411-100-2 136213-73-5 Xn; R48/22
R43
N; R50-53 Xn; N
R: 43-48/22-50/53
S: (2-)22-36/37-60-61 611-090-00-1 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate 413-290-2 93672-52-7 F; R11
Xn; R22
Xi; R41
R43
R52-53 F; Xn
R: 11-22-41-43-52/53
S: (2-)12-22-24-26-37/39-47-61 611-091-00-7 sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate 413-470-0 134595-59-8 R43 Xi
R: 43
S: (2-)22-24/25-37 611-092-00-2 tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate 413-210-6 — N; R51-53 N
R: 51/53
S: 61 611-093-00-8 sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate 410-770-3 146177-84-6 R43 Xi
R: 43
S: (2-)22-24-37 611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 411-600-0 143145-93-1 R53 R: 53
S: 61 611-095-00-9 hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide 412-240-7 89797-03-5 N; R51-53 N
R: 51/53
S: 22-61 611-096-00-4 methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate 413-040-2 149850-30-6 R43 Xi
R: 43
S: (2-)22-24-37 611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) 414-150-3 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 611-098-00-5 tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate 405-950-3 131013-83-7 T; R25
R52-53 T
R: 25-52/53
S: (1/2-)37-45-61 611-099-00-0 (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride 401-500-5 118658-99-4 Carc. Cat. 2; R45
N; R51-53 T; N
R: 45-51/53
S: 53-45-61 611-100-00-4 potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate 403-810-6 140876-13-7 Xi; R41 Xi
R: 41
S: (2-)26-39 611-101-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide 405-200-5 104366-25-8 R43 Xi
R: 43
S: (2-)22-24-37 611-103-00-0 trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) 407-110-1 — Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61 611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);
trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate 406-870-1 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 611-105-00-1 sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate 407-800-2 136213-75-7 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 611-106-00-7 hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate 410-180-6 157627-99-1 Xi; R41 Xi
R: 41
S: (2-)26-39 611-107-00-2 potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate 412-490-7 — R43 Xi
R: 43
S: (2-)22-24-37 611-108-00-8 disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate 413-600-6 6527-62-4 R52-53 R: 52/53
S: 61 611-109-00-3 Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) 407-710-3 — N; R51-53 N
R: 51/53
S: 61 611-110-00-9 tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene 408-210-8 124605-82-9 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-28-37-61 611-111-00-4 disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) 414-230-8 — R43 Xi
R: 43
S: (2-)22-24-37 611-112-00-X tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate 413-070-6 — R43 Xi
R: 43
S: (2-)22-24-37 611-113-00-5 lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) 414-280-0 149626-00-6 N; R51-53 N
R: 51/53
S: 24/25-61 611-114-00-0 lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) 414-250-7 149564-66-9 Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)22-26-39-61 611-115-00-6 trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) 414-290-5 149564-65-8 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 611-116-00-1 reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 414-620-8 — Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 611-117-00-7 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt 415-100-3 149850-29-3 R43 Xi
R: 43
S: (2-)22-24-37 611-118-00-2 sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt 413-990-8 R43 Xi
R: 43
S: (2-)22-24-37 611-119-00-8 tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 415-400-4 148878-22-2 Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 611-120-00-3 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt 418-340-7 157707-94-3 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)22-26-39-61 611-121-00-9 Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol 417-280-9 30785-74-1 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 611-122-00-4 hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel 417-250-5 151436-99-6 Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 611-123-00-X 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate 424-310-4 178452-66-9 Xi; R41 Xi
R: 41
S: (2-)26-39 611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate 424-320-9 Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 611-125-00-0 reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex 423-940-7 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 611-126-00-6 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride 424-120-1 174514-06-8 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 611-127-00-1 pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate 423-790-2 — R5
Xi; R41
R43
R52-53 Xi
R: 5-41-43-52/53
S: (2-)22-26-36/37/39-41-61 611-128-00-7 N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt 419-500-9 171599-85-2 Xi; R41
R43 Xi
R: 41-43
S: (2-)22-24-26-37/39 611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 418-230-9 163879-69-4 E; R2
Repr. Cat. 3; R62
Xn; R48/22
R43
N; R51-53 E; Xn; N
R: 2-43-48/22-62-51/53
S: (2-)26-35-36/37-61 611-130-00-8 tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate 418-520-5 183130-96-3 Xi; R36
N; R50-53 Xi; N
R: 36-50/53
S: (2-)26-39-60-61 611-131-00-3 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one 420-580-2 151798-26-4 Repr. Cat. 2; R61
R53 T
R: 61-53
S: 53-45-61 611-132-00-9 pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-210-2 178452-71-6 Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 611-133-00-4 Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt 419-260-5 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)26-39-61 611-134-00-X trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex 423-770-3 — Xi; R41
N; R51-53 Xi; N
R: 41-51/53
S: (2-)22-26-39-61 611-135-00-5 Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt 424-250-9 — Xi; R41
R52-53 Xi
R: 41-52/53
S: (2-)26-39-61 611-136-00-0 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate 424-260-3 — Repr. Cat. 3; R62
Xi; R41
N; R51-53 Xn; N
R: 41-62-51/53
S: (2-)22-26-36/37/39-61 611-137-00-6 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole 419-870-1 159038-16-1 R53 R: 53
S: 61 611-138-00-1 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole 415-910-7 152828-25-6 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 611-140-00-2 azafenidin (ISO)
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one — 68049-83-2 Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R48/22
N; R50-53 T; N
R: 61-48/22-62-50/53
S: 53-45-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % E
612-001-00-9 mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3] 200-820-0 [1]
204-697-4 [2]
200-875-0 [3] 74-89-5 [1]
124-40-3 [2]
75-50-3 [3] F+; R12
Xn; R20
Xi; R37/38-41 F+; Xn
R: 12-20-37/38-41
S: (2-)16-26-39 Xn; R20: C ≥ 5 %
Xi; R37/38-41: C ≥ 5 %
Xi; R36: 0,5 % ≤ C < 5 % 5
612-001-01-6 mono-methylamine ... %; [1]
di-methylamine ... %; [2]
tri-methylamine ... % [3] 200-820-0 [1]
204-697-4 [2]
200-875-0 [3] 74-89-5 [1]
124-40-3 [2]
75-50-3 [3] F+; R12
Xn; R20/22
C; R34 F+; C
R: 12-20/22-34
S: (1/2-)3-16-26-29-36/37/39-45 Xn; R20/22: C ≥ 15 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % B
612-002-00-4 ethylamine 200-834-7 75-04-7 F+; R12
Xi; R36/37 F+; Xi
R: 12-36/37
S: (2-)16-26-29 612-003-00-X diethylamine 203-716-3 109-89-7 F; R11
Xn; R20/21/22
C; R35 F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 612-004-00-5 triethylamine 204-469-4 121-44-8 F; R11
Xn; R20/21/22
C; R35 F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 612-005-00-0 butylamine 203-699-2 109-73-9 F; R11
Xn; R20/21/22
C; R35 F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 612-006-00-6 ethylenediamine;
1,2-diaminoethane 203-468-6 107-15-3 R10
Xn; R21/22
C; R34
R42/43 C
R: 10-21/22-34-42/43
S: (1/2-)23-26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 % 612-007-00-1 2-aminopropane;
isopropylamine 200-860-9 75-31-0 F+; R12
Xi; R36/37/38 F+; Xi
R: 12-36/37/38
S: (2-)16-26-29 612-008-00-7 aniline 200-539-3 62-53-3 Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R41
R43
N; R50 T; N
R: 23/24/25-40-41-43-48/23/24/25-68-50
S: (1/2-)26-27-36/37/39-45-46-61-63 T; R23/24/25: C ≥ 25 %
Xn; R20/21/22: 1 % ≤ C < 25 %
T; R48/23/24/25: C ≥ 1 %
Xn; R48/20/21/22: 0,2 % ≤ C < 1 % 612-009-00-2 salts of aniline — — Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R41
R43
N; R50 T; N
R: 23/24/25-40-41-43-48/23/24/25-68-50
S: (1/2-)26-27-36/37/39-45-61-63 T; R23/24/25: C ≥ 25 %
Xn; R20/21/22: 1 % ≤ C < 25 %
T; R48/23/24/25: C ≥ 1 %
Xn; R48/20/21/22: 0,2 % ≤ C < 1 % A
612-010-00-8 chloroanilines, with exception of those specified elsewhere in this Annex — — T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61 C
612-011-00-3 4-nitrosoaniline 211-535-6 659-49-4 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)25-28 612-012-00-9 o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3] 201-855-4 [1]
202-729-1 [2]
202-810-1 [3] 88-74-4 [1]
99-09-2 [2]
100-01-6 [3] T; R23/24/25
R33
R52-53 T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61 C
612-013-00-4 3-aminobenzene sulphonic acid;
metanilic acid 204-473-6 121-47-1 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)25-28 612-014-00-X sulphanilic acid;
4-aminobenzenesulphonic acid 204-482-5 121-57-3 Xi; R36/38
R43 Xi
R: 36/38-43
S: (2-)24-37 612-015-00-5 N-methylaniline 202-870-9 100-61-8 T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61 612-016-00-0 N,N-dimethylaniline 204-493-5 121-69-7 Carc. Cat. 3; R40
T; R23/24/25
N; R51-53 T; N
R: 23/24/25-40-51/53
S: (1/2-)28-36/37-45-61 612-017-00-6 N-methyl-N,2,4,6-tetranitroaniline;
tetryl 207-531-9 479-45-8 E; R2 ⊗
T; R23/24/25
R33 E; T
R: 2-23/24/25-33
S: (1/2-)35-45 612-018-00-1 bis(2,4,6-trinitrophenyl)amine;
hexyl 205-037-8 131-73-7 E; R2 ⊗
T+; R26/27/28
R33
N; R51-53 E; T+; N
R: 2-26/27/28-33-51/53
S: (1/2-)35-36-45-61 612-019-00-7 dipicrylamine, ammonium salt 220-639-0 2844-92-0 E ⊗
R1
T+; R26/27/28
R33
N; R51-53 E; T+; N
R: 1-26/27/28-33-51/53
S: (1/2-)28-36/37-45-61 612-020-00-2 1-naphthylamine 205-138-7 134-32-7 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)24-61 612-022-00-3 2-naphthylamine 202-080-4 91-59-8 Carc. Cat. 1; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 Carc. Cat. 1; R45: C ≥ 0,01 % E
612-023-00-9 phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4] 202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4] 100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4] Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R36/38
R43
N; R50 T; N
R: 45-23/24/25-36/38-43-48/23/24/25-68-50
S: 53-45-61 E
612-024-00-4 m-toluidine;
3-aminotoluene 203-583-1 108-44-1 T; R23/24/25
R33
N; R50 T; N
R: 23/24/25-33-50
S: (1/2-)28-36/37-45-61 612-025-00-X nitrotoluidines, with the exception of those specified elsewhere in this Annex — — T; R23/24/25
R33
N; R51-53 T; N
R: 23/24/25-33-51/53
S: (1/2-)28-36/37-45-61 C
612-026-00-5 diphenylamine 204-539-4 122-39-4 T; R23/24/25
R33
N; R50-53 T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61 612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex — — T; R23/24/25
R33
N; R51-53 T; N
R: 23/24/25-33-51/53
S: (1/2-)28-36/37-45-61 C
612-028-00-6 p-phenylenediamine 203-404-7 106-50-3 T; R23/24/25
Xi; R36
R43
N; R50-53 T+; N
R: 23/24/25-36-43-50/53
S: (1/2-)28-36/37-45-60-61 612-029-00-1 benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride 210-834-9 624-18-0 T; R23/24/25
Xi; R36
R43
N; R50-53 T; N
R: 23/24/25-36-43-50/53
S: (1/2-)28-36/37-45-60-61 612-030-00-7 2-methyl-p-phenylenediamine sulphate [1] 210-431-8 [1]
228-871-4 [2] 615-50-9 [1]
6369-59-1 [2] T; R25
Xn; R20/21
R43
N; R51-53 T; N
R: 20/21-25-43-51/53
S: (1/2-)24-37-45-61 612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2] 220-623-3 [1]
202-807-5 [2] 2836-04-6 [1]
99-98-9 [2] T; R23/24/25 T
R: 23/24/25
S: (1/2-)28-45 C
612-032-00-8 N,N,N',N'-tetramethyl-p-phenylenediamine 202-831-6 100-22-1 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)28 612-033-00-3 2-aminophenol 202-431-1 95-55-6 Xn; R20/22
Muta. Cat. 3; R68 Xn
R: 20/22-68
S: (2-)28-36/37 612-034-00-9 2-amino-4,6-dinitrophenol;
picramic acid 202-544-6 96-91-3 E; R1 ⊗
Xn; R20/21/22
R52-53 E; Xn
R: 1-20/21/22-52/53
S: (2-)35-61 612-035-00-4 2-methoxyaniline;
o-anisidine 201-963-1 90-04-0 Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25 T
R: 45-23/24/25-68
S: 53-45 E
612-036-00-X 3,3'-dimethoxybenzidine;
o-dianisidine 204-355-4 119-90-4 Carc. Cat. 2; R45
Xn; R22 T
R: 45-22
S: 53-45 E
612-037-00-5 salts of 3,3'-dimethoxybenzidine;
salts of o-dianisidine — — Carc. Cat. 2; R45
Xn; R22 T
R: 45-22
S: 53-45 AE
612-038-00-0 2-nitro-p-anisidine;
4-methoxy-2-nitroaniline 202-547-2 96-96-8 T+; R26/27/28
R33
R52-53 T+
R: 26/27/28-33-52/53
S: (1/2-)28-36/37-45-61 612-039-00-6 2-ethoxyaniline;
o-phenetidine 202-356-4 94-70-2 T; R23/24/25
R33 T
R: 23/24/25-33
S: (1/2-)28-36/37-45 612-040-00-1 2,4-dinitroaniline 202-553-5 97-02-9 T+; R26/27/28
R33
N; R51-53 T+; N
R: 26/27/28-33-51/53
S: (1/2-)28-36/37-45-61 612-041-00-7 4,4'-bi-o-toluidine 204-358-0 119-93-7 Carc. Cat. 2; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 E
612-042-00-2 benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine 202-199-1 92-87-5 Carc. Cat. 1; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 Carc. Cat. 1; R45: C ≥ 0,01 % E
612-043-00-8 N,N'-dimethylbenzidine — 2810-74-4 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)22-36 612-044-00-3 N,N'-diacetylbenzidine 210-338-2 613-35-4 Xn; R20/21/22 Xn
R: 20/21/22
S: (2-)22-36 612-046-00-4 allylamine 203-463-9 107-11-9 F; R11
T; R23/24/25
N; R51-53 F; T; N
R: 11-23/24/25-51/53
S: (1/2-)9-16-24/25-45-61 612-047-00-X benzylamine 202-854-1 100-46-9 Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-36/37/39-45 612-048-00-5 dipropylamine 205-565-9 142-84-7 F; R11
Xn; R20/21/22
C; R35 F; C
R: 11-20/21/22-35
S: (1/2-)16-26-36/37/39-45 C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 % 612-049-00-0 di-n-butylamine; [1]
di-sec-butylamine [2] 203-921-8 [1]
210-937-9 [2] 111-92-2 [1]
626-23-3 [2] R10
Xn; R20/21/22 Xn
R: 10-20/21/22
S: (2-) 612-050-00-6 cyclohexylamine 203-629-0 108-91-8 R10
Xn; R21/22
C; R34 C
R: 10-21/22-34
S: (1/2-)36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 % 612-051-00-1 4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline 202-974-4 101-77-9 Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R39/23/24/25
Xn; R48/20/21/22
R43
N; R51-53 T; N
R: 45-39/23/24/25-43-48/20/21/22-68-51/53
S: 53-45-61 E
612-052-00-7 (S)-sec-butylamine;
(S)-2-aminobutane; [1]
(R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3] 208-164-7 [1]
236-232-6 [2]
237-732-7 [3] 513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3] F; R11
Xn; R20/22
C; R35
N; R50 F; C; N
R: 11-20/22-35-50
S: (1/2-)9-16-26-28-36/37/39-45-61 C
612-053-00-2 N-ethylaniline 203-135-5 103-69-5 T; R23/24/25
R33 T
R: 23/24/25-33
S: (1/2-)28-37-45 612-054-00-8 N,N-diethylaniline 202-088-8 91-66-7 T; R23/24/25
R33
N; R51-53 T; N
R: 23/24/25-33-51/53
S: (1/2-)28-37-45-61 T; R23/24/25: C ≥ 5 %
Xn; R20/21/22: 1 % ≤ C < 5 % 612-055-00-3 N-methyl-o-toluidine; [1]
N-methyl-m-toluidine; [2]
N-methyl-p-toluidine [3] 210-260-9 [1]
211-795-0 [2]
210-769-6 [3] 611-21-2 [1]
696-44-6 [2]
623-08-5 [3] T; R23/24/25
R33
R52-53 T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61 C
612-056-00-9 N,N-dimethyl-p-toluidine; [1]
N,N-dimethyl-m-toluidine; [2]
N,N-dimethyl-o-toluidine [3] 202-805-4 [1]
204-495-6 [2]
210-199-8 [3] 99-97-8 [1]
121-72-2 [2]
609-72-3 [3] T; R23/24/25
R33
R52-53 T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61 T; R23/24/25: C ≥ 5 %
Xn; R20/21/22: 1 % ≤ C < 5 % C
612-057-00-4 piperazine 203-808-3 110-85-0 C; R34
R42/43
R52-53 C
R: 34-42/43-52/53
S: (1/2-)22-26-36/37/39-45-61 612-058-00-X 2,2'-iminodiethylamine;
diethylenetriamine 203-865-4 111-40-0 Xn; R21/22
C; R34
R43 C
R: 21/22-34-43
S: (1/2-)26-36/37/39-45 612-059-00-5 3,6-diazaoctanethylenediamin;
triethylenetetramine 203-950-6 112-24-3 Xn; R21
C; R34
R43
R52-53 C
R: 21-34-43-52/53
S: (1/2-)26-36/37/39-45-61 612-060-00-0 3,6,9-triazaundecamethylenediamine;
tetraethylenepentamine 203-986-2 112-57-2 Xn; R21/22
C; R34
R43
N; R51-53 C; N
R: 21/22-34-43-51/53
S: (1/2-)26-36/37/39-45-61 612-061-00-6 3-aminopropyldimethylamine;
N,N-dimethyl-1,3-diaminopropane 203-680-9 109-55-7 R10
Xn; R22
C; R34
R43 C
R: 10-22-34-43
S: (1/2-)26-36/37/39-45 612-062-00-1 3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane 203-236-4 104-78-9 R10
Xn; R21/22
C; R34
R43 C
R: 10-21/22-34-43
S: (1/2-)26-36/37/39-45 612-063-00-7 3,3'-iminodi(propylamine);
dipropylenetriamine 200-261-2 56-18-8 T+; R26
T; R24
Xn; R22
C; R35
R43 T+; C
R: 22-24-26-35-43
S: (1/2-)26-28-36/37/39-45 612-064-00-2 3,6,9,12-tetra-azatetradecamethylenediamine;
pentacthylenehexamine 223-775-9 4067-16-7 C; R34
R43
N; R50-53 C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-065-00-8 polyethlyenepolyamines with the exception of those specified elsewhere in this Annex — — Xn; R21/22
C; R34
R43
N; R50-53 C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-066-00-3 dicyclohexylamine 202-980-7 101-83-7 Xn; R22
C; R34
N; R50-53 C; N
R: 22-34-50/53
S: (1/2-)26-36/37/39-45-60-61 C; R34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 % 612-067-00-9 3-aminomethyl-3,5,5-trimethylcyclohexylamine 220-666-8 2855-13-2 Xn; R21/22
C; R34
R43
R52-53 C
R: 21/22-34-43-52/53
S: (1/2-)26-36/37/39-45-61 612-068-00-4 3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine 202-109-0 91-94-1 Carc. Cat. 2; R45
Xn; R21
R43
N; R50-53 T; N
R: 45-21-43-50/53
S: 53-45-60-61 E
612-069-00-X salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine —
—
— —
—
— Carc. Cat. 2; R45
Xn; R21
R43
N; R50-53 T; N
R: 45-21-43-50/53
S: 53-45-60-61 AE
612-070-00-5 salts of benzidine [ 208-519-6
208-520-1
244-236-4
252-984-8 531-85-1
531-86-2
21136-70-9
36341-27-2 Carc. Cat. 1; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 AE
612-071-00-0 salts of 2-naphthylamine 209-030-0
210-313-6 553-00-4
612-52-2 Carc. Cat. 1; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 AE
612-072-00-6 biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl 202-177-1 92-67-1 Carc. Cat. 1; R45
Xn; R22 T
R: 45-22
S: 53-45 E
612-073-00-1 salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl — — Carc. Cat. 1; R45
Xn; R22 T
R: 45-22
S: 53-45 AE
612-074-00-7 benzyldimethylamine 203-149-1 103-83-3 R10
Xn; R20/21/22
C; R34
R52-53 C
R: 10-20/21/22-34-52/53
S: (1/2-)26-36-45-61 612-075-00-2 2-aminoethyldimethylamine;
2-dimethylaminoethylamine 203-541-2 108-00-9 F; R11
Xn; R21/22
C; R35 F; C
R: 11-21/22-35
S: (1/2-)16-23-26-28-36-45 612-076-00-8 ethyldimethylamine 209-940-8 598-56-1 F+; R12 ⊗
Xn; R20/22
C; R34 F+; C
R: 12-20/22-34
S: (1/2-)3-16-26-36-45 612-077-00-3 dimethylnitrosoamine;
N-nitrosodimethylamine 200-549-8 62-75-9 Carc. Cat. 2; R45
T+; R26
T; R25-48/25
N; R51-53 T+; N
R: 45-25-26-48/25-51/53
S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,001 % E
612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline) 202-918-9 101-14-4 Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 E
612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline) — — Carc. Cat. 2; R45
Xn; R22
N; R50-53 T; N
R: 45-22-50/53
S: 53-45-60-61 AE
612-080-00-X 4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine 202-214-1 93-05-0 T; R25
C; R34 T
R: 25-34
S: (1/2-)26-36-45 612-081-00-5 salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts of o-tolidine 210-322-5
265-294-7
277-985-0 612-82-8
64969-36-4
74753-18-7 Carc. Cat. 2; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 AE
612-082-00-0 thiourea;
thiocarbamide 200-543-5 62-56-6 Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R22
N; R51-53 Xn; N
R: 22-40-51/53-63
S: (2-)36/37-61 612-083-00-6 1-methyl-3-nitro-1-nitrosoguanidine 200-730-1 70-25-7 Carc. Cat. 2; R45
Xn; R20
Xi; R36/38
N; R51-53 T; N
R: 45-20-36/38-51/53
S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
612-084-00-1 dapsone;
4,4'-diamino diphenyl sulfone 201-248-4 80-08-0 Xn; R22 Xn
R: 22
S: (2-)22 612-085-00-7 4,4'-methylenedi-o-toluidine 212-658-8 838-88-0 Carc. Cat. 2; R45
Xn; R22
R43
N; R50-53 T; N
R: 45-22-43-50/53
S: 53-45-60-61 E
612-086-00-2 amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl) methylamine 251-375-4 33089-61-1 Xn; R22-48/22
R43
N; R50-53 Xn; N
R: 22-43-48/22-50/53
S: (2-)22-24-60-36/37-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 612-087-00-8 guazatine (ISO) 108173-90-6 T+; R26
Xn; R21/22
Xi; R37/38-41
N; R50-53 T+; N
R: 21/22-26-37/38-41-50/53
S: (1/2-)26-28-36/37/39-38-45-46-60-61-63 612-088-00-3 simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 204-535-2 122-34-9 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61 612-089-00-9 1,5-naphthylenediamine 218-817-8 2243-62-1 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 612-090-00-4 2,2'-(nitrosoimino)bisethanol 214-237-4 1116-54-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 612-091-00-X o-toluidine;
2-aminotoluene 202-429-0 95-53-4 Carc. Cat. 2; R45
T; R23/25
Xi; R36
N; R50 T; N
R: 45-23/25-36-50
S: 53-45-61 E
612-092-00-5 N,N'-(2,2-dimethylpropylidene)hexamethylenediamine 401-660-6 1000-78-8 Xi; R38
R43 Xi
R: 38-43
S: (2-)24-37 612-093-00-0 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline 401-790-3 104147-32-2 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24/25-26-57-60-61 612-094-00-6 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride 402-190-4 — T; R48/25
Xn; R22-48/20
Xi; R41
R43
N; R50-53 T; N
R: 22-41-43-48/20-48/25-50/53
S: (1/2-)26-36/37/39-45-60-61 612-095-00-1 benzyl-2-hydroxydodecyldimethylammonium benzoate 402-610-6 113694-52-3 C; R34
Xn; R22
N; R50-53 C; N
R: 22-34-50/53
S: (1/2-)26-28-36/37/39-45-60-61 612-096-00-7 4,4'-carbonimidoylbis[N,N-dimethylaniline] 207-762-5 492-80-8 Carc. Cat. 3; R40
Xn; R22
Xi; R36
N; R51-53 Xn; N
R: 22-36-40-51/53
S: (2-)36/37-61 612-097-00-2 salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] — — Carc. Cat. 3; R40
Xn; R22
Xi; R36
N; R51-53 Xn; N
R: 22-36-40-51/53
S: (2-)36/37-61 A
612-098-00-8 nitrosodipropylamine 210-698-0 621-64-7 Carc. Cat. 2; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,001 % E
612-099-00-3 4-methyl-m-phenylenediamine;
2,4-toluenediamine 202-453-1 95-80-7 Carc. Cat. 2; R45
T; R25
Xn; R21
Xi; R36
R43
N; R51-53 T; N
R: 45-21-25-36-43-51/53
S: 53-45-61 E
612-100-00-7 propylenediamine 201-155-9 78-90-0 R10
Xn; R21/22
C; R35 C
R: 10-21/22-35
S: (1/2-)26-37/39-45 612-101-00-2 methenamine;
hexamethylenetetramine 202-905-8 100-97-0 F; R11
R42/43 F; Xn
R: 11-42/43
S: (2-)16-22-24-37 612-102-00-8 N,N-bis(3-aminopropyl)methylamine 203-336-8 105-83-9 T; R23/24
Xn; R22
C; R34 T
R: 22-23/24-34
S: (1/2-)26-36/37/39-45 612-103-00-3 N,N,N',N'-tetramethylethylenediamine 203-744-6 110-18-9 F; R11
Xn; R20/22
C; R34 F; C
R: 11-20/22-34
S: (1/2-)16-26-36/37/39-45 612-104-00-9 hexamethylenediamine 204-679-6 124-09-4 Xn; R21/22
Xi; R37
C; R34 C
R: 21/22-34-37
S: (1/2-)22-26-36/37/39-45 612-105-00-4 2-piperazin-1-ylethylamine 205-411-0 140-31-8 Xn; R21/22
C; R34
R43
R52-53 C
R: 21/22-34-43-52/53
S: (1/2-)26-36/37/39-45-61 612-106-00-X 2,6-diethylaniline 209-445-7 579-66-8 Xn; R22 Xn
R: 22
S: (2-)23-24 612-107-00-5 1-phenylethylamine; [1]
Dl-α-methylbenzylamine [2] 202-706-6 [1]
210-545-8 [2] 98-84-0 [1]
618-36-0 [2] Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-28-36/37/39-45 612-108-00-0 3-aminopropyltriethoxysilane 213-048-4 919-30-2 Xn; R22
C; R34 C
R: 22-34
S: (1/2-)26-36/37/39-45 612-109-00-6 bis(2-dimethylaminoethyl)(methyl)amine 221-201-1 3030-47-5 T; R24
Xn; R22
C; R34 T
R: 22-24-34
S: (1/2-)26-36/37/39-45 612-110-00-1 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) 229-962-1 6864-37-5 T; R23/24
Xn; R22
C; R35
N; R51-53 T; C; N
R: 22-23/24-35-51/53
S: (1/2-)26-36/37/39-45-61 612-111-00-7 2-methyl-m-phenylenediamine;
2,6-toluenediamine 212-513-9 823-40-5 Muta. Cat. 3; R68
Xn; R21/22
R43
N; R51-53 Xn; N
R: 21/22-43-51/53-68
S: (2-)24-36/37-61 612-112-00-2 p-anisidine;
4-methoxyaniline 203-254-2 104-94-9 T+; R26/27/28
R33
N; R50 T+; N
R: 26/27/28-33-50
S: (1/2-)28-36/37-45-61 612-113-00-8 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine 403-240-8 106264-79-3 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 612-114-00-3 R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate 404-390-7 — F; R11
R43
R52-53 F; Xi
R: 11-43-52/53
S: (2-)24-37-61 612-115-00-9 dimethyldioctadecylammonium hydrogen sulfate 404-050-8 123312-54-9 Xi; R36
R53 Xi
R: 36-53
S: (2-)26-39-61 612-116-00-4 C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate 404-690-8 68132-19-4 T; R23
C; R34
R43
N; R50-53 T; N
R: 23-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-117-00-X C12-14-tert-alkylamine, methylphosphonic acid salt 404-750-3 119415-07-5 Xn; R22
C; R34
N; R51-53 C; N
R: 22-34-51/53
S: (1/2-)26-28-36/37/39-45-61 612-118-00-5 A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide 405-080-4 — Xi; R41
N; R50-53 X; N
R: 41-50/53
S: (2-)22-26-39-60-61 612-119-00-0 benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate 405-330-2 — Xi; R38-41
N; R50-53 Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 612-120-00-6 aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 N; R50-53 N
R: 50/53
S: 60-61 612-121-00-1 amines, polyethylenepoly-;
HEPA 268-626-9 68131-73-7 Xn; R21/22
C; R34
R43
N; R50-53 C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-122-00-7 hydroxylamine 232-259-2 7803-49-8 R5 ⊗
Xn; R22-48/22
Xi; R37/38-41
R43
N; R50 Xn; N
R: 5-22-37/38-41-43-48/22-50
S: (2-)22-26-36/37/39-61 612-123-00-2 hydroxylammonium chloride;
hydroxylamine hydrochloride; [1]
bis(hydroxylammonium) sulphate;
hydroxylamine sulphate (2:1); [2]
hydroxylammonium hydrogensulphate;
hydroxylamine sulphate (1:1) [3] 226-798-2 [1]
233-118-8 [2]
233-154-4 [3] 5470-11-1 [1]
10039-54-0 [2]
10046-00-1 [3] ⊗ Xn; R22-48/22
Xi; R36/38
R43
N; R50 Xn; N
R: 22-36/38-43-48/22-50
S: (2-)22-24-37-61 612-124-00-8 N,N,N-trimethylanilinium chloride 205-319-0 138-24-9 T; R24/25 T
R: 24/25
S: (1/2-)25-39-45-53 612-125-00-3 2-methyl-p-phenylenediamine;
2,5-toluenediamine 202-442-1 95-70-5 T; R25
Xn; R20/21
R43
N; R51-53 T; N
R: 20/21-25-43-51/53
S: (1/2-)24-37-45-61 612-126-00-9 toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate 265-697-8 65321-67-7 Carc. Cat. 2; R45
T; R25
Xn; R21
Xi; R36
R43
N; R51-53 T; N
R: 45-21-25-36-43-51/53
S: 53-45-61 E
612-127-00-4 3-aminophenol 209-711-2 591-27-5 Xn; R20/22
N; R51-53 Xn; N
R: 20/22-51/53
S: (2-)28-61 612-128-00-X 4-aminophenol 204-616-2 123-30-8 Muta. Cat. 3; R68
Xn; R20/22
N; R50-53 Xn; N
R: 20/22-50/53-68
S: (2-)28-36/37-60-61 612-129-00-5 diisopropylamine 203-558-5 108-18-9 F; R11
Xn; R20/22
C; R34 F; C
R: 11-20/22-34
S: (1/2-)16-26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 612-130-00-0 2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2]
diethylmethylbenzenediamine [3] 218-255-3 [1]
218-256-9 [2]
270-877-4 [3] 2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3] Xn; R21/22-48/22
Xi; R36
N; R50-53 Xn; N
R: 21/22-36-48/22-50/53
S: (2-)26-28-36/37/39-60-61 C
612-131-00-6 didecyldimethylammonium chloride 230-525-2 7173-51-5 Xn; R22
C; R34 C
R: 22-34
S: (2-)26-36/37/39-45 612-132-00-1 N,N'-diphenyl-p-phenylenediamine;
N,N'-diphenyl-1,4-benzenediamine 200-806-4 74-31-7 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 247-162-0 25646-77-9 T; R25
Xn; R48/22
R43
N; R50-53 T; N
R: 25-43-48/22-50/53
S: (1/2-)24-37-45-60-61 612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 247-161-5 25646-71-3 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 612-135-00-8 N-2-naphthylaniline;
N-phenyl-2-naphthylamine 205-223-9 135-88-6 Carc. Cat. 3; R40
Xi; R36/38
R43
N; R51-53 Xn; N
R: 36/38-40-43-51/53
S: (2-)26-36/37-61 612-136-00-3 N-isopropyl-N'-phenyl-p-phenylenediamine 202-969-7 101-72-4 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 R43: C ≥ 0,1 % 612-137-00-9 4-chloroaniline 203-401-0 106-47-8 Carc. Cat. 2; R45
T; R23/24/25
R43
N; R50-53 T; N
R: 45-23/24/25-43-50/53
S: 53-45-60-61 E
612-138-00-4 furalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate 260-875-1 57646-30-7 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)36/37/39-61 612-139-00-X mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 277-328-8 73250-68-7 N; R51-53 N
R: 51/53
S: 61 612-140-00-5 quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides 264-151-6 63449-41-2 Xn; R21/22
C; R34
N; R50 C; N
R: 21/22-34-50
S: (2-)36/37/39-45-61 612-141-00-0 4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine) 243-420-1 19900-65-3 Carc. Cat. 3; R40
Xn; R22
N; R50-53 Xn; N
R: 22-40-50/53
S: (2-)36/37-60-61 612-142-00-6 biphenyl-2-ylamine 201-990-9 90-41-5 Carc. Cat. 3; R40
Xn; R22
R52-53 Xn
R: 22-40-52/53
S: (2-)36/37-61 612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride 218-130-3 2051-79-8 T; R25
Xi; R36
R43
N; R50-53 T; N
R: 25-36-43-50/53
S: (1/2-)24-26-37-45-60-61 612-144-00-7 flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine — 62924-70-3 Xi; R36/38
R43
N; R50-53 Xi; N
R: 36/38-43-50/53
S: (2-)36/37-60-61 612-145-00-2 o-phenylenediamine 202-430-6 95-54-5 Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R25
Xn; R20/21
Xi; R36
R43
N; R50-53 T; N
R: 20/21-25-36-40-43-50/53-68
S: (1/2-)28-36/37-45-60-61 612-146-00-8 o-phenylenediamine dihydrochloride 210-418-7 615-28-1 Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R25
Xn; R20/21
Xi; R36
R43
N; R50-53 T; N
R: 20/21-25-36-40-43-50/53-68
S: (1/2-)28-36/37-45-60-61 612-147-00-3 m-phenylenediamine 203-584-7 108-45-2 Muta. Cat. 3; R68
T; R23/24/25
Xi; R36
R43
N; R50-53 T; N
R: 23/24/25-36-43-50/53-68
S: (1/2-)28-36/37-45-60-61 612-148-00-9 m-phenylenediamine dihydrochloride 208-790-0 541-69-5 Muta. Cat. 3; R68
T; R23/24/25
Xi; R36
R43
N; R50-53 T; N
R: 23/24/25-36-43-50/53-68
S: (1/2-)28-36/37-45-60-61 612-149-00-4 1,3-diphenylguanidine 203-002-1 102-06-7 Repr. Cat. 3; R62
Xn; R22
Xi; R36/37/38
N; R51-53 Xn; N
R: 22-36/37/38-51/53-62
S: (2-)26-36/37/39-61 612-150-00-X spiroxamine (ISO);
8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Xn; R20/21/22
Xi; R38
R43
N; R50-53 Xn; N
R: 20/21/22-38-43-50/53
S: (2-)36/37/39-46-60-61 612-151-00-5 diaminotoluene, technical product - reaction mass of [2] and [3];
methyl-phenylenediamine; [1]
4-methyl-m-phenylene diamine; [2]
2-methyl-m-phenylene diamine [3] 246-910-3 [1]
202-453-1 [2]
212-513-9 [3] 25376-45-8 [1]
95-80-7 [2]
823-40-5 [3] Carc. Cat. 2; R45
T; R25
Xn; R20/21
Xi; R36
R43
N; R51-53 T; N
R: 45-20/21-25-36-43-51/53
S: 53-45-61 E
612-152-00-0 N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine 406-610-7 62478-82-4 R10
Xn; R20/22-48/20
C; R35
R52-53 C
R: 10-20/22-35-48/20-52/53
S: (1/2-)26-28-36/37/39-45-61 612-153-00-6 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride 407-020-2 132885-85-9 Xn; R22
R43
R52-53 Xn
R: 22-43-52/53
S: (2-)22-24-37-61 612-154-00-1 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] 410-890-6 95235-29-3 R53 R: 53
S: 61 612-155-00-7 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene 411-730-8 93071-94-4 R53 R: 53
S: 61 612-156-00-2 reaction mass of: trihexadecylmethylammonium chloride;
dihexadecyldimethylammonium chloride 405-620-9 — Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 612-157-00-8 (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride 410-780-8 — Xn; R22-48/22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-48/22-51/53
S: (2-)22-26-36/37/39-61 612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime 410-820-4 — R53 R: 53
S: 61 612-159-00-9 Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid 410-880-1 — Xn; R22
C; R34
N; R50-53 C; N
R: 22-34-50/53
S: (1/2-)23-26-36/37/39-45-60-61 612-160-00-4 p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3] 203-403-1 [1]
208-740-8 [2]
208-741-3 [3] 106-49-0 [1]
540-23-8 [2]
540-25-0 [3] Carc. Cat. 3; R40
T; R23/24/25
Xi; R36
R43
N; R50 T; N
R: 23/24/25-36-40-43-50
S: (1/2-)28-36/37-45-61 612-161-00-X 2,6-xylidine;
2,6-dimethylaniline 201-758-7 87-62-7 Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R37/38
N; R51-53 Xn; N
R: 20/21/22-37/38-40-51/53
S: (2-)23-25-36/37-61 612-162-00-5 dimethyldioctadecylammonium chloride;
DODMAC 203-508-2 107-64-2 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)24-26-39-46-60-61 612-163-00-0 metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester — 70630-17-0 Xn; R22
Xi; R41 Xn
R: 22-41
S: (2-)26-39-46 612-164-00-6 2-butyl-2-ethyl-1,5-diaminopentane 412-700-7 137605-95-9 Xn; R21/22-48/22
C; R34
R43
R52-53 C
R: 21/22-34-43-48/22-52/53
S: (1/2-)26-36/37/39-45-61 612-165-00-1 N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine 413-810-8 65181-78-4 N; R51-53 N
R: 51/53
S: 61 612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 411-830-1 114765-88-7 Xi; R41
R43
R52-53 Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 612-167-00-2 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride 410-490-1 — Xn; R22-48/22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-48/22-51/53
S: (2-)22-26-36/37/39-61 612-168-00-8 3,5-dichloro-2,6-difluoropyrdine-4-amine 220-630-1 2840-00-8 Xn; R21/22
N; R51-53 Xn; N
R: 21/22-51/53
S: (2-)36/37-61 612-170-00-9 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime 405-260-2 — Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 612-171-00-4 N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane 410-060-3 130728-76-6 Muta. Cat. 3; R68
R43
N; R51-53 Xn; N
R: 43-68-51/53
S: (2-)36/37-61 612-172-00-X 4,4'-methylenebis(N,N'-dimethylcyclohexanamine 412-840-9 13474-64-1 Xn; R22-48/22
C; R35
R52-53 C
R: 22-35-48/22-52/53
S: (1/2-)26-36/37/39-45-61 612-173-00-5 lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate 411-140-0 125328-86-1 Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)22-26-36/37/39-61 612-174-00-0 4,4-dimethoxybutylamine 407-690-6 19060-15-2 Xn; R22
C; R34
R43
R52-53 C
R: 22-34-43-52/53
S: (1/2-)26-36/37/39-45-61 612-175-00-6 2-(O-aminooxy)ethylamine dihydrochloride 412-310-7 37866-45-8 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 612-176-00-1 Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine 410-570-6 143747-73-3 N; R50-53 N
R: 50/53
S: 60-61 612-177-00-7 2-naphthylamino-6-sulfomethylamide 412-120-4 104295-55-8 Xn; R48/22
R43
N; R51-53 Xn; N
R: 43-48/22-51/53
S: (2-)22-36/37-61 612-178-00-2 1,4,7,10-tetraazacyclododecane disulfate 412-080-8 112193-77-8 Xn; R22
Xi; R37-41
R52-53 Xn
R: 22-37-41-52/53
S: (2-)26-36/37/39-61 612-179-00-8 1-(2-propenyl)pyridinium chloride 412-740-5 25965-81-5 Xn; R22
R43 Xn
R: 22-43
S: (2-)24-37 612-180-00-3 3-aminobenzylamine 412-230-2 4403-70-7 Xn; R22
C; R34
N; R51-53 C; N
R: 22-34-51/53
S: (1/2-)22-26-36/37/39-45-61 612-181-00-9 2-phenylthioaniline 413-030-8 1134-94-7 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 612-182-00-4 1-ethyl-1-methylmorpholinium bromide 418-210-1 65756-41-4 Muta. Cat. 3; R68 Xn
R: 68
S: (2-)36/37 612-183-00-X 1-ethyl-1-methylpyrrolidinium bromide 418-200-5 69227-51-6 Muta. Cat. 3; R68 Xn
R: 68
S: (2-)36/37 612-184-00-5 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one 403-830-5 89331-94-2 R52-53 R: 52/53
S: 61 612-185-00-0 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide 407-400-8 59493-72-0 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 612-186-00-6 bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate 406-770-8 149057-64-7 Xn; R48/22
Xi; R41
R43
N; R50-53 Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61 612-187-00-1 2,3,4-trifluoroaniline 407-170-9 3862-73-5 Xn; R21/22-48/22
Xi; R38-41
N; R51-53 Xn; N
R: 21/22-38-41-48/22-51/53
S: (2-)23-26-36/37/39-61 612-188-00-7 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) 407-560-9 107934-68-9 N; R51-53 N
R: 51/53
S: 61 612-189-00-2 4-amino-2-(aminomethyl)phenol dihydrochloride 412-510-4 135043-64-0 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61 612-190-00-8 4,4'-methylenebis(2-isopropyl-6-methylaniline) 415-150-6 16298-38-7 Xn; R48/22
N; R51-53 Xn; N
R: 48/22-51/53
S: (2-)36-61 612-191-00-3 Polymer of allylamine hydrochloride 415-050-2 71550-12-4 Xn; R22
R43 Xn
R: 22-43
S: (2-)36/37 612-192-00-9 2-isopropyl-4-(N-methyl)aminomethylthiazole 414-800-6 154212-60-9 Xn; R21/22
Xi; R38-41
N; R51-53 Xn; N
R: 21/22-38-41-51/53
S: (2-)26-36/37/39-61 612-193-00-4 3-methylaminomethylphenylamine 414-570-7 18759-96-1 Xn; R21/22
C; R34
R43
N; R50-53 C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-194-00-X 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride 414-670-0 141890-30-4 Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-50/53
S: (2-)26-39-60-61 612-195-00-5 bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate 415-210-1 160236-81-7 Xn; R20/22
Xi; R41
N; R50-53 Xn; N
R: 20/22-41-50/53
S: (2-)26-36/39-60-61 612-196-00-0 4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2] 202-441-6 [1]
221-627-8 [2] 95-69-2 [1]
3165-93-3 [2] Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25
N; R50-53 T; N
R: 45-23/24/25-68-50/53
S: 53-45-60-61 E
612-197-00-6 2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2] 205-282-0 [1]
[2] 137-17-7 [1]
21436-97-5 [2] Carc. Cat. 2; R45
T; R23/24/25
N; R51-53 T; N
R: 45-23/24/25-51/53
S: 53-45-61 E
612-198-00-1 4,4'-thiodianiline and its salts 205-370-9 139-65-1 Carc. Cat. 2; R45
Xn; R22
N; R51-53 T; N
R: 45-22-51/53
S: 53-45-61 E
612-199-00-7 4,4'-oxydianiline and its salts;
p-aminophenyl ether 202-977-0 101-80-4 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T; R23/24/25
N; R51-53 T; N
R: 45-46-23/24/25-62-51/53
S: 53-45-61 E
612-200-00-0 2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2] 210-406-1 [1]
254-323-9 [2] 615-05-4 [1]
39156-41-7 [2] Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R22
N; R51-53 T; N
R: 45-22-68-51/53
S: 53-45-61 E
612-201-00-6 N,N,N',N'-tetramethyl-4,4'-methylendianiline 202-959-2 101-61-1 Carc. Cat. 2; R45
N; R50-53 T; N
R: 45-50/53
S: 53-45-60-61 612-202-00-1 3,4-dichloroaniline 202-448-4 95-76-1 T; R23/24/25
Xi; R41
R43
N; R50-53 T; N
R: 23/24/25-41-43-50/53
S: (1/2-)26-36/37/39-45-60-61 612-204-00-2 C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 208-953-6 548-62-9 Carc. Cat. 3; R40
Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-40-41-50/53
S: (2-)26-36/37/39-46-60-61 612-205-00-8 C.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5) 208-953-6 548-62-9 Carc. Cat. 2; R45
Xn; R22
Xi; R41
N; R50-53 T; N
R: 45-22-41-50/53
S: 53-45-60-61 E
612-206-00-3 famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione — 131807-57-3 Xn; R48/22
N; R50-53 Xn; N
R: 48/22-50/53
S: (2-)46-60-61 612-207-00-9 4-ethoxyaniline;
p-phenetidine 205-855-5 156-43-4 Muta. Cat. 3; R68
Xn; R20/21/22
Xi; R36
R43 Xn
R: 20/21/22-36-43-68
S: (2-)36/37-46 612-209-00-X 6-methoxy-m-toluidine;
p-cresidine 204-419-1 120-71-8 Carc. Cat. 2; R45
Xn; R22 T
R: 45-22
S: 53-45 E
612-210-00-5 5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2] 202-765-8 [1]
256-960-8 [2] 99-55-8 [1]
51085-52-0 [2] Carc. Cat. 3; R40
T; R23/24/25
R52-53 T
R: 23/24/25-40-52/53
S: (1/2-)36/37-45-61 612-211-00-0 N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide 416-470-9 170292-97-4 Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 612-212-00-6 2,6-dichloro-4-trifluoromethylaniline 416-430-0 24279-39-8 Xn; R20/22
Xi; R38
R43
N; R50-53 Xn; N
R: 20/22-38-43-50/53
S: (2-)24-37-60-61 612-213-00-1 isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine 419-850-2 148348-13-4 C; R34
R52-53 C
R: 34-52/53
S: (1/2-)23-26-36/37/39-45-61 612-214-00-7 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine 421-390-2 89114-90-9 R53 R: 53
S: 61 612-215-00-2 3-chloro-2-(isopropylthio)aniline 421-700-6 179104-32-6 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 612-217-00-3 1-methoxy-2-propylamine 422-550-4 37143-54-7 F; R11
C; R34
Xn; R22
R52-53 F; C
R: 11-22-34-52/53
S: (1/2-)9-26-36/37/39-45-61 613-001-00-1 ethyleneimine;
aziridine 205-793-9 151-56-4 F; R11
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T+; R26/27/28
C; R34
N; R51-53 F; T+; N
R: 45-46-11-26/27/28-34-51/53
S: 53-45-61 D E
613-002-00-7 pyridine 203-809-9 110-86-1 F; R11
Xn; R20/21/22 F; Xn
R: 11-20/21/22
S: (2-)26-28 Xn; R20/21/22: C ≥ 5 % 613-003-00-2 1,2,3,4-tetranitrocarbazole — 6202-15-9 E ⊗
R1
Xn; R20/21/22 E; Xn
R: 1-20/21/22
S: (2-)35 613-004-00-8 crimidine (ISO);
2-chloro-6-methylpyrimidin-4-yldimethylamine 208-622-6 535-89-7 T+; R28 T+
R: 28
S: (1/2-)36/37-45 613-007-00-4 desmetryne (ISO);
6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine 213-800-1 1014-69-3 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 613-008-00-X dazomet (ISO);
tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione 208-576-7 533-74-4 Xn; R22
Xi; R36
N; R50-53 Xn; N
R: 22-36-50/53
S: (2-)15-22-24-60-61 613-009-00-5 2,4,6-trichloro-1,3,5-triazine;
cyanuric chloride 203-614-9 108-77-0 R14
T+; R26
Xn; R22
C; R34
R43 T+;
R: 14-22-26-34-43
S: (1/2-)26-28-36/37/39-45-46-63 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 613-010-00-0 ametryn (ISO);
2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine 212-634-7 834-12-8 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)36-60-61 613-011-00-6 amitrole (ISO);
1,2,4-triazol-3-ylamine 200-521-5 61-82-5 Repr. Cat. 3; R63
Xn; R48/22
N; R51-53 Xn; N
R: 48/22-63-51/53
S: (2-)13-36/37-61 613-012-00-1 bentazone (ISO);
3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 246-585-8 25057-89-0 Xn; R22
Xi; R36
R43
R52-53 Xn
R: 22-36-43-52/53
S: (2-)24-37-61 613-013-00-7 cyanazine (ISO);
2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile 244-544-9 21725-46-2 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)37-60-61 613-014-00-2 ethoxyquin (ISO);
6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline 202-075-7 91-53-2 Xn; R22 Xn
R: 22
S: (2-)24 613-015-00-8 fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate 238-134-9 14255-88-0 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 613-016-00-3 fuberidazole (ISO);
2-(2-furyl)benzimidazole 223-404-0 3878-19-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-60-61 613-017-00-9 bis (8-hydroxyquinolinium) sulphate 205-137-1 134-31-6 Xn; R22 Xn
R: 22
S: (2-)36 613-018-00-4 morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion — 7411-47-4 Xn; R22
Xi; R36/37/38
R52-53 Xn
R: 22-36/37/38-52/53
S: (2-)22-36-61 613-019-00-X thioquinox (ISO);
2-thio-1,3-dithiolo(4,5,b)quinoxaline 202-272-8 93-75-4 Xn; R22 Xn
R: 22
S: (2-)24 613-020-00-5 tridemorph (ISO);
2,6-dimethyl-4-tridecylmorpholine 246-347-3 24602-86-6 Repr. Cat. 2; R61
Xn; R20/22
Xi; R38
N; R50-53 T; N
R: 61-20/22-38-50/53
S: 53-45-60-61 E
613-021-00-0 dithianon (ISO);
5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile 222-098-6 3347-22-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24-60-61 613-022-00-6 pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex — — Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 A
613-023-00-1 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;
pyrethrin I 204-455-8 121-21-1 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 613-024-00-7 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
pyrethrin II 204-462-6 121-29-9 Xn; R20/21/22
N; R50-53 Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 613-025-00-2 cinerin I;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 246-948-0 25402-06-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-026-00-8 cinerin II;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate 204-454-2 121-20-0 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-027-00-3 piperidine 203-813-0 110-89-4 F; R11
T; R23/24
C; R34 F; T
R: 11-23/24-34
S: (1/2-)16-26-27-45 T; R23/24: C ≥ 5 %
Xn; R20/21: 1 % ≤ C < 5 %
C; R34: C ≥ 5 %
Xi: R36/38: 1 % ≤ C < 5 % 613-028-00-9 morpholine 203-815-1 110-91-8 R10
Xn; R20/21/22
C; R34 C
R: 10-20/21/22-34
S: (1/2-)23-36-45 C; R34: C ≥ 10 %
Xi; R36/38: 1 % ≤ C < 10 % 613-029-00-4 dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid 220-487-5 2782-57-2 O; R8
Xn; R22
R31
Xi; R36/37
N; R50-53 O; Xn; N
R: 8-22-31-36/37-50/53
S: (2-)8-26-41-60-61 613-030-00-X troclosene potassium; [1]
troclosene sodium [2] 218-828-8 [1]
220-767-7 [2] 2244-21-5 [1]
2893-78-9 [2] O; R8 ⊗
Xn; R22
R31
Xi; R36/37
N; R50-53 O; Xn; N
R: 8-22-31-36/37-50/53
S: (2-)8-26-41-60-61 Xn; R22: C ≥ 10 %
Xi; R36/37: C ≥ 10 %
R31: C ≥ 10 % 613-030-01-7 troclosene sodium, dihydrate 220-767-7 51580-86-0 Xn; R22
R31
Xi; R36/37
N; R50-53 Xn; N
R: 22-31-36/37-50/53
S: (2-)8-26-41-60-61 613-031-00-5 symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion 201-782-8 87-90-1 O; R8
Xn; R22
Xi; R36/37
R31
N; R50-53 O; Xn; N
R: 8-22-31-36/37-50/53
S: (2-)8-26-41-60-61 613-032-00-0 methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine 236-035-5 13108-52-6 Xn; R21/22
Xi; R36
R43 Xn
R: 21/22-36-43
S: (2-)26-28 613-033-00-6 2-methylaziridine;
propyleneimine 200-878-7 75-55-8 F; R11
Carc. Cat. 2; R45
T+; R26/27/28
Xi; R41
N; R51-53 F; T+; N
R: 45-11-26/27/28-41-51/53
S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
613-034-00-1 1,2-dimethylimidazole 217-101-2 1739-84-0 Xn; R22
Xi; R38-41 Xn
R: 22-38-41
S: (2-)24-26 613-035-00-7 1-methylimidazole 210-484-7 616-47-7 Xn; R21/22
C; R34 C
R: 21/22-34
S: (1/2-)26-36-45 613-036-00-2 2-methylpyridine;
2-picoline 203-643-7 109-06-8 R10
Xn; R20/21/22
Xi; R36/37 Xn
R: 10-20/21/22-36/37
S: (2-)26-36 613-037-00-8 4-methylpyridine;
4-picoline 203-626-4 108-89-4 R10
T; R24
Xn; R20/22
Xi; R36/37/38 T
R: 10-20/22-24-36/37/38
S: (1/2-)26-36-45 613-038-00-3 6-phenyl-1,3,5-triazine-2,4-diyldiamine;
6-phenyl-1,3,5-triazine-2,4-diamine;
benzoguanamine 202-095-6 91-76-9 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 613-039-00-9 ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol 202-506-9 96-45-7 Repr. Cat. 2; R61
Xn; R22 T
R: 61-22
S: 53-45 E
613-040-00-4 azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole 262-102-3 60207-31-0 Xn; R22 Xn
R: 22
S: (2-)46 613-041-00-X morpholine-4-carbonyl chloride 239-213-0 15159-40-7 R14
Carc. Cat. 3; R40
Xi; R36/38 Xn
R: 14-36/38-40
S: (2-)26-30-36-38 613-042-00-5 imazalil (ISO);
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Xn; R20/22
Xi; R41
N; R50-53 Xn; N
R: 20/22-41-50/53
S: (2-)26-39-60-61 613-043-00-0 imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]
281-291-3 [2] 58594-72-2 [1]
83918-57-4 [2] Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24/25-37-46-60-61 613-043-01-8 imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]
281-291-3 [2] 58594-72-2 [1]
83918-57-4 [2] Xn; R22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-50/53
S: (2-)26-36/37/39-45-60-61 C; R34: C ≥ 50 %
Xi; R38: 30 % ≤ C < 50 %
Xi; R41: 15 % ≤ C < 50 %
Xi; R36: 5 % ≤ C < 15 % 613-044-00-6 captan (ISO);
1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide 205-087-0 133-06-2 Carc. Cat. 3; R40
T; R23
Xi; R41
R43
N; R50 T; N
R: 23-40-41-43-50
S: (1/2-)26-29-36/37/39-45-61 613-045-00-1 folpet (ISO);
N-(trichloromethylthio)phthalimide 205-088-6 133-07-3 Carc. Cat. 3; R40
Xn; R20
Xi; R36
R43
N; R50 Xn; N
R: 20-36-40-43-50
S: (2-)36/37-46-61 613-046-00-7 captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide 219-363-3 2425-06-1 Carc. Cat. 2; R45
R43
N; R50-53 T; N
R: 45-43-50/53
S: 53-45-60-61 613-047-00-2 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;
dimetilan (ISO) 211-420-0 644-64-4 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)36/37-45-60-61 613-048-00-8 carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate 234-232-0 10605-21-7 Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
N; R50-53 T; N
R: 46-60-61-50/53
S: 53-45-60-61 613-049-00-3 benomyl (ISO);
methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate 241-775-7 17804-35-2 Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
Xi; R37/38
R43
N; R50-53 T; N
R: 46-60-61-37/38-43-50/53
S: 53-45-60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 613-050-00-9 carbadox (INN);
methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;
2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide 229-879-0 6804-07-5 F; R11
Carc. Cat. 2; R45
Xn; R22 F; T
R: 45-11-22
S: 53-45 E
613-051-00-4 molinate (ISO);
S-ethyl 1-perhydroazepinecarbothioate;
S-ethyl perhydroazepine-1-carbothioate 218-661-0 2212-67-1 Carc. Cat. 3; R40
Repr. Cat. 3; R62
Xn; R20/2248/22
R43
N; R50-53 Xn; N
R: 20/22-40-43-48/22-62-50/53
S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 613-052-00-X trifenmorph (ISO);
4-tritylmorpholine 215-812-2 1420-06-0 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-053-00-5 anilazine (ISO);
2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline 202-910-5 101-05-3 Xi; R36/38
N; R50-53 Xi; N
R: 36/38-50/53
S: (2-)22-60-61 613-054-00-0 thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole 205-725-8 148-79-8 N; R50-53 N
R: 50/53
S: 60-61 613-056-00-1 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;
difenzoquat methyl sulfate 256-152-5 43222-48-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-057-00-7 dodemorph (ISO);
4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Xi; R36/37/38
N; R51-53 Xi; N
R: 36/37/38-51/53
S: (2-)26-61 613-058-00-2 permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Xn; R20/22
R43
N; R50-53 Xn; N
R: 20/22-43-50/53
S: (2-)13-24-36/37/39-60-61 N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 % 613-059-00-8 profluralin (ISO);
N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine 247-656-6 26399-36-0 Xi; R36
N; R50-53 Xi; N
R: 36-50/53
S: (2-)60-61 613-060-00-3 resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate 233-940-7 10453-86-8 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60/61 613-061-00-9 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;
ryania 239-732-2 15662-33-6 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 613-062-00-4 sabadilla (ISO);
veratrine — 8051-02-3 Xi; R36/37/38 Xi
R: 36/37/38
S: (2-)36/37/39 613-063-00-X secbumeton (ISO);
2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 247-554-1 26259-45-0 Xn; R22
Xi; R36
N; R50-53 Xn; N
R: 22-36-50/53
S: (2-)60-61 613-064-00-5 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;
sesamex — 51-14-9 Xn; R22 Xn
R: 22
S: (2-) 613-065-00-0 simetryn (ISO);
2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine 213-801-7 1014-70-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-066-00-6 terbumeton (ISO);
2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 251-637-8 33693-04-8 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-067-00-1 propazine (ISO);
2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine 205-359-9 139-40-2 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 613-068-00-7 atrazine (ISO);
2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine 217-617-8 1912-24-9 Xn; R48/22
R43
N; R50-53 Xn; N
R: 43-48/22-50/53
S: (2-)36/37-60-61 613-069-00-2 ε-caprolactam 203-313-2 105-60-2 Xn; R20/22
Xi; R36/37/38 Xn
R: 20/22-36/37/38
S: (2-) 613-070-00-8 propylenethiourea — 2122-19-2 Repr. Cat. 3; R63
Xn; R22
R52-53 Xn
R: 22-52/53-63
S: (2-)36/37-46-61 613-071-00-3 2-fluoro-5-trifluoromethylpyridine 400-290-2 69045-82-5 R10
R43
R52-53 Xi
R: 10-43-52/53
S: (2-)24-37-61 613-072-00-9 N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine 401-280-0 91273-04-0 C; R34
R43
N; R51-53 C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61 613-073-00-4 N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine 401-410-6 10357-99-0 Xn; R48/22
R43
N; R51-53 Xn; N
R: 43-48/22-51/53
S: (2-)24-37-61 613-074-00-X 3-(3-methylpent-3-yl)isoxazol-5-ylamine 401-460-9 82560-06-3 T; R23/25
Xi; R41
R52-53 T
R: 23/25-41-52/53
S: (1/2-)22-26-36/37/39-45-61 613-075-00-5 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 401-570-7 89415-87-2 O; R8
T; R23
C; R34
Xn; R22
R43
N; R50 O; T; N
R: 8-22-23-34-43-50
S: (1/2-)8-26-36/37/39-45-61 613-076-00-0 3-chloro-5-trifluoromethyl-2-pyridylamine 401-670-0 79456-26-1 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 613-077-00-6 reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine 401-940-8 — Xn; R22
Xi; R36
N; R51-53 Xn; N
R: 22-36-51/53
S: (2-)22-26-61 613-078-00-1 N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine 401-990-0 106990-43-6 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 613-079-00-7 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers 402-520-7 — Xn; R21/22
Xi; R38
R43
N; R50-53 Xn; N
R: 21/22-38-43-50/53
S: (2-)36/37-60-61 613-080-00-2 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione 402-540-6 105254-85-1 C; R34
R43
N; R50-53 C; N
R: 34-43-50/53
S: (1/2-)26-28-36/37/39-45-60-61 613-081-00-8 1-butyl-2-methylpyridinium bromide 402-680-8 26576-84-1 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 613-082-00-3 2-methyl-1-pentylpyridinium bromide 402-690-2 — Xn; R21/22
R52-53 Xn
R: 21/22-52/53
S: (2-)36/37-61 613-083-00-9 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate 402-120-2 — C; R34
Xn; R48/22
R43
N; R50-53 C; N
R: 34-43-48/22-50/53
S: (1/2-)24-26-28-37/39-45-60-61 613-084-00-4 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate 402-490-5 106359-93-7 Xi; R36
N; R50-53 Xi; N
R: 36-50/53
S: (2-)26-60-61 613-085-00-X reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione 401-970-1 — R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 613-086-00-5 caffeine 200-362-1 58-08-2 Xn; R22 Xn
R: 22
S: (2-) 613-087-00-0 tetrahydrothiophene 203-728-9 110-01-0 F; R11
Xn; R20/21/22
Xi; R36/38
R52-53 F; Xn
R: 11-20/21/22-36/38-52/53
S: (2-)16-23-36/37-61 613-088-00-6 1,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one 220-120-9 2634-33-5 Xn; R22
Xi; R38-41
R43
N; R50 Xn; N
R: 22-38-41-43-50
S: (2-)24-26-37/39-61 R43: C ≥ 0,05 % 613-089-00-1 diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] 201-579-4 [1]
223-714-6 [2]
301-467-6 [3] 85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3] T+; R26
T; R48/25
Xn; R22
Xi; R36/37/38
R43
N; R50-53 T+; N
R: 22-26-36/37/38-43-48/25-50/53
S: (1/2-)28-36/37/39-45-60-61 613-090-00-7 paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 217-615-7 [1]
218-196-3 [2] 1910-42-5 [1]
2074-50-2 [2] T+; R26
T; R24/25-48/25
Xi; R36/37/38
N; R50-53 T+; N
R: 24/25-26-36/37/38-48/25-50/53
S: (1/2-)22-28-36/37/39-45-60-61 613-091-00-2 morfamquat dichloride; [1]
morfamquat sulfate [2] 225-062-8 [1]
[2] 4636-83-3 [1]
29873-36-7 [2] Xn; R22
Xi; R36/37/38
R52-53 Xn
R: 22-36/37/38-52/53
S: (2-)22-36-61 613-092-00-8 1,10-phenanthroline 200-629-2 66-71-7 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)45-60-61 613-093-00-3 hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 400-050-7 85153-92-0 R42/43 Xn
R: 42/43
S: (2-)22-24-37 613-094-00-9 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine 401-360-5 5248-39-5 Xn; R22-48/22 Xn
R: 22-48/22
S: (2-)22-36 613-095-00-4 sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate 403-080-9 92484-48-5 Xi; R41 Xi
R: 41
S: (2-)26-39 613-096-00-X 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine 403-580-7 62096-63-3 Xn; R22 Xn
R: 22
S: (2-) 613-097-00-5 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 403-690-5 111298-82-9 R42/43
R52-53 Xn
R: 42/43-52/53
S: (2-)22-24-37-61 613-098-00-0 N-(n-octyl)-2-pyrrolidone 403-700-8 2687-94-7 C; R34
N; R51-53 C; N
R: 34-51/53
S: (1/2-)23-26-36/37/39-45 613-099-00-6 1-dodecyl-2-pyrrolidone 403-730-1 2687-96-9 C; R34
R43
N; R50-53 C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 613-100-00-X 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione 404-230-6 — R43
R53 Xi
R: 43-53
S: (2-)24-37-61 613-101-00-5 N-tert-pentyl-2-benzothiazolesulfenamide 404-380-2 110799-28-5 R43
R52-53 Xi
R: 43-52/53
S: (2-)36/37-61 613-102-00-0 dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine 404-200-2 110488-70-5 N; R51-53 N
R: 51/53
S: 61 613-103-00-6 sodium 5-n-butylbenzotriazole 404-450-2 118685-34-0 Xn; R22
C; R34
R43
N; R51-53 C; N
R: 22-34-43-51/53
S: (1/2-)26-36/37/39-45-61 613-104-00-1 5-tert-butyl-3-isoxazolylamine hydrochloride 404-840-2 — Xn; R22-48/22
Xi; R41
R52-53 Xn
R: 22-41-48/22-52/53
S: (2-)26-36/39-61 613-105-00-7 hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) 405-160-9 124537-30-0 T; R25
R43
R52-53 T
R: 25-43-52/53
S: (1/2-)24-37-45-61 613-106-00-2 tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate 405-240-3 — R43 Xi
R: 43
S: (2-)24-37 613-107-00-8 hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate 405-280-1 76508-02-6 Xi; R36 Xi
R: 36
S: (2-)26 613-108-00-3 benzothiazole-2-thiol 205-736-8 149-30-4 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 613-109-00-9 bis(piperidinothiocarbonyl) disulphide 202-328-1 94-37-1 Xi; R36/37/38
R43 Xi
R: 36/37/38-43
S: (2-)24-26-37 613-110-00-4 dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate 262-784-2 61432-55-1 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 613-111-00-X 1,2,4-triazole 206-022-9 288-88-0 Repr. Cat. 3; R63
Xn; R22
Xi; R36 Xn
R: 22-36-63
S: (2-)36/37 613-112-00-5 octhilinone (ISO);
2-octyl-2H-isothiazol-3-one 247-761-7 26530-20-1 T; R23/24
Xn; R22
C; R34
R43
N; R50-53 T; N
R: 22-23/24-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 R43: C ≥ 0,05 % 613-113-00-0 2-(morpholinothio)benzothiazole 203-052-4 102-77-2 Xi; R36/38
R43
N; R51-53 Xi; N
R: 36/38-43-51/53
S: (2-)24-26-37-61 613-114-00-6 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;
1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine 225-208-0 4719-04-4 Xn; R22
R43 Xn
R: 22-43
S: (2-)24-37 R43: C ≥ 0,1 % 613-115-00-1 hymexazol (ISO);
3-hydroxy-5-methylisoxazole 233-000-6 10004-44-1 Xn; R22
Xi; R41
R52-53 Xn
R: 22-41-52/53
S: (2-)26-39-61 613-116-00-7 tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide 211-986-9 731-27-1 T; R23
Xn; R48/20
Xi; R36/37/38
R43
N; R50-53 T; N
R: 23-36/37/38-43-48/20-50/53
S: (1/2-)24-26-37-38-45-60-61 613-117-00-2 diniconazole (ISO);
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol — 76714-88-0 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-118-00-8 flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline; 253-703-1 37893-02-0 Xi; R36
N; R50-53 Xi; N
R: 36-50/53
S: (2-)26-60-61 613-119-00-3 (benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB 244-445-0 21564-17-0 T+; R26
Xn; R22
Xi; R36/38
R43
N; R50-53 T+; N
R: 22-26-36/38-43-50/53
S: (1/2-)28-36/37-38-45-60-61 613-120-00-9 bioresmethrin;
(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate 249-014-0 28434-01-7 N; R50-53 N
R: 50/53
S: 60-61 613-121-00-4 chlorsulfuron (ISO);
2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide; 265-268-5 64902-72-3 N; R50-53 N
R: 50/53
S: 60-61 613-122-00-X diclobutrazole (ISO);
(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol — 75736-33-3 Xi; R36
N; R51-53 Xi; N
R: 36-51/53
S: (2-)26-61 613-123-00-5 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;
etem 251-684-4 33813-20-6 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-124-00-0 fenpropimorph (ISO);
cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 266-719-9 67564-91-4 Repr. Cat. 3; R63
Xn; R22
Xi; R38
N; R51-53 Xn; N
R: 22-38-63-51/53
S: (2-)36/37-46-61 613-125-00-6 hexythiazox (ISO);
trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide — 78587-05-0 N; R50-53 N
R: 50/53
S: 60-61 613-126-00-1 imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate — 81334-34-1 Xi; R36
R52-53 Xi
R: 36-52/53
S: (2-)26-61 613-127-00-7 1,1-dimethylpiperidinium chloride;
mepiquat chloride 246-147-6 24307-26-4 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 613-128-00-2 prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide; 266-994-5 67747-09-5 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 613-129-00-8 metamitron (ISO);
4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one 255-349-3 41394-05-2 Xn; R22
N; R50 Xn; N
R: 22-50
S: (2-)61 613-131-00-9 pyroquilon (ISO);
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one — 57369-32-1 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 613-132-00-4 hexazinone (ISO);
3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione; 257-074-4 51235-04-2 Xn; R22
Xi; R36
N; R50-53 Xn; N
R: 22-36-50/53
S: (2-)60-61 613-133-00-X etridiazole (ISO);
5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. Cat. 3; R40
T; R23
Xn; R21/22
N; R50-53 T; N
R: 21/22-23-40-50/53
S: (1/2-)36/37-38-45-60-61 613-134-00-5 myclobutanil (ISO);
2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. Cat. 3; R63
Xn; R22
Xi; R36
N; R51-53 Xn; N
R: 22-36-51/53-63
S: (2-)36/37-46-61 613-135-00-0 di(benzothiazol-2-yl) disulphide 204-424-9 120-78-5 R31
R43
N; R50-53 Xi; N
R: 31-43-50/53
S: (2-)36/37-60-61 613-136-00-6 N-cyclohexylbenzothiazole-2-sulphenamide 202-411-2 95-33-0 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 613-137-00-1 methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-dimethylurea 242-505-0 18691-97-9 N; R50-53 N
R: 50/53
S: 60-61 613-138-00-7 quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline — 124495-18-7 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61 613-139-00-2 metsulfuron-methyl;
2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid — 74223-64-6 N; R50-53 N
R: 50/53
S: 60-61 613-140-00-8 cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione 200-636-0 66-81-9 Muta. Cat. 3; R68
Repr. Cat. 2; R61
T+; R28
N; R51-53 T+; N
R: 61-28-51/53-68
S: 53-45-61 E
613-141-00-3 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone 401-470-3 93686-63-6 R53 R: 53
S: 61 613-142-00-9 trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate 405-860-4 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)22-24-37-61 613-143-00-4 1-(3-phenylpropyl)-2-methylpyridinium bromide 405-930-4 10551-42-5 Xn; R22
Xi; R36
R52-53 Xn
R: 22-36-52/53
S: (2-)26-36/37-61 613-144-00-X Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate 406-460-2 125139-08-4 R52-53 R: 52/53
S: 61 613-145-00-5 (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate 406-960-0 77497-97-3 N; R51-53 N
R: 51/53
S: 61 613-146-00-0 N-ethyl-N-methylpiperidinium iodide 407-780-5 4186-71-4 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)22-61 613-147-00-6 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine 407-940-4 111681-72-2 Xi; R41 Xi
R: 41
S: (2-)26-39 613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 411-240-4 143683-23-2 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24/25-37-61 613-149-00-7 pyridaben (ISO);
2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 T; R23/25
N; R50-53 T; N
R: 23/25-50/53
S: (1/2-)36/37-45-60-61 613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — R53 R: 53
S: 61 613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 R53 R: 53
S: 61 613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 613-153-00-9 2,3,5-trichloropyridine 407-270-2 16063-70-0 R52-53 R: 52/53
S: 61 613-154-00-4 2-amino-4-chloro-6-methoxypyrimidine 410-050-9 5734-64-5 Xn; R22 Xn
R: 22
S: (2-)22 613-155-00-X 5-chloro-2,3-difluoropyridine 410-090-7 89402-43-7 R10
Xn; R22
R52-53 Xn
R: 10-22-52/53
S: (2-)23-36-61 613-156-00-5 2-butyl-4-chloro-5-formylimidazole 410-260-0 83857-96-9 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 613-157-00-0 2,4-diamino-5-methoxymethylpyrimidine 410-330-0 54236-98-5 Xn; R22-48/22
Xi; R36 Xn
R: 22-36-48/22
S: (2-)22-26-36 613-158-00-6 2,3-dichloro-5-trifluoromethyl-pyridine 410-340-5 69045-84-7 Xn; R20/22
Xi; R41
R43
N; R51-53 Xn; N
R: 20/22-41-43-51/53
S: (2-)24-26-37/39-61 613-159-00-1 fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline 410-580-0 120928-09-8 T; R25
Xn; R20
N; R50-53 T; N
R: 20-25-50/53
S: (1/2-)37-45-60-61 613-160-00-7 (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide 411-000-9 125224-62-6 R43 Xi
R: 43
S: (2-)24-37 613-163-00-3 azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea — 120162-55-2 N; R50-53 N
R: 50/53
S: 60-61 613-164-00-9 flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide — 142459-58-3 Xn; R22-48/22
R43
N; R50-53 Xn; N
R: 22-43-48/22-50/53
S: (2-)13-24-37-60-61 613-165-00-4 flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt — 144740-54-5 N; R50-53 N
R: 50/53
S: 60-61 613-166-00-X flumioxazin (ISO);
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide — 103361-09-7 Repr. Cat. 2; R61
N; R50-53 T; N
R: 61-50/53
S: 53-45-60-61 613-167-00-5 reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) — 55965-84-9 T; R23/24/25
C; R34
R43
N; R50-53 T; N
R: 23/24/25-34-43-50/53
S: (2-)26-28-36/37/39-45-60-61 C; R34: C ≥ 0,6 %
Xi; R36/38: 0,06 % ≤ C < 0,6 %
R43: C ≥ 0,0015 % 613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. Cat. 3; R40
Xn; R20/21/22-48/20
Xi; R37-41 Xn
R: 20/21/22-37-40-41-48/20
S: (2-)26-36/37/39 D
613-169-00-6 9-vinylcarbazole 216-055-0 1484-13-5 Muta. Cat. 3; R68
Xn; R21/22
Xi; R38
R43
N; R50-53 Xn; N
R: 21/22-38-43-50/53-68
S: 22-23-36/37-60-61 613-170-00-1 2,2-ethylmethylthiazolidine 404-500-3 694-64-4 Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61 613-171-00-7 hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol 413-050-7 79983-71-4 Xn; R22
R43
N; R51-53 Xn; N
R: 22-43-51/53
S: (2-)24-37-61 613-172-00-2 5-chloro-1,3-dihydro-2H-indol-2-one 412-200-9 17630-75-0 Repr. Cat. 3; R62
Xn; R22
R43
R52-53 Xn
R: 22-43-62-52/53
S: (2-)22-36/37-61 613-173-00-8 fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one 411-960-9 136426-54-5 T; R23/25-48/25
Xn; R21
Xi; R38
N; R50-53 T; N
R: 21-23/25-38-48/25-50/53
S: (1/2-)36/37/39-38-45-60-61 613-174-00-3 (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 407-760-6 112281-77-3 Carc. Cat. 3; R40
Xn; R20/22
N; R51-53 Xn; N
R: 20/22-40-51/53
S: (2-)36/37-41-61 613-175-00-9 epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. Cat. 3; R40
Repr. Cat. 3; R62
Repr. Cat. 3; R63
N; R51-53 Xn; N
R: 40-62-63-51/53
S: (2-)36/37-46-61 613-176-00-4 2-methyl-2-azabicyclo[2.2.1]heptane 404-810-9 4524-95-2 R10
Xn; R21/22-48/20
C; R34 C
R: 10-21/22-34-48/20
S: (1/2-)16-26-36/37/39-45 613-177-00-X 8-amino-7-methylquinoline 412-760-4 5470-82-6 Xn; R21/22
R43
N; R51-53 Xn; N
R: 21/22-43-51/53
S: (2-)36/37-61 613-178-00-5 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine 410-470-2 137796-06-6 C; R34
R43 C
R: 34-43
S: (1/2-)7/8-26-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 613-179-00-0 lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide 411-690-1 111337-53-2 Xn; R22
C; R34
R43
N; R51-53 C; N
R: 22-34-43-51/53
S: (1/2-)26-36/37/39-45-61 613-180-00-6 N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide 407-430-1 3741-80-8 N; R50-53 N
R: 50/53
S: 60-61 613-181-00-1 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone 405-090-9 67485-29-4 T; R48/25
Xn; R22
Xi; R36
N; R50-53 T; N
R: 22-36-48/25-50/53
S: (1/2-)22-26-36/37-45-60-61 613-182-00-7 1-(1-naphthylmethyl)quinolinium chloride 406-220-7 65322-65-8 Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R22
Xi; R38-41
R52-53 Xn
R: 22-38-40-41-52/53-68
S: (2-)22-26-36/37/39-61 613-183-00-2 reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;
5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one 413-640-4 — Xn; R48/22
N; R50-53 Xn; N
R: 48/22-50/53
S: (2-)36-60-61 613-184-00-8 nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate 413-670-8 — Xi; R36
R43 Xi
R: 36-43
S: (2-)24-26-37 613-185-00-3 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one 407-630-9 82633-79-2 T; R25
Xi; R41
R43
N; R50-53 T; N
R: 25-41-43-50/53
S: (1/2-)22-26-36/37/39-45-60-61 613-186-00-9 (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate 408-050-9 76855-69-1 Xi; R36
R43
N; R51-53 Xi; N
R: 36-43-51/53
S: (2-)24-26-37-61 613-188-00-X 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone 411-500-7 116256-11-2 Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)22-24-26-37/39-61 613-189-00-5 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane 414-030-0 52667-88-6 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 613-190-00-0 disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate 414-040-5 149530-93-8 Xn; R22
R43 Xn
R: 22-43
S: (2-)22-24-37 613-191-00-6 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 421-150-7 143860-04-2 Repr. Cat. 2; R60
C; R34
N; R50-53 T; N
R: 60-34-50/53
S: 53-45-60-61 613-193-00-7 pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate 414-930-3 — N; R51-53 N
R: 51/53
S: 61 613-194-00-2 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt 418-000-8 163062-28-0 Xi; R41 Xi
R: 41
S: (2-)22-26-39 613-195-00-8 2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one) 418-280-1 18600-59-4 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 613-196-00-3 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt 418-380-5 168113-78-8 Xi; R41 Xi
R: 41
S: (2-)26-39 613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 420-390-1 187547-46-2 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;
reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione 421-550-1 — Carc. Cat. 2; R45
Repr. Cat. 2; R61
R43
R52-53 T
R: 45-61-43-52/53
S: 53-45-61 613-200-00-3 Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts 420-980-7 — Xi; R41 Xi
R: 41
S: (2-)22-26-39 613-201-00-9 (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole 422-390-5 143322-57-0 Repr. Cat. 3; R62
T; R39-48/25
Xn; R20/22
Xi; R41
R43
N; R50-53 T; N
R: 20/22-39-41-43-48/25-62-50/53
S: (1/2-)53-45-60-61 613-202-00-4 pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one — 123312-89-0 Carc. Cat. 3; R40
R52-53 Xn
R: 40-52/53
S: (2-)36/37-61 613-203-00-X pyraflufen-ethyl; [1]
pyraflufen [2] [1]
[2] 129630-19-9 [1]
129630-17-7 [2] N; R50-53 N
R: 50/53
S: 60-61 613-204-00-5 oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;
5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one 254-637-6 39807-15-3 Repr. Cat. 3; R63
Xn; R48/22
N; R50-53 Xn; N
R: 48/22-63-50/53
S: (2-)36/37-46-60-61 613-205-00-0 propiconazole (ISO);
(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole 262-104-4 60207-90-1 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)36/37-46-60-61 613-206-00-6 fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one — 161326-34-7 N; R50-53 N
R: 50/53
S: 60-61 613-208-00-7 imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid — 114311-32-9 N; R50-53 N
R: 50/53
S: 60-61 613-209-00-2 cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride 417-430-3 63645-17-0 T; R25
Xn; R48/22
R43
N; R51-53 T; N
R: 25-43-48/22-51/53
S: (1/2-)22-36/37-45-61 613-210-00-8 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 417-650-1 88128-57-8 Xn; R48/22
R52-53 Xn
R: 48/22-52/53
S: (2-)23-25-36-61 613-211-00-3 N-methyl-4-(p-formylstyryl)pyridinium methylsulfate 418-240-3 74401-04-0 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 613-212-00-9 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) 418-320-8 133467-41-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-60-61 613-213-00-4 cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline 416-040-0 120807-02-5 R52-53 R: 52/53
S: 61 613-214-00-X N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide 416-260-7 147613-95-4 R53 R: 53
S: 61 613-215-00-5 2-chloromethyl-3,4-dimethoxypyridinium chloride 416-440-5 72830-09-2 Xn; R21/22-48/22
Xi; R38-41
R43
N; R51-53 Xn; N
R: 21/22-38-41-43-48/22-51/53
S: (2-)26-36/37/39-61 613-216-00-0 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole 416-490-8 162208-01-7 N; R50-53 N
R: 50/53
S: 60-61 613-217-00-6 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine 416-770-1 73754-27-5 R53 R: 53
S: 61 613-218-00-1 6-hydroxyindole 417-020-4 2380-86-1 Xn; R22
Xi; R41
R43
N; R51-53 Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61 613-219-00-7 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole 417-140-7 79185-77-6 Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)37-61 613-220-00-2 trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide 417-290-3 147086-81-5 Xn; R22 Xn
R: 22
S: (2-)36 613-221-00-8 2-chloro-5-methyl-pyridine 418-050-0 18368-64-4 Xn; R21/22
Xi; R38
R52-53 Xn
R: 21/22-38-52/53
S: (2-)23-25-36/37-61 613-222-00-3 4-(1-oxo-2-propenyl)-morpholine 418-140-1 5117-12-4 Xn; R22-48/22
Xi; R41
R43 Xn
R: 22-41-43-48/22
S: (2-)23-26-36/37/39 613-223-00-9 N-isopropyl-3-(4-fluorophenyl)-1H-indole 418-790-4 93957-49-4 R53 R: 53
S: 61 613-224-00-4 2,5-dimercaptomethyl-1,4-dithiane 419-770-8 136122-15-1 Xn; R22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. 421-290-9 — Xn; R48/22
R53 Xn
R: 48/22-53
S: (2-)22-36-61 613-226-00-5 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride 420-950-3 163831-67-2 Xi; R41
N; R50-53 Xi; N
R: 41-50/53
S: (2-)26-39-60-61 613-227-00-0 (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-600-2 99199-90-3 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-28-36/37-61 613-228-00-6 (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-630-6 793669-26-8 N; R51-53 N
R: 51/53
S: 24-61 613-230-00-7 florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide — 145701-23-1 N; R50-53 N
R: 50/53
S: 60-61 613-233-00-3 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane 423-230-7 56552-15-9 Xi; R41 Xi
R: 41
S: (2-)26-39 614-001-00-4 nicotine (ISO);
3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 T+; R27
T; R25
N; R51-53 T+; N
R: 25-27-51/53
S: (1/2-)36/37-45-61 614-002-00-X salts of nicotine — — T+; R26/27/28
N; R51-53 T+; N
R: 26/27/28-51/53
S: (1/2-)13-28-45-61 A
614-003-00-5 strychnine 200-319-7 57-24-9 T+; R27/28
N; R50-53 T+; N
R: 27/28-50/53
S: (1/2-)36/37-45-60-61 614-004-00-0 salts of strychnine — — T+; R26/28
N; R50-53 T+; N
R: 26/28-50/53
S: (1/2-)13-28-45-60-61 A
614-005-00-6 colchicine 200-598-5 64-86-8 T+; R26/28 T+
R: 26/28
S: (1/2-)13-45 614-006-00-1 brucine;
2,3-dimethoxystrychnine 206-614-7 357-57-3 T+; R26/28
R52-53 T+
R: 26/28-52/53
S: (1/2-)13-45-61 614-007-00-7 brucine sulphate; [1]
brucine nitrate; [2]
Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4] 4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4] T+; R26/28
R52-53 T+
R: 26/28-52/53
S: (1/2-)13-45-61 A
614-008-00-2 aconitine 206-121-7 302-27-2 T+; R26/28 T+
R: 26/28
S: (1/2-)24-45 614-009-00-8 salts of aconitine — — T+; R26/28 T+
R: 26/28
S: (1/2-)24-45 A
614-010-00-3 atropine 200-104-8 51-55-8 T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 614-011-00-9 salts of atropine — — T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 A
614-012-00-4 hyoscyamine 202-933-0 101-31-5 T+; R26/28 T+
R: 26/28
S: (1/2-)24-45 614-013-00-X salts of hyoscyamine — — T+; R26/28 T+
R: 26/28
S: (1/2-)24-45 A
614-014-00-5 hyoscine 200-090-3 51-34-3 T+; R26/27/28 T+
R: 26/27/28
S: (1/2-)25-45 614-015-00-0 salts of hyoscine — — T+; R26/27/28 T+
R: 26/27/28
S: (1/2-)25-45 A
614-016-00-6 pilocarpine 202-128-4 92-13-7 T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 614-017-00-1 salts of pilocarpine — — T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 A
614-018-00-7 papaverine 200-397-2 58-74-2 Xn; R22 Xn
R: 22
S: (2-)22 614-019-00-2 salts of papaverine — — Xn; R22 Xn
R: 22
S: (2-)22 A
614-020-00-8 physostigmine 200-332-8 57-47-6 T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 614-021-00-3 salts of physostigmine — — T+; R26/28 T+
R: 26/28
S: (1/2-)25-45 A
614-022-00-9 digitoxin 200-760-5 71-63-6 T; R23/25
R33 T
R: 23/25-33
S: (1/2-)45 614-023-00-4 ephedrine 206-080-5 299-42-3 Xn; R22 Xn
R: 22
S: (2-)22-25 614-024-00-X salts of ephedrine — — Xn; R22 Xn
R: 22
S: (2-)22-25 A
614-025-00-5 ouabain 211-139-3 630-60-4 T; R23/25
R33 T
R: 23/25-33
S: (1/2-)45 614-026-00-0 strophantin-K 234-239-9 11005-63-3 T; R23/25
R33 T
R: 23/25-33
S: (1/2-)45 614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;
red squill;
scilliroside 208-077-4 507-60-8 T+; R28 T+
R: 28
S: (1/2-)36/37-45 614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside 414-420-0 — Xi; R41 Xi
R: 41
S: (2-)26-39 614-029-00-7 constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside 419-640-0 68784-14-5 Xn; R22 Xn
R: 22
S: (2-) 615-001-00-7 methyl isocyanate 210-866-3 624-83-9 F+; R12 ⊗
Repr. Cat. 3; R63
T+; R26
T; R24/25
R42/43
Xi; R37/38-41 F+; T+
R: 12-24/25-26-37/38-41-42/43-63
S: (1/2-)26-27/28-36/37/39-45-63 615-002-00-2 methyl isothiocyanate 209-132-5 556-61-6 T; R23/25
C; R34
R43
N; R50-53 T; N
R: 23/25-34-43-50/53
S: (1/2-)36/37-38-45-60-61 615-003-00-8 thiocyanic acid 207-337-4 463-56-9 Xn; R20/21/22
R32
R52-53 Xn
R: 20/21/22-32-52/53
S: (2-)13-61 615-004-00-3 salts of thiocyanic acid — — Xn; R20/21/22
R32
R52-53 Xn
R: 20/21/22-32-52/53
S: (2-)13-61 A
615-005-00-9 4,4'-methylenediphenyl diisocyanate;
diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate;
diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4] 202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4] 101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4] Xn; R20
Xi; R36/37/38
R42/43 Xn
R: 20-36/37/38-42/43
S: (1/2-)23-36/37-45 Xi; R36/37/38: C ≥ 5 %
R42: C ≥ 0,1 % C
2
615-006-00-4 2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3] 202-039-0 [1]
209-544-5 [2]
247-722-4 [3] 91-08-7 [1]
584-84-9 [2]
26471-62-5 [3] Carc. Cat. 3; R40
T+; R26
Xi; R36/37/38
R42/43
R52-53 T+
R: 26-36/37/38-40-42/43-52/53
S: (1/2-)23-36/37-45-61 R42: C ≥ 0,1 % C
2
615-007-00-X 1,5-naphthylene diisocyanate 221-641-4 3173-72-6 Xn; R20
Xi; R36/37/38
R42
R52-53 Xn
R: 20-36/37/38-42-52/53
S: (2-)26-28-38-45-61 615-008-00-5 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;
isophorone di-isocyanate 223-861-6 4098-71-9 T; R23
Xi; R36/37/38
R42/43
N; R51-53 T; N
R: 23-36/37/38-42/43-51/53
S: (1/2-)26-28-38-45-61 T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 % 2
615-009-00-0 4,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate 225-863-2 5124-30-1 T; R23
Xi; R36/37/38
R42/43 T
R: 23-36/37/38-42/43
S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 % 2
615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 241-001-8 [1]
239-714-4 [2] 16938-22-0 [1]
15646-96-5 [2] T; R23
Xi; R36/37/38
R42 T
R: 23-36/37/38-42
S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42: C ≥ 0,5 % C
2
615-011-00-1 hexamethylene-di-isocyanate 212-485-8 822-06-0 T; R23
Xi; R36/37/38
R42/43 T
R: 23-36/37/38-42/43
S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 % 2
615-012-00-7 4-isocyanatosulphonyltoluene;
tosyl isocyanate 223-810-8 4083-64-1 R14
Xi; R36/37/38
R42 Xn
R: 14-36/37/38-42
S: (2-)26-28-30 Xi; R36/37/38: C ≥ 5 % 615-013-00-2 cyanamide;
carbanonitril 206-992-3 420-04-2 T; R25
Xn; R21
Xi; R36/38
R43 T
R: 21-25-36/38-43
S: (1/2-)3-22-36/37-45 615-014-00-8 tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate — 7276-58-6 Xn; R22 Xn
R: 22
S: (2-)24 615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate 204-081-5 115-31-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)24/25-60-61 615-016-00-9 potassium cyanate 209-676-3 590-28-3 Xn; R22 Xn
R: 22
S: (2-)24/25 615-017-00-4 calcium cyanamide 205-861-8 156-62-7 Xn; R22
Xi; R37-41 Xn
R: 22-37-41
S: (2-)22-26-36/37/39 615-018-00-X 2-(2-butoxyethoxy)ethyl thiocyanate 203-985-7 112-56-1 R10
T; R24/25 T
R: 10-24/25
S: (1/2-)13-36/37-45 615-019-00-5 dicyclohexylcarbodiimide 208-704-1 538-75-0 T; R24
Xn; R22
Xi; R41
R43 T
R: 22-24-41-43
S: (1/2-)24-26-37/39-45 615-020-00-0 methylene dithiocyanate 228-652-3 6317-18-6 T+; R26
T; R25
C; R34
R43
N; R50 T+; N
R: 25-26-34-43-50
S: (1/2-)26-28-36/37/39-45-61 615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC 219-514-3 2451-62-9 Muta. Cat. 2; R46
T; R23/25
Xn; R48/22
Xi; R41
R43
R52-53 T
R: 46-23/25-41-43-48/22-52/53
S: 53-45-61 E
615-022-00-1 methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate 410-550-7 79277-18-2 E; R2 ⊗
R14
Xn; R48/22
R42/43 E; Xn
R: 2-14-42/43-48/22
S: (2-)22-30-35-36/37 615-023-00-7 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate 410-900-9 83056-32-0 R10
R14
Muta. Cat. 3; R68
Xn; R20-48/22
Xi; R41
R42 Xn
R: 10-14-20-41-42-48/22-68
S: (2-)23-26-36/37/39 615-024-00-2 2-phenylethylisocyanate 413-080-0 1943-82-4 T; R23
Xn; R22
C; R35
R42/43
N; R51-53 T; C; N
R: 22-23-35-42/43-51/53
S: (1/2-)23-26-36/37/39-43-45-61 615-025-00-8 4,4'-ethylidenediphenyl dicyanate 405-740-1 47073-92-7 Xn; R20/22-48/22
Xi; R41
N; R50-53 Xn; N
R: 20/22-41-48/22-50/53
S: (2-)26-36/37/39-60-61 615-026-00-3 4,4'-methylenebis(2,6-dimethylphenyl cyanate) 405-790-4 101657-77-6 R43
R52-53 Xi
R: 43-52/53
S: (2-)22-24-37-61 615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 410-220-2 77375-79-2 E; R2 ⊗
R14
Xn; R22-48/22
Xi; R41
R42/43 E; Xn
R: 2-14-22-41-42/43-48/22
S: (2-)8-23-26-30-35-36/37/39 615-029-00-X 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane 411-280-2 — T+; R26
Xn; R22
C; R34
R42/43
R52-53 T+
R: 22-26-34-42/43-52/53
S: (1/2-)23-26-28-36/37/39-45-61 615-030-00-5 alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this Annex — — Xn; R20/21/22
R32
R52-53 Xn
R: 20/21/22-32-52/53
S: (2-)13-61 A
615-031-00-0 thallium salt of thiocyanic acid 222-571-7 3535-84-0 Xn; R20/21/22
R32
N; R51-53 Xn; N
R: 20/21/22-32-51/53
S: (2-)13-61 A
615-032-00-6 metal salts of thiocyanic acid not mentioned elsewhere in this Annex — — Xn; R20/21/22
R32
N; R50-53 Xn; N
R: 20/21/22-32-50/53
S: (2-)13-60-61 A
616-001-00-X N,N-dimethylformamide;
dimethyl formamide 200-679-5 68-12-2 Repr. Cat. 2; R61
Xn; R20/21
Xi; R36 T
R: 61-20/21-36
S: 53-45 E
616-002-00-5 2-fluoroacetamide 211-363-1 640-19-7 T+; R28
T; R24 T+
R: 24-28
S: (1/2-)36/37-45 616-003-00-0 acrylamide;
prop-2-enamide 201-173-7 79-06-1 Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T; R25-48/23/24/25
Xn; R20/21
Xi; R36/38
R43 T
R: 45-46-20/21-25-36/38-43-48/23/24/25-62
S: 53-45 DE
616-004-00-6 allidochlor (ISO);
N,N-diallylchloroacetamide 202-270-7 93-71-0 Xn; R21/22
Xi; R36/38
N; R51-53 Xn; N
R: 21/22-36/38-51/53
S: (2-)26-28-36/37/39-61 616-005-00-1 chlorthiamid (ISO);
2,6-dichloro (thiobenzamide) 217-637-7 1918-13-4 Xn; R22 Xn
R: 22
S: (2-)36 616-006-00-7 dichlofluanid (ISO);
N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide 214-118-7 1085-98-9 Xn; R20
Xi; R36
R43
N; R50-53 Xn; N
R: 20-36-43-50/53
S: (2-)24-37-60-61 616-007-00-2 diphenamid (ISO);
N,N-dimethyl-2,2-diphenylacetamide 213-482-4 957-51-7 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 616-008-00-8 propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropylacetanilide 217-638-2 1918-16-7 Xn; R22
Xi; R36
R43
N; R50-53 Xn; N
R: 22-36-43-50/53
S: (2-)24-37-60-61 616-009-00-3 propanil (ISO);
3',4'-dichloropropionanilide 211-914-6 709-98-8 Xn; R22
N; R50 Xn; N
R: 22-50
S: (2-)22-61 616-010-00-9 tosylchloramide sodium 204-854-7 127-65-1 Xn; R22
R31
C; R34
R42 C
R: 22-31-34-42
S: (1/2-)7-22-26-36/37/39-45 616-011-00-4 N,N-dimethylacetamide 204-826-4 127-19-5 Repr. Cat. 2; R61
Xn; R20/21 T
R: 61-20/21
S: 53-45 Repr. Cat. 2; R61: C ≥ 5 % E
616-012-00-X N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide 211-952-3 719-96-0 Xi; R38 Xi
R: 38
S: (2-)28 616-013-00-5 butyraldehyde oxime 203-792-8 110-69-0 T; R24
Xn; R22
Xi; R36 T
R: 22-24-36
S: (1/2-)23-36-45 616-014-00-0 2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime 202-496-6 96-29-7 Carc. Cat. 3; R40
Xn; R21
Xi; R41
R43 Xn
R: 21-40-41-43
S: (2-)13-23-26-36/37/39 616-015-00-6 alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 240-110-8 15972-60-8 Carc. Cat. 3; R40
Xn; R22
R43
N; R50-53 Xn; N
R: 22-40-43-50/53
S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,2,5 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 % 616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide — 5836-73-7 T+; R28 T+
R: 28
S: (1/2-)22-36/37-45 616-017-00-7 cartap hydrochloride 239-309-2 15263-52-2 Xn; R21/22
N; R50-53 Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61 616-018-00-2 N,N-diethyl-m-toluamide;
deet 205-149-7 134-62-3 Xn; R22
Xi; R36/38
R52-53 Xn
R: 22-36/38-52/53
S: (2-)61 616-019-00-8 perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide 253-718-3 37924-13-3 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-) 616-020-00-3 tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 251-793-7 34014-18-1 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)37-60-61 616-021-00-9 thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 246-901-4 25366-23-8 Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)60-61 616-022-00-4 acetamide 200-473-5 60-35-5 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 616-023-00-X N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide 401-980-6 — Xi; R38
R43 Xi
R: 38-43
S: (2-)24-37 616-024-00-5 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide 402-260-4 54942-74-4 R53 R: 53
S: 61 616-025-00-0 valinamide 402-840-7 20108-78-5 Repr. Cat. 3; R62
Xi; R36
R43 Xn
R: 36-43-62
S: (2-)26-36/37 616-026-00-6 thioacetamide 200-541-4 62-55-5 Carc. Cat. 2; R45
Xn; R22
Xi; R36/38
R52-53 T
R: 45-22-36/38-52/53
S: 53-45-61 E
616-027-00-1 tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate 403-760-5 — R43 Xi
R: 43
S: (2-)24-37 616-028-00-7 N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 403-790-9 108673-51-4 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 616-029-00-2 N,N'-ethylenebis(vinylsulfonylacetamide) 404-790-1 66710-66-5 Xi; R41
R43 Xi
R: 41-43
S: (2-)24-26-37/39 616-030-00-8 ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 250-010-6 30043-49-3 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 616-031-00-3 dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide 256-625-6 50563-36-5 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 616-032-00-9 diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide — 83164-33-4 R52-53 R: 52/53
S: 61 616-033-00-4 cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 274-050-9 69581-33-5 T; R25
Xn; R21
N; R50-53 T; N
R: 21-25-50/53
S: (1/2-)36/37-60-61 616-034-00-X pyracarbolid (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 246-419-4 24691-76-7 R52-53 R: 52/53
S: 61 616-035-00-5 cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61 616-036-00-0 2-chloracetamide 201-174-2 79-07-2 Repr. Cat. 3; R62
T; R25
R43 T
R: 25-43-62
S: (1/2-)22-36/37-45 R43: C ≥ 0,1 % 616-037-00-6 acetochlor (ISO);
2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide 251-899-3 34256-82-1 Xn; R20
Xi; R37/38
R43
N; R50-53 Xn; N
R: 20-37/38-43-50/53
S: (2-)36/37-60-61 616-038-00-1 (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride 406-010-5 88918-84-7 Xi; R41
R43
N; R51-53 Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61 616-039-00-7 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide 406-200-8 117827-06-2 R43 Xi
R: 43
S: (2-)24-37 616-040-00-2 potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide 406-650-5 97888-41-0 Xi; R41 Xi
R: 41
S: (2-)26-39 616-041-00-8 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide 406-840-8 101664-25-9 R53 R: 53
S: 61 616-042-00-3 N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide 407-070-5 142859-67-4 R43
R53 Xi
R: 43-53
S: (2-)22-24-37-61 616-043-00-9 isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 407-190-8 82558-50-7 R53 R: 53
S: 61 616-044-00-4 N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide 402-510-2 — N; R51-53 N
R: 51/53
S: 61 616-045-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide 405-190-2 122371-93-1 R43
R53 Xi
R: 43-53
S: 2-22-24-37-61 616-046-00-5 N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 406-390-2 — N; R50-53 N
R: 50/53
S: 60-61 616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide 406-640-0 — R43 Xi
R: 43
S: (2-)24-37 616-048-00-6 3'-trifluoromethylisobutyranilide 406-740-4 1939-27-1 Xn; R48/22
N; R51-53 Xn; N
R: 48/22-51/53
S: (2-)22-36-61 616-049-00-1 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide 408-150-2 99141-89-6 R53 R: 53
S: 61 616-050-00-7 lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 410-690-9 103055-07-8 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene 411-070-0 — R53 R: 53
S: 61 616-052-00-8 formamide 200-842-0 75-12-7 Repr. Cat. 2; R61 T
R: 61
S: 53-45 616-053-00-3 N-methylacetamide 201-182-6 79-16-3 Repr. Cat. 2; R61 T
R: 61
S: 53-45 616-054-00-9 iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 253-178-9 36734-19-7 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 616-055-00-4 propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 245-951-4 23950-58-5 Carc. Cat. 3; R40
N; R50-53 Xn; N
R: 40-50/53
S: (2-)36/37-60-61 616-056-00-X N-methylformamide 204-624-6 123-39-7 Repr. Cat. 2; R61
Xn; R21 T
R: 61-21
S: 53-45 E
616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide 412-790-8 — Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R48/22 T
R: 45-48/22
S: 53-45 E
616-058-00-0 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene 412-570-1 119462-56-5 Xn; R48/22
Xi; R41
R43
N; R50-53 Xn; N
R: 41-43-48/22-50/53
S: (2-)26-36/37/39-60-61 616-059-00-6 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide 412-650-6 121487-83-0 R53 R: 53
S: 61 616-060-00-1 Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) 413-770-1 — Xn; R22
C; R34
R43
N; R50-53 C; N
R: 22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61 616-061-00-7 N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide 413-610-0 124172-53-8 Xi; R36
R52-53 Xi
R: 36-52/53
S: (2-)26-61 616-062-00-2 N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide 411-590-8 70693-57-1 C; R34
R52-53 C
R: 34-52/53
S: (1/2-)26-36/37/39-45-61 616-063-00-8 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione 411-920-0 106917-30-0 T; R23
Xn; R22-48/22
C; R35
N; R50-53 T; C; N
R: 22-23-35-48/22-50/53
S: (1/2-)26-28-36/37/39-45-60-61 616-064-00-3 N-tert-butyl-3-methylpicolinamide 406-720-5 32998-95-1 R52-53 R: 52/53
S: 61 616-065-00-9 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea 411-970-3 79881-89-3 Xn; R22-48/22 Xn
R: 22-48/22
S: (2-)22-36 616-066-00-4 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone 405-100-1 115662-06-1 Repr. Cat. 3; R62 Xn
R: 62
S: (2-)22-36/37 616-067-00-X dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate 407-300-4 92683-20-0 R53 R: 53
S: 61 616-068-00-5 potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate 406-500-9 174393-75-0 R43 Xi
R: 43
S: (2-)22-24-37 616-069-00-0 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide 406-210-2 110560-22-0 R53 R: 53
S: 61 616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-530-2 — R53 R: 53
S: 22-61 616-071-00-1 reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) 406-550-1 — R43
R53 Xi
R: 43-53
S: (2-)22-24-37-61 616-072-00-7 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine 407-120-6 55612-11-8 R53 R: 53
S: 61 616-073-00-2 4'-ethoxy-2-benzimidazoleanilide 407-600-5 120187-29-3 Muta. Cat. 3; R68
R53 Xn
R: 68-53
S: (2-)22-36/37-61 616-074-00-8 N-butyl-2-(4-morpholinylcarbonyl)benzamide 407-730-2 104958-67-0 Xi; R36
R43
R52-53 Xi
R: 36-43-52/53
S: (2-)24-26-37-61 616-075-00-3 D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) 408-120-9 65197-96-8 Xn; R22
Xi; R41 Xn
R: 22-41
S: (2-)26-39-46 616-076-00-9 tebufenozide (ISO);
N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide 412-850-3 112410-23-8 N; R51-53 N
R: 51/53
S: 61 616-077-00-4 reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate 411-310-4 — Xi; R41 Xi
R: 41
S: (2-)26-39 616-078-00-X 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide 411-330-3 104541-33-5 R53 R: 53
S: 61 616-079-00-5 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate 411-700-4 140921-24-0 R43 Xi
R: 43
S: (2-)24-37 616-080-00-0 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) 411-850-0 119018-29-0 R52-53 R: 52/53
S: 61 616-081-00-6 5-bromo-8-naphtholactam 413-480-5 24856-00-6 Xn; R22
R43
N; R50-53 Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61 616-082-00-1 N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide 413-200-1 129604-78-0 R43 Xi
R: 43
S: (2-)24-37 616-083-00-7 [2-[(4-nitrophenyl)amino]ethyl]urea 410-700-1 27080-42-8 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 616-084-00-2 2,4-bis[N'-(4-methylphenyl)ureido]toluene 411-790-5 — N; R50-53 N
R: 50/53
S: 60-61 616-085-00-8 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione 412-190-6 168900-02-5 N; R50-53 N
R: 50/53
S: 60-61 616-086-00-3 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene 412-250-1 102387-48-4 R53 R: 53
S: 61 616-087-00-9 reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate 412-260-6 52658-19-2 Xi; R36
R43
N; R51-53 Xi; N
R: 36-43-51/53
S: (2-)26-36/37-61 616-088-00-4 2-aminosulfonyl-N,N-dimethylnicotinamide 413-440-7 112006-75-4 R43
R52-53 Xi
R: 43-52/53
S: (2-)24-37-61 616-089-00-X 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran 415-360-8 41107-56-6 Muta. Cat. 3; R68 Xn
R: 68
S: (2-)22-36/37 616-090-00-5 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride 415-660-9 70918-74-0 T; R23/24/25
Xn; R48/22
N; R51-53 T; N
R: 23/24/25-48/22-51/53
S: 53-45-61 616-091-00-0 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione 423-400-0 59653-74-6 Muta. Cat. 2; R46
T; R23
Xn; R22-48/22
Xi; R41
R43 T
R: 46-22-23-41-43-48/22
S: 53-45 E
616-092-00-6 Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide 404-035-6 — R43
R53 Xi
R: 43-53
S: (2-)24-37-61 616-093-00-1 Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride 406-620-1 129217-90-9 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 616-094-00-7 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea 406-370-3 58890-25-8 R43
R53 Xi
R: 43-53
S: (2-)24-37-61 616-095-00-2 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-690-3 43136-14-7 R53 R: 53
S: 61 616-096-00-8 N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide 408-110-4 110483-07-3 R53 R: 53
S: 61 616-097-00-3 N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide 411-840-6 83372-55-8 R53 R: 53
S: 61 616-098-00-9 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide 411-750-7 119126-15-7 N; R51-53 N
R: 51/53
S: 61 616-099-00-4 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide 414-170-2 135937-20-1 R53 R: 53
S: 61 616-100-00-8 1,3-dimethyl-1,3-bis(trimethylsilyl)urea 414-180-7 10218-17-4 Xn; R22
Xi; R38 Xn
R: 22-38
S: (2-)36/37 616-101-00-3 (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide 414-600-9 149182-72-9 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)61 616-102-00-9 reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] 415-870-0 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)36/37-61 616-103-00-4 (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide 415-030-3 120298-38-6 R43
N; R50-53 Xi; N
R: 43-50/53
S: (2-)24-37-60-61 616-104-00-X benalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate 275-728-7 71626-11-4 N; R50-53 N
R: 50/53
S: 60-61 616-105-00-5 chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea 239-592-2 15545-48-9 Carc. Cat. 3; R40
Repr. Cat. 3; R63
N; R50-53 Xn; N
R: 40-63-50/53
S: (2-)26-36/37-46-60-61 616-106-00-0 phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate 237-199-0 13684-63-4 N; R50-53 N
R: 50/53
S: 60-61 616-108-00-1 iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide — 144550-36-7 N; R50-53 N
R: 50/53
S: 60-61 616-109-00-7 sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea — 141776-32-1 N; R50-53 N
R: 50/53
S: 60-61 616-110-00-2 cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid 419-150-7 113136-77-9 Xn; R22
N; R51-53 Xn; N
R: 22-51/53
S: (2-)61 616-111-00-8 fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid 422-530-5 126833-17-8 N; R51-53 N
R: 51/53
S: 61 616-112-00-3 oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate — 144651-06-9 Xn; R48/22
N; R50-53 Xn; N
R: 48/22-50/53
S: (2-)46-60-61 616-113-00-9 desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate 237-198-5 13684-56-5 N; R50-53 N
R: 50/53
S: 60-61 N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 % 616-114-00-4 dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- 418-010-2 136897-58-0 R53 R: 53
S: 22-61 616-115-00-X N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide 416-150-9 136450-06-1 R53 R: 53
S: 61 616-116-00-5 N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate 416-790-9 143052-96-4 R53 R: 53
S: 61 616-117-00-0 N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide 416-860-9 777891-21-1 Repr. Cat. 3; R62
R43
N; R50-53 Xn; N
R: 43-62-50/53
S: (2-)22-36/37-60-61 616-118-00-6 N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride 417-950-0 65797-42-4 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 616-119-00-1 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide 418-060-5 118020-93-2 R53 R: 53
S: 61 616-120-00-7 reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide 420-600-1 — Xn; R48/22
N; R51-53 Xn; N
R: 48/22-51/53
S: (2-)36/37-61 616-121-00-2 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide 419-090-1 129205-19-2 R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 616-123-00-3 N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide 414-740-0 96141-86-5 N; R50-53 N
R: 50/53
S: 60-61 616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide 415-300-0 90076-65-6 T; R24/25
C; R34
R52-53 T
R: 24/25-34-52/53
S: (1/2-)22-26-36/37/39-45-61 616-125-00-4 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide 415-730-9 151338-11-3 N; R50-53 N
R: 50/53
S: 60-61 616-127-00-5 reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide) 430-050-2 — R43
N; R51-53 Xi; N
R: 43-51/53
S: (2-)24-37-61 616-128-00-0 N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide 417-530-7 123590-00-1 R53 R: 53
S: 61 616-129-00-6 N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide 419-710-0 42774-15-2 Xn; R22
Xi; R36 Xn
R: 22-36
S: (2-)22-25-26 616-130-00-1 N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide 421-780-2 150919-56-5 R53 R: 53
S: 61 616-132-00-2 N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide 423-250-6 130016-98-7 N; R50-53 N
R: 50/53
S: 60-61 616-133-00-8 N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide 423-990-1 149118-66-1 Xn; R22
Xi; R41
N; R50-53 Xn; N
R: 22-41-50/53
S: (2-)22-26-39-60-61 616-134-00-3 3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide 401-820-5 793710-14-2 R52-53 R: 52/53
S: 61 616-135-00-9 (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide 430-230-0 136522-17-3 Xn; R22
R52-53 Xn
R: 22-52/53
S: (2-)22-61 616-142-00-7 1,3-Bis(vinylsulfonylacetamido)propane 428-350-3 93629-90-4 Muta. Cat. 3; R68
Xi; R41
R43
R52-53 Xn
R: 41-43-68-52/53
S: (2-)22-26-36/37/39-61 616-143-00-2 N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide 422-560-9 149591-38-8 Repr. Cat. 3; R62
Xi; R36
R53 Xn
R: 36-62-53
S: (2-)26-36/37-61 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 O; R7
F; R11 O; F
R: 7-11
S: (2-)3/7-14-16-36/37/39 617-002-00-8 α,α-dimethylbenzyl hydroperoxide;
cumene hydroperoxide 201-254-7 80-15-9 O; R7
T; R23
Xn; R21/22-48/20/22
C; R34
N; R51-53 O; T; N
R: 7-21/22-23-34-48/20/22-51/53
S: (1/2-)3/7-14-36/37/39-45-50-61 C; R34: C ≥ 10 %
Xi; R37/38-41: 3 % ≤ C < 10 %
Xi; R36/37: 1 % ≤ C < 3 % 617-003-00-3 dilauroyl peroxide 203-326-3 105-74-8 O; R7 O
R: 7
S: (2-)3/7-14-36/37/39 617-004-00-9 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide 212-230-0 771-29-9 O; R7
Xn; R22
C; R34
N; R50-53 O; C; N
R: 7-22-34-50/53
S: (1/2-)3/7-14-26-36/37/39-45-60-61 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 617-006-00-X bis(α,α-dimethylbenzyl) peroxide 201-279-3 80-43-3 O; R7
Xi; R36/38
N; R51-53 O; Xi; N
R: 7-36/38-51/53
S: (2-)3/7-14-36/37/39-61 617-007-00-5 tert-butyl α,α-dimethylbenzyl peroxide 222-389-8 3457-61-2 O; R7
Xi; R38
N; R51-53 O; Xi; N
R: 7-38-51/53
S: (2-)3/7-14-36/37/39-61 617-008-00-0 dibenzoyl peroxide;
benzoyl peroxide 202-327-6 94-36-0 E; R2 ⊗
Xi; R36
R43 E; Xi
R: 2-36-43
S: (2-)3/7-14-36/37/39 617-010-00-1 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4] 201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4] 78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4] E; R2 ⊗
Xn; R22
C; R34 E; C
R: 2-22-34
S: (1/2-)3/7-14-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % C
617-012-00-2 8-p-menthyl hydroperoxide;
p-menthane hydroperoxide 201-281-4 80-47-7 O; R7
C; R34
Xn; R20 O; C
R: 7-20-34
S: (1/2-)3/7-14-36/37/39-45 C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 % 617-013-00-8 O,O-tert-butyl O-docosyl monoperoxyoxalate 404-300-6 116753-76-5 O; R7
N; R50-53 O; N
R: 7-50/53
S: (2-)7-14-36/37/39-47-60-61 617-014-00-3 6-(nonylamino)-6-oxo-peroxyhexanoic acid 406-680-9 104788-63-8 O; R7
Xi; R41
R43
N; R50 O; Xi; N
R: 7-41-43-50
S: (2-)3/7-14-26-36/37/39-61 617-015-00-9 bis(4-methylbenzoyl)peroxide 407-950-9 895-85-2 E; R2
O; R7
N; R50-53 E; N
R: 2-7-50/53
S: (2-)7-14-36/37/39-47-60-61 617-016-00-4 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate 413-910-1 — O; R7
R10
Xi; R38
N; R50-53 O; Xi; N
R: 7-10-38-50/53
S: (2-)7/47-14-36/37/39-60-61 617-017-00-X reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene 412-140-3 32144-25-5 O; R7 ⊗
R53 O
R: 7-53
S: (2-)3/7-14-36/37/39-61 617-018-00-5 reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight 410-840-3 71566-50-2 O; R7
N; R51-53 O; N
R: 7-51/53
S: (2-)3/7-14-36/37/39-61 617-019-00-0 6-(phthalimido)peroxyhexanoic acid 410-850-8 128275-31-0 O; R7
Xi; R41
N; R50 O; Xi; N
R: 7-41-50
S: (2-)3/7-14-26-36/37/39-61 617-020-00-6 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) 420-060-5 117663-11-3 R10
O; R7
N; R51-53 O; N
R: 7-10-51/53
S: (2-)7-14-36/37/39-47-61 647-001-00-8 glucosidase, β- 232-589-7 9001-22-3 R42 Xn
R: 42
S: (2-)22-24-36/37 647-002-00-3 cellulase 232-734-4 9012-54-8 R42 Xn
R: 42
S: (2-)22-24-36/37 647-003-00-9 cellobiohydrolase, exo- 253-465-9 37329-65-0 R42 Xn
R: 42
S: (2-)22-24-36/37 647-004-00-4 cellulases with the exception of those specified elsewhere in this Annex — — R42 Xn
R: 42
S: (2-)22-24-36/37 A
647-005-00-X bromelain, juice 232-572-4 9001-00-7 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-006-00-5 ficin 232-599-1 9001-33-6 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-007-00-0 papain 232-627-2 9001-73-4 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-008-00-6 pepsin A 232-629-3 9001-75-6 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-009-00-1 rennin 232-645-0 9001-98-3 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-010-00-7 trypsin 232-650-8 9002-07-7 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-011-00-2 chymotrypsin 232-671-2 9004-07-3 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-012-00-8 subtilisin 232-752-2 9014-01-1 Xi; R37/38-41
R42 Xn
R: 37/38-41-42
S: (2-)22-24-26-36/37/39 647-013-00-3 proteinase, microbial neutral 232-966-6 9068-59-1 Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-014-00-9 proteases with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38
R42 Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37 647-015-00-4 amylase, α- 232-565-6 9000-90-2 R42 Xn
R: 42
S: (2-)22-24-36/37 647-016-00-X amylases with the exception of those specified elsewhere in this Annex — — R42 Xn
R: 42
S: (2-)22-24-36/37 648-001-00-0 Distillates (coal tar), benzole fraction;
Light Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).] 283-482-7 84650-02-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-002-00-6 Tar oils, brown-coal;
Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] 302-674-4 94114-40-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-003-00-1 Benzol forerunnings (coal);
Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] 266-023-5 65996-88-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-004-00-7 Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] 309-984-9 101896-26-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-005-00-2 Aromatic hydrocarbons, C6-10, C8-rich;
Light Oil Redistillate, low boiling 292-697-5 90989-41-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-006-00-8 Solvent naphtha (coal), light;
Light Oil Redistillate, low boiling 287-498-5 85536-17-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-007-00-3 Solvent naphtha (coal), xylene-styrene cut;
Light Oil Redistillate, intermediate boiling 287-502-5 85536-20-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-008-00-9 Solvent naphtha (coal), coumarone-styrene contg.;
Light Oil Redistillate, intermediate boiling 287-500-4 85536-19-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-009-00-4 Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] 292-636-2 90641-12-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-010-00-X Aromatic hydrocarbons, C8;
Light Oil Redistillate, high boiling 292-694-9 90989-38-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-012-00-0 Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).] 295-281-1 91995-20-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-013-00-6 Aromatic hydrocarbons, C9-12, benzene distn.;
Light Oil Redistillate, high boiling 295-551-9 92062-36-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-014-00-1 Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.] 295-323-9 91995-61-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-015-00-7 Extract residues (coal tar), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).] 309-868-8 101316-63-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-016-00-2 Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] 298-725-2 93821-38-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-017-00-8 Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] 292-625-2 90641-02-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-018-00-3 Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling 309-867-2 101316-62-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-019-00-9 Extract residues (coal), light oil alk., indene naphtha fraction;
Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] 292-626-8 90641-03-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-020-00-4 Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] 266-013-0 65996-79-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-021-00-X Distillates (coal tar), light oils, neutral fraction;
Light Oil Extract Residues, high boiling;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.] 309-971-8 101794-90-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-022-00-5 Distillates (coal tar), light oils, acid exts.;
Light Oil Extract Residues, high boiling;
[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).] 292-609-5 90640-87-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-023-00-0 Distillates (coal tar), light oils;
Carbolic Oil;
[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).] 283-483-2 84650-03-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-024-00-6 Tar oils, coal;
Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] 266-016-7 65996-82-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-026-00-7 Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue;
[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] 292-624-7 90641-01-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-027-00-2 Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue;
[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] 266-021-4 65996-87-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-028-00-8 Extract oils (coal), light oil;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-622-6 90640-99-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-029-00-3 Pyridine, alkyl derivs.;
Crude Tar Bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] 269-929-9 68391-11-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-030-00-9 Tar bases, coal, picoline fraction;
Distillate Bases;
[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] 295-548-2 92062-33-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-031-00-4 Tar bases, coal, lutidine fraction;
Distillate Bases 293-766-2 91082-52-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-032-00-X Extract oils (coal), tar base, collidine fraction;
Distillate Bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] 273-077-3 68937-63-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-033-00-5 Tar bases, coal, collidine fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] 295-543-5 92062-28-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-034-00-0 Tar bases, coal, aniline fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] 295-541-4 92062-27-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-035-00-6 Tar bases, coal, toluidine fraction;
Distillate Bases 293-767-8 91082-53-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-036-00-1 Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).] 295-292-1 91995-31-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-037-00-7 Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.] 295-295-8 91995-35-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-038-00-2 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;
Redistillates;
[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] 295-329-1 91995-66-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-039-00-8 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] 310-170-0 122070-79-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-040-00-3 Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;
Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] 310-171-6 122070-80-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-041-00-9 Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).] 309-851-5 101316-45-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-042-00-4 Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] 284-900-0 84989-11-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-043-00-X Creosote oil, acenaphthene fraction, acenaphthene-free;
Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] 292-606-9 90640-85-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-044-00-5 Distillates (coal tar), heavy oils;
Heavy Anthracene Oil;
[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.] 292-607-4 90640-86-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-045-00-0 Distillates (coal tar), upper;
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] 266-026-1 65996-91-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-046-00-6 Anthracene oil, acid ext.;
Anthracene Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] 295-274-3 91995-14-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-047-00-1 Distillates (coal tar);
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] 266-027-7 65996-92-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-048-00-7 Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] 295-312-9 91995-51-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-049-00-2 Distillates (coal tar), pitch;
Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] 309-855-7 101316-49-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-050-00-8 Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.] 295-304-5 91995-42-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-051-00-3 Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.] 295-313-4 91995-52-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-052-00-9 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract;
[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-296-6 97926-76-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-053-00-4 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-297-1 97926-77-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-054-00-X Pitch;
Pitch 263-072-4 61789-60-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-055-00-5 Pitch, coal tar, high-temp.;
Pitch;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-056-00-0 Pitch, coal tar, high-temp., heat-treated;
Pitch;
[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 310-162-7 121575-60-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-057-00-6 Pitch, coal tar, high-temp., secondary;
Pitch Redistillate;
[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.] 302-650-3 94114-13-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-058-00-1 Residues (coal tar), pitch distn.;
Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] 295-507-9 92061-94-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-059-00-7 Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] 295-535-1 92062-20-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-060-00-2 Tar, coal, storage residues;
Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] 293-764-1 91082-50-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-061-00-8 Tar, coal, high-temp., residues;
Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] 309-726-5 100684-51-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-062-00-3 Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] 273-615-7 68990-61-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-063-00-9 Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] 295-549-8 92062-34-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-064-00-4 Extract residues (coal), brown;
Coal Tar Extract;
[The residue from extraction of dried coal.] 294-285-0 91697-23-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-065-00-X Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-454-1 92045-71-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-066-00-5 Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-455-7 92045-72-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-067-00-0 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-298-7 97926-78-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-068-00-6 Tar, coal, low-temp., distn. residues;
Tar Oil, intermediate boiling;
[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] 309-887-1 101316-85-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-069-00-1 Pitch, coal tar, low-temp;
Pitch Residue;
[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-651-4 90669-57-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-070-00-7 Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-654-0 90669-59-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-071-00-2 Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised;
Pitch Residue, heat-treated;
[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.] 292-653-5 90669-58-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-072-00-8 Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.] 269-159-3 68188-48-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-073-00-3 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-956-6 101794-74-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-074-00-9 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-957-1 101794-75-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-075-00-4 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-958-7 101794-76-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-076-00-X Pitch, coal tar-petroleum;
Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] 269-109-0 68187-57-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-077-00-5 Phenanthrene, distn. residues;
Heavy Anthracene Oil Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.] 310-169-5 122070-78-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-078-00-0 Distillates (coal tar), upper, fluorene-free;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] 284-899-7 84989-10-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-079-00-6 Anthracene oil;
Anthracene oil;
[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.] 292-602-7 90640-80-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-080-00-1 Residues (coal tar), creosote oil distn.;
Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.] 295-506-3 92061-93-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-081-00-7 Tar, coal;
Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.] 232-361-7 8007-45-2 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
648-082-00-2 Tar, coal, high-temp.;
Coal tar;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] 266-024-0 65996-89-6 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
648-083-00-8 Tar, coal, low-temp.;
Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] 266-025-6 65996-90-9 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
648-084-00-3 Distillates (coal), coke-oven light oil, naphthalene cut;
Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).] 285-076-5 85029-51-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-085-00-9 Distillates (coal tar), naphthalene oils;
Naphthalene Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).] 283-484-8 84650-04-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-086-00-4 Distillates (coal tar), naphthalene oils, naphthalene-low;
Naphthalene Oil Redistillate;
[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] 284-898-1 84989-09-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-087-00-X Distillates (coal tar), naphthalene oil crystn. mother liquor;
Naphthalene Oil Redistillate;
[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] 295-310-8 91995-49-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-088-00-5 Extract residues (coal), naphthalene oil, alk.;
Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] 310-166-9 121620-47-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-089-00-0 Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] 310-167-4 121620-48-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-090-00-6 Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] 292-612-1 90640-90-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-091-00-1 Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] 292-627-3 90641-04-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-092-00-7 Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).] 309-985-4 101896-27-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-093-00-2 Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] 309-972-3 101794-91-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-094-00-8 Distillates (coal tar), naphthalene oils, acid exts.;
Methylnaphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] 295-309-2 91995-48-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-095-00-3 Extract residues (coal), naphthalene oil alk., distn. residues;
Methylnaphthalene Oil Extract Residue;
[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] 292-628-9 90641-05-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-096-00-9 Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue;
[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] 284-901-6 84989-12-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-097-00-4 Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.] 310-165-3 121620-46-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-098-00-X Creosote oil, acenaphthene fraction;
Wash Oil;
[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] 292-605-3 90640-84-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-099-00-5 Creosote oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).] 263-047-8 61789-28-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-100-00-9 Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).] 274-565-9 70321-79-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-101-00-4 Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] 232-287-5 8001-58-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-102-00-X Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] 310-189-4 122384-77-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-103-00-5 Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] 292-603-2 90640-81-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-104-00-0 Anthracene oil, anthracene-low;
Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] 292-604-8 90640-82-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-105-00-6 Residues (coal tar), anthracene oil distn.;
Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.] 295-505-8 92061-92-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-106-00-1 Anthracene oil, anthracene paste, anthracene fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-275-9 91995-15-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-107-00-7 Anthracene oil, anthracene paste, carbazole fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.] 295-276-4 91995-16-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-108-00-2 Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] 295-278-5 91995-17-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-109-00-8 Tar oils, coal, low-temp.;
Tar Oil, high boiling;
[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).] 309-889-2 101316-87-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-110-00-3 Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] 310-191-5 122384-78-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-111-00-9 Phenols, ammonia liquor ext.;
Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.] 284-881-9 84988-93-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-112-00-4 Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-610-0 90640-88-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-113-00-X Extracts, coal tar oil alk.;
Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 266-017-2 65996-83-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-114-00-5 Distillates (coal tar), naphthalene oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.] 292-611-6 90640-89-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-115-00-0 Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols;
[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] 292-629-4 90641-06-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-116-00-6 Tar acids, coal, crude;
Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] 266-019-3 65996-85-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-117-00-1 Tar acids, brown-coal, crude;
Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] 309-888-7 101316-86-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-118-00-7 Tar acids, brown-coal gasification;
Crude Phenols;
[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] 295-536-7 92062-22-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-119-00-2 Tar acids, distn. residues;
Distillate Phenols;
[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).] 306-251-5 96690-55-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-120-00-8 Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-892-9 84989-04-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-121-00-3 Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.] 284-893-4 84989-05-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-122-00-9 Tar acids, xylenol fraction;
Distillate Phenols; [The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-895-5 84989-06-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-123-00-4 Tar acids, ethylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-891-3 84989-03-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-124-00-X Tar acids, 3,5-xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] 284-896-0 84989-07-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-125-00-5 Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.] 270-713-1 68477-23-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-126-00-0 Tar acids, cresylic, residues;
Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.] 271-418-0 68555-24-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-127-00-6 Phenols, C9-11;
Distillate Phenols 293-435-2 91079-47-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-128-00-1 Tar acids, cresylic;
Distillate Phenols;
[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.] 295-540-9 92062-26-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-129-00-7 Tar acids, brown-coal, C2-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of <{ITA}>m-<{/ITA}> and <{ITA}>p-<{/ITA}>ethylphenol as well as cresols and xylenols.] 302-662-9 94114-29-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-130-00-2 Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-623-1 90641-00-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-131-00-8 Tar bases, quinoline derivs.;
Distillate Bases 271-020-7 68513-87-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-132-00-3 Tar bases, coal, quinoline derivs. fraction;
Distillate Bases 274-560-1 70321-67-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-133-00-9 Tar bases, coal, distn. residues;
Distillate Bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] 295-544-0 92062-29-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-134-00-4 Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] 309-745-9 100801-63-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-135-00-X Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).] 309-748-5 100801-65-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-136-00-5 Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).] 309-749-0 100801-66-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-137-00-0 Extract residues (coal), tar oil alk., naphthalene distn. residues;
Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] 277-567-8 73665-18-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-138-00-6 Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).] 274-566-4 70321-80-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-139-00-1 Tar acids, cresylic, sodium salts, caustic solns.;
Alkaline Extract 272-361-4 68815-21-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-140-00-7 Extract oils (coal), tar base;
Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] 266-020-9 65996-86-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-141-00-2 Tar bases, coal, crude;
Crude Tar Bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] 266-018-8 65996-84-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 HJM
648-142-00-8 Residues (coal), liq. solvent extn.;
[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] 302-681-2 94114-46-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-143-00-3 Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] 302-682-8 94114-47-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-144-00-9 Coal liquids, liq. solvent extn.;
[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] 302-683-3 94114-48-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H M
648-145-00-4 Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).] 309-885-0 101316-83-0 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
648-146-00-X Tar, brown-coal, low-temp.;
[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] 309-886-6 101316-84-1 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
648-147-00-5 Light oil (coal), coke-oven;
Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] 266-012-5 65996-78-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-148-00-0 Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] 302-688-0 94114-52-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-149-00-6 Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-689-6 94114-53-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-150-00-1 Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-690-1 94114-54-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-151-00-7 Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] 302-691-7 94114-55-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
648-152-00-2 Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] 302-692-2 94114-56-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-153-00-8 Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] 302-693-8 94114-57-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
648-154-00-3 Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
648-155-00-9 Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;
[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] 302-695-9 94114-59-7 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
648-156-00-4 Light oil (coal), semi-coking process;
Fresh oil;
[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] 292-635-7 90641-11-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H J
649-001-00-3 Extracts (petroleum), light naphthenic distillate solvent 265-102-1 64742-03-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-002-00-9 Extracts (petroleum), heavy paraffinic distillate solvent 265-103-7 64742-04-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-003-00-4 Extracts (petroleum), light paraffinic distillate solvent 265-104-2 64742-05-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-004-00-X Extracts (petroleum), heavy naphthenic distillate solvent 265-111-0 64742-11-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-005-00-5 Extracts (petroleum), light vacuum gas oil solvent 295-341-7 91995-78-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-006-00-0 hydrocarbons C26-55, arom-rich 307-753-7 97722-04-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-007-00-6 fatty acids, tall-oil, reaction products with iminodiethanol and boric acid 400-160-5 — Xi; R38
N; R51-53 Xi; N
R: 38-51/53
S: (2-)28-37-61 649-008-00-1 Residues (petroleum), atm. tower;
Heavy Fuel oil;
[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-045-2 64741-45-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-009-00-7 Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-058-3 64741-57-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-010-00-2 Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-063-0 64741-61-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-011-00-8 Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-064-6 64741-62-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-012-00-3 Residues (petroleum), hydrocracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).] 265-076-1 64741-75-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-013-00-9 Residues (petroleum), thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-081-9 64741-80-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-014-00-4 Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-082-4 64741-81-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-015-00-X Gas oils (petroleum), hydrotreated vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-162-9 64742-59-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-016-00-5 Residues (petroleum), hydrodesulfurized atmospheric tower;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-181-2 64742-78-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-017-00-0 Gas oils (petroleum), hydrodesulfurized heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-189-6 64742-86-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-018-00-6 Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-193-8 64742-90-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-019-00-1 Residues (petroleum), atmospheric;
Heavy Fuel oil;
[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-777-3 68333-22-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-020-00-7 Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-782-0 68333-26-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-021-00-2 Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 269-783-6 68333-27-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-022-00-8 Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 269-784-1 68333-28-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-023-00-3 Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil 270-674-0 68476-32-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-024-00-9 Fuel oil, residual;
Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] 270-675-6 68476-33-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-025-00-4 Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).] 270-792-2 68478-13-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-026-00-X Residues (petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-796-4 68478-17-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-027-00-5 Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-983-0 68512-61-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-028-00-0 Residues (petroleum), light vacuum;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-984-6 68512-62-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-029-00-6 Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).] 271-013-9 68513-69-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-030-00-1 Fuel oil, No 6;
Heavy Fuel oil;
[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] 271-384-7 68553-00-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-031-00-7 Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] 271-763-7 68607-30-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-032-00-2 Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).] 272-184-2 68783-08-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-033-00-8 Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;
Heavy Fuel oil;
[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.] 272-187-9 68783-13-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-034-00-3 Distillates (petroleum), petroleum residues vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] 273-263-4 68955-27-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-035-00-9 Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[A complex residuum from the distillation of steam-cracked petroleum residues.] 273-272-3 68955-36-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-036-00-4 Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-683-0 70592-76-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-037-00-X Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).] 274-684-6 70592-77-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-038-00-5 Distillates (petroleum), vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-685-1 70592-78-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-039-00-0 Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 285-555-9 85117-03-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-040-00-6 Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] 292-657-7 90669-75-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-041-00-1 Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] 292-658-2 90669-76-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-042-00-7 Fuel oil, heavy, high-sulfur;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 295-396-7 92045-14-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-043-00-2 Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).] 295-511-0 92061-97-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-044-00-8 Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] 295-990-6 92201-59-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-045-00-3 Residual oils (petroleum);
Heavy Fuel oil;
[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] 298-754-0 93821-66-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-046-00-9 Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).] 308-733-0 98219-64-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-047-00-4 Distillates (petroleum), hydrodesulfurized full-range middle;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).] 309-863-0 101316-57-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-048-00-X Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.] 265-069-3 64741-67-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-049-00-5 Petroleum;
Crude oil;
[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-050-00-0 Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] 265-051-5 64741-50-0 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-051-00-6 Distillates (petroleum), heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] 265-052-0 64741-51-1 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-052-00-1 Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-053-6 64741-52-2 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-053-00-7 Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-054-1 64741-53-3 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-117-3 64742-18-3 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-055-00-8 Distillates (petroleum), acid-treated light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-118-9 64742-19-4 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-056-00-3 Distillates (petroleum), acid-treated heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).] 265-119-4 64742-20-7 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-057-00-9 Distillates (petroleum), acid-treated light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-121-5 64742-21-8 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-058-00-4 Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] 265-127-8 64742-27-4 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-059-00-X Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-128-3 64742-28-5 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-060-00-5 Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-135-1 64742-34-3 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-061-00-0 Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-136-7 64742-35-4 Carc. Cat. 1; R45 T
R: 45
S: 53-45 H
649-062-00-6 Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] 270-755-0 68477-73-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-063-00-1 Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-756-6 68477-74-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-064-00-7 Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] 270-757-1 68477-75-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-065-00-2 Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] 270-758-7 68477-76-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-066-00-8 Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] 270-760-8 68477-79-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-067-00-3 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] 270-765-5 68477-83-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-068-00-9 Gases (petroleum), C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-767-6 68477-85-0 ⊗ ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-069-00-4 Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] 270-768-1 68477-86-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-070-00-X Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-769-7 68477-87-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-071-00-5 Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.] 270-772-3 68477-90-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-072-00-0 Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-773-9 68477-91-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-073-00-6 Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] 270-777-0 68477-94-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-074-00-1 Gases (petroleum), Girbatol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-778-6 68477-95-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-075-00-7 Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas 270-782-8 68477-99-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-076-00-2 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-802-5 68478-21-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-077-00-8 Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-803-0 68478-22-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-078-00-3 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] 270-804-6 68478-24-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-079-00-9 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-806-7 68478-26-2 ⊗Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-080-00-4 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] 270-813-5 68478-32-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-081-00-X Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.] 270-814-0 68478-33-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-082-00-5 Tail gas (petroleum), vacuum residues thermal cracker;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-815-6 68478-34-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-083-00-0 Hydrocarbons, C3-4-rich, petroleum distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] 270-990-9 68512-91-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-084-00-6 Gases (petroleum), full-range straight-run naphtha dehexanizer off;
petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-000-8 68513-15-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-085-00-1 Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] 271-001-3 68513-16-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-086-00-7 Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-002-9 68513-17-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-087-00-2 Residues (petroleum), alkylation splitter, C4-rich;
Petroleum gas;
[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).] 271-010-2 68513-66-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-088-00-8 Hydrocarbons, C1-4;
Petroleum gas;
[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (-263 oF to 31 oF).] 271-032-2 68514-31-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-089-00-3 Hydrocarbons, C1-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).] 271-038-5 68514-36-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-090-00-9 Hydrocarbons, C1-3;
Petroleum gas;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (-263 oF to - 44 oF).] 271-259-7 68527-16-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-091-00-4 Hydrocarbons, C1-4, debutanizer fraction;
Petroleum gas 271-261-8 68527-19-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-092-00-X Gases (petroleum), C1-5, wet;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 271-624-0 68602-83-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-093-00-5 Hydrocarbons, C2-4;
Petroleum gas 271-734-9 68606-25-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-094-00-0 Hydrocarbons, C3;
Petroleum gas 271-735-4 68606-26-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-095-00-6 Gases (petroleum), alkylation feed;
Petroleum gas;
[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 271-737-5 68606-27-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-096-00-1 Gases (petroleum), depropanizer bottoms fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] 271-742-2 68606-34-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-097-00-7 Gases (petroleum), refinery blend;
Petroleum gas;
[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-183-7 68783-07-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-098-00-2 Gases (petroleum), catalytic cracking;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 272-203-4 68783-64-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-099-00-8 Gases (petroleum), C2-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).] 272-205-5 68783-65-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-100-00-1 Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-871-7 68918-99-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-101-00-7 Gases (petroleum), dehexanizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-872-2 68919-00-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-102-00-2 Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-878-5 68919-05-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-103-00-8 Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-879-0 68919-06-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-104-00-3 Gases (petroleum), straight-run naphtha catalytic reforming off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] 272-882-7 68919-09-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-105-00-9 Gases (petroleum), fluidized catalytic cracker splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.] 272-893-7 68919-20-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-106-00-4 Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-883-2 68919-10-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45
S: 53-45 H K
649-107-00-X Gases (petroleum), catalytic cracked naphtha debutanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-169-3 68952-76-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-108-00-5 Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-170-9 68952-77-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-110-00-6 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-176-1 68952-82-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-111-00-1 Gases (petroleum, light steam-cracked, butadiene conc.;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.] 273-265-5 68955-28-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-112-00-7 Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 273-270-2 68955-34-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-113-00-2 Hydrocarbons, C4;
Petroleum gas 289-339-5 87741-01-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-114-00-8 Alkanes, C1-4, C3-rich;
Petroleum gas 292-456-4 90622-55-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-115-00-3 Gases (petroleum), steam-cracker C3-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (-94 oF to 32 oF).] 295-404-9 92045-22-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-116-00-9 Hydrocarbons, C4, steam-cracker distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).] 295-405-4 92045-23-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-117-00-4 Petroleum gases, liquefied, sweetened, C4 fraction;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] 295-463-0 92045-80-2 F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46 F+; T
R: 12-45-46
S: 53-45 HKS
649-118-00-X Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;
Petroleum gas 306-004-1 95465-89-7 ⊗ Carc. Cat. 2; R45 T
R: 45
S: 53-45 H K
649-119-00-5 Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;
Petroleum gas 307-769-4 97722-19-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-120-00-0 Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] 270-746-1 68477-65-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-121-00-6 Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] 270-747-7 68477-66-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-122-00-1 Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.] 270-748-2 68477-67-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-123-00-7 Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-749-8 68477-68-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-124-00-2 Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-759-2 68477-77-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-125-00-8 Gases (petroleum), C6-8 catalytic reformer recycle;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-761-3 68477-80-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-126-00-3 Gases (petroleum), C6-8 catalytic reformer;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] 270-762-9 68477-81-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-127-00-9 Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;
Refinery gas 270-763-4 68477-82-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-128-00-4 Gases (petroleum), C2-return stream;
Refinery gas;
[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] 270-766-0 68477-84-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-129-00-X Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-774-4 68477-92-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-130-00-5 Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.] 270-776-5 68477-93-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-131-00-0 Gases (petroleum), hydrogen absorber off;
Refinery gas;
[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] 270-779-1 68477-96-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-132-00-6 Gases (petroleum), hydrogen-rich;
Refinery gas;
[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] 270-780-7 68477-97-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-133-00-1 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-781-2 68477-98-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-134-00-7 Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 270-783-3 68478-00-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-135-00-2 Gases (petroleum), reformer make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-784-9 68478-01-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-136-00-8 Gases (petroleum), reforming hydrotreater;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.] 270-785-4 68478-02-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-137-00-3 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] 270-787-5 68478-03-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-138-00-9 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-788-0 68478-04-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-139-00-4 Gases (petroleum), thermal cracking distn.;
Refinery gas;
[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-789-6 68478-05-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber;
Refinery gas;
[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-141-00-5 Tail gas (petroleum), catalytic reformed naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-807-2 68478-27-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-142-00-0 Tail gas (petroleum), catalytic reformed naphtha stabilizer;
Refinery gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-808-8 68478-28-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-143-00-6 Tail gas (petroleum), cracked distillate hydrotreater separator;
Refinery gas;
[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-809-3 68478-29-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-144-00-1 Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-810-9 68478-30-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-145-00-7 Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] 270-999-8 68513-14-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-146-00-2 Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-003-4 68513-18-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-147-00-8 Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-005-5 68513-19-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-148-00-3 Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] 271-258-1 68527-15-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-149-00-9 Gases (petroleum), benzene unit hydrotreater depentanizer overheads;
Refinery gas;
[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] 271-623-5 68602-82-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-150-00-4 Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;
Refinery gas;
[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 271-625-6 68602-84-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-151-00-X Petroleum products, refinery gases;
Refinery gas;
[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-750-6 68607-11-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-152-00-5 Gases (petroleum), hydrocracking low-pressure separator;
Refinery gas;
[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-182-1 68783-06-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-153-00-0 Gases (petroleum), refinery;
Refinery gas;
[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-338-9 68814-67-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-154-00-6 Gases (petroleum), platformer products separator off;
Refinery gas;
[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 272-343-6 68814-90-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-155-00-1 Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] 272-775-5 68911-58-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-156-00-7 Gases (petroleum), hydrotreated sour kerosine flash drum;
Refinery gas;
[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.] 272-776-0 68911-59-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-157-00-2 Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] 272-873-8 68919-01-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-158-00-8 Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-874-3 68919-02-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-159-00-3 Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] 272-875-9 68919-03-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-160-00-9 Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-876-4 68919-04-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-161-00-4 Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.] 272-880-6 68919-07-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-162-00-X Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-881-1 68919-08-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-163-00-5 Gases (petroleum), tar stripper off;
Refinery gas;
[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-884-8 68919-11-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-164-00-0 Gases (petroleum), unifiner stripper off;
Refinery gas;
[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] 272-885-3 68919-12-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-165-00-6 Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] 273-173-5 68952-79-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-166-00-1 Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;
Refinery gas;
[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 273-174-0 68952-80-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-167-00-7 Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-269-7 68955-33-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-169-00-8 Gases (petroleum), gas oil diethanolamine scrubber off;
Refinery gas;
[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 295-397-2 92045-15-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-170-00-3 Gases (petroleum), gas oil hydrodesulfurization effluent;
Refinery gas;
[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 295-398-8 92045-16-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-171-00-9 Gases (petroleum), gas oil hydrodesulfurization purge;
Refinery gas;
[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 295-399-3 92045-17-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-172-00-4 Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 295-400-7 92045-18-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-173-00-X Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] 295-401-2 92045-19-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-174-00-5 Gases (petroleum), residue visbaking off;
Refinery gas;
A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 295-402-8 92045-20-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-175-00-0 Foots oil (petroleum), acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-225-7 93924-31-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-176-00-6 Foots oil (petroleum), clay-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-226-2 93924-32-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-177-00-1 Gases (petroleum), C3-4;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60 oF to 30 oF.)] 268-629-5 68131-75-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-178-00-7 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;
Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-617-2 68307-98-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-179-00-2 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-618-8 68307-99-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-180-00-8 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-619-3 68308-00-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-181-00-3 Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-620-9 68308-01-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-182-00-9 Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-630-3 68308-10-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-183-00-4 Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-623-5 68308-03-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-184-00-X Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-624-0 68308-04-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-185-00-5 Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.] 269-625-6 68308-05-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-186-00-0 Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-626-1 68308-06-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-187-00-6 Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-627-7 68308-07-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-188-00-1 Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-629-8 68308-09-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-189-00-7 Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-631-9 68308-11-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-190-00-2 Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-632-4 68308-12-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-191-00-8 Gases (petroleum), catalytic cracked overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (-54 oF to 90 oF).] 270-071-2 68409-99-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-193-00-9 Alkanes, C1-2;
Petroleum gas 270-651-5 68475-57-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-194-00-4 Alkanes, C2-3;
Petroleum gas 270-652-0 68475-58-1 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-195-00-X Alkanes, C3-4;
Petroleum gas 270-653-6 68475-59-2 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-196-00-5 Alkanes, C4-5;
Petroleum gas 270-654-1 68475-60-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-197-00-0 Fuel gases;
Petroleum gas;
[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] 270-667-2 68476-26-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-198-00-6 Fuel gases, crude oil of distillates;
Petroleum gas;
[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).] 270-670-9 68476-29-9 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-199-00-1 Hydrocarbons, C3-4;
Petroleum gas 270-681-9 68476-40-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-200-00-5 Hydrocarbons, C4-5;
Petroleum gas 270-682-4 68476-42-6 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-201-00-0 Hydrocarbons, C2-4, C3-rich;
Petroleum gas 270-689-2 68476-49-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-202-00-6 Petroleum gases, liquefied;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-704-2 68476-85-7 F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46 F+; T
R: 12-45-46
S: 53-45 HKS
649-203-00-1 Petroleum gases, liquefied, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (-40 oF to 176 oF).] 270-705-8 68476-86-8 F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46 F+; T
R: 12-45-46
S: 45-53 HKS
649-204-00-7 Gases (petroleum), C3-4, isobutane-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] 270-724-1 68477-33-8 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-205-00-2 Distillates (petroleum), C3-6, piperylene-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] 270-726-2 68477-35-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-206-00-8 Gases (petroleum), butane splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-750-3 68477-69-0 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-207-00-3 Gases (petroleum), C2-;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] 270-751-9 68477-70-3 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-208-00-9 Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-752-4 68477-71-4 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-209-00-4 Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-754-5 68477-72-5 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-210-00-X Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-628-2 68308-08-7 ⊗ Carc. Cat. 1; R45
Muta. Cat. 2; R46 T
R: 45-46
S: 53-45 H K
649-211-00-5 Foots oil (petroleum), carbon-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-126-0 97862-76-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-212-00-0 Distillates (petroleum), sweetened middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-088-7 64741-86-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-213-00-6 Gas oils (petroleum), solvent-refined;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-092-9 64741-90-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-214-00-1 Distillates (petroleum), solvent-refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-093-4 64741-91-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-215-00-7 Gas oils (petroleum), acid-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-112-6 64742-12-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-216-00-2 Distillates (petroleum), acid-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-113-1 64742-13-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-217-00-8 Distillates (petroleum), acid-treated light;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-114-7 64742-14-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-218-00-3 Gas oils (petroleum), chemically neutralized;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-129-9 64742-29-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-219-00-9 Distillates (petroleum), chemically neutralized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-130-4 64742-30-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-220-00-4 Distillates (petroleum), clay-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-139-3 64742-38-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-221-00-X Distillates (petroleum), hydrotreated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-148-2 64742-46-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-222-00-5 Gas oils (petroleum), hydrodesulfurized;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-182-8 64742-79-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-223-00-0 Distillates (petroleum), hydrodesulfurized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-183-3 64742-80-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-224-00-6 Fuels, diesel;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).] 269-822-7 68334-30-5 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H N
649-225-00-1 Fuel oil, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).] 270-671-4 68476-30-2 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
649-226-00-7 Fuel oil, No 4;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] 270-673-5 68476-31-3 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
649-227-00-2 Fuels, diesel, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] 270-676-1 68476-34-6 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
649-228-00-8 Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).] 270-719-4 68477-29-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-229-00-3 Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).] 270-721-5 68477-30-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-230-00-9 Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil — unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).] 270-722-0 68477-31-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-231-00-4 Distillates (petroleum), highly refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] 292-615-8 90640-93-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-232-00-X Distillates (petroleum) catalytic reformer, heavy arom. conc.;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 295-294-2 91995-34-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-233-00-5 Gas oils, paraffinic;
Gasoil — unspecified;
[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).] 300-227-8 93924-33-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-234-00-0 Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil — unspecified 307-035-3 97488-96-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-235-00-6 Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-659-6 97675-85-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-236-00-1 Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-660-1 97675-86-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-237-00-7 Hydrocarbons, C11-17, solvent-extd. light naphthenic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 307-757-9 97722-08-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-238-00-2 Gas oils, hydrotreated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).] 308-128-1 97862-78-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-239-00-8 Distillates (petroleum), carbon-treated light paraffinic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] 309-667-5 100683-97-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-240-00-3 Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-668-0 100683-98-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-241-00-9 Distillates (petroleum), intermediate paraffinic, clay-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-669-6 100683-99-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-242-00-4 Alkanes, C12-26-branched and linear 292-454-3 90622-53-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-243-00-X Lubricating greases;
Grease;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] 278-011-7 74869-21-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-244-00-5 Slack wax (petroleum);
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 265-165-5 64742-61-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-245-00-0 Slack wax (petroleum), acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 292-659-8 90669-77-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-246-00-6 Slack wax (petroleum), clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] 292-660-3 90669-78-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-247-00-1 Slack wax (petroleum), hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 295-523-6 92062-09-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-248-00-7 Slack wax (petroleum), low-melting;
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-524-1 92062-10-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-249-00-2 Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-525-7 92062-11-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-250-00-8 Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-155-9 97863-04-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-251-00-3 Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-156-4 97863-05-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-252-00-9 Slack wax (petroleum), low-melting, silicic acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-158-5 97863-06-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-253-00-4 Slack wax (petroleum), carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] 309-723-9 100684-49-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-254-00-X Petrolatum;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 232-373-2 8009-03-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-255-00-5 Petrolatum (petroleum), oxidized;
Petrolatum;
[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] 265-206-7 64743-01-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-256-00-0 Petrolatum (petroleum), alumina-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 285-098-5 85029-74-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-257-00-6 Petrolatum (petroleum), hydrotreated;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] 295-459-9 92045-77-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-258-00-1 Petrolatum (petroleum), carbon-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-149-6 97862-97-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-259-00-7 Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-150-1 97862-98-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-260-00-2 Petrolatum (petroleum), clay-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] 309-706-6 100684-33-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H N
649-261-00-8 Gasoline, natural;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (-4 oF to 248 oF).] 232-349-1 8006-61-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-262-00-3 Naphtha;
Low boiling point naphtha;
[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 232-443-2 8030-30-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-263-00-9 Ligroine;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).] 232-453-7 8032-32-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-264-00-4 Naphtha (petroleum), heavy straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-041-0 64741-41-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-265-00-X Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (-4 oF to 428 oF).] 265-042-6 64741-42-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-266-00-5 Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (-4 oF to 356 oF).] 265-046-8 64741-46-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-267-00-0 Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).] 265-192-2 64742-89-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-268-00-6 Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (-127 oF to 210 oF).] 270-077-5 68410-05-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-269-00-1 Gasoline, vapor-recovery;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).] 271-025-4 68514-15-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-270-00-7 Gasoline, straight-run, topping-plant;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).] 271-727-0 68606-11-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-271-00-2 Naphtha (petroleum), unsweetened;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).] 272-186-3 68783-12-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-272-00-8 Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;
Low boiling point naphtha;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..] 272-931-2 68921-08-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-273-00-3 Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 309-945-6 101631-20-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-274-00-9 Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-066-7 64741-64-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-275-00-4 Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).] 265-067-2 64741-65-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-276-00-X Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).] 265-068-8 64741-66-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-277-00-5 Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] 265-073-5 64741-70-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-278-00-0 Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 265-086-6 64741-84-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-279-00-6 Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-095-5 64741-92-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-280-00-1 Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] 270-088-5 68410-71-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-281-00-7 Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] 270-349-3 68425-35-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-282-00-2 Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] 271-267-0 68527-27-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-283-00-8 Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] 295-315-5 91995-53-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-284-00-3 Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-430-0 92045-49-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-285-00-9 Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).] 295-436-3 92045-55-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-286-00-4 Naphtha (petroleum), isomerization, C6-fraction;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).] 295-440-5 92045-58-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-287-00-X Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).] 295-446-8 92045-64-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-288-00-5 Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).] 309-871-4 101316-67-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-289-00-0 Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-055-7 64741-54-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-290-00-6 Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (-4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-056-2 64741-55-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-291-00-1 Hydrocarbons, C3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).] 270-686-6 68476-46-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-292-00-7 Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-185-8 68783-09-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-293-00-2 Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;
Low boiling point cat-cracked naphtha.;
[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.] 295-311-3 91995-50-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-294-00-8 Naphtha (petroleum), heavy catalytic cracked, sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).] 295-431-6 92045-50-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-295-00-3 Naphtha (petroleum), light catalytic cracked sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approxim-ately 35 oC to 210 oC (95 oF to 410 oF).] 295-441-0 92045-59-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-296-00-9 Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 295-794-0 92128-94-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-297-00-4 Hydrocarbons, C8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).] 309-974-4 101794-97-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-298-00-X Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;
Low boiling point cat-cracked naphtha 309-987-5 101896-28-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-299-00-5 Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] 265-065-1 64741-63-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-300-00-9 Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-070-9 64741-68-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-301-00-4 Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).] 270-660-4 68475-79-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-302-00-X Hydrocarbons, C2-6, C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha 270-687-1 68476-47-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-303-00-5 Residues (petroleum), C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha;
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 270-794-3 68478-15-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-304-00-0 Naphtha (petroleum), light catalytic reformed, arom.-free;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] 270-993-5 68513-03-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-305-00-6 Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-008-1 68513-63-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-306-00-1 Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).] 271-058-4 68514-79-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-307-00-7 Naphtha (petroleum, full-range reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 272-895-8 68919-37-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-308-00-2 Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] 273-271-8 68955-35-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-309-00-8 Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).] 285-509-8 85116-58-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-310-00-3 Aromatic hydrocarbons, C8, catalytic reforming-derived;
Low boiling point cat-reformed naphtha 295-279-0 91995-18-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-311-00-9 Aromatic hydrocarbons, C7-12, C8-rich;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).] 297-401-8 93571-75-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-312-00-4 Gasoline, C5-11, high-octane stabilized reformed;
Low boiling point cat-reformed naphtha;
[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).] 297-458-9 93572-29-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-313-00-X Hydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.] 297-465-7 93572-35-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-314-00-5 Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.] 297-466-2 93572-36-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-315-00-0 Foots oil (petroleum), silicic acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-127-6 97862-77-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-316-00-6 Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).] 265-075-6 64741-74-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-317-00-1 Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).] 265-085-0 64741-83-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-318-00-7 Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] 267-563-4 67891-79-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-319-00-2 Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] 267-565-5 67891-80-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-320-00-8 Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).] 270-344-6 68425-29-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-321-00-3 Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;
Low boiling point thermally cracked naphtha;
A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] 270-658-3 68475-70-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-322-00-9 Distillates (petroleum), thermal cracked naphtha and gas oil;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).] 271-631-9 68603-00-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-323-00-4 Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).] 271-632-4 68603-01-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-324-00-X Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).] 271-634-5 68603-03-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-325-00-5 Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] 273-266-0 68955-29-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-326-00-0 Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).] 295-447-3 92045-65-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-327-00-6 Naphtha (petroleum), hydrotreated heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-150-3 64742-48-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-328-00-1 Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-151-9 64742-49-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-329-00-7 Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-178-6 64742-73-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-330-00-2 Naphtha (petroleum), hydrodesulfurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-185-4 64742-82-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-331-00-8 Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).] 270-092-7 68410-96-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-332-00-3 Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).] 270-093-2 68410-97-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-333-00-9 Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).] 270-094-8 68410-98-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-334-00-4 Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 270-988-8 68512-78-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-335-00-X Naphtha (petroleum), hydrodesulfurized thermal cracked light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).] 285-511-9 85116-60-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-336-00-5 Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 285-512-4 85116-61-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-337-00-0 Naphtha (petroleum), heavy steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha 295-432-1 92045-51-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-338-00-6 Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).] 295-433-7 92045-52-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-339-00-1 Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 295-438-4 92045-57-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-340-00-7 Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).] 295-443-1 92045-61-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-341-00-2 Solvent naphtha (petroleum), hydrotreated light naphthenic;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).] 295-529-9 92062-15-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-342-00-8 Naphtha (petroleum), light steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha;
[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.] 296-942-7 93165-55-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-343-00-3 Hydrocarbons, C6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-852-0 93763-33-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-344-00-9 Hydrocarbons, C9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-853-6 93763-34-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-345-00-4 Stoddard solvent;
Low boiling point naphtha — unspecified;
[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.] 232-489-3 8052-41-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-346-00-X Natural gas condensates (petroleum);
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] 265-047-3 64741-47-5 Carc. Cat. 2; R4
Xn; R65 T
R: 45-65
S: 53-45 H P
649-347-00-5 Natural gas (petroleum), raw liq. mix;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] 265-048-9 64741-48-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-348-00-0 Naphtha (petroleum), light hydrocracked;
Low boiling naphtha — unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-071-4 64741-69-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-349-00-6 Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).] 265-079-8 64741-78-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-350-00-1 Naphtha (petroleum), sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).] 265-089-2 64741-87-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-351-00-7 Naphtha (petroleum), acid-treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-115-2 64742-15-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-352-00-2 Naphtha (petroleum), chemically neutralized heavy;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-122-0 64742-22-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-353-00-8 Naphtha (petroleum), chemically neutralized light;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-123-6 64742-23-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-354-00-3 Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 265-170-2 64742-66-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-355-00-9 Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.] 265-187-5 64742-83-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-356-00-4 Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 265-199-0 64742-95-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-357-00-X Aromatic hydrocarbons, C6-10, acid-treated, neutralized;
Low boiling point naphtha — unspecified 268-618-5 68131-49-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-358-00-5 Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] 270-725-7 68477-34-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-359-00-0 Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-735-1 68477-50-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-360-00-6 Distillates (petroleum), steam-cracked, C5-12 fraction;
Low boiling point naphtha — unspecified;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-736-7 68477-53-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-361-00-1 Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;
Low boiling point naphtha — unspecified 270-738-8 68477-55-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-362-00-7 Extracts (petroleum), cold-acid, C4-6;
Low boiling point naphtha — unspecified;
[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 270-741-4 68477-61-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-363-00-2 Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-771-8 68477-89-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-364-00-8 Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha — unspecified;
[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4through C6.] 270-791-7 68478-12-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-365-00-3 Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha — unspecified;
[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-795-9 68478-16-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-366-00-9 Naphtha (petroleum), full-range coker;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).] 270-991-4 68513-02-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-367-00-4 Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).] 271-138-9 68516-20-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-368-00-X Naphtha (petroleum), clay-treated full-range straight-run;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).] 271-262-3 68527-21-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-369-00-5 Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.] 271-263-9 68527-22-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-370-00-0 Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).] 271-264-4 68527-23-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-371-00-6 Naphtha (petroleum), light steam-cracked, debenzenized;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).] 271-266-5 68527-26-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-372-00-1 Naphtha (petroleum), arom.-contg.;
Low boiling point naphtha — unspecified 271-635-0 68603-08-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-373-00-7 Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] 271-726-5 68606-10-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-374-00-2 Naphtha (petroleum), light, sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).] 272-206-0 68783-66-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-375-00-8 Natural gas condensates;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] 272-896-3 68919-39-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H J
649-376-00-3 Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 272-932-8 68921-09-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-377-00-9 Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).] 285-510-3 85116-59-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-378-00-4 Gasoline;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).] 289-220-8 86290-81-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-379-00-X Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;
Low boiling point naphtha — unspecified 292-698-0 90989-42-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-380-00-5 Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).] 295-298-4 91995-38-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-381-00-0 Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 295-302-4 91995-41-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-382-00-6 Extracts (petroleum), catalytic reformed light naphtha solvent;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 295-331-2 91995-68-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-383-00-1 Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).] 295-434-2 92045-53-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-384-00-7 Naphtha (petroleum), light, C5-rich, sweetened;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).] 295-442-6 92045-60-8 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-385-00-2 Hydrocarbons, C8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).] 295-444-7 92045-62-0 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-386-00-8 Hydrocarbons, C4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).] 295-445-2 92045-63-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-387-00-3 Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.] 296-028-8 92201-97-3 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-388-00-9 Distillates (petroleum), C6-rich;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).] 296-903-4 93165-19-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-389-00-4 Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha-unspecified;
[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).] 302-639-3 94114-03-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-390-00-X Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 305-750-5 95009-23-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-391-00-5 Extracts (petroleum) heavy naphtha solvent, clay-treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).] 308-261-5 97926-43-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-392-00-0 Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).] 308-713-1 98219-46-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-393-00-6 Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).] 308-714-7 98219-47-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-394-00-1 Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).] 309-862-5 101316-56-7 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-395-00-7 Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).] 309-870-9 101316-66-9 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-396-00-2 Naphtha (petroleum), hydrodesulfurized full-range coker;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).] 309-879-8 101316-76-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-397-00-8 Naphtha (petroleum), sweetened light;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).] 309-976-5 101795-01-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-398-00-3 Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] 310-012-0 102110-14-5 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-399-00-9 Hydrocarbons, C5-rich, dicyclopentadiene-contg.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).] 310-013-6 102110-15-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-400-00-2 Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha — unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).] 310-057-6 102110-55-4 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-401-00-8 Hydrocarbons, C ≥ 5, C5-6-rich;
Low boiling point naphtha — unspecified 270-690-8 68476-50-6 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-402-00-3 Hydrocarbons, C5-rich;
Low boiling point naphtha — unspecified 270-695-5 68476-55-1 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-403-00-9 Aromatic hydrocarbons, C8-10;
Low boiling point naphtha — unspecified 292-695-4 90989-39-2 Carc. Cat. 2; R45
Xn; R65 T
R: 45-65
S: 53-45 H P
649-404-00-4 Kerosine (petroleum);
Straight run kerosine;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).] 232-366-4 8008-20-6 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-405-00-X Solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).] 265-191-7 64742-88-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-406-00-5 Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] 265-200-4 64742-96-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-407-00-0 Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] 295-418-5 92045-37-9 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-408-00-6 Distillates (petroleum), steam-cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] 265-194-3 64742-91-2 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-409-00-1 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).] 270-728-3 68477-39-4 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-410-00-7 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] 270-729-9 68477-40-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-411-00-2 Distillates (petroleum), steam-cracked, C8-12 fraction;
Cracked kerosine;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 270-737-2 68477-54-3 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-412-00-8 Kerosine (petroleum), hydrodesulfurized thermal cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).] 285-507-7 85116-55-8 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-413-00-3 Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] 292-621-0 90640-98-5 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-414-00-9 Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).] 292-637-8 90641-13-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-415-00-4 Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.] 309-866-7 101316-61-4 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-416-00-X Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-938-8 101631-13-4 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-417-00-5 Solvent naphtha (petroleum), hydrocracked heavy arom.;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] 309-881-9 101316-80-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-418-00-0 Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-940-9 101631-15-6 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-419-00-6 Distillates (petroleum), alkylate;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).] 265-074-0 64741-73-7 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-420-00-1 Extracts (petroleum), heavy naphtha solvent;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-099-7 64741-98-6 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-421-00-7 Distillates (petroleum), chemically neutralized light;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-132-5 64742-31-0 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-422-00-2 Distillates (petroleum), hydrotreated light;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-149-8 64742-47-8 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-423-00-8 Kerosine (petroleum), hydrodesulfurized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-184-9 64742-81-0 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-424-00-3 Solvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] 265-198-5 64742-94-5 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-425-00-9 Naphtha (petroleum), heavy coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] 269-778-9 68333-23-3 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-426-00-4 Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).] 285-508-2 85116-57-0 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-427-00-X Kerosine (petroleum), sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] 294-799-5 91770-15-9 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-428-00-5 Kerosine (petroleum), solvent-refined sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] 295-416-4 92045-36-8 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-429-00-0 Hydrocarbons, C9-16, hydrotreated, dearomatized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-854-1 93763-35-0 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-430-00-6 Kerosine (petroleum), solvent-refined hydrodesulfurized;
Kerosine — unspecified 307-033-2 97488-94-3 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-431-00-1 Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] 309-864-6 101316-58-9 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-432-00-7 Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] 309-882-4 101316-81-8 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-433-00-2 Solvent naphtha (petroleum), hydrodesulfurized medium;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] 309-884-5 101316-82-9 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-434-00-8 Kerosine (petroleum), hydrotreated;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] 309-944-0 101631-19-0 Xn; R65 Xn
R: 65
S: (2-)23-24-62 H
649-435-00-3 Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 265-060-4 64741-59-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-436-00-9 Distillates (petroleum), intermediate catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 265-062-5 64741-60-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-437-00-4 Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).] 265-078-2 64741-77-1 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
649-438-00-X Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).] 265-084-5 64741-82-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-439-00-5 Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 269-781-5 68333-25-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-440-00-0 Distillates (petroleum), light steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] 270-662-5 68475-80-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-441-00-6 Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] 270-727-8 68477-38-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-442-00-1 Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] 271-260-2 68527-18-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-443-00-7 Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 285-505-6 85116-53-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-444-00-2 Gas oils (petroleum), thermal-cracked, hydrodesulfurized;
Cracked gasoil 295-411-7 92045-29-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-445-00-8 Residues (petroleum), hydrogenated steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).] 295-514-7 92062-00-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-446-00-3 Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] 295-517-3 92062-04-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-447-00-9 Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.] 295-991-1 92201-60-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-448-00-4 Residues (petroleum), steam-cracked heat-soaked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] 297-905-8 93763-85-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-449-00-X Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] 307-662-2 97675-88-2 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 H
649-450-00-5 Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] 308-278-8 97926-59-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-451-00-0 Distillates (petroleum), hydrodesulfurized middle coker;
Cracked gasoil;
[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] 309-865-1 101316-59-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-452-00-6 Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] 309-939-3 101631-14-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H
649-453-00-1 Distillates (petroleum), heavy hydrocracked;
Baseoil — unspecified;
[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] 265-077-7 64741-76-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-454-00-7 Distillates (petroleum), solvent-refined heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-090-8 64741-88-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-455-00-2 Distillates (petroleum), solvent-refined light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-091-3 64741-89-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-456-00-8 Residual oils (petroleum), solvent deasphalted;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-096-0 64741-95-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-457-00-3 Distillates (petroleum), solvent-refined heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] 265-097-6 64741-96-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-458-00-9 Distillates (petroleum), solvent-refined light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-098-1 64741-97-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-459-00-4 Residual oils (petroleum,) solvent-refined;
Baseoil — unspecified;
[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-101-6 64742-01-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-460-00-X Distillates (petroleum), clay-treated paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-137-2 64742-36-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-461-00-5 Distillates (petroleum), clay-treated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-138-8 64742-37-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-462-00-0 Residual oils (petroleum), clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-143-5 64742-41-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-463-00-6 Distillates (petroleum), clay-treated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-146-1 64742-44-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-464-00-1 Distillates (petroleum), clay-treated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-147-7 64742-45-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-465-00-7 Distillates (petroleum), hydrotreated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-155-0 64742-52-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-466-00-2 Distillates (petroleum), hydrotreated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-156-6 64742-53-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-467-00-8 Distillates (petroleum), hydrotreated heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-157-1 64742-54-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-468-00-3 Distillates (petroleum), hydrotreated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-158-7 64742-55-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-469-00-9 Distillates (petroleum), solvent-dewaxed light paraffinic;
Baseoil — unspecified;
[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-159-2 64742-56-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-470-00-4 Residual oils (petroleum), hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-160-8 64742-57-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-471-00-X Residual oils (petroleum), solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-166-0 64742-62-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-472-00-5 Distillates (petroleum), solvent-dewaxed heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-167-6 64742-63-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-473-00-0 Distillates (petroleum), solvent-dewaxed light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-168-1 64742-64-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-474-00-6 Distillates (petroleum), solvent-dewaxed heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-169-7 64742-65-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-475-00-1 Naphthenic oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-172-3 64742-68-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-476-00-7 Naphthenic oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-173-9 64742-69-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-477-00-2 Paraffin oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-174-4 64742-70-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-478-00-8 Paraffin oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-176-5 64742-71-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-479-00-3 Naphthenic oils (petroleum), complex dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-179-1 64742-75-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-480-00-9 Naphthenic oils (petroleum), complex dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-180-7 64742-76-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-481-00-4 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-736-3 72623-85-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-482-00-X Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] 276-737-9 72623-86-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-483-00-5 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-738-4 72623-87-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-484-00-0 Lubricating oils;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] 278-012-2 74869-22-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-485-00-6 Distillates (petroleum), complex dewaxed heavy paraffinci;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-613-7 90640-91-8 Carc. Cat. 2; R45 T
R: 4
S: 53-45 H L
649-486-00-1 Distillates (petroleum), complex dewaxed light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-614-2 90640-92-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-487-00-7 Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-616-3 90640-94-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-488-00-2 Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-617-9 90640-95-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-489-00-8 Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-618-4 90640-96-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-490-00-3 Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-620-5 90640-97-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-491-00-9 Residual oils (petroleum), hydrotreated solvent dewaxed;
Baseoil — unspecified 292-656-1 90669-74-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-492-00-4 Residual oils (petroleum), catalytic dewaxed;
Baseoil — unspecified 294-843-3 91770-57-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-493-00-X Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] 295-300-3 91995-39-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-494-00-5 Distillates (petroleum), dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] 295-301-9 91995-40-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-495-00-0 Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
Baseoil — unspecified;
[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] 295-306-6 91995-45-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-496-00-6 Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] 295-316-0 91995-54-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-497-00-1 Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;
Baseoil — unspecified 295-423-2 92045-42-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-498-00-7 Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
Baseoil — unspecified 295-424-8 92045-43-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-499-00-2 Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] 295-499-7 92061-86-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-500-00-6 Paraffin oils (petroleum), solvent-refined dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] 295-810-6 92129-09-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-501-00-1 Lubricating oils (petroleum), base oils, paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] 297-474-6 93572-43-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-502-00-7 Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
Baseoil — unspecified 297-857-8 93763-38-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-503-00-2 Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;
Baseoil — unspecified 300-257-1 93924-61-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-504-00-8 Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;
Baseoil — unspecified 305-588-5 94733-08-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-505-00-3 Distillates (petroleum), solvent-refined hydrocracked light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).] 305-589-0 94733-09-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-506-00-9 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-594-8 94733-15-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-507-00-4 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-595-3 94733-16-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-508-00-X Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified 305-971-7 95371-04-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-509-00-5 Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified 305-972-2 95371-05-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-510-00-0 Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
Baseoil — unspecified 305-974-3 95371-07-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-511-00-6 Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;
Baseoil — unspecified 305-975-9 95371-08-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-512-00-1 Distillates (petroleum), hydrocracked solvent-refined light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.] 307-010-7 97488-73-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-513-00-7 Distillates (petroleum), solvent-refined hydrogenated heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).] 307-011-2 97488-74-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-514-00-2 Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;
Baseoil — unspecified 307-034-8 97488-95-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-515-00-8 Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).] 307-661-7 97675-87-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-516-00-3 Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] 307-755-8 97722-06-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-517-00-9 Hydrocarbons, C13-27, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.] 307-758-4 97722-09-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-518-00-4 Hydrocarbons, C14-29, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] 307-760-5 97722-10-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-519-00-X Hydrocarbons, C27-42, dearomatized;
Baseoil — unspecified 308-131-8 97862-81-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-520-00-5 Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;
Baseoil — unspecified 308-132-3 97862-82-3 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-521-00-0 Hydrocarbons, C27-45, naphthenic vacuum distn.;
Baseoil — unspecified 308-133-9 97862-83-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-522-00-6 Hydrocarbons, C27-45, dearomatized;
Baseoil — unspecified 308-287-7 97926-68-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-523-00-1 Hydrocarbons, C20-58, hydrotreated;
Baseoil — unspecified 308-289-8 97926-70-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-524-00-7 Hydrocarbons, C27-42, naphthenic;
Baseoil — unspecified 308-290-3 97926-71-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-525-00-2 Residual oils (petroleum), carbon-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] 309-710-8 100684-37-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-526-00-8 Residual oils (petroleum), clay-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] 309-711-3 100684-38-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-527-00-3 Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] 309-874-0 101316-69-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-528-00-9 Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] 309-875-6 101316-70-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-529-00-4 Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] 309-876-1 101316-71-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-530-00-X Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] 309-877-7 101316-72-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-531-00-5 Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] 272-175-3 68783-00-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-532-00-0 Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 272-180-0 68783-04-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-533-00-6 Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] 272-342-0 68814-89-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-534-00-1 Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] 292-631-5 90641-07-9 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-535-00-7 Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF). 292-632-0 90641-08-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-536-00-2 Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).] 292-633-6 90641-09-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-537-00-8 Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 295-335-4 91995-73-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-538-00-3 Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 295-338-0 91995-75-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-539-00-9 Extracts (petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 295-339-6 91995-76-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-540-00-4 Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] 295-340-1 91995-77-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-541-00-X Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 295-342-2 91995-79-8 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-542-00-5 Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] 296-437-1 92704-08-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-543-00-0 Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-827-4 93763-10-1 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-544-00-6 Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-829-5 93763-11-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-545-00-1 Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-672-2 100684-02-4 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-546-00-7 Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-673-8 100684-03-5 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-547-00-2 Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-674-3 100684-04-6 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-548-00-8 Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-675-9 100684-05-7 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-549-00-3 Foots oil (petroleum);
Foots oil;
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 265-171-8 64742-67-2 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
649-550-00-9 Foots oil (petroleum), hydrotreated;
Foots oil 295-394-6 92045-12-0 Carc. Cat. 2; R45 T
R: 45
S: 53-45 H L
650-002-00-6 turpentine, oil 232-350-7 8006-64-2 R10
Xn; R20/21/22-65
Xi; R36/38
R43
N; R51-53 Xn; N
R: 10-20/21/22-36/38-43-51/53-65
S: (2-)36/37-46-61-62 650-003-00-1 fenson (ISO);
4-chlorophenyl benzenesulphonate; 201-274-6 80-38-6 Xn; R22
Xi; R36
N; R51-53 Xn; N
R: 22-36-51/53
S: (2-)24-26-61 650-004-00-7 norbormide (ISO);
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide 213-589-6 991-42-4 Xn; R22 Xn
R: 22
S: (2-) 650-005-00-2 (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone 201-501-9 83-79-4 T; R25
Xi; R36/37/38
N; R50-53 T; N
R: 25-36/37/38-50/53
S: (1/2-)22-24/25-36-45-60-61 650-006-00-8 benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime 207-807-9 495-73-8 T; R25
Xn; R21 T
R: 21-25
S: (1/2-)36/37-45 650-007-00-3 chlordimeform (ISO);
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine 228-200-5 6164-98-3 Carc. Cat. 3; R40
Xn; R21/22
N; R50-53 Xn; N
R: 21/22-40-50/53
S: (2-)22-36/37-60-61 650-008-00-9 drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone 227-197-8 5707-69-7 T; R25
N; R50-53 T; N
R: 25-50/53
S: (1/2-)22-24-36/37-45-60-61 650-009-00-4 chlordimeform hydrochloride;
N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride 243-269-1 19750-95-9 Carc. Cat. 3; R40
Xn; R22
N; R50-53 Xn; N
R: 22-40-50/53
S: (2-)22-36/37-60-61 650-010-00-X benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate 216-901-9 1694-09-3 Carc. Cat. 3; R40 Xn
R: 40
S: (2-)36/37 650-012-00-0 erionite — 12510-42-8 Carc. Cat. 1; R45 T
R: 45
S: 53-45 650-013-00-6 asbestos —
—
—
—
—
—
— 12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5 Carc. Cat. 1; R45
T; R48/23 T
R: 45-48/23 S: 53-45 E
650-014-00-1 diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate 401-770-4 — C; R34
Xn; R22 C
R: 22-34
S: (1/2-)26-36/37/39-45 650-015-00-7 rosin; colophony 232-475-7
232-484-6
277-299-1 8050-09-7
8052-10-6
73138-82-6 R43 Xi
R: 43
S: (2-)24-37 650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] — — Carc. Cat. 3; R40
Xi; R38 Xn
R: 38-40
S: (2-)36/37 AQR
650-017-00-8 Refractory Ceramic Fibres;
Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] — — Carc. Cat. 2; R49
Xi; R38 T
R: 49-38
S: 53-45 A R
650-018-00-3 reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid 406-230-1 — R10
Carc. Cat. 3; R40
C; R34
Xn; R20
R43
N; R50-53 C; N
R: 10-20-34-40-43-50/53
S: (1/2-)26-36/37/39-45-60-61 650-031-00-4 bis(4-hydroxy-N-methylanilinium) sulphate 200-237-1 55-55-0 Xn; R22-48/22
R43
N; R50-53 Xn; N
R: 22-43-48/22-50/53
S: (2-)36/37-46-60-61 650-032-00-X cyproconazole (ISO);
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol — 94361-06-5 Repr. Cat. 3; R63
Xn; R22
N; R50-53 Xn; N
R: 22-50/53-63
S: (2-)36/37-60-61 650-033-00-5 (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate — 66230-04-4 T; R23/25
R43
N; R50-53 T; N
R: 23/25-43-50/53
S: (1/2-)24-36/37/39-45-60-61 650-041-00-9 triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea — 82097-50-5 N; R50-53 N
R: 50/53
S: 60-61 650-042-00-4 reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates 417-450-2 — Xi; R36/38
R43
R52-53 Xi
R: 36/38-43-52/53
S: (2-)24-26-37-61 650-043-00-X reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate 420-310-3 — Xn; R22
N; R50-53 Xn; N
R: 22-50/53
S: (2-)22-56-60-61 650-044-00-5 mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin 420-480-9 158570-99-1 Xi; R38
R43
N; R50-53 Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61 650-045-00-0 reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate 417-110-3 — F; R11
Xi; R38-41
N; R51-53 F; Xi; N
R: 11-38-41-51/53
S: (2-)9-16-26-37/39-61 650-046-00-6 di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates 416-180-2 12222-04-7 Xn; R22-48/22
N; R51-53 Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61 650-047-00-1 dibenzylphenylsulfonium hexafluoroantimonate 417-760-8 134164-24-2 T; R48/25
Xn; R22
Xi; R41
R43
N; R51-53 T; N
R: 22-41-43-48/25-51/53
S: (1/2-)22-26-36/37/39-45-61 650-048-00-7 reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid 420-070-1 — O; R7
Xn; R20/21/22
C; R35
N; R50 O; C; N
R: 7-20/21/22-35-50
S: (1/2-)3/7-14-26-36/37/39-45-61 650-049-00-2 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl 417-960-5 — Xi; R38-41
R43
N; R50-53 Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61 650-050-00-8 reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8 — N; R51-53 N
R: 51/53
S: 61 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 N; R50-53 N
R: 50/53
S: 60-61 

after (02008R1272-20101201)

ANNEX VI
Harmonised classification and labelling for certain hazardous substances
Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.
Part 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.
Part 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.


1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED CLASSIFICATIONS AND LABELLING


1.1. Information listed for each entry


1.1.1. Numbering of entries and identification of a substance


1.1.1.1. Index numbers
Entries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled Index No.


1.1.1.2. EC numbers
The EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS)OJ C 146A, 15.6.1990.. The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of No-longer-polymers (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled EC No.


1.1.1.3. CAS number
The Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled CAS No.



1.1.1.4. International Chemical Identification
Wherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of No-longer-polymers are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.
Impurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.
Some substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.
Where specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.
Without prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.
Certain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: (containing ≥ xx % impurity). The reference in brackets is then to be considered as a part of the name, and must be included on the label.


1.1.1.5. Entries for groups of substances
A number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.
In some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase except those specified elsewhere in this Annex.
In some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.
Entries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.
EC or CAS numbers are not usually included for entries which comprise more than four individual substances.



1.1.2. Information related to the classification and labelling of each entry in Table 3.1


1.1.2.1. Classification codes


1.1.2.1.1. Hazard class and category codes
The classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.
The Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.

Table 1.1

see Note U in 1.1.3.

Hazard Class
Hazard Class and Category Code
Explosive
Unst. Expl.
Expl. 1.1
Expl. 1.2
Expl. 1.3
Expl. 1.4
Expl. 1.5
Expl. 1.6
Flammable gas
Flam. Gas 1
Flam. Gas 2
Flammable aerosol
Flam. Aerosol 1
Flam. Aerosol 2
Oxidising gas
Ox. Gas 1
Gases under pressure
Press. Gas
Flammable liquid
Flam. Liq. 1
Flam. Liq. 2
Flam. Liq. 3
Flammable solid
Flam. Sol. 1
Flam. Sol. 2
Self-reactive substance or mixture
Self-react. A
Self-react. B
Self-react. CD
Self-react. EF
Self-react. G
Pyrophoric liquid
Pyr. Liq. 1
Pyrophoric solid
Pyr. Sol. 1
Self-heating substance or mixture
Self-heat. 1
Self-heat. 2
Substance or mixture which in contact with water emits flammable gas
Water-react. 1
Water-react. 2
Water-react. 3
Oxidising liquid
Ox. Liq. 1
Ox. Liq. 2
Ox. Liq. 3
Oxidising solid
Ox. Sol. 1
Ox. Sol. 2
Ox. Sol. 3
Organic peroxide
Org. Perox. A
Org. Perox. B
Org. Perox. CD
Org. Perox. EF
Org. Perox. G
Substance or mixture corrosive to metals
Met. Corr. 1
Acute toxicity
Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 4
Skin corrosion/irritation
Skin Corr. 1A
Skin Corr. 1B
Skin Corr. 1C
Skin Irrit. 2
Serious eye damage/eye irritation
Eye Dam. 1
Eye Irrit. 2
Respiratory/skin sensitization
Resp. Sens. 1
Skin Sens. 1
Germ cell mutagenicity
Muta. 1A
Muta. 1B
Muta. 2
Carcinogenicity
Carc. 1A
Carc. 1B
Carc. 2
Reproductive toxicity
Repr. 1A
Repr. 1B
Repr. 2
Lact.
Specific target organ toxicity — single exposure
STOT SE 1
STOT SE 2
STOT SE 3
Specific target organ toxicity — repeated exposure
STOT RE 1
STOT RE 2
Aspiration hazard
Asp. Tox. 1
Hazardous to the aquatic environment
Aquatic Acute 1
Aquatic Chronic 1
Aquatic Chronic 2
Aquatic Chronic 3
Aquatic Chronic 4
Hazardous for the ozone layer
Ozone


1.1.2.1.2. Hazard statement codes
The hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:

H350i
May cause cancer by inhalation.
H360F
May damage fertility.
H360D
May damage the unborn child.
H361f
Suspected of damaging fertility.
H361d
Suspected of damaging the unborn child.
H360FD
May damage fertility. May damage the unborn child.
H361fd
Suspected of damaging fertility. Suspected of damaging the unborn child.
H360Fd
May damage fertility. Suspected of damaging the unborn child.
H360Df
May damage the unborn child. Suspected of damaging fertility.


1.1.2.2. Labelling codes
In the labelling column, the following elements are listed:

(i) the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;

(ii) the signal word code Dgr for Dangeror Wng for Warning, in accordance with the precedence rule in Article 20(3);

(iii) the hazard statement codes as specified in Annex III, in accordance with the classification;

(iv) the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.


1.1.2.3. Specific concentration limits and M-factors
Specific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.
Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.
In case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in the same column as the specific concentration limits. Where an M-factor is not given in Table 3.1, an M-factor based on available data for the substance shall be set by the manufacturer, importer or downstream user. When a mixture including the substance is classified by the manufacturer, importer or downstream user using the summation method, this M-factor shall be used. For the setting of M-factors, see paragraph 4.1.3.5.5.5 of Annex I.



1.1.3. Notes assigned to an entry
The note(s) assigned to an entry are listed in the column entitled Notes. The meaning of the notes is as follows:


1.1.3.1. Notes relating to the identification, classification and labelling of substances

Note A:
Without prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.
In Part 3, use is sometimes made of a general description such as ... compounds or ... salts. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.

Note B:
Some substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.
In Part 3 entries with Note B have a general designation of the following type: nitric acid … %.
In this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.

Note C:
Some organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.
In this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.

Note D:
Certain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.
However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words non-stabilised.

Note E (Table 3.2):
Substances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word Also.

Note F:
This substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.


Note G:
This substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.

Note H (Table 3.1):
The classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.
The final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.

Note H (Table 3.2):
The classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.

Note J:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.

Note K:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.

Note L:
The classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.

Note M:
The classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.


Note N:
The classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.

Note P:
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).
When the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.
This note applies only to certain complex oil-derived substances in Part 3.

Note Q:
The classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:

a short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or
a short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or
an appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or
absence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.

Note R:
The classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.

Note S:
This substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).
This substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).

Note T:
This substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.

Note U (Table 3.1):
When put on the market gases have to be classified as Gases under pressure, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.



1.1.3.2. Notes relating to the classification and labelling of mixtures

Note 1:
The concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.

Note 2:
The concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.

Note 3:
The concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.

Note 5:
The concentration limits for gaseous mixtures are expressed as volume per volume percentage.

Note 7:
Alloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.


1.1.4. Information related to the classification and labelling of each entry in Table 3.2


1.1.4.1. Classification codes
The classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;
The abbreviation for each of the categories of danger is shown below:

explosive: E
oxidising: O
extremely flammable: F+
highly flammable: F
flammable: R10
very toxic: T+
Toxic: T
harmful: Xn
corrosive: C
irritant: Xi
sensitising: R42 and/or R43
carcinogenic: Carc. Cat. (1, 2 or 3)
mutagenic: Muta. Cat. (1, 2 or 3)
toxic for reproduction: Repr. Cat. (1, 2 or 3)
dangerous for the environment: N or R52 and/or R53;



1.1.4.2. Labelling codes

(i) the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);

(ii) the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;

(iii) the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.
Note that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.
S1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.
S2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.
Safety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.


1.1.4.3. Specific Concentration Limits
The concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.
Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.
Where no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.


1.1.4.4. Non-conformity with Table 3.1 for physical hazards
It is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.
Until these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference  in Table 3.2.



1.2. Classifications and hazard statements in table 3.1 arising from translation of classifications listed in Annex i to directive 67/548/EEC


1.2.1. Minimum classification
For certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:

the manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;
the minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.
Minimum classification for a category is indicated by the reference * in the column Classification in Table 3.1.
The reference * can also be found in the column Specific concentration Limits and M-factors where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be translated into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.


1.2.2. Route of exposure cannot be excluded
For certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.
These hazard statements are indicated by the reference ** in Table 3.1.


1.2.3. Hazard statements for reproductive toxicity
Hazard statements H360 and H361 indicate a general concern for effects on both fertility and development: May damage/Suspected of damaging fertility or the unborn child. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.

In order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.
These hazard statements are indicated by the reference *** in Table 3.1.


1.2.4. Correct classification for physical hazards could not be established
For some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.
The entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.


2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION AND LABELLING
This Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.
The relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.
For all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.
A dossier for harmonised classification and labelling shall contain the following:

Proposal
The proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.
Justification for the proposed harmonised classification and labelling
A comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.
Justification for other effects at Community level
For other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.


3. PART 3: HARMONISED CLASSIFICATION AND LABELLING TABLES
Table 3.1: List of harmonised classification and labelling of hazardous substances is listed in the separate Volume IIIa.
Table 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC is listed in the separate Volume IIIb.


Table 3.1
List of harmonised classification and labelling of hazardous substances

Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Specific Conc. Limits, M-factors
Notes
Hazard Class and Category Code(s)
Hazard statement Code(s)
Pictogram, Signal Word Code(s)
Hazard statement Code(s)
Suppl. Hazard statement Code(s)


001-001-00-9
hydrogen
215-605-7
1333-74-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U


001-002-00-4
aluminium lithium hydride
240-877-9
16853-85-3
Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314




001-003-00-X
sodium hydride
231-587-3
7646-69-7
Water-react. 1
H260
GHS02
Dgr
H260



001-004-00-5
calcium hydride
232-189-2
7789-78-8
Water-react. 1
H260
GHS02
Dgr
H260



003-001-00-4
lithium
231-102-5
7439-93-2
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014


003-002-00-X
n-hexyllithium
404-950-0
21369-64-2
Water-react. 1
Pyr. Sol. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Dgr
H260
H250
H314
EUH014




003-003-00-5
(2-methylpropyl)lithium;
isobutyllithium
440-620-2
920-36-5
Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H314
H336
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H260
H250
H314
H336
H410
EUH014




004-001-00-7
beryllium
231-150-7
7440-41-7
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317



004-002-00-2
beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex
—
—
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411
GHS06
GHS08
GHS09
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317
H411


A
004-003-00-8
beryllium oxide
215-133-1
1304-56-9
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H350i
H330
H301
H372 **
H319
H335
H315
H317
GHS06
GHS08
Dgr
H350i
H330
H301
H372 **
H319
H335
H315
H317




005-001-00-X
boron trifluoride
231-569-5
7637-07-2
Press. Gas
Acute Tox. 2 *
Skin Corr. 1A
H330
H314
GHS04
GHS06
GHS05
Dgr
H330
H314
EUH014

U
005-002-00-5
boron trichloride
233-658-4
10294-34-5
Press. Gas
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1B
H330
H300
H314
GHS04
GHS06
GHS05
Dgr
H330
H300
H314
EUH014

U
005-003-00-0
boron tribromide
233-657-9
10294-33-4
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
H330
H300
H314
GHS06
GHS05
Dgr
H330
H300
H314
EUH014


005-004-00-6
trialkylboranes, solid
—
—
Pyr. Sol. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Dgr
H250
H314


A
005-004-01-3
trialkylboranes, liquid
—
—
Pyr. Liq. 1
Skin Corr. 1B
H250
H314
GHS02
GHS05
Dgr
H250
H314


A
005-005-00-1
trimethyl borate
204-468-9
121-43-7
Flam. Liq. 3
Acute Tox. 4 *
H226
H312
GHS02
GHS07
Wng
H226
H312





005-006-00-7
dibutyltin hydrogen borate
401-040-5
75113-37-0
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H341
H372**
H312
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H360FD
H341
H372
H312
H302
H318
H317
H410







005-007-00-2
boric acid; [1]
boric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. 1B
H360FD
GHS08
Dgr
H360FD

Repr. 1B; H360FD: C ≥ 5,5 %


005-008-00-8
diboron trioxide;
boric oxide
215-125-8
1303-86-2
Repr. 1B
H360FD
GHS08
Dgr
H360FD

Repr. 1B; H360FD: C ≥ 3,1 %


005-009-00-3
tetrabutylammonium butyltriphenylborate
418-080-4
120307-06-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



005-010-00-9
N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate
422-050-6
118612-00-3
Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H351
H302
H315
H318
GHS08
GHS05
GHS07
Dgr
H351
H302
H315
H318





005-011-00-4
disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]
215-540-4 [1]
235-541-3 [2]
237-560-2 [3]
1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]
Repr. 1B
H360FD
GHS08
Dgr
H360FD

Repr. 1B; H360FD: C ≥ 4,5 %


005-011-01-1
disodium tetraborate decahydrate;
borax decahydrate
215-540-4
1303-96-4
Repr. 1B
H360FD
GHS08
Dgr
H360FD

Repr. 1B; H360FD: C ≥ 8,5 %


005-011-02-9
disodium tetraborate pentahydrate;
borax pentahydrate
215-540-4
12179-04-3
Repr. 1B
H360FD
GHS08
Dgr
H360FD

Repr. 1B; H360FD: C ≥ 6,5 %



005-012-00-X
diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate
418-070-1
141714-54-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410





005-013-00-5
diethylmethoxyborane
425-380-9
7397-46-8
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H250
H332
H312
H302
H373**
H314
H317
H413
GHS02
GHS05
GHS08
GHS07
Dgr
H250
H332
H312
H302
H373**
H314
H317
H413




005-014-00-0
4-formylphenylboronic acid
438-670-5
87199-17-5
Skin Sens. 1
H317
GHS07
Wng
H317




005-015-00-6
1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
414-380-4
140681-55-6
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412




005-016-00-1
tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate
431-370-5
—
Aquatic Chronic 4
H413
—
H413




005-017-00-7
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Oxid. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318

Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %


005-017-01-4
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Oxid. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318

Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %


005-018-00-2
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
STOT SE 3
Eye Dam. 1
H360Df
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H335
H318

Repr. 1B; H360 Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %


005-018-01-X
perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H360Df
H332
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H332
H335
H318

Repr. 1B; H360 Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %


005-019-00-8
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Oxid. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318

Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %


005-019-01-5
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Oxid. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318

Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %



006-001-00-2
carbon monoxide
211-128-3
630-08-0
Flam. Gas 1
Press. Gas
Repr. 1A
Acute Tox. 3 *
STOT RE 1
H220
H360D ***
H331
H372 **
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H360D ***
H331
H372 **


U
006-002-00-8
phosgene;
carbonyl chloride
200-870-3
75-44-5
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
H330
H314
GHS04
GHS06
GHS05
Dgr
H330
H314


U
006-003-00-3
carbon disulphide
200-843-6
75-15-0
Flam. Liq. 2
Repr. 2
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
H225
H361fd
H372 **
H319
H315
GHS02
GHS08
GHS07
Dgr
H225
H361fd
H372 **
H319
H315

Repr. 2; H361fd: C ≥ 1 %
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤C < 1 %

006-004-00-9
calcium carbide
200-848-3
75-20-7
Water-react. 1
H260
GHS02
Dgr
H260


T
006-005-00-4
thiram (ISO);
tetramethylthiuram disulphide
205-286-2
137-26-8
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 **
H319
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H332
H302
H373 **
H319
H315
H317
H410

M = 10

006-006-00-X
hydrogen cyanide;
hydrocyanic acid
200-821-6
74-90-8
Flam. Liq. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H224
H330
H400
H410
GHS02
GHS06
GHS09
Dgr
H224
H330
H410



006-006-01-7
hydrogen cyanide … %;
hydrocyanic acid … %
200-821-6
74-90-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410


B


006-007-00-5
salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410
EUH032

A

006-008-00-0
antu (ISO);
1-(1-naphthyl)-2-thiourea
201-706-3
86-88-4
Acute Tox. 2 *
Carc. 2
H300
H351
GHS06
GHS08
Dgr
H300
H351



006-009-00-6
1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan
204-318-2
119-38-0
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



006-010-00-1
5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan
204-525-8
122-15-6
Acute Tox. 3 *
H301
GHS06
Dgr
H301






006-011-00-7
carbaryl (ISO);
1-naphthyl methylcarbamate
200-555-0
63-25-2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H351
H332
H302
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H302
H400

M=100


006-012-00-2
ziram (ISO);
zinc bis dimethyldithiocarbamate
205-288-3
137-30-4
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H373 **
H335
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H330
H302
H373 **
H335
H318
H317
H410

M = 100

006-013-00-8
metam-sodium (ISO);
sodium methyldithiocarbamate
205-293-0
137-42-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
EUH031


006-014-00-3
nabam (ISO);
disodium ethylenebis(N,N'-dithiocarbamate)
205-547-0
142-59-6
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H317
H410
GHS07
GHS09
Wng
H302
H335
H317
H410





006-015-00-9
diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4
330-54-1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H373
H410

M=10



006-016-00-4
propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate
204-043-8
114-26-1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



006-017-00-X
aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2
116-06-3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H410



006-018-00-5
aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate
217-990-7
2032-59-9
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410



006-019-00-0
di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-1
2303-16-4
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410



006-020-00-6
barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4
101-27-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



006-021-00-1
linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5
330-55-2
Repr. 1B
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H351
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H351
H302
H373 **
H410



006-022-00-7
decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
—
1563-67-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



006-023-00-2
mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-2
2032-65-7
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



006-024-00-8
proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate
205-443-5
140-93-2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411



006-025-00-3
allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]
249-013-5 [2]-[3]
584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410


C
006-026-00-9
carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-0
1563-66-2
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410



006-028-00-X
dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1
973-21-7
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



006-029-00-5
dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-4
6988-21-2
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411



006-030-00-0
EPTC (ISO);
S-ethyl dipropylthiocarbamate
212-073-8
759-94-4
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-031-00-6
formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-0
22259-30-9
Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H317
H410



006-032-00-1
monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-5
1746-81-2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410



006-033-00-7
metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-2
19937-59-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



006-034-00-2
pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate
214-215-4
1114-71-2
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



006-035-00-8
pirimicarb (ISO);
5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate
245-430-1
23103-98-2
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



006-036-00-3
benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea
217-685-9
1929-88-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-037-00-9
promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-0
2631-37-0
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



006-038-00-4
sulfallate (ISO);
2-chloroallyl N,N-dimethyldithiocarbamate
202-388-9
95-06-7
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410



006-039-00-X
tri-allate (ISO);
S-2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-7
2303-17-5
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410



006-040-00-5
3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan
—
2532-43-6
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



006-041-00-0
dimethylcarbamoyl chloride
201-208-6
79-44-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H331
H302
H319
H335
H315
GHS06
GHS08
Dgr
H350
H331
H302
H319
H335
H315

Carc. 1B; H350: C ≥ 0,001 %

006-042-00-6
monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1
150-68-5
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410



006-043-00-1
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA
—
140-41-0
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H319
H315
H410



006-044-00-7
isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-4
34123-59-6
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410

M = 10



006-045-00-2
methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate
240-815-0
16752-77-5
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410

M=100



006-046-00-8
bendiocarb (ISO);
2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate
245-216-8
22781-23-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H410
GHS06
GHS09
Dgr
H331
H301
H312
H410



006-047-00-3
bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
—
8065-36-9
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410



006-048-00-9
ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-9
29973-13-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



006-049-00-4
dixanthogen;
O,O-diethyl dithiobis(thioformate)
207-944-4
502-55-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-050-00-X
1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA
—
4482-55-7
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



006-051-00-5
ferbam (ISO);
iron tris(dimethyldithiocarbamate)
238-484-2
14484-64-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410



006-052-00-0
formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-0
23422-53-9
Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H317
H410



006-053-00-6
isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate
220-114-6
2631-40-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



006-054-00-1
mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3
315-18-4
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410



006-055-00-7
xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC
219-364-9
2425-10-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



006-056-00-2
metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC
214-446-0
1129-41-5
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



006-057-00-8
nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine
217-682-2
1929-82-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



006-058-00-3
noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
—
2163-79-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-059-00-9
oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-3
23135-22-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Chronic 2
H330
H300
H312
H411
GHS06
GHS09
Dgr
H330
H300
H312
H411



006-060-00-4
oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-2
5259-88-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



006-061-00-X
S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride
243-193-9
19622-19-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



006-062-00-5
methyl 3,4-dichlorophenylcarbanilate;
SWEP.
—
1918-18-9
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-063-00-0
thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate
248-924-5
28249-77-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



006-064-00-6
thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime
254-346-4
39196-18-4
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



006-065-00-1
3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid
—
15271-41-7
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Chronic 2
H300
H311
H411
GHS06
GHS09
Dgr
H300
H311
H411



006-066-00-7
vernolate (ISO);
S-propyl dipropylthiocarbamate
217-681-7
1929-77-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



006-067-00-2
XMC;
3,5-xylyl methylcarbamate
—
2655-14-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



006-068-00-8
diazomethane
206-382-7
334-88-3
Carc. 1B
H350
GHS08
Dgr
H350



006-069-00-3
thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-7
23564-05-8
Muta. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H332
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H332
H317
H410



006-070-00-9
furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide
262-302-0
60568-05-0
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



006-071-00-4
cyclooct-4-en-1-yl methyl carbonate
401-620-8
87731-18-8
Skin Sens. 1
H317
GHS07
Wng
H317



006-072-00-X
prosulfocarb (ISO);
S-benzyl N,N-dipropylthiocarbamate
401-730-6
52888-80-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



006-073-00-5
3-(dimethylamino)propylurea
401-950-2
31506-43-1
Eye Dam. 1
H318
GHS05
Dgr
H318



006-074-00-0
2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate
402-440-2
2094-99-7
Acute Tox. 2 *
Skin Corr. 1B
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H314
H373 **
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H330
H314
H373 **
H334
H317
H410





006-076-00-1
mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
—
8018-01-7
Repr. 2
Skin Sens. 1
Aquatic Acute 1
H361d***
H317
H400
GHS08
GHS07
GHS09
Wng
H361d***
H317
H400

M=10


006-077-00-7
maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)
235-654-8
12427-38-2
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H332
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d***
H332
H319
H317
H410

M=10


006-078-00-2
zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-1
12122-67-7
STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Wng
H335
H317



006-079-00-8
disulfiram;
tetraethylthiuramdisulfide
202-607-8
97-77-8
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410



006-080-00-3
tetramethylthiuram monosulphide
202-605-7
97-74-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



006-081-00-9
zinc bis(dibutyldithiocarbamate)
205-232-8
136-23-2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H317
H410



006-082-00-4
zinc bis(diethyldithiocarbamate)
238-270-9
14324-55-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H317
H410



006-083-00-X
butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-3
34681-10-2
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H226
H331
H311
H301
H319
H400
H410
GHS02
GHS06
GHS09
Dgr
H226
H331
H311
H301
H319
H410






006-084-00-5
carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-9
55285-14-8
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H317
H400
H410
GHS06
GHS09
Dgr
H330
H301
H317
H410




006-085-00-0
fenobucarb (ISO);
2-butylphenyl methylcarbamate
223-188-8
3766-81-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



006-086-00-6
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;
fenoxycarb
276-696-7
72490-01-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





006-087-00-1
furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate
265-974-3
65907-30-4
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H373**
H319
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H301
H373
H319
H315
H317
H410

M=100


006-088-00-7
benfuracarb (ISO);
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
—
82560-54-1
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H331
H302
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f***
H331
H302
H410






006-089-00-2
chlorine dioxide
233-162-8
10049-04-4
Ox. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H270
H330
H314
H400
GHS03
GHS04
GHS06
GHS05
GHS09
Dgr
H270
H330
H314
H400
EUH006
M = 1000
U
006-089-01-X
chlorine dioxide . . . %
233-162-8
10049-04-4
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400

Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 10 %
STOT SE 3; H335: C ≥ 3 %
M = 10
B

006-090-00-8
2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate
408-010-0
88558-41-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H332
H318
H412
GHS05
GHS07
Dgr
H332
H318
H412





006-091-00-3
propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)
—
9016-72-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H332
H373**
H317
H400
GHS08
GHS07
GHS09
Wng
H332
H373**
H317
H400




006-092-00-9
tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate
425-420-5
98737-29-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




006-093-00-4
2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)
427-180-7
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410




006-094-00-X
O-isobutyl-N-ethoxy carbonylthiocarbamate
434-350-4
103122-66-3
Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H226
H350
H340
H302
H373**
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H350
H340
H302
H373**
H317
H411




006-095-00-5
fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate
254-320-2
39148-24-8
Eye Dam. 1
H318
GHS05
Dgr
H318




006-096-00-0
chlorpropham (ISO);
isopropyl 3-chlorocarbanilate
202-925-7
101-21-3
Carc. 2
STOT RE 2 *
Aquatic Chronic 2
H351
H373**
H411
GHS08
GHS09
Wng
H351
H373**
H411




006-097-00-6
1-phenyl-3-(p-toluenesulfonyl)urea
424-620-1
13909-63-2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412




006-098-00-1
tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
429-170-8
134575-17-0
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgrg
H302
H373**
H318
H317




006-099-00-7
N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate
520-2
232938-43-1
Aquatic Chronic 2
H411
GHS09
H411




006-101-00-6
reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
423-070-8
—
Aquatic Chronic 4
H413
—
H413




006-102-00-1
O-hexyl-N-ethoxycarbonylthiocarbamate
432-750-3
—
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H340
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H302
H373**
H317
H411




006-103-00-7
N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea
445-760-8
—
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H400
H410
GHS05
GHS08
GHS09
Dgr
H318
H334
H410

M=100


007-001-00-5
ammonia, anhydrous
231-635-3
7664-41-7
Flam. Gas 2
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H221
H331
H314
H400
GHS04
GHS06
GHS05
GHS09
Dgr
H221
H331
H314
H400


U
007-001-01-2
ammonia ….%
215-647-6
1336-21-6
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400

STOT SE 3; H335: C ≥ 5 %
B


007-002-00-0
nitrogen dioxide; [1]
dinitrogen tetraoxide [2]
233-272-6 [1]
234-126-4 [2]
10102-44-0 [1]
10544-72-6 [2]
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314

*
STOT SE 3; H335: C ≥ 0,5 %
5

007-003-00-6
chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride
213-666-4
999-81-5
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



007-004-00-1
nitric acid … %
231-714-2
7697-37-2
Ox. Liq. 3
Skin Corr. 1A
H272
H314
GHS03
GHS05
Dgr
H272
H314

Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Ox. Liq. 3; H272: C ≥ 65 %
B
007-006-00-2
ethyl nitrite
203-722-6
109-95-5
Flam. Gas 1
Press. Gas
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H220
H332
H312
H302
GHS02
GHS04
GHS07
Dgr
H220
H332
H312
H302


U


007-007-00-8
ethyl nitrate
210-903-3
625-58-1
Unst. Expl
H200
GHS01
Dgr
H200




007-008-00-3
hydrazine
206-114-9
302-01-2
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H350
H331
H311
H301
H314
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H226
H350
H331
H311
H301
H314
H317
H410

Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 3 % ≤ C < 10 %

007-009-00-9
dicyclohexylammonium nitrite
221-515-9
3129-91-7
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302

*

007-010-00-4
sodium nitrite
231-555-9
7632-00-0
Ox. Sol. 3
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Dgr
H272
H301
H400

*

007-011-00-X
potassium nitrite
231-832-4
7758-09-0
Ox. Sol. 2
Acute Tox. 3 *
Aquatic Acute 1
H272
H301
H400
GHS03
GHS06
GHS09
Dgr
H272
H301
H400

*

007-012-00-5
N,N-dimethylhydrazine
200-316-0
57-14-7
Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H331
H301
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H331
H301
H314
H411



007-013-00-0
1,2-dimethylhydrazine
—
540-73-8
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H411

Carc. 1B; H350: C ≥ 0,01 %

007-014-00-6
salts of hydrazine
—
—
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H311
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H317
H410


A
007-015-00-1
O-ethylhydroxylamine
402-030-3
624-86-2
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H225
H331
H311
H301
H372 **
H319
H317
H400
GHS02
GHS06
GHS08
GHS09
Dgr
H225
H331
H311
H301
H372 **
H319
H317
H400



007-016-00-7
butyl nitrite
208-862-1
544-16-1
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
H225
H331
H301
GHS02
GHS06
Dgr
H225
H331
H301



007-017-00-2
isobutyl nitrite
208-819-7
542-56-3
Flam. Liq. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H350
H341
H332
H302
GHS02
GHS08
GHS07
Dgr
H225
H350
H341
H332
H302



007-018-00-8
sec-butyl nitrite
213-104-8
924-43-6
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302



007-019-00-3
tert-butyl nitrite
208-757-0
540-80-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302



007-020-00-9
pentyl nitrite; [1]
amyl nitrite, mixed isomers [2]
207-332-7 [1]
203-770-8 [2]
463-04-7 [1]
110-46-3 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302



007-021-00-4
hydrazobenzene;
1,2-diphenylhydrazine
204-563-5
122-66-7
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410



007-022-00-X
hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)
405-030-1
—
Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H302
H314
H317
H412
GHS08
GHS05
GHS07
Dgr
H350
H302
H314
H317
H412



007-023-00-5
sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate
405-510-0
—
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



007-024-00-0
2-(decylthio)ethylammonium chloride
405-640-8
36362-09-1
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H315
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H373 **
H315
H318
H410



007-025-00-6
(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride
406-090-1
81880-96-8
Muta. 2
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H301
H372 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H301
H372 **
H317
H410



007-026-00-1
oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide
413-230-5
122035-71-6
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



007-027-00-7
1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane
420-190-2
771478-66-1
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H314
H317
H410





007-028-00-2
hydroxylammonium nitrate
236-691-2
13465-08-2
Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H311
H302
H373**
H319
H315
H317
H400
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H351
H311
H302
H373**
H319
H315
H317
H400




007-029-00-8
diethyldimethylammonium hydroxide
419-400-5
95500-19-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314




008-001-00-8
oxygen
231-956-9
7782-44-7
Ox. Gas 1
Press. Gas
H270
GHS03
GHS04
Dgr
H270


U
008-003-00-9
hydrogen peroxide solution … %
231-765-0
7722-84-1
Ox. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H271
H332
H302
H314
GHS03
GHS05
GHS07
Dgr
H271
H332
H302
H314

Ox. Liq. 1; H271: C ≥ 70 %****
Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****
*
Skin Corr. 1A; H314: C ≥ 70 %
Skin Corr. 1B; H314: 50 % ≤ C < 70 %
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 8 %
STOT SE 3; H335; C ≥ 35 %
B


009-001-00-0
fluorine
231-954-8
7782-41-4
Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1A
H270
H330
H314
GHS04
GHS03
GHS06
GHS05
Dgr
H270
H330
H314





009-002-00-6
hydrogen fluoride
231-634-8
7664-39-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314



009-003-00-1
hydrofluoric acid … %
231-634-8
7664-39-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314

Skin Corr. 1A; H314: C ≥ 7 %
Skin Corr. 1B; H314: 1 % ≤ C < 7 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
B
009-004-00-7
sodium fluoride
231-667-8
7681-49-4
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Dgr
H301
H319
H315
EUH032


009-005-00-2
potassium fluoride
232-151-5
7789-23-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



009-006-00-8
ammonium fluoride
235-185-9
12125-01-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



009-007-00-3
sodium bifluoride;
sodium hydrogen difluoride
215-608-3
1333-83-1
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314

*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-008-00-9
potassium bifluoride;
potassium hydrogen difluoride
232-156-2
7789-29-9
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314

*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-009-00-4
ammonium bifluoride;
ammonium hydrogen difluoride
215-676-4
1341-49-7
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314

*
Skin Corr. 1B; H314: C ≥ 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-010-00-X
fluoroboric acid ... %
240-898-3
16872-11-0
Skin Corr. 1B
H314
GHS05
Dgr
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
009-011-00-5
fluorosilicic acid ... %
241-034-8
16961-83-4
Skin Corr. 1B
H314
GHS05
Dgr
H314


B
009-012-00-0
alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3]
240-934-8 [1]
240-896-2 [2]
240-968-3 [3]
16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301

*
A
009-013-00-6
fluorosilicates, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302

*
A
009-014-00-1
lead hexafluorosilicate
247-278-1
25808-74-6
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H332
H302
H373 **
H410


1
009-015-00-7
sulphuryl difluoride
220-281-5
2699-79-8
Press. Gas
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H373 **
H400
GHS04
GHS06
GHS08
GHS09
Dgr
H331
H373 **
H400


U
009-016-00-2
trisodium hexafluoroaluminate;
cryolite
237-410-6
239-148-8
13775-53-6
15096-52-3
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H372 **
H332
H302
H411
GHS08
GHS07
GHS09
Dgr
H372 **
H332
H302
H411


C
009-017-00-8
potassium mu-fluoro-bis(triethylaluminium)
400-040-2
12091-08-6
Flam. Sol. 1
Water-react. 1
Skin Corr. 1A
Acute Tox. 4 *
H228
H270
H314
H332
GHS02
GHS05
GHS07
Dgr
H228
H270
H314
H332
EUH014

T
009-018-00-3
magnesium hexafluorosilicate
241-022-2
16949-65-8
Acute Tox. 3 *
H301
GHS06
Dgr
H301

*

011-001-00-0
sodium
231-132-9
7440-23-5
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014


011-002-00-6
sodium hydroxide;
caustic soda
215-185-5
1310-73-2
Skin Corr. 1A
H314
GHS05
Dgr
H314

Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %

011-003-00-1
sodium peroxide
215-209-4
1313-60-6
Ox. Sol. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Dgr
H271
H314



011-004-00-7
sodium azide
247-852-1
26628-22-8
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H400
H410
EUH032


011-005-00-2
sodium carbonate
207-838-8
497-19-8
Eye Irrit. 2
H319
GHS07
Wng
H319



011-006-00-8
sodium cyanate
213-030-6
917-61-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



011-007-00-3
propoxycarbazone-sodium
—
181274-15-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M = 10

012-001-00-3
magnesium powder (pyrophoric)
231-104-6
7439-95-4
Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250


T
012-002-00-9
magnesium, powder or turnings
231-104-6
—
Flam. Sol. 1
Water-react. 2
Self-heat. 1
H228
H261
H252
GHS02
Dgr
H228
H261
H252


T
012-003-00-4
magnesium alkyls
—
—
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014

A


012-004-00-X
aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate
422-150-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





013-001-00-6
aluminium powder (pyrophoric)
231-072-3
7429-90-5
Water-react. 2
Pyr. Sol. 1
H261
H250
GHS02
Dgr
H261
H250


T


013-002-00-1
aluminium powder (stabilised)
231-072-3
7429-90-5
Water-react. 2
Flam. Sol. 1
H261
H228
GHS02
Dgr
H261
H228


T

013-003-00-7
aluminium chloride, anhydrous
231-208-1
7446-70-0
Skin Corr. 1B
H314
GHS05
Dgr
H314



013-004-00-2
aluminium alkyls
—
—
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
H250
H260
H314
GHS02
GHS05
Dgr
H250
H260
H314
EUH014

A
013-005-00-8
diethyl(ethyldimethylsilanolato)aluminium
401-160-8
55426-95-4
Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
H260
H250
H314
GHS02
GHS05
Dgr
H260
H250
H314
EUH014


013-006-00-3
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised
402-370-2
—
Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318



013-007-00-9
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)
403-430-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318



013-008-00-4
di-n-octylaluminium iodide
408-190-0
7585-14-0
Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H314
H410
EUH014


013-009-00-X
sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5
418-720-2
—
Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A
H228
H260
H250
H332
H314
GHS02
GHS05
GHS07
Dgr
H228
H260
H250
H332
H314
EUH014

T


013-010-00-5
hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)
430-650-4
151841-65-5
Aquatic Chronic 2
H411
GHS09
H411




014-001-00-9
trichlorosilane
233-042-5
10025-78-2
Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H224
H250
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H250
H332
H302
H314
EUH014
EUH029
*
STOT SE 3; H335: C ≥ 1 %
T
014-002-00-4
silicon tetrachloride
233-054-0
10026-04-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
EUH014


014-003-00-X
dimethyldichlorosilane
200-901-0
75-78-5
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315



014-004-00-5
trichloro(methyl)silane;
methyltrichlorosilane
200-902-6
75-79-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
EUH014
Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %

014-005-00-0
tetraethyl silicate;
ethyl silicate
201-083-8
78-10-4
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H319
H335
GHS02
GHS07
Wng
H226
H332
H319
H335



014-006-00-6
bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride
401-380-4
—
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



014-007-00-1
triethoxyisobutylsilane
402-810-3
17980-47-1
Skin Irrit. 2
H315
GHS07
Wng
H315



014-008-00-7
(chloromethyl)bis(4-fluorophenyl)methylsilane
401-200-4
85491-26-5
Aquatic Chronic 2
H411
GHS09
H411



014-009-00-2
isobutylisopropyldimethoxysilane
402-580-4
111439-76-0
Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H315
GHS02
GHS07
Wng
H226
H332
H315



014-010-00-8
disodium metasilicate
229-912-9
6834-92-0
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335



014-011-00-3
cyclohexyldimethoxymethylsilane
402-140-1
17865-32-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



014-012-00-9
bis(3-(trimethoxysilyl)propyl)amine
403-480-3
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



014-013-00-4
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)
404-920-7
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H312
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H411



014-014-00-X
etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane
253-704-7
37894-46-5
Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
H360D ***
H302
H373 **
GHS08
GHS07
Dgr
H360D ***
H302
H373 **



014-015-00-5
α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))
406-420-4
69430-40-6
Aquatic Chronic 4
H413
—
H413



014-016-00-0
reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6
—
Aquatic Chronic 2
H411
GHS09
H411



014-017-00-6
flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane
—
85509-19-9
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D ***
H302
H411



014-018-00-1
octamethylcyclotetrasiloxane
209-136-7
556-67-2
Repr. 2
Aquatic Chronic 4
H361f ***
H413
GHS08
Wng
H361f ***
H413



014-019-00-7
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
403-250-2
—
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360D ***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D ***
H302
H411



014-020-00-2
bis(1,1-dimethyl-2-propynyloxy)dimethylsilane
414-960-7
53863-99-3
Acute Tox. 4 *
H332
GHS07
Wng
H332



014-021-00-8
tris(isopropenyloxy)phenyl silane
411-340-8
52301-18-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H400
H410



014-022-00-3
reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)
401-530-9
—
Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H228
H370 **
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H228
H370 **
H332
H312
H302


T
014-023-00-9
α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole
408-160-7
125613-45-8
Aquatic Chronic 2
H411
GHS09
H411



014-024-00-4
1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene
412-620-2
121626-74-2
Aquatic Chronic 2
H411
GHS09
H411



014-025-00-X
4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine
411-400-3
102089-33-8
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H373 **
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H315
H318
H412



014-026-00-5
dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane
407-180-3
770722-36-6
Skin Corr. 1A
H314
GHS05
Dgr
H314



014-027-00-0
chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane
410-270-5
770722-46-8
Skin Corr. 1A
H314
GHS05
Dgr
H314



014-028-00-6
α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)
415-290-8
193159-06-7
Skin Sens. 1
H317
GHS07
Wng
H317



014-029-00-1
O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]
421-870-1
156145-66-3
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
H361f ***
H302
H373 **
GHS08
GHS07
Wng
H361f ***
H302
H373 **



014-030-00-7
[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium
422-060-0
137390-08-0
Acute Tox. 2 *
H300
GHS06
Dgr
H300



014-031-00-2
bis(1-methylethyl)-dimethoxysilane
421-540-7
18230-61-0
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H226
H315
H317
H412
GHS02
GHS07
Wng
H226
H315
H317
H412



014-032-00-8
dicyclopentyldimethoxysilane
404-370-8
126990-35-0
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410





014-033-00-3
2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica
419-030-4
125804-20-8
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336




014-034-00-9
3-hexylheptamethyltrisiloxane
428-700-5
1873-90-1
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413




014-035-00-4
2-(3,4-epoxycyclohexyl)ethyltriethoxy silane
425-050-4
10217-34-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




014-036-00-X
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H400
H410
GHS08
GHS09
Dgr
H360F***
H410

M=1000


014-037-00-5
2-butanone-O,O',O''-(phenylsilylidyne)trioxime
433-360-6
34036-80-1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412




014-038-00-0
S-(3-(triethoxysilyl)propyl) octanethioate
436-690-9
220727-26-4
Skin Sens. 1
H317
GHS07
Wng
H317




014-039-00-6
(2,3-dimethylbut-2-yl)-trimethoxysilane
439-360-2
142877-45-0
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412




014-041-00-7
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane
445-890-5
201290-01-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317




014-042-00-2
reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-010-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318




014-043-00-8
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)
432-200-2
—
Aquatic Chronic 2
H411
GHS09
H411




014-044-00-3
3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane
433-050-0
—
Aquatic Chronic 2
H411
GHS09
H411




014-045-00-9
magnesium sodium fluoride silicate
442-650-1
—
STOT RE 2 *
H373**
GHS08
Wng
H373**




015-001-00-1
white phosphorus
231-768-7
12185-10-3
Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H250
H330
H300
H314
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H250
H330
H300
H314
H400



015-002-00-7
red phosphorus
231-768-7
7723-14-0
Flam. Sol. 1
Aquatic Chronic 3
H228
H412
GHS02
Dgr
H228
H412





015-003-00-2
calcium phosphide;
tricalcium diphosphide
215-142-0
1305-99-3
Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
H260
H300
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H400
EUH029
M=100


015-004-00-8
aluminium phosphide
244-088-0
20859-73-8
Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
H260
H300
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H400
EUH029
EUH032
M=100


015-005-00-3
magnesium phosphide;
trimagnesium diphosphide
235-023-7
12057-74-8
Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
H260
H300
H400
GHS02
GHS06
GHS09
Dgr
H260
H300
H400
EUH029
M=100


015-006-00-9
trizinc diphosphide;
zinc phosphide
215-244-5
1314-84-7
Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H260
H300
H400
H410
GHS02
GHS06
GHS09
Dgr
H260
H300
H410
EUH029
EUH032
M=100
T

015-007-00-4
phosphorus trichloride
231-749-3
7719-12-2
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A
H330
H300
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H300
H373 **
H314
EUH014
EUH029


015-008-00-X
phosphorus pentachloride
233-060-3
10026-13-8
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H330
H302
H373 **
H314
GHS06
GHS08
GHS05
Dgr
H330
H302
H373 **
H314
EUH014
EUH029


015-009-00-5
phosphoryl trichloride
233-046-7
10025-87-3
Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A
H330
H372 **
H302
H314
GHS06
GHS08
GHS05
Dgr
H330
H372 **
H302
H314
EUH014
EUH029


015-010-00-0
phosphorus pentoxide
215-236-1
1314-56-3
Skin Corr. 1A
H314
GHS05
Dgr
H314



015-011-00-6
phosphoric acid ... %, orthophosphoric acid ... %
231-633-2
7664-38-2
Skin Corr. 1B
H314
GHS05
Dgr
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
015-012-00-1
tetraphosphorus trisulphide;
phosphorus sesquisulphid
215-245-0
1314-85-8
Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H302
H400
GHS02
GHS07
GHS09
Dgr
H228
H260
H302
H400


T
015-013-00-7
triethyl phosphate
201-114-5
78-40-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



015-014-00-2
tributyl phosphate
204-800-2
126-73-8
Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
H351
H302
H315
GHS08
GHS07
Wng
H351
H302
H315



015-015-00-8
tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
201-103-5
78-30-8
STOT SE 1
Aquatic Chronic 2
H370 **
H411
GHS08
GHS09
Dgr
H370 **
H411

STOT SE 1; H370: C ≥ 1 %
STOT SE 2; H371: 0,2 % ≤ C < 1 %
C
015-016-00-3
tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
201-105-6
78-32-0
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411

*
C


015-019-00-X
dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate
200-547-7
62-73-7
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
H330
H311
H301
H317
H400
GHS06
GHS09
Dgr
H330
H311
H301
H317
H400

M=1000


015-020-00-5
mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-1
7786-34-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410

M = 10000

015-021-00-0
trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-3
52-68-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H400
H410

M = 1000

015-022-00-6
phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-5
13171-21-6
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H300
H311
H410



015-023-00-1
pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate
—
108-34-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300



015-024-00-7
triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide
—
1031-47-6
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-025-00-2
TEPP (ISO);
tetraethyl pyrophosphate
203-495-3
107-49-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400



015-026-00-8
schradan (ISO);
octamethylpyrophosphoramide
205-801-0
152-16-9
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-027-00-3
sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate
222-995-2
3689-24-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410

M = 1000

015-028-00-9
demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8
298-03-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400



015-029-00-4
demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8
126-75-0
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-030-00-X
demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1
867-27-6
Acute Tox. 3 *
H301
GHS06
Dgr
H301



015-031-00-5
demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6
919-86-8
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H311
H301
H411
GHS06
GHS09
Dgr
H311
H301
H411



015-032-00-0
prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-2
2275-18-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 3
H310
H300
H412
GHS06
Dgr
H310
H300
H412



015-033-00-6
phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2
298-02-2
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410

M = 1000

015-034-00-1
parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-7
56-38-2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H300
H311
H372 **
H410

M = 100

015-035-00-7
parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1
298-00-0
Flam. Liq. 3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H330
H300
H311
H373 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H226
H330
H300
H311
H373 **
H410

M = 100

015-036-00-2
O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN
218-276-8
2104-64-5
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



015-037-00-8
phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate
218-892-7
2275-14-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410



015-038-00-3
coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-3
56-72-4
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410



015-039-00-9
azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-1
86-50-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H317
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H317
H410



015-040-00-4
diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8
333-41-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410






015-041-00-X
malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]
204-497-7
121-75-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410

M=1000


015-042-00-5
chlorthion
O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate
207-902-5
500-28-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

M = 100

015-043-00-0
phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate
—
5826-76-6
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302



015-044-00-6
carbophenothion (ISO);
4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate
212-324-1
786-19-6
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410



015-045-00-1
mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate
219-993-9
2595-54-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H400
H410



015-046-00-7
oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7
301-12-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
H311
H301
H400
GHS06
GHS09
Dgr
H311
H301
H400



015-047-00-2
ethion (ISO);
O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);
diethion
209-242-3
563-12-2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410

M = 10000



015-048-00-8
fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-9
55-38-9
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H312
H302
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H312
H302
H372**
H410

M=100


015-049-00-3
endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-3
2778-04-3
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301



015-050-00-9
thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6
640-15-3
Acute Tox. 3 *
Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312



015-051-00-4
dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-3
60-51-5
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



015-052-00-X
fenchlorphos (ISO);
O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate
206-082-6
299-84-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



015-053-00-5
menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate
201-123-4
78-57-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



015-054-00-0
fenitrothion (ISO);
O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2
122-14-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



015-055-00-6
naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3
300-76-5
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H312
H302
H319
H315
H400
GHS07
GHS09
Wng
H312
H302
H319
H315
H400

M = 1000



015-056-00-1
azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-6
2642-71-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410

M=100


015-057-00-7
formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate
219-818-6
2540-82-1
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



015-058-00-2
morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0
144-41-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410



015-059-00-8
vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-8
2275-23-2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Dgr
H301
H312
H400



015-060-00-3
disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3
298-04-4
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



015-061-00-9
dimefox (ISO);
tetramethylphosphorodiamidic fluoride
204-076-8
115-26-4
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-062-00-4
mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride
206-742-3
371-86-8
STOT SE 1
H370 **
GHS08
Dgr
H370 **



015-063-00-X
dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-7
78-34-2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H311
H400
H410
GHS06
GHS09
Dgr
H330
H300
H311
H410

M = 1000

015-064-00-5
bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate
225-399-0
4824-78-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410



015-065-00-0
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate
—
2703-37-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411



015-066-00-6
omethoate (ISO);
O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-8
1113-02-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
H301
H312
H400
GHS06
GHS09
Dgr
H301
H312
H400





015-067-00-1
phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate
218-996-2
2310-17-0
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H317
H400
H410
GHS06
GHS09
Dgr
H301
H332
H312
H317
H410

M=1000


015-068-00-7
dichlofenthion (ISO);
O—2,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-5
97-17-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410



015-069-00-2
methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4
950-37-8
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H312
H400
H410
GHS06
GHS09
Dgr
H300
H312
H410



015-070-00-8
cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-4
3734-95-0
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311



015-071-00-3
chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate
207-432-0
470-90-6
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410



015-072-00-9
monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-7
6923-22-4
Muta. 2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H330
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H330
H300
H311
H410



015-073-00-4
dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3
141-66-2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410



015-074-00-X
crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1
299-86-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



015-075-00-5
S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate
—
2635-50-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



015-076-00-0
potasan;
O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
—
299-45-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410

M = 1000

015-077-00-6
2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate
—
7076-53-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



015-078-00-1
demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-5
17040-19-6
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2
H301
H312
H411
GHS06
GHS09
Dgr
H301
H312
H411



015-079-00-7
acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate
250-241-2
30560-19-1
Acute Tox. 4 *
H302
GHS07
Wng
H302



015-080-00-2
amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
—
919-76-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



015-081-00-8
O,O,O',O'-tetrapropyl dithiopyrophosphate
221-817-0
3244-90-4
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



015-082-00-3
azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-3
5834-96-8
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302



015-083-00-9
bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4
741-58-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



015-084-00-4
chlorpyrifos (ISO);
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-4
2921-88-2
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H400
H410

M = 10000

015-085-00-X
chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4
115-78-6
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H301
H312
H319
H315
GHS06
Dgr
H301
H312
H319
H315



015-086-00-5
coumithoate (ISO);
O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
—
572-48-5
Acute Tox. 3 *
H301
GHS06
Dgr
H301



015-087-00-0
cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-3
2636-26-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



015-088-00-6
dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-3
10311-84-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H400
H410



015-089-00-1
ethoate-methyl (ISO);
ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1
116-01-8
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



015-090-00-7
fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3
115-90-2
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



015-091-00-2
fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate
213-408-0
944-22-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



015-092-00-8
phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-7
4104-14-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



015-093-00-3
leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-8
21609-90-5
Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H370 **
H312
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H370 **
H312
H410



015-094-00-9
mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3
950-10-7
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H310
H300
H411
GHS06
GHS09
Dgr
H310
H300
H411



015-095-00-4
methamidophos (ISO);
O,S-dimethyl phosphoramidothioate
233-606-0
10265-92-6
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
H330
H300
H311
H400
GHS06
GHS09
Dgr
H330
H300
H311
H400



015-096-00-X
oxydisulfoton (ISO);
O,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-1
2497-07-6
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410

M = 10

015-097-00-5
phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-0
2597-03-7
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410

M = 100

015-098-00-0
trichloronate (ISO);
O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1
327-98-0
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410



015-099-00-6
pirimiphos-ethyl (ISO);
O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-0
23505-41-1
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410





015-100-00-X
phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-3
14816-18-3
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f***
H302
H317
H410

M=1000



015-101-00-5
phosmet (ISO);
O,O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4
732-11-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410

M = 100



015-102-00-0
tris(2-chloroethyl)phosphate
204-118-5
115-96-8
Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H351
H360F***
H302
H411
GHS08
GHS07
GHS09
Dgr
H351
H360F***
H302
H411




015-103-00-6
phosphorus tribromide
232-178-2
7789-60-8
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014


015-104-00-1
diphosphorus pentasulphide;
phosphorus pentasulphide
215-242-4
1314-80-3
Flam. Sol. 1
Water-react. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H228
H260
H332
H302
H400
GHS02
GHS07
GHS09
Dgr
H228
H260
H332
H302
H400
EUH029

T
015-105-00-7
triphenyl phosphite
202-908-4
101-02-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410

Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %

015-106-00-2
hexamethylphosphoric triamide;
hexamethylphosphoramide
211-653-8
680-31-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340

Carc. 1B; H350: C ≥ 0,01 %

015-107-00-8
ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate
236-152-1
13194-48-4
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H301
H317
H400
H410
GHS06
GHS09
Dgr
H330
H310
H301
H317
H410



015-108-00-3
bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-3
2104-96-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M = 100

015-109-00-9
crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-5
7700-17-6
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410

M = 10

015-110-00-4
cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate
—
13067-93-1
Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H301
H370 **
H312
H319
H411
GHS06
GHS08
GHS09
Dgr
H301
H370 **
H312
H319
H411



015-111-00-X
phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2
947-02-4
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-112-00-5
thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6
297-97-2
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300





015-113-00-0
tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
260-515-3
57018-04-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410






015-114-00-6
chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate
246-538-1
24934-91-6
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS06
GHS09
Dgr
H317
H410

M=10


015-115-00-1
chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]
244-663-6
21923-23-9
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410

M=1000


015-116-00-7
demephion-O (ISO);
O,O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9
682-80-4
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311



015-117-00-2
demephion-S (ISO);
O,O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-9
2587-90-8
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311



015-118-00-8
demeton
—
8065-48-3
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400



015-119-00-3
dimethyl 4-(methylthio)phenyl phosphate
—
3254-63-5
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-120-00-9
ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate
225-875-8
5131-24-8
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



015-121-00-4
edifenphos (ISO);
O-ethyl S,S-diphenyl phosphorodithioate
241-178-1
17109-49-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H317
H410



015-122-00-X
etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate
253-855-9
38260-54-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M = 10

015-123-00-5
fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1
22224-92-6
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410

M = 100

015-124-00-0
fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate
244-437-7
21548-32-3
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



015-125-00-6
glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine
219-468-4
2439-99-8
Eye Dam. 1
H318
GHS05
Dgr
H318



015-126-00-1
heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-0
23560-59-0
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410

M = 100

015-127-00-7
iprobenfos(ISO);
S-benzyl diisopropyl phosphorothioate
247-449-0
26087-47-8
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



015-128-00-2
IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
—
5827-05-4
Acute Tox. 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H301
H400
H410
GHS06
GHS09
Dgr
H310
H301
H410

M = 100

015-129-00-8
isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-1
25311-71-1
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410

M = 100

015-130-00-3
isothioate (ISO);
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
—
36614-38-7
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301



015-131-00-9
isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-8
18854-01-8
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410



015-132-00-4
S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;
methylcarbophenothione
—
953-17-3
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410

M = 1000

015-133-00-X
piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate
—
24151-93-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M = 10

015-134-00-5
pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate
249-528-5
29232-93-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



015-135-00-0
profenofos (ISO)
O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;
255-255-2
41198-08-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

M = 1000

015-136-00-6
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO)
250-517-2
31218-83-4
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410

M = 100

015-137-00-1
pyrazophos (ISO);
O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-1
13457-18-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410



015-138-00-7
quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-6
13593-03-8
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410

M = 1000

015-139-00-2
terbufos (ISO);
S-tert-butylthiomethyl O,O-diethylphosphorodithioate;
235-963-8
13071-79-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410

M = 1000



015-140-00-8
triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate
245-986-5
24017-47-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H410

M=100


015-141-00-3
ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers
400-520-1
—
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H410



015-142-00-9
butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate
401-100-0
—
Flam. Liq. 2
Eye Irrit. 2
Aquatic Chronic 2
H225
H319
H411
GHS02
GHS07
GHS09
Dgr
H225
H319
H411


T
015-143-00-4
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,
reaction mass of isomers
401-740-0
—
Acute Tox. 4 *
H302
GHS07
Wng
H302



015-144-00-X
reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate
402-090-0
87025-52-3
Skin Corr. 1B
H314
GHS05
Dgr
H314



015-145-00-5
reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate
401-520-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



015-146-00-0
S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate
401-850-9
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



015-147-00-6
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)
400-930-0
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411



015-148-00-1
2-(diphosphonomethyl)succinic acid
403-070-4
51395-42-7
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317



015-149-00-7
reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide
403-470-9
—
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410



015-150-00-2
(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide
404-940-6
86608-70-0
Acute Tox. 4 *
Eye Dam. 1
STOT RE 2 *
Aquatic Chronic 3
H302
H318
H373 **
H412
GHS08
GHS05
GHS07
Dgr
H302
H318
H373 **
H412



015-151-00-8
tris(isopropyl/tert-butylphenyl) phosphate
405-010-2
—
Aquatic Chronic 2
H411
GHS09
H411



015-152-00-3
dioxabenzofos (ISO);
2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide
223-292-3
3811-49-2
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
Aquatic Chronic 2
H311
H301
H370 **
H411
GHS06
GHS08
GHS09
Dgr
H311
H301
H370 **
H411



015-153-00-9
isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate
255-863-8
42509-80-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H311
H301
H373 **
H317
H410



015-154-00-4
2-chloroethylphosphonic acid;
ethephon
240-718-3
16672-87-0
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H332
H312
H314
H412
GHS05
GHS07
Dgr
H332
H312
H314
H412

STOT SE 3; H335: C ≥ 5 %



015-155-00-X
glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
278-636-5
77182-82-2
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H360Fd
H332
H312
H302
H373**
GHS08
GHS07
Dgr
H360Fd
H332
H312
H302
H373**




015-156-00-5
methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]-[2]
30864-28-9 [1]
62610-77-9 [2]
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



015-157-00-0
phosphonic acid; [1]
phosphorous acid [2]
237-066-7 [1]
233-663-1
[2]
13598-36-2 [1]
10294-56-1 [2]
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314



015-158-00-6
(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)
402-340-9
32760-80-8
Aquatic Chronic 3
H412
—
H412



015-159-00-1
hydroxyphosphonoacetic acid
405-710-8
23783-26-8
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
H302
H373 **
H314
H317
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H314
H317



015-160-00-7
vanadyl pyrophosphate
406-260-5
58834-75-6
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412



015-161-00-2
divanadyl pyrophosphate
407-130-0
65232-89-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



015-162-00-8
vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped
407-350-7
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H332
H373 **
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H332
H373 **
H318
H411



015-163-00-3
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide
412-010-6
145052-34-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



015-164-00-9
calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate
400-480-5
36669-85-9
Aquatic Chronic 3
H412
—
H412



015-165-00-4
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



015-166-00-X
3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
410-290-4
80693-00-1
Aquatic Chronic 4
H413
—
H413



015-167-00-5
3-(hydroxyphenylphosphinyl)propanoic acid
411-200-6
14657-64-8
Eye Dam. 1
H318
GHS05
Dgr
H318



015-168-00-0
fosthiazate (ISO);
(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
—
98886-44-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H312
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H312
H317
H410
EUH070


015-169-00-6
tributyltetradecylphosphonium tetrafluoroborate
413-520-1
—
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H314
H317
H410



015-170-00-1
reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate
407-490-9
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



015-171-00-7
O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate
406-940-1
—
Aquatic Chronic 2
H411
GHS09
H411



015-172-00-2
reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6
—
Flam. Liq. 3
Skin Corr. 1B
Aquatic Chronic 2
H226
H314
H411
GHS02
GHS05
GHS09
Dgr
H226
H314
H411



015-173-00-8
methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate
414-080-3
117291-73-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



015-174-00-3
1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine
411-370-1
82857-68-9
Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 2
H301
H318
H411
GHS06
GHS05
GHS09
Dgr
H301
H318
H411



015-175-00-9
tert-butyl (triphenylphosphoranylidene) acetate
412-880-7
35000-38-5
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H301
H373 **
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H319
H317
H411



015-176-00-4
P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine
413-430-2
116163-96-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



015-177-00-X
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
412-170-7
83623-61-4
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373 **
H318
H317
GHS08
GHS05
Dgr
H373 **
H318
H317



015-178-00-5
(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate
418-570-8
25383-07-7
Repr. 2
Aquatic Chronic 2
H361f ***
H411
GHS08
GHS09
Wng
H361f ***
H411



015-179-00-0
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
422-720-8
166242-53-1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H302
H373 **
H314
H317
H410



015-180-00-6
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt
415-820-8
137590-32-0
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



015-181-00-1
phosphine
232-260-8
7803-51-2
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H220
H330
H314
H400
GHS02
GHS04
GHS06
GHS05
GHS09
Dgr
H220
H330
H314
H400


U


015-182-00-7
tetraisopropyldichloromethylenebisphosphonate
430-630-5
10596-22-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS06
Wng
H302
H319
H317




015-183-00-2
(1-hydroxydodecylidene)diphosphonic acid
425-230-2
16610-63-2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410





015-184-00-8
Salts of glyphosate, with the exception of those specified elsewhere in this Annex
—
—
Aquatic Chronic 2
H411
GHS09
H411


A
015-186-00-9
chlorpyrifos-methyl (ISO)
O,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-5
5598-13-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M = 10000

015-187-00-4
reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411





015-188-00-X
(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate
425-220-8
5945-33-5
Aquatic Chronic 4
H413
—
H413




015-189-00-5
phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
423-340-5
162881-26-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413





015-190-00-0
bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2
154862-43-8
Aquatic Chronic 4
H413
—
H413




015-191-00-6
dodecyldiphenyl phosphate
431-760-5
27460-02-2
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412




015-192-00-1
tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate
432-770-2
139189-30-3
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




015-193-00-7
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)
442-960-7
332350-93-3
Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H400
H410
GHS05
GHS06
GHS09
Dgr
H301
H318
H410




015-194-00-2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate
444-440-5
220689-12-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




015-195-00-8
reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate
433-860-4
—
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412




015-196-00-3
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3
—
Carc. 1B
Muta. 1B
Skin Sens. 1
H350
H340
H317
GHS08
GHS07
Dgr
H350
H340
H317




015-197-00-9
bis(2,4,4-trimethylpentyl)dithiophosphonic acid
420-160-9
107667-02-7
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H302
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H302
H314
H411




015-198-00-4
(4-phenylbutyl)phosphinic acid
420-450-5
86552-32-1
Carc. 2
Eye Dam. 1
H351
H318
GHS05
GHS08
Dgr
H351
H318





016-001-00-4
hydrogen sulphide
231-977-3
7783-06-4
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Aquatic Acute 1
H220
H330
H400
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H330
H400


U
016-002-00-X
barium sulphide
244-214-4
21109-95-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Wng
H332
H302
H400
EUH031


016-003-00-5
barium polysulphides
256-814-3
50864-67-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031


016-004-00-0
calcium sulphide
243-873-5
20548-54-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031


016-005-00-6
calcium polysulphides
215-709-2
1344-81-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400
EUH031


016-006-00-1
dipotassium sulphide;
potassium sulphide
215-197-0
1312-73-8
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031


016-007-00-7
potassium polysulphides
253-390-1
37199-66-9
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031


016-008-00-2
ammonium polysulphides
232-989-1
9080-17-5
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
EUH031: C ≥ 1 %



016-009-00-8
disodium sulfide;
sodium sulfide
215-211-5
1313-82-2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H311
H302
H314
H400
GHS06
GHS05
GHS09
Dgr
H311
H302
H314
H400




016-010-00-3
sodium polysulphides
215-686-9
1344-08-7
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
EUH031


016-011-00-9
sulphur dioxide
231-195-2
7446-09-5
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
H331
H314
GHS04
GHS06
GHS05
Dgr
H331
H314

*
U
5
016-012-00-4
disulphur dichloride;
sulfur monochloride
233-036-2
10025-67-9
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H301
H332
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H332
H314
H400
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 %

016-013-00-X
sulphur dichloride
234-129-0
10545-99-0
Skin Corr. 1B
STOT SE 3
Aquatic Acute 1
H314
H335
H400
GHS05
GHS07
GHS09
Dgr
H314
H335
H400
EUH014
STOT SE 3; H335: C ≥ 5 %

016-014-00-5
sulphur tetrachloride
—
13451-08-6
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH014
STOT SE 3; H335: C ≥ 5 %

016-015-00-0
thionyl dichloride;
thionyl chloride
231-748-8
7719-09-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H332
H302
H314
GHS05
GHS07
Dgr
H332
H302
H314
EUH014
EUH029
STOT SE 3; H335: C ≥ 1 %

016-016-00-6
sulphuryl chloride
232-245-6
7791-25-5
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014


016-017-00-1
chlorosulphonic acid
232-234-6
7790-94-5
Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014


016-018-00-7
fluorosulphonic acid
232-149-4
7789-21-1
Acute Tox. 4 *
Skin Corr. 1A
H332
H314
GHS05
GHS07
Dgr
H332
H314



016-019-00-2
oleum ... % SO3
—
—
Skin Corr. 1A
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335
EUH014

B
016-020-00-8
sulphuric acid ... %
231-639-5
7664-93-9
Skin Corr. 1A
H314
GHS05
Dgr
H314

Skin Corr. 1A; H314: C ≥ 15 %
Skin Irrit. 2; H315: 5 % ≤ C < 15 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %
B
016-021-00-3
methanethiol;
methyl mercaptan
200-822-1
74-93-1
Flam. Gas. 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H331
H410


U
016-022-00-9
ethanethiol;
ethyl mercaptan
200-837-3
75-08-1
Flam. Liq. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H400
H410
GHS02
GHS07
GHS09
Dgr
H225
H332
H410



016-023-00-4
dimethyl sulphate
201-058-1
77-78-1
Carc. 1B
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H350
H341
H330
H301
H314
H317
GHS06
GHS08
GHS05
Dgr
H350
H341
H330
H301
H314
H317

Carc. 1B; H350: C ≥ 0,01 %
Muta. 2; H341: C ≥ 0,01 %
STOT SE 3; H335: C ≥ 5 %

016-024-00-X
dimexano(ISO);
bis(methoxythiocarbonyl) disulphide
215-993-8
1468-37-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



016-025-00-5
disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES
205-259-5
149-26-8
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Dgr
H302
H315
H318



016-026-00-0
sulphamidic acid;
sulphamic acid;
sulfamic acid
226-218-8
5329-14-6
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412



016-027-00-6
diethyl sulphate
200-589-6
64-67-5
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H340
H332
H312
H302
H314
GHS05
GHS08
GHS07
Dgr
H350
H340
H332
H312
H302
H314



016-028-00-1
sodium dithionite;
sodium hydrosulphite
231-890-0
7775-14-6
Self-heat. 1
Acute Tox. 4 *
H251
H302
GHS02
GHS07
Dgr
H251
H302
EUH031


016-029-00-7
p-toluenesulphonic acid, containing more than 5 % H2SO4
—
—
Skin Corr. 1B
H314
GHS05
Dgr
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

016-030-00-2
p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)
203-180-0
104-15-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

STOT SE 3; H335: C ≥ 20 %

016-031-00-8
tetrahydrothiophene-1,1-dioxide;
sulpholane
204-783-1
126-33-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



016-032-00-3
1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide
214-317-9
1120-71-4
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H350
H312
H302
GHS08
GHS07
Dgr
H350
H312
H302

Carc. 1B; H350: C ≥ 0,01 %

016-033-00-9
dimethylsulfamoylchloride
236-412-4
13360-57-1
Carc. 1B
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H350
H330
H312
H302
H314
GHS06
GHS05
GHS08
Dgr
H350
H330
H312
H302
H314



016-034-00-4
tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)
400-010-9
81898-60-4
Skin Sens. 1
H317
GHS07
Wng
H317



016-035-00-X
pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate
400-120-7
—
Eye Irrit. 2
H319
GHS07
Wng
H319



016-036-00-5
tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate
400-130-1
—
Resp. Sens. 1
Aquatic Chronic 2
H334
H411
GHS08
GHS09
Dgr
H334
H411



016-037-00-0
disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate
400-350-8
85153-93-1
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



016-038-00-6
disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate
400-380-1
86393-35-3
Skin Sens. 1
H317
GHS07
Wng
H317



016-039-00-1
tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate
400-430-2
—
Skin Sens. 1
H317
GHS07
Wng
H317



016-040-00-7
reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate
400-570-4
—
Eye Irrit. 2
H319
GHS07
Wng
H319



016-041-00-2
calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate
400-710-4
—
Acute Tox. 4 *
H332
GHS07
Wng
H332



016-042-00-8
tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate
400-790-0
85665-97-0
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317



016-043-00-3
dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate
401-010-1
—
Skin Sens. 1
H317
GHS07
Wng
H317



016-044-00-9
disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate
401-320-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



016-045-00-4
lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate
401-560-2
108624-00-6
Skin Sens. 1
H317
GHS07
Wng
H317



016-046-00-X
sodium hydrogensulphate
231-665-7
7681-38-1
Eye Dam. 1
H318
GHS05
Dgr
H318



016-047-00-5
hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate
401-650-1
85665-96-9
Skin Sens. 1
H317
GHS07
Wng
H317



016-048-00-0
sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate
401-870-8
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



016-049-00-6
calcium octadecylxylenesulphonate
402-040-8
—
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411



016-050-00-1
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat
402-150-6
—
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



016-051-00-7
trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate
402-170-5
106359-91-5
Skin Sens. 1
H317
GHS07
Wng
H317



016-052-00-2
benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate
402-240-5
102561-46-6
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411



016-053-00-8
(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate
402-460-1
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413



016-054-00-3
sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate
400-030-8
—
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Sens. 1
H331
H372 **
H302
H319
H335
H317
GHS06
GHS08
Dgr
H331
H372 **
H302
H319
H335
H317



016-055-00-9
tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)
400-510-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



016-056-00-4
potassium hydrogensulphate
231-594-1
7646-93-7
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335



016-057-00-X
styrene-4-sulfonyl chloride
404-770-2
2633-67-2
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317



016-058-00-5
thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine
404-820-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Wng
H315
H317
H412



016-059-00-0
N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride
405-300-9
17339-60-5
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H317
H410



016-060-00-6
diammonium peroxodisulphate;
ammonium persulphate
231-786-5
7727-54-0
Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Dgr
H272
H302
H319
H335
H315
H334
H317



016-061-00-1
dipotassium peroxodisulphate;
potassium persulphate
231-781-8
7727-21-1
Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H272
H302
H319
H335
H315
H334
H317
GHS03
GHS08
GHS07
Dgr
H272
H302
H319
H335
H315
H334
H317



016-062-00-7
bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
—
17606-31-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



016-063-00-2
sodium metabisulphite
231-673-0
7681-57-4
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
EUH031


016-064-00-8
sodium hydrogensulphite . . . %;
sodium bisulphite . . . %
231-548-0
7631-90-5
Acute Tox. 4 *
H302
GHS07
Wng
H302
EUH031

B
016-065-00-3
sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate
400-100-8
84057-97-6
Aquatic Chronic 2
H411
GHS09
H411



016-066-00-9
tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)
404-070-7
116912-62-0
Aquatic Chronic 3
H412
—
H412



016-067-00-4
(4-methylphenyl)mesitylene sulfonate
407-530-5
67811-06-7
Aquatic Chronic 4
H413
—
H413



016-068-00-X
sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate
407-720-8
155160-86-4
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



016-069-00-5
3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid
407-990-7
141915-64-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



016-070-00-0
4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone
408-220-2
—
Aquatic Chronic 4
H413
—
H413



016-071-00-6
trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate
410-130-3
136248-03-8
Skin Sens. 1
H317
GHS07
Wng
H317



016-072-00-1
3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide
411-520-6
112195-27-4
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



016-073-00-7
tetrakis(phenylmethyl)thioperoxydi(carbothioamide)
404-310-0
10591-85-2
Aquatic Chronic 4
H413
—
H413



016-074-00-2
6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene
405-410-7
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411



016-075-00-8
2,2'-diallyl-4,4'-sulfonyldiphenol
411-570-9
41481-66-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



016-076-00-3
2,3-bis((2-mercaptoethyl)thio)-1-propanethiol
411-290-7
131538-00-6
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410



016-077-00-9
2-chloro-p-toluenesulfochloride
412-890-1
42413-03-6
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H314
H317
H412
GHS05
GHS07
Dgr
H314
H317
H412



016-078-00-4
4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide
413-300-5
56187-04-3
Aquatic Chronic 4
H413
—




016-079-00-X
N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide
412-920-3
16695-22-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



016-080-00-5
sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate
412-320-1
31361-99-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



016-081-00-0
hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide
418-350-1
—
Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H302
H319
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H302
H319
H317
H411



016-082-00-6
ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
—
126801-58-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



016-083-00-1
acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0
135158-54-2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H317
H410





016-084-00-7
prosulfuron (ISO);
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
—
94125-34-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=100


016-085-00-2
flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
—
104040-78-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



016-086-00-8
tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
402-590-9
109125-56-6
Eye Dam. 1
H318
GHS05
Dgr
H318



016-087-00-3
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate
403-490-8
104558-95-4
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H317
H400
H410
GHS07
GHS09
Wng
H319
H317
H410



016-088-00-9
4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid
407-280-7
71297-11-5
Aquatic Chronic 3
H412
—
H412



016-089-00-4
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene
413-840-1
—
Self-react. C ****
Aquatic Chronic 4
H242
H413
GHS02
Dgr
H242
H413



016-090-00-X
4-methyl-N-(methylsulfonyl)benzenesulfonamide
415-040-8
14653-91-9
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Dgr
H302
H335
H318



016-091-00-5
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate
414-110-5
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410





016-092-00-0
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1
—
Repr. 1A
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H361f
H315
H317
H410





016-093-00-6
reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4
140698-96-0
Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351





016-094-00-1
sulfur
231-722-6
7704-34-9
Skin Irrit. 2
H315
GHS07
Wng
H315




016-095-00-7
reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4
—
Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351



016-096-00-2
thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
—
79277-27-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





016-097-00-8
1-amino-2-methyl-2-propanethiol hydrochloride
434-480-1
32047-53-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412







017-001-00-7
chlorine
231-959-5
7782-50-5
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H331
H319
H335
H315
H400
GHS06
GHS09
Dgr
H331
H319
H335
H315
H400

M=100


017-002-00-2
hydrogen chloride
231-595-7
7647-01-0
Press. Gas
Acute Tox. 3 *
Skin Corr. 1A
H331
H314
GHS04
GHS06
GHS05
Dgr
H331
H314


U
5
017-002-01-X
hydrochloric acid ... %
231-595-7
—
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 %
B
017-003-00-8
barium chlorate
236-760-7
13477-00-4
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H332
H302
H411



017-004-00-3
potassium chlorate
223-289-7
3811-04-9
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H271
H332
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H332
H302
H411



017-005-00-9
sodium chlorate
231-887-4
7775-09-9
Ox. Sol. 1
Acute Tox. 4 *
Aquatic Chronic 2
H271
H302
H411
GHS03
GHS07
GHS09
Dgr
H271
H302
H411



017-006-00-4
perchloric acid ... %
231-512-4
7601-90-3
Ox. Liq. 1
Skin Corr. 1A
H271
H314
GHS03
GHS05
Dgr
H271
H314

Skin Corr. 1A; H314: C ≥ 50 %
Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 10 %
Ox. Liq. 1; H271: C > 50 %:
Ox. Liq. 2; H272: C ≤ 50 %:
B
017-007-00-X
barium perchlorate
236-710-4
13465-95-7
Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
H271
H332
H302
GHS03
GHS07
Dgr
H271
H332
H302



017-008-00-5
potassium perchlorate
231-912-9
7778-74-7
Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Dgr
H271
H302





017-009-00-0
ammonium perchlorate
232-235-1
7790-98-9
Expl. 1.1
Ox. Sol. 1
H201
H271
GHS01
Dgr
H201
H271


T


017-010-00-6
sodium perchlorate
231-511-9
7601-89-0
Ox. Sol. 1
Acute Tox. 4 *
H271
H302
GHS03
GHS07
Dgr
H271
H302



017-011-00-1
sodium hypochlorite, solution ... % Cl active
231-668-3
7681-52-9
Skin Corr. 1B
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
EUH031
EUH031: C ≥ 5 %
B


017-012-00-7
calcium hypochlorite
231-908-7
7778-54-3
Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H272
H302
H314
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H400
EUH031
Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H; 315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
STOT SE 3; H335: C ≥ 3 %
M=10
T

017-013-00-2
calcium chloride
233-140-8
10043-52-4
Eye Irrit. 2
H319
GHS07
Wng
H319



017-014-00-8
ammonium chloride
235-186-4
12125-02-9
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



017-015-00-3
(2-(aminomethyl)phenyl)acetylchloride hydrochloride
417-410-4
61807-67-8
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317



017-016-00-9
methyltriphenylphosphonium chloride
418-400-2
1031-15-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H411



017-017-00-4
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride
426-210-6
120086-58-0
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410



017-018-00-X
N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride
405-660-7
—
Aquatic Chronic 2
H411
GHS09
H411



017-019-00-5
(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride
415-110-8
54417-53-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



017-020-00-0
ethyl propoxy aluminium chloride
421-790-7
13014-29-4
Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014


017-021-00-6
behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride
423-420-1
136920-10-0
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410





017-023-00-7
[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides
425-520-9
197179-61-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




019-001-00-2
potassium
231-119-8
7440-09-7
Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014


019-002-00-8
potassium hydroxide;
caustic potash
215-181-3
1310-58-3
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314

Skin Corr. 1A; H314: C ≥ 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %

020-001-00-X
calcium
231-179-5
7440-70-2
Water-react. 2
H261
GHS02
Dgr
H261



020-002-00-5
calcium cyanide
209-740-0
592-01-8
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410
EUH032


020-003-00-0
reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4
—
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317



022-001-00-5
titanium tetrachloride
231-441-9
7550-45-0
Skin Corr. 1B
H314
GHS05
Dgr
H314
EUH014


022-002-00-0
titanium(4+) oxalate
403-260-7
—
Eye Dam. 1
H318
GHS05
Dgr
H318



022-003-00-6
bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium
412-000-1
125051-32-3
Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H228
H361f ***
H373 **
H411
GHS02
GHS08
GHS09
Dgr
H228
H361f ***
H373 **
H411


T


022-004-00-1
potassium titanium oxide (K2Ti6O13)
432-240-0
12056-51-8
Carc. 2
H351
GHS08
Dgr
H351




022-005-00-7
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium
419-840-8
169104-71-6
Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H228
H314
H317
H413
GHS02
GHS05
GHS07
Dgr
H228
H314
H317
H413




023-001-00-8
divanadium pentaoxide;
vanadium pentoxide
215-239-8
1314-62-1
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2
H341
H361d ***
H372 **
H332
H302
H335
H411
GHS08
GHS07
GHS09
Dgr
H341
H361d ***
H372 **
H332
H302
H335
H411



024-001-00-0
chromium (VI) trioxide
215-607-8
1333-82-0
Ox. Sol. 1
Carc. 1A
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H410

STOT SE 3; H335: C ≥ 1 %

024-002-00-6
potassium dichromate
231-906-6
7778-50-9
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

STOT SE 3; H335: C ≥ 5 %
3
024-003-00-1
ammonium dichromate
232-143-1
7789-09-5
Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
G
3


024-004-00-7
sodium dichromate
234-190-3
10588-01-9
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H400
H410
GHS03
GHS06
GHS05
GHS08
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H410

Resp. Sens. 1; H334: C ≥ 0,2 %
Skin Sens. 1; H317: C ≥ 0,2 %
STOT SE 3; H335: C ≥ 5 %




024-004-01-4
sodium dichromate, dihydrate
234-190-3
7789-12-0
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

STOT SE 3; H335: C ≥ 5 %
Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
3

024-005-00-2
chromyl dichloride;
chromic oxychloride
239-056-8
14977-61-8
Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350i
H340
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350i
H340
H314
H317
H410

Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 5 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: 0,5 % ≤ C < 5 %
Skin Sens. 1; H317: C ≥ 0,5 %
T
3
024-006-00-8
potassium chromate
232-140-5
7789-00-6
Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H340
H319
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H340
H319
H335
H315
H317
H410

Skin Sens. 1; H317: C ≥ 0,5 %
3
024-007-00-3
zinc chromates including zinc potassium chromate
—
—
Carc. 1A
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H410


A
024-008-00-9
calcium chromate
237-366-8
13765-19-0
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410



024-009-00-4
strontium chromate
232-142-6
7789-06-2
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H400
H410



024-010-00-X
dichromium tris(chromate);
chromium III chromate;
chromic chromate
246-356-2
24613-89-6
Ox. Sol. 1
Carc. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350
H314
H317
H410


T
024-011-00-5
ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)
400-110-2
109125-51-1
Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Dgr
H242
H410



024-012-00-0
trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)
400-810-8
—
Muta. 2
H341
GHS08
Wng
H341



024-013-00-6
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)
402-500-8
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



024-014-00-1
trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)
402-870-0
93952-24-0
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



024-015-00-7
disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)
404-930-1
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H332
H318
H411
GHS05
GHS07
GHS09
Dgr
H332
H318
H411



024-016-00-2
tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)
405-110-6
88377-66-6
STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413



024-017-00-8
Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex
—
—
Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H317
H410


A
024-018-00-3
sodium chromate
231-889-5
7775-11-3
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

Resp. Sens.; H334: C ≥ 0,2 %
Skin Sens.; H317: C ≥ 0,2 %
3
024-019-00-9
Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-230-1
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



024-020-00-4
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)
418-220-4
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412






024-021-00-X
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)
425-830-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318




025-001-00-3
manganese dioxide
215-202-6
1313-13-9
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302



025-002-00-9
potassium permanganate
231-760-3
7722-64-7
Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H410



025-003-00-4
manganese sulphate
232-089-9
7785-87-7
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411



025-004-00-X
bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate
411-760-1
116633-53-5
Aquatic Chronic 2
H411
GHS09
H411



025-005-00-5
reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)
417-660-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



026-001-00-6
(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate
407-840-0
100011-37-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412



026-002-00-1
(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate
407-880-9
117549-13-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412





026-003-00-7
iron (II) sulfate
231-753-5
7720-78-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315




026-003-01-4
iron (II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-5
7782-63-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315

Skin Irrit. 2; H315: C ≥ 25 %


026-004-00-2
potassium ferrite
430-010-4
12160-44-0
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317




027-001-00-9
cobalt
231-158-0
7440-48-4
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413





027-002-00-4
cobalt oxide
215-154-6
1307-96-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410

M=10


027-003-00-X
cobalt sulfide
215-273-3
1317-42-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M=10


027-004-00-5
cobalt dichloride
231-589-4
7646-79-9
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F***
H302
H334
H317
H410

Carc. 1B; H350i: C ≥ 0,01 %
M=10
1

027-005-00-0
cobalt sulfate
233-334-2
10124-43-3
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F***
H302
H334
H317
H410

Carc. 1B; H350i: C ≥ 0,01 %
M=10
1



027-006-00-6
cobalt acetate
200-755-8
71-48-7
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C ≥ 0,01 %
M=10
1

027-007-00-1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex
425-240-7
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411




027-008-00-7
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,2<n<3)
427-390-9
—
Skin Sens. 1
H317
GHS07
Wng
H317




027-009-00-2
cobalt nitrate
233-402-1
10141-05-6
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C ≥ 0,01 %
M=10
1

027-010-00-8
cobalt carbonate
208-169-4
513-79-1
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C ≥ 0,01 %
M=10
1


028-001-00-1
tetracarbonylnickel;
nickel tetracarbonyl
236-669-2
13463-39-3
Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H351
H360D ***
H330
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H225
H351
H360D ***
H330
H410





028-002-00-7
nickel
231-111-4
7440-02-0
Carc. 2
STOT RE 1
Skin Sens. 1
H351
H372**
H317
GHS08
GHS07
Dgr
H351
H372**
H317


S
7



028-002-01-4
nickel powder;
[particle diameter < 1 mm]
231-111-4
7440-02-0
Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H351
H372**
H317
H412
GHS08
GHS07
Dgr
H351
H372**
H317
H412






028-003-00-2
nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
215-215-7 [1]
234-323-5 [2]
- [3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413




028-004-00-8
nickel dioxide
234-823-3
12035-36-8
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413




028-005-00-3
dinickel trioxide
215-217-8
1314-06-3
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372**
H317
H413
GHS08
GHS07
Dgr
H350i
H372**
H317
H413




028-006-00-9
nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
240-841-2 [1]
234-349-7 [2]
- [3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372**
H317
H410




028-007-00-4
trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
234-829-6 [1]
- [2]
12035-72-2 [1]
12035-71-1 [2]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372**
H317
H410




028-008-00-X
nickel dihydroxide; [1]
nickel hydroxide [2]
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H410




028-009-00-5
nickel sulfate
232-104-9
7786-81-4
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410

STOT RE 1; H373: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1


028-010-00-0
nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[μ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]
222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]
3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410






028-011-00-6
nickel dichloride
231-743-0
7718-54-9
Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410

STOT RE. 1; H373: C ≥ 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1


028-012-00-1
nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H410

STOT RE. 1; H373: C ≥ 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1


028-013-00-7
nickel matte
273-749-6
69012-50-6
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-014-00-2
slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
295-859-3
92129-57-2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1


028-015-00-8
slimes and sludges, copper electrolyte refining, decopperised
305-433-1
94551-87-8
Carc. 1A
Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410


H

028-016-00-3
nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-1
13637-71-3
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-017-00-9
nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-018-00-4
nickel bis(sulfamidate);
nickel sulfamate
237-396-1
13770-89-3
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-019-00-X
nickel bis(tetrafluoroborate)
238-753-4
14708-14-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-021-00-0
nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-022-00-6
nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
E H

028-024-00-7
nickel dibenzoate
209-046-8
553-71-9
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-025-00-2
nickel bis(4-cyclohexylbutyrate)
223-463-2
3906-55-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1


028-026-00-8
nickel(II) stearate;
nickel(II) octadecanoate
218-744-1
2223-95-2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-027-00-3
nickel dilactate
—
16039-61-5
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-028-00-9
nickel(II) octanoate
225-656-7
4995-91-9
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H314
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-029-00-4
nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-030-00-X
nickel hexafluorosilicate
247-430-7
26043-11-8
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-031-00-5
nickel selenate
239-125-2
15060-62-5
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-032-00-0
nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410


H

028-033-00-6
diammonium nickel hexacyanoferrate
—
74195-78-1
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410


H

028-034-00-1
nickel dicyanide
209-160-8
557-19-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410
EUH032

H

028-035-00-7
nickel chromate
238-766-5
14721-18-7
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410


H

028-036-00-2
nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-037-00-8
dinickel hexacyanoferrate
238-946-3
14874-78-3
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-038-00-3
trinickel bis(arsenate);
nickel(II) arsenate
236-771-7
13477-70-8
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H372**
H317
H410


H

028-039-00-9
nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-040-00-4
nickel telluride
235-260-6
12142-88-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-041-00-X
trinickel tetrasulfide
—
12137-12-1
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-042-00-5
trinickel bis(arsenite)
—
74646-29-0
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-043-00-0
cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317


H

028-044-00-6
nickel tin trioxide;
nickel stannate
234-824-9
12035-38-0
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317


H

028-045-00-1
nickel triuranium decaoxide
239-876-6
15780-33-3
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317


H

028-046-00-7
nickel dithiocyanate
237-205-1
13689-92-4
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410
EUH032
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-047-00-2
nickel dichromate
239-646-5
15586-38-6
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-048-00-8
nickel(II) selenite
233-263-7
10101-96-9
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410


H

028-049-00-3
nickel selenide
215-216-2
1314-05-2
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-050-00-9
silicic acid, lead nickel salt
—
68130-19-8
Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360Df
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360Df
H372**
H317
H410


H

028-051-00-4
nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-052-00-X
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-6
68610-24-2
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317


H

028-053-00-5
nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %1
M=1
H

028-054-00-0
nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O1,O2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M=1
H

028-055-00-6
nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372**
H334
H317
H410


H

028-056-00-1
nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372**
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372**
H317
H410


H

028-057-00-7
dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317


H

028-058-00-2
cobalt lithium nickel oxide
442-750-5
—
Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H330
H372**
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H330
H372**
H317
H410




029-001-00-4
copper chloride;
copper (I) chloride;
cuprous chloride
231-842-9
7758-89-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H400
H410



029-002-00-X
dicopper oxide;
copper (I) oxide
215-270-7
1317-39-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



029-003-00-5
Naphthenic acids, copper salts;
copper naphthenate
215-657-0
1338-02-9
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H400
H410
GHS02
GHS07
GHS09
Wng
H226
H302
H410



029-004-00-0
copper sulphate
231-847-6
7758-98-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410



029-005-00-6
(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid
401-260-1
—
Eye Irrit. 2
H319
GHS07
Wng
H319



029-006-00-1
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)
403-210-4
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



029-007-00-7
(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide
404-670-9
89797-01-3
Skin Sens. 1
H317
GHS07
Wng
H317


G
029-008-00-2
copper(II) methanesulfonate
405-400-2
54253-62-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410



029-009-00-8
phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex
413-650-9
93971-95-0
Aquatic Chronic 3
H412
—
H412



029-010-00-3
reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)
407-700-9
101408-30-4
Skin Sens. 1
H317
GHS07
Wng
H317



029-011-00-9
sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex
412-730-0
150522-10-4
Skin Corr. 1B
H314
GHS05
Dgr
H314



029-012-00-4
sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)
407-340-2
124719-24-0
Eye Dam. 1
H318
GHS05
Dgr
H318





029-013-00-X
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)
407-580-8
130201-51-3
Eye Dam. 1
H318
GHS05
Dgr
H318






029-014-00-5
reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex
419-610-7
171866-24-3
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411





030-001-00-1
zinc powder — zinc dust (pyrophoric)
231-175-3
7440-66-6
Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1
H260
H250
H400
H410
GHS02
GHS09
Dgr
H260
H250
H410


T
030-001-01-9
zinc powder — zinc dust (stabilised)
231-175-3
7440-66-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



030-003-00-2
zinc chloride
231-592-0
7646-85-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410

STOT SE 3; H335: C ≥ 5 %

030-004-00-8
dimethylzinc; [1]
diethylzinc [2]
208-884-1 [1]
209-161-3 [2]
544-97-8 [1]
557-20-0 [2]
Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H250
H260
H314
H400
H410
GHS02
GHS05
GHS09
Dgr
H250
H260
H314
H410
EUH014


030-005-00-3
diamminediisocyanatozinc
401-610-3
—
Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H302
H318
H334
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H318
H334
H317
H400



030-006-00-9
zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2]
231-793-3 [1]
231-793-3 [2]
7446-19-7 [1]
7733-02-0 [2]
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410



030-007-00-4
bis(3,5-di-tert-butylsalicylato-O1,O2)zinc
403-360-0
42405-40-3
Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Dgr
H228
H302
H410


T
030-008-00-X
hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)
403-750-0
113036-91-2
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411





030-009-00-5
zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate
417-130-2
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411




030-010-00-0
2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt
430-740-3
—
Aquatic Chronic 2
H411
GHS09
H411




030-011-00-6
trizinc bis(orthophosphate)
231-944-3
7779-90-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
Aquatic Chronic 3
H412
—
H412




030-013-00-7
zinc oxide
215-222-5
1314-13-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





030-015-00-8
tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate
440-060-9
—
Aquatic Chronic 2
H411
GHS09
H411




033-001-00-X
arsenic
231-148-6
7440-38-2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410



033-002-00-5
arsenic compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410

*
A
1
033-003-00-0
diarsenic trioxide;
arsenic trioxide
215-481-4
1327-53-3
Carc. 1A
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H300
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H300
H314
H410



033-004-00-6
diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide
215-116-9
1303-28-2
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410





033-005-00-1
arsenic acid and its salts with the exception of those specified elsewhere in this Annex
—
—
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410


A

033-006-00-7
arsine
232-066-3
7784-42-1
Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H330
H373 **
H400
H410
GHS02
GHS04
GHS06
GHS08
GHS09
Dgr
H220
H330
H373 **
H410


U
033-007-00-2
tert-butylarsine
423-320-6
4262-43-5
Pyr. Liq. 1
Acute Tox. 2 *
H250
H330
GHS02
GHS06
Dgr
H250
H330



034-001-00-2
selenium
231-957-4
7782-49-2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4
H331
H301
H373 **
H413
GHS06
GHS08
Dgr
H331
H301
H373 **
H413





034-002-00-8
selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H373**
H410


A

034-003-00-3
sodium selenite
233-267-9
10102-18-8
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2
H300
H331
H317
H411
GHS06
GHS09
Dgr
H300
H331
H317
H411
EUH031


035-001-00-5
bromine
231-778-1
7726-95-6
Acute Tox. 2 *
Skin Corr. 1A
Aquatic Acute 1
H330
H314
H400
GHS06
GHS05
GHS09
Dgr
H330
H314
H400



035-002-00-0
hydrogen bromide
233-113-0
10035-10-6
Press. Gas
Skin Corr. 1A
STOT SE 3
H314
H335
GHS04
GHS05
GHS07
Dgr
H314
H335


U
035-002-01-8
hydrobromic acid ... %
—
—
Skin Corr. 1B
STOT SE 3
H314
H335
GHS05
GHS07
Dgr
H314
H335

Skin Corr. 1B; H314: C ≥ 40 %
Skin Irrit. 2; H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319: 10 % ≤ C < 40 %
STOT SE 3; H335: C ≥ 10 %
B
035-003-00-6
potassium bromate
231-829-8
7758-01-2
Ox. Sol. 1
Carc. 1B
Acute Tox. 3 *
H271
H350
H301
GHS03
GHS06
GHS08
Dgr
H271
H350
H301



035-004-00-1
2-hydroxyethylammonium perbromide
407-440-6
—
Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H272
H302
H314
H317
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H317
H400



040-001-00-3
zirconium powder (pyrophoric)
231-176-9
7440-67-7
Water-react. 1
Pyr. Sol. 1
H260
H250
GHS02
Dgr
H260
H250


T
040-002-00-9
zirconium powder, dry (non pyrophoric)
—
—
Self-heat. 1
H251
GHS02
Dgr
H251


T



040-003-00-4
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1,0: 1,0 to 1,0: 1,5
430-610-6
226996-19-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410






042-001-00-9
molybdenum trioxide
215-204-7
1313-27-5
Carc. 2
Eye Irrit. 2
STOT SE 3
H351
H319
H335
GHS08
GHS07
Wng
H351
H319
H335




042-002-00-4
tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)
404-760-8
117342-25-3
Acute Tox. 3 *
Eye Dam. 1
H331
H318
GHS06
GHS05
Dgr
H331
H318




042-003-00-X
tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)
404-860-1
116810-46-9
Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H228
H318
H400
H410
GHS02
GHS05
GHS09
Dgr
H228
H318
H410


T
042-004-00-5
Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)
412-780-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411





042-005-00-0
reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex
434-240-6
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




046-001-00-X
tetraammine palladium (II) hydrogen carbonate
425-270-0
134620-00-1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H318
H317
H410






047-001-00-2
silver nitrate
231-853-9
7761-88-8
Ox. Sol. 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H272
H314
H400
H410
GHS03
GHS05
GHS09
Dgr
H272
H314
H410






047-002-00-8
polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt
416-850-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




048-001-00-5
cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),
reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

*
A
1
048-002-00-0
cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]
215-146-2 [2]
7440-43-9 [1]
1306-19-0 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361fd
H330
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361fd
H330
H372 **
H410



048-003-00-6
cadmium diformate;
cadmiumformate
224-729-0
4464-23-7
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,25 %

048-004-00-1
cadmium cyanide
208-829-1
542-83-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H351
H373 **
H410
EUH032
STOT RE 2; H373: C ≥ 0,1 %
EUH032: C ≥ 1 %

048-005-00-7
cadmiumhexafluorosilicate(2-);
cadmium fluorosilica
241-084-0
17010-21-8
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,1 %

048-006-00-2
cadmium fluoride
232-222-0
7790-79-6
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2: 0,1 % ≤ C < 7 %

048-007-00-8
cadmium iodide
232-223-6
7790-80-9
Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H351
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,1 %

048-008-00-3
cadmium chloride
233-296-7
10108-64-2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %

048-009-00-9
cadmium sulphate
233-331-6
10124-36-4
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C ≥ 0,01 %
* oral
STOT RE 1; H372: C ≥ 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %

048-010-00-4
cadmium sulphide
215-147-8
1306-23-6
Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4
H350
H341
H361fd
H372 **
H302
H413
GHS08
GHS07
Dgr
H350
H341
H361fd
H372 **
H302
H413

*
STOT RE 1; H372: C ≥ 10 %
STOT RE 2; H373: 0,1 % ≤ C < 10 %
1
048-011-00-X
cadmium (pyrophoric)
231-152-8
7440-43-9
Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H250
H350
H341
H361fd
H330
H372 **
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H250
H350
H341
H361fd
H330
H372 **
H410



050-001-00-5
tin tetrachloride;
stannic chloride
231-588-9
7646-78-8
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412

STOT SE 3; H335: C ≥ 5 %



050-002-00-0
cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide
236-049-1
13121-70-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

M=1000


050-003-00-6
fentin acetate (ISO);
triphenyltin acetate
212-984-0
900-95-8
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410

M=10


050-004-00-1
fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-6
76-87-9
Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410

M=10


050-005-00-7
trimethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410

*
A
1
050-006-00-2
triethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410

*
A
1
050-007-00-8
tripropyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410

*
A
1


050-008-00-3
tributyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372**
H319
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H312
H372**
H319
H315
H410

*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
Skin Irrit. 2; C ≥ 1 %
Eye Irrit. 2; C ≥ 1 %
M=10
A
1

050-009-00-9
fluorotripentylstannane; [1]
hexapentyldistannoxane [2]
243-546-7 [1]
247-143-7 [2]
20153-49-5 [1]
25637-27-8 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

*
1
050-010-00-4
fluorotrihexylstannane
243-547-2
20153-50-8
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

*
1


050-011-00-X
triphenyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410

*
M=100
A
1

050-012-00-5
tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3]
215-910-5 [1]
221-437-5 [2]
230-358-5 [3]
1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410

*
A
1
050-013-00-0
trioctyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4
H319
H335
H315
H413
GHS07
Wng
H319
H335
H315
H413

Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %
A
1
050-017-00-2
fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-7
13356-08-6
Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H319
H315
H400
H410
GHS06
GHS09
Dgr
H330
H319
H315
H410





050-018-00-8
tin(II) methanesulphonate
401-640-7
53408-94-9
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H411




050-019-00-3
azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H-1,2,4-triazole
255-209-1
41083-11-8
Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H301
H335
H315
H318
H410



050-020-00-9
trioctylstannane
413-320-4
869-59-0
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4
H372 **
H315
H413
GHS08
GHS07
Dgr
H372 **
H315
H413





050-021-00-4
dichlorodioctyl stannane
222-583-2
3542-36-7
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H331
H372**
H412
GHS06
GHS08
Dgr
H331
H372**
H412




050-022-00-X
dibutyltin dichloride;
(DBTC)
211-670-0
683-18-1
Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H360FD
H330
H301
H312
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H360FD
H330
H301
H312
H372**
H314
H410

Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %
M=10


050-023-00-5
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5
—
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410

M=10


050-024-00-0
reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6
—
STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H315
H318
H317
H410





051-001-00-8
antimony trichloride
233-047-2
10025-91-9
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411

STOT SE 3; H335: C ≥ 5 %

051-002-00-3
antimony pentachloride
231-601-8
7647-18-9
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411

STOT SE 3; H335: C ≥ 5 %

051-003-00-9
antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411

*
A
1
051-004-00-4
antimony trifluoride
232-009-2
7783-56-4
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411



051-005-00-X
antimony trioxide
215-175-0
1309-64-4
Carc. 2
H351
GHS08
Wng
H351



051-006-00-5
diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate
403-500-0
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



051-007-00-0
bis(4-dodecylphenyl)iodonium hexafluoroantimonate
404-420-9
71786-70-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



053-001-00-3
iodine
231-442-4
7553-56-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H312
H400
GHS07
GHS09
Wng
H332
H312
H400



053-002-00-9
hydrogen iodide
233-109-9
10034-85-2
Press. Gas
Skin Corr. 1A
H314
GHS04
GHS05
Dgr
H314

Skin Corr. 1A; H314: C ≥ 10 %
Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %
Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %
STOT SE 3; H335: C ≥ 0,02 %
U
5
053-002-01-6
hydriodic acid ... %
—
—
Skin Corr. 1B
H314
GHS05
Dgr


Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
053-005-00-5
(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)
422-960-3
178233-72-2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373 **
H410



056-001-00-1
barium peroxide
215-128-4
1304-29-6
Ox. Sol. 2
Acute Tox. 4 *
Acute Tox. 4 *
H272
H332
H302
GHS03
GHS07
Dgr
H272
H332
H302



056-002-00-7
barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302

*
A
1
056-003-00-2
barium carbonate
208-167-3
513-77-9
Acute Tox. 4 *
H302
GHS07
Wng
H302



056-004-00-8
barium chloride
233-788-1
10361-37-2
Acute Tox. 3 *
Acute Tox. 4 *
H301
H332
GHS06
Dgr
H301
H332





064-001-00-8
gadolinium(III)sulfite trihydrate
456-900-2
51285-81-5
Aquatic Chronic 2
H411
GHS09
H411




072-001-00-4
hafnium tetra-n-butoxide
411-740-2
22411-22-9
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



074-001-00-X
hexasodium tungstate hydrate
412-770-9
12141-67-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412



074-002-00-5
Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione
408-250-6
—
Flam. Liq. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H332
H314
H317
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H314
H317
H410



076-001-00-5
osmium tetraoxide;
osmic acid
244-058-7
20816-12-0
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
H330
H310
H300
H314
GHS06
GHS05
Dgr
H330
H310
H300
H314



078-001-00-0
tetrachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317


A
078-002-00-6
diammonium tetrachloroplatinate
237-499-1
13820-41-2
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317



078-003-00-1
disodium tetrachloroplatinate
233-051-4
10026-00-3
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317



078-004-00-7
dipotassium tetrachloroplatinate
233-050-9
10025-99-7
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H315
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H315
H318
H334
H317



078-005-00-2
hexachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317


A
078-006-00-8
disodium hexachloroplatinate
240-983-5
16923-58-3
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317



078-007-00-3
dipotassium hexachloroplatinate
240-979-3
16921-30-5
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317



078-008-00-9
diammonium hexachloroplatinate
240-973-0
16919-58-7
Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H301
H318
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H318
H334
H317



078-009-00-4
hexachloroplatinic acid
241-010-7
16941-12-1
Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H301
H314
H334
H317
GHS06
GHS05
GHS08
Dgr
H301
H314
H334
H317





078-010-00-X
tetraammine platinum (II) hydrogen carbonate
426-730-3
123439-82-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




078-011-00-5
hydroxydisulfito platinum(II) acid
423-310-1
61420-92-6
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373
H314
H334
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373
H314
H334
H317
H412




078-012-00-0
platinum(IV) nitrate/nitric acid solution
432-400-1
—
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410






080-001-00-0
mercury
231-106-7
7439-97-6
Repr. 1B
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H330
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D***
H330
H372**
H410




080-002-00-6
inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,1 %
A
1
080-003-00-1
dimercury dichloride;
mercurous chloride;
calomel
233-307-5
10112-91-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410



080-004-00-7
organic compounds of mercury with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,1 %
A
1
080-005-00-2
mercury difulminate;
mercuric fulminate;
fulminate of mercury
211-057-8
628-86-4
Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H200
H331
H311
H301
H373 **
H400
H410



080-005-01-X
mercury difulminate;
mercuric fulminate;
fulminate of mercury [≥ 20 % phlegmatiser]
211-057-8
628-86-4
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373 **
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373 **
H400
H410





080-006-00-8
dimercury dicyanide oxide;
mercuric oxycyanide
215-629-8
1335-31-5
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H331
H311
H301
H373**
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373**
H410





080-007-00-3
dimethylmercury; [1]
diethylmercury [2]
209-805-3 [1]
211-000-7 [2]
593-74-8 [1]
627-44-1 [2]
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C ≥ 0,05 %
1
080-008-00-9
phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3]
200-242-9 [1]
202-866-7 [2]
-[3]
55-68-5 [1]
100-57-2 [2]
8003-05-2 [3]
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 **
H314
H410



080-009-00-4
2-methoxyethylmercury chloride
204-659-7
123-88-6
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 **
H314
H410





080-010-00-X
mercury dichloride;
mercuric chloride
231-299-8
7487-94-7
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H341
H361f***
H300
H372**
H314
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H341
H361f***
H300
H372**
H314
H410





080-011-00-5
phenylmercury acetate
200-532-5
62-38-4
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H301
H372 **
H314
H410



081-001-00-3
thallium
231-138-1
7440-28-0
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Dgr
H330
H300
H373 **
H413



081-002-00-9
thallium compounds, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H373 **
H411


A
081-003-00-4
dithallium sulphate;
thallic sulphate
231-201-3
7446-18-6
Acute Tox. 2 *
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 2
H300
H372 **
H315
H411
GHS06
GHS08
GHS09
Dgr
H300
H372 **
H315
H411



082-001-00-6
lead compounds with the exception of those specified elsewhere in this Annex
—
—
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H360Df
H332
H302
H373 **
H410

Repr. 2; H361f: C ≥ 2,5 %
*
STOT RE 2; H373: C ≥ 0,5 %
A
1
082-002-00-1
lead alkyls
—
—
Repr. 1A
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H330
H310
H300
H373 **
H410

Repr. 1A; H360D: C ≥ 0,1 %
*
STOT RE 2; H373: C ≥ 0,05 %
A
1
082-003-00-7
lead diazide;
lead azide
236-542-1
13424-46-9
Unst. Expl.
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H200
H360Df
H332
H302
H373 **
H410


1
082-003-01-4
lead diazide;
lead azide [≥ 20 % phlegmatiser]
236-542-1
13424-46-9
Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H360Df
H332
H302
H373 **
H410


1


082-004-00-2
lead chromate
231-846-0
7758-97-6
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410


1


082-005-00-8
lead di(acetate)
206-104-4
301-04-2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 **
H410


1
082-006-00-3
trilead bis(orthophosphate)
231-205-5
7446-27-7
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 **
H410


1
082-007-00-9
lead acetate, basic
215-630-3
1335-32-6
Carc. 2
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H351
H360Df
H373 **
H410


1
082-008-00-4
lead(II) methanesulphonate
401-750-5
17570-76-2
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H360Df
H332
H302
H373 **
H315
H318
GHS08
GHS05
GHS07
Dgr
H360Df
H332
H302
H373 **
H315
H318


1


082-009-00-X
lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-7
1344-37-2
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410


1

082-010-00-5
lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-9
12656-85-8
Carc. 1B
Repr. 1A
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H373**
H400
H410
GHS08
GHS09
Dgr
H350
H360Df
H373**
H410


1

082-011-00-0
lead hydrogen arsenate
232-064-2
7784-40-9
Carc. 1A
Repr. 1A
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H360Df
H331
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H360Df
H331
H301
H373 **
H410


1


082-012-00-6
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped
431-780-4
199876-46-5
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411




092-001-00-8
uranium
231-170-6
7440-61-1
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4
H330
H300
H373 **
H413
GHS06
GHS08
Dgr
H330
H300
H373 **
H413






092-002-00-3
uranium compounds with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H373**
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H373**
H411


A

601-001-00-4
methane
200-812-7
74-82-8
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
601-002-00-X
ethane
200-814-8
74-84-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
601-003-00-5
propane
200-827-9
74-98-6
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
601-004-00-0
butane; [1]
and isobutane [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


C U
601-004-01-8
butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340


C S U
601-005-00-6
2,2-dimethylpropane;
neopentane
207-343-7
463-82-1
Flam. Gas 1
Press. Gas
Aquatic Chronic 2
H220
H411
GHS02
GHS04
GHS09
Dgr
H220
H411


U
601-006-00-1
pentane
203-692-4
109-66-0
Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H225
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H336
H411
EUH066

C


601-007-00-7
hexane (containing < 5 % n-hexane (203-777-6));
2-methylpentane; [1]
3-methylpentane; [2]
2,2-dimethylbutane; [3]
2,3-dimethylbutane [4]
203-523-4 [1]
202-481-4 [2]
200-906-8 [3]
201-193-6 [4]
107-83-5 [1]
96-14-0 [2]
75-83-2 [3]
79-29-8 [4]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411


C

601-008-00-2
heptane;
n-heptane; [1]
2,4-dimethylpentane; [2]
2,2,3-trimethylbutane; [3]
3,3-dimethylpentane; [4]
2,3-dimethylpentane; [5]
3-methylhexane; [6]
2,2-dimethylpentane; [7]
2-methylhexane; [8]
3-ethylpentane; [9]
isoheptane; [10]
205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10]
142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410


C

601-009-00-8
octane;
n-octane; [1]
2,2,4-trimethylpentane; [2]
2,3,3-trimethylpentane; [3]
3,3-dimethylhexane; [4]
2,2,3-trimethylpentane; [5]
2,3,4-trimethylpentane; [6]
3,4-dimethylhexane; [7]
2,3-dimethylhexane; [8]
2,4-dimethylhexane; [9]
4-methylheptane; [10]
3-methylheptane; [11]
2,2-dimethylhexane; [12]
2,5-dimethylhexane; [13]
2-methylheptane; [14]
2,2,3,3-tetramethylbutane; [15]
3-ethyl-2-methylpentane; [16]
3-ethylhexane; [17]
3-ethyl-3-methylpentane; [18]
isooctane; [19]
203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19]
111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19]
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410


C

601-010-00-3
ethylene
200-815-3
74-85-1
Flam. Gas 1
Press. Gas
STOT SE 3
H220
H336
GHS02
GHS04
GHS07
Dgr
H220
H336


U
601-011-00-9
propene;
propylene
204-062-1
115-07-1
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
601-012-00-4
but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5]
203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5]
106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5]
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


C U
601-013-00-X
1,3-butadiene;
buta-1,3-diene
203-450-8
106-99-0
Flam. Gas 1
Press. Gas
Carc. 1A
Muta. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340


D U
601-014-00-5
isoprene (stabilised)
2-methyl-1,3-butadiene
201-143-3
78-79-5
Flam. Liq. 1
Carc. 1B
Muta. 2
Aquatic Chronic 3
H224
H350
H341
H412
GHS02
GHS08
Dgr
H224
H350
H341
H412


D
601-015-00-0
acetylene;
ethyne
200-816-9
74-86-2
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220
EUH006

U
601-016-00-6
cyclopropane
200-847-8
75-19-4
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
601-017-00-1
cyclohexane
203-806-2
110-82-7
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H225
H304
H315
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H410



601-018-00-7
methylcyclohexane
203-624-3
108-87-2
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411



601-019-00-2
1,4-dimethylcyclohexane
209-663-2
589-90-2
Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H304
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H304
H315
H336
H411



601-020-00-8
benzene
200-753-7
71-43-2
Flam. Liq. 2
Carc. 1A
Muta. 1B
STOT RE 1
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
H225
H350
H340
H372 **
H304
H319
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H340
H372 **
H304
H319
H315


E
601-021-00-3
toluene
203-625-9
108-88-3
Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
H225
H361d ***
H304
H373 **
H315
H336
GHS02
GHS08
GHS07
Dgr
H225
H361d ***
H304
H373 **
H315
H336



601-022-00-9
o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4]
202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4]
95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4]
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H226
H332
H312
H315
GHS02
GHS07
Wng
H226
H332
H312
H315

*
C
601-023-00-4
ethylbenzene
202-849-4
100-41-4
Flam. Liq. 2
Acute Tox. 4 *
H225
H332
GHS02
GHS07
Dgr
H225
H332



601-024-00-X
cumene; [1]
propylbenzene [2]
202-704-5 [1]
203-132-9 [2]
98-82-8 [1]
103-65-1 [2]
Flam. Liq. 3
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H226
H304
H335
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H304
H335
H411


C
601-025-00-5
mesitylene;
1,3,5-trimethylbenzene
203-604-4
108-67-8
Flam. Liq. 3
STOT SE 3
Aquatic Chronic 2
H226
H335
H411
GHS02
GHS07
GHS09
Wng
H226
H335
H411

STOT SE 3; H335: C ≥ 25 %

601-026-00-0
styrene
202-851-5
100-42-5
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H226
H332
H319
H315
GHS02
GHS07
Wng
H226
H332
H319
H315

*
D
601-027-00-6
2-phenylpropene;
α-methylstyrene
202-705-0
98-83-9
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2
H226
H319
H335
H411
GHS02
GHS07
GHS09
Wng
H226
H319
H335
H411

STOT SE 3; H335: C ≥ 25 %

601-028-00-1
2-methylstyrene;
2-vinyltoluene
210-256-7
611-15-4
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411



601-029-00-7
dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5]
138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5]
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H315
H317
H400
H410
GHS02
GHS07
GHS09
Wng
H226
H315
H317
H410


C
601-030-00-2
cyclopentane
206-016-6
287-92-3
Flam. Liq. 2
Aquatic Chronic 3
H225
H412
GHS02
Dgr
H225
H412



601-031-00-8
2,4,4-trimethylpent-1-ene
203-486-4
107-39-1
Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Dgr
H225
H411



601-032-00-3
benzo[a]pyrene;
benzo[def]chrysene
200-028-5
50-32-8
Carc. 1B
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H340
H360FD
H317
H410

Carc. 1B; H350: C ≥ 0,01 %



601-033-00-9
benz[a]anthracene
200-280-6
56-55-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410

M=100



601-034-00-4
benz[e]acephenanthrylene
205-911-9
205-99-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



601-035-00-X
benzo[j]fluoranthene
205-910-3
205-82-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



601-036-00-5
benzo[k]fluoranthene
205-916-6
207-08-9
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



601-037-00-0
n-hexane
203-777-6
110-54-3
Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2
H225
H361f ***
H304
H373 **
H315
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H361f ***
H304
H373 **
H315
H336
H411

STOT RE 2; H373: C ≥ 5 %



601-041-00-2
dibenz[a,h]anthracene
200-181-8
53-70-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410

Carc. 1B; H350: C ≥ 0,01 %
M=100



601-042-00-8
biphenyl;
diphenyl
202-163-5
92-52-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410



601-043-00-3
1,2,4-trimethylbenzene
202-436-9
95-63-6
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H332
H319
H335
H315
H411
GHS02
GHS07
GHS09
Wng
H226
H332
H319
H335
H315
H411



601-044-00-9
3a,4,7,7a-tetrahydro-4,7-methanoindene
201-052-9
77-73-6
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H225
H332
H302
H319
H335
H315
H411
GHS02
GHS07
GHS09
Dgr
H225
H332
H302
H319
H335
H315
H411



601-045-00-4
1,2,3,4-tetrahydronaphthalene
204-340-2
119-64-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411
EUH019


601-046-00-X
7-methylocta-1,6-diene
404-210-7
42152-47-6
Flam. Liq. 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H400
H410
GHS02
GHS09
Wng
H226
H410



601-047-00-5
m-mentha-1,3(8)-diene
404-150-1
17092-80-7
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



601-048-00-0
chrysene
205-923-4
218-01-9
Carc. 1B
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H400
H410
GHS08
GHS09
Dgr
H350
H341
H410



601-049-00-6
benzo[e]pyrene
205-892-7
192-97-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



601-051-00-7
4-phenylbut-1-ene
405-980-7
768-56-9
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



601-052-00-2
naphthalene
202-049-5
91-20-3
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS07
GHS08
GHS09
Wng
H351
H302
H410



601-053-00-8
nonylphenol; [1]
4-nonylphenol, branched [2]
246-672-0 [1]
284-325-5 [2]
25154-52-3 [1]
84852-15-3 [2]
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H361fd
H302
H314
H410



601-054-00-3
reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene
405-570-8
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



601-055-00-9
reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes
410-190-0
132983-41-6
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413



601-056-00-4
reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane
405-470-4
73807-39-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



601-057-00-X
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate
421-130-8
156679-41-3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410



601-058-00-5
di-L-para-menthene
417-870-6
83648-84-4
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



601-059-00-0
methyl 2-benzylidene-3-oxobutyrate
420-940-9
15768-07-7
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411



601-060-00-6
1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245
417-610-1
155522-09-1
Skin Sens. 1
H317
GHS07
Wng
H317



601-061-00-1
(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)
418-960-8
—
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411



601-062-00-7
reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane
417-030-9
151006-59-6
Aquatic Chronic 4
H413
—
H413



601-063-00-2
reaction mass of isomers of branched tetracosane
417-060-2
151006-61-0
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413



601-064-00-8
branched hexatriacontane
417-070-7
151006-62-1
Aquatic Chronic 4
H413
—
H413





601-065-00-3
reaction mass of: (1'α, 3'α, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411





601-066-00-9
1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone
426-820-2
78531-60-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



601-067-00-4
triethyl arsenate
427-700-2
15606-95-8
Carc. 1A
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H410



601-068-00-X
1,2-diacetoxybut-3-ene
421-720-5
18085-02-4
Acute Tox. 4 *
H302
GHS07
Wng
H302



601-069-00-5
2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide
422-680-1
287933-44-2
Aquatic Chronic 3
H412
—
H412





601-070-00-0
reaction mass of: branched icosane;
branched docosane;
branched tetracosane
417-050-8
151006-58-5
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413




601-071-00-6
1-dimethoxymethyl-2-nitro-benzene
423-830-9
20627-73-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





601-072-00-1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane
430-690-2
52783-21-8
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410





601-073-00-7
1-bromo-3,5-difluorobenzene
416-710-2
461-96-1
Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373 **
H315
H317
H400
H410
GHS02
GHS08
GHS07
GHS09
Wng
H226
H302
H373 **
H315
H317
H410



601-074-00-2
reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1
—
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411





601-075-00-8
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane
418-770-5
151882-81-4
Carc. 2
H351
GHS08
Wng
H351




601-076-00-3
ethynyl cyclopropane
425-430-1
6746-94-7
Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H315
H318
H412
GHS02
GHS05
Dgr
H225
H315
H318
H412




601-077-00-9
reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
426-510-7
196965-91-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




601-078-00-4
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane
427-040-5
—
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410




601-079-00-X
reaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene
429-620-3
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413




601-080-00-5
reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




601-081-00-0
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413




601-082-00-6
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410




601-083-00-1
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene
435-000-3
22094-83-3
Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4
H304
H315
H413
GHS08
GHS07
Dgr
H304
H315
H413




601-084-00-7
reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3
—
Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H304
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H304
H315
H410




601-085-00-2
isopentane;
2-methylbutane
201-142-8
78-78-4
Flam. Liq. 1
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2
H224
H304
H336
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H224
H304
H336
H411
EUH066


602-001-00-7
chloromethane;
methyl chloride
200-817-4
74-87-3
Flam. Gas 1
Press. Gas
Carc. 2
STOT RE 2 *
H220
H351
H373 **
GHS02
GHS04
GHS08
Dgr
H220
H351
H373 **


U
602-002-00-2
bromomethane;
methylbromide
200-813-2
74-83-9
Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone
H341
H331
H301
H373 **
H319
H335
H315
H400
EUH059
GHS04
GHS06
GHS08
GHS09
Dgr
H341
H331
H301
H373 **
H319
H335
H315
H400
EUH059

U
602-003-00-8
dibromomethane
200-824-2
74-95-3
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412

*

602-004-00-3
dichloromethane;
methylene chloride
200-838-9
75-09-2
Carc. 2
H351
GHS08
Wng
H351



602-005-00-9
methyl iodide;
iodomethane
200-819-5
74-88-4
Carc. 2
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
H351
H312
H331
H301
H335
H315
GHS06
GHS08
Dgr
H351
H312
H331
H301
H335
H315



602-006-00-4
trichloromethane;
chloroform
200-663-8
67-66-3
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
STOT RE 2 *
Skin Irrit. 2
H351
H302
H373 **
H373 **
H315
GHS07
GHS08
Wng
H351
H302
H373 **
H373 **
H315

*
STOT RE 2; H373: C ≥ 5 %




602-007-00-X
bromoform;
tribromomethane
200-854-6
75-25-2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H331
H302
H319
H315
H411
GHS06
GHS09
Dgr
H331
H302
H319
H315
H411




602-008-00-5
carbon tetrachloride;
tetrachloromethane
200-262-8
56-23-5
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
Ozone
H351
H331
H311
H301
H372 **
H412
EUH059
GHS06
GHS08
Dgr
H351
H331
H311
H301
H372 **
H412
EUH059
*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

602-009-00-0
chloroethane
200-830-5
75-00-3
Flam. Gas 1
Press. Gas
Carc. 2
Aquatic Chronic 3
H220
H351
H412
GHS02
GHS04
GHS08
Dgr
H220
H351
H412


U
602-010-00-6
1,2-dibromoethane
203-444-5
106-93-4
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H350
H331
H311
H301
H319
H335
H315
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H319
H335
H315
H411

*

602-011-00-1
1,1-dichloroethane
200-863-5
75-34-3
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
H225
H302
H319
H335
H412
GHS02
GHS07
Dgr
H225
H302
H319
H335
H412

*

602-012-00-7
1,2-dichloroethane;
ethylene dichloride
203-458-1
107-06-2
Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H302
H319
H335
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H302
H319
H335
H315



602-013-00-2
1,1,1-trichloroethane;
methyl chloroform
200-756-3
71-55-6
Acute Tox. 4 *
Ozone
H332
EUH059
GHS07
Wng
H332
EUH059

F
602-014-00-8
1,1,2-trichloroethane
201-166-9
79-00-5
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H351
H332
H312
H302
GHS08
GHS07
Wng
H351
H332
H312
H302
EUH066
*

602-015-00-3
1,1,2,2-tetrachloroethane
201-197-8
79-34-5
Acute Tox. 2 *
Acute Tox. 1
Aquatic Chronic 2
H330
H310
H411
GHS06
GHS09
Dgr
H330
H310
H411



602-016-00-9
1,1,2,2-tetrabromoethane
201-191-5
79-27-6
Acute Tox. 2 *
Eye Irrit. 2
Aquatic Chronic 3
H330
H319
H412
GHS06
Dgr
H330
H319
H412



602-017-00-4
pentachloroethane
200-925-1
76-01-7
Carc. 2
STOT RE 1
Aquatic Chronic 2
H351
H372 **
H411
GHS08
GHS09
Dgr
H351
H372 **
H411

STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

602-018-00-X
1-chloropropane; [1]
2-chloropropane [2]
208-749-7 [1]
200-858-8 [2]
540-54-5 [1]
75-29-6 [2]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302


C
602-019-00-5
1-bromopropane;
n-propyl bromide
203-445-0
106-94-5
Flam. Liq. 2
Repr. 1B
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
STOT SE 3
H225
H360FD
H373 **
H319
H335
H315
H336
GHS02
GHS08
GHS07
Dgr
H225
H360FD
H373 **
H319
H335
H315
H336



602-020-00-0
1,2-dichloropropane;
propylene dichloride
201-152-2
78-87-5
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H302
GHS02
GHS07
Dgr
H225
H332
H302



602-021-00-6
1,2-dibromo-3-chloropropane
202-479-3
96-12-8
Carc. 1B
Muta. 1B
Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H340
H360F ***
H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H340
H360F ***
H301
H373 **
H412



602-022-00-1
1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3]
208-846-4 [1]
210-885-7 [2]
210-467-4 [3]
543-59-9 [1]
625-29-6 [2]
616-20-6 [3]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302


C
602-023-00-7
vinyl chloride;
chloroethylene
200-831-0
75-01-4
Press. Gas
Flam. Gas 1
Carc. 1A
H220
H350
GHS02
GHS08
Dgr
H220
H350


D U
602-024-00-2
bromoethylene
209-800-6
593-60-2
Press. Gas
Flam. Gas 1
Carc. 1B
H220
H350
GHS02
GHS08
Dgr
H220
H350


U
602-025-00-8
1,1-dichloroethylene;
vinylidene chloride
200-864-0
75-35-4
Flam. Liq. 1
Carc. 2
Acute Tox. 4 *
H224
H351
H332
GHS02
GHS08
GHS07
Dgr
H224
H351
H332

*
D
602-026-00-3
1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3]
208-750-2 [1]
205-859-7 [2]
205-860-2 [3]
540-59-0 [1]
156-59-2 [2]
156-60-5 [3]
Flam. Liq. 2
Acute Tox. 4 *
Aquatic Chronic 3
H225
H332
H412
GHS02
GHS07
Dgr
H225
H332
H412

*
C
602-027-00-9
trichloroethylene;
trichloroethene
201-167-4
79-01-6
Carc. 1B
Muta. 2
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 3
H350
H341
H319
H315
H336
H412
GHS08
GHS07
Dgr
H350
H341
H319
H315
H336
H412



602-028-00-4
tetrachloroethylene
204-825-9
127-18-4
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411



602-029-00-X
3-chloropropene;
allyl chloride
203-457-6
107-05-1
Flam. Liq. 2
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400
GHS02
GHS08
GHS07
GHS09
Dgr
H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400


D


602-030-00-5
1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]
208-826-5 [1]
233-195-8 [2]
542-75-6 [1]
10061-01-5 [2]
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H311
H301
H332
H304
H319
H335
H315
H317
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H226
H311
H301
H332
H304
H319
H335
H315
H317
H410


C D

602-031-00-0
1,1-dichloropropene
209-253-3
563-58-6
Flam. Liq. 2
Acute Tox. 3 *
Aquatic Chronic 3
H225
H301
H412
GHS02
GHS06
Dgr
H225
H301
H412



602-032-00-6
3-chloro-2-methylpropene
209-251-2
563-47-3
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H302
H314
H317
H411



602-033-00-1
chlorobenzene
203-628-5
108-90-7
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2
H226
H332
H411
GHS02
GHS07
GHS09
Wng
H226
H332
H411

*

602-034-00-7
1,2-dichlorobenzene;
o-dichlorobenzene
202-425-9
95-50-1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410

*

602-035-00-2
1,4-dichlorobenzene;
p-dichlorobenzene
203-400-5
106-46-7
Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H319
H400
H410
GHS08
GHS09
Wng
H351
H319
H410



602-036-00-8
chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised)
204-818-0
126-99-8
Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H350
H332
H302
H373 **
H319
H335
H315
GHS02
GHS08
GHS07
Dgr
H225
H350
H332
H302
H373 **
H319
H335
H315


D
602-037-00-3
α-chlorotoluene;
benzyl chloride
202-853-6
100-44-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H373 **
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H350
H331
H302
H373 **
H335
H315
H318



602-038-00-9
α, α,α-trichlorotoluene;
benzotrichloride
202-634-5
98-07-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H350
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H350
H331
H302
H335
H315
H318



602-039-00-4
polychlorobiphenyls;
PCB
215-648-1
1336-36-3
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410

STOT RE 2; H373: C ≥ 0,005 %
C
602-040-00-X
2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4]
202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4]
95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4]
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Wng
H332
H411


C
602-041-00-5
penthachloronaphthalene
215-320-8
1321-64-8
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H312
H302
H319
H315
H410


C
602-042-00-0
1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex
—
—
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H312
H410


A C
602-043-00-6
lindane (ISO);
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane
200-401-2
58-89-9
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H312
H373 **
H362
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H332
H312
H373 **
H362
H410

M=10

602-044-00-1
camphechlor (ISO);
toxaphene;
232-283-3
8001-35-2
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H312
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H312
H335
H315
H410



602-045-00-7
DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane
200-024-3
50-29-3
Carc. 2
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H372 **
H410



602-046-00-2
heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-3
76-44-8
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H373 **
H410



602-047-00-8
chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-0
57-74-9
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H312
H302
H410



602-048-00-3
aldrin (ISO)
206-215-8
309-00-2
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H372 **
H410



602-049-00-9
dieldrin (ISO)
200-484-5
60-57-1
Carc. 2
Acute Tox. 1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H310
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H310
H301
H372 **
H410






602-050-00-4
isodrin;
(1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
207-366-2
465-73-6
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410

M=100


602-051-00-X
endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-7
72-20-8
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410





602-052-00-5
endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;
1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite
204-079-4
115-29-7
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H312
H400
H410
GHS06
GHS09
Dgr
H330
H300
H312
H410




602-053-00-0
isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4
297-78-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H310
H300
H400
GHS06
GHS09
Dgr
H310
H300
H400






602-054-00-6
3-iodpropene;
allyl iodide
209-130-4
556-56-9
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314




602-055-00-1
bromoethane;
ethyl bromide
200-825-8
74-96-4
Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
H225
H351
H332
H302
GHS02
GHS08
GHS07
Dgr
H225
H351
H332
H302



602-056-00-7
α, α,α-trifluorotoluene;
benzotrifluoride
202-635-0
98-08-8
Flam. Liq. 2
Aquatic Chronic 2
H225
H411
GHS02
GHS09
Dgr
H225
H411



602-057-00-2
α-bromotoluene;
benzyl bromide
202-847-3
100-39-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315



602-058-00-8
α, α-dichlorotoluene;
benzylidene chloride;
benzal chloride
202-709-2
98-87-3
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H351
H331
H302
H335
H315
H318
GHS06
GHS08
GHS05
Dgr
H351
H331
H302
H335
H315
H318



602-059-00-3
1-chlorobutane;
butyl chloride
203-696-6
109-69-3
Flam. Liq. 2
H225
GHS02
Dgr
H225



602-060-00-9
bromobenzene
203-623-8
108-86-1
Flam. Liq. 3
Skin Irrit. 2
Aquatic Chronic 2
H226
H315
H411
GHS02
GHS07
GHS09
Wng
H226
H315
H411



602-061-00-4
hexafluoropropene;
hexafluoropropylene
204-127-4
116-15-4
Press. Gas
Acute Tox. 4 *
STOT SE 3
H332
H335
GHS07
Wng
H332
H335


U
602-062-00-X
1,2,3-trichloropropane
202-486-1
96-18-4
Carc. 1B
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H360F ***
H332
H312
H302
GHS08
GHS07
Dgr
H350
H360F ***
H332
H312
H302


D
602-063-00-5
heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-0
1024-57-3
Carc. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H301
H373 **
H410



602-064-00-0
1,3-dichloro-2-propanol
202-491-9
96-23-1
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
H350
H301
H312
GHS06
GHS08
Dgr
H350
H301
H312



602-065-00-6
hexachlorobenzene
204-273-9
118-74-1
Carc. 1B
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372 **
H400
H410
GHS08
GHS09
Dgr
H350
H372 **
H410



602-066-00-1
tetrachloro-p-benzoquinone
204-274-4
118-75-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410



602-067-00-7
1,3-dichlorbenzene
208-792-1
541-73-1
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



602-068-00-2
ethylene bis(trichloroacetate)
219-732-9
2514-53-6
Skin Irrit. 2
H315
GHS07
Wng
H315



602-069-00-8
dichloroacetylene
—
7572-29-4
Unst. Expl.
Carc. 2
STOT RE 2 *
H200
H351
H373 **
GHS01
GHS08
Wng
H200
H351
H373 **



602-070-00-3
3-chloro-4,5,α, α,α-pentafluorotoluene
401-930-3
77227-99-7
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H226
H332
H302
H400
GHS02
GHS07
GHS09
Wng
H226
H332
H302
H400



602-071-00-9
bromobenzylbromotoluene, reaction mass of isomers
402-210-1
99688-47-8
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H317
H410



602-072-00-4
dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-3
76253-60-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



602-073-00-X
1,4-dichlorobut-2-ene
212-121-8
764-41-0
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H330
H311
H301
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H330
H311
H301
H314
H410

Carc. 1B; H350: C ≥ 0,01 %
STOT SE 3; H335: C ≥ 5 %

602-074-00-5
pentachlorobenzene
210-172-0
608-93-5
Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H228
H302
H400
H410
GHS02
GHS07
GHS09
Dgr
H228
H302
H410


T
602-075-00-0
4,4,5,5-tetrachloro-1,3-dioxolan-2-one
404-060-2
22432-68-4
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
H330
H302
H314
GHS06
GHS05
Dgr
H330
H302
H314





602-076-00-6
2,3,4-trichlorobut-1-ene
219-397-9
2431-50-7
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H302
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H331
H302
H319
H335
H315
H410

Carc. 2; H351: C ≥ 0,1 %


602-077-00-1
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex
219-196-6
2385-85-5
Carc. 2
Repr. 2
Lact.
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361fd
H362
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361fd
H362
H312
H302
H410



602-078-00-7
hexachlorocyclopentadiene
201-029-3
77-47-4
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H302
H314
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H311
H302
H314
H410



602-079-00-2
2,3-dichloropropene;
2,3-dichloropropylene
201-153-8
78-88-6
Flam. Liq. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H225
H341
H332
H312
H302
H335
H315
H318
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H225
H341
H332
H312
H302
H335
H315
H318
H412





602-080-00-8
alkanes, C10-13, chloro;
chlorinated paraffins, C10-13
287-476-5
85535-84-8
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
EUH066



602-081-00-3
2-chloro-4,5-difluorobenzoic acid
405-380-5
—
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H312
H302
H318
H317
GHS05
GHS07
Dgr
H312
H302
H318
H317



602-082-00-9
2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol
408-020-5
109678-33-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



602-083-00-4
diphenyl ether, pentabromo derivative pentabromodiphenyl ether
251-084-2
32534-81-9
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H362
H400
H410
GHS08
GHS09
Wng
H373 **
H362
H410



602-084-00-X
1,1-dichloro-1-fluoroethane
404-080-1
1717-00-6
Aquatic Chronic 3
Ozone
H412
EUH059
—
H412
EUH059


602-085-00-5
2-bromopropane
200-855-1
75-26-3
Flam. Liq. 2
Repr. 1A
STOT RE 2 *
H225
H360F ***
H373 **
GHS02
GHS08
Dgr
H225
H360F ***
H373 **
EUH066


602-086-00-0
trifluoroiodomethane;
trifluoromethyl iodide
219-014-5
2314-97-8
Muta. 2
H341
GHS08
Wng
H341



602-087-00-6
1,2,4-trichlorobenzene
204-428-0
120-82-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410



602-088-00-1
2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol
202-480-9
96-13-9
Carc. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H350
H361f ***
H311
H332
H302
H412
GHS08
GHS07
Dgr
H350
H361f ***
H311
H332
H302
H412



602-089-00-7
4-bromo-2-chlorofluorobenzene
405-580-2
60811-21-4
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410



602-090-00-2
1-allyl-3-chloro-4-fluorobenzene
406-630-6
121626-73-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



602-091-00-8
1,3-dichloro-4-fluorobenzene
406-160-1
1435-48-9
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
H302
H373 **
H315
H411
GHS08
GHS07
Wng
H302
H373 **
H315
H411



602-092-00-3
1-bromo-3,4,5-trifluorobenzene
418-480-9
138526-69-9
Flam. Liq. 3
Carc. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H351
H315
H318
H411
GHS02
GHS08
GHS05
GHS09
Dgr
H226
H351
H315
H318
H411



602-093-00-9
α, α,α,4-tetrachlorotoluene;
p-chlorobenzotrichloride
226-009-1
5216-25-1
Carc. 1B
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H350
H361f ***
H372 **
H312
H302
H335
H315
GHS08
GHS07
Dgr
H350
H361f ***
H372 **
H312
H302
H335
H315



602-094-00-4
diphenylether; octabromo derivate
251-087-9
32536-52-0
Repr. 1B
H360Df
GHS08
Dgr
H360Df





602-095-00-X
alkanes, C14-17, chloro;
chlorinated paraffins, C14-17
287-477-0
85535-85-9
Lact.
Aquatic Acute 1
Aquatic Chronic 1
H362
H400
H410
GHS09
Wng
H362
H410
EUH066




602-096-00-5
malachite green hydrochloride; [1]
malachite green oxalate [2]
209-322-8 [1]
219-441-7 [2]
569-64-2 [1]
2437-29-8 [2]
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H361d ***
H302
H318
H410



602-097-00-0
1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane
422-850-5
148757-89-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410





602-098-00-6
2-(3-bromophenoxy)tetrahydro-2H-pyran
429-030-6
57999-49-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




602-099-00-1
3-(4-fluorophenyl)-2-methylpropionylchloride
426-370-7
—
Skin Corr. 1A
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
EUH014
EUH029



602-100-00-5
reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
420-640-8
—
Aquatic Chronic 3
H412
—
H412




602-101-00-0
2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate
427-020-6
141772-37-4
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373**
H317
H410




602-102-00-6
1,1,1,3,3-pentafluorobutane
430-250-1
406-58-6
Flam. Liq. 2
H225
GHS02
Dgr
H225




602-103-00-1
1-(chlorophenylmethyl)-2-methylbenzene
431-450-1
41870-52-4
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410




602-104-00-7
1,1,2,2,3,3,4-heptafluorocyclopentane
430-710-1
15290-77-4
Aquatic Chronic 3
H412
—
H412




602-105-00-2
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate
422-100-7
102061-82-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




602-106-00-8
2-bromo-4,6-difluoroaniline
429-430-0
444-14-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411




602-107-00-3
3,3,4,4-tetrafluoro-4-iodo-1-butene
439-500-2
33831-83-3
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H302
H315
H411
GHS07
GHS09
Wng
H302
H315
H411




602-108-00-9
(2,3,5,6-tetrafluorophenyl)methanol
443-840-7
4084-38-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317




603-001-00-X
methanol
200-659-6
67-56-1
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
H225
H331
H311
H301
H370 **
GHS02
GHS06
GHS08
Dgr
H225
H331
H311
H301
H370 **

*
STOT SE 1; H370: C ≥ 10 %
STOT SE 2; H371: 3 % ≤ C < 10 %

603-002-00-5
ethanol;
ethyl alcohol
200-578-6
64-17-5
Flam. Liq. 2
H225
GHS02
Dgr
H225



603-003-00-0
propan-1-ol;
n-propanol
200-746-9
71-23-8
Flam. Liq. 2
Eye Dam. 1
STOT SE 3
H225
H318
H336
GHS02
GHS05
GHS07
Dgr
H225
H318
H336



603-004-00-6
butan-1-ol;
n-butanol
200-751-6
71-36-3
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H302
H335
H315
H318
H336
GHS02
GHS05
GHS07
Dgr
H226
H302
H335
H315
H318
H336





603-005-00-1
2-methylpropan-2-ol;
tert-butyl alcohol
200-889-7
75-65-0
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335




603-006-00-7
pentanol isomers, with the exception fo those specified elsewhere in this Annex
250-378-8

Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
H226
H332
H335
GHS02
GHS07
Wng
H226
H332
H335
EUH066

C
603-007-00-2
2-methylbutan-2-ol;
tert-pentanol
200-908-9
75-85-4
Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H225
H332
H335
H315
GHS02
GHS07
Dgr
H225
H332
H335
H315



603-008-00-8
4-methylpentan-2-ol;
methyl isobutyl carbinol
203-551-7
108-11-2
Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Wng
H226
H335

STOT SE 3; H335: C ≥ 25 %

603-009-00-3
cyclohexanol
203-630-6
108-93-0
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H332
H302
H335
H315
GHS07
Wng
H332
H302
H335
H315



603-010-00-9
2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3]
209-512-0 [1]
231-187-9 [2]
231-186-3 [3]
583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3]
Acute Tox. 4 *
H332
GHS07
Wng
H332


C
603-011-00-4
2-methoxyethanol;
ethylene glycol monomethyl ether
203-713-7
109-86-4
Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD
H332
H312
H302



603-012-00-X
2-ethoxyethanol;
ethylene glycol monoethyl ether
203-804-1
110-80-5
Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD
H332
H312
H302



603-013-00-5
2-isopropoxyethanol;
ethylene glycol monoisopropyl ether
203-685-6
109-59-1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H332
H312
H319
GHS07
Wng
H332
H312
H319



603-014-00-0
2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve
203-905-0
111-76-2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H332
H312
H302
H319
H315
GHS07
Wng
H332
H312
H302
H319
H315



603-015-00-6
allyl alcohol
203-470-7
107-18-6
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H225
H331
H311
H301
H319
H335
H315
H400
GHS02
GHS06
GHS09
Dgr
H225
H331
H311
H301
H319
H335
H315
H400



603-016-00-1
4-hydroxy-4-methylpentan-2-one;
diacetone alcohol
204-626-7
123-42-2
Eye Irrit. 2
H319
GHS07
Wng
H319

Eye Irrit. 2; H319: C ≥ 10 %



603-018-00-2
furfuryl alcohol
202-626-1
98-00-0
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
H351
H331
H312
H302
H373**
H319
H335
GHS06
GHS08
Dgr
H351
H331
H312
H302
H373**
H319
H335




603-019-00-8
dimethyl ether
204-065-8
115-10-6
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
603-020-00-3
ethyl methyl ether
—
540-67-0
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


U
603-021-00-9
methyl vinyl ether
203-475-4
107-25-5
Flam. Gas 1
Press. Gas
H220
GHS02
GHS04
Dgr
H220


D U
603-022-00-4
diethyl ether;
ether
200-467-2
60-29-7
Flam. Liq. 1
Acute Tox. 4 *
STOT SE 3
H224
H302
H336
GHS02
GHS07
Dgr
H224
H302
H336
EUH019
EUH066




603-023-00-X
ethylene oxide;
oxirane
200-849-9
75-21-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H220
H350
H340
H331
H319
H335
H315
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H350
H340
H331
H319
H335
H315




603-024-00-5
1,4-dioxane
204-661-8
123-91-1
Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3
H225
H351
H319
H335
GHS02
GHS08
GHS07
Dgr
H225
H351
H319
H335
EUH019
EUH066

D
603-025-00-0
tetrahydrofuran
203-726-8
109-99-9
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335
EUH019
Eye Irrit. 2; H319: C ≥ 25 %
STOT SE 3; H335: C ≥ 25 %

603-026-00-6
1-chloro-2,3-epoxypropane;
epichlorhydrin
203-439-8
106-89-8
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H350
H331
H311
H301
H314
H317

*

603-027-00-1
ethanediol;
ethylene glycol
203-473-3
107-21-1
Acute Tox. 4 *
H302
GHS07
Wng
H302



603-028-00-7
2-chloroethanol;
ethylene chlorohydrin
203-459-7
107-07-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300





603-029-00-2
bis(2-chloroethyl) ether
203-870-1
111-44-4
Carc. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H351
H330
H310
H300
GHS06
GHS08
Dgr
H351
H330
H310
H300




603-030-00-8
2-aminoethanol;
ethanolamine
205-483-3
141-43-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H332
H312
H302
H314
GHS05
GHS07
Dgr
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 5 %

603-031-00-3
1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME
203-794-9
110-71-4
Flam. Liq. 2
Repr. 1B
Acute Tox. 4 *
H225
H360FD
H332
GHS02
GHS08
GHS07
Dgr
H225
H360FD
H332
EUH019




603-032-00-9
ethylene dinitrate;
ethylene glycol dinitrate
211-063-0
628-96-6
Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
H200
H330
H310
H300
H373**
GHS01
GHS06
GHS08
Dgr
H200
H330
H310
H300
H373**




603-033-00-4
oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate
211-745-8
693-21-0
Unst. Expl
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H200
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Dgr
H200
H330
H310
H300
H373 **
H412



603-033-01-1
oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate;
[>25 % phlegmatiser]
211-745-8
693-21-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H201
H330
H310
H300
H373 **
H412
GHS01
GHS06
GHS08
Dgr
H201
H330
H310
H300
H373 **
H412



603-034-00-X
glycerol trinitrate;
nitroglycerine
200-240-8
55-63-0
Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H200
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H200
H330
H310
H300
H373 **
H411



603-034-01-7
glycerol trinitrate;
nitroglycerine;
[>40 % phlegmatiser]
200-240-8
55-63-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H201
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373 **
H411



603-035-00-5
pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.
201-084-3
78-11-5
Unst. Expl.
H200
GHS01
Dgr
H200



603-035-01-2
pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.;
[>20 % phlegmatiser]
201-084-3
78-11-5
Expl. 1.1
H201
GHS01
Dgr
H201


T
603-036-00-0
mannitol hexanitrate;
nitromannite
239-924-6
15825-70-4
Unst. Expl.
H200
GHS01
Dgr
H200



603-036-01-8
mannitol hexanitrate;
nitromannite;
[>40 % phlegmatiser]
239-924-6
15825-70-4
Expl. 1.1
H201
GHS01
Dgr
H201





603-037-00-6
cellulose nitrate;
nitrocellulose
—
—
Expl. 1.1
H201
GHS01
Dgr
H201


T


603-038-00-1
allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4
106-92-3
Flam. Liq. 3
Carc. 2
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412



603-039-00-7
butyl glycidyl ether;
butyl 2,3-epoxypropyl ether
219-376-4
2426-08-6
Flam. Liq. 3
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Chronic 3
H226
H351
H341
H332
H302
H335
H317
H412
GHS02
GHS08
GHS07
Wng
H226
H351
H341
H332
H302
H335
H317
H412



603-040-00-2
sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3]
204-699-5 [1]
212-736-1 [2]
212-737-7 [3]
124-41-4 [1]
865-33-8 [2]
865-34-9 [3]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Dgr
H251
H314
EUH014

T
603-041-00-8
potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2]
213-029-0 [1]
205-487-5 [2]
917-58-8 [1]
141-52-6 [2]
Self-heat 1
Skin Corr. 1B
H251
H314
GHS02
GHS05
Dgr
H251
H314
EUH014

T
603-042-00-3
aluminium-tri-isopropoxide
209-090-8
555-31-7
Flam. Sol. 1
H228
GHS02
Dgr
H228


T
603-043-00-9
triarimol (ISO);
2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol
—
26766-27-8
Acute Tox. 4 *
H302
GHS07
Wng
H302



603-044-00-4
dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0
115-32-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H312
H302
H315
H317
H410



603-045-00-X
diisopropyl ether; [1]
dipropyl ether [2]
203-560-6 [1]
203-869-6 [2]
108-20-3 [1]
111-43-3 [2]
Flam. Liq. 2
STOT SE 3
H225
H336
GHS02
GHS07
Dgr
H225
H336
EUH019
EUH066

C


603-046-00-5
bis(chloromethyl) ether;
oxybis(chloromethane)
208-832-8
542-88-1
Flam. Liq. 2
Carc. 1A
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
H225
H350
H330
H311
H302
GHS02
GHS06
GHS08
Dgr
H225
H350
H330
H311
H302

Carc. 1A; H350: C ≥ 0,001 %


603-047-00-0
2-dimethylaminoethanol;
N,N-dimethylethanolamine
203-542-8
108-01-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 5 %

603-048-00-6
2-diethylaminoethanol;
N,N-diethylethanolamine
202-845-2
100-37-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07 GHS09
Dgr
H226
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 5 %

603-049-00-1
chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol
201-246-3
80-06-8
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



603-050-00-7
1-(2-butoxypropoxy)propan-2-ol
246-011-6
24083-03-2
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



603-051-00-2
2-ethylbutan-1-ol
202-621-4
97-95-0
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



603-052-00-8
3-butoxypropan-2-ol;
propylene glycol monobutyl ether
225-878-4
5131-66-8
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315



603-053-00-3
2-methylpentane-2,4-diol
203-489-0
107-41-5
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315



603-054-00-9
di-n-butyl ether;
dibutyl ether
205-575-3
142-96-1
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H226
H319
H335
H315
H412
GHS02
GHS07
Wng
H226
H319
H335
H315
H412

STOT SE 3; H335: C ≥ 10 %

603-055-00-4
propylene oxide;
1,2-epoxypropane;
methyloxirane
200-879-2
75-56-9
Flam. Liq. 1
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H224
H350
H340
H332
H312
H302
H319
H335
H315
GHS02
GHS08
GHS07
Dgr
H224
H350
H340
H332
H312
H302
H319
H335
H315



603-056-00-X
[(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropyl o-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4]
218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4]
2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4]
Muta. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H315
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H315
H317
H411


C
603-057-00-5
benzyl alcohol
202-859-9
100-51-6
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302



603-058-00-0
1,3-propylene oxide
207-964-3
503-30-0
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302



603-059-00-6
hexan-1-ol
203-852-3
111-27-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



603-060-00-1
2,2'-bioxirane;
1,2:3,4-diepoxybutane
215-979-1
1464-53-5
Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H350
H340
H330
H311
H301
H314
GHS06
GHS08
GHS05
Dgr
H350
H340
H330
H311
H301
H314



603-061-00-7
tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol
202-625-6
97-99-4
Eye Irrit. 2
H319
GHS07
Wng
H319



603-062-00-2
tetrahydrofuran-2,5-diyldimethanol
203-239-0
104-80-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

STOT SE 3; H335: C ≥ 10 %

603-063-00-8
2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol
209-128-3
556-52-5
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H350
H341
H360F ***
H331
H312
H302
H319
H335
H315
GHS06
GHS08
Dgr
H350
H341
H360F ***
H331
H312
H302
H319
H335
H315





603-064-00-3
1-methoxy-2-propanol;
monopropylene glycol methyl ether
203-539-1
107-98-2
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336




603-065-00-9
resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene
202-987-5
101-90-6
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H351
H341
H312
H302
H319
H315
H317
H412
GHS08
GHS07
Wng
H351
H341
H312
H302
H319
H315
H317
H412






603-066-00-4
1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide
203-437-7
106-87-6
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H351
H331
H311
H301
GHS06
GHS08
Dgr
H351
H331
H311
H301

*


603-067-00-X
phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane
204-557-2
122-60-1
Carc. 1B
Muta. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H332
H335
H315
H317
H412
GHS08
GHS07
Dgr
H350
H341
H332
H335
H315
H317
H412



603-068-00-5
2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether
—
130014-35-6
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317



603-069-00-0
2,4,6-tris(dimethylaminomethyl)phenol
202-013-9
90-72-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315



603-070-00-6
2-amino-2-methylpropanol
204-709-8
124-68-5
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412



603-071-00-1
2,2'-iminodiethanol;
diethanolamine
203-868-0
111-42-2
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H302
H373 **
H315
H318
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H315
H318



603-072-00-7
1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether
219-371-7
2425-79-8
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H312
H319
H315
H317
GHS07
Wng
H332
H312
H319
H315
H317



603-073-00-2
bis-[4-(2,3-epoxipropoxi)phenyl]propane
216-823-5
1675-54-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317

Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %

603-074-00-8
reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700)
500-033-5
25068-38-6
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Wng
H319
H315
H317
H411

Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %

603-075-00-3
chlormethyl methyl ether;
chlorodimethyl ether
203-480-1
107-30-2
Flam. Liq. 2
Carc. 1A
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H350
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H225
H350
H332
H312
H302



603-076-00-9
but-2-yne-1,4-diol;
2-butyne-1,4-diol
203-788-6
110-65-6
Skin Corr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H331
H301
H312
H373 **
H317
GHS06
GHS05
GHS08
Dgr
H314
H331
H301
H312
H373 **
H317

Skin Corr. 1B; H314: C ≥ 50 %
Skin Irrit. 2; H315: 25 % ≤ C < 50 %
Eye Irrit. 2; H319: 25 % ≤ C < 50 %
D
603-077-00-4
1-dimethylaminopropan-2-ol;
dimepranol (INN)
203-556-4
108-16-7
Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
H226
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H302
H314



603-078-00-X
prop-2-yn-1-ol;
propargyl alcohol
203-471-2
107-19-7
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H226
H331
H311
H301
H314
H411
GHS02
GHS06
GHS05
GHS09
Dgr
H226
H331
H311
H301
H314
H411



603-079-00-5
2,2'-(methylimino)diethanol;
N-methyldiethanolamine
203-312-7
105-59-9
Eye Irrit. 2
H319
GHS07
Wng
H319



603-080-00-0
2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol
203-710-0
109-83-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05 GHS07
Dgr
H312
H302
H314

STOT SE 3; H335: C ≥ 5 %

603-081-00-6
2,2'-thiodiethanol;
thiodiglycol
203-874-3
111-48-8
Eye Irrit. 2
H319
GHS07
Wng
H319



603-082-00-1
1-aminopropan-2-ol;
isopropanolamine
201-162-7
78-96-6
Skin Corr. 1B
H314
GHS05
Dgr
H314



603-083-00-7
1,1'-iminodipropan-2-ol;
di-isopropanolamine
203-820-9
110-97-4
Eye Irrit. 2
H319
GHS07
Wng
H319



603-084-00-2
styrene oxide;
(epoxyethyl)benzene;
phenyloxirane
202-476-7
96-09-3
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
H350
H312
H319
GHS08
GHS07
Dgr
H350
H312
H319





603-085-00-8
bronopol (INN);
2-bromo-2-nitropropane-1,3-diol
200-143-0
52-51-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H312
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H335
H315
H318
H400

M=10


603-086-00-3
ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-3
23947-60-6
Acute Tox. 4 *
H312
GHS07
Wng
H312



603-087-00-9
2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol
202-377-9
94-96-2
Eye Dam. 1
H318
GHS05
Dgr
H318



603-088-00-4
2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide
222-598-4
3547-33-9
Eye Dam. 1
H318
GHS05
Dgr
H318



603-089-00-X
7,7-dimethyl-3-oxa-6-azaoctan-1-ol
400-390-6
—
Skin Corr. 1A
Acute Tox. 4 *
H314
H302
GHS05
GHS07
Dgr
H314
H302



603-090-00-5
2-(2-bromoethoxy)anisole
402-010-4
4463-59-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



603-091-00-0
exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol
402-470-6
87172-89-2
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318



603-092-00-6
2-methyl-4-phenylpentanol
402-770-7
92585-24-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



603-093-00-1
cinmethylin (ISO);
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-9
87818-31-3
Acute Tox. 4 *
Aquatic Chronic 2
H332
H411
GHS07
GHS09
Dgr
H332
H411



603-094-00-7
1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane
241-536-7
17557-23-2
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



603-095-00-2
2-(propyloxy)ethanol;
EGPE
220-548-6
2807-30-9
Acute Tox. 4 *
Eye Irrit. 2
H312
H319
GHS07
Wng
H312
H319



603-096-00-8
2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether
203-961-6
112-34-5
Eye Irrit. 2
H319
GHS07
Wng
H319



603-097-00-3
1,1',1''-nitrilotripropan-2-ol;
triisopropanolamine
204-528-4
122-20-3
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412



603-098-00-9
2-phenoxyethanol
204-589-7
122-99-6
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



603-099-00-4
3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride
403-440-5
93633-79-5
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



603-100-00-8
1,2-dimethoxypropane
404-630-0
7778-85-0
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH019


603-101-00-3
tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)
405-040-6
—
Eye Irrit. 2
H319
GHS07
Wng
H319



603-102-00-9
1,2-epoxybutane
203-438-2
106-88-7
Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H225
H351
H332
H312
H302
H319
H335
H315
H412
GHS02
GHS08
GHS07
Dgr
H225
H351
H332
H312
H302
H319
H335
H315
H412



603-103-00-4
oxirane, mono[(C12-14-alkyloxy)methyl] derivs.
271-846-8
68609-97-2
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



603-104-00-X
fenarimol (ISO);
2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-7
60168-88-9
Repr. 2
Lact.
Aquatic Chronic 2
H361fd
H362
H411
GHS08 GHS09
Wng
H361fd
H362
H411



603-105-00-5
furan
203-727-3
110-00-9
Flam. Liq. 1
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3
H224
H350
H341
H332
H302
H373 **
H315
H412
GHS02
GHS08
GHS07
Dgr
H224
H350
H341
H332
H302
H373 **
H315
H412
EUH019


603-106-00-0
2-methoxypropanol
216-455-5
1589-47-5
Flam. Liq. 3
Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H226
H360D ***
H335
H315
H318
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H360D ***
H335
H315
H318



603-107-00-6
2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether
203-906-6
111-77-3
Repr. 2
H361d ***
GHS08
Wng
H361d ***



603-108-00-1
2-methylpropan-1-ol;
iso-butanol
201-148-0
78-83-1
Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3
H226
H335
H315
H318
H336
GHS02
GHS05
GHS07
Dgr
H226
H335
H315
H318
H336





603-109-00-7
reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane
425-340-0
—
Aquatic Chronic 4
H413
—
H413




603-110-00-2
reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane
426-130-1
166301-21-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412




603-111-00-8
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane
426-530-6
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410




603-112-00-3
cyclopentyl 2-phenylethyl ether
428-340-9
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410




603-113-00-9
6-glycidyloxynapht-1-yl oxymethyloxirane
429-960-2
27610-48-6
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H341
H312
H315
H317
H412
GHS08
GHS07
Wng
H341
H312
H315
H317
H412




603-114-00-4
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene
430-830-2
26912-64-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




603-115-00-X
reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-580-0
—
STOT RE 2 *
Aquatic Chronic 4
H373**
H413
GHS08
Wng
H373**
H413




603-116-00-5
(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride
424-740-2
138271-16-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




603-117-00-0
propan-2-ol;
isopropyl alcohol;
isopropanol
200-661-7
67-63-0
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336



603-118-00-6
6-dimethylaminohexan-1-ol
404-680-3
1862-07-3
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412



603-119-00-1
1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)
405-840-5
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



603-120-00-7
2-methyl-5-phenylpentanol
405-890-8
25634-93-9
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315



603-121-00-2
4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone
406-057-1
114565-66-1
Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413



603-122-00-8
sodium 2-ethylhexanolate
406-150-7
38411-13-1
Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3
H228
H314
H412
GHS02
GHS05
Dgr
H228
H314
H412


T
603-123-00-3
4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol
406-330-5
122760-84-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411



603-124-00-9
1,4-bis[2-(vinyloxy)ethoxy]benzene
406-900-3
84563-49-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



603-125-00-4
2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol
407-850-5
89544-40-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



603-126-00-X
2-((4-methyl-2-nitrophenyl)amino)ethanol
408-090-7
100418-33-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412





603-127-00-5
butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4]
201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]
78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3
H226
H319
H335
H336
GHS02
GHS07
Wng
H226
H319
H335
H336


C

603-128-00-0
2-(phenylmethoxy)naphthalene
405-490-3
613-62-7
Aquatic Chronic 4
H413
—
H413



603-129-00-6
1-tert-butoxypropan-2-ol
406-180-0
57018-52-7
Flam. Liq. 3
Eye Dam. 1
H226
H318
GHS02
GHS05
Dgr
H226
H318



603-130-00-1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)
406-325-8
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



603-131-00-7
reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318



603-132-00-2
2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane
408-200-3
63187-91-7
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412



603-133-00-8
reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



603-134-00-3
reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.
410-450-3
—
Aquatic Chronic 4
H413
—
H413



603-135-00-9
bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium
410-500-4
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



603-136-00-4
3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol
410-910-3
104226-19-9
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



603-137-00-X
reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6
—
Eye Dam. 1
H318
GHS05
Dgr
H318



603-138-00-5
3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4
103694-68-4
Aquatic Chronic 3
H412
—
H412



603-139-00-0
bis(2-methoxyethyl) ether
203-924-4
111-96-6
Flam. Liq. 3
Repr. 1B
H226
H360FD
GHS02
GHS08
Dgr
H226
H360FD
EUH019


603-140-00-6
2,2' -oxybisethanol;
diethylene glycol
203-872-2
111-46-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



603-141-00-1
reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6
—
Aquatic Chronic 3
H412
—
H412



603-142-00-7
2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane
407-360-1
116230-20-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H373 **
H315
H318
GHS06
GHS08
GHS05
Dgr
H312
H302
H373 **
H315
H318



603-143-00-2
R—2,3-epoxy-1-propanol
404-660-4
57044-25-4
Self-react. C ****
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H242
H350
H341
H360F ***
H331
H312
H302
H314
GHS02
GHS06
GHS08
GHS05
Dgr
H242
H350
H341
H360F ***
H331
H312
H302
H314



603-144-00-8
reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6
111850-00-1
Aquatic Chronic 2
H411
GHS09
H411



603-145-00-3
2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane
406-970-5
129228-11-1
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



603-146-00-9
2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol
406-080-7
83016-70-0
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H302
H314
H412
GHS05
GHS07
Dgr
H302
H314
H412



603-147-00-4
(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
406-030-4
105812-81-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



603-148-00-X
1,4-bis[(vinyloxy)methyl]cyclohexane
413-370-7
17351-75-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07 GHS09
Wng
H317
H411



603-149-00-5
reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane
407-640-3
63767-86-2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07 GHS09
Wng
H319
H315
H411



603-150-00-0
(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol
411-580-3
107898-54-4
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



603-151-00-6
(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol
413-570-4
—
Aquatic Chronic 3
H412
—
H412



603-152-00-1
2-(4-tert-butylphenyl)ethanol
410-020-5
5406-86-0
Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H361f ***
H373 **
H318
H411
GHS08
GHS05
GHS09
Dgr
H361f ***
H373 **
H318
H411



603-153-00-7
3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol
410-010-0
104333-00-8
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



603-154-00-2
1-[(2-tert-butyl)cyclohexyloxy]-2-butanol
412-300-2
139504-68-0
Aquatic Chronic 2
H411
GHS09
H411




603-155-00-8
Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane
410-560-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




603-156-00-3
2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane
411-210-0
89544-48-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



603-157-00-9
6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol
411-450-6
143747-72-2
Aquatic Chronic 4
H413
—
H413



603-158-00-4
reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene
412-460-3
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07 GHS09
Wng
H315
H411



603-159-00-X
2-cyclododecylpropan-1-ol
411-410-8
118562-73-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



603-160-00-5
1,2-diethoxypropane
412-180-1
10221-57-5
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH019


603-161-00-0
1,3-diethoxypropane
413-140-6
3459-83-4
Flam. Liq. 3
H226
GHS02
Wng
H226



603-162-00-6
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]
413-420-8
144736-29-8
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411



603-163-00-1
2-phenyl-1,3-propanediol
411-810-2
1570-95-2
Eye Dam. 1
H318
GHS05
Dgr
H318



603-164-00-7
2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole
412-420-5
133909-99-6
Aquatic Chronic 4
H413
—
H413



603-165-00-2
reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1
—
Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317



603-166-00-8
R-1-chloro-2,3-epoxypropane
424-280-2
51594-55-9
Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H226
H350
H331
H311
H301
H314
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H350
H331
H311
H301
H314
H317



603-167-00-3
3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol
407-920-5
6390-69-8
Aquatic Chronic 4
H413
GHS05
Dgr
H413



603-168-00-9
3-(2-ethylhexyloxy)propane-1,2-diol
408-080-2
70445-33-9
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



603-169-00-4
(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
415-550-0
109887-53-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



603-170-00-X
reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-3
67739-11-1
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



603-171-00-5
5-thiazolylmethanol
414-780-9
38585-74-9
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



603-172-00-0
mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate
415-180-1
773058-82-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



603-173-00-6
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
421-750-9
57280-22-5
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



603-174-00-1
4-cyclohexyl-2-methyl-2-butanol
420-630-3
83926-73-2
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



603-175-00-7
2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol
203-988-3
112-59-4
Acute Tox. 4 *
Eye Dam. 1
H312
H318
GHS05
GHS07
Dgr
H312
H318



603-176-00-2
1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme
203-977-3
112-49-2
Repr. 1B
H360Df
GHS08
Dgr
H360Df
EUH019


603-177-00-8
1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2]
216-374-5 [1]
259-370-9 [2]
1569-02-4 [1]
54839-24-6 [2]
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336



603-178-00-3
2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol
203-951-1
112-25-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



603-179-00-9
ergocalciferol (ISO);
Vitamin D2
200-014-9
50-14-6
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **



603-180-00-4
colecalciferol;
Vitamin D3
200-673-2
67-97-0
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
H330
H311
H301
H372 **
GHS06
GHS08
Dgr
H330
H311
H301
H372 **



603-181-00-X
tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane
216-653-1
1634-04-4
Flam. Liq. 2
Skin Irrit. 2
H225
H315
GHS02
GHS07
Dgr
H225
H315





603-182-00-5
reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide
428-630-5
—
Skin Sens. 1
H317
GHS07
Wng
H317




603-183-00-0
2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol
205-592-6
143-22-6
Eye Dam. 1
H318
GHS05
Dgr
H318

Eye Dam. 1; H318: C ≥ 30 %
Eye Irrit. 2; H319: 20 % ≤ C < 30 %

603-184-00-6
2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol
416-380-1
146925-83-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



603-185-00-1
2,4-dichloro-3-ethyl-6-nitrophenol
420-740-1
99817-36-4
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410



603-186-00-7
trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
419-050-3
79944-37-9
Skin Sens. 1
H317
GHS07
Wng
H317



603-187-00-2
2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride
419-360-9
163661-77-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





603-188-00-8
reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene
426-970-9
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




603-189-00-3
reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol
405-250-8
—
Aquatic Chronic 2
H411
GHS09
H411





603-190-00-9
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane
424-030-2
62406-73-9
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412





603-191-00-4
2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol
419-740-4
137658-79-8
Aquatic Chronic 4
H413
—
H413





603-192-00-X
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol
423-240-1
125474-34-2
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410




603-193-00-5
disodium 9,10-anthracenedioxide
426-030-8
46492-07-3
Skin Corr. 1A
H314
GHS05
Dgr
H314




603-194-00-0
2-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5
111-41-1
Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Fd
H361
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Fd
H361
H314
H317

STOT SE 3; H335: C ≥ 5 %


603-195-00-6
2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol
430-810-3
154825-62-4
Aquatic Chronic 3
H412
—
H412



603-196-00-1
2-(7-ethyl-1H-indol-3-yl)ethanol
431-020-1
41340-36-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Wng
H302
H373 **
H411



603-197-00-7
tebuconazole (ISO);
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
403-640-2
107534-96-3
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H361d ***
H302
H411
GHS08
GHS07
GHS09
Wng
H361d ***
H302
H411



603-199-00-8
etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
—
153233-91-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M = 100



603-200-00-1
1-pentanol; [1]
3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
H226
H332
H335
H315
GHS02
GHS07
Wng
H226
H332
H335
H315




603-201-00-7
(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
416-120-5
—
Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413




603-202-00-2
4,4,5,5,5-pentafluoropentan-1-ol
421-360-9
148043-73-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




603-203-00-8
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane
427-580-1
—
Skin Irrit. 2
H315
GHS07
Wng
H315




603-204-00-3
reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane
428-110-8
—
Aquatic Chronic 3
H412
—
H412




603-205-00-9
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
426-200-1
172015-79-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H372**
H302
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318
H317
H412




603-206-00-4
2,2-dichloro-1,3-benzodioxol
426-850-6
2032-75-9
Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1
H226
H314
H302
H317
GHS02
GHS05
GHS07
Dgr
H226
H314
H302
H317
EUH014



603-207-00-X
2-isobutyl-2-isopropyl-1,3-dimethoxypropane
430-800-9
129228-21-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




603-208-00-5
1,2-diethoxyethane
211-076-1
629-14-1
Flam. Liq. 2
Repr. 1A
Eye Irrit. 2
H225
H360Df
H319
GHS02
GHS08
GHS07
Dgr
H225
H360Df
H319
EUH019



603-209-00-0
spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]
- [1]
- [2]
- [3]
- [1]
131929-60-7 [2]
131929-63-0 [3]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=10


603-210-00-6
2,4-diethyl-1,5-pentanediol
429-310-8
57987-55-0
Eye Dam. 1
H318
GHS05
Dgr
H318




603-211-00-1
2,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … %
221-221-0
3033-77-0
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H350
H341
H361f***
H312
H302
H373**
H318
H317
H412


B

603-212-00-7
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-9
1222-05-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




603-213-00-2
2-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4
994-05-8
Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
H225
H302
H336
GHS02
GHS07
Dgr
H225
H302
H336




603-214-00-8
1,1-diisopropoxycyclohexane
413-740-8
1132-95-2
Skin Corr. 1B
H314
GHS05
Dgr
H314




603-215-00-3
1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2
162241-33-0
Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H302
H373**
H318
H317
H400
H410
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H201
H302
H373**
H318
H317
H410




603-216-00-9
cis-1-amino-2,3-dihydro-1H-inden-2-ol
422-660-2
7480-35-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




603-217-00-4
2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite
423-560-1
161717-32-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




603-220-00-0
1-{]benzyl[}2-(2-methoxyphenoxy)ethyl{]amino[}-3-(9H-carbazol-4-yloxy)propan-2-ol
432-890-5
72955-94-3
Aquatic Chronic 4
H413
—
H413




603-221-00-6
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411




603-221-01-3
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H350
H302
H314
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H350
H302
H314
H411




603-222-00-1
(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
433-820-6
118058-74-5
Eye Irrit. 2
H319
GHS07
Wng
H319




603-223-00-7
2-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol
434-270-1
6261-30-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412




603-224-00-2
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane
435-790-1
297730-93-9
Aquatic Chronic 4
H413
—
H413




603-225-00-8
erythromycin A9-oxime (E);
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0
13127-18-9
Aquatic Chronic 2
H411
GHS09
H411




603-226-00-3
4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol
444-500-0
1440-00-2
Aquatic Chronic 3
H412
—
H412




603-227-00-9
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2
203574-04-3
****
Aquatic Acute 1
Aquatic Chronic 1
****
H400
H410
****
GHS09
Wng
****
H410




603-228-00-4
(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




603-229-00-X
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate
420-800-7
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410




603-230-00-5
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan
440-030-5
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4
H315
H318
H413
GHS05
Dgr
H315
H318
H413




603-231-00-0
(S)-1,1-diphenyl-1,2-propanediol
443-220-6
—
Aquatic Chronic 3
H412
—
H412




603-232-00-6
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane
444-420-6
—
Aquatic Chronic 4
H413
—
H413




603-233-00-1
reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0
—
Aquatic Chronic 2
H411
GHS09
H411




603-234-00-7
(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
444-480-3
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




604-001-00-2
phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol
203-632-7
108-95-2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
H341
H331
H311
H301
H373 **
H314
GHS06
GHS08 GHS05
Dgr
H341
H331
H311
H301
H373 **
H314

*
Skin Corr. 1B; H314: C ≥ 3 %
Skin Irrit. 2; H315: 1 % ≤ C < 3 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %

604-002-00-8
pentachlorophenol
201-778-6
87-86-5
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H330
H311
H301
H319
H335
H315
H410



604-003-00-3
sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2]
205-025-2 [1]
231-911-3 [2]
131-52-2 [1]
7778-73-6 [2]
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H311
H301
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H330
H311
H301
H319
H335
H315
H410



604-004-00-9
m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4]
203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4]
108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4]
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Dgr
H311
H301
H314

*
C


604-005-00-4
1,4-dihydroxybenzene;
hydroquinone;
quinol
204-617-8
123-31-9
Carc. 2
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H302
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H341
H302
H318
H317
H400

M=10


604-006-00-X
3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7]
202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7]
95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7]
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H301
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H301
H314
H411


C
604-007-00-5
2-naphthol
205-182-7
135-19-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H332
H302
H400
GHS07
GHS09
Wng
H332
H302
H400



604-008-00-0
2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4]
202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4]
95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4]
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H312
H302
H411
GHS07 GHS09
Wng
H332
H312
H302
H411


C
604-009-00-6
pyrogallol;
1,2,3-trihydroxybenzene
201-762-9
87-66-1
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H341
H332
H312
H302
H412
GHS08
GHS07
Wng
H341
H332
H312
H302
H412

*

604-010-00-1
resorcinol;
1,3-benzenediol
203-585-2
108-46-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
H302
H319
H315
H400
GHS07
GHS09
Wng
H302
H319
H315
H400

*

604-011-00-7
2,4-dichlorophenol
204-429-6
120-83-2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H311
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H311
H302
H314
H411



604-012-00-2
4-chloro-o-cresol;
4-chloro-2-methyl phenol
216-381-3
1570-64-5
Acute Tox. 3 *
Skin Corr. 1A
Aquatic Acute 1
H331
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H314
H400

STOT SE 3; H335: C ≥ 1 %

604-013-00-8
2,3,4,6-tetrachlorophenol
200-402-8
58-90-2
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H315
H400
H410
GHS06
GHS09
Dgr
H301
H319
H315
H410

*
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %

604-014-00-3
chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol
200-431-6
59-50-7
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H312
H302
H318
H317
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H318
H317
H400

*

604-015-00-9
2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene
200-733-8
70-30-4
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H301
H400
H410
GHS06
GHS09
Dgr
H311
H301
H410

*

604-016-00-4
1,2-dihydroxybenzene;
pyrocatechol
204-427-5
120-80-9
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H312
H302
H319
H315
GHS07
Wng
H312
H302
H319
H315



604-017-00-X
2,4,5-trichlorophenol
202-467-8
95-95-4
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410

*
Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %

604-018-00-5
2,4,6-trichlorophenol
201-795-9
88-06-2
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H315
H410



604-019-00-0
dichlorophen (ISO)
202-567-1
97-23-4
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410



604-020-00-6
2-phenylphenol (ISO)
biphenyl-2-ol;
2-hydroxybiphenyl;
201-993-5
90-43-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H319
H335
H315
H400
GHS07
GHS09
Wng
H319
H335
H315
H400



604-021-00-1
sodium 2-biphenylate;
2-phenylphenol, sodium salt
205-055-6
132-27-4
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H302
H335
H315
H318
H400
GHS05
GHS07
GHS09
Wng
H302
H335
H315
H318
H400



604-022-00-7
2,2-dimethyl-1,3-benzodioxol-4-ol
400-900-7
22961-82-6
Eye Dam. 1
H318
GHS05
Dgr
H318



604-023-00-2
2,4-dichloro-3-ethylphenol
401-060-4
—
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410



604-024-00-8
4,4-isobutylethylidenediphenol
401-720-1
6807-17-6
Repr. 1B
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360F ***
H319
H400
H410
GHS08
GHS09
Dgr
H360F ***
H319
H410



604-025-00-3
2,5-bis(1,1-dimethylbutyl)hydroquinone
400-220-0
—
Aquatic Chronic 2
H411
GHS09
H411



604-026-00-9
2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)
400-270-3
—
Aquatic Chronic 2
H411
GHS09
H411



604-027-00-4
2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone
400-530-6
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



604-028-00-X
4-amino-3-fluorophenol
402-230-0
399-95-1
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H350
H302
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H411



604-029-00-5
1-naphtol
201-969-4
90-15-3
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H312
H302
H335
H315
H318
GHS05
GHS07
Dgr
H312
H302
H335
H315
H318





604-030-00-0
bisphenol A;
4,4'-isopropylidenediphenol
201-245-8
80-05-7
Repr. 2
STOT SE 3
Eye Dam. 1
Skin Sens. 1
H361f***
H335
H318
H317
GHS05
GHS08
GHS07
Dgr
H361f
H335
H318
H317




604-031-00-6
guaiacol
201-964-7
90-05-1
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315



604-032-00-1
thymol
201-944-8
89-83-8
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411



604-033-00-7
isobutyl but-3-enoate
401-170-2
24342-03-8
Flam. Liq. 3
H226
GHS02
Wng
H226



604-034-00-2
4,4'-thiodi-o-cresol
403-330-7
24197-34-0
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



604-035-00-8
4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol
404-160-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



604-036-00-3
4,4'-oxybis(ethylenethio)diphenol
404-590-4
90884-29-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



604-037-00-9
3,5-xylenol;
3,5-dimethylphenol
203-606-5
108-68-9
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H311
H301
H314
GHS06
GHS05
Dgr
H311
H301
H314



604-038-00-4
4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2]
201-793-8 [1]
215-316-6 [2]
88-04-0 [1]
1321-23-9 [2]
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H302
H319
H315
H317
GHS07
Wng
H302
H319
H315
H317



604-039-00-X
ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl
266-362-9
66441-23-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



604-040-00-5
fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-9
72178-02-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



604-041-00-0
acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2]
256-634-5 [1]
263-560-7 [2]
50594-66-6 [1]
62476-59-9 [2]
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410



604-042-00-6
4-nitrosophenol
203-251-6
104-91-6
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H341
H302
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H341
H302
H318
H411



604-043-00-1
monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether
203-083-3
103-16-2
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



604-044-00-7
mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether
205-769-8
150-76-5
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317



604-045-00-2
2,3,5-trimethylhydroquinone
211-838-3
700-13-0
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H335
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H335
H315
H318
H317
H410



604-046-00-8
4-(4-isopropoxyphenylsulfonyl)phenol
405-520-5
95235-30-6
Aquatic Chronic 2
H411
GHS09
H411



604-047-00-3
4-(4-tolyloxy)biphenyl
405-730-7
51601-57-1
STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413



604-048-00-9
4,4',4''-(ethan-1,1,1-triyl)triphenol
405-800-7
27955-94-8
Aquatic Chronic 2
H411
GHS09
H411



604-049-00-4
4-4'-methylenebis(oxyethylenethio)diphenol
407-480-4
93589-69-6
Aquatic Chronic 2
H411
GHS09
H411



604-051-00-5
3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol
401-110-5
87113-78-8
Aquatic Chronic 3
H412
—
H412



604-052-00-0
2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)
403-800-1
103597-45-1
Aquatic Chronic 4
H413
—
H413



604-053-00-6
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol
410-760-9
157661-93-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



604-054-00-1
reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412





604-055-00-7
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane
413-900-7
85954-11-6
Carc. 2
Skin Sens. 1
H351
H317
GHS08
GHS07
Wng
H351
H317




604-056-00-2
2-(2-hydroxy-3,5-dinitroanilino)ethanol
412-520-9
99610-72-7
Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
H228
H361f ***
H302
GHS02
GHS07
GHS08
Dgr
H228
H361f ***
H302



604-057-00-8
reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6
401-680-5
—
Aquatic Chronic 2
H411
GHS09
H411



604-058-00-3
1,2-bis(3-methylphenoxy)ethane
402-730-9
54914-85-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



604-059-00-9
2-n-hexadecylhydroquinone
406-400-5
—
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H373 **
H315
H317
H413
GHS08
GHS07
Wng
H373 **
H315
H317
H413



604-060-00-4
9,9-bis(4-hydroxyphenyl)fluorene
406-950-6
3236-71-3
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410



604-061-00-X
reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl
407-740-7
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H315
H317
H412
GHS07
Wng
H315
H317
H412



604-062-00-5
2,4-dimethyl-6-(1-methyl-pentadecyl)phenol
411-220-5
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



604-063-00-0
5,6-dihydroxyindole
412-130-9
3131-52-0
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05 GHS07
GHS09
Dgr
H302
H318
H411



604-064-00-6
2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol
411-380-6
147315-50-2
Aquatic Chronic 4
H413
—
H413



604-065-00-1
4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)
407-460-5
111850-25-0
Aquatic Chronic 2
H411
GHS09
H411



604-066-00-7
reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



604-067-00-2
reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410



604-068-00-8
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride
415-170-5
90274-24-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
H332
H302
H317
GHS07
Wng
H332
H302
H317



604-069-00-3
2-(1-methylpropyl)-4-tert-butylphenol
421-740-4
51390-14-8
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411



604-070-00-9
triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-2
3380-34-5
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410

M = 100



604-071-00-4
4,4'-(1-{]4-[}1-(4-hydroxyphenyl)-1-methylethyl{]phenyl[}ethylidene)diphenol
425-600-3
110726-28-8
Aquatic Chronic 4
H413
—
H413




604-072-00-X
1,2-bis(phenoxymethyl)benzene
428-620-0
10403-74-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




604-073-00-5
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
428-010-4
82413-20-5
Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H360F***
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H351
H360F***
H317
H410




604-074-00-0
tetrabromobisphenol-A;
2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol
201-236-9
79-94-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




604-075-00-6
4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol
205-426-2
140-66-9
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410

M=10


604-076-00-1
phenolphthalein
201-004-7
77-09-8
Carc. 1B
Muta. 2
Repr. 2
H350
H341
H361f***
GHS08
Dgr
H350
H341
H361f***

Carc. 1A; H350: C ≥ 1 %


604-077-00-7
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol
419-750-9
98809-58-6
Aquatic Chronic 4
H413
—
H413




604-079-00-8
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol
428-970-4
13595-25-0
Repr. 2
Skin Sens. 1
Aquatic Chronic 2
H361f***
H317
H411
GHS08
GHS09
Wng
H361f***
H317
H411




604-080-00-3
4-fluoro-3-trifluoromethylphenol
432-560-0
61721-07-1
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Chronic 2
H332
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H314
H317
H411




604-081-00-9
1,1-bis(4-hydroxyphenyl)-1-phenylethane
433-130-5
1571-75-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




604-082-00-4
2-chloro-6-fluoro-phenol
433-890-8
2040-90-6
Muta. 1B
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H340
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H340
H361f***
H302
H314
H317
H411




604-083-00-X
4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol
439-270-3
260408-02-4
Aquatic Chronic 4
H413
—
H413




604-084-00-5
1-ethoxy-2,3-difluorobenzene
441-000-4
121219-07-6
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




604-087-00-1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8
—
Pyr. Sol. 1
Aquatic Chronic 4
H250
H413
GHS02
Dgr
H250
H413
EUH044



604-089-00-2
2-methyl-5-tert-butylthiophenol
444-970-7
—
Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H226
H361d***
H373**
H304
H319
H315
H317
H336
H400
H410
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H361d***
H373**
H304
H319
H315
H317
H336
H410





605-001-00-5
formaldehyde ...%
200-001-8
50-00-0
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H351
H331
H311
H301
H314
H317
GHS06
GHS08
GHS05
Dgr
H351
H331
H311
H301
H314
H317

*
Skin Corr. 1B; H314: C ≥25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 5 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 5 %
Skin Sens. 1; H317: C ≥ 0,2 %
B D
605-002-00-0
1,3,5-trioxan;
trioxymethylene
203-812-5
110-88-3
Flam. Sol. 1
Repr. 2
STOT SE 3
H228
H361d ***
H335
GHS02
GHS08
GHS07
Dgr
H228
H361d ***
H335


T
605-003-00-6
acetaldehyde;
ethanal
200-836-8
75-07-0
Flam. Liq. 1
Carc. 2
Eye Irrit. 2
STOT SE 3
H224
H351
H319
H335
GHS02
GHS08
GHS07
Dgr
H224
H351
H319
H335





605-004-00-1
2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde
204-639-8
123-63-7
Flam. Liq. 3
H226
GHS02
Wng
H226




605-005-00-7
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde
203-600-2
108-62-3
Flam. Sol. 2
Acute Tox. 4 *
H228
H302
GHS02
GHS07
Dgr
H228
H302





605-006-00-2
butyraldehyde
204-646-6
123-72-8
Flam. Liq. 2
H225
GHS02
Dgr
H225



605-007-00-8
1,1-dimethoxyethane;
dimethyl acetal
208-589-8
534-15-6
Flam. Liq. 2
H225
GHS02
Dgr
H225



605-008-00-3
acrylaldehyde;
acrolein;
prop-2-enal
203-453-4
107-02-8
Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H225
H330
H311
H301
H314
H400
GHS02
GHS06
GHS05
GHS09
Dgr
H225
H330
H311
H301
H314
H400


D
605-009-00-9
crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2]
224-030-0 [1]
204-647-1 [2]
4170-30-3 [1]
123-73-9 [2]
Flam. Liq. 2
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400





605-010-00-4
2-furaldehyde
202-627-7
98-01-1
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H331
H301
H312
H319
H335
H315
GHS06
GHS08
Dgr
H351
H331
H301
H312
H319
H335
H315





605-011-00-X
2-chlorobenzaldehyde;
o-chlorobenzaldehyde
201-956-3
89-98-5
Skin Corr. 1B
H314
GHS05
Dgr
H314



605-012-00-5
benzaldehyde
202-860-4
100-52-7
Acute Tox. 4 *
H302
GHS07
Wng
H302



605-013-00-0
chloralose (INN);
(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;
glucochloralose;
anhydroglucochloral
240-016-7
15879-93-3
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302



605-014-00-6
chloral hydrate;
2,2,2-trichloroethane-1,1-diol
206-117-5
302-17-0
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Dgr
H301
H319
H315



605-015-00-1
1,1-diethoxyethane;
acetal
203-310-6
105-57-7
Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2
H225
H319
H315
GHS02
GHS07
Dgr
H225
H319
H315



605-016-00-7
glyoxal...%;
ethandial...%
203-474-9
107-22-2
Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H341
H332
H319
H315
H317
GHS07
GHS08
Wng
H341
H332
H319
H315
H317

*
B
605-017-00-2
1,3-dioxolane
211-463-5
646-06-0
Flam. Liq. 2
H225
GHS02
Dgr
H225



605-018-00-8
propanal;
propionaldehyde
204-623-0
123-38-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315



605-019-00-3
citral
226-394-6
5392-40-5
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



605-020-00-9
safrole;
5-allyl-1,3-benzodioxole
202-345-4
94-59-7
Carc. 1B
Muta. 2
Acute Tox. 4 *
H350
H341
H302
GHS08
GHS07
Dgr
H350
H341
H302



605-021-00-4
formaldehyde, reaction products with butylphenol
294-145-9
91673-30-2
Skin Sens. 1
H317
GHS07
Wng
H317



605-022-00-X
glutaral;
glutaraldehyde;
1,5-pentanedial
203-856-5
111-30-8
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H331
H301
H314
H334
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H301
H314
H334
H317
H400

*
Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 10 %
Eye Dam. ; H318: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
STOT SE; H335: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 %



605-023-00-5
5-chloro-2-(4-chlorophenoxy)phenol
429-290-0
3380-30-1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




605-024-00-0
2-bromo-5-hydroxy-4-methoxybenzaldehyde
426-540-0
2973-59-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




605-025-00-6
chloroacetaldehyde
203-472-8
107-20-0
Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H351
H330
H311
H301
H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H330
H311
H301
H314
H400

STOT SE 3; H335: C ≥ 5 %

605-026-00-1
2,5,7,7-tetramethyloctanal
405-690-0
114119-97-0
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07 GHS09
Wng
H315
H317
H411



605-027-00-7
reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



605-028-00-2
β-methyl-3-(1-methylethyl)-benzenepropanal
412-050-4
125109-85-5
Aquatic Chronic 2
H411
GHS09
H411



605-029-00-8
2-cyclohexylpropanal
412-270-0
2109-22-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



605-030-00-3
1-(p-methoxyphenyl)acetaldehyde oxime
411-510-1
3353-51-3
Skin Sens. 1
H317
GHS07
Wng
H317



605-031-00-9
reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0
—
Skin Sens. 1
H317
GHS07
Wng
H317





605-032-00-4
3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal
425-370-4
93957-50-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




605-033-00-X
reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal
425-910-9
32480-08-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410




605-034-00-5
reaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
429-860-9
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




605-035-00-0
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal
426-330-9
177964-68-0
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H319
H317
H413
GHS07
Wng
H319
H317
H413




605-036-00-6
2-bromomalonaldehyde
430-470-6
2065-75-0
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318




605-037-00-1
trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1
120578-03-2
Aquatic Chronic 4
H413
—
H413




605-038-00-7
3-methyl-5-phenylpentan-1-al
433-900-0
55066-49-4
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H315
H317
H411
GHS07
GHS09
Wng
H302
H315
H317
H411




605-039-00-2
3,4-dihydroxy-5-nitrobenzaldehyde
441-810-8
116313-85-0
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317




606-001-00-8
acetone;
propan-2-one;
propanone
200-662-2
67-64-1
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066


606-002-00-3
butanone;
ethyl methyl ketone
201-159-0
78-93-3
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066


606-003-00-9
heptan-3-one;
butyl ethyl ketone
203-388-1
106-35-4
Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
H226
H332
H319
GHS02
GHS07
Wng
H226
H332
H319



606-004-00-4
4-methylpentan-2-one;
isobutyl methyl ketone
203-550-1
108-10-1
Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335
EUH066


606-005-00-X
2,6-dimethylheptan-4-one;
di-isobutyl ketone
203-620-1
108-83-8
Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Wng
H226
H335

STOT SE 3; H335: C ≥ 10 %

606-006-00-5
pentan-3-one;
diethyl ketone
202-490-3
96-22-0
Flam. Liq. 2
STOT SE 3
STOT SE 3
H225
H335
H336
GHS02
GHS07
Dgr
H225
H335
H336
EUH066


606-007-00-0
3-methylbutan-2-one;
methyl isopropyl ketone
209-264-3
563-80-4
Flam. Liq. 2
H225
GHS02
Dgr
H225



606-009-00-1
4-methylpent-3-en-2-one;
mesityl oxide
205-502-5
141-79-7
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302

*

606-010-00-7
cyclohexanone
203-631-1
108-94-1
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



606-011-00-2
2-methylcyclohexanone
209-513-6
583-60-8
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



606-012-00-8
3,5,5-trimethylcyclohex-2-enone;
isophorone
201-126-0
78-59-1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H351
H312
H302
H319
H335
GHS08
GHS07
Wng
H351
H312
H302
H319
H335

STOT SE 3; H335: C ≥ 10 %



606-013-00-3
p-benzoquinone;
quinone
203-405-2
106-51-4
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H331
H301
H319
H335
H315
H400
GHS06
GHS09
Dgr
H331
H301
H319
H335
H315
H400

M=10


606-014-00-9
chlorophacinone (ISO);
2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione
223-003-0
3691-35-8
Acute Tox. 1
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H331
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H310
H300
H331
H372 **
H410



606-016-00-X
pindone (ISO);
2-pivaloylindan-1,3-dione
201-462-8
83-26-1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H372 **
H410



606-017-00-5
diketene;
diketen
211-617-1
674-82-8
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332


D
606-018-00-0
dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone
204-210-5
117-80-6
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410



606-019-00-6
chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3
143-50-0
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H410



606-020-00-1
5-methylheptan-3-one
208-793-7
541-85-5
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335

STOT SE 3; H335: C ≥ 10 %



606-021-00-7
N-methyl-2-pyrrolidone;
1-methyl-2-pyrrolidone
212-828-1
872-50-4
Repr. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H360D***
H319
H335
H315
GHS08
GHS07
Dgr
H360D***
H319
H335
H315

Repr. 1B; H360D: C ≥ 5 %
STOT SE 3; H335: C ≥ 10 %


606-022-00-2
1-phenyl-3-pyrazolidone
202-155-1
92-43-3
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



606-023-00-8
4-methoxy-4-methylpentan-2-one
203-512-4
107-70-0
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



606-024-00-3
heptan-2-one;
methyl amyl ketone
203-767-1
110-43-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302



606-025-00-9
cyclopentanone
204-435-9
120-92-3
Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2
H226
H319
H315
GHS02
GHS07
Wng
H226
H319
H315



606-026-00-4
5-methylhexan-2-one;
isoamyl methyl ketone
203-737-8
110-12-3
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



606-027-00-X
heptan-4-one;
di-n-propyl ketone
204-608-9
123-19-3
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



606-028-00-5
2,4-dimethylpentan-3-one;
di-isopropyl ketone
209-294-7
565-80-0
Flam. Liq. 2
Acute Tox. 4 *
H225
H332
GHS02
GHS07
Dgr
H225
H332



606-029-00-0
pentane-2,4-dione;
acetylacetone
204-634-0
123-54-6
Flam. Liq. 3
Acute Tox. 4 *
H226
H302
GHS02
GHS07
Wng
H226
H302



606-030-00-6
hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone
209-731-1
591-78-6
Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3
H226
H361f ***
H372 **
H336
GHS02
GHS08
GHS07
Dgr
H226
H361f ***
H372 **
H336



606-031-00-1
3-propanolide;
1,3-propiolactone
200-340-1
57-57-8
Carc. 1B
Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
H350
H330
H319
H315
GHS06
GHS08
Dgr
H350
H330
H319
H315



606-032-00-7
hexachloroacetone
204-129-5
116-16-5
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



606-033-00-2
2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole
243-761-6
20354-26-1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411





606-034-00-8
metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-7
21087-64-9
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=10


606-035-00-3
chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon
216-920-2
1698-60-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



606-036-00-9
quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-3
2439-01-2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f ***
H332
H312
H302
H373 **
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f ***
H332
H312
H302
H373 **
H319
H317
H410



606-037-00-4
triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-8
43121-43-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



606-038-00-X
diphacinone (ISO);
2-diphenylacetylindan-1,3-dione
201-434-5
82-66-6
Acute Tox. 2 *
STOT RE 1
H300
H372 **
GHS06
GHS08
Dgr
H300
H372 **



606-039-00-5
5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one
400-680-2
—
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H400
H410
GHS07
GHS09
Wng
H332
H410



606-040-00-0
(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride
401-840-4
55845-90-4
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



606-041-00-6
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one
400-600-6
71868-10-5
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



606-042-00-1
acetophenone
202-708-7
98-86-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



606-043-00-7
2,4-di-tert-butylcyclohexanone
405-340-7
13019-04-0
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



606-044-00-2
2,4,6-trimethylbenzophenone
403-150-9
954-16-5
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410



606-045-00-8
oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-7
19666-30-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-046-00-3
reaction mass of cis- and trans-cyclohexadec-8-en-1-one
401-700-2
3100-36-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-047-00-9
2-benzyl-2-dimethylamino-4-morpholinobutyrophenone
404-360-3
119313-12-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-048-00-4
2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one
406-480-1
—
Aquatic Chronic 4
H413
—
H413



606-049-00-X
4-(trans-4-propylcyclohexyl)acetophenone
406-700-6
78531-61-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



606-050-00-5
6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione
412-480-2
72453-58-8
Aquatic Chronic 2
H411
GHS09
H411



606-051-00-0
4-pentylcyclohexanone
406-670-4
61203-83-6
Aquatic Chronic 2
H411
GHS09
H411



606-052-00-6
4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone
410-410-5
54574-82-2
Aquatic Chronic 3
H412
—
H412



606-053-00-1
flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one
—
96525-23-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-054-00-7
isoxaflutole (ISO);
5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone
—
141112-29-0
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H400
H410
GHS08
GHS09
Wng
H361d ***
H410



606-055-00-2
1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone
411-180-9
92836-10-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Wng
H302
H373 **
H411



606-056-00-8
4-chloro-3',4'-dimethoxybenzophenone
404-610-1
116412-83-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-057-00-3
4-propylcyclohexanone
406-810-4
40649-36-3
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412



606-058-00-9
4'-fluoro-2,2-dimethoxyacetophenone
407-500-1
21983-80-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



606-059-00-4
2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride
412-390-3
86386-75-6
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317



606-060-00-X
reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-061-00-5
(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone
423-290-4
66938-41-8
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H400
H410
GHS08
GHS09
Wng
H341
H410



606-062-00-0
tetrahydrothiopyran-3-carboxaldehyde
407-330-8
61571-06-0
Repr. 1B
Eye Dam. 1
Aquatic Chronic 3
H360D ***
H318
H412
GHS08
GHS05
Dgr
H360D ***
H318
H412



606-063-00-6
(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal
410-980-5
112704-51-5
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



606-064-00-1
pregn-5-ene-3,20-dione bis(ethylene ketal)
407-450-0
7093-55-2
Aquatic Chronic 4
H413
—
H413



606-065-00-7
1-(4-morpholinophenyl)butan-1-one
413-790-0
—
Aquatic Chronic 2
H411
GHS09
H411



606-066-00-2
(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone
410-440-9
164058-20-2
Aquatic Chronic 2
H411
GHS09
H411



606-067-00-8
reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-8
96792-67-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-068-00-3
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al
415-770-7
1638-05-7
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 **
H317
H412
GHS08
GHS07
Wng
H373 **
H317
H412



606-069-00-9
spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]
415-460-1
154171-76-3
Aquatic Chronic 2
H411
GHS09
H411



606-070-00-4
butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3
138164-12-2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H361fd
H302
H315
H410



606-071-00-X
17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one
421-050-3
13258-43-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-072-00-5
3-acetyl-1-phenyl-pyrrolidine-2,4-dione
421-600-2
719-86-8
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411



606-073-00-0
4,4'-bis(dimethylamino)benzophenone;
Michler's ketone
202-027-5
90-94-8
Carc. 1B
Muta. 2
Eye Dam. 1
H350
H341
H318
GHS08
GHS05
Dgr
H350
H341
H318





606-074-00-6
reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
425-570-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





606-075-00-1
1-benzyl-5-ethoxyimidazolidine-2,4-dione
417-340-4
65855-02-9
Acute Tox. 4 *
H302
GHS07
Wng
H302



606-076-00-7
1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione
418-630-3
136465-99-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



606-077-00-2
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone
418-650-2
104872-06-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-078-00-8
1-octylazepin-2-one
420-040-6
59227-88-2
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411



606-079-00-3
2-n-butyl-benzo[d]isothiazol-3-one
420-590-7
4299-07-4
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410




606-080-00-9
Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene
417-100-9
—
Aquatic Chronic 4
H413

H413




606-081-00-4
(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one
419-790-7
4229-69-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



606-082-00-X
reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7

STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H372 **
H317
H412
GHS08
GHS07
Dgr
H372 **
H317
H412



606-083-00-5
2-chloro-5-sec-hexadecylhydroquinone
407-750-1
137193-60-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Wng
H319
H315
H317
H412



606-084-00-0
1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione
414-540-3
484-33-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-085-00-6
(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one
418-530-1
79200-56-9
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317



606-086-00-1
1-(3,3-dimethylcyclohexyl)pent-4-en-1-one
422-330-8
56973-87-6
Aquatic Chronic 2
H411
GHS09
H411



606-087-00-7
6-ethyl-5-fluoro-4(3H)-pyrimidone
422-460-5
137234-87-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



606-088-00-2
2,4,4,7-tetramethyl-6-octen-3-one
422-520-0
74338-72-0
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



606-089-00-8
reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-2
12223-77-7
Aquatic Chronic 4
H413
—
H413





606-090-00-3
1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone
430-920-1
73096-98-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412





606-091-00-9
6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one
421-320-0
118289-55-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



606-092-00-4
reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3

Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





606-093-00-X
5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one
414-470-3
95885-13-5
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




606-094-00-5
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one
417-460-7
—
Aquatic Chronic 4
H413
—
H413




606-095-00-0
(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one
421-830-3
49805-30-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317




606-096-00-6
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
424-170-4
130603-71-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




606-097-00-1
2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone
424-210-0
23911-85-5
Aquatic Chronic 4
H413
—
H413




606-098-00-7
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione
431-220-9
158574-65-3
Aquatic Chronic 4
H413
—
H413




606-099-00-2
5-methoxy-4'-(trifluoromethyl)valerophenone
425-000-1
61718-80-7
Aquatic Chronic 2
H411
GHS09
H411




606-100-00-6
2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one
425-150-8
94723-86-1
Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H360F***
H302
H317
H412
GHS08
GHS07
Dgr
H360F***
H302
H317
H412




606-101-00-1
reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione
426-050-7
165038-51-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




606-102-00-7
4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone
431-490-8
79876-59-8
Aquatic Chronic 2
H411
GHS09
H411




606-103-00-2
1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone
426-460-6
—
Skin Sens. 1
H317
GHS07
Wng
H317




606-104-00-8
1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone
426-830-7
78531-59-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




606-105-00-3
3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
431-500-0
226065-73-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




606-106-00-9
1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone
427-320-7
83626-30-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




606-107-00-4
8-azaspiro[4.5]decane-7,9-dione
427-770-4
1075-89-4
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411




606-108-00-X
1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone
436-710-6
756-13-8
Aquatic Chronic 3
H412
—
H412




606-109-00-5
2-(4-methyl-3-pentenyl)anthraquinone
428-320-1
71308-16-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H314
GHS07
Wng
H302
H317
H314




606-110-00-0
5-ethoxy-5H-furan-2-one
428-330-4
2833-30-9
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
H314
H312
H302
H373**
H317
GHS05
GHS08
GHS07
Dgr
H314
H312
H302
H373**
H317




606-111-00-6
5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one
428-410-9
67014-36-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




606-112-00-1
(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
428-690-2
1668-86-6
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412




606-113-00-7
1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one
429-040-0
272460-97-6
Eye Dam. 1
Aquatic Chronic 4
H318
H314
GHS05
Dgr
H318
H314




606-114-00-2
4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone
429-150-9
67887-47-2
Aquatic Chronic 4
H413
—
H413




606-115-00-8
profoxydim (ISO);
2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{]butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
—
139001-49-3
Carc. 2
Repr. 2
Skin Sens. 1
H351
H361d
H317
GHS08
GHS07
Wng
H351
H361d
H317




606-116-00-3
tepraloxydim (ISO);
(RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
—
149979-41-9
Carc. 2
Repr. 2
H351
H361fd
GHS08
Wng
H351
H361fd




606-117-00-9
2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one
429-460-4
7078-98-0
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




606-118-00-4
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine
429-640-2
52870-46-9
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410




606-119-00-X
(E)-3-methyl-5-cyclopentadecen-1-one
429-900-5
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




606-120-00-5
2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one
430-170-5
114625-74-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




606-121-00-0
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
430-460-1
133636-82-5
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410




606-122-00-6
3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one
430-820-8
114341-88-7
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H315
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373**
H315
H318
H317
H410




606-123-00-1
4-hexadecyl-1-phenylpyrazolidin-3-one
430-840-7
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




606-124-00-7
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione
421-080-7
161462-35-7
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410




606-125-00-2
1-benzylimidazolidine-2,4-dione
421-340-1
6777-05-5
Acute Tox. 4 *
H302
GHS07
Wng
H302




606-126-00-8
1,4-bis(2,3-dihydroxypropylamino)anthraquinone
421-470-7
99788-75-7
Aquatic Chronic 2
H411
GHS09
H411




606-128-00-9
2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione
422-650-8
148935-94-8
Aquatic Chronic 4
H413
—
H413




606-129-00-4
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7
156732-13-7
Aquatic Chronic 4
H413
—
H413




606-130-00-X
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone
423-860-2
56309-94-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




606-131-00-5
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
427-230-8
5571-36-8
Repr. 1B
STOT RE 2 *
Aquatic Chronic 2
H360F***
H373**
H411
GHS08
GHS09
Dgr
H360F***
H373**
H411




606-132-00-0
(6β)-6,19-epoxyandrost-4-ene-3,17-dione
433-490-3
6563-83-3
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




606-134-00-1
androsta-1,4,9(11)-triene-3,17-dione
433-560-3
15375-21-0
Repr. 2
H361f***
GHS08
Wng
H361f***




606-135-00-7
cyclohexadecanone
438-930-8
2550-52-9
Aquatic Chronic 4
H413
—
H413




606-136-00-2
(3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
444-350-6
133413-70-4
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413




606-137-00-8
trans-7,7'-dimethyl-(4H, 4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione
444-750-0
211387-26-7
Aquatic Chronic 4
H413
—
H413




606-138-00-3
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone
444-800-1
141645-23-0
Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H302
H373**
H315
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H226
H302
H373**
H315
H318
H317
H410

M=10


606-139-00-9
(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
444-830-5
124379-29-9
Aquatic Chronic 4
H413
—
H413




606-140-00-4
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one
444-860-9
474510-57-1
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410




606-141-00-X
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate
418-410-7
—
Eye Irrit. 2
H319
GHS07
Wng
H319




606-142-00-5
reaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9
—
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411




607-001-00-0
formic acid ... %
200-579-1
64-18-6
Skin Corr. 1A
H314
GHS05
Dgr
H314

Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 10 % ≤ C < 90 %
Skin Irrit. 2; H315: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 2 % ≤ C < 10 %
B
607-002-00-6
acetic acid ... %
200-580-7
64-19-7
Flam. Liq. 3
Skin Corr. 1A
H226
H314
GHS02
GHS05
Dgr
H226
H314

Skin Corr. 1A; H314: C ≥ 90 %
Skin Corr. 1B; H314: 25 % ≤ C < 90 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B


607-003-00-1
chloroacetic acid
201-178-4
79-11-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H331
H311
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H400

STOT SE 3; H335: C ≥ 5 %


607-004-00-7
TCA (ISO);
trichloroacetic acid
200-927-2
76-03-9
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410

STOT SE 3; H335: C ≥ 1 %

607-005-00-2
TCA-sodium (ISO);
sodium trichloroacetate
211-479-2
650-51-1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H335
H400
H410
GHS07
GHS09
Wng
H335
H410



607-006-00-8
oxalic acid
205-634-3
144-62-7
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302

*



607-007-00-3
salts of oxalic acid with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302

*
A

607-008-00-9
acetic anhydride
203-564-8
108-24-7
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H332
H302
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Dam. 1; H318: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 1 % ≤ C < 5 %
STOT SE 3; H335: C ≥ 5 %

607-009-00-4
phthalic anhydride
201-607-5
85-44-9
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H335
H315
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H335
H315
H318
H334
H317



607-010-00-X
propionic anhydride
204-638-2
123-62-6
Skin Corr. 1B
H314
GHS05
Dgr
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

607-011-00-5
acetyl chloride
200-865-6
75-36-5
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014




607-012-00-0
benzoyl chloride
202-710-8
98-88-4
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H332
H312
H302
H314
H317
GHS05
GHS07
Dgr
H332
H312
H302
H314
H317




607-013-00-6
dimethyl carbonate
210-478-4
616-38-6
Flam. Liq. 2
H225
GHS02
Dgr
H225



607-014-00-1
methyl formate
203-481-7
107-31-3
Flam. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H224
H332
H302
H319
H335
GHS02
GHS07
Dgr
H224
H332
H302
H319
H335



607-015-00-7
ethyl formate
203-721-0
109-94-4
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H302
H319
H335
GHS02
GHS07
Dgr
H225
H332
H302
H319
H335



607-016-00-2
propyl formate; [1]
isopropyl formate [2]
203-798-0 [1]
210-901-2 [2]
110-74-7 [1]
625-55-8 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
H225
H319
H335
H336
GHS02
GHS07
Dgr
H225
H319
H335
H336


C
607-017-00-8
butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3]
209-772-5 [1]
212-105-0 [2]
208-818-1 [3]
592-84-7 [1]
762-75-4 [2]
542-55-2 [3]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335


C
607-018-00-3
isopentyl formate; [1]
2-methylbutyl formate [2]
203-769-2 [1]
252-343-2 [2]
110-45-2 [1]
35073-27-9 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H335
GHS02
GHS07
Dgr
H225
H319
H335


C
607-019-00-9
methyl chloroformate
201-187-3
79-22-1
Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H330
H312
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H312
H302
H314



607-020-00-4
ethyl chloroformate
208-778-5
541-41-3
Flam. Liq. 2
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H330
H302
H314
GHS02
GHS06
GHS05
Dgr
H225
H330
H302
H314



607-021-00-X
methyl acetate
201-185-2
79-20-9
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066


607-022-00-5
ethyl acetate
205-500-4
141-78-6
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066


607-023-00-0
vinyl acetate
203-545-4
108-05-4
Flam. Liq. 2
H225
GHS02
Dgr
H225


D
607-024-00-6
propyl acetate; [1]
isopropyl acetate [2]
203-686-1 [1]
203-561-1 [2]
109-60-4 [1]
108-21-4 [2]
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066

C
607-025-00-1
n-butyl acetate
204-658-1
123-86-4
Flam. Liq. 3
STOT SE 3
H226
H336
GHS02
GHS07
Wng
H226
H336
EUH066


607-026-00-7
sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3]
203-300-1 [1]
203-745-1 [2]
208-760-7 [3]
105-46-4 [1]
110-19-0 [2]
540-88-5 [3]
Flam. Liq. 2
H225
GHS02
Dgr
H225
EUH066

C
607-027-00-2
methyl propionate
209-060-4
554-12-1
Flam. Liq. 2
Acute Tox. 4 *
H225
H332
GHS02
GHS07
Dgr
H225
H332



607-028-00-8
ethyl propionate
203-291-4
105-37-3
Flam. Liq. 2
H225
GHS02
Dgr
H225



607-029-00-3
n-butyl propionate; [1]
sec-butyl propionate; [2]
iso-butyl propionate [3]
209-669-5 [1]
- [2]
208-746-0 [3]
590-01-2 [1]
591-34-4 [2]
540-42-1 [3]
Flam. Liq. 3
H226
GHS02
Wng
H226


C
607-030-00-9
propyl propionate
203-389-7
106-36-5
Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332



607-031-00-4
butyl butyrate
203-656-8
109-21-7
Flam. Liq. 3
H226
GHS02
Wng
H226


C
607-032-00-X
ethyl acrylate
205-438-8
140-88-5
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317

Skin Irrit. 2; H315: C ≥ 5 %
Eye Irrit. 2; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 %
D
607-033-00-5
n-butyl methacrylate
202-615-1
97-88-1
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317


D
607-034-00-0
methyl acrylate;
methyl propenoate
202-500-6
96-33-3
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317


D
607-035-00-6
methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate
201-297-1
80-62-6
Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H335
H315
H317
GHS02
GHS07
Dgr
H225
H335
H315
H317


D
607-036-00-1
2-methoxyethyl acetate;
methylglycol acetate
203-772-9
110-49-6
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H360FD
H332
H312
H302
GHS08
GHS07
Dgr
H360FD
H332
H312
H302





607-037-00-7
2-ethoxyethyl acetate;
ethylglycol acetate
203-839-2
111-15-9
Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD
H332
H312
H302




607-038-00-2
2-butoxyethyl acetate;
butylglycol acetate
203-933-3
112-07-2
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
GHS07
Wng
H332
H312



607-039-00-8
2,4-D (ISO);
2,4-dichlorophenoxyacetic acid
202-361-1
94-75-7
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H335
H318
H317
H412
GHS05
GHS07
Dgr
H302
H335
H318
H317
H412



607-040-00-3
salts of 2,4-D
—
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411


A
607-041-00-9
2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid
202-273-3
93-76-5
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410



607-042-00-4
salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid
—
—
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410


A
607-043-00-X
dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid
217-635-6
1918-00-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412



607-044-00-5
3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]
233-002-7 [2]
2300-66-5 [1]
10007-85-9 [2]
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412



607-045-00-0
dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid
204-390-5
120-36-5
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H312
H302
H315
H318
GHS05
GHS07
Dgr
H312
H302
H315
H318



607-046-00-6
salts of dichlorprop
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302


A
607-047-00-1
fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid
202-271-2
93-72-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410



607-048-00-7
salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410


A
607-049-00-2
mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]
202-264-4 [2]
7085-19-0 [1]
708519-0 [2]
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410

M=100

607-050-00-8
salts of mecoprop
—
—
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410


A


607-051-00-3
MCPA (ISO);
4-chloro-o-tolyloxyacetic acid
202-360-6
94-74-6
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410




607-052-00-9
salts and esters of MCPA
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410


A

607-053-00-4
MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid
202-365-3
94-81-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-054-00-X
salts and esters of MCPB
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302


A
607-055-00-5
endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8
129-67-9
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Dgr
H301
H312
H319
H335
H315



607-056-00-0
warfarin (ISO); [1]
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]
Repr. 1A
STOT RE 1
Aquatic Chronic 3
H360D ***
H372 **
H412
GHS08
Dgr
H360D ***
H372 **
H412



607-057-00-6
coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-1
81-82-3
STOT RE 2 *
Aquatic Chronic 3
H373 **
H412
GHS08
Wng
H373 **
H412



607-058-00-1
coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin
204-195-5
117-52-2
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3
H301
H372 **
H412
GHS06
GHS08
Dgr
H301
H372 **
H412



607-059-00-7
coumatetralyl;
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
227-424-0
5836-29-3
Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Chronic 3
H310
H300
H372 **
H412
GHS06
GHS08
Dgr
H310
H300
H372 **
H412



607-060-00-2
dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-9
66-76-2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 2
H372 **
H302
H411
GHS08
GHS07
GHS09
Dgr
H372 **
H302
H411



607-061-00-8
acrylic acid;
prop-2-enoic acid
201-177-9
79-10-7
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H226
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H332
H312
H302
H314
H400

STOT SE 3; H335: C ≥ 1 %
D
607-062-00-3
n-butyl acrylate
205-480-7
141-32-2
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317


D
607-063-00-9
isobutyric acid
201-195-7
79-31-2
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



607-064-00-4
benzyl chloroformate
207-925-0
501-53-1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410

STOT SE 3; H335: C ≥ 5 %



607-065-00-X
bromoacetic acid
201-175-8
79-08-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H331
H311
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H400




607-066-00-5
dichloroacetic acid
201-207-0
79-43-6
Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400



607-067-00-0
dichloroacetyl chloride
201-199-9
79-36-7
Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400



607-068-00-6
iodoacetic acid
200-590-1
64-69-7
Acute Tox. 3 *
Skin Corr. 1A
H301
H314
GHS06
GHS05
Dgr
H301
H314



607-069-00-1
ethyl bromoacetate
203-290-9
105-36-2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300



607-070-00-7
ethyl chloroacetate
203-294-0
105-39-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
H331
H311
H301
H400
GHS06
GHS09
Dgr
H331
H311
H301
H400



607-071-00-2
ethyl methacrylate
202-597-5
97-63-2
Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H319
H335
H315
H317


D
607-072-00-8
2-hydroxyethyl acrylate
212-454-9
818-61-1
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H311
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H311
H314
H317
H400

*
Skin Sens. 1; H317: C ≥ 0,2 %
D
607-073-00-3
4-CPA (ISO);
4-chlorophenoxyacetic acid
204-581-3
122-88-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-074-00-9
chlorfenac(ISO);
2,3,6-trichlorophenylacetic acid
201-599-3
85-34-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-075-00-4
chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-5
14437-17-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



607-076-00-X
dodine(ISO);
dodecylguanidinium acetate
219-459-5
2439-10-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410



607-077-00-5
erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate
—
136-25-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-078-00-0
fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate
—
4301-50-2
Acute Tox. 1
Acute Tox. 2 *
H310
H300
GHS06
Dgr
H310
H300



607-079-00-6
kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
—
4234-79-1
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2
H311
H302
H411
GHS06
GHS09
Dgr
H311
H302
H411



607-080-00-1
chloroacetyl chloride
201-171-6
79-04-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Aquatic Acute 1
H331
H311
H301
H372 **
H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H311
H301
H372 **
H314
H400
EUH014
EUH029


607-081-00-7
fluoroacetic acid
205-631-7
144-49-0
Acute Tox. 2 *
Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400



607-082-00-2
fluoroacetates, soluble
—
—
Acute Tox. 2 *
Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400


A
607-083-00-8
2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid
202-366-9
94-82-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-084-00-3
salts of 2,4-DB
—
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411


A


607-085-00-9
benzyl benzoate
204-402-9
120-51-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411




607-086-00-4
diallyl phthalate
205-016-3
131-17-9
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-088-00-5
methacrylic acid;
2-methylpropenoic acid
201-204-4
79-41-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314

STOT SE 3; H335: C ≥ 1 %
D
607-089-00-0
propionic acid ... %
201-176-3
79-09-4
Skin Corr. 1B
H314
GHS05
Dgr
H314

Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H319: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C ≥ 10 %
B
607-090-00-6
thioglycolic acid
200-677-4
68-11-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H331
H311
H301
H314
GHS06
GHS05
Dgr
H331
H311
H301
H314

*

607-091-00-1
trifluoroacetic acid . . . %
200-929-3
76-05-1
Acute Tox. 4 *
H332
GHS05
H332

*
B




Skin Corr. 1A
Aquatic Chronic 3
H314
H412
GHS07
Dgr
H314
H412



607-092-00-7
methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4]
208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4]
547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335


C
607-093-00-2
propionyl chloride
201-170-0
79-03-8
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014

B D
607-094-00-8
peracetic acid . . . %
201-186-8
79-21-0
Flam. Liq. 3
Org. Perox. D ****
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H226
H242
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H242
H332
H312
H302
H314
H400

*
STOT SE 3; H335: C ≥ 1 %
B D


607-095-00-3
maleic acid
203-742-5
110-16-7
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H302
H319
H335
H315
H317
GHS07
Wng
H302
H319
H335
H315
H317

Skin Sens. 1; H317: C ≥ 0,1 %


607-096-00-9
maleic anhydride
203-571-6
108-31-6
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H302
H314
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H314
H334
H317



607-097-00-4
benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride
209-008-0
552-30-7
STOT SE 3
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H335
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H335
H318
H334
H317



607-098-00-X
benzene-1,2:4,5-tetracarboxylic dianhydride;
benzene-1,2:4,5-tetracarboxylic dianhydride;
pyromellitic dianhydride
201-898-9
89-32-7
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317



607-099-00-5
1,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4]
201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4]
85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H334
H317
H412
GHS08
GHS05
Dgr
H318
H334
H317
H412


C
607-100-00-9
benzophenone-3,3',4,4'-tetracarboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride)
219-348-1
2421-28-5
Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335

Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %

607-101-00-4
1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride
204-077-3
115-27-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %

607-102-00-X
cyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicarboxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9 [1]
236-086-3 [2]
238-009-9 [3]
85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317


C


607-103-00-5
succinic anhydride
203-570-0
108-30-5
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H302
H319
H335
GHS07
Wng
H302
H319
H335

*
Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %



607-104-00-0
cyclopentane-1,2,3,4-tetracarboxylic dianhydride
227-964-7
6053-68-5
Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335

Eye Irrit. 2; H319: C ≥ 1 %
STOT SE 3; H335: C ≥ 1 %

607-105-00-6
8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]
204-957-7 [1]
212-557-9 [2]
220-384-5 [3]
129-64-6 [1]
826-62-0 [2]
2746-19-2 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317


C
607-106-00-1
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride
—
123748-85-6
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H302
H319
H335
H315
H334
GHS08
GHS07
Dgr
H302
H319
H335
H315
H334

STOT SE 3; H335: C ≥ 10 %
C
607-107-00-7
2-ethylhexyl acrylate
203-080-7
103-11-7
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H335
H315
H317
GHS07
Wng
H335
H315
H317


D
607-108-00-2
2-hydroxy-1-methylethylacrylate; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]
213-663-8 [2]
247-118-0 [3]
2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317

*
Skin Sens. 1; H317: C ≥ 0,2 %
C D
607-109-00-8
hexamethylene diacrylate;
hexane-1,6-diol diacrylate
235-921-9
13048-33-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-110-00-3
pentaerythritol triacrylate
222-540-8
3524-68-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-111-00-9
2,2-bis(acryloyloxymethyl)butyl acrylate;
trimethylolpropane triacrylate
239-701-3
15625-89-5
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-112-00-4
2,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate
218-741-5
2223-82-7
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317

*
D
607-113-00-X
isobutyl methacrylate
202-613-0
97-86-9
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H226
H319
H335
H315
H317
H400
GHS02
GHS07
GHS09
Wng
H226
H319
H335
H315
H317
H400


D
607-114-00-5
ethylene dimethacrylate
202-617-2
97-90-5
STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Wng
H335
H317

STOT SE 3; H335: C ≥ 10 %
D
607-115-00-0
isobutyl acrylate
203-417-8
106-63-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
H226
H332
H312
H315
H317
GHS02
GHS07
Wng
H226
H332
H312
H315
H317


D
607-116-00-6
cyclohexyl acrylate
221-319-3
3066-71-5
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H335
H315
H411
GHS07
GHS09
Wng
H335
H315
H411

STOT SE 3; H335: C ≥ 10 %
D
607-117-00-1
2,3-epoxypropyl acrylate;
glycidyl acrylate
203-440-3
106-90-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317

*
Skin Sens. 1; H317: C ≥ 0,2 %
D
607-118-00-7
1-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate
243-105-9
19485-03-1
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317


D
607-119-00-2
tetramethylene diacrylate;
1,4-butyleneglycol diacrylate
213-979-6
1070-70-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317


D
607-120-00-8
2,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate
223-791-6
4074-88-8
Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317

*
Skin Sens. 1; H317: C ≥ 0,2 %
D
607-121-00-3
8,9,10-trinorborn-2-yl acrylate
—
10027-06-2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
H312
H315
H317
GHS07
Wng
H312
H315
H317


D
607-122-00-9
pentaerythritol tetraacrylate
225-644-1
4986-89-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-123-00-4
2,3-epoxypropyl methacrylate;
glycidyl methacrylate
203-441-9
106-91-2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H312
H302
H319
H315
H317
GHS07
Wng
H332
H312
H302
H319
H315
H317


D
607-124-00-X
2-hydroxyethyl methacrylate
212-782-2
868-77-9
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-125-00-5
2-hydroxypropyl methacrylate; [1]
3-hydroxypropyl methacrylate [2]
213-090-3 [1]
220-426-2 [2]
923-26-2 [1]
2761-09-3 [2]
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317


C D
607-126-00-0
2,2'-(ethylenedioxy)diethyl diacrylate;
triethylene glycol diacrylate
216-853-9
1680-21-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-127-00-6
2-diethylaminoethyl methacrylate
203-275-7
105-16-8
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H332
H319
H315
H317
GHS07
Wng
H332
H319
H315
H317


D
607-128-00-1
2-tert-butylaminoethyl methacrylate
223-228-4
3775-90-4
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317


D
607-129-00-7
ethyl lactate;
ethyl DL-lactate; [1]
ethyl (S)-2-hydroxypropionate;
ethyl L-lactate;
ethyl-(S)-lactate [2]
202-598-0 [1]
211-694-1 [2]
97-64-3 [1]
687-47-8 [2]
Flam. Liq. 3
STOT SE 3
Eye Dam. 1
H226
H335
H318
GHS02
GHS05
GHS07
Dgr
H226
H335
H318


C
607-130-00-2
pentyl acetate; [1]
isopentyl acetate; [2]
1-methylbutyl acetate; [3]
2-methylbutyl acetat; [4]
2(or 3)-methylbutyl acetate [5]
211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5]
628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5]
Flam. Liq. 3
H226
GHS02
Wng
H226
EUH066

C
607-131-00-8
isopentyl propionate; [1]
pentyl propionate; [2]
2-methylbutyl propionate [3]
203-322-1 [1]
210-852-7 [2]
219-449-0 [3]
105-68-0 [1]
624-54-4 [2]
2438-20-2 [3]
Flam. Liq. 3
H226
GHS02
Wng
H226


C
607-132-00-3
2-dimethylaminoethyl methacrylate
220-688-8
2867-47-2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H312
H302
H319
H315
H317
GHS07
Wng
H312
H302
H319
H315
H317


D
607-133-00-9
monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H319
H335
H315
H411
GHS07
GHS09
Wng
H319
H335
H315
H411

STOT SE 3; H335: C ≥ 10 %
A
607-134-00-4
monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

STOT SE 3; H335: C ≥ 10 %
A
607-135-00-X
butyric acid
203-532-3
107-92-6
Skin Corr. 1B
H314
GHS05
Dgr
H314



607-136-00-5
butyryl chloride
205-498-5
141-75-3
Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314



607-137-00-0
methyl acetoacetate
203-299-8
105-45-3
Eye Irrit. 2
H319
GHS07
Wng
H319



607-138-00-6
butyl chloroformate;
chloroformic acid butyl ester
209-750-5
592-34-7
Flam. Liq. 3
Acute Tox. 3 *
Skin Corr. 1B
H226
H331
H314
GHS02
GHS06
GHS05
Dgr
H226
H331
H314



607-139-00-1
2-chloropropionic acid
209-952-3
598-78-7
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314



607-140-00-7
isobutyryl chloride
201-194-1
79-30-1
Flam. Liq. 2
Skin Corr. 1A
H225
H314
GHS02
GHS05
Dgr
H225
H314



607-141-00-2
oxydiethylene bis(chloroformate)
203-430-9
106-75-2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H411





607-142-00-8
propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate
203-687-7
109-61-5
Flam. Liq. 2
Acute Tox. 3 *
Skin Corr. 1B
H225
H331
H314
GHS02
GHS06
GHS05
Dgr
H225
H331
H314




607-143-00-3
valeric acid
203-677-2
109-52-4
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412



607-144-00-9
adipic acid
204-673-3
124-04-9
Eye Irrit. 2
H319
GHS07
Wng
H319



607-145-00-4
methanesulphonic acid
200-898-6
75-75-2
Skin Corr. 1B
H314
GHS05
Dgr
H314



607-146-00-X
fumaric acid
203-743-0
110-17-8
Eye Irrit. 2
H319
GHS07
Wng
H319



607-147-00-5
oxalic acid diethylester;
diethyl oxalate
202-464-1
95-92-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



607-148-00-0
guanidinium chloride;
guanadine hydrochloride
200-002-3
50-01-1
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315



607-149-00-6
urethane (INN);
ethyl carbamate
200-123-1
51-79-6
Carc. 1B
H350
GHS08
Dgr
H350



607-150-00-1
endothal (ISO);
7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid
205-660-5
145-73-3
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Dgr
H301
H312
H319
H335
H315



607-151-00-7
propargite (ISO);
2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite
219-006-1
2312-35-8
Carc. 2
Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H315
H318
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H331
H315
H318
H410

M = 10

607-152-00-2
2,3,6-TBA (ISO);
2,3,6-trichlorobenzoic acid
200-026-4
50-31-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-153-00-8
benazolin (ISO);
4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid
223-297-0
3813-05-6
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H319
H315
H412
GHS07
Wng
H319
H315
H412



607-154-00-3
ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;
benzoylprop-ethyl (ISO)
244-845-5
22212-55-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-155-00-9
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;
blasticidin-s
—
2079-00-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300



607-156-00-4
chlorfenson (ISO);
4-chlorophenyl 4-chlorobenzenesulfonate
201-270-4
80-33-1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410



607-157-00-X
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;
difenacoum
259-978-4
56073-07-5
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H300
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H300
H372 **
H410



607-158-00-5
sodium salt of chloroacetic acid;
sodium chloroacetate
223-498-3
3926-62-3
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
H301
H315
H400
GHS06
GHS09
Dgr
H301
H315
H400



607-159-00-0
chlorobenzilate (ISO);
ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;
ethyl 4,4'-dichlorobenzilate
208-110-2
510-15-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-160-00-6
isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;
clofop-isobutyl (ISO)
—
51337-71-4
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-161-00-1
diethanolamine salt of 4-CPA
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302





607-162-00-7
dalapon;
2,2-dichloropropionic acid; [1]
dalapon-sodium;
sodium 2,2-dichloropropionate [2]
200-923-0 [1]
204-828-5 [2]
75-99-0 [1]
127-20-8 [2]
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412




607-163-00-2
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;
dehydracetic acid
208-293-9
520-45-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-164-00-8
sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;
sodium dehydracetate
224-580-1
4418-26-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-165-00-3
diclofop-methyl (ISO)
methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;
methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;
257-141-8
51338-27-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



607-166-00-9
medinoterb acetate (ISO);
6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-6
2487-01-6
Acute Tox. 3 *
Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312



607-167-00-4
sodium 3-chloroacrylate
—
4312-97-4
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



607-168-00-X
dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;
propylisome
—
83-59-0
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H311
H302
H400
H410
GHS06
GHS09
Dgr
H311
H302
H410



607-169-00-5
sodium fluoroacetate
200-548-2
62-74-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
H330
H310
H300
H400
GHS06
GHS09
Dgr
H330
H310
H300
H400



607-170-00-0
bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;
thiocyclam-oxalate
250-859-2
31895-22-4
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



607-172-00-1
4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;
brodifacoum
259-980-5
56073-10-0
Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H310
H300
H372 **
H410



607-173-00-7
dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate
400-460-6
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-174-00-2
reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate
400-580-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



607-175-00-8
methyl 2-(2-nitrobenzylidene)acetoacetate
400-650-9
39562-27-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-176-00-3
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)
400-830-7
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





607-177-00-9
tribenuron-methyl (ISO);
2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester;
methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate
401-190-1
101200-48-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M=100



607-178-00-4
methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate
401-340-6
83055-99-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-179-00-X
(benzothiazol-2-ylthio)succinic acid
401-450-4
95154-01-1
Skin Sens. 1
H317
GHS07
Wng
H317



607-180-00-5
potassium 2-hydroxycarbazole-1-carboxylate
401-630-2
96566-70-0
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3
H302
H319
H335
H412
GHS07
Wng
H302
H319
H335
H412



607-181-00-0
3,5-dichloro-2,4-difluorobenzoyl fluoride
401-800-6
101513-70-6
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H331
H314
H302
H317
H412
GHS06
GHS05
Dgr
H331
H314
H302
H317
H412
EUH029


607-182-00-6
methyl 3-sulphamoyl-2-thenoate
402-050-2
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-183-00-1
zinc 2-hydroxy-5-C13-18alkylbenzoate
402-280-3
—
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H319
H315
H411
GHS07
GHS09
Wng
H319
H315
H411



607-184-00-7
S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate
402-290-8
85702-90-5
Flam. Liq. 3
Resp. Sens. 1
Skin Sens. 1
H226
H334
H317
GHS02
GHS08
Dgr
H226
H334
H317



607-185-00-2
ethyl trans-3-dimethylaminoacrylate
402-650-4
1117-37-9
Skin Sens. 1
H317
GHS07
Wng
H317



607-186-00-8
quinclorac (ISO);
3,7-dichloroquinoline-8-carboxylic acid
402-780-1
84087-01-4
Skin Sens. 1
H317
GHS07
Wng
H317



607-187-00-3
bis(2,2,6,6-tetramethyl-4-piperidyl) succinate
402-940-0
62782-03-0
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412



607-188-00-9
hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate
402-970-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





607-189-00-4
trimethylenediaminetetraacetic acid
400-400-9
1939-36-2
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318




607-190-00-X
methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)
401-890-7
77402-03-0
Carc. 1B
Muta. 1B
Acute Tox. 4 *
Eye Irrit. 2
H350
H340
H302
H319
GHS08
GHS07
Dgr
H350
H340
H302
H319



607-191-00-5
isobutyl 3,4-epoxybutyrate
401-920-9
100181-71-3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



607-192-00-0
disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate
402-360-8
92511-22-3
Eye Dam. 1
H318
GHS05
Dgr
H318



607-194-00-1
propylene carbonate
203-572-1
108-32-7
Eye Irrit. 2
H319
GHS07
Wng
H319





607-195-00-7
2-methoxy-1-methylethyl acetate
203-603-9
108-65-6
Flam. Liq. 3
H226
GHS02
Wng
H226




607-196-00-2
heptanoic acid
203-838-7
111-14-8
Skin Corr. 1B
H314
GHS05
Dgr
H314



607-197-00-8
nonanoic acid
203-931-2
112-05-0
Skin Corr. 1B
H314
GHS05
Dgr
H314



607-198-00-3
propyl 3,4,5-trihydroxybenzoate
204-498-2
121-79-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



607-199-00-9
octyl 3,4,5-trihydroxybenzoate
213-853-0
1034-01-1
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



607-200-00-2
dodecyl 3,4,5-trihydroxybenzoate
214-620-6
1166-52-5
Skin Sens. 1
H317
GHS07
Wng
H317



607-201-00-8
thiocarbonyl chloride
207-341-6
463-71-8
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H331
H302
H319
H335
H315
GHS06
Dgr
H331
H302
H319
H335
H315



607-203-00-9
2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate
279-452-8
80387-97-9
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3
H360D ***
H317
H412
GHS08
GHS07
Dgr
H360D ***
H317
H412



607-204-00-4
(chlorophenyl)(chlorotolyl)methane, mixed isomers
400-140-6
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-205-00-X
methyl chloroacetate
202-501-1
96-34-4
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H226
H331
H301
H335
H315
H318
GHS02
GHS06
GHS05
Dgr
H226
H331
H301
H335
H315
H318



607-206-00-5
isopropyl chloroacetate
203-301-7
105-48-6
Flam. Liq. 3
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H226
H301
H319
H335
H315
GHS02
GHS06
Dgr
H226
H301
H319
H335
H315



607-207-00-0
haloxyfop-etotyl (ISO);
2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;
haloxyfop-(2-ethoxyethyl)
402-560-5
87237-48-7
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-208-00-6
4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers
403-000-2
91853-67-7
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



607-209-00-1
reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate
403-030-6
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



607-210-00-7
methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)
403-230-3
77402-05-2
Carc. 1B
Muta. 1B
Skin Corr. 1B
Skin Sens. 1
H350
H340
H314
H317
GHS08
GHS05
GHS07
Dgr
H350
H340
H314
H317



607-211-00-2
methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate
403-270-1
6386-39-6
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-212-00-8
poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate
403-300-3
—
Skin Sens. 1
H317
GHS07
Wng
H317





607-213-00-3
ethyl 3,3-bis(tert-pentylperoxy)butyrate
403-320-2
67567-23-1
Org. Perox. D****
Flam. Liq. 3
Aquatic Chronic 2
H242
H226
H411
GHS02
GHS09
Dgr
H242
H226
H411




607-214-00-9
N,N-hydrazinodiacetic acid
403-510-5
19247-05-3
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H301
H373 **
H317
H412
GHS06
GHS08
Dgr
H301
H373 **
H317
H412



607-215-00-4
3-(3-tert-butyl-4-hydroxyphenyl)propionic acid
403-920-4
107551-67-7
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319





607-216-00-X
glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine
403-950-8
—
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H330
H302
H314
H400
GHS06
GHS05
GHS09
Dgr
H330
H302
H314
H400





607-217-00-5
2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate
403-960-2
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



607-218-00-0
dichlorprop-P (ISO);
(+)-R-2-(2,4-dichlorophenoxy)propionic acid
403-980-1
15165-67-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317



607-219-00-6
bis(2-ethylhexyl) dithiodiacetate
404-510-8
62268-47-7
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



607-221-00-7
6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid
404-550-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



607-222-00-2
6-(2,3-dimethylmaleimido)hexyl methacrylate
404-870-6
63740-41-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-223-00-8
transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
405-060-5
118712-89-3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



607-224-00-3
methyl 2-(3-nitrobenzylidene)acetoacetate
405-270-7
39562-17-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



607-225-00-9
3-azidosulfonylbenzoic acid
405-310-3
15980-11-7
Self-React. C ****
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H241
H373 **
H318
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H241
H373 **
H318
H317



607-226-00-4
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate
405-360-6
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H315
H318
H317
H412
GHS05
GHS07
Dgr
H315
H318
H317
H412



607-227-00-X
potassium 2-amino-2-methylpropionate octahydrate
405-560-3
120447-91-8
Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314



607-228-00-5
bis(2-methoxyethyl) phthalate
204-212-6
117-82-8
Repr. 1B
H360Df
GHS08
Dgr
H360Df



607-229-00-0
diethylcarbamoyl chloride
201-798-5
88-10-8
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H351
H332
H302
H319
H335
H315
GHS08
GHS07
Wng
H351
H332
H302
H319
H335
H315



607-230-00-6
2-ethylhexanoic acid
205-743-6
149-57-5
Repr. 2
H361d ***
GHS08
Wng
H361d ***





607-231-00-1
clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid
216-935-4
1702-17-6
Eye Dam. 1
H318
GHS05
Dgr
H318




607-232-00-7
pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
259-686-7
55512-33-9
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



607-233-00-2
hexyl acrylate
219-698-5
2499-95-8
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411



607-234-00-8
flurenol (ISO);
9-hydroxy-9H-fluorene-9-carboxylic acid
207-397-1
467-69-6
Aquatic Chronic 2
H411
GHS09
H411



607-235-00-3
mecrilate;
methyl 2-cyanoacrylate
205-275-2
137-05-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

STOT SE 3; H335: C ≥ 10 %

607-236-00-9
ethyl 2-cyanoacrylate
230-391-5
7085-85-0
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315

STOT SE 3; H335: C ≥ 10 %

607-237-00-4
benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;
flurazole
276-942-3
72850-64-7
Aquatic Chronic 2
H411
GHS09
H411



607-238-00-X
tau-fluvalinate (ISO);
cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate
—
102851-06-9
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410



607-239-00-5
fenpropathrin (ISO);
α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate
254-485-0
39515-41-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H312
H400
H410
GHS06
GHS09
Dgr
H330
H301
H312
H410



607-240-00-0
cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethylphthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]
216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7]
1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317


C
607-241-00-6
hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4]
243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4]
19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317


C
607-242-00-1
tetrachlorophthalic anhydride
204-171-4
117-08-8
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H334
H317
H400
H410
GHS08
GHS05
GHS09
Dgr
H318
H334
H317
H410



607-243-00-7
sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]
217-846-3 [1]
246-590-5 [2]
258-527-9 [3]
1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3]
Aquatic Chronic 3
H412
—
H412



607-244-00-2
isooctyl acrylate
249-707-8
29590-42-9
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410

STOT SE 3; H335: C ≥ 10 %



607-245-00-8
tert-butyl acrylate
216-768-7
1663-39-4
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H312
H302
H335
H315
H317
H411
GHS02
GHS07
GHS09
Wng
H225
H332
H312
H302
H335
H315
H317
H411


D

607-246-00-3
allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester
202-473-0
96-05-9
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
H226
H331
H312
H302
H400
GHS02
GHS06
GHS09
Dgr
H226
H331
H312
H302
H400



607-247-00-9
dodecyl methacrylate
205-570-6
142-90-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H319
H335
H315
H410

STOT SE 3; H335: C ≥ 10 %

607-248-00-4
naptalam-sodium (ISO);
sodium N-naphth-1-ylphthalamate
205-073-4
132-67-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-249-00-X
(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate
256-032-2
42978-66-5
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H335
H315
H317
H411
GHS07
GHS09
Wng
H319
H335
H315
H317
H411

STOT SE 3; H335: C ≥ 10 %

607-250-00-5
4H-3,1-benzoxazine-2,4(1H)-dione
204-255-0
118-48-9
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



607-251-00-0
2-methoxypropyl acetate
274-724-2
70657-70-4
Flam. Liq. 3
Repr. 1B
STOT SE 3
H226
H360D ***
H335
GHS02
GHS08
GHS07
Dgr
H226
H360D ***
H335





607-252-00-6
lambda-cyhalothrin (ISO);
reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)
415-130-7
91465-08-6
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H312
H400
H410
GHS06
GHS09
Dgr
H330
H301
H312
H410

M=10000


607-253-00-1
cyfluthrin (ISO);
α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
269-855-7
68359-37-5
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H331
H400
H410
GHS06
GHS09
Dgr
H300
H331
H410

M=1000


607-254-00-7
α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
beta-cyfluthrin
269-855-7
68359-37-5
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410



607-255-00-2
fluroxypyr (ISO);
4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid
—
69377-81-7
Aquatic Chronic 3
H412
—
H412



607-256-00-8
azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
—
131860-33-8
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H400
H410
GHS06
GHS09
Dgr
H331
H410



607-257-00-3
isopropyl propionate
211-300-8
637-78-5
Flam. Liq. 2
H225
GHS02
Dgr
H225



607-258-00-9
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate
403-990-6
70950-45-7
Aquatic Chronic 4
H413
—
H413



607-259-00-4
methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate
404-130-2
105560-93-8
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



607-260-00-X
ethyl 2-(3-nitrobenzylidene)acetoacetate
404-490-0
39562-16-8
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



607-261-00-5
iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate
404-800-4
118832-72-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-262-00-0
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
405-050-0
86393-33-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



607-263-00-6
potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate
405-680-6
—
Self-heat. 2 ****
Aquatic Chronic 2
H252
H411
GHS02
GHS09
Wng
H252
H411



607-264-00-1
2-chloro-4-(methylsulfonyl)benzoic acid
406-520-8
53250-83-2
Eye Dam. 1
H318
GHS05
Dgr
H318



607-265-00-7
ethyl-2-chloro-2,2-diphenylacetate
406-580-5
52460-86-3
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412



607-266-00-2
reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];
3,5-di-tert-butyl-salicylic acid
406-890-0
130296-87-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-267-00-8
tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate
407-620-4
33610-13-8
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412



607-268-00-3
2-methylpropyl (R)-2-hydroxypropanoate
407-770-0
61597-96-4
Eye Irrit. 2
H319
GHS07
Wng
H319



607-269-00-9
(R)-2-(4-hydroxyphenoxy)propanoic acid
407-960-3
94050-90-5
Eye Dam. 1
H318
GHS05
Dgr
H318



607-270-00-4
3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane
410-730-5
90498-90-1
Acute Tox. 4 *
H312
GHS07
Wng
H312



607-271-00-X
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane
417-420-9
156324-82-2
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



607-272-00-5
fluroxypyr-meptyl (ISO);
methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]
- [2]
81406-37-3 [1]
154486-27-8 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-273-00-0
ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate
404-520-2
—
Aquatic Chronic 3
H412
—
H412



607-274-00-6
2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate
405-350-1
54527-73-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-275-00-1
sodium benzoyloxybenzene-4-sulfonate
405-450-5
66531-87-1
Skin Sens. 1
H317
GHS07
Wng
H317



607-276-00-7
bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex
405-635-0
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410



607-277-00-2
reaction mass of: 2-(hexylthio)ethylamine hydrochloride;
sodium propionate
405-720-2
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



607-278-00-8
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;
sodium naphthylethylbenzenesulfonate
405-760-0
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



607-279-00-3
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate
405-960-8
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-280-00-9
sodium 4-chloro-1-hydroxybutane-1-sulfonate
406-190-5
54322-20-2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317



607-281-00-4
reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates
407-000-3
127519-17-9
Aquatic Chronic 2
H411
GHS09
H411



607-282-00-X
2-acetoxymethyl-4-benzyloxybut-1-yl acetate
407-140-5
131266-10-9
Aquatic Chronic 3
H412
—
H412



607-283-00-5
E-ethyl-4-oxo-4-phenylcrotonate
408-040-4
15121-89-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H317
H410



607-284-00-0
reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);
lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)
410-040-4
136213-76-8
Aquatic Chronic 2
H411
GHS09
H411



607-285-00-6
reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;
sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;
potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate
410-065-0
—
Skin Sens. 1
H317
GHS07
Wng




607-286-00-1
reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate
410-070-8
141880-36-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-287-00-7
O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate
410-140-8
—
Aquatic Chronic 3
H412
—
H412



607-288-00-2
tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
410-160-7
148732-74-5
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412



607-289-00-8
3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid
410-370-9
105488-33-3
Aquatic Chronic 4
H413
—
H413



607-290-00-3
reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;
ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate
410-540-2
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



607-291-00-9
dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate
410-630-1
104051-92-5
Aquatic Chronic 4
H413
—
H413



607-292-00-4
reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid
410-640-6
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410



607-293-00-X
reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate
410-650-0
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



607-294-00-5
sodium 2-benzoyloxy-1-hydroxyethane-sulfonate
410-680-4
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-295-00-0
reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tetracarboxylate
410-800-5
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-296-00-6
reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid
410-830-9
—
Aquatic Chronic 4
H413
—
H413



607-297-00-1
(E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)
410-960-6
92761-26-7
Eye Dam. 1
H318
GHS05
Dgr
H318



607-298-00-7
2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate
411-010-3
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-299-00-2
methyl 3-(acetylthio)-2-methyl-propanoate
411-040-7
97101-46-7
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



607-300-00-6
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25
411-430-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



607-301-00-1
reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid
411-860-5
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-302-00-7
reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid
411-910-6
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H315
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H411



607-303-00-2
1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
413-760-7
93107-30-3
Repr. 2
Aquatic Chronic 3
H361f ***
H412
GHS08
Wng
H361f ***
H412



607-304-00-8
fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
274-125-6
69806-50-4
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H400
H410
GHS08
GHS09
Dgr
H360D ***
H410



607-305-00-3
fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
—
79241-46-6
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H400
H410
GHS08
GHS09
Wng
H361d ***
H410



607-306-00-9
chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate
282-714-4
84332-86-5
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411



607-307-00-4
vinclozolin (ISO);
N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione
256-599-6
50471-44-8
Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H360FD
H317
H411
GHS08
GHS07
GHS09
Dgr
H351
H360FD
H317
H411



607-308-00-X
esters of 2,4-D
—
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410


A
607-309-00-5
carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
—
128639-02-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-310-00-0
kresoxim-methyl (ISO);
methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate
—
143390-89-0
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



607-311-00-6
benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate
246-591-0
25059-80-7
Aquatic Chronic 2
H411
GHS09
H411



607-312-00-1
methoxyacetic acid
210-894-6
625-45-6
Repr. 1B
Acute Tox. 4 *
Skin Corr. 1B
H360FD
H302
H314
GHS08
GHS05
GHS07
Dgr
H360FD
H302
H314

STOT SE 3; H335: C ≥ 5 %

607-313-00-7
neodecanoyl chloride
254-875-0
40292-82-8
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
H330
H302
H314
GHS06
GHS06
Dgr
H330
H302
H314

STOT SE 3; H335: C ≥ 5 %

607-314-00-2
ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate
247-525-3
26225-79-6
Aquatic Chronic 2
H411
GHS09
H411



607-315-00-8
glyphosate (ISO);
N-(phosphonomethyl)glycine
213-997-4
1071-83-6
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



607-316-00-3
glyphosate-trimesium;
glyphosate-trimethylsulfonium
—
81591-81-3
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07 GHS09
Wng
H302
H411



607-317-00-9
bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP
204-211-0
117-81-7
Repr. 1B
H360FD
GHS08
Dgr
H360FD



607-318-00-4
dibutyl phthalate;
DBP
201-557-4
84-74-2
Repr. 1B
Aquatic Acute 1
H360Df
H400
GHS08
GHS09
Dgr
H360Df
H400





607-319-00-X
deltamethrin (ISO);
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate
258-256-6
52918-63-5
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410

M=1000000


607-320-00-5
bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate
413-930-0
130066-57-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



607-321-00-0
(S)-methyl-2-chloropropionate
412-470-8
73246-45-4
Flam. Liq. 3
STOT RE 2 *
Eye Irrit. 2
H226
H373 **
H319
GHS02
GHS08
Wng
H226
H373 **
H319



607-322-00-6
4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid
413-120-7
107144-30-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-323-00-1
2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate
413-850-6
123968-25-2
Aquatic Chronic 4
H413
—
H413



607-324-00-7
reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;
dihydrogenated alkyl (C14-C18)amine
413-800-3
—
Aquatic Chronic 4
H413
—
H413



607-325-00-2
(S)-2-chloropropionic acid
411-150-5
29617-66-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



607-326-00-8
reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate
410-720-0
141847-13-4
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



607-327-00-3
2-(2-iodoethyl)-1,3-propanediol diacetate
411-780-0
127047-77-2
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-328-00-9
methyl 4-bromomethyl-3-methoxybenzoate
410-310-1
70264-94-7
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410



607-329-00-4
reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;
sodium 2-octadecenyl-amino-1,4-butandioate
411-250-9
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-330-00-X
(S)-2,3-dihydro-1H-indole-2-carboxylic acid
410-860-2
79815-20-6
Repr. 2
STOT RE 2 *
Skin Sens. 1
H361f ***
H373 **
H317
GHS08
GHS07
Wng
H361f ***
H373 **
H317



607-331-00-5
reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;
1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane
406-750-9
—
Aquatic Chronic 4
H413
—
H413



607-332-00-0
cyclopentyl chloroformate
411-460-0
50715-28-1
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H226
H331
H302
H373 **
H318
H317
GHS02
GHS06
GHS08
GHS05
Dgr
H226
H331
H302
H373 **
H318
H317



607-333-00-6
reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;
tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate
405-670-1
—
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H314
H410



607-334-00-1
ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
405-880-3
100501-62-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-335-00-7
methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate
406-250-0
72619-32-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



607-336-00-2
4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate
406-560-6
122760-85-4
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411



607-337-00-8
di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate
406-052-4
125078-60-6
Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H226
H302
H315
H318
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H302
H315
H318
H411



607-338-00-3
2-methylpropyl 2-hydroxy-2-methylbut-3-enoate
406-235-9
72531-53-4
Eye Irrit. 2
Skin Irrit. 2
H319
H315
GHS07
Wng
H319
H315



607-339-00-9
2,3,4,5-tetrachlorobenzoylchloride
406-760-3
42221-52-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317



607-340-00-4
1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate
406-990-4
—
Aquatic Chronic 2
H411
GHS09
H411



607-341-00-X
(9S)-9-amino-9-deoxyerythromycin
406-790-7
26116-56-3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



607-342-00-5
4-chlorobutyl veratrate
410-950-1
69788-75-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-343-00-0
4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)
407-410-2
—
Aquatic Chronic 4
H413
—
H413



607-344-00-6
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;
3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
407-810-7
—
STOT RE 2 *
H373 **
GHS08
Wng
H373 **



607-345-00-1
potassium 2-(2,4-dichlorophenoxy)-(R)-propionate
413-580-9
113963-87-4
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317



607-346-00-7
3-icosyl-4-henicosylidene-2-oxetanone
401-210-9
83708-14-9
Aquatic Chronic 4
H413
—
H413



607-347-00-2
sodium (R)-2-(2,4-dichlorophenoxy)propionate
413-340-3
119299-10-4
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317



607-348-00-8
magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)
413-360-2
—
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317



607-349-00-3
mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate
411-270-8
—
Aquatic Chronic 3
H412

H412



607-350-00-9
bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane
412-060-9
136210-32-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-351-00-4
methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate
407-550-4
69184-17-4
Aquatic Chronic 2
H411
GHS09
H411



607-352-00-X
4,4'-oxydiphthalic anhydride
412-830-4
1823-59-2
Aquatic Chronic 3
H412
—
H412



607-353-00-5
reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;
ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate
407-520-0
80657-64-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



607-354-00-0
ethyl 2-cyclohexylpropionate
412-280-5
2511-00-4
Aquatic Chronic 2
H411
GHS09
H411



607-355-00-6
p-tolyl 4-chlorobenzoate
411-530-0
15024-10-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



607-356-00-1
ethyl trans-2,2,6-trimethylcyclohexanecarboxylate
412-540-8
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



607-357-00-7
reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran
412-450-9
131766-73-9
Skin Sens. 1
H317
GHS07
Wng
H317



607-358-00-2
(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate
412-670-5
54275-93-3
Resp. Sens. 1
H334
GHS08
Dgr
H334



607-359-00-8
(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate
412-800-0
76109-32-5
Resp. Sens. 1
H334
GHS08
Dgr
H334



607-360-00-3
sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate
411-680-7
133167-77-8
Skin Sens. 1
H317
GHS07
Wng
H317



607-361-00-9
methyl (R)-2-(4-hydroxyphenoxy)propionate
411-950-4
96562-58-2
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



607-362-00-4
reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate
413-500-2
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H315
H318
H411
GHS05
GHS09
Dgr
H315
H318
H411



607-363-00-X
methyl-3-methoxyacrylate
412-900-4
5788-17-0
Skin Sens. 1
H317
GHS07
Wng
H317



607-364-00-5
3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione
413-330-9
134724-55-3
Aquatic Chronic 4
H413

H413



607-365-00-0
2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride
410-620-7
119154-86-8
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317



607-366-00-6
3,5-dimethylbenzoyl chloride
413-010-9
6613-44-1
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317



607-367-00-1
potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate
411-640-9
153352-59-1
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-368-00-7
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole
411-650-3
110895-43-7
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410



607-369-00-2
reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid
411-660-8
147027-04-1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317



607-370-00-8
2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol
412-210-3
41620-33-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-371-00-3
3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate
413-410-3
88150-62-3
Aquatic Chronic 4
H413
—
H413



607-372-00-9
ethoxylated bis phenol A di-(norbornene carboxylate)
412-410-0
—
Aquatic Chronic 3
H412
—
H412



607-373-00-4
(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
414-200-4
119738-06-6
Muta. 2
Repr. 1B
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H360Df
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H341
H360Df
H302
H373 **
H410



607-374-00-X
5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride
417-220-1
37441-29-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-375-00-5
reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;
trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
421-960-0
90035-08-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H372 **
H410



607-376-00-0
benzyl 2,4-dibromobutanoate
420-710-8
23085-60-1
Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f ***
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f ***
H315
H317
H410



607-377-00-6
trans-4-cyclohexyl-L-proline monohydrochloride
419-160-1
90657-55-9
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H361f ***
H302
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H361f ***
H302
H315
H318
H317



607-378-00-1
ammonium (Z)-α-methoxyimino-2-furylacetate
405-990-1
97148-39-5
Flam. Sol. 2
H228
GHS02
Dgr
H228


T
607-379-00-7
reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;
sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;
sodium [bis(2-hydroxyethyl)amino]methylsulfonate;
N,N-bis(2-hydroxyethyl)stearamide
401-230-8

Aquatic Chronic 3
H412
—
H412



607-380-00-2
reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate
407-320-3
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H315
H318
H412
GHS05
Dgr
H315
H318
H412



607-381-00-8
reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid
413-710-4
—
Aquatic Chronic 4
H413
—
H413



607-382-00-3
2-((4-amino-2-nitrophenyl)amino)benzoic acid
411-260-3
117907-43-4
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



607-383-00-9
reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-8
86403-32-9
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410



607-384-00-4
reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate
413-750-2
171090-93-0
Aquatic Chronic 4
H413
—
H413



607-385-00-X
Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate
414-590-6
125229-74-5
Aquatic Chronic 2
H411
GHS09
H411



607-386-00-5
reaction mass of: tetradecanoic acid (42,5- 47,5 %);
poly(1-7)lactate esters of tetradecanoic acid (52,5- 57,5 %)
412-580-6
174591-51-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410



607-387-00-0
reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid (60-65 %)
412-590-0
58856-63-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410



607-388-00-6
4-ethylamino-3-nitrobenzoic acid
412-090-2
2788-74-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412



607-389-00-1
trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate
414-130-4
119710-96-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



607-390-00-7
1,2,3,4-tetrahydro-6-nitro-quinoxaline
414-270-6
41959-35-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



607-391-00-2
dimethylcyclopropane-1,1-dicarboxylate
414-240-2
6914-71-2
Aquatic Chronic 3
H412
—
H412



607-392-00-8
2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate
414-260-1
88938-37-8
Aquatic Chronic 4
H413
—
H413



607-393-00-3
3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
415-750-8
106447-44-3
Skin Sens. 1
H317
GHS07
Wng
H317



607-394-00-9
5-methylpyrazine-2-carboxylic acid
413-260-9
5521-55-1
Eye Dam. 1
H318
GHS05
Dgr
H318



607-395-00-4
reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate
410-230-7
—
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411



607-396-00-X
bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate
414-840-4
147783-69-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410






607-397-00-5
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)
415-930-6
—
Repr. 2
Skin Sens. 1
H361f***
H317
GHS08
GHS07
Wng
H361f***
H317




607-398-00-0
ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate
414-820-5
125630-94-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-399-00-6
2,2-dimethyl 3-methyl-3-butenyl propanoate
415-610-6
104468-21-5
Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412



607-400-00-X
methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate
414-400-1
32750-89-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-401-00-5
ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate
414-450-4
88805-65-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317



607-402-00-0
methyl N-(phenoxycarbonyl)-L-valinate
414-500-5
153441-77-1
Aquatic Chronic 3
H412
—
H412



607-403-00-6
reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol
414-810-0
—
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H400
H410
GHS08
GHS05
GHS09
Dgr
H373 **
H318
H410



607-404-00-1
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-405-00-7
2-hexyldecyl-p-hydroxybenzoate
415-380-7
148348-12-3
Aquatic Chronic 2
H411
GHS09
H411



607-406-00-2
potassium 2,5-dichlorobenzoate
415-700-5
184637-62-5
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318



607-407-00-8
ethyl 2-carboxy-3-(2-thienyl)propionate
415-680-8
143468-96-6
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H315
H318
H317
GHS05
GHS07
Dgr
H315
H318
H317



607-408-00-3
potassium N-(4-fluorophenyl)glycinate
415-710-1
184637-63-6
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H373 **
H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H373 **
H318
H317
H412



607-409-00-9
reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass from Aspergillus terreus
415-840-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-410-00-4
mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate
415-880-5
779343-34-9
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410



607-411-00-X
oxiranemethanol, 4-methylbenzene-sulfonate, (S)-
417-210-7
70987-78-9
Carc. 1B
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H341
H318
H317
H411



607-412-00-5
ethyl 2-(1-cyanocyclohexyl)acetate
415-970-4
133481-10-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373 **
H412
GHS08
GHS07
Wng
H302
H373 **
H412



607-413-00-0
trans-4-phenyl-L-proline
416-020-1
96314-26-0
Repr. 2
Skin Sens. 1
H361f ***
H317
GHS08
GHS07
Wng
H361f ***
H317



607-414-00-6
tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
402-070-1
88122-99-0
Aquatic Chronic 4
H413
—
H413



607-415-00-1
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride)
419-590-1
—
Flam. Sol. 1
Skin Sens. 1
H228
H317
GHS02
GHS07
Dgr
H228
H317


T
607-416-00-7
4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide
420-730-7
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





607-417-00-2
3-chloropropyl chloroformiate
425-770-9
628-11-5
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H331
H302
H373**
H315
H318
H317
GHS06
GHS05
GHS08
Dgr
H331
H302
H373**
H315
H318
H317




607-418-00-8
2-ethylhexyl 4-aminobenzoate
420-170-3
26218-04-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-419-00-3
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid
422-240-9
166596-68-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



607-420-00-9
2,2-bis(hydroxymethyl)butanoic acid
424-090-1
10097-02-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



607-421-00-4
cypermethrin cis/trans +/- 40/60;
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H335
H400
H410
GHS07
GHS09
Wng
H332
H302
H335
H410





607-422-00-X
α-cypermethrin (ISO);
racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
67375-30-8
Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H301
H373**
H335
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373**
H335
H410

M=1000


607-423-00-5
esters of mecoprop and of mecoprop-P
—
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410


A
607-424-00-0
trifloxystrobin (ISO);
(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester
—
141517-21-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



607-425-00-6
metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-7
57837-19-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412



607-426-00-1
1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4]
284-032-2 [1]
- [2]
205-017-9 [3]
210-088-4 [4]
84777-06-0 [1]
- [2]
131-18-0 [3]
605-50-5 [4]
Repr. 1B
Aquatic Acute 1
H360FD
H400
GHS08
GHS09
Dgr
H360FD
H400



607-427-00-7
bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate
260-300-4
56634-95-8
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d ***
H332
H302
H317
H410





607-428-00-2
tetrasodium ethylene diamine tetraacetate
200-573-9
64-02-8
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318




607-429-00-8
edetic acid;
(EDTA)
200-449-4
60-00-4
Eye Irrit. 2
H319
GHS07
Wng
H319




607-430-00-3
BBP;
benzyl butyl phthalate e
201-622-7
85-68-7
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H400
H410
GHS08
GHS09
Dgr
H360Df
H410



607-431-00-9
prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
245-387-9
23031-36-9
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410



607-432-00-4
S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
- [1]
- [2]
87392-12-9 [1]
178961-20-1 [2]
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



607-433-00-X
cypermethrin cis/trans +/- 80/20;
(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H302
H335
H315
H317
H410



607-434-00-5
mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-0
16484-77-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



607-435-00-0
2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate
416-810-6
111969-64-3
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373 **
H318
H411
GHS08
GHS05
GHS09
Dgr
H373 **
H318
H411



607-436-00-6
2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate
417-350-9
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410



607-437-00-1
3-(4-aminophenyl)-2-cyano-2-propenoic acid
417-480-6
252977-62-1
Skin Sens. 1
H317
GHS07
Wng
H317



607-438-00-7
methyl-2-[(aminosulfonyl)methyl]benzoate
419-010-5
112941-26-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



607-439-00-2
methyl tetrahydro-2-furancarboxylate
420-670-1
37443-42-8
Eye Dam. 1
H318
GHS05
Dgr
H318



607-440-00-8
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate
421-220-7
144740-59-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



607-441-00-3
3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid
421-490-6
167684-63-1
Aquatic Chronic 4
H413
—
H413



607-442-00-9
benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate
416-050-5
87460-09-1
Eye Dam. 1
H318
GHS05
Dgr
H318




607-443-00-4
bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate
416-140-4
145650-60-8
Aquatic Chronic 4
H413
—
H413




607-444-00-X
reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate
416-230-3
35541-81-2
Aquatic Chronic 4
H413
—
H413



607-445-00-5
Iron (III) tris(4-methylbenzenesulfonate)
420-960-8
77214-82-5
Eye Dam. 1
H318
GHS05
Dgr
H318



607-446-00-0
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate
416-240-8
155522-12-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



607-447-00-6
sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate
416-370-5
156738-27-1
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



607-448-00-1
2,3,5,6-tetrafluorobenzoic acid
416-800-1
652-18-6
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318



607-449-00-7
reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]
417-080-1
—
Self-react. D ****
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410



607-450-00-2
2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
419-040-9
89604-92-2
Aquatic Chronic 4
H413
—
H413



607-451-00-8
4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt
417-640-5
161935-19-9
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



607-453-00-9
4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)
418-100-1
172964-15-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



607-454-00-4
reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid
418-170-3
116193-72-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



607-455-00-X
1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt
419-520-8
172890-93-6
Skin Sens. 1
H317
GHS07
Wng
H317



607-456-00-5
3-amino-4-chlorobenzoic acid, hexadecyl ester
419-700-6
143269-74-3
Aquatic Chronic 2
H411
GHS09
H411



607-457-00-0
tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)
420-350-1
172277-97-3
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



607-458-00-6
reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1
—
Aquatic Chronic 2
H411
GHS09
H411



607-459-00-1
isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate
418-930-4
—
Aquatic Chronic 4
H413
—
H413



607-460-00-7
3-tridecyloxy-propyl-ammonium 9-octadecenoate
418-990-1
778577-53-0
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H319
H315
H410



607-461-00-2
reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;
pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate
421-160-1
—
Aquatic Chronic 3
H412
—
H412



607-462-00-8
reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates
421-230-1
88230-35-7
Aquatic Chronic 2
H411
GHS09
H411



607-463-00-3
3-(phenothiazin-10-yl)propionic acid
421-260-5
362-03-8
Aquatic Chronic 2
H411
GHS09
H411



607-464-00-9
reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
421-280-4

Aquatic Chronic 3
H412
—
H412



607-465-00-4
tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate
421-440-3
778583-04-3
Aquatic Chronic 3
H412
—
H412



607-466-00-X
reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
421-480-1
—
Aquatic Chronic 2
H411
GHS09
H411



607-467-00-5
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate
419-430-9
56533-00-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H314
H410



607-468-00-0
reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate
419-450-8
—
Skin Sens. 1
H317
GHS07
Wng
H317



607-469-00-6
disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate
419-460-2
120029-06-3
Aquatic Chronic 3
H412
—
H412



607-470-00-1
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-100-0
154336-20-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412





607-471-00-7
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane
429-280-6
151900-44-6
Aquatic Chronic 4
H413
—
H413





607-472-00-2
ammonium iron(III) trimethylenediaminetetraacetate hemihydrate
400-660-3
111687-36-6
Aquatic Chronic 2
H411
GHS09
H411






607-473-00-8
pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid
426-590-3
187412-41-5
Skin Sens. 1
H317
GHS07
Wng
H317




607-474-00-3
(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid
410-430-4
117573-89-4
Aquatic Chronic 4
H413
—
H413



607-475-00-9
reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)
412-940-2
148878-18-6
Skin Sens. 1
H317
GHS07
Wng
H317



607-476-00-4
trisodium N,N-bis(carboxymethyl)-β-alanine
414-070-9
129050-62-0
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412





607-477-00-X
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt
426-740-8
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




607-478-00-5
tetramethylammonium hydrogen phthalate
416-900-5
79723-02-7
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H301
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H400



607-479-00-0
hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate
418-550-9
168689-49-4
Aquatic Chronic 4
H413
—
H413



607-480-00-6
1,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters
271-084-6
68515-42-4
Repr. 1B
H360Df
GHS08
Dgr
H360Df





607-481-00-1
reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate
430-290-8
—
Aquatic Chronic 4
H413
—
H413




607-482-00-7
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride
430-360-8
84793-24-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-483-00-2
1,2-benzenedicarboxylic acid;
di-C6-8-branched alkylesters, C7-rich
276-158-1
71888-89-6
Repr. 1B
H360D***
GHS08
Dgr
H360D***




607-484-00-8
ethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate
430-480-0
221452-67-1
Aquatic Chronic 4
H413
—
H413




607-485-00-3
(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate
430-510-2
—
Aquatic Chronic 4
H413
—
H413




607-486-00-9
potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate
402-110-8
110081-40-8
Aquatic Chronic 3
H412
—
H412




607-487-00-4
reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate
402-660-9
—
Repr. 1B
Aquatic Chronic 3
H360D ***
H412
GHS08
Dgr
H360D ***
H412



607-488-00-X
ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate
414-210-9
147379-38-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-489-00-5
reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate
414-890-7
71302-79-9
Skin Sens. 1
H317
GHS07
Wng
H317



607-490-00-0
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate
415-060-7
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317






607-491-00-6
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);
triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)
427-140-9
—
Carc. 2
H351
GHS08
Wng
H351




607-492-00-1
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate
415-490-5
141773-73-1
Aquatic Chronic 2
H411
GHS09
H411



607-493-00-7
methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate
415-670-3
78850-37-0
Eye Dam. 1
H318
GHS05
Dgr
H318



607-494-00-2
bis(2-ethylhexyl)octylphosphonate
417-170-0
52894-02-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-495-00-8
sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate
417-550-6
168151-92-6
Skin Sens. 1
H317
GHS07
Wng
H317



607-496-00-3
2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite
418-310-3
126050-54-2
Aquatic Chronic 4
H413
—
H413



607-497-00-9
cerium oxide isostearate
419-760-3
—
Aquatic Chronic 4
H413
—
H413



607-498-00-4
(E)-3,7-dimethyl-2,6-octadienylhexadecanoate
421-370-3
3681-73-0
Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413



607-499-00-X
bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)
421-660-1
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



607-500-00-3
calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate
421-670-4
—
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410



607-501-00-9
reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives
421-820-9
192268-65-8
Aquatic Chronic 4
H413
—
H413



607-502-00-4
(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate
422-200-0
178277-55-9
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H314
H302
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H411



607-503-00-X
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane
422-210-5
68957-94-8
Skin Corr. 1B
H314
GHS05
Dgr
H314





607-504-00-5
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate
422-670-7
—
Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361f
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f
H301
H373**
H410




607-505-00-0
pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate
422-930-1

Aquatic Chronic 3
H412
—
H412



607-506-00-6
reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate
422-970-8

Aquatic Chronic 2
H411
GHS09
H411



607-507-00-1
potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate
422-980-2
187026-95-5
Eye Dam. 1
H318
GHS05
Dgr
H318



607-508-00-7
disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]
423-110-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318





607-509-00-2
2-phenoxyethyl 4-aminobenzoate
430-880-5
88938-23-2
Aquatic Chronic 2
H411
GHS09
H411




607-510-00-8
(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
427-200-4
76646-91-8
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317




607-511-00-3
reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid
423-750-4
—
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411




607-512-00-9
trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate
423-970-0
182926-43-8
Aquatic Chronic 3
H412
—
H412



607-513-00-4
reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid
423-200-3
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412





607-514-00-X
potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate
427-240-2
134841-35-3
Skin Sens. 1
H317
GHS07
Wng
H317




607-515-00-5
reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate
429-650-7
147732-60-3
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



607-516-00-0
N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine
429-670-6
105996-54-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



607-517-00-6
(S)-α-(acetylthio)benzenepropanoic acid
430-300-0
76932-17-7
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317





607-518-00-1
3-oxoandrost-4-ene-17-β-carboxylic acid
414-990-0
302-97-6
Repr. 1A
Aquatic Chronic 4
H361f
H413
GHS08
Dgr
H361f
H413




607-519-00-7
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-280-0
176429-27-9
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410




607-520-00-2
reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate
427-740-0
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-521-00-8
tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate
429-270-1
136210-30-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




607-522-00-3
sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate
429-720-7
184246-86-4
Aquatic Chronic 3
H412
—
H412




607-523-00-9
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6', 13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6', 3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
430-200-7
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




607-524-00-4
tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters
430-310-5
—
Aquatic Chronic 4
H413

H413




607-525-00-X
(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid
431-520-1
64485-90-1
Flam. Sol. 1****
Carc. 2
Aquatic Chronic 3
H228
H351
H412
GHS02
GHS08
Dgr
H228
H351
H412




607-526-00-5
cartap (ISO);
1,3-bis(carbamoylthio)-2-(dimethylamino)propane
—
15263-53-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



607-527-00-0
reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate
423-180-6
—
STOT RE 2 *
H373 **
GHS08
Wng
H373 **






607-528-00-6
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid
430-900-2
192725-50-1
Eye Dam. 1
H318
GHS05
Dgr
H318




607-529-00-1
benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate
426-070-6
67299-45-0
Aquatic Chronic 3
H412
—
H412




607-530-00-7
reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate
406-040-9
125643-61-0
Aquatic Chronic 4
H413
—
H413




607-531-00-2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate
425-190-6
119916-05-1
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411




607-532-00-8
(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt
425-510-4
167944-94-7
Aquatic Chronic 3
H412
—
H412




607-533-00-3
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-910-4
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-534-00-9
ethyl 2-(3-benzoylphenyl)propanoate
414-920-9
60658-04-0
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H301
H372**
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H372**
H317
H411




607-535-00-4
potassium 4-iodo-2-sulfonato-benzoic acid
426-620-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




607-536-00-X
(2,6-xylyloxy) acetic acid
430-910-7
13335-71-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




607-537-00-5
isopropylammonium 2-(3-benzoylphenyl)propionate
417-970-1
—
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H312
H372**
H318
H410




607-539-00-6
propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate
431-000-2
198705-81-6
Aquatic Chronic 4
H413
—
H413




607-540-00-1
1-(mercaptomethyl)cyclopropylacetic acid
420-240-3
162515-68-6
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H312
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H317
H411




607-541-00-7
[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)
421-940-1
28698-31-9
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




607-542-00-2
methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate
422-110-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-543-00-8
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-480-8
176429-22-4
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410




607-544-00-3
ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate
427-490-2
158585-86-5
Aquatic Chronic 3
H412
—
H412




607-545-00-9
1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate
424-070-0
94346-09-5
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




607-546-00-4
reaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]methoxycarbonylmethylamino[}acetate;
methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]ethoxycarbonylmethylamino[}acetate
424-290-7
188070-47-5
Skin Sens. 1
H317
GHS07
Wng
H317




607-547-00-X
18-methylnonadecyl 2,2 -dimethylpropanoate
424-370-1
125496-22-2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic
H315
H317
H413
GHS07
Wng
H315
H317
H413




607-548-00-5
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate
431-010-7
154486-26-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




607-549-00-0
methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate
424-430-7
125778-19-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-550-00-6
2-amino-4-bromo-5-chlorobenzoic acid
424-700-4
—
Eye Dam. 1
Aquatic Chronic 3
H318
H410
GHS05
Dgr
H318
H410




607-551-00-1
tetrabutylammonium 2-amino-6-iodopurinate
424-710-9
156126-48-6
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373**
H315
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373**
H315
H318
H317
H411




607-552-00-7
hexadecyl 3-amino-4-isopropoxybenzoate
424-830-1
—
Aquatic Chronic 4
H413
—
H413




607-553-00-2
7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt
424-850-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318




607-554-00-8
2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid
424-870-1
27624-67-5
Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3
H201
H318
H412
GHS01
GHS05
Dgr
H201
H318
H412




607-555-00-3
1,1,3,3-tetramethylbutylperoxypivalate
424-980-8
22288-41-1
Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H242
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H242
H315
H317
H411




607-556-00-9
2-acetoxymethylene-4-acetylphenylacetate
425-160-2
24085-06-1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H318
H317
H400
H410
GHS05 GHS08 GHS07 GHS09 Dgr
H302
H373**
H318
H317
H410




607-557-00-4
salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid
425-210-3
169939-84-8
Skin Sens. 1
H317
GHS07
Wng
H317




607-558-00-X
2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate
425-250-1
147027-10-9
Aquatic Chronic 2
H411
GHS09
H411




607-559-00-5
coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid
425-400-6
179986-09-5
Aquatic Chronic 4
H413
—
H413




607-560-00-0
(R,S)-2-butyloctanedioic acid
431-210-4
50905-10-7
Eye Dam. 1
H318
GHS05
Dgr
H318




607-561-00-6
sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate
425-460-3
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




607-562-00-1
reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;
(2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate
425-530-3
98769-75-6
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




607-563-00-7
5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid
431-250-2
171850-30-9
Aquatic Chronic 2
H411
GHS09
H411




607-564-00-2
1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate
425-730-0
51178-75-7
Skin Sens. 1
H317
GHS07
Wng
H317




607-565-00-8
3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
425-820-1
88150-42-9
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H373**
H318
H410




607-566-00-3
reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate
426-140-6
—
Aquatic Chronic 4
H413
—
H413




607-567-00-9
potassium 3-iodo-6-methylbenzenesulfonate
426-300-5
—
Eye Dam. 1
H318
GHS05
Dgr
H318




607-568-00-4
potassium 2-chloro-3-(benzyloxy)propionate
426-350-8
138666-92-9
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317




607-569-00-X
reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;
sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate
426-470-0
—
Skin Sens. 1
H317
GHS07
Wng
H317




607-570-00-5
sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
426-520-1
71420-85-4
Skin Sens. 1
H317
GHS07
Wng
H317




607-571-00-0
2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate
431-400-7
57374-49-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-572-00-6
diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
426-790-0
162208-27-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373**
H317
H410




607-573-00-1
reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;
disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate
426-840-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318




607-574-00-7
[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate
426-890-4
77341-67-4
Eye Dam. 1
H318
GHS05
Dgr
H318




607-575-00-2
4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt
426-900-7
—
STOT SE 3
Aquatic Chronic 3
H335
H412
GHS07
Wng
H335
H412




607-576-00-8
branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate
427-030-0
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-577-00-3
(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate
427-100-0
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412




607-578-00-9
ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate
427-110-5
—
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4
H302
H373**
H413
GHS08
GHS07
Wng
H302
H373**
H413




607-579-00-4
diethyl[(p-ethoxyanilino)methylene]malonate
431-430-0
103976-28-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411




607-580-00-X
ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate
422-360-1
100491-29-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-581-00-5
ethyl 2-ethoxy-4-carboxymethylbenzoate
427-630-2
99469-99-5
Eye Dam. 1
H318
GHS05
Dgr
H318




607-582-00-0
reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
427-650-1
—
Aquatic Chronic 3
H412
—
H412




607-583-00-6
4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid
427-680-5
188907-52-0
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




607-584-00-1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate
427-710-7
215612-56-9
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




607-585-00-7
strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate
427-930-3
—
Skin Sens. 1
H317
GHS07
Wng
H317




607-586-00-2
dodecyl 3-amino-4-chlorobenzoate
428-020-9
6195-20-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




607-587-00-8
ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate
428-030-3
67914-69-6
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410




607-588-00-3
reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate
428-050-2
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




607-589-00-9
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate
428-070-1
91788-83-9
STOT RE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H372**
H302
H410




607-590-00-4
hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate
428-140-1
210706-50-6
Aquatic Chronic 4
H413
—
H413




607-591-00-X
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate
428-400-4
—
Eye Dam.
H318
GHS05
Dgr
H318




607-592-00-5
di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate
428-870-0
—
Aquatic Chronic 4
H413
—
H413




607-593-00-0
4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate
429-000-2
159235-16-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




607-594-00-6
ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
429-020-1
204254-96-6
STOT RE 2 *
Skin Sens. 1
H373**
H317
GHS08
GHS07
Wng
H373**
H317




607-595-00-1
N-amidino-N-methylglycine-2-oxopropionate
429-120-5
208535-04-0
Eye Dam. 1
H318
GHS05
Dgr
H318




607-596-00-7
ethyl 2-(4-phenoxyphenyl)lactate
429-220-9
132584-17-9
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




607-597-00-2
tetrasodium 4,4'-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2'-disulfonate
429-230-3
—
Eye Dam. 1
H318
GHS05
Dgr
H318




607-598-00-8
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate
429-240-8
212652-59-0
Eye Dam. 1
H318
GHS05
Dgr
H318




607-599-00-3
1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate
431-610-9
68860-54-8
Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410




607-600-00-7
(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate
431-700-8
—
Aquatic Chronic 2
H411
GHS09
H411




607-601-00-2
1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate
429-370-5
220410-74-2
Acute Tox. 4 *
H302
GHS07
Wng
H302




607-602-00-8
ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate
429-680-0
122665-86-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




607-603-00-3
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate
429-730-1
193562-37-7
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-604-00-9
guanidinium benzoate
429-820-0
26739-54-8
Acute Tox. 4 *
H302
GHS07
Wng
H302




607-605-00-4
methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate
429-890-2
144550-06-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-606-00-X
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
430-100-3
86978-24-7
Acute Tox. 4 *
H302
GHS07
Wng
H302




607-607-00-5
reaction mass of: calcium bis(C10-14 branched alkyl salicylate);
calcium bis(C18-30-alkyl salicylate);
calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;
calcium bis (C10-14 branched alkyl phenolate);
calcium bis (C18-30-alkyl phenolate);
calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;
C10-14 branched alkyl phenol;
C18-30-alkyl phenol
430-180-1
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




607-608-00-0
pentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate
430-210-1
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-609-00-6
ethyl (3R)-4-cyano-3-hydroxybutanoate
430-220-6
141942-85-0
Eye Irrit. 2
H319
GHS07
Wng
H319




607-610-00-1
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate
430-280-3
—
Skin Sens. 1
H317
GHS07
Wng
H317




607-611-00-7
methyl 3-amino-2,2,3-trimethylbutyrate
431-720-7
90886-53-6
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412




607-612-00-2
reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate
432-190-1
182176-52-9
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
H302
H373**
H318
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318




607-613-00-8
reaction mass of: succinic acid;
monopersuccinic acid;
dipersuccinic acid;
monomethyl ester of succinic acid;
monomethyl ester of persuccinic acid;
dimethyl succinate;
glutaric acid;
monoperglutaric acid;
diperglutaric acid;
monomethyl ester of glutaric acid;
monomethyl ester of perglutaric acid;
dimethyl glutarate;
adipic acid;
monoperadipic acid;
diperadipic acid;
monomethyl ester of adipic acid;
monomethyl ester of peradipic acid;
dimethyl adipate;
hydrogen peroxide;
methanol;
water
432-790-1
—
Muta. 2
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H341
H314
H332
H312
H302
GHS05
GHS08
GHS07
Dgr
H341
H314
H332
H312
H302




607-614-00-3
2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid
426-480-5
63562-33-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




607-615-00-9
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance
431-120-5
—
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H331
H302
H319
H317
GHS06
Dgr
H331
H302
H319
H317




607-616-00-4
2,4-dichloro-5-fluorobenzoylchloride
428-390-1
86393-34-2
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H335
H315
H318
H317
H412
GHS05
GHS07
Dgr
H335
H315
H318
H317
H412




607-617-00-X
bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate
430-700-5
10138-36-0
Skin Sens. 1
H317
GHS07
Wng
H317




607-618-00-5
menadione sodium bisulfite;
2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410




607-619-00-0
menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410




607-620-00-6
trisodium nitrilotriacetate
225-768-6
5064-31-3
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
H351
H302
H319
GHS08
GHS07
Wng
H351
H302
H319

Carc. 2; H351: C ≥ 5 %


607-621-00-1
milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410

M=100


607-622-00-7
2-ethylhexyl-2-ethylhexanoate
231-057-1
7425-14-1
Repr. 2
H361d***
GHS08
Wng
H361d***




607-623-00-2
diisobutyl phthalate
201-553-2
84-69-5
Repr. 1B
H360Df
GHS08
Dgr
H360Df

Repr. 1B; H360Df: C ≥ 25 %
Repr. 2; H361f: 5 % ≤ C < 25 %


607-624-00-8
perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Lact.
Aquatic Chronic 2
H351
H360D***
H372**
H332
H302
H362
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D***
H372**
H332
H302
H362
H411




607-625-00-3
clodinafop-propargyl (ISO)
—
105512-06-9
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410

Skin Sens. 1; H317: C ≥ 0,001 %
M=1


607-626-00-9
ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
401-290-5
103112-35-2
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410




607-627-00-4
[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate
416-360-0
162221-28-5
Skin Sens. 1
H317
GHS07
Wng
H317




607-628-00-X
4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine
419-240-6
171054-89-0
Eye Dam. 1
H318
GHS05
Dgr
H318




607-629-00-5
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid
419-270-1
123599-82-6
Eye Irrit. 2
H319
GHS07
Wng
H319




607-630-00-0
acrylic acid, 3-(trimethoxysilyl)propyl ester
419-560-6
4369-14-6
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H332
H314
H317
H412
GHS05
GHS07
Dgr
H332
H314
H317
H412




607-631-00-6
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate
442-300-8
—
Skin Sens. 1
H317
GHS07
Wng
H317




607-632-00-1
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide
420-210-1
111244-14-5
Aquatic Chronic 4
H413
—
H413




607-633-00-7
trisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate
440-480-2
341026-59-3
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-634-00-2
(S)-(–)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate
420-610-4
36394-75-9
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317




607-635-00-8
trisodium N-(3-propionato)-l-aspartate
422-090-4
172737-80-3
Eye Dam. 1
H318
GHS05
Dgr
H318




607-636-00-3
1-bromo-2-methylpropyl propionate
422-900-6
158894-67-8
Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1
H226
H351
H314
H317
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H351
H314
H317




607-637-00-9
disodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[}naphthalene-2-sulfonate
423-730-5
250688-43-8
Eye Dam. 1
H318
GHS05
Dgr
H318




607-638-00-4
2-hydroxybenzoic acid 2-butyloctyl ester
431-090-3
190085-41-7
Aquatic Chronic 4
H413
—
H413




607-639-00-X
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate
431-770-1
216698-07-6
Aquatic Chronic 4
H413
—
H413




607-641-00-0
2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid
431-930-9
43028-69-9
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317




607-642-00-6
3,6,9-trithiaundecamethylene-1,11-dimethacrylate
432-210-7
141631-22-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




607-643-00-1
dimethyl (2S)-2-hydroxysuccinate
432-310-0
617-55-0
Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1
H226
H318
H317
GHS02
GHS05
GHS07
Dgr
H226
H318
H317




607-644-00-7
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate
432-350-9
81752-87-6
Skin Irrit. 2
H315
GHS07
Wng
H315




607-645-00-2
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate
432-550-6
243858-01-7
Eye Dam. 1
H318
GHS05
Dgr
H318




607-646-00-8
d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;
tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Acute Tox. 4 *
H302
GHS07
Wng
H302




607-647-00-3
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane
433-530-1
143446-73-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H302
H317
H400
GHS07
GHS09
Wng
H302
H317
H400




607-649-00-4
[3-(chlorocarbonyl)-2-methylphenyl]acetate
433-690-0
167678-46-8
Skin Corr. 1A
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317




607-650-00-X
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate
433-910-5
145153-52-2
Skin Sens. 1
H317
GHS07
Wng
H317




607-651-00-5
sodium 2-(nonanoyloxy)benzenesulfonate
434-360-9
91125-43-8
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-652-00-0
ethyl N2-dodecanoyl-l-argininate hydrochloride
434-630-6
60372-77-2
Eye Dam. 1
Aquatic Acute 1
H318
H400
GHS05
GHS09
Dgr
H318
H400




607-653-00-6
tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate
434-840-8
225786-91-4
Aquatic Chronic 2
H411
GHS09
H411




607-654-00-1
(S)-3-hydroxy-γ-butyrolactone
434-990-4
7331-52-4
Skin Sens. 1
H317
GHS07
Wng
H317




607-655-00-7
ethyl 6,8-dichlorooctanoate
435-080-1
1070-64-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-656-00-2
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid
435-350-7
141250-43-3
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




607-657-00-8
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
436-920-8
172399-10-9
Eye Dam. 1
H318
GHS05
Dgr
H318




607-658-00-3
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9
371921-63-0
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




607-659-00-9
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid
442-030-0
321912-47-4
Eye Dam. 1
H318
GHS05
Dgr
H318




607-660-00-4
2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{]phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8
321679-52-1
Eye Dam. 1
H318
GHS05
Dgr
H318




607-661-00-X
1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate
442-850-9
114772-40-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




607-662-00-5
methyl 2-(acetylamino)-3-chloropropionate
442-860-3
87333-22-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




607-663-00-0
bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate
442-980-6
127474-91-3
Aquatic Chronic 4
H413
—
H413




607-664-00-6
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate
443-120-2
393509-79-0
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411




607-665-00-1
trans-methyl-2-ethyl-but-2-enoate
443-150-6
101226-85-1
Flam. Liq. 3
H226
GHS02
Wng
H226




607-666-00-7
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid
443-560-5
88784-33-2
Eye Irrit. 2
H319
GHS07
Wng
H319




607-667-00-2
chloro-1-ethylcyclohexyl carbonate
444-950-8
99464-83-2
Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317




607-668-00-8
trans-2-isopropyl-5-carboxy-1,3-dioxane
445-770-2
42031-28-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




607-669-00-3
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate
445-990-9
376588-17-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




607-670-00-9
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate
448-700-9
500791-70-8
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H373**
H318
H317
H410

M=10


607-671-00-4
diethyl 1,4-cyclohexanedicarboxylate
417-310-0
72903-27-6
Aquatic Chronic 2
H411
GHS09
H411




607-672-00-X
reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-673-00-5
1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate
419-570-0
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




607-675-00-6
reaction mass of: cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid
422-260-8
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




607-676-00-1
reaction mass of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid
423-670-1
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




607-677-00-7
2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate
424-660-8
—
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H373**
H318
H317




607-678-00-2
reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate
427-090-8
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-679-00-8
reaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate);
3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate);
3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate)
431-440-5
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411




607-680-00-3
tert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{]pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
432-810-9
—
Aquatic Chronic 4
H413
—
H413




607-681-00-9
reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate
432-910-2
—
Aquatic Chronic 4
H413
—
H413




607-682-00-4
complex reaction mass of Chinese gum rosin post reacted with acrylic acid
434-230-1
144413-22-9
Aquatic Chronic 4
H413
—
H413




607-683-00-X
reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)
435-450-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




607-684-00-5
alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts
435-660-2
243662-67-1
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317




607-685-00-0
ammonium 2-cocoyloxyethanesulfonate
441-050-7
—
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318




607-686-00-6
6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
441-550-5
—
Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351




607-687-00-1
reaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %)
442-800-6
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




607-688-00-7
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride
444-320-2
—
Acute Tox. 4 *
H302
GHS07
Wng
H302




607-689-00-2
reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers)
444-920-4
—
Aquatic Chronic 3
H412
—
H412




607-690-00-8
dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate
432-860-1
255387-46-3
Skin Sens. 1
H317
GHS07
Wng
H317




607-691-00-3
magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
448-690-6
—
Aquatic Chronic 4
H413
—
H413




607-692-00-9
zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
446-470-4
—
Aquatic Chronic 4
H413
—
H413




607-693-00-4
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate
443-860-6
302776-68-7
Aquatic Chronic 4
H413
—
H413




607-694-00-X
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate
443-870-0
163520-33-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410





607-696-00-0
pentyl formate
211-340-6
638-49-3
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Dgr
H226
H319
H335


C
607-697-00-6
tert-butyl propionate
—
20487-40-5
Flam. Liq. 2
H225
GHS02
Dgr
H225


C
608-001-00-3
acetonitrile;
cyanomethane
200-835-2
75-05-8
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H225
H332
H312
H302
H319
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319



608-002-00-9
trichloroacetonitrile
208-885-7
545-06-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411



608-003-00-4
acrylonitrile
203-466-5
107-13-1
Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H225
H350
H331
H311
H301
H335
H315
H318
H317
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H331
H311
H301
H335
H315
H318
H317
H411

*
D
608-004-00-X
2-hydroxy-2-methylpropionitrile;
2-cyanopropan-2-ol;
acetone cyanohydrin
200-909-4
75-86-5
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H400
H410
GHS06
GHS09
Dgr
H330
H310
H300
H410






608-005-00-5
n-butyronitrile
203-700-6
109-74-0
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H225
H331
H311
H301
GHS02
GHS06
Dgr
H225
H331
H311
H301




608-006-00-0
bromoxynil (ISO)
3,5-dibromo-4-hydroxybenzonitrile;
bromoxynil phenol
216-882-7
1689-84-5
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H330
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H330
H301
H317
H410

M = 10

608-007-00-6
ioxynil (ISO)
4-hydroxy-3,5-diiodobenzonitrile
216-881-1
1689-83-4
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H331
H301
H312
H373 **
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H331
H301
H312
H373 **
H319
H410

M = 10

608-008-00-1
chloroacetonitrile
203-467-0
107-14-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H331
H311
H301
H411
GHS06
GHS09
Dgr
H331
H311
H301
H411



608-009-00-7
malononitrile
203-703-2
109-77-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410



608-010-00-2
methacrylonitrile;
2-methyl-2-propene nitrile
204-817-5
126-98-7
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
H225
H331
H311
H301
H317
GHS02
GHS06
Dgr
H225
H331
H311
H301
H317

*
Skin Sens. 1; H317: C ≥ 0,2 %
D


608-011-00-8
oxalonitrile;
cyanogen
207-306-5
460-19-5
Press. Gas
Flam. Gas 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H331
H410




608-012-00-3
benzonitrile
202-855-7
100-47-0
Acute Tox. 4 *
Acute Tox. 4 *
H312
H302
GHS07
Wng
H312
H302



608-013-00-9
2-chlorobenzonitrile
212-836-5
873-32-5
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H312
H302
H319
GHS07
Wng
H312
H302
H319





608-014-00-4
chlorothalonil (ISO);
tetrachloroisophthalonitrile
217-588-1
1897-45-6
Carc. 2
Acute Tox. 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H330
H335
H318
H317
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H330
H335
H318
H317
H410

M=10


608-015-00-X
dichlobenil (ISO);
2,6-dichlorobenzonitrile
214-787-5
1194-65-6
Acute Tox. 4 *
Aquatic Chronic 2
H312
H411
GHS07
GHS09
Wng
H312
H411



608-016-00-5
1,4-Dicyano-2,3,5,6-tetra-chloro-benzene
401-550-8
1897-41-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



608-017-00-0
bromoxynil octanoate (ISO);
2,6-dibromo-4-cyanophenyl octanoate
216-885-3
1689-99-2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H331
H302
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H331
H302
H317
H410

M = 10

608-018-00-6
ioxynil octanoate (ISO);
4-cyano-2,6-diiodophenyl octanoate
223-375-4
3861-47-0
Repr. 2
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H301
H319
H317
H410

M = 10

608-019-00-1
2,2'-dimethyl-2,2'-azodipropiononitrile;
ADZN
201-132-3
78-67-1
Self-react. C
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H242
H332
H302
H412
GHS02
GHS07
Dgr
H242
H332
H302
H412


T


608-020-00-7
diphenoxymethylenecyanamide
427-300-8
79463-77-7
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




608-021-00-2
3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile
403-710-2
76823-93-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



608-022-00-8
3,7-dimethyloctanenitrile
403-620-3
40188-41-8
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07
GHS09
Wng
H315
H317
H411



608-023-00-3
fenbuconazole (ISO);
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
406-140-2
114369-43-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



608-024-00-9
2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile
407-650-8
97460-76-9
Aquatic Chronic 4
H413
—
H413



608-025-00-4
2-nitro-4,5-bis(benzyloxy)phenylacetonitrile
410-970-0
117568-27-1
Aquatic Chronic 4
H413
—
H413



608-026-00-X
3-cyano-3,5,5-trimethylcyclohexanone
411-490-4
7027-11-4
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H302
H373 **
H317
H412
GHS08
GHS07
Wng
H302
H373 **
H317
H412



608-027-00-5
reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(3-ethylphenyl)-2,2-dimethylpropanenitrile
412-660-0
—
Aquatic Chronic 2
H411
GHS09
H411



608-028-00-0
4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate
413-510-7
147374-67-2
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 **
H317
H411
GHS08
GHS09
Wng
H373 **
H317
H411



608-029-00-6
1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile
411-990-2
68612-94-2
Skin Sens. 1
H317
GHS07
Wng
H317



608-030-00-1
N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide
412-340-0
147741-93-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



608-031-00-7
2-benzyl-2-methyl-3-butenitrile
407-870-4
97384-48-0
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412





608-032-00-2
acetamiprid (ISO);
(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
—
135410-20-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




608-033-00-8
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide
407-970-8
75511-91-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412





608-034-00-3
chlorfenapyr (ISO);
4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
—
122453-73-0
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410

M=100


608-035-00-9
(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile
419-290-9
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



608-036-00-4
3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile
419-060-8
79026-02-1
Aquatic Chronic 4
H413
—
H413



608-037-00-X
reaction mass of: (E)-2,12-tridecadiennitrile;
(E)-3,12-tridecadiennitrile;
(Z)-3,12-tridecadiennitrile
422-190-8

Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



608-038-00-5
2,2,4-trimethyl-4-phenyl-butane-nitrile
422-580-8
75490-39-0
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



608-039-00-0
2-phenylhexanenitrile
423-460-8
3508-98-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



608-040-00-6
4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)
423-490-1
130755-46-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



608-041-00-1
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile
423-500-4
138401-24-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





608-042-00-7
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide
421-810-4
194602-27-2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411




608-043-00-2
3-(cis-3-hexenyloxy)propanenitril
415-220-6
142653-61-0
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410






608-044-00-8
2-cyclohexylidene-2-phenylacetonitrile
423-740-1
10461-98-0
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411




608-046-00-9
5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile
425-310-7
77889-90-8
Aquatic Chronic 4
H413
—
H413




608-047-00-4
2-piperidin-1-yl-benzonitrile
427-330-1
72752-52-4
Aquatic Chronic 2
H411
GHS09
H411




608-048-00-X
1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile
427-450-4
152630-47-2
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H302
H373**
H317
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H411




608-049-00-5
2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile
429-180-2
157362-53-3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




608-050-00-0
reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile
429-760-5
—
Aquatic Chronic 4
H413
—
H413




608-051-00-6
(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-760-2
219861-18-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




608-052-00-1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-770-7
128173-52-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




608-053-00-7
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-780-1
103146-25-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




608-054-00-2
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate
430-790-6
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411




608-055-00-8
fipronil (ISO);
5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
—
120068-37-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H372**
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H372**
H410

M=10


608-056-00-3
N-methyl-N-cyanomethylmorpholiniummethylsulfate
429-340-1
—
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318




608-057-00-9
4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate
431-200-1
208538-34-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317




608-059-00-X
5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
421-240-6
120068-79-3
Aquatic Chronic 2
H411
GHS09
H411




608-060-00-5
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
421-300-1
138564-59-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




608-062-00-6
2-fluoro-4-hydroxybenzonitrile
422-810-7
82380-18-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




608-063-00-1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile
441-070-6
61826-76-4
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410




608-064-00-7
cyanomethyltrimethylammoniummethylsulfate
433-720-2
—
Aquatic Chronic 3
H412
—
H412




608-065-00-2
salts of bromoxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H330
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H330
H301
H317
H410

M = 10
A
608-066-00-8
salts of ioxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H331
H301
H312
H373 **
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H361d ***
H331
H301
H312
H373 **
H319
H410

M = 10
A
609-001-00-6
1-nitropropane
203-544-9
108-03-2
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302

*

609-002-00-1
2-nitropropane
201-209-1
79-46-9
Flam. Liq. 3
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H226
H350
H332
H302
GHS02
GHS08
GHS07
Dgr
H226
H350
H332
H302



609-003-00-7
nitrobenzene
202-716-0
98-95-3
Carc. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 2
H351
H361f ***
H331
H311
H301
H372 **
H411
GHS06
GHS08
GHS09
Dgr
H351
H361f ***
H331
H311
H301
H372 **
H411



609-004-00-2
dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4]
246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4]
25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4]
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410





609-005-00-8
1,3,5-trinitrobenzene
202-752-7
99-35-4
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H330
H310
H300
H373**
H400
H410
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H410





609-006-00-3
4-nitrotoluene
202-808-0
99-99-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411





609-007-00-9
2,4-dinitrotoluene; [1]
dinitrotoluene [2]
204-450-0 [1]
246-836-1 [2]
121-14-2 [1]
25321-14-6 [2]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361f***
H331
H311
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H331
H311
H301
H373**
H410




609-008-00-4
2,4,6-trinitrotoluene;
TNT
204-289-6
118-96-7
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H201
H331
H311
H301
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H331
H311
H301
H373 **
H411





609-009-00-X
2,4,6-trinitrophenol;
picric acid
201-865-9
88-89-1
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H201
H331
H311
H301
GHS01
GHS06
Dgr
H201
H331
H311
H301





609-010-00-5
salts of picric acid
—
—
Unst. Expl
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H201
H331
H311
H301
GHS01
GHS06
Dgr
H201
H331
H311
H301


T
609-011-00-0
2,4,6-trinitroanisole
—
606-35-9
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H201
H332
H312
H302
H411
GHS01
GHS07
GHS09
Wng
H201
H332
H312
H302
H411



609-012-00-6
2,4,6-trinitro-m-cresol
210-027-1
602-99-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Wng
H201
H332
H312
H302



609-013-00-1
2,4,6-trinitro-m-xylene
211-187-5
632-92-8
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H201
H332
H312
H302
H373 **
GHS01
GHS08
GHS07
Wng
H201
H332
H312
H302
H373 **



609-015-00-2
4-nitrophenol;
p-nitrophenol
202-811-7
100-02-7
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
H332
H312
H302
H373 **
GHS08
GHS07
Wng
H332
H312
H302
H373 **



609-016-00-8
dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2]
247-096-2 [1]
275-732-9 [2]
25550-58-7 [1]
71629-74-8 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410






609-018-00-9
2,4,6-trinitroresorcinol;
styphnic acid
201-436-6
82-71-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Dgr
H201
H332
H312
H302




609-019-00-4
lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate
239-290-0
15245-44-0
Unst. Expl
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H200
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H200
H360Df
H332
H302
H373 **
H410


1
609-019-01-1
lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate (≥ 20 % phlegmatiser)
239-290-0
15245-44-0
Expl. 1.1
Repr. 1A
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H360Df
H332
H302
H373 **
H400
H410
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H360Df
H332
H302
H373 **
H410


1
609-020-00-X
DNOC (ISO);
4,6-dinitro-o-cresol
208-601-1
534-52-1
Muta. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H330
H310
H300
H315
H318
H317
H400
H410
GHS06
GHS08
GHS05
GHS07
GHS09
Dgr
H341
H330
H310
H300
H315
H318
H317
H410
EUH044


609-021-00-5
sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC;
potassium 4,6-dinitro-o-cresolate [2]
219-007-7 [1]
- [2]
2312-76-7 [1]
5787-96-2 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410



609-022-00-0
ammonium salt of DNOC;
ammonium 4,6-dinitro-o-tolyl oxide
221-037-0
2980-64-5
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H310
H300
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H410





609-023-00-6
dinocap (ISO);
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which octyl is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups
254-408-0
39300-45-3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H332
H302
H373**
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D***
H332
H302
H373**
H315
H317
H410

M=100


609-024-00-1
binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate
207-612-9
485-31-4
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H312
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D ***
H312
H302
H410



609-025-00-7
dinoseb(ISO);
6-sec-butyl-2,4-dinitrophenol
201-861-7
88-85-7
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H311
H301
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H311
H301
H319
H410
EUH044


609-026-00-2
salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex
—
—
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H311
H301
H319
H400
H410
GHS06
GHS08
GHS09
Dgr
H360Df
H311
H301
H319
H410
EUH044

A
609-027-00-8
dinocton;
reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate
—
63919-26-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



609-028-00-3
dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol
205-042-5
131-89-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410



609-029-00-9
salts and esters of dinex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410


A
609-030-00-4
dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol
215-813-8
1420-07-1
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D ***
H300
H311
H410
EUH044


609-031-00-X
salts and esters of dinoterb
—
—
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D ***
H300
H311
H410


A
609-032-00-5
bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime
236-129-6
13181-17-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



609-033-00-0
dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol
—
4097-36-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410



609-034-00-6
salts and esters of dinosam
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410


A
609-035-00-1
nitroethane
201-188-9
79-24-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302

*

609-036-00-7
nitromethane
200-876-6
75-52-5
Flam. Liq. 3
Acute Tox. 4 *
H226
H302
GHS02
GHS07
Wng
H226
H302

*

609-037-00-2
5-nitroacenaphthene
210-025-0
602-87-9
Carc. 1B
H350
GHS08
Dgr
H350



609-038-00-8
2-nitronaphthalene
209-474-5
581-89-5
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411



609-039-00-3
4-nitrobiphenyl
202-204-7
92-93-3
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411



609-040-00-9
nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether
217-406-0
1836-75-5
Carc. 1B
Repr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H360D ***
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H360D ***
H302
H410



609-041-00-4
2,4-dinitrophenol
200-087-7
51-28-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H311
H301
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H400



609-042-00-X
pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-2
40487-42-1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



609-043-00-5
quintozene (ISO);
pentachloronitrobenzene
201-435-0
82-68-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



609-044-00-0
tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2
117-18-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



609-045-00-6
reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;
dinocton-6
—
8069-76-9
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410





609-046-00-1
trifluralin (ISO) (containing < 0,5 ppm NPDA);
α, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA)
216-428-8
1582-09-8
Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410

M=10


609-047-00-7
2-nitroanisole
202-052-1
91-23-6
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302



609-048-00-2
sodium 3-nitrobenzenesulphonate
204-857-3
127-68-4
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



609-049-00-8
2,6-dinitrotoluene
210-106-0
606-20-2
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H412



609-050-00-3
2,3-dinitrotoluene
210-013-5
602-01-7
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361f ***
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H410



609-051-00-9
3,4-dinitrotoluene
210-222-1
610-39-9
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H411



609-052-00-4
3,5-dinitrotoluene
210-566-2
618-85-9
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H350
H341
H361f ***
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H412



609-053-00-X
hydrazine-trinitromethane
414-850-9
—
Expl. 1.1 ****
Self-react. A
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
H201
H240
H350
H331
H301
H317
GHS01
GHS06
GHS08
Dgr
H201
H240
H350
H331
H301
H317



609-054-00-5
2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5]
200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
- [5]
66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
- [5]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411



609-055-00-0
2,5-dinitrotoluene
210-581-4
619-15-8
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H350
H341
H361f ***
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H331
H311
H301
H373 **
H411



609-056-00-6
2,2-dibromo-2-nitroethanol
412-380-9
69094-18-4
Expl. 1.1
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H302
H373 **
H314
H317
H400
H410
GHS01
GHS08
GHS05
GHS07
GHS09
Dgr
H201
H351
H302
H373 **
H314
H317
H410

*
STOT SE 3; H335: C ≥ 1 %
T
609-057-00-1
3-chloro-2,4-difluoronitrobenzene
411-980-8
3847-58-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410



609-058-00-7
2-nitro-2-phenyl-1,3-propanediol
410-360-4
5428-02-4
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H372 **
H312
H302
H317
H411
GHS08
GHS07
GHS09
Dgr
H372 **
H312
H302
H317
H411
EUH070


609-059-00-2
2-chloro-6-(ethylamino)-4-nitrophenol
411-440-1
131657-78-8
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



609-060-00-8
4-[(3-hydroxypropyl)amino]-3-nitrophenol
406-305-9
92952-81-3
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



609-061-00-3
(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime
406-100-4
94097-88-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



609-062-00-9
2-bromo-2-nitropropanol
407-030-7
24403-04-1
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H311
H302
H373 **
H314
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H311
H302
H373 **
H314
H317
H410



609-063-00-4
2-[(4-chloro-2-nitrophenyl)amino]ethanol
413-280-8
59320-13-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



609-064-00-X
mesotrione(ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
—
104206-82-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



609-065-00-5
2-nitrotoluene
201-853-3
88-72-2
Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H350
H340
H361f ***
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H361f ***
H302
H411



609-066-00-0
lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
418-870-9
154212-58-5
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2 **
H332
H312
H302
H371 **
GHS08
GHS07
Dgr
H332
H312
H302
H371 **



609-067-00-6
sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine
416-280-6
156769-97-0
Skin Sens. 1
H317
GHS07
Wng
H317



609-068-00-1
musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-4
81-15-2
Expl. 1.1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H400
H410
GHS01
GHS08
GHS09
Wng
H201
H351
H410


T


609-069-00-7
musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone
201-328-9
81-14-1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410




609-070-00-2
1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene
415-580-4
130841-23-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



609-071-00-8
reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol
423-520-3
156137-33-6
Skin Sens. 1
H317
GHS07
Wng
H317





609-072-00-3
4-mesyl-2-nitrotoluene
430-550-0
1671-49-4
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f***
H302
H317
H412
GHS08
GHS07
Dgr
H361f***
H302
H317
H412




609-073-00-9
lithium potassium sodium N,N''-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N'-(2-aminoethyl)piperazine
427-850-9
—
Skin Sens. 1
H317
GHS07
Wng
H317




610-001-00-3
trichloronitromethane;
chloropicrin
200-930-9
76-06-2
Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H330
H302
H319
H335
H315
GHS06
Dgr
H330
H302
H319
H335
H315



610-002-00-9
1,1-dichloro-1-nitroethane
209-854-0
594-72-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301



610-003-00-4
chlorodinitrobenzene
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410


C
610-004-00-X
2-chloro-1,3,5-trinitrobenzene
201-864-3
88-88-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H330
H310
H300
H400
H410
GHS01
GHS06
GHS09
Dgr
H201
H330
H310
H300
H410



610-005-00-5
1-chloro-4-nitrobenzene
202-809-6
100-00-5
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H351
H341
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H351
H341
H331
H311
H301
H373 **
H411



610-006-00-0
chloronitroanilines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H310
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H411


A C
610-007-00-6
1-chloro-1-nitropropane
209-990-0
600-25-9
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302

*

610-008-00-1
2,6-dichloro-4-nitroanisole
403-350-6
17742-69-7
Acute Tox. 3 *
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411



610-009-00-7
2-chloro-4-nitroaniline
204-502-2
121-87-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



610-010-00-2
2-bromo-1-(2-furyl)-2-nitroethylene
406-110-9
35950-52-8
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H314
H317
H410



611-001-00-6
azobenzene
203-102-5
103-33-3
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H332
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H341
H332
H302
H373 **
H410



611-002-00-1
azoxybenzene
207-802-1
495-48-7
Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302



611-003-00-7
fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate
205-419-4
140-56-7
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 3
H301
H312
H412
GHS06
Dgr
H301
H312
H412



611-004-00-2
methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate
209-765-7
592-62-1
Carc. 1B
Repr. 1B
H350
H360D ***
GHS08
Dgr
H350
H360D ***



611-005-00-8
disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);
CI Direct Brown 95
240-221-1
16071-86-6
Carc. 1B
H350
GHS08
Dgr
H350



611-006-00-3
4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene
202-591-2
97-56-3
Carc. 1B
Skin Sens. 1
H350
H317
GHS08
Dgr
H350
H317



611-007-00-9
tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;
255-559-5
41814-78-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



611-008-00-4
4-aminoazobenzene;
4-phenylazoaniline
200-453-6
60-09-3
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



611-009-00-X
sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)
401-220-3
—
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412



611-010-00-5
2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide
403-010-7
106359-94-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



611-011-00-0
N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate
403-340-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dg
H318
H411



611-012-00-6
reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
403-410-1
114565-65-0
Skin Sens. 1
H317
GHS07
Wng
H317



611-013-00-1
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate
403-650-7
117409-78-6
Expl. 1.3 ****
Aquatic Chronic 2
H203
H411
GHS01
GHS09
Dgr
H203
H411



611-014-00-7
(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide
404-250-5
115099-55-3
Skin Sens. 1
H317
GHS07
Wng
H317



611-015-00-2
tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
404-320-5
116889-78-2
Skin Sens. 1
H317
GHS07
Wng
H317



611-016-00-8
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride
404-540-1
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-017-00-3
2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide
404-910-2
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-018-00-9
tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate
405-130-5
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-019-00-4
tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-150-4
106028-58-4
Skin Sens. 1
H317
GHS07
Wng
H317



611-020-00-X
tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-170-3
116340-05-7
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412



611-021-00-5
2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate
405-480-9
—
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 4
H302
H373 **
H315
H413
GHS08
GHS07
Wng
H302
H373 **
H315
H413



611-022-00-0
4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate
404-980-4
—
Self-react. C
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H331
H301
H312
H373 **
H318
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H301
H312
H373 **
H318
H317
H410


T
611-023-00-6
disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate
404-600-7
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-024-00-1
Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350


A
611-025-00-7
disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38
217-710-3
1937-37-7
Carc. 1B
Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***



611-026-00-2
tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6
220-012-1
2602-46-2
Carc. 1B
Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***



611-027-00-8
disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);
C.I. Direct Red 28
209-358-4
573-58-0
Carc. 1B
Repr. 2
H350
H361d ***
GHS08
Dgr
H350
H361d ***





611-028-00-3
C,C'-azodi(formamide)
204-650-8
123-77-3
Resp. Sens. 1
H334
GHS08
Dgr
H334




611-029-00-9
o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350


A H
611-030-00-4
o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex
—
—
Carc. 1B
H350
GHS08
Dgr
H350


A H
611-031-00-X
4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9
209-321-2
569-61-9
Carc. 1B
H350
GHS08
Dgr
H350



611-032-00-5
1,4,5,8-tetraaminoanthraquinone;
C.I. Disperse Blue 1
219-603-7
2475-45-8
Carc. 1B
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H350
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H350
H315
H318
H317



611-033-00-0
hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)
400-020-3
82027-60-9
Aquatic Chronic 2
H411
GHS09
H411



611-034-00-6
N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide
402-430-8
105076-77-5
Aquatic Chronic 4
H413
—
H413





611-035-00-1
tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate
403-660-1
107246-80-0
Aquatic Chronic 2
H411
GHS09
H411




611-036-00-7
2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate
405-440-0
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-037-00-2
3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate
406-055-0
124584-00-5
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



611-038-00-8
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate
406-820-9
—
Eye Irrit. 2
H319
GHS07
Wng
H319



611-039-00-3
7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid
407-050-6
117715-57-8
Skin Sens. 1
H317
GHS07
Wng
H317



611-040-00-9
3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid
407-670-7
115099-58-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



611-041-00-4
2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide
407-680-1
98809-11-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



611-042-00-X
trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate
411-770-6
136213-71-3
Aquatic Chronic 3
H412
—
H412



611-043-00-5
reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)
402-850-1
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



611-044-00-0
reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
403-720-7
117527-94-3
Aquatic Chronic 2
H411
GHS09
H411



611-045-00-6
2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene
404-830-8
—
Aquatic Chronic 4
H413
—
H413



611-046-00-1
4,4'-diamino-2-methylazobenzene
407-590-2
43151-99-1
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H410



611-047-00-7
reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-890-3
111381-11-4
Aquatic Chronic 4
H413
—
H413



611-048-00-2
reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-900-6
111381-12-5
Aquatic Chronic 4
H413
—
H413



611-049-00-8
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)
408-000-6
118658-98-3
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373 **
H317
H412
GHS08
Wng
H373 **
H317
H412






611-050-00-3
reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate
415-350-3
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412





611-051-00-9
2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride
411-110-7
136213-74-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



611-052-00-4
monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex
400-720-9
—
Aquatic Chronic 3
H412
—
H412



611-053-00-X
2,2'-azobis[2-methylpropionamidine] dihydrochloride
221-070-0
2997-92-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



611-055-00-0
C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-8
2832-40-8
Carc. 2
Skin Sens. 1
H351
H317
GHS08
GHS07
Wng
H351
H317



611-056-00-6
C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol
212-668-2
842-07-9
Carc. 2
Muta. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H341
H317
H413
GHS08
GHS07
Wng
H351
H341
H317
H413



611-057-00-1
6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile
400-340-3
85136-74-9
Carc. 1B
Aquatic Chronic 4
H350
H413
GHS08
Wng
H350
H413



611-058-00-7
(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate
402-060-7
108225-03-2
Carc. 1B
Eye Dam. 1
Aquatic Chronic 2
H350
H318
H411
GHS08
GHS05
GHS09
Dgr
H350
H318
H411



611-059-00-2
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate
412-960-1
148878-21-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



611-060-00-8
reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
413-180-4
187285-15-0
Eye Dam. 1
H318
GHS05
Dgr
H318



611-061-00-3
disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate
412-530-3
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



611-062-00-9
octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate
413-550-5
—
Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318



611-063-00-4
trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)
413-590-3
164058-22-4
Carc. 1B
H350
GHS08
Dgr
H350



611-064-00-X
4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol
410-600-8
124719-26-2
STOT RE 2 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H315
H410



611-065-00-5
4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol
410-610-2
111850-24-9
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H319
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H319
H315
H317
H410



611-066-00-0
tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
411-540-5
130201-57-9
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411





611-067-00-6
reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;
bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate
406-910-8
—
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




611-068-00-1
tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
400-690-7
85665-98-1
Aquatic Chronic 2
H411
GHS09
H411



611-069-00-7
N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline
413-380-1
—
Aquatic Chronic 2
H411
GHS09
H411



611-070-00-2
reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
405-665-4
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



611-071-00-8
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate
406-073-9
131013-81-5
Acute Tox. 3 *
Aquatic Chronic 3
H301
H412
GHS06
Dgr
H301
H412



611-072-00-3
2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride
407-010-8
118208-02-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411



611-073-00-9
dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate
407-310-9
122630-55-1
Aquatic Chronic 4
H413
—
H413



611-074-00-4
reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)
407-100-7
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-075-00-X
reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)
406-000-0
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



611-076-00-5
3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole
406-280-4
117584-16-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



611-077-00-0
dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)
407-230-4
126637-70-5
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



611-078-00-6
(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate
407-240-9
159604-94-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-079-00-1
disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate
410-390-8
147703-64-8
Eye Dam. 1
H318
GHS05
Dgr
H318



611-080-00-7
sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate
410-150-2
147703-65-9
Skin Sens. 1
H317
GHS07
Wng
H317



611-081-00-2
tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)
411-470-5
141048-13-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



611-082-00-8
reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);
pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)
407-570-3
—
Aquatic Chronic 2
H411
GHS09
H411



611-083-00-3
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)
411-560-4
—
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H372 **
H317
H411
GHS08
GHS07
GHS09
Dgr
H372 **
H317
H411





611-084-00-9
reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;
N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide
412-550-2
—
Aquatic Chronic 4
H413
—
H413




611-085-00-4
reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine
411-880-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-086-00-X
monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate
411-360-7
—
Aquatic Chronic 3
H412
—
H412



611-087-00-5
reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)
411-710-9
—
Aquatic Chronic 4
H413
—
H413



611-088-00-0
reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate
411-890-9
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412



611-089-00-6
2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate
411-100-2
136213-73-5
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H373 **
H317
H410



611-090-00-1
2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate
413-290-2
93672-52-7
Self-react. C
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H242
H302
H318
H317
H412
GHS02
GHS05
GHS07
Dgr
H242
H302
H318
H317
H412


T
611-091-00-7
sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate
413-470-0
134595-59-8
Skin Sens. 1
H317
GHS07
Wng
H317



611-092-00-2
tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate
413-210-6
—
Aquatic Chronic 2
H411
GHS09
H411



611-093-00-8
sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate
410-770-3
146177-84-6
Skin Sens. 1
H317
GHS07
Wng
H317



611-094-00-3
reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)
411-600-0
143145-93-1
Aquatic Chronic 4
H413
—
H413



611-095-00-9
hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide
412-240-7
89797-03-5
Aquatic Chronic 2
H411
GHS09
H411



611-096-00-4
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate
413-040-2
149850-30-6
Skin Sens. 1
H317
GHS07
Wng
H317



611-097-00-X
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)
414-150-3
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-098-00-5
tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate
405-950-3
131013-83-7
Acute Tox. 3 *
Aquatic Chronic 3
H301
H412
GHS06
Dgr
H301
H412



611-099-00-0
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride
401-500-5
118658-99-4
Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411



611-100-00-4
potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate
403-810-6
140876-13-7
Eye Dam. 1
H318
GHS05
Dgr
H318



611-101-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide
405-200-5
104366-25-8
Skin Sens. 1
H317
GHS07
Wng
H317





611-102-00-5
reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[}benzendiazoniumchlorid;
disodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{]phenylsulfonylamino[}benzen-diazoniumchlorid
424-500-7
—
Aquatic Chronic 3
H412
—
H412





611-103-00-0
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)
407-110-1
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



611-104-00-6
reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);
trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate
406-870-1
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-105-00-1
sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate
407-800-2
136213-75-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-106-00-7
hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate
410-180-6
157627-99-1
Eye Dam. 1
H318
GHS05
Dgr
H318



611-107-00-2
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate
412-490-7
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-108-00-8
disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate
413-600-6
6527-62-4
Aquatic Chronic 3
H412
—
H412



611-109-00-3
reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)
407-710-3
—
Aquatic Chronic 2
H411
GHS09
H411



611-110-00-9
tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene
408-210-8
124605-82-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



611-111-00-4
disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)
414-230-8
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-112-00-X
tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate
413-070-6
—
Skin Sens. 1
H317
GHS07
Wng
H317



611-113-00-5
lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)
414-280-0
149626-00-6
Aquatic Chronic 2
H411
GHS09
H411



611-114-00-0
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)
414-250-7
149564-66-9
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412



611-115-00-6
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)
414-290-5
149564-65-8
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



611-116-00-1
reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
414-620-8
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



611-117-00-7
1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt
415-100-3
149850-29-3
Skin Sens. 1
H317
GHS07
Wng
H317



611-118-00-2
sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt
413-990-8

Skin Sens. 1
H317
GHS07
Wng
H317



611-119-00-8
tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
415-400-4
148878-22-2
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



611-120-00-3
5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt
418-340-7
157707-94-3
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



611-121-00-9
main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol
417-280-9
30785-74-1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



611-122-00-4
hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel
417-250-5
151436-99-6
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



611-123-00-X
3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate
424-310-4
178452-66-9
Eye Dam. 1
H318
GHS05
Dgr
H318



611-124-00-5
reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate
424-320-9

Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



611-125-00-0
reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex
423-940-7
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



611-126-00-6
2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride
424-120-1
174514-06-8
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



611-127-00-1
pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate
423-790-2
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412


G
611-128-00-7
N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt
419-500-9
171599-85-2
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



611-129-00-2
reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
418-230-9
163879-69-4
Expl. 1.3 ****
Repr. 2
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H203
H361f ***
H373 **
H317
H411
GHS01
GHS08
GHS07
GHS09
Dgr
H203
H361f ***
H373 **
H317
H411





611-130-00-8
tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate
418-520-5
183130-96-3
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412




611-131-00-3
2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one
420-580-2
151798-26-4
Repr. 1B
Aquatic Chronic 4
H360D ***
H413
GHS08
Dgr
H360D ***
H413



611-132-00-9
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-210-2
178452-71-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



611-133-00-4
Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt
419-260-5
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



611-134-00-X
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex
423-770-3
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411



611-135-00-5
reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt
424-250-9
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412



611-136-00-0
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate
424-260-3
—
Repr. 2
Eye Dam. 1
Aquatic Chronic 2
H361f ***
H318
H411
GHS05
GHS08
GHS09
Dgr
H361f ***
H318
H411



611-137-00-6
6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole
419-870-1
159038-16-1
Aquatic Chronic 4
H413
—
H413



611-138-00-1
2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole
415-910-7
152828-25-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





611-139-00-7
reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride
424-510-1
—
Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411




611-140-00-2
azafenidin (ISO);
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
—
68049-83-2
Repr. 1B
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 **
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 **
H410

M = 1000



611-141-00-8
5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt
414-410-6
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




611-142-00-3
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride
425-740-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




611-143-00-9
reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);
trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)
428-260-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318




611-144-00-4
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
429-070-4
214362-06-8
Eye Dam. 1
H318
GHS05
Dgr
H318




611-145-00-X
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt
429-440-5
—
Eye Dam. 1
H318
GHS05
Dgr
H318




611-146-00-5
reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate
430-070-1
—
Aquatic Chronic 2
H411
GHS09
H411




611-147-00-0
sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate
430-090-0
205764-96-1
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




611-148-00-6
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol
429-590-1
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




611-149-00-1
2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate
427-570-7
193486-83-8
Aquatic Chronic 2
H411
GHS09
H411




611-150-00-7
tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate
440-460-3
—
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412




611-151-00-2
chrysoidine;
4-(phenylazo)benzene-1,3-diamine
207-803-7
495-54-5
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H315
H410




611-152-00-8
chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]
208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]
532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H341
H302
H315
H318
H410




611-153-00-3
chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]
286-946-7 [1]
304-236-8 [2]
85407-90-5 [1]
94247-67-3 [2]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H341
H302
H315
H318
GHS05
GHS08
GHS07
Dgr
H341
H302
H315
H318




611-154-00-9
trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate
403-670-6
92408-46-3
Aquatic Chronic 3
H412
—
H412




611-155-00-4
4,4'-oxybis(benzenesulfonylazide)
431-850-4
7456-68-0
Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H373**
H400
H410
GHS01
GHS08
GHS09
Dgr
H201
H373**
H410




611-156-00-X
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
432-270-4
221354-37-6
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361f***
H373**
H411
GHS08
GHS09
Wng
H361f***
H373**
H411




611-157-00-5
benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate
432-590-4
243869-48-9
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412




611-158-00-0
reaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride
421-520-8
—
****
Aquatic Chronic 4
****
H413
****
****
H413




611-159-00-6
disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate
421-880-6
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




611-160-00-1
reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;
1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)
422-760-6
—
****
Aquatic Chronic 4
****
H413
****
****
H413




611-161-00-7
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)
423-100-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318




611-162-00-2
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)
429-600-4
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




611-163-00-8
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate
429-610-9
—
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411




611-164-00-3
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;
2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2,2'-dimethyl-2,2'-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)
429-710-2
—
Self React D
Acute Tox. 4 *
Aquatic Chronic 2
H242
H302
H411
GHS02
GHS07
GHS09
Dgr
H242
H302
H411




611-165-00-9
reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
431-830-5
—
Aquatic Chronic 3
H412
—
H412




611-166-00-4
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
432-100-9
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




611-167-00-X
sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)
435-240-9
—
Aquatic Chronic 3
H412
—
H412




611-168-00-5
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid
435-440-6
—
Eye Dam. 1
H318
GHS05
Dgr
H318




611-169-00-0
sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate
435-800-2
—
Aquatic Chronic 3
H412
—
H412




611-170-00-6
reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)
435-880-9
—
Aquatic Chronic 3
H412
—
H412




611-171-00-1
reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate
436-890-6
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




611-172-00-7
reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
438-310-7
—
Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H242
H361f***
H302
H373**
H412
GHS02
GHS08
GHS07
Dgr
H242
H361f***
H302
H373**
H412




611-173-00-2
reaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt
440-510-4
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




611-174-00-8
reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
442-290-5
457624-86-1
Eye Dam. 1
H318
GHS05
Dgr
H318




611-175-00-3
reaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
trisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
disodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
tetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5
—
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




611-176-00-9
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate
444-250-2
—
Self-react. C****
Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411




611-177-00-4
reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)
444-290-0
508202-43-5
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




611-178-00-X
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
445-280-9
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




611-179-00-5
reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate
450-010-8
—
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




611-180-00-0
iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts
417-850-7
—
Aquatic Chronic 2
H411
GHS09
H411




612-001-00-9
mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Gas 1
Press. Gas
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H220
H332
H335
H315
H318
GHS02
GHS04
GHS05
GHS07
Dgr
H220
H332
H335
H315
H318

*
Skin Irrit. 2; H315: C ≥ 5 %
Eye Dam. 1; H318: C ≥ 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: C ≥ 5 %
U
5
612-001-01-6
mono-methylamine ... %; [1]
di-methylamine ... %; [2]
tri-methylamine ... % [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H224
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H332
H302
H314

*
STOT SE 3; H335: C ≥ 5 %
B
612-002-00-4
ethylamine
200-834-7
75-04-7
Flam. Gas 1
Press. Gas
Eye Irrit. 2
STOT SE 3
H220
H319
H335
GHS02
GHS04
GHS07
Dgr
H220
H319
H335


U
612-003-00-X
diethylamine
203-716-3
109-89-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 1 %

612-004-00-5
triethylamine
204-469-4
121-44-8
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 1 %

612-005-00-0
butylamine
203-699-2
109-73-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 1 %

612-006-00-6
ethylenediamine;
1,2-diaminoethane
203-468-6
107-15-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H226
H312
H302
H314
H334
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H314
H334
H317



612-007-00-1
2-aminopropane;
isopropylamine
200-860-9
75-31-0
Flam. Liq. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H224
H319
H335
H315
GHS02
GHS07
Dgr
H224
H319
H335
H315



612-008-00-7
aniline
200-539-3
62-53-3
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 **
H318
H317
H400

*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

612-009-00-2
salts of aniline
—
—
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 **
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 **
H318
H317
H400

*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %
A
612-010-00-8
chloroanilines (with exception of those specified elsewhere in this Annex)
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410


C
612-011-00-3
4-nitrosoaniline
211-535-6
659-49-4
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302



612-012-00-9
o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3]
201-855-4 [1]
202-729-1 [2]
202-810-1 [3]
88-74-4 [1]
99-09-2 [2]
100-01-6 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412


C
612-013-00-4
3-aminobenzene sulphonic acid;
metanilic acid
204-473-6
121-47-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302



612-014-00-X
sulphanilic acid;
4-aminobenzenesulphonic acid
204-482-5
121-57-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317



612-015-00-5
N-methylaniline
202-870-9
100-61-8
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410



612-016-00-0
N,N-dimethylaniline
204-493-5
121-69-7
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H351
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H411






612-017-00-6
N-methyl-N-2,4,6-tetranitroaniline;
tetryl
207-531-9
479-45-8
Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
H201
H331
H311
H301
H373**
GHS01
GHS06
GHS08
Dgr
H201
H331
H311
H301
H373**




612-018-00-1
bis(2,4,6-trinitrophenyl)amine;
hexyl
205-037-8
131-73-7
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373**
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H411




612-019-00-7
dipicrylamine, ammonium salt
220-639-0
2844-92-0
Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373**
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373**
H411




612-020-00-2
1-naphthylamine
205-138-7
134-32-7
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



612-022-00-3
2-naphthylamine
202-080-4
91-59-8
Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411

Carc. 1A; H350: C ≥ 0,01 %

612-023-00-9
phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4]
202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4]
100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4]
Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H372 **
H319
H315
H317
H400



612-024-00-4
m-toluidine;
3-aminotoluene
203-583-1
108-44-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
H331
H311
H301
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H400



612-025-00-X
nitrotoluidines, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411


C
612-026-00-5
diphenylamine
204-539-4
122-39-4
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H410



612-027-00-0
xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411


C
612-028-00-6
p-phenylenediamine
203-404-7
106-50-3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410



612-029-00-1
benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride
210-834-9
624-18-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410



612-030-00-7
2-methyl-p-phenylenediamine sulphate [1]
210-431-8 [1]
228-871-4 [2]
615-50-9 [1]
6369-59-1 [2]
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H301
H332
H312
H317
H411
GHS06
GHS09
Dgr
H301
H332
H312
H317
H411



612-031-00-2
N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]
202-807-5 [2]
2836-04-6 [1]
99-98-9 [2]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H331
H311
H301
GHS06
Dgr
H331
H311
H301


C
612-032-00-8
N,N,N',N'-tetramethyl-p-phenylenediamine
202-831-6
100-22-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302



612-033-00-3
2-aminophenol
202-431-1
95-55-6
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
H341
H332
H302
GHS08
GHS07
Wng
H341
H332
H302





612-034-00-9
2-amino-4,6-dinitrophenol;
picramic acid
202-544-6
96-91-3
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H201
H332
H312
H302
H412
GHS01
GHS07
Dgr
H201
H332
H312
H302
H412




612-034-01-6
2-amino-4,6-dinitrophenol;
picramic acid;
[≥ 20 % water]
202-544-6
96-91-3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412


G
612-035-00-4
2-methoxyaniline;
o-anisidine
201-963-1
90-04-0
Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
H350
H341
H331
H311
H301
GHS06
GHS08
Dgr
H350
H341
H331
H311
H301



612-036-00-X
3,3'-dimethoxybenzidine;
o-dianisidine
204-355-4
119-90-4
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302



612-037-00-5
salts of 3,3'-dimethoxybenzidine;
salts of o-dianisidine
—
—
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302


A
612-038-00-0
2-nitro-p-anisidine;
4-methoxy-2-nitroaniline
202-547-2
96-96-8
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3
H330
H310
H300
H373 **
H412
GHS06
GHS08
Dgr
H330
H310
H300
H373 **
H412



612-039-00-6
2-ethoxyaniline;
o-phenetidine
202-356-4
94-70-2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H311
H301
H373 **
GHS06
GHS08
Dgr
H331
H311
H301
H373 **



612-040-00-1
2,4-dinitroaniline
202-553-5
97-02-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2
H330
H310
H300
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H411



612-041-00-7
4,4'-bi-o-toluidine
204-358-0
119-93-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411



612-042-00-2
benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine
202-199-1
92-87-5
Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410

Carc. 1A; H350: C ≥ 0,01 %

612-043-00-8
N,N'-dimethylbenzidine
—
2810-74-4
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H332
H312
H302
GHS07
Wng
H332
H312
H302





612-044-00-3
N,N'-diacetylbenzidine
210-338-2
613-35-4
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H341
H332
H312
H302
GHS08
GHS07
Dgr
H350
H341
H332
H312
H302




612-046-00-4
allylamine
203-463-9
107-11-9
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H225
H331
H311
H301
H411
GHS02
GHS06
GHS09
Dgr
H225
H331
H311
H301
H411



612-047-00-X
benzylamine
202-854-1
100-46-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



612-048-00-5
dipropylamine
205-565-9
142-84-7
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314

STOT SE 3; H335: C ≥ 1 %

612-049-00-0
di-n-butylamine; [1]
di-sec-butylamine [2]
203-921-8 [1]
210-937-9 [2]
111-92-2 [1]
626-23-3 [2]
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302






612-050-00-6
cyclohexylamine
203-629-0
108-91-8
Flam. Liq. 3
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H361f***
H312
H302
H314
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H361f***
H312
H302
H314




612-051-00-1
4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline
202-974-4
101-77-9
Carc. 1B
Muta. 2
STOT SE 1
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H370 **
H373 **
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H370 **
H373 **
H317
H411



612-052-00-7
(S)-sec-butylamine;
(S)-2-aminobutane; [1]
(R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3]
208-164-7 [1]
236-232-6 [2]
237-732-7 [3]
513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3]
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H225
H332
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H225
H332
H302
H314
H400


C
612-053-00-2
N-ethylaniline
203-135-5
103-69-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H311
H301
H373 **
GHS06
GHS08
Dgr
H331
H311
H301
H373 **



612-054-00-8
N,N-diethylaniline
202-088-8
91-66-7
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411

*

612-055-00-3
N-methyl-o-toluidine; [1]
N-methyl-m-toluidine; [2]
N-methyl-p-toluidine [3]
210-260-9 [1]
211-795-0 [2]
210-769-6 [3]
611-21-2 [1]
696-44-6 [2]
623-08-5 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412


C
612-056-00-9
N,N-dimethyl-p-toluidine; [1]
N,N-dimethyl-m-toluidine; [2]
N,N-dimethyl-o-toluidine [3]
202-805-4 [1]
204-495-6 [2]
210-199-8 [3]
99-97-8 [1]
121-72-2 [2]
609-72-3 [3]
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3
H331
H311
H301
H373 **
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 **
H412

*
C


612-057-00-4
piperazine;
[solid]
203-808-3
110-85-0
Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H361fd
H314
H334
H317
GHS05
GHS08
Dgr
H361fd
H314
H334
H317






612-057-01-1
piperazine;
[liquid]
203-808-3
110-85-0
Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H361fd
H314
H334
H317
GHS05
GHS08
Dgr
H361fd
H314
H334
H317





612-058-00-X
2,2'-iminodiethylamine;
diethylenetriamine
203-865-4
111-40-0
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H312
H302
H314
H317
GHS05
GHS07
Dgr
H312
H302
H314
H317



612-059-00-5
3,6-diazaoctanethylenediamin;
triethylenetetramine
203-950-6
112-24-3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H314
H317
H412
GHS05
GHS07
Dgr
H312
H314
H317
H412



612-060-00-0
3,6,9-triazaundecamethylenediamine;
tetraethylenepentamine
203-986-2
112-57-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H411



612-061-00-6
3-aminopropyldimethylamine;
N,N-dimethyl-1,3-diaminopropane
203-680-9
109-55-7
Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H226
H302
H314
H317
GHS02
GHS05
GHS07
Dgr
H226
H302
H314
H317



612-062-00-1
3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane
203-236-4
104-78-9
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H226
H312
H302
H314
H317
GHS02
GHS05
GHS07
Dgr
H226
H312
H302
H314
H317



612-063-00-7
3,3'-iminodi(propylamine);
dipropylenetriamine
200-261-2
56-18-8
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
H330
H311
H302
H314
H317
GHS06
GHS05
Dgr
H330
H311
H302
H314
H317



612-064-00-2
3,6,9,12-tetra-azatetradecamethylenediamine;
pentacthylenehexamine
223-775-9
4067-16-7
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410



612-065-00-8
polyethlyenepolyamines with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410



612-066-00-3
dicyclohexylamine
202-980-7
101-83-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410



612-067-00-9
3-aminomethyl-3,5,5-trimethylcyclohexylamine
220-666-8
2855-13-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H314
H317
H412
GHS05
GHS07
Dgr
H312
H302
H314
H317
H412



612-068-00-4
3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine
202-109-0
91-94-1
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H312
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H312
H317
H410



612-069-00-X
salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine
—
—
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H312
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H312
H317
H410


A
612-070-00-5
salts of benzidine
208-519-6
208-520-1
244-236-4
252-984-8
531-85-1
531-86-2
21136-70-9
36341-27-2
Carc. 1A
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410


A
612-071-00-0
salts of 2-naphthylamine
209-030-0
210-313-6
553-00-4
612-52-2
Carc. 1A
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411


A
612-072-00-6
biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl
202-177-1
92-67-1
Carc. 1A
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302



612-073-00-1
salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl
—
—
Carc. 1A
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302


A
612-074-00-7
benzyldimethylamine
203-149-1
103-83-3
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H226
H332
H312
H302
H314
H412
GHS02
GHS05
GHS07
Dgr
H226
H332
H312
H302
H314
H412



612-075-00-2
2-aminoethyldimethylamine;
2-dimethylaminoethylamine
203-541-2
108-00-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H225
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H312
H302
H314





612-076-00-8
ethyldimethylamine
209-940-8
598-56-1
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314





612-077-00-3
dimethylnitrosoamine;
N-nitrosodimethylamine
200-549-8
62-75-9
Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 2
H350
H330
H301
H372 **
H411
GHS06
GHS08
GHS09
Dgr
H350
H330
H301
H372 **
H411

Carc. 1B; H350: C ≥ 0,001 %

612-078-00-9
2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline)
202-918-9
101-14-4
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410



612-079-00-4
salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline)
—
—
Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410


A
612-080-00-X
4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine
202-214-1
93-05-0
Acute Tox. 3 *
Skin Corr. 1B
H301
H314
GHS06
GHS05
Dgr
H301
H314



612-081-00-5
salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts of o-tolidine
210-322-5
265-294-7
277-985-0
612-82-8
64969-36-4
74753-18-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411


A
612-082-00-0
thiourea;
thiocarbamide
200-543-5
62-56-6
Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H351
H361d ***
H302
H411
GHS08
GHS07
GHS09
Wng
H351
H361d ***
H302
H411





612-083-00-6
1-methyl-3-nitro-1-nitrosoguanidine
200-730-1
70-25-7
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H332
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H332
H319
H315
H411

Carc. 1B; H350: C ≥ 0,01 %


612-084-00-1
dapsone;
4,4'-diamino diphenyl sulfone
201-248-4
80-08-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



612-085-00-7
4,4'-methylenedi-o-toluidine
212-658-8
838-88-0
Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H410



612-086-00-2
amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl) methylamine
251-375-4
33089-61-1
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410

M = 10

612-087-00-8
guazatine (ISO)

108173-90-6
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H312
H302
H335
H315
H318
H400
H410
GHS06
GHS05
GHS09
Dgr
H330
H312
H302
H335
H315
H318
H410



612-088-00-3
simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine
204-535-2
122-34-9
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



612-089-00-9
1,5-naphthylenediamine
218-817-8
2243-62-1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



612-090-00-4
2,2'-(nitrosoimino)bisethanol
214-237-4
1116-54-7
Carc. 1B
H350
GHS08
Dgr
H350



612-091-00-X
o-toluidine;
2-aminotoluene
202-429-0
95-53-4
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
H350
H331
H301
H319
H400
GHS06
GHS08
GHS09
Dgr
H350
H331
H301
H319
H400



612-092-00-5
N,N'-(2,2-dimethylpropylidene)hexamethylenediamine
401-660-6
1000-78-8
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



612-093-00-0
3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline
401-790-3
104147-32-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410





612-094-00-6
4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride
402-190-4
113674-95-6
STOT RE 1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H372**
H302
H373**
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H372**
H302
H373**
H318
H317
H410




612-095-00-1
benzyl-2-hydroxydodecyldimethylammonium benzoate
402-610-6
113694-52-3
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H410



612-096-00-7
4,4'-carbonimidoylbis[N,N-dimethylaniline]
207-762-5
492-80-8
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H351
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H411



612-097-00-2
salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]
—
—
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H351
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H351
H302
H319
H411


A


612-098-00-8
nitrosodipropylamine
210-698-0
621-64-7
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411

Carc. 1B; H350: C ≥ 0,001 %


612-099-00-3
4-methyl-m-phenylenediamine;
2,4-toluenediamine
202-453-1
95-80-7
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H361f***
H301
H312
H373**
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H301
H312
H373**
H317
H411




612-100-00-7
propylenediamine
201-155-9
78-90-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
H226
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H226
H312
H302
H314





612-101-00-2
methenamine;
hexamethylenetetramine
202-905-8
100-97-0
Flam. Sol. 2
Skin Sens. 1
H228
H317
GHS02
GHS07
Wng
H228
H317




612-102-00-8
N,N-bis(3-aminopropyl)methylamine
203-336-8
105-83-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
H331
H311
H302
H314
GHS06
GHS05
Dgr
H331
H311
H302
H314



612-103-00-3
N,N,N',N'-tetramethylethylenediamine
203-744-6
110-18-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314



612-104-00-9
hexamethylenediamine
204-679-6
124-09-4
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Corr. 1B
H312
H302
H335
H314
GHS05
GHS07
Dgr
H312
H302
H335
H314



612-105-00-4
2-piperazin-1-ylethylamine
205-411-0
140-31-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H314
H317
H412
GHS05
GHS07
Dgr
H312
H302
H314
H317
H412



612-106-00-X
2,6-diethylaniline
209-445-7
579-66-8
Acute Tox. 4 *
H302
—
H302



612-107-00-5
1-phenylethylamine; [1]
DL-α-methylbenzylamine [2]
202-706-6 [1]
210-545-8 [2]
98-84-0 [1]
618-36-0 [2]
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



612-108-00-0
3-aminopropyltriethoxysilane
213-048-4
919-30-2
Acute Tox. 4 *
Skin Corr. 1B
H302
H314
GHS05
GHS07
Dgr
H302
H314



612-109-00-6
bis(2-dimethylaminoethyl)(methyl)amine
221-201-1
3030-47-5
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
H311
H302
H314
GHS06
GHS05
Dgr
H311
H302
H314



612-110-00-1
2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)
229-962-1
6864-37-5
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Chronic 2
H331
H311
H302
H314
H411
GHS06
GHS05
GHS09
Dgr
H331
H311
H302
H314
H411



612-111-00-7
2-methyl-m-phenylenediamine;
2,6-toluenediamine
212-513-9
823-40-5
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H341
H312
H302
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H312
H302
H317
H411



612-112-00-2
p-anisidine;
4-methoxyaniline
203-254-2
104-94-9
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
H330
H310
H300
H373 **
H400
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 **
H400



612-113-00-8
6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine
403-240-8
106264-79-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



612-114-00-3
R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate
404-390-7
—
Flam. Sol. 1
Skin Sens. 1
Aquatic Chronic 3
H228
H317
H412
GHS02
GHS07
Wng
H228
H317
H412



612-115-00-9
dimethyldioctadecylammonium hydrogen sulfate
404-050-8
123312-54-9
Eye Irrit. 2
Aquatic Chronic 4
H319
H413
GHS07
Wng
H319
H413



612-116-00-4
C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate
404-690-8
68132-19-4
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H314
H317
H410



612-117-00-X
C12-14-tert-alkylamine, methylphosphonic acid salt
404-750-3
119415-07-5
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411



612-118-00-5
A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;
(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide
405-080-4
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



612-119-00-0
benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate
405-330-2
—
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410



612-120-00-6
aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline
277-704-1
74070-46-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



612-121-00-1
amines, polyethylenepoly-;
HEPA
268-626-9
68131-73-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410





612-122-00-7
hydroxylamine … %
[> 55 % in aqueous solution]
232-259-2
7803-49-8
Unst. Expl.
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
GHS01
GHS05
GHS08
GHS07
GHS09
Dgr
H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400


B




612-122-01-4
hydroxylamine …% [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400


B



612-123-00-2
hydroxylammonium chloride;
hydroxylamine hydrochloride; [1]
bis(hydroxylammonium) sulfate;
hydroxylamine sulfate (2:1) [2]
226-798-2 [1]
233-118-8 [2]
5470-11-1 [1]
10039-54-0 [2]
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H290
H351
H312
H302
H373**
H319
H315
H317
H400
GHS05
GHS08
GHS07
GHS09
Wng
H290
H351
H312
H302
H373**
H319
H315
H317
H400




612-124-00-8
N,N,N-trimethylanilinium chloride
205-319-0
138-24-9
Acute Tox. 3 *
Acute Tox. 3 *
H311
H301
GHS06
Dgr
H311
H301



612-125-00-3
2-methyl-p-phenylenediamine;
2,5-toluenediamine
202-442-1
95-70-5
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H301
H332
H312
H317
H411
GHS06
GHS09
Dgr
H301
H332
H312
H317
H411



612-126-00-9
toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate
265-697-8
65321-67-7
Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350
H301
H312
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H301
H312
H319
H317
H411



612-127-00-4
3-aminophenol
209-711-2
591-27-5
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411



612-128-00-X
4-aminophenol
204-616-2
123-30-8
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H332
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H332
H302
H410



612-129-00-5
diisopropylamine
203-558-5
108-18-9
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H225
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H302
H314

STOT SE 3; H335: C ≥ 5 %

612-130-00-0
2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2]
diethylmethylbenzenediamine [3]
218-255-3 [1]
218-256-9 [2]
270-877-4 [3]
2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3]
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H319
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373 **
H319
H410


C
612-131-00-6
didecyldimethylammonium chloride
230-525-2
7173-51-5
Acute Tox. 4 *
Skin Corr. 1B
H302
H314
GHS05
GHS07
Dgr
H302
H314



612-132-00-1
N,N'-diphenyl-p-phenylenediamine;
N,N'-diphenyl-1,4-benzenediamine
200-806-4
74-31-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



612-133-00-7
(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate
247-162-0
25646-77-9
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H410



612-134-00-2
N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate
247-161-5
25646-71-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



612-135-00-8
N-2-naphthylaniline;
N-phenyl-2-naphthylamine
205-223-9
135-88-6
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H351
H319
H315
H317
H411
GHS08
GHS07
GHS09
Wng
H351
H319
H315
H317
H411



612-136-00-3
N-isopropyl-N'-phenyl-p-phenylenediamine
202-969-7
101-72-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410

Skin Sens. 1; H317: C ≥ 0,1 %

612-137-00-9
4-chloroaniline
203-401-0
106-47-8
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H331
H311
H301
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H317
H410



612-138-00-4
furalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate
260-875-1
57646-30-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



612-139-00-X
mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide
277-328-8
73250-68-7
Aquatic Chronic 2
H411
GHS09
H411



612-140-00-5
quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides
264-151-6
63449-41-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H312
H302
H314
H400
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H400



612-141-00-0
4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine)
243-420-1
19900-65-3
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410



612-142-00-6
biphenyl-2-ylamine
201-990-9
90-41-5
Carc. 2
Acute Tox. 4 *
Aquatic Chronic 3
H351
H302
H412
GHS08
GHS07
Wng
H351
H302
H412



612-143-00-1
N5,N5-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride
218-130-3
2051-79-8
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H301
H319
H317
H410



612-144-00-7
flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
—
62924-70-3
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H315
H317
H410



612-145-00-2
o-phenylenediamine
202-430-6
95-54-5
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410



612-146-00-8
o-phenylenediamine dihydrochloride
210-418-7
615-28-1
Carc. 2
Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410



612-147-00-3
m-phenylenediamine
203-584-7
108-45-2
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410



612-148-00-9
m-phenylenediamine dihydrochloride
208-790-0
541-69-5
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410



612-149-00-4
1,3-diphenylguanidine
203-002-1
102-06-7
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H361f ***
H302
H319
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H361f ***
H302
H319
H335
H315
H411



612-150-00-X
spiroxamine (ISO);
8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine
—
118134-30-8
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H315
H317
H410





612-151-00-5
methyl-phenylene diamine;
diaminotoluene;
[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]
—
—
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H361f***
H301
H312
H373**
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f***
H301
H312
H373**
H319
H317
H411





612-152-00-0
N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine
406-610-7
62478-82-4
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3
H226
H332
H302
H373 **
H314
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H332
H302
H373 **
H314
H412



612-153-00-6
4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride
407-020-2
132885-85-9
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412



612-154-00-1
6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]
410-890-6
95235-29-3
Aquatic Chronic 4
H413
—
H413



612-155-00-7
2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene
411-730-8
93071-94-4
Aquatic Chronic 4
H413
—
H413



612-156-00-2
reaction mass of: trihexadecylmethylammonium chloride;
dihexadecyldimethylammonium chloride
405-620-9
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



612-157-00-8
(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride
410-780-8
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 **
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H411



612-158-00-3
reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime
410-820-4
—
Aquatic Chronic 4
H413
—
H413



612-159-00-9
Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid
410-880-1
—
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410



612-160-00-4
p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3]
203-403-1 [1]
208-740-8 [2]
208-741-3 [3]
106-49-0 [1]
540-23-8 [2]
540-25-0 [3]
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H331
H311
H301
H319
H317
H400
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H319
H317
H400



612-161-00-X
2,6-xylidine;
2,6-dimethylaniline
201-758-7
87-62-7
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H351
H332
H312
H302
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H351
H332
H312
H302
H335
H315
H411



612-162-00-5
dimethyldioctadecylammonium chloride;
DODMAC
203-508-2
107-64-2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



612-163-00-0
metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
—
70630-17-0
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318



612-164-00-6
2-butyl-2-ethyl-1,5-diaminopentane
412-700-7
137605-95-9
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H373 **
H314
H317
H412
GHS08
GHS05
GHS07
Dgr
H312
H302
H373 **
H314
H317
H412



612-165-00-1
N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine
413-810-8
65181-78-4
Aquatic Chronic 2
H411
GHS09
H411



612-166-00-7
reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)
411-830-1
114765-88-7
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412



612-167-00-2
5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride
410-490-1
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 **
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H411



612-168-00-8
3,5-dichloro-2,6-difluoropyrdine-4-amine
220-630-1
2840-00-8
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411






612-169-00-3
bis(N-methyl-N-phenylhydrazine)sulfate
423-170-1
618-26-8
Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H372**
H302
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H225
H372**
H302
H318
H317
H410




612-170-00-9
4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime
405-260-2
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



612-171-00-4
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane
410-060-3
130728-76-6
Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS09
Wng
H341
H317
H411



612-172-00-X
4,4'-methylenebis(N,N'-dimethylcyclohexanamine
412-840-9
13474-64-1
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Chronic 3
H302
H373 **
H314
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H314
H412



612-173-00-5
lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate
411-140-0
125328-86-1
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



612-174-00-0
4,4-dimethoxybutylamine
407-690-6
19060-15-2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412



612-175-00-6
2-(O-aminooxy)ethylamine dihydrochloride
412-310-7
37866-45-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



612-176-00-1
polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine
410-570-6
143747-73-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



612-177-00-7
2-naphthylamino-6-sulfomethylamide
412-120-4
104295-55-8
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 **
H317
H411
GHS08
GHS09
Wng
H373 **
H317
H411



612-178-00-2
1,4,7,10-tetraazacyclododecane disulfate
412-080-8
112193-77-8
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
Aquatic Chronic 3
H302
H335
H318
H412
GHS05
GHS07
Dgr
H302
H335
H318
H412



612-179-00-8
1-(2-propenyl)pyridinium chloride
412-740-5
25965-81-5
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



612-180-00-3
3-aminobenzylamine
412-230-2
4403-70-7
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411



612-181-00-9
2-phenylthioaniline
413-030-8
1134-94-7
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



612-182-00-4
1-ethyl-1-methylmorpholinium bromide
418-210-1
65756-41-4
Muta. 2
H341
GHS08
Wng
H341



612-183-00-X
1-ethyl-1-methylpyrrolidinium bromide
418-200-5
69227-51-6
Muta. 2
H341
GHS08
Wng
H341



612-184-00-5
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
403-830-5
89331-94-2
Aquatic Chronic 3
H412
—
H412



612-185-00-0
1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide
407-400-8
59493-72-0
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



612-186-00-6
bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate
406-770-8
149057-64-7
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 **
H318
H317
H410



612-187-00-1
2,3,4-trifluoroaniline
407-170-9
3862-73-5
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H373 **
H315
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H315
H318
H411



612-188-00-7
4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)
407-560-9
107934-68-9
Aquatic Chronic 2
H411
GHS09
H411



612-189-00-2
4-amino-2-(aminomethyl)phenol dihydrochloride
412-510-4
135043-64-0
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



612-190-00-8
4,4'-methylenebis(2-isopropyl-6-methylaniline)
415-150-6
16298-38-7
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411



612-191-00-3
polymer of allylamine hydrochloride
415-050-2
71550-12-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



612-192-00-9
2-isopropyl-4-(N-methyl)aminomethylthiazole
414-800-6
154212-60-9
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H411



612-193-00-4
3-methylaminomethylphenylamine
414-570-7
18759-96-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410



612-194-00-X
2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride
414-670-0
141890-30-4
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410



612-195-00-5
bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate
415-210-1
160236-81-7
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H410



612-196-00-0
4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2]
202-441-6 [1]
221-627-8 [2]
95-69-2 [1]
3165-93-3 [2]
Carc. 1B
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H331
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H410



612-197-00-6
2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2]
205-282-0 [1] - [2]
137-17-7 [1]
21436-97-5 [2]
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H411



612-198-00-1
4,4'-thiodianiline and its salts
205-370-9
139-65-1
Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411



612-199-00-7
4,4'-oxydianiline and its salts;
p-aminophenyl ether
202-977-0
101-80-4
Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2
H350
H340
H361f ***
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H340
H361f ***
H331
H311
H301
H411



612-200-00-0
2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2]
210-406-1 [1]
254-323-9 [2]
615-05-4 [1]
39156-41-7 [2]
Carc. 1B
Muta. 2
Acute Tox. 4 *
Aquatic Chronic 2
H350
H341
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H302
H411



612-201-00-6
N,N,N',N'-tetramethyl-4,4'-methylendianiline
202-959-2
101-61-1
Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410



612-202-00-1
3,4-dichloroaniline
202-448-4
95-76-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H318
H317
H410





612-203-00-7
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %)
417-360-3
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H312
H302
H315
GHS07
Wng
H312
H302
H315




612-204-00-2
C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6
548-62-9
Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H302
H318
H410



612-205-00-8
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5)
208-953-6
548-62-9
Carc. 1B
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H302
H318
H410



612-206-00-3
famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione
—
131807-57-3
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410



612-207-00-9
4-ethoxyaniline;
p-phenetidine
205-855-5
156-43-4
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H341
H332
H312
H302
H319
H317
GHS08
GHS07
Wng
H341
H332
H312
H302
H319
H317





612-208-00-4
N-methylbenzene-1,2-diammonium hydrogen phosphate
424-460-0
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




612-209-00-X
6-methoxy-m-toluidine;
p-cresidine
204-419-1
120-71-8
Carc. 1B
Acute Tox. 4 *
H350
H302
GHS08
GHS07
Dgr
H350
H302



612-210-00-5
5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]
256-960-8 [2]
99-55-8 [1]
51085-52-0 [2]
Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 3
H351
H331
H311
H301
H412
GHS06
GHS08
Dgr
H351
H331
H311
H301
H412



612-211-00-0
N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide
416-470-9
170292-97-4
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



612-212-00-6
2,6-dichloro-4-trifluoromethylaniline
416-430-0
24279-39-8
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H315
H317
H410



612-213-00-1
isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine
419-850-2
148348-13-4
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412



612-214-00-7
4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine
421-390-2
89114-90-9
Aquatic Chronic 4
H413
—
H413



612-215-00-2
3-chloro-2-(isopropylthio)aniline
421-700-6
179104-32-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411





612-216-00-8
1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt
425-870-2
19450-38-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




612-217-00-3
1-methoxy-2-propylamine
422-550-4
37143-54-7
Flam. Liq. 2
Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H225
H314
H302
H412
GHS02
GHS05
GHS07
Dgr
H225
H314
H302
H412





612-219-00-4
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
402-200-7
—
Aquatic Chronic 3
H412
—
H412




612-220-00-X
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine
431-060-1
153719-38-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412




612-221-00-5
2-amino-4-(trifluoromethyl)benzenethiol hydrochloride
429-560-8
4274-38-8
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H314
H332
H312
H302
H373**
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H312
H302
H373**
H317
H400




612-222-00-0
cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine
425-080-8
104860-26-6
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373**
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373**
H318
H410




612-223-00-6
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine
425-300-2
186450-73-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




612-224-00-1
N2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine
426-150-0
121246-28-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




612-225-00-7
1,4,7,10-tetraazacyclododecane
425-450-9
294-90-6
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H312
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H410




612-226-00-2
3-(2'-phenoxyethoxy)propylamine
427-870-8
6903-18-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H315
H318
H412
GHS05
GHS07
Dgr
H302
H315
H318
H412




612-227-00-8
benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride
428-290-8
120606-08-8
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410




612-228-00-3
reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine
414-340-6
—
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H332
H312
H302
H371
H318
H317
H412
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H332
H312
H302
H371
H318
H317
H412




612-229-00-9
mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
—
110235-47-7
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410




612-230-00-4
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide
431-530-4
—
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410




612-231-00-X
3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride
427-370-1
164288-56-6
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




612-232-00-5
reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid
430-410-9
186148-38-9
Aquatic Chronic 3
H412
—
H412




612-237-00-2
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H312
H302
H373**
H319
H315
H317
H400
HS01
GHS08
GHS07
GHS09
Dgr
H201
H351
H312
H302
H373**
H319
H315
H317
H400


T

612-238-00-8
(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%
222-048-3
3327-22-8
Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412


B

612-239-00-3
biphenyl-3,3', 4,4'-tetrayltetraamine;
diaminobenzidine
202-110-6
91-95-2
Carc. 1B
Muta. 2
H350
H341
GHS08
Dgr
H350
H341




612-240-00-9
pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline
—
53112-28-0
Aquatic Chronic 2
H411
GHS09
H411




612-241-00-4
piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H361fd
H319
H315
H334
H317
H412
GHS08
Dgr
H361fd
H319
H315
H334
H317
H412




612-242-00-X
cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
—
121552-61-2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M=10


612-243-00-5
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
420-560-3
79617-97-3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410

M=10


612-244-00-0
3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride
421-310-6
87691-88-1
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f***
H302
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f***
H302
H319
H317
H410




612-245-00-6
2-ethylphenylhydrazine hydrochloride
421-460-2
19398-06-2
Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H372**
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H372**
H302
H318
H317
H410

M=10


612-246-00-1
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride
429-740-6
40722-80-3
Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H350
H340
H373**
H317
H412
GHS08
GHS07
Dgr
H350
H340
H373**
H317
H412




612-247-00-7
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3
H372**
H302
H412
GHS08
GHS07
Dgr
H372**
H302
H412




612-248-00-2
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)
439-540-0
—
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413




612-249-00-8
4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
425-030-5
159939-85-2
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H361f***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H361f***
H302
H314
H317
H411




612-250-00-3
chloro-N,N-dimethylformiminium chloride
425-970-6
3724-43-4
Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A
H360D***
H302
H314
GHS05
GHS08
GHS07
Dgr
H360D***
H302
H314
EUH014



612-251-00-9
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H228
H361d***
H302
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Wng
H228
H361d***
H302
H315
H317
H411




612-252-00-4
imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
428-040-8
138261-41-3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410




612-253-00-X
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Aquatic Chronic 3
H412
—
H412




612-253-01-7
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Repr. 1B
Aquatic Chronic 3
H360D***
H412
GHS08
Dgr
H360D***
H412




612-254-00-5
reaction products of diisopropanolamine with formaldehyde (1:4)
432-440-8
220444-73-5
Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H302
H314
H317
H411




612-255-00-0
1-(3-methoxypropyl)-4-piperidinamine
431-950-8
179474-79-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H312
H302
H314
H412
GHS05
GHS07
Dgr
H312
H302
H314
H412




612-256-00-6
benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate
427-470-3
137864-22-3
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317




612-257-00-1
tripropylammonium dihydrogenphosphate
433-700-3
35687-90-2
Acute Tox. 4 *
H302
GHS07
Wng
H302




612-259-00-2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Eye Dam. 1
H318
GHS05
Dgr
H318




612-261-00-3
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline
441-190-9
121451-05-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410

M=10


612-265-00-5
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate
444-360-0
191617-13-7
Aquatic Chronic 3
H412
—
H412




612-266-00-0
3-chloro-4-(3-fluorobenzyloxy)aniline
445-590-4
202197-26-0
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H373**
H410




612-267-00-6
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine
418-370-0
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




612-269-00-7
reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline
420-720-2
—
Aquatic Chronic 4
H413
—
H413




612-270-00-2
(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride
433-010-2
—
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412




612-271-00-8
reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate
434-970-5
160987-57-5
Aquatic Chronic 4
H413
—
H413




612-272-00-3
ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate
435-210-5
—
Aquatic Chronic 2
H411
GHS09
H411




612-273-00-9
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride
435-650-8
—
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410




612-274-00-4
(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate
445-750-3
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412




612-275-00-X
fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil
447-880-6
206565-89-1
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410

M=10


612-276-00-5
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts
451-430-4
500717-36-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




612-277-00-0
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium
451-440-9
586372-44-3
Eye Dam. 1
H318
GHS05
Dgr
H318




612-278-00-6
ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
214-984-6
1239-45-8
Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *
H341
H330
H302
GHS06
GHS08
Dgr
H341
H330
H302




612-279-00-1
(R, S)-2-amino-3,3-dimethylbutane amide
447-860-7
144177-62-8
Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H361f***
H373**
H319
H315
H317
GHS08
GHS07
Wng
H361f***
H373**
H319
H315
H317




612-280-00-7
3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
205-057-7
132-32-1
Carc. 1B
H350
GHS08
Dgr
H350


H

613-001-00-1
ethyleneimine;
aziridine
205-793-9
151-56-4
Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H340
H330
H310
H300
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H340
H330
H310
H300
H314
H411


D
613-002-00-7
pyridine
203-809-9
110-86-1
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302

*



613-003-00-2
1,2,3,4-tetranitrocarbazole
—
6202-15-9
Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Dgr
H201
H332
H312
H302




613-004-00-8
crimidine (ISO);
2-chloro-6-methylpyrimidin-4-yldimethylamine
208-622-6
535-89-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300



613-007-00-4
desmetryne (ISO);
6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine
213-800-1
1014-69-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



613-008-00-X
dazomet (ISO);
tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione
208-576-7
533-74-4
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410



613-009-00-5
2,4,6-trichloro-1,3,5-triazine;
cyanuric chloride
203-614-9
108-77-0
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H330
H302
H314
H317
GHS06
GHS05
Dgr
H330
H302
H314
H317
EUH014
STOT SE 3; H335: C ≥ 5 %



613-010-00-0
ametryn (ISO);
2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine
212-634-7
834-12-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=100


613-011-00-6
amitrole (ISO);
1,2,4-triazol-3-ylamine
200-521-5
61-82-5
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361d ***
H373 **
H411
GHS08
GHS09
Wng
H361d ***
H373 **
H411



613-012-00-1
bentazone (ISO);
3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide
246-585-8
25057-89-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412



613-013-00-7
cyanazine (ISO);
2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile
244-544-9
21725-46-2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-014-00-2
ethoxyquin(ISO);
6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
202-075-7
91-53-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-015-00-8
fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate
238-134-9
14255-88-0
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



613-016-00-3
fuberidazole(ISO);
2-(2-furyl)benzimidazole
223-404-0
3878-19-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-017-00-9
bis (8-hydroxyquinolinium) sulphate
205-137-1
134-31-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-018-00-4
morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion
—
7411-47-4
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412



613-019-00-X
thioquinox(ISO);
2-thio-1,3-dithiolo(4,5,b)quinoxaline
202-272-8
93-75-4
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-020-00-5
tridemorph (ISO);
2,6-dimethyl-4-tridecylmorpholine
246-347-3
24602-86-6
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360D ***
H332
H302
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D ***
H332
H302
H315
H410



613-021-00-0
dithianon (ISO);
5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile
222-098-6
3347-22-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-022-00-6
pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410


A
613-023-00-1
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;
pyrethrin I
204-455-8
121-21-1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410



613-024-00-7
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
pyrethrin II
204-462-6
121-29-9
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410



613-025-00-2
cinerin I;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-0
25402-06-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-026-00-8
cinerin II;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate
204-454-2
121-20-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-027-00-3
piperidine
203-813-0
110-89-4
Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
H225
H331
H311
H314
GHS02
GHS06
GHS05
Dgr
H225
H331
H311
H314

*

613-028-00-9
morpholine
203-815-1
110-91-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dg
H226
H332
H312
H302
H314



613-029-00-4
dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid
220-487-5
2782-57-2
Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031

T


613-030-00-X
troclosene potassium; [1]
troclosene sodium [2]
218-828-8 [1]
220-767-7 [2]
2244-21-5 [1]
2893-78-9 [2]
Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031
*
STOT SE 3; H335: C ≥ 10 %
EUH031: C ≥ 10 %
G

613-030-01-7
troclosene sodium, dihydrate
220-767-7
51580-86-0
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H410
EUH031


613-031-00-5
symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion
201-782-8
87-90-1
Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031


613-032-00-0
methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-5
13108-52-6
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H312
H302
H319
H317
GHS07
Wng
H312
H302
H319
H317



613-033-00-6
2-methylaziridine;
propyleneimine
200-878-7
75-55-8
Flam. Liq. 2
Carc. 1B
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Eye Dam. 1
Aquatic Chronic 2
H225
H350
H330
H310
H300
H318
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H330
H310
H300
H318
H411

Carc. 1B; H350: C ≥ 0,01 %

613-034-00-1
1,2-dimethylimidazole
217-101-2
1739-84-0
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Dgr
H302
H315
H318



613-035-00-7
1-methylimidazole
210-484-7
616-47-7
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314



613-036-00-2
2-methylpyridine;
2-picoline
203-643-7
109-06-8
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H226
H332
H312
H302
H319
H335
GHS02
GHS07
Wng
H226
H332
H312
H302
H319
H335



613-037-00-8
4-methylpyridine;
4-picoline
203-626-4
108-89-4
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H226
H311
H332
H302
H319
H335
H315
GHS02
GHS06
Dgr
H226
H311
H332
H302
H319
H335
H315



613-038-00-3
6-phenyl-1,3,5-triazine-2,4-diyldiamine;
6-phenyl-1,3,5-triazine-2,4-diamine;
benzoguanamine
202-095-6
91-76-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



613-039-00-9
ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol
202-506-9
96-45-7
Repr. 1B
Acute Tox. 4 *
H360D ***
H302
GHS08
GHS07
Dgr
H360D ***
H302



613-040-00-4
azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole
262-102-3
60207-31-0
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-041-00-X
morpholine-4-carbonyl chloride
239-213-0
15159-40-7
Carc. 2
Eye Irrit. 2
Skin Irrit. 2
H351
H319
H315
GHS08
Wng
H351
H319
H315
EUH014


613-042-00-5
imazalil (ISO);
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
252-615-0
35554-44-0
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H410



613-043-00-0
imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



613-043-01-8
imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Wng
H302
H314
H317
H410

Skin Corr. 1B; H314: C ≥ 50 %
Skin Irrit. 2; H315: 30 % ≤ C < 50 %
Eye Dam. 1; H318: 15 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %



613-044-00-6
captan (ISO);
1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
205-087-0
133-06-2
Carc. 2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H331
H318
H317
H400
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H331
H318
H317
H400

M=10


613-045-00-1
folpet (ISO);
N-(trichloromethylthio)phthalimide
205-088-6
133-07-3
Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H332
H319
H317
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H319
H317
H400

M=10



613-046-00-7
captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide
219-363-3
2425-06-1
Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H317
H400
H410
GHS08
GHS09
Dgr
H350
H317
H410



613-047-00-2
1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;
dimetilan (ISO)
211-420-0
644-64-4
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410



613-048-00-8
carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate
234-232-0
10605-21-7
Muta. 1B
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD
H400
H410
GHS08
GHS09
Dgr
H340
H360FD
H410



613-049-00-3
benomyl (ISO);
methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate
241-775-7
17804-35-2
Muta. 1B
Repr. 1B
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H340
H360FD
H335
H315
H317
H410

M = 10

613-050-00-9
carbadox (INN);
methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;
2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide
229-879-0
6804-07-5
Flam. Sol. 1
Carc. 1B
Acute Tox. 4 *
H228
H350
H302
GHS02
GHS08
GHS07
Dgr
H228
H350
H302


T
613-051-00-4
molinate (ISO);
S-ethyl 1-perhydroazepinecarbothioate;
S-ethyl perhydroazepine-1-carbothioate
218-661-0
2212-67-1
Carc. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361f ***
H332
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361f ***
H332
H302
H373 **
H317
H410

M = 100

613-052-00-X
trifenmorph (ISO);
4-tritylmorpholine
215-812-2
1420-06-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-053-00-5
anilazine (ISO);
2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline
202-910-5
101-05-3
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410



613-054-00-0
thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole
205-725-8
148-79-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-056-00-1
1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;
difenzoquat methyl sulfate
256-152-5
43222-48-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS09
Wng
H302
H410



613-057-00-7
dodemorph (ISO);
4-cyclododecyl-2,6-dimethylmorpholine
216-474-9
1593-77-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H319
H335
H315
H411
GHS07
GHS09
Wng
H319
H335
H315
H411



613-058-00-2
permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
258-067-9
52645-53-1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H317
H410

M = 1000

613-059-00-8
profluralin (ISO);
N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
247-656-6
26399-36-0
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410





613-060-00-3
resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
233-940-7
10453-86-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=1000


613-061-00-9
6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;
ryania
239-732-2
15662-33-6
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



613-062-00-4
sabadilla (ISO);
veratrine
—
8051-02-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315



613-063-00-X
secbumeton (ISO);
2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
247-554-1
26259-45-0
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410



613-064-00-5
5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;
sesamex
—
51-14-9
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-065-00-0
simetryn (ISO);
2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine
213-801-7
1014-70-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-066-00-6
terbumeton (ISO);
2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
251-637-8
33693-04-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-067-00-1
propazine(ISO);
2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine
205-359-9
139-40-2
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



613-068-00-7
atrazine (ISO);
2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine
217-617-8
1912-24-9
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H317
H400
H410
GHS08
GHS09
Wng
H373 **
H317
H410



613-069-00-2
ε-caprolactam
203-313-2
105-60-2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H332
H302
H319
H335
H315
GHS07
Wng
H332
H302
H319
H335
H315



613-070-00-8
propylenethiourea
—
2122-19-2
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 3
H361d ***
H302
H412
GHS08
GHS07
Wng
H361d ***
H302
H412



613-071-00-3
2-fluoro-5-trifluoromethylpyridine
400-290-2
69045-82-5
Flam. Liq. 3
Skin Sens. 1
Aquatic Chronic 3
H226
H317
H412
GHS02
GHS07
Wng
H226
H317
H412



613-072-00-9
N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine
401-280-0
91273-04-0
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411



613-073-00-4
N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine
401-410-6
10357-99-0
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H373 **
H317
H411
GHS08
GHS09
Wng
H373 **
H317
H411



613-074-00-X
3-(3-methylpent-3-yl)isoxazol-5-ylamine
401-460-9
82560-06-3
Acute Tox. 3 *
Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 3
H331
H301
H318
H412
GHS06
GHS05
Dgr
H331
H301
H318
H412



613-075-00-5
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione
401-570-7
89415-87-2
Ox. Sol. 1 ****
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H271
H331
H314
H302
H317
H400
GHS03
GHS06
GHS05
GHS09
Dgr
H271
H331
H314
H302
H317
H400



613-076-00-0
3-chloro-5-trifluoromethyl-2-pyridylamine
401-670-0
79456-26-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



613-077-00-6
reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine
401-940-8
—
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H302
H319
H411
GHS07
GHS09
Wng
H302
H319
H411



613-078-00-1
N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine
401-990-0
106990-43-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



613-079-00-7
4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers
402-520-7
—
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H312
H302
H315
H317
H410



613-080-00-2
3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione
402-540-6
105254-85-1
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410



613-081-00-8
1-butyl-2-methylpyridinium bromide
402-680-8
26576-84-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



613-082-00-3
2-methyl-1-pentylpyridinium bromide
402-690-2
—
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H312
H302
H412
GHS07
Wng
H312
H302
H412



613-083-00-9
2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate
402-120-2
—
Skin Corr. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H373 **
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H314
H373 **
H317
H410



613-084-00-4
2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate
402-490-5
106359-93-7
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410



613-085-00-X
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione
401-970-1
—
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



613-086-00-5
caffeine
200-362-1
58-08-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-087-00-0
tetrahydrothiophene
203-728-9
110-01-0
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H225
H332
H312
H302
H319
H315
H412
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H315
H412



613-088-00-6
1,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one
220-120-9
2634-33-5
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H302
H315
H318
H317
H400
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H317
H400

Skin Sens. 1; H317: C ≥ 0,05 %

613-089-00-1
diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]
201-579-4 [1]
223-714-6 [2]
301-467-6 [3]
85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3]
Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H372 **
H302
H319
H335
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H372 **
H302
H319
H335
H315
H317
H410



613-090-00-7
paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]
218-196-3 [2]
1910-42-5 [1]
2074-50-2 [2]
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H372 **
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H311
H301
H372 **
H319
H335
H315
H410



613-091-00-2
morfamquat dichloride; [1]
morfamquat sulfate [2]
225-062-8 [1]
[2]
4636-83-3 [1]
29873-36-7 [2]
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412



613-092-00-8
1,10-phenanthroline
200-629-2
66-71-7
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



613-093-00-3
hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
400-050-7
85153-92-0
Resp. Sens. 1
Skin Sens. 1
H334
H317
GHS08
Dgr
H334
H317



613-094-00-9
4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine
401-360-5
5248-39-5
Acute Tox. 4 *
STOT RE 2 *
H302
H373 **
GHS08
GHS07
Wng
H302
H373 **



613-095-00-4
sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate
403-080-9
92484-48-5
Eye Dam. 1
H318
GHS05
Dgr
H318



613-096-00-X
2-amino-6-ethoxy-4-methylamino-1,3,5-triazine
403-580-7
62096-63-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-097-00-5
7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
403-690-5
111298-82-9
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H334
H317
H412
GHS08
Dgr
H334
H317
H412



613-098-00-0
N-(n-octyl)-2-pyrrolidone
403-700-8
2687-94-7
Skin Corr. 1B
Aquatic Chronic 2
H314
H411
GHS05
GHS09
Dgr
H314
H411



613-099-00-6
1-dodecyl-2-pyrrolidone
403-730-1
2687-96-9
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410



613-100-00-X
2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione
404-230-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



613-101-00-5
N—tert-pentyl-2-benzothiazolesulfenamide
404-380-2
110799-28-5
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



613-102-00-0
dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine
404-200-2
110488-70-5
Aquatic Chronic 2
H411
GHS09
H411



613-103-00-6
sodium 5-n-butylbenzotriazole
404-450-2
118685-34-0
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H411



613-104-00-1
5-tert-butyl-3-isoxazolylamine hydrochloride
404-840-2
—
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 3
H302
H373 **
H318
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H318
H412



613-105-00-7
hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)
405-160-9
124537-30-0
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412



613-106-00-2
tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate
405-240-3
—
Skin Sens. 1
H317
GHS07
Wng
H317



613-107-00-8
hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate
405-280-1
76508-02-6
Eye Irrit. 2
H319
GHS07
Wng
H319



613-108-00-3
benzothiazole-2-thiol
205-736-8
149-30-4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



613-109-00-9
bis(piperidinothiocarbonyl) disulphide
202-328-1
94-37-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H319
H335
H315
H317
GHS07
Wng
H319
H335
H315
H317



613-110-00-4
dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-2
61432-55-1
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



613-111-00-X
1,2,4-triazole
206-022-9
288-88-0
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
H361d ***
H302
H319
GHS08
GHS07
Wng
H361d ***
H302
H319



613-112-00-5
octhilinone (ISO);
2-octyl-2H-isothiazol-3-one
247-761-7
26530-20-1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H302
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H302
H314
H317
H410

Skin Sens. 1; H317: C ≥ 0,05 %

613-113-00-0
2-(morpholinothio)benzothiazole
203-052-4
102-77-2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H315
H317
H411
GHS07
GHS09
Wng
H319
H315
H317
H411



613-114-00-6
2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;
1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine
225-208-0
4719-04-4
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317

Skin Sens. 1; H317: C ≥ 0,1 %

613-115-00-1
hymexazol (ISO);
3-hydroxy-5-methylisoxazole
233-000-6
10004-44-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412





613-116-00-7
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Acute Tox. 2 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H330
H372**
H319
H335
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H330
H372**
H319
H335
H315
H317
H400

M=10




613-116-01-4
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H319
H335
H315
H317
H400
GHS07
GHS09
Wng
H319
H335
H315
H317
H400

M=10


613-117-00-2
diniconazole (ISO);
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol
—
76714-88-0
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-118-00-8
flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline
253-703-1
37893-02-0
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410



613-119-00-3
(benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB
244-445-0
21564-17-0
Acute Tox. 2 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H319
H315
H317
H400
H410
GHS06
GHS09
Dgr
H330
H302
H319
H315
H317
H410





613-120-00-9
bioresmethrin (ISO);
(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate
249-014-0
28434-01-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=1000


613-121-00-4
chlorsulfuron (ISO);
2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide
265-268-5
64902-72-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-122-00-X
diclobutrazole (ISO);
(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol
—
75736-33-3
Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411



613-123-00-5
5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;
etem
251-684-4
33813-20-6
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-124-00-0
fenpropimorph (ISO);
cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
266-719-9
67564-91-4
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2
H361d ***
H302
H315
H411
GHS08
GHS07
GHS09
Wng
H361d ***
H302
H315
H411



613-125-00-6
hexythiazox(ISO);
trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide
—
78587-05-0
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-126-00-1
imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate
—
81334-34-1
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412



613-127-00-7
1,1-dimethylpiperidinium chloride;
mepiquat chloride
246-147-6
24307-26-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



613-128-00-2
prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide
266-994-5
67747-09-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-129-00-8
metamitron (ISO);
4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-3
41394-05-2
Acute Tox. 4 *
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400



613-131-00-9
pyroquilon (ISO);
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one
—
57369-32-1
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



613-132-00-4
hexazinone (ISO);
3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione
257-074-4
51235-04-2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410



613-133-00-X
etridiazole (ISO);
5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole
219-991-8
2593-15-9
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H331
H312
H302
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H331
H312
H302
H410



613-134-00-5
myclobutanil(ISO);
2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile
—
88671-89-0
Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H361d ***
H302
H319
H411
GHS08
GHS07
GHS09
Wng
H361d ***
H302
H319
H411



613-135-00-0
di(benzothiazol-2-yl) disulphide
204-424-9
120-78-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
EUH031


613-136-00-6
N-cyclohexylbenzothiazole-2-sulphenamide
202-411-2
95-33-0
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



613-137-00-1
methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-dimethylurea
242-505-0
18691-97-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-138-00-7
quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline
—
124495-18-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410





613-139-00-2
metsulfuron-methyl (ISO);
2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid
—
74223-64-6
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=1000


613-140-00-8
cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione
200-636-0
66-81-9
Muta. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Chronic 2
H341
H360D ***
H300
H411
GHS06
GHS08
GHS09
Dgr
H341
H360D ***
H300
H411



613-141-00-3
1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone
401-470-3
93686-63-6
Aquatic Chronic 4
H413
—
H413



613-142-00-9
trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate
405-860-4
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



613-143-00-4
1-(3-phenylpropyl)-2-methylpyridinium bromide
405-930-4
10551-42-5
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3
H302
H319
H412
GHS07
Wng
H302
H319
H412



613-144-00-X
reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate
406-460-2
125139-08-4
Aquatic Chronic 3
H412
—
H412



613-145-00-5
(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate
406-960-0
77497-97-3
Aquatic Chronic 2
H411
GHS09
H411



613-146-00-0
N-ethyl-N-methylpiperidinium iodide
407-780-5
4186-71-4
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



613-147-00-6
4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine
407-940-4
111681-72-2
Eye Dam. 1
H318
GHS05
Dgr
H318



613-148-00-1
tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane
411-240-4
143683-23-2
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



613-149-00-7
pyridaben (ISO);
2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one
405-700-3
96489-71-3
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H400
H410
GHS06
GHS09
Dgr
H331
H301
H410



613-150-00-2
2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione
406-295-6
—
Aquatic Chronic 4
H413
—
H413



613-151-00-8
1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine
406-360-9
104218-44-2
Aquatic Chronic 4
H413
—
H413



613-152-00-3
phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate
406-600-2
89392-03-0
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



613-153-00-9
2,3,5-trichloropyridine
407-270-2
16063-70-0
Aquatic Chronic 3
H412
—
H412



613-154-00-4
2-amino-4-chloro-6-methoxypyrimidine
410-050-9
5734-64-5
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-155-00-X
5-chloro-2,3-difluoropyridine
410-090-7
89402-43-7
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 3
H226
H302
H412
GHS02
GHS07
Wng
H226
H302
H412



613-156-00-5
2-butyl-4-chloro-5-formylimidazole
410-260-0
83857-96-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



613-157-00-0
2,4-diamino-5-methoxymethylpyrimidine
410-330-0
54236-98-5
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
H302
H373 **
H319
GHS08
GHS07
Wng
H302
H373 **
H319



613-158-00-6
2,3-dichloro-5-trifluoromethyl-pyridine
410-340-5
69045-84-7
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H332
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H317
H411



613-159-00-1
fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline
410-580-0
120928-09-8
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H332
H400
H410
GHS06
GHS09
Dgr
H301
H332
H410



613-160-00-7
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide
411-000-9
125224-62-6
Skin Sens. 1
H317
GHS07
Wng
H317





613-161-00-2
2,4-diamino-6-hydroxymethylpteridinehydrobromide
430-620-0
76145-91-0
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412




613-162-00-8
(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide
423-260-0
100988-63-4
Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS07
GHS09
Wng
H341
H317
H411






613-163-00-3
azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea
—
120162-55-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=1000


613-164-00-9
flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide
—
142459-58-3
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410

M=100


613-165-00-4
flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt
—
144740-54-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=100


613-166-00-X
flumioxazin (ISO);
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
—
103361-09-7
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H400
H410
GHS08
GHS09
Dgr
H360D***
H410

M=1000


613-167-00-5
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)
—
55965-84-9
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H410

Skin Corr. 1B; H314: C ≥ 0,6 %
Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %
Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %
Skin Sens. 1; H317: C ≥ 0,0015 %

613-168-00-0
1-vinyl-2-pyrrolidone
201-800-4
88-12-0
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
H351
H332
H312
H302
H373 **
H335
H318
GHS06
GHS05
GHS09
Dgr
H351
H332
H312
H302
H373 **
H335
H318


D



613-169-00-6
9-vinylcarbazole
216-055-0
1484-13-5
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H312
H302
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H312
H302
H315
H317
H410

M=100


613-170-00-1
2,2-ethylmethylthiazolidine
404-500-3
694-64-4
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



613-171-00-7
hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol
413-050-7
79983-71-4
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411



613-172-00-2
5-chloro-1,3-dihydro-2H-indol-2-one
412-200-9
17630-75-0
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f ***
H302
H317
H412
GHS08
GHS07
Wng
H361f ***
H302
H317
H412



613-173-00-8
fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one
411-960-9
136426-54-5
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H372 **
H312
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H301
H372 **
H312
H315
H410






613-174-00-3
tetraconazole (ISO);
(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether
407-760-6
112281-77-3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2
H332
H302
H411
GHS07
GHS09
Wng
H332
H302
H411




613-175-00-9
epoxiconazole(ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2
133855-98-8
Carc. 2
Repr. 2
Aquatic Chronic 2
H351
H361fd
H411
GHS08
GHS09
Wng
H351
H361fd
H411



613-176-00-4
2-methyl-2-azabicyclo[2.2.1]heptane
404-810-9
4524-95-2
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
H226
H312
H302
H373 **
H314
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H373 **
H314



613-177-00-X
8-amino-7-methylquinoline
412-760-4
5470-82-6
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H317
H411
GHS07
GHS09
Wng
H312
H302
H317
H411



613-178-00-5
4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine
410-470-2
137796-06-6
Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317

STOT SE 3; H335: C ≥ 5 %

613-179-00-0
lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide
411-690-1
111337-53-2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H302
H314
H317
H411
GHS05
GHS07
Dgr
H302
H314
H317
H411



613-180-00-6
N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide
407-430-1
3741-80-8
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-181-00-1
5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone
405-090-9
67485-29-4
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H372 **
H302
H319
H400
H410
GHS08
GHS07
GHS09
Dgr
H372 **
H302
H319
H410



613-182-00-7
1-(1-naphthylmethyl)quinolinium chloride
406-220-7
65322-65-8
Carc. 2
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H351
H341
H302
H315
H318
H412
GHS08
GHS05
GHS07
Dgr
H351
H341
H302
H315
H318
H412



613-183-00-2
reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;
5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one
413-640-4
—
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410



613-184-00-8
nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate
413-670-8
—
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317



613-185-00-3
2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one
407-630-9
82633-79-2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H301
H318
H317
H410



613-186-00-9
(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate
408-050-9
76855-69-1
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411





613-187-00-4
5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene
410-530-8
—
Skin Sens. 1
H317
GHS07
Wng
H317




613-188-00-X
1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone
411-500-7
116256-11-2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



613-189-00-5
1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane
414-030-0
52667-88-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



613-190-00-0
disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate
414-040-5
149530-93-8
Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317



613-191-00-6
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine
421-150-7
143860-04-2
Repr. 1B
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360F ***
H314
H400
H410
GHS08
GHS05
GHS09
Dgr
H360F ***
H314
H410





613-192-00-1
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane
426-750-2
151860-15-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




613-193-00-7
pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate
414-930-3
—
Aquatic Chronic 2
H411
GHS09
H411



613-194-00-2
6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt
418-000-8
163062-28-0
Eye Dam. 1
H318
GHS05
Dgr
H318



613-195-00-8
2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)
418-280-1
18600-59-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



613-196-00-3
5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt
418-380-5
168113-78-8
Eye Dam. 1
H318
GHS05
Dgr
H318



613-197-00-9
reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine
420-390-1
187547-46-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





613-198-00-4
2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine
415-500-8
145963-84-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412




613-199-00-X
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;
reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione
421-550-1
—
Carc. 1B
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3
H350
H360D ***
H317
H412
GHS08
Dgr
H350
H360D ***
H317
H412



613-200-00-3
Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts
420-980-7
—
Eye Dam. 1
H318
GHS05
Dgr
H318



613-201-00-9
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole
422-390-5
143322-57-0
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f ***
H372 **
H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H361f ***
H372 **
H332
H302
H317
H410
EUH070


613-202-00-4
pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one
—
123312-89-0
Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412





613-203-00-X
pyraflufen-ethyl (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]
pyraflufen (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]
- [1]
- [2]
129630-19-9 [1]
129630-17-7 [2]
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=1000


613-204-00-5
oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;
5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one
254-637-6
39807-15-3
Repr. 1A
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360Fd
H373**
H400
H410
GHS08
GHS09
Dgr
H360Fd
H373**
H410

M=1000


613-205-00-0
propiconazole(ISO);
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole
262-104-4
60207-90-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



613-206-00-6
fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one
—
161326-34-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-208-00-7
imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
—
114311-32-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-209-00-2
cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride
417-430-3
63645-17-0
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2
H301
H373 **
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H317
H411



613-210-00-8
2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane
417-650-1
88128-57-8
STOT RE 2 *
Aquatic Chronic 3
H373 **
H412
GHS08
Wng
H373 **
H412



613-211-00-3
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate
418-240-3
74401-04-0
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



613-212-00-9
4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)
418-320-8
133467-41-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



613-213-00-4
cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline
416-040-0
120807-02-5
Aquatic Chronic 3
H412
—
H412



613-214-00-X
N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide
416-260-7
147613-95-4
Aquatic Chronic 4
H413
—
H413



613-215-00-5
2-chloromethyl-3,4-dimethoxypyridinium chloride
416-440-5
72830-09-2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373 **
H315
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 **
H315
H318
H317
H411



613-216-00-0
6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole
416-490-8
162208-01-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



613-217-00-6
4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine
416-770-1
73754-27-5
Aquatic Chronic 4
H413
—
H413



613-218-00-1
6-hydroxyindole
417-020-4
2380-86-1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411



613-219-00-7
7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole
417-140-7
79185-77-6
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



613-220-00-2
trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide
417-290-3
147086-81-5
Acute Tox. 4 *
H302
GHS07
Wng
H302



613-221-00-8
2-chloro-5-methyl-pyridine
418-050-0
18368-64-4
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 3
H312
H302
H315
H412
GHS07
Wng
H312
H302
H315
H412



613-222-00-3
4-(1-oxo-2-propenyl)-morpholine
418-140-1
5117-12-4
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373 **
H318
H317
GHS08
GHS05
GHS07
Dgr
H302
H373 **
H318
H317



613-223-00-9
N-isopropyl-3-(4-fluorophenyl)-1H-indole
418-790-4
93957-49-4
Aquatic Chronic 4
H413
—
H413



613-224-00-4
2,5-dimercaptomethyl-1,4-dithiane
419-770-8
136122-15-1
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410



613-225-00-X
reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.
421-290-9
—
STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413



613-226-00-5
1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride
420-950-3
163831-67-2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410



613-227-00-0
(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-600-2
99199-90-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



613-228-00-6
(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-630-6
793669-26-8
Aquatic Chronic 2
H411
GHS09
H411





613-229-00-1
1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine
411-930-5
106917-31-1
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410




613-230-00-7
florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide
—
145701-23-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410






613-231-00-2
2,6-diamino-3-((pyridine-3-yl)azo)pyridine
421-430-9
28365-08-4
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373**
H411
GHS08
GHS07
GHS09
Wng
H302
H373**
H411




613-232-00-8
3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide
431-030-6
163269-30-5
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H373**
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H331
H373**
H318
H410




613-233-00-3
4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane
423-230-7
56552-15-9
Eye Dam. 1
H318
GHS05
Dgr
H318





613-234-00-9
imidazo[1,2-b]pyridazin hydrochloride
431-510-5
18087-70-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319




613-235-00-4
2,3-dihydro-2,2-dimethyl-1H-perimidine
424-060-6
6364-17-6
Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H317
H410




613-236-00-X
2-chloro-3-trifluoromethylpyridine
424-520-6
65753-47-1
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H372**
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H372**
H314
H412




613-237-00-5
6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine
424-950-4
133949-92-5
Aquatic Chronic 4
H413
—
H413




613-238-00-0
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate
430-890-1
81992-66-7
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410




613-239-00-6
2-[3-(methylamino)propyl]-1H-benzimidazole
425-760-4
64137-52-6
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412




613-241-00-7
3-(2H-tetrazol-5-yl)pyridine
426-810-8
3250-74-6
Eye Dam. 1
H318
GHS05
Dgr
H318




613-242-00-2
reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts
426-860-0
191877-09-5
Eye Dam. 1
H318
GHS05
Dgr
H318




613-243-00-8
4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)
427-350-0
182235-14-9
Aquatic Chronic 2
H411
GHS09
H411




613-244-00-3
5,7-dichloro-4-hydroxyquinoline
427-420-0
21873-52-9
Aquatic Chronic 2
H411
GHS09
H411




613-245-00-9
2-fluoro-6-trifluoromethylpyridine
428-100-3
94239-04-0
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H226
H332
H302
H412
GHS02
GHS07
Wng
H226
H332
H302
H412




613-246-00-4
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
428-200-7
103577-66-8
Aquatic Chronic 3
H412
—
H412




613-247-00-X
3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole
428-910-7
107786-36-7
Aquatic Chronic 4
H413
—
H413




613-248-00-5
3,4-dimethyl-1H-pyrazole
429-130-1
2820-37-3
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




613-249-00-0
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
429-300-3
155601-30-2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411




613-250-00-6
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine
429-990-6
—
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412




613-251-00-1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole
430-560-5
180637-89-2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317




613-253-00-2
2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)
430-580-4
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
EUH019



613-254-00-8
forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea
—
68157-60-8
Carc. 2
Aquatic Chronic 2
H351
H411
GHS08
GHS09
Wng
H351
H411




613-255-00-3
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)
424-270-8
—
Eye Dam. 1
H318
GHS05
Dgr
H318




613-256-00-9
3'5'-anhydro thymidine
425-810-5
38313-48-3
Aquatic Chronic 3
H412
—
H412




613-257-00-4
2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate
426-400-9
170222-39-6
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




613-258-00-X
reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt
427-730-6
202420-04-0
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412




613-259-00-5
reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate
428-790-6
72963-72-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410




613-260-00-0
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin
430-730-9
—
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410




613-261-00-6
pyrazole-1-carboxamidine monohydrochloride
429-520-1
4023-02-3
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H373**
H318
H317
H412
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
H412




613-262-00-1
disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene
427-310-2
180850-95-7
Eye Dam. 1
H318
GHS05
Dgr
H318




613-263-00-7
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate
429-570-2
—
Skin Sens. 1
H317
GHS07
Wng
H317




613-266-00-3
2-chloro-5-chloromethylthiazole
429-830-5
105827-91-6
Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H311
H314
H302
H317
H411
GHS06
GHS05
GHS09
Dgr
H311
H314
H302
H317
H411




613-267-00-9
thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
428-650-4
153719-23-4
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=10


613-268-00-4
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine
425-930-8
151213-39-7
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H314
H332
H302
H373**
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H302
H373**
H411




613-269-00-X
2-thiazolidinylidenecyanamide
427-720-1
26364-65-8
Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412




613-270-00-5
5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide
428-150-6
113171-13-4
Aquatic Chronic 3
H412
—
H412




613-271-00-0
tritosulfuron (ISO) (containing ≤ 0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)
—
142469-14-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M=10


613-272-00-6
pyraclostrobin (ISO);
methyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate
—
—
Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H331
H315
H400
H410
GHS06
GHS09
Dgr
H331
H315
H410

M=100


613-273-00-1
tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine
427-600-9
192439-46-6
Aquatic Chronic 2
H411
GHS09
H411




613-274-00-7
2,6-dichloro-1-fluoropyridiniumtetrafluoroborate
427-400-1
140623-89-8
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H302
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H302
H317
H410




613-275-00-2
3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride
424-530-0
93076-03-0
Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H301
H371**
H373**
H318
H317
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H371
H373**
H318
H317
H411




613-276-00-8
1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one
426-110-2
98377-35-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




613-277-00-3
(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one
427-070-9
—
Aquatic Chronic 4
H413
—
H413




613-278-00-9
(3-aminophenyl)pyridin-3-ylmethanone
428-230-0
79568-06-2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410




613-279-00-4
2-ethyl-2,3-dihydro-2-methyl-1H-perimidine
424-380-6
43057-68-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410




613-280-00-X
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea
230-625-6
7226-23-5
Repr. 2
Acute Tox. 4 *
Eye Dam. 1
H361f***
H302
H318
GHS05
GHS08
GHS07
Dgr
H361f***
H302
H318




613-281-00-5
quinoline
202-051-6
91-22-5
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H350
H341
H312
H302
H319
H315
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H312
H302
H319
H315
H411




613-282-00-0
triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
—
131983-72-7
Aquatic Chronic 2
H411
GHS09
H411




613-283-00-6
ketoconazole;
1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
265-667-4
65277-42-1
Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H360F***
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H360F***
H301
H373**
H410




613-284-00-1
metconazole (ISO);
(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
—
125116-23-6
Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2
H361d***
H302
H411
GHS08
GHS07
GHS09
Wng
H361d***
H302
H411




613-285-00-7
1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
Expl. 1.3
H203
GHS01
Dgr
H203




613-286-00-2
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]
418-260-2
183196-57-8
Skin Sens. 1
H317
GHS07
Wng
H317




613-286-01-X
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
Repr. 1B
Skin Sens. 1
H360D***
H317
GHS08
GHS07
Dgr
H360D***
H317




613-287-00-8
1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole
419-540-7
160194-26-3
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




613-288-00-3
1,3-bis(dimethylcarbamoyl)-imidazolium chloride
420-930-4
135756-61-5
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




613-289-00-9
3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole
432-020-4
142623-48-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




613-290-00-4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride
432-470-1
189012-93-9
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410




613-291-00-X
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
434-820-9
106461-41-0
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373**
H400
H410
GHS08
GHS09
Wng
H373**
H410




613-292-00-5
N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
435-010-8
26157-73-3
Muta. 2
Aquatic Chronic 3
H341
H412
GHS08
Wng
H341
H412




613-293-00-0
2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester
448-050-6
444065-11-6
Aquatic Chronic 4
H413
—
H413




613-294-00-6
2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester
448-260-8
379268-96-9
Aquatic Chronic 4
H413
—
H413




613-295-00-1
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride
448-720-8
363138-44-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




613-296-00-7
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate
418-270-7
—
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




613-297-00-2
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole
420-820-6
—
Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2
H226
H302
H411
GHS02
GHS07
GHS09
Wng
H226
H302
H411




613-298-00-8
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate
421-560-6
—
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2
H373**
H318
H411
GHS05
GHS08
GHS09
Dgr
H373**
H318
H411




613-299-00-3
main component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt
422-610-1
—
Eye Dam. 1
H318
GHS05
Dgr
H318




613-300-00-7
1-imidazol-1-yl-octadecan-2-ol
434-120-3
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




613-301-00-2
dimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate
443-910-7
—
Aquatic Chronic 4
H413
—
H413




613-302-00-8
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate
432-980-4
243858-60-8
Eye Dam. 1
H318
GHS05
Dgr
H318




613-303-00-3
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine
429-800-1
95737-68-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




613-304-00-9
5,6-dihydroxy-2,3-dihydro-1H-indolium bromide
421-170-6
138937-28-7
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318




613-305-00-4
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole
448-630-9
3147-77-1
Aquatic Chronic 4
H413
—
H413




613-306-00-X
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate
433-520-5
82911-69-1
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411




613-307-00-5
clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine
—
210880-92-5
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410

M=10


613-308-00-0
2-amino-5-methylthiazole
423-800-5
7305-71-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373**
H410




613-309-00-6
1-methyl-3-phenyl-1-piperazine
431-180-2
5271-27-2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H312
H302
H315
H318
H412
GHS05
GHS07
Dgr
H312
H302
H315
H318
H412




613-310-00-1
(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
432-360-3
105813-13-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410




613-311-00-7
methyl-5-nitrophenyl-guanidine
435-500-1
152460-07-6
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412




613-312-00-2
2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride
420-200-5
—
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412




613-313-00-8
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione
442-780-9
173838-67-0
Aquatic Chronic 3
H412
—
H412




613-314-00-3
4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-7
7693-82-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




613-315-00-9
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate
430-390-1
—
Acute Tox. 4 *
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412




613-316-00-4
trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)
257-765-0
52234-82-9
Muta. 2
Eye Dam. 1
Skin Sens. 1
H341
H318
H317
GHS05
GHS08
GHS07
Dgr
H341
H318
H317


H

614-001-00-4
nicotine (ISO);
3-(N-methyl-2-pyrrolidinyl)pyridine
200-193-3
54-11-5
Acute Tox. 1
Acute Tox. 3 *
Aquatic Chronic 2
H310
H301
H411
GHS06
GHS09
Dgr
H310
H301
H411



614-002-00-X
salts of nicotine
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2
H330
H310
H300
H411
GHS06
GHS09
Dgr
H330
H310
H300
H411


A
614-003-00-5
strychnine
200-319-7
57-24-9
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410



614-004-00-0
salts of strychnine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H330
H300
H400
H410
GHS06
GHS09
Dgr
H330
H300
H410


A


614-005-00-6
colchicine
200-598-5
64-86-8
Muta. 1B
Acute Tox. 2 *
H340
H300
GHS06
GHS08
Dgr
H340
H300




614-006-00-1
brucine;
2,3-dimethoxystrychnine
206-614-7
357-57-3
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412



614-007-00-7
brucine sulphate; [1]
brucine nitrate; [2]
strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4]
4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4]
Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Chronic 3
H330
H300
H412
GHS06
Dgr
H330
H300
H412


A
614-008-00-2
aconitine
206-121-7
302-27-2
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300



614-009-00-8
salts of aconitine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300


A
614-010-00-3
atropine
200-104-8
51-55-8
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300



614-011-00-9
salts of atropine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300


A
614-012-00-4
hyoscyamine
202-933-0
101-31-5
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300



614-013-00-X
salts of hyoscyamine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300


A
614-014-00-5
hyoscine
200-090-3
51-34-3
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300



614-015-00-0
salts of hyoscine
—
—
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
H330
H310
H300
GHS06
Dgr
H330
H310
H300


A
614-016-00-6
pilocarpine
202-128-4
92-13-7
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300



614-017-00-1
salts of pilocarpine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300


A
614-018-00-7
papaverine
200-397-2
58-74-2
Acute Tox. 4 *
H302
GHS07
Wng
H302



614-019-00-2
salts of papaverine
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302


A
614-020-00-8
physostigmine
200-332-8
57-47-6
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300



614-021-00-3
salts of physostigmine
—
—
Acute Tox. 2 *
Acute Tox. 2 *
H330
H300
GHS06
Dgr
H330
H300


A
614-022-00-9
digitoxin
200-760-5
71-63-6
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **



614-023-00-4
ephedrine
206-080-5
299-42-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



614-024-00-X
salts of ephedrine
—
—
Acute Tox. 4 *
H302
GHS07
Wng
H302


A
614-025-00-5
ouabain
211-139-3
630-60-4
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **



614-026-00-0
strophantin-K
234-239-9
11005-63-3
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
H331
H301
H373 **
GHS06
GHS08
Dgr
H331
H301
H373 **



614-027-00-6
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;
red squill;
scilliroside
208-077-4
507-60-8
Acute Tox. 2 *
H300
GHS06
Dgr
H300



614-028-00-1
reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside
414-420-0
—
Eye Dam. 1
H318
GHS05
Dgr
H318



614-029-00-7
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside
419-640-0
68784-14-5
Acute Tox. 4 *
H302
GHS07
Wng
H302





615-001-00-7
methyl isocyanate
210-866-3
624-83-9
Flam. Liq. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Resp. Sens. 1
Skin Sens. 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H225
H361d***
H330
H311
H301
H334
H317
H335
H315
H318
GHS02
GHS06
GHS05
GHS08
Dgr
H225
H361d***
H330
H311
H301
H334
H317
H335
H315
H318




615-002-00-2
methyl isothiocyanate
209-132-5
556-61-6
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H314
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H301
H314
H317
H410



615-003-00-8
thiocyanic acid
207-337-4
463-56-9
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032




615-004-00-3
salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
EUH032

A

615-005-00-9
4,4'-methylenediphenyl diisocyanate;
diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate;
diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4]
202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4]
101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4]
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H351
H332
H373**
H319
H335
H315
H334
H317
GHS08
GHS07
Dgr
H351
H332
H373**
H319
H335
H315
H334
H317

Eye Irrit. 2; H319: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %
Resp. Sens. 1; H334: C ≥ 0,1 %
STOT SE 3; H335: C ≥ 5 %
C
2

615-006-00-4
2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3]
202-039-0 [1]
209-544-5 [2]
247-722-4 [3]
91-08-7 [1]
584-84-9 [2]
26471-62-5 [3]
Carc. 2
Acute Tox. 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H351
H330
H319
H335
H315
H334
H317
H412
GHS06
GHS08
Dgr
H351
H330
H319
H335
H315
H334
H317
H412

Resp. Sens. 1; H334: C ≥ 0,1 %
C
615-007-00-X
1,5-naphthylene diisocyanate
221-641-4
3173-72-6
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Aquatic Chronic 3
H332
H319
H335
H315
H334
H412
GHS08
GHS07
Dgr
H332
H319
H335
H315
H334
H412



615-008-00-5
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;
isophorone di-isocyanate
223-861-6
4098-71-9
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H319
H335
H315
H334
H317
H411
GHS06
GHS08
GHS09
Dgr
H331
H319
H335
H315
H334
H317
H411

*
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens.1; H317: C ≥ 0,5 %
2
615-009-00-0
4,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate
225-863-2
5124-30-1
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317

*
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 %
2
615-010-00-6
2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]
241-001-8 [1]
239-714-4 [2]
16938-22-0 [1]
15646-96-5 [2]
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H331
H319
H335
H315
H334
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334

*
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 %
C
2
615-011-00-1
hexamethylene-di-isocyanate
212-485-8
822-06-0
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
H331
H319
H335
H315
H334
H317
GHS06
GHS08
Dgr
H331
H319
H335
H315
H334
H317

*
Resp. Sens. 1; H334: C ≥ 0,5 %
Skin Sens. 1; H317: C ≥ 0,5 %
2
615-012-00-7
4-isocyanatosulphonyltoluene;
tosyl isocyanate
223-810-8
4083-64-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334
EUH014
Eye Irrit.; H319: C ≥ 5 %
STOT SE 3; H335: C ≥ 5 %
Skin Irrit. 2; H315: C ≥ 5 %

615-013-00-2
cyanamide;
carbanonitril
206-992-3
420-04-2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H301
H312
H319
H315
H317
GHS06
Dgr
H301
H312
H319
H315
H317



615-014-00-8
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate
—
7276-58-6
Acute Tox. 4 *
H302
GHS07
Wng
H302



615-015-00-3
1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate
204-081-5
115-31-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



615-016-00-9
potassium cyanate
209-676-3
590-28-3
Acute Tox. 4 *
H302
GHS07
Wng
H302



615-017-00-4
calcium cyanamide
205-861-8
156-62-7
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H302
H335
H318
GHS05
GHS07
Dgr
H302
H335
H318



615-018-00-X
2-(2-butoxyethoxy)ethyl thiocyanate
203-985-7
112-56-1
Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
H226
H311
H301
GHS02
GHS06
Dgr
H226
H311
H301



615-019-00-5
dicyclohexylcarbodiimide
208-704-1
538-75-0
Acute Tox. 3 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H311
H302
H318
H317
GHS06
GHS05
Dgr
H311
H302
H318
H317



615-020-00-0
methylene dithiocyanate
228-652-3
6317-18-6
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H330
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H330
H301
H314
H317
H400



615-021-00-6
1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC
219-514-3
2451-62-9
Muta. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H340
H331
H301
H373 **
H318
H317
H412
GHS06
GHS08
GHS05
Dgr
H340
H331
H301
H373 **
H318
H317
H412





615-022-00-1
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate
410-550-7
79277-18-2
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
H373**
H334
H317
GHS08
Dgr
H373**
H334
H317
EUH014




615-023-00-7
2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate
410-900-9
83056-32-0
Flam. Liq. 3
Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
H226
H341
H332
H373 **
H318
H334
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H341
H332
H373 **
H318
H334
EUH014


615-024-00-2
2-phenylethylisocyanate
413-080-0
1943-82-4
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2
H331
H302
H314
H334
H317
H411
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H314
H334
H317
H411



615-025-00-8
4,4'-ethylidenediphenyl dicyanate
405-740-1
47073-92-7
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H373 **
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H332
H302
H373 **
H318
H410



615-026-00-3
4,4'-methylenebis(2,6-dimethylphenyl cyanate)
405-790-4
101657-77-6
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412





615-028-00-4
ethyl 2-(isocyanatosulfonyl)benzoate
410-220-2
77375-79-2
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H302
H373**
H318
H334
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H334
H317
EUH014




615-029-00-X
2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane
411-280-2
—
Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H330
H302
H314
H334
H317
H412
GHS06
GHS08
GHS05
Dgr
H330
H302
H314
H334
H317
H412





615-030-00-5
alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412


A

615-031-00-0
thallium thiocyanate
222-571-7
3535-84-0
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2
Aquatic Chronic 2
H330
H300
H312
H373**
H411
GHS06
GHS08
GHS09
Dgr
H330
H300
H312
H373**
H411




615-032-00-6
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410


A



615-033-00-1
reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)
430-980-9
—
Aquatic Chronic 4
H413
—
H413




615-034-00-7
reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)
430-750-8
—
Aquatic Chronic 4
H413
—
H413




615-035-00-2
reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)
430-930-6
122886-55-9
Aquatic Chronic 4
H413
—
H413




615-036-00-8
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)
430-940-0
—
Aquatic Chronic 4
H413
—
H413




615-037-00-3
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)
430-950-5
—
Aquatic Chronic 4
H413
—
H413




615-038-00-9
reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)
430-960-1
—
Aquatic Chronic 4
H413
—
H413




615-039-00-4
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)
430-970-4
—
Aquatic Chronic 4
H413
—
H413




615-044-00-1
4-chlorophenylisocyanate
203-176-9
104-12-1
Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H302
H335
H315
H318
H334
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H302
H335
H315
H318
H334
H410




615-045-00-7
4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)
420-530-1
—
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413




616-001-00-X
N,N-dimethylformamide;
dimethyl formamide
200-679-5
68-12-2
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
H360D ***
H332
H312
H319
GHS08
GHS07
Dgr
H360D ***
H332
H312
H319



616-002-00-5
2-fluoroacetamide
211-363-1
640-19-7
Acute Tox. 2 *
Acute Tox. 3 *
H300
H311
GHS06
Dgr
H300
H311



616-003-00-0
acrylamide;
prop-2-enamide
201-173-7
79-06-1
Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H350
H340
H361f ***
H301
H372 **
H332
H312
H319
H315
H317
GHS06
GHS08
Dgr
H350
H340
H361f ***
H301
H372 **
H332
H312
H319
H315
H317


D
616-004-00-6
allidochlor (ISO);
N,N-diallylchloroacetamide
202-270-7
93-71-0
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411



616-005-00-1
chlorthiamid (ISO);
2,6-dichloro (thiobenzamide)
217-637-7
1918-13-4
Acute Tox. 4 *
H302
GHS07
Wng
H302





616-006-00-7
dichlofluanid (ISO);
N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide
214-118-7
1085-98-9
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H332
H319
H317
H400
GHS07
GHS09
Wng
H332
H319
H317
H400

M=10


616-007-00-2
diphenamid (ISO);
N,N-dimethyl-2,2-diphenylacetamide
213-482-4
957-51-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



616-008-00-8
propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropylacetanilide
217-638-2
1918-16-7
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H317
H400
H410
GHS07
GHS09
Wng
H302
H319
H317
H410





616-009-00-3
propanil (ISO);
3', 4'-dichloropropionanilide
211-914-6
709-98-8
Acute Tox. 4 *
Aquatic Acute 1
H302
H400
GHS07
GHS09
Wng
H302
H400

M=10



616-010-00-9
tosylchloramide sodium
204-854-7
127-65-1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
H302
H314
H334
GHS08
GHS05
GHS07
Dg
H302
H314
H334
EUH031


616-011-00-4
N,N-dimethylacetamide
204-826-4
127-19-5
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
H360D ***
H332
H312
GHS08
GHS07
Dgr
H360D ***
H332
H312

Repr. 1B; H360D: C ≥ 5 %

616-012-00-X
N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide
211-952-3
719-96-0
Skin Irrit. 2
H315
GHS07
Wng
H315



616-013-00-5
butyraldehyde oxime
203-792-8
110-69-0
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
H311
H302
H319
GHS06
Dgr
H311
H302
H319



616-014-00-0
2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime
202-496-6
96-29-7
Carc. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H351
H312
H318
H317
GHS08
GHS05
GHS07
Dgr
H351
H312
H318
H317



616-015-00-6
alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide
240-110-8
15972-60-8
Carc. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H317
H410

M=10

616-016-00-1
1-(3,4-dichlorophenylimino) thiosemicarbazide
—
5836-73-7
Acute Tox. 2 *
H300
GHS06
Dgr
H300



616-017-00-7
cartap hydrochloride
239-309-2
15263-52-2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410



616-018-00-2
N,N-diethyl-m-toluamide;
deet
205-149-7
134-62-3
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H315
H412
GHS07
Wng
H302
H319
H315
H412



616-019-00-8
perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;
253-718-3
37924-13-3
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



616-020-00-3
tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
251-793-7
34014-18-1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



616-021-00-9
thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea
246-901-4
25366-23-8
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



616-022-00-4
acetamide
200-473-5
60-35-5
Carc. 2
H351
GHS08
Wng
H351



616-023-00-X
N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide
401-980-6
—
Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317



616-024-00-5
2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide
402-260-4
54942-74-4
Aquatic Chronic 4
H413
—
H413



616-025-00-0
valinamide
402-840-7
20108-78-5
Repr. 2
Eye Irrit. 2
Skin Sens. 1
H361f ***
H319
H317
GHS08
Wng
H361f ***
H319
H317



616-026-00-6
thioacetamide
200-541-4
62-55-5
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H350
H302
H319
H315
H412
GHS08
GHS07
Dgr
H350
H302
H319
H315
H412



616-027-00-1
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate
403-760-5
—
Skin Sens. 1
H317
GHS07
Wng
H317



616-028-00-7
N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
403-790-9
108673-51-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-029-00-2
N,N'-ethylenebis(vinylsulfonylacetamide)
404-790-1
66710-66-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317



616-030-00-8
ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
250-010-6
30043-49-3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



616-031-00-3
dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;
256-625-6
50563-36-5
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



616-032-00-9
diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
—
83164-33-4
Aquatic Chronic 3
H412
—
H412



616-033-00-4
cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-9
69581-33-5
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410



616-034-00-X
pyracarbolid; (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide
246-419-4
24691-76-7
Aquatic Chronic 3
H412
—
H412



616-035-00-5
cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-0
57966-95-7
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



616-036-00-0
2-chloracetamide
201-174-2
79-07-2
Repr. 2
Acute Tox. 3 *
Skin Sens. 1
H361f ***
H301
H317
GHS06
GHS08
Dgr
H361f ***
H301
H317

Skin Sens. 1; H317: C ≥ 0,1 %

616-037-00-6
acetochlor (ISO);
2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide
251-899-3
34256-82-1
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H335
H315
H317
H410



616-038-00-1
(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride
406-010-5
88918-84-7
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411



616-039-00-7
3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide
406-200-8
117827-06-2
Skin Sens. 1
H317
GHS07
Wng
H317



616-040-00-2
potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide
406-650-5
97888-41-0
Eye Dam. 1
H318
GHS05
Dgr
H318



616-041-00-8
3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide
406-840-8
101664-25-9
Aquatic Chronic 4
H413
—
H413



616-042-00-3
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide
407-070-5
142859-67-4
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-043-00-9
isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide
407-190-8
82558-50-7
Aquatic Chronic 4
H413
—
H413



616-044-00-4
N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide
402-510-2
—
Aquatic Chronic 2
H411
GHS09
H411



616-045-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide
405-190-2
122371-93-1
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-046-00-5
N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
406-390-2
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-047-00-0
reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
406-640-0
—
Skin Sens. 1
H317
GHS07
Wng
H317



616-048-00-6
3'-trifluoromethylisobutyranilide
406-740-4
1939-27-1
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411



616-049-00-1
2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide
408-150-2
99141-89-6
Aquatic Chronic 4
H413
—
H413



616-050-00-7
lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
410-690-9
103055-07-8
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



616-051-00-2
reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene
411-070-0
—
Aquatic Chronic 4
H413
—
H413



616-052-00-8
formamide
200-842-0
75-12-7
Repr. 1B
H360D ***
GHS08
Dgr
H360D ***



616-053-00-3
N-methylacetamide
201-182-6
79-16-3
Repr. 1B
H360D ***
GHS08
Dgr
H360D ***



616-054-00-9
iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-9
36734-19-7
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



616-055-00-4
propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide
245-951-4
23950-58-5
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410



616-056-00-X
N-methylformamide
204-624-6
123-39-7
Repr. 1B
Acute Tox. 4 *
H360D ***
H312
GHS08
GHS07
Dg
H360D ***
H312



616-057-00-5
reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide
412-790-8
—
Carc. 1B
Muta. 2
STOT RE 2 *
H350
H341
H373 **
GHS08
Dgr
H350
H341
H373 **



616-058-00-0
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
412-570-1
119462-56-5
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 **
H318
H317
H410



616-059-00-6
4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide
412-650-6
121487-83-0
Aquatic Chronic 4
H413
—
H413



616-060-00-1
Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)
413-770-1
—
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410



616-061-00-7
N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide
413-610-0
124172-53-8
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412



616-062-00-2
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide
411-590-8
70693-57-1
Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412



616-063-00-8
3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione
411-920-0
106917-30-0
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H373 **
H314
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H302
H373 **
H314
H410



616-064-00-3
N—tert-butyl-3-methylpicolinamide
406-720-5
32998-95-1
Aquatic Chronic 3
H412
—
H412



616-065-00-9
3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea
411-970-3
79881-89-3
Acute Tox. 4 *
STOT RE 2 *
H302
H373 **
GHS08
GHS07
Wng
H302
H373 **



616-066-00-4
5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone
405-100-1
115662-06-1
Repr. 2
H361f ***
GHS08
Wng
H361f ***



616-067-00-X
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate
407-300-4
92683-20-0
Aquatic Chronic 4
H413
—
H413



616-068-00-5
potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate
406-500-9
174393-75-0
Skin Sens. 1
H317
GHS07
Wng
H317



616-069-00-0
1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide
406-210-2
110560-22-0
Aquatic Chronic 4
H413
—
H413



616-070-00-6
reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-530-2
—
Aquatic Chronic 4
H413
—
H413



616-071-00-1
reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)
406-550-1
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-072-00-7
1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine
407-120-6
55612-11-8
Aquatic Chronic 4
H413
—
H413



616-073-00-2
4'-ethoxy-2-benzimidazoleanilide
407-600-5
120187-29-3
Muta. 2
Aquatic Chronic 4
H341
H413
GHS08
Wng
H341
H413



616-074-00-8
N-butyl-2-(4-morpholinylcarbonyl)benzamide
407-730-2
104958-67-0
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H317
H412
GHS07
Wng
H319
H317
H412



616-075-00-3
D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
408-120-9
65197-96-8
Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318



616-076-00-9
tebufenozide (ISO);
N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide
412-850-3
112410-23-8
Aquatic Chronic 2
H411
GHS09
H411



616-077-00-4
reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate
411-310-4
—
Eye Dam. 1
H318
GHS05
Dgr
H318



616-078-00-X
2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide
411-330-3
104541-33-5
Aquatic Chronic 4
H413
—
H413



616-079-00-5
1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate
411-700-4
140921-24-0
Skin Sens. 1
H317
GHS07
Wng
H317



616-080-00-0
4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)
411-850-0
119018-29-0
Aquatic Chronic 3
H412
—
H412



616-081-00-6
5-bromo-8-naphtholactam
413-480-5
24856-00-6
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410



616-082-00-1
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide
413-200-1
129604-78-0
Skin Sens. 1
H317
GHS07
Wng
H317



616-083-00-7
[2-[(4-nitrophenyl)amino]ethyl]urea
410-700-1
27080-42-8
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



616-084-00-2
2,4-bis[N'-(4-methylphenyl)ureido]toluene
411-790-5
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-085-00-8
3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione
412-190-6
168900-02-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-086-00-3
2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene
412-250-1
102387-48-4
Aquatic Chronic 4
H413
—
H413



616-087-00-9
reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate
412-260-6
52658-19-2
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H319
H317
H411
GHS07
GHS09
Wng
H319
H317
H411



616-088-00-4
2-aminosulfonyl-N,N-dimethylnicotinamide
413-440-7
112006-75-4
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412



616-089-00-X
5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran
415-360-8
41107-56-6
Muta. 2
H341
GHS08
Wng
H341



616-090-00-5
1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride
415-660-9
70918-74-0
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 2
H331
H311
H301
H373 **
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 **
H411



616-091-00-0
1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione
423-400-0
59653-74-6
Muta. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H340
H331
H302
H373 **
H318
H317
GHS06
GHS08
GHS05
Dgr
H340
H331
H302
H373 **
H318
H317



616-092-00-6
Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide
404-035-6
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-093-00-1
Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride
406-620-1
129217-90-9
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



616-094-00-7
3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea
406-370-3
58890-25-8
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413



616-095-00-2
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-690-3
43136-14-7
Aquatic Chronic 4
H413
—
H413



616-096-00-8
N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide
408-110-4
110483-07-3
Aquatic Chronic 4
H413
—
H413



616-097-00-3
N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide
411-840-6
83372-55-8
Aquatic Chronic 4
H413
—
H413



616-098-00-9
1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide
411-750-7
119126-15-7
Aquatic Chronic 2
H411
GHS09
H411



616-099-00-4
2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide
414-170-2
135937-20-1
Aquatic Chronic 4
H413
—
H413



616-100-00-8
1,3-dimethyl-1,3-bis(trimethylsilyl)urea
414-180-7
10218-17-4
Acute Tox. 4 *
Skin Irrit. 2
H302
H315
GHS07
Wng
H302
H315



616-101-00-3
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
414-600-9
149182-72-9
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



616-102-00-9
reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]
415-870-0
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



616-103-00-4
(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide
415-030-3
120298-38-6
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410



616-104-00-X
benalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate
275-728-7
71626-11-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-105-00-5
chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea
239-592-2
15545-48-9
Carc. 2
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d ***
H400
H410
GHS08
GHS09
Wng
H351
H361d ***
H410



616-106-00-0
phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate
237-199-0
13684-63-4
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





616-107-00-6
cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
—
142891-20-1
Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410




616-108-00-1
iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide
—
144550-36-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-109-00-7
sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea
—
141776-32-1
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-110-00-2
cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
419-150-7
113136-77-9
Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411



616-111-00-8
fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid
422-530-5
126833-17-8
Aquatic Chronic 2
H411
GHS09
H411



616-112-00-3
oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate
—
144651-06-9
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H400
H410
GHS08
GHS09
Wng
H373 **
H410



616-113-00-9
desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate
237-198-5
13684-56-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=10

616-114-00-4
dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-
418-010-2
136897-58-0
Aquatic Chronic 4
H413
—
H413



616-115-00-X
N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide
416-150-9
136450-06-1
Aquatic Chronic 4
H413
—
H413



616-116-00-5
N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate
416-790-9
143052-96-4
Aquatic Chronic 4
H413
—
H413



616-117-00-0
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide
416-860-9
777891-21-1
Repr. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f ***
H317
H400
H410
GHS08
GHS09
Wng
H361f ***
H317
H410



616-118-00-6
N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride
417-950-0
65797-42-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412



616-119-00-1
2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide
418-060-5
118020-93-2
Aquatic Chronic 4
H413
—
H413



616-120-00-7
reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide
420-600-1
—
STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411



616-121-00-2
2,4-dihydroxy-N-(2-methoxyphenyl)benzamide
419-090-1
129205-19-2
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411





616-122-00-8
methylneodecanamide
414-460-9
105726-67-8
Acute Tox. 4 *
H302
GHS07
Wng
H302




616-123-00-3
N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide
414-740-0
96141-86-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





616-124-00-9
lithium bis(trifluoromethylsulfonyl)imide
415-300-0
90076-65-6
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 3
H311
H301
H373**
H314
H412
GHS06
GHS05
GHS08
Dgr
H311
H301
H373**
H314
H412





616-125-00-4
3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide
415-730-9
151338-11-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
410





616-126-00-X
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide
423-960-6
139756-01-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H302
H373**
H412
GHS08
GHS07
Wng
H302
H373**
H412




616-127-00-5
reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)
430-050-2
—
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411



616-128-00-0
N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide
417-530-7
123590-00-1
Aquatic Chronic 4
H413
—
H413



616-129-00-6
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide
419-710-0
42774-15-2
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319



616-130-00-1
N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide
421-780-2
150919-56-5
Aquatic Chronic 4
H413
—
H413






616-131-00-7
1-aminocyclopentanecarboxamide
422-950-9
17193-28-1
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
H372**
H302
H318
GHS05
GHS08
GHS07
Dgr
H372**
H302
H318




616-132-00-2
N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide
423-250-6
130016-98-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



616-133-00-8
N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide
423-990-1
149118-66-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410



616-134-00-3
3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide
401-820-5
793710-14-2
Aquatic Chronic 3
H412
—
H412



616-135-00-9
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide
430-230-0
136522-17-3
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412





616-136-00-4
reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)
430-380-7
—
Aquatic Chronic 2
H411
GHS09
H411




616-137-00-X
4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane
401-130-4
71526-07-3
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




616-138-00-5
benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide
431-600-4
112226-61-6
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




616-139-00-0
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide
420-380-5
136465-81-1
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412




616-140-00-6
N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]
429-380-1
133336-92-2
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




616-141-00-1
zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide
—
156052-68-5
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410

M=10


616-142-00-7
1,3-Bis(vinylsulfonylacetamido)propane
428-350-3
93629-90-4
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H341
H318
H317
H412
GHS08
GHS05
GHS07
Dgr
H341
H318
H317
H412



616-143-00-2
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide
422-560-9
149591-38-8
Repr. 2
Eye Irrit. 2
Aquatic Chronic 4
H361f ***
H319
H413
GHS08
Wng
H361f ***
H319
H413





616-144-00-8
3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-130-1
—
Aquatic Chronic 4
H413
—
H413




616-145-00-3
pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide
—
106700-29-2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410

M=100


616-146-00-9
N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide
431-330-7
142776-95-2
Aquatic Chronic 4
H413
—
H413




616-147-00-4
1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide
424-160-1
139481-22-4
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




616-148-00-X
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
424-550-1
84245-12-5
Carc. 1B
Muta. 1B
Repr. 1B
H350
H340
H360FD
GHS08
Dgr
H350
H340
H360FD




616-150-00-0
(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride
425-260-6
—
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H373**
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H373**
H318
H317
H411




616-151-00-6
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide
425-650-6
171887-03-9
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412




616-152-00-1
4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide
425-850-3
125971-96-2
Aquatic Chronic 4
H413
—
H413




616-153-00-7
4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide
425-860-8
125971-57-5
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




616-154-00-2
3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-110-0
—
Aquatic Chronic 4
H413
—
H413




616-155-00-8
N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide
431-040-0
104560-40-9
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




616-156-00-3
6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide
430-500-8
204277-61-2
Aquatic Chronic 4
H413
—
H413




616-157-00-9
3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride
427-780-9
114565-70-7
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410




616-158-00-4
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide
427-880-2
90357-53-2
STOT RE 2 *
Aquatic Chronic 2
H373**
H411
GHS08
GHS09
Wng
H373**
H411




616-160-00-5
2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]
429-090-3
61551-69-7
Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412




616-161-00-0
2,4-dichloro-5-hydroxyacetanilide
429-110-0
67669-19-6
Aquatic Chronic 3
H412
—
H412




616-162-00-6
isostearic acid monoisopropanolamide
431-540-9
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411




616-163-00-1
4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]
430-350-3
192463-88-0
Aquatic Chronic 4
H413
—
H413




616-164-00-7
dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
—
149961-52-4
Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H361d***
H332
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361d***
H332
H410

M=10


616-165-00-2
beflubutamid (ISO);
(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide
—
113614-08-7
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=100


616-166-00-8
cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide
—
120116-88-3
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410

M=10


616-167-00-3
N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide
418-290-6
168612-06-4
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317




616-168-00-9
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium
418-440-0
136997-71-2
Skin Sens. 1
H317
GHS07
Wng
H317




616-169-00-4
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one
420-220-4
92771-56-7
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




616-170-00-X
(2R)-2-amino-2-phenylacetamide
420-370-0
6485-67-2
Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317




616-171-00-5
2-(para-chlorophenyl)glycineamide
420-830-0
102333-75-5
Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317




616-172-00-0
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl
423-840-3
14691-89-5
Acute Tox. 4 *
H302
GHS07
Wng
H302




616-174-00-1
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
424-560-4
151257-01-1
Acute Tox. 4 *
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319




616-175-00-7
2-(2-hexyldecyloxy)benzamide
431-230-3
202483-62-3
Aquatic Chronic 4
H413
—
H413




616-176-00-2
3-N,N-bis(methoxyethyl)aminoacetanilide
432-530-7
24294-01-7
Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412




616-177-00-8
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide
432-970-1
217324-98-6
Aquatic Chronic 4
H413
—
H413




616-178-00-3
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide
434-500-9
52583-35-4
Aquatic Chronic 4
H413
—
H413




616-179-00-9
2-chloro-N-(4-methylphenyl)acetamide
435-170-9
16634-82-5
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410




616-180-00-4
N,N-(dimethylamino)thioacetamide hydrochloride
435-470-1
27366-72-9
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360D***
H400
H410
GHS08
GHS09
Dgr
H360D***
H410




616-181-00-X
4'-methyldodecane-1-sulfonanilide
435-490-9
17417-32-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




616-182-00-5
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
435-860-1
214417-91-1
Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411




616-183-00-0
N-dodecyl-4-methoxybenzamide
442-340-6
1854-15-5
Aquatic Chronic 4
H413
—
H413




616-184-00-6
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide
442-560-2
105043-55-8
Aquatic Chronic 4
H413
—
H413




616-186-00-7
N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)
443-010-4
53641-10-4
Aquatic Chronic 3
H412
—
H412




616-188-00-8
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide
443-980-9
221215-20-9
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




616-189-00-3
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide
444-780-4
452962-97-9
Aquatic Chronic 4
H413
—
H413




616-190-00-9
N-decyl-4-nitrobenzamide
445-880-0
64026-19-3
Aquatic Chronic 4
H413
—
H413




616-191-00-4
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide
446-190-2
406488-30-0
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H319
H315
H317
H411
GHS07
GHS09
Wng
H302
H319
H315
H317
H411




616-192-00-X
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide
448-060-0
727678-39-9
Aquatic Chronic 4
H413
—
H413




616-193-00-5
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide
449-940-7
368450-39-9
Aquatic Chronic 4
H413
—
H413




616-194-00-0
2,2-diethoxy-N,N-dimethylacetamide
449-950-1
34640-92-1
Eye Irrit. 2
H319
GHS07
Wng
H319




616-196-00-1
disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide
419-990-4
—
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410




616-197-00-7
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide
422-500-1
—
STOT RE 2 *
H373**
GHS08
Wng
H373**




616-198-00-2
1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene
423-300-7
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




616-200-00-1
reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);
12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)
432-430-3
—
Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413




616-201-00-7
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine
432-840-2
220926-97-6
Acute Tox. 4 *
Aquatic Chronic 4
H332
H413
GHS07
Wng
H332
H413




616-202-00-2
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide
434-330-5
—
Carc. 2
Skin Sens. 1
Aquatic Chronic 4
H351
H317
H413
GHS08
GHS07
Wng
H351
H317
H413




616-203-00-8
reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide
442-280-0
—
Aquatic Chronic 4
H413
—
H413




616-204-00-3
N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]
451-060-3
122886-55-9
Aquatic Chronic 4
H413
—
H413




617-001-00-2
di-tert-butyl peroxide
203-733-6
110-05-4
Org. Perox. E
Flam. Liq. 2
H242
H225
GHS02
Dgr
H242
H225



617-002-00-8
α, α-dimethylbenzyl hydroperoxide;
cumene hydroperoxide
201-254-7
80-15-9
Org. Perox. E
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 2
H242
H331
H312
H302
H373 **
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H312
H302
H373 **
H314
H411

Skin Corr. 1B; H314: C ≥ 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Dam. 1; H318: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %
STOT SE 3; H335: C < 10 %

617-003-00-3
dilauroyl peroxide
203-326-3
105-74-8
Org. Perox. D
H242
GHS02
Dgr
H242



617-004-00-9
1,2,3,4-tetrahydro-1-naphthyl hydroperoxide
212-230-0
771-29-9
Org. Perox. D
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H242
H302
H314
H400
H410
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H410

STOT SE 3; H335: C ≥ 5 %

617-006-00-X
bis(α, α-dimethylbenzyl) peroxide
201-279-3
80-43-3
Org. Perox. F
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H242
H319
H315
H411
GHS02
GHS07
GHS09
Wng
H242
H319
H315
H411



617-007-00-5
tert-butyl α, α-dimethylbenzyl peroxide
222-389-8
3457-61-2
Org. Perox. E Skin Irrit. 2
Aquatic Chronic 2
H242
H315
H411
GHS02
GHS07
GHS09
Wng
H242
H315
H411





617-008-00-0
dibenzoyl peroxide;
benzoyl peroxide
202-327-6
94-36-0
Org. Perox. B
Eye Irrit. 2
Skin Sens. 1
H214
H319
H317
GHS01
GHS02
GHS07
Dgr
H214
H319
H317




617-010-00-1
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
Org. Perox. A
Skin Corr. 1B
Acute Tox. 4 *
H242
H314
H302
GHS01
GHS05
GHS07
Dgr
H242
H314
H302

STOT SE 3; H335: C ≥ 5 %
C


617-010-01-9
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
[≤ 91 % solution]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
H242
H302
H314
GHS02
GHS05
GHS07
Dgr
H242
H302
H314

STOT SE 3; H335: C ≥ 5 %
C T
617-012-00-2
8-p-menthyl hydroperoxide;
p-menthane hydroperoxide
201-281-4
80-47-7
Org. Perox. D
Skin Corr. 1B
Acute Tox. 4 *
H242
H314
H332
GHS02
GHS05
GHS07
Dgr
H242
H314
H332

STOT SE 3; H335: C ≥ 5 %

617-013-00-8
O,O-tert-butyl O-docosyl monoperoxyoxalate
404-300-6
116753-76-5
Org. Perox. C ****
Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Dgr
H242
H410



617-014-00-3
6-(nonylamino)-6-oxo-peroxyhexanoic acid
406-680-9
104788-63-8
Org. Perox. C ****
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H242
H318
H317
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H318
H317
H400



617-015-00-9
bis(4-methylbenzoyl)peroxide
407-950-9
895-85-2
Org. Perox. B ****
Aquatic Acute 1
Aquatic Chronic 1
H241
H400
H410
GHS01
GHS02
GHS09
Dgr
H241
H410



617-016-00-4
3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate
413-910-1
—
Org. Perox. C ****
Flam. Liq. 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H242
H226
H315
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H226
H315
H410






617-017-00-X
reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene
412-140-3
32144-25-5
Org. Perox. D
Aquatic Chronic 4
H242
H413
GHS02
Dgr
H242
H413


T

617-018-00-5
reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight
410-840-3
71566-50-2
Org. Perox. C ****
Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411


T
617-019-00-0
6-(phthalimido)peroxyhexanoic acid
410-850-8
128275-31-0
Org. Perox. D
Eye Dam. 1
Aquatic Acute 1
H242
H318
H400
GHS02
GHS05
GHS09
DgDgr
H242
H318
H400


T
617-020-00-6
1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)
420-060-5
117663-11-3
Flam. Liq. 3
Org. Perox. D ****
Aquatic Chronic 2
H226
H242
H411
GHS02
GHS09
Dgr
H226
H242
H411





617-021-00-1
methylethylketone peroxide trimer
429-320-2
—
Org. Perox. B****
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1
H241
H304
H315
H317
GHS01
GHS02
GHS08
GHS07
Dgr
H241
H304
H315
H317




617-022-00-7
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate
442-480-8
—
Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H242
H302
H314
H317
H411
GHS02
GHS05
GHS07
GHS09
Dgr
H242
H302
H314
H317
H411




647-001-00-8
glucosidase, β-
232-589-7
9001-22-3
Resp. Sens. 1
H334
GHS08
Dgr
H334



647-002-00-3
cellulase
232-734-4
9012-54-8
Resp. Sens. 1
H334
GHS08
Dgr
H334



647-003-00-9
cellobiohydrolase, exo-
253-465-9
37329-65-0
Resp. Sens. 1
H334
GHS08
Dgr
H334



647-004-00-4
cellulases with the exception of those specified elsewhere in this Annex
—
—
Resp. Sens. 1
H334
GHS08
Dgr
H334


A
647-005-00-X
bromelain, juice
232-572-4
9001-00-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-006-00-5
ficin
232-599-1
9001-33-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-007-00-0
papain
232-627-2
9001-73-4
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-008-00-6
pepsin A
232-629-3
9001-75-6
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-009-00-1
rennin
232-645-0
9001-98-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-010-00-7
trypsin
232-650-8
9002-07-7
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-011-00-2
chymotrypsin
232-671-2
9004-07-3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-012-00-8
subtilisin
232-752-2
9014-01-1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
H335
H315
H318
H334
GHS08
GHS05 GHS07
Dgr
H335
H315
H318
H334



647-013-00-3
proteinase, microbial neutral
232-966-6
9068-59-1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-014-00-9
proteases with the exception of those specified elsewhere in this Annex
—
—
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H319
H335
H315
H334
GHS08
GHS07
Dgr
H319
H335
H315
H334



647-015-00-4
amylase, α-
232-565-6
9000-90-2
Resp. Sens. 1
H334
GHS08
Dgr
H334



647-016-00-X
amylases with the exception of those specified elsewhere in this Annex
—
—
Resp. Sens. 1
H334
GHS08
Dgr
H334





647-017-00-5
laccase
420-150-4
80498-15-3
Resp. Sens. 1
H334
GHS08
Dgr
H334




648-001-00-0
Distillates (coal tar), benzole fraction;
Light Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]
283-482-7
84650-02-2
Carc. 1B
H350
GHS08
Dgr
H350


H


648-002-00-6
Tar oils, brown-coal;
Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]
302-674-4
94114-40-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-003-00-1
Benzol forerunnings (coal);
Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]
266-023-5
65996-88-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-004-00-7
Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]
309-984-9
101896-26-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-005-00-2
Aromatic hydrocarbons, C6-10, C8-rich;
Light Oil Redistillate, low boiling
292-697-5
90989-41-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-006-00-8
Solvent naphtha (coal), light;
Light Oil Redistillate, low boiling
287-498-5
85536-17-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-007-00-3
Solvent naphtha (coal), xylene-styrene cut;
Light Oil Redistillate, intermediate boiling
287-502-5
85536-20-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-008-00-9
Solvent naphtha (coal), coumarone-styrene contg.;
Light Oil Redistillate, intermediate boiling
287-500-4
85536-19-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-009-00-4
Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
292-636-2
90641-12-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-010-00-X
Aromatic hydrocarbons, C8;
Light Oil Redistillate, high boiling
292-694-9
90989-38-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-012-00-0
Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]
295-281-1
91995-20-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-013-00-6
Aromatic hydrocarbons, C9-12, benzene distn.;
Light Oil Redistillate, high boiling
295-551-9
92062-36-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-014-00-1
Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]
295-323-9
91995-61-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-015-00-7
Extract residues (coal tar), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]
309-868-8
101316-63-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-016-00-2
Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]
298-725-2
93821-38-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-017-00-8
Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]
292-625-2
90641-02-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-018-00-3
Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling
309-867-2
101316-62-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-019-00-9
Extract residues (coal), light oil alk., indene naphtha fraction;
Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]
292-626-8
90641-03-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-020-00-4
Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]
266-013-0
65996-79-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-021-00-X
Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]
309-971-8
101794-90-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-022-00-5
Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;
[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]
292-609-5
90640-87-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-023-00-0
Distillates (coal tar), light oils; Carbolic Oil;
[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]
283-483-2
84650-03-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-024-00-6
Tar oils, coal;
Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]
266-016-7
65996-82-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-026-00-7
Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue;
[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]
292-624-7
90641-01-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-027-00-2
Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue;
[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]
266-021-4
65996-87-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-028-00-8
Extract oils (coal), light oil;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-622-6
90640-99-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-029-00-3
Pyridine, alkyl derivs.;
Crude Tar Bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]
269-929-9
68391-11-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-030-00-9
Tar bases, coal, picoline fraction;
Distillate Bases;
[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]
295-548-2
92062-33-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-031-00-4
Tar bases, coal, lutidine fraction;
Distillate Bases
293-766-2
91082-52-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-032-00-X
Extract oils (coal), tar base, collidine fraction;
Distillate Bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]
273-077-3
68937-63-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-033-00-5
Tar bases, coal, collidine fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]
295-543-5
92062-28-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-034-00-0
Tar bases, coal, aniline fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]
295-541-4
92062-27-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-035-00-6
Tar bases, coal, toluidine fraction;
Distillate Bases
293-767-8
91082-53-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-036-00-1
Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]
295-292-1
91995-31-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-037-00-7
Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]
295-295-8
91995-35-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-038-00-2
Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;
Redistillates;
[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]
295-329-1
91995-66-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-039-00-8
Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]
310-170-0
122070-79-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-040-00-3
Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;
Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]
310-171-6
122070-80-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-041-00-9
Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]
309-851-5
101316-45-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-042-00-4
Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]
284-900-0
84989-11-7
Carc. 1B
H350
GHS08
Dgr
H350


H M


648-043-00-X
Creosote oil, acenaphthene fraction, acenaphthene-free;
Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]
292-606-9
90640-85-0
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-044-00-5
Distillates (coal tar), heavy oils;
Heavy Anthracene Oil;
[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]
292-607-4
90640-86-1
Carc. 1B
H350
GHS08
Dgr
H350


H
648-045-00-0
Distillates (coal tar), upper;
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]
266-026-1
65996-91-0
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-046-00-6
Anthracene oil, acid ext.;
Anthracene Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]
295-274-3
91995-14-1
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-047-00-1
Distillates (coal tar);
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]
266-027-7
65996-92-1
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-048-00-7
Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]
295-312-9
91995-51-6
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-049-00-2
Distillates (coal tar), pitch;
Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]
309-855-7
101316-49-8
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-050-00-8
Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]
295-304-5
91995-42-5
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-051-00-3
Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]
295-313-4
91995-52-7
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-052-00-9
Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract;
[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-296-6
97926-76-6
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-053-00-4
Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-297-1
97926-77-7
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-054-00-X
Pitch;
Pitch
263-072-4
61789-60-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-055-00-5
Pitch, coal tar, high-temp.;
Pitch;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-2
65996-93-2
Carc. 1B
H350
GHS08
Dgr
H350


H
648-056-00-0
Pitch, coal tar, high-temp., heat-treated;
Pitch;
[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
310-162-7
121575-60-8
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-057-00-6
Pitch, coal tar, high-temp., secondary;
Pitch Redistillate;
[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]
302-650-3
94114-13-3
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-058-00-1
Residues (coal tar), pitch distn.;
Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]
295-507-9
92061-94-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-059-00-7
Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]
295-535-1
92062-20-9
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-060-00-2
Tar, coal, storage residues;
Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]
293-764-1
91082-50-7
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-061-00-8
Tar, coal, high-temp., residues;
Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]
309-726-5
100684-51-3
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-062-00-3
Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]
273-615-7
68990-61-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-063-00-9
Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]
295-549-8
92062-34-5
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-064-00-4
Extract residues (coal), brown;
Coal Tar Extract;
[The residue from extraction of dried coal.]
294-285-0
91697-23-3
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-065-00-X
Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-454-1
92045-71-1
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-066-00-5
Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-455-7
92045-72-2
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-067-00-0
Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-298-7
97926-78-8
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-068-00-6
Tar, coal, low-temp., distn. residues;
Tar Oil, intermediate boiling;
[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]
309-887-1
101316-85-2
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-069-00-1
Pitch, coal tar, low-temp;
Pitch Residue;
[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-651-4
90669-57-1
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-070-00-7
Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-654-0
90669-59-3
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-071-00-2
Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised;
Pitch Residue, heat-treated;
[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]
292-653-5
90669-58-2
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-072-00-8
Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]
269-159-3
68188-48-7
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-073-00-3
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-956-6
101794-74-5
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-074-00-9
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-957-1
101794-75-6
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-075-00-4
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-958-7
101794-76-7
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-076-00-X
Pitch, coal tar-petroleum;
Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]
269-109-0
68187-57-5
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-077-00-5
Phenanthrene, distn. residues;
Heavy Anthracene Oil Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]
310-169-5
122070-78-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-078-00-0
Distillates (coal tar), upper, fluorene-free;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]
284-899-7
84989-10-6
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-079-00-6
Anthracene oil;
Anthracene oil;
[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]
292-602-7
90640-80-5
Carc. 1B
H350
GHS08
Dgr
H350


H M


648-080-00-1
Residues (coal tar), creosote oil distn.;
Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]
295-506-3
92061-93-3
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-081-00-7
Tar, coal;
Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]
232-361-7
8007-45-2
Carc. 1A
H350
GHS08
Dgr
H350


H
648-082-00-2
Tar, coal, high-temp.;
Coal tar;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]
266-024-0
65996-89-6
Carc. 1A
H350
GHS08
Dgr
H350


H
648-083-00-8
Tar, coal, low-temp.;
Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]
266-025-6
65996-90-9
Carc. 1A
H350
GHS08
Dgr
H350


H


648-084-00-3
Distillates (coal), coke-oven light oil, naphthalene cut;
Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]
285-076-5
85029-51-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-085-00-9
Distillates (coal tar), naphthalene oils;
Naphthalene Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]
283-484-8
84650-04-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-086-00-4
Distillates (coal tar), naphthalene oils, naphthalene-low;
Naphthalene Oil Redistillate;
[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]
284-898-1
84989-09-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-087-00-X
Distillates (coal tar), naphthalene oil crystn. mother liquor;
Naphthalene Oil Redistillate;
[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]
295-310-8
91995-49-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-088-00-5
Extract residues (coal), naphthalene oil, alk.;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]
310-166-9
121620-47-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-089-00-0
Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]
310-167-4
121620-48-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-090-00-6
Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]
292-612-1
90640-90-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-091-00-1
Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]
292-627-3
90641-04-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-092-00-7
Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]
309-985-4
101896-27-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-093-00-2
Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]
309-972-3
101794-91-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-094-00-8
Distillates (coal tar), naphthalene oils, acid exts.;
Methylnaphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]
295-309-2
91995-48-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-095-00-3
Extract residues (coal), naphthalene oil alk., distn. residues;
Methylnaphthalene Oil Extract Residue;
[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]
292-628-9
90641-05-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-096-00-9
Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue;
[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]
284-901-6
84989-12-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-097-00-4
Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]
310-165-3
121620-46-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-098-00-X
Creosote oil, acenaphthene fraction;
Wash Oil;
[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
292-605-3
90640-84-9
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-099-00-5
Creosote oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]
263-047-8
61789-28-4
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-100-00-9
Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]
274-565-9
70321-79-8
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-101-00-4
Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]
232-287-5
8001-58-9
Carc. 1B
H350
GHS08
Dgr
H350


H


648-102-00-X
Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]
310-189-4
122384-77-4
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-103-00-5
Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]
292-603-2
90640-81-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-104-00-0
Anthracene oil, anthracene-low;
Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]
292-604-8
90640-82-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-105-00-6
Residues (coal tar), anthracene oil distn.;
Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]
295-505-8
92061-92-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-106-00-1
Anthracene oil, anthracene paste, anthracene fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]
295-275-9
91995-15-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-107-00-7
Anthracene oil, anthracene paste, carbazole fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]
295-276-4
91995-16-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-108-00-2
Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]
295-278-5
91995-17-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-109-00-8
Tar oils, coal, low-temp.;
Tar Oil, high boiling;
[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]
309-889-2
101316-87-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-110-00-3
Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]
310-191-5
122384-78-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-111-00-9
Phenols, ammonia liquor ext.;
Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]
284-881-9
84988-93-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-112-00-4
Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-610-0
90640-88-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-113-00-X
Extracts, coal tar oil alk.;
Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
266-017-2
65996-83-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-114-00-5
Distillates (coal tar), naphthalene oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-611-6
90640-89-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-115-00-0
Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols;
[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]
292-629-4
90641-06-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-116-00-6
Tar acids, coal, crude;
Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]
266-019-3
65996-85-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-117-00-1
Tar acids, brown-coal, crude;
Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]
309-888-7
101316-86-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-118-00-7
Tar acids, brown-coal gasification;
Crude Phenols;
[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]
295-536-7
92062-22-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-119-00-2
Tar acids, distn. residues;
Distillate Phenols;
[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]
306-251-5
96690-55-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-120-00-8
Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-892-9
84989-04-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-121-00-3
Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]
284-893-4
84989-05-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-122-00-9
Tar acids, xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-895-5
84989-06-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-123-00-4
Tar acids, ethylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-891-3
84989-03-7
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-124-00-X
Tar acids, 3,5-xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]
284-896-0
84989-07-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-125-00-5
Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]
270-713-1
68477-23-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-126-00-0
Tar acids, cresylic, residues;
Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]
271-418-0
68555-24-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-127-00-6
Phenols, C9-11;
Distillate Phenols
293-435-2
91079-47-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-128-00-1
Tar acids, cresylic;
Distillate Phenols;
[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]
295-540-9
92062-26-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-129-00-7
Tar acids, brown-coal, C2-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]
302-662-9
94114-29-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-130-00-2
Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-623-1
90641-00-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-131-00-8
Tar bases, quinoline derivs.;
Distillate Bases
271-020-7
68513-87-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-132-00-3
Tar bases, coal, quinoline derivs. fraction;
Distillate Bases
274-560-1
70321-67-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-133-00-9
Tar bases, coal, distn. residues;
Distillate Bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]
295-544-0
92062-29-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-134-00-4
Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]
309-745-9
100801-63-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-135-00-X
Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]
309-748-5
100801-65-8
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-136-00-5
Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]
309-749-0
100801-66-9
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-137-00-0
Extract residues (coal), tar oil alk., naphthalene distn. residues;
Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]
277-567-8
73665-18-6
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-138-00-6
Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]
274-566-4
70321-80-1
Carc. 1B
H350
GHS08
Dgr
H350


H M

648-139-00-1
Tar acids, cresylic, sodium salts, caustic solns.;
Alkaline Extract
272-361-4
68815-21-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-140-00-7
Extract oils (coal), tar base;
Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]
266-020-9
65996-86-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-141-00-2
Tar bases, coal, crude;
Crude Tar Bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]
266-018-8
65996-84-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


HJM

648-142-00-8
Residues (coal), liq. solvent extn.;
[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]
302-681-2
94114-46-2
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-143-00-3
Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]
302-682-8
94114-47-3
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-144-00-9
Coal liquids, liq. solvent extn.;
[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]
302-683-3
94114-48-4
Carc. 1B
H350
GHS08
Dgr
H350


H M
648-145-00-4
Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]
309-885-0
101316-83-0
Carc. 1A
H350
GHS08
Dgr
H350


H
648-146-00-X
Tar, brown-coal, low-temp.;
[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]
309-886-6
101316-84-1
Carc. 1A
H350
GHS08
Dgr
H350


H


648-147-00-5
Light oil (coal), coke-oven;
Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]
266-012-5
65996-78-3
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-148-00-0
Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]
302-688-0
94114-52-0
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-149-00-6
Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-689-6
94114-53-1
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-150-00-1
Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-690-1
94114-54-2
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J


648-151-00-7
Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]
302-691-7
94114-55-3
Carc. 1B
H350
GHS08
Dgr
H350


H


648-152-00-2
Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]
302-692-2
94114-56-4
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-153-00-8
Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]
302-693-8
94114-57-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

648-154-00-3
Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]
302-694-3
94114-58-6
Carc. 2
H351
GHS08
Wng
H350


H
648-155-00-9
Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;
[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]
302-695-9
94114-59-7
Carc. 2
H351
GHS08
Wng
H350


H


648-156-00-4
Light oil (coal), semi-coking process;
Fresh oil;
[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]
292-635-7
90641-11-5
Carc. 1B
Muta. 1B
H350
H340
GHS08
Dgr
H350
H340


H J

649-001-00-3
Extracts (petroleum), light naphthenic distillate solvent
265-102-1
64742-03-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-002-00-9
Extracts (petroleum), heavy paraffinic distillate solvent
265-103-7
64742-04-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-003-00-4
Extracts (petroleum), light paraffinic distillate solvent
265-104-2
64742-05-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-004-00-X
Extracts (petroleum), heavy naphthenic distillate solvent
265-111-0
64742-11-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-005-00-5
Extracts (petroleum), light vacuum gas oil solvent
295-341-7
91995-78-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-006-00-0
hydrocarbons C26-55, arom-rich
307-753-7
97722-04-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-007-00-6
fatty acids, tall-oil, reaction products with iminodiethanol and boric acid
400-160-5
—
Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411



649-008-00-1
Residues (petroleum), atm. tower;
Heavy Fuel oil;
[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-045-2
64741-45-3
Carc. 1B
H350
GHS08
Dgr
H350


H
649-009-00-7
Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-058-3
64741-57-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-010-00-2
Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-063-0
64741-61-3
Carc. 1B
H350
GHS08
Dgr
H350


H
649-011-00-8
Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-064-6
64741-62-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-012-00-3
Residues (petroleum), hydrocracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]
265-076-1
64741-75-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-013-00-9
Residues (petroleum), thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-081-9
64741-80-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-014-00-4
Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-082-4
64741-81-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-015-00-X
Gas oils (petroleum), hydrotreated vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-162-9
64742-59-2
Carc. 1B
H350
GHS08
Dgr
H350


H
649-016-00-5
Residues (petroleum), hydrodesulfurized atmospheric tower;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-181-2
64742-78-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-017-00-0
Gas oils (petroleum), hydrodesulfurized heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-189-6
64742-86-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-018-00-6
Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-193-8
64742-90-1
Carc. 1B
H350
GHS08
Dgr
H350


H
649-019-00-1
Residues (petroleum), atmospheric;
Heavy Fuel oil;
[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-777-3
68333-22-2
Carc. 1B
H350
GHS08
Dgr
H350


H
649-020-00-7
Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-782-0
68333-26-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-021-00-2
Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
269-783-6
68333-27-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-022-00-8
Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
269-784-1
68333-28-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-023-00-3
Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil
270-674-0
68476-32-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-024-00-9
Fuel oil, residual;
Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]
270-675-6
68476-33-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-025-00-4
Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]
270-792-2
68478-13-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-026-00-X
Residues (petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-796-4
68478-17-1
Carc. 1B
H350
GHS08
Dgr
H350


H
649-027-00-5
Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-983-0
68512-61-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-028-00-0
Residues (petroleum), light vacuum;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-984-6
68512-62-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-029-00-6
Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]
271-013-9
68513-69-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-030-00-1
Fuel oil, No 6;
Heavy Fuel oil;
[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]
271-384-7
68553-00-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-031-00-7
Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]
271-763-7
68607-30-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-032-00-2
Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]
272-184-2
68783-08-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-033-00-8
Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;
Heavy Fuel oil;
[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]
272-187-9
68783-13-1
Carc. 1B
H350
GHS08
Dgr
H350


H
649-034-00-3
Distillates (petroleum), petroleum residues vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]
273-263-4
68955-27-1
Carc. 1B
H350
GHS08
Dgr
H350


H
649-035-00-9
Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[A complex residuum from the distillation of steam-cracked petroleum residues.]
273-272-3
68955-36-2
Carc. 1B
H350
GHS08
Dgr
H350


H
649-036-00-4
Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-683-0
70592-76-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-037-00-X
Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]
274-684-6
70592-77-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-038-00-5
Distillates (petroleum), vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-685-1
70592-78-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-039-00-0
Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
285-555-9
85117-03-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-040-00-6
Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]
292-657-7
90669-75-3
Carc. 1B
H350
GHS08
Dgr
H350


H
649-041-00-1
Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]
292-658-2
90669-76-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-042-00-7
Fuel oil, heavy, high-sulfur;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
295-396-7
92045-14-2
Carc. 1B
H350
GHS08
Dgr
H350


H
649-043-00-2
Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]
295-511-0
92061-97-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-044-00-8
Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]
295-990-6
92201-59-7
Carc. 1B
H350
GHS08
Dgr
H350


H
649-045-00-3
Residual oils (petroleum);
Heavy Fuel oil;
[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]
298-754-0
93821-66-0
Carc. 1B
H350
GHS08
Dgr
H350


H
649-046-00-9
Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]
308-733-0
98219-64-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-047-00-4
Distillates (petroleum), hydrodesulfurized full-range middle;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]
309-863-0
101316-57-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-048-00-X
Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]
265-069-3
64741-67-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-049-00-5
Petroleum;
Crude oil;
[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]
232-298-5
8002-05-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-050-00-0
Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]
265-051-5
64741-50-0
Carc. 1A
H350
GHS08
Dgr
H350


H
649-051-00-6
Distillates (petroleum), heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]
265-052-0
64741-51-1
Carc. 1A
H350
GHS08
Dgr
H350


H
649-052-00-1
Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-053-6
64741-52-2
Carc. 1A
H350
GHS08
Dgr
H350


H
649-053-00-7
Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-054-1
64741-53-3
Carc. 1A
H350
GHS08
Dgr
H350


H
649-054-00-2
Distillates (petroleum), acid-treated heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-117-3
64742-18-3
Carc. 1A
H350
GHS08
Dgr
H350


H
649-055-00-8
Distillates (petroleum), acid-treated light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-118-9
64742-19-4
Carc. 1A
H350
GHS08
Dgr
H350


H
649-056-00-3
Distillates (petroleum), acid-treated heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]
265-119-4
64742-20-7
Carc. 1A
H350
GHS08
Dgr
H350


H
649-057-00-9
Distillates (petroleum), acid-treated light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-121-5
64742-21-8
Carc. 1A
H350
GHS08
Dgr
H350


H
649-058-00-4
Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]
265-127-8
64742-27-4
Carc. 1A
H350
GHS08
Dgr
H350


H
649-059-00-X
Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-128-3
64742-28-5
Carc. 1A
H350
GHS08
Dgr
H350


H
649-060-00-5
Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-135-1
64742-34-3
Carc. 1A
H350
GHS08
Dgr
H350


H
649-061-00-0
Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-136-7
64742-35-4
Carc. 1A
H350
GHS08
Dgr
H350


H


649-062-00-6
Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-0
68477-73-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-063-00-1
Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-6
68477-74-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-064-00-7
Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-1
68477-75-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-065-00-2
Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-7
68477-76-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-066-00-8
Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-8
68477-79-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-067-00-3
Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-5
68477-83-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-068-00-9
Gases (petroleum), C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-6
68477-85-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-069-00-4
Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-1
68477-86-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-070-00-X
Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-7
68477-87-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-071-00-5
Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]
270-772-3
68477-90-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-072-00-0
Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-9
68477-91-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-073-00-6
Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-0
68477-94-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-074-00-1
Gases (petroleum), Girbotol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-6
68477-95-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-075-00-7
Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas
270-782-8
68477-99-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-076-00-2
Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-802-5
68478-21-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-077-00-8
Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-803-0
68478-22-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-078-00-3
Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]
270-804-6
68478-24-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-079-00-9
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-806-7
68478-26-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-080-00-4
Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]
270-813-5
68478-32-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-081-00-X
Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]
270-814-0
68478-33-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-082-00-5
Tail gas (petroleum), vacuum residues thermal cracker;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-815-6
68478-34-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-083-00-0
Hydrocarbons, C3-4-rich, petroleum distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]
270-990-9
68512-91-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-084-00-6
Gases (petroleum), full-range straight-run naphtha dehexanizer off;
petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-000-8
68513-15-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-085-00-1
Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]
271-001-3
68513-16-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-086-00-7
Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-002-9
68513-17-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-087-00-2
Residues (petroleum), alkylation splitter, C4-rich;
Petroleum gas;
[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27,8 °C (11 °F to 82 °F).]
271-010-2
68513-66-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-088-00-8
Hydrocarbons, C1-4;
Petroleum gas;
[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]
271-032-2
68514-31-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-089-00-3
Hydrocarbons, C1-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]
271-038-5
68514-36-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-090-00-9
Hydrocarbons, C1-3;
Petroleum gas;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]
271-259-7
68527-16-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-091-00-4
Hydrocarbons, C1-4, debutanizer fraction;
Petroleum gas
271-261-8
68527-19-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-092-00-X
Gases (petroleum), C1-5, wet;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
271-624-0
68602-83-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-093-00-5
Hydrocarbons, C2-4;
Petroleum gas
271-734-9
68606-25-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-094-00-0
Hydrocarbons, C3;
Petroleum gas
271-735-4
68606-26-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-095-00-6
Gases (petroleum), alkylation feed;
Petroleum gas;
[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
271-737-5
68606-27-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-096-00-1
Gases (petroleum), depropanizer bottoms fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]
271-742-2
68606-34-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-097-00-7
Gases (petroleum), refinery blend;
Petroleum gas;
[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-183-7
68783-07-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-098-00-2
Gases (petroleum), catalytic cracking;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
272-203-4
68783-64-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-099-00-8
Gases (petroleum), C2-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]
272-205-5
68783-65-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-100-00-1
Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-871-7
68918-99-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-101-00-7
Gases (petroleum), dehexanizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-872-2
68919-00-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-102-00-2
Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-878-5
68919-05-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-103-00-8
Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-879-0
68919-06-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-104-00-3
Gases (petroleum), straight-run naphtha catalytic reforming off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]
272-882-7
68919-09-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-105-00-9
Gases (petroleum), fluidized catalytic cracker splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]
272-893-7
68919-20-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-106-00-4
Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-883-2
68919-10-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-107-00-X
Gases (petroleum), catalytic cracked naphtha debutanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-169-3
68952-76-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-108-00-5
Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-170-9
68952-77-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-109-00-0
Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-175-6
68952-81-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-110-00-6
Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-176-1
68952-82-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-111-00-1
Gases (petroleum, light steam-cracked, butadiene conc.;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]
273-265-5
68955-28-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-112-00-7
Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
273-270-2
68955-34-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-113-00-2
Hydrocarbons, C4;
Petroleum gas
289-339-5
87741-01-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-114-00-8
Alkanes, C1-4, C3-rich;
Petroleum gas
292-456-4
90622-55-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-115-00-3
Gases (petroleum), steam-cracker C3-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]
295-404-9
92045-22-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-116-00-9
Hydrocarbons, C4, steam-cracker distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]
295-405-4
92045-23-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-117-00-4
Petroleum gases, liquefied, sweetened, C4 fraction;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]
295-463-0
92045-80-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKSU

649-118-00-X
Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;
Petroleum gas
306-004-1
95465-89-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-119-00-5
Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;
Petroleum gas
307-769-4
97722-19-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-120-00-0
Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]
270-746-1
68477-65-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-121-00-6
Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
270-747-7
68477-66-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-122-00-1
Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]
270-748-2
68477-67-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-123-00-7
Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-749-8
68477-68-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-124-00-2
Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-759-2
68477-77-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-125-00-8
Gases (petroleum), C6-8 catalytic reformer recycle;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-761-3
68477-80-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-126-00-3
Gases (petroleum), C6-8 catalytic reformer;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]
270-762-9
68477-81-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-127-00-9
Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;
Refinery gas
270-763-4
68477-82-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-128-00-4
Gases (petroleum), C2-return stream;
Refinery gas;
[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]
270-766-0
68477-84-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-129-00-X
Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-774-4
68477-92-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-130-00-5
Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]
270-776-5
68477-93-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-131-00-0
Gases (petroleum), hydrogen absorber off;
Refinery gas;
[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]
270-779-1
68477-96-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-132-00-6
Gases (petroleum), hydrogen-rich;
Refinery gas;
[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]
270-780-7
68477-97-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-133-00-1
Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-781-2
68477-98-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-134-00-7
Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
270-783-3
68478-00-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-135-00-2
Gases (petroleum), reformer make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-784-9
68478-01-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-136-00-8
Gases (petroleum), reforming hydrotreater;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-785-4
68478-02-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-137-00-3
Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
270-787-5
68478-03-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-138-00-9
Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-788-0
68478-04-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-139-00-4
Gases (petroleum), thermal cracking distn.;
Refinery gas;
[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-789-6
68478-05-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-140-00-X
Tail gas (petroleum), catalytic cracker refractionation absorber;
Refinery gas;
[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-805-1
68478-25-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-141-00-5
Tail gas (petroleum), catalytic reformed naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-807-2
68478-27-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-142-00-0
Tail gas (petroleum), catalytic reformed naphtha stabilizer;
Refinery gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-808-8
68478-28-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-143-00-6
Tail gas (petroleum), cracked distillate hydrotreater separator;
Refinery gas;
[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-809-3
68478-29-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-144-00-1
Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-810-9
68478-30-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-145-00-7
Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]
270-999-8
68513-14-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-146-00-2
Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-003-4
68513-18-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-147-00-8
Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-005-5
68513-19-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-148-00-3
Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]
271-258-1
68527-15-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-149-00-9
Gases (petroleum), benzene unit hydrotreater depentanizer overheads;
Refinery gas;
[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]
271-623-5
68602-82-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-150-00-4
Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;
Refinery gas;
[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
271-625-6
68602-84-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-151-00-X
Petroleum products, refinery gases;
Refinery gas;
[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-750-6
68607-11-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-152-00-5
Gases (petroleum), hydrocracking low-pressure separator;
Refinery gas;
[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-182-1
68783-06-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-153-00-0
Gases (petroleum), refinery;
Refinery gas;
[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-338-9
68814-67-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-154-00-6
Gases (petroleum), platformer products separator off;
Refinery gas;
[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
272-343-6
68814-90-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-155-00-1
Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]
272-775-5
68911-58-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-156-00-7
Gases (petroleum), hydrotreated sour kerosine flash drum;
Refinery gas;
[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
272-776-0
68911-59-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-157-00-2
Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]
272-873-8
68919-01-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-158-00-8
Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-874-3
68919-02-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-159-00-3
Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]
272-875-9
68919-03-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-160-00-9
Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-876-4
68919-04-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-161-00-4
Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]
272-880-6
68919-07-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-162-00-X
Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-881-1
68919-08-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-163-00-5
Gases (petroleum), tar stripper off;
Refinery gas;
[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-884-8
68919-11-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-164-00-0
Gases (petroleum), unifiner stripper off;
Refinery gas;
[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]
272-885-3
68919-12-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-165-00-6
Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]
273-173-5
68952-79-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-166-00-1
Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;
Refinery gas;
[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
273-174-0
68952-80-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-167-00-7
Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-269-7
68955-33-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-168-00-2
Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-563-5
68989-88-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-169-00-8
Gases (petroleum), gas oil diethanolamine scrubber off;
Refinery gas;
[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
295-397-2
92045-15-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-170-00-3
Gases (petroleum), gas oil hydrodesulfurization effluent;
Refinery gas;
[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
295-398-8
92045-16-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-171-00-9
Gases (petroleum), gas oil hydrodesulfurization purge;
Refinery gas;
[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
295-399-3
92045-17-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-172-00-4
Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
295-400-7
92045-18-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-173-00-X
Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]
295-401-2
92045-19-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-174-00-5
Gases (petroleum), residue visbaking off;
Refinery gas;
[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
295-402-8
92045-20-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-175-00-0
Foots oil (petroleum), acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-225-7
93924-31-3
Flam. Gas 1
Press. Gas
Carc. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340


H K U
649-176-00-6
Foots oil (petroleum), clay-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-226-2
93924-32-4
Flam. Gas 1
Press. Gas
Carc. 1B
H220
H350
H340
GHS02
GHS04
GHS08
Dgr
H220
H350
H340


H K U



649-177-00-1
Gases (petroleum), C3-4;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]
268-629-5
68131-75-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-178-00-7
Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;
Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-617-2
68307-98-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-179-00-2
Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-618-8
68307-99-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-180-00-8
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-619-3
68308-00-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-181-00-3
Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-620-9
68308-01-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-182-00-9
Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-630-3
68308-10-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-183-00-4
Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-623-5
68308-03-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-184-00-X
Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-624-0
68308-04-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-185-00-5
Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-625-6
68308-05-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-186-00-0
Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-626-1
68308-06-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-187-00-6
Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-627-7
68308-07-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-188-00-1
Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-629-8
68308-09-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-189-00-7
Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-631-9
68308-11-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-190-00-2
Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-632-4
68308-12-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-191-00-8
Gases (petroleum), catalytic cracked overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]
270-071-2
68409-99-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-193-00-9
Alkanes, C1-2;
Petroleum gas
270-651-5
68475-57-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-194-00-4
Alkanes, C2-3;
Petroleum gas
270-652-0
68475-58-1
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-195-00-X
Alkanes, C3-4;
petroleum gas
270-653-6
68475-59-2
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-196-00-5
Alkanes, C4-5;
Petroleum gas
270-654-1
68475-60-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-197-00-0
Fuel gases;
Petroleum gas;
[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]
270-667-2
68476-26-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-198-00-6
Fuel gases, crude oil of distillates;
Petroleum gas;
[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]
270-670-9
68476-29-9
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-199-00-1
Hydrocarbons, C3-4;
Petroleum gas
270-681-9
68476-40-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-200-00-5
Hydrocarbons, C4-5;
Petroleum gas
270-682-4
68476-42-6
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-201-00-0
Hydrocarbons, C2-4, C3-rich;
Petroleum gas
270-689-2
68476-49-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-202-00-6
Petroleum gases, liquefied;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]
270-704-2
68476-85-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKSU

649-203-00-1
Petroleum gases, liquefied, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]
270-705-8
68476-86-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKSU

649-204-00-7
gases (petroleum), C3-4, isobutane-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]
270-724-1
68477-33-8
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-205-00-2
Distillates (petroleum), C3-6, piperylene-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]
270-726-2
68477-35-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-206-00-8
Gases (petroleum), butane splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-750-3
68477-69-0
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-207-00-3
Gases (petroleum), C2-3-;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]
270-751-9
68477-70-3
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-208-00-9
Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-752-4
68477-71-4
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-209-00-4
Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-754-5
68477-72-5
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-210-00-X
Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-628-2
68308-08-7
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340


HKU

649-211-00-5
Foots oil (petroleum), carbon-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-126-0
97862-76-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-212-00-0
Distillates (petroleum), sweetened middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-088-7
64741-86-2
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-213-00-6
Gas oils (petroleum), solvent-refined;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-092-9
64741-90-8
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-214-00-1
Distillates (petroleum), solvent-refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-093-4
64741-91-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-215-00-7
Gas oils (petroleum), acid-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-112-6
64742-12-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-216-00-2
Distillates (petroleum), acid-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-113-1
64742-13-8
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-217-00-8
Distillates (petroleum), acid-treated light;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-114-7
64742-14-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-218-00-3
Gas oils (petroleum), chemically neutralized;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-129-9
64742-29-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-219-00-9
Distillates (petroleum), chemically neutralized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-130-4
64742-30-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-220-00-4
Distillates (petroleum), clay-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-139-3
64742-38-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-221-00-X
Distillates (petroleum), hydrotreated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-148-2
64742-46-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-222-00-5
Gas oils (petroleum), hydrodesulfurized;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-182-8
64742-79-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-223-00-0
Distillates (petroleum), hydrodesulfurized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-183-3
64742-80-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-224-00-6
Fuels, diesel;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]
269-822-7
68334-30-5
Carc. 2
H351
GHS08
Wng
H351


H N
649-225-00-1
Fuel oil, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]
270-671-4
68476-30-2
Carc. 2
H351
GHS08
Wng
H351


H
649-226-00-7
Fuel oil, No 4;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]
270-673-5
68476-31-3
Carc. 2
H351
GHS08
Wng
H351


H
649-227-00-2
Fuels, diesel, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]
270-676-1
68476-34-6
Carc. 2
H351
GHS08
Wng
H351


H
649-228-00-8
Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]
270-719-4
68477-29-2
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-229-00-3
Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]
270-721-5
68477-30-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-230-00-9
Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil — unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]
270-722-0
68477-31-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-231-00-4
Distillates (petroleum), highly refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]
292-615-8
90640-93-0
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-232-00-X
Distillates (petroleum) catalytic reformer, heavy arom. conc.;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
295-294-2
91995-34-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-233-00-5
Gas oils, paraffinic;
Gasoil — unspecified;
[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]
300-227-8
93924-33-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-234-00-0
Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil — unspecified
307-035-3
97488-96-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-235-00-6
Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-659-6
97675-85-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-236-00-1
Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-660-1
97675-86-0
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-237-00-7
Hydrocarbons, C11-17, solvent-extd. light naphthenic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
307-757-9
97722-08-2
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-238-00-2
Gas oils, hydrotreated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]
308-128-1
97862-78-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-239-00-8
Distillates (petroleum), carbon-treated light paraffinic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]
309-667-5
100683-97-4
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-240-00-3
Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-668-0
100683-98-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-241-00-9
Distillates (petroleum), intermediate paraffinic, clay-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-669-6
100683-99-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-242-00-4
Alkanes, C12-26-branched and linear
292-454-3
90622-53-0
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-243-00-X
Lubricating greases;
Grease;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]
278-011-7
74869-21-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-244-00-5
Slack wax (petroleum);
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
265-165-5
64742-61-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-245-00-0
Slack wax (petroleum), acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
292-659-8
90669-77-5
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-246-00-6
Slack wax (petroleum), clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]
292-660-3
90669-78-6
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-247-00-1
Slack wax (petroleum), hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
295-523-6
92062-09-4
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-248-00-7
Slack wax (petroleum), low-melting;
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-524-1
92062-10-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-249-00-2
Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-525-7
92062-11-8
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-250-00-8
Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-155-9
97863-04-2
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-251-00-3
Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-156-4
97863-05-3
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-252-00-9
Slack wax (petroleum), low-melting, silicic acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-158-5
97863-06-4
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-253-00-4
Slack wax (petroleum), carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]
309-723-9
100684-49-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-254-00-X
Petrolatum;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
232-373-2
8009-03-8
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-255-00-5
Petrolatum (petroleum), oxidized;
Petrolatum;
[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]
265-206-7
64743-01-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-256-00-0
Petrolatum (petroleum), alumina-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
285-098-5
85029-74-9
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-257-00-6
Petrolatum (petroleum), hydrotreated;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]
295-459-9
92045-77-7
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-258-00-1
Petrolatum (petroleum), carbon-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-149-6
97862-97-0
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-259-00-7
Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-150-1
97862-98-1
Carc. 1B
H350
GHS08
Dgr
H350


H N
649-260-00-2
Petrolatum (petroleum), clay-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]
309-706-6
100684-33-1
Carc. 1B
H350
GHS08
Dgr
H350


H N



649-261-00-8
Gasoline, natural;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]
232-349-1
8006-61-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-262-00-3
Naphtha;
Low boiling point naphtha;
[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]
232-443-2
8030-30-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-263-00-9
Ligroine;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]
232-453-7
8032-32-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-264-00-4
Naphtha (petroleum), heavy straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-041-0
64741-41-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-265-00-X
Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]
265-042-6
64741-42-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-266-00-5
Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]
265-046-8
64741-46-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-267-00-0
Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]
265-192-2
64742-89-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-268-00-6
Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]
270-077-5
68410-05-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-269-00-1
Gasoline, vapor-recovery;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C (– 4 °F to 384 °F).]
271-025-4
68514-15-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-270-00-7
Gasoline, straight-run, topping-plant;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]
271-727-0
68606-11-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-271-00-2
Naphtha (petroleum), unsweetened;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]
272-186-3
68783-12-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-272-00-8
Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]
272-931-2
68921-08-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-273-00-3
Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]
309-945-6
101631-20-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-274-00-9
Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]
265-066-7
64741-64-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-275-00-4
Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]
265-067-2
64741-65-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-276-00-X
Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]
265-068-8
64741-66-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-277-00-5
Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]
265-073-5
64741-70-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-278-00-0
Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]
265-086-6
64741-84-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-279-00-6
Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-095-5
64741-92-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-280-00-1
Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]
270-088-5
68410-71-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-281-00-7
Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]
270-349-3
68425-35-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-282-00-2
Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]
271-267-0
68527-27-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-283-00-8
Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]
295-315-5
91995-53-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-284-00-3
Naphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]
295-430-0
92045-49-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-285-00-9
Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]
295-436-3
92045-55-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-286-00-4
Naphtha (petroleum), isomerization, C6-fraction;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]
295-440-5
92045-58-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-287-00-X
Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]
295-446-8
92045-64-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-288-00-5
Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]
309-871-4
101316-67-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-289-00-0
Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-055-7
64741-54-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-290-00-6
Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-056-2
64741-55-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-291-00-1
Hydrocarbons, C3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]
270-686-6
68476-46-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-292-00-7
Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-185-8
68783-09-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-293-00-2
Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;
Low boiling point cat-cracked naphtha.;
[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]
295-311-3
91995-50-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-294-00-8
Naphtha (petroleum), heavy catalytic cracked, sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]
295-431-6
92045-50-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-295-00-3
Naphtha (petroleum), light catalytic cracked sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]
295-441-0
92045-59-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-296-00-9
Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]
295-794-0
92128-94-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-297-00-4
Hydrocarbons, C8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]
309-974-4
101794-97-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-298-00-X
Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;
Low boiling point cat-cracked naphtha
309-987-5
101896-28-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-299-00-5
Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
265-065-1
64741-63-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-300-00-9
Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-070-9
64741-68-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-301-00-4
Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]
270-660-4
68475-79-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-302-00-X
Hydrocarbons, C2-6, C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha
270-687-1
68476-47-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-303-00-5
Residues (petroleum), C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha;
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
270-794-3
68478-15-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-304-00-0
Naphtha (petroleum), light catalytic reformed, arom.-free;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]
270-993-5
68513-03-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-305-00-6
Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-008-1
68513-63-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-306-00-1
Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]
271-058-4
68514-79-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-307-00-7
Naphtha (petroleum), full-range reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]
272-895-8
68919-37-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-308-00-2
Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
273-271-8
68955-35-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-309-00-8
Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]
285-509-8
85116-58-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-310-00-3
Aromatic hydrocarbons, C8, catalytic reforming-derived;
Low boiling point cat-reformed naphtha
295-279-0
91995-18-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-311-00-9
Aromatic hydrocarbons, C7-12, C8-rich;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]
297-401-8
93571-75-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-312-00-4
Gasoline, C5-11, high-octane stabilised reformed;
Low boiling point cat-reformed naphtha;
[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]
297-458-9
93572-29-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-313-00-X
Hydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]
297-465-7
93572-35-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-314-00-5
Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]
297-466-2
93572-36-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P


649-315-00-0
Foots oil (petroleum), silicic acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-127-6
97862-77-6
Carc. 1B
H350
H304
GHS08
Dgr
H350
H304


H L


649-316-00-6
Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]
265-075-6
64741-74-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-317-00-1
Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]
265-085-0
64741-83-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-318-00-7
Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]
267-563-4
67891-79-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-319-00-2
Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]
267-565-5
67891-80-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-320-00-8
Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]
270-344-6
68425-29-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-321-00-3
Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]
270-658-3
68475-70-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-322-00-9
Distillates (petroleum), thermal cracked naphtha and gas oil;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]
271-631-9
68603-00-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-323-00-4
Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]
271-632-4
68603-01-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-324-00-X
Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]
271-634-5
68603-03-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-325-00-5
Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]
273-266-0
68955-29-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-326-00-0
Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]
295-447-3
92045-65-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-327-00-6
Naphtha (petroleum), hydrotreated heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-150-3
64742-48-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-328-00-1
Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]
265-151-9
64742-49-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-329-00-7
Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
265-178-6
64742-73-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-330-00-2
Naphtha (petroleum), hydrodesulfurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-185-4
64742-82-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-331-00-8
Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]
270-092-7
68410-96-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-332-00-3
Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]
270-093-2
68410-97-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-333-00-9
Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]
270-094-8
68410-98-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-334-00-4
Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]
270-988-8
68512-78-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-335-00-X
Naphtha (petroleum), hydrodesulfurized thermal cracked light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]
285-511-9
85116-60-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-336-00-5
Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
285-512-4
85116-61-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-337-00-0
Naphtha (petroleum), heavy steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha
295-432-1
92045-51-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-338-00-6
Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]
295-433-7
92045-52-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-339-00-1
Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]
295-438-4
92045-57-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-340-00-7
Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]
295-443-1
92045-61-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-341-00-2
Solvent naphtha (petroleum), hydrotreated light naphthenic;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]
295-529-9
92062-15-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-342-00-8
Naphtha (petroleum), light steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]
296-942-7
93165-55-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-343-00-3
Hydrocarbons, C6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-852-0
93763-33-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-344-00-9
Hydrocarbons, C9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-853-6
93763-34-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-345-00-4
Stoddard solvent;
Low boiling point naphtha - unspecified;
[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]
232-489-3
8052-41-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-346-00-X
Natural gas condensates (petroleum);
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]
265-047-3
64741-47-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-347-00-5
Natural gas (petroleum), raw liq. mix;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]
265-048-9
64741-48-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-348-00-0
Naphtha (petroleum), light hydrocracked;
Low boiling naphtha - unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]
265-071-4
64741-69-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-349-00-6
Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]
265-079-8
64741-78-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-350-00-1
Naphtha (petroleum), sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]
265-089-2
64741-87-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-351-00-7
Naphtha (petroleum), acid-treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-115-2
64742-15-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-352-00-2
Naphtha (petroleum), chemically neutralized heavy;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-122-0
64742-22-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-353-00-8
Naphtha (petroleum), chemically neutralized light;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
265-123-6
64742-23-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-354-00-3
Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]
265-170-2
64742-66-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-355-00-9
Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]
265-187-5
64742-83-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-356-00-4
Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]
265-199-0
64742-95-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-357-00-X
Aromatic hydrocarbons, C6-10, acid-treated, neutralized;
Low boiling point naphtha - unspecified
268-618-5
68131-49-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-358-00-5
Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]
270-725-7
68477-34-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-359-00-0
Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-735-1
68477-50-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-360-00-6
Distillates (petroleum), steam-cracked, C5-12 fraction;
Low boiling point naphtha - unspecified;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-736-7
68477-53-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-361-00-1
Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;
Low boiling point naphtha - unspecified
270-738-8
68477-55-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-362-00-7
Extracts (petroleum), cold-acid, C4-6;
Low boiling point naphtha - unspecified;
[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
270-741-4
68477-61-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-363-00-2
Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-771-8
68477-89-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-364-00-8
Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha - unspecified;
[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-791-7
68478-12-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr



H P

649-365-00-3
Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha - unspecified;
[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-795-9
68478-16-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-366-00-9
Naphtha (petroleum), full-range coker;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]
270-991-4
68513-02-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-367-00-4
Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]
271-138-9
68516-20-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-368-00-X
Naphtha (petroleum), clay-treated full-range straight-run;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]
271-262-3
68527-21-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-369-00-5
Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]
271-263-9
68527-22-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-370-00-0
Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]
271-264-4
68527-23-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-371-00-6
Naphtha (petroleum), light steam-cracked, debenzenized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]
271-266-5
68527-26-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-372-00-1
Naphtha (petroleum), arom.-contg.;
Low boiling point naphtha - unspecified
271-635-0
68603-08-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-373-00-7
Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]
271-726-5
68606-10-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-374-00-2
Naphtha (petroleum), light, sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]
272-206-0
68783-66-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-375-00-8
Natural gas condensates;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]
272-896-3
68919-39-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-376-00-3
Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
272-932-8
68921-09-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-377-00-9
Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]
285-510-3
85116-59-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-378-00-4
Gasoline;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]
289-220-8
86290-81-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-379-00-X
Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;
Low boiling point naphtha - unspecified
292-698-0
90989-42-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-380-00-5
Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]
295-298-4
91995-38-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-381-00-0
Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
295-302-4
91995-41-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-382-00-6
Extracts (petroleum), catalytic reformed light naphtha solvent;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]
295-331-2
91995-68-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-383-00-1
Naphtha (petroleum), hydrodesulfurized light, dearomatized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]
295-434-2
92045-53-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-384-00-7
Naphtha (petroleum), light, C5-rich, sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]
295-442-6
92045-60-8
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-385-00-2
Hydrocarbons, C8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]
295-444-7
92045-62-0
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-386-00-8
Hydrocarbons, C4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]
295-445-2
92045-63-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-387-00-3
Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]
296-028-8
92201-97-3
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-388-00-9
Distillates (petroleum), C6-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]
296-903-4
93165-19-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-389-00-4
Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha-unspecified;
[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]
302-639-3
94114-03-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-390-00-X
Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
305-750-5
95009-23-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-391-00-5
Extracts (petroleum) heavy naphtha solvent, clay-treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]
308-261-5
97926-43-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-392-00-0
Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]
308-713-1
98219-46-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-393-00-6
Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]
308-714-7
98219-47-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-394-00-1
Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]
309-862-5
101316-56-7
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-395-00-7
Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]
309-870-9
101316-66-9
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-396-00-2
Naphtha (petroleum), hydrodesulfurised full-range coker;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]
309-879-8
101316-76-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-397-00-8
Naphtha (petroleum), sweetened light;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]
309-976-5
101795-01-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-398-00-3
Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]
310-012-0
102110-14-5
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-399-00-9
Hydrocarbons, C5-rich, dicyclopentadiene-contg.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]
310-013-6
102110-15-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-400-00-2
Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]
310-057-6
102110-55-4
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-401-00-8
Hydrocarbons, C≥5, C5-6-rich;
Low boiling point naphtha - unspecified
270-690-8
68476-50-6
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-402-00-3
Hydrocarbons, C5-rich;
Low boiling point naphtha - unspecified
270-695-5
68476-55-1
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-403-00-9
Aromatic hydrocarbons, C8-10;
Low boiling point naphtha - unspecified
292-695-4
90989-39-2
Carc. 1B
Muta. 1B
Asp. Tox. 1
H350
H340
H304
GHS08
Dgr
H350
H340
H304


H P

649-404-00-4
Kerosine (petroleum);
Straight run kerosine;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]
232-366-4
8008-20-6
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-405-00-X
Solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]
265-191-7
64742-88-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-406-00-5
Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]
265-200-4
64742-96-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-407-00-0
Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]
295-418-5
92045-37-9
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-408-00-6
Distillates (petroleum), steam-cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]
265-194-3
64742-91-2
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-409-00-1
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]
270-728-3
68477-39-4
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-410-00-7
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]
270-729-9
68477-40-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-411-00-2
Distillates (petroleum), steam-cracked, C8-12 fraction;
Cracked kerosine;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
270-737-2
68477-54-3
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-412-00-8
Kerosine (petroleum), hydrodesulfurized thermal cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]
285-507-7
85116-55-8
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-413-00-3
Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]
292-621-0
90640-98-5
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-414-00-9
Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]
292-637-8
90641-13-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-415-00-4
Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]
309-866-7
101316-61-4
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-416-00-X
Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-938-8
101631-13-4
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-417-00-5
Solvent naphtha (petroleum), hydrocracked heavy arom.;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]
309-881-9
101316-80-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-418-00-0
Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-940-9
101631-15-6
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-419-00-6
Distillates (petroleum), alkylate;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]
265-074-0
64741-73-7
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-420-00-1
Extracts (petroleum), heavy naphtha solvent;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-099-7
64741-98-6
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-421-00-7
Distillates (petroleum), chemically neutralized light;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-132-5
64742-31-0
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-422-00-2
Distillates (petroleum), hydrotreated light;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-149-8
64742-47-8
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-423-00-8
Kerosine (petroleum), hydrodesulfurized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-184-9
64742-81-0
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-424-00-3
Solvent naphtha (petroleum), heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]
265-198-5
64742-94-5
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-425-00-9
Naphtha (petroleum), heavy coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]
269-778-9
68333-23-3
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-426-00-4
Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]
285-508-2
85116-57-0
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-427-00-X
Kerosine (petroleum), sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]
294-799-5
91770-15-9
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-428-00-5
Kerosine (petroleum), solvent-refined sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]
295-416-4
92045-36-8
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-429-00-0
Hydrocarbons, C9-16, hydrotreated, dearomatized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-854-1
93763-35-0
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-430-00-6
Kerosine (petroleum), solvent-refined hydrodesulfurized;
Kerosine — unspecified
307-033-2
97488-94-3
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-431-00-1
Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]
309-864-6
101316-58-9
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-432-00-7
Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]
309-882-4
101316-81-8
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-433-00-2
Solvent naphtha (petroleum), hydrodesulfurized medium;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]
309-884-5
101316-82-9
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-434-00-8
Kerosine (petroleum), hydrotreated;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]
309-944-0
101631-19-0
Asp. Tox. 1
H304
GHS08
Dgr
H304


H
649-435-00-3
Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
265-060-4
64741-59-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-436-00-9
Distillates (petroleum), intermediate catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
265-062-5
64741-60-2
Carc. 1B
H350
GHS08
Dgr
H350


H
649-437-00-4
Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]
265-078-2
64741-77-1
Carc. 2
H351
GHS08
Wng
H351


H
649-438-00-X
Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]
265-084-5
64741-82-8
Carc. 1B
H350
GHS08
Dgr
H350


H
649-439-00-5
Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
269-781-5
68333-25-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-440-00-0
Distillates (petroleum), light steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]
270-662-5
68475-80-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-441-00-6
Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]
270-727-8
68477-38-3
Carc. 1B
H350
GHS08
Dgr
H350


H
649-442-00-1
Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]
271-260-2
68527-18-4
Carc. 1B
H350
GHS08
Dgr
H350


H
649-443-00-7
Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
285-505-6
85116-53-6
Carc. 1B
H350
GHS08
Dgr
H350


H
649-444-00-2
Gas oils (petroleum), thermal-cracked, hydrodesulfurized;
Cracked gasoil
295-411-7
92045-29-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-445-00-8
Residues (petroleum), hydrogenated steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]
295-514-7
92062-00-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-446-00-3
Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]
295-517-3
92062-04-9
Carc. 1B
H350
GHS08
Dgr
H350


H
649-447-00-9
Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]
295-991-1
92201-60-0
Carc. 1B
H350
GHS08
Dgr
H350


H
649-448-00-4
Residues (petroleum), steam-cracked heat-soaked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]
297-905-8
93763-85-0
Carc. 1B
H350
GHS08
Dgr
H350


H
649-449-00-X
Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]
307-662-2
97675-88-2
Carc. 2
H351
GHS08
Wng
H351


H
649-450-00-5
Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]
308-278-8
97926-59-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-451-00-0
Distillates (petroleum), hydrodesulfurized middle coker;
Cracked gasoil;
[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]
309-865-1
101316-59-0
Carc. 1B
H350
GHS08
Dgr
H350


H
649-452-00-6
Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]
309-939-3
101631-14-5
Carc. 1B
H350
GHS08
Dgr
H350


H
649-453-00-1
Distillates (petroleum), heavy hydrocracked;
Baseoil — unspecified;
[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]
265-077-7
64741-76-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-454-00-7
Distillates (petroleum), solvent-refined heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-090-8
64741-88-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-455-00-2
Distillates (petroleum), solvent-refined light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-091-3
64741-89-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-456-00-8
Residual oils (petroleum), solvent deasphalted;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-096-0
64741-95-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-457-00-3
Distillates (petroleum), solvent-refined heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]
265-097-6
64741-96-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-458-00-9
Distillates (petroleum), solvent-refined light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-098-1
64741-97-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-459-00-4
Residual oils (petroleum,) solvent-refined;
Baseoil — unspecified;
[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-101-6
64742-01-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-460-00-X
Distillates (petroleum), clay-treated paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-137-2
64742-36-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-461-00-5
Distillates (petroleum), clay-treated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-138-8
64742-37-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-462-00-0
Residual oils (petroleum), clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-143-5
64742-41-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-463-00-6
Distillates (petroleum), clay-treated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-146-1
64742-44-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-464-00-1
Distillates (petroleum), clay-treated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-147-7
64742-45-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-465-00-7
Distillates (petroleum), hydrotreated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-155-0
64742-52-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-466-00-2
Distillates (petroleum), hydrotreated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-156-6
64742-53-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-467-00-8
Distillates (petroleum), hydrotreated heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-157-1
64742-54-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-468-00-3
Distillates (petroleum), hydrotreated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-158-7
64742-55-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-469-00-9
Distillates (petroleum), solvent-dewaxed light paraffinic;
Baseoil — unspecified;
[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-159-2
64742-56-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-470-00-4
Residual oils (petroleum), hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-160-8
64742-57-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-471-00-X
Residual oils (petroleum), solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-166-0
64742-62-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-472-00-5
Distillates (petroleum), solvent-dewaxed heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-167-6
64742-63-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-473-00-0
Distillates (petroleum), solvent-dewaxed light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-168-1
64742-64-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-474-00-6
Distillates (petroleum), solvent-dewaxed heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-169-7
64742-65-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-475-00-1
Naphthenic oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-172-3
64742-68-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-476-00-7
Naphthenic oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-173-9
64742-69-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-477-00-2
Paraffin oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-174-4
64742-70-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-478-00-8
Paraffin oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-176-5
64742-71-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-479-00-3
Naphthenic oils (petroleum), complex dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-179-1
64742-75-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-480-00-9
Naphthenic oils (petroleum), complex dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-180-7
64742-76-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-481-00-4
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-736-3
72623-85-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-482-00-X
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]
276-737-9
72623-86-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-483-00-5
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-738-4
72623-87-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-484-00-0
Lubricating oils;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]
278-012-2
74869-22-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-485-00-6
Distillates (petroleum), complex dewaxed heavy paraffinci;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-613-7
90640-91-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-486-00-1
Distillates (petroleum), complex dewaxed light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-614-2
90640-92-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-487-00-7
Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-616-3
90640-94-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-488-00-2
Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-617-9
90640-95-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-489-00-8
Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-618-4
90640-96-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-490-00-3
Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-620-5
90640-97-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-491-00-9
Residual oils (petroleum), hydrotreated solvent dewaxed;
Baseoil — unspecified
292-656-1
90669-74-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-492-00-4
Residual oils (petroleum), catalytic dewaxed;
Baseoil — unspecified
294-843-3
91770-57-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-493-00-X
Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]
295-300-3
91995-39-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-494-00-5
Distillates (petroleum), dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]
295-301-9
91995-40-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-495-00-0
Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
Baseoil — unspecified;
[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]
295-306-6
91995-45-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-496-00-6
Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]
295-316-0
91995-54-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-497-00-1
Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;
Baseoil — unspecified
295-423-2
92045-42-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-498-00-7
Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
Baseoil — unspecified
295-424-8
92045-43-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-499-00-2
Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]
295-499-7
92061-86-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-500-00-6
Paraffin oils (petroleum), solvent-refined dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]
295-810-6
92129-09-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-501-00-1
Lubricating oils (petroleum), base oils, paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]
297-474-6
93572-43-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-502-00-7
Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
Baseoil — unspecified
297-857-8
93763-38-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-503-00-2
Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;
Baseoil — unspecified
300-257-1
93924-61-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-504-00-8
Distillates (petroleum), solvent-refined hydrotreated heavy;
hydrogenated;
Baseoil — unspecified
305-588-5
94733-08-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-505-00-3
Distillates (petroleum), solvent-refined hydrocracked light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]
305-589-0
94733-09-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-506-00-9
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-594-8
94733-15-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-507-00-4
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-595-3
94733-16-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-508-00-X
Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-971-7
95371-04-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-509-00-5
Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-972-2
95371-05-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-510-00-0
Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
Baseoil — unspecified
305-974-3
95371-07-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-511-00-6
Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;
Baseoil — unspecified
305-975-9
95371-08-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-512-00-1
Distillates (petroleum), hydrocracked solvent-refined light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]
307-010-7
97488-73-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-513-00-7
Distillates (petroleum), solvent-refined hydrogenated heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]
307-011-2
97488-74-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-514-00-2
Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;
Baseoil — unspecified
307-034-8
97488-95-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-515-00-8
Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]
307-661-7
97675-87-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-516-00-3
Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]
307-755-8
97722-06-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-517-00-9
Hydrocarbons, C13-27, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).]
307-758-4
97722-09-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-518-00-4
Hydrocarbons, C14-29, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]
307-760-5
97722-10-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-519-00-X
Hydrocarbons, C27-42, dearomatized;
Baseoil — unspecified
308-131-8
97862-81-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-520-00-5
Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;
Baseoil — unspecified
308-132-3
97862-82-3
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-521-00-0
Hydrocarbons, C27-45, naphthenic vacuum distn.;
Baseoil — unspecified
308-133-9
97862-83-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-522-00-6
Hydrocarbons, C27-45, dearomatized;
Baseoil — unspecified
308-287-7
97926-68-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-523-00-1
Hydrocarbons, C20-58, hydrotreated;
Baseoil — unspecified
308-289-8
97926-70-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-524-00-7
Hydrocarbons, C27-42, naphthenic;
Baseoil — unspecified
308-290-3
97926-71-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-525-00-2
Residual oils (petroleum), carbon-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]
309-710-8
100684-37-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-526-00-8
Residual oils (petroleum), clay-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]
309-711-3
100684-38-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-527-00-3
Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]
309-874-0
101316-69-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-528-00-9
Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]
309-875-6
101316-70-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-529-00-4
Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]
309-876-1
101316-71-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-530-00-X
Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]
309-877-7
101316-72-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-531-00-5
Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]
272-175-3
68783-00-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-532-00-0
Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
272-180-0
68783-04-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-533-00-6
Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]
272-342-0
68814-89-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-534-00-1
Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]
292-631-5
90641-07-9
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-535-00-7
Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).
292-632-0
90641-08-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-536-00-2
Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]
292-633-6
90641-09-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-537-00-8
Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
295-335-4
91995-73-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-538-00-3
Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
295-338-0
91995-75-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-539-00-9
Extracts (petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
295-339-6
91995-76-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-540-00-4
Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]
295-340-1
91995-77-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-541-00-X
Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
295-342-2
91995-79-8
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-542-00-5
Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
296-437-1
92704-08-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-543-00-0
Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-827-4
93763-10-1
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-544-00-6
Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-829-5
93763-11-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-545-00-1
Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-672-2
100684-02-4
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-546-00-7
Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-673-8
100684-03-5
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-547-00-2
Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-674-3
100684-04-6
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-548-00-8
Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-675-9
100684-05-7
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-549-00-3
Foots oil (petroleum);
Foots oil;
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
265-171-8
64742-67-2
Carc. 1B
H350
GHS08
Dgr
H350


H L
649-550-00-9
Foots oil (petroleum), hydrotreated;
Foots oil
295-394-6
92045-12-0
Carc. 1B
H350
GHS08
Dgr
H350


H L
650-002-00-6
turpentine, oil
232-350-7
8006-64-2
Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H226
H332
H312
H302
H304
H319
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Dgr
H226
H332
H312
H302
H304
H319
H315
H317
H411



650-003-00-1
fenson (ISO);
4-chlorophenyl benzenesulphonate;
201-274-6
80-38-6
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2
H302
H319
H411
GHS07
GHS09
Wng
H302
H319
H411



650-004-00-7
norbormide (ISO);
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide
213-589-6
991-42-4
Acute Tox. 4 *
H302
GHS07
Wng
H302



650-005-00-2
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone
201-501-9
83-79-4
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H335
H315
H400
H410
GHS06
GHS09
Dgr
H301
H319
H335
H315
H410



650-006-00-8
benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime
207-807-9
495-73-8
Acute Tox. 3 *
Acute Tox. 4 *
H301
H312
GHS06
Dgr
H301
H312



650-007-00-3
chlordimeform (ISO);
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine
228-200-5
6164-98-3
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H312
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H312
H302
H410



650-008-00-9
drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
227-197-8
5707-69-7
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410



650-009-00-4
chlordimeform hydrochloride;
N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride
243-269-1
19750-95-9
Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410



650-010-00-X
benzyl violet 4B;
α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate
216-901-9
1694-09-3
Carc. 2
H351
GHS08
Wng
H351



650-012-00-0
erionite
—
12510-42-8
Carc. 1A
H350
GHS08
Dgr
H350



650-013-00-6
asbestos
—
—
—
—
—
—
—
12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5
Carc. 1A
STOT RE 1
H350
H372 **
GHS08
Dgr
H350
H372 **



650-014-00-1
diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate
401-770-4
—
Skin Corr. 1B
Acute Tox. 4 *
H314
H302
GHS05
GHS07
Dgr
H314
H302



650-015-00-7
rosin;
colophony
232-475-7
232-484-6
277-299-1
8050-09-7
8052-10-6
73138-82-6
Skin Sens. 1
H317
GHS07
Wng
H317





650-016-00-2
Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
—
—
Carc. 2
H351
GHS08
Wng
H351


AQR

650-017-00-8
Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
—
—
Carc. 1B
H350i
GHS08
Dgr
H350i


AR

650-018-00-3
Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid
406-230-1
—
Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H226
H351
H314
H332
H317
H400
H410
GHS02
GHS08
GHS05 GHS07
GHS09
Dgr
H226
H351
H314
H332
H317
H410



650-031-00-4
bis(4-hydroxy-N-methylanilinium) sulphate
200-237-1
55-55-0
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410



650-032-00-X
cyproconazole (ISO);
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol
—
94361-06-5
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H302
H400
H410
GHS08
GHS07 GHS09
Wng
H361d ***
H302
H410




650-033-00-5
(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;
esfenvalerate
—
66230-04-4
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H301
H317
H400
H410
GHS06
GHS09
Dgr
H331
H301
H317
H410




650-041-00-9
triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
—
82097-50-5
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410



650-042-00-4
reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates
417-450-2
—
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H319
H315
H317
H412
GHS07
Wng
H319
H315
H317
H412



650-043-00-X
reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate
420-310-3
—
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410



650-044-00-5
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin
420-480-9
158570-99-1
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H317
H400
H410
GHS07
GHS09
Wng
H315
H317
H410



650-045-00-0
reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate
417-110-3
—
Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H225
H315
H318
H411
GHS02
GHS05
GHS09
Dgr
H225
H315
H318
H411



650-046-00-6
di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates
416-180-2
12222-04-7
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2
H302
H373 **
H411
GHS08
GHS07
GHS09
Wng
H302
H373 **
H411



650-047-00-1
dibenzylphenylsulfonium hexafluoroantimonate
417-760-8
134164-24-2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H372 **
H302
H318
H317
H411
GHS08
GHS05 GHS07
GHS09
Dgr
H372 **
H302
H318
H317
H411



650-048-00-7
reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid
420-070-1
—
Org. Perox. D ****
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
H242
H332
H312
H302
H314
H400
GHS02
GHS05 GHS07
GHS09
Dgr
H242
H332
H312
H302
H314
H400



650-049-00-2
2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl
417-960-5
—
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05 GHS07
GHS09
Dgr
H315
H318
H317
H410



650-050-00-8
reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers
423-600-8
—
Aquatic Chronic 2
H411
GHS09
H411



650-055-00-5
silver sodium zirconium hydrogenphosphate
422-570-3
155925-27-2
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410





Table 3.2
The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC

Index No
International Chemical Identification
EC No
CAS No
Classification
Labelling
Concentration Limits
Notes
001-001-00-9
hydrogen
215-605-7
1333-74-0
F+; R12
F+
R: 12
S: (2-)9-16-33




001-002-00-4
aluminium lithium hydride
240-877-9
16853-85-3
F; R15
C; R35
F; C
R: 15-35
S: (1/2-)7/8-26-36/37/39-43-45



001-003-00-X
sodium hydride
231-587-3
7646-69-7
F; R15
F
R: 15
S: (2-)7/8-24/25-43


001-004-00-5
calcium hydride
232-189-2
7789-78-8
F; R15
F
R: 15
S: (2-)7/8-24/25-43


003-001-00-4
lithium
231-102-5
7439-93-2
F; R15
R14
C; R34
F; C
R: 14/15-34
S: (1/2-)8-43-45


003-002-00-X
n-hexyllithium
404-950-0
21369-64-2
F; R15-17
R14
C; R35
F; C
R: 14/15-17-35
S: (1/2-)6-16-26-30-36/37/39-43-45




003-003-00-5
(2-methylpropyl)lithium;
isobutyllithium
440-620-2
920-36-5
F; R15-17
R14
C; R35
R67
N; R50-53
F; C; N
R: 14/15-17-35-67-50/53
S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61




004-001-00-7
beryllium
231-150-7
7440-41-7
Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43
T+
R: 49-25-26-36/37/38-43-48/23
S: 53-45

E
004-002-00-2
beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex
—
—
Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43
N; R51-53
T+; N
R: 49-25-26-36/37/38-43-48/23-51/53
S: 53-45-61

AE
004-003-00-8
beryllium oxide
215-133-1
1304-56-9
Carc. Cat. 2; R49
T+; R26
T; R25-48/23
Xi; R36/37/38
R43
T+
R: 49-25-26-36/37/38-43-48/23
S: 53-45

E
005-001-00-X
boron trifluoride
231-569-5
7637-07-2
R14
T+; R26
C; R35
T+; C
R: 14-26-35
S: (1/2-)9-26-28-36/37/39-45


005-002-00-5
boron trichloride
233-658-4
10294-34-5
R14
T+; R26/28
C; R34
T+
R: 14-26/28-34
S: (1/2-)9-26-28-36/37/39-45


005-003-00-0
boron tribromide
233-657-9
10294-33-4
R14
T+; R26/28
C; R35
T+; C
R: 14-26/28-35
S: (1/2-)9-26-28-36/37/39-45


005-004-00-6
trialkylboranes
—
—
F; R17
C; R34
F; C
R: 17-34
S: (1/2-)7-23-26-36/37/39-43-45

A
005-005-00-1
trimethyl borate
204-468-9
121-43-7
R10
Xn; R21
Xn
R: 10-21
S: (2-)23-25





005-006-00-7
dibutyltin hydrogen borate
401-040-5
75113-37-0
Muta. Cat. 3; R68
Repr. Cat. 2; R60-61
T; R48/25
Xn; R21/22
Xi; R41
R43
N; R50-53
T; N
R: 60-61-21/22-41-43-48/25-68-50/53
S: 53-45-60-61

E



005-007-00-2
boric acid; [1]
boric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
Repr. Cat. 2; R60-61: C ≥ 5,5 %


005-008-00-8
diboron trioxide;
boric oxide
215-125-8
1303-86-2
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
Repr. Cat. 2; R60-61: C ≥ 3,1 %


005-009-00-3
tetrabutylammonium butyltriphenylborate
418-080-4
120307-06-4
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-56-61


005-010-00-9
N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate
422-050-6
118612-00-3
Carc. Cat. 3; R40
Xn; R22
Xi; R38-41
Xn
R: 22-38-40-41
S: (2-)22-26-36/37/39




005-011-00-4
disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]
215-540-4 [1]
235-541-3 [2]
237-560-2 [3]
1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
Repr. Cat. 2; R60-61: C ≥ 4,5 %


005-011-01-1
disodium tetraborate decahydrate;
borax decahydrate
215-540-4
1303-96-4
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
Repr. Cat. 2; R60-61: C ≥ 8,5 %


005-011-02-9
disodium tetraborate pentahydrate;
borax pentahydrate
215-540-4
12179-04-3
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45
Repr. Cat. 2; R60-61: C ≥ 6,5 %


005-012-00-X
diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate
418-070-1
141714-54-7
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61




005-013-00-5
diethylmethoxyborane
425-380-9
7397-46-8
F; R17
Xn; R20/21/22-48/22
C; R34
R43
R53
F; C
R: 17-20/21/22-34-43-48/22-53
S: (1/2-)6-26-36/37/39-43-45-61



005-014-00-0
4-formylphenylboronic acid
438-670-5
87199-17-5
R43
Xi
R: 43
S: (2-)24-37



005-015-00-6
1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
414-380-4
140681-55-6
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)21-26-36/37/39-61



005-016-00-1
tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate
431-370-5
-
R53
R: 53
S: 61



005-017-00-7
sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
234-390-0 [3]
231-556-4 [4]
231-556-4 [5]
15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]
O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22
Xi; R37-41
O; T
R: 61-8-22-37-41-62
S: 53-45
Repr. Cat. 2; R61: C ≥ 6,5 %
Repr. Cat. 3; R62: C ≥ 9 %
Xi; R41: C ≥ 22 %
Xi; R36: 14 % ≤ C < 22 %
E

005-017-01-4
sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
234-390-0 [3]
231-556-4 [4]
231-556-4 [5]
15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]
-
O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R23
Xn; R22
Xi; R37-41
O; T
R: 61-8-22-23-37-41-62
S: 53-45
Repr. Cat. 2; R61: C ≥ 6,5 %
Repr. Cat. 3; R62: C ≥ 9 %
Xi; R41: C ≥ 22 %
Xi; R36: 14 % ≤ C < 22 %
E

005-018-00-2
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
-
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R37-41
T
R: 61-37-41-62
S: 53-45-47
Repr. Cat. 2; R61: C ≥ 10 %
Repr. Cat. 3; R62: C ≥ 14 %
Xi; R41: C ≥ 36 %
Xi; R36: 22 % ≤ C < 36 %


005-018-01-X
perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
-
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R20
Xi; R37-41
T
R: 61-20-37-41-62
S: 53-45-47
Repr. Cat. 2; R61: C ≥ 10 %
Repr. Cat. 3; R62: C ≥ 14 %
Xi; R41: C ≥ 36 %
Xi; R36: 22 % ≤ C < 36 %
E

006-001-00-2
carbon monoxide
211-128-3
630-08-0
F+; R12
Repr. Cat. 1; R61
T; R23-48/23
F+; T
R: 61-12-23-48/23
S: 53-45

E
006-002-00-8
phosgene;
carbonyl chloride
200-870-3
75-44-5
T+; R26
C; R34
T+
R: 26-34
S: (1/2-)9-26-36/37/39-45


006-003-00-3
carbon disulphide
200-843-6
75-15-0
F; R11
Repr. Cat. 3; R62-63
T; R48/23
Xi; R36/38
F; T
R: 11-36/38-48/23-62-63
S: (1/2-)16-33-36/37-45
Repr. Cat. 3; R62-63: C ≥ 1 %
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 %

006-004-00-9
calcium carbide
200-848-3
75-20-7
F; R15
F
R: 15
S: (2-)8-43


006-005-00-4
thiram (ISO);
tetramethylthiuram disulphide
205-286-2
137-26-8
Xn; R20/22-48/22
Xi; R36/38
R43
N; R50-53
Xn; N
R: 20/22-36/38-43-48/22-50/53
S: (2-)26-36/37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

006-006-00-X
hydrogen cyanide;
hydrocyanic acid
200-821-6
74-90-8
F+; R12
T+; R26
N; R50-53
F+; T+; N
R: 12-26-50/53
S: (1/2-)7/9-16-36/37-38-45-60-61


006-006-01-7
hydrogen cyanide ...%;
hydrocyanic acid ...%
200-821-6
74-90-8
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)7/9-36/37-38-45-60-61

B


006-007-00-5
salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex
—
—
T+; R26/27/28
R32
N; R50-53
T+; N
R: 26/27/28-32-50/53
S: (1/2-)7-28-29-45-60-61

A


006-008-00-0
antu (ISO);
1-(1-naphthyl)-2-thiourea
201-706-3
86-88-4
T+; R28
Carc. Cat. 3; R40
T+
R: 28-40
S: (1/2-)25-36/37-45


006-009-00-6
1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan
204-318-2
119-38-0
T+; R27/28
T+
R: 27/28
S: (1/2-)28-36/37/39-45


006-010-00-1
5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan
204-525-8
122-15-6
T; R25
T
R: 25
S: (1/2-)36/37-45




006-011-00-7
carbaryl (ISO);
1-naphthyl methylcarbamate
200-555-0
63-25-2
Carc. Cat. 3; R40
Xn; R20/22
N; R50
Xn; N
R: 20/22-40-50
S: (2-)36/37-46-61
N; R50: C ≥ 0,25 %


006-012-00-2
ziram (ISO);
zinc bis dimethyldithiocarbamate
205-288-3
137-30-4
T+; R26
Xn; R22-48/22
Xi; R37-41
R43
N; R50-53
T+; N
R: 22-26-37-41-43-48/22-50/53
S: (1/2-)22-26-28-36/37/39-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

006-013-00-8
metam-sodium (ISO);
sodium methyldithiocarbamate
205-293-0
137-42-8
Xn; R22
R31
C; R34
R43
N; R50-53
C; N
R: 22-31-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


006-014-00-3
nabam (ISO);
disodium ethylenebis(N,N'-dithiocarbamate)
205-547-0
142-59-6
Xn; R22
Xi; R37
R43
N; R50-53
Xn; N
R: 22-37-43-50/53
S: (2-)8-24/25-46-60-61





006-015-00-9
diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4
330-54-1
Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-40-48/22-50/53
S: (2-)13-36/37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


006-016-00-4
propoxur (ISO);
2-isopropyloxyphenyl N-methylcarbamate;
2-isopropoxyphenyl methylcarbamate
204-043-8
114-26-1
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)37-45-60-61


006-017-00-X
aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2
116-06-3
T+; R26/28
T; R24
N; R50-53
T+; N
R: 24-26/28-50/53
S: (1/2-)22-36/37-45-60-61


006-018-00-5
aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate
217-990-7
2032-59-9
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61


006-019-00-0
di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-1
2303-16-4
Carc. Cat. 3; R40
Xn; R22
N; R50-53
Xn; N
R: 22-40-50/53
S: (2-)25-36/37-60-61


006-020-00-6
barban (ISO);
4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4
101-27-9
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-36/37-60-61


006-021-00-1
linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5
330-55-2
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53
T; N
R: 61-22-40-48/22-62-50/53
S: 53-45-60-61

E
006-022-00-7
decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
—
1563-67-3
T; R23/24/25
T
R: 23/24/25
S: (1/2-)13-36/37-45


006-023-00-2
mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-2
2032-65-7
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)22-37-45-60-61


006-024-00-8
proxan-sodium (ISO);
sodium O-isopropyldithiocarbonate
205-443-5
140-93-2
Xn; R22
Xi; R38
N; R51-53
Xn; N
R: 22-38-51/53
S: (2-)13-61


006-025-00-3
allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]
249-013-5 [2]
- [3]
584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3]
Xn; R20/22
N; R50-53
Xn; N
R: 20/22-50/53
S: (2-)36-60-61

C
006-026-00-9
carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-0
1563-66-2
T+; R26/28
N; R50-53
T+; N
R: 26/28-50/53
S: (1/2-)36/37-45-60-61


006-028-00-X
dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1
973-21-7
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)37-45-60-61


006-029-00-5
dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-4
6988-21-2
T; R25
N; R51-53
T; N
R: 25-51/53
S: (1/2-)37-45-61


006-030-00-0
EPTC (ISO);
S-ethyl dipropylthiocarbamate
212-073-8
759-94-4
Xn; R22
Xn
R: 22
S: (2-)23


006-031-00-6
formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-0
22259-30-9
T+; R26/28
R43
N; R50-53
T+; N
R: 26/28-43-50/53
S: (1/2-)24-28-37/39-45-60-61


006-032-00-1
monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-5
1746-81-2
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)22-60-61


006-033-00-7
metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-2
19937-59-8
N; R50-53
N
R: 50/53
S: 60-61


006-034-00-2
pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate
214-215-4
1114-71-2
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)23-61


006-035-00-8
pirimicarb (ISO);
5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate
245-430-1
23103-98-2
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)22-37-45-60-61


006-036-00-3
benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea
217-685-9
1929-88-0
Xn; R22
Xn
R: 22
S: (2-)24/25


006-037-00-9
promecarb (ISO);
3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-0
2631-37-0
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)24-37-45-60-61


006-038-00-4
sulfallate (ISO);
2-chloroallyl N,N-dimethyldithiocarbamate
202-388-9
95-06-7
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

E
006-039-00-X
tri-allate (ISO);
S-2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-7
2303-17-5
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)24-37-60-61


006-040-00-5
3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan
—
2532-43-6
T; R23/24/25
T
R: 23/24/25
S: (1/2-)13-45


006-041-00-0
dimethylcarbamoyl chloride
201-208-6
79-44-7
Carc. Cat. 2; R45
T; R23
Xn; R22
Xi; R36/37/38
T
R: 45-22-23-36/37/38
S: 53-45
Carc. Cat. 2; R45: C ≥ 0,001 %
E
006-042-00-6
monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1
150-68-5
Carc. Cat. 3; R40
Xn; R22
N; R50-53
Xn; N
R: 22-40-50/53
S: (2-)36/37-60-61


006-043-00-1
3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA
—
140-41-0
Xi; R36/38
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 36/38-40-50/53
S: (2-)36/37-60-61


006-044-00-7
isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-4
34123-59-6
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %



006-045-00-2
methomyl (ISO);
1-(methylthio)ethylideneamino N-methylcarbamate
240-815-0
16752-77-5
T+; R28
N; R50-53
T+; N
R: 28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


006-046-00-8
bendiocarb (ISO);
2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate
245-216-8
22781-23-3
T; R23/25
Xn; R21
N; R50-53
T; N
R: 21-23/25-50/53
S: (1/2-)22-36/37-45-60-61


006-047-00-3
bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
—
8065-36-9
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61


006-048-00-9
ethiofencarb (ISO);
2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-9
29973-13-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


006-049-00-4
dixanthogen;
O,O-diethyl dithiobis(thioformate)
207-944-4
502-55-6
Xn; R22
Xn
R: 22
S: (2-)24


006-050-00-X
1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA
—
4482-55-7
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)60-61


006-051-00-5
ferbam (ISO);
iron tris(dimethyldithiocarbamate)
238-484-2
14484-64-1
Xi; R36/37/38
N; R50-53
Xi; N
R: 36/37/38-50/53
S: (2-)60-61


006-052-00-0
formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-0
23422-53-9
T+; R26/28
R43
N; R50-53
T+; N
R: 26/28-43-50/53
S: (1/2-)24-28-37/39-45-60-61


006-053-00-6
isoprocarb (ISO);
2-isopropylphenyl N-methylcarbamate
220-114-6
2631-40-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


006-054-00-1
mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3
315-18-4
T+; R28
Xn; R21
N; R50-53
T+; N
R: 21-28-50/53
S: (1/2-)36/37-45-60-61


006-055-00-7
xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC
219-364-9
2425-10-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


006-056-00-2
metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC
214-446-0
1129-41-5
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


006-057-00-8
nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine
217-682-2
1929-82-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)24-61


006-058-00-3
noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
—
2163-79-3
Xn; R22
Xn
R: 22
S: (2-)


006-059-00-9
oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-3
23135-22-0
T+; R26/28
Xn; R21
N; R51-53
T+; N
R: 21-26/28-51/53
S: (1/2-)36/37-45-61


006-060-00-4
oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-2
5259-88-1
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


006-061-00-X
S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride
243-193-9
19622-19-6
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


006-062-00-5
methyl 3,4-dichlorophenylcarbanilate;
SWEP.
—
1918-18-9
Xn; R22
Xn
R: 22
S: (2-)


006-063-00-0
thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate;
248-924-5
28249-77-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


006-064-00-6
thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime;
254-346-4
39196-18-4
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)27-36/37-45-60-61


006-065-00-1
3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid
—
15271-41-7
T+; R28
T; R24
N; R51-53
T+; N
R: 24-28-51/53
S: (1/2-)28-36/37-45-61


006-066-00-7
vernolate (ISO);
S-propyl dipropylthiocarbamate;
217-681-7
1929-77-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


006-067-00-2
XMC;
3,5-xylyl methylcarbamate
—
2655-14-3
Xn; R22
Xn
R: 22
S: (2-)


006-068-00-8
diazomethane
206-382-7
334-88-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45


006-069-00-3
thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-7
23564-05-8
Muta. Cat. 3; R68
Xn; R20
R43
N; R50-53
Xn; N
R: 20-43-50/53-68
S: (2-)36/37-46-60-61


006-070-00-9
furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide;
262-302-0
60568-05-0
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


006-071-00-4
cyclooct-4-en-1-yl methyl carbonate
401-620-8
87731-18-8
R43
Xi
R: 43
S: (2-)24-37


006-072-00-X
prosulfocarb(ISO);
S-benzyl N,N-dipropylthiocarbamate;
401-730-6
52888-80-9
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61


006-073-00-5
3-(dimethylamino)propylurea
401-950-2
31506-43-1
Xi; R41
Xi
R: 41
S: (2-)26-39


006-074-00-0
2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate
402-440-2
2094-99-7
T+; R26
C; R34
Xn; R48/20
R42/43
N; R50-53
T+; N
R: 26-34-42/43-48/20-50/53
S: (1/2-)7-15-28-36/37/39-38-45-60-61




006-076-00-1
mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
—
8018-01-7
Repr. Cat. 3; R63
R43
N; R50
Xn; N
R: 43-63-50
S: (2-)36/37-46-61
N; R50: C ≥ 2,5 %


006-077-00-7
maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)
235-654-8
12427-38-2
Repr. Cat. 3; R63
Xn; R20
Xi; R36
R43
N; R50-53
Xn; N
R: 20-36-43-63-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


006-078-00-2
zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-1
12122-67-7
Xi; R37
R43
Xi
R: 37-43
S: (2-)8-24/25-46


006-079-00-8
disulfiram;
tetraethylthiuramdisulfide
202-607-8
97-77-8
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)24-37-60-61


006-080-00-3
tetramethylthiuram monosulphide
202-605-7
97-74-5
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-26-37-61


006-081-00-9
zinc bis(dibutyldithiocarbamate)
205-232-8
136-23-2
Xi; R36/37/38
R43
N; R50-53
Xi; N
R: 36/37/38-43-50/53
S: (2-)24-37-60-61


006-082-00-4
zinc bis(diethyldithiocarbamate)
238-270-9
14324-55-1
Xn; R22
Xi; R36/37/38
R43
N; R50-53
Xn; N
R: 22-36/37/38-43-50/53
S: (2-)24-37-60-61


006-083-00-X
butocarboxim (ISO);
3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-3
34681-10-2
R10
T; R23/24/25
Xi; R36
N; R50-53
T; N
R: 10-23/24/25-36-50/53
S: (1/2-)36/37-45-60-61




006-084-00-5
carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-9
55285-14-8
T+; R26
T; R25
R43
N; R50-53
T+; N
R: 25-26-43-50/53
S: (1/2-)28-36/37-38-45-63-60-61




006-085-00-0
fenobucarb (ISO);
2-butylphenyl methylcarbamate;
223-188-8
3766-81-2
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


006-086-00-6
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;
fenoxycarb
276-696-7
72490-01-8
N; R50-53
N
R: 50/53
S: 60-61




006-087-00-1
furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate
265-974-3
65907-30-4
T+; R26
T; R25
Xn; R48/22
Xi; R36/38
R43
N; R50-53
T+; N
R: 25-26-36/38-43-48/22-50/53
S: (1/2-)28-36/37-38-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


006-088-00-7
benfuracarb (ISO);
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
—
82560-54-1
Repr. Cat. 3; R62
T; R23
Xn; R22
N; R50-53
T; N
R: 22-23-62-50/53
S: (1/2-)36/37-45-60-61




006-089-00-2
chlorine dioxide
233-162-8
10049-04-4
O; R8
R6
T+; R26
C; R34
N; R50
O; T+; N
R: 6-8-26-34-50
S: (1/2-)23-26-28-36/37/39-38-45-61
N; R50: C ≥ 0,02 %
5
006-089-01-X
chlorine dioxide … %
233-162-8
10049-04-4
T; R25
C; R34
N; R50
T; N
R: 25-34-50
S: (1/2-)23-26-28-36/37/39-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 3 % ≤ C < 10 %
Xi; R36: 0,3 % ≤ C < 3 %
N; R50: C ≥ 3 %
B

006-090-00-8
2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate
408-010-0
88558-41-2
Xn; R20
Xi; R41
R52-53
Xn
R: 20-41-52/53
S: (2-)22-26-39-61




006-091-00-3
propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)
-
9016-72-2
Xn; R20-48/20/22
R43
N; R50
Xn; N
R: 20-43-48/20/22-50
S: (1/2-)24-37-46-61



006-092-00-9
tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate
425-420-5
98737-29-2
N; R50-53
N
R: 50/53
S: 60-61



006-093-00-4
2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)
427-180-7
-
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)15-22-29-36/37-60-61



006-094-00-X
O-isobutyl-N-ethoxy carbonylthiocarbamate
434-350-4
103122-66-3
R10
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22-48/22
R43
N; R51-53
T; N
R: 45-46-10-22-43-48/22-51/53
S: 53-45-61

E

006-095-00-5
fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate
254-320-2
39148-24-8
Xi; R41
Xi
R: 41
S: (2-)26-39-46



006-096-00-0
chlorpropham (ISO);
isopropyl 3-chlorocarbanilate
202-925-7
101-21-3
Carc. Cat. 3; R40
Xn; R48/22
N; R51-53
Xn; N
R: 40-48/22-51/53
S: (2-)36/37-61



006-097-00-6
1-phenyl-3-(p-toluenesulfonyl)urea
424-620-1
13909-63-2
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36-61



006-098-00-1
tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
429-170-8
134575-17-0
Xn; R22-48/22
Xi; R41
R43
Xn
R: 22-41-43-48/22
S: (2-)22-26-36/37/39



006-099-00-7
N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate
432-520-2
232938-43-1
N; R51-53
N
R: 51/53
S: 22-61



006-101-00-6
reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
423-070-8
-
R53
R: 53
S: 61



006-102-00-1
O-hexyl-N-ethoxycarbonylthiocarbamate
432-750-3
-
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22-48/22
R43
N; R51-53
T; N
R: 45-46-22-43-48/22-51/53
S: 53-45-61

E

006-103-00-7
N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea
445-760-8
-
Xi; R41
R42
N; R50-53
Xn; N
R: 41-42-50/53
S: (2-)22-26-39-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


007-001-00-5
ammonia, anhydrous
231-635-3
7664-41-7
R10
T; R23
C; R34
N; R50
T; N
R: 10-23-34-50
S: (1/2-)9-16-26-36/37/39-45-61


007-001-01-2
ammonia ....%
215-647-6
1336-21-6
C; R34
N; R50
C; N
R: 34-50
S: (1/2-)26-36/37/39-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
B


007-002-00-0
nitrogen dioxide; [1]
dinitrogen tetraoxide [2]
233-272-6 [1]
234-126-4 [2]
10102-44-0 [1]
10544-72-6 [2]
O; R8
T+; R26
C; R34
O; T+
R: 8-26-34
S: (1/2-)9-26-28-36/37/39-45
T+; R26: C ≥ 10 %
T; R23: 1 % ≤ C < 10 %
Xn; R20: 0,1 % ≤ C < 1 %
5


007-003-00-6
chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride
213-666-4
999-81-5
Xn; R21/22
Xn
R: 21/22
S: (2-)36/37


007-004-00-1
nitric acid ... %
231-714-2
7697-37-2
O; R8
C; R35
O; C
R: 8-35
S: (1/2-)23-26-36-45
C; R35: C ≥ 20 %
C; R34: 5 % ≤ C < 20 %
Footnote:
O; R8: C ≥ 70 %
B
007-006-00-2
ethyl nitrite
203-722-6
109-95-5
E; R2
Xn; R20/21/22
E; Xn
R: 2-20/21/22
S: (2-)




007-007-00-8
ethyl nitrate
210-903-3
625-58-1
E; R3
E
R: 3
S: (2-)23-24/25



007-008-00-3
hydrazine
206-114-9
302-01-2
R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43
N; R50-53
T; N
R: 45-10-23/24/25-34-43-50/53
S: 53-45-60-61
C; R34: C ≥ 10 %
Xi; R36/38: 3 % ≤ C < 10 %
E
007-009-00-9
dicyclohexylammonium nitrite
221-515-9
3129-91-7
Xn; R20/22
Xn
R: 20/22
S: (2-)15-41
Xn; R20/22: C ≥ 10 %

007-010-00-4
sodium nitrite
231-555-9
7632-00-0
O; R8
T; R25
N; R50
O; T; N
R: 8-25-50
S: (1/2-)45-61
T; R25: C ≥ 5 %
Xn; R22: 1 % ≤ C < 5 %

007-011-00-X
potassium nitrite
231-832-4
7758-09-0
O; R8
T; R25
N; R50
O; T; N
R: 8-25-50
S: (1/2-)45-61
T; R25: C ≥ 5 %
Xn; R22: 1 % ≤ C < 5 %

007-012-00-5
N,N-dimethylhydrazine
200-316-0
57-14-7
F; R11
Carc. Cat. 2; R45
T; R23/25
C; R34
N; R51-53
F; T; N
R: 45-11-23/25-34-51/53
S: 53-45-61

E
007-013-00-0
1,2-dimethylhydrazine
—
540-73-8
Carc. Cat. 2; R45
T; R23/24/25
N; R51-53
T; N
R: 45-23/24/25-51/53
S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %
E
007-014-00-6
salts of hydrazine
—
—
Carc. Cat. 2; R45
T; R23/24/25
R43
N; R50-53
T; N
R: 45-23/24/25-43-50/53
S: 53-45-60-61

AE
007-015-00-1
O-ethylhydroxylamine
402-030-3
624-86-2
F; R11
T; R23/24/25-48/23
Xi; R36
R43
N; R50
F; T; N
R: 11-23/24/25-36-43-48/23-50
S: (1/2-)16-26-36/37/39-45-60-61


007-016-00-7
butyl nitrite
208-862-1
544-16-1
F; R11
T; R23/25
F; T
R: 11-23/25
S: (1/2-)16-24-45


007-017-00-2
isobutyl nitrite
208-819-7
542-56-3
F; R11
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22
F; T
R: 11-20/22-45-68
S: 53-45

E
007-018-00-8
sec-butyl nitrite
213-104-8
924-43-6
F; R11
Xn; R20/22
F; Xn
R: 11-20/22
S: (2-)16-24-46


007-019-00-3
tert-butyl nitrite
208-757-0
540-80-7
F; R11
Xn; R20/22
F; Xn
R: 11-20/22
S: (2-)16-24-46


007-020-00-9
pentyl nitrite; [1]
amyl nitrite, mixed isomers [2]
207-332-7 [1]
203-770-8 [2]
463-04-7 [1]
110-46-3 [2]
F; R11
Xn; R20/22
F; Xn
R: 11-20/22
S: (2-)16-24-46


007-021-00-4
hydrazobenzene;
1,2-diphenylhydrazine
204-563-5
122-66-7
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

E
007-022-00-X
hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)
405-030-1
—
Carc. Cat. 2; R45
Xn; R22
C; R34
R43
R52-53
T
R: 45-22-34-43-52/53
S: 53-45-61

E
007-023-00-5
sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate
405-510-0
—
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37


007-024-00-0
2-(decylthio)ethylammonium chloride
405-640-8
36362-09-1
Xn; R48/22
Xi; R38-41
N; R50-53
Xn; N
R: 38-41-48/22-50/53
S: (2-)26-36/37/39-60-61


007-025-00-6
(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride
406-090-1
81880-96-8
Muta. Cat. 3; R68
T; R25-48/25
R43
N; R50-53
T; N
R: 25-43-48/25-68-50/53
S: (1/2-)22-36/37/39-45-60-61


007-026-00-1
oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide
413-230-5
122035-71-6
Xi; R41
R43
Xi
R: 41-43
S: (2-)8-22-24-26-30-37/39


007-027-00-7
1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane
420-190-2
771478-66-1
C; R34
Xn; R21/22-48/21
R43
N; R50-53
C; N
R: 21/22-34-43-48/21-50/53
S: (1/2-)7-26-36/37/39-45-60-61





007-028-00-2
hydroxylammonium nitrate
236-691-2
13465-08-2
E; R2
Carc. Cat. 3; R40
T; R24
Xn; R22-48/22
Xi; R36/38
R43
N; R50
E; T; N
R: 2-22-24-36/38-40-43-48/22-50
S: (1/2-)26-36/37-45-61



007-029-00-8
diethyldimethylammonium hydroxide
419-400-5
95500-19-9
Xn; R21/22
C; R35
C
R: 21/22-35
S: (1/2-)26-36/37/39-45



008-001-00-8
oxygen
231-956-9
7782-44-7
O; R8
O
R: 8
S: (2-)17


008-003-00-9
hydrogen peroxide solution ... %
231-765-0
7722-84-1
R5
O; R8
C; R35
Xn; R20/22
O; C
R: 5-8-20/22-35
S: (1/2-)17-26-28-36/37/39-45
Xn; R20: C ≥ 50 %
Xn; R22: C ≥ 8 %
C; R35: C ≥ 70 %
C; R34: 50 % ≤ C < 70 %
Xi; R37/38: 35 % ≤ C < 50 %
Xi; R41: 8 % ≤ C < 50 %
Xi; R36: 5 % ≤ C < 8 %
Footnote:
O; R8: C ≥ 50 %
R5: C ≥ 70 %
B


009-001-00-0
fluorine
231-954-8
7782-41-4
O; R8
T+; R26
C; R35
O; T+; C
R: 8-26-35
S: (1/2-)9-26-28-36/37/39-45




009-002-00-6
hydrogen fluoride
231-634-8
7664-39-3
T+; R26/27/28
C; R35
T+; C
R: 26/27/28-35
S: (1/2-)7/9-26-36/37/39-45


009-003-00-1
hydrofluoric acid ... %
231-634-8
7664-39-3
T+; R26/27/28
C; R35
T+; C
R: 26/27/28-35
S: (1/2-)7/9-26-36/37-45
C; R35: C ≥ 7 %
C; R34: 1 % ≤ C < 7 %
Xi; R36: 0,1 % ≤ C < 1 %
B
009-004-00-7
sodium fluoride
231-667-8
7681-49-4
T; R25
Xi; R36/38
R32
T
R: 25-32-36/38
S: (1/2-)22-36-45


009-005-00-2
potassium fluoride
232-151-5
7789-23-3
T; R23/24/25
T
R: 23/24/25
S: (1/2-)26-45


009-006-00-8
ammonium fluoride
235-185-9
12125-01-8
T; R23/24/25
T
R: 23/24/25
S: (1/2-)26-45


009-007-00-3
sodium bifluoride;
sodium hydrogen difluoride
215-608-3
1333-83-1
T; R25
C; R34
T; C
R: 25-34
S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 %

009-008-00-9
potassium bifluoride;
potassium hydrogen difluoride
232-156-2
7789-29-9
T; R25
C; R34
T; C
R: 25-34
S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 %

009-009-00-4
ammonium bifluoride;
ammonium hydrogen difluoride
215-676-4
1341-49-7
T; R25
C; R34
T; C
R: 25-34
S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %
C; R34: C ≥ 1 %
Xi; R36/38: 0,1 % ≤ C < 1 %

009-010-00-X
fluoroboric acid ... %
240-898-3
16872-11-0
C; R34
C
R: 34
S: (1/2-)26-27-45
C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 %
B
009-011-00-5
fluorosilicic acid ... %
241-034-8
16961-83-4
C; R34
C
R: 34
S: (1/2-)26-27-45

B
009-012-00-0
alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3]
240-934-8 [1]
240-896-2 [2]
240-968-3 [3]
16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3]
T; R23/24/25
T
R: 23/24/25
S: (1/2-)26-45
T; R23/24/25: C ≥ 10 %
Xn; R20/21/22: 1 % ≤ C < 10 %
A
009-013-00-6
fluorosilicates, with the exception of those specified elsewhere in this annex
—
—
Xn; R22
Xn
R: 22
S: (2-)13-24/25
Xn; R22: C ≥ 10 %
A
009-014-00-1
lead hexafluorosilicate
247-278-1
25808-74-6
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53
T; N
R: 61-62-20/22-33-50/53
S: 53-45-60-61

E
1
009-015-00-7
sulphuryl difluoride
220-281-5
2699-79-8
T; R23
Xn; R48/20
N; R50
T; N
R: 23-48/20-50
S: (1/2-)45-63-60-61


009-016-00-2
trisodium hexafluoroaluminate;
cryolite
237-410-6
239-148-8
13775-53-6
15096-52-3
T; R48/23/25
Xn; R20/22
N; R51-53
T; N
R: 20/22-48/23/25-51/53
S: (1/2-)22-37-45-61

C
009-017-00-8
potassium mu-fluoro-bis(triethylaluminium)
400-040-2
12091-08-6
F; R11-14/15
C; R35
Xn; R20
F; C
R: 11-14/15-20-35
S: (1/2-)16-30-36/39-43-45


009-018-00-3
magnesium hexafluorosilicate
241-022-2
16949-65-8
T; R25
T
R: 25
S: (1/2-)24/25-45
T; R25: C ≥ 10 %
Xn; R22: 1 % ≤ C < 10 %

011-001-00-0
sodium
231-132-9
7440-23-5
F; 15
R14
C; R34
F; C
R: 14/15-34
S: (1/2-)5-8-43-45


011-002-00-6
sodium hydroxide;
caustic soda
215-185-5
1310-73-2
C; R35
C
R: 35
S: (1/2-)26-37/39-45
C; R35: C ≥ 5 %
C; R34: 2 % ≤ C < 5 %
Xi; R36/38: 0,5 % ≤ C < 2 %

011-003-00-1
sodium peroxide
215-209-4
1313-60-6
O; R8
C; R35
O; C
R: 8-35
S: (1/2-)8-27-39-45


011-004-00-7
sodium azide
247-852-1
26628-22-8
T+; R28
R32
N; R50-53
T+; N
R: 28-32-50/53
S: (1/2-)28-45-60-61


011-005-00-2
sodium carbonate
207-838-8
497-19-8
Xi; R36
Xi
R: 36
S: (2-)22-26


011-006-00-8
sodium cyanate
213-030-6
917-61-3
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)24/25-61


011-007-00-3
propoxycarbazone-sodium
—
181274-15-7
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

012-001-00-3
magnesium powder (pyrophoric)
231-104-6
7439-95-4
F; R15-17
F
R: 15-17
S: (2-)7/8-43


012-002-00-9
magnesium, powder or turnings
231-104-6
—
F; R11-15
F
R: 11-15
S: (2-)7/8-43


012-003-00-4
magnesium alkyls
—
—
R14
F; R17
C; R34
F; C
R: 14-17-34
S: (1/2-)16-43-45

A


012-004-00-X
aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate
422-150-1
-
N; R50-53
N
R: 50/53
S: 60-61



013-001-00-6
aluminium powder (pyrophoric)
231-072-3
7429-90-5
F; R15-17
F
R: 15-17
S: (2-)7/8-43




013-002-00-1
aluminium powder (stabilised)
231-072-3
7429-90-5
F; R11-15
F
R: 11-15
S: (2-)7/8-43

T

013-003-00-7
aluminium chloride, anhydrous
231-208-1
7446-70-0
C; R34
C
R: 34
S: (1/2-)7/8-28-45


013-004-00-2
aluminium alkyls
—
—
R14
F; R17
C; R34
F; C
R: 14-17-34
S: (1/2-)16-43-45

A
013-005-00-8
diethyl(ethyldimethylsilanolato)aluminium
401-160-8
55426-95-4
F; R 15-17
R14
C; R35
F; C
R: 14/15-17-35
S: (1/2-)6-16-30-36/39-43-45


013-006-00-3
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised
402-370-2
—
R10
Xi; R41
Xi
R: 10-41
S: (2-)26-39


013-007-00-9
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)
403-430-0
—
Xi; R41
Xi
R: 41
S: (2-)26-39


013-008-00-4
di-n-octylaluminium iodide
408-190-0
7585-14-0
R14
F; R17
C; R34
N; R50-53
F; C; N
R: 14-17-34-50/53
S: (1/2-)6-16-26-36/37/39-43-45-60-61


013-009-00-X
sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5
418-720-2
—
F; R11-15-17
R14
Xn; R20
C; R35
F; C
R: 11-14/15-17-20-35
S: (1/2-)6-16-26-30-36/37/39-43-45




013-010-00-5
hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide)
430-650-4
151841-65-5
N; R51-53
N
R: 51/53
S: 61



014-001-00-9
trichlorosilane
233-042-5
10025-78-2
F+; R12
R14
F; R17
Xn; R20/22
R29
C; R35
F+; C
R: 12-14-17-20/22-29-35
S: (2-)7/9-16-26-36/37/39-43-45
Xn; R20/22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

014-002-00-4
silicon tetrachloride
233-054-0
10026-04-7
R14
Xi; R36/37/38
Xi
R: 14-36/37/38
S: (2-)7/8-26


014-003-00-X
dimethyldichlorosilane
200-901-0
75-78-5
F; R11
Xi; R36/37/38
F; Xi
R: 11-36/37/38
S: (2-)


014-004-00-5
trichloro(methyl)silane;
methyltrichlorosilane
200-902-6
75-79-6
R14
F; R11
Xi; R36/37/38
F; Xi
R: 11-14-36/37/38
S: (2-)26-39
Xi; R36/37/38: C ≥ 1 %

014-005-00-0
tetraethyl silicate;
ethyl silicate
201-083-8
78-10-4
R10
Xn; R20
Xi; R36/37
Xn
R: 10-20-36/37
S: (2-)


014-006-00-6
bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride
401-380-4
—
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


014-007-00-1
triethoxyisobutylsilane
402-810-3
17980-47-1
Xi; R38
Xi
R: 38
S: (2-)24


014-008-00-7
(chloromethyl)bis(4-fluorophenyl)methylsilane
401-200-4
85491-26-5
N; R51-53
N
R: 51/53
S: 61


014-009-00-2
isobutylisopropyldimethoxysilane
402-580-4
111439-76-0
R10
Xn; R20
Xi; R38
Xn
R: 10-20-38
S: (2-)25-26-36/37


014-010-00-8
disodium metasilicate
229-912-9
6834-92-0
C; R34
Xi; R37
C
R: 34-37
S: (1/2-)13-24/25-36/37/39-45


014-011-00-3
cyclohexyldimethoxymethylsilane
402-140-1
17865-32-6
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)24-61


014-012-00-9
bis(3-(trimethoxysilyl)propyl)amine
403-480-3
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)24-26-39-61


014-013-00-4
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)
404-920-7
—
Xn; R21/22
C; R34
N; R51-53
C; N
R: 21/22-34-51/53
S: (1/2-)26-36/37/39-45-61


014-014-00-X
etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane;
253-704-7
37894-46-5
Repr. Cat. 2; R61
Xn; R22-48/22
T
R: 61-22-48/22
S: 53-45

E
014-015-00-5
α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))
406-420-4
69430-40-6
R53
R: 53
S: 61


014-016-00-0
reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6
—
N; R51-53
N
R: 51/53
S: 61


014-017-00-6
flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane
—
85509-19-9
Carc. Cat. 3; R40
Repr. Cat. 2; R61
Xn; R22
N; R51-53
T; N
R: 61-22-40-51/53
S: 53-45-61

E
014-018-00-1
octamethylcyclotetrasiloxane
209-136-7
556-67-2
Repr. Cat. 3; R62
R53
Xn
R: 53-62
S: (2-)36/37-46-51-61


014-019-00-7
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
403-250-2
—
Carc. Cat. 3; R40
Repr. Cat. 2; R61
Xn; R22
N; R51-53
T; N
R: 61-22-40-51/53
S: 53-45-61

E
014-020-00-2
bis(1,1-dimethyl-2-propynyloxy)dimethylsilane
414-960-7
53863-99-3
Xn; R20
Xn
R: 20
S: (2)


014-021-00-8
tris(isopropenyloxy)phenyl silane
411-340-8
52301-18-5
N; R50-53
N
R: 50/53
S: 60-61


014-022-00-3
reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)
401-530-9
—
F; R11
T; R39/23/24/25
Xn; R20/21/22
F; T
R: 11-20/21/22-39/23/24/25
S: (1/2-)16-29-36/37-45


014-023-00-9
α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole
408-160-7
125613-45-8
N; R51-53
N
R: 51/53
S: 61


014-024-00-4
1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene
412-620-2
121626-74-2
N; R51-53
N
R: 51/53
S: 61


014-025-00-X
4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine
411-400-3
102089-33-8
Xn; R22-48/21
Xi; R38-41
R52-53
Xn
R: 22-38-41-48/21-52/53
S: (2-)26-36/37/39-61


014-026-00-5
dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane
407-180-3
770722-36-6
C; R35
C
R: 35
S: (1/2-)26-36/37/39-45


014-027-00-0
chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane
410-270-5
770722-46-8
C; R35
C
R: 35
S: (1/2-)8-26-28-36/37/39-45


014-028-00-6
α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)
415-290-8
193159-06-7
R43
Xi
R: 43
S: (2-)24-37


014-029-00-1
O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]
421-870-1
156145-66-3
Repr. Cat. 3; R62
Xn; R22-48/22
Xn
R: 22-48/22-62
S: (2-)36/37


014-030-00-7
[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium
422-060-0
137390-08-0
T+; R28
T+
R: 28
S: (1/2-)6-22-28-36/37-45


014-031-00-2
bis(1-methylethyl)-dimethoxysilane
421-540-7
18230-61-0
R10
Xi; R38
R43
R52-53
Xi
R: 10-38-43-52/53
S: (2-)24-37-61


014-032-00-8
dicyclopentyldimethoxysilane
404-370-8
126990-35-0
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61




014-033-00-3
2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica
419-030-4
125804-20-8
F; R11
Xi; R36
R67
F; Xi
R: 11-36-67
S: (2-)16-26



014-034-00-9
3-hexylheptamethyltrisiloxane
428-700-5
1873-90-1
Xn; R20
R53
Xn
R: 20-53
S: (2-)61



014-035-00-4
2-(3,4-epoxycyclohexyl)ethyltriethoxy silane
425-050-4
10217-34-2
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



014-036-00-X
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
Repr. Cat.2; R60
N; R50-53
T; N
R: 60-50/53
S: 53-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


014-037-00-5
2-butanone-O, O', O''-(phenylsilylidyne)trioxime
433-360-6
34036-80-1
Xn; R48/22
R43
R52-53
Xn
R: 43-48/22-52/53
S: (2-)36/37-61



014-038-00-0
S-(3-(triethoxysilyl)propyl) octanethioate
436-690-9
220727-26-4
R43
Xi
R: 43
S: (2-)24-37



014-039-00-6
(2,3-dimethylbut-2-yl)-trimethoxysilane
439-360-2
142877-45-0
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61



014-041-00-7
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane
445-890-5
201290-01-9
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37



014-042-00-2
reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-010-0
-
Xi; R41
Xi
R: 41
S: (2-)26-39



014-043-00-8
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)
432-200-2
-
F; R11
Xi; R37/38-41
R52-53
F; Xi
R: 11-37/38-41-52/53
S: (2-)6-26-36/39-61



014-044-00-3
3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane
433-050-0
-
N; R51-53
N
R: 51/53
S: 61



014-045-00-9
magnesium sodium fluoride silicate
442-650-1
-
Xn; R48/20
Xn
R: 48/20
S: (2-)22-36



015-001-00-1
white phosphorus
231-768-7
12185-10-3
F; R17
T+; R26/28
C; R35
N; R50
F; T+; C; N
R: 17-26/28-35-50
S: (1/2-)5-26-38-45-61


015-002-00-7
red phosphorus
231-768-7
7723-14-0
F; R11
R16
R52-53
F
R: 11-16-52/53
S: (2-)7-43-61




015-003-00-2
calcium phosphide;
tricalcium diphosphide
215-142-0
1305-99-3
F; R15
T+; R28
R29
N; R50
F; T+; N
R: 15/29-28-50
S: (1/2-)22-28-36/37-43-45-61
N; R50: C ≥ 0,25 %


015-004-00-8
aluminium phosphide
244-088-0
20859-73-8
F; R15
T+; R28
R29
R32
N; R50
F; T+; N
R: 15/29-28-32-50
S: (1/2-)3/9/14-28-30-36/37-43-45-61
N; R50: C ≥ 0,25 %


015-005-00-3
magnesium phosphide;
trimagnesium diphosphide
235-023-7
12057-74-8
F; R15
T+; R28
R29
N; R50
F; T+; N
R: 15/29-28-50
S: (1/2-)22-28-43-45-61
N; R50: C ≥ 0,25 %


015-006-00-9
trizinc diphosphide;
zinc phosphide
215-244-5
1314-84-7
F; R15
T+; R28
R29
R32
N; R50-53
F; T+; N
R: 15/29-28-32-50/53
S: (1/2-)28-30-36/37-43-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
T

015-007-00-4
phosphorus trichloride
231-749-3
7719-12-2
R14
T+; R26/28
Xn; R48/20
C; R35
R29
T+; C
R: 14-26/28-35-48/20
S: (1/2-)7/8-26-36/37/39-45


015-008-00-X
phosphorus pentachloride
233-060-3
10026-13-8
R14
T+; R26
Xn; R22-48/20
C; R34
R29
T+
R: 14-22-26-34-48/20
S: (1/2-)7/8-26-36/37/39-45


015-009-00-5
phosphoryl trichloride
233-046-7
10025-87-3
R14
T+; R26
T; R48/23
Xn; R22
C; R35
R29
T+; C
R: 14-22-26-35-48/23
S: (1/2-)7/8-26-36/37/39-45


015-010-00-0
phosphorus pentoxide
215-236-1
1314-56-3
C; R35
C
R: 35
S: (1/2-)22-26-45


015-011-00-6
phosphoric acid ... %, orthophosphoric acid ... %
231-633-2
7664-38-2
C; R34
C
R: 34
S: (1/2-)26-45
C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 %
B
015-012-00-1
tetraphosphorus trisulphide;
phosphorus sesquisulphid
215-245-0
1314-85-8
F; R11
Xn; R22
N; R50
F; Xn; N
R: 11-22-50
S: (2-)7-16-24/25-61


015-013-00-7
triethyl phosphate
201-114-5
78-40-0
Xn; R22
Xn
R: 22
S: (2-)25


015-014-00-2
tributyl phosphate
204-800-2
126-73-8
Carc. Cat. 3; R40
Xn; R22
Xi; R38
Xn
R: 22-38-40
S: (2-)36/37-46


015-015-00-8
tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
201-103-5
78-30-8
T; R39/23/24/25
N; R51-53
T; N
R: 39/23/24/25-51/53
S: (1/2-)20/21-28-45-61
T; R39/23/24/25: C ≥ 1 %
Xn; R68/20/21/22: 0,2 % ≤ C < 1 %
C
015-016-00-3
tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
201-105-6
78-32-0
Xn; R21/22
N; R51-53
Xn; N
R: 21/22-51/53
S: (2-)28-61
Xn; R21/22: C ≥ 5 %
C


015-019-00-X
dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate
200-547-7
62-73-7
T+; R26
T; R24/25
R43
N; R50
T+; N
R: 24/25-26-43-50
S: (1/2-)28-36/37-45-61
N; R50: C ≥ 0,025 %


015-020-00-5
mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-1
7786-34-7
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %

015-021-00-0
trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-3
52-68-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-022-00-6
phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-5
13171-21-6
T+; R28
T; R24
Muta. Cat. 3; R68
N; R50-53
T+; N
R: 24-28-50/53-68
S: (1/2-)23-36/37-45-60-61


015-023-00-1
pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate
—
108-34-9
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)13-28-45


015-024-00-7
triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide
—
1031-47-6
T+; R27/28
T+
R: 27/28
S: (1/2-)22-28-36/37-45


015-025-00-2
TEPP (ISO);
tetraethyl pyrophosphate
203-495-3
107-49-3
T+; R27/28
N; R50
T+; N
R: 27/28-50
S: (1/2-)36/37/39-38-45-61


015-026-00-8
schradan (ISO);
octamethylpyrophosphoramide
205-801-0
152-16-9
T+; R27/28
T+
R: 27/28
S: (1/2-)36/37-38-45


015-027-00-3
sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate
222-995-2
3689-24-5
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-028-00-9
demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8
298-03-3
T+; R27/28
N; R50
T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61


015-029-00-4
demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8
126-75-0
T+; R27/28
T+
R: 27/28
S: (1/2-)28-36/37-45


015-030-00-X
demeton-O-methyl (ISO);
O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1
867-27-6
T; R25
T
R: 25
S: (1/2-)24-36/37-45


015-031-00-5
demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6
919-86-8
T; R24/25
N; R51-53
T; N
R: 24/25-51/53
S: (1/2-)28-36/37-45-61


015-032-00-0
prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-2
2275-18-5
T+; R27/28
R52-53
T+
R: 27/28-52/53
S: (1/2-)28-36/37-45-61


015-033-00-6
phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2
298-02-2
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-034-00-1
parathion (ISO);
O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-7
56-38-2
T+; R26/28
T; R24-48/25
N; R50-53
T+; N
R: 24-26/28-48/25-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-035-00-7
parathion — methyl (ISO);
O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1
298-00-0
R5
R10
T+; R26/28
T; R24
Xn; R48/22
N; R50-53
T+; N
R: 5-10-24-26/28-48/22-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-036-00-2
O-ethyl O-4-nitrophenyl phenylphosphonothioate;
EPN
218-276-8
2104-64-5
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)22-36/37-45-60-61


015-037-00-8
phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate
218-892-7
2275-14-1
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61


015-038-00-3
coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-3
56-72-4
T+; R28
Xn; R21
N; R50-53
T+; N
R: 21-28-50/53
S: (1/2-)28-36/37-45-60-61


015-039-00-9
azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-1
86-50-0
T+; R26/28
T; R24
R43
N; R50-53
T+; N
R: 24-26/28-43-50/53
S: (1/2-)28-36/37-45-60-61


015-040-00-4
diazinon (ISO);
O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8
333-41-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24/25-60-61




015-041-00-X
malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]
204-497-7
121-75-5
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


015-042-00-5
chlorthion
O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate
207-902-5
500-28-7
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-043-00-0
phosnichlor (ISO);
O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate
—
5826-76-6
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)13


015-044-00-6
carbophenothion (ISO);
4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate
212-324-1
786-19-6
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61


015-045-00-1
mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate
219-993-9
2595-54-2
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)36/37-45-60-61


015-046-00-7
oxydemeton-methyl;
S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7
301-12-2
T; R24/25
N; R50
T; N
R: 24/25-50
S: (1/2-)23-36/37-45-61


015-047-00-2
ethion (ISO);
O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);
diethion
209-242-3
563-12-2
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)25-36/37-45-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %



015-048-00-8
fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-9
55-38-9
Muta. Cat. 3; R68
T; R23-48/25
Xn; R21/22
N; R50-53
T; N
R: 21/22-23-48/25-68-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


015-049-00-3
endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-3
2778-04-3
T; R24/25
T
R: 24/25
S: (1/2-)36/37-45


015-050-00-9
thiometon (ISO);
S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6
640-15-3
T; R25
Xn; R21
T
R: 21-25
S: (1/2-)36/37-45


015-051-00-4
dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-3
60-51-5
Xn; R21/22
Xn
R: 21/22
S: (2-)36/37


015-052-00-X
fenchlorphos (ISO);
O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate
206-082-6
299-84-3
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)25-36/37-60-61


015-053-00-5
menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate
201-123-4
78-57-9
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


015-054-00-0
fenitrothion (ISO);
O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2
122-14-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


015-055-00-6
naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3
300-76-5
Xn; R21/22
Xi; R36/38
N; R50
Xn; N
R: 21/22-36/38-50
S: (2-)36/37-61
N; R50: C ≥ 0,025 %



015-056-00-1
azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-6
2642-71-9
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


015-057-00-7
formothion (ISO);
N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate
219-818-6
2540-82-1
Xn; R21/22
Xn
R: 21/22
S: (2-)36/37


015-058-00-2
morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0
144-41-2
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61


015-059-00-8
vamidothion (ISO);
O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-8
2275-23-2
T; R25
Xn; R21
N; R50
T; N
R: 21-25-50
S: (1/2-)36/37-45-61


015-060-00-3
disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3
298-04-4
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61


015-061-00-9
dimefox (ISO);
tetramethylphosphorodiamidic fluoride
204-076-8
115-26-4
T+; R27/28
T+
R: 27/28
S: (1/2-)23-28-36/37-38-45


015-062-00-4
mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride
206-742-3
371-86-8
T+; R39/26/27/28
T+
R: 39/26/27/28
S: (1/2-)13-45


015-063-00-X
dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-7
78-34-2
T+; R26/28
T; R24
N; R50-53
T+; N
R: 24-26/28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-064-00-5
bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate
225-399-0
4824-78-6
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)28-36/37-45-60-61


015-065-00-0
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate
—
2703-37-9
T+; R26/27/28
N; R51-53
T+; N
R: 26/27/28-51/53
S: (1/2-)13-28-45-61


015-066-00-6
omethoate (ISO);
O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-8
1113-02-6
T; R25
Xn; R21
N; R50
T; N
R: 21-25-50
S: (1/2-)23-36/37-45-61




015-067-00-1
phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate
218-996-2
2310-17-0
T; R25
Xn; R20/21
R43
N; R50-53
T; N
R: 20/21-25-43-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


015-068-00-7
dichlofenthion (ISO);
O-,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-5
97-17-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


015-069-00-2
methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4
950-37-8
T+; R28
Xn; R21
N; R50-53
T+; N
R: 21-28-50/53
S: (1/2-)22-28-36/37-45-60-61


015-070-00-8
cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-4
3734-95-0
T+; R28
T; R24
T+
R: 24-28
S: (1/2-)36/37-45


015-071-00-3
chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate
207-432-0
470-90-6
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61


015-072-00-9
monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-7
6923-22-4
Muta. Cat. 3; R68
T+; R26/28
T; R24
N; R50-53
T+; N
R: 24-26/28-50/53-68
S: (1/2-)36/37-45-60-61


015-073-00-4
dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3
141-66-2
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61


015-074-00-X
crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1
299-86-5
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


015-075-00-5
S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate
—
2635-50-9
T; R23/24/25
T
R: 23/24/25
S: (1/2-)13-45


015-076-00-0
potasan;
O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
—
299-45-6
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)13-28-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-077-00-6
2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate
—
7076-53-1
T; R23/24/25
T
R: 23/24/25
S: (1/2-)13-45


015-078-00-1
demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-5
17040-19-6
T; R25
Xn; R21
N; R51-53
T; N
R: 21-25-51/53
S: (1/2-)22-28-36/37-45-61


015-079-00-7
acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate
250-241-2
30560-19-1
Xn; R22
Xn
R: 22
S: (2-)36


015-080-00-2
amidithion (ISO);
2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
—
919-76-6
Xn; R22
Xn
R: 22
S: (2-)24-36


015-081-00-8
O,O,O',O'-tetrapropyl dithiopyrophosphate
221-817-0
3244-90-4
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


015-082-00-3
azothoate (ISO);
O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-3
5834-96-8
Xn; R20/22
Xn
R: 20/22
S: (2-)13


015-083-00-9
bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4
741-58-2
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24-36-60-61


015-084-00-4
chlorpyrifos (ISO);
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-4
2921-88-2
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)45-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %

015-085-00-X
chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4
115-78-6
T; R25
Xn; R21
Xi; R36/38
T
R: 21-25-36/38
S: (1/2-)36/37/39-45


015-086-00-5
coumithoate (ISO);
O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
—
572-48-5
T; R25
T
R: 25
S: (1/2-)28-36/37-45


015-087-00-0
cyanophos (ISO);
O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-3
2636-26-2
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


015-088-00-6
dialifos (ISO);
2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-3
10311-84-9
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61


015-089-00-1
ethoate-methyl (ISO);
ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1
116-01-8
Xn; R21/22
Xn
R: 21/22
S: (2-)36/37


015-090-00-7
fensulfothion (ISO);
O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3
115-90-2
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)23-28-36/37-45-60-61


015-091-00-2
fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate
213-408-0
944-22-9
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61


015-092-00-8
phosacetim (ISO);
O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-7
4104-14-7
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)28-36/37-45-60-61


015-093-00-3
leptophos (ISO);
O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-8
21609-90-5
T; R25-39/25
Xn; R21
N; R50-53
T; N
R: 21-25-39/25-50/53
S: (1/2-)25-36/37/39-45-60-61


015-094-00-9
mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3
950-10-7
T+; R27/28
N; R51-53
T+; N
R: 27/28-51/53
S: (1/2-)36/37/39-45-61


015-095-00-4
methamidophos (ISO);
O,S-dimethyl phosphoramidothioate
233-606-0
10265-92-6
T+; R26/28
T; R24
N; R50
T+; N
R: 24-26/28-50
S: (1/2-)28-36/37-45-61


015-096-00-X
oxydisulfoton (ISO);
O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-1
2497-07-6
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

015-097-00-5
phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-0
2597-03-7
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)22-36/37-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-098-00-0
trichloronate (ISO);
O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1
327-98-0
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)23-28-36/37-45-60-61


015-099-00-6
pirimiphos-ethyl (ISO);
O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-0
23505-41-1
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)23-36/37-45-60-61




015-100-00-X
phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-3
14816-18-3
Repr. Cat. 3; R62
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-62-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


015-101-00-5
phosmet (ISO);
O,O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4
732-11-6
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)22-36/37-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %




015-102-00-0
tris(2-chloroethyl)phosphate
204-118-5
115-96-8
Carc. Cat. 3; R40
Repr. Cat. 2; R60
Xn; R22
N; R51-53
T; N
R: 60-22-40-51/53
S: 53-45-61

E

015-103-00-6
phosphorus tribromide
232-178-2
7789-60-8
R14
C; R34
Xi; R37
C
R: 14-34-37
S: (1/2-)26-45


015-104-00-1
diphosphorus pentasulphide;
phosphorus pentasulphide
215-242-4
1314-80-3
F; R11
R29
Xn; R20/22
N; R50
F; Xn; N
R: 11-20/22-29-50
S: (2-)61


015-105-00-7
triphenyl phosphite
202-908-4
101-02-0
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)28-60-61
Xi; R36/38: C ≥ 5 %

015-106-00-2
hexamethylphosphoric triamide;
hexamethylphosphoramide
211-653-8
680-31-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45
Carc. Cat. 2; R45: C ≥ 0,01 %

015-107-00-8
ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate
236-152-1
13194-48-4
T+; R26/27
T; R25
R43
N; R50-53
T+; N
R: 25-26/27-43-50/53
S: (1/2-)27/28-36/37/39-45-60-61


015-108-00-3
bromophos (ISO);
O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-3
2104-96-3
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-) 46-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-109-00-9
crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-5
7700-17-6
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

015-110-00-4
cyanofenphos (ISO);
O-4-cyanophenyl O-ethyl phenylphosphonothioate
—
13067-93-1
T; R25-39/25
Xn; R21
Xi; R36
N; R51-53
T; N
R: 21-25-36-39/25-51/53
S: (1/2-)36/37-45-61


015-111-00-X
phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2
947-02-4
T+; R27/28
T+
R: 27/28
S: (1/2-)28-36/37-45


015-112-00-5
thionazin (ISO);
O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6
297-97-2
T+; R27/28
T+
R: 27/28
S: (1/2-)36/37/39-38-45




015-113-00-0
tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
260-515-3
57018-04-9
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61





015-114-00-6
chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate
246-538-1
24934-91-6
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)27-28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


015-115-00-1
chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]
244-663-6
21923-23-9
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


015-116-00-7
demephion-O (ISO);
O,O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9
682-80-4
T+; R28
T; R24
T+
R: 24-28
S: (1/2-)28-36/37-45


015-117-00-2
demephion-S (ISO);
O,O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-9
2587-90-8
T+; R28
T; R24
T+
R: 24-28
S: (1/2-)28-36/37-45


015-118-00-8
demeton
—
8065-48-3
T+; R27/28
N; R50
T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61


015-119-00-3
dimethyl 4-(methylthio)phenyl phosphate
—
3254-63-5
T+; R27/28
T+
R: 27/28
S: (1/2-)28-36/37-45


015-120-00-9
ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate;
225-875-8
5131-24-8
Xi; R38
R43
Xi
R: 38-43
S: (2-)36/37


015-121-00-4
edifenphos (ISO);
O-ethyl S,S-diphenyl phosphorodithioate
241-178-1
17109-49-8
T; R23/25
Xn; R21
R43
N; R50-53
T; N
R: 21-23/25-43-50/53
S: (1/2-)36/37-45-60-61


015-122-00-X
etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate;
253-855-9
38260-54-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

015-123-00-5
fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-1
22224-92-6
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-124-00-0
fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate;
244-437-7
21548-32-3
T+; R27/28
T+
R: 27/28
S: (1/2-)36/37-45


015-125-00-6
glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine
219-468-4
2439-99-8
Xi; R41
Xi
R: 41
S: (2-)26


015-126-00-1
heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-0
23560-59-0
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)23-28-37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-127-00-7
iprobenfos (ISO);
S-benzyl diisopropyl phosphorothioate
247-449-0
26087-47-8
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


015-128-00-2
IPSP;
S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
—
5827-05-4
T+; R27
T; R25
N; R50-53
T+; N
R: 25-27-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-129-00-8
isofenphos (ISO);
O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-1
25311-71-1
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-130-00-3
isothioate (ISO)
S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
—
36614-38-7
T; R24/25
T
R: 24/25
S: (1/2-)28-36/37-45


015-131-00-9
isoxathion (ISO);
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-8
18854-01-8
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61


015-132-00-4
S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;
methylcarbophenothione
—
953-17-3
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-133-00-X
piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate
—
24151-93-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

015-134-00-5
pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate
249-528-5
29232-93-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


015-135-00-0
profenofos (ISO);
O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate
255-255-2
41198-08-7
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)36/37-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-136-00-6
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO)
250-517-2
31218-83-4
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

015-137-00-1
pyrazophos (ISO);
O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-1
13457-18-6
Xn; R20/22
N; R50-53
Xn; N
R: 20/22-50/53
S: (2-)36/37-46-60-61


015-138-00-7
quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-6
13593-03-8
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)22-36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

015-139-00-2
terbufos (ISO)
S-tert-butylthiomethyl O,O-diethylphosphorodithioate;
235-963-8
13071-79-9
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %



015-140-00-8
triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate
245-986-5
24017-47-8
T; R23/25
Xn; R21
N; R50-53
T; N
R: 21-23/25-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


015-141-00-3
ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers
400-520-1
—
C; R34
Xn; R22
N; R50-53
C; N
R: 22-34-50/53
S: (1/2-)24/25-26-28-39-45-60-61


015-142-00-9
butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate
401-100-0
—
F; R11
Xi; R36
N; R51-53
F; Xi; N
R: 11-36-51/53
S: (2-)7/9-16-26-43-61


015-143-00-4
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers
401-740-0
—
Xn; R22
Xn
R: 22
S: (2-)


015-144-00-X
reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate
402-090-0
87025-52-3
C; R34
C
R: 34
S: (1/2-)26-36/37/39-45


015-145-00-5
reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate
401-520-4
—
N; R50-53
N
R: 50/53
S: 60-61


015-146-00-0
S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate
401-850-9
—
N; R50-53
N
R: 50/53
S: 60-61


015-147-00-6
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)
400-930-0
—
Xi; R38-41
N; R51-53
R43
Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61


015-148-00-1
2-(diphosphonomethyl)succinic acid
403-070-4
51395-42-7
C; R34
R43
C
R: 34-43
S: (1/2-)26-36/37/39-45


015-149-00-7
reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide
403-470-9
—
C; R34
N; R50-53
C; N
R: 34-50/53
S: (1/2-)26-36/37/39-45-60-61


015-150-00-2
(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide
404-940-6
86608-70-0
Xn; R22
Xi; R41
R33
R52-53
Xn
R: 22-33-41-52/53
S: (2-)22-26-39-61


015-151-00-8
tris(isopropyl/tert-butylphenyl) phosphate
405-010-2
—
N; R51-53
N
R: 51/53
S: 61


015-152-00-3
dioxabenzofos (ISO);
2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide;
223-292-3
3811-49-2
T; R24/25-39/25
N; R51-53
T; N
R: 24/25-39/25-51/53
S: (1/2-)36/37-38-45-61


015-153-00-9
isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate;
255-863-8
42509-80-8
T+; R26
T; R24/25
Xn; R48/20
R43
N; R50-53
T+; N
R: 24/25-26-43-48/20-50/53
S: (1/2-)28-36/37-38-45-59-61


015-154-00-4
2-chloroethylphosphonic acid;
ethephon
240-718-3
16672-87-0
Xn; R20/21
C; R34
R52-53
C
R: 20/21-34-52/53
S: (1/2-)26-28-36/37/39-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %



015-155-00-X
glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
278-636-5
77182-82-2
Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R20/21/22-48/20/22
T
R: 60-20/21/22-48/20/22-63
S: 53-45

E

015-156-00-5
methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]
- [2]
30864-28-9 [1]
62610-77-9 [2]
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61


015-157-00-0
phosphonic acid; [1]
phosphorous acid [2]
237-066-7 [1]
233-663-1 [2]
13598-36-2 [1]
10294-56-1 [2]
Xn; R22
C; R35
C
R: 22-35
S: (1/2-)26-36/37/39-45


015-158-00-6
(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)
402-340-9
32760-80-8
R52-53
R: 52/53
S: 61


015-159-00-1
hydroxyphosphonoacetic acid
405-710-8
23783-26-8
Xn; R22-48/22
C; R34
R43
C
R: 22-34-43-48/22
S: (1/2-)22-26-36/37/39-45


015-160-00-7
vanadyl pyrophosphate
406-260-5
58834-75-6
Xi; R36
R43
R52-53
Xi
R: 36-43-52/53
S: (2-)24-26-37-61


015-161-00-2
divanadyl pyrophosphate
407-130-0
65232-89-5
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61


015-162-00-8
vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped
407-350-7
—
Xn; R20-48/22
Xi; R41
N; R51-53
Xn; N
R: 20-41-48/22-51/53
S: (2-)22-26-36/39-61


015-163-00-3
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide
412-010-6
145052-34-2
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


015-164-00-9
calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate
400-480-5
36669-85-9
R52-53
R: 52/53
S: 61


015-165-00-4
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7
—
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)15-26-39-60-61


015-166-00-X
3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
410-290-4
80693-00-1
R53
R: 53
S: 61


015-167-00-5
3-(hydroxyphenylphosphinyl)propanoic acid
411-200-6
14657-64-8
Xi; R41
Xi
R: 41
S: (2-)26-39


015-168-00-0
fosthiazate (ISO);
(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
—
98886-44-3
T; R23/25-39
Xn; R21
Xi; R41
R43
N; R50-53
T; N
R: 21-23/25-39-41-43-50/53
S: (1/2-)53-45-25-26-39-60-61


015-169-00-6
tributyltetradecylphosphonium tetrafluoroborate
413-520-1
—
Xn; R22-48/22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-48/22-50/53
S: (1/2-)26-28-36/37/39-45-60-61


015-170-00-1
reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate
407-490-9
—
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-36/37/39-45


015-171-00-7
O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate
406-940-1
—
N; R51-53
N
R: 51/53
S: 61


015-172-00-2
reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6
—
R10
C; R34
N; R51-53
C; N
R: 10-34-51/53
S: (1/2-)23-26-28-36/37/39-45-61


015-173-00-8
methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate
414-080-3
117291-73-3
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)23-36-60-61


015-174-00-3
1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine
411-370-1
82857-68-9
T; R25
Xi; R41
N; R51-53
T; N
R: 25-41-51/53
S: (1/2-)26-37/39-41-45-61


015-175-00-9
tert-butyl (triphenylphosphoranylidene) acetate
412-880-7
35000-38-5
T; R25
Xn; R48/22
Xi; R36
R43
N; R51-53
T; N
R: 25-36-43-48/22-51/53
S: (1/2-)26-36/37/39-45-61


015-176-00-4
P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine
413-430-2
116163-96-3
N; R50-53
N
R: 50/53
S: 60-61


015-177-00-X
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
412-170-7
83623-61-4
Xn; R48/22
Xi; R41
R43
Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39


015-178-00-5
(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate
418-570-8
25383-07-7
Repr. Cat. 3; R62
N; R51-53
Xn; N
R: 62-51/53
S: (2-)22-36/37-61


015-179-00-0
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine
422-720-8
166242-53-1
Carc. Cat. 3; R40
Xn; R22-48/22
C; R34
R43
N; R50-53
C; N
R: 22-34-40-43-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61


015-180-00-6
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt
415-820-8
137590-32-0
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


015-181-00-1
phosphine
232-260-8
7803-51-2
F+; R12
R17
T+; R26
C; R34
N; R50
F+; T+; N
R: 12-17-26-34-50
S: (1/2-)28-36/37-45-61-63




015-182-00-7
tetraisopropyldichloromethylenebisphosphonate
430-630-5
10596-22-2
Xn; R22
Xi; R36
R43
Xn
R: 22-36-43
S: (2-)24-26-37



015-183-00-2
(1-hydroxydodecylidene)diphosphonic acid
425-230-2
16610-63-2
C; R34
N; R50-53
C; N
R: 34-50/53
S: (1/2-)26-36/37/39-45-60-61



015-184-00-8
Salts of glyphosate, with the exception of those specified elsewhere in this Annex
—
—
N; R51-53
N
R: 51/53
S: 61

A
015-186-00-9
chlorpyrifos-methyl (ISO),
O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-5
5598-13-0
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)36/37-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %

015-187-00-4
reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61




015-188-00-X
(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate
425-220-8
5945-33-5
R53
R: 53
S: 61



015-189-00-5
phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
423-340-5
162881-26-7
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61




015-190-00-0
bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2
154862-43-8
R53
R: 53
S: 61



015-191-00-6
dodecyldiphenyl phosphate
431-760-5
27460-02-2
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)37-61



015-192-00-1
tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate
432-770-2
139189-30-3
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



015-193-00-7
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)
442-960-7
332350-93-3
T; R25
Xi; R41
N; R50-53
T; N
R: 25-41-50/53
S: (1/2-)26-39-45-60-61



015-194-00-2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate
444-440-5
220689-12-3
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61



015-195-00-8
reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate
433-860-4
-
Xi; R36
R43
R52-53
Xi
R: 36-43-52/53
S: (2-)24-26-37-61



015-196-00-3
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3
-
Carc. Cat.2; R45
Muta. Cat.2; R46
R43
T
R: 45-46-43
S: 53-45



015-197-00-9
bis(2,4,4-trimethylpentyl)dithiophosphonic acid
420-160-9
107667-02-7
R10
T; R23
Xn; R22
C; R34
N; R51-53
T; N
R: 10-22-23-34-51/53
S: (1/2-)9-26-36/37/39-45-61



015-198-00-4
(4-phenylbutyl)phosphinic acid
420-450-5
86552-32-1
Carc. Cat.3; R40
Xi; R41
Xn
R: 40-41
S: (2-)23-26-36/37/39




016-001-00-4
hydrogen sulphide
231-977-3
7783-06-4
F+; R12
T+; R26
N; R50
F+; T+; N
R: 12-26-50
S: (1/2-)9-16-36-38-45-61


016-002-00-X
barium sulphide
244-214-4
21109-95-5
R31
Xn; R20/22
N; R50
Xn; N
R: 20/22-31-50
S: (2-)28-61


016-003-00-5
barium polysulphides
256-814-3
50864-67-0
R31
Xi; R36/37/38
N; R50
Xi; N
R: 31-36/37/38-50
S: (2-)28-61


016-004-00-0
calcium sulphide
243-873-5
20548-54-3
R31
Xi; R36/37/38
N; R50
Xi; N
R: 31-36/37/38-50
S: (2-)28-61


016-005-00-6
calcium polysulphides
215-709-2
1344-81-6
R31
Xi; R36/37/38
N; R50
Xi; N
R: 31-36/37/38-50
S: (2-)28-61


016-006-00-1
dipotassium sulphide;
potassium sulphide
215-197-0
1312-73-8
R31
C; R34
N; R50
C; N
R: 31-34-50
S: (1/2-)26-45-61


016-007-00-7
potassium polysulphides
253-390-1
37199-66-9
R31
C; R34
N; R50
C; N
R: 31-34-50
S: (1/2-)26-45-61


016-008-00-2
ammonium polysulphides
232-989-1
9080-17-5
R31
C; R34
N; R50
C; N
R: 31-34-50
S: (1/2-)26-45-61
C; R34: C ≥ 5 %
Xi; R36/38: 1 % ≤ C < 5 %
R31: C ≥ 1 %



016-009-00-8
disodium sulfide;
sodium sulfide
215-211-5
1313-82-2
T; R24
Xn; R22
C; R34
R31
N; R50
T; C; N
R: 22-24-31-34-50
S: (1/2-)26-36/37/39-45-61




016-010-00-3
sodium polysulphides
215-686-9
1344-08-7
T; R25
R31
C; R34
N; R50
T; N
R: 25-31-34-50
S: (1/2-)26-36/37/39-45-61


016-011-00-9
sulphur dioxide
231-195-2
7446-09-5
T; R23
C; R34
T
R: 23-34
S: (1/2-)9-26-36/37/39-45
T; R23: C ≥ 20 %
Xn; R20: 5 % ≤ C < 20 %
5
016-012-00-4
disulphur dichloride;
sulfur monochloride
233-036-2
10025-67-9
R14
T; R25
Xn; R20
R29
C; R35
N; R50
T; C; N
R: 14-20-25-29-35-50
S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

016-013-00-X
sulphur dichloride
234-129-0
10545-99-0
R14
C; R34
Xi; R37
N; R50
C; N
R: 14-34-37-50
S: (1/2-)26-45-61


016-014-00-5
sulphur tetrachloride
—
13451-08-6
R14
C; R34
N; R50
C; N
R: 14-34-50
S: (1/2-)26-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

016-015-00-0
thionyl dichloride;
thionyl chloride
231-748-8
7719-09-7
R14
Xn; R20/22
R29
C; R35
C
R: 14-20/22-29-35
S: (1/2-)26-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

016-016-00-6
sulphuryl chloride
232-245-6
7791-25-5
R14
C; R34
Xi; R37
C
R: 14-34-37
S: (1/2-)26-45


016-017-00-1
chlorosulphonic acid
232-234-6
7790-94-5
R14
C; R35
Xi; R37
C
R: 14-35-37
S: (1/2-)26-45


016-018-00-7
fluorosulphonic acid
232-149-4
7789-21-1
Xn; R20
C; R35
C
R: 20-35
S: (1/2-)26-45


016-019-00-2
oleum ... % SO3
—
—
R14
C; R35
Xi; R37
C
R: 14-35-37
S: (1/2-)26-30-45

B
016-020-00-8
sulphuric acid ... %
231-639-5
7664-93-9
C; R35
C
R: 35
S: (1/2-)26-30-45
C; R35: C ≥ 15 %
Xi; R36/38: 5 % ≤ C < 15 %
B
016-021-00-3
methanethiol;
methyl mercaptan
200-822-1
74-93-1
F+; R12
T; R23
N; R50-53
F+; T; N
R: 12-23-50/53
S: (2-)16-25-60-61


016-022-00-9
ethanethiol;
ethyl mercaptan
200-837-3
75-08-1
F; R11
Xn; R20
N; R50-53
F; Xn; N
R: 11-20-50/53
S: (2-)16-25-60-61


016-023-00-4
dimethyl sulphate
201-058-1
77-78-1
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T+; R26
T; R25
C; R34
R43
T+
R: 45-25-26-34-43-68
S: 53-45
Car. Cat. 2; R45: C ≥ 0,01 %
Muta. Cat. 3, R68: C ≥ 0,01 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
E
016-024-00-X
dimexano (ISO);
bis(methoxythiocarbonyl) disulphide
215-993-8
1468-37-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


016-025-00-5
disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES
205-259-5
149-26-8
Xn; R22
Xi; R38-41
Xn
R: 22-38-41
S: (2-)26


016-026-00-0
sulphamidic acid;
sulphamic acid;
sulfamic acid
226-218-8
5329-14-6
Xi; R36/38
R52-53
Xi
R: 36/38-52/53
S: (2-)26-28-61


016-027-00-6
diethyl sulphate
200-589-6
64-67-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R20/21/22
C; R34
T
R: 45-46-20/21/22-34
S: 53-45

E
016-028-00-1
sodium dithionite;
sodium hydrosulphite
231-890-0
7775-14-6
R7
R31
Xn; R22
Xn
R: 7-22-31
S: (2-)7/8-26-28-43


016-029-00-7
p-toluenesulphonic acid, containing more than 5 % H2SO4
—
—
C; R34
C
R: 34
S: (1/2-)26-37/39-45
C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 %

016-030-00-2
p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)
203-180-0
104-15-4
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)26-37


016-031-00-8
tetrahydrothiophene-1,1-dioxide;
sulpholane
204-783-1
126-33-0
Xn; R22
Xn
R: 22
S: (2-)25


016-032-00-3
1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide
214-317-9
1120-71-4
Carc. Cat. 2; R45
Xn; R21/22
T
R: 45-21/22
S: 53-45
Carc. Cat. 2; R45: C ≥ 0,01 %
E
016-033-00-9
dimethylsulfamoylchloride
236-412-4
13360-57-1
Carc. Cat. 2; R45
T+; R26
Xn; R21/22
C; R34
T+
R: 45-21/22-26-34
S: 53-45

E
016-034-00-4
tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)
400-010-9
81898-60-4
R43
Xi
R: 43
S: (2-)22-24-37


016-035-00-X
pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate
400-120-7
—
Xi; R36
Xi
R: 36
S: (2-)22-26


016-036-00-5
tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate
400-130-1
—
R42
N; R51-53
Xn; N
R: 42-51/53
S: (2-)22-61


016-037-00-0
disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate
400-350-8
85153-93-1
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


016-038-00-6
disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate
400-380-1
86393-35-3
R43
Xi
R: 43
S: (2-)22-24-37


016-039-00-1
tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate
400-430-2
—
R43
Xi
R: 43
S: (2-)22-24-37


016-040-00-7
reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate
400-570-4
—
Xi; R36
Xi
R: 36
S: (2-)26


016-041-00-2
calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate
400-710-4
—
Xn; R20
Xn
R: 20
S: (2-)


016-042-00-8
tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate
400-790-0
85665-97-0
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)22-24/25-37


016-043-00-3
dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate
401-010-1
—
R43
Xi
R: 43
S: (2-)24-37


016-044-00-9
disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate
401-320-7
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


016-045-00-4
lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate
401-560-2
108624-00-6
R43
Xi
R: 43
S: (2-)22-24-37


016-046-00-X
sodium hydrogensulphate
231-665-7
7681-38-1
Xi; R41
Xi
R: 41
S: (2-)24-26


016-047-00-5
hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate
401-650-1
85665-96-9
R43
Xi
R: 43
S: (2-)22-24-37


016-048-00-0
sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate
401-870-8
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-61


016-049-00-6
calcium octadecylxylenesulphonate
402-040-8
—
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)26-28-36/37/39-45-61


016-050-00-1
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat
402-150-6
—
Xi; R36
R43
Xi
R: 36-43
S: (2-)22-24-26-37


016-051-00-7
trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate
402-170-5
106359-91-5
R43
Xi
R: 43
S: (2-)22-24-37


016-052-00-2
benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate
402-240-5
102561-46-6
Xn; R20
N; R51-53
Xn; N
R: 20-51/53
S: (2-)22-61


016-053-00-8
(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate
402-460-1
—
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)24-37-61


016-054-00-3
sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate
400-030-8
—
T; R23-48/23
Xn; R22
Xi; R36/37
R43
T
R: 22-23-36/37-43-48/23
S: (1/2-)22-24-36-45


016-055-00-9
tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)
400-510-7
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


016-056-00-4
potassium hydrogensulphate
231-594-1
7646-93-7
C; R34
Xi; R37
C
R: 34-37
S: (1/2-)26-36/37/39-45


016-057-00-X
styrene-4-sulfonyl chloride
404-770-2
2633-67-2
Xi; R38-41
R43
Xi
R: 38-41-43
S: (2-)24-26-37/39


016-058-00-5
thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine
404-820-3
—
Xi; R38
R43
R52-53
Xi
R: 38-43-52/53
S: (2-)36/37-61


016-059-00-0
N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride
405-300-9
17339-60-5
Xn; R22
Xi; R36
R43
N; R50-53
Xn; N
R: 22-36-43-50/53
S: (2-)26-36/37-60-61


016-060-00-6
diammonium peroxodisulphate;
ammonium persulphate
231-786-5
7727-54-0
O; R8
Xn; R22
Xi; R36/37/38
R42/43
O; Xn
R: 8-22-36/37/38-42/43
S: (2-)22-24-26-37


016-061-00-1
dipotassium peroxodisulphate;
potassium persulphate
231-781-8
7727-21-1
O; R8
Xn; R22
Xi; R36/37/38
R42/43
O; Xn
R: 8-22-36/37/38-42/43
S: (2-)22-24-26-37


016-062-00-7
bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
—
17606-31-4
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


016-063-00-2
sodium metabisulphite
231-673-0
7681-57-4
Xn; R22
Xi; R41
R31
Xn
R: 22-31-41
S: (2-)26-39-46


016-064-00-8
sodium hydrogensulphite … %;
sodium bisulphite … %
231-548-0
7631-90-5
Xn; R22
R31
Xn
R: 22-31
S: (2-)25-46

B
016-065-00-3
sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate
400-100-8
84057-97-6
N; R51-53
N
R: 51/53
S: 61


016-066-00-9
tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)
404-070-7
116912-62-0
R52-53
R: 52/53
S: 61


016-067-00-4
(4-methylphenyl)mesitylene sulfonate
407-530-5
67811-06-7
R53
R: 53
S: 61


016-068-00-X
sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate
407-720-8
155160-86-4
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


016-069-00-5
3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid
407-990-7
141915-64-2
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


016-070-00-0
4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone
408-220-2
—
R53
R: 53
S: 61


016-071-00-6
trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate
410-130-3
136248-03-8
R43
Xi
R: - 43
S: (2-)22-24-37


016-072-00-1
3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide
411-520-6
112195-27-4
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61


016-073-00-7
tetrakis(phenylmethyl)thioperoxydi(carbothioamide)
404-310-0
10591-85-2
R53
R: 53
S: 61


016-074-00-2
6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene
405-410-7
—
Xi; R38-41
R43
N; R51-53
Xi; N
R: 38-41-43-51/53
S: (2-)26-36/37/39-61


016-075-00-8
2,2'-diallyl-4,4'-sulfonyldiphenol
411-570-9
41481-66-7
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


016-076-00-3
2,3-bis((2-mercaptoethyl)thio)-1-propanethiol
411-290-7
131538-00-6
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)23-24/25-36-60-61


016-077-00-9
2-chloro-p-toluenesulfochloride
412-890-1
42413-03-6
C; R34
R43
R52-53
C
R: 34-43-52/53
S: (1/2-)23-26-36/37/39-45-61


016-078-00-4
4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide
413-300-5
56187-04-3
R53
R: 53
S: 61


016-079-00-X
N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide
412-920-3
16695-22-0
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


016-080-00-5
sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate
412-320-1
31361-99-6
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


016-081-00-0
hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide
418-350-1
—
Muta. Cat. 3; R68
Xn; R22
Xi; R36
R43
N; R51-53
Xn; N
R: 22-36-43-68-51/53
S: (2-)26-36/37-61


016-082-00-6
ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
—
126801-58-9
N; R50-53
N
R: 50/53
S: 60-61


016-083-00-1
acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0
135158-54-2
Xi; R36/37/38
R43
N; R50-53
Xi; N
R: 36/37/38-43-50/53
S: (2-)24/25-37-46-59-60-61




016-084-00-7
prosulfuron (ISO);
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
—
94125-34-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


016-085-00-2
flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
—
104040-78-0
N; R50-53
N
R: 50/53
S: 60-61


016-086-00-8
tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
402-590-9
109125-56-6
Xi; R41
Xi
R: 41
S: (2-)22-26-39


016-087-00-3
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate
403-490-8
104558-95-4
Xi; R36
R43
N; R50-53
Xi; N
R: 36-43-50/53
S: (2-)24-26-37-60-61


016-088-00-9
4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid
407-280-7
71297-11-5
R52-53
R: 52/53
S: 61


016-089-00-4
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene
413-840-1
—
E; R2
F; R11
R53
E
R: 2-11-53
S: (2-)33-35-40-61


016-090-00-X
4-methyl-N-(methylsulfonyl)benzenesulfonamide
415-040-8
14653-91-9
Xn; R22
Xi; R37-41
Xn
R: 22-37-41
S: (2-)26-39


016-091-00-5
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate
414-110-5
—
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61




016-092-00-0
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1
-
Repr. Cat. 3; R62
Xi; R38
R43
N; R50-53
Xn; N
R: 38-43-62-50/53
S: (2-)36/37-60-61



016-093-00-6
reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4
140698-96-0
F; R11
Carc. Cat. 3; R40
F; Xn
R: 11-40
S: (2-)7-36/37




016-094-00-1
sulfur
231-722-6
7704-34-9
Xi; R38
Xi
R: 38
S: (2-)46



016-095-00-7
reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4
—
F; R11
Carc. Cat. 3; R40
F; Xn
R: 11-40
S: (2-)7-36/37


016-096-00-2
thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
—
79277-27-3
N; R50-53
N
R: 50/53
S: 60-61




016-097-00-8
1-amino-2-methyl-2-propanethiol hydrochloride
434-480-1
32047-53-3
Xn; R22
C; R34
R43
R52-53
C
R: 22-34-43-52/53
S: (1/2-)22-26-36/37/39-45-61





017-001-00-7
chlorine
231-959-5
7782-50-5
T; R23
Xi; R36/37/38
N; R50
T; N
R: 23-36/37/38-50
S: (1/2-)9-45-61
N; R50: C ≥ 0,25 %


017-002-00-2
hydrogen chloride
231-595-7
7647-01-0
T; R23
C; R35
T; C
R: 23-35
S: (1/2-)9-26-36/37/39-45

5
017-002-01-X
hydrochloric acid ... %
231-595-7
—
C; R34
Xi; R37
C
R: 34-37
S: (1/2-)26-45
C; R34-37: C ≥ 25 %
Xi; R36/37/38: 10 % ≤ C < 25 %
B
017-003-00-8
barium chlorate
236-760-7
13477-00-4
O; R9
Xn; R20/22
N; R51-53
O; Xn; N
R: 9-20/22-51/53
S: (2-)13-27-61


017-004-00-3
potassium chlorate
223-289-7
3811-04-9
O; R9
Xn; R20/22
N; R51-53
O; Xn; N
R: 9-20/22-51/53
S: (2-)13-16-27-61


017-005-00-9
sodium chlorate
231-887-4
7775-09-9
O; R9
Xn; R22
N; R51-53
O; Xn; N
R: 9-22-51/53
S: (2-)13-17-46-61


017-006-00-4
perchloric acid ... %
231-512-4
7601-90-3
R5
O; R8
C; R35
O; C
R: 5-8-35
S: (1/2-)23-26-36-45
C; R35: C ≥ 50 %
C; R34: 10 % ≤ C < 50 %
Xi; R36/38: 1 % ≤ C < 10 %
Footnote
O; R5-8: C > 50 %
B
017-007-00-X
barium perchlorate
236-710-4
13465-95-7
O; R9
Xn; R20/22
O; Xn
R: 9-20/22
S: (2-)27


017-008-00-5
potassium perchlorate
231-912-9
7778-74-7
O; R9
Xn; R22
O; Xn
R: 9-22
S: (2-)13-22-27




017-009-00-0
ammonium perchlorate;
[containing ≥ 80 % of 0-30 μm particles]
232-235-1
7790-98-9
E; R3
O; R9
E
R: 3-9
S: (2-)14-16-36/37

T



017-009-01-8
ammonium perchlorate;
[containing < 80 % of 0-30 μm particles]
232-235-1
7790-98-9
E; R2
O; R9
E
R: 2-9
S: (2-)14-16-36/37

T

017-010-00-6
sodium perchlorate
231-511-9
7601-89-0
O; R9
Xn; R22
O; Xn
R: 9-22
S: (2-)13-22-27


017-011-00-1
sodium hypochlorite, solution ... % Cl active
231-668-3
7681-52-9
C; R34
R31
N; R50
C; N
R: 31-34-50
S: (1/2-)28-45-50-61
R31: C ≥ 5 %
B



017-012-00-7
calcium hypochlorite
231-908-7
7778-54-3
O; R8
C; R34
Xn; R22
R31
N; R50
O; C; N
R: 8-22-31-34-50
S: (1/2-)26-36/37/39-45-61
C; R34: C ≥ 10 %
Xi; R37/38-41: 3 % ≤ C < 10 %
Xi; R36: 0,5 % ≤ C < 3 %
N; R50: C ≥ 2,5 %


017-013-00-2
calcium chloride
233-140-8
10043-52-4
Xi; R36
Xi
R: 36
S: (2-)22-24


017-014-00-8
ammonium chloride
235-186-4
12125-02-9
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)22


017-015-00-3
(2-(aminomethyl)phenyl)acetylchloride hydrochloride
417-410-4
61807-67-8
Xn; R22
C; R35
R43
C
R: 22-35-43
S: (1/2-)26-36/37/39-45


017-016-00-9
methyltriphenylphosphonium chloride
418-400-2
1031-15-8
Xn; R21/22
Xi; R38-41
N; R51-53
Xn; N
R: 21/22-38-41-51/53
S: (2-)22-26-36/37/39-61


017-017-00-4
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride
426-210-6
120086-58-0
C; R34
N; R50-53
C; N
R: 34-50/53
S: (2-)26-36/37/39-45-60-61


017-018-00-X
N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride
405-660-7
—
N; R51-53
N
R: 51/53
S: 61


017-019-00-5
(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride
415-110-8
54417-53-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


017-020-00-0
ethyl propoxy aluminium chloride
421-790-7
13014-29-4
F; R15
R 14
C; R35
F; C
R: 14/15-35
S: (1/2-)16-23-26-30-36/37/39-43-45


017-021-00-6
behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride
423-420-1
136920-10-0
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)26-36/37/39-60-61




017-023-00-7
[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides
425-520-9
197179-61-6
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61



019-001-00-2
potassium
231-119-8
7440-09-7
F; R15
R14
C; R34
F; C
R: 14/15-34
S: (1/2-)5-8-45


019-002-00-8
potassium hydroxide;
caustic potash
215-181-3
1310-58-3
Xn; R22
C; R35
C
R: 22-35
S: (1/2-)26-36/37/39-45
C; R35: C ≥ 5 %
C; R34: 2 % ≤ C < 5 %
Xi; R36/38: 0.5 % ≤ C < 2 %

020-001-00-X
calcium
231-179-5
7440-70-2
F; R15
F
R: 15
S: (2-)8-24/25-43


020-002-00-5
calcium cyanide
209-740-0
592-01-8
T+; R28
R32
N; R50-53
T+; N
R: 28-32-50/53
S: (1/2-)7/8-23-36/37-45-60-61


020-003-00-0
reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4
—
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)24-26-37


022-001-00-5
titanium tetrachloride
231-441-9
7550-45-0
R14
C; R34
C
R: 14-34
S: (1/2-)7/8-26-36/37/39-45


022-002-00-0
titanium(4+) oxalate
403-260-7
—
Xi; R41
Xi
R: 41
S: (2-)26-39


022-003-00-6
bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium
412-000-1
125051-32-3
F; R11
Repr. Cat. 3; R62
Xn; R48/22
N; R51-53
F; Xn; N
R: 11-48/22-62-51/53
S: (2-)7-22-33-36/37-61




022-004-00-1
potassium titanium oxide (K2Ti6O13)
432-240-0
12056-51-8
Carc. Cat.3; R40
Xn
R: 40
S: (2-)22-36/37



022-005-00-7
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium
419-840-8
169104-71-6
F; R11
C; R34
R43
R53
F; C
R: 11-34-43-53
S: (1/2-)6-9-16-26-36/37/39-45-61



023-001-00-8
divanadium pentaoxide;
vanadium pentoxide
215-239-8
1314-62-1
Muta. Cat. 3; R68
Repr. Cat. 3; R63
T; R48/23
Xn; R20/22
Xi; R37
N; R51-53
T; N
R: 20/22-37-48/23-51/53-63-68
S: (1/2-)36/37-38-45-61


024-001-00-0
chromium (VI) trioxide
215-607-8
1333-82-0
O; R9
Carc. Cat. 1; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T+; R26
T; R24/25-48/23
C; R35
R42/43
N; R50-53
O; T+; N
R: 45-46-9-24/25-26-35-42/43-48/23-62-50/53
S: 53-45-60-61
C: R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
E
024-002-00-6
potassium dichromate
231-906-6
7778-50-9
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
T+; N; O
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
C; R34: C ≥ 10 %:
Xi; R36/37/38: 5 % ≤ C < 10 %
E
3
024-003-00-1
ammonium dichromate
232-143-1
7789-09-5
E; R2
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
E; T+; N
R: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 %
E
3


024-004-00-7
sodium dichromate
234-190-3
10588-01-9
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
O; T+; N
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
C; R34: C ≥ 25 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 %
E



024-004-01-4
sodium dichromate, dihydrate
234-190-3
7789-12-0
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
T+; N; O
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
R42/43: C ≥ 0,2 %
E
3

024-005-00-2
chromyl dichloride;
chromic oxychloride
239-056-8
14977-61-8
O; R8
Carc. Cat. 2; R49
Muta. Cat. 2; R46
C; R35
R43
N; R50-53
O; T; C; N
R: 49-46-8-35-43-50/53
S: 53-45-60-61
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 0,5 % ≤ C < 5 %
R43: C ≥ 0,5 %
3
024-006-00-8
potassium chromate
232-140-5
7789-00-6
Carc. Cat. 2; R49
Muta. Cat. 2; R46
Xi; R36/37/38
R43
N; R50-53
T; N
R: 49-46-36/37/38-43-50/53
S: 53-45-60-61
R43: C ≥ 0,5 %
3
024-007-00-3
zinc chromates including zinc potassium chromate
—
—
Carc. Cat. 1; R45
Xn; R22
R43
N; R50-53
T; N
R: 45-22-43-50/53
S: 53-45-60-61

AE
024-008-00-9
calcium chromate
237-366-8
13765-19-0
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

E
024-009-00-4
strontium chromate
232-142-6
7789-06-2
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

E
024-010-00-X
dichromium tris(chromate);
chromium III chromate;
chromic chromate
246-356-2
24613-89-6
O; R8
Carc. Cat. 2; R45
C; R35
R43
N; R50-53
O; T; C; N
R: 45-8-35-43-50/53
S: 53-45-60-61


024-011-00-5
ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)
400-110-2
109125-51-1
F; R11
N; R50-53
F; N
R: 11-50/53
S: (2-)33-60-61


024-012-00-0
trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)
400-810-8
—
Muta. Cat. 3; R68
Xn
R: 68
S: (2-)22-36/37


024-013-00-6
trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)
402-500-8
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


024-014-00-1
trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)
402-870-0
93952-24-0
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


024-015-00-7
disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)
404-930-1
—
Xn; R20
Xi; R41
N; R51-53
Xn; N
R: 20-41-51/53
S: (2-)26-39-61


024-016-00-2
tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)
405-110-6
88377-66-6
Xn; R48/22
R53
Xn
R: 48/22-53
S: (2-)22-36-61


024-017-00-8
Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex
—
—
Carc. Cat. 2; R49
R43
N; R50-53
T; N
R: 49-43-50/53
S: 53-45-60-61

A
024-018-00-3
sodium chromate
231-889-5
7775-11-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
T+; N
R: 45-46-60-61-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
R42/43: C ≥ 0,2 %
E
3
024-019-00-9
Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-230-1
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


024-020-00-4
trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)
418-220-4
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61




024-021-00-X
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)
425-830-4
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



025-001-00-3
manganese dioxide
215-202-6
1313-13-9
Xn; R20/22
Xn
R: 20/22
S: (2-)25


025-002-00-9
potassium permanganate
231-760-3
7722-64-7
O; R8
Xn; R22
N; R50-53
O; Xn; N
R: 8-22-50/53
S: (2-)60-61


025-003-00-4
manganese sulphate
232-089-9
7785-87-7
Xn; R48/20/22
N; R51-53
Xn; N
R: 48/20/22-51/53
S: (2-)22-61


025-004-00-X
bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate
411-760-1
116633-53-5
N; R51-53
N
R: 51/53
S: 61


025-005-00-5
reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)
417-660-4
—
N; R50-53
N
R: 50/53
S: 60-61


026-001-00-6
(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate
407-840-0
100011-37-8
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61


026-002-00-1
(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate
407-880-9
117549-13-0
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)26-61




026-003-00-7
iron (II) sulfate
231-753-5
7720-78-7
Xn; R22
Xi; R36/38
Xn
R: 22-36/38
S: (2-)46



026-003-01-4
iron (II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-5
7782-63-0
Xn; R22
Xi; R36/38
Xn
R: 22-36/38
S: (2-)46
Xi; R38: C ≥ 25 %


026-004-00-2
potassium ferrite
430-010-4
12160-44-0
C; R34
R43
C
R: 34-43
S: (1/2-)22-26-36/37/39-40-45




027-001-00-9
cobalt
231-158-0
7440-48-4
R42/43
R53
Xn
R: 42/43-53
S: (2-)22-24-37-61




027-002-00-4
cobalt oxide
215-154-6
1307-96-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


027-003-00-X
cobalt sulfide
215-273-3
1317-42-6
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


027-004-00-5
cobalt dichloride
231-589-4
7646-79-9
Carc. Cat. 2; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R60
Xn; R22
R42/43
N; R50-53
T; N
R: 49-60-22-42/43-68-50/53
S: 53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
E
1

027-005-00-0
cobalt sulfate
233-334-2
10124-43-3
Carc. Cat. 2; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R60
Xn; R22
R42/43
N; R50-53
T; N
R: 49-60-22-42/43-68-50/53
S: 53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
E
1




027-006-00-6
cobalt acetate
200-755-8
71-48-7
Carc. Cat. 2; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R60
R42/43
N; R50-53
T; N
R: 49-60-42/43-68-50/53
S: 53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
1

027-007-00-1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex
425-240-7
-
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)22-26-39-61



027-008-00-7
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2<n<3)
427-390-9
-
R43
Xi
R: 43
S: (2-)24-37



027-009-00-2
cobalt nitrate
233-402-1
10141-05-6
Carc. Cat. 2; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R60
R42/43
N; R50-53
T; N
R: 49-60-42/43-68-50/53
S: 53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
1

027-010-00-8
cobalt carbonate
208-169-4
513-79-1
Carc. Cat. 2; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R60
R42/43
N; R50-53
T; N
R: 49-60-42/43-68-50/53
S: 53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
1

028-001-00-1
tetracarbonylnickel;
nickel tetracarbonyl
236-669-2
13463-39-3
F; R11
Carc. Cat. 3; R40
Repr. Cat. 2; R61
T+; R26
N; R50-53
F; T+; N
R: 61-11-26-40-50/53
S: 53-45-60-61

E



028-002-00-7
nickel
231-111-4
7440-02-0
Carc. Cat. 3; R40
T; R48/23
R43
T
R: 40-43-48/23
S: (2-)36/37/39-45

S
7



028-002-01-4
nickel powder;
[particle diameter < 1 mm]
231-111-4
7440-02-0
Carc. Cat. 3; R40
T; R48/23
R43
R52-53
T
R: 40-43-48/23-52/53
S: (2-)36/37/39-45-61





028-003-00-2
nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
215-215-7 [1]
234-323-5 [2]
- [3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61

E

028-004-00-8
nickel dioxide
234-823-3
12035-36-8
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61

E

028-005-00-3
dinickel trioxide
215-217-8
1314-06-3
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61

E

028-006-00-9
nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
240-841-2 [1]
234-349-7 [2]
- [3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61

E

028-007-00-4
trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
234-829-6 [1]
- [2]
12035-72-2 [1]
12035-71-1 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61

E

028-008-00-X
nickel dihydroxide; [1]
nickel hydroxide [2]
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. Cat. 1; R49
Repr. Cat. 2; R61
Muta. Cat. 3; R68
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61

E

028-009-00-5
nickel sulfate
232-104-9
7786-81-4
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,1 % ≤ C < 1 %
Xi; R38: C ≥ 20 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E

028-010-00-0
nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[μ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]
222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]
3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61

E



028-011-00-6
nickel dichloride
231-743-0
7718-54-9
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R23/25-48/23
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-23/25-38-42/43-48/23-68-50/53
S: 53-45-60-61
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,1 % ≤ C < 1 %
Xi; R38: C ≥ 20 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E

028-012-00-1
nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
O; R8
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38-41
R42/43
N; R50-53
O; T; N
R: 49-61-8-20/22-38-41-42/43-48/23-68-50/53
S: 53-45-60-61
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,1 % ≤ C < 1 %
Xi; R38: C ≥ 20 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E

028-013-00-7
nickel matte
273-749-6
69012-50-6
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-014-00-2
slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
295-859-3
92129-57-2
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E

028-015-00-8
slimes and sludges, copper electrolyte refining, decopperised
305-433-1
94551-87-8
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-62-68-50/53
S: 53-45-60-61

E H

028-016-00-3
nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-1
13637-71-3
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
C; R34
R42/43
N; R50-53
T; N
R: 49-61-34-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %
Xn; R48/20: 0,1 % ≤ C < 1 %
C; R34: C ≥ 5 %:
Xi; R36/38: 1 % ≤ C < 5 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-017-00-9
nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53
T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53:2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-018-00-4
nickel bis(sulfamidate);
nickel sulfamate
237-396-1
13770-89-3
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-019-00-X
nickel bis(tetrafluoroborate)
238-753-4
14708-14-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-021-00-0
nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-022-00-6
nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53
T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-024-00-7
nickel dibenzoate
209-046-8
553-71-9
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-025-00-2
nickel bis(4-cyclohexylbutyrate)
223-463-2
3906-55-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


028-026-00-8
nickel(II) stearate;
nickel(II) octadecanoate
218-744-1
2223-95-2
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E U

028-027-00-3
nickel dilactate
-
16039-61-5
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-028-00-9
nickel(II) octanoate
225-656-7
4995-91-9
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat 2; R61
T; R48/23
C; R35
R42/43
N; R50-53
T; C; N
R: 49-61-35-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-029-00-4
nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-030-00-X
nickel hexafluorosilicate
247-430-7
26043-11-8
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-031-00-5
nickel selenate
239-125-2
15060-62-5
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-032-00-0
nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61

E H

028-033-00-6
diammonium nickel hexacyanoferrate
-
74195-78-1
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61

E H

028-034-00-1
nickel dicyanide
209-160-8
557-19-7
Carc. Cat. 1; R49
T; R48/23
R42/43
R32
N; R50-53
T; N
R: 49-32-42/43-48/23-50/53
S: 53-45-60-61

E H

028-035-00-7
nickel chromate
238-766-5
14721-18-7
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61

E H

028-036-00-2
nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-037-00-8
dinickel hexacyanoferrate
238-946-3
14874-78-3
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-038-00-3
trinickel bis(arsenate);
nickel(II) arsenate
236-771-7
13477-70-8
Carc. Cat. 1; R45
T; R48/23
R43
N; R50-53
T; N
R: 45-43-48/23-50/53
S: 53-45-60-61

E H

028-039-00-9
nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. Cat. 1; R49
T; R48/23
R43
N: R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-040-00-4
nickel telluride
235-260-6
12142-88-0
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-041-00-X
trinickel tetrasulfide
-
12137-12-1
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-042-00-5
trinickel bis(arsenite)
-
74646-29-0
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-043-00-0
cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45

E H

028-044-00-6
nickel tin trioxide;
nickel stannate
234-824-9
12035-38-0
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45

E H

028-045-00-1
nickel triuranium decaoxide
239-876-6
15780-33-3
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45

E H

028-046-00-7
nickel dithiocyanate
237-205-1
13689-92-4
Carc. Cat. 1; R49
Muta. Cat. 3;R68
Repr. Cat. 2; R61
T; R48/23
R42/43
R32
N; R50-53
T; N
R: 49-61-32-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-047-00-2
nickel dichromate
239-646-5
15586-38-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-048-00-8
nickel(II) selenite
233-263-7
10101-96-9
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61

E H

028-049-00-3
nickel selenide
215-216-2
1314-05-2
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-050-00-9
silicic acid, lead nickel salt
-
68130-19-8
Carc. Cat. 1: R49
Repr. Cat. 1: R61
Repr. Cat. 3; R62
T; R48/23
R43
N; R50-53
T; N
R: 49-61-43-48/23-62-50/53
S: 53-45-60-61

E H

028-051-00-4
nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-052-00-X
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-6
68610-24-2
Carc. Cat. 1: R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45

E H

028-053-00-5
nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-054-00-0
nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O1,O2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
T R48/23: C ≥ 1 %:
Xn; R48/20: 0,1 % ≤ C < 1 %
R43: C ≥ 0,01 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %
E H

028-055-00-6
nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61

E H

028-056-00-1
nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61

E H

028-057-00-7
dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45

E H

028-058-00-2
cobalt lithium nickel oxide
442-750-5
-
Carc. Cat. 1; R49
T+; R26
T; R48/23
R43
N; R50-53
T+; N
R: 49-26-43-48/23-50/53
S: 53-45-60-61

E

029-001-00-4
copper chloride;
copper (I) chloride;
cuprous chloride
231-842-9
7758-89-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61


029-002-00-X
dicopper oxide;
copper (I) oxide
215-270-7
1317-39-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61


029-003-00-5
Naphthenic acids, copper salts;
copper naphthenate
215-657-0
1338-02-9
R10
Xn; R22
N; R50-53
Xn; N
R: 10-22-50/53
S: (2-)60-61


029-004-00-0
copper sulphate
231-847-6
7758-98-7
Xn; R22
Xi; R36/38
N; R50-53
Xn; N
R: 22-36/38-50/53
S: (2-)22-60-61


029-005-00-6
(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid
401-260-1
—
Xi; R36
Xi
R: 36
S: (2-)26


029-006-00-1
tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)
403-210-4
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)22-26-39-61


029-007-00-7
(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide
404-670-9
89797-01-3
E; R2
R43
E; Xi
R: 2-43
S: (2-)22-24-35-37


029-008-00-2
copper(II) methanesulfonate
405-400-2
54253-62-2
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)26-36/37/39-60-61


029-009-00-8
phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex
413-650-9
93971-95-0
R52-53
R: 52/53
S: 61


029-010-00-3
reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)
407-700-9
101408-30-4
R43
Xi
R: 43
S: (2-)24-37


029-011-00-9
sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex
412-730-0
150522-10-4
C; R34
C
R: 34
S: (1/2-)22-26-36/37/39-45


029-012-00-4
sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)
407-340-2
124719-24-0
Xi; R41
Xi
R: 41
S: (2-)26-39




029-013-00-X
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)
407-580-8
130201-51-3
Xi; R41
Xi
R: 41
S: (2-)26-39





029-014-00-5
reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex
419-610-7
171866-24-3
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)22-36-61



030-001-00-1
zinc powder — zinc dust (pyrophoric)
231-175-3
7440-66-6
F; R15-17
N; R50-53
F; N
R: 15-17-50/53
S: (2-)43-46-60-61


030-001-01-9
zinc powder — zinc dust (stabilised)
231-175-3
7440-66-6
N; R50-53
N
R: 50/53
S: 60-61


030-003-00-2
zinc chloride
231-592-0
7646-85-7
C; R34
Xn; R22
N; R50-53
C; N
R: 22-34-50/53
S: (1/2-)26-36/37/39-45-60-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

030-004-00-8
dimethylzinc; [1]
diethylzinc [2]
208-884-1 [1]
209-161-3 [2]
544-97-8 [1]
557-20-0 [2]
F; R17
R14
C; R34
N; R50-53
F; C; N
R: 14-17-34-50/53
S: (1/2-)16-43-45-60-61


030-005-00-3
diamminediisocyanatozinc
401-610-3
—
Xn; R22
Xi; R41
R42/43
N; R50
Xn; N
R: 22-41-42/43-50
S: (2-)22-26-36/37/39-41-61


030-006-00-9
zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2]
231-793-3 [1]
231-793-3 [2]
7446-19-7 [1]
7733-02-0 [2]
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)22-26-39-46-60-61


030-007-00-4
bis(3,5-di-tert-butylsalicylato-O1,O2)zinc
403-360-0
42405-40-3
F; R11
Xn; R22
N; R50-53
F; Xn; N
R: 11-22-50/53
S: (2-)7-22-60-61


030-008-00-X
hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)
403-750-0
113036-91-2
Xn; R20
N; R51-53
Xn; N
R: 20-51/53
S: (2-)22-57-61




030-009-00-5
zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate
417-130-2
-
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61



030-010-00-0
2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt
430-740-3
-
N; R51-53
N
R: 51/53
S: 61



030-011-00-6
trizinc bis(orthophosphate)
231-944-3
7779-90-0
N; R50-53
N
R: 50/53
S: 60-61





030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
R52-53
R: 52/53
S: 61



030-013-00-7
zinc oxide
215-222-5
1314-13-2
N; R50-53
N
R: 50/53
S: 60-61




030-015-00-8
tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate
440-060-9
-
N; R51-53
N
R: 51/53
S: 61



033-001-00-X
arsenic
231-148-6
7440-38-2
T; R23/25
N; R50-53
T; N
R: 23/25-50/53
S: (1/2-)20/21-28-45-60-61


033-002-00-5
arsenic compounds, with the exception of those specified elsewhere in this Annex
—
—
T; R23/25
N; R50-53
T; N
R: 23/25-50/53
S: (1/2-)20/21-28-45-60-61
T; R23/25: C ≥ 0,2 %
Xn; R20/22: 0,1 % ≤ C < 0,2 %
A
1
033-003-00-0
diarsenic trioxide;
arsenic trioxide
215-481-4
1327-53-3
Carc. Cat. 1; R45
T+; R28
C; R34
N; R50-53
T+; N
R: 45-28-34-50/53
S: 53-45-60-61

E
033-004-00-6
diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide
215-116-9
1303-28-2
Carc. Cat. 1; R45
T; R23/25
N; R50-53
T; N
R: 45-23/25-50/53
S: 53-45-60-61

E


033-005-00-1
arsenic acid and its salts with the exception of those specified elsewhere in this Annex
—
—
Carc. Cat. 1; R45
T; R23/25
N; R50-53
T; N
R: 45-23/25-50/53
S: 53-45-60-61

AE


033-006-00-7
arsine
232-066-3
7784-42-1
F+; R12
T+; R26
Xn; R48/20
N; R50-53
F+; T+; N
R: 12-26-48/20-50/53
S: (1/2-)9-16-28-33-36/37-45-60-61


033-007-00-2
tert-butylarsine
423-320-6
4262-43-5
F; R17
T+; R26
F; T+
R: 17-26
S: (1/2-)9-28-36/37-43-45


034-001-00-2
selenium
231-957-4
7782-49-2
T; R23/25
R33
R53
T
R: 23/25-33-53
S: (1/2-)20/21-28-45-61




034-002-00-8
selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex
—
—
T; R23/25
R33
N; R50-53
T; N
R: 23/25-33-50/53
S: (1/2-)20/21-28-45-60-61

A

034-003-00-3
sodium selenite
233-267-9
10102-18-8
T+; R28
T; R23
R31
R43
N; R51-53
T+; N
R: 23-28-31-43-51/53
S: (1/2-)28-36/37-45-61


035-001-00-5
bromine
231-778-1
7726-95-6
T+; R26
C; R35
N; R50
T+; C; N
R: 26-35-50
S: (1/2-)7/9-26-45-61


035-002-00-0
hydrogen bromide
233-113-0
10035-10-6
C; R35
Xi; R37
C
R: 35-37
S: (1/2-)7/9-26-45


035-002-01-8
hydrobromic acid ... %
—
—
C; R34
Xi; R37
C
R: 34-37
S: (1/2-)7/9-26-45
C; R34: C ≥ 40 %
Xi; R36/38: 10 % ≤ C < 40 %
Xi; R37: C ≥ 10 %
B
035-003-00-6
potassium bromate
231-829-8
7758-01-2
O; R9
Carc. Cat. 2; R45
T; R25
T; O
R: 45-9-25
S: 53-45

E
035-004-00-1
2-hydroxyethylammonium perbromide
407-440-6
—
O; R8
Xn; R22
C; R35
R43
N; R50
O; C; N
R: 8-22-35-43-50
S: (1/2-)3/7-14-26-36/37/39-45-60-61


040-001-00-3
zirconium powder (pyrophoric)
231-176-9
7440-67-7
F; R15-17
F
R: 15-17
S: (2-)7/8-43


040-002-00-9
zirconium powder (non pyrophoric)
—
—
F; R15
F
R: 15
S: (2-)7/8-43




040-003-00-4
reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5
430-610-6
226996-19-6
N; R50-53
N
R: 50/53
S: 60-61





042-001-00-9
molybdenum trioxide
215-204-7
1313-27-5
Carc. Cat. 3; R40
Xi; R36/37
Xn
R: 36/37-40
S: (2-)22-36/37



042-002-00-4
tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)
404-760-8
117342-25-3
T; R23
Xi; R41
T
R: 23-41
S: (1/2-)26-36/37/39-45



042-003-00-X
tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)
404-860-1
116810-46-9
F; R11
Xi; R41
N; R50-53
F; Xi; N
R: 11-41-50/53
S: (2-)26-39-60-61


042-004-00-5
Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)
412-780-3
—
Xi; R38
R43
N; R51-53
Xi; N
R: 38-43-51/53
S: 24/25-37-61




042-005-00-0
reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex
434-240-6
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



046-001-00-X
tetraammine palladium (II) hydrogen carbonate
425-270-0
134620-00-1
Xn; R22-48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61





047-001-00-2
silver nitrate
231-853-9
7761-88-8
O; R8
C; R34
N; R50-53
O; C; N
R: 8-34-50/53
S: (1/2-)26-36/37/39-45-60-61





047-002-00-8
polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt
416-850-4
-
N; R50-53
N
R: 50/53
S: 60-61



048-001-00-5
cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
—
—
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)60-61
Xn; R20/21/22: C ≥ 0,1 %
A
1
048-002-00-0
cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]
215-146-2 [2]
7440-43-9 [1]
1306-19-0 [2]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T+; R26
T; R48/23/25
N; R50-53
T+; N
R: 45-26-48/23/25-62-63-68-50/53
S: 53-45-60-61

E
048-003-00-6
cadmium diformate;
cadmiumformate
224-729-0
4464-23-7
T; R23/25
R33
Xn; R68
N; R50-53
T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %
Xn; R20/22: 0,25 % ≤ C < 10 %
R33: C ≥ 0,25 %

048-004-00-1
cadmium cyanide
208-829-1
542-83-6
T+; R26/27/28
R32
R33
Xn; R68
N; R50-53
T+; N
R: 26/27/28-32-33-68-50/53
S: (1/2-)7-28-29-45-60-61
R32: C ≥ 1 %
R33: C ≥ 0,1 %

048-005-00-7
cadmiumhexafluorosilicate(2-);
cadmium fluorosilica
241-084-0
17010-21-8
T; R23/25
R33
Xn; R68
N; R50-53
T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %
Xn; R20/22: 0,1 % ≤ C < 10 %
R33: C ≥ 0,1 %

048-006-00-2
cadmium fluoride
232-222-0
7790-79-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53
T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-007-00-8
cadmium iodide
232-223-6
7790-80-9
T; R23/25
R33
Xn; R68
N; R50-53
T; N
R: 23/25-33-68-50/53
S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %
Xn; R20/22: 0,1 % ≤ C < 10 %
R33: C ≥ 0,1 %

048-008-00-3
cadmium chloride
233-296-7
10108-64-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53
T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-009-00-9
cadmium sulphate
233-331-6
10124-36-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23/25
N; R50-53
T+; N
R: 45-46-60-61-25-26-48/23/25-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
T; R25: C ≥ 10 %
Xn; R22: 0,1 % ≤ C < 10 %
T; R48/23/25: C ≥ 7 %
Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-010-00-4
cadmium sulphide
215-147-8
1306-23-6
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T; R48/23/25
Xn; R22
R53
T;
R: 45-22-48/23/25-62-63-68-53
S: 53-45-61
Xn; R22: C ≥ 10 %
T; R48/23/25: C ≥ 10 %
Xn; R48/20/22: 0,1 % ≤ C < 10 %
E
1
048-011-00-X
cadmium (pyrophoric)
231-152-8
7440-43-9
F; R17
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62-63
T+; R26
T; R48/23/25
N; R50-53
F; T+; N
R: 45-17-26-48/23/25-62-63-68-50/53
S: 53-45-7/8-43-60-61

E
050-001-00-5
tin tetrachloride;
stannic chloride
231-588-9
7646-78-8
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)7/8-26-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %



050-002-00-0
cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide
236-049-1
13121-70-5
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


050-003-00-6
fentin acetate (ISO);
triphenyltin acetate
212-984-0
900-95-8
Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53
T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61
Xi; R37: C ≥ 20 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


050-004-00-1
fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-6
76-87-9
Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53
T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61
Xi; R37: C ≥ 20 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


050-005-00-7
trimethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)26-27-28-45-60-61
T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
A
1
050-006-00-2
triethyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)26-27-28-45-60-61
T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
A
1
050-007-00-8
tripropyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61
T; R23/24/25: C ≥ 0,5 %
Xn; R20/21/22: 0,1 % ≤ C < 0,5 %
A
1


050-008-00-3
tributyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53
T; N
R: 21-25-36/38-48/23/25-50/53
S: (1/2-)36/37/39-45-60-61
T; R25: C ≥ 2,5 %
Xn; R22: 0,25 % ≤ C < 2,5 %
Xn: R21: C ≥ 1 %
T; R48/23/25: C ≥ 1 %
Xn; R48/20/22: 0,25 % ≤ C < 1 %
Xi; R36/38: C ≥ 1 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
A
1

050-009-00-9
fluorotripentylstannane; [1]
hexapentyldistannoxane [2]
243-546-7 [1]
247-143-7 [2]
20153-49-5 [1]
25637-27-8 [2]
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %
1
050-010-00-4
fluorotrihexylstannane
243-547-2
20153-50-8
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %
1


050-011-00-X
triphenyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,25 % ≤ C < 1 %
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
A
1

050-012-00-5
tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3]
215-910-5 [1]
221-437-5 [2]
230-358-5 [3]
1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %
A
1
050-013-00-0
trioctyltin compounds, with the exception of those specified elsewhere in this Annex
—
—
Xi; R36/37/38
R53
Xi
R: 36/37/38-53
S: (2-)61
Xi; R36/37/38: C ≥ 1 %
A
1
050-017-00-2
fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-7
13356-08-6
T+; R26
Xi; R36/38
N; R50-53
T+; N
R: 26-36/38-50/53
S: (1/2-)28-36/37-45-60-61




050-018-00-8
tin(II) methanesulphonate
401-640-7
53408-94-9
C; R34
Xn; R22
R43
N; R51-53
C; N
R: 22-34-43-51/53
S: (1/2-)22-26-36/37/39-45-61




050-019-00-3
azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H-1,2,4-triazole;
255-209-1
41083-11-8
T+; R26
T; R25
Xi; R37/38-41
N; R50-53
T+; N
R: 25-26-37/38-41-50/53
S: (1/2-)26-28-36/37/39-38-45-60-61


050-020-00-9
trioctylstannane
413-320-4
869-59-0
T; R48/25
Xi; R38
R53
T
R: 38-48/25-53
S: (1/2-)23-36/37-45-61




050-021-00-4
dichlorodioctyl stannane
222-583-2
3542-36-7
T; R23-48/25
R53
T
R: 23-48/25-53
S: (1/2-)38-45-61



050-022-00-X
dibutyltin dichloride;
(DBTC)
211-670-0
683-18-1
Mut. Cat. 3; R68
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/25
C; R34
Xn; R21
N; R50-53
T+; C; N
R: 60-61-21-25-26-34-48/25-68-50/53
S: 53-45-60-61
C; R34: C ≥ 10 %
Xi; R36/38: 0,01 % ≤ C < 10 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
E

050-023-00-5
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5
-
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)23-36-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


050-024-00-0
reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6
-
T; R48/25
Xn; R22
Xi; R38-41
R43
N; R50-53
T; N
R: 22-38-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61




051-001-00-8
antimony trichloride
233-047-2
10025-91-9
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)26-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

051-002-00-3
antimony pentachloride
231-601-8
7647-18-9
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)26-45-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

051-003-00-9
antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex
—
—
Xn; R20/22
N; R51-53
Xn; N
R: 20/22-51/53
S: (2-)61
Xn; R20/22: C ≥ 0,25 %
A
1
051-004-00-4
antimony trifluoride
232-009-2
7783-56-4
T; R23/24/25
N; R51-53
T; N
R: 23/24/25-51/53
S: (1/2-)7-26-45-61


051-005-00-X
antimony trioxide
215-175-0
1309-64-4
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)22-36/37


051-006-00-5
diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate
403-500-0
—
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


051-007-00-0
bis(4-dodecylphenyl)iodonium hexafluoroantimonate
404-420-9
71786-70-4
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


053-001-00-3
iodine
231-442-4
7553-56-2
Xn; R20/21
N; R50
Xn; N
R: 20/21-50
S: (2-)23-25-61


053-002-00-9
hydrogen iodide
233-109-9
10034-85-2
C; R35
C
R: 35
S: (1/2-)9-26-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 0,2 % ≤ C < 10 %
Xi; R36/37/38: 0,02 % ≤ C < 0,2 %
5
053-002-01-6
hydriodic acid ... %
—
—
C; R34
C
R: 34
S: (1/2-)26-45
C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 %
B


053-003-00-4
iodoxybenzene
—
696-33-3
E; R2
E
R: 2
S: (2-)35



053-004-00-X
calcium iodoxybenzoate
—
—
E; R2
E
R: 2
S: (2-)35

C

053-005-00-5
(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)
422-960-3
178233-72-2
Xn; R21/22-48/22
N; R50-53
Xn; N
R: 21/22-48/22-50/53
S: (2-)22-36/37-60-61


056-001-00-1
barium peroxide
215-128-4
1304-29-6
O; R8
Xn; R20/22
O; Xn
R: 8-20/22
S: (2-)13-27


056-002-00-7
barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex
—
—
Xn; R20/22
Xn
R: 20/22
S: (2-)28
Xn; R20/22: C ≥ 1 %
A
1
056-003-00-2
barium carbonate
208-167-3
513-77-9
Xn; R22
Xn
R: 22
S: (2-)24/25


056-004-00-8
barium chloride
233-788-1
10361-37-2
T; R25
Xn; R20
T
R: 20-25
S: (1/2-)45





064-001-00-8
gadolinium(III)sulfite trihydrate
456-900-2
51285-81-5
N; R51-53
N
R: 51/53
S: 61



072-001-00-4
hafnium tetra-n-butoxide
411-740-2
22411-22-9
Xi; R41
R43
Xi
R: 41-43
S: (2-)24/25-26-37/39


074-001-00-X
hexasodium tungstate hydrate
412-770-9
12141-67-2
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61


074-002-00-5
Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione
408-250-6
—
F; R11
Xn; R20
C; R34
R43
N; R50-53
F; C; N
R: 11-20-34-43-50/53
S: (1/2-)16-26-29-33-36/37/39-45-60-61


076-001-00-5
osmium tetraoxide;
osmic acid
244-058-7
20816-12-0
T+; R26/27/28
C; R34
T+
R: 26/27/28-34
S: (1/2-)7/9-26-45


078-001-00-0
tetrachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
T; R25
Xi; R41
R42/43
T
R: 25-41-42/43
S: (2-)22-26-36/37/39-45

A
078-002-00-6
diammonium tetrachloroplatinate
237-499-1
13820-41-2
T; R25
Xi; R38-41
R42/43
T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45


078-003-00-1
disodium tetrachloroplatinate
233-051-4
10026-00-3
T; R25
Xi; R38-41
R42/43
T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45


078-004-00-7
dipotassium tetrachloroplatinate
233-050-9
10025-99-7
T; R25
Xi; R38-41
R42/43
T
R: 25-38-41-42/43
S: (2-)22-26-36/37/39-45


078-005-00-2
hexachloroplatinates with the exception of those specified elsewhere in this Annex
—
—
T; R25
Xi; R41
R42/43
T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45

A
078-006-00-8
disodium hexachloroplatinate
240-983-5
16923-58-3
T; R25
Xi; R41
R42/43
T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45


078-007-00-3
dipotassium hexachloroplatinate
240-979-3
16921-30-5
T; R25
Xi; R41
R42/43
T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45


078-008-00-9
diammonium hexachloroplatinate
240-973-0
16919-58-7
T; R25
Xi; R41
R42/43
T
R: 25-41-42/43
S: (1/2-)22-26-36/37/39-45


078-009-00-4
hexachloroplatinic acid
241-010-7
16941-12-1
T; R25
C; R34
R42/43
T
R: 25-34-42/43
S: (1/2-)22-26-36/37/39-45




078-010-00-X
tetraammine platinum (II) hydrogen carbonate
426-730-3
123439-82-7
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61



078-011-00-5
hydroxydisulfito platinum(II) acid
423-310-1
61420-92-6
Xn; R22-48/20/21/22
C; R35
R42/43
R52-53
C
R: 22-35-42/43-48/20/21/22-52/53
S: (1/2-)23-24-26-28-36/37/39-45-61



078-012-00-0
platinum(IV) nitrate/nitric acid solution
432-400-1
-
C; R35
N; R50-53
C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61





080-001-00-0
mercury
231-106-7
7439-97-6
Repr. Cat. 2; R61
T+; R26
T; R48/23
N; R50-53
T+; N
R: 61-26-48/23-50/53
S: 53-45-60-61

E

080-002-00-6
inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex
—
—
T+; R26/27/28
R33
N; R50-53
T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-45-60-61
T+; R26/27/28: C ≥ 2 %
T; R23/24/25: 0,5 % ≤ C < 2 %
Xn; R20/21/22: 0,1 % ≤ C < 0,5 %
R33: C ≥ 0,1 %
A
1
080-003-00-1
dimercury dichloride;
mercurous chloride;
calomel
233-307-5
10112-91-1
Xn; R22
Xi; R36/37/38
N; R50-53
Xn; N
R: 22-36/37/38-50/53
S: (2-)13-24/25-46-60-61


080-004-00-7
organic compounds of mercury with the exception of those specified elsewhere in this Annex
—
—
T+; R26/27/28
R33
N; R50-53
T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-36-45-60-61
T+; R26/27/28: C ≥ 2 %
T; R23/24/25: 0,5 % ≤ C < 2 %
Xn; R20/21/22: 0,05 % ≤ C < 0,5 %
R33: C ≥ 0,05 %
A
1
080-005-00-2
mercury difulminate;
mercuric fulminate;
fulminate of mercury
211-057-8
628-86-4
E; R3
T; R23/24/25
R33
N; R50-53
E; T; N
R: 3-23/24/25-33-50/53
S: (1/2-)3-45-60-61




080-006-00-8
dimercury dicyanide oxide;
mercuric oxycyanide
215-629-8
1335-31-5
E; R2
T; R23/24/25
R33
N; R50-53
E; T; N
R: 2-23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61




080-007-00-3
dimethylmercury; [1]
diethylmercury [2]
209-805-3 [1]
211-000-7 [2]
593-74-8 [1]
627-44-1 [2]
T+; R26/27/28
R33
N; R50-53
T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-36-45-60-61
T+; R26/27/28: C ≥ 0,5 %
T; R23/24/25: 0,1 % ≤ C < 0,5 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
R33: C ≥ 0,05 %
1
080-008-00-9
phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3]
200-242-9 [1]
202-866-7 [2]
- [3]
55-68-5 [1]
100-57-2 [2]
8003-05-2 [3]
T; R25-48/24/25
C; R34
N; R50-53
T; N
R: 25-34-48/24/25-50/53
S: (1/2-)23-24/25-37-45-60-61


080-009-00-4
2-methoxyethylmercury chloride
204-659-7
123-88-6
T; R25-48/25
C; R34
N; R50-53
T; N
R: 25-34-48/25-50/53
S: (1/2-)36/37/39-45-60-61




080-010-00-X
mercury dichloride;
mercuric chloride
231-299-8
7487-94-7
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T+; R28
T; R48/24/25
C; R34
N; R50-53
T+; N
R: 28-34-48/24/25-62-68-50/53
S: (1/2-)26-36/37/39-45-60-61



080-011-00-5
phenylmercury acetate
200-532-5
62-38-4
T; R25-48/24/25
C; R34
N; R50-53
T; N
R: 25-34-48/24/25-50/53
S: (1/2-)23-24/25-37-45-60-61


081-001-00-3
thallium
231-138-1
7440-28-0
T+; R26/28
R33
R53
T+
R: 26/28-33-53
S: (1/2-)13-28-45-61


081-002-00-9
thallium compounds, with the exception of those specified elsewhere in this Annex
—
—
T+; R26/28
R33
N; R51-53
T+; N
R: 26/28-33-51/53
S: (1/2-)13-28-45-61

A
081-003-00-4
dithallium sulphate;
thallic sulphate
231-201-3
7446-18-6
T+; R28
T; R48/25
Xi; R38
N; R51-53
T+; N
R: 28-38-48/25-51/53
S: (1/2-)13-36/37-45-61


082-001-00-6
lead compounds with the exception of those specified elsewhere in this Annex
—
—
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53
T; N
R: 61-20/22-33-62-50/53
S: 53-45-60-61
Repr. Cat. 3; R62: C ≥ 2,5 %
Xn; R20/22: C ≥ 1 %
R33: C ≥ 0,5 %
AE
1
082-002-00-1
lead alkyls
—
—
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T+; R26/27/28
R33
N; R50-53
T+; N
R: 61-26/27/28-33-62-50/53
S: 53-45-60-61
Repr. Cat. 1; R61: C ≥ 0,1 %
T+; R26/27/28: C ≥ 0,25 %
T; R23/24/25: 0,1 % ≤ C < 0,25 %
Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
R33: C ≥ 0,05 %
AE
1
082-003-00-7
lead diazide;
lead azide
236-542-1
13424-46-9
E; R3
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53
E; T; N
R: 61-3-20/22-33-50/53-62
S: 53-45-60-61

E
1


082-004-00-2
lead chromate
231-846-0
7758-97-6
Carc. Cat. 2; R45
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53
T; N
R: 45-61-33-62-50/53
S: 53-45-60-61

1

082-005-00-8
lead di(acetate)
206-104-4
301-04-2
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53
T; N
R: 61-33-48/22-50/53-62
S: 53-45-60-61

E
1
082-006-00-3
trilead bis(orthophosphate)
231-205-5
7446-27-7
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53
T; N
R: 61-33-48/22-50/53-62
S: 53-45-60-61

E
1
082-007-00-9
lead acetate, basic;
215-630-3
1335-32-6
Carc. Cat. 3; R40
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R48/22
R33
N; R50-53
T; N
R: 61-33-40-48/22-50/53-62
S: 53-45-60-61

E
1
082-008-00-4
lead(II) methanesulphonate
401-750-5
17570-76-2
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22-48/20/22
Xi; R38-41
N; R58
R33
T; N
R: 61-62-20/22-33-38-41-48/20/22-58
S: 53-45-57-61

E
1


082-009-00-X
lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-7
1344-37-2
Carc. Cat. 2; R45
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53
T; N
R: 45-61-33-62-50/53
S: 53-45-60-61

1

082-010-00-5
lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-9
12656-85-8
Carc. Cat. 2; R45
Repr. Cat. 1; R61
Repr. Cat. 3; R62
R33
N; R50-53
T; N
R: 45-61-33-62-50/53
S: 53-45-60-61

1


082-011-00-0
lead hydrogen arsenate
232-064-2
7784-40-9
Carc. Cat. 1; R45
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R23/25
R33
N; R50-53
T; N
R: 45-61-23/25-33-50/53-62
S: 53-45-60-61

E
1


082-012-00-6
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped
431-780-4
199876-46-5
Xn; R22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61



092-001-00-8
uranium
231-170-6
7440-61-1
T+; R26/28
R33
R53
T+
R: 26/28-33-53
S: (1/2-)20/21-45-61




092-002-00-3
uranium compounds with the exception of those specified elsewhere in this Annex
—
—
T+; R26/28
R33
N; R51-53
T+; N
R: 26/28-33-51/53
S: (1/2-)20/21-45-61

A

601-001-00-4
methane
200-812-7
74-82-8
F+; R12
F+
R: 12
S: (2-)9-16-33


601-002-00-X
ethane
200-814-8
74-84-0
F+; R12
F+
R: 12
S: (2-)9-16-33


601-003-00-5
propane
200-827-9
74-98-6
F+; R12
F+
R: 12
S: (2-)9-16


601-004-00-0
butane; [1]
and isobutane [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
F+; R12
F+
R: 12
S: (2-)9-16

C
601-004-01-8
butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]
isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
203-448-7 [1]
200-857-2 [2]
106-97-8 [1]
75-28-5 [2]
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

CS
601-005-00-6
2,2-dimethylpropane;
neopentane
207-343-7
463-82-1
F+; R12
N; R51-53
F+; N
R: 12-51/53
S: (2-)9-16-33-61


601-006-00-1
pentane; [1]
isopentane;
2-methylbutane [2]
203-692-4 [1]
201-142-8 [2]
109-66-0 [1]
78-78-4 [2]
F+; R12
Xn; R65
R66
R67
N; R51-53
F+; Xn; N
R: 12-51/53-65-66-67
S: (2-)9-16-29-33-61-62

C


601-007-00-7
hexane (containing < 5 % n-hexane (203-777-6));
2-methylpentane; [1]
3-methylpentane; [2]
2,2-dimethylbutane; [3]
2,3-dimethylbutane [4]
203-523-4 [1]
202-481-4 [2]
200-906-8 [3]
201-193-6 [4]
107-83-5 [1]
96-14-0 [2]
75-83-2 [3]
79-29-8 [4]
F; R11
Xn; R65
Xi; R38
R67
N; R51-53
F; Xn; N
R: 11-38-65-67-51/53
S: (2-)9-16-29-33-61-62

C

601-008-00-2
heptane;
n-heptane; [1]
2,4-dimethylpentane; [2]
2,2,3-trimethylbutane; [3]
3,3-dimethylpentane; [4]
2,3-dimethylpentane; [5]
3-methylhexane; [6]
2,2-dimethylpentane; [7]
2-methylhexane; [8]
3-ethylpentane; [9]
isoheptane; [10]
205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10]
142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10]
F; R11
Xn; R65
Xi; R38
R67
N; R50-53
F; Xn; N
R: 11-38-65-67-50/53
S: (2-)9-16-29-33-60-61-62

C

601-009-00-8
octane;
n-octane; [1]
2,2,4-trimethylpentane; [2]
2,3,3-trimethylpentane; [3]
3,3-dimethylhexane; [4]
2,2,3-trimethylpentane; [5]
2,3,4-trimethylpentane; [6]
3,4-dimethylhexane; [7]
2,3-dimethylhexane; [8]
2,4-dimethylhexane; [9]
4-methylheptane; [10]
3-methylheptane; [11]
2,2-dimethylhexane; [12]
2,5-dimethylhexane; [13]
2-methylheptane; [14]
2,2,3,3-tetramethylbutane; [15]
3-ethyl-2-methylpentane; [16]
3-ethylhexane; [17]
3-ethyl-3-methylpentane; [18]
isooctane; [19]
203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19]
111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19]
F; R11
Xn; R65
Xi; R38
R67
N; R50-53
F; Xn; N
R: 11-38-65-67-50/53
S: (2-)9-16-29-33-60-61-62

C

601-010-00-3
ethylene
200-815-3
74-85-1
F+; R12
R67
F+
R: 12-67
S: (2-)9-16-33-45


601-011-00-9
propene;
propylene
204-062-1
115-07-1
F+; R12
F+
R: 12
S: (2-)9-16-33


601-012-00-4
but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5]
203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5]
106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5]
F+; R12
F+
R: 12
S: (2-)9-16-33

C
601-013-00-X
1,3-butadiene;
buta-1,3-diene
203-450-8
106-99-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

D
601-014-00-5
isoprene (stabilised)
2-methyl-1,3-butadiene
201-143-3
78-79-5
F+; R12
Carc. Cat. 2; R45
Muta. Cat. 3; R68
R52-53
F+; T
R: 45-12-68-52/53
S: 53-45-61

D
601-015-00-0
acetylene;
ethyne
200-816-9
74-86-2
R5
R6
F+; R12
F+
R: 5-6-12
S: (2-)9-16-33


601-016-00-6
cyclopropane
200-847-8
75-19-4
F+; R12
F+
R: 12
S: (2-)9-16-33


601-017-00-1
cyclohexane
203-806-2
110-82-7
F; R11
Xn; R65
Xi; R38
R67
N; R50-53
F; Xn; N
R: 11-38-65-67-50/53
S: (2-)9-16-25-33-60-61-62


601-018-00-7
methylcyclohexane
203-624-3
108-87-2
F; R11
Xn; R65
Xi; R38
R67
N; R51-53
F; Xn; N
R: 11-38-51/53-65-67
S: (2-)9-16-33-61-62


601-019-00-2
1,4-dimethylcyclohexane
209-663-2
589-90-2
F; R11
Xn; R65
Xi; R38
R67
N; R51-53
F; Xn; N
R: 11-38-51/53-65-67
S: (2-)9-16-33-61-62


601-020-00-8
benzene
200-753-7
71-43-2
F; R11
Carc. Cat. 1; R45
Muta. Cat. 2; R46
T; R48/23/24/25
Xn; R65
Xi; R36/38
F; T
R: 45-46-11-36/38-48/23/24/25-65
S: 53-45

E
601-021-00-3
toluene
203-625-9
108-88-3
F; R11
Repr. Cat. 3; R63
Xn; R48/20-65
Xi; R38
R67
F; Xn
R: 11-38-48/20-63-65-67
S: (2-)36/37-46-62


601-022-00-9
o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4]
202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4]
95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4]
R10
Xn; R20/21
Xi; R38
Xn
R: 10-20/21-38
S: (2-)25
Xn; R20/21: C ≥ 12,5 %
C
601-023-00-4
ethylbenzene
202-849-4
100-41-4
F; R11
Xn; R20
F; Xn
R: 11-20
S: (2-)16-24/25-29


601-024-00-X
cumene; [1]
propylbenzene [2]
202-704-5 [1]
203-132-9 [2]
98-82-8 [1]
103-65-1 [2]
R10
Xn; R65
Xi; R37
N; R51-53
Xn; N
R: 10-37-51/53-65
S: (2-)24-37-61-62

C
601-025-00-5
mesitylene;
1,3,5-trimethylbenzene
203-604-4
108-67-8
R10
Xi; R37
N; R51-53
Xi; N
R: 10-37-51/53
S: (2-)61
Xi; R37: C ≥ 25 %

601-026-00-0
styrene
202-851-5
100-42-5
R10
Xn; R20
Xi; R36/38
Xn
R: 10-20-36/38
S: (2-)23
Xn; R20: C ≥ 12,5 %
Xi; R36/38: C ≥ 12,5 %
D
601-027-00-6
2-phenylpropene;
α-methylstyrene
202-705-0
98-83-9
R10
Xi; R36/37
N; R51-53
Xi; N
R: 10-36/37-51/53
S: (2-)61
Xi; R36/37: C ≥ 25 %

601-028-00-1
2-methylstyrene;
2-vinyltoluene
210-256-7
611-15-4
Xn; R20
N; R51-53
Xn; N
R: 20-51/53
S: (2-)24-61


601-029-00-7
dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5]
138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5]
R10
Xi; R38
R43
N; R50-53
Xi; N
R: 10-38-43-50/53
S: (2-)24-37-60-61

C
601-030-00-2
cyclopentane
206-016-6
287-92-3
F; R11
R52-53
F
R: 11-52/53
S: (2-)9-16-29-33-61


601-031-00-8
2,4,4-trimethylpent-1-ene
203-486-4
107-39-1
F; R11
N; R51-53
F; N
R: 11-51/53
S: (2-)9-16-29-33-61


601-032-00-3
benzo[a]pyrene;
benzo[def]chrysene
200-028-5
50-32-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
R43
N; R50-53
T; N
R: 45-46-60-61-43-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %



601-033-00-9
benz[a]anthracene
200-280-6
56-55-3
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %



601-034-00-4
benz[e]acephenanthrylene
205-911-9
205-99-2
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


601-035-00-X
benzo[j]fluoranthene
205-910-3
205-82-3
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


601-036-00-5
benzo[k]fluoranthene
205-916-6
207-08-9
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


601-037-00-0
n-hexane
203-777-6
110-54-3
F; R11
Repr. Cat. 3; R62
Xn; R65-48/20
Xi; R38
R67
N; R51-53
F; Xn; N
R: 11-38-48/20-62-65-67-51/53
S: (2-)9-16-29-33-36/37-61-62
Xn; R48/20: C ≥ 5 %



601-041-00-2
dibenz[a,h]anthracene
200-181-8
53-70-3
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


601-042-00-8
biphenyl;
diphenyl
202-163-5
92-52-4
Xi; R36/37/38
N; R50-53
Xi; N
R: 36/37/38-50/53
S: (2-)23-60-61


601-043-00-3
1,2,4-trimethylbenzene
202-436-9
95-63-6
R10
Xn; R20
Xi; R36/37/38
N; R51-53
Xn; N
R: 10-20-36/37/38-51/53
S: (2-)26-61


601-044-00-9
3a,4,7,7a-tetrahydro-4,7-methanoindene
201-052-9
77-73-6
F; R11
Xn; R20/22
Xi; R36/37/38
N; R51-53
F; Xn; N
R: 11-20/22-36/37/38-51/53
S: (2-)36/37-61


601-045-00-4
1,2,3,4-tetrahydronaphthalene
204-340-2
119-64-2
R19
Xi; R36/38
N; R51-53
Xi; N
R: 19-36/38-51/53
S: (2-)26-28-61


601-046-00-X
7-methylocta-1,6-diene
404-210-7
42152-47-6
R10
N; R50-53
N
R: 10-50/53
S: (2-)60-61


601-047-00-5
m-mentha-1,3(8)-diene
404-150-1
17092-80-7
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


601-048-00-0
chrysene
205-923-4
218-01-9
Carc. Cat. 2; R45
Muta. Cat. 3; R68
N; R50-53
T; N
R: 45-68-50/53
S: 53-45-60-61


601-049-00-6
benzo[e]pyrene
205-892-7
192-97-2
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


601-051-00-7
4-phenylbut-1-ene
405-980-7
768-56-9
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


601-052-00-2
naphthalene
202-049-5
91-20-3
Carc. Cat. 3; R40
Xn; R22
N; R50-53
Xn; N
R: 22-40-50/53
S: (2-)36/37-46-60-61


601-053-00-8
nonylphenol; [1]
4-nonylphenol, branched [2]
246-672-0 [1]
284-325-5 [2]
25154-52-3 [1]
84852-15-3 [2]
Repr. Cat. 3; R62-63
Xn; R22
C; R34
N; R50-53
C; N
R: 22-34-62-63-50/53
S: (1/2-)26-36/37/39-45-46-60-61


601-054-00-3
reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene
405-570-8
—
N; R50-53
N
R: 50/53
S: 60-61


601-055-00-9
reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes
410-190-0
132983-41-6
Xi; R36
R53
Xi
R: 36-53
S: (2-)26-61


601-056-00-4
reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane
405-470-4
73807-39-3
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37-60-61


601-057-00-X
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate
421-130-8
156679-41-3
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61


601-058-00-5
di-L-para-menthene
417-870-6
83648-84-4
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)23-24-37-60-61


601-059-00-0
methyl 2-benzylidene-3-oxobutyrate
420-940-9
15768-07-7
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)26-37/39-61


601-060-00-6
1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245
417-610-1
155522-09-1
R43
Xi
R: 43
S: (2-)22-24-37


601-061-00-1
(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)
418-960-8
—
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61


601-062-00-7
reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane
417-030-9
151006-59-6
R53
R: 53
S: 61


601-063-00-2
reaction mass of isomers of branched tetracosane
417-060-2
151006-61-0
Xn; R20
R53
Xn
R: 20-53
S: (2-)61


601-064-00-8
branched hexatriacontane
417-070-7
151006-62-1
R53
R: 53
S: 61




601-065-00-3
reaction mass of: (1'α, 3'α, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)36/37-61



601-066-00-9
1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone
426-820-2
78531-60-9
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


601-067-00-4
triethyl arsenate
427-700-2
15606-95-8
Carc. Cat. 1; R45
T; R23/25
N; R50-53
T; N
R: 45-23/25-50/53
S: 53-45-60-61

E
601-068-00-X
1,2-diacetoxybut-3-ene
421-720-5
18085-02-4
Xn; R22
Xn
R: 22
S: (2-)


601-069-00-5
2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide
422-680-1
287933-44-2
R52-53
R: 52/53
S: 61




601-070-00-0
reaction mass of: branched icosane;
branched docosane;
branched tetracosane
417-050-8
151006-58-5
Xn; R20
R53
Xn
R: 20-53
S: (2-)61




601-071-00-6
1-dimethoxymethyl-2-nitro-benzene
423-830-9
20627-73-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61




601-072-00-1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane
430-690-2
52783-21-8
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37-60-61



601-073-00-7
1-bromo-3,5-difluorobenzene
416-710-2
461-96-1
R10
Xn; R22-48/22
Xi; R38
R43
N; R50-53
Xn; N
R: 10-22-38-43-48/22-50/53
S: (2-)24-36/37-60-61


601-074-00-2
reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1
—
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)26-37-61




601-075-00-8
4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane
418-770-5
151882-81-4
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)22-36/37



601-076-00-3
ethynyl cyclopropane
425-430-1
6746-94-7
F; R11
R4
Xi; R38-41
R52-53
F; Xi
R: 4-11-38-41-52/53
S: (2-)9-16-26-33-37/39-61



601-077-00-9
reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane
426-510-7
196965-91-0
N; R50-53
N
R: 50/53
S: 60-61



601-078-00-4
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane
427-040-5
-
C; R34
N; R50-53
C; N
R: 34-50/53
S: (1/2-)23-26-36/37/39-45-57-60-61



601-079-00-X
reaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene
429-620-3
-
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)24-37-61



601-080-00-5
reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6
-
N; R50-53
N
R: 50/53
S: 60-61



601-081-00-0
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)36/37-61



601-082-00-6
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4
-
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)23-26-37/39-57-60-61



601-083-00-1
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene
435-000-3
22094-83-3
Xn; R65
Xi; R38
R53
Xn
R: 38-65-53
S: (2-)37-62-61



601-084-00-7
reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3
-
Xn; R65
Xi; R38
N; R50-53
Xn; N
R: 38-65-50/53
S: (2-)37-62-60-61



602-001-00-7
chloromethane;
methyl chloride
200-817-4
74-87-3
F+; R12
Carc. Cat. 3; R40
Xn; R48/20
F+; Xn
R: 12-40-48/20
S: (2-)9-16-33


602-002-00-2
bromomethane;
methylbromide
200-813-2
74-83-9
Muta. Cat. 3; R68
T; R23/25
Xn; R48/20
Xi; R36/37/38
N; R50
N; R59
T; N
R: 23/25-36/37/38-48/20-50-59-68
S: (1/2-)15-27-36/39-38-45-59-61


602-003-00-8
dibromomethane
200-824-2
74-95-3
Xn; R20
R52-53
Xn
R: 20-52/53
S: (2-)24-61
Xn; R20: C ≥ 12,5 %

602-004-00-3
dichloromethane;
methylene chloride
200-838-9
75-09-2
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)23-24/25-36/37


602-005-00-9
methyl iodide;
iodomethane
200-819-5
74-88-4
Carc. Cat. 3; R40
Xn; R21
T; R23/25
Xi; R37/38
T
R: 21-23/25-37/38-40
S: (1/2-)36/37-38-45


602-006-00-4
trichloromethane;
chloroform
200-663-8
67-66-3
Xn; R22-48/20/22
Xi; R38
Carc. Cat. 3; R40
Xn
R: 22-38-40-48/20/22
S: (2-)36/37
Xn; R22: C ≥ 5 %
Xn; R48/20/22: C ≥ 5 %



602-007-00-X
bromoform;
tribromomethane
200-854-6
75-25-2
T; R23
Xn; R22
Xi; R36/38
N; R51-53
T; N
R: 22-23-36/38-51/53
S: (1/2-)28-45-63-61




602-008-00-5
carbon tetrachloride;
tetrachloromethane
200-262-8
56-23-5
Carc. Cat. 3; R40
T; R23/24/25-48/23
N; R59
R52-53
T; N
R: 23/24/25-40-48/23-59-52/53
S: (1/2-)23-36/37-45-59-61
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 %
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 %

602-009-00-0
chloroethane
200-830-5
75-00-3
F+; R12
Carc. Cat. 3; R40
R52-53
F+; Xn
R: 12-40-52/53
S: (2-)9-16-33-36/37-61


602-010-00-6
1,2-dibromoethane
203-444-5
106-93-4
Carc. Cat. 2; R45
T; R23/24/25
Xi; R36/37/38
N; R51-53
T; N
R: 45-23/24/25-36/37/38-51/53
S: 53-45-61
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,1 % ≤ C < 1 %
E
602-011-00-1
1,1-dichloroethane
200-863-5
75-34-3
F; R11
Xn; R22
Xi; R36/37
R52-53
F; Xn
R: 11-22-36/37-52/53
S: (2-)16-23-61
Xn; R22: C ≥ 12,5 %

602-012-00-7
1,2-dichloroethane;
ethylene dichloride
203-458-1
107-06-2
F; R11
Carc. Cat. 2; R45
Xn; R22
Xi; R36/37/38
F; T
R: 45-11-22-36/37/38
S: 53-45

E
602-013-00-2
1,1,1-trichloroethane;
methyl chloroform
200-756-3
71-55-6
Xn; R20
N; R59
Xn; N
R: 20-59
S: (2-)24/25-59-61

F
602-014-00-8
1,1,2-trichloroethane
201-166-9
79-00-5
Carc. Cat. 3; R40
Xn; R20/21/22
R66
Xn
R: 20/21/22-40-66
S: (2-)9-36/37-46
Xn; R20/21/22: C ≥ 5 %

602-015-00-3
1,1,2,2-tetrachloroethane
201-197-8
79-34-5
T+; R26/27
N; R51-53
T+; N
R: 26/27-51/53
S: (1/2-)38-45-61


602-016-00-9
1,1,2,2-tetrabromoethane
201-191-5
79-27-6
T+; R26
Xi; R36
R52-53
T+
R: 26-36-52/53
S: (1/2-)24-27-45-61


602-017-00-4
pentachloroethane
200-925-1
76-01-7
Carc. Cat. 3; R40
T; R48/23
N; R51-53
T; N
R: 40-48/23-51/53
S: (1/2-)23-36/37-45-61
T; R48/23: C ≥ 1 %
Xn; R48/20: 0,2 % ≤ C < 1 %

602-018-00-X
1-chloropropane; [1]
2-chloropropane [2]
208-749-7 [1]
200-858-8 [2]
540-54-5 [1]
75-29-6 [2]
F; R11
Xn; R20/21/22
F; Xn
R: 11-20/21/22
S: (2-)9-29

C
602-019-00-5
1-bromopropane;
n-propyl bromide
203-445-0
106-94-5
F; R11
Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R48/20
Xi; R36/37/38
R67
F; T
R: 60-11-36/37/38-48/20-63-67
S: 53-45

E
602-020-00-0
1,2-dichloropropane;
propylene dichloride
201-152-2
78-87-5
F; R11
Xn; R20/22
F; Xn
R: 11-20/22
S: (2-)16-24


602-021-00-6
1,2-dibromo-3-chloropropane
202-479-3
96-12-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 1; R60
T; R25
Xn; R48/20/22
R52-53
T
R: 45-46-60-25-48/20/22-52/53
S: 53-45-61

E
602-022-00-1
1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3]
208-846-4 [1]
210-885-7 [2]
210-467-4 [3]
543-59-9 [1]
625-29-6 [2]
616-20-6 [3]
F; R11
Xn; R20/21/22
F; Xn
R: 11-20/21/22
S: (2-)9-29

C
602-023-00-7
vinyl chloride;
chloroethylene
200-831-0
75-01-4
F+; R12
Carc. Cat. 1; R45
F+; T
R: 45-12
S: 53-45

D
602-024-00-2
bromoethylene
209-800-6
593-60-2
F+; R12
Carc. Cat. 2; R45
F+; T
R: 45-12
S: 53-45


602-025-00-8
1,1-dichloroethylene;
vinylidene chloride
200-864-0
75-35-4
F+; R12
Carc. Cat. 3; R40
Xn; R20
F+; Xn
R: 12-20-40
S: (2-)7-16-29-36/37-46
Xn; R20: C ≥ 12,5 %
D
602-026-00-3
1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3]
208-750-2 [1]
205-859-7 [2]
205-860-2 [3]
540-59-0 [1]
156-59-2 [2]
156-60-5 [3]
F; R11
Xn; R20
R52-53
F; Xn
R: 11-20-52/53
S: (2-)7-16-29-61
Xn; R20: C ≥ 12,5 %
C
602-027-00-9
trichloroethylene;
trichloroethene
201-167-4
79-01-6
Carc. Cat. 2; R45
Muta. Cat. 3; R68
R67
Xi; R36/38
R52-53
T
R: 45-36/38-52/53-67
S: 53-45-61


602-028-00-4
tetrachloroethylene
204-825-9
127-18-4
Carc. Cat. 3; R40
N; R51-53
Xn; N
R: 40-51/53
S: (2-)23-36/37-61


602-029-00-X
3-chloropropene;
allyl chloride
203-457-6
107-05-1
F; R11
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R20/21/22-48/20
Xi; R36/37/38
N; R50
F; Xn; N
R: 11-20/21/22-36/37/38-40-48/20-68-50
S: (2-)16-25-26-36/37-46-61

D


602-030-00-5
1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]
208-826-5 [1]
233-195-8 [2]
542-75-6 [1]
10061-01-5 [2]
R10
T; R24/25
Xn; R20-65
Xi; R36/37/38
R43
N; R50-53
T; N
R: 10-20-24/25-36/37/38-43-65-50/53
S: (1/2-)36/37-45-60-61

C D


602-031-00-0
1,1-dichloropropene
209-253-3
563-58-6
F; R11
T; R25
R52-53
F; T
R: 11-25-52/53
S: (1/2-)16-29-33-45-61


602-032-00-6
3-chloro-2-methylpropene
209-251-2
563-47-3
F; R11
Xn; R20/22
C; R34
R43
N; R51-53
F; C; N
R: 11-20/22-34-43-51/53
S: (2-)9-16-26-29-36/37/39-45-61


602-033-00-1
chlorobenzene
203-628-5
108-90-7
R10
Xn; R20
N; R51-53
Xn; N
R: 10-20-51/53
S: (2-)24/25-61
Xn; R20: C ≥ 5 %

602-034-00-7
1,2-dichlorobenzene;
o-dichlorobenzene
202-425-9
95-50-1
Xn; R22
Xi; R36/37/38
N; R50-53
Xn; N
R: 22-36/37/38-50/53
S: (2-)23-60-61
Xn; R22: C ≥ 5 %

602-035-00-2
1,4-dichlorobenzene;
p-dichlorobenzene
203-400-5
106-46-7
Carc. Cat. 3; R40
Xi; R36
N; R50-53
Xn; N
R: 36-40-50/53
S: (2-)36/37-46-60-61


602-036-00-8
chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised)
204-818-0
126-99-8
F; R11
Carc. Cat. 2; R45
Xn; R20/22-48/20
Xi; R36/37/38
F; T
R: 45-11-20/22-36/37/38-48/20
S: 53-45

D E
602-037-00-3
α-chlorotoluene;
benzyl chloride
202-853-6
100-44-7
Carc. Cat. 2; R45
T; R23
Xn; R22-48/22
Xi; R37/38-41
T
R: 45-22-23-37/38-41-48/22
S: 53-45

E
602-038-00-9
α,α,α-trichlorotoluene;
benzotrichloride
202-634-5
98-07-7
Carc. Cat. 2; R45
T; R23
Xn; R22
Xi; R37/38-41
T
R: 45-22-23-37/38-41
S: 53-45

E
602-039-00-4
polychlorobiphenyls;
PCB
215-648-1
1336-36-3
R33
N; R50-53
N
R: 33-50/53
S: (2-)-60-61
R33: C ≥ 0,005 %
C
602-040-00-X
2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4]
202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4]
95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4]
Xn; R20
N; R51-53
Xn; N
R: 20-51/53
S: (2-)24/25-61

C
602-041-00-5
penthachloronaphthalene
215-320-8
1321-64-8
Xn; R21/22
Xi; R36/38
N; R50-53
Xn; N
R: 21/22-36/38-50/53
S: (2-)-60-61

C
602-042-00-0
1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex
—
—
Carc. Cat. 3; R40
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-40-50/53
S: (1/2-)22-36/37-45-60-61

A C
602-043-00-6
lindane (ISO)
γ-HCH or γ-BHC;
γ-1,2,3,4,5,6-hexachlorocyclohexane;
200-401-2
58-89-9
T; R25
Xn; R20/21-48/22
R64
N; R50-53
T; N
R: 20/21-25-48/22-64-50/53
S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

602-044-00-1
camphechlor (ISO)
toxaphene;
232-283-3
8001-35-2
Carc. Cat. 3; R40
T; R25
Xn; R21
Xi; R37/38
N; R50-53
T; N
R: 21-25-37/38-40-50/53
S: (1/2-)36/37-45-60-61


602-045-00-7
DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane
200-024-3
50-29-3
T; R25-48/25
Carc. Cat. 3; R40
N; R50-53
T; N
R: 25-40-48/25-50/53
S: (1/2-)22-36/37-45-60-61


602-046-00-2
heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-3
76-44-8
T; R24/25
Carc. Cat. 3; R40
R33
N; R50-53
T; N
R: 24/25-33-40-50/53
S: (1/2-)36/37-45-60-61


602-047-00-8
chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-0
57-74-9
Carc. Cat. 3; R40
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-40-50/53
S: (2-)36/37-60-61


602-048-00-3
aldrin (ISO)
206-215-8
309-00-2
T; R24/25-48/24/25
Carc. Cat. 3; R40
N; R50-53
T; N
R: 24/25-40-48/24/25-50/53
S: (1/2-)22-36/37-45-60-61


602-049-00-9
dieldrin (ISO)
200-484-5
60-57-1
T+; R27
T; R25-48/25
Carc. Cat. 3; R40
N; R50-53
T+; N
R: 25-27-40-48/25-50/53
S: (1/2-)22-36/37-45-60-61




602-050-00-4
isodrin;
(1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene
207-366-2
465-73-6
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)13-28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


602-051-00-X
endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-7
72-20-8
T+; R28
T; R24
N; R50-53
T+; N
R: 24-28-50/53
S: (1/2-)22-36/37-45-60-61




602-052-00-5
endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;
1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite
204-079-4
115-29-7
T+; R26/28
Xn; R21
N; R50-53
T+; N
R: 21-26/28-50/53
S: (1/2-)28-36/37-45-60-61-63




602-053-00-0
isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4
297-78-9
T+; R27/28
N; R50
T+; N
R: 27/28-50
S: (1/2-)28-36/37-45-61




602-054-00-6
3-iodpropene;
allyl iodide
209-130-4
556-56-9
F; R11
C; R34
F; C
R: 11-34
S: (1/2-)7-16-26-45



602-055-00-1
bromoethane;
ethyl bromide
200-825-8
74-96-4
F; R11
Carc. Cat. 3; R40
Xn; R20/22
F; Xn
R: 11-20/22-40
S: (2-)36/37


602-056-00-7
α,α,α-trifluorotoluene;
benzotrifluoride
202-635-0
98-08-8
F; R11
N; R51-53
F; N
R: 11-51/53
S: (2-)16-23-61


602-057-00-2
α-bromotoluene;
benzyl bromide
202-847-3
100-39-0
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)39


602-058-00-8
α,α-dichlorotoluene;
benzylidene chloride;
benzal chloride
202-709-2
98-87-3
Carc. Cat. 3; R40
T; R23
Xn; R22
Xi; R37/38-41
T
R: 22-23-37/38-40-41
S: (1/2-)36/37-38-45


602-059-00-3
1-chlorobutane;
butyl chloride
203-696-6
109-69-3
F; R11
F
R: 11
S: (2-)9-16-29


602-060-00-9
bromobenzene
203-623-8
108-86-1
R10
Xi; R38
N; R51-53
Xi; N
R: 10-38-51/53
S: (2-)61


602-061-00-4
hexafluoropropene;
hexafluoropropylene
204-127-4
116-15-4
Xn; R20
Xi; R37
Xn
R: 20-37
S: (2-)41


602-062-00-X
1,2,3-trichloropropane
202-486-1
96-18-4
Carc. Cat. 2; R45
Repr. Cat. 2; R60
Xn; R20/21/22
T
R: 45-60-20/21/22
S: 53-45

E D
602-063-00-5
heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-0
1024-57-3
T; R25
Carc. Cat. 3; R40
R33
N; R50-53
T; N
R: 25-33-40-50/53
S: (1/2-)36/37-45-60-61


602-064-00-0
1,3-dichloro-2-propanol
202-491-9
96-23-1
Carc. Cat. 2; R45
T; R25
Xn; R21
T
R: 45-21-25
S: 53-45

E
602-065-00-6
hexachlorobenzene
204-273-9
118-74-1
Carc. Cat. 2; R45
T; R48/25
N; R50-53
T; N
R: 45-48/25-50/53
S: 53-45-60-61

E
602-066-00-1
tetrachloro-p-benzoquinone
204-274-4
118-75-2
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)37-60-61


602-067-00-7
1,3-dichlorbenzene
208-792-1
541-73-1
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


602-068-00-2
ethylene bis(trichloroacetate)
219-732-9
2514-53-6
Xi; R38
Xi
R: 38
S: (2-)


602-069-00-8
dichloroacetylene
—
7572-29-4
E; R2
Carc. Cat. 3; R40
Xn; R48/20
E; Xn
R: 2-40-48/20
S: (2-)36/37


602-070-00-3
3-chloro-4,5,α, α,α-pentafluorotoluene
401-930-3
77227-99-7
R10
Xn; R20/22
N; R50-58
Xn; N
R: 10-20/22-50-58
S: (2-)51-60-61


602-071-00-9
bromobenzylbromotoluene, reaction mass of isomers
402-210-1
99688-47-8
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53
S: (2-)24-37-41-60-61


602-072-00-4
dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-3
76253-60-6
N; R50-53
N
R: 50/53
S: 60-61


602-073-00-X
1,4-dichlorobut-2-ene
212-121-8
764-41-0
Carc. Cat. 2; R45
T+; R26
T; R24/25
C; R34
N; R50-53
T+; N
R: 45-24/25-26-34-50/53
S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
E
602-074-00-5
pentachlorobenzene
210-172-0
608-93-5
F; R11
Xn; R22
N; R50-53
F; Xn; N
R: 11-22-50/53
S: (2-)41-46-50-60-61


602-075-00-0
4,4,5,5-tetrachloro-1,3-dioxolan-2-one
404-060-2
22432-68-4
T+; R26
Xn; R22
C; R34
T+
R: 22-26-34
S: (1/2-)9-26-28-36/37/39-45




602-076-00-6
2,3,4-trichlorobut-1-ene
219-397-9
2431-50-7
Carc. Cat. 3; R40
T; R23
Xn; R22
Xi; R36/37/38
N; R50-53
T; N
R: 22-23-36/37/38-40-50/53
S: (1/2-)36/37-45-60-61
Carc. Cat. 3; R40: C ≥ 0,1 %


602-077-00-1
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;
mirex
219-196-6
2385-85-5
Carc. Cat. 3; R40
Repr. Cat. 3; R62-63
R64
Xn; R21/22
N; R50/53
Xn; N
R: 21/22-40-50/53-62-63-64
S: (2-)13-36/37-46-60-61


602-078-00-7
hexachlorocyclopentadiene
201-029-3
77-47-4
T+; R26
T; R24
Xn; R22
C; R34
N; R50-53
T+; N
R: 22-24-26-34-50/53
S: (1/2-)25-39-45-53-60-61


602-079-00-2
2,3-dichloropropene;
2,3-dichloropropylene
201-153-8
78-88-6
F; R11
Muta. Cat. 3; R68
Xn; R20/21/22
Xi; R37/38-41
R52-53
F; Xn
R: 11-20/21/22-37/38-41-52/53-68
S: (2-)9-16-23-26-36/37/39-61




602-080-00-8
alkanes, C10-13, chloro;
chlorinated paraffins, C10-13
287-476-5
85535-84-8
Carc. Cat. 3; R40
R66
N; R50-53
Xn; N
R: 40-66-50/53
S: (2-)24-36/37-46-60-61



602-081-00-3
2-chloro-4,5-difluorobenzoic acid
405-380-5
—
Xn; R21/22
Xi; R41
R43
Xn
R: 21/22-41-43
S: (2-)26-36/37/39


602-082-00-9
2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol
408-020-5
109678-33-3
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-41-61


602-083-00-4
diphenyl ether, pentabromo derivative pentabromodiphenyl ether
251-084-2
32534-81-9
Xn; R48/21/22
R64
N; R50-53
Xn; N
R: 48/21/22-50/53-64
S: (1/2-)36/37-45-60-61


602-084-00-X
1,1-dichloro-1-fluoroethane
404-080-1
1717-00-6
R52-53
N; R59
N
R: 52/53-59
S: 59-61


602-085-00-5
2-bromopropane
200-855-1
75-26-3
F; R11
Repr. Cat. 1; R60
Xn; R48/20
R66
F; T
R: 60-11-48/20-66
S: 53-45

E
602-086-00-0
trifluoroiodomethane;
trifluoromethyl iodide
219-014-5
2314-97-8
Muta. Cat. 3; R68
Xn
R: 68
S: (2-)36/37


602-087-00-6
1,2,4-trichlorobenzene
204-428-0
120-82-1
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-50/53
S: (2-)23-37/39-60-61


602-088-00-1
2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol
202-480-9
96-13-9
Carc. Cat. 2; R45
Repr. Cat. 3; R62
T; R24
Xn; R20/22
R52-53
T
R: 45-20/22-24-52/53-62
S: 53-45-61

E
602-089-00-7
4-bromo-2-chlorofluorobenzene
405-580-2
60811-21-4
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-50/53
S: (2-)26-36/37-60-61


602-090-00-2
1-allyl-3-chloro-4-fluorobenzene
406-630-6
121626-73-1
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)23-37-61


602-091-00-8
1,3-dichloro-4-fluorobenzene
406-160-1
1435-48-9
Xn; R22-48/20/22
Xi; R38
N; R51-53
Xn; N
R: 22-38-48/20/22-51/53
S: (2-)36/37-61


602-092-00-3
1-bromo-3,4,5-trifluorobenzene
418-480-9
138526-69-9
R10
Carc. Cat. 3; R40
Xi; R38-41
N; R51-53
Xn; N
R: 10-38-40-41-51/53
S: (2-)23-26-36/37/39-61


602-093-00-9
α, α,α,4-tetrachlorotoluene;
p-chlorobenzotrichloride
226-009-1
5216-25-1
Carc. Cat. 2; R45
Repr. Cat. 3; R62
T; R48/23
Xn; R21/22
Xi; R37/38
T
R: 45-21/22-37/38-48/23-62
S: 53-45

E
602-094-00-4
diphenylether; octabromo derivate
251-087-9
32536-52-0
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-62
S: 53-45




602-095-00-X
alkanes, C14-17, chloro;
chlorinated paraffins, C14-17
287-477-0
85535-85-9
R64
R66
N; R50-53
N
R: 64-66-50/53
S: (2-)24-60-61



602-096-00-5
malachite green hydrochloride; [1]
malachite green oxalate [2]
209-322-8 [1]
219-441-7 [2]
569-64-2 [1]
2437-29-8 [2]
Repr. Cat. 3; R63
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-63-50/53
S: (2-)26-36/37-39-46-60-61


602-097-00-0
1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane
422-850-5
148757-89-5
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61




602-098-00-6
2-(3-bromophenoxy)tetrahydro-2H-pyran
429-030-6
57999-49-2
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



602-099-00-1
3-(4-fluorophenyl)-2-methylpropionylchloride
426-370-7
-
R14
R29
C; R35
Xn; R22
R52-53
C
R: 14-22-29-35-52/53
S: (1/2-)26-36/37/39-45-61



602-100-00-5
reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
420-640-8
-
R52-53
R: 52/53
S: 61



602-101-00-0
2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate
427-020-6
141772-37-4
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53
S: (2-)36/37-60-61



602-102-00-6
1,1,1,3,3-pentafluorobutane
430-250-1
406-58-6
F; R11
F
R: 11
S: (2-)3-9-16-41



602-103-00-1
1-(chlorophenylmethyl)-2-methylbenzene
431-450-1
41870-52-4
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)36/37-60-61



602-104-00-7
1,1,2,2,3,3,4-heptafluorocyclopentane
430-710-1
15290-77-4
R52-53
R: 52/53
S: 61



602-105-00-2
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate
422-100-7
102061-82-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39



602-106-00-8
2-bromo-4,6-difluoroaniline
429-430-0
444-14-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)25-61



602-107-00-3
3,3,4,4-tetrafluoro-4-iodo-1-butene
439-500-2
33831-83-3
Xn; R22
Xi; R38
N; R51-53
Xn; N
R: 22-38-51/53
S: (2-)37-61



602-108-00-9
(2,3,5,6-tetrafluorophenyl)methanol
443-840-7
4084-38-2
Xn; R22
Xi; R36
R43
Xn
R: 22-36-43
S: (2-)26-36/37



603-001-00-X
methanol
200-659-6
67-56-1
F; R11
T; R23/24/25-39/23/24/25
F; T
R: 11-23/24/25-39/23/24/25
S: (1/2-)7-16-36/37-45
T; R23/24/25: C ≥ 20 %
Xn; R20/21/22: 3 % ≤ C < 20 %
T; R39/23/24/25: C ≥ 10 %
Xn; R68/20/21/22: 3 % ≤ C < 10 %

603-002-00-5
ethanol;
ethyl alcohol
200-578-6
64-17-5
F; R11
F
R: 11
S: (2-)7-16


603-003-00-0
propan-1-ol;
n-propanol
200-746-9
71-23-8
F; R11
Xi; R41
R67
F; Xi
R: 11-41-67
S: (2-)7-16-24-26-39


603-004-00-6
butan-1-ol;
n-butanol
200-751-6
71-36-3
R10
Xn; R22
Xi; R37/38-41
R67
Xn
R: 10-22-37/38-41-67
S: (2-)7/9-13-26-37/39-46




603-005-00-1
2-methylpropan-2-ol;
tert-butyl alcohol
200-889-7
75-65-0
F; R11
Xn; R20
Xi; R36/37
F; Xn
R: 11-20-36/37
S: (2-)9-16-46



603-006-00-7
pentanol isomers, with the exception fo those specified elsewhere in this Annex
250-378-8

R10
Xn; R20
Xi; R37
R66
Xn
R: 10-20-37-66
S: (2-)46

C
603-007-00-2
2-methylbutan-2-ol;
tert-pentanol
200-908-9
75-85-4
F; R11
Xn; R20
Xi; R37/38
F; Xn
R: 11-20-37/38
S: (2-)46


603-008-00-8
4-methylpentan-2-ol;
methyl isobutyl carbinol
203-551-7
108-11-2
R10
Xi; R37
Xi
R: 10-37
S: (2-)24/25
Xi; R37: C ≥ 25 %

603-009-00-3
cyclohexanol
203-630-6
108-93-0
Xn; R20/22
Xi; R37/38
Xn
R: 20/22-37/38
S: (2-)24/25


603-010-00-9
2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3]
209-512-0 [1]
231-187-9 [2]
231-186-3 [3]
583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3]
Xn; R20
Xn
R: 20
S: (2-)24/25

C
603-011-00-4
2-methoxyethanol;
ethylene glycol monomethyl ether
203-713-7
109-86-4
R10
Repr. Cat. 2; R60-61
Xn; R20/21/22
T
R: 60-61-10-20/21/22
S: 53-45

E
603-012-00-X
2-ethoxyethanol;
ethylene glycol monoethyl ether
203-804-1
110-80-5
R10
Repr. Cat. 2; R60-61
Xn; R20/21/22
T
R: 60-61-10-20/21/22
S: 53-45

E
603-013-00-5
2-isopropoxyethanol;
ethylene glycol monoisopropyl ether
203-685-6
109-59-1
Xn; R20/21
Xi; R36
Xn
R: 20/21-36
S: (2-)24/25


603-014-00-0
2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve
203-905-0
111-76-2
Xn; R20/21/22
Xi; R36/38
Xn
R: 20/21/22-36/38
S: (2-)36/37-46


603-015-00-6
allyl alcohol
203-470-7
107-18-6
R10
T; R23/24/25
Xi; R36/37/38
N; R50
T; N
R: 10-23/24/25-36/37/38-50
S: (1/2-)36/37/39-38-45-61


603-016-00-1
4-hydroxy-4-methylpentan-2-one;
diacetone alcohol
204-626-7
123-42-2
Xi; R36
Xi
R: 36
S: (2-)24/25
Xi; R36: C ≥ 10 %



603-018-00-2
furfuryl alcohol
202-626-1
98-00-0
Carc. Cat. 3; R40
T; R23
Xn; R21/22-48/20
Xi; R36/37
T
R: 21/22-23-36/37-40-48/20
S: (1/2-)36/37-45-63



603-019-00-8
dimethyl ether
204-065-8
115-10-6
F+; R12
F+
R: 12
S: (2-)9-16-33


603-020-00-3
ethyl methyl ether
—
540-67-0
F+; R12
F+
R: 12
S: (2-)9-16-33


603-021-00-9
methyl vinyl ether
203-475-4
107-25-5
F+; R12
F+
R: 12
S: (2-)9-16-33

D
603-022-00-4
diethyl ether;
ether
200-467-2
60-29-7
F+; R12
R19
Xn; R22
R66
R67
F+; Xn
R: 12-19-22-66-67
S: (2-)9-16-29-33




603-023-00-X
ethylene oxide;
oxirane
200-849-9
75-21-8
F+; R12
R6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T; R23
Xi; R36/37/38
F+; T
R: 45-46-6-12-23-36/37/38
S: 53-45

E

603-024-00-5
1,4-dioxane
204-661-8
123-91-1
F; R11-19
Carc. Cat. 3; R40
Xi; R36/37
R66
F; Xn
R: 11-19-36/37-40-66
S: (2-)9-16-36/37-46

D
603-025-00-0
tetrahydrofuran
203-726-8
109-99-9
F; R11-19
Xi; R36/37
F; Xi
R: 11-19-36/37
S: (2-)16-29-33
Xi; R36/37: C ≥ 25 %

603-026-00-6
1-chloro-2,3-epoxypropane;
epichlorhydrin
203-439-8
106-89-8
R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43
T
R: 45-10-23/24/25-34-43
S: 53-45
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,1 % ≤ C < 1 %
E
603-027-00-1
ethanediol;
ethylene glycol
203-473-3
107-21-1
Xn; R22
Xn
R: 22
S: (2-)


603-028-00-7
2-chloroethanol;
ethylene chlorohydrin
203-459-7
107-07-3
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)7/9-28-45




603-029-00-2
bis(2-chloroethyl) ether
203-870-1
111-44-4
Carc. Cat. 3; R40
T+; R26/27/28
T+
R: 26/27/28-40
S: (1/2-)7/9-27-28-36/37-45



603-030-00-8
2-aminoethanol;
ethanolamine
205-483-3
141-43-5
Xn; R20/21/22
C; R34
C
R: 20/21/22-34
S: (1/2-)26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

603-031-00-3
1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME
203-794-9
110-71-4
F; R11
R19
Repr. Cat. 2; R60
Repr. Cat. 2; R61
Xn; R20
F; T
R: 60-61-11-19-20
S: 53-45

E


603-032-00-9
ethylene dinitrate;
ethylene glycol dinitrate
211-063-0
628-96-6
E; R3
T+; R26/27/28
R33
E; T+
R: 3-26/27/28-33
S: (1/2-)27/28-33-35-36/37-45



603-033-00-4
oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate
211-745-8
693-21-0
E; R3
T+; R26/27/28
R33
R52-53
E; T+
R: 3-26/27/28-33-52/53
S: (1/2-)33-35-36/37-45-61


603-034-00-X
glycerol trinitrate;
nitroglycerine
200-240-8
55-63-0
E; R3
T+; R26/27/28
R33
N; R51-53
E; T+; N
R: 3-26/27/28-33-51/53
S: (1/2-)33-35-36/37-45-61


603-035-00-5
pentaerythritol tetranitrate;
P.E.T.N.
201-084-3
78-11-5
E; R3
E
R: 3
S: (2-)35


603-036-00-0
mannitol hexanitrate;
nitromannite
239-924-6
15825-70-4
E; R3
E
R: 3
S: (2-)35




603-037-00-6
cellulose nitrate;
nitrocellulose
—
—
E; R3
E
R: 3
S: (2-)35

T


603-037-01-3
cellulose nitrate;
nitrocellulose, containing a maximum of 12,6 % nitrogen
—
—
F; R11 $
F
R: 11
S: (2-)16-33-37/39



603-038-00-1
allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4
106-92-3
R10
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R20/22
Xi; R37/38-41
R43
R52-53
Xn
R: 10-20/22-37/38-40-41-43-52/53-62-68
S: (2-)24/25-26-36/37/39-61


603-039-00-7
butyl glycidyl ether;
butyl 2,3-epoxypropyl ether
219-376-4
2426-08-6
R10
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R20/22
Xi; R37
R43
R52-53
Xn
R: 10-20/22-37-40-43-52/53-68
S: (2-)24/25-36/37-61


603-040-00-2
sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3]
204-699-5 [1]
212-736-1 [2]
212-737-7 [3]
124-41-4 [1]
865-33-8 [2]
865-34-9 [3]
F; R11
C; R34
R14
F; C
R: 11-14-34
S: (1/2-)8-16-26-43-45


603-041-00-8
potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2]
213-029-0 [1]
205-487-5 [2]
917-58-8 [1]
141-52-6 [2]
F; R11
C; R34
R14
F; C
R: 11-14-34
S: (1/2-)8-16-26-43-45


603-042-00-3
aluminium-tri-isopropoxide
209-090-8
555-31-7
F; R11
F
R: 11
S: (2-)8-16


603-043-00-9
triarimol (ISO);
2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol
—
26766-27-8
Xn; R22
Xn
R: 22
S: (2-)


603-044-00-4
dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0
115-32-2
Xn; R21/22
Xi; R38
R43
N; R50-53
Xn; N
R: 21/22-38-43-50/53
S: (2-)36/37-60-61


603-045-00-X
diisopropyl ether; [1]
dipropyl ether [2]
203-560-6 [1]
203-869-6 [2]
108-20-3 [1]
111-43-3 [2]
F; R11
R19
R66
R67
F
R: 11-19-66-67
S: (2-)9-16-29-33

C


603-046-00-5
bis(chloromethyl) ether;
oxybis(chloromethane)
208-832-8
542-88-1
F; R11
Carc. Cat. 1; R45
T+; R26
T; R24
Xn; R22
F; T+
R: 45-11-22-24-26
S: 53-45
Carc. Cat. 1; R45: C ≥ 0,001 %
E

603-047-00-0
2-dimethylaminoethanol;
N,N-dimethylethanolamine
203-542-8
108-01-0
R10
Xn; R20/21/22
C; R34
C
R: 10-20/21/22-34
S: (1/2-)25-26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

603-048-00-6
2-diethylaminoethanol;
N,N-diethylethanolamine
202-845-2
100-37-8
R10
Xn; R20/21/22
C; R34
C
R: 10-20/21/22-34
S: (1/2-)25-26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

603-049-00-1
chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol
201-246-3
80-06-8
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)36-61


603-050-00-7
1-(2-Butoxypropoxy)propan-2-ol
246-011-6
24083-03-2
Xn; R21/22
Xn
R: 21/22
S: (2-)


603-051-00-2
2-ethylbutan-1-ol
202-621-4
97-95-0
Xn; R21/22
Xn
R: 21/22
S: (2-)


603-052-00-8
3-butoxypropan-2-ol;
propylene glycol monobutyl ether
225-878-4
5131-66-8
Xi; R36/38
Xi
R: 36/38
S: (2-)


603-053-00-3
2-methylpentane-2,4-diol
203-489-0
107-41-5
Xi; R36/38
Xi
R: 36/38
S: (2-)
Xi; R36/38: C ≥ 10 %

603-054-00-9
di-n-butyl ether;
dibutyl ether
205-575-3
142-96-1
R10
Xi; R36/37/38
R52-53
Xi
R: 10-36/37/38-52/53
S: (2-)61
Xi; R36/37/38: C ≥ 10 %

603-055-00-4
propylene oxide;
1,2-epoxypropane;
methyloxirane
200-879-2
75-56-9
F+; R12
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R20/21/22
Xi; R36/37/38
F+; T
R: 45-46-12-20/21/22-36/37/38
S: 53-45

E
603-056-00-X
[(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropyl o-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4]
218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4]
2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4]
Muta. Cat. 3; R68
Xi; R38
R43
N; R51-53
Xn; N
R: 38-43-51/53-68
S: (2-)36/37-61

C
603-057-00-5
benzyl alcohol
202-859-9
100-51-6
Xn; R20/22
Xn
R: 20/22
S: (2-)26


603-058-00-0
1,3-propylene oxide
207-964-3
503-30-0
F; R11
Xn; R20/21/22
F; Xn
R: 11-20/21/22
S: (2-)9-16-26-29


603-059-00-6
hexan-1-ol
203-852-3
111-27-3
Xn; R22
Xn
R: 22
S: (2-)24/25


603-060-00-1
2,2'-bioxirane;
1,2:3,4-diepoxybutane
215-979-1
1464-53-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T+; R26
T; R24/25
C; R34
T+
R: 45-46-24/25-26-34
S: 53-45

E
603-061-00-7
tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol
202-625-6
97-99-4
Xi; R36
Xi
R: 36
S: (2-)39
Xi; R36: C ≥ 10 %

603-062-00-2
tetrahydrofuran-2,5-diyldimethanol
203-239-0
104-80-3
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)39
Xi; R36/37/38: C ≥ 10 %

603-063-00-8
2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol
209-128-3
556-52-5
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 2; R60
T; R23
Xn; R21/22
Xi; R36/37/38
T
R: 45-60-21/22-23-36/37/38-68
S: 53-45

E


603-064-00-3
1-methoxy-2-propanol;
monopropylene glycol methyl ether
203-539-1
107-98-2
R10
R67
R: 10-67
S: (2-)



603-065-00-9
resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene
202-987-5
101-90-6
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
R43
R52-53
Xn
R: 21/22-36/38-40-43-52/53-68
S: (2-)23-36/37-61





603-066-00-4
1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide
203-437-7
106-87-6
Carc. Cat. 3; R40
T; R23/24/25
T
R: 23/24/25-40
S: (1/2-)36/37-45-63
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,1 % ≤ C < 1 %


603-067-00-X
phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane
204-557-2
122-60-1
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20
Xi; R37/38
R43
R52-53
T
R: 45-20-37/38-43-68-52/53
S: 53-45-61

E
603-068-00-5
2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether
—
130014-35-6
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)26-28-37/39


603-069-00-0
2,4,6-tris(dimethylaminomethyl)phenol
202-013-9
90-72-2
Xn; R22
Xi; R36/38
Xn
R: 22-36/38
S: (2-)26-28


603-070-00-6
2-amino-2-methylpropanol
204-709-8
124-68-5
Xi; R36/38
R52-53
Xi
R: 36/38-52/53
S: (2-)61
Xi; R36/38: C ≥ 10 %

603-071-00-1
2,2'-iminodiethanol;
diethanolamine
203-868-0
111-42-2
Xn; R22-48/22
Xi; R38-41
Xn
R: 22-38-41-48/22
S: (2-)26-36/37/39-46


603-072-00-7
1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether
219-371-7
2425-79-8
Xn; R20/21
Xi; R36/38
R43
Xn
R: 20/21-36/38-43
S: (2-)26-28-37/39


603-073-00-2
bis-[4-(2,3-epoxipropoxi)phenyl]propane
216-823-5
1675-54-3
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)28-37/39
Xi; R36/38: C ≥ 5 %

603-074-00-8
reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700)
500-033-5
25068-38-6
Xi; R36/38
R43
N; R51-53
Xi; N
R: 36/38-43-51/53
S: (2-)28-37/39-61
Xi; R36/38: C ≥ 5 %

603-075-00-3
chlormethyl methyl ether;
chlorodimethyl ether
203-480-1
107-30-2
F; R11
Carc. Cat. 1; R45
Xn; R20/21/22
F; T
R: 45-11-20/21/22
S: 53-45

E
603-076-00-9
but-2-yne-1,4-diol;
2-butyne-1,4-diol
203-788-6
110-65-6
C; R34
T; R23/25
Xn; R21-48/22
R43
C; T
R: 21-23/25-34-43-48/22
S: (1/2-)25-26-36/37/39-45-46
C; R34: C ≥ 50 %
Xi; R36/38: 25 % ≤ C < 50 %
D
603-077-00-4
1-dimethylaminopropan-2-ol;
dimepranol (INN)
203-556-4
108-16-7
R10
Xn; R22
C; R34
C
R: 10-22-34
S: (1/2-)23-26-36-45


603-078-00-X
prop-2-yn-1-ol;
propargyl alcohol
203-471-2
107-19-7
R10
T; R23/24/25
C; R34
N; R51-53
T; N
R: 10-23/24/25-34-51/53
S: (1/2-)26-28-36-45-61


603-079-00-5
2,2'-(methylimino)diethanol;
N-methyldiethanolamine
203-312-7
105-59-9
Xi; R36
Xi
R: 36
S: (2-)24


603-080-00-0
2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol
203-710-0
109-83-1
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

603-081-00-6
2,2'-thiodiethanol;
thiodiglycol
203-874-3
111-48-8
Xi; R36
Xi
R: 36
S: (2-)


603-082-00-1
1-aminopropan-2-ol;
isopropanolamine
201-162-7
78-96-6
C; R34
C
R: 34
S: (1/2-)23-26-36-45


603-083-00-7
1,1'-iminodipropan-2-ol;
di-isopropanolamine
203-820-9
110-97-4
Xi; R36
Xi
R: 36
S: (2-)26


603-084-00-2
styrene oxide;
(epoxyethyl)benzene;
phenyloxirane
202-476-7
96-09-3
Carc. Cat. 2; R45
Xn; R21
Xi; R36
T
R: 45-21-36
S: 53-45

E


603-085-00-8
bronopol (INN);
2-bromo-2-nitropropane-1,3-diol
200-143-0
52-51-7
Xn; R21/22
Xi; R37/38-41
N; R50
Xn; N
R: 21/22-37/38-41-50
S: (2-)26-36/37/39-61
N; R50: C ≥ 2,5 %


603-086-00-3
ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-3
23947-60-6
Xn; R21
Xn
R: 21
S: (2-)36/37


603-087-00-9
2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol
202-377-9
94-96-2
Xi; R41
Xi
R: 41
S: (2-)25-26-39-46


603-088-00-4
2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide
222-598-4
3547-33-9
Xi; R41
Xi
R: 41
S: (2-)26


603-089-00-X
7,7-dimethyl-3-oxa-6-azaoctan-1-ol
400-390-6
—
C; R35
Xn; R22
C
R: 22-35
S: (1/2-)26-28-36/37/39-45


603-090-00-5
2-(2-bromoethoxy)anisole
402-010-4
4463-59-6
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


603-091-00-0
exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol
402-470-6
87172-89-2
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39


603-092-00-6
2-methyl-4-phenylpentanol
402-770-7
92585-24-5
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


603-093-00-1
cinmethylin (ISO)
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-9
87818-31-3
Xn; R20
N; R51-53
Xn; N
R: 20-51/53
S: (2-)23-61


603-094-00-7
1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane
241-536-7
17557-23-2
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37


603-095-00-2
2-(propyloxy)ethanol;
EGPE
220-548-6
2807-30-9
Xn; R21
Xi; R36
Xn
R: 21-36
S: (2-)26-36/37-46


603-096-00-8
2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether
203-961-6
112-34-5
Xi; R36
Xi
R: 36
S: (2-)24-26


603-097-00-3
1,1',1''-nitrilotripropan-2-ol;
triisopropanolamine
204-528-4
122-20-3
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61


603-098-00-9
2-phenoxyethanol
204-589-7
122-99-6
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)26


603-099-00-4
3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride
403-440-5
93633-79-5
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


603-100-00-8
1,2-dimethoxypropane
404-630-0
7778-85-0
F; R11-19
F
R: 11-19
S: (2-)9-16-24/25-33


603-101-00-3
tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)
405-040-6
—
Xi; R36
Xi
R: 36
S: (2-)25-26


603-102-00-9
1,2-epoxybutane
203-438-2
106-88-7
F; R11
Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R36/37/38
R52-53
F; Xn
R: 11-20/21/22-36/37/38-40-52/53
S: (2-)9-16-29-36/37-61


603-103-00-4
oxirane, mono[(C12-14-alkyloxy)methyl] derivs.
271-846-8
68609-97-2
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37


603-104-00-X
fenarimol (ISO);
2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-7
60168-88-9
Repr. Cat. 3; R62-63
R64
N; R51-53
Xn; N
R: 51/53-62-63-64
S: (2-)36/37-61


603-105-00-5
furan
203-727-3
110-00-9
F+; R12
R19
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22-48/22
Xi; R38
R52-53
F+; T
R: 45-12-19-20/22-38-48/22-68-52/53
S: 53-45-61

E
603-106-00-0
2-methoxypropanol
216-455-5
1589-47-5
R10
Repr. Cat. 2; R61
Xi; R37/38-41
T
R: 61-10-37/38-41
S: 53-45


603-107-00-6
2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether
203-906-6
111-77-3
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)36/37


603-108-00-1
2-methylpropan-1-ol;
iso-butanol
201-148-0
78-83-1
R10
Xi; R37/38-41
R67
Xi
R: 10-37/38-41-67
S: (2-)7/9-13-26-37/39-46




603-109-00-7
reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane
425-340-0
-
R53
R: 53
S: 21-23-61



603-110-00-2
reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane
426-130-1
166301-21-9
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)23-37-61



603-111-00-8
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane
426-530-6
-
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)24-37-60-61



603-112-00-3
cyclopentyl 2-phenylethyl ether
428-340-9
-
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37-60-61



603-113-00-9
6-glycidyloxynapht-1-yl oxymethyloxirane
429-960-2
27610-48-6
Muta. Cat. 3; R68
Xn; R21
Xi; R38
R43
R52-53
Xn
R: 21-38-43-68-52/53
S: (2-)36/37/39-61



603-114-00-4
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene
430-830-2
26912-64-1
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)23-37-61



603-115-00-X
reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-580-0
-
Xn; R48/22
R53
Xn
R: 48/22-53
S: 2-36-61



603-116-00-5
(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride
424-740-2
138271-16-6
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61



603-117-00-0
propan-2-ol;
isopropyl alcohol;
isopropanol
200-661-7
67-63-0
F; R11
Xi; R36
R67
F; Xi
R: 11-36-67
S: (2-)7-16-24/25-26


603-118-00-6
6-dimethylaminohexan-1-ol
404-680-3
1862-07-3
Xn; R22
C; R34
R52-53
C
R: 22-34-52/53
S: (1/2-)26-36/37/39-45-61


603-119-00-1
1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)
405-840-5
—
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


603-120-00-7
2-methyl-5-phenylpentanol
405-890-8
25634-93-9
Xi; R36/38
Xi
R: 36/38
S: (2-)26-37


603-121-00-2
4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone
406-057-1
114565-66-1
Carc. Cat. 3; R40
R43
R53
Xn
R: 40-43-53
S: (2-)36/37-61


603-122-00-8
sodium 2-ethylhexanolate
406-150-7
38411-13-1
F; R11
C; R34
R52-53
F; C
R: 11-34-52/53
S: (1/2-)7-26-36/37/39-45-61


603-123-00-3
4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol
406-330-5
122760-84-3
Xi; R38
R43
N; R51-53
Xi; N
R: 38-43-51/53
S: (2-)24-37-61


603-124-00-9
1,4-bis[2-(vinyloxy)ethoxy]benzene
406-900-3
84563-49-5
N; R50-53
N
R: 50/53
S: 60-61


603-125-00-4
2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol
407-850-5
89544-40-1
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)26-39-61


603-126-00-X
2-((4-methyl-2-nitrophenyl)amino)ethanol
408-090-7
100418-33-5
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)36/37-61




603-127-00-5
butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4]
201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]
78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]
R10
Xi; R36/37
R67
Xi
R: 10-36/37-67
S: (2-)7/9-13-24/25-26-46

C

603-128-00-0
2-(phenylmethoxy)naphthalene
405-490-3
613-62-7
R53
R: 53
S: 61


603-129-00-6
1-tert-butoxypropan-2-ol
406-180-0
57018-52-7
R10
Xi; R41
Xi
R: 10-41
S: (2-)26-39


603-130-00-1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)
406-325-8
—
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)39-61


603-131-00-7
reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1
—
Xi; R41
Xi
R: 41
S: (2-)26-39


603-132-00-2
2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane
408-200-3
63187-91-7
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61


603-133-00-8
reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1
—
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-36-61


603-134-00-3
reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.
410-450-3
—
R53
R: 53
S: 61


603-135-00-9
bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium
410-500-4
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


603-136-00-4
3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol
410-910-3
104226-19-9
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


603-137-00-X
reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6
—
Xi; R41
Xi
R: 41
S: (2-)26-39


603-138-00-5
3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4
103694-68-4
R52-53
R: 52/53
S: 61


603-139-00-0
bis(2-methoxyethyl) ether
203-924-4
111-96-6
R10
R19
Repr. Cat. 2; R60-61
T
R: 60-61-10-19
S: 53-45


603-140-00-6
2,2' -oxybisethanol;
diethylene glycol
203-872-2
111-46-6
Xn; R22
Xn
R: 22
S: (2-)46


603-141-00-1
reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6
—
R52-53
R: 52/53
S: 61


603-142-00-7
2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane
407-360-1
116230-20-7
Xn; R21/22-48/20
Xi; R38-41
Xn
R: 21/22-38-41-48/20
S: (2-)26-36/37/39


603-143-00-2
R-2,3-epoxy-1-propanol
404-660-4
57044-25-4
E; R2
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 2; R60
T; R23
Xn; R21/22
C; R34
E; T
R: 45-60-2-21/22-23-34-68
S: 53-45

E
603-144-00-8
reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6
111850-00-1
N; R51-53
N
R: 51/53
S: 61


603-145-00-3
2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane
406-970-5
129228-11-1
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)36/37-61


603-146-00-9
2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol
406-080-7
83016-70-0
Xn; R22
C; R34
R52-53
C
R: 22-34-52/53
S: (1/2-)23-26-36/37/39-45-61


603-147-00-4
(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
406-030-4
105812-81-5
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-24-26-37/39-61


603-148-00-X
1,4-bis[(vinyloxy)methyl]cyclohexane
413-370-7
17351-75-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


603-149-00-5
reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane
407-640-3
63767-86-2
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)26-37-61


603-150-00-0
(±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol
411-580-3
107898-54-4
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)24/25-37-60-61


603-151-00-6
(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol
413-570-4
—
R52-53
R: 52/53
S: 61


603-152-00-1
2-(4-tert-butylphenyl)ethanol
410-020-5
5406-86-0
Repr. Cat. 3; R62
Xn; R48/22
Xi; R41
N; R51-53
Xn; N
R: 41-48/22-62-51/53
S: (2-)26-36/37/39-61


603-153-00-7
3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol
410-010-0
104333-00-8
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


603-154-00-2
1-[(2-tert-butyl)cyclohexyloxy]-2-butanol
412-300-2
139504-68-0
N; R51-53
N
R: 51/53
S: 61



603-155-00-8
Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane
410-560-1
—
N; R50-53
N
R: 50/53
S: 60-61



603-156-00-3
2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane
411-210-0
89544-48-9
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


603-157-00-9
6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol
411-450-6
143747-72-2
R53
R: 53
S: 61


603-158-00-4
reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene
412-460-3
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


603-159-00-X
2-cyclododecylpropan-1-ol
411-410-8
118562-73-5
N; R50-53
N
R: 50/53
S: 60-61


603-160-00-5
1,2-diethoxypropane
412-180-1
10221-57-5
F; R11
R19
F
R: 11-19
S: (2-)9-16-24-33


603-161-00-0
1,3-diethoxypropane
413-140-6
3459-83-4
R10
R: 10
S: (2-)9-24


603-162-00-6
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]
413-420-8
144736-29-8
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61


603-163-00-1
2-phenyl-1,3-propanediol
411-810-2
1570-95-2
Xi; R41
Xi
R: 41
S: (2-)26-39


603-164-00-7
2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole
412-420-5
133909-99-6
R53
R: 53
S: 61


603-165-00-2
reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1
—
Muta. Cat. 3; R68
R43
Xn
R: 43-68
S: (2-)36/37


603-166-00-8
R-1-chloro-2,3-epoxypropane
424-280-2
51594-55-9
R10
Carc. Cat. 2; R45
T; R23/24/25
C; R34
R43
T
R: 45-10-23/24/25-34-43
S: 53-45

E
603-167-00-3
3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol
407-920-5
6390-69-8
R53
R: 53
S: 61


603-168-00-9
3-(2-ethylhexyloxy)propane-1,2-diol
408-080-2
70445-33-9
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


603-169-00-4
(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine
415-550-0
109887-53-8
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61


603-170-00-X
reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-3
67739-11-1
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


603-171-00-5
5-thiazolylmethanol
414-780-9
38585-74-9
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


603-172-00-0
mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate
415-180-1
773058-82-5
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61


603-173-00-6
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
421-750-9
57280-22-5
Xi; R36
R43
Xi
R: 36-43
S: (2-)26-36/37


603-174-00-1
4-cyclohexyl-2-methyl-2-butanol
420-630-3
83926-73-2
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


603-175-00-7
2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol
203-988-3
112-59-4
Xn; R21
Xi; R41
Xn
R: 21-41
S: (2-)26-36/37/39-46


603-176-00-2
1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme
203-977-3
112-49-2
R19
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-19-62
S: 53-45


603-177-00-8
1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEA [2]
216-374-5 [1]
259-370-9 [2]
1569-02-4 [1]
54839-24-6 [2]
R10
R67
R: 10-67
S: (2-)24


603-178-00-3
2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol
203-951-1
112-25-4
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-36/37/39-45


603-179-00-9
ergocalciferol (ISO);
Vitamin D2
200-014-9
50-14-6
T+; R26
T; R24/25-48/25
T+
R: 24/25-26-48/25
S: (1/2-)28-36/37-45


603-180-00-4
colecalciferol;
Vitamin D3
200-673-2
67-97-0
T+; R26
T; R24/25-48/25
T+
R: 24/25-26-48/25
S: (1/2-)28-36/37-45


603-181-00-X
tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane
216-653-1
1634-04-4
F; R11
Xi; R38
F; Xi
R: 11-38
S: (2-)9-16-24




603-182-00-5
reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide
428-630-5
-
R43
Xi
R: 43
S: (2-)24-37



603-183-00-0
2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol
205-592-6
143-22-6
Xi; R41
Xi
R: 41
S: (2-)26-39-46
Xi; R41: C ≥ 30 %
Xi; R36: 20 % ≤ C < 30 %

603-184-00-6
2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol
416-380-1
146925-83-9
N; R50-53
N
R: 50/53
S: 60-61


603-185-00-1
2,4-dichloro-3-ethyl-6-nitrophenol
420-740-1
99817-36-4
T; R25
Xi; R41
R43
N; R50-53
T; N
R: 25-41-43-50/53
S: (1/2-)26-36/37/39-45-60-61


603-186-00-7
trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol
419-050-3
79944-37-9
R43
Xi
R: 43
S: (2-)22-24/25-26-37


603-187-00-2
2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride
419-360-9
163661-77-6
N; R50-53
N
R: 50/53
S: 60-61




603-188-00-8
reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene
426-970-9
-
N; R50-53
N
R: 50/53
S: 60-61



603-189-00-3
reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol
405-250-8
—
N; R51-53
N
R: 51/53
S: 61




603-190-00-9
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane
424-030-2
62406-73-9
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)24-37-61



603-191-00-4
2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol
419-740-4
137658-79-8
R53
R: 53
S: 61





603-192-00-X
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol
423-240-1
125474-34-2
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)23-24-26-37/39-60-61



603-193-00-5
disodium 9,10-anthracenedioxide
426-030-8
46492-07-3
C; R35
C
R: 35
S: (1/2-)26-36/37/39-45



603-194-00-0
2-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5
111-41-1
Repr. Cat. 2; R61
Repr. Cat. 3; R62
C; R34
R43
T
R: 61-34-43-62
S: 53-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %


603-195-00-6
2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol
430-810-3
154825-62-4
R52-53
R: 52/53
S: 61


603-196-00-1
2-(7-ethyl-1H-indol-3-yl)ethanol
431-020-1
41340-36-7
Xn; 22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)36/37/39-61


603-197-00-7
tebuconazole (ISO);
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
403-640-2
107534-96-3
Repr. Cat. 3; R63
Xn; R22
N; R51-53
Xn; N
R: 22-51/53-63
S: (2-)22-36/37-61


603-199-00-8
etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
—
153233-91-1
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %



603-200-00-1
1-pentanol; [1]
3-pentanol [2]
200-752-1 [1]
209-526-7 [2]
71-41-0 [1]
584-02-1 [2]
R10
Xn; R20
Xi; R37/38
Xn
R: 10-20-37/38
S: (1/2-)36/37-46



603-201-00-7
(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol
416-120-5
-
Xi; R38
R53
Xi
R: 38-53
S: (2-)37-61



603-202-00-2
4,4,5,5,5-pentafluoropentan-1-ol
421-360-9
148043-73-6
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)23-61



603-203-00-8
(1R, 3S, 7R, 8R, 10R, 13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane
427-580-1
-
Xi; R38
Xi
R: 38
S: (2-)37



603-204-00-3
reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane
428-110-8
-
R52-53
R: 52/53
S: 61



603-205-00-9
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
426-200-1
172015-79-1
T; R48/25
Xn; R22
Xi; R41
R43
R52-53
T
R: 22-41-43-48/25-52/53
S: (1/2-)22-26-36/37/39-45-61



603-206-00-4
2,2-dichloro-1,3-benzodioxol
426-850-6
2032-75-9
R10
R14
C; R35
Xn; R22
R43
C
R: 10-14-22-35-43
S: (1/2-)7/8-23-26-36/37/39-45



603-207-00-X
2-isobutyl-2-isopropyl-1,3-dimethoxypropane
430-800-9
129228-21-3
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)23-37-61



603-208-00-5
1,2-diethoxyethane
211-076-1
629-14-1
F; R11
R19
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R36
F; T
R: 61-11-19-36-62
S: 53-45



603-209-00-0
spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]
- [1]
- [2]
- [3]
- [1]
131929-60-7 [2]
131929-63-0 [3]
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


603-210-00-6
2,4-diethyl-1,5-pentanediol
429-310-8
57987-55-0
Xi; R41
Xi
R: 41
S: (2-)26-39



603-211-00-1
2,3-epoxypropyltrimethylammonium chloride …%;
glycidyl trimethylammonium chloride …%
221-221-0
3033-77-0
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R21/22-48/22
Xi; R41
R43
R52-53
T
R: 45-21/22-41-43-48/22-62-68-52/53
S: 53-45-61

B E

603-212-00-7
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-9
1222-05-5
N; R50-53
N
R: 50/53
S: 60-61



603-213-00-2
2-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4
994-05-8
F; R11
Xn; R22
R67
F; Xn
R: 11-22-67
S: (2-)9-16-23-33



603-214-00-8
1,1-diisopropoxycyclohexane
413-740-8
1132-95-2
C; R34
C
R: 34
S: (1/2-)23-26-36/37/39-45



603-215-00-3
1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2
162241-33-0
E; R2
Xn; R22-48/22
Xi; R41
R43
N; R50-53
E; Xn; N
R: 2-22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61



603-216-00-9
cis-1-amino-2,3-dihydro-1H-inden-2-ol
422-660-2
7480-35-5
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61



603-217-00-4
2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite
423-560-1
161717-32-4
R43
R53
Xi
R: 43-53
S: (2-)24-37/39-61



603-220-00-0
1-{]benzyl[}2-(2-methoxyphenoxy)ethyl{]amino[}-3-(9H-carbazol-4-yloxy)propan-2-ol
432-890-5
72955-94-3
R53
R: 53
S: 61



603-221-00-6
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Xn; R22
C; R34
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61



603-221-01-3
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Carc. Cat. 2; R45
Xn; R22
C; R34
N; R51-53
T; N
R: 45-22-34-51/53
S: 53-45-61

E

603-222-00-1
(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
433-820-6
118058-74-5
Xi; R36
Xi
R: 36
S: (2-)26



603-223-00-7
2-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol
434-270-1
6261-30-9
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61



603-224-00-2
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane
435-790-1
297730-93-9
R53
R: 53
S: 61



603-225-00-8
erythromycin A9-oxime (E);
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0
13127-18-9
N; R51-53
N
R: 51/53
S: 61



603-226-00-3
4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol
444-500-0
1440-00-2
R52-53
R: 52/53
S: 61



603-227-00-9
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2
203574-04-3
O; R7
N; R50-53
O; N
R: 7-50/53
S: (2-)3/7-14-36/37/39-60-61



603-228-00-4
(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)36/37-61



603-229-00-X
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate
420-800-7
-
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61



603-230-00-5
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan
440-030-5
-
Xi; R38-41
R53
Xi
R: 38-41-53
S: (2-)26-37/39-61



603-231-00-0
(S)-1,1-diphenyl-1,2-propanediol
443-220-6
-
R52-53
R: 52/53
S: 22-61



603-232-00-6
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane
444-420-6
-
R53
R: 53
S: 61



603-233-00-1
reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0
-
N; R51-53
N
R: 51/53
S: 61



603-234-00-7
(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
444-480-3
-
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61



604-001-00-2
phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol
203-632-7
108-95-2
Muta. Cat. 3; R68
T; R23/24/25
Xn; R48/20/21/22
C; R34
T;
R: 23/24/25-34-48/20/21/22-68
S: (1/2-)24/25-26-28-36/37/39-45
T; R23/24/25: C ≥ 10 %
Xn; R20/21/22: 3 % ≤ C < 10 %
C; R34: C ≥ 3 %
Xi; R36/38: 1 % ≤ C < 3 %

604-002-00-8
pentachlorophenol
201-778-6
87-86-5
Carc. Cat. 3; R40
T+; R26
T; R24/25
Xi; R36/37/38
N; R50-53
T+; N
R: 24/25-26-36/37/38-40-50/53
S: (1/2-)22-36/37-45-52-60-61


604-003-00-3
sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2]
205-025-2 [1]
231-911-3 [2]
131-52-2 [1]
7778-73-6 [2]
Carc. Cat. 3; R40
T+; R26
T; R24/25
Xi; R36/37/38
N; R50-53
T+; N
R: 24/25-26-36/37/38-40-50/53
S: (1/2-)22-28-36/37-45-52-60-61


604-004-00-9
m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4]
203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4]
108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4]
T; R24/25
C; R34
T
R: 24/25-34
S: (1/2-)36/37/39-45
T; R24/25: C ≥ 5 %
Xn; R21/22: 1 % ≤ C < 5 %
C; R34: C ≥ 5 %
Xi; R36/38: 1 % ≤ C < 5 %
C


604-005-00-4
1,4-dihydroxybenzene;
hydroquinone;
quinol
204-617-8
123-31-9
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R22
Xi; R41
R43
N; R50
Xn; N
R: 22-40-41-43-68-50
S: (2-)26-36/37/39-61
N; R50: C ≥ 2,5 %


604-006-00-X
3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7]
202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7]
95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7]
T; R24/25
C; R34
N; R51-53
T; N
R: 24/25-34-51/53
S: (1/2-)26-36/37/39-45-61

C
604-007-00-5
2-naphthol
205-182-7
135-19-3
Xn; R20/22
N; R50
Xn; N
R: 20/22-50
S: (2-)24/25-61


604-008-00-0
2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4]
202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4]
95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4]
Xn; R20/21/22
N; R51-53
Xn; N
R: 20/21/22-51/53
S: (2-)28-61

C
604-009-00-6
pyrogallol;
1,2,3-trihydroxybenzene
201-762-9
87-66-1
Muta. Cat. 3; R68
Xn; R20/21/22
R52-53
Xn
R: 20/21/22-68-52/53
S: (2-)36/37-61
Xn; R20/21/22: C ≥ 10 %

604-010-00-1
resorcinol;
1,3-benzenediol
203-585-2
108-46-3
Xn; R22
Xi; R36/38
N; R50
Xn; N
R: 22-36/38-50
S: (2-)26-61
Xn; R22: C ≥ 10 %

604-011-00-7
2,4-dichlorophenol
204-429-6
120-83-2
T; R24
Xn; R22
C; R34
N; R51-53
T; N
R: 22-24-34-51/53
S: (1/2-)26-36/37/39-45-61


604-012-00-2
4-chloro-o-cresol;
4-chloro-2-methyl phenol
216-381-3
1570-64-5
T; R23
C; R35
N; R50
T; C; N
R: 23-35-50
S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

604-013-00-8
2,3,4,6-tetrachlorophenol
200-402-8
58-90-2
T; R25
Xi; R36/38
N; R50-53
T; N
R: 25-36/38-50/53
S: (1/2-)26-28-37-45-60-61
T; R25: C ≥ 5 %
Xn; R22: 0,5 % ≤ C < 5 %
Xi; R36/38: C ≥ 5 %

604-014-00-3
chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol
200-431-6
59-50-7
Xn; R21/22
Xi; R41
R43
N; R50
Xn; N
R: 21/22-41-43-50
S: (2-)26-36/37/39-61
Xn; R21/22: C ≥ 10 %

604-015-00-9
2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene
200-733-8
70-30-4
T; R24/25
N; R50-53
T; N
R: 24/25-50/53
S: (1/2-)20-37-45-60-61
T; R24/25: C ≥ 2 %
Xn; R21/22: 0,2 % ≤ C < 2 %

604-016-00-4
1,2-dihydroxybenzene;
pyrocatechol
204-427-5
120-80-9
Xn; R21/22
Xi; R36/38
Xn
R: 21/22-36/38
S: (2-)22-26-37


604-017-00-X
2,4,5-trichlorophenol
202-467-8
95-95-4
Xn; R22
Xi; R36/38
N; R50-53
Xn; N
R: 22-36/38-50/53
S: (2-)26-28-60-61
Xn; R22: C ≥ 20 %
Xi; R36/38: C ≥ 5 %

604-018-00-5
2,4,6-trichlorophenol
201-795-9
88-06-2
Carc. Cat. 3; R40
Xn; R22
Xi; R36/38
N; R50-53
Xn; N
R: 22-36/38-40-50/53
S: (2-)36/37-60-61


604-019-00-0
dichlorophen (ISO)
202-567-1
97-23-4
Xn; R22
Xi; R36
N; R50-53
Xn; N
R: 22-36-50/53
S: (2-)26-60-61


604-020-00-6
2-phenylphenol (ISO);
biphenyl-2-ol;
2-hydroxybiphenyl;
201-993-5
90-43-7
Xi; R36/37/38
N; R50
Xi; N
R: 36/37/38-50
S: (2-)22-61


604-021-00-1
sodium 2-biphenylate;
2-phenylphenol, sodium salt
205-055-6
132-27-4
Xn; R22
Xi; R37/38-41
N; R50
Xn; N
R: 22-37/38-41-50
S: (2-)22-26-61


604-022-00-7
2,2-dimethyl-1,3-benzodioxol-4-ol
400-900-7
22961-82-6
Xi; R41
Xi
R: 41
S: (2-)24-26-39


604-023-00-2
2,4-dichloro-3-ethylphenol
401-060-4
—
C; R34
N; R50-53
C; N
R: 34-50/53
S: (1/2-)26-36/39-45-60-61


604-024-00-8
4,4-isobutylethylidenediphenol
401-720-1
6807-17-6
Repr. Cat. 2; R60
Xi; R36
N; R50-53
T; N
R: 60-36-50/53
S: 53-45-60-61


604-025-00-3
2,5-bis(1,1-dimethylbutyl)hydroquinone
400-220-0
—
N; R51-53
N
R: 51/53
S: 61


604-026-00-9
2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)
400-270-3
—
N; R51-53
N
R: 51/53
S: 61


604-027-00-4
2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone
400-530-6
—
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24/25-26-37-61


604-028-00-X
4-amino-3-fluorophenol
402-230-0
399-95-1
Carc. Cat. 2; R45
Xn; R22
R43
N; R51-53
T; N
R: 45-22-43-51/53
S: 53-45-61

E
604-029-00-5
1-naphtol
201-969-4
90-15-3
Xn; R21/22
Xi; R37/38-41
Xn
R: 21/22-37/38-41
S: (2-)22-26-37/39




604-030-00-0
bisphenol A;
4,4'-isopropylidenediphenol
201-245-8
80-05-7
Repr. Cat. 3; R62
Xi; R37-41
R43
R52
Xn
R: 37-41-43-62-52
S: (2-)26-36/37-39-46-61



604-031-00-6
guaiacol
201-964-7
90-05-1
Xn; R22
Xi; R36/38
Xn
R: 22-36/38
S: (2-)26


604-032-00-1
thymol
201-944-8
89-83-8
Xn; R22
C; R34
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)26-28-36/37/39-45-61


604-033-00-7
isobutyl but-3-enoate
401-170-2
24342-03-8
R10
R: 10
S: (2-)


604-034-00-2
4,4'-thiodi-o-cresol
403-330-7
24197-34-0
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


604-035-00-8
4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol
404-160-6
—
R43
R53
X
R: 43-53
S: (2-)24-37-61


604-036-00-3
4,4'-oxybis(ethylenethio)diphenol
404-590-4
90884-29-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


604-037-00-9
3,5-xylenol;
3,5-dimethylphenol
203-606-5
108-68-9
T; R24/25
C; R34
T
R: 24/25-34
S: (1/2-)26-28-36/37/39-45


604-038-00-4
4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2]
201-793-8 [1]
215-316-6 [2]
88-04-0 [1]
1321-23-9 [2]
Xn; R22
Xi; R36/38
R43
Xn
R: 22-36/38-43
S: (2-)24-37


604-039-00-X
ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl
266-362-9
66441-23-4
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


604-040-00-5
fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-9
72178-02-0
Xn; R22
Xn
R: 22
S: (2-)


604-041-00-0
acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2]
256-634-5 [1]
263-560-7 [2]
50594-66-6 [1]
62476-59-9 [2]
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-50/53
S: (2-)24-39-60-61


604-042-00-6
4-nitrosophenol
203-251-6
104-91-6
Muta. Cat. 3; R68
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53-68
S: (2-)26-36/37/39-47-49-61


604-043-00-1
monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether
203-083-3
103-16-2
Xi; R36
R43
Xi
R: 36-43
S: (2-)24/25-26-37


604-044-00-7
mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether
205-769-8
150-76-5
Xn; R22
Xi; R36
R43
Xn
R: 22-36-43
S: (2-)24/25-26-37/39-46


604-045-00-2
2,3,5-trimethylhydroquinone
211-838-3
700-13-0
Xn; R20
Xi; R37/38-41
R43
N; R50-53
Xn; N
R: 20-37/38-41-43-50/53
S: (2-)24-26-37/39-60-61


604-046-00-8
4-(4-isopropoxyphenylsulfonyl)phenol
405-520-5
95235-30-6
N; R51-53
N
R: 51/53
S: 61


604-047-00-3
4-(4-tolyloxy)biphenyl
405-730-7
51601-57-1
Xn; R48/22
R53
Xn
R: 48/22-53
S: (2-)22-36-61


604-048-00-9
4,4',4''-(ethan-1,1,1-triyl)triphenol
405-800-7
27955-94-8
N; R51-53
N
R: 51/53
S: 61


604-049-00-4
4-4'-methylenebis(oxyethylenethio)diphenol
407-480-4
93589-69-6
N; R51-53
N
R: 51/53
S: 61


604-051-00-5
3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol
401-110-5
87113-78-8
R52-53
R: 52/53
S: 61


604-052-00-0
2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)
403-800-1
103597-45-1
R53
R: 53
S: 61


604-053-00-6
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol
410-760-9
157661-93-3
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


604-054-00-1
reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61




604-055-00-7
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane
413-900-7
85954-11-6
Carc. Cat. 3; R40
R43
Xn
R: 40-43
S: (2-)22-36/37



604-056-00-2
2-(2-hydroxy-3,5-dinitroanilino)ethanol
412-520-9
99610-72-7
F; R11
Repr. Cat. 3; R62
Xn; R22
F; Xn
R: 11-22-62
S: (2-)22-33-36/37


604-057-00-8
reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;
isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6
401-680-5
—
N; R51-53
N
R: 51/53
S: 61


604-058-00-3
1,2-bis(3-methylphenoxy)ethane
402-730-9
54914-85-1
N; R50-53
N
R: 50/53
S: 60-61


604-059-00-9
2-n-hexadecylhydroquinone
406-400-5
—
Xn; R48/22
Xi; R38
R43
R53
Xn
R: 38-43-48/22-53
S: (2-)22-36/37-61


604-060-00-4
9,9-bis(4-hydroxyphenyl)fluorene
406-950-6
3236-71-3
Xi; R36-38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)26-37-60-61


604-061-00-X
reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl
407-740-7
—
Xi; R38
R43
R52-53
Xi
R: 38-43-52/53
S: (2-)24-37-61


604-062-00-5
2,4-dimethyl-6-(1-methyl-pentadecyl)phenol
411-220-5
—
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


604-063-00-0
5,6-dihydroxyindole
412-130-9
3131-52-0
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-36/37/39-61


604-064-00-6
2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol
411-380-6
147315-50-2
R53
R: 53
S: 61


604-065-00-1
4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)
407-460-5
111850-25-0
N; R51-53
N
R: 51/53
S: 61


604-066-00-7
reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8
—
N; R50-53
N
R: 50/53
S: 60-61


604-067-00-2
reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61


604-068-00-8
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride
415-170-5
90274-24-1
Xn; R20/22
R43
Xn
R: 20/22-43
S: (2-)24-26-37


604-069-00-3
2-(1-methylpropyl)-4-tert-butylphenol
421-740-4
51390-14-8
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)26-36/37/39-45-61


604-070-00-9
triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-2
3380-34-5
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: 26-39-46-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %



604-071-00-4
4,4'-(1-{]4-[}1-(4-hydroxyphenyl)-1-methylethyl{]phenyl[}ethylidene)diphenol
425-600-3
110726-28-8
R53
R: 53
S: 61



604-072-00-X
1,2-bis(phenoxymethyl)benzene
428-620-0
10403-74-4
N; R50-53
N
R: 50/53
S: 22-60-61



604-073-00-5
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
428-010-4
82413-20-5
Carc. Cat. 3; R40
Repr. Cat. 2; R60
R43
N; R50-53
T; N
R: 60-40-43-50/53
S: 53-45-60-61



604-074-00-0
tetrabromobisphenol-A;
2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol
201-236-9
79-94-7
N; R50-53
N
R: 50/53
S: 60-61



604-075-00-6
4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol
205-426-2
140-66-9
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


604-076-00-1
phenolphthalein
201-004-7
77-09-8
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T
R: 45-62-68
S: 53-45
Carc. Cat. 2; R45: C ≥ 1 %


604-077-00-7
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol
419-750-9
98809-58-6
R53
R: 53
S: 61



604-079-00-8
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol
428-970-4
13595-25-0
Repr. Cat.3; R62
R43
N; R51-53
Xn; N
R: 43-62-51/53
S: (2-)22-36/37-61



604-080-00-3
4-fluoro-3-trifluoromethylphenol
432-560-0
61721-07-1
Xn; R20
C; R35
R43
N; R51-53
C; N
R: 20-35-43-51/53
S: (1/2-)26-28-36/37/39-45-61



604-081-00-9
1,1-bis(4-hydroxyphenyl)-1-phenylethane
433-130-5
1571-75-1
N; R50-53
N
R: 50/53
S: 25-60-61



604-082-00-4
2-chloro-6-fluoro-phenol
433-890-8
2040-90-6
Muta. Cat.2; R46
Repr. Cat.3; R62
Xn; R22
C; R34
R43
N; R51-53
T; N
R: 46-22-34-43-62-51/53
S: 53-45-61

E

604-083-00-X
4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol
439-270-3
260408-02-4
R53
R: 53
S: 61



604-084-00-5
1-ethoxy-2,3-difluorobenzene
441-000-4
121219-07-6
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)23-61



604-087-00-1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8
-
F; R17
R44
R53
F
R: 17-44-53
S: (2-)15-22-61



604-089-00-2
2-methyl-5-tert-butylthiophenol
444-970-7
-
R10
Repr. Cat.3; R63
Xn; R48/20/22-65
Xi; R36/38
R43
R67
N; R50-53
Xn; N
R: 10-36/38-43-48/20/22-63-65-67-50/53
S: (2-)26-36/37-62-60-61



605-001-00-5
formaldehyde … %
200-001-8
50-00-0
Carc. Cat. 3; R40
T; R23/24/25
C; R34
R43
T
R: 23/24/25-34-40-43
S: (1/2-)26-36/37/39-45-51
T; R23/24/25: C ≥25 %
Xn; R20/21/22: 5 % ≤ C < 25 %
C; R34: C ≥25 %
Xi; R36/37/38: 5 % ≤ C < 25 %
R43: C ≥ 0,2 %
B D
605-002-00-0
1,3,5-trioxan;
trioxymethylene
203-812-5
110-88-3
F; R11
Repr. Cat. 3; R63
Xi; R37
F; Xn
R: 11-37-63
S: (2-)36/37-46


605-003-00-6
acetaldehyde;
ethanal
200-836-8
75-07-0
F+; R12
Carc. Cat. 3; R40
Xi; R36/37
F+; Xn
R: 12-36/37-40
S: (2-)16-33-36/37




605-004-00-1
2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde
204-639-8
123-63-7
R10
R: 10
S: (2-)29



605-005-00-7
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde
203-600-2
108-62-3
F; R11
Xn; R22
F; Xn
R: 11-22
S: (2-)13-16-25-46



605-006-00-2
butyraldehyde
204-646-6
123-72-8
F; R11
F
R: 11
S: (2-)9-29-33


605-007-00-8
1,1-dimethoxyethane;
dimethyl acetal
208-589-8
534-15-6
F; R11
F
R: 11
S: (2-)9-16-33


605-008-00-3
acrylaldehyde;
acrolein;
prop-2-enal
203-453-4
107-02-8
F; R11
T+; R26
T; R24/25
C; R34
N; R50
F; T+; N
R: 11-24/25-26-34-50
S: 23-26-28-36/37/39-45-61

D
605-009-00-9
crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2]
224-030-0 [1]
204-647-1 [2]
4170-30-3 [1]
123-73-9 [2]
F; R11
Muta. Cat. 3; R68
T+; R26
T; R24/25
Xn; R48/22
Xi; R37/38-41
N; R50
F; T+; N
R: 11-24/25-26-37/38-41-48/22-50-68
S: (1/2-)26-28-36/37/39-45-61





605-010-00-4
2-furaldehyde
202-627-7
98-01-1
Carc. Cat. 3; R40
T; R23/25
Xn; R21
Xi; R36/37/38
T
R: 21-23/25-36/37/38-40
S: (1/2-)26-36/37-45



605-011-00-X
2-chlorobenzaldehyde;
o-chlorobenzaldehyde
201-956-3
89-98-5
C; R34
C
R: 34
S: (1/2-)26-45


605-012-00-5
benzaldehyde
202-860-4
100-52-7
Xn; R22
Xn
R: 22
S: (2-)24


605-013-00-0
chloralose (INN);
(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;
glucochloralose;
anhydroglucochloral
240-016-7
15879-93-3
Xn; R20/22
Xn
R: 20/22
S: (2-)16-24/25-28


605-014-00-6
chloral hydrate;
2,2,2-trichloroethane-1,1-diol
206-117-5
302-17-0
T; R25
Xi; R36/38
T
R: 25-36/38
S: (1/2-)25-45


605-015-00-1
1,1-diethoxyethane;
acetal
203-310-6
105-57-7
F; R11
Xi; R36/38
F; Xi
R: 11-36/38
S: (2-)9-16-33
Xi; R36/38: C ≥ 10 %

605-016-00-7
glyoxal … %;
ethandial … %
203-474-9
107-22-2
Muta. Cat. 3; R68
Xn; R20
Xi; R36/38
R43
Xn
R: 20-36/38-43-68
S: (2-)36/37
Xn; R20: C ≥ 10 %
Xi; R36/38: C ≥ 10 %
B
605-017-00-2
1,3-dioxolane
211-463-5
646-06-0
F; R11
F
R: 11
S: (2-)16


605-018-00-8
propanal;
propionaldehyde
204-623-0
123-38-6
F; R11
Xi; R36/37/38
F; Xi
R: 11-36/37/38
S: (2-)9-16-29


605-019-00-3
citral
226-394-6
5392-40-5
Xi; R38
R43
Xi
R: 38-43
S: (2-)24/25-37


605-020-00-9
safrole;
5-allyl-1,3-benzodioxole
202-345-4
94-59-7
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R22
T
R: 45-22-68
S: 53-45

E
605-021-00-4
formaldehyde, reaction products with butylphenol
294-145-9
91673-30-2
R43
Xi
R: 43
S: (2-)24-37


605-022-00-X
glutaral;
glutaraldehyde;
1,5-pentanedial
203-856-5
111-30-8
T; R23/25
C; R34
R42/43
N; R50
T; N
R: 23/25-34-42/43-50
S: (1/2-)26-36/37/39-45-61
T; R25: C ≥ 50 %
Xn; R22: 2 % ≤ C < 50 %
T; R23: C ≥ 25 %
Xn; R20: 2 % ≤ C < 25 %
C; R34: C ≥ 10 %
Xi; R37/38-41: 2 % ≤ C < 10 %
Xi; R36/37/38: 0,5 % ≤ C < 2 %
R43: C ≥ 0,5 %



605-023-00-5
5-chloro-2-(4-chlorophenoxy)phenol
429-290-0
3380-30-1
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61



605-024-00-0
2-bromo-5-hydroxy-4-methoxybenzaldehyde
426-540-0
2973-59-3
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



605-025-00-6
chloroacetaldehyde
203-472-8
107-20-0
Carc. Cat. 3; R40
T+; R26
T; R24/25
C; R34
N; R50
T+; N
R: 24/25-26-34-40-50
S: (1/2-)26-28-36/37/39-45-61


605-026-00-1
2,5,7,7-tetramethyloctanal
405-690-0
114119-97-0
Xi; R38
R43
N; R51-53
Xi; N
R: 38-43-51/53
S: (2-)24-37-61


605-027-00-7
reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


605-028-00-2
β-methyl-3-(1-methylethyl)-benzenepropanal
412-050-4
125109-85-5
N; R51-53
N
R: 51/53
S: 61


605-029-00-8
2-cyclohexylpropanal
412-270-0
2109-22-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


605-030-00-3
1-(p-methoxyphenyl)acetaldehyde oxime
411-510-1
3353-51-3
R43
Xi
R: 43
S: (2-)24-37


605-031-00-9
reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0
—
R43
Xi
R: 43
S: (2-)24-37





605-032-00-4
3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal
425-370-4
93957-50-7
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)22-24-37-60-61



605-033-00-X
reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal
425-910-9
32480-08-3
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37-60-61



605-034-00-5
reaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde
429-860-9
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



605-035-00-0
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal
426-330-9
177964-68-0
Xi; R36
R43
R53
Xi
R: 36-43-53
S: (2-)24-26-37-61



605-036-00-6
2-bromomalonaldehyde
430-470-6
2065-75-0
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39



605-037-00-1
trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1
120578-03-2
R53
R: 53
S: 22-61



605-038-00-7
3-methyl-5-phenylpentan-1-al
433-900-0
55066-49-4
Xn; R22
Xi; R38
R43
N; R51-53
Xn; N
R: 22-38-43-51/53
S: (2-)36/37-61



605-039-00-2
3,4-dihydroxy-5-nitrobenzaldehyde
441-810-8
116313-85-0
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)22-24-26-37/39




606-001-00-8
acetone;
propan-2-one;
propanone
200-662-2
67-64-1
F; R11
Xi; R36
R66
R67
F; Xi
R: 11-36-66-67
S: (2-)9-16-26


606-002-00-3
butanone;
ethyl methyl ketone
201-159-0
78-93-3
F; R11
Xi; R36
R66
R67
F; Xi
R: 11-36-66-67
S: (2-)9-16


606-003-00-9
heptan-3-one;
butyl ethyl ketone
203-388-1
106-35-4
R10
Xn; R20
Xi; R36
Xn
R: 10-20-36
S: (2-)24


606-004-00-4
4-methylpentan-2-one;
isobutyl methyl ketone
203-550-1
108-10-1
F; R11
Xn; R20
Xi; R36/37
R66
F; Xn
R: 11-20-36/37-66
S: (2-)9-16-29


606-005-00-X
2,6-dimethylheptan-4-one;
di-isobutyl ketone
203-620-1
108-83-8
R10
Xi; R37
Xi
R: 10-37
S: (2-)24
Xi; R37: C ≥ 10 %

606-006-00-5
pentan-3-one;
diethyl ketone
202-490-3
96-22-0
F; R11
Xi; R37
R66
R67
F; Xi
R: 11-37-66-67
S: (2-)9-16-25-33


606-007-00-0
3-methylbutan-2-one;
methyl isopropyl ketone
209-264-3
563-80-4
F; R11
F
R: 11
S: (2-)9-16-33


606-009-00-1
4-methylpent-3-en-2-one;
mesityl oxide
205-502-5
141-79-7
R10
Xn; R20/21/22
Xn
R: 10-20/21/22
S: (2-)25
Xn; R20/21/22: C ≥ 5 %

606-010-00-7
cyclohexanone
203-631-1
108-94-1
R10
Xn; R20
Xn
R: 10-20
S: (2-)25


606-011-00-2
2-methylcyclohexanone
209-513-6
583-60-8
R10
Xn; R20
Xn
R: 10-20
S: (2-)25


606-012-00-8
3,5,5-trimethylcyclohex-2-enone;
isophorone
201-126-0
78-59-1
Carc. Cat. 3; R40
Xn; R21/22
Xi; R36/37
Xn
R: 21/22-36/37-40
S: (2-)13-23-36/37/39-46
Xi; R36/37: C ≥ 10 %



606-013-00-3
p-benzoquinone;
quinone
203-405-2
106-51-4
T; R23/25
Xi; R36/37/38
N; R50
T; N
R: 23/25-36/37/38-50
S: (1/2-)26-28-45-61
N; R50: C ≥ 2,5 %


606-014-00-9
chlorophacinone (ISO);
2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione
223-003-0
3691-35-8
T+; R27/28
T; R23-48/24/25
N; R50-53
T+; N
R: 23-27/28-48/24/25-50/53
S: (1/2-)36/37-45-60-61


606-016-00-X
pindone (ISO);
2-pivaloylindan-1,3-dione
201-462-8
83-26-1
T; R25-48/25
N; R50-53
T; N
R: 25-48/25-50/53
S: (1/2-)37-45-60-61


606-017-00-5
diketene;
diketen
211-617-1
674-82-8
R10
Xn; R20
Xn
R: 10-20
S: (2-)3

D
606-018-00-0
dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone
204-210-5
117-80-6
Xn; R22
Xi; R36/38
N; R50-53
Xn; N
R: 22-36/38-50/53
S: (2-)26-60-61


606-019-00-6
chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3
143-50-0
Carc. Cat. 3; R40
T; R24/25
N; R50-53
T; N
R: 24/25-40-50/53
S: (1/2-)22-36/37-45-60-61


606-020-00-1
5-methylheptan-3-one
208-793-7
541-85-5
R10
Xi; R36/37
Xi
R: 10-36/37
S: (2-)23
Xi; R36/37: C ≥ 10 %



606-021-00-7
N-methyl-2-pyrrolidone;
1-methyl-2-pyrrolidone
212-828-1
872-50-4
Repr. Cat. 2; R61
Xi; R36/37/38
T
R: 61-36/37/38
S: 53-45
Repr. Cat. 2; R61: C ≥ 5 %
Xi; R36/37/38: C ≥ 10 %


606-022-00-2
1-phenyl-3-pyrazolidone
202-155-1
92-43-3
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


606-023-00-8
4-methoxy-4-methylpentan-2-one
203-512-4
107-70-0
R10
Xn; R20
Xn
R: 10-20
S: (2-)23-24/25


606-024-00-3
heptan-2-one;
methyl amyl ketone
203-767-1
110-43-0
R10
Xn; R20/22
Xn
R: 10-20/22
S: (2-)24/25


606-025-00-9
cyclopentanone
204-435-9
120-92-3
R10
Xi; R36/38
Xi
R: 10-36/38
S: (2-)23


606-026-00-4
5-methylhexan-2-one;
isoamyl methyl ketone
203-737-8
110-12-3
R10
Xn; R20
Xn
R: 10-20
S: (2-)23-24/25


606-027-00-X
heptan-4-one;
di-n-propyl ketone
204-608-9
123-19-3
R10
Xn; R20
Xn
R: 10-20
S: (2-)24/25


606-028-00-5
2,4-dimethylpentan-3-one;
di-isopropyl ketone
209-294-7
565-80-0
F; R11
Xn; R20
F; Xn
R: 11-20
S: (2-)9-16-24/25


606-029-00-0
pentane-2,4-dione;
acetylacetone
204-634-0
123-54-6
R10
Xn; R22
Xn
R: 10-22
S: (2-)21-23-24/25


606-030-00-6
hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone
209-731-1
591-78-6
R10
Repr. Cat. 3; R62
T; R48/23
R67
T
R: 10-48/23-62-67
S: (1/2-)36/37-45


606-031-00-1
3-propanolide;
1,3-propiolactone
200-340-1
57-57-8
Carc. Cat. 2; R45
T+; R26
Xi; R36/38
T+
R: 45-26-36/38
S: 53-45

E
606-032-00-7
hexachloroacetone
204-129-5
116-16-5
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)24/25-61


606-033-00-2
2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole
243-761-6
20354-26-1
Xn; R21/22
Xi; R36/38
N; R51-53
Xn; N
R: 21/22-36/38-51/53
S: (2-)36/37-61




606-034-00-8
metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-7
21087-64-9
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


606-035-00-3
chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon
216-920-2
1698-60-8
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


606-036-00-9
quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-3
2439-01-2
Repr. Cat. 3; R62
Xn; R20/21/22-48/22
Xi; R36
R43
N; R50-53
Xn; N
R: 20/21/22-36-43-48/22-50/53-62
S: (2-)24-37-60-61


606-037-00-4
triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-8
43121-43-3
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61


606-038-00-X
diphacinone (ISO);
2-diphenylacetylindan-1,3-dione
201-434-5
82-66-6
T+; R28
T; R48/23/24/25
T+
R: 28-48/23/24/25
S: (1/2-)36/37-45


606-039-00-5
5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one
400-680-2
—
Xn; R20
N; R50-53
Xn; N
R: 20-50/53
S: (2-)60-61


606-040-00-0
(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride
401-840-4
55845-90-4
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


606-041-00-6
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one
400-600-6
71868-10-5
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-61


606-042-00-1
acetophenone
202-708-7
98-86-2
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)26


606-043-00-7
2,4-di-tert-butylcyclohexanone
405-340-7
13019-04-0
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


606-044-00-2
2,4,6-trimethylbenzophenone
403-150-9
954-16-5
Xn; R22
Xi; R36
N; R50-53
Xn; N
R: 22-36-50/53
S: (2-)26-60-61


606-045-00-8
oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-7
19666-30-9
N; R50-53
N
R: 50/53
S: 60-61


606-046-00-3
reaction mass of cis- and trans-cyclohexadec-8-en-1-one
401-700-2
3100-36-5
N; R50-53
N
R: 50/53
S: 60-61


606-047-00-9
2-benzyl-2-dimethylamino-4-morpholinobutyrophenone
404-360-3
119313-12-1
N; R50-53
N
R: 50/53
S: 60-61


606-048-00-4
2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one
406-480-1
—
R53
R: 53
S: 61


606-049-00-X
4-(trans-4-propylcyclohexyl)acetophenone
406-700-6
78531-61-0
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


606-050-00-5
6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione
412-480-2
72453-58-8
N; R51-53
N
R: 51/53
S: 61


606-051-00-0
4-pentylcyclohexanone
406-670-4
61203-83-6
N; R51-53
N
R: 51/53
S: 61


606-052-00-6
4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone
410-410-5
54574-82-2
R52-53
R: 52/53
S: 61


606-053-00-1
flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one
—
96525-23-4
N; R50-53
N
R: 50/53
S: 60-61


606-054-00-7
isoxaflutole (ISO);
5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone
—
141112-29-0
Repr. Cat. 3; R63
N; R50-53
Xn; N
R: 50/53-63
S: (2-)36/37-60-61


606-055-00-2
1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone
411-180-9
92836-10-7
Xn; R22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)24-36-61


606-056-00-8
4-chloro-3',4'-dimethoxybenzophenone
404-610-1
116412-83-0
N; R50-53
N
R: 50/53
S: 60-61


606-057-00-3
4-propylcyclohexanone
406-810-4
40649-36-3
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)25-37-61


606-058-00-9
4'-fluoro-2,2-dimethoxyacetophenone
407-500-1
21983-80-2
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


606-059-00-4
2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride
412-390-3
86386-75-6
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)22-26-36/37/39


606-060-00-X
reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7
—
N; R50-53
N
R: 50/53
S: 60-61


606-061-00-5
(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone
423-290-4
66938-41-8
Muta. Cat. 3; R68
N; R50-53
Xn; N
R: 68-50/53
S: (2-)22-36/37-60-61


606-062-00-0
tetrahydrothiopyran-3-carboxaldehyde
407-330-8
61571-06-0
Repr. Cat. 2; R61
Xi; R41
R52-53
T
R: 61-41-52/53
S: 53-45-61


606-063-00-6
(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal
410-980-5
112704-51-5
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37


606-064-00-1
pregn-5-ene-3,20-dione bis(ethylene ketal)
407-450-0
7093-55-2
R53
R: 53
S: 61


606-065-00-7
1-(4-morpholinophenyl)butan-1-one
413-790-0
—
N; R51-53
N
R: 51/53
S: 61


606-066-00-2
(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone
410-440-9
164058-20-2
N; R51-53
N
R: 51/53
S: 61


606-067-00-8
reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-8
96792-67-5
N; R50-53
N
R: 50/53
S: 60-61


606-068-00-3
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al
415-770-7
1638-05-7
Xn; R48/22
R43
R52-53
Xn
R: 43-48/22-52/53
S: (2-)22-36/37-61


606-069-00-9
spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]
415-460-1
154171-76-3
N; R51-53
N
R: 51/53
S: 24-61


606-070-00-4
butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3
138164-12-2
Repr. Cat. 3; R62-63
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-62-63-50/53
S: (2-)22-36/37-60-61


606-071-00-X
17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one
421-050-3
13258-43-0
N; R50-53
N
R: 50/53
S: 22-60-61


606-072-00-5
3-acetyl-1-phenyl-pyrrolidine-2,4-dione
421-600-2
719-86-8
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)22-36/37-61


606-073-00-0
4,4'-bis(dimethylamino)benzophenone;
Michler's ketone
202-027-5
90-94-8
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xi; R41
T
R: 45-41-68
S: 53-45




606-074-00-6
reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene
425-570-1
-
N; R50-53
N
R: 50/53
S: 60-61



606-075-00-1
1-benzyl-5-ethoxyimidazolidine-2,4-dione
417-340-4
65855-02-9
Xn; R22
Xn
R: 22
S: (2-)22


606-076-00-7
1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione
418-630-3
136465-99-1
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39


606-077-00-2
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone
418-650-2
104872-06-2
N; R50-53
N
R: 50/53
S: 60-61


606-078-00-8
1-octylazepin-2-one
420-040-6
59227-88-2
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53
S: (1/2-)26-36/37/39-45-61


606-079-00-3
2-n-butyl-benzo[d]isothiazol-3-one
420-590-7
4299-07-4
C; R34
R43
N; R50-53
C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61



606-080-00-9
Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene
417-100-9
—
R53
R: 53
S: 61



606-081-00-4
(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one
419-790-7
4229-69-0
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-36/37-61


606-082-00-X
reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7

T; R48/25
R43
R52-53
T
R: 43-48/25-52/53
S: (1/2-)25-36/37-45-61


606-083-00-5
2-chloro-5-sec-hexadecylhydroquinone
407-750-1
137193-60-3
Xi; R36/38
R43
R52-53
Xi
R: 36/38-43-52/53
S: (2-)24-26-37-61


606-084-00-0
1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione
414-540-3
484-33-3
N; R50-53
N
R: 50/53
S: 60-61


606-085-00-6
(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one
418-530-1
79200-56-9
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)24-26-37/39


606-086-00-1
1-(3,3-dimethylcyclohexyl)pent-4-en-1-one
422-330-8
56973-87-6
N; R51-53
N
R: 51/53
S: 61


606-087-00-7
6-ethyl-5-fluoro-4(3H)-pyrimidone
422-460-5
137234-87-8
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


606-088-00-2
2,4,4,7-tetramethyl-6-octen-3-one
422-520-0
74338-72-0
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


606-089-00-8
reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-2
12223-77-7
R53
R: 53
S: 61




606-090-00-3
1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone
430-920-1
73096-98-7
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61



606-091-00-9
6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one
421-320-0
118289-55-7
N; R50-53
N
R: 50/53
S: 60-61


606-092-00-4
reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3

N; R50-53
N
R: 50/53
S: 60-61




606-093-00-X
5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one
414-470-3
95885-13-5
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-36-61



606-094-00-5
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one
417-460-7
-
R53
R: 53
S: 61



606-095-00-0
(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one
421-830-3
49805-30-3
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37



606-096-00-6
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
424-170-4
130603-71-3
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



606-097-00-1
2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone
424-210-0
23911-85-5
R53
R: 53
S: 61



606-098-00-7
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione
431-220-9
158574-65-3
R53
R: 53
S: 61



606-099-00-2
5-methoxy-4'-(trifluoromethyl)valerophenone
425-000-1
61718-80-7
N; R51-53
N
R: 51/53
S: 61



606-100-00-6
2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one
425-150-8
94723-86-1
Repr. Cat.2; R60
Xn; R22
R43
R52-53
T
R: 60-22-43-52/53
S: 53-45-61

E

606-101-00-1
reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione
426-050-7
165038-51-7
N; R50-53
N
R: 50/53
S: 60-61



606-102-00-7
4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone
431-490-8
79876-59-8
N; R51-53
N
R: 51/53
S: 61



606-103-00-2
1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone
426-460-6
-
R43
Xi
R: 43
S: (2-)24-37



606-104-00-8
1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone
426-830-7
78531-59-6
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



606-105-00-3
3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione
431-500-0
226065-73-2
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61



606-106-00-9
1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone
427-320-7
83626-30-6
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



606-107-00-4
8-azaspiro[4.5]decane-7,9-dione
427-770-4
1075-89-4
T; R25
N; R51-53
T; N
R: 25-51/53
S: (1/2-)22-36-45-61



606-108-00-X
1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone
436-710-6
756-13-8
R52-53
R: 52/53
S: 61



606-109-00-5
2-(4-methyl-3-pentenyl)anthraquinone
428-320-1
71308-16-2
Xn; R22
R43
R53
Xn
R: 22-43-53
S: (2-)22-24-37-61



606-110-00-0
5-ethoxy-5H-furan-2-one
428-330-4
2833-30-9
C; R34
Xn; R21/22-48/22
R43
C
R: 21/22-34-43-48/22
S: (1/2-)23-26-36/37/39-45



606-111-00-6
5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one
428-410-9
67014-36-2
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61



606-112-00-1
(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
428-690-2
1668-86-6
Xn; R22
Xi; R36
R52-53
Xn
R: 22-36-52/53
S: (2-)22-26-61



606-113-00-7
1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one
429-040-0
272460-97-6
Xi; R41
R53
Xi
R: 41-53
S: (2-)26-39-61



606-114-00-2
4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone
429-150-9
67887-47-2
R53
R: 53
S: 61



606-115-00-8
profoxydim (ISO);
2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{]butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
-
139001-49-3
Carc. Cat. 3; R40
Repr. Cat. 3; R63
R43
Xn
R: 40-43-63
S: (2-)36/37-46



606-116-00-3
tepraloxydim (ISO);
(RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one
-
149979-41-9
Carc. Cat. 3; R40
Repr. Cat. 3; R62-63
Xn
R: 40-62-63
S: (2-)36/37-46



606-117-00-9
2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one
429-460-4
7078-98-0
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



606-118-00-4
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine
429-640-2
52870-46-9
Xi; R36
N; R50-53
Xi; N
R: 36-50/53
S: (2-)26-60-61



606-119-00-X
(E)-3-methyl-5-cyclopentadecen-1-one
429-900-5
-
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61



606-120-00-5
2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one
430-170-5
114625-74-0
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)46-61



606-121-00-0
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)
430-460-1
133636-82-5
C; R34
R43
N; R50-53
C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-57-60-61



606-122-00-6
3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one
430-820-8
114341-88-7
Xn; R22-48/22
Xi; R38-41
R43
N; R50-53
Xn; N
R: 22-38-41-43-48/22-50/53
S: (2-)26-36/37/39-60-61



606-123-00-1
4-hexadecyl-1-phenylpyrazolidin-3-one
430-840-7
-
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



606-124-00-7
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione
421-080-7
161462-35-7
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)36-60-61



606-125-00-2
1-benzylimidazolidine-2,4-dione
421-340-1
6777-05-5
Xn; R22
Xn
R: 22
S: (2-)22



606-126-00-8
1,4-bis(2,3-dihydroxypropylamino)anthraquinone
421-470-7
99788-75-7
N; R51-53
N
R: 51/53
S: 61



606-128-00-9
2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione
422-650-8
148935-94-8
R53
R: 53
S: 61



606-129-00-4
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7
156732-13-7
R53
R: 53
S: 61



606-130-00-X
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone
423-860-2
56309-94-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



606-131-00-5
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
427-230-8
5571-36-8
Repr. Cat. 2; R60
Xn; R48/22
N; R51-53
T; N
R: 60-48/22-51/53
S: 53-45-61

E

606-132-00-0
(6β)-6,19-epoxyandrost-4-ene-3,17-dione
433-490-3
6563-83-3
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



606-134-00-1
androsta-1,4,9(11)-triene-3,17-dione
433-560-3
15375-21-0
Repr. Cat.3; R62
Xn
R: 62
S: (2-)22-36/37



606-135-00-7
cyclohexadecanone
438-930-8
2550-52-9
R53
R: 53
S: 61



606-136-00-2
(3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
444-350-6
133413-70-4
Xi; R36
R53
Xi
R: 36-53
S: (2-)26-61



606-137-00-8
trans-7,7'-dimethyl-(4H, 4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione
444-750-0
211387-26-7
R53
R: 53
S: 22-61



606-138-00-3
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone
444-800-1
141645-23-0
R10
Xn; R22-48/22
Xi; R38-41
R43
N; R50-53
Xn; N
R: 10-22-38-41-43-48/22-50/53
S: (2-)23-26-36/37/39-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %3


606-139-00-9
(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
444-830-5
124379-29-9
R53
R: 53
S: 61



606-140-00-4
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one
444-860-9
474510-57-1
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61



606-141-00-X
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate
418-410-7
-
Xi; R36
Xi
R: 36
S: (2-)26



606-142-00-5
reaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9
-
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61



607-001-00-0
formic acid … %
200-579-1
64-18-6
C; R35
C
R: 35
S: (1/2-)23-26-45
C; R35: C ≥ 90 %
C; R34: 10 % ≤ C < 90 %
Xi; R36/38: 2 % ≤ C < 10 %
B
607-002-00-6
acetic acid … %
200-580-7
64-19-7
R10
C; R35
C
R: 10-35
S: (1/2-)23-26-45
C; R35: C ≥ 90 %
C; R34: 25 % ≤ C < 90 %
Xi; R36/38: 10 % ≤ C < 25 %
B


607-003-00-1
chloroacetic acid
201-178-4
79-11-8
T; R23/24/25
C; R34
N; R50
T; N
R: 23/24/25-34-50
S: (1/2-)26-36/37/39-45-61-63
C; R34: C ≥ 10 %
Xn; 36/37/38: 5 % ≤ C < 10 %


607-004-00-7
TCA (ISO);
trichloroacetic acid
200-927-2
76-03-9
C; R35
N; R50-53
C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

607-005-00-2
TCA-sodium (ISO);
sodium trichloroacetate
211-479-2
650-51-1
Xi; R37
N; R50-53
Xi; N
R: 37-50/53
S: (2-)46-60-61


607-006-00-8
oxalic acid
205-634-3
144-62-7
Xn; R21/22
Xn
R: 21/22
S: (2-)24/25
Xn; R21/22: C ≥ 5 %



607-007-00-3
salts of oxalic acid with the exception of those specified elsewhere in this Annex
—
—
Xn; R21/22
Xn
R: 21/22
S: (2-)24/25
Xn; R21/22: C ≥ 5 %
A

607-008-00-9
acetic anhydride
203-564-8
108-24-7
R10
Xn; R20/22
C; R34
C
R: 10-20/22-34
S: (1/2-)26-36/37/39-45
C; R34: C ≥ 25 %
Xi; R37/38-41: 5 % ≤ C < 25 %
Xi; R36: 1 % ≤ C < 5 %

607-009-00-4
phthalic anhydride
201-607-5
85-44-9
Xn; R22
Xi; R37/38-41
R42/43
Xn
R: 22-37/38-41-42/43
S: (2-)23-24/25-26-37/39-46


607-010-00-X
propionic anhydride
204-638-2
123-62-6
C; R34
C
R: 34
S: (1/2-)26-45
C; R34: C ≥ 25 %
Xi; R36/38: 10 % ≤ C < 25 %

607-011-00-5
acetyl chloride
200-865-6
75-36-5
F; R11
R14
C; R34
F; C
R: 11-14-34
S: (1/2-)9-16-26-45




607-012-00-0
benzoyl chloride
202-710-8
98-88-4
Xn; R20/21/22
C; R34
R43
C
R: 20/21/22-34-43
S: (1/2-)26-36/37/39-45



607-013-00-6
dimethyl carbonate
210-478-4
616-38-6
F; R11
F
R: 11
S: (2-)9-16


607-014-00-1
methyl formate
203-481-7
107-31-3
F+; R12
Xn; R20/22
Xi; R36/37
F+; Xn
R: 12-20/22-36/37
S: (2-)9-16-24-26-33


607-015-00-7
ethyl formate
203-721-0
109-94-4
F; R11
Xn; R20/22
Xi; R36/37
F; Xn
R: 11-20/22-36/37
S: (2-)9-16-24-26-33


607-016-00-2
propyl formate; [1]
isopropyl formate [2]
203-798-0 [1]
210-901-2 [2]
110-74-7 [1]
625-55-8 [2]
F; R11
Xi; R36/37
R67
F; Xi
R: 11-36/37-67
S: (2-)9-16-24-33

C
607-017-00-8
butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3]
209-772-5 [1]
212-105-0 [2]
208-818-1 [3]
592-84-7 [1]
762-75-4 [2]
542-55-2 [3]
F; R11
Xi; R36/37
F; Xi
R: 11-36/37
S: (2-)9-16-24-33

C
607-018-00-3
isopentyl formate; [1]
pentyl formate; [2]
2-methylbutyl formate [3]
203-769-2 [1]
211-340-6 [2]
252-343-2 [3]
110-45-2 [1]
638-49-3 [2]
35073-27-9 [3]
R10
Xi; R36/37
Xi
R: 10-36/37
S: (2-)24

C
607-019-00-9
methyl chloroformate
201-187-3
79-22-1
F; R11
T+; R26
Xn; R21/22
C; R34
F; T+
R: 11-21/22-26-34
S: (1/2-)14-26-28-36/37/39-45-46-63


607-020-00-4
ethyl chloroformate
208-778-5
541-41-3
F; R11
T+; R26
Xn; R22
C; R34
F; T+
R: 11-22-26-34
S: (1/2-)9-16-26-28-33-36/37/39-45


607-021-00-X
methyl acetate
201-185-2
79-20-9
F; R11
Xi; R36
R66
R67
F; Xi
R: 11-36-66-67
S: (2-)16-26-29-33


607-022-00-5
ethyl acetate
205-500-4
141-78-6
F; R11
Xi; R36
R66
R67
F; Xi
R: 11-36-66-67
S: (2-)16-26-33


607-023-00-0
vinyl acetate
203-545-4
108-05-4
F; R11
F
R: 11
S: (2-)16-23-29-33

D
607-024-00-6
propyl acetate; [1]
isopropyl acetate [2]
203-686-1 [1]
203-561-1 [2]
109-60-4 [1]
108-21-4 [2]
F; R11
Xi; R36
R66
R67
F; Xi
R: 11-36-66-67
S: (2-)16-26-29-33

C
607-025-00-1
n-butyl acetate
204-658-1
123-86-4
R10
R66
R67
R: 10-66-67
S: (2-)25


607-026-00-7
sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3]
203-300-1 [1]
203-745-1 [2]
208-760-7 [3]
105-46-4 [1]
110-19-0 [2]
540-88-5 [3]
F; R11
R66
F
R: 11-66
S: (2-)16-23-25-29-33

C
607-027-00-2
methyl propionate
209-060-4
554-12-1
F; R11
Xn; R20
F; Xn
R: 11-20
S: (2-)16-24-29-33


607-028-00-8
ethyl propionate
203-291-4
105-37-3
F; R11
F
R: 11
S: (2-)16-23-24-29-33


607-029-00-3
n-butyl propionate; [1]
sec-butyl propionate; [2]
tert-butyl propionate; [3]
iso-butyl propionate [4]
209-669-5 [1]
- [2]
- [3]
208-746-0 [4]
590-01-2 [1]
591-34-4 [2]
20487-40-5 [3]
540-42-1 [4]
R10
R: 10
S: (2-)

C
607-030-00-9
propyl propionate
203-389-7
106-36-5
R10
Xn; R20
Xn
R: 10-20
S: (2-)24


607-031-00-4
butyl butyrate
203-656-8
109-21-7
R10
R: 10
S: (2-)

C
607-032-00-X
ethyl acrylate
205-438-8
140-88-5
F; R11
Xn; R20/21/22
Xi; R36/37/38
R43
F; Xn
R: 11-20/21/22-36/37/38-43
S: (2-)9-16-33-36/37
Xi; 36/37/38: C ≥ 5 %
D
607-033-00-5
n-butyl methacrylate
202-615-1
97-88-1
R10
Xi; R36/37/38
R43
Xi
R: 10-36/37/38-43
S: (2-)

D
607-034-00-0
methyl acrylate;
methyl propenoate
202-500-6
96-33-3
F; R11
Xn; R20/21/22
Xi; R36/37/38
R43
F; Xn
R: 11-20/21/22-36/37/38-43
S: (2-)9-25-26-33-36/37-43

D
607-035-00-6
methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate
201-297-1
80-62-6
F; R11
Xi; R37/38
R43
F; Xi
R: 11-37/38-43
S: (2-)24-37-46

D
607-036-00-1
2-methoxyethyl acetate;
methylglycol acetate
203-772-9
110-49-6
Repr. Cat. 2; R60-61
Xn; R20/21/22
T
R: 60-61-20/21/22
S: 53-45

E



607-037-00-7
2-ethoxyethyl acetate;
ethylglycol acetate
203-839-2
111-15-9
R10
Repr. Cat. 2; R60-61
Xn; R20/21/22
T
R: 60-61-10-20/21/22
S: 53-45

E

607-038-00-2
2-butoxyethyl acetate;
butylglycol acetate
203-933-3
112-07-2
Xn; R20/21
Xn
R: 20/21
S: (2-)24


607-039-00-8
2,4-D (ISO);
2,4-dichlorophenoxyacetic acid
202-361-1
94-75-7
Xn; R22
Xi; R37-41
R43
R52-53
Xn
R: 22-37-41-43-52/53
S: (2-)24/25-26-36/37/39-46-61


607-040-00-3
salts of 2,4-D
—
—
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24/25-26-36/37/39-46-61

A
607-041-00-9
2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid
202-273-3
93-76-5
Xn; R22
Xi; R36/37/38
N; R50-53
Xn; N
R: 22-36/37/38-50/53
S: (2-)24-60-61


607-042-00-4
salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid
—
—
Xn; R22
Xi; R36/37/38
N; R50-53
Xn; N
R: 22-36/37/38-50/53
S: (2-)24-60-61

A
607-043-00-X
dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid
217-635-6
1918-00-9
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)26-61


607-044-00-5
3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]
233-002-7 [2]
2300-66-5 [1]
10007-85-9 [2]
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61


607-045-00-0
dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid
204-390-5
120-36-5
Xn; R21/22
Xi; R38-41
Xn
R: 21/22-38-41
S: (2-)26-36/37


607-046-00-6
salts of dichlorprop
—
—
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)13

A
607-047-00-1
fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid
202-271-2
93-72-1
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-50/53
S: (2-)37-60-61


607-048-00-7
salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid
—
—
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61

A
607-049-00-2
mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]
202-264-4 [2]
7085-19-0 [1]
7085-19-0 [2]
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-50/53
S: (2-)13-26-37/39-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

607-050-00-8
salts of mecoprop
—
—
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-50/53
S: (2-)13-26-37/39-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
A


607-051-00-3
MCPA (ISO);
4-chloro-o-tolyloxyacetic acid
202-360-6
94-74-6
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-50/53
S: (2-)26-37-39-60-61



607-052-00-9
salts and esters of MCPA
—
—
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61

A

607-053-00-4
MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid
202-365-3
94-81-5
N; R50-53
N
R: 50/53
S: 60-61


607-054-00-X
salts and esters of MCPB
—
—
Xn; R22
Xn
R: 22
S: (2-)24/25

A
607-055-00-5
endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8
129-67-9
T; R25
Xn; R21
Xi; R36/37/38
T
R: 21-25-36/37/38
S: (1/2-)36/37/39-45


607-056-00-0
warfarin (ISO); [1]
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]
Repr. Cat. 1; R61
T; R48/25
R52-53
T
R: 61-48/25-52/53
S: 53-45-61

E
607-057-00-6
coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-1
81-82-3
Xn; R48/22
R52-53
Xn
R: 48/22-52/53
S: (2-)37-61


607-058-00-1
coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin
204-195-5
117-52-2
T; R25-48/25
R52-53
T
R: 25-48/25-52/53
S: (1/2-)37-45-61


607-059-00-7
coumatetralyl;
4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
227-424-0
5836-29-3
T+; R27/28
T; R48/24/25
R52-53
T+
R: 27/28-48/24/25-52/53
S: (1/2-)28-36/37-45-61


607-060-00-2
dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-9
66-76-2
T; R48/25
Xn; R22
N; R51-53
T; N
R: 22-48/25-51/53
S: (1/2-)37-45-61


607-061-00-8
acrylic acid;
prop-2-enoic acid
201-177-9
79-10-7
R10
Xn; R20/21/22
C; R35
N; R50
C; N
R: 10-20/21/22-35-50
S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
D
607-062-00-3
n-butyl acrylate
205-480-7
141-32-2
R10
Xi; R36/37/38
R43
Xi
R: 10-36/37/38-43
S: (2-)9

D
607-063-00-9
isobutyric acid
201-195-7
79-31-2
Xn; R21/22
Xn
R: 21/22
S: (2-)


607-064-00-4
benzyl chloroformate
207-925-0
501-53-1
C; R34
N; R50-53
C; N
R: 34-50/53
S: (1/2-)26-45-60-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %



607-065-00-X
bromoacetic acid
201-175-8
79-08-3
T; R23/24/25
C; R35
R43
N; R50
T; C; N
R: 23/24/25-35-43-50
S: (1/2-)26-36/37/39-45-61



607-066-00-5
dichloroacetic acid
201-207-0
79-43-6
C; R35
N; R50
C; N
R: 35-50
S: (1/2-)26-45-61


607-067-00-0
dichloroacetyl chloride
201-199-9
79-36-7
C; R35
N; R50
C; N
R: 35-50
S: (1/2-)9-26-45-61


607-068-00-6
iodoacetic acid
200-590-1
64-69-7
T; R25
C; R35
T; C
R: 25-35
S: (1/2-)22-36/37/39-45


607-069-00-1
ethyl bromoacetate
203-290-9
105-36-2
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)7/9-26-45


607-070-00-7
ethyl chloroacetate
203-294-0
105-39-5
T; R23/24/25
N; R50
T; N
R: 23/24/25-50
S: (1/2-)7/9-45-61


607-071-00-2
ethyl methacrylate
202-597-5
97-63-2
F; R11
Xi; R36/37/38
R43
F; Xi
R: 11-36/37/38-43
S: (2-)9-16-29-33

D
607-072-00-8
2-hydroxyethyl acrylate
212-454-9
818-61-1
T; R24
C; R34
R43
N; R50
T; N
R: 24-34-43-50
S: (1/2-)26-36/39-45-61
T; R24: C ≥ 2 %
Xn; R21: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 %
D
607-073-00-3
4-CPA (ISO);
4-chlorophenoxyacetic acid
204-581-3
122-88-3
Xn; R22
Xn
R: 22
S: (2-)


607-074-00-9
chlorfenac (ISO);
2,3,6-trichlorophenylacetic acid
201-599-3
85-34-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)36-61


607-075-00-4
chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-5
14437-17-3
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


607-076-00-X
dodine (ISO);
dodecylguanidinium acetate
219-459-5
2439-10-3
Xn; R22
Xi; R36/38
N; R50-53
Xn; N
R: 22-36/38-50/53
S: (2-)26-60-61


607-077-00-5
erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate
—
136-25-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


607-078-00-0
fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate
—
4301-50-2
T+; R27/28
T+
R: 27/28
S: (1/2-)28-36/
37-45


607-079-00-6
kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
—
4234-79-1
T; R24
Xn; R22
N; R51-53
T; N
R: 22-24-51/53
S: (1/2-)36/37-45-61


607-080-00-1
chloroacetyl chloride
201-171-6
79-04-9
R14
R29
T; R23/24/25-48/23
C; R35
N; R50
T; C; N
R: 14-23/24/25-29-35-48/23-50
S: (1/2-)7/8-9-26-36/37/39-45-61


607-081-00-7
fluoroacetic acid
205-631-7
144-49-0
T+; R28
N; R50
T+; N
R: 28-50
S: (1/2-)20-22-26-45-61


607-082-00-2
fluoroacetates, soluble
—
—
T+; R28
N; R50
T+; N
R: 28-50
S: (1/2-)20-22-26-45-61

A
607-083-00-8
2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid
202-366-9
94-82-6
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)25-29-46-61


607-084-00-3
salts of 2,4-DB
—
—
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)26-29-39-46-61

A


607-085-00-9
benzyl benzoate
204-402-9
120-51-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)25-46-61




607-086-00-4
diallyl phthalate
205-016-3
131-17-9
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24/25-60-61


607-088-00-5
methacrylic acid;
2-methylpropenoic acid
201-204-4
79-41-4
Xn; R21/22
C; R35
C
R: 21/22-35
S: (1/2-)26-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
D
607-089-00-0
propionic acid … %
201-176-3
79-09-4
C; R34
C
R: 34
S: (1/2-)23-36-45
C; R34: C ≥ 25 %
Xi; R36/37/38: 10 % ≤ C < 25 %
B
607-090-00-6
thioglycolic acid
200-677-4
68-11-1
T; R23/24/25
C; R34
T
R: 23/24/25-34
S: (1/2-)25-27-28-45
T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 %

607-091-00-1
trifluoroacetic acid . . . %
200-929-3
76-05-1
Xn; R20
C; R35
R52-53
C
R: 20-35-52/53
S: (1/2-)9-26-27-28-45-61
Xn; R20: C ≥ 10 %
B
607-092-00-7
methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4]
208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4]
547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]
R10
Xi; R36/37
Xi
R: 10-36/37
S: (2-)24

C
607-093-00-2
propionyl chloride
201-170-0
79-03-8
F; R11
R14
C; R34
F; C
R: 11-14-34
S: (1/2-)9-16-26-45

B D
607-094-00-8
peracetic acid . . . %
201-186-8
79-21-0
R10
O; R7
Xn; R20/21/22
C; R35
N; R50
O; C; N
R: 7-10-20/21/22-35-50
S: (1/2-)3/7-14-36/37/39-45-61
Xn; R20/21/22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %
B D



607-095-00-3
maleic acid
203-742-5
110-16-7
Xn; R22
Xi; R36/37/38
R43
Xn
R: 22-36/37/38-43
S: (2-)24-26-28-37-46
R43: C ≥ 0,1 %


607-096-00-9
maleic anhydride
203-571-6
108-31-6
Xn; R22
C; R34
R42/43
C
R: 22-34-42/43
S: (2-)22-26-36/37/39-45


607-097-00-4
benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride
209-008-0
552-30-7
Xi; R37-41
R42/43
Xn
R: 37-41-42/43
S: (2-)22-26-36/37/39


607-098-00-X
benzene-1,2:4,5-tetracarboxylic dianhydride;
benzene-1,2:4,5-tetracarboxylic dianhydride;
pyromellitic dianhydride
201-898-9
89-32-7
Xi; R41
R42/43
Xn
R: 41-42/43
S: (2-)22-24-26-37/39


607-099-00-5
1,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4]
201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4]
85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4]
Xi; R41
R42/43
R52-53
Xn
R: 41-42/43-52/53
S: (2-)22-24-26-37/39-61

C
607-100-00-9
benzophenone-3,3',4,4'-tetracarboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride)
219-348-1
2421-28-5
Xi; R36/37
Xi
R: 36/37
S: (2-)25
Xi; R36/37: C ≥ 1 %

607-101-00-4
1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride
204-077-3
115-27-5
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)25
Xi; R36/37/38: C ≥ 1 %

607-102-00-X
cyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicarboxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9 [1]
236-086-3 [2]
238-009-9 [3]
85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3]
Xi; R41
R42/43
Xn
R: 41-42/43
S: (2-)23-24-26-37/39

C



607-103-00-5
succinic anhydride
203-570-0
108-30-5
Xn; R22
Xi; R36/37
Xn
R: 22-36/37
S: (2-)25-46
Xn; R22: C ≥ 5 %
Xi; R36/37: C ≥ 1 %


607-104-00-0
cyclopentane-1,2,3,4-tetracarboxylic dianhydride
227-964-7
6053-68-5
Xi; R36/37
Xi
R: 36/37
S: (2-)25
Xi; R36/37: C ≥ 1 %

607-105-00-6
8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]
204-957-7 [1]
212-557-9 [2]
220-384-5 [3]
129-64-6 [1]
826-62-0 [2]
2746-19-2 [3]
Xi; R41
R42/43
Xn
R: 41-42/43
S: (2-)22-24-26-37/39

C
607-106-00-1
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride
—
123748-85-6
Xn; R22
Xi; R36/37/38
R42
Xn
R: 22-36/37/38-42
S: (2-)39
Xi; R36/37/38: C ≥ 10 %
C
607-107-00-7
2-ethylhexyl acrylate
203-080-7
103-11-7
Xi; R37/38
R43
Xi
R: 37/38-43
S: (2-)36/37-46

D
607-108-00-2
2-hydroxy-1-methylethylacrylate; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]
213-663-8 [2]
247-118-0 [3]
2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3]
T; R23/24/25
C; R34
R43
T
R: 23/24/25-34-43
S: (1/2-)26-36/37/39-45
T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 %
C D
607-109-00-8
hexamethylene diacrylate;
hexane-1,6-diol diacrylate
235-921-9
13048-33-4
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)39

D
607-110-00-3
pentaerythritol triacrylate
222-540-8
3524-68-3
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)39

D
607-111-00-9
2,2-bis(acryloyloxymethyl)butyl acrylate;
trimethylolpropane triacrylate
239-701-3
15625-89-5
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)39

D
607-112-00-4
2,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate
218-741-5
2223-82-7
T; R24
Xi; R36/38
R43
T
R: 24-36/38-43
S: (1/2-)28-39-45
T; R24: C ≥ 5 %
Xn; R21: 0,2 % ≤ C < 5 %
D
607-113-00-X
isobutyl methacrylate
202-613-0
97-86-9
R10
Xi; R36/37/38
R43
N; R50
Xi; N
R: 10-36/37/38-43-50
S: (2-)24-37-61

D
607-114-00-5
ethylene dimethacrylate
202-617-2
97-90-5
Xi; R37
R43
Xi
R: 37-43
S: (2-)24-37
Xi; R37: C ≥ 10 %
D
607-115-00-0
isobutyl acrylate
203-417-8
106-63-8
R10
Xn; R20/21
Xi; R38
R43
Xn
R: 10-20/21-38-43
S: (2-)9-24-37
Xi; R38: C ≥ 10 %
D
607-116-00-6
cyclohexyl acrylate
221-319-3
3066-71-5
Xi; R37/38
N; R51-53
Xi; N
R: 37/38-51/53
S: (2-)61
Xi; R37/38: C ≥ 10 %
D
607-117-00-1
2,3-epoxypropyl acrylate;
glycidyl acrylate
203-440-3
106-90-1
T; R23/24/25
C; R34
R43
T
R: 23/24/25-34-43
S: (1/2-)26-36/37/39-45
T; R23/24/25: C ≥ 2 %
Xn; R20/21/22: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 %
D
607-118-00-7
1-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate
243-105-9
19485-03-1
Xn; R21
C; R34
R43
C
R: 21-34-43
S: (1/2-)26-36/37/39-45

D
607-119-00-2
tetramethylene diacrylate;
1,4-butyleneglycol diacrylate
213-979-6
1070-70-8
Xn; R21
C; R34
R43
C
R: 21-34-43
S: (1/2-)26-36/37/39-45

D
607-120-00-8
2,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate
223-791-6
4074-88-8
T; R24
Xi; R36/38
R43
T
R: 24-36/38-43
S: (1/2-)28-39-45
T; R24: C ≥ 2 %
Xn; R21: 0,2 % ≤ C < 2 %
R43: C ≥ 0,2 %
D
607-121-00-3
8,9,10-trinorborn-2-yl acrylate
—
10027-06-2
Xn; R21
Xi; R38
R43
Xn
R: 21-38-43
S: (2-)28
Xi; R38: C ≥ 10 %
D
607-122-00-9
pentaerythritol tetraacrylate
225-644-1
4986-89-4
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)26-39

D
607-123-00-4
2,3-epoxypropyl methacrylate;
glycidyl methacrylate
203-441-9
106-91-2
Xn; R20/21/22
Xi; R36/38
R43
Xn
R: 20/21/22-36/38-43
S: (2-)26-28
Xi; R36/38: C ≥ 10 %
D
607-124-00-X
2-hydroxyethyl methacrylate
212-782-2
868-77-9
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)26-28

D
607-125-00-5
2-hydroxypropyl methacrylate; [1]
3-hydroxypropyl methacrylate [2]
213-090-3 [1]
220-426-2 [2]
923-26-2 [1]
2761-09-3 [2]
Xi; R36
R43
Xi
R: 36-43
S: (2-)24/25-26-37/39

C D
607-126-00-0
2,2'-(ethylenedioxy)diethyl diacrylate;
triethylene glycol diacrylate
216-853-9
1680-21-3
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)26-28

D
607-127-00-6
2-diethylaminoethyl methacrylate
203-275-7
105-16-8
Xn; R20
Xi; R36/38
R43
Xn
R: 20-36/38-43
S: (2-)26
Xi; R36/38: C ≥ 10 %
D
607-128-00-1
2-tert-butylaminoethyl methacrylate
223-228-4
3775-90-4
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)26

D
607-129-00-7
ethyl lactate;
ethyl DL-lactate; [1]
ethyl (S)-2-hydroxypropionate;
ethyl L-lactate;
ethyl-(S)-lactate [2]
202-598-0 [1]
211-694-1 [2]
97-64-3 [1]
687-47-8 [2]
R10
Xi; R37-41
Xi
R: 10-37-41
S: (2-)24-26-39

C
607-130-00-2
pentyl acetate; [1]
isopentyl acetate; [2]
1-methylbutyl acetate; [3]
2-methylbutyl acetat; [4]
2(or 3)-methylbutyl acetate [5]
211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5]
628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5]
R10
R66
R: 10-66
S: (2-)23-25

C
607-131-00-8
isopentyl propionate; [1]
pentyl propionate; [2]
2-methylbutyl propionate [3]
203-322-1 [1]
210-852-7 [2]
219-449-0 [3]
105-68-0 [1]
624-54-4 [2]
2438-20-2 [3]
R10
R: 10
S: (2-)23-24

C
607-132-00-3
2-dimethylaminoethyl methacrylate
220-688-8
2867-47-2
Xn; R21/22
Xi; R36/38
R43
Xn
R: 21/22-36/38-43
S: (2-)26-28
Xi; R36/38: C ≥ 10 %
D
607-133-00-9
monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex
—
—
Xi; R36/37/38
N; R51-53
Xi; N
R: 36/37/38-51/53
S: (2-)26-28-61
Xi; R36/37/38: C ≥ 10 %
A
607-134-00-4
monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex
—
—
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)26-28
Xi; R36/37/38: C ≥ 10 %
A
607-135-00-X
butyric acid
203-532-3
107-92-6
C; R34
C
R: 34
S: (1/2-)26-36-45


607-136-00-5
butyryl chloride
205-498-5
141-75-3
F; R11
C; R34
F; C
R: 11-34
S: (1/2-)16-23-26-36-45


607-137-00-0
methyl acetoacetate
203-299-8
105-45-3
Xi; R36
Xi
R: 36
S: (2-)26


607-138-00-6
butyl chloroformate;
chloroformic acid butyl ester
209-750-5
592-34-7
R10
T; R23
C; R34
T
R: 10-23-34
S: (1/2-)26-36-45


607-139-00-1
2-chloropropionic acid
209-952-3
598-78-7
Xn; R22
C; R35
C
R: 22-35
S: (1/2-)23-26-28-36-45


607-140-00-7
isobutyryl chloride
201-194-1
79-30-1
F; R11
C; R35
F; C
R: 11-35
S: (1/2-)16-23-26-36-45


607-141-00-2
oxydiethylene bis(chloroformate)
203-430-9
106-75-2
Xn; R22
Xi; R38-41
N; R51-53
Xn; N
R: 22-38-41-51/53
S: (2-)23-26-61




607-142-00-8
propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate
203-687-7
109-61-5
F; R11
T; R23
C; R34
F; T
R: 11-23-34
S: (1/2-)16-26-36-45



607-143-00-3
valeric acid
203-677-2
109-52-4
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)26-36-45-61


607-144-00-9
adipic acid
204-673-3
124-04-9
Xi; R36
Xi
R: 36
S: (2-)


607-145-00-4
methanesulphonic acid
200-898-6
75-75-2
C; R34
C
R: 34
S: (1/2-)26-36-45


607-146-00-X
fumaric acid
203-743-0
110-17-8
Xi; R36
Xi
R: 36
S: (2-)26


607-147-00-5
oxalic acid diethylester;
diethyl oxalate
202-464-1
95-92-1
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)23


607-148-00-0
guanidinium chloride;
guanadine hydrochloride
200-002-3
50-01-1
Xn; R22
Xi; R36/38
Xn
R: 22-36/38
S: (2-)22


607-149-00-6
urethane (INN);
ethyl carbamate
200-123-1
51-79-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45


607-150-00-1
endothal (ISO);
7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid
205-660-5
145-73-3
T; R25
Xn; R21
Xi; R36/37/38
T
R: 21-25-36/37/38
S: (1/2-)36/37/39-45


607-151-00-7
propargite (ISO);
2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite
219-006-1
2312-35-8
Carc. Cat. 3; R40
T; R23
Xi; R38-41
N; R50-53
T; N
R: 23-38-40-41-50/53
S: (1/2-)26-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

607-152-00-2
2,3,6-TBA (ISO);
2,3,6-trichlorobenzoic acid
200-026-4
50-31-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


607-153-00-8
benazolin (ISO);
4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid
223-297-0
3813-05-6
Xi; R36/38
R52-53
Xi
R: 36/38-52/53
S: (2-)22-61


607-154-00-3
ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;
benzoylprop-ethyl (ISO)
244-845-5
22212-55-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24-60-61


607-155-00-9
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;
blasticidin-s
—
2079-00-7
T+; R28
T+
R: 28
S: (1/2-)24/25-36/37-45


607-156-00-4
chlorfenson (ISO);
4-chlorophenyl 4-chlorobenzenesulfonate
201-270-4
80-33-1
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-50/53
S: (2-)37-60-61


607-157-00-X
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;
difenacoum
259-978-4
56073-07-5
T+; R28
T; R48/25
N; R50-53
T+; N
R: 28-48/25-50/53
S: (1/2-)36/37-45-60-61


607-158-00-5
sodium salt of chloroacetic acid;
sodium chloroacetate
223-498-3
3926-62-3
T; R25
Xi; R38
N; R50
T; N
R: 25-38-50
S: (1/2-)22-37-45-61


607-159-00-0
chlorobenzilate (ISO);
ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;
ethyl 4,4'-dichlorobenzilate
208-110-2
510-15-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


607-160-00-6
isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;
clofop-isobutyl (ISO)
—
51337-71-4
Xn; R22
Xn
R: 22
S: (2-)


607-161-00-1
diethanolamine salt of 4-CPA
—
—
Xn; R22
Xn
R: 22
S: (2-)




607-162-00-7
dalapon;
2,2-dichloropropionic acid; [1]
dalapon-sodium;
sodium 2,2-dichloropropionate [2]
200-923-0 [1]
204-828-5 [2]
75-99-0 [1]
127-20-8 [2]
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-39-61



607-163-00-2
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;
dehydracetic acid
208-293-9
520-45-6
Xn; R22
Xn
R: 22
S: (2-)


607-164-00-8
sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;
sodium dehydracetate
224-580-1
4418-26-2
Xn; R22
Xn
R: 22
S: (2-)


607-165-00-3
diclofop-methyl (ISO);
methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;
methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;
257-141-8
51338-27-3
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


607-166-00-9
medinoterb acetate (ISO);
6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-6
2487-01-6
T; R25
Xn; R21
T
R: 21-25
S: (1/2-)36/37-45


607-167-00-4
sodium 3-chloroacrylate
—
4312-97-4
Xn; R21/22
Xn
R: 21/22
S: (2-)36/37


607-168-00-X
dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;
propylisome
—
83-59-0
T; R24
Xn; R22
N; R50-53
T; N
R: 22-24-50/53
S: (1/2-)36/37-45-60-61


607-169-00-5
sodium fluoroacetate
200-548-2
62-74-8
T+; R26/27/28
N; R50
T+; N
R: 26/27/28-50
S: (1/2-)13-22-36/37-45-61


607-170-00-0
bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;
thiocyclam-oxalate
250-859-2
31895-22-4
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-46-60-61


607-172-00-1
4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;
brodifacoum
259-980-5
56073-10-0
T+; R27/28
T; R48/24/25
N; R50-53
T+; N
R: 27/28-48/24/25-50/53
S: (1/2-)36/37-45-60-61


607-173-00-7
dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate
400-460-6
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


607-174-00-2
reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate
400-580-9
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)28-61


607-175-00-8
methyl 2-(2-nitrobenzylidene)acetoacetate
400-650-9
39562-27-1
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-176-00-3
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)
400-830-7
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)36/37-61




607-177-00-9
tribenuron-methyl (ISO);
2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester;
methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-methylureidosulfonyl)benzoate
401-190-1
101200-48-0
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


607-178-00-4
methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate
401-340-6
83055-99-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-179-00-X
(benzothiazol-2-ylthio)succinic acid
401-450-4
95154-01-1
R43
Xi
R: 43
S: (2-)24-37


607-180-00-5
potassium 2-hydroxycarbazole-1-carboxylate
401-630-2
96566-70-0
Xn; R22
Xi; R36/37
R52-53
Xn
R: 22-36/37-52/53
S: (2-)22-26-61


607-181-00-0
3,5-dichloro-2,4-difluorobenzoyl fluoride
401-800-6
101513-70-6
T; R23
C; R34
Xn; R22
R29
R43
R52-53
T; C
R: 22-23-29-34-43-52/53
S: (1/2-)26-36/37/39-45-61


607-182-00-6
methyl 3-sulphamoyl-2-thenoate
402-050-2
—
R43
Xi
R: 43
S: (2-)24-37


607-183-00-1
zinc 2-hydroxy-5-C13-18alkylbenzoate
402-280-3
—
Xi; R36/38
N; R51-53
Xi; N
R: 36/38-51/53
S: (2-)26-61


607-184-00-7
S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate
402-290-8
85702-90-5
R10
R42/43
Xn
R: 10-42/43
S: (2-)23-24-37


607-185-00-2
ethyl trans-3-dimethylaminoacrylate
402-650-4
1117-37-9
R43
Xi
R: 43
S: (2-)24-37


607-186-00-8
quinclorac (ISO);
3,7-dichloroquinoline-8-carboxylic acid
402-780-1
84087-01-4
R43
Xi
R: 43
S: (2-)24-37


607-187-00-3
bis(2,2,6,6-tetramethyl-4-piperidyl) succinate
402-940-0
62782-03-0
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61


607-188-00-9
hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate
402-970-4
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61




607-189-00-4
trimethylenediaminetetraacetic acid
400-400-9
1939-36-2
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)22-26-39



607-190-00-X
methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)
401-890-7
77402-03-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22
Xi; R36
T
R: 45-46-22-36
S: 53-45

E
607-191-00-5
isobutyl 3,4-epoxybutyrate
401-920-9
100181-71-3
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-28-36/37-60-61


607-192-00-0
disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate
402-360-8
92511-22-3
Xi; R41
Xi
R: 41
S: (2-)26-39


607-194-00-1
propylene carbonate
203-572-1
108-32-7
Xi; R36
Xi
R: 36
S: (2-)




607-195-00-7
2-methoxy-1-methylethyl acetate
203-603-9
108-65-6
R10
R: 10
S: (2-)



607-196-00-2
heptanoic acid
203-838-7
111-14-8
C; R34
C
R: 34
S: (1/2-)26-28-36/37/39-45


607-197-00-8
nonanoic acid
203-931-2
112-05-0
C; R34
C
R: 34
S: (1/2-)26-28-36/37/39-45


607-198-00-3
propyl 3,4,5-trihydroxybenzoate
204-498-2
121-79-9
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37


607-199-00-9
octyl 3,4,5-trihydroxybenzoate
213-853-0
1034-01-1
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37


607-200-00-2
dodecyl 3,4,5-trihydroxybenzoate
214-620-6
1166-52-5
R43
Xi
R: 43
S: (2-)24-37


607-201-00-8
thiocarbonyl chloride
207-341-6
463-71-8
T; R23
Xn; R22
Xi; R36/37/38
T
R: 22-23-36/37/38
S: (1/2-)7-9-36/37-45


607-203-00-9
2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate
279-452-8
80387-97-9
Repr. Cat. 2; R61
R43
R52-53
T
R: 61-43-52/53
S: 53-45-61


607-204-00-4
(chlorophenyl)(chlorotolyl)methane, mixed isomers
400-140-6
—
N; R50-53
N
R: 50/53
S: 60-61


607-205-00-X
methyl chloroacetate
202-501-1
96-34-4
R10
T; R23/25
Xi; R37/38-41
T
R: 10-23/25-37/38-41
S: (1/2-)26-37/39-45


607-206-00-5
isopropyl chloroacetate
203-301-7
105-48-6
R10
T; R25
Xi; R36/37/38
T
R: 10-25-36/37/38
S: (1/2-)26-37/39-45


607-207-00-0
haloxyfop-etotyl (ISO)
2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;
haloxyfop-(2-ethoxyethyl)
402-560-5
87237-48-7
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-36-60-61


607-208-00-6
4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers
403-000-2
91853-67-7
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37/39-60-61


607-209-00-1
reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate
403-030-6
—
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61


607-210-00-7
methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)
403-230-3
77402-05-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
C; R34
R43
T
R: 45-46-34-43
S: 53-45


607-211-00-2
methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate
403-270-1
6386-39-6
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)36-61


607-212-00-8
poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate
403-300-3
—
R43
Xi
R: 43
S: (2-)24-37




607-213-00-3
ethyl 3,3-bis(tert-pentylperoxy)butyrate
403-320-2
67567-23-1
E; R3
O; R7
R10
N; R51-53
E; N
R: 3-7-10-51/53
S: (2-)3/7-14-33-36/37/39-61



607-214-00-9
N,N-hydrazinodiacetic acid
403-510-5
19247-05-3
T; R25
Xn; R48/22
R43
R52-53
T
R: 25-43-48/22-52/53
S: (1/2-)26-36/37/39-45-61


607-215-00-4
3-(3-tert-butyl-4-hydroxyphenyl)propionic acid
403-920-4
107551-67-7
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)25-26-36




607-216-00-X
glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine
403-950-8
—
T+; R26
Xn; R22
C; R34
N; R50
T+; N
R: 22-26-34-50
S: (1/2-)26-36/37/39-38-45-61




607-217-00-5
2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate
403-960-2
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


607-218-00-0
dichlorprop-P (ISO);
(+)-R-2-(2,4-dichlorophenoxy)propionic acid
403-980-1
15165-67-0
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)24-26-37/39


607-219-00-6
bis(2-ethylhexyl) dithiodiacetate
404-510-8
62268-47-7
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24/25-37-61


607-221-00-7
6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid
404-550-6
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


607-222-00-2
6-(2,3-dimethylmaleimido)hexyl methacrylate
404-870-6
63740-41-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-223-00-8
transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
405-060-5
118712-89-3
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)36/37-60-61


607-224-00-3
methyl 2-(3-nitrobenzylidene)acetoacetate
405-270-7
39562-17-9
Xi; R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


607-225-00-9
3-azidosulfonylbenzoic acid
405-310-3
15980-11-7
E; R2
Xn; R48/22
Xi; R41
R43
E; Xn
R: 2-41-43-48/22
S: (2-)22-26-35-36/37/39


607-226-00-4
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate
405-360-6
—
Xi; R38-41
R43
R52-53
Xi
R: 38-41-43-52/53
S: (2-)24-26-37/39-61


607-227-00-X
potassium 2-amino-2-methylpropionate octahydrate
405-560-3
120447-91-8
Xn; R22
C; R35
C
R: 22-35
S: (1/2-)26-28-36/37/39-45


607-228-00-5
bis(2-methoxyethyl) phthalate
204-212-6
117-82-8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-62
S: 53-45


607-229-00-0
diethylcarbamoyl chloride
201-798-5
88-10-8
Carc. Cat. 3; R40
Xn; R20/22
Xi; R36/37/38
Xn
R: 20/22-36/37/38-40
S: (2-)26-36/37


607-230-00-6
2-ethylhexanoic acid
205-743-6
149-57-5
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)36/37




607-231-00-1
clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid
216-935-4
1702-17-6
Xi; R41
Xi
R: 41
S: (2-)26-39



607-232-00-7
pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
259-686-7
55512-33-9
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


607-233-00-2
hexyl acrylate
219-698-5
2499-95-8
Xi; R36/37/38
R43
N; R51-53
Xi; N
R: 36/37/38-43-51/53
S: (2-)24-26-37-61


607-234-00-8
flurenol (ISO);
9-hydroxy-9H-fluorene-9-carboxylic acid
207-397-1
467-69-6
N; R51-53
N
R: 51/53
S: 61


607-235-00-3
mecrilate;
methyl 2-cyanoacrylate
205-275-2
137-05-3
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)23-24/25-26
Xi; R36/37/38: C ≥ 10 %

607-236-00-9
ethyl 2-cyanoacrylate
230-391-5
7085-85-0
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)23-24/25-26
Xi; R36/37/38: C ≥ 10 %

607-237-00-4
benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;
flurazole
276-942-3
72850-64-7
N; R51-53
N
R: 51/53
S: 61


607-238-00-X
tau-fluvalinate (ISO);
cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate
—
102851-06-9
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-50/53
S: (2-)24-59-61


607-239-00-5
fenpropathrin (ISO);
α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate;
254-485-0
39515-41-8
T+; R26
T; R25
Xn; R21
N; R50-53
T+; N
R: 21-25-26-50/53
S: (1/2-)28-36/37-38-45-60-61


607-240-00-0
cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethylphthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]
216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7]
1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7]
Xi; R41
R42/43
Xn
R: 41-42/43
S: (2-)22-24-26-37/39

C
607-241-00-6
hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4]
243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4]
19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4]
Xi; R41
R42/43
Xn
R: 41-42/43
S: (2-)22-24-26-37/39

C
607-242-00-1
tetrachlorophthalic anhydride
204-171-4
117-08-8
Xi; R41
R42/43
N; R50-53
Xn; N
R: 41-42/43-50/53
S: (2-)22-24-26-37/39-60-61


607-243-00-7
sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]
217-846-3 [1]
246-590-5 [2]
258-527-9 [3]
1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3]
R52-53
R: 52/53
S: 61


607-244-00-2
isooctyl acrylate
249-707-8
29590-42-9
Xi; R36/37/38
N; R50-53
Xi; N
R: 36/37/38-50/53
S: (2-)26-28-60-61
Xi; R36/37/38: C ≥ 10 %



607-245-00-8
tert-butyl acrylate
216-768-7
1663-39-4
F; R11
Xn; R20/21/22
Xi; R37/38
R43
N; R51-53
F; Xn; N
R: 11-20/21/22-37/38-43-51/53
S: (2-)16-25-37-61

D

607-246-00-3
allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester
202-473-0
96-05-9
R10
T; R23
Xn; R21/22
N; R50
T; N
R: 10-21/22-23-50
S: (1/2-)36/37-45-61


607-247-00-9
dodecyl methacrylate
205-570-6
142-90-5
Xi; 36/37/38
N; R50-53
Xi; N
R: 36/37/38-50/53
S: (2-)26-28-60-61
Xi; R36/37/38: C ≥ 10 %

607-248-00-4
naptalam-sodium (ISO);
sodium N-naphth-1-ylphthalamate
205-073-4
132-67-2
Xn; R22
Xn
R: 22
S: (2-)


607-249-00-X
(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate
256-032-2
42978-66-5
Xi; R36/37/38
R43
N; R51-53
Xi; N
R: 36/37/38-43-51/53
S: (2-)24-37-61
Xi; R36/37/38: C ≥ 10 %

607-250-00-5
4H-3,1-benzoxazine-2,4(1H)-dione
204-255-0
118-48-9
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37


607-251-00-0
2-methoxypropyl acetate
274-724-2
70657-70-4
R10
Repr. Cat. 2; R61
Xi; R37
T
R: 61-10-37
S: 53-45




607-252-00-6
lambda-cyhalothrin (ISO);
reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)
415-130-7
91465-08-6
T+; R26
T; R25
Xn; R21
N; R50-53
T+; N
R: 21-25-26-50/53
S: (1/2-)28-36/37/39-38-45-60-61
N; R50-53: C ≥ 0,0025 %
N; R51-53: 0,00025 % ≤ C < 0,0025 %
R52-53: 0,000025 % ≤ C < 0,00025 %


607-253-00-1
cyfluthrin (ISO);
α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
269-855-7
68359-37-5
T+; R28
T; R23
N; R50-53
T+; N
R: 23-28-50/53
S: (1/2-)28-36/37/39-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


607-254-00-7
α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
beta-cyfluthrin
269-855-7
68359-37-5
T+; R26/28
N; R50-53
T+; N
R: 26/28-50/53
S: (1/2-)36/37/39-45-60-61


607-255-00-2
fluroxypyr (ISO);
4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid
—
69377-81-7
R52-53
R: 52/53
S: 61


607-256-00-8
azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
—
131860-33-8
T; R23
N; 50-53
T; N
R: 23-50/53
S: (1/2-)22-45-60-61


607-257-00-3
isopropyl propionate
211-300-8
637-78-5
F; R11
F
R: 11
S: (2-)16-23-24-29-33


607-258-00-9
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate
403-990-6
70950-45-7
R53
R: 53
S: 61


607-259-00-4
methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate
404-130-2
105560-93-8
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


607-260-00-X
ethyl 2-(3-nitrobenzylidene)acetoacetate
404-490-0
39562-16-8
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


607-261-00-5
iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate
404-800-4
118832-72-7
N; R50-53
N
R: 50/53
S: 60-61


607-262-00-0
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
405-050-0
86393-33-1
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


607-263-00-6
potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate
405-680-6
—
E; R2
N; R51-53
E; N
R: 2-51/53
S: (2-)35-61


607-264-00-1
2-chloro-4-(methylsulfonyl)benzoic acid
406-520-8
53250-83-2
Xi; R41
Xi
R: 41
S: (2-)26-39


607-265-00-7
ethyl-2-chloro-2,2-diphenylacetate
406-580-5
52460-86-3
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)37-61


607-266-00-2
reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];
3,5-di-tert-butyl-salicylic acid
406-890-0
130296-87-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61


607-267-00-8
tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate
407-620-4
33610-13-8
R42/43
R52-53
Xn
R: 42/43-52/53
S: (2-)22-24-37-61


607-268-00-3
2-methylpropyl (R)-2-hydroxypropanoate
407-770-0
61597-96-4
Xi; R36
Xi
R: 36
S: (2-)26


607-269-00-9
(R)-2-(4-hydroxyphenoxy)propanoic acid
407-960-3
94050-90-5
Xi; R41
Xi
R: 41
S: (2-)26-39


607-270-00-4
3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane
410-730-5
90498-90-1
Xn; R21
Xn
R: 21
S: (2-)36/37


607-271-00-X
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane
417-420-9
156324-82-2
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


607-272-00-5
fluroxypyr-meptyl (ISO);
methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]
- [2]
81406-37-3 [1]
154486-27-8 [2]
N; R50-53
N
R: 50/53
S: 60-61


607-273-00-0
ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate
404-520-2
—
R52-53
R: 52/53
S: 61


607-274-00-6
2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate
405-350-1
54527-73-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-275-00-1
sodium benzoyloxybenzene-4-sulfonate
405-450-5
66531-87-1
R43
Xi
R: 43
S: (2-)24-37


607-276-00-7
bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex
405-635-0
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61


607-277-00-2
reaction mass of: 2-(hexylthio)ethylamine hydrochloride;
sodium propionate
405-720-2
—
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61


607-278-00-8
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;
sodium naphthylethylbenzenesulfonate
405-760-0
—
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


607-279-00-3
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate
405-960-8
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-280-00-9
sodium 4-chloro-1-hydroxybutane-1-sulfonate
406-190-5
54322-20-2
Xn; R22
Xi; R36
R43
Xn
R: 22-36-43
S: (2-)22-26-36/37


607-281-00-4
reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates
407-000-3
127519-17-9
N; R51-53
N
R: 51/53
S: 61


607-282-00-X
2-acetoxymethyl-4-benzyloxybut-1-yl acetate
407-140-5
131266-10-9
R52-53
R: 52/53
S: 61


607-283-00-5
E-ethyl-4-oxo-4-phenylcrotonate
408-040-4
15121-89-8
Xn; R21/22
Xi; R38-41
R43
N; R50-53
Xn; N
R: 21/22-38-41-43-50/53
S: (2-)26-36/37/39-60-61


607-284-00-0
reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);
lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)
410-040-4
136213-76-8
N; R51-53
N
R: 51/53
S: 61


607-285-00-6
reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;
sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;
potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate
410-065-0
—
R43
Xi
R: 43
S: (2-)22-24-37


607-286-00-1
reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate
410-070-8
141880-36-6
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


607-287-00-7
O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate
410-140-8
—
R52-53
R: 52/53
S: 61


607-288-00-2
Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively
410-160-7
148732-74-5
Xi; R36
R43
R52-53
Xi
R: 36-43-52/53
S: (2-)22-26-36/37-61


607-289-00-8
3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid
410-370-9
105488-33-3
R53
R: 53
S: 61


607-290-00-3
reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;
ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate
410-540-2
—
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


607-291-00-9
dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate
410-630-1
104051-92-5
R53
R: 53
S: 61


607-292-00-4
reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid
410-640-6
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61


607-293-00-X
reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate
410-650-0
—
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)26-36/37/39-61


607-294-00-5
sodium 2-benzoyloxy-1-hydroxyethane-sulfonate
410-680-4
—
R43
Xi
R: 43
S: (2-)24-37


607-295-00-0
reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tetracarboxylate
410-800-5
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-296-00-6
reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid
410-830-9
—
R53
R: 53
S: 61


607-297-00-1
(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)
410-960-6
92761-26-7
Xi; R41
Xi
R: 41
S: (2-)26-39


607-298-00-7
2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate
411-010-3
—
R43
Xi
R: 43
S: (2-)22-36/37


607-299-00-2
methyl 3-(acetylthio)-2-methyl-propanoate
411-040-7
97101-46-7
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


607-300-00-6
trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25
411-430-7
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)26-36/37/39


607-301-00-1
reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid
411-860-5
—
R43
N; R51-53
Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61


607-302-00-7
reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid
411-910-6
—
Xi; R38-41
R43
N; R51-53
Xi; N
R: 38-41-43-51/53
S: (2-)24-26-37/39-61


607-303-00-2
1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
413-760-7
93107-30-3
Repr. Cat. 3; R62
R52-53
Xn
R: 62-52/53
S: (2-)22-36/37-61


607-304-00-8
fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
274-125-6
69806-50-4
Repr. Cat. 2; R61
N; R50-53
T; N
R: 61-50/53
S: 53-45-60-61


607-305-00-3
fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
—
79241-46-6
Repr. Cat. 3; R63
N; R50-53
Xn; N
R: 50/53-63
S: (2-)29-36/37-46-60-61


607-306-00-9
chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate
282-714-4
84332-86-5
Carc. Cat. 3; R40
N; R51-53
Xn; N
R: 40-51/53
S: (2-)36/37-61


607-307-00-4
vinclozolin (ISO);
N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione
256-599-6
50471-44-8
Carc. Cat. 3; R40
Repr. Cat. 2; R60-61
R43
N; R51-53
T; N
R: 60-61-40-43-51/53
S: 53-45-61


607-308-00-X
esters of 2,4-D
—
—
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)26-29-36/37-46-60-61

A
607-309-00-5
carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
—
128639-02-1
N; R50-53
N
R: 50/53
S: 60-61


607-310-00-0
kresoxim-methyl (ISO);
methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate
—
143390-89-0
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


607-311-00-6
benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate
246-591-0
25059-80-7
N; R51-53
N
R: 51/53
S: 61


607-312-00-1
methoxyacetic acid
210-894-6
625-45-6
Repr. Cat. 2; R60-61
Xn; R22
C; R34
T
R: 60-61-22-34
S: 53-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
E
607-313-00-7
neodecanoyl chloride
254-875-0
40292-82-8
T+; R26
Xn; R22
C; R34
T+
R: 22-26-34
S: (1/2-)26-28-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

607-314-00-2
ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate
247-525-3
26225-79-6
N; R51-53
N
R: 51/53
S: 61


607-315-00-8
glyphosate (ISO);
N-(phosphonomethyl)glycine
213-997-4
1071-83-6
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


607-316-00-3
glyphosate-trimesium;
glyphosate-trimethylsulfonium
—
81591-81-3
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)36/37-46-61


607-317-00-9
bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP
204-211-0
117-81-7
Repr. Cat. 2; R60-61
T
R: 60-61
S: 53-45


607-318-00-4
dibutyl phthalate;
DBP
201-557-4
84-74-2
Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R50
T; N
R: 61-50-62
S: 53-45-61




607-319-00-X
deltamethrin (ISO);
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate
258-256-6
52918-63-5
T; R23/25
N; R50-53
T; N
R: 23/25-50/53
S: (1/2-)24-28-36/37/39-38-45-60-61
N; R50-53: C ≥ 0,000025 %
N; R51-53: 0,0000025 % ≤ C < 0,000025 %
R52-53: 0,00000025 % ≤ C < 0,0000025 %


607-320-00-5
bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate
413-930-0
130066-57-8
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


607-321-00-0
(S)-methyl-2-chloropropionate
412-470-8
73246-45-4
R10
Xn; R48/22
Xi; R36
Xn
R: 10-36-48/22
S: (2-)23-26-36


607-322-00-6
4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid
413-120-7
107144-30-9
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-61


607-323-00-1
2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate
413-850-6
123968-25-2
R53
R: 53
S: 61


607-324-00-7
reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;
dihydrogenated alkyl (C14-C18)amine
413-800-3
—
R53
R: 53
S: 61


607-325-00-2
(S)-2-chloropropionic acid
411-150-5
29617-66-1
Xn; R21/22
C; R35
C
R: 21/22-35
S: (1/2-)23-26-28-36/37/39-45


607-326-00-8
reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate
410-720-0
141847-13-4
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


607-327-00-3
2-(2-iodoethyl)-1,3-propanediol diacetate
411-780-0
127047-77-2
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)36-61


607-328-00-9
methyl 4-bromomethyl-3-methoxybenzoate
410-310-1
70264-94-7
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)26-36/37/39-60-61


607-329-00-4
reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;
sodium 2-octadecenyl-amino-1,4-butandioate
411-250-9
—
R43
Xi
R: 43
S: (2-)24-26-37/39


607-330-00-X
(S)-2,3-dihydro-1H-indole-2-carboxylic acid
410-860-2
79815-20-6
Repr. Cat. 3; R62
Xn; R48/22
R43
Xn
R: 43-48/22-62
S: (2-)22-25-26-36/37


607-331-00-5
reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;
1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane
406-750-9
—
R53
R: 53
S: 23-61


607-332-00-0
cyclopentyl chloroformate
411-460-0
50715-28-1
R10
T; R23
Xn; R22-48/22
Xi; R41
R43
T
R: 10-22-23-41-43-48/22
S: (1/2-)26-36/37/39-45


607-333-00-6
reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;
tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate
405-670-1
—
Xn; R22-48/22
C; R34
N; R50-53
C; N
R: 22-34-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61


607-334-00-1
ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
405-880-3
100501-62-0
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


607-335-00-7
methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate
406-250-0
72619-32-0
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


607-336-00-2
4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate
406-560-6
122760-85-4
Xi; R38
R43
N; R51-53
Xi; N
R: 38-43-51/53
S: (2-)36/37-61


607-337-00-8
di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate
406-052-4
125078-60-6
R10
Xn; R22
Xi; R38-41
N; R51-53
Xn; N
R: 10-22-38-41-51/53
S: (2-)26-37/39-61


607-338-00-3
2-methylpropyl 2-hydroxy-2-methylbut-3-enoate
406-235-9
72531-53-4
Xi; R36/38
Xi
R: 36/38
S: (2-)26-37


607-339-00-9
2,3,4,5-tetrachlorobenzoylchloride
406-760-3
42221-52-3
Xn; R22
C; R34
R43
C
R: 22-34-43
S: (1/2-)26-36/37/39-45


607-340-00-4
1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate
406-990-4
—
N; R51-53
N
R: 51/53
S: 61


607-341-00-X
(9S)-9-amino-9-deoxyerythromycin
406-790-7
26116-56-3
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


607-342-00-5
4-chlorobutyl veratrate
410-950-1
69788-75-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


607-343-00-0
4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)
407-410-2
—
R53
R: 53
S: 61


607-344-00-6
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;
3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
407-810-7
—
Xn; R48/22
Xn
R: 48/22
S: (2-)21-22-36/37


607-345-00-1
potassium 2-(2,4-dichlorophenoxy)-(R)-propionate
413-580-9
113963-87-4
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)24-26-37/39


607-346-00-7
3-icosyl-4-henicosylidene-2-oxetanone
401-210-9
83708-14-9
R53
R: 53
S: 61


607-347-00-2
sodium (R)-2-(2,4-dichlorophenoxy)propionate
413-340-3
119299-10-4
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)22-26-36/37/39


607-348-00-8
magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)
413-360-2
—
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)22-26-36/37/39


607-349-00-3
mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate
411-270-8
—
R52-53
R: 52/53
S: 61


607-350-00-9
bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane
412-060-9
136210-32-7
R43
R52-53
Xi
R: 43-52/53
S: (2-)36/37-61


607-351-00-4
methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate
407-550-4
69184-17-4
N; R51-53
N
R: 51/53
S: 20/21-61


607-352-00-X
4,4'-oxydiphthalic anhydride
412-830-4
1823-59-2
R52-53
R: 52/53
S: 61


607-353-00-5
reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;
ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate
407-520-0
80657-64-3
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


607-354-00-0
ethyl 2-cyclohexylpropionate
412-280-5
2511-00-4
N; R51-53
N
R: 51/53
S: 61


607-355-00-6
p-tolyl 4-chlorobenzoate
411-530-0
15024-10-9
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


607-356-00-1
ethyl trans-2,2,6-trimethylcyclohexanecarboxylate
412-540-8
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


607-357-00-7
reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran
412-450-9
131766-73-9
R43
Xi
R: 43
S: (2-)24-37


607-358-00-2
(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate
412-670-5
54275-93-3
R42
Xn
R: 42
S: (2-)22


607-359-00-8
(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate
412-800-0
76109-32-5
R42
Xn
R: 42
S: (2-)22


607-360-00-3
sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate
411-680-7
133167-77-8
R43
Xi
R: 43
S: (2-)24-37


607-361-00-9
methyl (R)-2-(4-hydroxyphenoxy)propionate
411-950-4
96562-58-2
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


607-362-00-4
reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate
413-500-2
—
Xi; R38-41
N; R51-53
Xi; N
R: 38-41-51/53
S: (2-)26-37/39-61


607-363-00-X
methyl-3-methoxyacrylate
412-900-4
5788-17-0
R43
Xi
R: 43
S: (2-)24-37


607-364-00-5
3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione
413-330-9
134724-55-3
R53
R: 53
S: 61


607-365-00-0
2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride
410-620-7
119154-86-8
Xn; R22
C; R34
R43
C
R: 22-34-43
S: (1/2-)22-26-36/37/39-45


607-366-00-6
3,5-dimethylbenzoyl chloride
413-010-9
6613-44-1
C; R34
R43
C
R: 34-43
S: (1/2-)26-36/37/39-45


607-367-00-1
potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate
411-640-9
153352-59-1
Xn; R22
Xn
R: 22
S: (2-)37


607-368-00-7
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole
411-650-3
110895-43-7
T; R23/25
N; R50-53
T; N
R: 23/25-50/53
S: (1/2-)37-38-45-60-61


607-369-00-2
reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid
411-660-8
147027-04-1
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)22-24-26-37/39


607-370-00-8
2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol
412-210-3
41620-33-1
N; R50-53
N
R: 50/53
S: 60-61


607-371-00-3
3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate
413-410-3
88150-62-3
R53
R: 53
S: 61


607-372-00-9
ethoxylated bis phenol A di-(norbornene carboxylate)
412-410-0
—
R52-53
R: 52/53
S: 61


607-373-00-4
(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate
414-200-4
119738-06-6
Muta. Cat. 3; R68
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22-48/22
N; R50-53
T; N
R: 61-22-48/22-62-68-50/53
S: 53-45-60-61

E
607-374-00-X
5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride
417-220-1
37441-29-5
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-36/37-61


607-375-00-5
reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;
trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
421-960-0
90035-08-8
T+; R26/27/28
T; R48/23/24/25
N; R50-53
T+; N
R: 26/27/28-48/23/24/25-50/53
S: (1/2-)28-36/37/39-45-60-61


607-376-00-0
benzyl 2,4-dibromobutanoate
420-710-8
23085-60-1
Repr. Cat. 3; R62
Xi; R38
R43
N; R50-53
Xn; N
R: 38-43-62-50/53
S: (2-)23-36/37-41-60-61


607-377-00-6
trans-4-cyclohexyl-L-proline monohydrochloride
419-160-1
90657-55-9
Repr. Cat. 3; R62
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43-62
S: (2-)22-26-36/37/39


607-378-00-1
ammonium (Z)-α-methoxyimino-2-furylacetate
405-990-1
97148-39-5
F; R11
F
R: 11
S: (2-)22-43


607-379-00-7
reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;
sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;
sodium [bis(2-hydroxyethyl)amino]methylsulfonate;
N,N-bis(2-hydroxyethyl)stearamide
401-230-8

R52-53
R: 52/53
S: 61


607-380-00-2
reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate
407-320-3
—
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61


607-381-00-8
reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid
413-710-4
—
R53
R: 53
S: 61


607-382-00-3
2-((4-amino-2-nitrophenyl)amino)benzoic acid
411-260-3
117907-43-4
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


607-383-00-9
reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-8
86403-32-9
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61


607-384-00-4
reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate
413-750-2
171090-93-0
R53
R: 53
S: 61


607-385-00-X
Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate
414-590-6
125229-74-5
N; R51-53
N
R: 51/53
S: 61


607-386-00-5
reaction mass of: tetradecanoic acid (42.5-47.5 %);
poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %)
412-580-6
174591-51-6
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61


607-387-00-0
reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid (60-65 %)
412-590-0
58856-63-6
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61


607-388-00-6
4-ethylamino-3-nitrobenzoic acid
412-090-2
2788-74-1
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)22-24-37-61


607-389-00-1
trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate
414-130-4
119710-96-2
Xn; R22
Xn
R: 22
S: (2-)22


607-390-00-7
1,2,3,4-tetrahydro-6-nitro-quinoxaline
414-270-6
41959-35-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-61


607-391-00-2
dimethylcyclopropane-1,1-dicarboxylate
414-240-2
6914-71-2
R52-53
R: 52/53
S: 61


607-392-00-8
2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate
414-260-1
88938-37-8
R53
R: 53
S: 61


607-393-00-3
3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
415-750-8
106447-44-3
R43
Xi
R: 43
S: (2-)22-24-37


607-394-00-9
5-methylpyrazine-2-carboxylic acid
413-260-9
5521-55-1
Xi; R41
Xi
R: 41
S: (2-)26-39


607-395-00-4
reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate
410-230-7
—
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53
S: (1/2-)26-36/37/39-45-61


607-396-00-X
bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate
414-840-4
147783-69-5
N; R50-53
N
R: 50/53
S: 22-60-61




607-397-00-5
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)
415-930-6
—
Repr. Cat. 3; R62
R43
Xn
R: 43-62
S: (2-)23-36/37



607-398-00-0
ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate
414-820-5
125630-94-6
N; R50-53
N
R: 50/53
S: 60-61


607-399-00-6
2,2-dimethyl 3-methyl-3-butenyl propanoate
415-610-6
104468-21-5
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)37-61


607-400-00-X
methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate
414-400-1
32750-89-3
N; R50-53
N
R: 50/53
S: 60-61


607-401-00-5
ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate
414-450-4
88805-65-6
Xi; R38-41
R43
Xi
R: 38-41-43
S: (2-)24-26-37/39


607-402-00-0
methyl N-(phenoxycarbonyl)-L-valinate
414-500-5
153441-77-1
R52-53
R: 52/53
S: 61


607-403-00-6
reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol
414-810-0
—
Xn; R48/22
Xi; R41
N; R50-53
Xn; N
R: 41-48/22-50/53
S: (2-)22-26-36/39-60-61


607-404-00-1
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4
—
R43
Xi
R: 43
S: (2-)24-37


607-405-00-7
2-hexyldecyl-p-hydroxybenzoate
415-380-7
148348-12-3
N; R51-53
N
R: 51/53
S: 61


607-406-00-2
potassium 2,5-dichlorobenzoate
415-700-5
184637-62-5
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39


607-407-00-8
ethyl 2-carboxy-3-(2-thienyl)propionate
415-680-8
143468-96-6
Xi; R38-41
R43
Xi
R: 38-41-43
S: (2-)24-26-37/39


607-408-00-3
potassium N-(4-fluorophenyl)glycinate
415-710-1
184637-63-6
Xn; R48/22
Xi; R41
R43
R52-53
Xn
R: 41-43-48/22-52/53
S: (2-)22-26-36/37/39-61


607-409-00-9
reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass from Aspergillus terreus
415-840-7
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)36/37-61


607-410-00-4
mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate
415-880-5
779343-34-9
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61


607-411-00-X
oxiranemethanol, 4-methylbenzene-sulfonate, (S)-
417-210-7
70987-78-9
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xi; R41
R43
N; R51-53
T; N
R: 45-41-43-68-51/53
S: 53-45-61


607-412-00-5
ethyl 2-(1-cyanocyclohexyl)acetate
415-970-4
133481-10-4
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)36/37-61


607-413-00-0
trans-4-phenyl-L-proline
416-020-1
96314-26-0
Repr. Cat. 3; R62
R43
Xn
R: 43-62
S: (2-)22-36/37


607-414-00-6
tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
402-070-1
88122-99-0
R53
R: 53
S: 61


607-415-00-1
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)
419-590-1
—
F; R11
R43
F; Xi
R: 11-43
S: (2-)24-37-43


607-416-00-7
4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide
420-730-7
—
N; R50-53
N
R: 50/53
S: 60-61




607-417-00-2
3-chloropropyl chloroformiate
425-770-9
628-11-5
T; R23
Xn; R22-48/22
Xi; R38-41
R43
T
R: 22-23-38-41-43-48/22
S: (1/2-)26-36/37/39-45



607-418-00-8
2-ethylhexyl 4-aminobenzoate
420-170-3
26218-04-2
N; R50-53
N
R: 50/53
S: 60-61


607-419-00-3
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid
422-240-9
166596-68-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)26-36/37/39


607-420-00-9
2,2-bis(hydroxymethyl)butanoic acid
424-090-1
10097-02-6
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


607-421-00-4
cypermethrin cis/trans +/- 40/60;
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Xn; R20/22
Xi; R37
N; R50-53
Xn; N
R: 20/22-37-50/53
S: (2-)24-36/37/39-60-61





607-422-00-X
α-cypermethrin (ISO);
racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
67375-30-8
T; R25
Xn; R48/22
Xi; R37
N; R50-53
T; N
R: 25-37-48/22-50/53
S: (1/2-)36/37/39-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


607-423-00-5
esters of mecoprop and of mecoprop-P
—
—
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)13-36/37-60-61

A
607-424-00-0
trifloxystrobin (ISO);
(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester
—
141517-21-7
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61


607-425-00-6
metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-7
57837-19-1
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)13-24-37-46-61


607-426-00-1
1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4]
284-032-2 [1]
- [2]
205-017-9 [3]
210-088-4 [4]
84777-06-0 [1]
- [2]
131-18-0 [3]
605-50-5 [4]
Repr. Cat. 2; R60-61
N; R50
T; N
R: 60-61-50
S: 53-45-61


607-427-00-7
bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate
260-300-4
56634-95-8
Repr. Cat. 3; R63
Xn; R20/22
R43
N; R50-53
Xn; N
R: 20/22-43-63-50/53
S: (2-)36/37-46-60-61




607-428-00-2
tetrasodium ethylene diamine tetraacetate
200-573-9
64-02-8
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39-46



607-429-00-8
edetic acid;
(EDTA)
200-449-4
60-00-4
Xi; R36
Xi
R: 36
S: (2-)26



607-430-00-3
BBP;
benzyl butyl phthalate
201-622-7
85-68-7
Repr. Cat. 2; R61
Repr. Cat. 3; R62
N; R50-53
T; N
R: 61-62-50/53
S: 53-45-60-61


607-431-00-9
prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
245-387-9
23031-36-9
T; R23
Xn; R22
N; R50-53
T; N
R: 22-23-50/53
S: (1/2-)45-60-61


607-432-00-4
S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1]
(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
- [1]
- [2]
87392-12-9 [1]
178961-20-1 [2]
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


607-433-00-X
cypermethrin cis/trans +/- 80/20;
(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-9
52315-07-8
Xn; R22
Xi; R37/38
R43
N; R50-53
Xn; N
R: 22-37/38-43-50/53
S: (2-)36/37/39-60-61


607-434-00-5
mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-0
16484-77-8
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)13-26-37/39-46-61


607-435-00-0
2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate
416-810-6
111969-64-3
Xn; R48/22
Xi; R41
N; R51-53
Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61


607-436-00-6
2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate
417-350-9
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-28-37/39-60-61


607-437-00-1
3-(4-aminophenyl)-2-cyano-2-propenoic acid
417-480-6
252977-62-1
R43
Xi
R: 43
S: (2-)22-24-37


607-438-00-7
methyl-2-[(aminosulfonyl)methyl]benzoate
419-010-5
112941-26-1
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)22-26


607-439-00-2
methyl tetrahydro-2-furancarboxylate
420-670-1
37443-42-8
Xi; R41
Xi
R: 41
S: (2-)26-39


607-440-00-8
methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate
421-220-7
144740-59-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


607-441-00-3
3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid
421-490-6
167684-63-1
R53
R: 53
S: 57-61


607-442-00-9
benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate
416-050-5
87460-09-1
Xi; R41
Xi
R: 41
S: (2-)26-36/39



607-443-00-4
bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate
416-140-4
145650-60-8
R53
R: 53
S: 61



607-444-00-X
reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate
416-230-3
35541-81-2
R53
R: 53
S: 61


607-445-00-5
Iron (III) tris(4-methylbenzenesulfonate)
420-960-8
77214-82-5
Xi; R41
Xi
R: 41
S: (2-)24-26-39


607-446-00-0
methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate
416-240-8
155522-12-6
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61


607-447-00-6
sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate
416-370-5
156738-27-1
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


607-448-00-1
2,3,5,6-tetrafluorobenzoic acid
416-800-1
652-18-6
Xi; R38-41
Xi
R: 38-41
S: (2-)22-26-37/39


607-449-00-7
reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]
417-080-1
—
E; R2
R43
N; R50-53
E; Xi; N
R: 2-43-50/53
S: (2-)24-37-60-61


607-450-00-2
2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
419-040-9
89604-92-2
R53
R: 53
S: 61


607-451-00-8
4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt
417-640-5
161935-19-9
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


607-453-00-9
4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)
418-100-1
172964-15-7
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


607-454-00-4
reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid
418-170-3
116193-72-7
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)25-26-39-61


607-455-00-X
1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt
419-520-8
172890-93-6
R43
Xi
R: 43
S: (2-)22-24-37


607-456-00-5
3-amino-4-chlorobenzoic acid, hexadecyl ester
419-700-6
143269-74-3
N; R51-53
N
R: 51/53
S: 61


607-457-00-0
tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)
420-350-1
172277-97-3
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


607-458-00-6
reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1
—
N; R51-53
N
R: 51/53
S: 61


607-459-00-1
isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate
418-930-4
—
R53
R: 53
S: 61


607-460-00-7
3-tridecyloxy-propyl-ammonium 9-octadecenoate
418-990-1
778577-53-0
Xn; R48/22
Xi; R36/38
N; R50-53
Xn; N
R: 36/38-48/22-50/53
S: (2-)23-26-37/39-60-61


607-461-00-2
reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;
pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate
421-160-1
—
R52-53
R: 52/53
S: 61


607-462-00-8
reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates
421-230-1
88230-35-7
N; R51-53
N
R: 51/53
S: 61


607-463-00-3
3-(phenothiazin-10-yl)propionic acid
421-260-5
362-03-8
N; R51-53
N
R: 51/53
S: 24/25-61


607-464-00-9
reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
421-280-4

R52-53
R: 52/53
S: 61


607-465-00-4
tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate
421-440-3
778583-04-3
R52-53
R: 52/53
S: 61


607-466-00-X
reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
421-480-1
—
N; R51-53
N
R: 51/53
S: 37/39-61


607-467-00-5
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate
419-430-9
56533-00-7
Xn; R21/22-48/22
C; R34
N; R50-53
C; N
R: 21/22-34-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61


607-468-00-0
reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate
419-450-8
—
R43
Xi
R: 43
S: (2-)22-24-37


607-469-00-6
disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate
419-460-2
120029-06-3
R52-53
R: 52/53
S: 61


607-470-00-1
potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-100-0
154336-20-6
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)39-22-26-61




607-471-00-7
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane
429-280-6
151900-44-6
R53
R: 53
S: 61




607-472-00-2
ammonium iron(III) trimethylenediaminetetraacetate hemihydrate
400-660-3
111687-36-6
N; R51-53
N
R: 51/53
S: 61





607-473-00-8
pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid
426-590-3
187412-41-5
R43
Xi
R: 43
S: (2-)24-37



607-474-00-3
(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid
410-430-4
117573-89-4
R53
R: 53
S: 61


607-475-00-9
reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)
412-940-2
148878-18-6
R43
Xi
R: 43
S: (2-)22-24-37


607-476-00-4
trisodium N,N-bis(carboxymethyl)-β-alanine
414-070-9
129050-62-0
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)26-36/37/39-45-61




607-477-00-X
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt
426-740-8
-
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



607-478-00-5
tetramethylammonium hydrogen phthalate
416-900-5
79723-02-7
T; R25
Xn; R48/22
N; R50
T; N
R: 25-48/22-50
S: (1/2-)25-36-45-61


607-479-00-0
hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate
418-550-9
168689-49-4
R53
R: 53
S: 61


607-480-00-6
1,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters
271-084-6
68515-42-4
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-62
S: 53-45




607-481-00-1
reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate
430-290-8
-
R53
R: 53
S: 61



607-482-00-7
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride
430-360-8
84793-24-8
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



607-483-00-2
1,2-benzenedicarboxylic acid;
di-C6-8-branched alkylesters, C7-rich
276-158-1
71888-89-6
Repr. Cat. 2; R61
T
R: 61
S: 53-45



607-484-00-8
ethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate
430-480-0
221452-67-1
R53
R: 53
S: 61



607-485-00-3
(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate
430-510-2
-
R53
R: 53
S: 22-61



607-486-00-9
potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate
402-110-8
110081-40-8
R52-53
R: 52/53
S: 22-61



607-487-00-4
reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate
402-660-9
—
Repr. Cat. 2; R61
R52-53
T
R: 61-52/53
S: 53-45-61


607-488-00-X
ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate
414-210-9
147379-38-2
N; R50-53
N
R: 50/53
S: 60-61


607-489-00-5
reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate
414-890-7
71302-79-9
R43
Xi
R: 43
S: (2-)24-37


607-490-00-0
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate
415-060-7
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39




607-491-00-6
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);
triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)
427-140-9
-
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37



607-492-00-1
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate
415-490-5
141773-73-1
N; R51-53
N
R: 51/53
S: 61


607-493-00-7
methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate
415-670-3
78850-37-0
Xi; R41
Xi
R: 41
S: (2-)26-39


607-494-00-2
bis(2-ethylhexyl)octylphosphonate
417-170-0
52894-02-7
N; R50-53
N
R: 50/53
S: 60-61


607-495-00-8
sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate
417-550-6
168151-92-6
R43
Xi
R: 43
S: (2-)24-37


607-496-00-3
2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite
418-310-3
126050-54-2
R53
R: 53
S: 61


607-497-00-9
cerium oxide isostearate
419-760-3
—
R53
R: 53
S: 61


607-498-00-4
(E)-3,7-dimethyl-2,6-octadienylhexadecanoate
421-370-3
3681-73-0
Xi; R38
R53
Xi
R: 38-53
S: (2-)37-61


607-499-00-X
bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)
421-660-1
—
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61


607-500-00-3
calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate
421-670-4
—
Xi; R38
N; R50-53
Xi; N
R: 38-50/53
S: (2-)37-60-61


607-501-00-9
reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives
421-820-9
192268-65-8
R53
R: 53
S: 61


607-502-00-4
(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate
422-200-0
178277-55-9
C; R34
Xn; R22
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61


607-503-00-X
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane
422-210-5
68957-94-8
C; R34
C
R: 34
S: (1/2-)26-36/37/39-45




607-504-00-5
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate
422-670-7
-
Repr. Cat. 3; R62
T; R25
Xn; R48/22
N; R50-53
T; N
R: 25-48/22-62-50/53
S: (1/2-)36/37-45-60-61



607-505-00-0
pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate
422-930-1

R52-53
R: 52/53
S: 22-61


607-506-00-6
reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate
422-970-8

N; R51-53
N
R: 51/53
S: 22-61


607-507-00-1
potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate
422-980-2
187026-95-5
Xi; R41
Xi
R: 41
S: (2-)22-26-39


607-508-00-7
disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]
423-110-4
—
Xi; R41
Xi
R: 41
S: (2-)22-26-39




607-509-00-2
2-phenoxyethyl 4-aminobenzoate
430-880-5
88938-23-2
N; R51-53
N
R: 51/53
S: 61



607-510-00-8
(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
427-200-4
76646-91-8
Xn; R22
Xi; R38-41
R43
Xn
R: 22-38-41-43
S: (2-)24-26-37/39



607-511-00-3
reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid
423-750-4
-
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61



607-512-00-9
trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate
423-970-0
182926-43-8
R52-53
R: 52/53
S: 22-61


607-513-00-4
reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid
423-200-3
—
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-26-36/37/39-61




607-514-00-X
potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate
427-240-2
134841-35-3
R43
Xi
R: 43
S: (2-)24-37



607-515-00-5
reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate
429-650-7
147732-60-3
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


607-516-00-0
N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine
429-670-6
105996-54-1
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39


607-517-00-6
(S)-α-(acetylthio)benzenepropanoic acid
430-300-0
76932-17-7
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)22-26-36/37/39




607-518-00-1
3-oxoandrost-4-ene-17-β-carboxylic acid
414-990-0
302-97-6
Repr. Cat. 3; R62
R53
Xn
R: 62-53
S: (2-)36/37-61



607-519-00-7
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-280-0
176429-27-9
Xi; R37/38-41
N; R50-53
Xi; N
R: 37/38-41-50/53
S: (2-)26-37/39-60-61



607-520-00-2
reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate
427-740-0
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39



607-521-00-8
tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate
429-270-1
136210-30-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)36/37-61



607-522-00-3
sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate
429-720-7
184246-86-4
R52-53
R: 52/53
S: 61



607-523-00-9
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6', 13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6', 3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
430-200-7
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



607-524-00-4
tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters
430-310-5
-
R53
R: 53
S: 61



607-525-00-X
(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid
431-520-1
64485-90-1
E; R2
Carc. Cat. 3; R40
R52-53
E; Xn
R: 2-40-52/53
S: (2-)23-25-35-36/37-61



607-526-00-5
cartap (ISO);
1,3-bis(carbamoylthio)-2-(dimethylamino)propane
—
15263-53-3
N; R50-53
N
R: 50/53
S: 60-61


607-527-00-0
reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate
423-180-6
—
Xn; R48/22
Xn
R: 48/22
S: (2-)36




607-528-00-6
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid
430-900-2
192725-50-1
Xi; R41
Xi
R: 41
S: (2-)26-39



607-529-00-1
benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate
426-070-6
67299-45-0
R52-53
R: 52/53
S: 61



607-530-00-7
reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate
406-040-9
125643-61-0
R53
R: 53
S: 61



607-531-00-2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate
425-190-6
119916-05-1
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)22-36-61



607-532-00-8
(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt
425-510-4
167944-94-7
R52-53
R: 52/53
S: 61



607-533-00-3
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
414-910-4
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



607-534-00-9
ethyl 2-(3-benzoylphenyl)propanoate
414-920-9
60658-04-0
T; R25-48/25
R43
N; R51-53
T; N
R: 25-43-48/25-51/53
S: (1/2-)36/37-45-61



607-535-00-4
potassium 4-iodo-2-sulfonato-benzoic acid
426-620-5
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



607-536-00-X
(2,6-xylyloxy) acetic acid
430-910-7
13335-71-2
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)26-39-61



607-537-00-5
isopropylammonium 2-(3-benzoylphenyl)propionate
417-970-1
-
T; R25-48/25
Xn; R21
Xi; R41
N; R50-53
T; N
R: 21-25-41-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61



607-539-00-6
propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate
431-000-2
198705-81-6
R53
R: 53
S: 61



607-540-00-1
1-(mercaptomethyl)cyclopropylacetic acid
420-240-3
162515-68-6
C; R34
Xn; R21/22
R43
N; R51-53
C; N
R: 21/22-34-43-51/53
S: (1/2-)22-26-36/37/39-45-61



607-541-00-7
[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)
421-940-1
28698-31-9
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61



607-542-00-2
methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate
422-110-1
-
N; R50-53
N
R: 50/53
S: 60-61



607-543-00-8
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]
427-480-8
176429-22-4
Xi; R37/38-41
N; R50-53
Xi; N
R: 37/38-41-50/53
S: (2-)26-37/39-60-61



607-544-00-3
ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate
427-490-2
158585-86-5
R52-53
R: 52/53
S: 61



607-545-00-9
1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate
424-070-0
94346-09-5
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61



607-546-00-4
reaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]methoxycarbonylmethylamino[}acetate;
methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]ethoxycarbonylmethylamino[}acetate
424-290-7
188070-47-5
R43
Xi
R: 43
S: (2-)22-24-37



607-547-00-X
18-methylnonadecyl 2,2 -dimethylpropanoate
424-370-1
125496-22-2
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)24-37-61



607-548-00-5
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate
431-010-7
154486-26-7
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



607-549-00-0
methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate
424-430-7
125778-19-0
N; R50-53
N
R: 50/53
S: 60-61



607-550-00-6
2-amino-4-bromo-5-chlorobenzoic acid
424-700-4
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



607-551-00-1
tetrabutylammonium 2-amino-6-iodopurinate
424-710-9
156126-48-6
Xn; R21/22-48/22
Xi; R38-41
R43
N; R51-53
Xn; N
R: 21/22-38-41-43-48/22-51/53
S: (2-)26-36/37/39-61



607-552-00-7
hexadecyl 3-amino-4-isopropoxybenzoate
424-830-1
-
R53
R: 53
S: 35-61



607-553-00-2
7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt
424-850-0
-
Xi; R41
Xi
R: 41
S: (2-)26-39



607-554-00-8
2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid
424-870-1
27624-67-5
E; R3
Xi; R41
R52-53
E; Xi
R: 3-41-52/53
S: (2-)22-26-35-39-61



607-555-00-3
1,1,3,3-tetramethylbutylperoxypivalate
424-980-8
22288-41-1
F; R11
O; R7
Xi; R38
R43
N; R51-53
F; O; Xi; N
R: 7-11-38-43-51/53
S: (2-)7-14-16-36/37/39-47-61



607-556-00-9
2-acetoxymethylene-4-acetylphenylacetate
425-160-2
24085-06-1
Xn; R22-48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61



607-557-00-4
salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid
425-210-3
169939-84-8
R43
Xi
R: 43
S: (2-)24-37



607-558-00-X
2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate
425-250-1
147027-10-9
N; R51-53
N
R: 51/53
S: 61



607-559-00-5
coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid
425-400-6
179986-09-5
R53
R: 53
S: 61



607-560-00-0
(R,S)-2-butyloctanedioic acid
431-210-4
50905-10-7
Xi; R41
Xi
R: 41
S: (2-)26-39



607-561-00-6
sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate
425-460-3
-
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



607-562-00-1
reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;
(2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate
425-530-3
98769-75-6
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



607-563-00-7
5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid
431-250-2
171850-30-9
N; R51-53
N
R: 51/53
S: 61



607-564-00-2
1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate
425-730-0
51178-75-7
R43
Xi
R: 43
S: (2-)24-37



607-565-00-8
3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
425-820-1
88150-42-9
T; R25
Xn; R48/22
Xi; R41
N; R50-53
T; N
R: 25-41-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61



607-566-00-3
reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate
426-140-6
-
R53
R: 53
S: 61



607-567-00-9
potassium 3-iodo-6-methylbenzenesulfonate
426-300-5
-
Xi; R41
Xi
R: 41
S: (2-)26-39



607-568-00-4
potassium 2-chloro-3-(benzyloxy)propionate
426-350-8
138666-92-9
Xn; R22-48/22
Xi; R41
R43
Xn
R: 22-41-43-48/22
S: (2-)26-36/37/39



607-569-00-X
reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;
sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate
426-470-0
-
R43
Xi
R: 43
S: (2-)22-24-37



607-570-00-5
sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate
426-520-1
71420-85-4
R43
Xi
R: 43
S: (2-)24-37



607-571-00-0
2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate
431-400-7
57374-49-9
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



607-572-00-6
diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate
426-790-0
162208-27-7
Xn; R21/22-48/22
R43
N; R50-53
Xn; N
R: 21/22-43-48/22-50/53
S: (2-)36/37-60-61



607-573-00-1
reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;
disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate
426-840-1
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-574-00-7
[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate
426-890-4
77341-67-4
Xi; R41
Xi
R: 41
S: (2-)26-39



607-575-00-2
4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt
426-900-7
-
Xi; R37
R52-53
Xi
R: 37-52/53
S: (2-)61



607-576-00-8
branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate
427-030-0
-
N; R50-53
N
R: 50/53
S: 60-61



607-577-00-3
(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate
427-100-0
-
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)22-24-26-37/39-61



607-578-00-9
ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate
427-110-5
-
Xn; R22-48/22
R53
Xn
R: 22-48/22-53
S: (2-)36-61



607-579-00-4
diethyl[(p-ethoxyanilino)methylene]malonate
431-430-0
103976-28-9
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61



607-580-00-X
ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate
422-360-1
100491-29-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61



607-581-00-5
ethyl 2-ethoxy-4-carboxymethylbenzoate
427-630-2
99469-99-5
Xi; R41
Xi
R: 41
S: (2-)26-39



607-582-00-0
reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
427-650-1
-
R52-53
R: 52/53
S: 22-61



607-583-00-6
4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid
427-680-5
188907-52-0
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61



607-584-00-1
trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate
427-710-7
215612-56-9
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61



607-585-00-7
strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate
427-930-3
-
R43
Xi
R: 43
S: (2-)22-24-37



607-586-00-2
dodecyl 3-amino-4-chlorobenzoate
428-020-9
6195-20-6
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



607-587-00-8
ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate
428-030-3
67914-69-6
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)36-60-61



607-588-00-3
reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate
428-050-2
-
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)36/37-60-61



607-589-00-9
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate
428-070-1
91788-83-9
T; R48/25
Xn; R22
N; R50-53
T; N
R: 22-48/25-50/53
S: (1/2-)22-36-45-57-60-61



607-590-00-4
hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate
428-140-1
210706-50-6
R53
R: 53
S: 61



607-591-00-X
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate
428-400-4
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-592-00-5
di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate
428-870-0
-
R53
R: 53
S: 61



607-593-00-0
4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate
429-000-2
159235-16-2
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



607-594-00-6
ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
429-020-1
204254-96-6
Xn; R48/22
R43
Xn
R: 43-48/22
S: (2-)22-36/37



607-595-00-1
N-amidino-N-methylglycine-2-oxopropionate
429-120-5
208535-04-0
Xi; R41
Xi
R: 41
S: (2-)26-39



607-596-00-7
ethyl 2-(4-phenoxyphenyl)lactate
429-220-9
132584-17-9
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)36/37-57-60-61



607-597-00-2
tetrasodium 4,4'-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2'-disulfonate
429-230-3
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-598-00-8
trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate
429-240-8
212652-59-0
Xi; R41
Xi
R: 41
S: (2-)26-39



607-599-00-3
1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate
431-610-9
68860-54-8
O; R7
R43
N; R50-53
O; Xi; N
R: 7-43-50/53
S: (2-)3-14-36/37/39-60-61



607-600-00-7
(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate
431-700-8
-
N; R51-53
N
R: 51/53
S: 61



607-601-00-2
1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate
429-370-5
220410-74-2
Xn; R22
Xn
R: 22
S: (2-)



607-602-00-8
ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate
429-680-0
122665-86-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



607-603-00-3
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate
429-730-1
193562-37-7
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



607-604-00-9
guanidinium benzoate
429-820-0
26739-54-8
Xn; R22
Xn
R: 22
S: (2-)22-25



607-605-00-4
methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate
429-890-2
144550-06-1
N; R50-53
N
R: 50/53
S: 60-61



607-606-00-X
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
430-100-3
86978-24-7
Xn; R22
Xn
R: 22
S: (2-)22



607-607-00-5
reaction mass of: calcium bis(C10-14 branched alkyl salicylate);
calcium bis(C18-30-alkyl salicylate);
calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;
calcium bis (C10-14 branched alkyl phenolate);
calcium bis (C18-30-alkyl phenolate);
calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;
C10-14 branched alkyl phenol;
C18-30-alkyl phenol
430-180-1
-
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)24-37-61



607-608-00-0
pentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate
430-210-1
-
N; R50-53
N
R: 50/53
S: 60-61



607-609-00-6
ethyl (3R)-4-cyano-3-hydroxybutanoate
430-220-6
141942-85-0
Xi; R36
Xi
R: 36
S: (2-)26



607-610-00-1
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate
430-280-3
-
R43
Xi
R: 43
S: (2-)22-24-37



607-611-00-7
methyl 3-amino-2,2,3-trimethylbutyrate
431-720-7
90886-53-6
C; R34
Xn; R22
R52-53
C
R: 22-34-52/53
S: (1/2-)23-26-36/37/39-45-61



607-612-00-2
reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate
432-190-1
182176-52-9
Xn; R22-48/22
Xi; R41
Xn
R: 22-41-48/22
S: (2-)26-36/37/39



607-613-00-8
reaction mass of: succinic acid;
monopersuccinic acid;
dipersuccinic acid;
monomethyl ester of succinic acid;
monomethyl ester of persuccinic acid;
dimethyl succinate;
glutaric acid;
monoperglutaric acid;
diperglutaric acid;
monomethyl ester of glutaric acid;
monomethyl ester of perglutaric acid;
dimethyl glutarate;
adipic acid;
monoperadipic acid;
diperadipic acid;
monomethyl ester of adipic acid;
monomethyl ester of peradipic acid;
dimethyl adipate;
hydrogen peroxide;
methanol;
water
432-790-1
-
Muta. Cat. 3; R68
C; R34
Xn; R20/21/22
C
R: 20/21/22-34-68
S: (1/2-)26-28-36/37/39-45



607-614-00-3
2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid
426-480-5
63562-33-4
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



607-615-00-9
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance
431-120-5
-
T; R23
Xn; R22
Xi; R36
R43
T
R: 22-23-36-43
S: (1/2-)24-26-37-45



607-616-00-4
2,4-dichloro-5-fluorobenzoylchloride
428-390-1
86393-34-2
Xi; R37/38-41
R43
R52-53
Xi
R: 37/38-41-43-52/53
S: (2-)24-26-37/39-61



607-617-00-X
bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate
430-700-5
10138-36-0
R43
Xi
R: 43
S: (2-)24-37



607-618-00-5
menadione sodium bisulfite;
2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61



607-619-00-0
menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61



607-620-00-6
trisodium nitrilotriacetate
225-768-6
5064-31-3
Carc. Cat. 3; R40
Xn; R22
Xi; R36
Xn
R: 22-36-40
S: (2-)26-36/37-46
Carc. Cat. 3; R40: C ≥ 5 %


607-621-00-1
milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
-
-
Xn; R20/22
N; R50-53
Xn; N
R: 20/22-50/53
S: (2-)46-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


607-622-00-7
2-ethylhexyl-2-ethylhexanoate
231-057-1
7425-14-1
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)36/37



607-623-00-2
diisobutyl phthalate
201-553-2
84-69-5
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-62
S: 53-45
Repr. Cat. 2; R61: C ≥ 25 %
Repr. Cat. 3; R62: C ≥ 5 %


607-624-00-8
perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. Cat. 3; R40
Repr. Cat. 2; R61
T; R48/25
Xn; R20/22
R64
N; R51-53
T; N
R: 61-20/22-40-48/25-64-51/53
S: 53-45-61

E

607-625-00-3
clodinafop-propargyl (ISO)
-
105512-06-9
Xn; R22-48/22
R43
N; R50-53.
Xn; N
R: 22-43-48/22-50/53
S: (2-)24-36/37-46-60-61
R43: C ≥ 0,001 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


607-626-00-9
ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
401-290-5
103112-35-2
Carc. Cat.2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61



607-627-00-4
[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate
416-360-0
162221-28-5
R43
Xi
R: 43
S: (2-)22-24-37



607-628-00-X
4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine
419-240-6
171054-89-0
Xi; R41
Xi
R: 41
S: (2-)26-39



607-629-00-5
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid
419-270-1
123599-82-6
Xi; R36
Xi
R: 36
S: (2-)26



607-630-00-0
acrylic acid, 3-(trimethoxysilyl)propyl ester
419-560-6
4369-14-6
Xn; R20
C; R34
R43
R52-53
C
R: 20-34-43-52/53
S: (1/2-)26-36/37/39-45-61



607-631-00-6
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate
442-300-8
-
R43
Xi
R: 43
S: (2-)24-37



607-632-00-1
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide
420-210-1
111244-14-5
R53
R: 53
S: 61



607-633-00-7
trisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate
440-480-2
341026-59-3
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



607-634-00-2
(S)-(-)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate
420-610-4
36394-75-9
Xn; R22
C; R34
R43
C
R: 22-34-43
S: (1/2-)23-26-36/37/39-45



607-635-00-8
trisodium N-(3-propionato)-l-aspartate
422-090-4
172737-80-3
Xi; R41
Xi
R: 41
S: (2-)26-39



607-636-00-3
1-bromo-2-methylpropyl propionate
422-900-6
158894-67-8
R10
Carc. Cat.3; R40
C; R34
R43
C
R: 10-34-40-43
S: (1/2-)7/9-8-23-26-36/37/39-45



607-637-00-9
disodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[}naphthalene-2-sulfonate
423-730-5
250688-43-8
Xi; R41
Xi
R: 41
S: (2-)26-39



607-638-00-4
2-hydroxybenzoic acid 2-butyloctyl ester
431-090-3
190085-41-7
R53
R: 53
S: 61



607-639-00-X
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate
431-770-1
216698-07-6
R53
R: 53
S: 61



607-641-00-0
2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid
431-930-9
43028-69-9
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37



607-642-00-6
3,6,9-trithiaundecamethylene-1,11-dimethacrylate
432-210-7
141631-22-3
N; R50-53
N
R: 50/53
S: 60-61



607-643-00-1
dimethyl (2S)-2-hydroxysuccinate
432-310-0
617-55-0
R10
Xi; R41
R43
Xi
R: 10-41-43
S: (2-)24-26-37/39-43



607-644-00-7
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate
432-350-9
81752-87-6
Xi; R38
Xi
R: 38
S: (2-)37



607-645-00-2
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate
432-550-6
243858-01-7
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-646-00-8
d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;
tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Xn; R22
Xn
R: 22
S: (2-)25



607-647-00-3
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane
433-530-1
143446-73-5
Xn; R22
R43
N; R50
Xn; N
R: 22-43-50
S: (2-)24-37-57-61



607-649-00-4
[3-(chlorocarbonyl)-2-methylphenyl]acetate
433-690-0
167678-46-8
C; R35
R43
C
R: 35-43
S: (1/2-)7/8-26-36/37/39-45



607-650-00-X
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate
433-910-5
145153-52-2
R43
Xi
R: 43
S: (2-)24-37



607-651-00-5
sodium 2-(nonanoyloxy)benzenesulfonate
434-360-9
91125-43-8
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39



607-652-00-0
ethyl N2-dodecanoyl-l-argininate hydrochloride
434-630-6
60372-77-2
Xi; R41
N; R50
Xi; N
R: 41-50
S: (2-)26-39-61



607-653-00-6
tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate
434-840-8
225786-91-4
N; R51-53
N
R: 51/53
S: 61



607-654-00-1
(S)-3-hydroxy-γ-butyrolactone
434-990-4
7331-52-4
R43
Xi
R: 43
S: (2-)23-24-37



607-655-00-7
ethyl 6,8-dichlorooctanoate
435-080-1
1070-64-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



607-656-00-2
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid
435-350-7
141250-43-3
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61



607-657-00-8
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
436-920-8
172399-10-9
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-658-00-3
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9
371921-63-0
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



607-659-00-9
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid
442-030-0
321912-47-4
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-660-00-4
2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{]phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8
321679-52-1
Xi; R41
Xi
R: 41
S: (2-)22-26-39



607-661-00-X
1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate
442-850-9
114772-40-6
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61



607-662-00-5
methyl 2-(acetylamino)-3-chloropropionate
442-860-3
87333-22-0
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61



607-663-00-0
bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate
442-980-6
127474-91-3
R53
R: 53
S: 61



607-664-00-6
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate
443-120-2
393509-79-0
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61



607-665-00-1
trans-methyl-2-ethyl-but-2-enoate
443-150-6
101226-85-1
R10
R: 10
S: 23



607-666-00-7
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid
443-560-5
88784-33-2
Xi; R36
Xi
R: 36
S: (2-)26



607-667-00-2
chloro-1-ethylcyclohexyl carbonate
444-950-8
99464-83-2
Muta. Cat.3; R68
R43
Xn
R: 43-68
S: (2-)23-36/37



607-668-00-8
trans-2-isopropyl-5-carboxy-1,3-dioxane
445-770-2
42031-28-7
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61



607-669-00-3
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate
445-990-9
376588-17-9
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



607-670-00-9
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate
448-700-9
500791-70-8
Xn; R48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


607-671-00-4
diethyl 1,4-cyclohexanedicarboxylate
417-310-0
72903-27-6
N; R51-53
N
R: 51/53
S: 61



607-672-00-X
reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



607-673-00-5
1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate
419-570-0
-
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61



607-675-00-6
reaction mass of: cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid
422-260-8
-
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61



607-676-00-1
reaction mass of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid
423-670-1
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39



607-677-00-7
2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate
424-660-8
-
Xn; R48/22
Xi; R41
R43
Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39



607-678-00-2
reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate
427-090-8
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)23-25-36/37-61



607-679-00-8
reaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate);
3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate);
3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate)
431-440-5
-
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)22-26-39-61



607-680-00-3
tert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{]pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
432-810-9
-
R53
R: 53
S: 61



607-681-00-9
reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate
432-910-2
-
R53
R: 53
S: 61



607-682-00-4
complex reaction mass of Chinese gum rosin post reacted with acrylic acid
434-230-1
144413-22-9
R53
R: 53
S: 61



607-683-00-X
reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)
435-450-0
-
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



607-684-00-5
alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts
435-660-2
243662-67-1
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37



607-685-00-0
ammonium 2-cocoyloxyethanesulfonate
441-050-7
-
Xi; R38-41
Xi
R: 38-41
S: (2-)26-37/39



607-686-00-6
6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
441-550-5
-
E; R2
F; R11
Carc. Cat. 3; R40
E; Xn
R: 2-11-40
S: (2-)7-22-36/37



607-687-00-1
reaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);
2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %)
442-800-6
-
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61



607-688-00-7
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride
444-320-2
-
Xn; R22
Xn
R: 22
S: (2-)



607-689-00-2
reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers)
444-920-4
-
R52-53
R: 52/53
S: 61



607-690-00-8
dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate
432-860-1
255387-46-3
R43
Xi
R: 43
S: (2-)24-37



607-691-00-3
magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
448-690-6
-
R53
R: 53
S: 61



607-692-00-9
zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
446-470-4
-
R53
R: 53
S: 61



607-693-00-4
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate
443-860-6
302776-68-7
R53
R: 53
S: 61



607-694-00-X
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate
443-870-0
163520-33-0
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-36/37-60-61



608-001-00-3
acetonitrile;
cyanomethane
200-835-2
75-05-8
F; R11
Xn; R20/21/22
Xi; R36
F; Xn
R: 11-20/21/22-36
S: (2-)16-36/37


608-002-00-9
trichloroacetonitrile
208-885-7
545-06-2
T; R23/24/25
N; R51-53
T; N
R: 23/24/25-51/53
S: (1/2-)45-61


608-003-00-4
acrylonitrile
203-466-5
107-13-1
F; R11
Carc. Cat. 2; R45
T; R23/24/25
Xi; R37/38-41
R43
N; R51-53
F; T; N
R: 45-11-23/24/25-37/38-41-43-51/53
S: - 53-45-61
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 %
D E
608-004-00-X
2-hydroxy-2-methylpropionitrile;
2-cyanopropan-2-ol;
acetone cyanohydrin
200-909-4
75-86-5
T+; R26/27/28
N; R50-53
T+; N
R: 26/27/28-50/53
S: (1/2-)7/9-27-45-60-61




608-005-00-5
n-butyronitrile
203-700-6
109-74-0
F; R11
T; R23/24/25
F; T
R: 11-23/24/25
S: (1/2-)16-36/37-45-63



608-006-00-0
bromoxynil (ISO)
3,5-dibromo-4-hydroxybenzonitrile;
bromoxynil phenol
216-882-7
1689-84-5
Repr. Cat. 3; R63
T+; R26
T; R25
R43
N; R50-53
T+; N
R: 25-26-43-63-50/53
S: (1/2-)27/28-36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

608-007-00-6
ioxynil (ISO)
4-hydroxy-3,5-diiodobenzonitrile
216-881-1
1689-83-4
Repr. Cat. 3; R63
T; R23/25
Xn; R21-48/22
Xi; R36
N; R50-53
T; N
R: 21-23/25-36-48/22-63-50/53
S: (1/2-)36/37-45-60-61-63
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

608-008-00-1
chloroacetonitrile
203-467-0
107-14-2
T; R23/24/25
N; R51-53
T; N
R: 23/24/25-51/53
S: (1/2-)45-61


608-009-00-7
malononitrile
203-703-2
109-77-3
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)23-27-45-60-61


608-010-00-2
methacrylonitrile;
2-methyl-2-propene nitrile
204-817-5
126-98-7
F; R11
T; R23/24/25
R43
F; T
R: 11-23/24/25-43
S: (1/2-)9-16-18-29-45
T; R23/24/25: C ≥ 1 %
Xn; R20/21/22: 0,2 % ≤ C < 1 %
R43: C ≥ 0,2 %
D


608-011-00-8
oxalonitrile;
cyanogen
207-306-5
460-19-5
F+; R12
T; R23
N; R50-53
F+; T; N
R: 12-23-50/53
S: (1/2-)9-16-23-33-45-63-60-61



608-012-00-3
benzonitrile
202-855-7
100-47-0
Xn; R21/22
Xn
R: 21/22
S: (2-)23


608-013-00-9
2-chlorobenzonitrile
212-836-5
873-32-5
Xn; R21/22
Xi; R36
Xn
R: 21/22-36
S: (2-)23




608-014-00-4
chlorothalonil (ISO);
tetrachloroisophthalonitrile
217-588-1
1897-45-6
Carc. Cat. 3; R40
T+; R26
Xi; R37-41
R43
N; R50-53
T+; N
R: 26-37-40-41-43-50/53
S: (1/2-)28-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


608-015-00-X
dichlobenil (ISO);
2,6-dichlorobenzonitrile
214-787-5
1194-65-6
Xn; R21
N; R51-53
Xn; N
R: 21-51/53
S: (2-)36/37-61


608-016-00-5
1,4-Dicyano-2,3,5,6-tetra-chloro-benzene
401-550-8
1897-41-2
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


608-017-00-0
bromoxynil octanoate (ISO);
2,6-dibromo-4-cyanophenyl octanoate
216-885-3
1689-99-2
Repr. Cat. 3; R63
T; R23
Xn; R22
R43
N; R50-53
T; N
R: 22-23-43-63-50/53
S: (1/2-)36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

608-018-00-6
ioxynil octanoate (ISO);
4-cyano-2,6-diiodophenyl octanoate
223-375-4
3861-47-0
Repr. Cat. 3; R63
T; R25
Xi; R36
R43
N; R50-53
T; N
R: 25-36-43-63-50/53
S: (1/2-)26-36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

608-019-00-1
2,2'-dimethyl-2,2'-azodipropiononitrile;
ADZN
201-132-3
78-67-1
E; R2
F; R11
Xn; R20/22
R52-53
E; Xn
R: 2-11-20/22-52/53
S: (2-)39-41-47-61




608-020-00-7
diphenoxymethylenecyanamide
427-300-8
79463-77-7
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



608-021-00-2
3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile
403-710-2
76823-93-3
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37


608-022-00-8
3,7-dimethyloctanenitrile
403-620-3
40188-41-8
Xi; R38
R43
N; R51-53
Xi; N
R: 38-43-51/53
S: (2-)36/37-61


608-023-00-3
fenbuconazole (ISO)
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
406-140-2
114369-43-6
N; R50-53
N
R: 50/53
S: 60-61


608-024-00-9
2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile
407-650-8
97460-76-9
R53
R: 53
S: 61


608-025-00-4
2-nitro-4,5-bis(benzyloxy)phenylacetonitrile
410-970-0
117568-27-1
R53
R: 53
S: 61


608-026-00-X
3-cyano-3,5,5-trimethylcyclohexanone
411-490-4
7027-11-4
Xn; R22-48/22
R43
R52-53
Xn
R: 22-43-48/22-52/53
S: (2-)36/37-61


608-027-00-5
reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(3-ethylphenyl)-2,2-dimethylpropanenitrile
412-660-0
—
N; R51-53
N
R: 51/53
S: 61


608-028-00-0
4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate
413-510-7
147374-67-2
Xn; R48/20/21
R43
N; R51-53
Xn; N
R: 43-48/20/21-51/53
S: (2-)36/37-61


608-029-00-6
1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile
411-990-2
68612-94-2
R43
Xi
R: 43
S: (2-)24-37


608-030-00-1
N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide
412-340-0
147741-93-3
N; R50-53
N
R: 50/53
S: 60-61


608-031-00-7
2-benzyl-2-methyl-3-butenitrile
407-870-4
97384-48-0
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61




608-032-00-2
acetamiprid (ISO);
(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
-
135410-20-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)46-61




608-033-00-8
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide
407-970-8
75511-91-0
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61




608-034-00-3
chlorfenapyr (ISO);
4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
—
122453-73-0
T; R23
Xn; R22
N; R50-53
T; N
R: 22-23-50/53
S: (1/2-)13-36/37-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


608-035-00-9
(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile
419-290-9
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


608-036-00-4
3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile
419-060-8
79026-02-1
R53
R: 53
S: 61


608-037-00-X
reaction mass of: (E)-2,12-tridecadiennitrile;
(E)-3,12-tridecadiennitrile;
(Z)-3,12-tridecadiennitrile
422-190-8

N; R50-53
N
R: 50/53
S: 60-61


608-038-00-5
2,2,4-trimethyl-4-phenyl-butane-nitrile
422-580-8
75490-39-0
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


608-039-00-0
2-phenylhexanenitrile
423-460-8
3508-98-3
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)23-60-61


608-040-00-6
4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)
423-490-1
130755-46-3
N; R50-53
N
R: 50/53
S: 60-61


608-041-00-1
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile
423-500-4
138401-24-8
N; R50-53
N
R: 50/53
S: 60-61




608-042-00-7
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide
421-810-4
194602-27-2
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61



608-043-00-2
3-(cis-3-hexenyloxy)propanenitril
415-220-6
142653-61-0
T; R23
Xn; R22
N; R50-53
T; N
R: 22-23-50/53
S: (1/2-)13-36/37-45-60-61




608-044-00-8
2-cyclohexylidene-2-phenylacetonitrile
423-740-1
10461-98-0
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)46-61



608-046-00-9
5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile
425-310-7
77889-90-8
R53
R: 53
S: 61



608-047-00-4
2-piperidin-1-yl-benzonitrile
427-330-1
72752-52-4
N; R51-53
N
R: 51/53
S: 61



608-048-00-X
1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile
427-450-4
152630-47-2
Xn; R22-48/22
R43
N; R51-53
Xn; N
R: 22-43-48/22-51/53
S: (2-)36/37-61



608-049-00-5
2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile
429-180-2
157362-53-3
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61



608-050-00-0
reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile
429-760-5
-
R53
R: 53
S: 61



608-051-00-6
(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-760-2
219861-18-4
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)36/37-61



608-052-00-1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-770-7
128173-52-4
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)36/37-61



608-053-00-7
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile
430-780-1
103146-25-4
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)36/37-61



608-054-00-2
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate
430-790-6
-
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)22-26-36/37/39-61



608-055-00-8
fipronil (ISO);
5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
-
120068-37-3
T; R23/24/25-48/25
N; R50-53
T; N
R: 23/24/25-48/25-50/53
S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


608-056-00-3
N-methyl-N-cyanomethylmorpholiniummethylsulfate
429-340-1
-
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)22-26-39



608-057-00-9
4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate
431-200-1
208538-34-5
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)22-24-26-37/39



608-059-00-X
5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
421-240-6
120068-79-3
N; R51-53
N
R: 51/53
S: 22-61



608-060-00-5
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
421-300-1
138564-59-7
N; R50-53
N
R: 50/53
S: 22-60-61



608-062-00-6
2-fluoro-4-hydroxybenzonitrile
422-810-7
82380-18-5
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



608-063-00-1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile
441-070-6
61826-76-4
T; R25
Xi; R41
R43
N; R50-53
T; N
R: 25-41-43-50/53
S: (1/2-)9-26-36/37/39-45-60-61



608-064-00-7
cyanomethyltrimethylammoniummethylsulfate
433-720-2
-
R52-53
R: 52/53
S: 61



608-065-00-2
salts of bromoxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. Cat. 3; R63
T+; R26
T; R25
R43
N; R50-53
T+; N
R: 25-26-43-50/53
S: (1/2-)27/28-36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
A
608-066-00-8
salts of ioxynil with the exception of those specified elsewhere in this Annex
—
—
Repr. Cat. 3; R63
T; R23/25
Xn; R21-48/22
Xi; R36
N; R50-53
T; N
R: 21-23/25-36-48/22-63-50/53
S: (1/2-)36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %
A
609-001-00-6
1-nitropropane
203-544-9
108-03-2
R10
Xn; R20/21/22
Xn
R: 10-20/21/22
S: (2-)9
Xn; R20/21/22: C ≥ 5 %

609-002-00-1
2-nitropropane
201-209-1
79-46-9
R10
Carc. Cat. 2; R45
Xn; R20/22
T
R: 45-10-20/22
S: 53-45

E
609-003-00-7
nitrobenzene
202-716-0
98-95-3
Carc. Cat. 3; R40
Repr. Cat. 3; R62
T; R23/24/25-48/23/24
N; R51-53
T; N
R: 23/24/25-40-48/23/24-51/53-62
S: (1/2-)28-36/37-45-61


609-004-00-2
dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4]
246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4]
25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4]
T+; R26/27/28
R33
N; R50-53
T+; N
R: 26/27/28-33-50/53
S: (1/2-)28-36/37-45-60-61




609-005-00-8
1,3,5-trinitrobenzene
202-752-7
99-35-4
E; R3
T+; R26/27/28
R33
N; R50-53
E; T+; N
R: 3-26/27/28-33-50/53
S: (1/2-)28-36/37-45-60-61



609-006-00-3
4-nitrotoluene
202-808-0
99-99-0
T; R23/24/25
R33
N; R51-53
T; N
R: 23/24/25-33-51/53
S: (1/2-)28-37-45-61




609-007-00-9
2,4-dinitrotoluene; [1]
dinitrotoluene [2]
204-450-0 [1]
246-836-1 [2]
121-14-2 [1]
25321-14-6 [2]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53
T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61

E


609-008-00-4
2,4,6-trinitrotoluene;
TNT
204-289-6
118-96-7
E; R2
T; R23/24/25
R33
N; R51-53
E; T; N
R: 2-23/24/25-33-51/53
S: (1/2-)35-45-61




609-009-00-X
2,4,6-trinitrophenol;
picric acid
201-865-9
88-89-1
E; R3
R4
T; R23/24/25
E; T
R: 3-4-23/24/25
S: (1/2-)28-35-36/37-45



609-010-00-5
salts of picric acid
—
—
E; R3
T; R23/24/25
E; T
R: 3-23/24/25
S: (1/2-)28-35-37-45

A
609-011-00-0
2,4,6-trinitroanisole
—
606-35-9
E; R2
Xn; R20/21/22
N; R51-53
E; Xn; N
R: 2-20/21/22-51/53
S: (2-)35-61


609-012-00-6
2,4,6-trinitro-m-cresol
210-027-1
602-99-3
E; R2
R4
Xn; R20/21/22
E; Xn
R: 2-4-20/21/22
S: (2-)35


609-013-00-1
2,4,6-trinitro-m-xylene
211-187-5
632-92-8
E; R2
Xn; R20/21/22
R33
E; Xn
R: 2-20/21/22-33
S: (2-)35


609-015-00-2
4-nitrophenol;
p-nitrophenol
202-811-7
100-02-7
Xn; R20/21/22
R33
Xn
R: 20/21/22-33
S: (2-)28


609-016-00-8
dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2]
247-096-2 [1]
275-732-9 [2]
25550-58-7 [1]
71629-74-8 [2]
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)28-37-45-60-61





609-018-00-9
2,4,6-trinitroresorcinol;
styphnic acid
201-436-6
82-71-3
E; R3
R4
Xn; R20/21/22
E; Xn
R: 3-4-20/21/22
S: (2-)35-36/37



609-019-00-4
lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate
239-290-0
15245-44-0
E; R3
Repr. Cat. 1; R61
Repr. Cat. 3; R62
Xn; R20/22
R33
N; R50-53
E; T; N
R: 61-3-20/22-33-50/53-62
S: 53-45-60-61

E
1
609-020-00-X
DNOC (ISO);
4,6-dinitro-o-cresol
208-601-1
534-52-1
Muta. Cat. 3; R68
T+; R26/27/28
Xi; R38-41
R43
R44
N; R50-53
T+; N
R: 26/27/28-38-41-43-44-50/53-68
S: (1/2-)36/37-45-60-61


609-021-00-5
sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC;
potassium 4,6-dinitro-o-cresolate [2]
219-007-7 [1]
[2]
2312-76-7 [1]
5787-96-2 [2]
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)13-45-60-61


609-022-00-0
ammonium salt of DNOC;
ammonium 4,6-dinitro-o-tolyl oxide
221-037-0
2980-64-5
T+; R26/27/28
R33
N; R50-53
T+; N
R: 26/27/28-33-50/53
S: (1/2-)13-28-45-60-61




609-023-00-6
dinocap (ISO);
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which octyl is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups
254-408-0
39300-45-3
Repr. Cat. 2; R61
Xn; R20/22-48/22
Xi; R38
R43
N; R50-53
T; N
R: 61-20/22-38-43-48/22-50/53
S: 53-45-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %
E

609-024-00-1
binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate
207-612-9
485-31-4
Repr. Cat. 2; R61
Xn; R21/22
N; R50-53
T; N
R: 61-21/22-50/53
S: 53-45-60-61

E
609-025-00-7
dinoseb (ISO);
6-sec-butyl-2,4-dinitrophenol
201-861-7
88-85-7
R44
T; R24/25
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R36
N; R50-53
T; N
R: 61-62-24/25-36-44-50/53
S: 53-45-60-61

E
609-026-00-2
salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex
—
—
R44
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R24/25
Xi; R36
N; R50-53
T; N
R: 61-62-24/25-36-44-50/53
S: 53-45-60-61

AE
609-027-00-8
dinocton;
reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate
—
63919-26-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


609-028-00-3
dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol
205-042-5
131-89-5
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61


609-029-00-9
salts and esters of dinex
—
—
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61

A
609-030-00-4
dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol
215-813-8
1420-07-1
Repr. Cat. 2; R61
T+; R28
T; R24
R44
N; R50-53
T+; N
R: 61-24-28-44-50/53
S: 53-45-60-61

E
609-031-00-X
salts and esters of dinoterb
—
—
Repr. Cat. 2; R61
T+; R28
T; R24
N; R50-53
T+; N
R: 61-24-28-50/53
S: 45-53-60-61

AE
609-032-00-5
bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime
236-129-6
13181-17-4
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)25-60-61


609-033-00-0
dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol
—
4097-36-3
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61


609-034-00-6
salts and esters of dinosam
—
—
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)13-45-60-61

A
609-035-00-1
nitroethane
201-188-9
79-24-3
R10
Xn; R20/22
Xn
R: 10-20/22
S: (2-)9-25-41
Xn; R20/22: C ≥ 12,5 %

609-036-00-7
nitromethane
200-876-6
75-52-5
R5-10
Xn; R22
Xn
R: 5-10-22
S: (2-)41
Xn; R22: C ≥ 12,5 %

609-037-00-2
5-nitroacenaphthene
210-025-0
602-87-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45


609-038-00-8
2-nitronaphthalene
209-474-5
581-89-5
Carc. Cat. 2; R45
N; R51-53
T; N
R: 45-51/53
S: 53-45-61


609-039-00-3
4-nitrobiphenyl
202-204-7
92-93-3
Carc. Cat. 2; R45
N; R51-53
T; N
R: 45-51/53
S: 53-45-61


609-040-00-9
nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether
217-406-0
1836-75-5
Carc. Cat. 2; R45
Repr. Cat. 2; R61
Xn; R22
N; R50-53
T; N
R: 45-61-22-50/53
S: 53-45-60-61

E
609-041-00-4
2,4-dinitrophenol
200-087-7
51-28-5
T; R23/24/25
R33
N; R50
T; N
R: 23/24/25-33-50
S: (1/2-)28-37-45-61


609-042-00-X
pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-2
40487-42-1
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-29-37-60-61


609-043-00-5
quintozene (ISO);
pentachloronitrobenzene
201-435-0
82-68-8
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)13-24-37-60-61


609-044-00-0
tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2
117-18-0
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


609-045-00-6
reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;
dinocton-6
—
8069-76-9
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61




609-046-00-1
trifluralin (ISO) (containing < 0,5 ppm NPDA);
α, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA)
216-428-8
1582-09-8
Carc. Cat. 3; R40
R43
N; R50-53
Xn; N
R: 40-43-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


609-047-00-7
2-nitroanisole
202-052-1
91-23-6
Carc. Cat. 2; R45
Xn; R22
T
R: 45-22
S: 53-45

E
609-048-00-2
sodium 3-nitrobenzenesulphonate
204-857-3
127-68-4
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37


609-049-00-8
2,6-dinitrotoluene
210-106-0
606-20-2
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
R52-53
T
R: 45-23/24/25-48/22-62-68-52/53
S: 53-45-61

E
609-050-00-3
2,3-dinitrotoluene
210-013-5
602-01-7
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53
T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61

E
609-051-00-9
3,4-dinitrotoluene
210-222-1
610-39-9
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R51-53
T; N
R: 45-23/24/25-48/22-62-68-51/53
S: 53-45-61

E
609-052-00-4
3,5-dinitrotoluene
210-566-2
618-85-9
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
R52-53
T
R: 45-23/24/25-48/22-62-68-52/53
S: 53-45-61

E
609-053-00-X
hydrazine-trinitromethane
414-850-9
—
E; R3
O; R8
Carc. Cat. 2; R45
T; R23/25
R43
E; T
R: 45-3-8-23/25-43
S: 53-45

E
609-054-00-5
2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5]
200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
[5]
66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
[5]
T; R23/24/25
R33
N; R51-53
T; N
R: 23/24/25-33-51
S: (1/2-)28-37-45-61


609-055-00-0
2,5-dinitrotoluene
210-581-4
619-15-8
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R51-53
T; N
R: 45-23/24/25-48/22-62-68-51/53
S: 53-45-61

E
609-056-00-6
2,2-dibromo-2-nitroethanol
412-380-9
69094-18-4
E; R2
Carc. Cat. 3; R40
Xn; R22-48/22
C; R35
R43
N; R50-53
E; C; N
R: 2-22-35-40-43-48/22-50/53
S: (1/2-)23-26-36/37/39-45-60-61
Xn; R22: C ≥ 10 %
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

609-057-00-1
3-chloro-2,4-difluoronitrobenzene
411-980-8
3847-58-3
Xn; R22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-50/53
S: (1/2-)22-26-28-36/37/39-45-60-61


609-058-00-7
2-nitro-2-phenyl-1,3-propanediol
410-360-4
5428-02-4
T; R39-48/25
Xn; R21/22
Xi; R41
R43
N; R51-53
T; N
R: 21/22-39-41-43-48/25-51/53
S: 53-45-61


609-059-00-2
2-chloro-6-(ethylamino)-4-nitrophenol
411-440-1
131657-78-8
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)22-24-37/39-61


609-060-00-8
4-[(3-hydroxypropyl)amino]-3-nitrophenol
406-305-9
92952-81-3
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


609-061-00-3
(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime
406-100-4
94097-88-8
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


609-062-00-9
2-bromo-2-nitropropanol
407-030-7
24403-04-1
T; R24
Xn; R22-48/22
C; R34
R43
N; R50-53
T; N
R: 22-24-34-43-48/22-50/53
S: (1/2-)26-36/37/39-45-60-61


609-063-00-4
2-[(4-chloro-2-nitrophenyl)amino]ethanol
413-280-8
59320-13-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-61


609-064-00-X
mesotrione (ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
—
104206-82-8
N; R50-53
N
R: 50/53
S: 60-61


609-065-00-5
2-nitrotoluene
201-853-3
88-72-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
Xn; R22
N; R51-53
T; N
R: 45-46-22-62-51/53
S: 53-45-61

E
609-066-00-0
lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
418-870-9
154212-58-5
Xn; R20/21/22-68/20/21/22
Xn
R: 20/21/22-68/20/21/22
S: (2-)36/37


609-067-00-6
sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine
416-280-6
156769-97-0
R43
Xi
R: 43
S: (2-)22-24-37


609-068-00-1
musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-4
81-15-2
E; R2
Carc. Cat. 3; R40
N; R50-53
E; Xn; N
R: 2-40-50/53
S: (2-)36/37-46-60-61




609-069-00-7
musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone
201-328-9
81-14-1
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61



609-070-00-2
1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene
415-580-4
130841-23-5
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)36/37/39-60-61


609-071-00-8
reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol
423-520-3
156137-33-6
R43
Xi
R: 43
S: (2-)22-24-37




609-072-00-3
4-mesyl-2-nitrotoluene
430-550-0
1671-49-4
Repr. Cat. 3; R62
Xn; R22
R43
R52-53
Xn
R: 22-43-62-52/53
S: (2-)22-36/37-61



609-073-00-9
lithium potassium sodium N,N''-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N'-(2-aminoethyl)piperazine
427-850-9
-
R43
Xi
R: 43
S: (2-)22-24-37



610-001-00-3
trichloronitromethane;
chloropicrin
200-930-9
76-06-2
Xn; R22
T+; R26
Xi; R36/37/38
T+
R: 22-26-36/37/38
S: (1/2-)36/37-38-45


610-002-00-9
1,1-dichloro-1-nitroethane
209-854-0
594-72-9
T; R23/24/25
T
R: 23/24/25
S: (1/2-)26-45


610-003-00-4
chlorodinitrobenzene
—
—
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61

C
610-004-00-X
2-chloro-1,3,5-trinitrobenzene
201-864-3
88-88-0
E; R2
T+; R26/27/28
N; R50-53
E; T+; N
R: 2-26/27/28-50/53
S: (1/2-)28-36/37-45-60-61


610-005-00-5
1-chloro-4-nitrobenzene
202-809-6
100-00-5
Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25
Xn; R48/20/21/22
N; R51-53
T; N
R: 23/24/25-40-48/20/21/22-68-51/53
S: (1/2-)28-36/37-45-61


610-006-00-0
chloronitroanilines with the exception of those specified elsewhere in this Annex
—
—
T+; R26/27/28
R33
N; R51-53
T+; N
R: 26/27/28-33-51/53
S: (1/2-)28-36/37-45-61

A C
610-007-00-6
1-chloro-1-nitropropane
209-990-0
600-25-9
Xn; R20/22
Xn
R: 20/22
S: (2-)
Xn; R20/22: C ≥ 5 %

610-008-00-1
2,6-dichloro-4-nitroanisole
403-350-6
17742-69-7
T; R25
N; R51-53
T; N
R: 25-51/53
S: (1/2-)36/37-45-61


610-009-00-7
2-chloro-4-nitroaniline
204-502-2
121-87-9
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-24-61


610-010-00-2
2-bromo-1-(2-furyl)-2-nitroethylene
406-110-9
35950-52-8
Xn; R22-48/22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-48/22-50/53
S: (1/2-)22-26-36/37/39-45-60-61


611-001-00-6
azobenzene
203-102-5
103-33-3
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/22-48/22
N; R50-53
T; N
R: 45-20/22-48/22-68-50/53
S: 53-45-60-61

E
611-002-00-1
azoxybenzene
207-802-1
495-48-7
Xn; R20/22
Xn
R: 20/22
S: (2-)28


611-003-00-7
fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate
205-419-4
140-56-7
T; R25
Xn; R21
R52-53
T
R: 21-25-52/53
S: (1/2-)36/37-45-61


611-004-00-2
methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate
209-765-7
592-62-1
Carc. Cat. 2; R45
Repr. Cat. 2; R61
T
R: 45-61
S: 53-45


611-005-00-8
disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);
CI Direct Brown 95
240-221-1
16071-86-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45


611-006-00-3
4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene
202-591-2
97-56-3
Carc. Cat. 2; R45
R43
T
R: 45-43
S: 53-45


611-007-00-9
tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole
255-559-5
41814-78-2
Xn; R22
Xn
R: 22
S: (2-)


611-008-00-4
4-aminoazobenzene;
4-phenylazoaniline
200-453-6
60-09-3
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


611-009-00-X
sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)
401-220-3
—
Xn; R20
R52-53
Xn
R: 20-52/53
S: (2-)61


611-010-00-5
2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide
403-010-7
106359-94-8
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


611-011-00-0
N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate
403-340-1
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


611-012-00-6
reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
403-410-1
114565-65-0
R43
Xi
R: 43
S: (2-)22-24-26-37


611-013-00-1
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate
403-650-7
117409-78-6
E; R2
N; R51-53
E; N
R: 2-51/53
S: (2-)35-61


611-014-00-7
(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide
404-250-5
115099-55-3
R43
Xi
R: 43
S: (2-)22-24-37


611-015-00-2
tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
404-320-5
116889-78-2
R43
Xi
R: 43
S: (2-)22-24-37


611-016-00-8
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride
404-540-1
—
R43
Xi
R: 43
S: (2-)22-24-37


611-017-00-3
2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide
404-910-2
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


611-018-00-9
tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate
405-130-5
—
R43
Xi
R: 43
S: (2-)24-37


611-019-00-4
tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-150-4
106028-58-4
R43
Xi
R: 43
S: (2-)24-37


611-020-00-X
tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate
405-170-3
116340-05-7
T; R25
R43
R52-53
T
R: 25-43-52/53
S: (1/2-)22-24-37-45-61


611-021-00-5
2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate
405-480-9
—
Xn; R22-48/22
Xi; R38
R53
Xn
R: 22-38-48/22-53
S: (2-)22-36/37-61


611-022-00-0
4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate
404-980-4
—
E; R2
T; R23/25
Xn; R21-48/22
Xi; R41
R43
N; R50/53
E; T; N
R: 2-21-23/25-41-43-48/22-50/53
S: (1/2-)3-12-26-35-36/37/39-45-61


611-023-00-6
disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate
404-600-7
—
R43
X
R: 43
S: (2-)22-24-37


611-024-00-1
Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex
—
—
Carc. Cat. 2; R45
T
R: 45
S: 53-45

A
611-025-00-7
disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38
217-710-3
1937-37-7
Carc. Cat. 2; R45
Repr. Cat. 3; R63
T
R: 45-63
S: 53-45


611-026-00-2
tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6
220-012-1
2602-46-2
Carc. Cat. 2; R45
Repr. Cat. 3; R63
T
R: 45-63
S: 53-45


611-027-00-8
disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);
C.I. Direct Red 28
209-358-4
573-58-0
Carc. Cat. 2; R45
Repr. Cat. 3; R63
T
R: 45-63
S: 53-45




611-028-00-3
C,C'-azodi(formamide)
204-650-8
123-77-3
E; R2
R42
E; Xn
R: 2-42
S: (2-)22-24-37



611-029-00-9
o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex
—
—
Carc. Cat. 2; R45
T
R: 45
S: 53-45

A H
611-030-00-4
o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex
—
—
Carc. Cat. 2; R45
T
R: 45
S: 53-45

A H
611-031-00-X
4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9
209-321-2
569-61-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45


611-032-00-5
1,4,5,8-tetraaminoanthraquinone;
C.I. Disperse Blue 1
219-603-7
2475-45-8
Carc. Cat. 2; R45
Xi; R38-41
R43
T
R: 45-38-41-43
S: 53-45


611-033-00-0
hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)
400-020-3
82027-60-9
N; R51-53
N
R: 51/53
S: 61


611-034-00-6
N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide
402-430-8
105076-77-5
R53
R: 53
S: 61




611-035-00-1
tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate
403-660-1
107246-80-0
N; R51-53
N
R: 51/53
S: 61



611-036-00-7
2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate
405-440-0
—
R43
Xi
R: 43
S: (2-)22-24-37


611-037-00-2
3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate
406-055-0
124584-00-5
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)22-24-26-37/39-61


611-038-00-8
trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate
406-820-9
—
Xi; R36
Xi
R: 36
S: (2-)25-26


611-039-00-3
7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid
407-050-6
117715-57-8
R43
Xi
R: 43
S: (2-)22-24-37


611-040-00-9
3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid
407-670-7
115099-58-6
N; R50-53
N
R: 50/53
S: 60-61


611-041-00-4
2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide
407-680-1
98809-11-1
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61


611-042-00-X
trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate
411-770-6
136213-71-3
R52-53
R: 52/53
S: 61


611-043-00-5
reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)
402-850-1
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


611-044-00-0
reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
403-720-7
117527-94-3
N; R51-53
N
R: 51/53
S: 61


611-045-00-6
2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene
404-830-8
—
R53
R: 53
S: 61


611-046-00-1
4,4'-diamino-2-methylazobenzene
407-590-2
43151-99-1
T; R25
Xn; R48/22
R43
N; R50-53
T; N
R: 25-43-48/22-50/53
S: (1/2-)22-28-36/37-45-60-61


611-047-00-7
reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-890-3
111381-11-4
R53
R: 53
S: 61


611-048-00-2
reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-900-6
111381-12-5
R53
R: 53
S: 61


611-049-00-8
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)
408-000-6
118658-98-3
Xn; R48/22
R43
R52-53
Xn
R: 43-48/22-52/53
S: (2-)22-36/37-61




611-050-00-3
reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate
415-350-3
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61




611-051-00-9
2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride
411-110-7
136213-74-6
N; R50-53
N
R: 50/53
S: 60-61


611-052-00-4
monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex
400-720-9
—
R52-53
R: 52/53
S: 61


611-053-00-X
2,2'-azobis[2-methylpropionamidine] dihydrochloride
221-070-0
2997-92-4
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37


611-055-00-0
C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-8
2832-40-8
Carc. Cat. 3; R40
R43
Xn
R: 40-43
S: (2-)22-36/37-46


611-056-00-6
C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol
212-668-2
842-07-9
Carc. Cat. 3; R40
Muta. Cat. 3; R68
R43
R53
Xn
R: 40-43-53-68
S: (2-)22-36/37-46-61


611-057-00-1
6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile
400-340-3
85136-74-9
Carc. Cat. 2; R45
R53
T
R: 45-53
S: 53-45-61


611-058-00-7
(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate
402-060-7
108225-03-2
Carc. Cat. 2; R45
Xi; R41
N; R51-53
T; N
R: 45-41-51/53
S: 53-45-61


611-059-00-2
octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate
412-960-1
148878-21-1
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61


611-060-00-8
reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
413-180-4
187285-15-0
Xi; R41
Xi
R: 41
S: (2-)22-26-39


611-061-00-3
disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate
412-530-3
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


611-062-00-9
octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate
413-550-5
—
Xi; R38-41
Xi
R: 38-41
S: (2-)22-26-37/39


611-063-00-4
trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)
413-590-3
164058-22-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45


611-064-00-X
4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol
410-600-8
124719-26-2
Xn; R48/22
Xi; R38
N; R50-53
Xn; N
R: 38-48/22-50/53
S: (2-)23-25-36/37-60-61


611-065-00-5
4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol
410-610-2
111850-24-9
Xn; R48/22
Xi; R36/38
R43
N; R50-53
Xn; N
R: 36/38-43-48/22-50/53
S: (2-)23-26-36/37-60-61


611-066-00-0
tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
411-540-5
130201-57-9
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)22-24-26-37/39-61




611-067-00-6
reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;
bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate
406-910-8
—
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61



611-068-00-1
tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
400-690-7
85665-98-1
N; R51-53
N
R: 51/53
S: 61


611-069-00-7
N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline
413-380-1
—
N; R51-53
N
R: 51/53
S: 61


611-070-00-2
reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
405-665-4
—
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


611-071-00-8
tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate
406-073-9
131013-81-5
T; R25
R52-53
T
R: 25-52/53
S: (1/2-)37-45-61


611-072-00-3
2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride
407-010-8
118208-02-9
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)26-39-61


611-073-00-9
dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate
407-310-9
122630-55-1
R53
R: 53
S: 61


611-074-00-4
reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)
407-100-7
—
R43
Xi
R: 43
S: (2-)22-24-37


611-075-00-X
reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)
406-000-0
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


611-076-00-5
3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole
406-280-4
117584-16-4
N; R50-53
N
R: 50/53
S: 60-61


611-077-00-0
dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)
407-230-4
126637-70-5
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37


611-078-00-6
(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate
407-240-9
159604-94-1
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


611-079-00-1
disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate
410-390-8
147703-64-8
Xi; R41
Xi
R: 41
S: (2-)22-26-39


611-080-00-7
sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate
410-150-2
147703-65-9
R43
Xi
R: 43
S: (2-)22-24-37


611-081-00-2
tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)
411-470-5
141048-13-7
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


611-082-00-8
reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);
pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)
407-570-3
—
N; R51-53
N
R: 51/53
S: 61


611-083-00-3
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)
411-560-4
—
T; R48/25
R43
N; R51-53
T; N
R: 43-48/25-51/53
S: (1/2-)22-36/37-45-61



611-084-00-9
reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;
N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide
412-550-2
—
R53
R: 53
S: 61



611-085-00-4
reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine
411-880-4
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


611-086-00-X
monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate
411-360-7
—
R52-53
R: 52/53
S: 61


611-087-00-5
reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)
411-710-9
—
R53
R: 53
S: 61


611-088-00-0
reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate
411-890-9
—
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61


611-089-00-6
2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate
411-100-2
136213-73-5
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53
S: (2-)22-36/37-60-61


611-090-00-1
2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate
413-290-2
93672-52-7
F; R11
Xn; R22
Xi; R41
R43
R52-53
F; Xn
R: 11-22-41-43-52/53
S: (2-)12-22-24-26-37/39-47-61


611-091-00-7
sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate
413-470-0
134595-59-8
R43
Xi
R: 43
S: (2-)22-24/25-37


611-092-00-2
tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate
413-210-6
—
N; R51-53
N
R: 51/53
S: 61


611-093-00-8
sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate
410-770-3
146177-84-6
R43
Xi
R: 43
S: (2-)22-24-37


611-094-00-3
reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)
411-600-0
143145-93-1
R53
R: 53
S: 61


611-095-00-9
hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide
412-240-7
89797-03-5
N; R51-53
N
R: 51/53
S: 22-61


611-096-00-4
methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate
413-040-2
149850-30-6
R43
Xi
R: 43
S: (2-)22-24-37


611-097-00-X
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)
414-150-3
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


611-098-00-5
tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate
405-950-3
131013-83-7
T; R25
R52-53
T
R: 25-52/53
S: (1/2-)37-45-61


611-099-00-0
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride
401-500-5
118658-99-4
Carc. Cat. 2; R45
N; R51-53
T; N
R: 45-51/53
S: 53-45-61


611-100-00-4
potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate
403-810-6
140876-13-7
Xi; R41
Xi
R: 41
S: (2-)26-39


611-101-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide
405-200-5
104366-25-8
R43
Xi
R: 43
S: (2-)22-24-37





611-102-00-5
reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[}benzendiazoniumchlorid;
disodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{]phenylsulfonylamino[}benzen-diazoniumchlorid
424-500-7
-
R52-53
R: 52/53
S: 61



611-103-00-0
trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)
407-110-1
—
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61


611-104-00-6
reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);
trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate
406-870-1
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


611-105-00-1
sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate
407-800-2
136213-75-7
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


611-106-00-7
hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate
410-180-6
157627-99-1
Xi; R41
Xi
R: 41
S: (2-)26-39


611-107-00-2
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate
412-490-7
—
R43
Xi
R: 43
S: (2-)22-24-37


611-108-00-8
disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate
413-600-6
6527-62-4
R52-53
R: 52/53
S: 61


611-109-00-3
Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)
407-710-3
—
N; R51-53
N
R: 51/53
S: 61


611-110-00-9
tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene
408-210-8
124605-82-9
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-28-37-61


611-111-00-4
disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)
414-230-8
—
R43
Xi
R: 43
S: (2-)22-24-37


611-112-00-X
tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate
413-070-6
—
R43
Xi
R: 43
S: (2-)22-24-37


611-113-00-5
lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)
414-280-0
149626-00-6
N; R51-53
N
R: 51/53
S: 24/25-61


611-114-00-0
lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)
414-250-7
149564-66-9
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61


611-115-00-6
trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)
414-290-5
149564-65-8
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


611-116-00-1
reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
414-620-8
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


611-117-00-7
1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt
415-100-3
149850-29-3
R43
Xi
R: 43
S: (2-)22-24-37


611-118-00-2
sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt
413-990-8

R43
Xi
R: 43
S: (2-)22-24-37


611-119-00-8
tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
415-400-4
148878-22-2
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


611-120-00-3
5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt
418-340-7
157707-94-3
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61


611-121-00-9
Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol
417-280-9
30785-74-1
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


611-122-00-4
hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel
417-250-5
151436-99-6
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


611-123-00-X
3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate
424-310-4
178452-66-9
Xi; R41
Xi
R: 41
S: (2-)26-39


611-124-00-5
reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate
424-320-9

Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


611-125-00-0
reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex
423-940-7
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


611-126-00-6
2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride
424-120-1
174514-06-8
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


611-127-00-1
pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate
423-790-2
—
R5
Xi; R41
R43
R52-53
Xi
R: 5-41-43-52/53
S: (2-)22-26-36/37/39-41-61


611-128-00-7
N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt
419-500-9
171599-85-2
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39


611-129-00-2
reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
418-230-9
163879-69-4
E; R2
Repr. Cat. 3; R62
Xn; R48/22
R43
N; R51-53
E; Xn; N
R: 2-43-48/22-62-51/53
S: (2-)26-35-36/37-61




611-130-00-8
tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate
418-520-5
183130-96-3
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-39-61



611-131-00-3
2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one
420-580-2
151798-26-4
Repr. Cat. 2; R61
R53
T
R: 61-53
S: 53-45-61


611-132-00-9
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-210-2
178452-71-6
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


611-133-00-4
Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt
419-260-5
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61


611-134-00-X
trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex
423-770-3
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)22-26-39-61


611-135-00-5
Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt
424-250-9
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61


611-136-00-0
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate
424-260-3
—
Repr. Cat. 3; R62
Xi; R41
N; R51-53
Xn; N
R: 41-62-51/53
S: (2-)22-26-36/37/39-61


611-137-00-6
6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole
419-870-1
159038-16-1
R53
R: 53
S: 61


611-138-00-1
2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole
415-910-7
152828-25-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61




611-139-00-7
reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride
424-510-1
-
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61




611-140-00-2
azafenidin (ISO)
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
—
68049-83-2
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R48/22
N; R50-53
T; N
R: 61-48/22-62-50/53
S: 53-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %
E


611-141-00-8
5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt
414-410-6
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



611-142-00-3
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride
425-740-5
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



611-143-00-9
reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);
trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)
428-260-4
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



611-144-00-4
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
429-070-4
214362-06-8
Xi; R41
Xi
R: 41
S: (2-)22-26-39



611-145-00-X
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt
429-440-5
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



611-146-00-5
reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate
430-070-1
-
N; R51-53
N
R: 51/53
S: 61



611-147-00-0
sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate
430-090-0
205764-96-1
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



611-148-00-6
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol
429-590-1
-
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61



611-149-00-1
2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate
427-570-7
193486-83-8
N; R51-53
N
R: 51/53
S: 61



611-150-00-7
tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate
440-460-3
-
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-39-61



611-151-00-2
chrysoidine;
4-(phenylazo)benzene-1,3-diamine
207-803-7
495-54-5
Muta. Cat. 3; R68
Xn; R22
Xi; R38
N; R50-53
Xn; N
R: 22-38-68-50/53
S: (2-)23-26-36/37-46-60-61



611-152-00-8
chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]
208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]
532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]
Muta. Cat. 3; R68
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-68-50/53
S: (2-)23-26-36/37/39-46-60-61



611-153-00-3
chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]
286-946-7 [1]
304-236-8 [2]
85407-90-5 [1]
94247-67-3 [2]
Muta. Cat. 3; R68
Xn; R22
Xi; R38-41
Xn
R: 22-38-41-68
S: (2-)23-26-36/37/39-46



611-154-00-9
trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate
403-670-6
92408-46-3
R52-53
R: 52/53
S: 61



611-155-00-4
4,4'-oxybis(benzenesulfonylazide)
431-850-4
7456-68-0
E; R3
F; R11
Xn; R48/22
N; R50-53
E; Xn; N
R: 3-11-48/22-50/53
S: (2-)14-22-33-35-36-60-61



611-156-00-X
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
432-270-4
221354-37-6
Repr. Cat. 3; R62
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-62-51/53
S: (2-)36/37-61



611-157-00-5
benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate
432-590-4
243869-48-9
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61



611-158-00-0
reaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride
421-520-8
-
F; R11
R53
F
R: 11-53
S: (2-)3-12-16-33-61



611-159-00-6
disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate
421-880-6
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



611-160-00-1
reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;
1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)
422-760-6
-
F; R11
R53
F
R: 11-53
S: (2-)3-12-33-61



611-161-00-7
trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O, N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O, N]chromate(III)
423-100-1
-
Xi; R41
Xi
R: 41
S: (2-)26-39



611-162-00-2
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)
429-600-4
-
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



611-163-00-8
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate
429-610-9
-
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61



611-164-00-3
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;
2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2,2'-dimethyl-2,2'-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)
429-710-2
-
R10
R32
R44
Xn; R22
N; R51-53
Xn; N
R: 10-22-32-44-51/53
S: (2-)12-15-16-47-51-61



611-165-00-9
reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
431-830-5
-
R52-53
R: 52/53
S: 61



611-166-00-4
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
432-100-9
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



611-167-00-X
sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)
435-240-9
-
R52-53
R: 52/53
S: 61



611-168-00-5
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid
435-440-6
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



611-169-00-0
sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate
435-800-2
-
R52-53
R: 52/53
S: 61



611-170-00-6
reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)
435-880-9
-
R52-53
R: 52/53
S: 22-61



611-171-00-1
reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate
436-890-6
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61



611-172-00-7
reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
438-310-7
-
E; R2
Repr. Cat. 3; R62
Xn; R22-48/22
R52-53
E; Xn
R: 2-22-48/22-62-52/53
S: (2-)22-35-36/37-61



611-173-00-2
reaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt
440-510-4
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-26-36/37/39



611-174-00-8
reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
442-290-5
457624-86-1
Xi; R41
Xi
R: 41
S: (2-)22-26-39



611-175-00-3
reaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
trisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
disodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;
tetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5
-
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61



611-176-00-9
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate
444-250-2
-
E; R2
F; R11
N; R51-53
E; N
R: 2-11-51/53
S: (2-)22-61



611-177-00-4
reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)
444-290-0
508202-43-5
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61



611-178-00-X
reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
445-280-9
-
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61



611-179-00-5
reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate
450-010-8
-
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39



611-180-00-0
iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts
417-850-7
-
N; R51-53
N
R: 51/53
S: 22-61



612-001-00-9
mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
F+; R12
Xn; R20
Xi; R37/38-41
F+; Xn
R: 12-20-37/38-41
S: (2-)16-26-39
Xn; R20: C ≥ 5 %
Xi; R37/38-41: C ≥ 5 %
Xi; R36: 0,5 % ≤ C < 5 %
5
612-001-01-6
mono-methylamine ... %; [1]
di-methylamine ... %; [2]
tri-methylamine ... % [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
F+; R12
Xn; R20/22
C; R34
F+; C
R: 12-20/22-34
S: (1/2-)3-16-26-29-36/37/39-45
Xn; R20/22: C ≥ 15 %
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
B
612-002-00-4
ethylamine
200-834-7
75-04-7
F+; R12
Xi; R36/37
F+; Xi
R: 12-36/37
S: (2-)16-26-29


612-003-00-X
diethylamine
203-716-3
109-89-7
F; R11
Xn; R20/21/22
C; R35
F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

612-004-00-5
triethylamine
204-469-4
121-44-8
F; R11
Xn; R20/21/22
C; R35
F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

612-005-00-0
butylamine
203-699-2
109-73-9
F; R11
Xn; R20/21/22
C; R35
F; C
R: 11-20/21/22-35
S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

612-006-00-6
ethylenediamine;
1,2-diaminoethane
203-468-6
107-15-3
R10
Xn; R21/22
C; R34
R42/43
C
R: 10-21/22-34-42/43
S: (1/2-)23-26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 %

612-007-00-1
2-aminopropane;
isopropylamine
200-860-9
75-31-0
F+; R12
Xi; R36/37/38
F+; Xi
R: 12-36/37/38
S: (2-)16-26-29


612-008-00-7
aniline
200-539-3
62-53-3
Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R41
R43
N; R50
T; N
R: 23/24/25-40-41-43-48/23/24/25-68-50
S: (1/2-)26-27-36/37/39-45-46-61-63
T; R23/24/25: C ≥ 25 %
Xn; R20/21/22: 1 % ≤ C < 25 %
T; R48/23/24/25: C ≥ 1 %
Xn; R48/20/21/22: 0,2 % ≤ C < 1 %

612-009-00-2
salts of aniline
—
—
Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R41
R43
N; R50
T; N
R: 23/24/25-40-41-43-48/23/24/25-68-50
S: (1/2-)26-27-36/37/39-45-61-63
T; R23/24/25: C ≥ 25 %
Xn; R20/21/22: 1 % ≤ C < 25 %
T; R48/23/24/25: C ≥ 1 %
Xn; R48/20/21/22: 0,2 % ≤ C < 1 %
A
612-010-00-8
chloroanilines, with exception of those specified elsewhere in this Annex
—
—
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61

C
612-011-00-3
4-nitrosoaniline
211-535-6
659-49-4
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)25-28


612-012-00-9
o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3]
201-855-4 [1]
202-729-1 [2]
202-810-1 [3]
88-74-4 [1]
99-09-2 [2]
100-01-6 [3]
T; R23/24/25
R33
R52-53
T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61

C
612-013-00-4
3-aminobenzene sulphonic acid;
metanilic acid
204-473-6
121-47-1
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)25-28


612-014-00-X
sulphanilic acid;
4-aminobenzenesulphonic acid
204-482-5
121-57-3
Xi; R36/38
R43
Xi
R: 36/38-43
S: (2-)24-37


612-015-00-5
N-methylaniline
202-870-9
100-61-8
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61


612-016-00-0
N,N-dimethylaniline
204-493-5
121-69-7
Carc. Cat. 3; R40
T; R23/24/25
N; R51-53
T; N
R: 23/24/25-40-51/53
S: (1/2-)28-36/37-45-61




612-017-00-6
N-methyl-N-2,4,6-tetranitroaniline;
tetryl
207-531-9
479-45-8
E; R3
T; R23/24/25
R33
E; T
R: 3-23/24/25-33
S: (1/2-)35-36/37-45-63



612-018-00-1
bis(2,4,6-trinitrophenyl)amine;
hexyl
205-037-8
131-73-7
E; R3
T+; R26/27/28
R33
N; R51-53
E; T+; N
R: 3-26/27/28-33-51/53
S: (1/2-)27/28-35-36/37-45-61-63



612-019-00-7
dipicrylamine, ammonium salt
220-639-0
2844-92-0
E; R3
T+; R26/27/28
R33
N; R51-53
E; T+; N
R: 3-26/27/28-33-51/53
S: (1/2-)27/28-36/37-45-61-63



612-020-00-2
1-naphthylamine
205-138-7
134-32-7
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)24-61


612-022-00-3
2-naphthylamine
202-080-4
91-59-8
Carc. Cat. 1; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61
Carc. Cat. 1; R45: C ≥ 0,01 %
E
612-023-00-9
phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4]
202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4]
100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25-48/23/24/25
Xi; R36/38
R43
N; R50
T; N
R: 45-23/24/25-36/38-43-48/23/24/25-68-50
S: 53-45-61

E
612-024-00-4
m-toluidine;
3-aminotoluene
203-583-1
108-44-1
T; R23/24/25
R33
N; R50
T; N
R: 23/24/25-33-50
S: (1/2-)28-36/37-45-61


612-025-00-X
nitrotoluidines, with the exception of those specified elsewhere in this Annex
—
—
T; R23/24/25
R33
N; R51-53
T; N
R: 23/24/25-33-51/53
S: (1/2-)28-36/37-45-61

C
612-026-00-5
diphenylamine
204-539-4
122-39-4
T; R23/24/25
R33
N; R50-53
T; N
R: 23/24/25-33-50/53
S: (1/2-)28-36/37-45-60-61


612-027-00-0
xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex
—
—
T; R23/24/25
R33
N; R51-53
T; N
R: 23/24/25-33-51/53
S: (1/2-)28-36/37-45-61

C
612-028-00-6
p-phenylenediamine
203-404-7
106-50-3
T; R23/24/25
Xi; R36
R43
N; R50-53
T+; N
R: 23/24/25-36-43-50/53
S: (1/2-)28-36/37-45-60-61


612-029-00-1
benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride
210-834-9
624-18-0
T; R23/24/25
Xi; R36
R43
N; R50-53
T; N
R: 23/24/25-36-43-50/53
S: (1/2-)28-36/37-45-60-61


612-030-00-7
2-methyl-p-phenylenediamine sulphate [1]
210-431-8 [1]
228-871-4 [2]
615-50-9 [1]
6369-59-1 [2]
T; R25
Xn; R20/21
R43
N; R51-53
T; N
R: 20/21-25-43-51/53
S: (1/2-)24-37-45-61


612-031-00-2
N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]
202-807-5 [2]
2836-04-6 [1]
99-98-9 [2]
T; R23/24/25
T
R: 23/24/25
S: (1/2-)28-45

C
612-032-00-8
N,N,N',N'-tetramethyl-p-phenylenediamine
202-831-6
100-22-1
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)28


612-033-00-3
2-aminophenol
202-431-1
95-55-6
Xn; R20/22
Muta. Cat. 3; R68
Xn
R: 20/22-68
S: (2-)28-36/37




612-034-00-9
2-amino-4,6-dinitrophenol;
picramic acid
202-544-6
96-91-3
E; R2
Xn; R20/21/22
R52-53
E; Xn
R: 2-20/21/22-52/53
S: (2-)35-36/37-46-61




612-035-00-4
2-methoxyaniline;
o-anisidine
201-963-1
90-04-0
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25
T
R: 45-23/24/25-68
S: 53-45

E
612-036-00-X
3,3'-dimethoxybenzidine;
o-dianisidine
204-355-4
119-90-4
Carc. Cat. 2; R45
Xn; R22
T
R: 45-22
S: 53-45

E
612-037-00-5
salts of 3,3'-dimethoxybenzidine;
salts of o-dianisidine
—
—
Carc. Cat. 2; R45
Xn; R22
T
R: 45-22
S: 53-45

AE
612-038-00-0
2-nitro-p-anisidine;
4-methoxy-2-nitroaniline
202-547-2
96-96-8
T+; R26/27/28
R33
R52-53
T+
R: 26/27/28-33-52/53
S: (1/2-)28-36/37-45-61


612-039-00-6
2-ethoxyaniline;
o-phenetidine
202-356-4
94-70-2
T; R23/24/25
R33
T
R: 23/24/25-33
S: (1/2-)28-36/37-45


612-040-00-1
2,4-dinitroaniline
202-553-5
97-02-9
T+; R26/27/28
R33
N; R51-53
T+; N
R: 26/27/28-33-51/53
S: (1/2-)28-36/37-45-61


612-041-00-7
4,4'-bi-o-toluidine
204-358-0
119-93-7
Carc. Cat. 2; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61

E
612-042-00-2
benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine
202-199-1
92-87-5
Carc. Cat. 1; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61
Carc. Cat. 1; R45: C ≥ 0,01 %
E
612-043-00-8
N,N'-dimethylbenzidine
—
2810-74-4
Xn; R20/21/22
Xn
R: 20/21/22
S: (2-)22-36




612-044-00-3
N,N'-diacetylbenzidine
210-338-2
613-35-4
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/21/22
T
R: 45-20/21/22-68
S: 53-45

E


612-046-00-4
allylamine
203-463-9
107-11-9
F; R11
T; R23/24/25
N; R51-53
F; T; N
R: 11-23/24/25-51/53
S: (1/2-)9-16-24/25-45-61


612-047-00-X
benzylamine
202-854-1
100-46-9
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-36/37/39-45


612-048-00-5
dipropylamine
205-565-9
142-84-7
F; R11
Xn; R20/21/22
C; R35
F; C
R: 11-20/21/22-35
S: (1/2-)16-26-36/37/39-45
C; R35: C ≥ 10 %
C; R34: 5 % ≤ C < 10 %
Xi; R36/37/38: 1 % ≤ C < 5 %

612-049-00-0
di-n-butylamine; [1]
di-sec-butylamine [2]
203-921-8 [1]
210-937-9 [2]
111-92-2 [1]
626-23-3 [2]
R10
Xn; R20/21/22
Xn
R: 10-20/21/22
S: (2-)




612-050-00-6
cyclohexylamine
203-629-0
108-91-8
R10
Repr. Cat. 3; R62
Xn; R21/22
C; R34
C
R: 10-21/22-34-62
S: (1/2-)26-36/37/39-45
C; 34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 %


612-051-00-1
4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline
202-974-4
101-77-9
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R39/23/24/25
Xn; R48/20/21/22
R43
N; R51-53
T; N
R: 45-39/23/24/25-43-48/20/21/22-68-51/53
S: 53-45-61

E
612-052-00-7
(S)-sec-butylamine;
(S)-2-aminobutane; [1]
(R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3]
208-164-7 [1]
236-232-6 [2]
237-732-7 [3]
513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3]
F; R11
Xn; R20/22
C; R35
N; R50
F; C; N
R: 11-20/22-35-50
S: (1/2-)9-16-26-28-36/37/39-45-61

C
612-053-00-2
N-ethylaniline
203-135-5
103-69-5
T; R23/24/25
R33
T
R: 23/24/25-33
S: (1/2-)28-37-45


612-054-00-8
N,N-diethylaniline
202-088-8
91-66-7
T; R23/24/25
R33
N; R51-53
T; N
R: 23/24/25-33-51/53
S: (1/2-)28-37-45-61
T; R23/24/25: C ≥ 5 %
Xn; R20/21/22: 1 % ≤ C < 5 %

612-055-00-3
N-methyl-o-toluidine; [1]
N-methyl-m-toluidine; [2]
N-methyl-p-toluidine [3]
210-260-9 [1]
211-795-0 [2]
210-769-6 [3]
611-21-2 [1]
696-44-6 [2]
623-08-5 [3]
T; R23/24/25
R33
R52-53
T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61

C
612-056-00-9
N,N-dimethyl-p-toluidine; [1]
N,N-dimethyl-m-toluidine; [2]
N,N-dimethyl-o-toluidine [3]
202-805-4 [1]
204-495-6 [2]
210-199-8 [3]
99-97-8 [1]
121-72-2 [2]
609-72-3 [3]
T; R23/24/25
R33
R52-53
T
R: 23/24/25-33-52/53
S: (1/2-)28-36/37-45-61
T; R23/24/25: C ≥ 5 %
Xn; R20/21/22: 1 % ≤ C < 5 %
C


612-057-00-4
piperazine;
[solid]
203-808-3
110-85-0
Repr. Cat. 3; R62-63
C; R34
R42/43
Xn; C
R: 34-42/43-62-63
S: (1/2-)22-26-36/37/39-45





612-057-01-1
piperazine;
[liquid]
203-808-3
110-85-0
Repr. Cat. 3; R62-63
C; R34
R42/43
Xn; C
R: 34-42/43-62-63
S: (1/2-)23-26-36/37/39-45



612-058-00-X
2,2'-iminodiethylamine;
diethylenetriamine
203-865-4
111-40-0
Xn; R21/22
C; R34
R43
C
R: 21/22-34-43
S: (1/2-)26-36/37/39-45


612-059-00-5
3,6-diazaoctanethylenediamin;
triethylenetetramine
203-950-6
112-24-3
Xn; R21
C; R34
R43
R52-53
C
R: 21-34-43-52/53
S: (1/2-)26-36/37/39-45-61


612-060-00-0
3,6,9-triazaundecamethylenediamine;
tetraethylenepentamine
203-986-2
112-57-2
Xn; R21/22
C; R34
R43
N; R51-53
C; N
R: 21/22-34-43-51/53
S: (1/2-)26-36/37/39-45-61


612-061-00-6
3-aminopropyldimethylamine;
N,N-dimethyl-1,3-diaminopropane
203-680-9
109-55-7
R10
Xn; R22
C; R34
R43
C
R: 10-22-34-43
S: (1/2-)26-36/37/39-45


612-062-00-1
3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane
203-236-4
104-78-9
R10
Xn; R21/22
C; R34
R43
C
R: 10-21/22-34-43
S: (1/2-)26-36/37/39-45


612-063-00-7
3,3'-iminodi(propylamine);
dipropylenetriamine
200-261-2
56-18-8
T+; R26
T; R24
Xn; R22
C; R35
R43
T+; C
R: 22-24-26-35-43
S: (1/2-)26-28-36/37/39-45


612-064-00-2
3,6,9,12-tetra-azatetradecamethylenediamine;
pentacthylenehexamine
223-775-9
4067-16-7
C; R34
R43
N; R50-53
C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


612-065-00-8
polyethlyenepolyamines with the exception of those specified elsewhere in this Annex
—
—
Xn; R21/22
C; R34
R43
N; R50-53
C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


612-066-00-3
dicyclohexylamine
202-980-7
101-83-7
Xn; R22
C; R34
N; R50-53
C; N
R: 22-34-50/53
S: (1/2-)26-36/37/39-45-60-61
C; R34: C ≥ 10 %
Xi; R36/38: 2 % ≤ C < 10 %

612-067-00-9
3-aminomethyl-3,5,5-trimethylcyclohexylamine
220-666-8
2855-13-2
Xn; R21/22
C; R34
R43
R52-53
C
R: 21/22-34-43-52/53
S: (1/2-)26-36/37/39-45-61


612-068-00-4
3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine
202-109-0
91-94-1
Carc. Cat. 2; R45
Xn; R21
R43
N; R50-53
T; N
R: 45-21-43-50/53
S: 53-45-60-61

E
612-069-00-X
salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine
—
—
—
—
—
—
Carc. Cat. 2; R45
Xn; R21
R43
N; R50-53
T; N
R: 45-21-43-50/53
S: 53-45-60-61

AE
612-070-00-5
salts of benzidine [
208-519-6
208-520-1
244-236-4
252-984-8
531-85-1
531-86-2
21136-70-9
36341-27-2
Carc. Cat. 1; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

AE
612-071-00-0
salts of 2-naphthylamine
209-030-0
210-313-6
553-00-4
612-52-2
Carc. Cat. 1; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61

AE
612-072-00-6
biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl
202-177-1
92-67-1
Carc. Cat. 1; R45
Xn; R22
T
R: 45-22
S: 53-45

E
612-073-00-1
salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl
—
—
Carc. Cat. 1; R45
Xn; R22
T
R: 45-22
S: 53-45

AE
612-074-00-7
benzyldimethylamine
203-149-1
103-83-3
R10
Xn; R20/21/22
C; R34
R52-53
C
R: 10-20/21/22-34-52/53
S: (1/2-)26-36-45-61


612-075-00-2
2-aminoethyldimethylamine;
2-dimethylaminoethylamine
203-541-2
108-00-9
F; R11
Xn; R21/22
C; R35
F; C
R: 11-21/22-35
S: (1/2-)16-23-26-28-36-45




612-076-00-8
ethyldimethylamine
209-940-8
598-56-1
F; R11
Xn; R20/22
C; R34
F; C
R: 11-20/22-34
S: (1/2-)3-16-26-36-45




612-077-00-3
dimethylnitrosoamine;
N-nitrosodimethylamine
200-549-8
62-75-9
Carc. Cat. 2; R45
T+; R26
T; R25-48/25
N; R51-53
T+; N
R: 45-25-26-48/25-51/53
S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,001 %
E
612-078-00-9
2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline)
202-918-9
101-14-4
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

E
612-079-00-4
salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline)
—
—
Carc. Cat. 2; R45
Xn; R22
N; R50-53
T; N
R: 45-22-50/53
S: 53-45-60-61

AE
612-080-00-X
4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine
202-214-1
93-05-0
T; R25
C; R34
T
R: 25-34
S: (1/2-)26-36-45


612-081-00-5
salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts of o-tolidine
210-322-5
265-294-7
277-985-0
612-82-8
64969-36-4
74753-18-7
Carc. Cat. 2; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61

AE
612-082-00-0
thiourea;
thiocarbamide
200-543-5
62-56-6
Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R22
N; R51-53
Xn; N
R: 22-40-51/53-63
S: (2-)36/37-61




612-083-00-6
1-methyl-3-nitro-1-nitrosoguanidine
200-730-1
70-25-7
Carc. Cat. 2; R45
Xn; R20
Xi; R36/38
N; R51-53
T; N
R: 45-20-36/38-51/53
S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %
E

612-084-00-1
dapsone;
4,4'-diamino diphenyl sulfone
201-248-4
80-08-0
Xn; R22
Xn
R: 22
S: (2-)22


612-085-00-7
4,4'-methylenedi-o-toluidine
212-658-8
838-88-0
Carc. Cat. 2; R45
Xn; R22
R43
N; R50-53
T; N
R: 45-22-43-50/53
S: 53-45-60-61

E
612-086-00-2
amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl) methylamine
251-375-4
33089-61-1
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)22-24-60-36/37-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

612-087-00-8
guazatine (ISO)

108173-90-6
T+; R26
Xn; R21/22
Xi; R37/38-41
N; R50-53
T+; N
R: 21/22-26-37/38-41-50/53
S: (1/2-)26-28-36/37/39-38-45-46-60-61-63


612-088-00-3
simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine
204-535-2
122-34-9
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61


612-089-00-9
1,5-naphthylenediamine
218-817-8
2243-62-1
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


612-090-00-4
2,2'-(nitrosoimino)bisethanol
214-237-4
1116-54-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45


612-091-00-X
o-toluidine;
2-aminotoluene
202-429-0
95-53-4
Carc. Cat. 2; R45
T; R23/25
Xi; R36
N; R50
T; N
R: 45-23/25-36-50
S: 53-45-61

E
612-092-00-5
N,N'-(2,2-dimethylpropylidene)hexamethylenediamine
401-660-6
1000-78-8
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37


612-093-00-0
3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline
401-790-3
104147-32-2
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24/25-26-57-60-61




612-094-00-6
4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride
402-190-4
113674-95-6
T; R48/25
Xn; R22-48/20
Xi; R41
R43
N; R50-53
T; N
R: 22-41-43-48/20-48/25-50/53
S: (1/2-)26-36/37/39-45-60-61



612-095-00-1
benzyl-2-hydroxydodecyldimethylammonium benzoate
402-610-6
113694-52-3
C; R34
Xn; R22
N; R50-53
C; N
R: 22-34-50/53
S: (1/2-)26-28-36/37/39-45-60-61


612-096-00-7
4,4'-carbonimidoylbis[N,N-dimethylaniline]
207-762-5
492-80-8
Carc. Cat. 3; R40
Xn; R22
Xi; R36
N; R51-53
Xn; N
R: 22-36-40-51/53
S: (2-)36/37-61


612-097-00-2
salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]
—
—
Carc. Cat. 3; R40
Xn; R22
Xi; R36
N; R51-53
Xn; N
R: 22-36-40-51/53
S: (2-)36/37-61

A


612-098-00-8
nitrosodipropylamine
210-698-0
621-64-7
Carc. Cat. 2; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,001 %
E

612-099-00-3
4-methyl-m-phenylenediamine;
2,4-toluenediamine
202-453-1
95-80-7
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
R43
N; R51-53
T; N
R: 45-21-25-43-48/22-62-68-51/53
S: 53-45-61

E


612-100-00-7
propylenediamine
201-155-9
78-90-0
R10
Xn; R21/22
C; R35
C
R: 10-21/22-35
S: (1/2-)26-37/39-45




612-101-00-2
methenamine;
hexamethylenetetramine
202-905-8
100-97-0
F; R11
R43
F; Xi
R: 11-43
S: (2-)24-37



612-102-00-8
N,N-bis(3-aminopropyl)methylamine
203-336-8
105-83-9
T; R23/24
Xn; R22
C; R34
T
R: 22-23/24-34
S: (1/2-)26-36/37/39-45


612-103-00-3
N,N,N',N'-tetramethylethylenediamine
203-744-6
110-18-9
F; R11
Xn; R20/22
C; R34
F; C
R: 11-20/22-34
S: (1/2-)16-26-36/37/39-45


612-104-00-9
hexamethylenediamine
204-679-6
124-09-4
Xn; R21/22
Xi; R37
C; R34
C
R: 21/22-34-37
S: (1/2-)22-26-36/37/39-45


612-105-00-4
2-piperazin-1-ylethylamine
205-411-0
140-31-8
Xn; R21/22
C; R34
R43
R52-53
C
R: 21/22-34-43-52/53
S: (1/2-)26-36/37/39-45-61


612-106-00-X
2,6-diethylaniline
209-445-7
579-66-8
Xn; R22
Xn
R: 22
S: (2-)23-24


612-107-00-5
1-phenylethylamine; [1]
Dl-α-methylbenzylamine [2]
202-706-6 [1]
210-545-8 [2]
98-84-0 [1]
618-36-0 [2]
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-28-36/37/39-45


612-108-00-0
3-aminopropyltriethoxysilane
213-048-4
919-30-2
Xn; R22
C; R34
C
R: 22-34
S: (1/2-)26-36/37/39-45


612-109-00-6
bis(2-dimethylaminoethyl)(methyl)amine
221-201-1
3030-47-5
T; R24
Xn; R22
C; R34
T
R: 22-24-34
S: (1/2-)26-36/37/39-45


612-110-00-1
2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)
229-962-1
6864-37-5
T; R23/24
Xn; R22
C; R35
N; R51-53
T; C; N
R: 22-23/24-35-51/53
S: (1/2-)26-36/37/39-45-61


612-111-00-7
2-methyl-m-phenylenediamine;
2,6-toluenediamine
212-513-9
823-40-5
Muta. Cat. 3; R68
Xn; R21/22
R43
N; R51-53
Xn; N
R: 21/22-43-51/53-68
S: (2-)24-36/37-61


612-112-00-2
p-anisidine;
4-methoxyaniline
203-254-2
104-94-9
T+; R26/27/28
R33
N; R50
T+; N
R: 26/27/28-33-50
S: (1/2-)28-36/37-45-61


612-113-00-8
6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine
403-240-8
106264-79-3
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


612-114-00-3
R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate
404-390-7
—
F; R11
R43
R52-53
F; Xi
R: 11-43-52/53
S: (2-)24-37-61


612-115-00-9
dimethyldioctadecylammonium hydrogen sulfate
404-050-8
123312-54-9
Xi; R36
R53
Xi
R: 36-53
S: (2-)26-39-61


612-116-00-4
C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate
404-690-8
68132-19-4
T; R23
C; R34
R43
N; R50-53
T; N
R: 23-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


612-117-00-X
C12-14-tert-alkylamine, methylphosphonic acid salt
404-750-3
119415-07-5
Xn; R22
C; R34
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)26-28-36/37/39-45-61


612-118-00-5
A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide
405-080-4
—
Xi; R41
N; R50-53
X; N
R: 41-50/53
S: (2-)22-26-39-60-61


612-119-00-0
benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate
405-330-2
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61


612-120-00-6
aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline
277-704-1
74070-46-5
N; R50-53
N
R: 50/53
S: 60-61


612-121-00-1
amines, polyethylenepoly-;
HEPA
268-626-9
68131-73-7
Xn; R21/22
C; R34
R43
N; R50-53
C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61




612-122-00-7
hydroxylamine....% [> 55 % in aqueous solution]
232-259-2
7803-49-8
E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R37/38-41
R43
N; R50
E; Xn; N
R: 2-21/22-37/38-40-41-43-48/22-50
S: (2-)26-36/37/39-61

B



612-122-01-4
hydroxylamine …% [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
R5
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R37/38-41
R43
N; R50
Xn; N
R: 5-21/22-37/38-40-41-43-48/22-50
S: (2-)26-36/37/39-46-61

B



612-123-00-2
hydroxylammonium chloride;
hydroxylamine hydrochloride; [1]
bis(hydroxylammonium) sulfate;
hydroxylamine sulfate (2:1) [2]
226-798-2 [1]
233-118-8 [2]
5470-11-1 [1]
10039-54-0 [2]
E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R36/38
R43
N; R50
E; Xn; N
R: 2-21/22-36/38-40-43-48/22-50
S: (2-)36/37-61



612-124-00-8
N,N,N-trimethylanilinium chloride
205-319-0
138-24-9
T; R24/25
T
R: 24/25
S: (1/2-)25-39-45-53


612-125-00-3
2-methyl-p-phenylenediamine;
2,5-toluenediamine
202-442-1
95-70-5
T; R25
Xn; R20/21
R43
N; R51-53
T; N
R: 20/21-25-43-51/53
S: (1/2-)24-37-45-61


612-126-00-9
toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate
265-697-8
65321-67-7
Carc. Cat. 2; R45
T; R25
Xn; R21
Xi; R36
R43
N; R51-53
T; N
R: 45-21-25-36-43-51/53
S: 53-45-61

E
612-127-00-4
3-aminophenol
209-711-2
591-27-5
Xn; R20/22
N; R51-53
Xn; N
R: 20/22-51/53
S: (2-)28-61


612-128-00-X
4-aminophenol
204-616-2
123-30-8
Muta. Cat. 3; R68
Xn; R20/22
N; R50-53
Xn; N
R: 20/22-50/53-68
S: (2-)28-36/37-60-61


612-129-00-5
diisopropylamine
203-558-5
108-18-9
F; R11
Xn; R20/22
C; R34
F; C
R: 11-20/22-34
S: (1/2-)16-26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

612-130-00-0
2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2]
diethylmethylbenzenediamine [3]
218-255-3 [1]
218-256-9 [2]
270-877-4 [3]
2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3]
Xn; R21/22-48/22
Xi; R36
N; R50-53
Xn; N
R: 21/22-36-48/22-50/53
S: (2-)26-28-36/37/39-60-61

C
612-131-00-6
didecyldimethylammonium chloride
230-525-2
7173-51-5
Xn; R22
C; R34
C
R: 22-34
S: (2-)26-36/37/39-45


612-132-00-1
N,N'-diphenyl-p-phenylenediamine;
N,N'-diphenyl-1,4-benzenediamine
200-806-4
74-31-7
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


612-133-00-7
(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate
247-162-0
25646-77-9
T; R25
Xn; R48/22
R43
N; R50-53
T; N
R: 25-43-48/22-50/53
S: (1/2-)24-37-45-60-61


612-134-00-2
N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate
247-161-5
25646-71-3
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


612-135-00-8
N-2-naphthylaniline;
N-phenyl-2-naphthylamine
205-223-9
135-88-6
Carc. Cat. 3; R40
Xi; R36/38
R43
N; R51-53
Xn; N
R: 36/38-40-43-51/53
S: (2-)26-36/37-61


612-136-00-3
N-isopropyl-N'-phenyl-p-phenylenediamine
202-969-7
101-72-4
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
R43: C ≥ 0,1 %

612-137-00-9
4-chloroaniline
203-401-0
106-47-8
Carc. Cat. 2; R45
T; R23/24/25
R43
N; R50-53
T; N
R: 45-23/24/25-43-50/53
S: 53-45-60-61

E
612-138-00-4
furalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate
260-875-1
57646-30-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)36/37/39-61


612-139-00-X
mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide
277-328-8
73250-68-7
N; R51-53
N
R: 51/53
S: 61


612-140-00-5
quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides
264-151-6
63449-41-2
Xn; R21/22
C; R34
N; R50
C; N
R: 21/22-34-50
S: (2-)36/37/39-45-61


612-141-00-0
4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine)
243-420-1
19900-65-3
Carc. Cat. 3; R40
Xn; R22
N; R50-53
Xn; N
R: 22-40-50/53
S: (2-)36/37-60-61


612-142-00-6
biphenyl-2-ylamine
201-990-9
90-41-5
Carc. Cat. 3; R40
Xn; R22
R52-53
Xn
R: 22-40-52/53
S: (2-)36/37-61


612-143-00-1
N5,N5-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride
218-130-3
2051-79-8
T; R25
Xi; R36
R43
N; R50-53
T; N
R: 25-36-43-50/53
S: (1/2-)24-26-37-45-60-61


612-144-00-7
flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
—
62924-70-3
Xi; R36/38
R43
N; R50-53
Xi; N
R: 36/38-43-50/53
S: (2-)36/37-60-61


612-145-00-2
o-phenylenediamine
202-430-6
95-54-5
Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R25
Xn; R20/21
Xi; R36
R43
N; R50-53
T; N
R: 20/21-25-36-40-43-50/53-68
S: (1/2-)28-36/37-45-60-61


612-146-00-8
o-phenylenediamine dihydrochloride
210-418-7
615-28-1
Carc. Cat. 3; R40
Muta. Cat. 3; R68
T; R25
Xn; R20/21
Xi; R36
R43
N; R50-53
T; N
R: 20/21-25-36-40-43-50/53-68
S: (1/2-)28-36/37-45-60-61


612-147-00-3
m-phenylenediamine
203-584-7
108-45-2
Muta. Cat. 3; R68
T; R23/24/25
Xi; R36
R43
N; R50-53
T; N
R: 23/24/25-36-43-50/53-68
S: (1/2-)28-36/37-45-60-61


612-148-00-9
m-phenylenediamine dihydrochloride
208-790-0
541-69-5
Muta. Cat. 3; R68
T; R23/24/25
Xi; R36
R43
N; R50-53
T; N
R: 23/24/25-36-43-50/53-68
S: (1/2-)28-36/37-45-60-61


612-149-00-4
1,3-diphenylguanidine
203-002-1
102-06-7
Repr. Cat. 3; R62
Xn; R22
Xi; R36/37/38
N; R51-53
Xn; N
R: 22-36/37/38-51/53-62
S: (2-)26-36/37/39-61


612-150-00-X
spiroxamine (ISO);
8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine
—
118134-30-8
Xn; R20/21/22
Xi; R38
R43
N; R50-53
Xn; N
R: 20/21/22-38-43-50/53
S: (2-)36/37/39-46-60-61




612-151-00-5
methyl-phenylene diamine;
diaminotoluene;
[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]
—
—
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
Xi; R36
R43
N; R51-53
T; N
R: 45-21-25-36-43-48/22-62-68-51/53
S: 53-45-61

E

612-152-00-0
N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine
406-610-7
62478-82-4
R10
Xn; R20/22-48/20
C; R35
R52-53
C
R: 10-20/22-35-48/20-52/53
S: (1/2-)26-28-36/37/39-45-61


612-153-00-6
4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride
407-020-2
132885-85-9
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)22-24-37-61


612-154-00-1
6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]
410-890-6
95235-29-3
R53
R: 53
S: 61


612-155-00-7
2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene
411-730-8
93071-94-4
R53
R: 53
S: 61


612-156-00-2
reaction mass of: trihexadecylmethylammonium chloride;
dihexadecyldimethylammonium chloride
405-620-9
—
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


612-157-00-8
(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride
410-780-8
—
Xn; R22-48/22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-48/22-51/53
S: (2-)22-26-36/37/39-61


612-158-00-3
reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime
410-820-4
—
R53
R: 53
S: 61


612-159-00-9
Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid
410-880-1
—
Xn; R22
C; R34
N; R50-53
C; N
R: 22-34-50/53
S: (1/2-)23-26-36/37/39-45-60-61


612-160-00-4
p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3]
203-403-1 [1]
208-740-8 [2]
208-741-3 [3]
106-49-0 [1]
540-23-8 [2]
540-25-0 [3]
Carc. Cat. 3; R40
T; R23/24/25
Xi; R36
R43
N; R50
T; N
R: 23/24/25-36-40-43-50
S: (1/2-)28-36/37-45-61


612-161-00-X
2,6-xylidine;
2,6-dimethylaniline
201-758-7
87-62-7
Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R37/38
N; R51-53
Xn; N
R: 20/21/22-37/38-40-51/53
S: (2-)23-25-36/37-61


612-162-00-5
dimethyldioctadecylammonium chloride;
DODMAC
203-508-2
107-64-2
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)24-26-39-46-60-61


612-163-00-0
metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
—
70630-17-0
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39-46


612-164-00-6
2-butyl-2-ethyl-1,5-diaminopentane
412-700-7
137605-95-9
Xn; R21/22-48/22
C; R34
R43
R52-53
C
R: 21/22-34-43-48/22-52/53
S: (1/2-)26-36/37/39-45-61


612-165-00-1
N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine
413-810-8
65181-78-4
N; R51-53
N
R: 51/53
S: 61


612-166-00-7
reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)
411-830-1
114765-88-7
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61


612-167-00-2
5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride
410-490-1
—
Xn; R22-48/22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-48/22-51/53
S: (2-)22-26-36/37/39-61


612-168-00-8
3,5-dichloro-2,6-difluoropyrdine-4-amine
220-630-1
2840-00-8
Xn; R21/22
N; R51-53
Xn; N
R: 21/22-51/53
S: (2-)36/37-61




612-169-00-3
bis(N-methyl-N-phenylhydrazine)sulfate
423-170-1
618-26-8
F; R11
T; R48/25
Xn; R22
Xi; R41
R43
N; R50-53
F; T; N
R: 11-22-41-43-48/25-50/53
S: (1/2-)22-26-33-36/37/39-45-60-61




612-170-00-9
4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime
405-260-2
—
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


612-171-00-4
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane
410-060-3
130728-76-6
Muta. Cat. 3; R68
R43
N; R51-53
Xn; N
R: 43-68-51/53
S: (2-)36/37-61


612-172-00-X
4,4'-methylenebis(N,N'-dimethylcyclohexanamine
412-840-9
13474-64-1
Xn; R22-48/22
C; R35
R52-53
C
R: 22-35-48/22-52/53
S: (1/2-)26-36/37/39-45-61


612-173-00-5
lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate
411-140-0
125328-86-1
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)22-26-36/37/39-61


612-174-00-0
4,4-dimethoxybutylamine
407-690-6
19060-15-2
Xn; R22
C; R34
R43
R52-53
C
R: 22-34-43-52/53
S: (1/2-)26-36/37/39-45-61


612-175-00-6
2-(O-aminooxy)ethylamine dihydrochloride
412-310-7
37866-45-8
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


612-176-00-1
Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine
410-570-6
143747-73-3
N; R50-53
N
R: 50/53
S: 60-61


612-177-00-7
2-naphthylamino-6-sulfomethylamide
412-120-4
104295-55-8
Xn; R48/22
R43
N; R51-53
Xn; N
R: 43-48/22-51/53
S: (2-)22-36/37-61


612-178-00-2
1,4,7,10-tetraazacyclododecane disulfate
412-080-8
112193-77-8
Xn; R22
Xi; R37-41
R52-53
Xn
R: 22-37-41-52/53
S: (2-)26-36/37/39-61


612-179-00-8
1-(2-propenyl)pyridinium chloride
412-740-5
25965-81-5
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37


612-180-00-3
3-aminobenzylamine
412-230-2
4403-70-7
Xn; R22
C; R34
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)22-26-36/37/39-45-61


612-181-00-9
2-phenylthioaniline
413-030-8
1134-94-7
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


612-182-00-4
1-ethyl-1-methylmorpholinium bromide
418-210-1
65756-41-4
Muta. Cat. 3; R68
Xn
R: 68
S: (2-)36/37


612-183-00-X
1-ethyl-1-methylpyrrolidinium bromide
418-200-5
69227-51-6
Muta. Cat. 3; R68
Xn
R: 68
S: (2-)36/37


612-184-00-5
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
403-830-5
89331-94-2
R52-53
R: 52/53
S: 61


612-185-00-0
1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide
407-400-8
59493-72-0
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


612-186-00-6
bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate
406-770-8
149057-64-7
Xn; R48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61


612-187-00-1
2,3,4-trifluoroaniline
407-170-9
3862-73-5
Xn; R21/22-48/22
Xi; R38-41
N; R51-53
Xn; N
R: 21/22-38-41-48/22-51/53
S: (2-)23-26-36/37/39-61


612-188-00-7
4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)
407-560-9
107934-68-9
N; R51-53
N
R: 51/53
S: 61


612-189-00-2
4-amino-2-(aminomethyl)phenol dihydrochloride
412-510-4
135043-64-0
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61


612-190-00-8
4,4'-methylenebis(2-isopropyl-6-methylaniline)
415-150-6
16298-38-7
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)36-61


612-191-00-3
Polymer of allylamine hydrochloride
415-050-2
71550-12-4
Xn; R22
R43
Xn
R: 22-43
S: (2-)36/37


612-192-00-9
2-isopropyl-4-(N-methyl)aminomethylthiazole
414-800-6
154212-60-9
Xn; R21/22
Xi; R38-41
N; R51-53
Xn; N
R: 21/22-38-41-51/53
S: (2-)26-36/37/39-61


612-193-00-4
3-methylaminomethylphenylamine
414-570-7
18759-96-1
Xn; R21/22
C; R34
R43
N; R50-53
C; N
R: 21/22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


612-194-00-X
2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride
414-670-0
141890-30-4
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)26-39-60-61


612-195-00-5
bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate
415-210-1
160236-81-7
Xn; R20/22
Xi; R41
N; R50-53
Xn; N
R: 20/22-41-50/53
S: (2-)26-36/39-60-61


612-196-00-0
4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2]
202-441-6 [1]
221-627-8 [2]
95-69-2 [1]
3165-93-3 [2]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T; R23/24/25
N; R50-53
T; N
R: 45-23/24/25-68-50/53
S: 53-45-60-61

E
612-197-00-6
2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2]
205-282-0 [1]
[2]
137-17-7 [1]
21436-97-5 [2]
Carc. Cat. 2; R45
T; R23/24/25
N; R51-53
T; N
R: 45-23/24/25-51/53
S: 53-45-61

E
612-198-00-1
4,4'-thiodianiline and its salts
205-370-9
139-65-1
Carc. Cat. 2; R45
Xn; R22
N; R51-53
T; N
R: 45-22-51/53
S: 53-45-61

E
612-199-00-7
4,4'-oxydianiline and its salts;
p-aminophenyl ether
202-977-0
101-80-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T; R23/24/25
N; R51-53
T; N
R: 45-46-23/24/25-62-51/53
S: 53-45-61

E
612-200-00-0
2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2]
210-406-1 [1]
254-323-9 [2]
615-05-4 [1]
39156-41-7 [2]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R22
N; R51-53
T; N
R: 45-22-68-51/53
S: 53-45-61

E
612-201-00-6
N,N,N',N'-tetramethyl-4,4'-methylendianiline
202-959-2
101-61-1
Carc. Cat. 2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61


612-202-00-1
3,4-dichloroaniline
202-448-4
95-76-1
T; R23/24/25
Xi; R41
R43
N; R50-53
T; N
R: 23/24/25-41-43-50/53
S: (1/2-)26-36/37/39-45-60-61




612-203-00-7
C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: <3 %)
417-360-3
-
Xn; R21/22
Xi; R38
Xn
R: 21/22-38
S: (2-)25-36/37



612-204-00-2
C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6
548-62-9
Carc. Cat. 3; R40
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-40-41-50/53
S: (2-)26-36/37/39-46-60-61


612-205-00-8
C.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5)
208-953-6
548-62-9
Carc. Cat. 2; R45
Xn; R22
Xi; R41
N; R50-53
T; N
R: 45-22-41-50/53
S: 53-45-60-61

E
612-206-00-3
famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione
—
131807-57-3
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)46-60-61


612-207-00-9
4-ethoxyaniline;
p-phenetidine
205-855-5
156-43-4
Muta. Cat. 3; R68
Xn; R20/21/22
Xi; R36
R43
Xn
R: 20/21/22-36-43-68
S: (2-)36/37-46




612-208-00-4
N-methylbenzene-1,2-diammonium hydrogen phosphate
424-460-0
-
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)22-25-36/37-61



612-209-00-X
6-methoxy-m-toluidine;
p-cresidine
204-419-1
120-71-8
Carc. Cat. 2; R45
Xn; R22
T
R: 45-22
S: 53-45

E
612-210-00-5
5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]
256-960-8 [2]
99-55-8 [1]
51085-52-0 [2]
Carc. Cat. 3; R40
T; R23/24/25
R52-53
T
R: 23/24/25-40-52/53
S: (1/2-)36/37-45-61


612-211-00-0
N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide
416-470-9
170292-97-4
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


612-212-00-6
2,6-dichloro-4-trifluoromethylaniline
416-430-0
24279-39-8
Xn; R20/22
Xi; R38
R43
N; R50-53
Xn; N
R: 20/22-38-43-50/53
S: (2-)24-37-60-61


612-213-00-1
isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine
419-850-2
148348-13-4
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)23-26-36/37/39-45-61


612-214-00-7
4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine
421-390-2
89114-90-9
R53
R: 53
S: 61


612-215-00-2
3-chloro-2-(isopropylthio)aniline
421-700-6
179104-32-6
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61




612-216-00-8
1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt
425-870-2
19450-38-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



612-217-00-3
1-methoxy-2-propylamine
422-550-4
37143-54-7
F; R11
C; R34
Xn; R22
R52-53
F; C
R: 11-22-34-52/53
S: (1/2-)9-26-36/37/39-45-61




612-219-00-4
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
402-200-7
-
R52-53
R: 52/53
S: 61



612-220-00-X
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine
431-060-1
153719-38-1
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)22-24-37-61



612-221-00-5
2-amino-4-(trifluoromethyl)benzenethiol hydrochloride
429-560-8
4274-38-8
C; R34
Xn; R20/21/22-48/22
R43
N; R50
C; N
R: 20/21/22-34-43-48/22-50
S: (1/2-)26-36/37/39-45-61



612-222-00-0
cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine
425-080-8
104860-26-6
Xn; R21/22-48/22
Xi; R41
N; R50-53
Xn; N
R: 21/22-41-48/22-50/53
S: (2-)26-36/37/39-60-61



612-223-00-6
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine
425-300-2
186450-73-7
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61



612-224-00-1
N2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine
426-150-0
121246-28-4
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61



612-225-00-7
1,4,7,10-tetraazacyclododecane
425-450-9
294-90-6
C; R34
Xn; R21/22
N; R50-53
C; N
R: 21/22-34-50/53
S: (1/2-)22-26-36/37/39-45-60-61



612-226-00-2
3-(2'-phenoxyethoxy)propylamine
427-870-8
6903-18-0
Xn; R22
Xi; R38-41
R52-53
Xn
R: 22-38-41-52/53
S: (2-)23-26-37/39-61



612-227-00-8
benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride
428-290-8
120606-08-8
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)22-26-39-60-61



612-228-00-3
reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine
414-340-6
-
R10
Xn; R20/21/22-68/20/21/22
Xi; R41
R43
R52-53
Xn
R: 10-20/21/22-41-43-68/20/21/22-52/53
S: (2-)26-36/37/39-61



612-229-00-9
mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
-
110235-47-7
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61



612-230-00-4
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide
431-530-4
-
C; R35
R43
N; R50-53
C; N
R: 35-43-50/53
S: (1/2-)26-28-36/37/39-45-60-61



612-231-00-X
3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride
427-370-1
164288-56-6
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61



612-232-00-5
reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid
430-410-9
186148-38-9
R52-53
R: 52/53
S: 61



612-237-00-2
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R36/38
R43
N; R50
E; Xn; N
R: 2-21/22-36/38-40-43-48/22-50
S: (2-)36/37-61

T

612-238-00-8
(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%
222-048-3
3327-22-8
Carc. Cat. 3, R40
R52-53
Xn
R: 40-52/53
S: 36/37-61

B

612-239-00-3
biphenyl-3,3', 4,4'-tetrayltetraamine;
diaminobenzidine
202-110-6
91-95-2
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T
R: 45-68
S: 53-45



612-240-00-9
pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline
-
53112-28-0
N; R51-53
N
R: 51/53
S: 61



612-241-00-4
piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. Cat. 3; R62-63
Xi; R36/38
R42/43
R52-53
Xn
R: 36/38-42/43-62-63-52/53
S: (1/2-)22-36/37-45-63-61



612-242-00-X
cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
-
121552-61-2
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


612-243-00-5
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
420-560-3
79617-97-3
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


612-244-00-0
3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride
421-310-6
87691-88-1
Repr. Cat. 3; R62
Xn; R22
Xi; R36
R43
N; R50-53
Xn; N
R: 22-36-43-62-50/53
S: (2-)22-26-36/37/39-60-61



612-245-00-6
2-ethylphenylhydrazine hydrochloride
421-460-2
19398-06-2
Carc. Cat. 3; R40
T; R48/25
Xn; R22
Xi; R41
R43
N; R50-53
T; N
R: 22-40-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


612-246-00-1
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride
429-740-6
40722-80-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/22
R43
R52-53
T
R: 45-46-43-48/22-52/53
S: 53-45-61

E

612-247-00-7
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
T; R48/25
Xn; R22
R52-53
T
R: 22-48/25-52/53
S: (1/2-)22-36-45-61



612-248-00-2
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)
439-540-0
-
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)24-37-61



612-249-00-8
4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
425-030-5
159939-85-2
Repr. Cat. 3; R62
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-43-62-51/53
S: (1/2-)22-26-36/37/39-45-61



612-250-00-3
chloro-N,N-dimethylformiminium chloride
425-970-6
3724-43-4
R14
Repr. Cat. 2; R61
Xn; R22
C; R35
T; C
R: 61-14-22-35
S: 53-45

E

612-251-00-9
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
F; R11
Repr. Cat. 3; R63
Xn; R22
Xi; R38
R43
N; R51-53
F; Xn; N
R: 11-22-38-43-63-51/53
S: (2-)7-22-33-36/37-61



612-252-00-4
imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
428-040-8
138261-41-3
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-57-60-61



612-253-00-X
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
R52-53
R: R52/53
S: 61



612-253-01-7
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Repr. Cat. 2; R61
R52-53
T
R: 61-52/53
S: 53-45-61



612-254-00-5
reaction products of diisopropanolamine with formaldehyde (1:4)
432-440-8
220444-73-5
Carc. Cat. 3; R40
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-40-43-51/53
S: (1/2-)13-25-26-36/37/39-45-61



612-255-00-0
1-(3-methoxypropyl)-4-piperidinamine
431-950-8
179474-79-4
Xn; R21/22
C; R34
R52-53
C
R: 21/22-34-52/53
S: (1/2-)26-36/37/39-45-61



612-256-00-6
benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate
427-470-3
137864-22-3
Xn; R22
R43
Xn
R: 22-43
S: (2-)36/37



612-257-00-1
tripropylammonium dihydrogenphosphate
433-700-3
35687-90-2
Xn; R22
Xn
R: 22
S: (2-)22



612-259-00-2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Xi; R41
Xi
R: 41
S: (2-)26-39



612-261-00-3
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline
441-190-9
121451-05-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


612-265-00-5
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate
444-360-0
191617-13-7
R52-53
R: 52/53
S: 61



612-266-00-0
3-chloro-4-(3-fluorobenzyloxy)aniline
445-590-4
202197-26-0
Muta. Cat. 3; R68
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-68-50/53
S: (2-)22-36/37-60-61



612-267-00-6
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine
418-370-0
-
R43
R53
Xi
R: 43-53
S: (2-)36/37-61



612-269-00-7
reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline
420-720-2
-
R53
R: 53
S: 22-61



612-270-00-2
(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride
433-010-2
-
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)22-36/37-61



612-271-00-8
reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate
434-970-5
160987-57-5
R53
R: 53
S: 61



612-272-00-3
ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate
435-210-5
-
N; R51-53
N
R: 51/53
S: 61



612-273-00-9
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride
435-650-8
-
Xn; R22
C; R35
N; R50-53
C; N
R: 22-35-50/53
S: (1/2-)26-36/37/39-45-60-61



612-274-00-4
(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate
445-750-3
-
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)22-24-26-37/39-61



612-275-00-X
fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil
447-880-6
206565-89-1
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)23-26-36/37/39-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


612-276-00-5
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts
451-430-4
500717-36-2
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-36/37/39-61



612-277-00-0
reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium
451-440-9
586372-44-3
Xi; R41
Xi
R: 41
S: (2-)22-26-39



612-278-00-6
ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
214-984-6
1239-45-8
Muta. Cat. 3; R68
T+; R26
Xn; R22
T+
R: 22-26-68
S: (1/2-)28-36/37-45-63



612-279-00-1
(R, S)-2-amino-3,3-dimethylbutane amide
447-860-7
144177-62-8
Repr. Cat. 3; R62
Xn; R48/22
Xi; R36/38
R43
Xn
R: 36/38-43-48/22-62
S: (2-)22-26-36/37



612-280-00-7
3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
205-057-7
132-32-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H

613-001-00-1
ethyleneimine;
aziridine
205-793-9
151-56-4
F; R11
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T+; R26/27/28
C; R34
N; R51-53
F; T+; N
R: 45-46-11-26/27/28-34-51/53
S: 53-45-61

D E
613-002-00-7
pyridine
203-809-9
110-86-1
F; R11
Xn; R20/21/22
F; Xn
R: 11-20/21/22
S: (2-)26-28
Xn; R20/21/22: C ≥ 5 %



613-003-00-2
1,2,3,4-tetranitrocarbazole
—
6202-15-9
E; R2
Xn; R20/21/22
E; Xn
R: 2-20/21/22
S: (2-)35-36/37



613-004-00-8
crimidine (ISO);
2-chloro-6-methylpyrimidin-4-yldimethylamine
208-622-6
535-89-7
T+; R28
T+
R: 28
S: (1/2-)36/37-45


613-007-00-4
desmetryne (ISO);
6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine
213-800-1
1014-69-3
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


613-008-00-X
dazomet (ISO);
tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione
208-576-7
533-74-4
Xn; R22
Xi; R36
N; R50-53
Xn; N
R: 22-36-50/53
S: (2-)15-22-24-60-61


613-009-00-5
2,4,6-trichloro-1,3,5-triazine;
cyanuric chloride
203-614-9
108-77-0
R14
T+; R26
Xn; R22
C; R34
R43
T+;
R: 14-22-26-34-43
S: (1/2-)26-28-36/37/39-45-46-63
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %



613-010-00-0
ametryn (ISO);
2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine
212-634-7
834-12-8
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)36-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %



613-011-00-6
amitrole (ISO);
1,2,4-triazol-3-ylamine
200-521-5
61-82-5
Repr. Cat. 3; R63
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-63-51/53
S: (2-)13-36/37-61


613-012-00-1
bentazone (ISO);
3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide
246-585-8
25057-89-0
Xn; R22
Xi; R36
R43
R52-53
Xn
R: 22-36-43-52/53
S: (2-)24-37-61


613-013-00-7
cyanazine (ISO);
2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile
244-544-9
21725-46-2
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)37-60-61


613-014-00-2
ethoxyquin (ISO);
6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
202-075-7
91-53-2
Xn; R22
Xn
R: 22
S: (2-)24


613-015-00-8
fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate
238-134-9
14255-88-0
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


613-016-00-3
fuberidazole (ISO);
2-(2-furyl)benzimidazole
223-404-0
3878-19-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61


613-017-00-9
bis (8-hydroxyquinolinium) sulphate
205-137-1
134-31-6
Xn; R22
Xn
R: 22
S: (2-)36


613-018-00-4
morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion
—
7411-47-4
Xn; R22
Xi; R36/37/38
R52-53
Xn
R: 22-36/37/38-52/53
S: (2-)22-36-61


613-019-00-X
thioquinox (ISO);
2-thio-1,3-dithiolo(4,5,b)quinoxaline
202-272-8
93-75-4
Xn; R22
Xn
R: 22
S: (2-)24


613-020-00-5
tridemorph (ISO);
2,6-dimethyl-4-tridecylmorpholine
246-347-3
24602-86-6
Repr. Cat. 2; R61
Xn; R20/22
Xi; R38
N; R50-53
T; N
R: 61-20/22-38-50/53
S: 53-45-60-61

E
613-021-00-0
dithianon (ISO);
5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile
222-098-6
3347-22-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24-60-61


613-022-00-6
pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex
—
—
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61

A
613-023-00-1
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;
pyrethrin I
204-455-8
121-21-1
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61


613-024-00-7
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
pyrethrin II
204-462-6
121-29-9
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61


613-025-00-2
cinerin I;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-0
25402-06-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-026-00-8
cinerin II;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate
204-454-2
121-20-0
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-027-00-3
piperidine
203-813-0
110-89-4
F; R11
T; R23/24
C; R34
F; T
R: 11-23/24-34
S: (1/2-)16-26-27-45
T; R23/24: C ≥ 5 %
Xn; R20/21: 1 % ≤ C < 5 %
C; R34: C ≥ 5 %
Xi: R36/38: 1 % ≤ C < 5 %

613-028-00-9
morpholine
203-815-1
110-91-8
R10
Xn; R20/21/22
C; R34
C
R: 10-20/21/22-34
S: (1/2-)23-36-45
C; R34: C ≥ 10 %
Xi; R36/38: 1 % ≤ C < 10 %

613-029-00-4
dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid
220-487-5
2782-57-2
O; R8
Xn; R22
R31
Xi; R36/37
N; R50-53
O; Xn; N
R: 8-22-31-36/37-50/53
S: (2-)8-26-41-60-61




613-030-00-X
troclosene potassium; [1]
troclosene sodium [2]
218-828-8 [1]
220-767-7 [2]
2244-21-5 [1]
2893-78-9 [2]
E; R2
O; R8
Xn; R22
Xi; R36/37
R31
N; R50-53
E; Xn; N
R: 2-8-22-31-36/37-50/53
S: (2-)8-26-41-45-60-61
Xn; R22: C ≥ 10 %
Xi; R36/37: C ≥ 10 %
R31: C ≥ 10 %
T

613-030-01-7
troclosene sodium, dihydrate
220-767-7
51580-86-0
Xn; R22
R31
Xi; R36/37
N; R50-53
Xn; N
R: 22-31-36/37-50/53
S: (2-)8-26-41-60-61


613-031-00-5
symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion
201-782-8
87-90-1
O; R8
Xn; R22
Xi; R36/37
R31
N; R50-53
O; Xn; N
R: 8-22-31-36/37-50/53
S: (2-)8-26-41-60-61


613-032-00-0
methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-5
13108-52-6
Xn; R21/22
Xi; R36
R43
Xn
R: 21/22-36-43
S: (2-)26-28


613-033-00-6
2-methylaziridine;
propyleneimine
200-878-7
75-55-8
F; R11
Carc. Cat. 2; R45
T+; R26/27/28
Xi; R41
N; R51-53
F; T+; N
R: 45-11-26/27/28-41-51/53
S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %
E
613-034-00-1
1,2-dimethylimidazole
217-101-2
1739-84-0
Xn; R22
Xi; R38-41
Xn
R: 22-38-41
S: (2-)24-26


613-035-00-7
1-methylimidazole
210-484-7
616-47-7
Xn; R21/22
C; R34
C
R: 21/22-34
S: (1/2-)26-36-45


613-036-00-2
2-methylpyridine;
2-picoline
203-643-7
109-06-8
R10
Xn; R20/21/22
Xi; R36/37
Xn
R: 10-20/21/22-36/37
S: (2-)26-36


613-037-00-8
4-methylpyridine;
4-picoline
203-626-4
108-89-4
R10
T; R24
Xn; R20/22
Xi; R36/37/38
T
R: 10-20/22-24-36/37/38
S: (1/2-)26-36-45


613-038-00-3
6-phenyl-1,3,5-triazine-2,4-diyldiamine;
6-phenyl-1,3,5-triazine-2,4-diamine;
benzoguanamine
202-095-6
91-76-9
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


613-039-00-9
ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol
202-506-9
96-45-7
Repr. Cat. 2; R61
Xn; R22
T
R: 61-22
S: 53-45

E
613-040-00-4
azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole
262-102-3
60207-31-0
Xn; R22
Xn
R: 22
S: (2-)46


613-041-00-X
morpholine-4-carbonyl chloride
239-213-0
15159-40-7
R14
Carc. Cat. 3; R40
Xi; R36/38
Xn
R: 14-36/38-40
S: (2-)26-30-36-38


613-042-00-5
imazalil (ISO);
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
252-615-0
35554-44-0
Xn; R20/22
Xi; R41
N; R50-53
Xn; N
R: 20/22-41-50/53
S: (2-)26-39-60-61


613-043-00-0
imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24/25-37-46-60-61


613-043-01-8
imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Xn; R22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-50/53
S: (2-)26-36/37/39-45-60-61
C; R34: C ≥ 50 %
Xi; R38: 30 % ≤ C < 50 %
Xi; R41: 15 % ≤ C < 50 %
Xi; R36: 5 % ≤ C < 15 %



613-044-00-6
captan (ISO);
1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
205-087-0
133-06-2
Carc. Cat. 3; R40
T; R23
Xi; R41
R43
N; R50
T; N
R: 23-40-41-43-50
S: (1/2-)26-29-36/37/39-45-61
N; R50: C ≥ 2,5 %


613-045-00-1
folpet (ISO);
N-(trichloromethylthio)phthalimide
205-088-6
133-07-3
Carc. Cat. 3; R40
Xn; R20
Xi; R36
R43
N; R50
Xn; N
R: 20-36-40-43-50
S: (2-)36/37-46-61
N; R50: C ≥ 2,5 %


613-046-00-7
captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide
219-363-3
2425-06-1
Carc. Cat. 2; R45
R43
N; R50-53
T; N
R: 45-43-50/53
S: 53-45-60-61


613-047-00-2
1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;
dimetilan (ISO)
211-420-0
644-64-4
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)36/37-45-60-61


613-048-00-8
carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate
234-232-0
10605-21-7
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
N; R50-53
T; N
R: 46-60-61-50/53
S: 53-45-60-61


613-049-00-3
benomyl (ISO);
methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate
241-775-7
17804-35-2
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
Xi; R37/38
R43
N; R50-53
T; N
R: 46-60-61-37/38-43-50/53
S: 53-45-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

613-050-00-9
carbadox (INN);
methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;
2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide
229-879-0
6804-07-5
F; R11
Carc. Cat. 2; R45
Xn; R22
F; T
R: 45-11-22
S: 53-45

E
613-051-00-4
molinate (ISO);
S-ethyl 1-perhydroazepinecarbothioate;
S-ethyl perhydroazepine-1-carbothioate
218-661-0
2212-67-1
Carc. Cat. 3; R40
Repr. Cat. 3; R62
Xn; R20/2248/22
R43
N; R50-53
Xn; N
R: 20/22-40-43-48/22-62-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

613-052-00-X
trifenmorph (ISO);
4-tritylmorpholine
215-812-2
1420-06-0
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-053-00-5
anilazine (ISO);
2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline
202-910-5
101-05-3
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)22-60-61


613-054-00-0
thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole
205-725-8
148-79-8
N; R50-53
N
R: 50/53
S: 60-61


613-056-00-1
1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;
difenzoquat methyl sulfate
256-152-5
43222-48-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-057-00-7
dodemorph (ISO);
4-cyclododecyl-2,6-dimethylmorpholine
216-474-9
1593-77-7
Xi; R36/37/38
N; R51-53
Xi; N
R: 36/37/38-51/53
S: (2-)26-61


613-058-00-2
permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
258-067-9
52645-53-1
Xn; R20/22
R43
N; R50-53
Xn; N
R: 20/22-43-50/53
S: (2-)13-24-36/37/39-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %

613-059-00-8
profluralin (ISO);
N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
247-656-6
26399-36-0
Xi; R36
N; R50-53
Xi; N
R: 36-50/53
S: (2-)60-61




613-060-00-3
resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
233-940-7
10453-86-8
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-061-00-9
6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;
ryania
239-732-2
15662-33-6
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


613-062-00-4
sabadilla (ISO);
veratrine
—
8051-02-3
Xi; R36/37/38
Xi
R: 36/37/38
S: (2-)36/37/39


613-063-00-X
secbumeton (ISO);
2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
247-554-1
26259-45-0
Xn; R22
Xi; R36
N; R50-53
Xn; N
R: 22-36-50/53
S: (2-)60-61


613-064-00-5
5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;
sesamex
—
51-14-9
Xn; R22
Xn
R: 22
S: (2-)


613-065-00-0
simetryn (ISO);
2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine
213-801-7
1014-70-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-066-00-6
terbumeton (ISO);
2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
251-637-8
33693-04-8
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-067-00-1
propazine (ISO);
2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine
205-359-9
139-40-2
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


613-068-00-7
atrazine (ISO);
2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine
217-617-8
1912-24-9
Xn; R48/22
R43
N; R50-53
Xn; N
R: 43-48/22-50/53
S: (2-)36/37-60-61


613-069-00-2
ε-caprolactam
203-313-2
105-60-2
Xn; R20/22
Xi; R36/37/38
Xn
R: 20/22-36/37/38
S: (2-)


613-070-00-8
propylenethiourea
—
2122-19-2
Repr. Cat. 3; R63
Xn; R22
R52-53
Xn
R: 22-52/53-63
S: (2-)36/37-46-61


613-071-00-3
2-fluoro-5-trifluoromethylpyridine
400-290-2
69045-82-5
R10
R43
R52-53
Xi
R: 10-43-52/53
S: (2-)24-37-61


613-072-00-9
N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine
401-280-0
91273-04-0
C; R34
R43
N; R51-53
C; N
R: 34-43-51/53
S: (1/2-)26-28-36/37/39-45-61


613-073-00-4
N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine
401-410-6
10357-99-0
Xn; R48/22
R43
N; R51-53
Xn; N
R: 43-48/22-51/53
S: (2-)24-37-61


613-074-00-X
3-(3-methylpent-3-yl)isoxazol-5-ylamine
401-460-9
82560-06-3
T; R23/25
Xi; R41
R52-53
T
R: 23/25-41-52/53
S: (1/2-)22-26-36/37/39-45-61


613-075-00-5
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione
401-570-7
89415-87-2
O; R8
T; R23
C; R34
Xn; R22
R43
N; R50
O; T; N
R: 8-22-23-34-43-50
S: (1/2-)8-26-36/37/39-45-61


613-076-00-0
3-chloro-5-trifluoromethyl-2-pyridylamine
401-670-0
79456-26-1
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


613-077-00-6
reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine
401-940-8
—
Xn; R22
Xi; R36
N; R51-53
Xn; N
R: 22-36-51/53
S: (2-)22-26-61


613-078-00-1
N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine
401-990-0
106990-43-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


613-079-00-7
4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers
402-520-7
—
Xn; R21/22
Xi; R38
R43
N; R50-53
Xn; N
R: 21/22-38-43-50/53
S: (2-)36/37-60-61


613-080-00-2
3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione
402-540-6
105254-85-1
C; R34
R43
N; R50-53
C; N
R: 34-43-50/53
S: (1/2-)26-28-36/37/39-45-60-61


613-081-00-8
1-butyl-2-methylpyridinium bromide
402-680-8
26576-84-1
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


613-082-00-3
2-methyl-1-pentylpyridinium bromide
402-690-2
—
Xn; R21/22
R52-53
Xn
R: 21/22-52/53
S: (2-)36/37-61


613-083-00-9
2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate
402-120-2
—
C; R34
Xn; R48/22
R43
N; R50-53
C; N
R: 34-43-48/22-50/53
S: (1/2-)24-26-28-37/39-45-60-61


613-084-00-4
2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate
402-490-5
106359-93-7
Xi; R36
N; R50-53
Xi; N
R: 36-50/53
S: (2-)26-60-61


613-085-00-X
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione
401-970-1
—
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


613-086-00-5
caffeine
200-362-1
58-08-2
Xn; R22
Xn
R: 22
S: (2-)


613-087-00-0
tetrahydrothiophene
203-728-9
110-01-0
F; R11
Xn; R20/21/22
Xi; R36/38
R52-53
F; Xn
R: 11-20/21/22-36/38-52/53
S: (2-)16-23-36/37-61


613-088-00-6
1,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one
220-120-9
2634-33-5
Xn; R22
Xi; R38-41
R43
N; R50
Xn; N
R: 22-38-41-43-50
S: (2-)24-26-37/39-61
R43: C ≥ 0,05 %

613-089-00-1
diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]
201-579-4 [1]
223-714-6 [2]
301-467-6 [3]
85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3]
T+; R26
T; R48/25
Xn; R22
Xi; R36/37/38
R43
N; R50-53
T+; N
R: 22-26-36/37/38-43-48/25-50/53
S: (1/2-)28-36/37/39-45-60-61


613-090-00-7
paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]
218-196-3 [2]
1910-42-5 [1]
2074-50-2 [2]
T+; R26
T; R24/25-48/25
Xi; R36/37/38
N; R50-53
T+; N
R: 24/25-26-36/37/38-48/25-50/53
S: (1/2-)22-28-36/37/39-45-60-61


613-091-00-2
morfamquat dichloride; [1]
morfamquat sulfate [2]
225-062-8 [1]
[2]
4636-83-3 [1]
29873-36-7 [2]
Xn; R22
Xi; R36/37/38
R52-53
Xn
R: 22-36/37/38-52/53
S: (2-)22-36-61


613-092-00-8
1,10-phenanthroline
200-629-2
66-71-7
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)45-60-61


613-093-00-3
hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
400-050-7
85153-92-0
R42/43
Xn
R: 42/43
S: (2-)22-24-37


613-094-00-9
4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine
401-360-5
5248-39-5
Xn; R22-48/22
Xn
R: 22-48/22
S: (2-)22-36


613-095-00-4
sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate
403-080-9
92484-48-5
Xi; R41
Xi
R: 41
S: (2-)26-39


613-096-00-X
2-amino-6-ethoxy-4-methylamino-1,3,5-triazine
403-580-7
62096-63-3
Xn; R22
Xn
R: 22
S: (2-)


613-097-00-5
7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
403-690-5
111298-82-9
R42/43
R52-53
Xn
R: 42/43-52/53
S: (2-)22-24-37-61


613-098-00-0
N-(n-octyl)-2-pyrrolidone
403-700-8
2687-94-7
C; R34
N; R51-53
C; N
R: 34-51/53
S: (1/2-)23-26-36/37/39-45


613-099-00-6
1-dodecyl-2-pyrrolidone
403-730-1
2687-96-9
C; R34
R43
N; R50-53
C; N
R: 34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


613-100-00-X
2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione
404-230-6
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


613-101-00-5
N-tert-pentyl-2-benzothiazolesulfenamide
404-380-2
110799-28-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)36/37-61


613-102-00-0
dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine
404-200-2
110488-70-5
N; R51-53
N
R: 51/53
S: 61


613-103-00-6
sodium 5-n-butylbenzotriazole
404-450-2
118685-34-0
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-43-51/53
S: (1/2-)26-36/37/39-45-61


613-104-00-1
5-tert-butyl-3-isoxazolylamine hydrochloride
404-840-2
—
Xn; R22-48/22
Xi; R41
R52-53
Xn
R: 22-41-48/22-52/53
S: (2-)26-36/39-61


613-105-00-7
hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)
405-160-9
124537-30-0
T; R25
R43
R52-53
T
R: 25-43-52/53
S: (1/2-)24-37-45-61


613-106-00-2
tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate
405-240-3
—
R43
Xi
R: 43
S: (2-)24-37


613-107-00-8
hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate
405-280-1
76508-02-6
Xi; R36
Xi
R: 36
S: (2-)26


613-108-00-3
benzothiazole-2-thiol
205-736-8
149-30-4
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


613-109-00-9
bis(piperidinothiocarbonyl) disulphide
202-328-1
94-37-1
Xi; R36/37/38
R43
Xi
R: 36/37/38-43
S: (2-)24-26-37


613-110-00-4
dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-2
61432-55-1
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


613-111-00-X
1,2,4-triazole
206-022-9
288-88-0
Repr. Cat. 3; R63
Xn; R22
Xi; R36
Xn
R: 22-36-63
S: (2-)36/37


613-112-00-5
octhilinone (ISO);
2-octyl-2H-isothiazol-3-one
247-761-7
26530-20-1
T; R23/24
Xn; R22
C; R34
R43
N; R50-53
T; N
R: 22-23/24-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61
R43: C ≥ 0,05 %

613-113-00-0
2-(morpholinothio)benzothiazole
203-052-4
102-77-2
Xi; R36/38
R43
N; R51-53
Xi; N
R: 36/38-43-51/53
S: (2-)24-26-37-61


613-114-00-6
2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;
1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine
225-208-0
4719-04-4
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37
R43: C ≥ 0,1 %

613-115-00-1
hymexazol (ISO);
3-hydroxy-5-methylisoxazole
233-000-6
10004-44-1
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)26-39-61




613-116-00-7
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
T+; R26
T; R48/23
Xi; R36/37/38
R43
N; R50
T+; N
R: 26-36/37/38-43-48/23-50
S: (1/2-)28-36/37/39-45-63-61
N; R50: C ≥ 2,5 %




613-116-01-4
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Xi; R36/37/38
R43
N; R50
Xi; N
R: 36/37/38-43-50
S: (2-)25-36/37-46-61
N; R50: C ≥ 2,5 %



613-117-00-2
diniconazole (ISO);
(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol
—
76714-88-0
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-118-00-8
flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline;
253-703-1
37893-02-0
Xi; R36
N; R50-53
Xi; N
R: 36-50/53
S: (2-)26-60-61


613-119-00-3
(benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB
244-445-0
21564-17-0
T+; R26
Xn; R22
Xi; R36/38
R43
N; R50-53
T+; N
R: 22-26-36/38-43-50/53
S: (1/2-)28-36/37-38-45-60-61




613-120-00-9
bioresmethrin (ISO);
(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate
249-014-0
28434-01-7
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-121-00-4
chlorsulfuron (ISO);
2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide;
265-268-5
64902-72-3
N; R50-53
N
R: 50/53
S: 60-61


613-122-00-X
diclobutrazole (ISO);
(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol
—
75736-33-3
Xi; R36
N; R51-53
Xi; N
R: 36-51/53
S: (2-)26-61


613-123-00-5
5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;
etem
251-684-4
33813-20-6
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-124-00-0
fenpropimorph (ISO);
cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
266-719-9
67564-91-4
Repr. Cat. 3; R63
Xn; R22
Xi; R38
N; R51-53
Xn; N
R: 22-38-63-51/53
S: (2-)36/37-46-61


613-125-00-6
hexythiazox (ISO);
trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide
—
78587-05-0
N; R50-53
N
R: 50/53
S: 60-61


613-126-00-1
imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate
—
81334-34-1
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61


613-127-00-7
1,1-dimethylpiperidinium chloride;
mepiquat chloride
246-147-6
24307-26-4
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


613-128-00-2
prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide;
266-994-5
67747-09-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


613-129-00-8
metamitron (ISO);
4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-3
41394-05-2
Xn; R22
N; R50
Xn; N
R: 22-50
S: (2-)61


613-131-00-9
pyroquilon (ISO);
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one
—
57369-32-1
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


613-132-00-4
hexazinone (ISO);
3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione;
257-074-4
51235-04-2
Xn; R22
Xi; R36
N; R50-53
Xn; N
R: 22-36-50/53
S: (2-)60-61


613-133-00-X
etridiazole (ISO);
5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole
219-991-8
2593-15-9
Carc. Cat. 3; R40
T; R23
Xn; R21/22
N; R50-53
T; N
R: 21/22-23-40-50/53
S: (1/2-)36/37-38-45-60-61


613-134-00-5
myclobutanil (ISO);
2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile
—
88671-89-0
Repr. Cat. 3; R63
Xn; R22
Xi; R36
N; R51-53
Xn; N
R: 22-36-51/53-63
S: (2-)36/37-46-61


613-135-00-0
di(benzothiazol-2-yl) disulphide
204-424-9
120-78-5
R31
R43
N; R50-53
Xi; N
R: 31-43-50/53
S: (2-)36/37-60-61


613-136-00-6
N-cyclohexylbenzothiazole-2-sulphenamide
202-411-2
95-33-0
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


613-137-00-1
methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-dimethylurea
242-505-0
18691-97-9
N; R50-53
N
R: 50/53
S: 60-61


613-138-00-7
quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline
—
124495-18-7
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61




613-139-00-2
metsulfuron-methyl (ISO);
2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid
—
74223-64-6
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-140-00-8
cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione
200-636-0
66-81-9
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T+; R28
N; R51-53
T+; N
R: 61-28-51/53-68
S: 53-45-61

E
613-141-00-3
1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone
401-470-3
93686-63-6
R53
R: 53
S: 61


613-142-00-9
trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate
405-860-4
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61


613-143-00-4
1-(3-phenylpropyl)-2-methylpyridinium bromide
405-930-4
10551-42-5
Xn; R22
Xi; R36
R52-53
Xn
R: 22-36-52/53
S: (2-)26-36/37-61


613-144-00-X
Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate
406-460-2
125139-08-4
R52-53
R: 52/53
S: 61


613-145-00-5
(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate
406-960-0
77497-97-3
N; R51-53
N
R: 51/53
S: 61


613-146-00-0
N-ethyl-N-methylpiperidinium iodide
407-780-5
4186-71-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)22-61


613-147-00-6
4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine
407-940-4
111681-72-2
Xi; R41
Xi
R: 41
S: (2-)26-39


613-148-00-1
tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane
411-240-4
143683-23-2
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24/25-37-61


613-149-00-7
pyridaben (ISO);
2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one
405-700-3
96489-71-3
T; R23/25
N; R50-53
T; N
R: 23/25-50/53
S: (1/2-)36/37-45-60-61


613-150-00-2
2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione
406-295-6
—
R53
R: 53
S: 61


613-151-00-8
1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine
406-360-9
104218-44-2
R53
R: 53
S: 61


613-152-00-3
phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate
406-600-2
89392-03-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


613-153-00-9
2,3,5-trichloropyridine
407-270-2
16063-70-0
R52-53
R: 52/53
S: 61


613-154-00-4
2-amino-4-chloro-6-methoxypyrimidine
410-050-9
5734-64-5
Xn; R22
Xn
R: 22
S: (2-)22


613-155-00-X
5-chloro-2,3-difluoropyridine
410-090-7
89402-43-7
R10
Xn; R22
R52-53
Xn
R: 10-22-52/53
S: (2-)23-36-61


613-156-00-5
2-butyl-4-chloro-5-formylimidazole
410-260-0
83857-96-9
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


613-157-00-0
2,4-diamino-5-methoxymethylpyrimidine
410-330-0
54236-98-5
Xn; R22-48/22
Xi; R36
Xn
R: 22-36-48/22
S: (2-)22-26-36


613-158-00-6
2,3-dichloro-5-trifluoromethyl-pyridine
410-340-5
69045-84-7
Xn; R20/22
Xi; R41
R43
N; R51-53
Xn; N
R: 20/22-41-43-51/53
S: (2-)24-26-37/39-61


613-159-00-1
fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline
410-580-0
120928-09-8
T; R25
Xn; R20
N; R50-53
T; N
R: 20-25-50/53
S: (1/2-)37-45-60-61


613-160-00-7
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide
411-000-9
125224-62-6
R43
Xi
R: 43
S: (2-)24-37





613-161-00-2
2,4-diamino-6-hydroxymethylpteridinehydrobromide
430-620-0
76145-91-0
Xn; R48/22
R43
R52-53
Xn
R: 43-48/22-52/53
S: (2-)22-36/37-61



613-162-00-8
(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide
423-260-0
100988-63-4
Muta. Cat. 3; R68
R43
N; R51-53
Xn; N
R: 43-68-51/53
S: (2-)36/37-61





613-163-00-3
azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea
—
120162-55-2
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-164-00-9
flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide
—
142459-58-3
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)13-24-37-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


613-165-00-4
flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt
—
144740-54-5
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


613-166-00-X
flumioxazin (ISO);
N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
—
103361-09-7
Repr. Cat. 2; R61
N; R50-53
T; N
R: 61-50/53
S: 53-45-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %



613-167-00-5
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)
—
55965-84-9
T; R23/24/25
C; R34
R43
N; R50-53
T; N
R: 23/24/25-34-43-50/53
S: (2-)26-28-36/37/39-45-60-61
C; R34: C ≥ 0,6 %
Xi; R36/38: 0,06 % ≤ C < 0,6 %
R43: C ≥ 0,0015 %

613-168-00-0
1-vinyl-2-pyrrolidone
201-800-4
88-12-0
Carc. Cat. 3; R40
Xn; R20/21/22-48/20
Xi; R37-41
Xn
R: 20/21/22-37-40-41-48/20
S: (2-)26-36/37/39

D


613-169-00-6
9-vinylcarbazole
216-055-0
1484-13-5
Muta. Cat. 3; R68
Xn; R21/22
Xi; R38
R43
N; R50-53
Xn; N
R: 21/22-38-43-68-50/53
S: (2-)22-23-36/37-60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


613-170-00-1
2,2-ethylmethylthiazolidine
404-500-3
694-64-4
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61


613-171-00-7
hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol
413-050-7
79983-71-4
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61


613-172-00-2
5-chloro-1,3-dihydro-2H-indol-2-one
412-200-9
17630-75-0
Repr. Cat. 3; R62
Xn; R22
R43
R52-53
Xn
R: 22-43-62-52/53
S: (2-)22-36/37-61


613-173-00-8
fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one
411-960-9
136426-54-5
T; R23/25-48/25
Xn; R21
Xi; R38
N; R50-53
T; N
R: 21-23/25-38-48/25-50/53
S: (1/2-)36/37/39-38-45-60-61





613-174-00-3
tetraconazole (ISO);
(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether
407-760-6
112281-77-3
Xn; R20/22
N; R51-53
Xn; N
R: 20/22-51/53
S: (2-)36-61



613-175-00-9
epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2
133855-98-8
Carc. Cat. 3; R40
Repr. Cat. 3; R62
Repr. Cat. 3; R63
N; R51-53
Xn; N
R: 40-62-63-51/53
S: (2-)36/37-46-61


613-176-00-4
2-methyl-2-azabicyclo[2.2.1]heptane
404-810-9
4524-95-2
R10
Xn; R21/22-48/20
C; R34
C
R: 10-21/22-34-48/20
S: (1/2-)16-26-36/37/39-45


613-177-00-X
8-amino-7-methylquinoline
412-760-4
5470-82-6
Xn; R21/22
R43
N; R51-53
Xn; N
R: 21/22-43-51/53
S: (2-)36/37-61


613-178-00-5
4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine
410-470-2
137796-06-6
C; R34
R43
C
R: 34-43
S: (1/2-)7/8-26-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

613-179-00-0
lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide
411-690-1
111337-53-2
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-43-51/53
S: (1/2-)26-36/37/39-45-61


613-180-00-6
N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide
407-430-1
3741-80-8
N; R50-53
N
R: 50/53
S: 60-61


613-181-00-1
5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone
405-090-9
67485-29-4
T; R48/25
Xn; R22
Xi; R36
N; R50-53
T; N
R: 22-36-48/25-50/53
S: (1/2-)22-26-36/37-45-60-61


613-182-00-7
1-(1-naphthylmethyl)quinolinium chloride
406-220-7
65322-65-8
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R22
Xi; R38-41
R52-53
Xn
R: 22-38-40-41-52/53-68
S: (2-)22-26-36/37/39-61


613-183-00-2
reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;
5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one
413-640-4
—
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)36-60-61


613-184-00-8
nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate
413-670-8
—
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37


613-185-00-3
2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one
407-630-9
82633-79-2
T; R25
Xi; R41
R43
N; R50-53
T; N
R: 25-41-43-50/53
S: (1/2-)22-26-36/37/39-45-60-61


613-186-00-9
(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate
408-050-9
76855-69-1
Xi; R36
R43
N; R51-53
Xi; N
R: 36-43-51/53
S: (2-)24-26-37-61




613-187-00-4
5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene
410-530-8
-
R43
Xi
R: 43
S: (2-)24-37



613-188-00-X
1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone
411-500-7
116256-11-2
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)22-24-26-37/39-61


613-189-00-5
1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane
414-030-0
52667-88-6
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


613-190-00-0
disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate
414-040-5
149530-93-8
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37


613-191-00-6
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine
421-150-7
143860-04-2
Repr. Cat. 2; R60
C; R34
N; R50-53
T; N
R: 60-34-50/53
S: 53-45-60-61




613-192-00-1
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane
426-750-2
151860-15-0
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61



613-193-00-7
pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate
414-930-3
—
N; R51-53
N
R: 51/53
S: 61


613-194-00-2
6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt
418-000-8
163062-28-0
Xi; R41
Xi
R: 41
S: (2-)22-26-39


613-195-00-8
2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)
418-280-1
18600-59-4
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


613-196-00-3
5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt
418-380-5
168113-78-8
Xi; R41
Xi
R: 41
S: (2-)26-39


613-197-00-9
reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine
420-390-1
187547-46-2
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61




613-198-00-4
2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine
415-500-8
145963-84-4
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36-61



613-199-00-X
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;
reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione
421-550-1
—
Carc. Cat. 2; R45
Repr. Cat. 2; R61
R43
R52-53
T
R: 45-61-43-52/53
S: 53-45-61


613-200-00-3
Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts
420-980-7
—
Xi; R41
Xi
R: 41
S: (2-)22-26-39


613-201-00-9
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole
422-390-5
143322-57-0
Repr. Cat. 3; R62
T; R39-48/25
Xn; R20/22
Xi; R41
R43
N; R50-53
T; N
R: 20/22-39-41-43-48/25-62-50/53
S: (1/2-)53-45-60-61


613-202-00-4
pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one
—
123312-89-0
Carc. Cat. 3; R40
R52-53
Xn
R: 40-52/53
S: (2-)36/37-61





613-203-00-X
pyraflufen-ethyl (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]
pyraflufen (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]
- [1]
- [2]
129630-19-9 [1]
129630-17-7 [2]
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-204-00-5
oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;
5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one
254-637-6
39807-15-3
Repr. Cat. 3; R63
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-63-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


613-205-00-0
propiconazole (ISO);
(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
262-104-4
60207-90-1
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)36/37-46-60-61


613-206-00-6
fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one
—
161326-34-7
N; R50-53
N
R: 50/53
S: 60-61


613-208-00-7
imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
—
114311-32-9
N; R50-53
N
R: 50/53
S: 60-61


613-209-00-2
cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride
417-430-3
63645-17-0
T; R25
Xn; R48/22
R43
N; R51-53
T; N
R: 25-43-48/22-51/53
S: (1/2-)22-36/37-45-61


613-210-00-8
2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane
417-650-1
88128-57-8
Xn; R48/22
R52-53
Xn
R: 48/22-52/53
S: (2-)23-25-36-61


613-211-00-3
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate
418-240-3
74401-04-0
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61


613-212-00-9
4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)
418-320-8
133467-41-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-60-61


613-213-00-4
cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline
416-040-0
120807-02-5
R52-53
R: 52/53
S: 61


613-214-00-X
N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide
416-260-7
147613-95-4
R53
R: 53
S: 61


613-215-00-5
2-chloromethyl-3,4-dimethoxypyridinium chloride
416-440-5
72830-09-2
Xn; R21/22-48/22
Xi; R38-41
R43
N; R51-53
Xn; N
R: 21/22-38-41-43-48/22-51/53
S: (2-)26-36/37/39-61


613-216-00-0
6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole
416-490-8
162208-01-7
N; R50-53
N
R: 50/53
S: 60-61


613-217-00-6
4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine
416-770-1
73754-27-5
R53
R: 53
S: 61


613-218-00-1
6-hydroxyindole
417-020-4
2380-86-1
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61


613-219-00-7
7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole
417-140-7
79185-77-6
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61


613-220-00-2
trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide
417-290-3
147086-81-5
Xn; R22
Xn
R: 22
S: (2-)36


613-221-00-8
2-chloro-5-methyl-pyridine
418-050-0
18368-64-4
Xn; R21/22
Xi; R38
R52-53
Xn
R: 21/22-38-52/53
S: (2-)23-25-36/37-61


613-222-00-3
4-(1-oxo-2-propenyl)-morpholine
418-140-1
5117-12-4
Xn; R22-48/22
Xi; R41
R43
Xn
R: 22-41-43-48/22
S: (2-)23-26-36/37/39


613-223-00-9
N-isopropyl-3-(4-fluorophenyl)-1H-indole
418-790-4
93957-49-4
R53
R: 53
S: 61


613-224-00-4
2,5-dimercaptomethyl-1,4-dithiane
419-770-8
136122-15-1
Xn; R22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


613-225-00-X
reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.
421-290-9
—
Xn; R48/22
R53
Xn
R: 48/22-53
S: (2-)22-36-61


613-226-00-5
1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride
420-950-3
163831-67-2
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61


613-227-00-0
(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-600-2
99199-90-3
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-28-36/37-61


613-228-00-6
(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran
419-630-6
793669-26-8
N; R51-53
N
R: 51/53
S: 24-61




613-229-00-1
1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine
411-930-5
106917-31-1
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61



613-230-00-7
florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide
—
145701-23-1
N; R50-53
N
R: 50/53
S: 60-61




613-231-00-2
2,6-diamino-3-((pyridine-3-yl)azo)pyridine
421-430-9
28365-08-4
Xn; R22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61



613-232-00-8
3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide
431-030-6
163269-30-5
T; R23
Xn; R48/22
Xi; R41
N; R50-53
T; N
R: 23-41-48/22-50/53
S: (1/2-)26-36/39-45-57-60-61



613-233-00-3
4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane
423-230-7
56552-15-9
Xi; R41
Xi
R: 41
S: (2-)26-39




613-234-00-9
imidazo[1,2-b]pyridazin hydrochloride
431-510-5
18087-70-2
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)26



613-235-00-4
2,3-dihydro-2,2-dimethyl-1H-perimidine
424-060-6
6364-17-6
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)28-36/37-60-61



613-236-00-X
2-chloro-3-trifluoromethylpyridine
424-520-6
65753-47-1
T; R24/25-48/25
C; R34
R52-53
T
R: 24/25-34-48/25-52/53
S: (1/2-)23-26-36/37/39-45-61



613-237-00-5
6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine
424-950-4
133949-92-5
R53
R: 53
S: 61



613-238-00-0
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate
430-890-1
81992-66-7
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)22-24-37-60-61



613-239-00-6
2-[3-(methylamino)propyl]-1H-benzimidazole
425-760-4
64137-52-6
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61



613-241-00-7
3-(2H-tetrazol-5-yl)pyridine
426-810-8
3250-74-6
Xi; R41
Xi
R: 41
S: (2-)22-26-39



613-242-00-2
reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts
426-860-0
191877-09-5
Xi; R41
Xi
R: 41
S: (2-)22-26-39



613-243-00-8
4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)
427-350-0
182235-14-9
N; R51-53
N
R: 51/53
S: 61



613-244-00-3
5,7-dichloro-4-hydroxyquinoline
427-420-0
21873-52-9
N; R51-53
N
R: 51/53
S: 61



613-245-00-9
2-fluoro-6-trifluoromethylpyridine
428-100-3
94239-04-0
R10
Xn; R20/22
R52-53
Xn
R: 10-20/22-52/53
S: (2-)16-61



613-246-00-4
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine
428-200-7
103577-66-8
R52-53
R: 52/53
S: 61



613-247-00-X
3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole
428-910-7
107786-36-7
R53
R: 53
S: 61



613-248-00-5
3,4-dimethyl-1H-pyrazole
429-130-1
2820-37-3
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)26-39-61



613-249-00-0
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
429-300-3
155601-30-2
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61



613-250-00-6
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine
429-990-6
-
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61



613-251-00-1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole
430-560-5
180637-89-2
Xn; R22-48/22
Xi; R41
R43
Xn
R: 22-41-43-48/22
S: (2-)26-36/37/39



613-253-00-2
2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)
430-580-4
-
R19
Xi; R38
N; R51-53
Xi; N
R: 19-38-51/53
S: (2-)37-61



613-254-00-8
forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea
-
68157-60-8
Carc. Cat. 3; R40
N; R51-53
Xn; N
R: 40-51/53
S: (2-)36/37-46-61



613-255-00-3
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)
424-270-8
-
Xi; R41
Xi
R: 41
S: (2-)26-39



613-256-00-9
3'5'-anhydro thymidine
425-810-5
38313-48-3
R52-53
R: 52/53
S: 61



613-257-00-4
2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate
426-400-9
170222-39-6
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



613-258-00-X
reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt
427-730-6
202420-04-0
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)26-28-36/37/39-45-61



613-259-00-5
reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate
428-790-6
72963-72-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61



613-260-00-0
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin
430-730-9
-
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)22-26-39-60-61



613-261-00-6
pyrazole-1-carboxamidine monohydrochloride
429-520-1
4023-02-3
Xn; R22-48/22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-48/22-52/53
S: (2-)22-26-36/37/39-61



613-262-00-1
disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene
427-310-2
180850-95-7
Xi; R41
Xi
R: 41
S: (2-)26-39



613-263-00-7
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate
429-570-2
-
R43
Xi
R: 43
S: (2-)24-37



613-266-00-3
2-chloro-5-chloromethylthiazole
429-830-5
105827-91-6
T; R24
C; R34
Xn; R22
R43
N; R51-53
T; N
R: 22-24-34-43-51/53
S: (1/2-)26-36/37/39-45-61



613-267-00-9
thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
428-650-4
153719-23-4
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


613-268-00-4
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine
425-930-8
151213-39-7
C; R34
Xn; R20/22-48/22
N; R51-53
C; N
R: 20/22-34-48/22-51/53
S: (1/2-)26-36/37/39-45-61



613-269-00-X
2-thiazolidinylidenecyanamide
427-720-1
26364-65-8
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36-61



613-270-00-5
5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide
428-150-6
113171-13-4
R52-53
R: 52/53
S: 61



613-271-00-0
tritosulfuron (ISO) (containing ≤ 0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)
-
142469-14-5
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


613-272-00-6
pyraclostrobin (ISO);
methyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate
-
-
T; R23
Xi; R38
N; R50-53
T; N
R: 23-38-50/53
S: (1/2-)45-60-61-63
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


613-273-00-1
tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine
427-600-9
192439-46-6
N; R51-53
N
R: 51/53
S: 61



613-274-00-7
2,6-dichloro-1-fluoropyridiniumtetrafluoroborate
427-400-1
140623-89-8
C; R34
Xn; R22
R43
N; R50-53
C; N
R: 22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61



613-275-00-2
3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride
424-530-0
93076-03-0
T; R25
Xn; R68/21-48/22
Xi; R41
R43
N; R51-53
T; N
R: 25-41-43-48/22-68/21-51/53
S: (1/2-)22-26-36/37/39-45-61



613-276-00-8
1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one
426-110-2
98377-35-6
R43
R52-53
Xi
R: 43-52/53
S: (2-)24/25-37-61



613-277-00-3
(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one
427-070-9
-
R53
R: 53
S: 61



613-278-00-9
(3-aminophenyl)pyridin-3-ylmethanone
428-230-0
79568-06-2
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61



613-279-00-4
2-ethyl-2,3-dihydro-2-methyl-1H-perimidine
424-380-6
43057-68-7
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)36/37-60-61



613-280-00-X
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea
230-625-6
7226-23-5
Repr. Cat. 3; R62
Xn; R22
Xi; R41
Xn
R: 22-41-62
S: 26-36/37/39



613-281-00-5
quinoline
202-051-6
91-22-5
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
N; R51-53
T; N
R: 45-21/22-36/38-68-51/53
S: 53-45-61

E

613-282-00-0
triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
-
131983-72-7
N; R51-53
N
R: 51/53
S: 61



613-283-00-6
ketoconazole;
1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
265-667-4
65277-42-1
Repr. Cat. 2; R60
T; R25
Xn; R48/22
N; R50-53
T; N
R: 60-25-48/22-50/53
S: 53-45-60-61

E

613-284-00-1
metconazole (ISO);
(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
-
125116-23-6
Repr. Cat. 3; R63
Xn; R22
N; R51-53
Xn; N
R: 22-63-51/53
S: (2-)36/37-46-61



613-285-00-7
1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
E; R2
E
R: 2
S: 16-35



613-286-00-2
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]
418-260-2
183196-57-8
R43
Xi
R: 43
S: (2-)24-37



613-286-01-X
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
Repr. Cat. 2; R61
R43
T
R: 61-43
S: 53-45



613-287-00-8
1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole
419-540-7
160194-26-3
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61



613-288-00-3
1,3-bis(dimethylcarbamoyl)-imidazolium chloride
420-930-4
135756-61-5
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-37/39-61



613-289-00-9
3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole
432-020-4
142623-48-1
N; R50-53
N
R: 50/53
S: 60-61



613-290-00-4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride
432-470-1
189012-93-9
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61



613-291-00-X
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
434-820-9
106461-41-0
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61



613-292-00-5
N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
435-010-8
26157-73-3
Muta. Cat. 3; R68
R52-53
Xn
R: 68-52/53
S: (2-)36/37-61



613-293-00-0
2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester
448-050-6
444065-11-6
R53
R: 53
S: 61



613-294-00-6
2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester
448-260-8
379268-96-9
R53
R: 53
S: 61



613-295-00-1
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride
448-720-8
363138-44-7
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61



613-296-00-7
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate
418-270-7
-
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-47-61



613-297-00-2
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole
420-820-6
-
R10
Xn; R22
N; R51-53
Xn; N
R: 10-22-51/53
S: (2-)16-61



613-298-00-8
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate
421-560-6
-
Xn; R48/22
Xi; R41
N; R51-53
Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61



613-299-00-3
main component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;
main component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt
422-610-1
-
Xi; R41
Xi
R: 41
S: (2-)22-26-39



613-300-00-7
1-imidazol-1-yl-octadecan-2-ol
434-120-3
-
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



613-301-00-2
dimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate
443-910-7
-
R53
R: 53
S: 61



613-302-00-8
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate
432-980-4
243858-60-8
Xi; R41
Xi
R: 41
S: (2-)22-26-39



613-303-00-3
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine
429-800-1
95737-68-1
N; R50-53
N
R: 50/53
S: 60-61



613-304-00-9
5,6-dihydroxy-2,3-dihydro-1H-indolium bromide
421-170-6
138937-28-7
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)22-26-39



613-305-00-4
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole
448-630-9
3147-77-1
R53
R: 53
S: 61



613-306-00-X
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate
433-520-5
82911-69-1
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61



613-307-00-5
clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine
-
210880-92-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


613-308-00-0
2-amino-5-methylthiazole
423-800-5
7305-71-7
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)22-36-60-61



613-309-00-6
1-methyl-3-phenyl-1-piperazine
431-180-2
5271-27-2
Xn; R21/22
Xi; R38-41
R52-53
Xn
R: 21/22-38-41-52/53
S: (2-)26-36/37/39-61



613-310-00-1
(–)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
432-360-3
105813-13-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61



613-311-00-7
methyl-5-nitrophenyl-guanidine
435-500-1
152460-07-6
Xn; R22
Xi; R36
R43
R52-53
Xn
R: 22-36-43-52/53
S: (2-)22-24-26-37-61



613-312-00-2
2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride
420-200-5
-
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)22-26-36/37/39-61



613-313-00-8
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione
442-780-9
173838-67-0
R52-53
R: 52/53
S: 61



613-314-00-3
4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-7
7693-82-5
N; R50-53
N
R: 50/53
S: 22-24-60-61



613-315-00-9
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate
430-390-1
-
Xn; R20
R52-53
Xn
R: 20-52/53
S: (2-)25-61



613-316-00-4
trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)
257-765-0
52234-82-9
Muta. Cat. 3; R68
Xi; R41
R43
Xn
R: 41-43-68
S: 26-36/37/39-42

H


614-001-00-4
nicotine (ISO);
3-(N-methyl-2-pyrrolidinyl)pyridine
200-193-3
54-11-5
T+; R27
T; R25
N; R51-53
T+; N
R: 25-27-51/53
S: (1/2-)36/37-45-61


614-002-00-X
salts of nicotine
—
—
T+; R26/27/28
N; R51-53
T+; N
R: 26/27/28-51/53
S: (1/2-)13-28-45-61

A
614-003-00-5
strychnine
200-319-7
57-24-9
T+; R27/28
N; R50-53
T+; N
R: 27/28-50/53
S: (1/2-)36/37-45-60-61


614-004-00-0
salts of strychnine
—
—
T+; R26/28
N; R50-53
T+; N
R: 26/28-50/53
S: (1/2-)13-28-45-60-61

A


614-005-00-6
colchicine
200-598-5
64-86-8
Muta. Cat. 2; R46
T+; R28
T+
R: 46-28
S: 53-45

E

614-006-00-1
brucine;
2,3-dimethoxystrychnine
206-614-7
357-57-3
T+; R26/28
R52-53
T+
R: 26/28-52/53
S: (1/2-)13-45-61


614-007-00-7
brucine sulphate; [1]
brucine nitrate; [2]
Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4]
4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4]
T+; R26/28
R52-53
T+
R: 26/28-52/53
S: (1/2-)13-45-61

A
614-008-00-2
aconitine
206-121-7
302-27-2
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45


614-009-00-8
salts of aconitine
—
—
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45

A
614-010-00-3
atropine
200-104-8
51-55-8
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45


614-011-00-9
salts of atropine
—
—
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45

A
614-012-00-4
hyoscyamine
202-933-0
101-31-5
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45


614-013-00-X
salts of hyoscyamine
—
—
T+; R26/28
T+
R: 26/28
S: (1/2-)24-45

A
614-014-00-5
hyoscine
200-090-3
51-34-3
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)25-45


614-015-00-0
salts of hyoscine
—
—
T+; R26/27/28
T+
R: 26/27/28
S: (1/2-)25-45

A
614-016-00-6
pilocarpine
202-128-4
92-13-7
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45


614-017-00-1
salts of pilocarpine
—
—
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45

A
614-018-00-7
papaverine
200-397-2
58-74-2
Xn; R22
Xn
R: 22
S: (2-)22


614-019-00-2
salts of papaverine
—
—
Xn; R22
Xn
R: 22
S: (2-)22

A
614-020-00-8
physostigmine
200-332-8
57-47-6
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45


614-021-00-3
salts of physostigmine
—
—
T+; R26/28
T+
R: 26/28
S: (1/2-)25-45

A
614-022-00-9
digitoxin
200-760-5
71-63-6
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45


614-023-00-4
ephedrine
206-080-5
299-42-3
Xn; R22
Xn
R: 22
S: (2-)22-25


614-024-00-X
salts of ephedrine
—
—
Xn; R22
Xn
R: 22
S: (2-)22-25

A
614-025-00-5
ouabain
211-139-3
630-60-4
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45


614-026-00-0
strophantin-K
234-239-9
11005-63-3
T; R23/25
R33
T
R: 23/25-33
S: (1/2-)45


614-027-00-6
bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;
red squill;
scilliroside
208-077-4
507-60-8
T+; R28
T+
R: 28
S: (1/2-)36/37-45


614-028-00-1
reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside
414-420-0
—
Xi; R41
Xi
R: 41
S: (2-)26-39


614-029-00-7
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside
419-640-0
68784-14-5
Xn; R22
Xn
R: 22
S: (2-)




615-001-00-7
methyl isocyanate
210-866-3
624-83-9
F; R11
Repr. Cat. 3; R63
T+; R26
T; R24/25
R42/43
Xi; R37/38-41
F; T+
R: 11-24/25-26-37/38-41-42/43-63
S: (1/2-)16-26-27/28-36/37/39-45-63



615-002-00-2
methyl isothiocyanate
209-132-5
556-61-6
T; R23/25
C; R34
R43
N; R50-53
T; N
R: 23/25-34-43-50/53
S: (1/2-)36/37-38-45-60-61


615-003-00-8
thiocyanic acid
207-337-4
463-56-9
Xn; R20/21/22
R32
R52-53
Xn
R: 20/21/22-32-52/53
S: (2-)13-61




615-004-00-3
salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Xn; R20/21/22
R32
R52-53
Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61

A

615-005-00-9
4,4'-methylenediphenyl diisocyanate;
diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate;
diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4]
202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4]
101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4]
Carc. Cat. 3; R40
Xn; R20-48/20
Xi; R36/37/38
R42/43
Xn
R: 20-36/37/38-40-42/43-48/20
S: (1/2-)23-36/37-45
Xi; R36/37/38: C ≥ 5 %
R42: C ≥ 0,1 %
C
2


615-006-00-4
2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3]
202-039-0 [1]
209-544-5 [2]
247-722-4 [3]
91-08-7 [1]
584-84-9 [2]
26471-62-5 [3]
Carc. Cat. 3; R40
T+; R26
Xi; R36/37/38
R42/43
R52-53
T+
R: 26-36/37/38-40-42/43-52/53
S: (1/2-)23-36/37-45-61
R42: C ≥ 0,1 %
C
2
615-007-00-X
1,5-naphthylene diisocyanate
221-641-4
3173-72-6
Xn; R20
Xi; R36/37/38
R42
R52-53
Xn
R: 20-36/37/38-42-52/53
S: (2-)26-28-38-45-61


615-008-00-5
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;
isophorone di-isocyanate
223-861-6
4098-71-9
T; R23
Xi; R36/37/38
R42/43
N; R51-53
T; N
R: 23-36/37/38-42/43-51/53
S: (1/2-)26-28-38-45-61
T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 %
2
615-009-00-0
4,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate
225-863-2
5124-30-1
T; R23
Xi; R36/37/38
R42/43
T
R: 23-36/37/38-42/43
S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 %
2
615-010-00-6
2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]
241-001-8 [1]
239-714-4 [2]
16938-22-0 [1]
15646-96-5 [2]
T; R23
Xi; R36/37/38
R42
T
R: 23-36/37/38-42
S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42: C ≥ 0,5 %
C
2
615-011-00-1
hexamethylene-di-isocyanate
212-485-8
822-06-0
T; R23
Xi; R36/37/38
R42/43
T
R: 23-36/37/38-42/43
S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %
Xn; R20: 0,5 % ≤ C < 2 %
R42/43: C ≥ 0,5 %
2
615-012-00-7
4-isocyanatosulphonyltoluene;
tosyl isocyanate
223-810-8
4083-64-1
R14
Xi; R36/37/38
R42
Xn
R: 14-36/37/38-42
S: (2-)26-28-30
Xi; R36/37/38: C ≥ 5 %

615-013-00-2
cyanamide;
carbanonitril
206-992-3
420-04-2
T; R25
Xn; R21
Xi; R36/38
R43
T
R: 21-25-36/38-43
S: (1/2-)3-22-36/37-45


615-014-00-8
tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate
—
7276-58-6
Xn; R22
Xn
R: 22
S: (2-)24


615-015-00-3
1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate
204-081-5
115-31-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)24/25-60-61


615-016-00-9
potassium cyanate
209-676-3
590-28-3
Xn; R22
Xn
R: 22
S: (2-)24/25


615-017-00-4
calcium cyanamide
205-861-8
156-62-7
Xn; R22
Xi; R37-41
Xn
R: 22-37-41
S: (2-)22-26-36/37/39


615-018-00-X
2-(2-butoxyethoxy)ethyl thiocyanate
203-985-7
112-56-1
R10
T; R24/25
T
R: 10-24/25
S: (1/2-)13-36/37-45


615-019-00-5
dicyclohexylcarbodiimide
208-704-1
538-75-0
T; R24
Xn; R22
Xi; R41
R43
T
R: 22-24-41-43
S: (1/2-)24-26-37/39-45


615-020-00-0
methylene dithiocyanate
228-652-3
6317-18-6
T+; R26
T; R25
C; R34
R43
N; R50
T+; N
R: 25-26-34-43-50
S: (1/2-)26-28-36/37/39-45-61


615-021-00-6
1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC
219-514-3
2451-62-9
Muta. Cat. 2; R46
T; R23/25
Xn; R48/22
Xi; R41
R43
R52-53
T
R: 46-23/25-41-43-48/22-52/53
S: 53-45-61

E


615-022-00-1
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate
410-550-7
79277-18-2
R14
Xn; R48/22
R42/43
Xn
R: 14-42/43-48/22
S: (2-)22-30-35-36/37-45



615-023-00-7
2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate
410-900-9
83056-32-0
R10
R14
Muta. Cat. 3; R68
Xn; R20-48/22
Xi; R41
R42
Xn
R: 10-14-20-41-42-48/22-68
S: (2-)23-26-36/37/39


615-024-00-2
2-phenylethylisocyanate
413-080-0
1943-82-4
T; R23
Xn; R22
C; R35
R42/43
N; R51-53
T; C; N
R: 22-23-35-42/43-51/53
S: (1/2-)23-26-36/37/39-43-45-61


615-025-00-8
4,4'-ethylidenediphenyl dicyanate
405-740-1
47073-92-7
Xn; R20/22-48/22
Xi; R41
N; R50-53
Xn; N
R: 20/22-41-48/22-50/53
S: (2-)26-36/37/39-60-61


615-026-00-3
4,4'-methylenebis(2,6-dimethylphenyl cyanate)
405-790-4
101657-77-6
R43
R52-53
Xi
R: 43-52/53
S: (2-)22-24-37-61





615-028-00-4
ethyl 2-(isocyanatosulfonyl)benzoate
410-220-2
77375-79-2
R14
Xn; R22-48/22
Xi; R41
R42/43
Xn
R: 14-22-41-42/43-48/22
S: (2-)8-23-26-30-35-36/37/39



615-029-00-X
2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane
411-280-2
—
T+; R26
Xn; R22
C; R34
R42/43
R52-53
T+
R: 22-26-34-42/43-52/53
S: (1/2-)23-26-28-36/37/39-45-61




615-030-00-5
alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Xn; R20/21/22
R32
R52-53
Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61

A

615-031-00-0
thallium thiocyanate
222-571-7
3535-84-0
T+; R26/28
Xn; R21
R32
R33
N; R51-53
T+; N
R: 21-26/28-32-33-51/53
S: (1/2-)13-28-36/37-45-61



615-032-00-6
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
—
—
Xn; R20/21/22
R32
N; R50-53
Xn; N
R: 20/21/22-32-50/53
S: (2-)13-36/37-46-60-61

A



615-033-00-1
reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)
430-980-9
-
R53
R: 53
S: 61



615-034-00-7
reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)
430-750-8
-
R53
R: 53
S: 61



615-035-00-2
reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)
430-930-6
122886-55-9
R53
R: 53
S: 61



615-036-00-8
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)
430-940-0
-
R53
R: 53
S: 61



615-037-00-3
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)
430-950-5
-
R53
R: 53
S: 61



615-038-00-9
reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)
430-960-1
-
R53
R: 53
S: 61



615-039-00-4
reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)
430-970-4
-
R53
R: 53
S: 61



615-044-00-1
4-chlorophenylisocyanate
203-176-9
104-12-1
T+; R26
Xn; R22
Xi; R37/38-41
R42
N; R50-53
T+; N
R: 22-26-37/38-41-42-50/53
S: (1/2-)26-28-36/37/39-45-63-60-61



615-045-00-7
4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)
420-530-1
-
R42/43
R53
Xn
R: 42/43-53
S: (2-)23-24-37-45-61



616-001-00-X
N,N-dimethylformamide;
dimethyl formamide
200-679-5
68-12-2
Repr. Cat. 2; R61
Xn; R20/21
Xi; R36
T
R: 61-20/21-36
S: 53-45

E
616-002-00-5
2-fluoroacetamide
211-363-1
640-19-7
T+; R28
T; R24
T+
R: 24-28
S: (1/2-)36/37-45


616-003-00-0
acrylamide;
prop-2-enamide
201-173-7
79-06-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 3; R62
T; R25-48/23/24/25
Xn; R20/21
Xi; R36/38
R43
T
R: 45-46-20/21-25-36/38-43-48/23/24/25-62
S: 53-45

DE
616-004-00-6
allidochlor (ISO);
N,N-diallylchloroacetamide
202-270-7
93-71-0
Xn; R21/22
Xi; R36/38
N; R51-53
Xn; N
R: 21/22-36/38-51/53
S: (2-)26-28-36/37/39-61


616-005-00-1
chlorthiamid (ISO);
2,6-dichloro (thiobenzamide)
217-637-7
1918-13-4
Xn; R22
Xn
R: 22
S: (2-)36




616-006-00-7
dichlofluanid (ISO);
N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide
214-118-7
1085-98-9
Xn; R20
Xi; R36
R43
N; R50
Xn; N
R: 20-36-43-50
S: (2-)24-37-61
N; R50: C ≥ 2,5 %


616-007-00-2
diphenamid (ISO);
N,N-dimethyl-2,2-diphenylacetamide
213-482-4
957-51-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


616-008-00-8
propachlor (ISO);
2-chloro-N-isopropylacetanilide;
α-chloro-N-isopropylacetanilide
217-638-2
1918-16-7
Xn; R22
Xi; R36
R43
N; R50-53
Xn; N
R: 22-36-43-50/53
S: (2-)24-37-60-61




616-009-00-3
propanil (ISO);
3', 4'-dichloropropionanilide
211-914-6
709-98-8
Xn; R22
N; R50
Xn; N
R: 22-50
S: (2-)22-61
N; R50: C ≥ 2,5 %



616-010-00-9
tosylchloramide sodium
204-854-7
127-65-1
Xn; R22
R31
C; R34
R42
C
R: 22-31-34-42
S: (1/2-)7-22-26-36/37/39-45


616-011-00-4
N,N-dimethylacetamide
204-826-4
127-19-5
Repr. Cat. 2; R61
Xn; R20/21
T
R: 61-20/21
S: 53-45
Repr. Cat. 2; R61: C ≥ 5 %
E
616-012-00-X
N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide
211-952-3
719-96-0
Xi; R38
Xi
R: 38
S: (2-)28


616-013-00-5
butyraldehyde oxime
203-792-8
110-69-0
T; R24
Xn; R22
Xi; R36
T
R: 22-24-36
S: (1/2-)23-36-45


616-014-00-0
2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime
202-496-6
96-29-7
Carc. Cat. 3; R40
Xn; R21
Xi; R41
R43
Xn
R: 21-40-41-43
S: (2-)13-23-26-36/37/39


616-015-00-6
alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide
240-110-8
15972-60-8
Carc. Cat. 3; R40
Xn; R22
R43
N; R50-53
Xn; N
R: 22-40-43-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,2,5 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %

616-016-00-1
1-(3,4-dichlorophenylimino) thiosemicarbazide
—
5836-73-7
T+; R28
T+
R: 28
S: (1/2-)22-36/37-45


616-017-00-7
cartap hydrochloride
239-309-2
15263-52-2
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-50/53
S: (2-)36/37-60-61


616-018-00-2
N,N-diethyl-m-toluamide;
deet
205-149-7
134-62-3
Xn; R22
Xi; R36/38
R52-53
Xn
R: 22-36/38-52/53
S: (2-)61


616-019-00-8
perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide
253-718-3
37924-13-3
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)


616-020-00-3
tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
251-793-7
34014-18-1
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)37-60-61


616-021-00-9
thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea
246-901-4
25366-23-8
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)60-61


616-022-00-4
acetamide
200-473-5
60-35-5
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37


616-023-00-X
N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide
401-980-6
—
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37


616-024-00-5
2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide
402-260-4
54942-74-4
R53
R: 53
S: 61


616-025-00-0
valinamide
402-840-7
20108-78-5
Repr. Cat. 3; R62
Xi; R36
R43
Xn
R: 36-43-62
S: (2-)26-36/37


616-026-00-6
thioacetamide
200-541-4
62-55-5
Carc. Cat. 2; R45
Xn; R22
Xi; R36/38
R52-53
T
R: 45-22-36/38-52/53
S: 53-45-61

E
616-027-00-1
tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate
403-760-5
—
R43
Xi
R: 43
S: (2-)24-37


616-028-00-7
N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
403-790-9
108673-51-4
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


616-029-00-2
N,N'-ethylenebis(vinylsulfonylacetamide)
404-790-1
66710-66-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39


616-030-00-8
ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
250-010-6
30043-49-3
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


616-031-00-3
dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide
256-625-6
50563-36-5
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


616-032-00-9
diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
—
83164-33-4
R52-53
R: 52/53
S: 61


616-033-00-4
cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-9
69581-33-5
T; R25
Xn; R21
N; R50-53
T; N
R: 21-25-50/53
S: (1/2-)36/37-60-61


616-034-00-X
pyracarbolid (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide
246-419-4
24691-76-7
R52-53
R: 52/53
S: 61


616-035-00-5
cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-0
57966-95-7
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)36/37-60-61


616-036-00-0
2-chloracetamide
201-174-2
79-07-2
Repr. Cat. 3; R62
T; R25
R43
T
R: 25-43-62
S: (1/2-)22-36/37-45
R43: C ≥ 0,1 %

616-037-00-6
acetochlor (ISO);
2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide
251-899-3
34256-82-1
Xn; R20
Xi; R37/38
R43
N; R50-53
Xn; N
R: 20-37/38-43-50/53
S: (2-)36/37-60-61


616-038-00-1
(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride
406-010-5
88918-84-7
Xi; R41
R43
N; R51-53
Xi; N
R: 41-43-51/53
S: (2-)24-26-37/39-61


616-039-00-7
3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide
406-200-8
117827-06-2
R43
Xi
R: 43
S: (2-)24-37


616-040-00-2
potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide
406-650-5
97888-41-0
Xi; R41
Xi
R: 41
S: (2-)26-39


616-041-00-8
3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide
406-840-8
101664-25-9
R53
R: 53
S: 61


616-042-00-3
N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide
407-070-5
142859-67-4
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61


616-043-00-9
isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide
407-190-8
82558-50-7
R53
R: 53
S: 61


616-044-00-4
N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide
402-510-2
—
N; R51-53
N
R: 51/53
S: 61


616-045-00-X
2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide
405-190-2
122371-93-1
R43
R53
Xi
R: 43-53
S: 2-22-24-37-61


616-046-00-5
N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide
406-390-2
—
N; R50-53
N
R: 50/53
S: 60-61


616-047-00-0
reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
406-640-0
—
R43
Xi
R: 43
S: (2-)24-37


616-048-00-6
3'-trifluoromethylisobutyranilide
406-740-4
1939-27-1
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)22-36-61


616-049-00-1
2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide
408-150-2
99141-89-6
R53
R: 53
S: 61


616-050-00-7
lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
410-690-9
103055-07-8
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


616-051-00-2
reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene
411-070-0
—
R53
R: 53
S: 61


616-052-00-8
formamide
200-842-0
75-12-7
Repr. Cat. 2; R61
T
R: 61
S: 53-45


616-053-00-3
N-methylacetamide
201-182-6
79-16-3
Repr. Cat. 2; R61
T
R: 61
S: 53-45


616-054-00-9
iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-9
36734-19-7
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


616-055-00-4
propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide
245-951-4
23950-58-5
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-60-61


616-056-00-X
N-methylformamide
204-624-6
123-39-7
Repr. Cat. 2; R61
Xn; R21
T
R: 61-21
S: 53-45

E
616-057-00-5
reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide
412-790-8
—
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R48/22
T
R: 45-48/22
S: 53-45

E
616-058-00-0
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
412-570-1
119462-56-5
Xn; R48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 41-43-48/22-50/53
S: (2-)26-36/37/39-60-61


616-059-00-6
4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide
412-650-6
121487-83-0
R53
R: 53
S: 61


616-060-00-1
Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)
413-770-1
—
Xn; R22
C; R34
R43
N; R50-53
C; N
R: 22-34-43-50/53
S: (1/2-)26-36/37/39-45-60-61


616-061-00-7
N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide
413-610-0
124172-53-8
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61


616-062-00-2
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide
411-590-8
70693-57-1
C; R34
R52-53
C
R: 34-52/53
S: (1/2-)26-36/37/39-45-61


616-063-00-8
3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione
411-920-0
106917-30-0
T; R23
Xn; R22-48/22
C; R35
N; R50-53
T; C; N
R: 22-23-35-48/22-50/53
S: (1/2-)26-28-36/37/39-45-60-61


616-064-00-3
N-tert-butyl-3-methylpicolinamide
406-720-5
32998-95-1
R52-53
R: 52/53
S: 61


616-065-00-9
3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea
411-970-3
79881-89-3
Xn; R22-48/22
Xn
R: 22-48/22
S: (2-)22-36


616-066-00-4
5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone
405-100-1
115662-06-1
Repr. Cat. 3; R62
Xn
R: 62
S: (2-)22-36/37


616-067-00-X
dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate
407-300-4
92683-20-0
R53
R: 53
S: 61


616-068-00-5
potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate
406-500-9
174393-75-0
R43
Xi
R: 43
S: (2-)22-24-37


616-069-00-0
1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide
406-210-2
110560-22-0
R53
R: 53
S: 61


616-070-00-6
reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-530-2
—
R53
R: 53
S: 22-61


616-071-00-1
reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)
406-550-1
—
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61


616-072-00-7
1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine
407-120-6
55612-11-8
R53
R: 53
S: 61


616-073-00-2
4'-ethoxy-2-benzimidazoleanilide
407-600-5
120187-29-3
Muta. Cat. 3; R68
R53
Xn
R: 68-53
S: (2-)22-36/37-61


616-074-00-8
N-butyl-2-(4-morpholinylcarbonyl)benzamide
407-730-2
104958-67-0
Xi; R36
R43
R52-53
Xi
R: 36-43-52/53
S: (2-)24-26-37-61


616-075-00-3
D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)
408-120-9
65197-96-8
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)26-39-46


616-076-00-9
tebufenozide (ISO);
N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide
412-850-3
112410-23-8
N; R51-53
N
R: 51/53
S: 61


616-077-00-4
reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate
411-310-4
—
Xi; R41
Xi
R: 41
S: (2-)26-39


616-078-00-X
2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide
411-330-3
104541-33-5
R53
R: 53
S: 61


616-079-00-5
1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate
411-700-4
140921-24-0
R43
Xi
R: 43
S: (2-)24-37


616-080-00-0
4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)
411-850-0
119018-29-0
R52-53
R: 52/53
S: 61


616-081-00-6
5-bromo-8-naphtholactam
413-480-5
24856-00-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61


616-082-00-1
N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide
413-200-1
129604-78-0
R43
Xi
R: 43
S: (2-)24-37


616-083-00-7
[2-[(4-nitrophenyl)amino]ethyl]urea
410-700-1
27080-42-8
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


616-084-00-2
2,4-bis[N'-(4-methylphenyl)ureido]toluene
411-790-5
—
N; R50-53
N
R: 50/53
S: 60-61


616-085-00-8
3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione
412-190-6
168900-02-5
N; R50-53
N
R: 50/53
S: 60-61


616-086-00-3
2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene
412-250-1
102387-48-4
R53
R: 53
S: 61


616-087-00-9
reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate
412-260-6
52658-19-2
Xi; R36
R43
N; R51-53
Xi; N
R: 36-43-51/53
S: (2-)26-36/37-61


616-088-00-4
2-aminosulfonyl-N,N-dimethylnicotinamide
413-440-7
112006-75-4
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61


616-089-00-X
5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran
415-360-8
41107-56-6
Muta. Cat. 3; R68
Xn
R: 68
S: (2-)22-36/37


616-090-00-5
1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride
415-660-9
70918-74-0
T; R23/24/25
Xn; R48/22
N; R51-53
T; N
R: 23/24/25-48/22-51/53
S: 53-45-61


616-091-00-0
1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione
423-400-0
59653-74-6
Muta. Cat. 2; R46
T; R23
Xn; R22-48/22
Xi; R41
R43
T
R: 46-22-23-41-43-48/22
S: 53-45

E
616-092-00-6
Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide
404-035-6
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


616-093-00-1
Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride
406-620-1
129217-90-9
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


616-094-00-7
3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea
406-370-3
58890-25-8
R43
R53
Xi
R: 43-53
S: (2-)24-37-61


616-095-00-2
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-690-3
43136-14-7
R53
R: 53
S: 61


616-096-00-8
N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide
408-110-4
110483-07-3
R53
R: 53
S: 61


616-097-00-3
N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide
411-840-6
83372-55-8
R53
R: 53
S: 61


616-098-00-9
1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide
411-750-7
119126-15-7
N; R51-53
N
R: 51/53
S: 61


616-099-00-4
2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide
414-170-2
135937-20-1
R53
R: 53
S: 61


616-100-00-8
1,3-dimethyl-1,3-bis(trimethylsilyl)urea
414-180-7
10218-17-4
Xn; R22
Xi; R38
Xn
R: 22-38
S: (2-)36/37


616-101-00-3
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide
414-600-9
149182-72-9
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61


616-102-00-9
reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]
415-870-0
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)36/37-61


616-103-00-4
(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide
415-030-3
120298-38-6
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61


616-104-00-X
benalaxyl (ISO);
methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate
275-728-7
71626-11-4
N; R50-53
N
R: 50/53
S: 60-61


616-105-00-5
chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea
239-592-2
15545-48-9
Carc. Cat. 3; R40
Repr. Cat. 3; R63
N; R50-53
Xn; N
R: 40-63-50/53
S: (2-)26-36/37-46-60-61


616-106-00-0
phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate
237-199-0
13684-63-4
N; R50-53
N
R: 50/53
S: 60-61




616-107-00-6
cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
-
142891-20-1
Carc. Cat. 3; R40
R43
N; R50-53
Xn; N
R: 40-43-50/53
S: (2-)24-37-46-60-61




616-108-00-1
iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide
—
144550-36-7
N; R50-53
N
R: 50/53
S: 60-61


616-109-00-7
sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea
—
141776-32-1
N; R50-53
N
R: 50/53
S: 60-61


616-110-00-2
cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
419-150-7
113136-77-9
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61


616-111-00-8
fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid
422-530-5
126833-17-8
N; R51-53
N
R: 51/53
S: 61


616-112-00-3
oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate
—
144651-06-9
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)46-60-61


616-113-00-9
desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate
237-198-5
13684-56-5
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %

616-114-00-4
dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-
418-010-2
136897-58-0
R53
R: 53
S: 22-61


616-115-00-X
N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide
416-150-9
136450-06-1
R53
R: 53
S: 61


616-116-00-5
N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate
416-790-9
143052-96-4
R53
R: 53
S: 61


616-117-00-0
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide
416-860-9
777891-21-1
Repr. Cat. 3; R62
R43
N; R50-53
Xn; N
R: 43-62-50/53
S: (2-)22-36/37-60-61


616-118-00-6
N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride
417-950-0
65797-42-4
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61


616-119-00-1
2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide
418-060-5
118020-93-2
R53
R: 53
S: 61


616-120-00-7
reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide
420-600-1
—
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)36/37-61


616-121-00-2
2,4-dihydroxy-N-(2-methoxyphenyl)benzamide
419-090-1
129205-19-2
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61




616-122-00-8
methylneodecanamide
414-460-9
105726-67-8
Xn; R22
Xn
R: 22
S: (2-)



616-123-00-3
N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide
414-740-0
96141-86-5
N; R50-53
N
R: 50/53
S: 60-61





616-124-00-9
lithium bis(trifluoromethylsulfonyl)imide
415-300-0
90076-65-6
T; R24/25
Xn; R48/22
C; R34
R52-53
T
R: 24/25-34-48/22-52/53
S: (1/2-)22-26-36/37/39-45-61



616-125-00-4
3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide
415-730-9
151338-11-3
N; R50-53
N
R: 50/53
S: 60-61




616-126-00-X
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide
423-960-6
139756-01-7
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36/37-61



616-127-00-5
reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)
430-050-2
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61


616-128-00-0
N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide
417-530-7
123590-00-1
R53
R: 53
S: 61


616-129-00-6
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide
419-710-0
42774-15-2
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)22-25-26


616-130-00-1
N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide
421-780-2
150919-56-5
R53
R: 53
S: 61




616-131-00-7
1-aminocyclopentanecarboxamide
422-950-9
17193-28-1
T; R48/25
Xn; R22
Xi; R41
T
R: 22-41-48/25
S: (1/2-)22-26-36/39-45




616-132-00-2
N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide
423-250-6
130016-98-7
N; R50-53
N
R: 50/53
S: 60-61


616-133-00-8
N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide
423-990-1
149118-66-1
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)22-26-39-60-61


616-134-00-3
3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide
401-820-5
793710-14-2
R52-53
R: 52/53
S: 61


616-135-00-9
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide
430-230-0
136522-17-3
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-61




616-136-00-4
reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)
430-380-7
-
N; R51-53
N
R: 51/53
S: 61



616-137-00-X
4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane
401-130-4
71526-07-3
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



616-138-00-5
benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide
431-600-4
112226-61-6
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



616-139-00-0
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide
420-380-5
136465-81-1
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61



616-140-00-6
N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]
429-380-1
133336-92-2
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



616-141-00-1
zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide
-
156052-68-5
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


616-142-00-7
1,3-Bis(vinylsulfonylacetamido)propane
428-350-3
93629-90-4
Muta. Cat. 3; R68
Xi; R41
R43
R52-53
Xn
R: 41-43-68-52/53
S: (2-)22-26-36/37/39-61


616-143-00-2
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide
422-560-9
149591-38-8
Repr. Cat. 3; R62
Xi; R36
R53
Xn
R: 36-62-53
S: (2-)26-36/37-61




616-144-00-8
3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-130-1
-
R53
R: 53
S: 61



616-145-00-3
pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide
-
106700-29-2
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-46-60-61
N; R50-53: C ≥ 0, 25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


616-146-00-9
N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide
431-330-7
142776-95-2
R53
R: 53
S: 22-61



616-147-00-4
1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide
424-160-1
139481-22-4
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61



616-148-00-X
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
424-550-1
84245-12-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T
R: 45-46-60-61
S: 53-45



616-150-00-0
(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride
425-260-6
-
Xn; R48/22
Xi; R41
R43
N; R51-53
Xn; N
R: 41-43-48/22-51/53
S: (2-)22-26-36/37/39-61



616-151-00-6
N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide
425-650-6
171887-03-9
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)24-26-37/39-61



616-152-00-1
4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide
425-850-3
125971-96-2
R53
R: 53
S: 61



616-153-00-7
4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide
425-860-8
125971-57-5
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61



616-154-00-2
3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide
431-110-0
-
R53
R: 53
S: 61



616-155-00-8
N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide
431-040-0
104560-40-9
N; R50-53
N
R: 50/53
S: 60-61



616-156-00-3
6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide
430-500-8
204277-61-2
R53
R: 53
S: 61



616-157-00-9
3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride
427-780-9
114565-70-7
Xn; R22
Xi; R41
N; R50-53
Xn; N
R: 22-41-50/53
S: (2-)26-39-60-61



616-158-00-4
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide
427-880-2
90357-53-2
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)36-61



616-160-00-5
2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]
429-090-3
61551-69-7
R43
R52-53
Xi
R: 43-52/53
S: (2-)12-15-24-37-61



616-161-00-0
2,4-dichloro-5-hydroxyacetanilide
429-110-0
67669-19-6
R52-53
R: 52/53
S: 61



616-162-00-6
isostearic acid monoisopropanolamide
431-540-9
-
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61



616-163-00-1
4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]
430-350-3
192463-88-0
R53
R: 53
S: 61



616-164-00-7
dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
-
149961-52-4
Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20
N; R50-53
Xn; N
R: 20-40-63-50/53
S: (2-)36/37-46-60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


616-165-00-2
beflubutamid (ISO);
(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide
-
113614-08-7
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


616-166-00-8
cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide
-
120116-88-3
N; R50-53
N
R: 50/53
S: 60-61
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


616-167-00-3
N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide
418-290-6
168612-06-4
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37



616-168-00-9
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium
418-440-0
136997-71-2
R43
Xi
R: 43
S: (2-)22-24-37



616-169-00-4
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one
420-220-4
92771-56-7
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



616-170-00-X
(2R)-2-amino-2-phenylacetamide
420-370-0
6485-67-2
Xi; R36
R43
Xi
R: 36-43
S: (2-)22-26-36/37



616-171-00-5
2-(para-chlorophenyl)glycineamide
420-830-0
102333-75-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39



616-172-00-0
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl
423-840-3
14691-89-5
Xn; R22
Xn
R: 22
S: (2-)22



616-174-00-1
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
424-560-4
151257-01-1
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)22-26



616-175-00-7
2-(2-hexyldecyloxy)benzamide
431-230-3
202483-62-3
R53
R: 53
S: 61



616-176-00-2
3-N,N-bis(methoxyethyl)aminoacetanilide
432-530-7
24294-01-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-24-61



616-177-00-8
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide
432-970-1
217324-98-6
R53
R: 53
S: 61



616-178-00-3
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide
434-500-9
52583-35-4
R53
R: 53
S: 22-61



616-179-00-9
2-chloro-N-(4-methylphenyl)acetamide
435-170-9
16634-82-5
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)22-26-36/37/39-60-61



616-180-00-4
N,N-(dimethylamino)thioacetamide hydrochloride
435-470-1
27366-72-9
Repr. Cat. 2; R61
N; R50-53
T; N
R: 61-50/53
S: 53-45-60-61



616-181-00-X
4'-methyldodecane-1-sulfonanilide
435-490-9
17417-32-2
N; R50-53
N
R: 50/53
S: 60-61



616-182-00-5
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
435-860-1
214417-91-1
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61



616-183-00-0
N-dodecyl-4-methoxybenzamide
442-340-6
1854-15-5
R53
R: 53
S: 61



616-184-00-6
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide
442-560-2
105043-55-8
R53
R: 53
S: 61



616-186-00-7
N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)
443-010-4
53641-10-4
R52-53
R: 52/53
S: 61



616-188-00-8
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide
443-980-9
221215-20-9
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



616-189-00-3
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide
444-780-4
452962-97-9
R53
R: 53
S: 61



616-190-00-9
N-decyl-4-nitrobenzamide
445-880-0
64026-19-3
R53
R: 53
S: 61



616-191-00-4
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide
446-190-2
406488-30-0
Xn; R22
Xi; R36/38
R43
N; R51-53
Xn; N
R: 22-36/38-43-51/53
S: (2-)24-26-37-61



616-192-00-X
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide
448-060-0
727678-39-9
R53
R: 53
S: 61



616-193-00-5
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide
449-940-7
368450-39-9
R53
R: 53
S: 61



616-194-00-0
2,2-diethoxy-N,N-dimethylacetamide
449-950-1
34640-92-1
Xi; R36
Xi
R: 36
S: (2-)26



616-196-00-1
disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide
419-990-4
-
N; R50-53
N
R: 50/53
S: 60-61



616-197-00-7
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide
422-500-1
-
Xn; R48/22
Xn
R: 48/22
S: (2-)22-36



616-198-00-2
1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene
423-300-7
-
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



616-200-00-1
reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);
12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)
432-430-3
-
R43
R53
Xi
R: 43-53
S: (2-)24-37-61



616-201-00-7
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine
432-840-2
220926-97-6
Xn; R20
R53
Xn
R: 20-53
S: (2-)22-61



616-202-00-2
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide
434-330-5
-
Carc. Cat. 3; R40
R43
R53
Xn
R: 40-43-53
S: (2-)36/37-61



616-203-00-8
reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide
442-280-0
-
R53
R: 53
S: 61



616-204-00-3
N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]
451-060-3
122886-55-9
R53
R: 53
S: 61



617-001-00-2
di-tert-butyl peroxide
203-733-6
110-05-4
O; R7
F; R11
O; F
R: 7-11
S: (2-)3/7-14-16-36/37/39


617-002-00-8
α,α-dimethylbenzyl hydroperoxide;
cumene hydroperoxide
201-254-7
80-15-9
O; R7
T; R23
Xn; R21/22-48/20/22
C; R34
N; R51-53
O; T; N
R: 7-21/22-23-34-48/20/22-51/53
S: (1/2-)3/7-14-36/37/39-45-50-61
C; R34: C ≥ 10 %
Xi; R37/38-41: 3 % ≤ C < 10 %
Xi; R36/37: 1 % ≤ C < 3 %

617-003-00-3
dilauroyl peroxide
203-326-3
105-74-8
O; R7
O
R: 7
S: (2-)3/7-14-36/37/39


617-004-00-9
1,2,3,4-tetrahydro-1-naphthyl hydroperoxide
212-230-0
771-29-9
O; R7
Xn; R22
C; R34
N; R50-53
O; C; N
R: 7-22-34-50/53
S: (1/2-)3/7-14-26-36/37/39-45-60-61
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

617-006-00-X
bis(α,α-dimethylbenzyl) peroxide
201-279-3
80-43-3
O; R7
Xi; R36/38
N; R51-53
O; Xi; N
R: 7-36/38-51/53
S: (2-)3/7-14-36/37/39-61


617-007-00-5
tert-butyl α,α-dimethylbenzyl peroxide
222-389-8
3457-61-2
O; R7
Xi; R38
N; R51-53
O; Xi; N
R: 7-38-51/53
S: (2-)3/7-14-36/37/39-61




617-008-00-0
dibenzoyl peroxide;
benzoyl peroxide
202-327-6
94-36-0
E; R3
O; R7
Xi; R36
R43
E; Xi
R: 3-7-36-43
S: (2-)3/7-14-36/37/39



617-010-00-1
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
E; R3
O; R7
C; R34
Xn; R22
E; C
R: 3-7-22-34
S: (1/2-)3/7-14-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
C

617-012-00-2
8-p-menthyl hydroperoxide;
p-menthane hydroperoxide
201-281-4
80-47-7
O; R7
C; R34
Xn; R20
O; C
R: 7-20-34
S: (1/2-)3/7-14-36/37/39-45
C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %

617-013-00-8
O,O-tert-butyl O-docosyl monoperoxyoxalate
404-300-6
116753-76-5
O; R7
N; R50-53
O; N
R: 7-50/53
S: (2-)7-14-36/37/39-47-60-61


617-014-00-3
6-(nonylamino)-6-oxo-peroxyhexanoic acid
406-680-9
104788-63-8
O; R7
Xi; R41
R43
N; R50
O; Xi; N
R: 7-41-43-50
S: (2-)3/7-14-26-36/37/39-61


617-015-00-9
bis(4-methylbenzoyl)peroxide
407-950-9
895-85-2
E; R2
O; R7
N; R50-53
E; N
R: 2-7-50/53
S: (2-)7-14-36/37/39-47-60-61


617-016-00-4
3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate
413-910-1
—
O; R7
R10
Xi; R38
N; R50-53
O; Xi; N
R: 7-10-38-50/53
S: (2-)7/47-14-36/37/39-60-61




617-017-00-X
reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene
412-140-3
32144-25-5
E; R2
O; R7
R53
E
R: 2-7-53
S: (2-)3/7-14-36/37/39-61

T

617-018-00-5
reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight
410-840-3
71566-50-2
O; R7
N; R51-53
O; N
R: 7-51/53
S: (2-)3/7-14-36/37/39-61


617-019-00-0
6-(phthalimido)peroxyhexanoic acid
410-850-8
128275-31-0
O; R7
Xi; R41
N; R50
O; Xi; N
R: 7-41-50
S: (2-)3/7-14-26-36/37/39-61


617-020-00-6
1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)
420-060-5
117663-11-3
R10
O; R7
N; R51-53
O; N
R: 7-10-51/53
S: (2-)7-14-36/37/39-47-61




617-021-00-1
methylethylketone peroxide trimer
429-320-2
-
E; R2
O; R7
Xn; R65
Xi; R38
R43
E; Xn
R: 2-7-38-43-65
S: (2-)3/7-14-23-36/37/39-62



617-022-00-7
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate
442-480-8
-
O; R7
Xn; R22
C; R34
R43
N; R51-53
O; C; N
R: 7-22-34-43-51/53
S: (1/2-)3/7-14-26-36/37/39-45-50-61



647-001-00-8
glucosidase, β-
232-589-7
9001-22-3
R42
Xn
R: 42
S: (2-)22-24-36/37


647-002-00-3
cellulase
232-734-4
9012-54-8
R42
Xn
R: 42
S: (2-)22-24-36/37


647-003-00-9
cellobiohydrolase, exo-
253-465-9
37329-65-0
R42
Xn
R: 42
S: (2-)22-24-36/37


647-004-00-4
cellulases with the exception of those specified elsewhere in this Annex
—
—
R42
Xn
R: 42
S: (2-)22-24-36/37

A
647-005-00-X
bromelain, juice
232-572-4
9001-00-7
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-006-00-5
ficin
232-599-1
9001-33-6
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-007-00-0
papain
232-627-2
9001-73-4
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-008-00-6
pepsin A
232-629-3
9001-75-6
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-009-00-1
rennin
232-645-0
9001-98-3
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-010-00-7
trypsin
232-650-8
9002-07-7
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-011-00-2
chymotrypsin
232-671-2
9004-07-3
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-012-00-8
subtilisin
232-752-2
9014-01-1
Xi; R37/38-41
R42
Xn
R: 37/38-41-42
S: (2-)22-24-26-36/37/39


647-013-00-3
proteinase, microbial neutral
232-966-6
9068-59-1
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-014-00-9
proteases with the exception of those specified elsewhere in this Annex
—
—
Xi; R36/37/38
R42
Xn
R: 36/37/38-42
S: (2-)22-24-26-36/37


647-015-00-4
amylase, α-
232-565-6
9000-90-2
R42
Xn
R: 42
S: (2-)22-24-36/37


647-016-00-X
amylases with the exception of those specified elsewhere in this Annex
—
—
R42
Xn
R: 42
S: (2-)22-24-36/37




647-017-00-5
laccase
420-150-4
80498-15-3
R42
Xn
R: 42
S: (2-)23-45




648-001-00-0
Distillates (coal tar), benzole fraction;
Light Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]
283-482-7
84650-02-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H


648-002-00-6
Tar oils, brown-coal;
Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]
302-674-4
94114-40-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-003-00-1
Benzol forerunnings (coal);
Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]
266-023-5
65996-88-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-004-00-7
Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]
309-984-9
101896-26-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-005-00-2
Aromatic hydrocarbons, C6-10, C8-rich;
Light Oil Redistillate, low boiling
292-697-5
90989-41-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-006-00-8
Solvent naphtha (coal), light;
Light Oil Redistillate, low boiling
287-498-5
85536-17-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-007-00-3
Solvent naphtha (coal), xylene-styrene cut;
Light Oil Redistillate, intermediate boiling
287-502-5
85536-20-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-008-00-9
Solvent naphtha (coal), coumarone-styrene contg.;
Light Oil Redistillate, intermediate boiling
287-500-4
85536-19-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-009-00-4
Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
292-636-2
90641-12-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-010-00-X
Aromatic hydrocarbons, C8;
Light Oil Redistillate, high boiling
292-694-9
90989-38-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-012-00-0
Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]
295-281-1
91995-20-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-013-00-6
Aromatic hydrocarbons, C9-12, benzene distn.;
Light Oil Redistillate, high boiling
295-551-9
92062-36-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-014-00-1
Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]
295-323-9
91995-61-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-015-00-7
Extract residues (coal tar), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]
309-868-8
101316-63-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-016-00-2
Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]
298-725-2
93821-38-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-017-00-8
Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]
292-625-2
90641-02-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-018-00-3
Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling
309-867-2
101316-62-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-019-00-9
Extract residues (coal), light oil alk., indene naphtha fraction;
Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]
292-626-8
90641-03-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-020-00-4
Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]
266-013-0
65996-79-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-021-00-X
Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]
309-971-8
101794-90-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-022-00-5
Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;
[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]
292-609-5
90640-87-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-023-00-0
Distillates (coal tar), light oils; Carbolic Oil;
[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]
283-483-2
84650-03-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-024-00-6
Tar oils, coal;
Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]
266-016-7
65996-82-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-026-00-7
Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue;
[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]
292-624-7
90641-01-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-027-00-2
Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue;
[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]
266-021-4
65996-87-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-028-00-8
Extract oils (coal), light oil;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-622-6
90640-99-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-029-00-3
Pyridine, alkyl derivs.;
Crude Tar Bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]
269-929-9
68391-11-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-030-00-9
Tar bases, coal, picoline fraction;
Distillate Bases;
[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]
295-548-2
92062-33-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-031-00-4
Tar bases, coal, lutidine fraction;
Distillate Bases
293-766-2
91082-52-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-032-00-X
Extract oils (coal), tar base, collidine fraction;
Distillate Bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]
273-077-3
68937-63-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-033-00-5
Tar bases, coal, collidine fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]
295-543-5
92062-28-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-034-00-0
Tar bases, coal, aniline fraction;
Distillate Bases;
[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]
295-541-4
92062-27-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-035-00-6
Tar bases, coal, toluidine fraction;
Distillate Bases
293-767-8
91082-53-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-036-00-1
Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]
295-292-1
91995-31-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-037-00-7
Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]
295-295-8
91995-35-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-038-00-2
Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;
Redistillates;
[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]
295-329-1
91995-66-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-039-00-8
Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]
310-170-0
122070-79-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-040-00-3
Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;
Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]
310-171-6
122070-80-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-041-00-9
Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]
309-851-5
101316-45-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-042-00-4
Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]
284-900-0
84989-11-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M


648-043-00-X
Creosote oil, acenaphthene fraction, acenaphthene-free;
Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]
292-606-9
90640-85-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-044-00-5
Distillates (coal tar), heavy oils;
Heavy Anthracene Oil;
[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]
292-607-4
90640-86-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
648-045-00-0
Distillates (coal tar), upper;
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]
266-026-1
65996-91-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-046-00-6
Anthracene oil, acid ext.;
Anthracene Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]
295-274-3
91995-14-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-047-00-1
Distillates (coal tar);
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]
266-027-7
65996-92-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-048-00-7
Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]
295-312-9
91995-51-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-049-00-2
Distillates (coal tar), pitch;
Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]
309-855-7
101316-49-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-050-00-8
Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]
295-304-5
91995-42-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-051-00-3
Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]
295-313-4
91995-52-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-052-00-9
Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract;
[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-296-6
97926-76-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-053-00-4
Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-297-1
97926-77-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-054-00-X
Pitch;
Pitch
263-072-4
61789-60-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-055-00-5
Pitch, coal tar, high-temp.;
Pitch;
[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-2
65996-93-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
648-056-00-0
Pitch, coal tar, high-temp., heat-treated;
Pitch;
[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
310-162-7
121575-60-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-057-00-6
Pitch, coal tar, high-temp., secondary;
Pitch Redistillate;
[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]
302-650-3
94114-13-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-058-00-1
Residues (coal tar), pitch distn.;
Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]
295-507-9
92061-94-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-059-00-7
Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]
295-535-1
92062-20-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-060-00-2
Tar, coal, storage residues;
Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]
293-764-1
91082-50-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-061-00-8
Tar, coal, high-temp., residues;
Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]
309-726-5
100684-51-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-062-00-3
Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]
273-615-7
68990-61-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-063-00-9
Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]
295-549-8
92062-34-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-064-00-4
Extract residues (coal), brown;
Coal Tar Extract;
[The residue from extraction of dried coal.]
294-285-0
91697-23-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-065-00-X
Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-454-1
92045-71-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-066-00-5
Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-455-7
92045-72-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-067-00-0
Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-298-7
97926-78-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-068-00-6
Tar, coal, low-temp., distn. residues;
Tar Oil, intermediate boiling;
[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]
309-887-1
101316-85-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-069-00-1
Pitch, coal tar, low-temp;
Pitch Residue;
[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-651-4
90669-57-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-070-00-7
Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-654-0
90669-59-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-071-00-2
Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised;
Pitch Residue, heat-treated;
[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]
292-653-5
90669-58-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-072-00-8
Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]
269-159-3
68188-48-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-073-00-3
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-956-6
101794-74-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-074-00-9
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-957-1
101794-75-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-075-00-4
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-958-7
101794-76-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-076-00-X
Pitch, coal tar-petroleum;
Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]
269-109-0
68187-57-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-077-00-5
Phenanthrene, distn. residues;
Heavy Anthracene Oil Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]
310-169-5
122070-78-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-078-00-0
Distillates (coal tar), upper, fluorene-free;
Wash Oil Redistillate;
[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]
284-899-7
84989-10-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-079-00-6
Anthracene oil;
Anthracene oil;
[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]
292-602-7
90640-80-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M


648-080-00-1
Residues (coal tar), creosote oil distn.;
Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]
295-506-3
92061-93-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-081-00-7
Tar, coal;
Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]
232-361-7
8007-45-2
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
648-082-00-2
Tar, coal, high-temp.;
Coal tar;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]
266-024-0
65996-89-6
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
648-083-00-8
Tar, coal, low-temp.;
Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]
266-025-6
65996-90-9
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H


648-084-00-3
Distillates (coal), coke-oven light oil, naphthalene cut;
Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]
285-076-5
85029-51-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-085-00-9
Distillates (coal tar), naphthalene oils;
Naphthalene Oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]
283-484-8
84650-04-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-086-00-4
Distillates (coal tar), naphthalene oils, naphthalene-low;
Naphthalene Oil Redistillate;
[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]
284-898-1
84989-09-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-087-00-X
Distillates (coal tar), naphthalene oil crystn. mother liquor;
Naphthalene Oil Redistillate;
[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]
295-310-8
91995-49-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-088-00-5
Extract residues (coal), naphthalene oil, alk.;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]
310-166-9
121620-47-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-089-00-0
Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]
310-167-4
121620-48-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-090-00-6
Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]
292-612-1
90640-90-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-091-00-1
Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]
292-627-3
90641-04-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-092-00-7
Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]
309-985-4
101896-27-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-093-00-2
Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;
Methylnaphthalene Oil;
[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]
309-972-3
101794-91-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-094-00-8
Distillates (coal tar), naphthalene oils, acid exts.;
Methylnaphthalene Oil Extract Residue;
[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]
295-309-2
91995-48-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-095-00-3
Extract residues (coal), naphthalene oil alk., distn. residues;
Methylnaphthalene Oil Extract Residue;
[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]
292-628-9
90641-05-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-096-00-9
Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue;
[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]
284-901-6
84989-12-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-097-00-4
Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]
310-165-3
121620-46-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-098-00-X
Creosote oil, acenaphthene fraction;
Wash Oil;
[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
292-605-3
90640-84-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-099-00-5
Creosote oil;
[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]
263-047-8
61789-28-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-100-00-9
Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]
274-565-9
70321-79-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M


648-101-00-4
Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]
232-287-5
8001-58-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H


648-102-00-X
Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]
310-189-4
122384-77-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-103-00-5
Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]
292-603-2
90640-81-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-104-00-0
Anthracene oil, anthracene-low;
Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]
292-604-8
90640-82-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-105-00-6
Residues (coal tar), anthracene oil distn.;
Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]
295-505-8
92061-92-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-106-00-1
Anthracene oil, anthracene paste, anthracene fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]
295-275-9
91995-15-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-107-00-7
Anthracene oil, anthracene paste, carbazole fraction;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]
295-276-4
91995-16-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-108-00-2
Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]
295-278-5
91995-17-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-109-00-8
Tar oils, coal, low-temp.;
Tar Oil, high boiling;
[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]
309-889-2
101316-87-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-110-00-3
Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]
310-191-5
122384-78-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-111-00-9
Phenols, ammonia liquor ext.;
Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]
284-881-9
84988-93-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-112-00-4
Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-610-0
90640-88-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-113-00-X
Extracts, coal tar oil alk.;
Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
266-017-2
65996-83-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-114-00-5
Distillates (coal tar), naphthalene oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-611-6
90640-89-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-115-00-0
Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols;
[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]
292-629-4
90641-06-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-116-00-6
Tar acids, coal, crude;
Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]
266-019-3
65996-85-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-117-00-1
Tar acids, brown-coal, crude;
Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]
309-888-7
101316-86-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-118-00-7
Tar acids, brown-coal gasification;
Crude Phenols;
[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]
295-536-7
92062-22-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-119-00-2
Tar acids, distn. residues;
Distillate Phenols;
[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]
306-251-5
96690-55-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-120-00-8
Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-892-9
84989-04-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-121-00-3
Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]
284-893-4
84989-05-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-122-00-9
Tar acids, xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-895-5
84989-06-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-123-00-4
Tar acids, ethylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-891-3
84989-03-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-124-00-X
Tar acids, 3,5-xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]
284-896-0
84989-07-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-125-00-5
Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]
270-713-1
68477-23-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-126-00-0
Tar acids, cresylic, residues;
Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]
271-418-0
68555-24-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-127-00-6
Phenols, C9-11;
Distillate Phenols
293-435-2
91079-47-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-128-00-1
Tar acids, cresylic;
Distillate Phenols;
[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]
295-540-9
92062-26-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-129-00-7
Tar acids, brown-coal, C2-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]
302-662-9
94114-29-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-130-00-2
Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-623-1
90641-00-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-131-00-8
Tar bases, quinoline derivs.;
Distillate Bases
271-020-7
68513-87-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-132-00-3
Tar bases, coal, quinoline derivs. fraction;
Distillate Bases
274-560-1
70321-67-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-133-00-9
Tar bases, coal, distn. residues;
Distillate Bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]
295-544-0
92062-29-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-134-00-4
Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]
309-745-9
100801-63-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-135-00-X
Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]
309-748-5
100801-65-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-136-00-5
Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]
309-749-0
100801-66-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-137-00-0
Extract residues (coal), tar oil alk., naphthalene distn. residues;
Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]
277-567-8
73665-18-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-138-00-6
Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]
274-566-4
70321-80-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M

648-139-00-1
Tar acids, cresylic, sodium salts, caustic solns.;
Alkaline Extract
272-361-4
68815-21-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-140-00-7
Extract oils (coal), tar base;
Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]
266-020-9
65996-86-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-141-00-2
Tar bases, coal, crude;
Crude Tar Bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]
266-018-8
65996-84-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

HJM

648-142-00-8
Residues (coal), liq. solvent extn.;
[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]
302-681-2
94114-46-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-143-00-3
Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]
302-682-8
94114-47-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-144-00-9
Coal liquids, liq. solvent extn.;
[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]
302-683-3
94114-48-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H M
648-145-00-4
Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]
309-885-0
101316-83-0
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
648-146-00-X
Tar, brown-coal, low-temp.;
[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]
309-886-6
101316-84-1
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H


648-147-00-5
Light oil (coal), coke-oven;
Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]
266-012-5
65996-78-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-148-00-0
Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]
302-688-0
94114-52-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-149-00-6
Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-689-6
94114-53-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-150-00-1
Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-690-1
94114-54-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-151-00-7
Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]
302-691-7
94114-55-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H


648-152-00-2
Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]
302-692-2
94114-56-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-153-00-8
Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]
302-693-8
94114-57-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

648-154-00-3
Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]
302-694-3
94114-58-6
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
648-155-00-9
Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;
[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]
302-695-9
94114-59-7
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H


648-156-00-4
Light oil (coal), semi-coking process;
Fresh oil;
[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]
292-635-7
90641-11-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T
R: 45-46
S: 53-45

H J

649-001-00-3
Extracts (petroleum), light naphthenic distillate solvent
265-102-1
64742-03-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-002-00-9
Extracts (petroleum), heavy paraffinic distillate solvent
265-103-7
64742-04-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-003-00-4
Extracts (petroleum), light paraffinic distillate solvent
265-104-2
64742-05-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-004-00-X
Extracts (petroleum), heavy naphthenic distillate solvent
265-111-0
64742-11-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-005-00-5
Extracts (petroleum), light vacuum gas oil solvent
295-341-7
91995-78-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-006-00-0
hydrocarbons C26-55, arom-rich
307-753-7
97722-04-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-007-00-6
fatty acids, tall-oil, reaction products with iminodiethanol and boric acid
400-160-5
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)28-37-61


649-008-00-1
Residues (petroleum), atm. tower;
Heavy Fuel oil;
[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-045-2
64741-45-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-009-00-7
Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-058-3
64741-57-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-010-00-2
Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-063-0
64741-61-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-011-00-8
Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-064-6
64741-62-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-012-00-3
Residues (petroleum), hydrocracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]
265-076-1
64741-75-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-013-00-9
Residues (petroleum), thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-081-9
64741-80-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-014-00-4
Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-082-4
64741-81-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-015-00-X
Gas oils (petroleum), hydrotreated vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-162-9
64742-59-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-016-00-5
Residues (petroleum), hydrodesulfurized atmospheric tower;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-181-2
64742-78-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-017-00-0
Gas oils (petroleum), hydrodesulfurized heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-189-6
64742-86-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-018-00-6
Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-193-8
64742-90-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-019-00-1
Residues (petroleum), atmospheric;
Heavy Fuel oil;
[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-777-3
68333-22-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-020-00-7
Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-782-0
68333-26-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-021-00-2
Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
269-783-6
68333-27-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-022-00-8
Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
269-784-1
68333-28-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-023-00-3
Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil
270-674-0
68476-32-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-024-00-9
Fuel oil, residual;
Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]
270-675-6
68476-33-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-025-00-4
Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]
270-792-2
68478-13-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-026-00-X
Residues (petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-796-4
68478-17-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-027-00-5
Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-983-0
68512-61-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-028-00-0
Residues (petroleum), light vacuum;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-984-6
68512-62-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-029-00-6
Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]
271-013-9
68513-69-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-030-00-1
Fuel oil, No 6;
Heavy Fuel oil;
[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]
271-384-7
68553-00-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-031-00-7
Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]
271-763-7
68607-30-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-032-00-2
Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]
272-184-2
68783-08-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-033-00-8
Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;
Heavy Fuel oil;
[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]
272-187-9
68783-13-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-034-00-3
Distillates (petroleum), petroleum residues vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]
273-263-4
68955-27-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-035-00-9
Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[A complex residuum from the distillation of steam-cracked petroleum residues.]
273-272-3
68955-36-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-036-00-4
Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-683-0
70592-76-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-037-00-X
Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]
274-684-6
70592-77-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-038-00-5
Distillates (petroleum), vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-685-1
70592-78-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-039-00-0
Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
285-555-9
85117-03-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-040-00-6
Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]
292-657-7
90669-75-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-041-00-1
Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]
292-658-2
90669-76-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-042-00-7
Fuel oil, heavy, high-sulfur;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
295-396-7
92045-14-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-043-00-2
Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]
295-511-0
92061-97-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-044-00-8
Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]
295-990-6
92201-59-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-045-00-3
Residual oils (petroleum);
Heavy Fuel oil;
[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]
298-754-0
93821-66-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-046-00-9
Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]
308-733-0
98219-64-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-047-00-4
Distillates (petroleum), hydrodesulfurized full-range middle;
Heavy Fuel oil;
[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]
309-863-0
101316-57-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-048-00-X
Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]
265-069-3
64741-67-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-049-00-5
Petroleum;
Crude oil;
[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]
232-298-5
8002-05-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-050-00-0
Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]
265-051-5
64741-50-0
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-051-00-6
Distillates (petroleum), heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]
265-052-0
64741-51-1
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-052-00-1
Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-053-6
64741-52-2
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-053-00-7
Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-054-1
64741-53-3
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-054-00-2
Distillates (petroleum), acid-treated heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-117-3
64742-18-3
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-055-00-8
Distillates (petroleum), acid-treated light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-118-9
64742-19-4
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-056-00-3
Distillates (petroleum), acid-treated heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]
265-119-4
64742-20-7
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-057-00-9
Distillates (petroleum), acid-treated light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-121-5
64742-21-8
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-058-00-4
Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]
265-127-8
64742-27-4
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-059-00-X
Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-128-3
64742-28-5
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-060-00-5
Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-135-1
64742-34-3
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H
649-061-00-0
Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-136-7
64742-35-4
Carc. Cat. 1; R45
T
R: 45
S: 53-45

H


649-062-00-6
Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-0
68477-73-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-063-00-1
Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-6
68477-74-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-064-00-7
Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-1
68477-75-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-065-00-2
Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-7
68477-76-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-066-00-8
Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-8
68477-79-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-067-00-3
Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-5
68477-83-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-068-00-9
Gases (petroleum), C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-6
68477-85-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-069-00-4
Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-1
68477-86-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-070-00-X
Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-7
68477-87-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-071-00-5
Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]
270-772-3
68477-90-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-072-00-0
Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-9
68477-91-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-073-00-6
Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-0
68477-94-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-074-00-1
Gases (petroleum), Girbotol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-6
68477-95-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-075-00-7
Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas
270-782-8
68477-99-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-076-00-2
Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-802-5
68478-21-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-077-00-8
Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-803-0
68478-22-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-078-00-3
Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]
270-804-6
68478-24-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-079-00-9
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-806-7
68478-26-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-080-00-4
Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]
270-813-5
68478-32-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-081-00-X
Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]
270-814-0
68478-33-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-082-00-5
Tail gas (petroleum), vacuum residues thermal cracker;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-815-6
68478-34-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-083-00-0
Hydrocarbons, C3-4-rich, petroleum distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]
270-990-9
68512-91-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-084-00-6
Gases (petroleum), full-range straight-run naphtha dehexanizer off;
petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-000-8
68513-15-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-085-00-1
Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]
271-001-3
68513-16-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-086-00-7
Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-002-9
68513-17-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-087-00-2
Residues (petroleum), alkylation splitter, C4-rich;
Petroleum gas;
[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27.8 °C (11 °F to 82 °F).]
271-010-2
68513-66-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-088-00-8
Hydrocarbons, C1-4;
Petroleum gas;
[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]
271-032-2
68514-31-8
F+; R12
Carc. Cat 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-089-00-3
Hydrocarbons, C1-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]
271-038-5
68514-36-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-090-00-9
Hydrocarbons, C1-3;
Petroleum gas;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]
271-259-7
68527-16-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-091-00-4
Hydrocarbons, C1-4, debutanizer fraction;
Petroleum gas
271-261-8
68527-19-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-092-00-X
Gases (petroleum), C1-5, wet;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
271-624-0
68602-83-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-093-00-5
Hydrocarbons, C2-4;
Petroleum gas
271-734-9
68606-25-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-094-00-0
Hydrocarbons, C3;
Petroleum gas
271-735-4
68606-26-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-095-00-6
Gases (petroleum), alkylation feed;
Petroleum gas;
[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
271-737-5
68606-27-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-096-00-1
Gases (petroleum), depropanizer bottoms fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]
271-742-2
68606-34-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-097-00-7
Gases (petroleum), refinery blend;
Petroleum gas;
[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-183-7
68783-07-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-098-00-2
Gases (petroleum), catalytic cracking;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
272-203-4
68783-64-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-099-00-8
Gases (petroleum), C2-4, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]
272-205-5
68783-65-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-100-00-1
Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-871-7
68918-99-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-101-00-7
Gases (petroleum), dehexanizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-872-2
68919-00-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-102-00-2
Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-878-5
68919-05-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-103-00-8
Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-879-0
68919-06-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-104-00-3
Gases (petroleum), straight-run naphtha catalytic reforming off;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]
272-882-7
68919-09-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-105-00-9
Gases (petroleum), fluidized catalytic cracker splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]
272-893-7
68919-20-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-106-00-4
Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-883-2
68919-10-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-107-00-X
Gases (petroleum), catalytic cracked naphtha debutanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-169-3
68952-76-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-108-00-5
Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-170-9
68952-77-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-109-00-0
Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-175-6
68952-81-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-110-00-6
Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-176-1
68952-82-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-111-00-1
Gases (petroleum, light steam-cracked, butadiene conc.;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]
273-265-5
68955-28-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-112-00-7
Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
273-270-2
68955-34-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-113-00-2
Hydrocarbons, C4;
Petroleum gas
289-339-5
87741-01-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-114-00-8
Alkanes, C1-4, C3-rich;
Petroleum gas
292-456-4
90622-55-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-115-00-3
Gases (petroleum), steam-cracker C3-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]
295-404-9
92045-22-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-116-00-9
Hydrocarbons, C4, steam-cracker distillate;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]
295-405-4
92045-23-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-117-00-4
Petroleum gases, liquefied, sweetened, C4 fraction;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]
295-463-0
92045-80-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

HKS

649-118-00-X
Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;
Petroleum gas
306-004-1
95465-89-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-119-00-5
Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;
Petroleum gas
307-769-4
97722-19-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-120-00-0
Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]
270-746-1
68477-65-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-121-00-6
Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
270-747-7
68477-66-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-122-00-1
Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]
270-748-2
68477-67-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-123-00-7
Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-749-8
68477-68-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-124-00-2
Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-759-2
68477-77-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-125-00-8
Gases (petroleum), C6-8 catalytic reformer recycle;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-761-3
68477-80-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-126-00-3
Gases (petroleum), C6-8 catalytic reformer;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]
270-762-9
68477-81-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-127-00-9
Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;
Refinery gas
270-763-4
68477-82-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-128-00-4
Gases (petroleum), C2-return stream;
Refinery gas;
[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]
270-766-0
68477-84-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-129-00-X
Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-774-4
68477-92-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-130-00-5
Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]
270-776-5
68477-93-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-131-00-0
Gases (petroleum), hydrogen absorber off;
Refinery gas;
[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]
270-779-1
68477-96-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-132-00-6
Gases (petroleum), hydrogen-rich;
Refinery gas;
[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]
270-780-7
68477-97-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-133-00-1
Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-781-2
68477-98-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-134-00-7
Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
270-783-3
68478-00-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-135-00-2
Gases (petroleum), reformer make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-784-9
68478-01-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-136-00-8
Gases (petroleum), reforming hydrotreater;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-785-4
68478-02-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-137-00-3
Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
270-787-5
68478-03-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-138-00-9
Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-788-0
68478-04-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-139-00-4
Gases (petroleum), thermal cracking distn.;
Refinery gas;
[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-789-6
68478-05-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-140-00-X
Tail gas (petroleum), catalytic cracker refractionation absorber;
Refinery gas;
[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-805-1
68478-25-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-141-00-5
Tail gas (petroleum), catalytic reformed naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-807-2
68478-27-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-142-00-0
Tail gas (petroleum), catalytic reformed naphtha stabilizer;
Refinery gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-808-8
68478-28-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-143-00-6
Tail gas (petroleum), cracked distillate hydrotreater separator;
Refinery gas;
[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-809-3
68478-29-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-144-00-1
Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-810-9
68478-30-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-145-00-7
Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]
270-999-8
68513-14-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-146-00-2
Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-003-4
68513-18-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-147-00-8
Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-005-5
68513-19-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-148-00-3
Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]
271-258-1
68527-15-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-149-00-9
Gases (petroleum), benzene unit hydrotreater depentanizer overheads;
Refinery gas;
[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]
271-623-5
68602-82-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-150-00-4
Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;
Refinery gas;
[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
271-625-6
68602-84-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-151-00-X
Petroleum products, refinery gases;
Refinery gas;
[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-750-6
68607-11-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-152-00-5
Gases (petroleum), hydrocracking low-pressure separator;
Refinery gas;
[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-182-1
68783-06-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-153-00-0
Gases (petroleum), refinery;
Refinery gas;
[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-338-9
68814-67-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-154-00-6
Gases (petroleum), platformer products separator off;
Refinery gas;
[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
272-343-6
68814-90-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-155-00-1
Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]
272-775-5
68911-58-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-156-00-7
Gases (petroleum), hydrotreated sour kerosine flash drum;
Refinery gas;
[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
272-776-0
68911-59-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-157-00-2
Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]
272-873-8
68919-01-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-158-00-8
Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-874-3
68919-02-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-159-00-3
Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]
272-875-9
68919-03-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-160-00-9
Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-876-4
68919-04-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-161-00-4
Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]
272-880-6
68919-07-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-162-00-X
Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-881-1
68919-08-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-163-00-5
Gases (petroleum), tar stripper off;
Refinery gas;
[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-884-8
68919-11-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-164-00-0
Gases (petroleum), unifiner stripper off;
Refinery gas;
[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]
272-885-3
68919-12-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-165-00-6
Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]
273-173-5
68952-79-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-166-00-1
Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;
Refinery gas;
[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
273-174-0
68952-80-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-167-00-7
Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-269-7
68955-33-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-168-00-2
Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-563-5
68989-88-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-169-00-8
Gases (petroleum), gas oil diethanolamine scrubber off;
Refinery gas;
[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
295-397-2
92045-15-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-170-00-3
Gases (petroleum), gas oil hydrodesulfurization effluent;
Refinery gas;
[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
295-398-8
92045-16-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-171-00-9
Gases (petroleum), gas oil hydrodesulfurization purge;
Refinery gas;
[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
295-399-3
92045-17-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-172-00-4
Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
295-400-7
92045-18-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-173-00-X
Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]
295-401-2
92045-19-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-174-00-5
Gases (petroleum), residue visbaking off;
Refinery gas;
[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
295-402-8
92045-20-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-175-00-0
Foots oil (petroleum), acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-225-7
93924-31-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-176-00-6
Foots oil (petroleum), clay-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-226-2
93924-32-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L


649-177-00-1
Gases (petroleum), C3-4;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]
268-629-5
68131-75-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-178-00-7
Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;
Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-617-2
68307-98-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-179-00-2
Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-618-8
68307-99-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-180-00-8
Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-619-3
68308-00-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-181-00-3
Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-620-9
68308-01-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-182-00-9
Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-630-3
68308-10-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-183-00-4
Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-623-5
68308-03-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-184-00-X
Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-624-0
68308-04-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-185-00-5
Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-625-6
68308-05-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-186-00-0
Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-626-1
68308-06-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-187-00-6
Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-627-7
68308-07-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-188-00-1
Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-629-8
68308-09-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-189-00-7
Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-631-9
68308-11-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-190-00-2
Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-632-4
68308-12-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-191-00-8
Gases (petroleum), catalytic cracked overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]
270-071-2
68409-99-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-193-00-9
Alkanes, C1-2;
Petroleum gas
270-651-5
68475-57-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-194-00-4
Alkanes, C2-3;
Petroleum gas
270-652-0
68475-58-1
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-195-00-X
Alkanes, C3-4;
petroleum gas
270-653-6
68475-59-2
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-196-00-5
Alkanes, C4-5;
Petroleum gas
270-654-1
68475-60-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-197-00-0
Fuel gases;
Petroleum gas;
[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]
270-667-2
68476-26-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-198-00-6
Fuel gases, crude oil of distillates;
Petroleum gas;
[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]
270-670-9
68476-29-9
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-199-00-1
Hydrocarbons, C3-4;
Petroleum gas
270-681-9
68476-40-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-200-00-5
Hydrocarbons, C4-5;
Petroleum gas
270-682-4
68476-42-6
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-201-00-0
Hydrocarbons, C2-4, C3-rich;
Petroleum gas
270-689-2
68476-49-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-202-00-6
Petroleum gases, liquefied;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]
270-704-2
68476-85-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

HKS

649-203-00-1
Petroleum gases, liquefied, sweetened;
Petroleum gas;
[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]
270-705-8
68476-86-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

HKS

649-204-00-7
gases (petroleum), C3-4, isobutane-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]
270-724-1
68477-33-8
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-205-00-2
Distillates (petroleum), C3-6, piperylene-rich;
Petroleum gas;
[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]
270-726-2
68477-35-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-206-00-8
Gases (petroleum), butane splitter overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-750-3
68477-69-0
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-207-00-3
Gases (petroleum), C2-3-;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]
270-751-9
68477-70-3
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-208-00-9
Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-752-4
68477-71-4
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-209-00-4
Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-754-5
68477-72-5
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-210-00-X
Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-628-2
68308-08-7
F+; R12
Carc. Cat. 1; R45
Muta. Cat. 2; R46
F+; T
R: 45-46-12
S: 53-45

H K

649-211-00-5
Foots oil (petroleum), carbon-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-126-0
97862-76-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-212-00-0
Distillates (petroleum), sweetened middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-088-7
64741-86-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-213-00-6
Gas oils (petroleum), solvent-refined;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-092-9
64741-90-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-214-00-1
Distillates (petroleum), solvent-refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-093-4
64741-91-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-215-00-7
Gas oils (petroleum), acid-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-112-6
64742-12-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-216-00-2
Distillates (petroleum), acid-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-113-1
64742-13-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-217-00-8
Distillates (petroleum), acid-treated light;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-114-7
64742-14-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-218-00-3
Gas oils (petroleum), chemically neutralized;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-129-9
64742-29-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-219-00-9
Distillates (petroleum), chemically neutralized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-130-4
64742-30-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-220-00-4
Distillates (petroleum), clay-treated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-139-3
64742-38-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-221-00-X
Distillates (petroleum), hydrotreated middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-148-2
64742-46-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-222-00-5
Gas oils (petroleum), hydrodesulfurized;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-182-8
64742-79-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-223-00-0
Distillates (petroleum), hydrodesulfurized middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-183-3
64742-80-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-224-00-6
Fuels, diesel;
Gasoil — unspecified;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]
269-822-7
68334-30-5
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H N
649-225-00-1
Fuel oil, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]
270-671-4
68476-30-2
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
649-226-00-7
Fuel oil, No 4;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]
270-673-5
68476-31-3
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
649-227-00-2
Fuels, diesel, No 2;
Gasoil — unspecified;
[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]
270-676-1
68476-34-6
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
649-228-00-8
Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]
270-719-4
68477-29-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-229-00-3
Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil — unspecified;
[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]
270-721-5
68477-30-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-230-00-9
Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil — unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]
270-722-0
68477-31-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-231-00-4
Distillates (petroleum), highly refined middle;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]
292-615-8
90640-93-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-232-00-X
Distillates (petroleum) catalytic reformer, heavy arom. conc.;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
295-294-2
91995-34-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-233-00-5
Gas oils, paraffinic;
Gasoil — unspecified;
[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]
300-227-8
93924-33-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-234-00-0
Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil — unspecified
307-035-3
97488-96-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-235-00-6
Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-659-6
97675-85-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-236-00-1
Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-660-1
97675-86-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-237-00-7
Hydrocarbons, C11-17, solvent-extd. light naphthenic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
307-757-9
97722-08-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-238-00-2
Gas oils, hydrotreated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]
308-128-1
97862-78-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-239-00-8
Distillates (petroleum), carbon-treated light paraffinic;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]
309-667-5
100683-97-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-240-00-3
Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-668-0
100683-98-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-241-00-9
Distillates (petroleum), intermediate paraffinic, clay-treated;
Gasoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-669-6
100683-99-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-242-00-4
Alkanes, C12-26-branched and linear
292-454-3
90622-53-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-243-00-X
Lubricating greases;
Grease;
[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]
278-011-7
74869-21-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-244-00-5
Slack wax (petroleum);
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
265-165-5
64742-61-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-245-00-0
Slack wax (petroleum), acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
292-659-8
90669-77-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-246-00-6
Slack wax (petroleum), clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]
292-660-3
90669-78-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-247-00-1
Slack wax (petroleum), hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
295-523-6
92062-09-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-248-00-7
Slack wax (petroleum), low-melting;
Slack wax;
[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-524-1
92062-10-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-249-00-2
Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-525-7
92062-11-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-250-00-8
Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-155-9
97863-04-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-251-00-3
Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-156-4
97863-05-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-252-00-9
Slack wax (petroleum), low-melting, silicic acid-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-158-5
97863-06-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-253-00-4
Slack wax (petroleum), carbon-treated;
Slack wax;
[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]
309-723-9
100684-49-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-254-00-X
Petrolatum;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
232-373-2
8009-03-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-255-00-5
Petrolatum (petroleum), oxidized;
Petrolatum;
[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]
265-206-7
64743-01-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-256-00-0
Petrolatum (petroleum), alumina-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
285-098-5
85029-74-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-257-00-6
Petrolatum (petroleum), hydrotreated;
Petrolatum;
[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]
295-459-9
92045-77-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-258-00-1
Petrolatum (petroleum), carbon-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-149-6
97862-97-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-259-00-7
Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-150-1
97862-98-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N
649-260-00-2
Petrolatum (petroleum), clay-treated;
Petrolatum;
[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]
309-706-6
100684-33-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H N


649-261-00-8
Gasoline, natural;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]
232-349-1
8006-61-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-262-00-3
Naphtha;
Low boiling point naphtha;
[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]
232-443-2
8030-30-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-263-00-9
Ligroine;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]
232-453-7
8032-32-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-264-00-4
Naphtha (petroleum), heavy straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-041-0
64741-41-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-265-00-X
Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]
265-042-6
64741-42-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-266-00-5
Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]
265-046-8
64741-46-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-267-00-0
Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]
265-192-2
64742-89-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-268-00-6
Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]
270-077-5
68410-05-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-269-00-1
Gasoline, vapor-recovery;
Low boiling point naphtha;
[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C(-4 °F to 384 °F).]
271-025-4
68514-15-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-270-00-7
Gasoline, straight-run, topping-plant;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]
271-727-0
68606-11-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-271-00-2
Naphtha (petroleum), unsweetened;
Low boiling point naphtha;
[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]
272-186-3
68783-12-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-272-00-8
Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]
272-931-2
68921-08-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-273-00-3
Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]
309-945-6
101631-20-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-274-00-9
Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]
265-066-7
64741-64-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-275-00-4
Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]
265-067-2
64741-65-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-276-00-X
Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]
265-068-8
64741-66-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-277-00-5
Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]
265-073-5
64741-70-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-278-00-0
Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]
265-086-6
64741-84-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-279-00-6
Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-095-5
64741-92-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-280-00-1
Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]
270-088-5
68410-71-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-281-00-7
Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]
270-349-3
68425-35-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-282-00-2
Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]
271-267-0
68527-27-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-283-00-8
Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]
295-315-5
91995-53-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-284-00-3
Naphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]
295-430-0
92045-49-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-285-00-9
Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]
295-436-3
92045-55-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-286-00-4
Naphtha (petroleum), isomerization, C6-fraction;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]
295-440-5
92045-58-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-287-00-X
Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]
295-446-8
92045-64-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-288-00-5
Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]
309-871-4
101316-67-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-289-00-0
Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-055-7
64741-54-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-290-00-6
Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-056-2
64741-55-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-291-00-1
Hydrocarbons, C3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]
270-686-6
68476-46-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-292-00-7
Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-185-8
68783-09-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-293-00-2
Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;
Low boiling point cat-cracked naphtha.;
[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]
295-311-3
91995-50-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-294-00-8
Naphtha (petroleum), heavy catalytic cracked, sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]
295-431-6
92045-50-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-295-00-3
Naphtha (petroleum), light catalytic cracked sweetened;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]
295-441-0
92045-59-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-296-00-9
Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]
295-794-0
92128-94-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-297-00-4
Hydrocarbons, C8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]
309-974-4
101794-97-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-298-00-X
Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;
Low boiling point cat-cracked naphtha
309-987-5
101896-28-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-299-00-5
Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
265-065-1
64741-63-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-300-00-9
Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-070-9
64741-68-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-301-00-4
Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]
270-660-4
68475-79-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-302-00-X
Hydrocarbons, C2-6, C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha
270-687-1
68476-47-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-303-00-5
Residues (petroleum), C6-8 catalytic reformer;
Low boiling point cat-reformed naphtha;
[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
270-794-3
68478-15-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-304-00-0
Naphtha (petroleum), light catalytic reformed, arom.-free;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]
270-993-5
68513-03-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-305-00-6
Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-008-1
68513-63-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-306-00-1
Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]
271-058-4
68514-79-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-307-00-7
Naphtha (petroleum), full-range reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]
272-895-8
68919-37-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-308-00-2
Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
273-271-8
68955-35-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-309-00-8
Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]
285-509-8
85116-58-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-310-00-3
Aromatic hydrocarbons, C8, catalytic reforming-derived;
Low boiling point cat-reformed naphtha
295-279-0
91995-18-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-311-00-9
Aromatic hydrocarbons, C7-12, C8-rich;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]
297-401-8
93571-75-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-312-00-4
Gasoline, C5-11, high-octane stabilised reformed;
Low boiling point cat-reformed naphtha;
[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]
297-458-9
93572-29-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-313-00-X
Hydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]
297-465-7
93572-35-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-314-00-5
Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]
297-466-2
93572-36-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P


649-315-00-0
Foots oil (petroleum), silicic acid-treated;
Foots oil;
[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-127-6
97862-77-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L


649-316-00-6
Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]
265-075-6
64741-74-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-317-00-1
Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]
265-085-0
64741-83-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-318-00-7
Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]
267-563-4
67891-79-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-319-00-2
Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]
267-565-5
67891-80-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-320-00-8
Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]
270-344-6
68425-29-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-321-00-3
Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]
270-658-3
68475-70-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-322-00-9
Distillates (petroleum), thermal cracked naphtha and gas oil;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]
271-631-9
68603-00-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-323-00-4
Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]
271-632-4
68603-01-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-324-00-X
Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]
271-634-5
68603-03-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-325-00-5
Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]
273-266-0
68955-29-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-326-00-0
Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]
295-447-3
92045-65-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-327-00-6
Naphtha (petroleum), hydrotreated heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-150-3
64742-48-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-328-00-1
Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]
265-151-9
64742-49-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-329-00-7
Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
265-178-6
64742-73-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-330-00-2
Naphtha (petroleum), hydrodesulfurized heavy;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-185-4
64742-82-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-331-00-8
Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]
270-092-7
68410-96-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-332-00-3
Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]
270-093-2
68410-97-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-333-00-9
Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]
270-094-8
68410-98-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-334-00-4
Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]
270-988-8
68512-78-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-335-00-X
Naphtha (petroleum), hydrodesulfurized thermal cracked light;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]
285-511-9
85116-60-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-336-00-5
Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
285-512-4
85116-61-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-337-00-0
Naphtha (petroleum), heavy steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha
295-432-1
92045-51-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-338-00-6
Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]
295-433-7
92045-52-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-339-00-1
Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]
295-438-4
92045-57-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-340-00-7
Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]
295-443-1
92045-61-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-341-00-2
Solvent naphtha (petroleum), hydrotreated light naphthenic;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]
295-529-9
92062-15-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-342-00-8
Naphtha (petroleum), light steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]
296-942-7
93165-55-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-343-00-3
Hydrocarbons, C6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-852-0
93763-33-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-344-00-9
Hydrocarbons, C9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-853-6
93763-34-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-345-00-4
Stoddard solvent;
Low boiling point naphtha - unspecified;
[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]
232-489-3
8052-41-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-346-00-X
Natural gas condensates (petroleum);
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]
265-047-3
64741-47-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-347-00-5
Natural gas (petroleum), raw liq. mix;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]
265-048-9
64741-48-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-348-00-0
Naphtha (petroleum), light hydrocracked;
Low boiling naphtha - unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]
265-071-4
64741-69-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-349-00-6
Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]
265-079-8
64741-78-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-350-00-1
Naphtha (petroleum), sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]
265-089-2
64741-87-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-351-00-7
Naphtha (petroleum), acid-treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]
265-115-2
64742-15-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-352-00-2
Naphtha (petroleum), chemically neutralized heavy;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]
265-122-0
64742-22-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-353-00-8
Naphtha (petroleum), chemically neutralized light;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]
265-123-6
64742-23-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-354-00-3
Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]
265-170-2
64742-66-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-355-00-9
Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]
265-187-5
64742-83-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-356-00-4
Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]
265-199-0
64742-95-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-357-00-X
Aromatic hydrocarbons, C6-10, acid-treated, neutralized;
Low boiling point naphtha - unspecified
268-618-5
68131-49-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-358-00-5
Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]
270-725-7
68477-34-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-359-00-0
Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-735-1
68477-50-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-360-00-6
Distillates (petroleum), steam-cracked, C5-12 fraction;
Low boiling point naphtha - unspecified;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-736-7
68477-53-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-361-00-1
Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;
Low boiling point naphtha - unspecified
270-738-8
68477-55-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-362-00-7
Extracts (petroleum), cold-acid, C4-6;
Low boiling point naphtha - unspecified;
[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
270-741-4
68477-61-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-363-00-2
Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-771-8
68477-89-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-364-00-8
Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha - unspecified;
[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-791-7
68478-12-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-365-00-3
Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha - unspecified;
[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-795-9
68478-16-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-366-00-9
Naphtha (petroleum), full-range coker;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]
270-991-4
68513-02-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-367-00-4
Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]
271-138-9
68516-20-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-368-00-X
Naphtha (petroleum), clay-treated full-range straight-run;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]
271-262-3
68527-21-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-369-00-5
Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]
271-263-9
68527-22-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-370-00-0
Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]
271-264-4
68527-23-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-371-00-6
Naphtha (petroleum), light steam-cracked, debenzenized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]
271-266-5
68527-26-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-372-00-1
Naphtha (petroleum), arom.-contg.;
Low boiling point naphtha - unspecified
271-635-0
68603-08-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-373-00-7
Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]
271-726-5
68606-10-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-374-00-2
Naphtha (petroleum), light, sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]
272-206-0
68783-66-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-375-00-8
Natural gas condensates;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]
272-896-3
68919-39-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-376-00-3
Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
272-932-8
68921-09-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-377-00-9
Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]
285-510-3
85116-59-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-378-00-4
Gasoline;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]
289-220-8
86290-81-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-379-00-X
Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;
Low boiling point naphtha - unspecified
292-698-0
90989-42-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-380-00-5
Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]
295-298-4
91995-38-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-381-00-0
Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
295-302-4
91995-41-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-382-00-6
Extracts (petroleum), catalytic reformed light naphtha solvent;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]
295-331-2
91995-68-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-383-00-1
Naphtha (petroleum), hydrodesulfurized light, dearomatized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]
295-434-2
92045-53-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-384-00-7
Naphtha (petroleum), light, C5-rich, sweetened;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]
295-442-6
92045-60-8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-385-00-2
Hydrocarbons, C8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]
295-444-7
92045-62-0
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-386-00-8
Hydrocarbons, C4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]
295-445-2
92045-63-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-387-00-3
Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]
296-028-8
92201-97-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-388-00-9
Distillates (petroleum), C6-rich;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]
296-903-4
93165-19-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-389-00-4
Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha-unspecified;
[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]
302-639-3
94114-03-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-390-00-X
Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
305-750-5
95009-23-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-391-00-5
Extracts (petroleum) heavy naphtha solvent, clay-treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]
308-261-5
97926-43-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-392-00-0
Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]
308-713-1
98219-46-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-393-00-6
Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]
308-714-7
98219-47-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-394-00-1
Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]
309-862-5
101316-56-7
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-395-00-7
Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]
309-870-9
101316-66-9
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-396-00-2
Naphtha (petroleum), hydrodesulfurised full-range coker;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]
309-879-8
101316-76-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-397-00-8
Naphtha (petroleum), sweetened light;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]
309-976-5
101795-01-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-398-00-3
Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]
310-012-0
102110-14-5
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-399-00-9
Hydrocarbons, C5-rich, dicyclopentadiene-contg.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]
310-013-6
102110-15-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-400-00-2
Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha - unspecified;
[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]
310-057-6
102110-55-4
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-401-00-8
Hydrocarbons, C≥5, C5-6-rich;
Low boiling point naphtha - unspecified
270-690-8
68476-50-6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-402-00-3
Hydrocarbons, C5-rich;
Low boiling point naphtha - unspecified
270-695-5
68476-55-1
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-403-00-9
Aromatic hydrocarbons, C8-10;
Low boiling point naphtha - unspecified
292-695-4
90989-39-2
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R65
T
R: 45-46-65
S: 53-45

H P

649-404-00-4
Kerosine (petroleum);
Straight run kerosine;
[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]
232-366-4
8008-20-6
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-405-00-X
Solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]
265-191-7
64742-88-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-406-00-5
Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]
265-200-4
64742-96-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-407-00-0
Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]
295-418-5
92045-37-9
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-408-00-6
Distillates (petroleum), steam-cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]
265-194-3
64742-91-2
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-409-00-1
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]
270-728-3
68477-39-4
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-410-00-7
Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]
270-729-9
68477-40-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-411-00-2
Distillates (petroleum), steam-cracked, C8-12 fraction;
Cracked kerosine;
[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
270-737-2
68477-54-3
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-412-00-8
Kerosine (petroleum), hydrodesulfurized thermal cracked;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]
285-507-7
85116-55-8
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-413-00-3
Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]
292-621-0
90640-98-5
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-414-00-9
Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;
Cracked kerosine;
[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]
292-637-8
90641-13-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-415-00-4
Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]
309-866-7
101316-61-4
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-416-00-X
Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-938-8
101631-13-4
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-417-00-5
Solvent naphtha (petroleum), hydrocracked heavy arom.;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]
309-881-9
101316-80-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-418-00-0
Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-940-9
101631-15-6
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-419-00-6
Distillates (petroleum), alkylate;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]
265-074-0
64741-73-7
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-420-00-1
Extracts (petroleum), heavy naphtha solvent;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-099-7
64741-98-6
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-421-00-7
Distillates (petroleum), chemically neutralized light;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-132-5
64742-31-0
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-422-00-2
Distillates (petroleum), hydrotreated light;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-149-8
64742-47-8
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-423-00-8
Kerosine (petroleum), hydrodesulfurized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-184-9
64742-81-0
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-424-00-3
Solvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]
265-198-5
64742-94-5
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-425-00-9
Naphtha (petroleum), heavy coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]
269-778-9
68333-23-3
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-426-00-4
Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine — unspecified;
[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]
285-508-2
85116-57-0
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-427-00-X
Kerosine (petroleum), sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]
294-799-5
91770-15-9
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-428-00-5
Kerosine (petroleum), solvent-refined sweetened;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]
295-416-4
92045-36-8
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-429-00-0
Hydrocarbons, C9-16, hydrotreated, dearomatized;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-854-1
93763-35-0
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-430-00-6
Kerosine (petroleum), solvent-refined hydrodesulfurized;
Kerosine — unspecified
307-033-2
97488-94-3
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-431-00-1
Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]
309-864-6
101316-58-9
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-432-00-7
Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]
309-882-4
101316-81-8
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-433-00-2
Solvent naphtha (petroleum), hydrodesulfurized medium;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]
309-884-5
101316-82-9
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-434-00-8
Kerosine (petroleum), hydrotreated;
Kerosine — unspecified;
[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]
309-944-0
101631-19-0
Xn; R65
Xn
R: 65
S: (2-)23-24-62

H
649-435-00-3
Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
265-060-4
64741-59-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-436-00-9
Distillates (petroleum), intermediate catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
265-062-5
64741-60-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-437-00-4
Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]
265-078-2
64741-77-1
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
649-438-00-X
Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]
265-084-5
64741-82-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-439-00-5
Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
269-781-5
68333-25-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-440-00-0
Distillates (petroleum), light steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]
270-662-5
68475-80-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-441-00-6
Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]
270-727-8
68477-38-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-442-00-1
Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]
271-260-2
68527-18-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-443-00-7
Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
285-505-6
85116-53-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-444-00-2
Gas oils (petroleum), thermal-cracked, hydrodesulfurized;
Cracked gasoil
295-411-7
92045-29-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-445-00-8
Residues (petroleum), hydrogenated steam-cracked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]
295-514-7
92062-00-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-446-00-3
Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]
295-517-3
92062-04-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-447-00-9
Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]
295-991-1
92201-60-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-448-00-4
Residues (petroleum), steam-cracked heat-soaked naphtha;
Cracked gasoil;
[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]
297-905-8
93763-85-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-449-00-X
Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]
307-662-2
97675-88-2
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

H
649-450-00-5
Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]
308-278-8
97926-59-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-451-00-0
Distillates (petroleum), hydrodesulfurized middle coker;
Cracked gasoil;
[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]
309-865-1
101316-59-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-452-00-6
Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]
309-939-3
101631-14-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H
649-453-00-1
Distillates (petroleum), heavy hydrocracked;
Baseoil — unspecified;
[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]
265-077-7
64741-76-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-454-00-7
Distillates (petroleum), solvent-refined heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-090-8
64741-88-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-455-00-2
Distillates (petroleum), solvent-refined light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-091-3
64741-89-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-456-00-8
Residual oils (petroleum), solvent deasphalted;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-096-0
64741-95-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-457-00-3
Distillates (petroleum), solvent-refined heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]
265-097-6
64741-96-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-458-00-9
Distillates (petroleum), solvent-refined light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-098-1
64741-97-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-459-00-4
Residual oils (petroleum,) solvent-refined;
Baseoil — unspecified;
[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-101-6
64742-01-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-460-00-X
Distillates (petroleum), clay-treated paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-137-2
64742-36-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-461-00-5
Distillates (petroleum), clay-treated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-138-8
64742-37-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-462-00-0
Residual oils (petroleum), clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-143-5
64742-41-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-463-00-6
Distillates (petroleum), clay-treated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-146-1
64742-44-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-464-00-1
Distillates (petroleum), clay-treated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-147-7
64742-45-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-465-00-7
Distillates (petroleum), hydrotreated heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-155-0
64742-52-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-466-00-2
Distillates (petroleum), hydrotreated light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-156-6
64742-53-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-467-00-8
Distillates (petroleum), hydrotreated heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-157-1
64742-54-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-468-00-3
Distillates (petroleum), hydrotreated light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-158-7
64742-55-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-469-00-9
Distillates (petroleum), solvent-dewaxed light paraffinic;
Baseoil — unspecified;
[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-159-2
64742-56-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-470-00-4
Residual oils (petroleum), hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-160-8
64742-57-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-471-00-X
Residual oils (petroleum), solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-166-0
64742-62-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-472-00-5
Distillates (petroleum), solvent-dewaxed heavy naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-167-6
64742-63-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-473-00-0
Distillates (petroleum), solvent-dewaxed light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-168-1
64742-64-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-474-00-6
Distillates (petroleum), solvent-dewaxed heavy paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-169-7
64742-65-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-475-00-1
Naphthenic oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-172-3
64742-68-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-476-00-7
Naphthenic oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-173-9
64742-69-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-477-00-2
Paraffin oils (petroleum), catalytic dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-174-4
64742-70-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-478-00-8
Paraffin oils (petroleum), catalytic dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-176-5
64742-71-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-479-00-3
Naphthenic oils (petroleum), complex dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-179-1
64742-75-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-480-00-9
Naphthenic oils (petroleum), complex dewaxed light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon' numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-180-7
64742-76-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-481-00-4
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-736-3
72623-85-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-482-00-X
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]
276-737-9
72623-86-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-483-00-5
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-738-4
72623-87-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-484-00-0
Lubricating oils;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]
278-012-2
74869-22-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-485-00-6
Distillates (petroleum), complex dewaxed heavy paraffinci;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-613-7
90640-91-8
Carc. Cat. 2; R45
T
R: 4
S: 53-45

H L
649-486-00-1
Distillates (petroleum), complex dewaxed light paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-614-2
90640-92-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-487-00-7
Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-616-3
90640-94-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-488-00-2
Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-617-9
90640-95-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-489-00-8
Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
Baseoil — unspecified;
[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-618-4
90640-96-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-490-00-3
Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-620-5
90640-97-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-491-00-9
Residual oils (petroleum), hydrotreated solvent dewaxed;
Baseoil — unspecified
292-656-1
90669-74-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-492-00-4
Residual oils (petroleum), catalytic dewaxed;
Baseoil — unspecified
294-843-3
91770-57-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-493-00-X
Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]
295-300-3
91995-39-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-494-00-5
Distillates (petroleum), dewaxed light paraffinic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]
295-301-9
91995-40-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-495-00-0
Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
Baseoil — unspecified;
[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]
295-306-6
91995-45-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-496-00-6
Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]
295-316-0
91995-54-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-497-00-1
Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;
Baseoil — unspecified
295-423-2
92045-42-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-498-00-7
Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
Baseoil — unspecified
295-424-8
92045-43-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-499-00-2
Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]
295-499-7
92061-86-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-500-00-6
Paraffin oils (petroleum), solvent-refined dewaxed heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]
295-810-6
92129-09-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-501-00-1
Lubricating oils (petroleum), base oils, paraffinic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]
297-474-6
93572-43-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-502-00-7
Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
Baseoil — unspecified
297-857-8
93763-38-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-503-00-2
Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;
Baseoil — unspecified
300-257-1
93924-61-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-504-00-8
Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;
Baseoil — unspecified
305-588-5
94733-08-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-505-00-3
Distillates (petroleum), solvent-refined hydrocracked light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]
305-589-0
94733-09-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-506-00-9
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-594-8
94733-15-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-507-00-4
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-595-3
94733-16-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-508-00-X
Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-971-7
95371-04-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-509-00-5
Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;
Baseoil — unspecified
305-972-2
95371-05-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-510-00-0
Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
Baseoil — unspecified
305-974-3
95371-07-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-511-00-6
Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;
Baseoil — unspecified
305-975-9
95371-08-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-512-00-1
Distillates (petroleum), hydrocracked solvent-refined light;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]
307-010-7
97488-73-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-513-00-7
Distillates (petroleum), solvent-refined hydrogenated heavy;
Baseoil — unspecified;
[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]
307-011-2
97488-74-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-514-00-2
Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;
Baseoil — unspecified
307-034-8
97488-95-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-515-00-8
Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]
307-661-7
97675-87-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-516-00-3
Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]
307-755-8
97722-06-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-517-00-9
Hydrocarbons, C13-27, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.]
307-758-4
97722-09-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-518-00-4
Hydrocarbons, C14-29, solvent-extd. light naphthenic;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]
307-760-5
97722-10-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-519-00-X
Hydrocarbons, C27-42, dearomatized;
Baseoil — unspecified
308-131-8
97862-81-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-520-00-5
Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;
Baseoil — unspecified
308-132-3
97862-82-3
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-521-00-0
Hydrocarbons, C27-45, naphthenic vacuum distn.;
Baseoil — unspecified
308-133-9
97862-83-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-522-00-6
Hydrocarbons, C27-45, dearomatized;
Baseoil — unspecified
308-287-7
97926-68-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-523-00-1
Hydrocarbons, C20-58, hydrotreated;
Baseoil — unspecified
308-289-8
97926-70-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-524-00-7
Hydrocarbons, C27-42, naphthenic;
Baseoil — unspecified
308-290-3
97926-71-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-525-00-2
Residual oils (petroleum), carbon-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]
309-710-8
100684-37-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-526-00-8
Residual oils (petroleum), clay-treated solvent-dewaxed;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]
309-711-3
100684-38-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-527-00-3
Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]
309-874-0
101316-69-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-528-00-9
Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]
309-875-6
101316-70-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-529-00-4
Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]
309-876-1
101316-71-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-530-00-X
Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;
Baseoil — unspecified;
[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]
309-877-7
101316-72-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-531-00-5
Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]
272-175-3
68783-00-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-532-00-0
Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
272-180-0
68783-04-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-533-00-6
Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]
272-342-0
68814-89-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-534-00-1
Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]
292-631-5
90641-07-9
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-535-00-7
Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).
292-632-0
90641-08-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-536-00-2
Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]
292-633-6
90641-09-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-537-00-8
Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
295-335-4
91995-73-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-538-00-3
Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
295-338-0
91995-75-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-539-00-9
Extracts (petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
295-339-6
91995-76-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-540-00-4
Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]
295-340-1
91995-77-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-541-00-X
Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
295-342-2
91995-79-8
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-542-00-5
Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
296-437-1
92704-08-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-543-00-0
Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-827-4
93763-10-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-544-00-6
Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-829-5
93763-11-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-545-00-1
Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-672-2
100684-02-4
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-546-00-7
Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-673-8
100684-03-5
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-547-00-2
Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-674-3
100684-04-6
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-548-00-8
Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-675-9
100684-05-7
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-549-00-3
Foots oil (petroleum);
Foots oil;
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
265-171-8
64742-67-2
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
649-550-00-9
Foots oil (petroleum), hydrotreated;
Foots oil
295-394-6
92045-12-0
Carc. Cat. 2; R45
T
R: 45
S: 53-45

H L
650-002-00-6
turpentine, oil
232-350-7
8006-64-2
R10
Xn; R20/21/22-65
Xi; R36/38
R43
N; R51-53
Xn; N
R: 10-20/21/22-36/38-43-51/53-65
S: (2-)36/37-46-61-62


650-003-00-1
fenson (ISO);
4-chlorophenyl benzenesulphonate;
201-274-6
80-38-6
Xn; R22
Xi; R36
N; R51-53
Xn; N
R: 22-36-51/53
S: (2-)24-26-61


650-004-00-7
norbormide (ISO);
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide
213-589-6
991-42-4
Xn; R22
Xn
R: 22
S: (2-)


650-005-00-2
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone
201-501-9
83-79-4
T; R25
Xi; R36/37/38
N; R50-53
T; N
R: 25-36/37/38-50/53
S: (1/2-)22-24/25-36-45-60-61


650-006-00-8
benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime
207-807-9
495-73-8
T; R25
Xn; R21
T
R: 21-25
S: (1/2-)36/37-45


650-007-00-3
chlordimeform (ISO);
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine
228-200-5
6164-98-3
Carc. Cat. 3; R40
Xn; R21/22
N; R50-53
Xn; N
R: 21/22-40-50/53
S: (2-)22-36/37-60-61


650-008-00-9
drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
227-197-8
5707-69-7
T; R25
N; R50-53
T; N
R: 25-50/53
S: (1/2-)22-24-36/37-45-60-61


650-009-00-4
chlordimeform hydrochloride;
N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride
243-269-1
19750-95-9
Carc. Cat. 3; R40
Xn; R22
N; R50-53
Xn; N
R: 22-40-50/53
S: (2-)22-36/37-60-61


650-010-00-X
benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate
216-901-9
1694-09-3
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37


650-012-00-0
erionite
—
12510-42-8
Carc. Cat. 1; R45
T
R: 45
S: 53-45


650-013-00-6
asbestos
—
—
—
—
—
—
—
12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5
Carc. Cat. 1; R45
T; R48/23
T
R: 45-48/23 S: 53-45

E
650-014-00-1
diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate
401-770-4
—
C; R34
Xn; R22
C
R: 22-34
S: (1/2-)26-36/37/39-45


650-015-00-7
rosin; colophony
232-475-7
232-484-6
277-299-1
8050-09-7
8052-10-6
73138-82-6
R43
Xi
R: 43
S: (2-)24-37




650-016-00-2
Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
—
—
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37

AQR

650-017-00-8
Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
—
—
Carc. Cat. 2; R49
T
R: 49
S: 53-45

AR


650-018-00-3
reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid
406-230-1
—
R10
Carc. Cat. 3; R40
C; R34
Xn; R20
R43
N; R50-53
C; N
R: 10-20-34-40-43-50/53
S: (1/2-)26-36/37/39-45-60-61


650-031-00-4
bis(4-hydroxy-N-methylanilinium) sulphate
200-237-1
55-55-0
Xn; R22-48/22
R43
N; R50-53
Xn; N
R: 22-43-48/22-50/53
S: (2-)36/37-46-60-61


650-032-00-X
cyproconazole (ISO);
(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
—
94361-06-5
Repr. Cat. 3; R63
Xn; R22
N; R50-53
Xn; N
R: 22-50/53-63
S: (2-)36/37-60-61



650-033-00-5
(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate
—
66230-04-4
T; R23/25
R43
N; R50-53
T; N
R: 23/25-43-50/53
S: (1/2-)24-36/37/39-45-60-61



650-041-00-9
triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
—
82097-50-5
N; R50-53
N
R: 50/53
S: 60-61


650-042-00-4
reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates
417-450-2
—
Xi; R36/38
R43
R52-53
Xi
R: 36/38-43-52/53
S: (2-)24-26-37-61


650-043-00-X
reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate
420-310-3
—
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-56-60-61


650-044-00-5
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin
420-480-9
158570-99-1
Xi; R38
R43
N; R50-53
Xi; N
R: 38-43-50/53
S: (2-)24-37-60-61


650-045-00-0
reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate
417-110-3
—
F; R11
Xi; R38-41
N; R51-53
F; Xi; N
R: 11-38-41-51/53
S: (2-)9-16-26-37/39-61


650-046-00-6
di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates
416-180-2
12222-04-7
Xn; R22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61


650-047-00-1
dibenzylphenylsulfonium hexafluoroantimonate
417-760-8
134164-24-2
T; R48/25
Xn; R22
Xi; R41
R43
N; R51-53
T; N
R: 22-41-43-48/25-51/53
S: (1/2-)22-26-36/37/39-45-61


650-048-00-7
reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid
420-070-1
—
O; R7
Xn; R20/21/22
C; R35
N; R50
O; C; N
R: 7-20/21/22-35-50
S: (1/2-)3/7-14-26-36/37/39-45-61


650-049-00-2
2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl
417-960-5
—
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61


650-050-00-8
reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers
423-600-8
—
N; R51-53
N
R: 51/53
S: 61


650-055-00-5
silver sodium zirconium hydrogenphosphate
422-570-3
155925-27-2
N; R50-53
N
R: 50/53
S: 60-61

No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.